PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Shaukat, A; Levitt, MD; Taylor, BC; MacDonald, R; Shamliyan, TA; Kane, RL; Wilt, TJ				Shaukat, Aasma; Levitt, Michael D.; Taylor, Brent C.; MacDonald, Roderick; Shamliyan, Tatyana A.; Kane, Robert L.; Wilt, Timothy J.			Systematic Review: Effective Management Strategies for Lactose Intolerance	ANNALS OF INTERNAL MEDICINE			English	Review							DIFFERING ETHNIC BACKGROUNDS; FREE DAIRY DRINKS; DOUBLE-BLIND; COMPARATIVE TOLERANCE; BETA-GALACTOSIDASE; LACTASE DEFICIENCY; ACIDOPHILUS MILK; HYDROLYZED MILK; INGESTION; MALABSORPTION	Background: Lactose intolerance resulting in gastrointestinal symptoms is a common health concern. Diagnosis and management of this condition remain unclear. Purpose: To assess the maximum tolerable dose of lactose and interventions for reducing symptoms of lactose intolerance among persons with lactose intolerance and malabsorption. Data Sources: Multiple electronic databases, including MEDLINE and the Cochrane Library, for trials published in English from 1967 through November 2009. Study Selection: Randomized, controlled trials of individuals with lactose intolerance or malabsorption. Data Extraction: Three investigators independently reviewed articles, extracted data, and assessed study quality. Data Synthesis: 36 unique randomized studies (26 on lactase- or lactose-hydrolyzed milk supplements, lactose-reduced milk, or tolerable doses of lactose; 7 on probiotics; 2 on incremental lactose administration for colonic adaptation; and 1 on another agent) met inclusion criteria. Moderate-quality evidence indicated that 12 to 15 g of lactose (approximately 1 cup of milk) is well tolerated by most adults. Evidence was insufficient that lactose-reduced solution or milk with a lactose content of 0 to 2 g, compared with greater than 12 g, is effective in reducing symptoms of lactose intolerance. Evidence for probiotics, colonic adaptation, and other agents was also insufficient. Limitations: Most studies evaluated persons with lactose malabsorption rather than lactose intolerance. Variation in enrollment criteria, outcome reporting, and the composition and dosing of studied agents precluded pooling of results and limited interpretation. Conclusion: Most individuals with presumed lactose intolerance or malabsorption can tolerate 12 to 15 g of lactose. Additional studies are needed to determine the effectiveness of lactose intolerance treatment.	Minnesota Evidence Based Practice Ctr, Minneapolis Vet Affairs Med Ctr, Ctr Chron Dis Outcomes Res, Minneapolis, MN USA; Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities	Wilt, TJ (corresponding author), Minneapolis Vet Affairs Med Ctr, Ctr Chron Dis Outcomes Res 111 0, 1 Vet Dr, Minneapolis, MN 55417 USA.	tim.wilt@med.va.gov	Shamliyan, Tatyana/AAU-8323-2020; Taylor, Brent C/A-8069-2009	Taylor, Brent C/0000-0002-2140-8377; Shamliyan, Tatyana/0000-0003-3584-2008	Agency for Healthcare Research and Quality, Rockville, Maryland [HHSA 290-2007-10064-I]	Agency for Healthcare Research and Quality, Rockville, Maryland(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This research was conducted by the Minnesota Evidence-based Practice Center under contract to the Agency for Healthcare Research and Quality, Rockville, Maryland (contract HHSA 290-2007-10064-I).	Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; BRAND JC, 1991, AM J CLIN NUTR, V54, P148, DOI 10.1093/ajcn/54.1.148; Briet F, 1997, GUT, V41, P632, DOI 10.1136/gut.41.5.632; Cappello G, 2005, DIGEST LIVER DIS, V37, P316, DOI 10.1016/j.dld.2004.12.007; CAVALLISFORZA LT, 1987, HUM NUTR-CLIN NUTR, V41C, P19; CHENG AHR, 1979, AM J CLIN NUTR, V32, P1989, DOI 10.1093/ajcn/32.10.1989; Gremse DA, 2003, CLIN PEDIATR, V42, P341, DOI 10.1177/000992280304200406; HAVERBERG L, 1980, AM J CLIN NUTR, V33, P17, DOI 10.1093/ajcn/33.1.17; Hertzler SR, 1996, AM J CLIN NUTR, V64, P232, DOI 10.1093/ajcn/64.2.232; Jarvinen RMK, 2003, EUR J CLIN NUTR, V57, P701, DOI 10.1038/sj.ejcn.1601600; Jiang TA, 1996, J DAIRY SCI, V79, P750, DOI 10.3168/jds.S0022-0302(96)76422-6; JOHNSON AO, 1993, AM J CLIN NUTR, V57, P399, DOI 10.1093/ajcn/57.3.399; JONES DV, 1976, AM J CLIN NUTR, V29, P633, DOI 10.1093/ajcn/29.6.633; KWON PH, 1980, AM J CLIN NUTR, V33, P22, DOI 10.1093/ajcn/33.1.22; LEREBOURS E, 1989, AM J CLIN NUTR, V49, P823, DOI 10.1093/ajcn/49.5.823; Lin MY, 1998, DIGEST DIS SCI, V43, P133, DOI 10.1023/A:1018840507952; LIN MY, 1993, DIGEST DIS SCI, V38, P2022, DOI 10.1007/BF01297079; LISKER R, 1978, GASTROENTEROLOGY, V74, P1283; MARTINI MC, 1987, AM J CLIN NUTR, V46, P636, DOI 10.1093/ajcn/46.4.636; Montalto M, 2005, EUR J CLIN NUTR, V59, P489, DOI 10.1038/sj.ejcn.1602098; Mustapha A, 1997, J DAIRY SCI, V80, P1537, DOI 10.3168/jds.S0022-0302(97)76083-1; NEWCOMER AD, 1983, AM J CLIN NUTR, V38, P257, DOI 10.1093/ajcn/38.2.257; NIELSEN OH, 1984, J PEDIATR GASTR NUTR, V3, P219, DOI 10.1097/00005176-198403000-00009; PAIGE DM, 1975, AM J CLIN NUTR, V28, P818, DOI 10.1093/ajcn/28.8.818; PEDERSEN ER, 1982, SCAND J GASTROENTERO, V17, P861, DOI 10.3109/00365528209181106; PERMAN JA, 1981, J CLIN INVEST, V67, P643, DOI 10.1172/JCI110079; REASONER J, 1981, AM J CLIN NUTR, V34, P54, DOI 10.1093/ajcn/34.1.54; RORICK MH, 1979, J GERONTOL, V34, P191, DOI 10.1093/geronj/34.2.191; ROSADO JL, 1984, GASTROENTEROLOGY, V87, P1072; SAVAIANO DA, 1984, AM J CLIN NUTR, V40, P1219, DOI 10.1093/ajcn/40.6.1219; Schulz KF, 2002, LANCET, V359, P614, DOI 10.1016/S0140-6736(02)07750-4; SCRIMSHAW N S, 1988, American Journal of Clinical Nutrition, V48, P1083; SORENSEN KL, 1983, SCAND J GASTROENTERO, V18, P1063, DOI 10.3109/00365528309181841; Suarez FL, 1997, AM J CLIN NUTR, V65, P1502, DOI 10.1093/ajcn/65.5.1502; SUAREZ FL, 1995, NEW ENGL J MED, V333, P1, DOI 10.1056/NEJM199507063330101; Suarez FL, 1998, AM J CLIN NUTR, V68, P1118, DOI 10.1093/ajcn/68.5.1118; Unger M., 1981, Nutrition Research, V1, P227, DOI 10.1016/S0271-5317(81)80022-X; Vesa TH, 1996, AM J CLIN NUTR, V64, P197, DOI 10.1093/ajcn/64.2.197; Vesa TH, 1997, EUR J CLIN NUTR, V51, P633, DOI 10.1038/sj.ejcn.1600460; Wampold BE, 2007, J CLIN PSYCHOL, V63, P379, DOI 10.1002/jclp.20354; Wilt TJ, 2010, AHRQ PUBLICATION, V197; Xenos K, 1998, EUR J DRUG METAB PH, V23, P350, DOI 10.1007/BF03189363	42	138	142	2	56	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 15	2010	152	12					797	+		10.7326/0003-4819-152-12-201006150-00241	http://dx.doi.org/10.7326/0003-4819-152-12-201006150-00241			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611OP	20404262				2022-12-28	WOS:000278827700006
J	Goodson, JD				Goodson, John D.			Patient Protection and Affordable Care Act: Promise and Peril for Primary Care	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MEDICAL HOME	The Patient Protection and Affordable Care Act (PPACA) of 2010 brings both promise and peril for primary care. This Act has the potential to reestablish primary care as the foundation of U. S. health care delivery. The legislation authorizes specific programs to stabilize and expand the primary care physician workforce, provides an immediate 10% increase in primary care physician payment, creates an opportunity to correct the skewed resource-based relative value scale, and supports innovation in primary care practice. Nevertheless, the peril is that the PPACA initiatives may not alter the current trend toward an increasingly specialized physician workforce. To realize the potential for the PPACA to achieve a more equitable balance between generalist and specialist physicians, all primary care advocates must actively engage in the long rebuilding process.	[Goodson, John D.] Massachusetts Gen Hosp, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Goodson, JD (corresponding author), Massachusetts Gen Hosp, 15 Parkman St, Boston, MA 02114 USA.							American College of Physicians, 2008, SHORT PRIM CAR PHYS; Barr MS, 2008, JAMA-J AM MED ASSOC, V300, P834, DOI 10.1001/jama.300.7.834; Bodenheimer T, 2007, ANN INTERN MED, V146, P301, DOI 10.7326/0003-4819-146-4-200702200-00011; Daaleman TP, 2008, J AM BOARD FAM MED, V21, P451, DOI 10.3122/jabfm.2008.05.080083; GINSBURG PB, 2005, HLTH AFF MILLWOOD S; Goodson JD, 2001, J GEN INTERN MED, V16, P250, DOI 10.1046/j.1525-1497.2001.016004250.x; Goodson JD, 2007, JAMA-J AM MED ASSOC, V298, P2308, DOI 10.1001/jama.298.19.2308; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x	8	51	51	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 1	2010	152	11					742	744		10.7326/0003-4819-152-11-201006010-00249	http://dx.doi.org/10.7326/0003-4819-152-11-201006010-00249			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608CT	20404263				2022-12-28	WOS:000278560000009
J	Steinwachs, D; Allen, JD; Barlow, WE; Duncan, RP; Egede, LE; Friedman, LS; Keating, NL; Kim, P; Lave, JR; LaVeist, TA; Ness, RB; Optican, RJ; Virnig, BA				Steinwachs, Donald; Allen, Jennifer Dacey; Barlow, William Eric; Duncan, R. Paul; Egede, Leonard E.; Friedman, Lawrence S.; Keating, Nancy L.; Kim, Paula; Lave, Judith R.; LaVeist, Thomas A.; Ness, Roberta B.; Optican, Robert J.; Virnig, Beth A.			National Institutes of Health State-of-the-Science Conference Statement: Enhancing Use and Quality of Colorectal Cancer Screening	ANNALS OF INTERNAL MEDICINE			English	Article									[Steinwachs, Donald] Johns Hopkins Univ, Baltimore, MD 21218 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; Harvard Univ, Sch Med, Boston, MA USA; Tufts Univ, Sch Med, Boston, MA 02111 USA; Univ Washington, Seattle, WA 98195 USA; Univ Florida, Gainesville, FL USA; Translating Res Communities, Green Cove Springs, FL USA; Med Univ S Carolina, Charleston, SC 29425 USA; Univ Pittsburgh, Pittsburgh, PA USA; Univ Texas Sch Publ Hlth, Houston, TX USA; Baptist Mem Hosp, Memphis, TN 38146 USA; Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Harvard Medical School; Tufts University; University of Washington; University of Washington Seattle; State University System of Florida; University of Florida; Medical University of South Carolina; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Baptist Memorial Hospital Memphis; University of Minnesota System; University of Minnesota Twin Cities	Steinwachs, D (corresponding author), Johns Hopkins Univ, Baltimore, MD 21218 USA.		Allen, Jennifer/M-2113-2015; Keating, Nancy L/I-9968-2019	Keating, Nancy L/0000-0002-8274-4681	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))			0	75	76	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 18	2010	152	10					663	+		10.7326/0003-4819-152-10-201005180-00237	http://dx.doi.org/10.7326/0003-4819-152-10-201005180-00237			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	598RJ	20388702				2022-12-28	WOS:000277855500006
J	Balasubramanian, R; Smith, SM; Rawat, S; Yatsunyk, LA; Stemmler, TL; Rosenzweig, AC				Balasubramanian, Ramakrishnan; Smith, Stephen M.; Rawat, Swati; Yatsunyk, Liliya A.; Stemmler, Timothy L.; Rosenzweig, Amy C.			Oxidation of methane by a biological dicopper centre	NATURE			English	Article							METHYLOCOCCUS-CAPSULATUS BATH; X-RAY-ABSORPTION; METAL CENTERS; ACTIVE-SITE; MONOOXYGENASE PMMO; COPPER; CLUSTER; CATALYSIS; PROTEINS	Vast world reserves of methane gas are underutilized as a feedstock for the production of liquid fuels and chemicals owing to the lack of economical and sustainable strategies for the selective oxidation of methane to methanol(1). Current processes to activate the strong C-H bond (104 kcal mol(-1)) in methane require high temperatures, are costly and inefficient, and produce waste(2). In nature, methanotrophic bacteria perform this reaction under ambient conditions using metalloenzymes called methane mono-oxygenases (MMOs). MMOs thus provide the optimal model for an efficient, environmentally sound catalyst(3). There are two types of MMO. Soluble MMO (sMMO) is expressed by several strains of methanotroph under copper-limited conditions and oxidizes methane with a well-characterized catalytic di-iron centre(4). Particulate MMO ( pMMO) is an integral membrane metalloenzyme produced by all methanotrophs and is composed of three subunits, pmoA, pmoB and pmoC, arranged in a trimeric alpha(3)beta(3)gamma(3) complex(5). Despite 20 years of research and the availability of two crystal structures, the metal composition and location of the pMMO metal active site are not known. Here we show that pMMO activity is dependent on copper, not iron, and that the copper active site is located in the soluble domains of the pmoB subunit rather than within the membrane. Recombinant soluble fragments of pmoB (spmoB) bind copper and have propylene and methane oxidation activities. Disruption of each copper centre in spmoB by mutagenesis indicates that the active site is a dicopper centre. These findings help resolve the pMMO controversy and provide a promising new approach to developing environmentally friendly C-H oxidation catalysts.	[Rawat, Swati; Stemmler, Timothy L.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; [Balasubramanian, Ramakrishnan; Smith, Stephen M.; Yatsunyk, Liliya A.; Rosenzweig, Amy C.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; [Balasubramanian, Ramakrishnan; Smith, Stephen M.; Yatsunyk, Liliya A.; Rosenzweig, Amy C.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	Wayne State University; Northwestern University; Northwestern University	Stemmler, TL (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA.	tstemmle@med.wayne.edu; amyr@northwestern.edu	Balasubramanian, Ramakrishnan/C-7620-2011	rawat, swati/0000-0003-3905-0446	US National Institutes of Health (NIH) [GM070473, DK068139]; Department of Energy, Office of Biological and Environmental Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070473] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US National Institutes of Health (NIH) grants GM070473 (A. C. R.) and DK068139 (T. L. S.). Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL). The SSRL is a national user facility operated by Stanford University on behalf of the US Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the NIH, National Center for Research Resources, Biomedical Technology Program.	Ankudinov AL, 1997, PHYS REV B, V56, pR1712, DOI 10.1103/PhysRevB.56.R1712; Arakawa H, 2001, CHEM REV, V101, P953, DOI 10.1021/cr000018s; Balasubramanian R, 2007, ACCOUNTS CHEM RES, V40, P573, DOI 10.1021/ar700004s; BATLIWALA H, 1995, BIOCHEM J, V307, P433, DOI 10.1042/bj3070433; Chan SI, 2008, ACCOUNTS CHEM RES, V41, P969, DOI 10.1021/ar700277n; Chan SI, 2007, ANGEW CHEM INT EDIT, V46, P1992, DOI 10.1002/anie.200604647; Chen KHC, 2004, J CHIN CHEM SOC-TAIP, V51, P1081, DOI 10.1002/jccs.200400162; Choi DW, 2003, J BACTERIOL, V185, P5755, DOI 10.1128/JB.185.19.5755-5764.2003; George G. N., 2001, EXAFSPAK; Hakemian AS, 2008, BIOCHEMISTRY-US, V47, P6793, DOI 10.1021/bi800598h; Hakemian AS, 2007, ANNU REV BIOCHEM, V76, P223, DOI 10.1146/annurev.biochem.76.061505.175355; Hermans I, 2009, TOP CATAL, V52, P1162, DOI 10.1007/s11244-009-9268-3; KAU LS, 1987, J AM CHEM SOC, V109, P6433, DOI 10.1021/ja00255a032; Kitmitto A, 2005, BIOCHEMISTRY-US, V44, P10954, DOI 10.1021/bi050820u; Lieberman RL, 2006, INORG CHEM, V45, P8372, DOI 10.1021/ic060739v; Lieberman RL, 2003, P NATL ACAD SCI USA, V100, P3820, DOI 10.1073/pnas.0536703100; Lieberman RL, 2005, NATURE, V434, P177, DOI 10.1038/nature03311; Martinho M, 2007, J AM CHEM SOC, V129, P15783, DOI 10.1021/ja077682b; Merkx M, 2001, ANGEW CHEM INT EDIT, V40, P2782, DOI 10.1002/1521-3773(20010803)40:15<2782::AID-ANIE2782>3.0.CO;2-P; MILLER KW, 1977, CHEM PHYS LIPIDS, V20, P229, DOI 10.1016/0009-3084(77)90039-1; Miyaji A, 2009, J MOL CATAL B-ENZYM, V57, P211, DOI 10.1016/j.molcatb.2008.09.005; Myronova N, 2006, BIOCHEMISTRY-US, V45, P11905, DOI 10.1021/bi061294p; Nguyen HHT, 1996, J AM CHEM SOC, V118, P12766, DOI 10.1021/ja961778g; PRIOR SD, 1985, FEMS MICROBIOL LETT, V29, P105; Que L, 2008, NATURE, V455, P333, DOI 10.1038/nature07371; RIGGSGELASCO PJ, 1995, COORDIN CHEM REV, V144, P245, DOI 10.1016/0010-8545(95)01144-E; Rosenzweig AC, 2008, BIOCHEM SOC T, V36, P1134, DOI 10.1042/BST0361134; Shiota Y, 2009, INORG CHEM, V48, P838, DOI 10.1021/ic8003933; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Woertink JS, 2009, P NATL ACAD SCI USA, V106, P18908, DOI 10.1073/pnas.0910461106; Yatsunyk LA, 2007, J BIOL CHEM, V282, P8622, DOI 10.1074/jbc.M609533200; Yu SSF, 2003, J BACTERIOL, V185, P5915, DOI 10.1128/JB.185.20.5915-5924.2003; Yu SSF, 2007, BIOCHEMISTRY-US, V46, P13762, DOI 10.1021/bi700883g; Zahn JA, 1996, J BACTERIOL, V178, P1018, DOI 10.1128/jb.178.4.1018-1029.1996	34	379	393	8	425	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 6	2010	465	7294					115	U131		10.1038/nature08992	http://dx.doi.org/10.1038/nature08992			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591OW	20410881	Green Submitted, Green Accepted			2022-12-28	WOS:000277311900042
J	Smrekar, SE; Stofan, ER; Mueller, N; Treiman, A; Elkins-Tanton, L; Helbert, J; Piccioni, G; Drossart, P				Smrekar, Suzanne E.; Stofan, Ellen R.; Mueller, Nils; Treiman, Allan; Elkins-Tanton, Linda; Helbert, Joern; Piccioni, Giuseppe; Drossart, Pierre			Recent Hotspot Volcanism on Venus from VIRTIS Emissivity Data	SCIENCE			English	Article							ROTATIONAL ELEMENTS; WORKING GROUP; SURFACE; SATELLITES; NIGHTSIDE; PLANETS; ORIGIN; PYRITE	The questions of whether Venus is geologically active and how the planet has resurfaced over the past billion years have major implications for interior dynamics and climate change. Nine "hotspots"-areas analogous to Hawaii, with volcanism, broad topographic rises, and large positive gravity anomalies suggesting mantle plumes at depth-have been identified as possibly active. This study used variations in the thermal emissivity of the surface observed by the Visible and Infrared Thermal Imaging Spectrometer on the European Space Agency's Venus Express spacecraft to identify compositional differences in lava flows at three hotspots. The anomalies are interpreted as a lack of surface weathering. We estimate the flows to be younger than 2.5 million years and probably much younger, about 250,000 years or less, indicating that Venus is actively resurfacing.	[Smrekar, Suzanne E.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Stofan, Ellen R.] Proxemy Res, Laytonville, MD 20882 USA; [Mueller, Nils] Univ Munster, Inst Planetol, D-48149 Munster, Germany; [Treiman, Allan] Lunar & Planetary Inst, Houston, TX 77058 USA; [Elkins-Tanton, Linda] MIT, Cambridge, MA 02139 USA; [Mueller, Nils; Helbert, Joern] German Aerosp Ctr, Inst Planetary Res, D-12489 Berlin, Germany; [Piccioni, Giuseppe] Ist Nazl Astrofis Ist Astrofis Spaziale & Fis Cos, I-00133 Rome, Italy; [Drossart, Pierre] Univ Paris Diderot, UPMC, CNRS, Observ Paris,LESIA, F-92195 Meudon, France	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Munster; Massachusetts Institute of Technology (MIT); Helmholtz Association; German Aerospace Centre (DLR); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite	Smrekar, SE (corresponding author), CALTECH, Jet Prop Lab, Mail Stop 183-501,4800 Oak Grove Dr, Pasadena, CA 91109 USA.	ssmrekar@jpl.nasa.gov	Helbert, Jorn/P-1570-2019; Piccioni, Giuseppe/T-9272-2017; Elkins-Tanton, Linda/C-5508-2008; Drossart, Pierre/H-8670-2013; Smrekar, Suzanne/AAH-8074-2020	Helbert, Jorn/0000-0001-5346-9505; Piccioni, Giuseppe/0000-0002-7893-6808; Elkins-Tanton, Linda/0000-0003-4008-1098; Smrekar, Suzanne/0000-0001-8775-075X; Mueller, Nils/0000-0001-9229-8921	Jet Propulsion Laboratory, California Institute of Technology; Planetary Geology and Geophysics Program; NASA; European Space Agency; Agenzia Spaziale Italiana; Centre National des Etudes Spatiales; CNRS/Institut National des Sciences de l'Univers	Jet Propulsion Laboratory, California Institute of Technology; Planetary Geology and Geophysics Program(National Aeronautics & Space Administration (NASA)); NASA(National Aeronautics & Space Administration (NASA)); European Space Agency(European Space AgencyEuropean Commission); Agenzia Spaziale Italiana(Agenzia Spaziale Italiana (ASI)); Centre National des Etudes Spatiales; CNRS/Institut National des Sciences de l'Univers(Centre National de la Recherche Scientifique (CNRS))	This research was carried out in part at the Jet Propulsion Laboratory, California Institute of Technology, and was sponsored by the Planetary Geology and Geophysics Program and NASA. We gratefully acknowledge the work of the entire Venus Express and VIRTIS teams. We thank the European Space Agency, Agenzia Spaziale Italiana, Centre National des Etudes Spatiales, CNRS/Institut National des Sciences de l'Univers, and the other national space agencies that have supported this research. VIRTIS is led by INAF-IASF, Rome, Italy, and LESIA, Observatoire de Paris, France.	Anderson FS, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2004JE002395; [Anonymous], [No title captured]; Baldridge AM, 2009, REMOTE SENS ENVIRON, V113, P711, DOI 10.1016/j.rse.2008.11.007; Bullock MA, 2001, ICARUS, V150, P19, DOI 10.1006/icar.2000.6570; CAMPBELL DB, 1992, J GEOPHYS RES-PLANET, V97, P16249, DOI 10.1029/92JE01634; Choblet G, 2009, PHYS EARTH PLANET IN, V173, P290, DOI 10.1016/j.pepi.2009.01.005; DAVIES ME, 1986, CELESTIAL MECH, V39, P103, DOI 10.1007/BF01232291; DAVIES ME, 1992, J GEOPHYS RES-PLANET, V97, P13141, DOI 10.1029/92JE01166; Elkins-Tanton LT, 2007, CONTRIB MINERAL PETR, V153, P191, DOI 10.1007/s00410-006-0140-1; FEGLEY B, 1995, ICARUS, V115, P159, DOI 10.1006/icar.1995.1086; FEGLEY B, 1989, NATURE, V337, P55, DOI 10.1038/337055a0; Fegley B, 1995, ICARUS, V118, P373, DOI 10.1006/icar.1995.1197; Fegley B, 1997, ICARUS, V128, P474, DOI 10.1006/icar.1997.5744; FEGLEY B, 1992, P LUNAR PLANET SCI, V22, P3; Gibson SA, 2000, EARTH PLANET SC LETT, V174, P355, DOI 10.1016/S0012-821X(99)00274-5; Glaze LS, 1999, J GEOPHYS RES-PLANET, V104, P18899, DOI 10.1029/1998JE000619; Hashimoto GL, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002082; Hashimoto GL, 2001, ICARUS, V154, P239, DOI 10.1006/icar.2001.6713; HELBERT J, 2009, VENUS GEOCHEMISTRY P; Helbert J, 2009, EARTH PLANET SC LETT, V285, P347, DOI 10.1016/j.epsl.2009.02.031; Helbert J, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033609; HOOPER PR, 1997, GEOPH MONOG SERIES, V100, P1; KEDDIE ER, 1995, J GEOPHYS RES, V101, P11729; Kilburn C.R., 2000, ENCY VOLCANOES, P291; Konopliv AS, 1999, ICARUS, V139, P3, DOI 10.1006/icar.1999.6086; LECACHEUX J, 1993, PLANET SPACE SCI, V41, P543, DOI 10.1016/0032-0633(93)90035-Z; MCGILL GE, 1981, GEOPHYS RES LETT, V8, P737, DOI 10.1029/GL008i007p00737; Meadows VS, 1996, J GEOPHYS RES-PLANET, V101, P4595, DOI 10.1029/95JE03567; Mueller N, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003118; PARMENTIER EM, 1992, GEOPHYS RES LETT, V19, P2015, DOI 10.1029/92GL01862; PHILLIPS RJ, 1995, GEOPHYS RES LETT, V22, P1517, DOI 10.1029/95GL01412; PHILLIPS RJ, 1992, J GEOPHYS RES-PLANET, V97, P15923, DOI 10.1029/92JE01696; PHILLIPS RJ, 1984, ANNU REV EARTH PL SC, V12, P411, DOI 10.1146/annurev.ea.12.050184.002211; PIETERS CM, 1986, SCIENCE, V234, P1379, DOI 10.1126/science.234.4782.1379; Rappaport NJ, 1999, ICARUS, V139, P19, DOI 10.1006/icar.1999.6081; Reese CC, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002782; ROBERTS KM, 1992, J GEOPHYS RES-PLANET, V97, P15991, DOI 10.1029/92JE01245; Schaffer B., 1992, Horticultural Reviews, V13, P257, DOI 10.1002/9780470650509.ch7; Seidelmann PK, 2002, CELEST MECH DYN ASTR, V82, P83, DOI 10.1023/A:1013939327465; Simons M, 1997, GEOPHYS J INT, V131, P24, DOI 10.1111/j.1365-246X.1997.tb00593.x; Smrekar SE, 1999, ICARUS, V139, P100, DOI 10.1006/icar.1999.6090; Stofan ER, 2005, GEOL SOC AM SPEC PAP, V388, DOI 10.1130/2005.2388(47); Stofan ER, 2005, ICARUS, V173, P312, DOI 10.1016/j.icarus.2004.08.004; STOFAN ER, 1995, J GEOPHYS RES, V23, P317; STOFAN ER, 2009, LUNAR PLANET SCI, V39; STOFAN ER, 2005, ANN M PLAN GEOL MAPP, P20; STROM RG, 1994, J GEOPHYS RES-PLANET, V99, P10899, DOI 10.1029/94JE00388; Treiman A. H., 1994, LUNAR PLANET SCI, VXXV, P1415; 2009, NEW SCI, V23, P52	49	167	176	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2010	328	5978					605	608		10.1126/science.1186785	http://dx.doi.org/10.1126/science.1186785			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589OJ	20378775				2022-12-28	WOS:000277159800038
J	Rollnick, S; Butler, CC; Kinnersley, P; Gregory, J; Mash, B				Rollnick, Stephen; Butler, Christopher C.; Kinnersley, Paul; Gregory, John; Mash, Bob			Competent Novice Motivational interviewing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COMMITMENT LANGUAGE; EFFICACY		[Rollnick, Stephen; Butler, Christopher C.; Kinnersley, Paul] Cardiff Univ, Sch Med, Dept Publ Hlth & Primary Care, Cardiff CF14 4XN, S Glam, Wales; [Gregory, John] Cardiff Univ, Sch Med, Dept Child Hlth, Cardiff CF14 4XN, S Glam, Wales; [Mash, Bob] Univ Stellenbosch, Dept Family Med & Primary Care, ZA-7505 Tygerberg, South Africa	Cardiff University; Cardiff University; Stellenbosch University	Rollnick, S (corresponding author), Cardiff Univ, Sch Med, Dept Publ Hlth & Primary Care, Cardiff CF14 4XN, S Glam, Wales.	rollnick@cardiff.ac.uk	Bischof, Gallus/G-7290-2014	Bischof, Gallus/0000-0003-0432-5497; Butler, Christopher/0000-0002-0102-3453; Mash, Robert/0000-0001-7373-0774	ESRC [ES/G007543/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Aharonovich E, 2008, PSYCHOL ADDICT BEHAV, V22, P557, DOI 10.1037/a0012971; Amrhein PC, 2003, J CONSULT CLIN PSYCH, V71, P862, DOI 10.1037/0022-006X.71.5.862; Burke BL, 2003, J CONSULT CLIN PSYCH, V71, P843, DOI 10.1037/0022-006X.71.5.843; Butler CC, 1999, BRIT J GEN PRACT, V49, P611; DiClemente C.C., 2002, MOTIVATIONAL INTERVI, V2nd ed., P201; Hettema J, 2005, ANNU REV CLIN PSYCHO, V1, P91, DOI 10.1146/annurev.clinpsy.1.102803.143833; Lai DTC, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006936.pub2, 10.1002/14651858.CD006936.pub3]; Lundahl BW, 2010, RES SOCIAL WORK PRAC, V20, P137, DOI 10.1177/1049731509347850; McCambridge J, 2004, ADDICTION, V99, P39, DOI 10.1111/j.1360-0443.2004.00564.x; Miller WR, 2009, AM PSYCHOL, V64, P527, DOI 10.1037/a0016830; Miller WR, 2009, BEHAV COGN PSYCHOTH, V37, P129, DOI 10.1017/S1352465809005128; MILLER WR, 1988, BEHAV PSYCHOTHER, V16, P251, DOI 10.1017/S0141347300014129; Moyers TB, 2007, ALCOHOL CLIN EXP RES, V31, p40S, DOI 10.1111/j.1530-0277.2007.00492.x; Rollnick S., 2008, MOTIVATIONAL INTERVI; Rollnick S., 1999, HLTH BEHAV CHANGE GU, V1st; Rubak S, 2005, BRIT J GEN PRACT, V55, P305	16	198	201	0	37	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 27	2010	340								c1900	10.1136/bmj.c1900	http://dx.doi.org/10.1136/bmj.c1900			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	591PM	20423957	Green Accepted			2022-12-28	WOS:000277314100002
J	Hoffman, JE				Hoffman, Jennifer E.			PHYSICS Sign Flips and Spin Fluctuations in Iron High-T-c Superconductors	SCIENCE			English	Editorial Material									Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University	Hoffman, JE (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	jhoffman@physics.harvard.edu	Hoffman, Jennifer E/H-4334-2011	Hoffman, Jennifer E/0000-0003-2752-5379				Chen CT, 2010, NAT PHYS, V6, P260, DOI 10.1038/NPHYS1531; Christianson AD, 2008, NATURE, V456, P930, DOI 10.1038/nature07625; Dai PC, 1999, SCIENCE, V284, P1344, DOI 10.1126/science.284.5418.1344; Hanaguri T, 2010, SCIENCE, V328, P474, DOI 10.1126/science.1187399; Hoffman JE, 2002, SCIENCE, V297, P1148, DOI 10.1126/science.1072640; Hsu FC, 2008, P NATL ACAD SCI USA, V105, P14262, DOI 10.1073/pnas.0807325105; Kamihara Y, 2008, J AM CHEM SOC, V130, P3296, DOI 10.1021/ja800073m; Kondo T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.147003; Kuroki K, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.024501; Li SL, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.054503; Mazin II, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.057003; Putti M, 2010, SUPERCOND SCI TECH, V23, DOI 10.1088/0953-2048/23/3/034003; Qiu YM, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.067008; WOLLMAN DA, 1993, PHYS REV LETT, V71, P2134, DOI 10.1103/PhysRevLett.71.2134; Xia Y, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.037002	16	4	4	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 23	2010	328	5977					441	443		10.1126/science.1188927	http://dx.doi.org/10.1126/science.1188927			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YR	20413484				2022-12-28	WOS:000276952400024
J	Cannarrozzi, G; Schraudolph, NN; Faty, M; von Rohr, P; Friberg, MT; Roth, AC; Gonnet, P; Gonnet, G; Barral, Y				Cannarrozzi, Gina; Schraudolph, Nicol N.; Faty, Mahamadou; von Rohr, Peter; Friberg, Markus T.; Roth, Alexander C.; Gonnet, Pedro; Gonnet, Gaston; Barral, Yves			A Role for Codon Order in Translation Dynamics	CELL			English	Article							AMINOACYL-TRANSFER-RNA; SACCHAROMYCES-CEREVISIAE; PROTEIN-SYNTHESIS; EXPRESSION PROFILES; GENE-EXPRESSION; CELL-CYCLE; USAGE; YEAST; BIAS; GENOME	The genetic code is degenerate. Each amino acid is encoded by up to six synonymous codons; the choice between these codons influences gene expression. Here, we show that in coding sequences, once a particular codon has been used, subsequent occurrences of the same amino acid do not use codons randomly, but favor codons that use the same tRNA. The effect is pronounced in rapidly induced genes, involves both frequent and rare codons and diminishes only slowly as a function of the distance between subsequent synonymous codons. Furthermore, we found that in S. cerevisiae codon correlation accelerates translation relative to the translation of synonymous yet anticorrelated sequences. The data suggest that tRNA diffusion away from the ribosome is slower than translation, and that some tRNA channeling takes place at the ribosome. They also establish that the dynamics of translation leave a significant signature at the level of the genome.	[Cannarrozzi, Gina; Schraudolph, Nicol N.; von Rohr, Peter; Friberg, Markus T.; Roth, Alexander C.; Gonnet, Pedro; Gonnet, Gaston] ETH, Inst Computat Sci, CH-8092 Zurich, Switzerland; [Faty, Mahamadou; Barral, Yves] ETH, Inst Biochem, CH-8093 Zurich, Switzerland; [Cannarrozzi, Gina; Roth, Alexander C.; Gonnet, Gaston] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics	Gonnet, G (corresponding author), ETH, Inst Computat Sci, CH-8092 Zurich, Switzerland.	gonnet@inf.ethz.ch; yves.barral@bc.biol.ethz.ch	Cannarozzi, Gina/S-1595-2019; Gonnet, Pedro/A-6935-2008	Cannarozzi, Gina/0000-0002-0704-663X; Gonnet, Pedro/0000-0003-4509-7291; Barral, Yves/0000-0002-0989-3373	Swiss National Science Foundation [107782]; Origin and Function of Codon Bias; ETH Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Origin and Function of Codon Bias; ETH Zurich(ETH Zurich)	We acknowledge the Swiss National Science Foundation ( Project no. 107782, Origin and Function of Codon Bias) and the ETH Zurich for funding support.; We thank the Computational Biochemistry Research Group, Steven A. Benner, Ari Helenius, three anonymous reviewers and Lara Szewczak for helpful discussions.	Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dittmar KA, 2005, EMBO REP, V6, P151, DOI 10.1038/sj.embor.7400341; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Duret L, 2000, TRENDS GENET, V16, P287, DOI 10.1016/S0168-9525(00)02041-2; Elf J, 2003, SCIENCE, V300, P1718, DOI 10.1126/science.1083811; Friberg MT, 2006, LECT NOTES COMPUT SC, V4175, P1; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Gaucher EA, 2001, P NATL ACAD SCI USA, V98, P548, DOI 10.1073/pnas.98.2.548; Gonnet GH, 2000, BIOINFORMATICS, V16, P101, DOI 10.1093/bioinformatics/16.2.101; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Haugen AC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r95; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; IRVIN JD, 1972, BIOCHEMISTRY-US, V11, P1915, DOI 10.1021/bi00760a028; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kowarik M, 2002, MOL CELL, V10, P769, DOI 10.1016/S1097-2765(02)00685-8; Kulikova T, 2004, NUCLEIC ACIDS RES, V32, pD27, DOI 10.1093/nar/gkh120; Lyons TJ, 2000, P NATL ACAD SCI USA, V97, P7957, DOI 10.1073/pnas.97.14.7957; NEGRUTSKII BS, 1991, P NATL ACAD SCI USA, V88, P4991, DOI 10.1073/pnas.88.11.4991; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; Percudani R, 1997, J MOL BIOL, V268, P322, DOI 10.1006/jmbi.1997.0942; Petrushenko ZM, 2002, EUR J BIOCHEM, V269, P4811, DOI 10.1046/j.1432-1033.2002.03178.x; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Roberts GG, 2006, MOL GENET GENOMICS, V276, P170, DOI 10.1007/s00438-006-0133-9; Schutze Norbert, 2005, Cell Commun Signal, V3, P5, DOI 10.1186/1478-811X-3-5; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SHARP PM, 1993, BIOCHEM SOC T, V21, P835, DOI 10.1042/bst0210835; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; SPIRIN AS, 1999, RIBOSOMES, P243; STAPULIONIS R, 1995, P NATL ACAD SCI USA, V92, P7158, DOI 10.1073/pnas.92.16.7158; Thanaraj TA, 1996, PROTEIN SCI, V5, P1594, DOI 10.1002/pro.5560050814; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554; Zouridis H, 2008, BIOPHYS J, V95, P1018, DOI 10.1529/biophysj.107.126128	36	246	257	0	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2010	141	2					355	367		10.1016/j.cell.2010.02.036	http://dx.doi.org/10.1016/j.cell.2010.02.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	584GF	20403329	Bronze			2022-12-28	WOS:000276738400024
J	Cheng, XP; Jin, J; Hu, L; Shen, DB; Dong, XP; Samie, MA; Knoff, J; Eisinger, B; Liu, ML; Huang, SM; Caterina, MJ; Dempsey, P; Michael, LE; Dlugosz, AA; Andrews, NC; Clapham, DE; Xu, HX				Cheng, Xiping; Jin, Jie; Hu, Lily; Shen, Dongbiao; Dong, Xian-ping; Samie, Mohammad A.; Knoff, Jayne; Eisinger, Brian; Liu, Mei-ling; Huang, Susan M.; Caterina, Michael J.; Dempsey, Peter; Michael, Lowell Evan; Dlugosz, Andrzej A.; Andrews, Nancy C.; Clapham, David E.; Xu, Haoxing			TRP Channel Regulates EGFR Signaling in Hair Morphogenesis and Skin Barrier Formation	CELL			English	Article							EPIDERMAL-GROWTH-FACTOR; RECEPTOR TYROSINE KINASE; MICE LACKING; FACTOR-ALPHA; WAVY HAIR; DIFFERENTIATION; EXPRESSION; KERATINOCYTES; MUTATION; TEMPERATURE	A plethora of growth factors regulate keratinocyte proliferation and differentiation that control hair morphogenesis and skin barrier formation. Wavy hair phenotypes in mice result from naturally occurring loss-of-function mutations in the genes for TGF-alpha and EGFR. Conversely, excessive activities of TGF-alpha/EGFR result in hairless phenotypes and skin cancers. Unexpectedly, we found that mice lacking the Trpv3 gene also exhibit wavy hair coat and curly whiskers. Here we show that keratinocyte TRPV3, a member of the transient receptor potential (TRP) family of Ca2+-permeant channels, forms a signaling complex with TGF-alpha/EGFR. Activation of EGFR leads to increased TRPV3 channel activity, which in turn stimulates TGF-alpha release. TRPV3 is also required for the formation of the skin barrier by regulating the activities of transglutaminases, a family of Ca2+-dependent crosslinking enzymes essential for keratinocyte cornification. Our results show that a TRP channel plays a role in regulating growth factor signaling by direct complex formation.	[Jin, Jie; Clapham, David E.; Xu, Haoxing] Childrens Hosp Boston, Manton Ctr Orphan Dis, Dept Cardiol, Boston, MA 02115 USA; [Cheng, Xiping; Hu, Lily; Shen, Dongbiao; Dong, Xian-ping; Samie, Mohammad A.; Knoff, Jayne; Eisinger, Brian; Liu, Mei-ling; Xu, Haoxing] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Jin, Jie; Andrews, Nancy C.] Childrens Hosp Boston, Div Hematol & Oncol, Boston, MA 02115 USA; [Huang, Susan M.; Caterina, Michael J.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21025 USA; [Huang, Susan M.; Caterina, Michael J.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21025 USA; [Dempsey, Peter] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Dempsey, Peter] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Michael, Lowell Evan; Dlugosz, Andrzej A.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; [Michael, Lowell Evan; Dlugosz, Andrzej A.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Andrews, Nancy C.] Duke Univ, Sch Med, Dept Pediat, Durham, NC 27710 USA; [Andrews, Nancy C.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Harvard University; Boston Children's Hospital; University of Michigan System; University of Michigan; Harvard University; Boston Children's Hospital; Johns Hopkins University; Johns Hopkins University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Duke University; Duke University	Clapham, DE (corresponding author), Childrens Hosp Boston, Manton Ctr Orphan Dis, Dept Cardiol, Enders 1350,320 Longwood Ave, Boston, MA 02115 USA.	dclapham@enders.tch.harvard.edu; haoxingx@umich.edu	xu, hao/GWQ-7394-2022; Clapham, David/S-1123-2019; Clapham, David/R-5974-2019	Clapham, David/0000-0002-4459-9428; Andrews, Nancy/0000-0003-0243-4462; Dong, Xianping/0000-0002-4496-7104; Bissonette, Jayne/0000-0001-8376-9242	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062792] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAMS NIH HHS [R01 AR045973] Funding Source: Medline; NINDS NIH HHS [R01 NS062792-02, R01 NS062792] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Asakawa M, 2006, J INVEST DERMATOL, V126, P2664, DOI 10.1038/sj.jid.5700468; Ballaro C, 2005, EMBO REP, V6, P755, DOI 10.1038/sj.embor.7400458; Byrne C, 2003, J ANAT, V202, P113, DOI 10.1046/j.1469-7580.2003.00142.x; Chung MK, 2004, J BIOL CHEM, V279, P21569, DOI 10.1074/jbc.M401872200; COFFEY RJ, 1987, NATURE, V328, P817, DOI 10.1038/328817a0; COULOMBE PA, 1989, J CELL BIOL, V109, P2295, DOI 10.1083/jcb.109.5.2295; Denda M, 2007, J INVEST DERMATOL, V127, P654, DOI 10.1038/sj.jid.5700590; Denning MF, 2000, EXP DERMATOL, V9, P192, DOI 10.1034/j.1600-0625.2000.009003192.x; DLUGOSZ AA, 1994, CELL GROWTH DIFFER, V5, P1283; Du X, 2004, GENETICS, V166, P331, DOI 10.1534/genetics.166.1.331; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Huang SM, 2008, J NEUROSCI, V28, P13727, DOI 10.1523/JNEUROSCI.5741-07.2008; Koch PJ, 2000, J CELL BIOL, V151, P389, DOI 10.1083/jcb.151.2.389; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; LUETTEKE NC, 1993, CELL, V73, P263, DOI 10.1016/0092-8674(93)90228-I; LUETTEKE NC, 1994, GENE DEV, V8, P399, DOI 10.1101/gad.8.4.399; MANN GB, 1993, CELL, V73, P249, DOI 10.1016/0092-8674(93)90227-H; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; MURILLAS R, 1995, EMBO J, V14, P5216, DOI 10.1002/j.1460-2075.1995.tb00206.x; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; PANDIELLA A, 1991, J BIOL CHEM, V266, P5769; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Peus D, 1997, J INVEST DERMATOL, V109, P751, DOI 10.1111/1523-1747.ep12340759; Ponec M, 1997, ARCH DERMATOL RES, V289, P317, DOI 10.1007/s004030050198; Raghunath M, 1998, ARCH DERMATOL RES, V290, P621, DOI 10.1007/s004030050362; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; SAKAI Y, 1994, CELL GROWTH DIFFER, V5, P527; Schneider MR, 2008, AM J PATHOL, V173, P14, DOI 10.2353/ajpath.2008.070942; Sevilla LM, 2007, J CELL BIOL, V179, P1599, DOI 10.1083/jcb.200706187; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Wakita N, 1999, J BIOL CHEM, V274, P37285, DOI 10.1074/jbc.274.52.37285; Wang X, 2006, J CELL BIOL, V172, P409, DOI 10.1083/jcb.200510002; Wang XM, 1997, P NATL ACAD SCI USA, V94, P219, DOI 10.1073/pnas.94.1.219; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207	44	194	203	4	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2010	141	2					331	343		10.1016/j.cell.2010.03.013	http://dx.doi.org/10.1016/j.cell.2010.03.013			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	584GF	20403327	Bronze, Green Accepted			2022-12-28	WOS:000276738400022
J	Liu, QH; Paroo, Z				Liu, Qinghua; Paroo, Zain			MOLECULAR BIOLOGY Dicer's Cut and Switch	SCIENCE			English	Editorial Material							DEATH GENE CED-3; APOPTOSIS; ENZYME; INITIATION; PROTEIN; RNAI		[Liu, Qinghua; Paroo, Zain] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Liu, QH (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	qinghua.liu@utsouthwestern.edu; zain.paroo@utsouthwestern.edu						Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; Nakagawa A, 2010, SCIENCE, V328, P327, DOI 10.1126/science.1182374; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Ye XC, 2007, J BIOL CHEM, V282, P28373, DOI 10.1074/jbc.M705208200; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017	12	1	1	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 16	2010	328	5976					314	315		10.1126/science.1189245	http://dx.doi.org/10.1126/science.1189245			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583NR	20395499				2022-12-28	WOS:000276685000023
J	Meijer, GI				Meijer, G. I.			Cooling Energy-Hungry Data Centers	SCIENCE			English	Editorial Material									IBM Res Zurich, CH-8803 Ruschlikon, Switzerland	International Business Machines (IBM)	Meijer, GI (corresponding author), IBM Res Zurich, CH-8803 Ruschlikon, Switzerland.	inm@zurich.ibm.com						Barroso L., 2009, SYNTHESIS LECT COMPU; CHUDZIK M, 2007, IEEE VLSI 2007; European Commission, 2008, COD COND DAT CTR EN; Fischer M., INT TECHNOLOGY ROADM, V12th; *INT DAT CORP, 2009, 221346 INT DAT CORP; KURD NA, 2010, IEEE ISSCC 2010; Mistry K., 2007, IEEE IEDM 2007, V10.2; Seymour J., 1986, Patent, Patent No. 4590538; TUCKERMAN DB, 1981, ELECTRON DEVIC LETT, V2, P126, DOI 10.1109/EDL.1981.25367; US Environmental Protection Agency, 2007, REP C SERV DAT CTR E; WARE M, 2010, IEEE HPCA 2010	11	92	98	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 16	2010	328	5976					318	319		10.1126/science.1182769	http://dx.doi.org/10.1126/science.1182769			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583NR	20395502				2022-12-28	WOS:000276685000026
J	Phelps, J; Webb, EL; Agrawal, A				Phelps, Jacob; Webb, Edward L.; Agrawal, Arun			LAND USE Does REDD plus Threaten to Recentralize Forest Governance?	SCIENCE			English	Editorial Material							DEFORESTATION; NEPAL		[Phelps, Jacob; Webb, Edward L.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Agrawal, Arun] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA	National University of Singapore; University of Michigan System; University of Michigan	Webb, EL (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.	ted.webb@nus.edu.sg	Agrawal, Arun/A-4257-2009; Webb, Edward L/E-8343-2011	Agrawal, Arun/0000-0001-6796-2958; Webb, Edward L/0000-0001-5554-9955; Phelps, Jacob/0000-0001-6489-1103				Agrawal A., 2008, DECENTRALIZATION FOR, P44; Agrawal A, 2008, SCIENCE, V320, P1460, DOI 10.1126/science.1155369; ANGELSEN A., 2008, MOVING AHEAD REDD IS, P11, DOI [10.17528/cifor/002601, DOI 10.17528/CIFOR/002601]; Brockington Dan, 2002, FORTRESS CONSERVATIO; Cacho OJ, 2005, ENVIRON DEV ECON, V10, P597, DOI 10.1017/S1355770X05002056; Capistrano D, 2005, Politics of Decentralization: Forests, People and Power, P296; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Chhatre A, 2009, P NATL ACAD SCI USA, V106, P17667, DOI 10.1073/pnas.0905308106; Davis C., 2009, REV 25 READINESS PLA; Griffiths Tom, 2007, SEEING RED AVOIDED D; Malla YB, 2001, ENVIRON HIST, V6, P287, DOI 10.2307/3985088; Miles L, 2008, SCIENCE, V320, P1454, DOI 10.1126/science.1155358; *MIN FIN REP IND, 2009, BUDG STAT 2008 2009; Minang P.A., 2010, REDD COPENHAGEN WAY; Nagendra H, 2002, ENVIRON CONSERV, V29, P530, DOI 10.1017/S0376892902000383; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; Nepstad D, 2009, SCIENCE, V326, P1350, DOI 10.1126/science.1182108; Niles JO, 2002, PHILOS T ROY SOC A, V360, P1621, DOI 10.1098/rsta.2002.1023; Oestreicher JS, 2009, GLOBAL ENVIRON CHANG, V19, P279, DOI 10.1016/j.gloenvcha.2009.01.003; Ostrom E, 2006, P NATL ACAD SCI USA, V103, P19224, DOI 10.1073/pnas.0607962103; Peluso NL, 2001, J ASIAN STUD, V60, P761, DOI 10.2307/2700109; Ribot JC, 2006, WORLD DEV, V34, P1864, DOI 10.1016/j.worlddev.2005.11.020; Somanathan E, 2009, P NATL ACAD SCI USA, V106, P4143, DOI 10.1073/pnas.0810049106; Sutherland WJ, 2010, TRENDS ECOL EVOL, V25, P1, DOI 10.1016/j.tree.2009.10.003; Wardell DA, 2006, WORLD DEV, V34, P1887, DOI 10.1016/j.worlddev.2005.11.021; Webb EL, 2008, DECENTRALIZATION FOR; WERTZKANOUNNIKO.S, 2009, 46 CTR INT FOR; 2010, M DEFORESTATION BOOS	28	367	374	5	157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2010	328	5976					312	313		10.1126/science.1187774	http://dx.doi.org/10.1126/science.1187774			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	583NR	20395498				2022-12-28	WOS:000276685000022
J	Drife, JO				Drife, James Owen			Can the NHS cut costs without substantially damaging the quality of health care? No	BRITISH MEDICAL JOURNAL			English	Editorial Material									Leeds Gen Infirm, Leeds LS1 3EX, W Yorkshire, England	Leeds General Infirmary; University of Leeds	Drife, JO (corresponding author), Leeds Gen Infirm, Leeds LS1 3EX, W Yorkshire, England.	j.o.drife@leeds.ac.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 14	2010	340								c1966	10.1136/bmj.c1966	http://dx.doi.org/10.1136/bmj.c1966			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	586KB	20392773				2022-12-28	WOS:000276905400009
J	Horton, R				Horton, Richard			Offline: The grey zone situation	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 10	2010	375	9722					1238	1238		10.1016/S0140-6736(10)60521-1	http://dx.doi.org/10.1016/S0140-6736(10)60521-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	585VN	20382314				2022-12-28	WOS:000276858400011
J	James, MT; Hemmelgarn, BR; Tonelli, M				James, Matthew T.; Hemmelgarn, Brenda R.; Tonelli, Marcello			Renal Medicine 2 Early recognition and prevention of chronic kidney disease	LANCET			English	Article							GLOMERULAR-FILTRATION-RATE; CONVERTING-ENZYME-INHIBITION; URINARY ALBUMIN EXCRETION; EVALUATION PROGRAM KEEP; BLOOD-PRESSURE CONTROL; ALL-CAUSE MORTALITY; SERUM CYSTATIN-C; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; RISK-FACTORS	Chronic kidney disease is a common disorder and its prevalence is increasing worldwide. Early diagnosis on the basis of presence of proteinuria or reduced estimated glomerular filtration rate could permit early intervention to reduce the risks of cardiovascular events, kidney failure, and death that are associated with chronic kidney disease. In developed countries, screening for the disorder is most efficient when targeted at high-risk groups including elderly people and those with concomitant illness (such as diabetes, hypertension, or cardiovascular disease) or a family history of chronic kidney disease, although the role of screening in developing countries is not yet clear. Effective strategies are available to slow the progression of chronic kidney disease and reduce cardiovascular risk. Treatment of high blood pressure is recommended for all individuals with, or at risk of, chronic kidney disease. Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers is preferred for patients with diabetic chronic kidney disease or those with the proteinuric non-diabetic disorder. Glycaemic control can help prevent the onset of early stages of chronic kidney disease in individuals with diabetes. Use of statins and aspirin is beneficial for most patients with chronic kidney disease who are at high cardiovascular risk, although research is needed to ascertain how to best prevent cardiovascular disease in this cohort. Models of care that facilitate delivery of the many complex aspects of treatment simultaneously could enhance management, although effects on clinical outcomes need further assessment. Novel clinical methods to better identify patients at risk of progression to later stages of chronic kidney disease, including kidney failure, are needed to target management to high-risk subgroups.	[Tonelli, Marcello] Univ Alberta, Dept Med, Div Nephrol & Immunol, Edmonton, AB T6G 2G3, Canada; [Tonelli, Marcello] Univ Alberta, Ctr Hlth Econ, Edmonton, AB T6G 2G3, Canada; [James, Matthew T.; Hemmelgarn, Brenda R.] Univ Calgary, Dept Med, Calgary, AB, Canada; [James, Matthew T.; Hemmelgarn, Brenda R.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada	University of Alberta; University of Alberta; University of Calgary; University of Calgary	Tonelli, M (corresponding author), Univ Alberta, Dept Med, Div Nephrol & Immunol, Clin Sci Bldg 7-129, Edmonton, AB T6G 2G3, Canada.	mtonelli-admin@med.ualberta.ca	Tonelli, Marcello/B-3028-2009; Hemmelgarn, Brenda R./I-6894-2012	Tonelli, Marcello/0000-0002-0846-3187; 				Agodoa LY, 2001, JAMA-J AM MED ASSOC, V285, P2719, DOI 10.1001/jama.285.21.2719; Akbari A, 2004, ARCH INTERN MED, V164, P1788, DOI 10.1001/archinte.164.16.1788; Archibald G, 2007, NEPHROL DIAL TRANSPL, V22, P2455, DOI 10.1093/ndt/gfm268; Atkins RC, 2005, KIDNEY INT, V68, pS83, DOI 10.1111/j.1523-1755.2005.09815.x; Baigent C, 2005, AM J KIDNEY DIS, V45, P473, DOI 10.1053/j.ajkd.2004.11.015; Bang H, 2007, ARCH INTERN MED, V167, P374, DOI 10.1001/archinte.167.4.374; Barnett AH, 2004, NEW ENGL J MED, V351, P1952, DOI 10.1056/NEJMoa042274; Barsoum RS, 2006, NEW ENGL J MED, V354, P997, DOI 10.1056/NEJMp058318; Bauer C, 2008, J AM SOC NEPHROL, V19, P844, DOI 10.1681/ASN.2008010110; Bilous R, 2009, ANN INTERN MED, V151, P11, DOI 10.7326/0003-4819-151-1-200907070-00120; Boulware LE, 2003, JAMA-J AM MED ASSOC, V290, P3101, DOI 10.1001/jama.290.23.3101; Brantsma AH, 2008, J AM SOC NEPHROL, V19, P1785, DOI 10.1681/ASN.2007101065; Brantsma AH, 2008, NEPHROL DIAL TRANSPL, V23, P3851, DOI 10.1093/ndt/gfn356; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Chan MR, 2007, AM J MED, V120, P1063, DOI 10.1016/j.amjmed.2007.04.024; Chaturvedi N, 1997, LANCET, V349, P1787, DOI 10.1016/S0140-6736(96)10244-0; Chertow GM, 2001, JAMA-J AM MED ASSOC, V286, P2839, DOI 10.1001/jama.286.22.2839; Cirillo M, 2008, ARCH INTERN MED, V168, P617, DOI 10.1001/archinte.168.6.617; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Codreanu I, 2006, NEPHROLOGY, V11, P321, DOI 10.1111/j.1440-1797.2006.00587.x; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Cooper WO, 2006, NEW ENGL J MED, V354, P2443, DOI 10.1056/NEJMoa055202; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Crowe E, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1530; Curtis BM, 2005, NEPHROL DIAL TRANSPL, V20, P147, DOI 10.1093/ndt/gfh585; Curtis BM, 2007, AM J KIDNEY DIS, V50, P733, DOI 10.1053/j.ajkd.2007.08.004; Dangas G, 2005, AM J CARDIOL, V95, P13, DOI 10.1016/j.amjcard.2004.08.056; de Brito-Ashurst I, 2009, J AM SOC NEPHROL, V20, P2075, DOI 10.1681/ASN.2008111205; Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487; Drey N, 2003, AM J KIDNEY DIS, V42, P677, DOI 10.1016/S0272-6386(03)00916-8; Einhorn LM, 2009, ARCH INTERN MED, V169, P1156, DOI 10.1001/archinternmed.2009.132; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Foster MC, 2008, AM J KIDNEY DIS, V52, P39, DOI 10.1053/j.ajkd.2008.03.003; Foster MC, 2007, ARCH INTERN MED, V167, P1386, DOI 10.1001/archinte.167.13.1386; Fouque D, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001892.pub3; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Fried LF, 2009, CLIN J AM SOC NEPHRO, V4, P361, DOI 10.2215/CJN.03350708; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Garg AX, 2002, KIDNEY INT, V61, P1486, DOI 10.1046/j.1523-1755.2002.00270.x; Garg AX, 2002, KIDNEY INT, V61, P2165, DOI 10.1046/j.1523-1755.2002.00356.x; Gerstein HC, 2000, LANCET, V355, P253; Glassock RJ, 2008, CLIN J AM SOC NEPHRO, V3, P1563, DOI 10.2215/CJN.00960208; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hailpern SM, 2007, J AM SOC NEPHROL, V18, P2205, DOI 10.1681/ASN.2006101165; Halbesma N, 2006, J AM SOC NEPHROL, V17, P2582, DOI 10.1681/ASN.2005121352; Hallan SI, 2006, BMJ-BRIT MED J, V333, P1047, DOI 10.1136/bmj.39001.657755.BE; Hallan SI, 2006, J AM SOC NEPHROL, V17, P2275, DOI 10.1681/ASN.2005121273; Hallan SI, 2009, J AM SOC NEPHROL, V20, P1069, DOI 10.1681/ASN.2008070730; Haroun MK, 2003, J AM SOC NEPHROL, V14, P2934, DOI 10.1097/01.ASN.0000095249.99803.85; Harris LE, 1998, AM J MED, V105, P464, DOI 10.1016/S0002-9343(98)00329-5; Hemmelgarn BR, 2007, J AM SOC NEPHROL, V18, P993, DOI 10.1681/ASN.2006080860; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hou FF, 2006, NEW ENGL J MED, V354, P131, DOI 10.1056/NEJMoa053107; Hsu CY, 2008, KIDNEY INT, V74, P101, DOI 10.1038/ki.2008.107; Hsu CY, 2009, ARCH INTERN MED, V169, P342, DOI 10.1001/archinternmed.2008.605; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Imai E, 2007, CLIN J AM SOC NEPHRO, V2, P1360, DOI 10.2215/CJN.00980207; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; Ishani A, 2006, J AM SOC NEPHROL, V17, P1444, DOI 10.1681/ASN.2005091012; Jafar TH, 2003, ANN INTERN MED, V139, P244, DOI 10.7326/0003-4819-139-4-200308190-00006; Jafar TH, 2006, NEW ENGL J MED, V354, P995, DOI 10.1056/NEJMp058319; Jafar TH, 2001, ANN INTERN MED, V135, P73, DOI 10.7326/0003-4819-135-2-200107170-00007; Jain AK, 2009, KIDNEY INT, V76, P318, DOI 10.1038/ki.2009.158; James MT, 2008, ARCH INTERN MED, V168, P2333, DOI 10.1001/archinte.168.21.2333; Jurkovitz CT, 2008, AM J KIDNEY DIS, V51, pS3, DOI 10.1053/j.ajkd.2007.12.022; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Khurana A, 2008, ARCH INTERN MED, V168, P593, DOI 10.1001/archinte.168.6.593; Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Kunz R, 2008, ANN INTERN MED, V148, P30, DOI 10.7326/0003-4819-148-1-200801010-00190; Lea J, 2005, ARCH INTERN MED, V165, P947, DOI 10.1001/archinte.165.8.947; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin A, 2008, CAN MED ASSOC J, V179, P1154, DOI 10.1503/cmaj.080351; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Lin JL, 2003, NEW ENGL J MED, V348, P277, DOI 10.1056/NEJMoa021672; Locatelli F, 2006, KIDNEY INT, V69, P2118, DOI 10.1038/sj.ki.5001547; MAKI DD, 1995, ARCH INTERN MED, V155, P1073, DOI 10.1001/archinte.155.10.1073; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Mann JFE, 2008, LANCET, V372, P547, DOI 10.1016/S0140-6736(08)61236-2; Mann JFE, 2009, ANN INTERN MED, V151, P1, DOI 10.7326/0003-4819-151-1-200907070-00122; Maschio G, 1996, NEW ENGL J MED, V334, P939, DOI 10.1056/NEJM199604113341502; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; McCullough PA, 2008, AM J KIDNEY DIS, V51, pS38, DOI 10.1053/j.ajkd.2007.12.017; McLaughlin K, 2001, AM J KIDNEY DIS, V38, P1122, DOI 10.1053/ajkd.2001.28619; Melamed ML, 2008, CLIN J AM SOC NEPHRO, V3, P1569, DOI 10.2215/CJN.02370508; Miller WG, 2008, AM J KIDNEY DIS, V52, P645, DOI 10.1053/j.ajkd.2008.07.032; Noble E, 2008, NEPHROL DIAL TRANSPL, V23, P3845, DOI 10.1093/ndt/gfn385; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; Otero A, 2005, KIDNEY INT, V68, P16, DOI 10.1111/j.1523-1755.2005.09904.x; Palmer AJ, 2008, NEPHROL DIAL TRANSPL, V23, P1216, DOI 10.1093/ndt/gfn082; Parving HH, 2008, NEW ENGL J MED, V358, P2433, DOI 10.1056/NEJMoa0708379; Parving HH, 2009, NEPHROL DIAL TRANSPL, V24, P1663, DOI 10.1093/ndt/gfn721; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Perico N, 2005, KIDNEY INT, V68, pS87, DOI 10.1111/j.1523-1755.2005.09715.x; Powe NR, 2009, AM J KIDNEY DIS, V53, pS64, DOI 10.1053/j.ajkd.2008.07.050; Rahman M, 2005, ARCH INTERN MED, V165, P936, DOI 10.1001/archinte.165.8.936; Richards N, 2008, NEPHROL DIAL TRANSPL, V23, P549, DOI 10.1093/ndt/gfm857; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167; Ruggenenti P, 1999, LANCET, V354, P359, DOI 10.1016/S0140-6736(98)10363-X; Ruggenenti P, 1998, LANCET, V352, P1252, DOI 10.1016/S0140-6736(98)04433-X; Ruggenenti P, 2003, KIDNEY INT, V63, P2254, DOI 10.1046/j.1523-1755.2003.00033.x; Ruggenenti P, 2005, LANCET, V365, P939, DOI 10.1016/S0140-6736(05)71082-5; Ruggenenti P, 2008, J AM SOC NEPHROL, V19, P1213, DOI 10.1681/ASN.2007090970; Ruilope LM, 2001, J AM SOC NEPHROL, V12, P218, DOI 10.1681/ASN.V122218; Ryu S, 2008, J AM SOC NEPHROL, V19, P1798, DOI 10.1681/ASN.2007121286; Safarinejad MR, 2009, J NEPHROL, V22, P99; Sandhu S, 2006, J AM SOC NEPHROL, V17, P2006, DOI 10.1681/ASN.2006010012; Sarnak MJ, 2005, ANN INTERN MED, V142, P342, DOI 10.7326/0003-4819-142-5-200503010-00009; Seliger SL, 2008, J AM SOC NEPHROL, V19, P2414, DOI 10.1681/ASN.2008010022; Shankar A, 2006, AM J EPIDEMIOL, V164, P263, DOI 10.1093/aje/kwj173; Shannon H, 2000, NEW ENGL J MED, V342, P381; Solomon D, 2002, ARCH INTERN MED, V162, P2640, DOI 10.1001/archinte.162.17.2002; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stengel B, 2003, EPIDEMIOLOGY, V14, P479, DOI 10.1097/01.EDE.0000071413.55296.c4; Stevens LA, 2008, AM J KIDNEY DIS, V51, P395, DOI 10.1053/j.ajkd.2007.11.018; Stevens PE, 2007, KIDNEY INT, V72, P92, DOI 10.1038/sj.ki.5002273; Strippoli GFM, 2008, BMJ-BRIT MED J, V336, P645, DOI 10.1136/bmj.39472.580984.AE; Tozawa M, 2003, HYPERTENSION, V41, P1341, DOI 10.1161/01.HYP.0000069699.92349.8C; Tseng CL, 2008, ARCH INTERN MED, V168, P55, DOI 10.1001/archinternmed.2007.9; Wang Y, 2008, KIDNEY INT, V73, P19, DOI 10.1038/sj.ki.5002586; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; White SL, 2008, B WORLD HEALTH ORGAN, V86, P229, DOI 10.2471/BLT.07.041715; Wilhelm-Leen ER, 2009, AM J MED, V122, P664, DOI 10.1016/j.amjmed.2009.01.026; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317; Zhang LX, 2008, AM J KIDNEY DIS, V51, P373, DOI 10.1053/j.ajkd.2007.11.009; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117	135	420	452	0	47	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 10	2010	375	9722					1296	1309		10.1016/S0140-6736(09)62004-3	http://dx.doi.org/10.1016/S0140-6736(09)62004-3			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585VN	20382326				2022-12-28	WOS:000276858400032
J	Dirks, PHGM; Kibii, JM; Kuhn, BF; Steininger, C; Churchill, SE; Kramers, JD; Pickering, R; Farber, DL; Meriaux, AS; Herries, AIR; King, GCP; Berger, LR				Dirks, Paul H. G. M.; Kibii, Job M.; Kuhn, Brian F.; Steininger, Christine; Churchill, Steven E.; Kramers, Jan D.; Pickering, Robyn; Farber, Daniel L.; Meriaux, Anne-Sophie; Herries, Andy I. R.; King, Geoffrey C. P.; Berger, Lee R.			Geological Setting and Age of Australopithecus sediba from Southern Africa	SCIENCE			English	Article							STERKFONTEIN; PALEOENVIRONMENTS; GEOCHRONOLOGY; SURFACES; DESERT; SKULL; HOMO	We describe the geological, geochronological, geomorphological, and faunal context of the Malapa site and the fossils of Australopithecus sediba. The hominins occur with a macrofauna assemblage that existed in Africa between 2.36 and 1.50 million years ago (Ma). The fossils are encased in water-laid, clastic sediments that were deposited along the lower parts of what is now a deeply eroded cave system, immediately above a flowstone layer with a U-Pb date of 2.026 +/- 0.021 Ma. The flowstone has a reversed paleomagnetic signature and the overlying hominin-bearing sediments are of normal polarity, indicating deposition during the 1.95- to 1.78-Ma Olduvai Subchron. The two hominin specimens were buried together in a single debris flow that lithified soon after deposition in a phreatic environment inaccessible to scavengers.	[Dirks, Paul H. G. M.] James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia; [Dirks, Paul H. G. M.; Steininger, Christine; Kramers, Jan D.; Berger, Lee R.] Univ Witwatersrand, Sch Geosci, ZA-2050 Johannesburg, South Africa; [Kibii, Job M.; Kuhn, Brian F.; Steininger, Christine; Churchill, Steven E.; Berger, Lee R.] Univ Witwatersrand, Inst Human Evolut, ZA-2050 Johannesburg, South Africa; [Churchill, Steven E.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Kramers, Jan D.] Univ Bern, Inst Geol Sci, CH-3012 Bern, Switzerland; [Kramers, Jan D.] Univ Johannesburg, Dept Geol, ZA-2006 Auckland Pk, South Africa; [Pickering, Robyn] Univ Melbourne, Sch Earth Sci, Melbourne, Vic 3010, Australia; [Farber, Daniel L.] Lawrence Livermore Natl Lab, Ctr Accelerator Mass Spectrometry, Livermore, CA 94550 USA; [Farber, Daniel L.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Meriaux, Anne-Sophie] Univ Newcastle, Sch Geog Polit & Sociol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Herries, Andy I. R.] Univ New S Wales, Sch Med Sci, UNSW Archaeomagnetism Lab, Sydney, NSW 2052, Australia; [Herries, Andy I. R.] Univ Liverpool, Dept Earth & Ocean Sci, Geomagnetism Lab, Liverpool L69 3BX, Merseyside, England; [King, Geoffrey C. P.] Inst Phys Globe Paris, Lab Tecton, F-75252 Paris, France	James Cook University; University of Witwatersrand; University of Witwatersrand; Duke University; University of Bern; University of Johannesburg; University of Melbourne; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Santa Cruz; Newcastle University - UK; University of New South Wales Sydney; University of Liverpool; UDICE-French Research Universities; Universite Paris Cite	Dirks, PHGM (corresponding author), James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia.	paul.dirks@jcu.edu.au	Churchill, Steven/AAA-9386-2022; Berger, Lee Rogers/AAC-3484-2020; Meriaux, Anne-Sophie/G-1754-2010; Farber, Daniel L/F-9237-2011	Berger, Lee Rogers/0000-0002-0367-7629; Meriaux, Anne-Sophie/0000-0002-5112-0948; Herries, Andy/0000-0002-2905-2002; Steininger, Christine/0000-0002-9082-0672	Palaeontological Scientific Trust (PAST); Institute for Human Evolution; University of the Witwatersrand; School of Geosciences, University of the Witwatersrand; AfricaArray; France-SA; Khure Africa project; LLNL GEO-CAMS; US-NSF [EAR-0345895]; Swiss National Science Foundation; UNSW Faculty of Medicine; ARC [DP0877603]; Liverpool University	Palaeontological Scientific Trust (PAST); Institute for Human Evolution; University of the Witwatersrand; School of Geosciences, University of the Witwatersrand; AfricaArray; France-SA; Khure Africa project; LLNL GEO-CAMS; US-NSF(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); UNSW Faculty of Medicine; ARC(Australian Research Council); Liverpool University	We thank the South African Heritage Resource Agency for allowing work on the Malapa site; the Nash family for granting access to the Malapa site and continued support; the Palaeontological Scientific Trust (PAST), the Institute for Human Evolution, University of the Witwatersrand and the School of Geosciences, University of the Witwatersrand, for funding; and the University of the Witwatersrand's Schools of Geosciences and Anatomical Sciences and the Bernard Price Institute for Palaeontology for support and facilities. Further support was provided by AfricaArray (P. H. G. M. D.), the France-SA, !Khure Africa project (G. C. P. K., D. L. F., A.-S.M.), and LLNL GEO-CAMS and the US-NSF EAR-0345895 (D. L. F.). R. P. is supported by a Swiss National Science Foundation Post-Doctoral Grant and gratefully acknowledges J. Woodhead, A. Grieg, and the team at Melbourne University. A. I. R. H. was funded through a UNSW Faculty of Medicine research grant and ARC Discovery Grant DP0877603 and acknowledges the support of the Liverpool University Geomagnetism Laboratory staff. Contributions to mapping and sample preparation by G. Charlesworth and Z. Jinnah are kindly acknowledged.	Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Berger LR, 2002, AM J PHYS ANTHROPOL, V119, P192, DOI 10.1002/ajpa.10156; Blatt H., 2006, PETROLOGY IGNEOUS SE; Brain C.K., 1995, PALAEOCLIMATE EVOLUT, P385; Brain C.K., 1981, HUNTERS HUNTED INTRO; BRAIN CK, 2004, SWARTKRANS CAVES CHR; BROOM R, 1949, NATURE, V164, P322, DOI 10.1038/164322a0; BROWN FH, 1985, ANCESTORS HARD EVIDE, P82; Brugal JP, 2003, CR PALEVOL, V2, P675, DOI 10.1016/j.crpv.2003.09.028; Clarke RJ, 1998, S AFR J SCI, V94, P460; Coussot P, 1996, EARTH-SCI REV, V40, P209, DOI 10.1016/0012-8252(95)00065-8; de Ruiter DJ, 2009, J HUM EVOL, V56, P497, DOI 10.1016/j.jhevol.2009.01.009; Eriksson K.A., 1974, T GEOL SOC S AFR, V77, P211; Eriksson P.G., 2006, GEOLOGY S AFRICA, P237; Hall SR, 2008, TECTONOPHYSICS, V459, P186, DOI 10.1016/j.tecto.2007.11.073; HUGHES AR, 1977, NATURE, V265, P310, DOI 10.1038/265310a0; Lanphere MA, 2002, GEOL SOC AM BULL, V114, P559, DOI 10.1130/0016-7606(2002)114<0559:RAFTOT>2.0.CO;2; Lewis ME, 2007, VERTEBR PALEOBIOL PA, P77, DOI 10.1007/978-1-4020-3098-7_4; Martin DM, 1998, J GEOL SOC LONDON, V155, P311, DOI 10.1144/gsjgs.155.2.0311; Matmon A, 2009, GEOL SOC AM BULL, V121, P688, DOI 10.1130/B26422.1; Nishiizumi K, 2005, EARTH PLANET SC LETT, V237, P499, DOI 10.1016/j.epsl.2005.05.032; OGG JG, 2004, GEOLOGIC TIME SCALE, P63, DOI [DOI 10.1017/CBO9780511536045.006, DOI 10.2277/0511074050]; PARTRIDGE TC, 1978, NATURE, V275, P282, DOI 10.1038/275282a0; Partridge TC, 2003, SCIENCE, V300, P607, DOI 10.1126/science.1081651; Partridge TC, 2000, OXFORD MGR GEOL GEOP, P100; Pickering R, 2007, J HUM EVOL, V53, P602, DOI 10.1016/j.jhevol.2007.02.005; Retallack G.J., 1990, SOILS INTRO PALAEOPE; Tucker M.E., 1991, SEDIMENTARY PETROLOG; Woodhead J, 2006, QUAT GEOCHRONOL, V1, P208, DOI 10.1016/j.quageo.2006.08.002	29	111	122	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2010	328	5975					205	208		10.1126/science.1184950	http://dx.doi.org/10.1126/science.1184950			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	580OU	20378812	Green Submitted			2022-12-28	WOS:000276459600036
J	Meng, ZY; Lang, TC; Wessel, S; Assaad, FF; Muramatsu, A				Meng, Z. Y.; Lang, T. C.; Wessel, S.; Assaad, F. F.; Muramatsu, A.			Quantum spin liquid emerging in two-dimensional correlated Dirac fermions	NATURE			English	Article							VALENCE-BOND STATE; MOTT INSULATOR; HUBBARD-MODEL; GROUND-STATE; MONTE-CARLO; TRIANGULAR LATTICE; HONEYCOMB LATTICE; OPTICAL LATTICE; SUPERCONDUCTIVITY; GRAPHENE	At sufficiently low temperatures, condensed-matter systems tend to develop order. A notable exception to this behaviour is the case of quantum spin liquids, in which quantum fluctuations prevent a transition to an ordered state down to the lowest temperatures. There have now been tentative observations of such states in some two-dimensional organic compounds, yet quantum spin liquids remain elusive in microscopic two-dimensional models that are relevant to experiments. Here we show, by means of large-scale quantum Monte Carlo simulations of correlated fermions on a honeycomb lattice (a structure realized in, for example, graphene), that a quantum spin liquid emerges between the state described by massless Dirac fermions and an antiferromagnetically ordered Mott insulator. This unexpected quantum-disordered state is found to be a short-range resonating valence-bond liquid, akin to the one proposed for high-temperature superconductors: the possibility of unconventional superconductivity through doping therefore arises in our system. We foresee the experimental realization of this model system using ultra-cold atoms, or group IV elements arranged in honeycomb lattices.	[Meng, Z. Y.; Wessel, S.; Muramatsu, A.] Univ Stuttgart, Inst Theoret Phys 3, D-70550 Stuttgart, Germany; [Lang, T. C.; Assaad, F. F.] Univ Wurzburg, Inst Theoret Phys & Astrophys, D-97074 Wurzburg, Germany	University of Stuttgart; University of Wurzburg	Meng, ZY (corresponding author), Univ Stuttgart, Inst Theoret Phys 3, Pfaffenwaldring 57, D-70550 Stuttgart, Germany.	meng@theo3.physik.uni-stuttgart.de	Lang, Thomas C./W-8675-2019; Assaad, Fakher/B-4754-2013; Lang, Thomas/B-7370-2011; Meng, Zi Yang/F-5212-2012	Lang, Thomas C./0000-0001-9619-6762; Lang, Thomas/0000-0001-9619-6762; Meng, Zi Yang/0000-0001-9771-7494; Wessel, Stefan/0000-0002-6353-5083	Deutsche Forschungsgemeinschaft (DFG) [AS120/4-3, FG1162, SFB/TRR21, WE3649]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We thank L. Balents, S. Capponi, A. H. Castro Neto, A. Georges, M. Hermele, A. Lauchli, E. Molinari, Y. Motome, S. Sachdev, K. P. Schmidt and S. Sorella for discussions. We are grateful to S. A. Kivelson for thoroughly reading our manuscript and providing important suggestions. F. F. A. is grateful to the Kavli Institute for Theoretical Physics of the University of California, Santa Barbara, for hospitality and acknowledges support by the Deutsche Forschungsgemeinschaft (DFG) through grants AS120/4-3 and FG1162. A. M. thanks the Aspen Center for Physics for hospitality and acknowledges partial support by the DFG through grant SFB/TRR21. S. W. acknowledges support by the DFG through grants SFB/TRR21 and WE3649. We thank the John von Neumann Institute for Computing, Julich; the Hochleistungsrechenzentrum, Stuttgart; the BW Grid; and the Leibniz-Rechenzentrum, Munchen, for the allocation of CPU time.	ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; Assaad FF, 2008, LECT NOTES PHYS, V739, P277, DOI 10.1007/978-3-540-74686-7_10; Assaad FF, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.075103; ASSAAD FF, 1993, PHYS REV LETT, V71, P1915, DOI 10.1103/PhysRevLett.71.1915; BYERS N, 1961, PHYS REV LETT, V7, P46, DOI 10.1103/PhysRevLett.7.46; Cahangirov S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.236804; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; CHAYES JT, 1989, COMMUN MATH PHYS, V123, P53, DOI 10.1007/BF01244017; Chen YL, 2009, SCIENCE, V325, P178, DOI 10.1126/science.1173034; Drut JE, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.026802; Duan LM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.090402; FAZEKAS P, 1974, PHILOS MAG, V30, P423, DOI 10.1080/14786439808206568; Feldbacher M, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.073105; Fradkin E, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.224415; FURUKAWA N, 1991, J PHYS SOC JPN, V60, P3669, DOI 10.1143/JPSJ.60.3669; HALDANE FDM, 1988, PHYS REV LETT, V61, P2015, DOI 10.1103/PhysRevLett.61.2015; Herbut IF, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.146401; Hermele M, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.214437; Hermele M, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.035125; Jordens R, 2008, NATURE, V455, P204, DOI 10.1038/nature07244; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.226801; KIVELSON SA, 1987, PHYS REV B, V35, P8865, DOI 10.1103/PhysRevB.35.8865; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Lee SS, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.036403; Mizusaki T, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.014421; Moessner R, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.024504; Moessner R, 2001, PHYS REV LETT, V86, P1881, DOI 10.1103/PhysRevLett.86.1881; MOESSNER R, 2008, QUANTUM DIMER MODELS; Nakano H., 2006, ANGEW CHEM, V118, P6451, DOI DOI 10.1002/ANGE.200600321; Nam MS, 2007, NATURE, V449, P584, DOI 10.1038/nature06182; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Paiva T, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.085123; Pauling L., 1960, NATURE CHEM BOND, P183; Raghu S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.156401; Rantner W, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.144501; ROKHSAR DS, 1988, PHYS REV LETT, V61, P2376, DOI 10.1103/PhysRevLett.61.2376; Ryu S, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.205319; Schneider U, 2008, SCIENCE, V322, P1520, DOI 10.1126/science.1165449; Shimizu Y, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.107001; SORELLA S, 1992, EUROPHYS LETT, V19, P699, DOI 10.1209/0295-5075/19/8/007; SUGIYAMA G, 1986, ANN PHYS-NEW YORK, V168, P1, DOI 10.1016/0003-4916(86)90107-7; Uchoa B, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.146801; WEINBERG S, 2005, QUANTUM THEORY FIELD, V1, P1; WEN XG, 1991, PHYS REV B, V44, P2664, DOI 10.1103/PhysRevB.44.2664; Yamashita M, 2009, NAT PHYS, V5, P44, DOI 10.1038/NPHYS1134; Zhang HJ, 2009, NAT PHYS, V5, P438, DOI 10.1038/NPHYS1270; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	50	466	468	0	179	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					847	U50		10.1038/nature08942	http://dx.doi.org/10.1038/nature08942			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20376143	Green Submitted			2022-12-28	WOS:000276397300028
J	Bernards, R				Bernards, Rene			It's Diagnostics, Stupid	CELL			English	Article							METASTATIC COLORECTAL-CANCER; BREAST-CANCER; GENE-EXPRESSION; LUNG-CANCER; THERAPY; DETERMINANT; RESISTANCE; SIGNATURES; DISCOVERY; CETUXIMAB		[Bernards, Rene] Netherlands Canc Inst, Ctr Biomed Genet, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; [Bernards, Rene] Netherlands Canc Inst, Canc Genom Ctr, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Bernards, R (corresponding author), Netherlands Canc Inst, Ctr Biomed Genet, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.bernards@nki.nl		Bernards, Rene/0000-0001-8677-3423	Centre of Biomedical Genetics; Cancer Genomics Centre; Netherlands Organisation for Scientific Research (NWO); Dutch Cancer Society	Centre of Biomedical Genetics; Cancer Genomics Centre; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society(KWF Kankerbestrijding)	I thank P. Borst and members of my laboratory for helpful discussions and comments on the manuscript. The work of the author was supported by grants from the Centre of Biomedical Genetics, the Cancer Genomics Centre, the Netherlands Organisation for Scientific Research (NWO), and the Dutch Cancer Society.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Barker AD, 2009, CLIN PHARMACOL THER, V86, P97, DOI 10.1038/clpt.2009.68; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; EARLE CC, 2008, DEVITA HELLMAN ROSEN, P369; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fojo T, 2009, JNCI-J NATL CANCER I, V101, P1044, DOI 10.1093/jnci/djp177; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Hartwell LH, 1997, SCIENCE, V278, P1064, DOI 10.1126/science.278.5340.1064; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Iorns E, 2008, CANCER CELL, V13, P91, DOI 10.1016/j.ccr.2008.01.001; Janne PA, 2009, NAT REV DRUG DISCOV, V8, P709, DOI 10.1038/nrd2871; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Lee JK, 2007, P NATL ACAD SCI USA, V104, P13086, DOI 10.1073/pnas.0610292104; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Pantel K, 2009, NAT REV CLIN ONCOL, V6, P339, DOI 10.1038/nrclinonc.2009.44; Pinkel D, 2005, ANNU REV GENOM HUM G, V6, P331, DOI 10.1146/annurev.genom.6.080604.162140; Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; Spurrier B, 2008, NAT PROTOC, V3, P1796, DOI 10.1038/nprot.2008.179; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tomasello G, 2008, EXPERT REV ANTICANC, V8, P1883, DOI 10.1586/14737140.8.12.1883; van 't Veer LJ, 2008, NATURE, V452, P564, DOI 10.1038/nature06915; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558	28	36	37	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 1	2010	141	1					13	17		10.1016/j.cell.2010.03.018	http://dx.doi.org/10.1016/j.cell.2010.03.018			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	577GS	20371338	Bronze			2022-12-28	WOS:000276211100005
J	Hogan, MC; Foreman, KJ; Naghavi, M; Ahn, SY; Wang, MR; Makela, SM; Lopez, AD; Lozano, R; Murray, CJL				Hogan, Margaret C.; Foreman, Kyle J.; Naghavi, Mohsen; Ahn, Stephanie Y.; Wang, Mengru; Makela, Susanna M.; Lopez, Alan D.; Lozano, Rafael; Murray, Christopher J. L.			Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5	LANCET			English	Article							PREGNANCY-RELATED MORTALITY; DEVELOPING-WORLD; DEATHS; REGRESSION; IMPROVE; DECLINE; HEALTH; CHINA	Background Maternal mortality remains a major challenge to health systems worldwide. Reliable information about the rates and trends in maternal mortality is essential for resource mobilisation, and for planning and assessment of progress towards Millennium Development Goal 5 (MDG 5), the target for which is a 75% reduction in the maternal mortality ratio (MMR) from 1990 to 2015. We assessed levels and trends in maternal mortality for 181 countries. Methods We constructed a database of 2651 observations of maternal mortality for 181 countries for 1980-2008, from vital registration data, censuses, surveys, and verbal autopsy studies. We used robust analytical methods to generate estimates of maternal deaths and the MMR for each year between 1980 and 2008. We explored the sensitivity of our data to model specification and show the out-of-sample predictive validity of our methods. Findings We estimated that there were 342 900 (uncertainty interval 302 100-394 300) maternal deaths worldwide in 2008, down from 526 300 (446 400-629 600) in 1980. The global MMR decreased from 422 (358-505) in 1980 to 320 (272-388) in 1990, and was 251 (221-289) per 100 000 livebirths in 2008. The yearly rate of decline of the global MMR since 1990 was 1.3% (1.0-1.5). During 1990-2008, rates of yearly decline in the MMR varied between countries, from 8.8% (8.7-14.1) in the Maldives to an increase of 5.5% (5.2-5.6) in Zimbabwe. More than 50% of all maternal deaths were in only six countries in 2008 (India, Nigeria, Pakistan, Afghanistan, Ethiopia, and the Democratic Republic of the Congo). In the absence of HIV, there would have been 281 500 (243 900-327 900) maternal deaths worldwide in 2008. Interpretation Substantial, albeit varied, progress has been made towards MDG 5. Although only 23 countries are on track to achieve a 75% decrease in MMR by 2015, countries such as Egypt, China, Ecuador, and Bolivia have been achieving accelerated progress.	[Hogan, Margaret C.; Foreman, Kyle J.; Naghavi, Mohsen; Ahn, Stephanie Y.; Wang, Mengru; Makela, Susanna M.; Lozano, Rafael; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Hogan, Margaret C.] Univ Washington, Dept Hlth Serv, Sch Publ Hlth, Seattle, WA 98121 USA; [Lopez, Alan D.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Queensland	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.	cjlm@uwashington.edu	Lopez, Alan D/F-1487-2010; Lozano, Rafael/T-5352-2018; Lopez, Alan/AAA-2734-2022	Lopez, Alan D/0000-0001-5818-6512; Lozano, Rafael/0000-0002-7356-8823; 	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This research was supported by funding from the Bill & Melinda Gates Foundation. We thank Janaki O'Brien for assistance with data preparation; Emmanuela Gakidou for valuable inputs on the final draft; Julie K Rajaratnam and Stephen S Lim for contributions to the analytical process; and Haidong Wang, David Phillips, Krycia Cowling, Jacob Marcus, Rebecca Myerson, Kathryn Andrews, Laura Dwyer, and Alison Levin-Rector for assistance with data.	AbouZahr C, 2001, B WORLD HEALTH ORGAN, V79, P561; [Anonymous], MILL DEV GOALS REP 2; [Anonymous], 1996, UNICEF REVISED 1990; [Anonymous], WORLD POP PROSP 2008; ATRASH HK, 1995, OBSTET GYNECOL, V86, P700, DOI 10.1016/0029-7844(95)00200-B; Bicego G, 2002, AIDS, V16, P1078, DOI 10.1097/00002030-200205030-00019; Borghi J, 2006, LANCET, V368, P1457, DOI 10.1016/S0140-6736(06)69383-5; Boschi-Pinto C, 2008, B WORLD HEALTH ORGAN, V86, P710, DOI 10.2471/BLT.07.050054; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Campbell C, 2005, B WORLD HEALTH ORGAN, V83, P462; CAMPBELL OMR, 1999, MEASURING PROGR SAFE; *CDC, 2010, INT REPR HLTH SURV P; Chowdhury ME, 2007, LANCET, V370, P1320, DOI 10.1016/S0140-6736(07)61573-6; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Deneux-Tharaux C, 2005, OBSTET GYNECOL, V106, P684, DOI 10.1097/01.AOG.0000174580.24281.e6; Fang J, 2008, LANCET, V372, P1619, DOI 10.1016/S0140-6736(08)61356-2; Fortney JA, 2009, CLIN OBSTET GYNECOL, V52, P224, DOI 10.1097/GRF.0b013e3181a4bddb; Frenk J, 2006, LANCET, V368, P954, DOI 10.1016/S0140-6736(06)69376-8; Gakidou E, 2006, DEMOGRAPHY, V43, P569, DOI 10.1353/dem.2006.0024; Garenne M, 1997, STUD FAMILY PLANN, V28, P132, DOI 10.2307/2138115; *GLOB HLTH IN, US PRES EM PLAN AIDS; Goodburn E, 2001, BRIT MED J, V322, P917, DOI 10.1136/bmj.322.7291.917; GRAHAM W, 1989, STUD FAMILY PLANN, V20, P125, DOI 10.2307/1966567; Graham WJ, 2006, INT J GYNECOL OBSTET, V94, P234, DOI 10.1016/j.ijgo.2006.04.004; Graham WJ, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-12; Graham WJ, 2008, BEST PRACT RES CL OB, V22, P425, DOI 10.1016/j.bpobgyn.2007.12.001; Hakkert R, 2001, STAT MED, V20, P3505, DOI 10.1002/sim.1075; HANDCOCK MS, 1994, J AM STAT ASSOC, V89, P368, DOI 10.2307/2290832; Hill K, 2006, B WORLD HEALTH ORGAN, V84, P173, DOI 10.2471/BLT.05.027714; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; Hill K, 2009, B WORLD HEALTH ORGAN, V87, P288, DOI 10.2471/BLT.08.052233; Horon IL, 2005, AM J PUBLIC HEALTH, V95, P478, DOI 10.2105/AJPH.2004.040063; Hoyert Donna L, 2007, Vital Health Stat 3, P1; *I HLTH SYST, 2002, IND CAUS DEATH DAT V; *INT C POP DEV, 1995, SUMM ICPD PROGR ACT; Kao SY, 1997, ACTA OBSTET GYN SCAN, V76, P629, DOI 10.3109/00016349709024602; Karimian-Teherani D, 2002, ACTA OBSTET GYN SCAN, V81, P323; KNOTTERS M, 1995, GEODERMA, V67, P227, DOI 10.1016/0016-7061(95)00011-C; LANCLAGAN OZ, 2007, STAT PROBABIL LETT, V77, P401; Laurenti R, 1997, Rev Panam Salud Publica, V1, P18; Li J, 2007, BJOG-INT J OBSTET GY, V114, P865, DOI 10.1111/j.1471-0528.2007.01362.x; MacKay AP, 2000, AM J PREV MED, V19, P35, DOI 10.1016/S0749-3797(00)00171-9; *MACR INC, 2010, MEASURE DH S STATCOM; McIntyre J, 2003, BRIT MED BULL, V67, P127, DOI 10.1093/bmb/ldg012; Mills S, 2008, MATERN CHILD HLTH J, V12, P577, DOI 10.1007/s10995-007-0289-x; Morris SS, 2003, INT J EPIDEMIOL, V32, P1041, DOI 10.1093/ije/dyg241; NAGHAVI M, POPUL HLTH IN PRESS; Obaid TA, 2009, INT J GYNECOL OBSTET, V106, P102, DOI 10.1016/j.ijgo.2009.03.017; OBERMEYER Z, PLOS MED IN PRESS; Ordi J, 2009, PLOS MED, V6, P174, DOI 10.1371/journal.pmed.1000036; Pattinson R, 2009, B WORLD HEALTH ORGAN, V87, P734, DOI 10.2471/BLT.09.071001; RAJARATNAM JK, LANCET IN PRESS; *REG GEN IND, 2006, SAMPL REG SYST; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; ROSENFIELD A, 1985, LANCET, V2, P83; Schuitemaker N, 1997, OBSTET GYNECOL, V90, P78, DOI 10.1016/S0029-7844(97)00128-2; Shiffman J, 2000, STUD FAMILY PLANN, V31, P274, DOI 10.1111/j.1728-4465.2000.00274.x; Stanton C, 2000, STUD FAMILY PLANN, V31, P111, DOI 10.1111/j.1728-4465.2000.00111.x; Stanton C, 2001, B WORLD HEALTH ORGAN, V79, P657; Starrs AM, 2006, LANCET, V368, P1130, DOI 10.1016/S0140-6736(06)69385-9; StataCorp, 2009, STAT BAS REF MAN REL; STECKLOV G, 1995, STUD FAMILY PLANN, V26, P33, DOI 10.2307/2138049; *TECHN GROUP MON M, 2004, MILL DEV GOALS BRAZ; Tomz M., 2003, J STAT SOFTW, V8, P1; Turner Linda A, 2002, Chronic Dis Can, V23, P22; UN Development Group, 2003, IND MON MILL DEV GOA; *UNICEF, 2004, MAT MORT 2000 EST DE; United Nations, 2009, MILL DEV GOALS REP 2; United Nations General Assembly, 2000, ARES552 UN GEN ASS; Vahidnia F, 2007, POPUL ENVIRON, V28, P259, DOI 10.1007/s11111-007-0050-9; *WHO, 2010, WHO MORT DAT; *WHO, 1991, MAT MORT GLOB FACTB; World Health Organization, 2007, MAT MORT 2005 EST DE; World Health Organization, 2001, MAT MORT 1995 EST DE; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization, 2004, INT STAT CLASS DIS R; YADAMSUREN B, 2007, B WORLD HEALTH ORGAN, V88, P192; Yazbeck AS, 2007, LANCET, V370, P1291, DOI 10.1016/S0140-6736(07)61553-0; 2010, MEASURE DHS DEMOGRAP	79	1302	1348	1	151	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 8	2010	375	9726					1609	1623		10.1016/S0140-6736(10)60518-1	http://dx.doi.org/10.1016/S0140-6736(10)60518-1			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	597CX	20382417				2022-12-28	WOS:000277734700027
J	Ji, YH; Resch, W; Corbett, E; Yamane, A; Casellas, R; Schatz, DG				Ji, Yanhong; Resch, Wolfgang; Corbett, Elizabeth; Yamane, Arito; Casellas, Rafael; Schatz, David G.			The In Vivo Pattern of Binding of RAG1 and RAG2 to Antigen Receptor Loci	CELL			English	Article							HEAVY-CHAIN LOCUS; V(D)J RECOMBINATION; CHROMOSOMAL TRANSLOCATIONS; HISTONE H3; SYNAPTIC COMPLEX; ACTIVE-SITE; DNA BREAKS; CLEAVAGE; REPAIR; ACCESSIBILITY	The critical initial step in V(D)J recombination, binding of RAG1 and RAG2 to recombination signal sequences flanking antigen receptor V, D, and J gene segments, has not previously been characterized in vivo. Here, we demonstrate that RAG protein binding occurs in a highly focal manner to a small region of active chromatin encompassing Ig kappa and Tcr alpha J gene segments and Igh and Tcr beta J and J-proximal D gene segments. Formation of these small RAG-bound regions, which we refer to as recombination centers, occurs in a developmental stage- and lineage-specific manner. Each RAG protein is independently capable of specific binding within recombination centers. While RAG1 binding was detected only at regions containing recombination signal sequences, RAG2 binds at thousands of sites in the genome containing histone 3 trimethylated at lysine 4. We propose that recombination centers coordinate V(D)J recombination by providing discrete sites within which gene segments are captured for recombination.	[Resch, Wolfgang; Yamane, Arito; Casellas, Rafael] NIAMSD, NIH, Bethesda, MD 20892 USA; [Ji, Yanhong; Corbett, Elizabeth; Schatz, David G.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Casellas, Rafael] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Corbett, Elizabeth; Schatz, David G.] Howard Hughes Med Inst, Chevy Chase, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Yale University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute	Casellas, R (corresponding author), NIAMSD, NIH, Bethesda, MD 20892 USA.	casellar@mail.nih.gov; david.schatz@yale.edu	Schatz, David/A-6748-2013; Yamane, Arito/A-2959-2013	Schatz, David/0000-0002-5669-1176; Resch, Wolfgang/0000-0001-7594-5963	Public Health Service [AI32524]; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032524, R01AI032524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041148] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank S. Desiderio, R. Sen, and R. Subrahmanyam for lentiviral vectors expressing WT and W453A RAG2, M. Nussenzweig for providing the HG BAC, B. Sleckman and A. Bredemeyer for providing cell lines and technical advice, S. Zhou for help with the analysis of mice, J. Duke for analysis of genome-wide H3K4me3 data, the Yale Transgenic Mouse Service for generating transgenic mice, members of the Schatz lab for helpful discussions, the Yale Immunobiology Cell Sorting Facility for cell sorting, and M. Krangel, M. Schlissel, and B. Sleckman for critical reading of the manuscript. This work was supported in part by Public Health Service grant AI32524 to D. G. S. and in part by the Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health. D.G.S. is an investigator of the Howard Hughes Medical Institute.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bassing CH, 2008, EUR J IMMUNOL, V38, P2564, DOI 10.1002/eji.200838347; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Chakraborty T, 2007, MOL CELL, V27, P842, DOI 10.1016/j.molcel.2007.07.010; Cobb RM, 2006, ADV IMMUNOL, V91, P45, DOI 10.1016/S0065-2776(06)91002-5; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; Cui XP, 2007, P NATL ACAD SCI USA, V104, P17046, DOI 10.1073/pnas.0610928104; Curry JD, 2005, NAT IMMUNOL, V6, P1272, DOI 10.1038/ni1270; De P, 2004, IMMUNOL REV, V200, P70, DOI 10.1111/j.0105-2896.2004.00154.x; Fugmann SD, 2000, MOL CELL, V5, P97, DOI 10.1016/S1097-2765(00)80406-2; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Golding A, 1999, EMBO J, V18, P3712, DOI 10.1093/emboj/18.13.3712; Grazini U, 2010, MOL CELL, V37, P282, DOI 10.1016/j.molcel.2009.12.035; Hawwari A, 2007, P NATL ACAD SCI USA, V104, P903, DOI 10.1073/pnas.0608248104; Hewitt SL, 2009, NAT IMMUNOL, V10, P655, DOI 10.1038/ni.1735; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Jiang H, 2005, MOL CELL, V18, P699, DOI 10.1016/j.molcel.2005.05.011; Jones JM, 2002, EMBO J, V21, P4162, DOI 10.1093/emboj/cdf394; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; Kim DR, 1999, GENE DEV, V13, P3070, DOI 10.1101/gad.13.23.3070; Krangel MS, 2007, NAT IMMUNOL, V8, P686, DOI 10.1038/ni1484; Kwon J, 1998, MOL CELL, V2, P829, DOI 10.1016/S1097-2765(00)80297-X; Landree MA, 1999, GENE DEV, V13, P3059, DOI 10.1101/gad.13.23.3059; Lee GS, 2004, CELL, V117, P171, DOI 10.1016/S0092-8674(04)00301-0; LEU TMJ, 1995, MOL CELL BIOL, V15, P5657; Lieber MR, 2006, DNA REPAIR, V5, P1234, DOI 10.1016/j.dnarep.2006.05.013; Liu Y, 2007, IMMUNITY, V27, P561, DOI 10.1016/j.immuni.2007.09.005; Marculescu R, 2006, DNA REPAIR, V5, P1246, DOI 10.1016/j.dnarep.2006.05.015; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Matthews AGW, 2009, NAT IMMUNOL, V10, P817, DOI 10.1038/ni.1776; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; Mundy CL, 2002, MOL CELL BIOL, V22, P69, DOI 10.1128/MCB.22.1.69-77.2002; Raghavan SC, 2004, NATURE, V428, P88, DOI 10.1038/nature02355; Ranganath S, 2008, J IMMUNOL, V180, P2339, DOI 10.4049/jimmunol.180.4.2339; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Rval P, 2008, NUCLEIC ACIDS RES, V36, P2060, DOI 10.1093/nar/gkn049; Shimazaki N, 2009, MOL CELL, V34, P535, DOI 10.1016/j.molcel.2009.05.011; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; Swanson PC, 2004, IMMUNOL REV, V200, P90, DOI 10.1111/j.0105-2896.2004.00159.x; Tsai AG, 2008, CELL, V135, P1130, DOI 10.1016/j.cell.2008.10.035; VICTOR KD, 1994, J IMMUNOL, V152, P3467; Whitehurst CE, 1999, IMMUNITY, V10, P313, DOI 10.1016/S1074-7613(00)80031-X; Wu C, 2007, P NATL ACAD SCI USA, V104, P4002, DOI 10.1073/pnas.0700081104; Ye J, 2004, IMMUNOGENETICS, V56, P399, DOI 10.1007/s00251-004-0712-z; Yin FF, 2009, NAT STRUCT MOL BIOL, V16, P499, DOI 10.1038/nsmb.1593; Yu W, 1999, SCIENCE, V285, P1080, DOI 10.1126/science.285.5430.1080	50	210	212	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2010	141	3					419	431		10.1016/j.cell.2010.03.010	http://dx.doi.org/10.1016/j.cell.2010.03.010			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	589UX	20398922	Bronze, Green Accepted			2022-12-28	WOS:000277180800014
J	Kok, M; de Souza, DK				Kok, Maarten; de Souza, Dziedzom Komi			Young Voices demand health research goals	LANCET			English	Editorial Material									[Kok, Maarten] Vrije Univ Amsterdam, Dept Hlth Sci, NL-1081 HV Amsterdam, Netherlands; [de Souza, Dziedzom Komi] Univ Ghana, Noguchi Mem Inst Med Res, Dept Parasitol, Legon, Ghana	Vrije Universiteit Amsterdam; University of Ghana	Kok, M (corresponding author), Vrije Univ Amsterdam, Dept Hlth Sci, NL-1081 HV Amsterdam, Netherlands.	maarten.kok@falw.vu.nl	de Souza, Dziedzom/ABC-8432-2021	de Souza, Dziedzom/0000-0001-5000-6177; Van den Bergh, Rafael/0000-0001-6277-8713; Brijnath, Bianca/0000-0002-0536-6859				AHMEDOV M, 2008, GOVERNANCE POLICY FR, P92502; [Anonymous], MONITORING FINANCIAL; *GLOB FOR HLTH RES, 2009, YOUNG VOIC RES HLTH, P92502; KENNEDY A, 2008, B WHO, V86, P92502; Matlin SA, 2008, LANCET, V372, P1521, DOI 10.1016/S0140-6736(08)61630-X; *NAT SCI BOARD, 2009, SCI ENG IND 2008, P92502; *ORG EC COOP DEV, 2005, PAR DECL EFF ACCR AG, P92502; The Commission on Health Research for Development, 1990, HLTH RES ESS LINK EQ; Wolffers I, 1998, LANCET, V351, P1652, DOI 10.1016/S0140-6736(97)10237-9; World Health Organization, 2004, WORLD REP KNOWL BETT	10	12	11	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 24	2010	375	9724					1416	1417		10.1016/S0140-6736(10)60584-3	http://dx.doi.org/10.1016/S0140-6736(10)60584-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	590FL	20417843				2022-12-28	WOS:000277210000008
J	Lohmann, KJ				Lohmann, Kenneth J.			Q&A ANIMAL BEHAVIOUR Magnetic-field perception	NATURE			English	Editorial Material							MAGNETORECEPTION; ORIENTATION; DESIGN; BIRDS		Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Lohmann, KJ (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	klohmann@email.unc.edu						Gegear RJ, 2008, NATURE, V454, P1014, DOI 10.1038/nature07183; Johnsen S, 2008, PHYS TODAY, V61, P29, DOI 10.1063/1.2897947; Kirschvink JL, 2010, J R SOC INTERFACE, V7, pS179, DOI 10.1098/rsif.2009.0491.focus; Lohmann KJ, 2007, J EXP BIOL, V210, P3697, DOI 10.1242/jeb.001313; Ritz T, 2010, J R SOC INTERFACE, V7, pS135, DOI 10.1098/rsif.2009.0456.focus; Rodgers CT, 2009, P NATL ACAD SCI USA, V106, P353, DOI 10.1073/pnas.0711968106; Wiltschko W, 2005, J COMP PHYSIOL A, V191, P675, DOI 10.1007/s00359-005-0627-7	7	107	115	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 22	2010	464	7292					1140	1142		10.1038/4641140a	http://dx.doi.org/10.1038/4641140a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20414302				2022-12-28	WOS:000276891100026
J	Scharfmann, R; Polak, M				Scharfmann, Raphael; Polak, Michel			Transcribing Neonatal Diabetes Mellitus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							IN-VIVO; CELLS		[Scharfmann, Raphael; Polak, Michel] Univ Paris 05, INSERM, U845, Hop Necker,Growth & Signaling Res Ctr, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Scharfmann, R (corresponding author), Univ Paris 05, INSERM, U845, Hop Necker,Growth & Signaling Res Ctr, Paris, France.		scharfmann, raphael/L-3296-2017	Scharfmann, Raphael/0000-0001-7619-337X				Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Smith SB, 2010, NATURE, V463, P775, DOI 10.1038/nature08748; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	5	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 22	2010	362	16					1538	1539		10.1056/NEJMcibr1001845	http://dx.doi.org/10.1056/NEJMcibr1001845			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	586GP	20410520				2022-12-28	WOS:000276894700017
J	Lilford, R; Pronovost, P				Lilford, Richard; Pronovost, Peter			Using hospital mortality rates to judge hospital performance: a bad idea that just won't go away	BRITISH MEDICAL JOURNAL			English	Editorial Material							QUALITY; CARE; DISEASE; SURGERY; BRISTOL; OUTLIER		[Lilford, Richard] Univ Birmingham, Birmingham B15 2TT, W Midlands, England; [Pronovost, Peter] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Qual & Safety Res Grp, Baltimore, MD 21231 USA	University of Birmingham; Johns Hopkins University	Lilford, R (corresponding author), Univ Birmingham, Birmingham B15 2TT, W Midlands, England.	r.j.lilford@bham.ac.uk			Medical Research Council [G0800808] Funding Source: Medline; Engineering and Physical Sciences Research Council [EP/F063822/1] Funding Source: researchfish; EPSRC [EP/F063822/1] Funding Source: UKRI; MRC [G0800808] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alberti G, 2009, MID STAFFORDSHIRE NH; Aylin P, 2001, LANCET, V358, P181, DOI 10.1016/S0140-6736(01)05404-6; BENYEHUDA N, 1980, AM J SOCIOL, V86, P1, DOI 10.1086/227200; BODGANICH W, 2010, NY TIMES A      0225, P17; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Brown C, 2008, QUAL SAF HEALTH CARE, V17, P170, DOI 10.1136/qshc.2007.023655; *CAR QUAL COMM, 2008, INP SURV 2008 MID ST; Colin Thome D., 2009, MIDSTAFFORDSHIRE NHS; *COMM HEALTHC AUD, 2009, INV MID STAFF NHS FD; Ettinger WH, 2008, AM J MED QUAL, V23, P90, DOI 10.1177/1062860607313141; FISCHHOFF B, 1975, J EXP PSYCHOL HUMAN, V1, P288, DOI 10.1037/0096-1523.1.3.288; FRANCIS R, 2010, HC375I STAT OFF, V1; Goffman E, 1986, TOUCHSTONE BOOK, P1; HILGARTNER S, 1988, AM J SOCIOL, V94, P53, DOI 10.1086/228951; Hofer TP, 1996, MED CARE, V34, P737, DOI 10.1097/00005650-199608000-00002; *HOUS COMM HLTH CO, 2009, HC151I, V1; Jha AK, 2005, NEW ENGL J MED, V353, P265, DOI 10.1056/NEJMsa051249; Kmietowicz Z, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c656; Lilford R, 2004, LANCET, V363, P1147, DOI 10.1016/S0140-6736(04)15901-1; Lilford RJ, 2007, BMJ-BRIT MED J, V335, P648, DOI 10.1136/bmj.39317.641296.AD; MANT J, 1995, BMJ-BRIT MED J, V311, P793, DOI 10.1136/bmj.311.7008.793; McQueen L, 2004, J AM MED INFORM ASSN, V11, P339, DOI 10.1197/jamia.M1499; *MINAP STEER GROUP, 2009, NHS MAN HEART ATT 8; Mohammed MA, 2001, LANCET, V357, P463, DOI 10.1016/S0140-6736(00)04019-8; Mohammed MA, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b780; Nicholl J, 2007, J EPIDEMIOL COMMUN H, V61, P1010, DOI 10.1136/jech.2007.061747; Pitches DW, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-91; Pronovost PJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c309; PRONOVOST PJ, 2009, JAMA-J AM MED ASSOC, V201, P1273; Redfern Michael, 2001, ROYAL LIVERPOOL CHIL; SIMBORG DW, 1981, NEW ENGL J MED, V304, P1602, DOI 10.1056/NEJM198106253042611; UVA MS, 1995, J THORAC CARDIOV SUR, V109, P164, DOI 10.1016/S0022-5223(95)70432-9; Wilson B, 2002, INT J QUAL HEALTH C, V14, P175, DOI 10.1093/oxfordjournals.intqhc.a002609; 2009, FOSTERS	34	153	153	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 20	2010	340								c2016	10.1136/bmj.c2016	http://dx.doi.org/10.1136/bmj.c2016			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	589HM	20406861				2022-12-28	WOS:000277137700006
J	Ding, L; Ellis, MJ; Li, SQ; Larson, DE; Chen, K; Wallis, J; Harris, CC; McLellan, MD; Fulton, RS; Fulton, LL; Abbott, RM; Hoog, J; Dooling, DJ; Koboldt, DC; Schmidt, H; Kalicki, J; Zhang, QY; Chen, L; Lin, L; Wendl, MC; McMichael, JF; Magrini, VJ; Cook, L; McGrath, SD; Vickery, TL; Appelbaum, E; DeSchryver, K; Davies, S; Guintoli, T; Lin, L; Crowder, R; Tao, Y; Snider, JE; Smith, SM; Dukes, AF; Sanderson, GE; Pohl, CS; Delehaunty, KD; Fronick, CC; Pape, KA; Reed, JS; Robinson, JS; Hodges, JS; Schierding, W; Dees, ND; Shen, D; Locke, DP; Wiechert, ME; Eldred, JM; Peck, JB; Oberkfell, BJ; Lolofie, JT; Du, FY; Hawkins, AE; O'Laughlin, MD; Bernard, KE; Cunningham, M; Elliott, G; Mason, MD; Thompson, DM; Ivanovich, JL; Goodfellow, PJ; Perou, CM; Weinstock, GM; Aft, R; Watson, M; Ley, TJ; Wilson, RK; Mardis, ER				Ding, Li; Ellis, Matthew J.; Li, Shunqiang; Larson, David E.; Chen, Ken; Wallis, Johnw.; Harris, Christopher C.; McLellan, Michael D.; Fulton, Robert S.; Fulton, Lucinda L.; Abbott, Rachel M.; Hoog, Jeremy; Dooling, David J.; Koboldt, Daniel C.; Schmidt, Heather; Kalicki, Joelle; Zhang, Qunyuan; Chen, Lei; Lin, Ling; Wendl, Michael C.; McMichael, Joshua F.; Magrini, Vincent J.; Cook, Lisa; McGrath, Sean D.; Vickery, Tammi L.; Appelbaum, Elizabeth; DeSchryver, Katherine; Davies, Sherri; Guintoli, Therese; Lin, Li; Crowder, Robert; Tao, Yu; Snider, Jacqueline E.; Smith, Scott M.; Dukes, Adam F.; Sanderson, Gabriel E.; Pohl, Craig S.; Delehaunty, Kim D.; Fronick, Catrina C.; Pape, Kimberley A.; Reed, Jerry S.; Robinson, Jody S.; Hodges, Jennifer S.; Schierding, William; Dees, Nathan D.; Shen, Dong; Locke, Devin P.; Wiechert, Madeline E.; Eldred, James M.; Peck, Josh B.; Oberkfell, Benjamin J.; Lolofie, Justin T.; Du, Feiyu; Hawkins, Amy E.; O'Laughlin, Michelle D.; Bernard, Kelly E.; Cunningham, Mark; Elliott, Glendoria; Mason, Mark D.; Thompson, Dominic M., Jr.; Ivanovich, Jennifer L.; Goodfellow, Paul J.; Perou, Charles M.; Weinstock, George M.; Aft, Rebecca; Watson, Mark; Ley, Timothy J.; Wilson, Richard K.; Mardis, Elaine R.			Genome remodelling in a basal-like breast cancer metastasis and xenograft	NATURE			English	Article							MYELOID-LEUKEMIA GENOME; COLORECTAL CANCERS; SOMATIC MUTATIONS; TUMOR-SUPPRESSOR; LUNG-CANCER; DIFFERENTIATION; RESOLUTION; SUBTYPES; TAZ	Massively parallel DNA sequencing technologies provide an unprecedented ability to screen entire genomes for genetic changes associated with tumour progression. Here we describe the genomic analyses of four DNA samples from an African-American patient with basal-like breast cancer: peripheral blood, the primary tumour, a brain metastasis and a xenograft derived from the primary tumour. The metastasis contained two de novo mutations and a large deletion not present in the primary tumour, and was significantly enriched for 20 shared mutations. The xenograft retained all primary tumour mutations and displayed a mutation enrichment pattern that resembled the metastasis. Two overlapping large deletions, encompassing CTNNA1, were present in all three tumour samples. The differential mutation frequencies and structural variation patterns in metastasis and xenograft compared with the primary tumour indicate that secondary tumours may arise from a minority of cells within the primary tumour.	[Ding, Li; Larson, David E.; Chen, Ken; Wallis, Johnw.; Harris, Christopher C.; McLellan, Michael D.; Fulton, Robert S.; Fulton, Lucinda L.; Abbott, Rachel M.; Dooling, David J.; Koboldt, Daniel C.; Schmidt, Heather; Kalicki, Joelle; Chen, Lei; Lin, Ling; Wendl, Michael C.; McMichael, Joshua F.; Magrini, Vincent J.; Cook, Lisa; McGrath, Sean D.; Vickery, Tammi L.; Appelbaum, Elizabeth; Smith, Scott M.; Dukes, Adam F.; Sanderson, Gabriel E.; Pohl, Craig S.; Delehaunty, Kim D.; Fronick, Catrina C.; Pape, Kimberley A.; Reed, Jerry S.; Robinson, Jody S.; Hodges, Jennifer S.; Schierding, William; Dees, Nathan D.; Shen, Dong; Locke, Devin P.; Wiechert, Madeline E.; Eldred, James M.; Peck, Josh B.; Oberkfell, Benjamin J.; Lolofie, Justin T.; Du, Feiyu; Hawkins, Amy E.; O'Laughlin, Michelle D.; Bernard, Kelly E.; Cunningham, Mark; Elliott, Glendoria; Mason, Mark D.; Weinstock, George M.; Ley, Timothy J.; Wilson, Richard K.; Mardis, Elaine R.] Washington Univ, Genome Ctr, Sch Med, St Louis, MO 63108 USA; [Ding, Li; Wallis, Johnw.; Fulton, Robert S.; Fulton, Lucinda L.; Dooling, David J.; Zhang, Qunyuan; Wendl, Michael C.; Magrini, Vincent J.; Weinstock, George M.; Ley, Timothy J.; Wilson, Richard K.; Mardis, Elaine R.] Washington Univ, Dept Genet, Sch Med, St Louis, MO 63108 USA; [Ellis, Matthew J.; Li, Shunqiang; Hoog, Jeremy; DeSchryver, Katherine; Davies, Sherri; Guintoli, Therese; Lin, Li; Crowder, Robert; Snider, Jacqueline E.; Ley, Timothy J.] Washington Univ, Dept Med, Sch Med, St Louis, MO 63108 USA; [Ellis, Matthew J.; Ley, Timothy J.; Wilson, Richard K.; Mardis, Elaine R.] Washington Univ, Siteman Canc Ctr, Sch Med, St Louis, MO 63108 USA; [Zhang, Qunyuan] Washington Univ, Div Stat Genom, Sch Med, St Louis, MO 63108 USA; [Tao, Yu] Washington Univ, Div Biostat, Sch Med, St Louis, MO 63108 USA; [Thompson, Dominic M., Jr.; Ivanovich, Jennifer L.; Goodfellow, Paul J.; Aft, Rebecca] Washington Univ, Dept Surg, Sch Med, St Louis, MO 63108 USA; [Thompson, Dominic M., Jr.; Ivanovich, Jennifer L.; Goodfellow, Paul J.; Aft, Rebecca] Washington Univ, Young Womens Breast Canc Program, Sch Med, St Louis, MO 63108 USA; [Watson, Mark] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63108 USA; [Perou, Charles M.] Univ N Carolina, Lineberger Canc Ctr, Dept Genet, Chapel Hill, NC 27599 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of North Carolina; University of North Carolina Chapel Hill	Wilson, RK (corresponding author), Washington Univ, Genome Ctr, Sch Med, St Louis, MO 63108 USA.	rwilson@wustl.edu	Chen, Ken/A-1074-2009; Weinstock, George M/C-6314-2013; Wendl, Michael C/A-2741-2008; Magrini, Vincent/AAT-5830-2020; Chen, Ken/AAU-1432-2021; Wilson, Richard K./AAF-4139-2019; Perou, Charles M/H-9934-2014; Mardis, Elaine/W-2202-2019; McGrath, Sean David/AAT-3540-2020	Weinstock, George M/0000-0002-2997-4592; Magrini, Vincent/0000-0002-2019-4872; Chen, Ken/0000-0003-4013-5279; Wilson, Richard K./0000-0002-1992-1358; Perou, Charles M/0000-0001-9827-2247; McGrath, Sean David/0000-0001-9064-8449; MCLELLAN, MICHAEL/0000-0002-2703-8784; Larson, David/0000-0001-7934-5906; Schierding, William/0000-0001-5659-2701; Locke, Devin/0000-0002-2527-0475; Davies, Sherri/0000-0002-7141-8354	Washington University in St Louis; National Human Genome Research Institute (NHGRI) [U54 HG003079]; National Cancer Institute (NCI) [1 U01 CA114722-01]; Susan G Komen Breast Cancer Foundation [BCTR0707808]; Fashion Footwear Charitable Foundation, Inc. [NCI U10 CA076001, NCI 3P50 CA68438]; Breast Cancer Research Foundation; Institute of Clinical and Translational Sciences at Washington University [UL1 RR024992]; Illumina, Inc.; NATIONAL CANCER INSTITUTE [U10CA076001, P50CA068438, U01CA114722] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER	Washington University in St Louis; National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Fashion Footwear Charitable Foundation, Inc.; Breast Cancer Research Foundation; Institute of Clinical and Translational Sciences at Washington University; Illumina, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the many members of The Genome Center and Siteman Cancer Center at Washington University in St Louis for support. This work was funded by grants to R. K. W. from Washington University in St Louis and the National Human Genome Research Institute (NHGRI U54 HG003079), and grants to M. J. E. from the National Cancer Institute (NCI 1 U01 CA114722-01), the Susan G Komen Breast Cancer Foundation (BCTR0707808), and the Fashion Footwear Charitable Foundation, Inc. NCI U10 CA076001 and a Breast Cancer Research Foundation grant awarded to the American College of Surgeons Oncology Group supported the acquisition of samples for recurrence testing. The tissue procurement core was supported by an NCI core grant to the Siteman Cancer Center (NCI 3P50 CA68438). The Human and Mouse Linked Evaluation of Tumors Core was supported by the Institute of Clinical and Translational Sciences at Washington University (CTSA grant UL1 RR024992). We also thank Illumina, Inc. for their support and role in the Washington University Cancer Genome Initiative.	BAIPAI S, 2009, J BIOL CHEM, V284, P18252; Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Citron ML, 2003, J CLIN ONCOL, V21, P1431, DOI 10.1200/JCO.2003.09.081; Clark AM, 2004, GENE CHROMOSOME CANC, V41, P99, DOI 10.1002/gcc.20069; Gandara ML, 2003, MOL CELL BIOL, V23, P7377, DOI 10.1128/MCB.23.20.7377-7390.2003; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Kamal M, 2010, BREAST CANCER RES TR, V121, P555, DOI 10.1007/s10549-009-0500-4; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Mao JH, 2008, SCIENCE, V321, P1499, DOI 10.1126/science.1162981; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Mullighan CG, 2009, P NATL ACAD SCI USA, V106, P9414, DOI 10.1073/pnas.0811761106; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Plumb CL, 2009, AM J PATHOL, V175, P1662, DOI 10.2353/ajpath.2009.090007; Sacco F, 2009, J BIOL CHEM, V284, P22048, DOI 10.1074/jbc.M109.002758; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Toomes C, 2003, GENE CHROMOSOME CANC, V37, P132, DOI 10.1002/gcc.10191; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zhang W, 2006, MOL CANCER RES, V4, P935, DOI 10.1158/1541-7786.MCR-06-0253	30	916	958	0	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2010	464	7291					999	1005		10.1038/nature08989	http://dx.doi.org/10.1038/nature08989			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20393555	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000276635000030
J	Khaleeli, Z; Healy, DG; Briddon, A; Lunn, MP; Reilly, MM; Land, J; Giovannoni, G				Khaleeli, Zhaleh; Healy, Daniel G.; Briddon, Anthony; Lunn, Michael P.; Reilly, Mary M.; Land, John; Giovannoni, Gavin			Lesson of the Week Copper deficiency as a treatable cause of poor balance	BRITISH MEDICAL JOURNAL			English	Article							CNS DEMYELINATION; ZINC; MYELOPATHY; ANEMIA; MYELONEUROPATHY; HYPOCUPREMIA; ADULTS		[Giovannoni, Gavin] Barts & London Queen Marys Sch Med & Dent, Dept Clin Neurosci, London E1 2AT, England; [Khaleeli, Zhaleh] Natl Hosp Neurol & Neurosurg, Dept Neurol, London WC1N 3BG, England; [Healy, Daniel G.; Lunn, Michael P.; Reilly, Mary M.] Natl Hosp Neurol & Neurosurg, MRC, Ctr Neuromuscular Dis, London WC1N 3BG, England; [Briddon, Anthony; Land, John] Natl Hosp Neurol & Neurosurg, Neurometab Unit, London WC1N 3BG, England	University of London; Queen Mary University London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Giovannoni, G (corresponding author), Barts & London Queen Marys Sch Med & Dent, Dept Clin Neurosci, London E1 2AT, England.	g.giovannoni@qmul.ac.uk	Khaleeli, zhaleh/AAB-7161-2022	Lunn, Michael/0000-0003-3174-6027; Reilly, Mary/0000-0003-0686-905X	Medical Research Council [G0601943] Funding Source: Medline; MRC [G0601943] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		DUNLAP WM, 1974, ANN INTERN MED, V80, P470, DOI 10.7326/0003-4819-80-4-470; FIELDS M, 1984, AM J CLIN NUTR, V39, P289, DOI 10.1093/ajcn/39.2.289; Harless W, 2006, AM J HEMATOL, V81, P546, DOI 10.1002/ajh.20647; Hedera P, 2003, ARCH NEUROL-CHICAGO, V60, P1303, DOI 10.1001/archneur.60.9.1303; Juhasz-Pocsine K, 2007, NEUROLOGY, V68, P1843, DOI 10.1212/01.wnl.0000262768.40174.33; Kumar N, 2006, NEURORADIOLOGY, V48, P78, DOI 10.1007/s00234-005-0016-5; Kumar N, 2005, MAYO CLIN PROC, V80, P943, DOI 10.4065/80.7.943; Kumar N, 2004, NEUROLOGY, V63, P33, DOI 10.1212/01.WNL.0000132644.52613.FA; Kumar N, 2004, J NEUROL, V251, P747, DOI 10.1007/s00415-004-0428-x; Kumar N, 2003, NEUROLOGY, V61, P273, DOI 10.1212/01.WNL.0000073542.02761.5F; Kumar N, 2007, CLIN CHEM LAB MED, V45, P1402, DOI 10.1515/CCLM.2007.292; Kumar N, 2006, MAYO CLIN PROC, V81, P1371, DOI 10.4065/81.10.1371; Nations SP, 2008, NEUROLOGY, V71, P639, DOI 10.1212/01.wnl.0000312375.79881.94; ODELL BL, 1993, AM J CLIN NUTR, V58, P771, DOI 10.1093/ajcn/58.5.771S; PRASAD AS, 1978, JAMA-J AM MED ASSOC, V240, P2166, DOI 10.1001/jama.240.20.2166; Prodan CI, 2007, AM J HEMATOL, V82, P288, DOI 10.1002/ajh.20766; Prodan CI, 2000, NEUROLOGY, V54, P1705, DOI 10.1212/WNL.54.8.1705; Prodan CI, 2002, NEUROLOGY, V59, P1453, DOI 10.1001/archneur.59.9.1453; Schleper B, 2001, J NEUROL, V248, P705, DOI 10.1007/s004150170118; Spinazzi M, 2007, J NEUROL, V254, P1012, DOI 10.1007/s00415-006-0479-2; Willis MS, 2005, AM J CLIN PATHOL, V123, P125, DOI 10.1309/V6GVYW2QTYD5C5PJ	21	5	5	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 12	2010	340								c508	10.1136/bmj.c508	http://dx.doi.org/10.1136/bmj.c508			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	586JS	20385722				2022-12-28	WOS:000276904100010
J	Hildebrandt, F				Hildebrandt, Friedhelm			Renal Medicine 1 Genetic kidney diseases	LANCET			English	Article							BARDET-BIEDL-SYNDROME; INHERITED HYPOKALEMIC ALKALOSIS; RESISTANT NEPHROTIC SYNDROME; CHAPERONIN-LIKE PROTEIN; BARTTERS-SYNDROME; JOUBERT-SYNDROME; MOLECULAR-GENETICS; POSITIONAL CLONING; BLEBBED PHENOTYPE; DOMAIN PROTEIN	Knowledge of the primary cause of a disease is essential for elucidation of its mechanisms, and for adequate classification, prognosis, and treatment. Recently, the causes of many kidney diseases have been shown to be single-gene defects eg, steroid-resistant nephrotic syndrome, which is caused by podocin mutations in about 25% of children and nearly 15% of adults with the disease. Knowledge of a disease-causing mutation in a single-gene disorder represents one of the most robust diagnostic examples of personalised medicine because the mutation conveys an almost 100% risk of developing the disease by a defined age. Whereas single-gene diseases are rare disorders, polygenic risk alleles arise in common adult-onset diseases. In this Review, I will discuss prominent renal single-gene kidney disorders, and polygenic risk alleles of common disorders. I delineate how emerging techniques of total exome capture and large-scale sequencing will assist molecular genetic diagnosis, prognosis, and specific treatment, and lead to an improved elucidation of disease mechanisms, thus enabling development of new targeted drugs.	[Hildebrandt, Friedhelm] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Hildebrandt, Friedhelm] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Hildebrandt, Friedhelm] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Hildebrandt, F (corresponding author), Univ Michigan Hlth Syst, Howard Hughes Med Inst, Dept Pediat, 8220C MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	fhilde@umich.edu			National Institutes of Health [DK076683, DK1069274, DK1068306, DK064614, DK045345, RC1-DK086542]; Thrasher Research Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064614, R01DK076683, RC1DK086542, R01DK068306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thrasher Research Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from National Institutes of Health to me (DK076683, DK1069274, DK1068306, DK064614, DK045345, and RC1-DK086542) and the Thrasher Research Fund. I am an investigator at the Howard Hughes Medical Institute, a Doris Duke Distinguished Clinical Scientist, and the Frederick G L Huetwell Professor.	Abdelhak S, 1997, NAT GENET, V15, P157, DOI 10.1038/ng0297-157; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Attanasio M, 2007, NAT GENET, V39, P1018, DOI 10.1038/ng2072; Baala L, 2007, AM J HUM GENET, V81, P170, DOI 10.1086/519494; Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; Badano JL, 2003, AM J HUM GENET, V72, P650, DOI 10.1086/368204; BICHET DG, 1992, AM J HUM GENET, V51, P1089; Birkenhager R, 2001, NAT GENET, V29, P310, DOI 10.1038/ng752; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Chen F, 2009, PEDIATR NEPHROL, V24, P1621, DOI 10.1007/s00467-008-1072-y; DEEN PMT, 1994, SCIENCE, V264, P92, DOI 10.1126/science.8140421; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; FANCONI G, 1951, Helv Paediatr Acta, V6, P1; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Glaudemans B, 2009, J CLIN INVEST, V119, P936, DOI 10.1172/JCI36948; Grieshammer U, 2004, DEV CELL, V6, P709, DOI 10.1016/S1534-5807(04)00108-X; Groenen PMA, 1998, GENOMICS, V49, P218, DOI 10.1006/geno.1998.5254; Harris PC, 2008, CLIN J AM SOC NEPHRO, V3, P1, DOI 10.2215/CJN.05061107; Heeringa SF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007771; Henske EP, 2004, CURR MOL MED, V4, P825, DOI 10.2174/1566524043359610; Hildebrandt F, 2005, NAT REV GENET, V6, P928, DOI 10.1038/nrg1727; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Hildebrandt F, 2007, J AM SOC NEPHROL, V18, P1855, DOI 10.1681/ASN.2006121344; Hildebrandt F, 2009, J AM SOC NEPHROL, V20, P23, DOI 10.1681/ASN.2008050456; Hinkes B, 2008, J AM SOC NEPHROL, V19, P365, DOI 10.1681/ASN.2007040452; Hinkes B, 2006, NAT GENET, V38, P1397, DOI 10.1038/ng1918; Hinkes BG, 2007, PEDIATRICS, V119, pE907, DOI 10.1542/peds.2006-2164; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Hoefele J, 2007, J AM SOC NEPHROL, V18, P2789, DOI 10.1681/ASN.2007020243; Hoskins BE, 2007, AM J HUM GENET, V80, P800, DOI 10.1086/513322; Ichikawa I, 2002, KIDNEY INT, V61, P889, DOI 10.1046/j.1523-1755.2002.00188.x; Igarashi P, 2002, J AM SOC NEPHROL, V13, P2384, DOI 10.1097/01.ASN.0000028643.17901.42; Jenkins D, 2005, J AM SOC NEPHROL, V16, P2141, DOI 10.1681/ASN.2004090776; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Karle SM, 2002, J AM SOC NEPHROL, V13, P388, DOI 10.1681/ASN.V132388; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; KESTILA M, 1994, GENOMICS, V19, P570, DOI 10.1006/geno.1994.1109; Kiefer SM, 2003, HUM MOL GENET, V12, P2221, DOI 10.1093/hmg/ddg233; Kim E, 2007, NAT MED, V13, P1409, DOI 10.1038/nm1207-1409; Kim JC, 2005, J CELL SCI, V118, P1007, DOI 10.1242/jcs.01676; Knoers NVAM, 2009, PEDIATR NEPHROL, V24, P697, DOI 10.1007/s00467-008-0968-x; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Kohlhase J, 1998, NAT GENET, V18, P81, DOI 10.1038/ng0198-81; Konrad M, 2004, AM J PHYSIOL-RENAL, V286, pF599, DOI 10.1152/ajprenal.00312.2003; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Kuwayama F, 2002, NEPHROL DIAL TRANSPL, V17, P45, DOI 10.1093/ndt/17.suppl_9.45; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Locke JM, 2009, DIABETIC MED, V26, P570, DOI 10.1111/j.1464-5491.2009.02705.x; Lu WN, 2007, AM J HUM GENET, V80, P616, DOI 10.1086/512735; Machuca E, 2009, HUM MOL GENET, V18, pR185, DOI 10.1093/hmg/ddp328; Machuca E, 2009, KIDNEY INT, V75, P727, DOI 10.1038/ki.2008.650; McGregor L, 2003, NAT GENET, V34, P203, DOI 10.1038/ng1142; Mollet G, 2002, NAT GENET, V32, P300, DOI 10.1038/ng996; Mykytyn K, 2002, NAT GENET, V31, P435, DOI 10.1038/ng935; Mykytyn K, 2001, NAT GENET, V28, P188, DOI 10.1038/88925; Nakano Takako, 2003, Tokai J Exp Clin Med, V28, P121; Nishimura DY, 2001, HUM MOL GENET, V10, P865, DOI 10.1093/hmg/10.8.865; Olbrich H, 2003, NAT GENET, V34, P455, DOI 10.1038/ng1216; Otto E, 2002, AM J HUM GENET, V71, P1161, DOI 10.1086/344395; Otto EA, 2005, NAT GENET, V37, P282, DOI 10.1038/ng1520; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Otto EA, 2008, J AM SOC NEPHROL, V19, P587, DOI 10.1681/ASN.2007040490; Pohl M, 2002, KIDNEY INT, V61, P10, DOI 10.1046/j.1523-1755.2002.00086.x; Reidy KJ, 2009, SEMIN NEPHROL, V29, P321, DOI 10.1016/j.semnephrol.2009.03.009; ROSENTHAL W, 1992, NATURE, V359, P233, DOI 10.1038/359233a0; Ruf RG, 2004, P NATL ACAD SCI USA, V101, P8090, DOI 10.1073/pnas.0308475101; Ruf RG, 2004, J AM SOC NEPHROL, V15, P722, DOI 10.1097/01.ASN.0000113552.59155.72; SANYANUSIN P, 1995, HUM MOL GENET, V4, P2183, DOI 10.1093/hmg/4.11.2183; Sayer JA, 2008, NEPHRON EXP NEPHROL, V110, pE37, DOI 10.1159/000151730; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Sheffield VC, 2001, CURR OPIN GENET DEV, V11, P317, DOI 10.1016/S0959-437X(00)00196-9; Shimazaki A, 2005, DIABETES, V54, P1171, DOI 10.2337/diabetes.54.4.1171; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Simon DB, 1996, AM J PHYSIOL-RENAL, V271, pF961, DOI 10.1152/ajprenal.1996.271.5.F961; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; Skinner MA, 2008, AM J HUM GENET, V82, P344, DOI 10.1016/j.ajhg.2007.10.008; Slavotinek AM, 2000, NAT GENET, V26, P15, DOI 10.1038/79116; SMITH CH, 1945, AM J DIS CHILD, V69, P369; Stoetzel C, 2006, NAT GENET, V38, P521, DOI 10.1038/ng1771; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Torres VE, 2009, KIDNEY INT, V76, P149, DOI 10.1038/ki.2009.128; Tory K, 2007, J AM SOC NEPHROL, V18, P1566, DOI 10.1681/ASN.2006101164; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Van Esch H, 2000, NATURE, V406, P419, DOI 10.1038/35019088; Vrontou S, 2003, NAT GENET, V34, P209, DOI 10.1038/ng1168; Watnick T, 2003, NAT GENET, V34, P355, DOI 10.1038/ng0803-355; Weber S, 2004, KIDNEY INT, V66, P571, DOI 10.1111/j.1523-1755.2004.00776.x; Weber S, 2008, J AM SOC NEPHROL, V19, P891, DOI 10.1681/ASN.2006111282; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Woolf AS, 2000, KIDNEY INT, V58, P500, DOI 10.1046/j.1523-1755.2000.00196.x; Ye X, 2004, DNA SEQUENCE, V15, P213, DOI 10.1080/10425170410001679165; Zaghloul NA, 2009, J CLIN INVEST, V119, P428, DOI 10.1172/JCI37041	97	199	204	4	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 10	2010	375	9722					1287	1295		10.1016/S0140-6736(10)60236-X	http://dx.doi.org/10.1016/S0140-6736(10)60236-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585VN	20382325	Green Accepted			2022-12-28	WOS:000276858400031
J	Rendell, L; Boyd, R; Cownden, D; Enquist, M; Eriksson, K; Feldman, MW; Fogarty, L; Ghirlanda, S; Lillicrap, T; Laland, KN				Rendell, L.; Boyd, R.; Cownden, D.; Enquist, M.; Eriksson, K.; Feldman, M. W.; Fogarty, L.; Ghirlanda, S.; Lillicrap, T.; Laland, K. N.			Why Copy Others? Insights from the Social Learning Strategies Tournament	SCIENCE			English	Article							EVOLUTION; INFORMATION; ANIMALS; PARADOX; RULES	Social learning (learning through observation or interaction with other individuals) is widespread in nature and is central to the remarkable success of humanity, yet it remains unclear why copying is profitable and how to copy most effectively. To address these questions, we organized a computer tournament in which entrants submitted strategies specifying how to use social learning and its asocial alternative (for example, trial-and-error learning) to acquire adaptive behavior in a complex environment. Most current theory predicts the emergence of mixed strategies that rely on some combination of the two types of learning. In the tournament, however, strategies that relied heavily on social learning were found to be remarkably successful, even when asocial information was no more costly than social information. Social learning proved advantageous because individuals frequently demonstrated the highest-payoff behavior in their repertoire, inadvertently filtering information for copiers. The winning strategy (discountmachine) relied nearly exclusively on social learning and weighted information according to the time since acquisition.	[Rendell, L.; Fogarty, L.; Laland, K. N.] Univ St Andrews, Sch Biol, Ctr Social Learning & Cognit Evolut, St Andrews KY16 9TS, Fife, Scotland; [Boyd, R.] Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90095 USA; [Cownden, D.] Queens Univ, Dept Math & Stat, Kingston, ON K7L 3N6, Canada; [Enquist, M.] Stockholm Univ, Dept Zool, S-11691 Stockholm, Sweden; [Enquist, M.; Eriksson, K.; Ghirlanda, S.] Stockholm Univ, Ctr Study Cultural Evolut, S-11691 Stockholm, Sweden; [Eriksson, K.] Malardalen Univ, Sch Educ Culture & Commun, S-72123 Vasteras, Sweden; [Feldman, M. W.] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Ghirlanda, S.] Univ Bologna, Dept Psychol, I-40127 Bologna, Italy; [Lillicrap, T.] Queens Univ, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada	University of St Andrews; University of California System; University of California Los Angeles; Queens University - Canada; Stockholm University; Stockholm University; Malardalen University; Stanford University; University of Bologna; Queens University - Canada	Rendell, L (corresponding author), Univ St Andrews, Sch Biol, Ctr Social Learning & Cognit Evolut, Queens Terrace, St Andrews KY16 9TS, Fife, Scotland.	ler4@st-andrews.ac.uk; knl1@st-andrews.ac.uk	Rendell, Luke/G-2594-2010; Edgar, William D/J-8792-2013; Eriksson, Kimmo/F-6253-2013; Rendell, Luke/AAF-9070-2019; Laland, Kevin N/C-9482-2011	Rendell, Luke/0000-0002-1121-9142; Edgar, William D/0000-0002-7996-9273; Eriksson, Kimmo/0000-0002-7164-0924; Cownden, Daniel/0000-0002-5348-4841; Ghirlanda, Stefano/0000-0002-7270-9612; Laland, Kevin/0000-0002-2457-0900	European Commission [FP6-2004-NESTPATH-043434]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028016] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge the use of the U.K. National Grid Service (www.grid-support.ac.uk) in carrying out this work. We thank all those who entered the tournament for contributing to its success. We are also very grateful to R. Axelrod for providing advice and support with regard to the tournament design. This research was supported by the CULTAPTATION project (European Commission contract FP6-2004-NESTPATH-043434).	[Anonymous], 2002, IMITATION ANIMALS AR; Apesteguia J, 2007, J ECON THEORY, V136, P217, DOI 10.1016/j.jet.2006.07.006; Auer P, 2002, MACH LEARN, V47, P235, DOI 10.1023/A:1013689704352; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bergemann D, 1996, ECONOMETRICA, V64, P1125, DOI 10.2307/2171959; Boyd R., 1985, CULTURE EVOLUTIONARY; CAVALLI-SFORZA L.L, 1981, CULTURAL TRANSMISSIO; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Enquist M, 2007, AM ANTHROPOL, V109, P727, DOI 10.1525/AA.2007.109.4.727; Feldman MW, 1996, ANTHROPOL SCI, V104, P209, DOI 10.1537/ase.104.209; Galef BG, 2009, ADV STUD BEHAV, V39, P117, DOI 10.1016/S0065-3454(09)39004-X; Giraldeau LA, 2002, PHILOS T R SOC B, V357, P1559, DOI 10.1098/rstb.2002.1065; Gross R, 2008, J R SOC INTERFACE, V5, P1193, DOI 10.1098/rsif.2007.1348; Henrich J, 2003, EVOL ANTHROPOL, V12, P123, DOI 10.1002/evan.10110; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; Henrich J, 2002, J COGNITION CULTURE, V2, P87, DOI [10.1163/156853702320281836, DOI 10.1163/156853702320281836]; HEYES CM, 1994, BIOL REV, V69, P207, DOI 10.1111/j.1469-185X.1994.tb01506.x; Hoppitt W, 2008, ADV STUD BEHAV, V38, P105, DOI 10.1016/S0065-3454(08)00003-X; Kameda T, 2002, EVOL HUM BEHAV, V23, P373, DOI 10.1016/S1090-5138(02)00101-0; Kendal J, 2009, J THEOR BIOL, V260, P210, DOI 10.1016/j.jtbi.2009.05.029; Kendal JR, 2009, BEHAV ECOL, V20, P238, DOI 10.1093/beheco/arp016; Koulouriotis DE, 2008, APPL MATH COMPUT, V196, P913, DOI 10.1016/j.amc.2007.07.043; Laland KN, 2004, LEARN BEHAV, V32, P4; Nino-Mora J, 2007, TOP, V15, P161, DOI 10.1007/s11750-007-0025-0; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Papadimitriou CH, 1999, MATH OPER RES, V24, P293, DOI 10.1287/moor.24.2.293; Rendell L, 2010, EVOLUTION, V64, P534, DOI 10.1111/j.1558-5646.2009.00817.x; Richerson P. J, 2005, NOT GENES ALONE; ROGERS AR, 1988, AM ANTHROPOL, V90, P819, DOI 10.1525/aa.1988.90.4.02a00030; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Schlag KH, 1998, J ECON THEORY, V78, P130, DOI 10.1006/jeth.1997.2347; Suddendorf T, 2007, BEHAV BRAIN SCI, V30, P299, DOI 10.1017/S0140525X07001975; Tilman D., 1982, Monographs in Population Biology, pi; van Bergen Y, 2004, P ROY SOC B-BIOL SCI, V271, P957, DOI 10.1098/rspb.2004.2684; Wakano JY, 2004, THEOR POPUL BIOL, V66, P249, DOI 10.1016/j.tpb.2004.06.005; Whitehead H, 2004, BIOL CONSERV, V120, P427, DOI 10.1016/j.biocon.2004.03.017	36	558	571	4	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2010	328	5975					208	213		10.1126/science.1184719	http://dx.doi.org/10.1126/science.1184719			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	580OU	20378813	Green Accepted			2022-12-28	WOS:000276459600037
J	Cahill, DP; Barker, FG; Davis, KR; Kalva, SP; Sahai, I; Frosch, MP				Cahill, Daniel P.; Barker, Fred G.; Davis, Kenneth R.; Kalva, Sanjeeva P.; Sahai, Inderneel; Frosch, Matthew P.			Case 10-2010: A 37-Year-Old Woman with Weakness and a Mass in the Brain.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MAGNETIC-RESONANCE SPECTROSCOPY; REACTIVE PROTEIN-LEVELS; OF-THE-LITERATURE; DIFFERENTIAL-DIAGNOSIS; MANAGEMENT; LOCUS; MAPS		[Cahill, Daniel P.; Barker, Fred G.] Massachusetts Gen Hosp, Neurosurg Serv, Boston, MA 02114 USA; [Davis, Kenneth R.; Kalva, Sanjeeva P.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Sahai, Inderneel] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Frosch, Matthew P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Cahill, Daniel P.; Barker, Fred G.] Harvard Univ, Sch Med, Dept Surg, Cambridge, MA 02138 USA; [Davis, Kenneth R.; Kalva, Sanjeeva P.] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Sahai, Inderneel] Harvard Univ, Sch Med, Dept Pediat, Cambridge, MA 02138 USA; [Frosch, Matthew P.] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Harvard University	Cahill, DP (corresponding author), Massachusetts Gen Hosp, Neurosurg Serv, Boston, MA 02114 USA.		Frosch, Matthew P/ABD-7456-2021	Frosch, Matthew P/0000-0002-3940-9861; Cahill, Daniel/0000-0003-2552-6546				Abdalla SA, 2006, J MED GENET, V43, P97, DOI 10.1136/jmg.2005.030833; Bagdatoglu H, 1992, J Neurosurg Sci, V36, P139; Bayrak-Toydemir P, 2006, AM J MED GENET A, V140A, P2155, DOI 10.1002/ajmg.a.31450; Bernardini Gary L, 2004, Curr Neurol Neurosci Rep, V4, P448, DOI 10.1007/s11910-004-0067-8; Carpenter J, 2007, EUR J CLIN MICROBIOL, V26, P1, DOI 10.1007/s10096-006-0236-6; Cole SG, 2005, J MED GENET, V42, P577, DOI 10.1136/jmg.2004.028712; Corson MA, 2001, ORAL DIS, V7, P61, DOI 10.1034/j.1601-0825.2001.0070112.x; Cottin V, 2007, MEDICINE, V86, P1, DOI 10.1097/MD.0b013e31802f8da1; Erdogan C, 2005, J COMPUT ASSIST TOMO, V29, P663, DOI 10.1097/01.rct.0000168868.50256.55; Fritsch M, 1997, MINIM INVAS NEUROSUR, V40, P103, DOI 10.1055/s-2008-1053427; GRIMSTAD IA, 1992, J NEUROSURG, V77, P732, DOI 10.3171/jns.1992.77.5.0732; GUTTMACHER AE, 1995, NEW ENGL J MED, V333, P918, DOI 10.1056/NEJM199510053331407; Hakan T, 2006, J INFECTION, V52, P359, DOI 10.1016/j.jinf.2005.07.019; HIRSCHBERG H, 1987, J NEUROSURG, V67, P358, DOI 10.3171/jns.1987.67.3.0358; Kapsalaki EZ, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/6/E7; Kastrup O, 2008, SEMIN NEUROL, V28, P511, DOI 10.1055/s-0028-1083688; Lai PH, 2007, SURG NEUROL, V68, pS25, DOI 10.1016/j.surneu.2007.07.080; Li X, 1999, ENDOD DENT TRAUMATOL, V15, P95; MAMELAK AN, 1995, NEUROSURGERY, V36, P76, DOI 10.1227/00006123-199501000-00010; Moorthy RK, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/6/E3; Shovlin CL, 2008, THORAX, V63, P259, DOI 10.1136/thx.2007.087452; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; Tseng JH, 2006, SURG NEUROL, V65, P557, DOI 10.1016/j.surneu.2005.09.029; 2003, N ENGL J MED, V348, P2125	24	9	10	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 8	2010	362	14					1326	1333		10.1056/NEJMcpc1000960	http://dx.doi.org/10.1056/NEJMcpc1000960			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579SN	20375410				2022-12-28	WOS:000276393700013
J	Adam, C; Vidal, V				Adam, Claudia; Vidal, Valerie			Mantle Flow Drives the Subsidence of Oceanic Plates	SCIENCE			English	Article							REGIONAL VARIATIONS; THERMAL STRUCTURE; AGE-DEPTH; HEAT-FLOW; CONVECTION; LITHOSPHERE; BATHYMETRY; TOPOGRAPHY; ANOMALIES; HOTSPOTS	The subsidence of the sea floor is generally considered a consequence of its passive cooling and densifying since its formation at the ridge and is therefore regarded as a function of lithospheric age only. However, the lithosphere is defined as the thermal boundary layer of mantle convection, which should thus determine its structure. We examined the evolution of the lithosphere structure and depth along trajectories representative of the underlying mantle flow. We show that along these flow lines, the sea-floor depth varies as the square root of the distance from the ridge (as given by the boundary-layer equation) along the entire plate, without any flattening. Contrary to previous models, no additional heat supply is required at the base of the lithosphere.	[Adam, Claudia] Japan Agcy Marine Earth Sci & Technol, Inst Res Earth Evolut, Yokosuka, Kanagawa 2370061, Japan; [Adam, Claudia] Univ Evora, Ctr Geofis, P-7002554 Evora, Portugal; [Vidal, Valerie] Univ Lyon, Ecole Normale Super Lyon, CNRS, Phys Lab, F-69364 Lyon 07, France	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of Evora; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Adam, C (corresponding author), Japan Agcy Marine Earth Sci & Technol, Inst Res Earth Evolut, 2-15 Natsushima, Yokosuka, Kanagawa 2370061, Japan.	adam@uevora.pt	M & C, Matter & Complexity/B-9044-2011	Adam, Claudia/0000-0003-0602-2158; Vidal, Valerie/0000-0002-0413-1601				Cochran JR, 2001, J GEOPHYS RES-SOL EA, V106, P19233, DOI 10.1029/2001JB000379; Conrad CP, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB002991; Crosby AG, 2006, GEOPHYS J INT, V166, P553, DOI 10.1111/j.1365-246X.2006.03015.x; DAVIES GF, 1992, J GEOL, V100, P151, DOI 10.1086/629582; DAVIES GF, 1988, J GEOPHYS RES-SOLID, V93, P10467, DOI 10.1029/JB093iB09p10467; Doin MP, 1996, EARTH PLANET SC LETT, V142, P121, DOI 10.1016/0012-821X(96)00082-9; Doin MP, 2000, GEOPHYS J INT, V143, P582, DOI 10.1046/j.1365-246X.2000.00229.x; EBERLE MA, 1995, GEOPHYS RES LETT, V22, P473, DOI 10.1029/94GL03297; GAFFIN SR, 1994, GEOPHYS RES LETT, V21, P1947, DOI 10.1029/94GL01594; Gripp AE, 2002, GEOPHYS J INT, V150, P321, DOI 10.1046/j.1365-246X.2002.01627.x; Huang JS, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003153; Humler E, 1999, EARTH PLANET SC LETT, V173, P7, DOI 10.1016/S0012-821X(99)00218-6; KANE KA, 1994, J GEOPHYS RES-SOL EA, V99, P21759, DOI 10.1029/94JB01747; LAGO B, 1990, PHYS EARTH PLANET IN, V61, P253, DOI 10.1016/0031-9201(90)90109-B; MARTY JC, 1989, EARTH PLANET SC LETT, V94, P301, DOI 10.1016/0012-821X(89)90148-9; Muller RD, 1997, J GEOPHYS RES-SOL EA, V102, P3211, DOI 10.1029/96JB01781; PARKER RL, 1973, NATURE-PHYS SCI, V242, P137, DOI 10.1038/physci242137a0; PARSONS B, 1978, J GEOPHYS RES, V83, P4485, DOI 10.1029/JB083iB09p04485; PARSONS B, 1977, J GEOPHYS RES, V82, P803, DOI 10.1029/JB082i005p00803; Perrot K, 1998, EARTH PLANET SC LETT, V160, P593, DOI 10.1016/S0012-821X(98)00114-9; SCHROEDER W, 1984, J GEOPHYS RES, V89, P9873, DOI 10.1029/JB089iB12p09873; SCLATER JG, 1975, J GEOPHYS RES, V80, P1031, DOI 10.1029/JB080i008p01031; Sharp WD, 2006, SCIENCE, V313, P1281, DOI 10.1126/science.1128489; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; STEIN CA, 1992, NATURE, V359, P123, DOI 10.1038/359123a0; TURCOTTE T, 2002, GEODYNAMICS; YUEN DA, 1985, NATURE, V313, P125, DOI 10.1038/313125a0	27	19	19	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 2	2010	328	5974					83	85		10.1126/science.1185906	http://dx.doi.org/10.1126/science.1185906			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577DR	20360105	Green Submitted			2022-12-28	WOS:000276202200039
J	Neronov, A; Vovk, I				Neronov, Andrii; Vovk, Ievgen			Evidence for Strong Extragalactic Magnetic Fields from Fermi Observations of TeV Blazars	SCIENCE			English	Article							ACTIVE GALACTIC NUCLEI; GAMMA-RAY EMISSION; BACKGROUND-RADIATION; HESS; DISCOVERY; CONSTRAINTS; LIMITS	Magnetic fields in galaxies are produced via the amplification of seed magnetic fields of unknown nature. The seed fields, which might exist in their initial form in the intergalactic medium, were never detected. We report a lower bound B >= 3 x 10(-16) gauss on the strength of intergalactic magnetic fields, which stems from the nonobservation of GeV gamma-ray emission from electromagnetic cascade initiated by tera-electron volt gamma rays in intergalactic medium. The bound improves as lambda(-1/2)(B) if magnetic field correlation length, lambda(B), is much smaller than a megaparsec. This lower bound constrains models for the origin of cosmic magnetic fields.	[Neronov, Andrii; Vovk, Ievgen] Observ Geneva, ISDC Data Ctr Astrophys, CH-1290 Versoix, Switzerland	University of Geneva	Neronov, A (corresponding author), Observ Geneva, ISDC Data Ctr Astrophys, Ch Ecogia 16, CH-1290 Versoix, Switzerland.	Andrii.Neronov@unige.ch	Neronov, Andrii/U-6691-2019					Abdo AA, 2009, ASTROPHYS J, V707, P1310, DOI 10.1088/0004-637X/707/2/1310; Aharonian F, 2008, ASTRON ASTROPHYS, V478, P387, DOI 10.1051/0004-6361:20078604; Aharonian F, 2007, ASTRON ASTROPHYS, V475, pL9, DOI 10.1051/0004-6361:20078462; Aharonian F, 2007, ASTRON ASTROPHYS, V473, pL25, DOI 10.1051/0004-6361:20078412; Aharonian F, 2007, ASTRON ASTROPHYS, V470, P475, DOI 10.1051/0004-6361:20077057; Aharonian F, 2006, ASTRON ASTROPHYS, V455, P461, DOI 10.1051/0004-6361:20054732; Aharonian F, 2006, NATURE, V440, P1018, DOI 10.1038/nature04680; AHARONIAN FA, 1994, ASTROPHYS J, V423, pL5, DOI 10.1086/187222; Barrow JD, 1997, PHYS REV LETT, V78, P3610, DOI 10.1103/PhysRevLett.78.3610; Blasi P, 1999, ASTROPHYS J, V514, pL79, DOI 10.1086/311958; BLUMENTHAL GR, 1970, REV MOD PHYS, V42, P237, DOI 10.1103/RevModPhys.42.237; d'Avezac P, 2007, ASTRON ASTROPHYS, V469, P857, DOI 10.1051/0004-6361:20066712; Demozzi V, 2009, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2009/08/025; Diaz-Gil A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.241301; Dolag K, 1999, ASTRON ASTROPHYS, V348, P351; Dolag K, 2005, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2005/01/009; Dolag K, 2009, ASTROPHYS J, V703, P1078, DOI 10.1088/0004-637X/703/1/1078; Durrer R, 2000, PHYS REV D, V61, DOI 10.1103/PhysRevD.61.043001; Elyiv A, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.023010; Fan YZ, 2004, ASTRON ASTROPHYS, V415, P483, DOI 10.1051/0004-6361:20034472; Franceschini A, 2008, ASTRON ASTROPHYS, V487, P837, DOI 10.1051/0004-6361:200809691; Giovannini M, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.063003; GOULD RJ, 1967, PHYS REV, V155, P1404, DOI 10.1103/PhysRev.155.1404; GOULD RJ, 1966, PHYS REV LETT, V16, P252, DOI 10.1103/PhysRevLett.16.252; Grasso D, 2001, PHYS REP, V348, P163, DOI 10.1016/S0370-1573(00)00110-1; HOGAN CJ, 1983, PHYS REV LETT, V51, P1488, DOI 10.1103/PhysRevLett.51.1488; Jedamzik K, 2000, PHYS REV LETT, V85, P700, DOI 10.1103/PhysRevLett.85.700; Kahniashvili T, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.023009; Kristiansen JR, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.123004; KRONBERG PP, 1994, REP PROG PHYS, V57, P325, DOI 10.1088/0034-4885/57/4/001; Kulsrud RM, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/4/046901; Lewis A, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.043011; Mack A, 2002, PHYS REV D, V65, DOI 10.1103/PhysRevD.65.123004; Murase K, 2008, ASTROPHYS J LETT, V686, pL67, DOI 10.1086/592997; Neronov A, 2007, JETP LETT+, V85, P473, DOI 10.1134/S0021364007100013; Neronov A, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.123012; PLAGA R, 1995, NATURE, V374, P430, DOI 10.1038/374430a0; QUASHNOCK JM, 1989, ASTROPHYS J, V344, pL49, DOI 10.1086/185528; RATRA B, 1992, ASTROPHYS J, V391, pL1, DOI 10.1086/186384; Seshadri TR, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.081303; Seshadri TR, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.101301; Sigl G, 1997, PHYS REV D, V55, P4582, DOI 10.1103/PhysRevD.55.4582; Subramanian K, 1998, PHYS REV LETT, V81, P3575, DOI 10.1103/PhysRevLett.81.3575; TURNER MS, 1988, PHYS REV D, V37, P2743, DOI 10.1103/PhysRevD.37.2743; VACHASPATI T, 1991, PHYS LETT B, V265, P258, DOI 10.1016/0370-2693(91)90051-Q; Vallee JP, 2004, NEW ASTRON REV, V48, P763, DOI 10.1016/j.newar.2004.03.017; Widrow LM, 2002, REV MOD PHYS, V74, P775, DOI 10.1103/RevModPhys.74.775; Yamazaki DG, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.043005	48	644	645	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	2010	328	5974					73	75		10.1126/science.1184192	http://dx.doi.org/10.1126/science.1184192			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577DR	20360103	Green Submitted			2022-12-28	WOS:000276202200036
J	Ray-Gallet, D; Almouzni, G				Ray-Gallet, Dominique; Almouzni, Genevieve			Mixing or Not Mixing	SCIENCE			English	Editorial Material							NUCLEOSOME ASSEMBLY PATHWAYS; H3; REPLICATION; VARIANTS; H4		[Ray-Gallet, Dominique; Almouzni, Genevieve] Inst Curie, CNRS, UMR218, Lab Nucl Dynam & Genome Plast, F-75248 Paris 05, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS)	Ray-Gallet, D (corresponding author), Inst Curie, CNRS, UMR218, Lab Nucl Dynam & Genome Plast, 26 Rue Ulm, F-75248 Paris 05, France.	Genevieve.Almouzni@curie.fr	Almouzni, Genevieve/ABG-1029-2021; Ray-Gallet, Dominique/A-9224-2019	Almouzni, Genevieve/0000-0001-5570-0723; 				Allis C. D., 2006, EPIGENETICS; Annunziato AT, 2005, J BIOL CHEM, V280, P12065, DOI 10.1074/jbc.R400039200; Benson LJ, 2006, J BIOL CHEM, V281, P9287, DOI 10.1074/jbc.M512956200; English CM, 2005, BIOCHEMISTRY-US, V44, P13673, DOI 10.1021/bi051333h; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Nakatani Y, 2004, COLD SPRING HARB SYM, V69, P273, DOI 10.1101/sqb.2004.69.273; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; Sarma K, 2005, NAT REV MOL CELL BIO, V6, P139, DOI 10.1038/nrm1567; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Xu M, 2010, SCIENCE, V328, P94, DOI 10.1126/science.1178994	13	10	11	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	2010	328	5974					56	57		10.1126/science.1188653	http://dx.doi.org/10.1126/science.1188653			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577DR	20360101				2022-12-28	WOS:000276202200032
J	Frearson, JA; Brand, S; McElroy, SP; Cleghorn, LAT; Smid, O; Stojanovski, L; Price, HP; Guther, MLS; Torrie, LS; Robinson, DA; Hallyburton, I; Mpamhanga, CP; Brannigan, JA; Wilkinson, AJ; Hodgkinson, M; Hui, R; Qiu, W; Raimi, OG; van Aalten, DMF; Brenk, R; Gilbert, IH; Read, KD; Fairlamb, AH; Ferguson, MAJ; Smith, DF; Wyatt, PG				Frearson, Julie A.; Brand, Stephen; McElroy, Stuart P.; Cleghorn, Laura A. T.; Smid, Ondrej; Stojanovski, Laste; Price, Helen P.; Guther, M. Lucia S.; Torrie, Leah S.; Robinson, David A.; Hallyburton, Irene; Mpamhanga, Chidochangu P.; Brannigan, James A.; Wilkinson, Anthony J.; Hodgkinson, Michael; Hui, Raymond; Qiu, Wei; Raimi, Olawale G.; van Aalten, Daan M. F.; Brenk, Ruth; Gilbert, Ian H.; Read, Kevin D.; Fairlamb, Alan H.; Ferguson, Michael A. J.; Smith, Deborah F.; Wyatt, Paul G.			N-myristoyltransferase inhibitors as new leads to treat sleeping sickness	NATURE			English	Article							VARIANT SURFACE GLYCOPROTEIN; TRYPANOSOMA-BRUCEI; AFRICAN TRYPANOSOMES; MYRISTOYL-COA; DRUG TARGET; SUBSTRATE PROTEINS; ENDOCYTOSIS; LEISHMANIA; TRAFFICKING; COMPLEXES	African sleeping sickness or human African trypanosomiasis, caused by Trypanosoma brucei spp., is responsible for similar to 30,000 deaths each year. Available treatments for this disease are poor, with unacceptable efficacy and safety profiles, particularly in the late stage of the disease when the parasite has infected the central nervous system. Here we report the validation of a molecular target and the discovery of associated lead compounds with the potential to address this lack of suitable treatments. Inhibition of this target-T. brucei N-myristoyltransferase-leads to rapid killing of trypanosomes both in vitro and in vivo and cures trypanosomiasis in mice. These high-affinity inhibitors bind into the peptide substrate pocket of the enzyme and inhibit protein N-myristoylation in trypanosomes. The compounds identified have promising pharmaceutical properties and represent an opportunity to develop oral drugs to treat this devastating disease. Our studies validate T. brucei N-myristoyltransferase as a promising therapeutic target for human African trypanosomiasis.	[Frearson, Julie A.; Brand, Stephen; McElroy, Stuart P.; Cleghorn, Laura A. T.; Smid, Ondrej; Stojanovski, Laste; Guther, M. Lucia S.; Torrie, Leah S.; Robinson, David A.; Hallyburton, Irene; Mpamhanga, Chidochangu P.; Brenk, Ruth; Gilbert, Ian H.; Read, Kevin D.; Fairlamb, Alan H.; Ferguson, Michael A. J.; Wyatt, Paul G.] Univ Dundee, Div Biol Chem & Drug Discovery, Drug Discovery Unit, Coll Life Sci, Dundee DD1 5EH, Scotland; [Raimi, Olawale G.; van Aalten, Daan M. F.] Univ Dundee, Div Mol Microbiol, Coll Life Sci, Dundee DD1 5EH, Scotland; [Price, Helen P.; Hodgkinson, Michael; Smith, Deborah F.] Univ York, Dept Biol, Ctr Immunol & Infect, York YO10 5YW, N Yorkshire, England; [Brannigan, James A.; Wilkinson, Anthony J.] Univ York, Dept Chem, Struct Biol Lab, York YO10 5YW, N Yorkshire, England; [Price, Helen P.; Hodgkinson, Michael; Smith, Deborah F.] Univ York, Hull York Med Sch, York YO10 5YW, N Yorkshire, England; [Hui, Raymond; Qiu, Wei] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada	University of Dundee; University of Dundee; University of York - UK; University of York - UK; University of Hull; University of York - UK; University of Toronto; Structural Genomics Consortium	Wyatt, PG (corresponding author), Univ Dundee, Div Biol Chem & Drug Discovery, Drug Discovery Unit, Coll Life Sci, Dundee DD1 5EH, Scotland.	p.g.wyatt@dundee.ac.uk	Ferguson, Michael A. J./F-7829-2010; Fairlamb, Alan/A-5272-2009	Ferguson, Michael A. J./0000-0003-1321-8714; Fairlamb, Alan/0000-0001-5134-0329; Raimi, Olawale G./0000-0003-2782-7318; Price, Helen/0000-0003-1537-4390; van Aalten, Daan/0000-0002-1499-6908; Wilkinson, Anthony/0000-0003-4577-9479; Wyatt, Paul/0000-0002-0397-245X; Cleghorn, Laura/0000-0001-6218-0092; Gilbert, Ian/0000-0002-5238-1314; Brenk, Ruth/0000-0002-6204-5488; Robinson, David/0000-0003-1979-5918; Hallyburton, Irene/0000-0003-4883-5560; Brand, Stephen/0000-0002-7010-5348	Wellcome Trust [WT077705, WT083481, WT077503, WT085622]; Scottish Funding Council [HR04013]; Translational Biology Theme of SULSA; European Regional Development Fund; Wolfson Foundation; Canadian Institutes for Health Research [1097737]; Canadian Foundation for Innovation and Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation, Merck; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; Medical Research Council [G0900138] Funding Source: researchfish; MRC [G0900138] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Scottish Funding Council; Translational Biology Theme of SULSA; European Regional Development Fund(European Commission); Wolfson Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation and Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet(GlaxoSmithKline); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation, Merck; Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Wellcome Trust (WT077705, WT083481, WT077503 and WT085622), Scottish Funding Council (HR04013) and by the Translational Biology Theme of SULSA. We thank the European Regional Development Fund and the Wolfson Foundation for grants that provided relevant infrastructure for this work. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation and Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck, the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. Wewould like to thank all members of the Drug Discovery Unit for their technical assistance in this study, particularly B. Rao, I. Collie and D. James.	Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; Armah DA, 1999, J BIOL CHEM, V274, P5931, DOI 10.1074/jbc.274.9.5931; Bhatnagar RS, 1999, BBA-MOL CELL BIOL L, V1441, P162, DOI 10.1016/S1388-1981(99)00155-9; Bowyer PW, 2008, CHEMMEDCHEM, V3, P402, DOI 10.1002/cmdc.200700301; Bowyer PW, 2007, BIOCHEM J, V408, P173, DOI 10.1042/BJ20070692; Brenk R, 2008, CHEMMEDCHEM, V3, P435, DOI 10.1002/cmdc.200700139; Denny PW, 2000, J BIOL CHEM, V275, P11017, DOI 10.1074/jbc.275.15.11017; DOERING TL, 1991, SCIENCE, V252, P1851, DOI 10.1126/science.1829548; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engstler M, 2007, CELL, V131, P505, DOI 10.1016/j.cell.2007.08.046; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Farazi TA, 2001, BIOCHEMISTRY-US, V40, P6335, DOI 10.1021/bi0101401; FERGUSON MAJ, 1985, J BIOL CHEM, V260, P4547; FERGUSON MAJ, 1984, J BIOL CHEM, V259, P3011; Georgopapadakou NH, 2002, EXPERT OPIN INV DRUG, V11, P1117, DOI 10.1517/13543784.11.8.1117; Giang DG, 1998, J BIOL CHEM, V273, P6595, DOI 10.1074/jbc.273.12.6595; Hall B, 2004, MOL BIOCHEM PARASIT, V138, P67, DOI 10.1016/j.molbiopara.2004.07.007; Hertz-Fowler C, 2001, MOL BIOCHEM PARASIT, V116, P25, DOI 10.1016/S0166-6851(01)00296-1; Hill BT, 2005, J VIROL, V79, P1133, DOI 10.1128/JVI.79.2.1133-1141.2005; Maurer-Stroh S, 2002, J MOL BIOL, V317, P541, DOI 10.1006/jmbi.2002.5426; Mills E, 2007, MOL BIOCHEM PARASIT, V152, P22, DOI 10.1016/j.molbiopara.2006.11.008; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Overath P, 2004, MOL MICROBIOL, V53, P735, DOI 10.1111/j.1365-2958.2004.04224.x; Panethymitaki C, 2006, BIOCHEM J, V396, P277, DOI 10.1042/BJ20051886; Patterson S, 2009, CHEMMEDCHEM, V4, P1341, DOI 10.1002/cmdc.200900098; Price HP, 2007, MOL BIOL CELL, V18, P864, DOI 10.1091/mbc.E06-08-0736; Price HP, 2010, MOL BIOCHEM PARASIT, V169, P55, DOI 10.1016/j.molbiopara.2009.09.006; Price HP, 2005, J CELL SCI, V118, P831, DOI 10.1242/jcs.01624; Price HP, 2003, J BIOL CHEM, V278, P7206, DOI 10.1074/jbc.M211391200; Raz B, 1997, ACTA TROP, V68, P139, DOI 10.1016/S0001-706X(97)00079-X; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Selvakumar P, 2007, PROG LIPID RES, V46, P1, DOI 10.1016/j.plipres.2006.05.002; Sheng CQ, 2009, J COMPUT AID MOL DES, V23, P375, DOI 10.1007/s10822-009-9267-2; Sienkiewicz N, 2008, MOL MICROBIOL, V69, P520, DOI 10.1111/j.1365-2958.2008.06305.x; Thuita JK, 2008, ACTA TROP, V108, P6, DOI 10.1016/j.actatropica.2008.07.006; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wingard Jennifer N, 2008, J Biol Chem, V283, P23388, DOI 10.1074/jbc.M803178200	39	214	215	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 1	2010	464	7289					728	U100		10.1038/nature08893	http://dx.doi.org/10.1038/nature08893			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	577EO	20360736	Green Accepted			2022-12-28	WOS:000276205000038
J	Rosing, MT; Bird, DK; Sleep, NH; Bjerrum, CJ				Rosing, Minik T.; Bird, Dennis K.; Sleep, Norman H.; Bjerrum, Christian J.			No climate paradox under the faint early Sun	NATURE			English	Article							CONTINENTAL-CRUST; ATMOSPHERIC CO2; EVOLUTION; OXYGEN; EARTH; MODELS; CH4; GREENHOUSE; PALEOSOLS; GREENLAND	Environmental niches in which life first emerged and later evolved on the Earth have undergone dramatic changes in response to evolving tectonic/geochemical cycles and to biologic interventions(1-3), as well as increases in the Sun's luminosity of about 25 to 30 per cent over the Earth's history(4). It has been inferred that the greenhouse effect of atmospheric CO2 and/or CH4 compensated for the lower solar luminosity and dictated an Archaean climate in which liquid water was stable in the hydrosphere(5-8). Here we demonstrate, however, that the mineralogy of Archaean sediments, particularly the ubiquitous presence of mixed-valence Fe(II-III) oxides (magnetite) in banded iron formations(9) is inconsistent with such high concentrations of greenhouse gases and the metabolic constraints of extant methanogens. Prompted by this, and the absence of geologic evidence for very high greenhouse-gas concentrations(10-13), we hypothesize that a lower albedo on the Earth, owing to considerably less continental area and to the lack of biologically induced cloud condensation nuclei(14), made an important contribution to moderating surface temperature in the Archaean eon. Our model calculations suggest that the lower albedo of the early Earth provided environmental conditions above the freezing point of water, thus alleviating the need for extreme greenhouse-gas concentrations to satisfy the faint early Sun paradox.	[Rosing, Minik T.; Bird, Dennis K.; Bjerrum, Christian J.] Univ Copenhagen, Nord Ctr Earth Evolut, DK-1350 Copenhagen K, Denmark; [Rosing, Minik T.] Univ Copenhagen, Nat Hist Museum Denmark, DK-1350 Copenhagen K, Denmark; [Bjerrum, Christian J.] Univ Copenhagen, Dept Geog & Geol, DK-1350 Copenhagen K, Denmark; [Rosing, Minik T.; Bird, Dennis K.] Stanford Univ, Dept Geol & Environm Sci, Stanford, CA 94305 USA; [Sleep, Norman H.] Stanford Univ, Dept Geophys, Stanford, CA 94305 USA	University of Copenhagen; University of Copenhagen; University of Copenhagen; Stanford University; Stanford University	Rosing, MT (corresponding author), Univ Copenhagen, Nord Ctr Earth Evolut, Oster Voldgade 5-7, DK-1350 Copenhagen K, Denmark.	minik@snm.ku.dk	Rosing, Minik/A-9977-2013; Bjerrum, Christian/A-4247-2015; Bjerrum, Christian Jannik/AAZ-5488-2021	Rosing, Minik/0000-0001-7559-661X; Bjerrum, Christian/0000-0002-7804-1633; Bjerrum, Christian Jannik/0000-0002-7804-1633	Danish National Research Foundation; Allan C. Cox Professorship; Department of Geological and Environmental Sciences, Stanford University; NSF	Danish National Research Foundation(Danmarks Grundforskningsfond); Allan C. Cox Professorship; Department of Geological and Environmental Sciences, Stanford University(Stanford University); NSF(National Science Foundation (NSF))	This study was carried out at the Nordic Center for Earth Evolution funded by the Danish National Research Foundation and the research was supported by an Allan C. Cox Professorship to M. T. R. and endowment funds from the Department of Geological and Environmental Sciences from Stanford University to D. K. B., and NSF grants to N. H. S. We are grateful for comments from D. Lowe, D. Canfield, F. Selsis, P. Ditlevsen and the "Ice and climate group'' of the Niels Bohr Institute. We thank R. Caballero and J. Bendtsen for comments on the radiation balance model. We thank J. Kasting, A. Lenardic and N. Sheldon for constructive reviews.	ARMSTRONG RL, 1991, AUST J EARTH SCI, V38, P613, DOI 10.1080/08120099108727995; Bjerrum CJ, 2002, NATURE, V417, P159, DOI 10.1038/417159a; CABALLERO R, 2008, CLIMT OBJECT ORIENTE; CALDEIRA K, 1992, NATURE, V360, P721, DOI 10.1038/360721a0; Canfield DE, 2006, PHILOS T R SOC B, V361, P1819, DOI 10.1098/rstb.2006.1906; CATLING DC, 2001, EARTH SCI, V293, P839; Chapelle FH, 2002, NATURE, V415, P312, DOI 10.1038/415312a; CHARECHA P, 2005, GEOBIOLOGY, V3, P53; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Collerson KD, 1999, SCIENCE, V283, P1519, DOI 10.1126/science.283.5407.1519; Condie KC, 2000, TECTONOPHYSICS, V322, P153, DOI 10.1016/S0040-1951(00)00061-5; Flament N, 2008, EARTH PLANET SC LETT, V275, P326, DOI 10.1016/j.epsl.2008.08.029; GOUGH DO, 1981, SOL PHYS, V74, P21, DOI 10.1007/BF00151270; Haqq-Misra JD, 2008, ASTROBIOLOGY, V8, P1127, DOI 10.1089/ast.2007.0197; Hartmann D. L., 1994, GLOBAL PHYS CLIMATOL; Hessler AM, 2004, NATURE, V428, P736, DOI 10.1038/nature02471; Hoehler TM, 2002, ANTON LEEUW INT J G, V81, P575, DOI 10.1023/A:1020517924466; Jaffres JBD, 2007, EARTH-SCI REV, V83, P83, DOI 10.1016/j.earscirev.2007.04.002; JOHNSON JW, 1992, COMPUT GEOSCI-UK, V18, P899, DOI 10.1016/0098-3004(92)90029-Q; Kasting JF, 2006, EARTH PLANET SC LETT, V252, P82, DOI 10.1016/j.epsl.2006.09.029; Kasting JF, 2001, ORIGINS LIFE EVOL B, V31, P271, DOI 10.1023/A:1010600401718; KASTING JF, 1993, SCIENCE, V259, P920, DOI 10.1126/science.11536547; Kiehl JT, 1997, B AM METEOROL SOC, V78, P197, DOI 10.1175/1520-0477(1997)078<0197:EAGMEB>2.0.CO;2; KIEHL JT, 1987, J GEOPHYS RES-ATMOS, V92, P2991, DOI 10.1029/JD092iD03p02991; KLEIN C, 1992, DEV PRECAMBRIAN GEOL, V10, P383, DOI DOI 10.1016/S0166-2635%2808%2970124-5; Knauth LP, 2003, GEOL SOC AM BULL, V115, P566, DOI 10.1130/0016-7606(2003)115<0566:HACTIF>2.0.CO;2; Kral TA, 1998, ORIGINS LIFE EVOL B, V28, P311, DOI 10.1023/A:1006552412928; Kump LR, 2008, SCIENCE, V320, P195, DOI 10.1126/science.1153883; Kump LR, 2001, GEOCHEM GEOPHY GEOSY, V2; Lowe DR, 2004, GEOLOGY, V32, P493, DOI 10.1130/G20342.1; MCLENNAN SM, 1983, NATURE, V306, P169, DOI 10.1038/306169a0; Nagler TF, 1998, PRECAMBRIAN RES, V91, P233, DOI 10.1016/S0301-9268(98)00051-5; Ohmoto H, 2004, NATURE, V429, P395, DOI 10.1038/nature02573; Pavlov AA, 2000, J GEOPHYS RES-PLANET, V105, P11981, DOI 10.1029/1999JE001134; Peck WH, 2001, GEOCHIM COSMOCHIM AC, V65, P4215, DOI 10.1016/S0016-7037(01)00711-6; Peixoto J.P., 1992, PHYS CLIMATE, P520; Rey PF, 2008, GEOLOGY, V36, P635, DOI 10.1130/G25031A.1;; Rosing MT, 2004, EARTH PLANET SC LETT, V217, P237, DOI 10.1016/S0012-821X(03)00609-5; Rosing MT, 1996, GEOLOGY, V24, P43, DOI 10.1130/0091-7613(1996)024<0043:EPOESS>2.3.CO;2; ROSSOW WB, 1982, SCIENCE, V217, P1245, DOI 10.1126/science.217.4566.1245; RYE R, 1995, NATURE, V378, P603, DOI 10.1038/378603a0; Rye R, 1998, AM J SCI, V298, P621, DOI 10.2475/ajs.298.8.621; Sheldon ND, 2006, PRECAMBRIAN RES, V147, P148, DOI 10.1016/j.precamres.2006.02.004; Sleep NH, 2006, EARTH PLANET SC LETT, V241, P594, DOI 10.1016/j.epsl.2005.11.020; Sleep NH, 2007, GEOBIOLOGY, V5, P101, DOI 10.1111/j.1472-4669.2007.00105.x; Tice MM, 2004, NATURE, V431, P549, DOI 10.1038/nature02888; Valley JW, 2002, GEOLOGY, V30, P351, DOI 10.1130/0091-7613(2002)030<0351:ACEE>2.0.CO;2; Wielicki BA, 1996, B AM METEOROL SOC, V77, P853, DOI 10.1175/1520-0477(1996)077<0853:CATERE>2.0.CO;2; Wilde SA, 2001, NATURE, V409, P175, DOI 10.1038/35051550	51	159	163	1	126	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 1	2010	464	7289					744	U117		10.1038/nature08955	http://dx.doi.org/10.1038/nature08955			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577EO	20360739				2022-12-28	WOS:000276205000042
J	Sarewitz, D				Sarewitz, Daniel			Missing weapons	NATURE			English	Editorial Material									Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC USA	Arizona State University	Sarewitz, D (corresponding author), Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC USA.	dsarewitz@gmail.com							0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 1	2010	464	7289					672	672		10.1038/464672a	http://dx.doi.org/10.1038/464672a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	577EO	20360712	Bronze			2022-12-28	WOS:000276205000014
J	Winstock, AR; Ford, C; Witton, J				Winstock, Adam R.; Ford, Chris; Witton, John			Assessment and management of cannabis use disorders in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Review							WITHDRAWAL; MARIJUANA; DEPENDENCE; OUTCOMES; TOBACCO; RISK		[Winstock, Adam R.; Witton, John] Kings Coll London, Inst Psychiat, Natl Addict Ctr, London SE5 8AF, England; [Ford, Chris] NTA, SMMGP, London SE1 6LH, England	University of London; King's College London	Winstock, AR (corresponding author), Kings Coll London, Inst Psychiat, Natl Addict Ctr, London SE5 8AF, England.	Adam.winstock@kcl.ac.uk		Winstock, Adam/0000-0001-7854-8015				Aldington S, 2008, EUR RESPIR J, V31, P280, DOI 10.1183/09031936.00065707; Aldington S, 2007, THORAX, V62, P1058, DOI 10.1136/thx.2006.077081; *ASH SCOTL HLTH SC, 2008, FAGS N HASH ESS GUID; Budney AJ, 2004, AM J PSYCHIAT, V161, P1967, DOI 10.1176/appi.ajp.161.11.1967; Budney AJ, 2007, DRUG ALCOHOL DEPEN, V86, P22, DOI 10.1016/j.drugalcdep.2006.04.014; Copeland J, 2009, MANAGEMENT CANNABIS; Crippa JA, 2009, HUM PSYCHOPHARM CLIN, V24, P515, DOI 10.1002/hup.1048; Dennis M, 2002, ADDICTION, V97, P4, DOI 10.1046/j.1360-0443.97.s01.10.x; *DEP HLTH NAT TREA, 2009, STAT NAT DRUG TREATM; DiClemente C.C., 2002, MOTIVATIONAL INTERVI, V2nd ed., P201; Hall W, 2009, LANCET, V374, P1383, DOI 10.1016/S0140-6736(09)61037-0; Haney M, 2001, PSYCHOPHARMACOLOGY, V155, P171, DOI 10.1007/s002130000657; HARDWICK S, 2008, HOME OFFICE POTENCY; Henry JA, 2003, BRIT MED J, V326, P942, DOI 10.1136/bmj.326.7396.942; Hoare J., 2009, DRUG MISUSE DECLARED; Litt MD, 2008, ADDICTION, V103, P638, DOI 10.1111/j.1360-0443.2008.02137.x; McCambridge J, 2004, ADDICTION, V99, P39, DOI 10.1111/j.1360-0443.2004.00564.x; Moore BA, 2001, J SUBST ABUSE, V13, P583, DOI 10.1016/S0899-3289(01)00093-1; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Smith N, 2005, ADDICTION, V100, P1558, DOI 10.1111/j.1360-0443.2005.01295.x; Solowij N, 2002, JAMA-J AM MED ASSOC, V287, P1123, DOI 10.1001/jama.287.9.1123; Sugranyes G, 2009, EUR PSYCHIAT, V24, P282, DOI 10.1016/j.eurpsy.2009.01.002; Tan WC, 2009, CAN MED ASSOC J, V180, P814, DOI 10.1503/cmaj.081040; Taylor DR, 2002, ADDICTION, V97, P1055, DOI 10.1046/j.1360-0443.2002.00169.x; Vandrey R, 2009, CNS DRUGS, V23, P543, DOI 10.2165/00023210-200923070-00001; Verdoux H, 2003, PSYCHOL MED, V33, P23, DOI 10.1017/S0033291702006384; Winstock AR, 2009, J PSYCHOPHARMACOL, V23, P84, DOI 10.1177/0269881108089584; Yucel M, 2008, ARCH GEN PSYCHIAT, V65, P694, DOI 10.1001/archpsyc.65.6.694; Zammit S, 2008, BRIT J PSYCHIAT, V193, P357, DOI 10.1192/bjp.bp.107.046375	29	25	26	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2010	340								c1571	10.1136/bmj.c1571	http://dx.doi.org/10.1136/bmj.c1571			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	579VM	20360216				2022-12-28	WOS:000276404500006
J	Nestle, M				Nestle, Marion			Health Care Reform in Action -- Calorie Labeling Goes National.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NYU, Dept Nutr Food Studies & Publ Hlth, New York, NY 10012 USA	New York University	Nestle, M (corresponding author), NYU, Dept Nutr Food Studies & Publ Hlth, New York, NY 10012 USA.							Center for Science in the Public Interest, 2003, AN GUESS NEED NUTR L; Elbel B, 2009, HEALTH AFFAIR, V28, pW1110, DOI 10.1377/hlthaff.28.6.w1110; Farley TA, 2009, HEALTH AFFAIR, V28, pW1098, DOI 10.1377/hlthaff.28.6.w1098; Larson N, 2009, MENU LABELING DOES P; Urban LE, 2010, J AM DIET ASSOC, V110, P116, DOI 10.1016/j.jada.2009.10.003	5	34	34	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 24	2010	362	25					2343	2345		10.1056/NEJMp1003814	http://dx.doi.org/10.1056/NEJMp1003814			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	614GO	20375399				2022-12-28	WOS:000279043800002
J	Asselin-Labat, ML; Vaillant, F; Sheridan, JM; Pal, B; Wu, D; Simpson, ER; Yasuda, H; Smyth, GK; Martin, TJ; Lindeman, GJ; Visvader, JE				Asselin-Labat, Marie-Liesse; Vaillant, Francois; Sheridan, Julie M.; Pal, Bhupinder; Wu, Di; Simpson, Evan R.; Yasuda, Hisataka; Smyth, Gordon K.; Martin, T. John; Lindeman, Geoffrey J.; Visvader, Jane E.			Control of mammary stem cell function by steroid hormone signalling	NATURE			English	Article							ESTROGEN-RECEPTOR-ALPHA; BREAST-CANCER; PROGESTERONE-RECEPTOR; GLAND MORPHOGENESIS; MICE LACKING; PROLIFERATION; LIGAND; RISK; DIFFERENTIATION; ACTIVATOR	The ovarian hormones oestrogen and progesterone profoundly influence breast cancer risk(1-3), underpinning the benefit of endocrine therapies in the treatment of breast cancer(4). Modulation of their effects through ovarian ablation or chemoprevention strategies also significantly decreases breast cancer incidence(5,6). Conversely, there is an increased risk of breast cancer associated with pregnancy in the short term(7). The cellular mechanisms underlying these observations, however, are poorly defined. Here we demonstrate that mouse mammary stem cells (MaSCs)(8,9) are highly responsive to steroid hormone signalling, despite lacking the oestrogen and progesterone receptors(10). Ovariectomy markedly diminished MaSC number and outgrowth potential in vivo, whereas MaSC activity increased in mice treated with oestrogen plus progesterone. Notably, even three weeks of treatment with the aromatase inhibitor letrozole was sufficient to reduce the MaSC pool. In contrast, pregnancy led to a transient 11-fold increase in MaSC numbers, probably mediated through paracrine signalling from RANK ligand. The augmented MaSC pool indicates a cellular basis for the short-term increase in breast cancer incidence that accompanies pregnancy. These findings further indicate that breast cancer chemoprevention may be achieved, in part, through suppression of MaSC function.	[Asselin-Labat, Marie-Liesse; Vaillant, Francois; Sheridan, Julie M.; Pal, Bhupinder; Wu, Di; Smyth, Gordon K.; Lindeman, Geoffrey J.; Visvader, Jane E.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Wu, Di; Smyth, Gordon K.; Visvader, Jane E.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Simpson, Evan R.] Monash Med Ctr, Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia; [Yasuda, Hisataka] Oriental Yeast Co, Nagahama Inst Biochem Sci, Shiga 5260804, Japan; [Martin, T. John] St Vincents Inst, Fitzroy, Vic 3065, Australia; [Lindeman, Geoffrey J.] Royal Melbourne Hosp, Dept Med Oncol, Parkville, Vic 3050, Australia; [Lindeman, Geoffrey J.] Univ Melbourne, Dept Med, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Melbourne; Monash University; Prince Henry's Institute of Medical Research; Oriental Yeast Co., Ltd.; St. Vincent's Institute of Medical Research; Royal Melbourne Hospital; University of Melbourne	Lindeman, GJ (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia.	lindeman@wehi.edu.au; visvader@wehi.edu.au	Pal, Bhupinder/AAF-4011-2020; Smyth, Gordon/B-5276-2008; Wu, Di/AAB-7566-2021	Smyth, Gordon/0000-0001-9221-2892; Wu, Di/0000-0001-8331-2357; Pal, Bhupinder/0000-0002-3684-4331; Sheridan, Julie/0000-0002-1478-3662; Lindeman, Geoffrey/0000-0001-9386-2416	Australian Research Council; Victorian Breast Cancer Research Consortium; National Health and Medical Research Council (Australia); Susan G. Komen Foundation; National Breast Cancer Foundation; Australian Cancer Research Foundation	Australian Research Council(Australian Research Council); Victorian Breast Cancer Research Consortium; National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); National Breast Cancer Foundation; Australian Cancer Research Foundation	We are grateful to A. Morcom and T. Ward for technical assistance, T. Bouras for advice, S. Mihajlovic for histology and F. Battye for FACS support. We thank C. Clarke for providing the hPRa7 antibody, A. Burgess for AG1478, A. Parlow for prolactin, and the Australian Genome Research Facility for RNA bioanalyses. M.-L. A.-L. is supported by an Australian Research Council Postdoctoral Fellowship. This work was supported by the Victorian Breast Cancer Research Consortium (J.E.V. and G.J.L.), the National Health and Medical Research Council (Australia), the Susan G. Komen Foundation, the National Breast Cancer Foundation and the Australian Cancer Research Foundation.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Anderson E, 2004, J MAMMARY GLAND BIOL, V9, P3, DOI 10.1023/B:JOMG.0000023584.01750.16; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Asselin-Labat ML, 2006, J NATL CANCER I, V98, P1011, DOI 10.1093/jnci/djj267; Brisken C, 1998, P NATL ACAD SCI USA, V95, P5076, DOI 10.1073/pnas.95.9.5076; Ciarloni L, 2007, P NATL ACAD SCI USA, V104, P5455, DOI 10.1073/pnas.0611647104; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Fernandez-Valdivia R, 2008, ENDOCRINOLOGY, V149, P6236, DOI 10.1210/en.2008-0768; Fernandez-Valdivia R, 2009, DEV BIOL, V328, P127, DOI 10.1016/j.ydbio.2009.01.019; Fisher CR, 1998, P NATL ACAD SCI USA, V95, P6965, DOI 10.1073/pnas.95.12.6965; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gonzalez-Suarez E, 2007, MOL CELL BIOL, V27, P1442, DOI 10.1128/MCB.01298-06; Hankinson SE, 2004, BREAST CANCER RES, V6, P213, DOI 10.1186/bcr921; Howell A, 2008, BEST PRACT RES CL EN, V22, P615, DOI 10.1016/j.beem.2008.09.002; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Kim NS, 2006, MOL CELL BIOL, V26, P1002, DOI 10.1128/MCB.26.3.1002-1013.2006; LAMBE M, 1994, NEW ENGL J MED, V331, P5, DOI 10.1056/NEJM199407073310102; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Lydon JP, 2000, J MAMMARY GLAND BIOL, V5, P325, DOI 10.1023/A:1009555013246; Mallepell S, 2006, P NATL ACAD SCI USA, V103, P2196, DOI 10.1073/pnas.0510974103; Mueller SO, 2002, ENDOCRINOLOGY, V143, P2357, DOI 10.1210/en.143.6.2357; Mulac-Jericevic B, 2003, P NATL ACAD SCI USA, V100, P9744, DOI 10.1073/pnas.1732707100; Parker WH, 2009, OBSTET GYNECOL, V113, P1027, DOI 10.1097/AOG.0b013e3181a11c64; PIKE MC, 1993, EPIDEMIOL REV, V15, P17, DOI 10.1093/oxfordjournals.epirev.a036102; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Ritchie ME, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-261; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Srivastava S, 2003, J BIOL CHEM, V278, P46171, DOI 10.1074/jbc.M308545200; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Visvanathan K, 2009, J CLIN ONCOL, V27, P3235, DOI 10.1200/JCO.2008.20.5179; Williams N, 2008, LANCET ONCOL, V9, P45, DOI 10.1016/S1470-2045(07)70385-6	37	513	530	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 10	2010	465	7299					798	802		10.1038/nature09027	http://dx.doi.org/10.1038/nature09027			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20383121				2022-12-28	WOS:000278551800049
J	Owen, AM; Hampshire, A; Grahn, JA; Stenton, R; Dajani, S; Burns, AS; Howard, RJ; Ballard, CG				Owen, Adrian M.; Hampshire, Adam; Grahn, Jessica A.; Stenton, Robert; Dajani, Said; Burns, Alistair S.; Howard, Robert J.; Ballard, Clive G.			Putting brain training to the test	NATURE			English	Article							SPATIAL WORKING-MEMORY; VISUOSPATIAL MEMORY; EXECUTIVE FUNCTIONS; FLUID INTELLIGENCE; SCHIZOPHRENIA; DEFICITS; LESIONS	'Brain training', or the goal of improved cognitive function through the regular use of computerized tests, is a multimillion-pound industry(1), yet in our view scientific evidence to support its efficacy is lacking. Modest effects have been reported in some studies of older individuals(2,3) and preschool children(4), and video-game players outperform non-players on some tests of visual attention(5). However, the widely held belief that commercially available computerized brain-training programs improve general cognitive function in the wider population in our opinion lacks empirical support. The central question is not whether performance on cognitive tests can be improved by training, but rather, whether those benefits transfer to other untrained tasks or lead to any general improvement in the level of cognitive functioning. Here we report the results of a six-week online study in which 11,430 participants trained several times each week on cognitive tasks designed to improve reasoning, memory, planning, visuospatial skills and attention. Although improvements were observed in every one of the cognitive tasks that were trained, no evidence was found for transfer effects to untrained tasks, even when those tasks were cognitively closely related.	[Owen, Adrian M.; Hampshire, Adam; Grahn, Jessica A.] MRC Cognit & Brain Sci Unit, Cambridge CB2 7EF, England; [Stenton, Robert; Dajani, Said; Howard, Robert J.; Ballard, Clive G.] Kings Coll London, Inst Psychiat, London SE5 8AF, England; [Burns, Alistair S.] Univ Manchester, Manchester M13 9PL, Lancs, England; [Burns, Alistair S.] Manchester Acad Hlth Sci Ctr, Manchester M13 9PL, Lancs, England	University of London; King's College London; University of Manchester; University of Manchester	Owen, AM (corresponding author), MRC Cognit & Brain Sci Unit, 15 Chaucer Rd, Cambridge CB2 7EF, England.	adrian.owen@mrc-cbu.cam.ac.uk	Grahn, Jessica/A-1371-2010; Owen, Adrian M/B-4997-2015; Howard, Robert/E-4890-2010	Grahn, Jessica/0000-0001-7270-2114; Burns, Alistair/0000-0002-9837-0645; Howard, Robert/0000-0002-3071-2338; Ballard, Clive/0000-0003-0022-5632	Medical Research Council [U.1055.01.002.00001.01, U.1055.01.003.00001.01]; Alzheimer's Society (UK); MRC [MC_U105559847, MC_U105559837] Funding Source: UKRI; Medical Research Council [MC_U105559847, MC_U105559837] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Society (UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	A.M.O., A. H. and J.A.G. are supported by the Medical Research Council (U.1055.01.002.00001.01 and U.1055.01.003.00001.01). C. G. B. and S. D. are supported by the Alzheimer's Society (UK). We thank the BBC Lab UK team for their contribution, which included the website, task design, data acquisition, recruitment of participants and coordination.	AAMODT S, 2007, NY TIMES; BADDELEY AD, 1968, PSYCHON SCI, V10, P341; Bor D, 2006, NEUROPSYCHOLOGIA, V44, P229, DOI 10.1016/j.neuropsychologia.2005.05.010; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Conklin HM, 2000, AM J PSYCHIAT, V157, P275, DOI 10.1176/appi.ajp.157.2.275; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; DUNCAN J, 1995, NEUROPSYCHOLOGIA, V33, P261, DOI 10.1016/0028-3932(94)00124-8; Elliott R, 1997, PSYCHOPHARMACOLOGY, V131, P196, DOI 10.1007/s002130050284; Fowler K S, 1995, Appl Neuropsychol, V2, P72, DOI 10.1207/s15324826an0202_4; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Jakala P, 1999, NEUROPSYCHOPHARMACOL, V20, P119, DOI 10.1016/S0893-133X(98)00055-4; Mehta MA, 2000, J NEUROSCI, V20; OLTON DS, 1982, SPATIAL ABILITIES, P325; OWEN AM, 1993, NEUROPSYCHOLOGIA, V31, P627, DOI 10.1016/0028-3932(93)90135-M; Owen AM, 1996, EUR J NEUROSCI, V8, P353, DOI 10.1111/j.1460-9568.1996.tb01219.x; Owen AM, 1996, BRAIN, V119, P1597, DOI 10.1093/brain/119.5.1597; OWEN AM, 1990, NEUROPSYCHOLOGIA, V28, P1021, DOI 10.1016/0028-3932(90)90137-D; OWEN AM, 1992, BRAIN, V115, P1727, DOI 10.1093/brain/115.6.1727; Papp KV, 2009, ALZHEIMERS DEMENT, V5, P50, DOI 10.1016/j.jalz.2008.10.008; PASSINGHAM RE, 1985, BEHAV NEUROSCI, V99, P3, DOI 10.1037/0735-7044.99.1.3; Roca M, 2010, BRAIN, V133, P234, DOI 10.1093/brain/awp269; SAHAKIAN BJ, 1988, BRAIN, V111, P695, DOI 10.1093/brain/111.3.695; Smith GE, 2009, J AM GERIATR SOC, V57, P594, DOI 10.1111/j.1532-5415.2008.02167.x; Thorell LB, 2009, DEVELOPMENTAL SCI, V12, P106, DOI 10.1111/j.1467-7687.2008.00745.x; Turner DC, 2003, PSYCHOPHARMACOLOGY, V165, P260, DOI 10.1007/s00213-002-1250-8; Williams-Gray CH, 2007, J NEUROSCI, V27, P4832, DOI 10.1523/JNEUROSCI.0774-07.2007; Wood SJ, 2002, PSYCHOL MED, V32, P429, DOI 10.1017/S0033291702005275; Wright SB, 2008, FRONT HUM NEUROSCI, V1, DOI 10.3389/neuro.09.008.2007	29	651	673	7	410	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 10	2010	465	7299					775	U6		10.1038/nature09042	http://dx.doi.org/10.1038/nature09042			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20407435	Green Accepted			2022-12-28	WOS:000278551800044
J	Deuss, A; Irving, JCE; Woodhouse, JH				Deuss, Arwen; Irving, Jessica C. E.; Woodhouse, John H.			Regional Variation of Inner Core Anisotropy from Seismic Normal Mode Observations	SCIENCE			English	Article							FREE OSCILLATIONS; MAXWELL STRESSES; CONSTRAINTS; EARTH; SOLIDIFICATION; HETEROGENEITY; INVERSION; VELOCITY; SPECTRA; GROWTH	Earth's solid inner core is surrounded by a convecting liquid outer core, creating the geodynamo driving the planet's magnetic field. Seismic studies using compressional body waves suggest hemispherical variation in the anisotropic structure of the inner core, but are poorly constrained because of limited earthquake and receiver distribution. Here, using normal mode splitting function measurements from large earthquakes, based on extended cross-coupling theory, we observe both regional variations and eastern versus western hemispherical anisotropy in the inner core. The similarity of this pattern with Earth's magnetic field suggests freezing-in of crystal alignment during solidification or texturing by Maxwell stress as origins of the anisotropy. These observations limit the amount of inner core super rotation, but would be consistent with oscillation.	[Deuss, Arwen; Irving, Jessica C. E.] Univ Cambridge, Dept Earth Sci, Cambridge CB3 0EZ, England; [Woodhouse, John H.] Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England	University of Cambridge; University of Oxford	Deuss, A (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge CB3 0EZ, England.	afd28@cam.ac.uk	Deuss, Arwen/F-6254-2012	Deuss, Arwen/0000-0003-3193-5987; Irving, Jessica C.E./0000-0002-0866-8246	European Research Council (ERC) under the European Community [(FP7/2007-2013)/ERC, 204995]; Natural Environment Research Council [NE/C510916/1] Funding Source: researchfish	European Research Council (ERC) under the European Community(European Research Council (ERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	J. Ritsema and H. van Heijst assisted in building the normal mode data set. We appreciate the suggestions by V. Cormier and two anonymous reviewers. The research was funded by the European Research Council (ERC) under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement number 204995.	Aubert J, 2008, NATURE, V454, P758, DOI 10.1038/nature07109; Beghein C, 2003, SCIENCE, V299, P552, DOI 10.1126/science.1078159; Bergman MI, 1997, NATURE, V389, P60, DOI 10.1038/37962; BLOXHAM J, 1987, NATURE, V325, P511, DOI 10.1038/325511a0; Buffett BA, 2001, NATURE, V413, P60, DOI 10.1038/35092543; BUFFETT BA, 1992, NATURE, V356, P329, DOI 10.1038/356329a0; Deuss A, 2001, GEOPHYS J INT, V146, P833, DOI 10.1046/j.1365-246X.2001.00502.x; Durek JJ, 1999, GEOPHYS J INT, V139, P599, DOI 10.1046/j.1365-246x.1999.00961.x; GIARDINI D, 1988, J GEOPHYS RES-SOLID, V93, P13716, DOI 10.1029/JB093iB11p13716; Gubbins D, 2003, GEOPHYS J INT, V155, P609, DOI 10.1046/j.1365-246X.2003.02064.x; He X, 1996, J GEOPHYS RES-SOL EA, V101, P20053, DOI 10.1029/96JB01783; Irving JCE, 2009, GEOPHYS J INT, V178, P962, DOI 10.1111/j.1365-246X.2009.04211.x; Ishii M, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000712; Jackson A, 2000, PHILOS T ROY SOC A, V358, P957, DOI 10.1098/rsta.2000.0569; JEANLOZ R, 1988, GEOPHYS RES LETT, V15, P72, DOI 10.1029/GL015i001p00072; JOHNSON CL, 1995, GEOPHYS J INT, V122, P489, DOI 10.1111/j.1365-246X.1995.tb07010.x; Karato S, 1999, NATURE, V402, P871, DOI 10.1038/47235; Kelly P, 1997, GEOPHYS J INT, V128, P315, DOI 10.1111/j.1365-246X.1997.tb01557.x; MORELLI A, 1986, GEOPHYS RES LETT, V13, P1545, DOI 10.1029/GL013i013p01545; Niu FL, 2001, NATURE, V410, P1081, DOI 10.1038/35074073; Resovsky JS, 1998, J GEOPHYS RES-SOL EA, V103, P783, DOI 10.1029/97JB02482; Ritsema J, 1999, SCIENCE, V286, P1925, DOI 10.1126/science.286.5446.1925; Romanowicz B, 2000, J GEOPHYS RES-SOL EA, V105, P21559, DOI 10.1029/2000JB900144; Song XD, 1996, NATURE, V382, P221, DOI 10.1038/382221a0; Tanaka S, 1997, J GEOPHYS RES-SOL EA, V102, P2925, DOI 10.1029/96JB03187; WOODHOUSE JH, 1986, GEOPHYS RES LETT, V13, P1549, DOI 10.1029/GL013i013p01549; Yoshida S, 1996, J GEOPHYS RES-SOL EA, V101, P28085, DOI 10.1029/96JB02700; Yu WC, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004868	28	88	88	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 21	2010	328	5981					1018	1020		10.1126/science.1188596	http://dx.doi.org/10.1126/science.1188596			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598YW	20395476				2022-12-28	WOS:000277877100038
J	MacLennan, CA; Gilchrist, JJ; Gordon, MA; Cunningham, AF; Cobbold, M; Goodall, M; Kingsley, RA; van Oosterhout, JJG; Msefula, CL; Mandala, WL; Leyton, DL; Marshall, JL; Gondwe, EN; Bobat, S; Lopez-Macias, C; Doffinger, R; Henderson, IR; Zijlstra, EE; Dougan, G; Drayson, MT; MacLennan, ICM; Molyneux, ME				MacLennan, Calman A.; Gilchrist, James J.; Gordon, Melita A.; Cunningham, Adam F.; Cobbold, Mark; Goodall, Margaret; Kingsley, Robert A.; van Oosterhout, Joep J. G.; Msefula, Chisomo L.; Mandala, Wilson L.; Leyton, Denisse L.; Marshall, Jennifer L.; Gondwe, Esther N.; Bobat, Saeeda; Lopez-Macias, Constantino; Doffinger, Rainer; Henderson, Ian R.; Zijlstra, Eduard E.; Dougan, Gordon; Drayson, Mark T.; MacLennan, Ian C. M.; Molyneux, Malcolm E.			Dysregulated Humoral Immunity to Nontyphoidal Salmonella in HIV-Infected African Adults	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; PNEUMOCOCCAL VACCINATION; AIDS PATIENTS; BACTEREMIA; TYPHIMURIUM; ACTIVATION; ANTIBODIES; RESISTANCE; CHILDREN; KEY	Nontyphoidal Salmonellae are a major cause of life-threatening bacteremia among HIV-infected individuals. Although cell-mediated immunity controls intracellular infection, antibodies protect against Salmonella bacteremia. We report that high-titer antibodies specific for Salmonella lipopolysaccharide (LPS) are associated with a lack of Salmonella-killing in HIV-infected African adults. Killing was restored by genetically shortening LPS from the target Salmonella or removing LPS-specific antibodies from serum. Complement-mediated killing of Salmonella by healthy serum is shown to be induced specifically by antibodies against outer membrane proteins. This killing is lost when excess antibody against Salmonella LPS is added. Thus, our study indicates that impaired immunity against nontyphoidal Salmonella bacteremia in HIV infection results from excess inhibitory antibodies against Salmonella LPS, whereas serum killing of Salmonella is induced by antibodies against outer membrane proteins.	[MacLennan, Calman A.; Gilchrist, James J.; Cunningham, Adam F.; Cobbold, Mark; Goodall, Margaret; Marshall, Jennifer L.; Gondwe, Esther N.; Bobat, Saeeda; Drayson, Mark T.; MacLennan, Ian C. M.] Univ Birmingham, MRC, Ctr Immune Regulat & Clin Immunol Serv, Inst Biomed Res,Sch Immun & Infect, Birmingham, W Midlands, England; [MacLennan, Calman A.; Gilchrist, James J.; Gordon, Melita A.; van Oosterhout, Joep J. G.; Msefula, Chisomo L.; Mandala, Wilson L.; Gondwe, Esther N.; Molyneux, Malcolm E.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Program, Blantyre, Malawi; [MacLennan, Calman A.] Univ Liverpool, Div Med Microbiol, Liverpool L69 3BX, Merseyside, England; [MacLennan, Calman A.; Msefula, Chisomo L.] Univ Malawi, Coll Med, Dept Microbiol, Blantyre, Malawi; [Gilchrist, James J.] Univ Oxford, John Radcliffe Hosp, Div Med Sci, Clin Acad Grad Sch, Oxford OX3 9DU, England; [Gordon, Melita A.] Univ Liverpool, Gastroenterol Unit, Liverpool L69 3BX, Merseyside, England; [Gordon, Melita A.; van Oosterhout, Joep J. G.; Zijlstra, Eduard E.; Molyneux, Malcolm E.] Univ Malawi, Coll Med, Dept Med, Blantyre, Malawi; [Kingsley, Robert A.; Dougan, Gordon] Wellcome Trust Sanger Inst, Cambridge, England; [Msefula, Chisomo L.; Mandala, Wilson L.; Gondwe, Esther N.; Molyneux, Malcolm E.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Mandala, Wilson L.] Univ Malawi, Coll Med, Dept Biochem, Blantyre, Malawi; [Leyton, Denisse L.; Henderson, Ian R.] Univ Birmingham, Sch Immun & Infect, Birmingham, W Midlands, England; [Lopez-Macias, Constantino] Specialties Hosp, Natl Med Ctr Siglo XXI, Mexican Inst Social Secur, Med Res Unit Immunochem, Mexico City, DF, Mexico; [Doffinger, Rainer] Addenbrookes Hosp, Dept Clin Biochem & Immunol, Cambridge, England	University of Birmingham; University of Malawi; University of Liverpool; University of Malawi; University of Oxford; University of Liverpool; University of Malawi; Wellcome Trust Sanger Institute; Liverpool School of Tropical Medicine; University of Liverpool; University of Malawi; University of Birmingham; Instituto Mexicano del Seguro Social; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	MacLennan, CA (corresponding author), Univ Birmingham, MRC, Ctr Immune Regulat & Clin Immunol Serv, Inst Biomed Res,Sch Immun & Infect, Birmingham, W Midlands, England.	c.maclennan@bham.ac.uk	Henderson, Ian/AAD-5369-2019; Msefula, Chisomo/AAY-9107-2020; Leyton, Denisse L/A-6915-2015; MacLennan, Calman A/L-9343-2014; López Macías, Constatino III Roberto/ABG-3414-2021; Gordon, Melita/F-5563-2012	Leyton, Denisse L/0000-0003-4808-9289; MacLennan, Calman A/0000-0001-9694-0846; López Macías, Constatino III Roberto/0000-0003-0530-492X; Lopez-Macias, Constantino III Roberto/0000-0002-7756-8468; Gilchrist, James J/0000-0003-2045-6788; Gordon, Melita/0000-0002-0629-0884; Drayson, Mark/0000-0002-1528-7564; Mandala, Wilson/0000-0001-9386-9239; Henderson, Ian/0000-0002-9954-4977; Cunningham, Adam/0000-0003-0248-964X; Marshall, Jennifer/0000-0002-1727-8290; Msefula, Chisomo/0000-0003-2304-886X; Kingsley, Robert/0000-0002-0194-6485	GlaxoSmithKline; Wellcome Trust; University of Birmingham; Medical Research Council, UK; UK Biotechnology and Biological Sciences Research Council, UK; National Institute for Health Research Cambridge Biomedical Research Center; National Council for Science and Technology (CONACyT) Mexico [SALUD-2007-C01-69779]; BBSRC [BB/F022778/1] Funding Source: UKRI; MRC [G8402371, G0701275, G9818340, G108/574] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F022778/1] Funding Source: researchfish; Medical Research Council [G108/574, G8402371, G9818340, G9818340B, G0701275] Funding Source: researchfish	GlaxoSmithKline(GlaxoSmithKline); Wellcome Trust(Wellcome TrustEuropean Commission); University of Birmingham; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute for Health Research Cambridge Biomedical Research Center(National Institute for Health Research (NIHR)); National Council for Science and Technology (CONACyT) Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the individuals who participated in this study and the staff at the Malawi-Liverpool-Wellcome Trust Clinical Research Programme and Queen Elizabeth Central Hospital, Blantyre, Malawi, for their support. We are grateful to T. Plant, K. Stephens, A. Seeley, and the Clinical Immunology Service, Birmingham, UK, for technical assistance and to F. Gotch and P. Kelleher for helpful discussions. This work was supported by a Clinical Research Fellowship from GlaxoSmithKline (C. A. M.); Tropical Research Fellowships from the Wellcome Trust (C. A. M. and M. A. G.); a Programme Grant from the Wellcome Trust (M. E. M.); a Scientific Projects Committee Research Grant from the University of Birmingham (C. A. M.); the Medical Research Council and UK Biotechnology and Biological Sciences Research Council, UK (A. F. C., D. L. L., and I. R. H.); National Institute for Health Research Cambridge Biomedical Research Center (R. D.); and the National Council for Science and Technology (CONACyT) Mexico, grant number SALUD-2007-C01-69779 (C. L.-M.).	ALLAN JS, 1985, SCIENCE, V228, P1091, DOI 10.1126/science.2986290; AMMANN AJ, 1984, JAMA-J AM MED ASSOC, V251, P1447, DOI 10.1001/jama.251.11.1447; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; BLANDEN RV, 1966, J EXP MED, V124, P585, DOI 10.1084/jem.124.4.585; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Bustarnante J, 2008, CURR OPIN IMMUNOL, V20, P39, DOI 10.1016/j.coi.2007.10.005; CHART H, 1994, METHODS PRACTICAL LA, P11; CLUMECK N, 1983, LANCET, V1, P642; De Milito A, 2004, BLOOD, V103, P2180, DOI 10.1182/blood-2003-07-2375; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Fierer J, 2001, J CLIN INVEST, V107, P775, DOI 10.1172/JCI12561; French N, 1998, AIDS, V12, P1683, DOI 10.1097/00002030-199813000-00017; Gil-Cruz C, 2009, P NATL ACAD SCI USA, V106, P9803, DOI 10.1073/pnas.0812431106; Gilks CF, 1998, BRIT MED BULL, V54, P383, DOI 10.1093/oxfordjournals.bmb.a011695; GILKS CF, 1990, LANCET, V336, P545, DOI 10.1016/0140-6736(90)92096-Z; Gordon MA, 2002, AIDS, V16, P1633, DOI 10.1097/00002030-200208160-00009; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; GRANT MD, 1990, J IMMUNOL, V144, P1241; GRUENEWALD R, 1994, CLIN INFECT DIS, V18, P358, DOI 10.1093/clinids/18.3.358; Huber M, 2006, EUR J IMMUNOL, V36, P701, DOI 10.1002/eji.200535593; JACOBS JL, 1985, ANN INTERN MED, V102, P186, DOI 10.7326/0003-4819-102-2-186; JOINER KA, 1982, J EXP MED, V155, P809, DOI 10.1084/jem.155.3.809; Kassa-Kelembho E, 2003, ACTA TROP, V89, P67, DOI 10.1016/j.actatropica.2003.09.004; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; LEVINE WC, 1991, J INFECT DIS, V164, P81, DOI 10.1093/infdis/164.1.81; MacLennan C, 2004, J INFECT DIS, V190, P1755, DOI 10.1086/425021; MacLennan CA, 2008, J CLIN INVEST, V118, P1553, DOI 10.1172/JCI33998; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; NORMANN B, 1972, ACTA PATH MICRO IM B, VB 80, P891; OPRAVIL M, 1991, CLIN EXP IMMUNOL, V84, P185, DOI 10.1111/j.1365-2249.1991.tb08146.x; SHIRAI A, 1992, J CLIN INVEST, V89, P561, DOI 10.1172/JCI115621; Tejiokem MC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001260; VUGIA DJ, 1993, J INFECT DIS, V168, P564, DOI 10.1093/infdis/168.3.564	33	122	122	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2010	328	5977					508	512		10.1126/science.1180346	http://dx.doi.org/10.1126/science.1180346			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YR	20413503	Green Accepted			2022-12-28	WOS:000276952400045
J	Roberts, JW				Roberts, Jeffrey W.			MOLECULAR BIOLOGY Syntheses That Stay Together	SCIENCE			English	Editorial Material							TERMINATION FACTOR-RHO; ESCHERICHIA-COLI; RNA-POLYMERASE; ANTITERMINATION PROTEIN; BACTERIOPHAGE-LAMBDA; PHAGE-LAMBDA; N-GENE; TRANSCRIPTION; ELONGATION; DNA		Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Roberts, JW (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	jwr7@cornell.edu						ADHYA S, 1974, P NATL ACAD SCI USA, V71, P2534, DOI 10.1073/pnas.71.6.2534; BARIK S, 1987, CELL, V50, P885, DOI 10.1016/0092-8674(87)90515-0; Belogurov GA, 2009, EMBO J, V28, P112, DOI 10.1038/emboj.2008.268; Burmann BM, 2010, SCIENCE, V328, P501, DOI 10.1126/science.1184953; Cardinale CJ, 2008, SCIENCE, V320, P935, DOI 10.1126/science.1152763; CONDON C, 1995, MICROBIOL REV, V59, P623, DOI 10.1128/MMBR.59.4.623-645.1995; FRANKLIN NC, 1974, J MOL BIOL, V89, P33, DOI 10.1016/0022-2836(74)90161-2; HORWITZ RJ, 1987, CELL, V51, P631, DOI 10.1016/0092-8674(87)90132-2; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; LI J, 1993, GENE DEV, V7, P161, DOI 10.1101/gad.7.1.161; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; Reeder TC, 1996, CELL, V87, P767, DOI 10.1016/S0092-8674(00)81395-1; RICHARDSON JP, 1975, P NATL ACAD SCI USA, V72, P1725, DOI 10.1073/pnas.72.5.1725; SULLIVAN SL, 1992, J BACTERIOL, V174, P1339, DOI 10.1128/jb.174.4.1339-1344.1992; Svetlov V, 2007, NUCLEIC ACIDS RES, V35, P5694, DOI 10.1093/nar/gkm600; VOGEL U, 1994, J BACTERIOL, V176, P2807, DOI 10.1128/JB.176.10.2807-2813.1994; YANG XJ, 1989, P NATL ACAD SCI USA, V86, P5301, DOI 10.1073/pnas.86.14.5301	19	11	11	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 23	2010	328	5977					436	437		10.1126/science.1189971	http://dx.doi.org/10.1126/science.1189971			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YR	20413480				2022-12-28	WOS:000276952400020
J	Rogelj, J; Nabel, J; Chen, C; Hare, W; Markmann, K; Meinshausen, M; Schaeffer, M; Macey, K; Hohne, N				Rogelj, Joeri; Nabel, Julia; Chen, Claudine; Hare, William; Markmann, Kathleen; Meinshausen, Malte; Schaeffer, Michiel; Macey, Kirsten; Hoehne, Niklas			Copenhagen Accord pledges are paltry	NATURE			English	Editorial Material									[Rogelj, Joeri; Nabel, Julia; Chen, Claudine; Hare, William; Markmann, Kathleen; Meinshausen, Malte] Potsdam Inst Climate Impact Res, D-14473 Potsdam, Germany; [Schaeffer, Michiel; Macey, Kirsten] Climate Analyt, D-14467 Potsdam, Germany; [Hoehne, Niklas] Ecofys, D-50829 Cologne, Germany	Potsdam Institut fur Klimafolgenforschung	Rogelj, J (corresponding author), Potsdam Inst Climate Impact Res, D-14473 Potsdam, Germany.	malte.meinshausen@pik-potsdam.de	Rogelj, Joeri/I-7108-2012; Hare, Bill/A-8527-2013; Meinshausen, Malte/AAG-6505-2019; Meinshausen, Malte/A-7037-2011; Höhne, Niklas/AAZ-2422-2020; Höhne, Niklas/L-8971-2013	Rogelj, Joeri/0000-0003-2056-9061; Hare, Bill/0000-0003-1242-8250; Meinshausen, Malte/0000-0003-4048-3521; Meinshausen, Malte/0000-0003-4048-3521; Höhne, Niklas/0000-0001-9246-8759; 				Bowen A., 2009, MITIGATING CLIMATE C; Houghton R. A, 2008, TRENDS COMPENDIUM DA; ICAO, 2009, HIGH LEV M INT AV CL; *ICS, 2009, SHIPP WORLD TRAD RED; LEVIN K, 2010, COMP ANNEX I EMISSIO; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; *POTSD I CLIM IMP, 2009, PRIMAP4 BAS REF; Riahi K, 2007, TECHNOL FORECAST SOC, V74, P887, DOI 10.1016/j.techfore.2006.05.026; Stern N., 2009, DECIDING OUR FUTURE; UNEP, 2010, CLOS AR WE 2 DEGR LI	10	151	152	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 22	2010	464	7292					1126	1128		10.1038/4641126a	http://dx.doi.org/10.1038/4641126a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	586FR	20414291				2022-12-28	WOS:000276891100016
J	Lamont, T; Watts, F; Stanley, J; Scarpello, J; Panesar, S				Lamont, Tara; Watts, Frances; Stanley, John; Scarpello, John; Panesar, Sukhmeet			Safety Alerts Reducing risks of tourniquets left on after finger and toe surgery: summary of a safety report from the National Patient Safety Agency	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lamont, Tara; Watts, Frances; Scarpello, John; Panesar, Sukhmeet] Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England; [Stanley, John] Wrightington Hosp Upper Limb Unit, Wigan WN6 9EP, England		Lamont, T (corresponding author), Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England.	tara.lamont@npsa.nhs.uk						de Boer HL, 2007, EUR J PLAST SURG, V30, P91, DOI 10.1007/s00238-007-0144-8; Haas F, 1999, CHIRURG, V70, P608, DOI 10.1007/s001040050696; King C., 2008, TXB PEDIAT EMERGENCY; Medicines and Healthcare Products Regulatory Agency, 2010, MED DEV AL MDA 2010; Smith IM, 2002, J HAND SURG-BRIT EUR, V27B, P363, DOI 10.1054/jhsb.2002.0781; Tucker S, 2002, INJURY, V33, P76, DOI 10.1016/S0020-1383(01)00095-X	6	8	8	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 21	2010	340								c1981	10.1136/bmj.c1981	http://dx.doi.org/10.1136/bmj.c1981			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589HN	20410165				2022-12-28	WOS:000277137900003
J	Niparko, JK; Tobey, EA; Thal, DJ; Eisenberg, LS; Wang, NY; Quittner, AL; Fink, NE				Niparko, John K.; Tobey, Emily A.; Thal, Donna J.; Eisenberg, Laurie S.; Wang, Nae-Yuh; Quittner, Alexandra L.; Fink, Nancy E.		CDaCI Investigative Team	Spoken Language Development in Children Following Cochlear Implantation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRELINGUALLY DEAF-CHILDREN; CHILDHOOD DEVELOPMENT; SPEECH RECOGNITION; INFANTS; OUTCOMES; COMMUNICATION; SCHOOL; AGE	Context Cochlear implantation is a surgical alternative to traditional amplification (hearing aids) that can facilitate spoken language development in young children with severe to profound sensorineural hearing loss (SNHL). Objective To prospectively assess spoken language acquisition following cochlear implantation in young children. Design, Setting, and Participants Prospective, longitudinal, and multidimensional assessment of spoken language development over a 3-year period in children who underwent cochlear implantation before 5 years of age (n=188) from 6 US centers and hearing children of similar ages (n=97) from 2 preschools recruited between November 2002 and December 2004. Follow-up completed between November 2005 and May 2008. Main Outcome Measures Performance on measures of spoken language comprehension and expression (Reynell Developmental Language Scales). Results Children undergoing cochlear implantation showed greater improvement in spoken language performance (10.4; 95% confidence interval [CI], 9.6-11.2 points per year in comprehension; 8.4; 95% CI, 7.8-9.0 in expression) than would be predicted by their preimplantation baseline scores (5.4; 95% CI, 4.1-6.7, comprehension; 5.8; 95% CI, 4.6-7.0, expression), although mean scores were not restored to age-appropriate levels after 3 years. Younger age at cochlear implantation was associated with significantly steeper rate increases in comprehension (1.1; 95% CI, 0.5-1.7 points per year younger) and expression (1.0; 95% CI, 0.6-1.5 points per year younger). Similarly, each 1-year shorter history of hearing deficit was associated with steeper rate increases in comprehension (0.8; 95% CI, 0.2-1.2 points per year shorter) and expression (0.6; 95% CI, 0.2-1.0 points per year shorter). In multivariable analyses, greater residual hearing prior to cochlear implantation, higher ratings of parent-child interactions, and higher socioeconomic status were associated with greater rates of improvement in comprehension and expression. Conclusion The use of cochlear implants in young children was associated with better spoken language learning than would be predicted from their preimplantation scores. JAMA. 2010;303(15):1498-1506 www.jama.com	[Niparko, John K.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol, Baltimore, MD 21205 USA; [Wang, Nae-Yuh] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Tobey, Emily A.] Univ Texas Dallas, Callier Ctr Commun Disorders, Dallas, TX 75235 USA; [Thal, Donna J.] Univ Calif San Diego, Sch Speech Language & Hearing Sci, San Diego, CA 92103 USA; [Eisenberg, Laurie S.] House Ear Res Inst, Los Angeles, CA USA; [Quittner, Alexandra L.] Univ Miami, Dept Psychol, Miami, FL USA; [Niparko, John K.; Fink, Nancy E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Wang, Nae-Yuh] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; University of Texas System; University of Texas Dallas; University of California System; University of California San Diego; House Research Institute; University of Miami; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Niparko, JK (corresponding author), Johns Hopkins Univ Hosp, 601 N Caroline St,JHOC-6161A, Baltimore, MD 21287 USA.	jnipark1@jhmi.edu	Clark, James/AAB-5996-2021; lee, yujun/P-6069-2014	lee, yujun/0000-0002-5821-7355; Wang, Nae-Yuh/0000-0001-6513-9730	National Institute on Deafness and Other Communication Disorders [R01 DC004797]; CityBridge Foundation; Sidgmore Family Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004797] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); CityBridge Foundation; Sidgmore Family Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The CDaCl was supported by grant R01 DC004797 from the National Institute on Deafness and Other Communication Disorders, the CityBridge Foundation, and the Sidgmore Family Foundation. Warranties on the implant devices used by children with implants in this study were discounted by 50% by the Advanced Bionics Corporation, Cochlear Corporation, and the MedEl Corporation.	Barker DH, 2009, DEV PSYCHOPATHOL, V21, P373, DOI 10.1017/S0954579409000212; Bayley N, 1993, BAYLEY SCALES INFANT; Bradham T, 2008, INT J PEDIATR OTORHI, V72, P1023, DOI 10.1016/j.ijporl.2008.03.005; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Dettman SJ, 2007, EAR HEARING, V28, p11S, DOI 10.1097/AUD.0b013e31803153f8; Eisenberg LS, 2006, AUDIOL NEURO-OTOL, V11, P259, DOI 10.1159/000093302; Estes KG, 2007, PSYCHOL SCI, V18, P254, DOI 10.1111/j.1467-9280.2007.01885.x; Fink Nancy E, 2007, Cochlear Implants Int, V8, P92, DOI 10.1002/cii.333; Francis HW, 2008, OTOL NEUROTOL, V29, P502, DOI 10.1097/MAO.0b013e318170b60b; Geers A, 2008, INT J AUDIOL, V47, pS21, DOI 10.1080/14992020802339167; Holt RF, 2008, EAR HEARING, V29, P492, DOI 10.1097/AUD.0b013e31816c409f; Kuhl PK, 2007, DEVELOPMENTAL SCI, V10, P110, DOI 10.1111/j.1467-7687.2007.00572.x; KUHL PK, 1994, CURR OPIN NEUROBIOL, V4, P812, DOI 10.1016/0959-4388(94)90128-7; Lin FR, 2008, OTOL NEUROTOL, V29, P208, DOI 10.1097/MAO.0b013e31812f6fa6; Marschark M, 2007, J DEAF STUD DEAF EDU, V12, P269, DOI 10.1093/deafed/enm013; Moeller MP, 2006, CHILD DEV, V77, P751, DOI 10.1111/j.1467-8624.2006.00901.x; Nicholas JG, 2007, J SPEECH LANG HEAR R, V50, P1048, DOI 10.1044/1092-4388(2007/073); Nikolopoulos TP, 2004, ARCH OTOLARYNGOL, V130, P629, DOI 10.1001/archotol.130.5.629; Niparko John K, 2004, JAMA, V291, P2378, DOI 10.1001/jama.291.19.2378; Quittner AL, 2004, ARCH OTOLARYNGOL, V130, P547, DOI 10.1001/archotol.130.5.547; REYNELL J, 1985, REYNELL DEV LANGUAGE; Reynell J. K., 1990, REYNELL DEV LANGUAGE; ROBBINS AM, 1991, AM J OTOL, V12, P144; Roid G.H., 2002, LEITER INT PERFORMAN; SAFFRAN JR, 1996, SCIENCE, V274, P5294; Sharma A, 2004, ARCH OTOLARYNGOL, V130, P511, DOI 10.1001/archotol.130.5.511; Spencer PE, 1996, CHILD DEV, V67, P3176, DOI 10.2307/1131773; STREETER LA, 1976, NATURE, V259, P39, DOI 10.1038/259041a0; Svirsky MA, 2000, PSYCHOL SCI, V11, P153, DOI 10.1111/1467-9280.00231; Svirsky MA, 2000, ANN OTO RHINOL LARYN, V109, P123, DOI 10.1177/0003489400109S1254; Tobey EA, 2003, EAR HEARING, V24, p36S, DOI 10.1097/01.AUD.0000051688.48224.A6; WALKER D, 1994, CHILD DEV, V65, P606, DOI 10.2307/1131404; Wang NY, 2008, OTOL NEUROTOL, V29, P240, DOI 10.1097/MAO.0b013e3181627a37; Werker JF, 2003, J PEDIATR-US, V143, pS62, DOI 10.1067/S0022-3476(03)00403-7; Zimmerman-Phillips S, 2000, ANN OTO RHINOL LARYN, V109, P42, DOI 10.1177/0003489400109S1217	35	633	659	9	162	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2010	303	15					1498	1506		10.1001/jama.2010.451	http://dx.doi.org/10.1001/jama.2010.451			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	585SJ	20407059	Green Accepted, Bronze			2022-12-28	WOS:000276849000026
J	Mello, MM; Gallagher, TH				Mello, Michelle M.; Gallagher, Thomas H.			Malpractice Reform -- Opportunities for Leadership by Health Care Institutions and Liability Insurers.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Gallagher, Thomas H.] Univ Washington, Dept Med, Seattle, WA USA; [Gallagher, Thomas H.] Univ Washington, Dept Bioeth & Humanities, Seattle, WA USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Mello, MM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.			Mello, Michelle/0000-0003-2877-4270				Boothman Richard C, 2009, J Health Life Sci Law, V2, P125; Kraman SS, 1999, ANN INTERN MED, V131, P963, DOI 10.7326/0003-4819-131-12-199912210-00010; Mello MM, 2006, MILBANK Q, V84, P459, DOI 10.1111/j.1468-0009.2006.00455.x; OBAMA B, 2010, COMMUNICATION   0302	4	33	33	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 15	2010	362	15					1353	1356		10.1056/NEJMp1001603	http://dx.doi.org/10.1056/NEJMp1001603			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	582XY	20357276				2022-12-28	WOS:000276635300001
J	McMahon, GT; Katz, JT; Thorndike, ME; Levy, BD; Loscalzo, J				McMahon, Graham T.; Katz, Joel T.; Thorndike, Mary E.; Levy, Bruce D.; Loscalzo, Joseph			Evaluation of a Redesign Initiative in an Internal-Medicine Residency.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DUTY HOUR REFORM; WORK HOURS; CARE; EDUCATION; OUTCOMES; SLEEP; ASSOCIATION; PERFORMANCE; CURRICULUM; REDUCTION	Background: Several organizations have advocated for comprehensive redesign of graduate medical training, but the effect that residency redesign will have on measures of patient satisfaction, resident and intern (trainee) satisfaction, and patient care is unknown. Methods: We designed an experimental inpatient-medicine service with reduced resident workload comprising two teams, with each team consisting of two attending physicians, two residents, and three interns. Attending physicians, selected for their teaching prowess, supervised the teams throughout the workday and during bedside team-teaching rounds. This experimental model was compared with a control model comprising two teams, with each consisting of one resident and two interns, plus multiple supervising attending physicians who volunteered to participate. Patients were alternately assigned to the experimental teams and the control teams, subject to limits on the number of patients interns are allowed to admit. Results: Over a 12-month period, 1892 patients were assigned to the experimental teams and 2096 to the control teams; the average census per intern was 3.5 and 6.6 patients, respectively. Overall satisfaction was significantly higher among trainees on the experimental teams than among those on the control teams (78% and 55%, respectively; P=0.002). As compared with the control teams, the experimental teams were not associated with a higher average length of patient stay or readmission rate; adherence to standards for quality of inpatient care was similar in both groups of teams. Interns on the experimental teams spent more time in learning and teaching activities than did interns on the control teams (learning: 20% of total time vs. 10%, P=0.01; teaching: 8% of total time vs. 2%, P=0.006). Conclusions: As compared with a traditional inpatient care model, an experimental model characterized by reduced trainee workload and increased participation of attending physicians was associated with higher trainee satisfaction and increased time for educational activities. N Engl J Med 2010;362:1304-11.	[McMahon, Graham T.; Katz, Joel T.; Thorndike, Mary E.; Levy, Bruce D.; Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	McMahon, GT (corresponding author), Brigham & Womens Hosp, Dept Med, 221 Longwood Ave, Boston, MA 02115 USA.	gmcmahon@partners.org	McMahon, Graham/D-3740-2009; Loscalzo, Joseph/ABD-8980-2021	McMahon, Graham/0000-0003-4288-6535; 				*ACCR COUNC GRAD M, 2009, POL PROC; [Anonymous], PATIENT SATISFACTION; Arora VM, 2008, JAMA-J AM MED ASSOC, V300, P1146, DOI 10.1001/jama.300.10.1146; Bell BM, 2007, JAMA-J AM MED ASSOC, V298, P2865, DOI 10.1001/jama.298.24.2865-c; Boex JR, 2003, ACAD MED, V78, P939, DOI 10.1097/00001888-200309000-00022; Boud D., 2005, REFLECTION TURNING E; *COMM OPT GRAD MED, 2008, RES DUT HOURS ENH SL; Fitzgibbons JP, 2006, ANN INTERN MED, V144, P920, DOI 10.7326/0003-4819-144-12-200606200-00010; Fletcher KE, 2005, JAMA-J AM MED ASSOC, V294, P1088, DOI 10.1001/jama.294.9.1088; Glasheen JJ, 2008, MT SINAI J MED, V75, P436, DOI 10.1002/msj.20077; GOTTLIEB DJ, 1991, ARCH INTERN MED, V151, P2065, DOI 10.1001/archinte.151.10.2065; Gustin W, 2009, ACAD MED, V84, P368, DOI 10.1097/ACM.0b013e3181970cf5; Hauer KE, 2004, ARCH INTERN MED, V164, P1866, DOI 10.1001/archinte.164.17.1866; Horwitz LI, 2007, ANN INTERN MED, V147, P97, DOI 10.7326/0003-4819-147-2-200707170-00163; Hsueh Yeh, 2002, Hist Psychol, V5, P163, DOI 10.1037/1093-4510.5.2.163; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; Ludmerer K., 1999, TIME HEAL AM MED ED; Meltzer DO, 2007, JAMA-J AM MED ASSOC, V298, P1055, DOI 10.1001/jama.298.9.1055; Morey JC, 2002, HEALTH SERV RES, V37, P1553, DOI 10.1111/1475-6773.01104; Nielsen PE, 2007, OBSTET GYNECOL, V109, P48, DOI 10.1097/01.AOG.0000250900.53126.c2; *NY STAT HLTH DEP, 1987, FIN REP NEW YORK STA; Peterson MC, 2009, MAYO CLIN PROC, V84, P248, DOI 10.1016/S0025-6196(11)61142-7; Philibert I, 2005, SLEEP, V28, P1392, DOI 10.1093/sleep/28.11.1392; Pronovost P, 2003, J CRIT CARE, V18, P71, DOI 10.1053/jcrc.2003.50008; Regan-Smith M, 2007, TEACH LEARN MED, V19, P278, DOI 10.1080/10401330701366739; Southern WN, 2007, ARCH INTERN MED, V167, P1869, DOI 10.1001/archinte.167.17.1869; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P984, DOI 10.1001/jama.298.9.984; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P975, DOI 10.1001/jama.298.9.975; Wald HS, 2009, ACAD MED, V84, P830, DOI 10.1097/ACM.0b013e3181a8592f; Weinberger SE, 2006, ANN INTERN MED, V144, P927, DOI 10.7326/0003-4819-144-12-200606200-00124; Yaghoubian A, 2008, ARCH SURG-CHICAGO, V143, P847, DOI 10.1001/archsurg.143.9.847	32	70	71	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 8	2010	362	14					1304	1311		10.1056/NEJMsa0908136	http://dx.doi.org/10.1056/NEJMsa0908136			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579SN	20375407				2022-12-28	WOS:000276393700009
J	Rosenquist, JN; Murabito, J; Fowler, JH; Christakis, NA				Rosenquist, J. Niels; Murabito, Joanne; Fowler, James H.; Christakis, Nicholas A.			The Spread of Alcohol Consumption Behavior in a Large Social Network	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; LONGITUDINAL ANALYSIS; COGNITIVE FUNCTION; COLLEGE DRINKING; PEER INFLUENCES; RISK; ADOLESCENTS; SMOKING; MODELS; ONSET	Background: Alcohol consumption has important health-related consequences and numerous biological and social determinants. Objective: To explore quantitatively whether alcohol consumption behavior spreads from person to person in a large social network of friends, coworkers, siblings, spouses, and neighbors, followed for 32 years. Design: Longitudinal network cohort study. Setting: The Framingham Heart Study. Participants: 12 067 persons assessed at several time points between 1971 and 2003. Measurements: Self-reported alcohol consumption (number of drinks per week on average over the past year and number of days drinking within the past week) and social network ties, measured at each time point. Results: Clusters of drinkers and abstainers were present in the network at all time points, and the clusters extended to 3 degrees of separation. These clusters were not only due to selective formation of social ties among drinkers but also seem to reflect interpersonal influence. Changes in the alcohol consumption behavior of a person's social network had a statistically significant effect on that person's subsequent alcohol consumption behavior. The behaviors of immediate neighbors and coworkers were not significantly associated with a person's drinking behavior, but the behavior of relatives and friends was. Limitations: A nonclinical measure of alcohol consumption was used. Also, it is unclear whether the effects on long-term health are positive or negative, because alcohol has been shown to be both harmful and protective. Finally, not all network ties were observed. Conclusion: Network phenomena seem to influence alcohol consumption behavior. This has implications for clinical and public health interventions and further supports group-level interventions to reduce problematic drinking.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Boston, MA 02115 USA; Boston Univ, Sch Med, Boston, MA 02118 USA; Univ Calif San Diego, San Diego, CA 92103 USA; Harvard Univ, Cambridge, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Boston University; University of California System; University of California San Diego; Harvard University	Christakis, NA (corresponding author), Harvard Univ, Sch Med, 180-A Longwood Ave, Boston, MA 02115 USA.	christakis@hcp.med.harvard.edu	Fowler, James H/C-2750-2008; Christakis, Nicholas A/C-3205-2009	Fowler, James H/0000-0001-7795-1638; Murabito, Joanne/0000-0002-0192-7516	National Institutes of Health [R01AG2444801]; Robert Wood Johnson Foundation; National Heart, Lung, and Blood Institute [N01HC25195]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Grant Support: By the National Institutes of Health (grant R01AG2444801) and a Pioneer Award from the Robert Wood Johnson Foundation. The Framingham Heart Study is supported by the National Heart, Lung, and Blood Institute (grant N01HC25195).	Bearman PS, 2004, AM J PUBLIC HEALTH, V94, P89, DOI 10.2105/AJPH.94.1.89; Berkowitz A., 2004, SOCIAL NORMS APPROAC; Borsari B, 2003, J STUD ALCOHOL, V64, P331, DOI 10.15288/jsa.2003.64.331; Borsari B, 2001, J SUBST ABUSE, V13, P391, DOI 10.1016/S0899-3289(01)00098-0; Bullers S, 2001, ADDICT BEHAV, V26, P181, DOI 10.1016/S0306-4603(00)00099-X; Cacioppo JT, 2009, J PERS SOC PSYCHOL, V97, P977, DOI 10.1037/a0016076; Carrington PJ, 2005, MODELS METHODS SOCIA, V28; CHRISTAKIS NA, 2009, CONNECTED SUPRISING; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Del Boca FK, 2003, ADDICTION, V98, P1, DOI 10.1046/j.1359-6357.2003.00586.x; Duncan GJ, 2005, J ABNORM CHILD PSYCH, V33, P375, DOI 10.1007/s10802-005-3576-2; Espeland MA, 2006, NEUROEPIDEMIOLOGY, V27, P1, DOI 10.1159/000093532; FITZPATRICK GL, 1986, DIRECT LINE DISTANCE; Fowler JH, 2008, J HEALTH ECON, V27, P1400, DOI 10.1016/j.jhealeco.2008.07.001; Fowler JH, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2338; Galea S, 2004, EPIDEMIOL REV, V26, P36, DOI 10.1093/epirev/mxh007; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; HOSKING JRM, 1980, J ROY STAT SOC B MET, V42, P170; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; KELLEY JF, 2008, MGH TXB COMPREHENSIV; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; MACLURE M, 1993, EPIDEMIOL REV, V15, P328, DOI 10.1093/oxfordjournals.epirev.a036124; Malchodi CS, 2003, OBSTET GYNECOL, V101, P504, DOI 10.1016/S0029-7844(02)03070-3; MCKNIGHT AJ, 1986, ACCIDENT ANAL PREV, V18, P339, DOI 10.1016/0001-4575(86)90047-3; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mukamal KJ, 2006, ARCH INTERN MED, V166, P2145, DOI 10.1001/archinte.166.19.2145; Naimi TS, 2003, JAMA-J AM MED ASSOC, V289, P70, DOI 10.1001/jama.289.1.70; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Pagan JL, 2006, BEHAV GENET, V36, P483, DOI 10.1007/s10519-006-9062-y; Perkins HW, 2002, J STUD ALCOHOL, P164, DOI 10.15288/jsas.2002.s14.164; Peterson P., 1994, J RES ADOLESCENCE, V4, P203, DOI DOI 10.1207/s15327795jra0402_3; PRENTICE DA, 1996, ADV SOCIAL PSYCHOL, V28; Prescott CA, 1999, AM J PSYCHIAT, V156, P34, DOI 10.1176/ajp.156.1.34; Reid MC, 2006, J GERIATR PSYCH NEUR, V19, P98, DOI 10.1177/0891988706286513; Reifman A, 1998, J STUD ALCOHOL, V59, P311, DOI 10.15288/jsa.1998.59.311; ROSENQUIST JN, MOL PSYCHIA IN PRESS; SACKETT DL, 1975, CIRCULATION, V52, P589, DOI 10.1161/01.CIR.52.4.589; Schildcrout JS, 2005, BIOSTATISTICS, V6, P633, DOI 10.1093/biostatistics/kxi033; *SUBST AB MENT HLT, 1999, 1998 NAT SURV DRUG U; *SUBST AB MENT HLT, 2003, NHSDA 1999 SER H, V22; Substance Abuse and Mental Health Services Administration, 2003, 2002 NAT SURV DRUG U; Szabo G, 2006, ARXIVPHYSICS0611177; Tanner M. A., 1996, TOOLS STAT INFERENCE; Trautner H.M., 2000, DEV SOCIAL PSYCHOL G; WILSNACK SC, 1991, AM J PUBLIC HEALTH, V81, P305, DOI 10.2105/AJPH.81.3.305; Wing RR, 1999, J CONSULT CLIN PSYCH, V67, P132, DOI 10.1037/0022-006X.67.1.132	48	357	361	2	86	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 6	2010	152	7					426	W141		10.7326/0003-4819-152-7-201004060-00007	http://dx.doi.org/10.7326/0003-4819-152-7-201004060-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	579QI	20368648	Green Accepted			2022-12-28	WOS:000276386900003
J	Kaufmann, K; Wellmer, F; Muino, JM; Ferrier, T; Wuest, SE; Kumar, V; Serrano-Mislata, A; Madueno, F; Krajewski, P; Meyerowitz, EM; Angenent, GC; Riechmann, JL				Kaufmann, Kerstin; Wellmer, Frank; Muino, Jose M.; Ferrier, Thilia; Wuest, Samuel E.; Kumar, Vijaya; Serrano-Mislata, Antonio; Madueno, Francisco; Krajewski, Pawel; Meyerowitz, Elliot M.; Angenent, Gerco C.; Riechmann, Jose Luis			Orchestration of Floral Initiation by APETALA1	SCIENCE			English	Article							TRANSCRIPTION FACTORS; MERISTEM IDENTITY; FLOWERING TIME; EXPRESSION; ACTIVATION; INDUCTION; FRUITFULL; MICRORNA; PATHWAY; LEAFY	The MADS-domain transcription factor APETALA1 (AP1) is a key regulator of Arabidopsis flower development. To understand the molecular mechanisms underlying AP1 function, we identified its target genes during floral initiation using a combination of gene expression profiling and genome-wide binding studies. Many of its targets encode transcriptional regulators, including known floral repressors. The latter genes are down-regulated by AP1, suggesting that it initiates floral development by abrogating the inhibitory effects of these genes. Although AP1 acts predominantly as a transcriptional repressor during the earliest stages of flower development, at more advanced stages it also activates regulatory genes required for floral organ formation, indicating a dynamic mode of action. Our results further imply that AP1 orchestrates floral initiation by integrating growth, patterning, and hormonal pathways.	[Ferrier, Thilia; Riechmann, Jose Luis] CRAG, Barcelona 08034, Spain; [Kaufmann, Kerstin; Angenent, Gerco C.] Plant Res Int, Business Unit Biosci, NL-6700 AA Wageningen, Netherlands; [Kaufmann, Kerstin] Wageningen Univ, Mol Biol Lab, NL-6700 AP Wageningen, Netherlands; [Wellmer, Frank; Wuest, Samuel E.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin 2, Ireland; [Muino, Jose M.] Plant Res Int, Appl Bioinformat, NL-6700 AA Wageningen, Netherlands; [Kumar, Vijaya; Meyerowitz, Elliot M.; Riechmann, Jose Luis] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Serrano-Mislata, Antonio; Madueno, Francisco] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia 46022, Spain; [Krajewski, Pawel] Polish Acad Sci, Inst Plant Genet, PL-60479 Poznan, Poland; [Angenent, Gerco C.] CBSG, NL-6700 AB Wageningen, Netherlands; [Riechmann, Jose Luis] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); University of Barcelona; Wageningen University & Research; Trinity College Dublin; California Institute of Technology; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Polish Academy of Sciences; Institute of Plant Genetics of the Polish Academy of Sciences; Centre for BioSystems Genomics; ICREA	Riechmann, JL (corresponding author), CRAG, Barcelona 08034, Spain.	jriechma@caltech.edu	Meyerowitz, Elliot M/A-7118-2009; Riechmann, José Luis/M-7005-2018; Madueño, Francisco/L-5167-2014; Kaufmann, Kerstin/GXF-3402-2022; Serrano-Mislata, Antonio/M-3254-2015; Angenent, Gerco C./A-5993-2011; Ding, Cheng-Qiang/B-6287-2011; Kaufmann, Kerstin/A-2662-2012	Riechmann, José Luis/0000-0003-1108-1945; Madueño, Francisco/0000-0001-7598-3003; Kaufmann, Kerstin/0000-0001-7960-6256; Serrano-Mislata, Antonio/0000-0002-8828-1809; Kaufmann, Kerstin/0000-0001-7960-6256; Wuest, Samuel/0000-0003-3982-0770; Wellmer, Frank/0000-0002-2095-0981; Muino, Jose M/0000-0002-6403-7262	Science Foundation Ireland [06/IN.1/B851]; European Union (EU) [Transistor-MRTNCT-2004-512285, IRG-224864]; NSF [2010-0520193]; Spanish Ministerio de Ciencia e Innovacion [BFU2008-04251, BIO2006-10994, BIO2009-10876]; Millard and Muriel Jacobs Laboratory at Caltech; Netherlands Proteomics Centre; CBSG; Horizon [93519020]; CRAG; ICREA Funding Source: Custom	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Union (EU)(CGIAREuropean Commission); NSF(National Science Foundation (NSF)); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Millard and Muriel Jacobs Laboratory at Caltech; Netherlands Proteomics Centre; CBSG; Horizon; CRAG; ICREA(ICREA)	We are grateful to T. Mastro for help with microarray hybridizations, S. Kushnir for generating AP1 antibodies, Y. Hanzawa and D. Bradley for providing transferred DNA (T-DNA) insertion lines, and E. Graciet for help with AP1-GR detection in nuclear extracts. This work was supported by grants from Science Foundation Ireland (06/IN.1/B851 to F. W.), European Union (EU)-Marie Curie program (Transistor-MRTNCT-2004-512285 to G. C. A. and IRG-224864 to J.L.R.), NSF (2010-0520193 to J.L.R. and E. M. M.), Spanish Ministerio de Ciencia e Innovacion (BFU2008-04251 to J.L.R. and BIO2006-10994 and BIO2009-10876 to F. M.), and by the Millard and Muriel Jacobs Laboratory at Caltech. G. C. A. was also supported by the Netherlands Proteomics Centre and CBSG, which are part of the Netherlands Genomic Initiative. K. K. and J.M.M. were supported by fellowships from the EU-Marie Curie program; J.M.M. was also supported by CBSG and a Horizon grant (#93519020). T. F. was supported by a fellowship from CRAG. Microarray data have been deposited with the National Center for Biotechnology Information Gene Expression Omnibus under accession numbers GSE20184 and GSE20138 and the sequencing data under accession number GSE20176.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Achard P, 2009, CURR BIOL, V19, P1188, DOI 10.1016/j.cub.2009.05.059; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Castillejo C, 2008, CURR BIOL, V18, P1338, DOI 10.1016/j.cub.2008.07.075; Chuck G, 2005, CURR OPIN PLANT BIOL, V8, P67, DOI 10.1016/j.pbi.2004.11.002; Ferrandiz C, 2000, DEVELOPMENT, V127, P725; Gomez-Mena C, 2005, DEVELOPMENT, V132, P429, DOI 10.1242/dev.01600; Gomez-Mena C, 2008, PLANT CELL, V20, P2059, DOI 10.1105/tpc.108.059188; Gregis V, 2008, PLANT J, V56, P891, DOI 10.1111/j.1365-313X.2008.03648.x; Gregis V, 2009, PLANT J, V60, P626, DOI 10.1111/j.1365-313X.2009.03985.x; Kaufmann K, 2009, PLOS BIOL, V7, P854, DOI 10.1371/journal.pbio.1000090; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Liljegren SJ, 1999, PLANT CELL, V11, P1007, DOI 10.1105/tpc.11.6.1007; Liu C, 2007, DEVELOPMENT, V134, P1901, DOI 10.1242/dev.003103; Liu C, 2009, DEV CELL, V16, P711, DOI 10.1016/j.devcel.2009.03.011; Longabaugh WJR, 2005, DEV BIOL, V283, P1, DOI 10.1016/j.ydbio.2005.04.023; MANDEL MA, 1992, NATURE, V360, P273, DOI 10.1038/360273a0; Mathieu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000148; Ng M, 2001, PLANT CELL, V13, P739, DOI 10.1105/tpc.13.4.739; Riechmann JL, 1996, NUCLEIC ACIDS RES, V24, P3134, DOI 10.1093/nar/24.16.3134; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Sridhar VV, 2006, DEVELOPMENT, V133, P3159, DOI 10.1242/dev.02498; Wagner D, 1999, SCIENCE, V285, P582, DOI 10.1126/science.285.5427.582; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wellmer F, 2006, PLOS GENET, V2, P1012, DOI 10.1371/journal.pgen.0020117; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Yamaguchi A, 2009, DEV CELL, V17, P268, DOI 10.1016/j.devcel.2009.06.007	28	366	388	3	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	2010	328	5974					85	89		10.1126/science.1185244	http://dx.doi.org/10.1126/science.1185244			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577DR	20360106	Green Submitted			2022-12-28	WOS:000276202200040
J	Collins, F				Collins, Francis			Has the revolution arrived?	NATURE			English	Editorial Material									[Collins, Francis] NIH, Bethesda, MD 20892 USA; [Collins, Francis] NHGRI, Bethesda, MD USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Collins, F (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.	francis.collins@nih.gov							0	184	191	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 1	2010	464	7289					674	675		10.1038/464674a	http://dx.doi.org/10.1038/464674a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	577EO	20360716	Green Published, Bronze			2022-12-28	WOS:000276205000018
J	Golub, TR				Golub, Todd R.			Counterpoint: Data first	NATURE			English	Editorial Material									Broad Inst, Canc Program, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Golub, TR (corresponding author), Broad Inst, Canc Program, Cambridge, MA 02142 USA.	golub@broadinstitute.org							0	41	43	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 1	2010	464	7289					679	679		10.1038/464679a	http://dx.doi.org/10.1038/464679a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	577EO	20360719				2022-12-28	WOS:000276205000021
J	Murton, JB; Bateman, MD; Dallimore, SR; Teller, JT; Yang, ZR				Murton, Julian B.; Bateman, Mark D.; Dallimore, Scott R.; Teller, James T.; Yang, Zhirong			Identification of Younger Dryas outburst flood path from Lake Agassiz to the Arctic Ocean	NATURE			English	Article							LAURENTIDE ICE-SHEET; TUKTOYAKTUK COASTLANDS; CLIMATE-CHANGE; PALEOTOPOGRAPHY; STRATIGRAPHY; MELTWATER; OVERFLOW; HISTORY; VALLEY; MARGIN	The melting Laurentide Ice Sheet discharged thousands of cubic kilometres of freshwater each year into surrounding oceans, at times suppressing the Atlantic meridional overturning circulation and triggering abrupt climate change(1-4). Understanding the physical mechanisms leading to events such as the Younger Dryas cold interval requires identification of the paths and timing of the freshwater discharges. Although Broecker et al. hypothesized in 1989 that an outburst from glacial Lake Agassiz triggered the Younger Dryas(1), specific evidence has so far proved elusive, leading Broecker to conclude in 2006 that "our inability to identify the path taken by the flood is disconcerting''(2). Here we identify the missing flood path-evident from gravels and a regional erosion surface-running through the Mackenzie River system in the Canadian Arctic Coastal Plain. Our modelling of the isostatically adjusted surface in the upstream Fort McMurray region, and a slight revision of the ice margin at this time, allows Lake Agassiz to spill into the Mackenzie drainage basin. From optically stimulated luminescence dating we have determined the approximate age of this Mackenzie River flood into the Arctic Ocean to be shortly after 13,000 years ago, near the start of the Younger Dryas. We attribute to this flood a boulder terrace near Fort McMurray with calibrated radiocarbon dates of over 11,500 years ago. A large flood into the Arctic Ocean at the start of the Younger Dryas leads us to reject the widespread view that Agassiz overflow at this time was solely eastward into the North Atlantic Ocean.	[Murton, Julian B.] Univ Sussex, Dept Geog, Permafrost Lab, Brighton BN1 9QJ, E Sussex, England; [Bateman, Mark D.] Univ Sheffield, Dept Geog, Sheffield Ctr Int Drylands Res, Sheffield S10 2TN, S Yorkshire, England; [Dallimore, Scott R.] Geol Survey Canada, Sidney, BC V8L 4B2, Canada; [Teller, James T.; Yang, Zhirong] Univ Manitoba, Dept Geol Sci, Winnipeg, MB R3T 2N2, Canada	University of Sussex; University of Sheffield; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada; University of Manitoba	Murton, JB (corresponding author), Univ Sussex, Dept Geog, Permafrost Lab, Brighton BN1 9QJ, E Sussex, England.	j.b.murton@sussex.ac.uk	de Baranda, Pilar Sainz/ABH-1235-2020	de Baranda, Pilar Sainz/0000-0002-1379-5151; bateman, mark/0000-0003-1756-6046; Murton, Julian/0000-0002-9469-5856	Royal Society; Quaternary Research Association; British Society for Geomorphology; Geological Survey of Canada; Natural Sciences and Engineering Research Council of Canada	Royal Society(Royal Society of London); Quaternary Research Association; British Society for Geomorphology; Geological Survey of Canada(Natural Resources Canada); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The Mackenzie Delta research was funded by the Royal Society, the Quaternary Research Association, the British Society for Geomorphology and the Geological Survey of Canada. The Aurora Research Institute (Inuvik) and the Polar Continental Shelf Project provided logistical support. J. T. T. and Z. Y. thank the Natural Sciences and Engineering Research Council of Canada for support through the Discovery Grants Program. We thank R. A. Ashurst, P. Coles and D. K. Murton for laboratory and cartographic assistance, J. R. Mackay for drawing our attention to the Fort Good Hope region, and C. D. Clark, M. R. Frogley and E. J. Rhodes for comments. We also thank V. R. Baker and G. A. Duller for reviews that improved the manuscript considerably.	ANDRIASHEK LD, 2007, BURIED CHANNELS GLAC; BAKER VR, 1985, QUATERNARY SCI REV, V4, P1, DOI 10.1016/0277-3791(85)90027-7; Bateman MD, 2006, QUATERNARY SCI REV, V25, P2552, DOI 10.1016/j.quascirev.2005.07.023; BLASCO SM, 1990, GEOLOGY N AM, V50, P491; BROECKER WS, 1989, NATURE, V341, P318, DOI 10.1038/341318a0; Broecker WS, 2006, SCIENCE, V312, P1146, DOI 10.1126/science.1123253; Carlson AE, 2007, P NATL ACAD SCI USA, V104, P6556, DOI 10.1073/pnas.0611313104; Clark PU, 2001, SCIENCE, V293, P283, DOI 10.1126/science.1062517; DREXLER CW, 1985, GEOLOGICAL ASS CANAD, V26, P309; Dyke AS, 2004, DEV QUA SCI, V2, P373, DOI 10.1016/S1571-0866(04)80209-4; Fisher TG, 2002, QUATERNARY SCI REV, V21, P873, DOI 10.1016/S0277-3791(01)00148-2; Hill PR, 1996, CAN J EARTH SCI, V33, P1064, DOI 10.1139/e96-081; LEMMEN DS, 1994, QUATERNARY SCI REV, V13, P805, DOI 10.1016/0277-3791(94)90003-5; Leverington DW, 2000, QUATERNARY RES, V54, P174, DOI 10.1006/qres.2000.2157; Licciardi JM, 1999, GEOPH MONOG SERIES, V112, P177; MACKAY JR, 1973, CAN J EARTH SCI, V10, P26, DOI 10.1139/e73-003; MACKAY JR, 1963, DEP MINES TECHNICAL, V8; Murton JB, 2005, QUATERNARY SCI REV, V24, P681, DOI 10.1016/j.quascirev.2004.06.008; Murton JB, 2009, PERMAFROST PERIGLAC, V20, P107, DOI 10.1002/ppp.647; PELLETIER BR, 1987, 40 GEOL SURV CAN; Polyak L, 2007, QUATERNARY RES, V67, P234, DOI 10.1016/j.yqres.2006.08.001; Rayburn JA, 2007, PALAEOGEOGR PALAEOCL, V246, P62, DOI 10.1016/j.palaeo.2006.10.027; SMITH DG, 1993, GEOLOGY, V21, P9, DOI 10.1130/0091-7613(1993)021<0009:GLATNO>2.3.CO;2; Tarasov L, 2005, NATURE, V435, P662, DOI 10.1038/nature03617; Teller JT, 2006, QUATERNARY SCI REV, V25, P1142, DOI 10.1016/j.quascirev.2006.01.011; Teller JT, 2005, QUATERNARY SCI REV, V24, P1890, DOI 10.1016/j.quascirev.2005.01.008; Teller JT, 2002, QUATERNARY SCI REV, V21, P879, DOI 10.1016/S0277-3791(01)00145-7; THORLEIFSON LH, 1996, FIELD TRIP GUIDE BOO, P55; Yang ZR, 2005, J PALEOLIMNOL, V33, P483, DOI 10.1007/s10933-005-0813-1	29	190	194	1	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 1	2010	464	7289					740	743		10.1038/nature08954	http://dx.doi.org/10.1038/nature08954			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577EO	20360738				2022-12-28	WOS:000276205000041
J	Robb, E; Jarman, B; Suntharalingam, G; Higgens, C; Tennant, R; Elcock, K				Robb, Elizabeth; Jarman, Brian; Suntharalingam, Ganesh; Higgens, Clare; Tennant, Rachel; Elcock, Karen			Quality Improvement Report Using care bundles to reduce in-hospital mortality: quantitative survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ADMINISTRATIVE DATA; DEATH; SAFETY	Problem To reduce hospital inpatient mortality and thus increase public confidence in the quality of patient care in an urban acute hospital trust after adverse media coverage. Design Eight care bundles of treatments known to be effective in reducing in-hospital mortality were used in the intervention year; adjusted mortality ( from hospital episode statistics) was compared to the preceding year for the 13 diagnoses targeted by the intervention care bundles, 43 non-targeted diagnoses, and overall mortality for the 56 hospital standardised mortality ratio (HSMR) diagnoses covering 80% of hospital deaths. Setting Acute hospital trust in north west London. Strategies for change Use of clinical guidelines in care bundles in eight targeted clinical areas. Interventions Use of care bundles in treatment areas for the diagnoses leading to most deaths in the trust in 2006-7. Key measures for improvement Change in adjusted mortality in targeted and non-targeted diagnostic groups; hospital standardised mortality ratio (HSMR) during the intervention year compared with the preceding year. Effect of the change The standardised mortality ratio (SMR) of the targeted diagnoses and the HSMR both showed significant reductions, and the non-targeted diagnoses showed a slight reduction. Cumulative sum charts showed significant reductions of SMRs in 11 of the 13 diagnoses targeted in the year of the quality improvements, compared with the preceding year The HSMR of the trust fell from 89.6 in 2006-7 to 71.1 in 2007-8 to become the lowest among acute trusts in England. 255 fewer deaths occurred in the trust (174 of these in the targeted diagnoses) in 2007-8 for the HSMR diagnoses than if the 2006-7 HSMR had been applicable. From 2006-7 to 2007-8 there was a 5.7% increase in admissions, 7.9% increase in expected deaths, and 14.5% decrease in actual deaths. Lessons learnt Implementing care bundles can lead to reductions in death rates in the clinical diagnostic areas targeted and in the overall hospital mortality rate.	[Jarman, Brian] Univ London Imperial Coll Sci Technol & Med, London EC1A 9LA, England; [Robb, Elizabeth; Suntharalingam, Ganesh; Higgens, Clare; Tennant, Rachel] NW London Hosp NHS Trust, Harrow HA1 3UJ, Middx, England; [Robb, Elizabeth] London S Bank Univ, London SE1 0AA, England; [Jarman, Brian] Inst Healthcare Improvement, Cambridge, MA 02138 USA; [Elcock, Karen] Thames Valley Univ, Slough SL1 1YG, Berks, England	Imperial College London; London South Bank University; Institute for Healthcare Improvement; University of West London	Jarman, B (corresponding author), Univ London Imperial Coll Sci Technol & Med, London EC1A 9LA, England.	b.jarman@imperial.ac.uk	Elcock, Karen Suzanne/I-2856-2019	Elcock, Karen Suzanne/0000-0002-4950-5929; Suntharalingam, Ganesh/0000-0002-8189-8320				*AG HEALTHC RES QU, CLIN PRACT GUID ARCH; [Anonymous], 2006, BBC NEWS        0427; Aylin P, 2007, EUR J VASC ENDOVASC, V33, P461, DOI 10.1016/j.ejvs.2006.10.033; Aylin P, 2007, BMJ-BRIT MED J, V334, P1044, DOI 10.1136/bmj.39168.496366.55; Berwick DM, 2006, JAMA-J AM MED ASSOC, V295, P324, DOI 10.1001/jama.295.3.324; Bottle A, 2006, BMJ-BRIT MED J, V332, P947, DOI 10.1136/bmj.38790.468519.55; Bottle A, 2008, HEALTH SERV RES, V43, P10, DOI 10.1111/j.1475-6773.2007.00742.x; Breslow N. E., 1987, STATISTICAL METHODS, V2, P69; *BRIST ROYAL INF I, 2001, BRIST ROYAL INF INQ; *CDCP, GUID TOP; Darzi A., 2008, HIGH QUALITY CARE AL; Department of Health, 2007, NAT I HLTH CLIN EXC; Elixhauser A., 1993, AHCPR PUBLICATION; Fillingham D., 2008, LEAN HEALTHCARE IMPR; *FOST INT, FOST HOSP GUID METH; *HAM HLTH SCI, 2009, HOSP STAND MORT RAT; HANCOCK C, 2007, WELSH CRITICAL CARE; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; *HEALTHC COMM, 2005, REV MAT SERV PROV N; *I HEALTHC IMPR, OV 100000 LIV CAMP; *I MED, 1999, ERR IS HUM BUILD SAF; Institute for Healthcare Improvement, 2006, RAIS BAR BUNDL TREAT; Institute of Medicine Committee on Quality of Health Care in America, 2001, CROSS QUAL CHASM NEW; Jarman B, 2005, BRIT MED J, V330, P329, DOI 10.1136/bmj.330.7487.329; Jarman B, 1999, BMJ-BRIT MED J, V318, P1515, DOI 10.1136/bmj.318.7197.1515; Mayo, 1933, HUMAN PROBLEMS IND C; McCannon CJ, 2006, BRIT MED J, V332, P1328, DOI 10.1136/bmj.332.7553.1328; *N W LOND HOSP NHS, 2008, REV N W LOND HOSP NH; PUZIC S, 2008, HOSP MORTALITY RATES; Steiner S H, 2000, Biostatistics, V1, P441, DOI 10.1093/biostatistics/1.4.441; The Bristol Royal Infirmary Inquiry, 2001, LEARN BRIST REP PUBL; Vincent C, 2003, NEW ENGL J MED, V348, P1051, DOI 10.1056/NEJMhpr020760; Vincent C, 2007, BRIT MED J, V334, P51, DOI 10.1136/bmj.39071.441609.80; Wright J, 2006, J ROY SOC MED, V99, P303, DOI 10.1258/jrsm.99.6.303	34	53	55	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2010	340								c1234	10.1136/bmj.c1234	http://dx.doi.org/10.1136/bmj.c1234			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579VM	20360220				2022-12-28	WOS:000276404500001
J	Van de Veire, S; Stalmans, I; Heindryckx, F; Oura, H; Tijeras-Raballand, A; Schmidt, T; Loges, S; Albrecht, I; Jonckx, B; Vinckier, S; Van Steenkiste, C; Tugues, S; Rolny, C; De Mol, M; Dettori, D; Hainaud, P; Coenegrachts, L; Contreres, JO; Van Bergen, T; Cuervo, H; Xiao, WH; Le Henaff, C; Buysschaert, I; Masouleh, BK; Geerts, A; Schomber, T; Bonnin, P; Lambert, V; Haustraete, J; Zacchigna, S; Rakic, JM; Jimenez, W; Noel, A; Giacca, M; Colle, I; Foidart, JM; Tobelem, G; Morales-Ruiz, M; Vilar, J; Maxwell, P; Vinores, SA; Carmeliet, G; Dewerchin, M; Claesson-Welsh, L; Dupuy, E; Van Vlierberghe, H; Christofori, G; Mazzone, M; Detmar, M; Collen, D; Carmeliet, P				Van de Veire, Sara; Stalmans, Ingeborg; Heindryckx, Femke; Oura, Hajimu; Tijeras-Raballand, Annemilai; Schmidt, Thomas; Loges, Sonja; Albrecht, Imke; Jonckx, Bart; Vinckier, Stefan; Van Steenkiste, Christophe; Tugues, Sonia; Rolny, Charlotte; De Mol, Maria; Dettori, Daniela; Hainaud, Patricia; Coenegrachts, Lieve; Contreres, Jean-Olivier; Van Bergen, Tine; Cuervo, Henar; Xiao, Wei-Hong; Le Henaff, Carole; Buysschaert, Ian; Masouleh, Behzad Kharabi; Geerts, Anja; Schomber, Tibor; Bonnin, Philippe; Lambert, Vincent; Haustraete, Jurgen; Zacchigna, Serena; Rakic, Jean-Marie; Jimenez, Wladimiro; Noel, Agnes; Giacca, Mauro; Colle, Isabelle; Foidart, Jean-Michel; Tobelem, Gerard; Morales-Ruiz, Manuel; Vilar, Jose; Maxwell, Patrick; Vinores, Stanley A.; Carmeliet, Geert; Dewerchin, Mieke; Claesson-Welsh, Lena; Dupuy, Evelyne; Van Vlierberghe, Hans; Christofori, Gerhard; Mazzone, Massimiliano; Detmar, Michael; Collen, Desire; Carmeliet, Peter			Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease	CELL			English	Article							PLACENTA GROWTH-FACTOR; HEPATOCELLULAR-CARCINOMA; PATHOLOGICAL CONDITIONS; MOUSE MODEL; METASTASIS; ANGIOGENESIS; MICE; PROGRESSION; HYPOXIA; LUNG	Our findings that PlGF is a cancer target and anti-PlGF is useful for anticancer treatment have been challenged by Bais et al. Here we take advantage of carcinogen-induced and transgenic tumor models as well as ocular neovascularization to report further evidence in support of our original findings of PlGF as a promising target for anticancer therapies. We present evidence for the efficacy of additional anti-PlGF antibodies and their ability to phenocopy genetic deficiency or silencing of PlGF in cancer and ocular disease but also show that not all anti-PlGF antibodies are effective. We also provide additional evidence for the specificity of our anti-PlGF antibody and experiments to suggest that anti-PlGF treatment will not be effective for all tumors and why. Further, we show that PlGF blockage inhibits vessel abnormalization rather than density in certain tumors while enhancing VEGF-targeted inhibition in ocular disease. Our findings warrant further testing of anti-PlGF therapies.	[Van de Veire, Sara; Schmidt, Thomas; Loges, Sonja; Vinckier, Stefan; De Mol, Maria; Dettori, Daniela; Cuervo, Henar; Buysschaert, Ian; Masouleh, Behzad Kharabi; Vinores, Stanley A.; Dewerchin, Mieke; Mazzone, Massimiliano; Carmeliet, Peter] Katholieke Univ Leuven, Vesalius Res Ctr, B-3000 Louvain, Belgium; [Van de Veire, Sara; Schmidt, Thomas; Loges, Sonja; Jonckx, Bart; Vinckier, Stefan; De Mol, Maria; Dettori, Daniela; Cuervo, Henar; Buysschaert, Ian; Masouleh, Behzad Kharabi; Vinores, Stanley A.; Dewerchin, Mieke; Mazzone, Massimiliano; Collen, Desire; Carmeliet, Peter] VIB, Vesalius Res Ctr, B-3000 Louvain, Belgium; [Van de Veire, Sara; Stalmans, Ingeborg; Van Bergen, Tine] Katholieke Univ Leuven, Lab Ophthalmol, B-3000 Louvain, Belgium; [Heindryckx, Femke; Van Steenkiste, Christophe; Geerts, Anja; Colle, Isabelle; Van Vlierberghe, Hans] Ghent Univ Hosp, Dept Gastroenterol & Hepatol, B-9000 Ghent, Belgium; [Oura, Hajimu; Detmar, Michael] ETH, Inst Pharmaceut Sci, CH-8057 Zurich, Switzerland; [Tijeras-Raballand, Annemilai; Hainaud, Patricia; Contreres, Jean-Olivier; Le Henaff, Carole; Bonnin, Philippe; Tobelem, Gerard; Dupuy, Evelyne] INSERM, U965, Inst Vaisseaux & Sang Angiogenese & Rech Translat, Paris, France; [Albrecht, Imke; Schomber, Tibor; Christofori, Gerhard] Univ Basel, Inst Biochem & Genet, CH-4051 Basel, Switzerland; [Tugues, Sonia; Jimenez, Wladimiro; Morales-Ruiz, Manuel] Univ Barcelona, Biochem & Mol Genet Serv, IDIBAPS, Hosp Clin Barcelona,CIBEREHD, E-08036 Barcelona, Spain; [Tugues, Sonia; Rolny, Charlotte; Claesson-Welsh, Lena] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, S-75185 Uppsala, Sweden; [Coenegrachts, Lieve; Carmeliet, Geert] Katholieke Univ Leuven, Lab Expt Med & Endocrinol, B-3000 Louvain, Belgium; [Xiao, Wei-Hong; Vinores, Stanley A.] Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21218 USA; [Lambert, Vincent; Rakic, Jean-Marie; Noel, Agnes; Foidart, Jean-Michel] Univ Liege, Lab Tumour & Dev Biol, GIGA Canc, B-4000 Liege, Belgium; [Haustraete, Jurgen] VIB, Prot Serv Facil, B-9052 Ghent, Belgium; [Zacchigna, Serena; Giacca, Mauro] Int Ctr Genet Engn & Biotechnol, I-34149 Trieste, Italy; [Jimenez, Wladimiro] Univ Barcelona, Dept Physiol, Barcelona 08036, Spain; [Vilar, Jose] Univ Paris 05, INSERM, U970, Hop Europeen Georges Pompidou,Cardiovasc Res Ctr, F-75270 Paris 06, France; [Maxwell, Patrick] UCL, Rayne Inst, Div Med, London WC1E 6JF, England	KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; Ghent University; Ghent University Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Basel; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Uppsala University; KU Leuven; Johns Hopkins University; Johns Hopkins Medicine; University of Liege; Flanders Institute for Biotechnology (VIB); International Center for Genetic Engineering & Biotechnology (ICGEB); University of Barcelona; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of London; King's College London; University College London	Carmeliet, P (corresponding author), Katholieke Univ Leuven, Vesalius Res Ctr, B-3000 Louvain, Belgium.	peter.carmeliet@vib-kuleuven.be	Morales-Ruiz, Manuel/AAM-1487-2020; Carmeliet, Peter/AAQ-5140-2020; Morales-Ruiz, Manuel/Z-2332-2019; Cuervo, Henar/AAF-4152-2019; Giacca, Mauro/J-9287-2016; Maxwell, Patrick H/C-5557-2008; Morales-Ruiz, Manuel/L-1031-2014; Bonnin, Philippe/Y-5872-2019; Schmidt, Thomas/Y-8431-2019; Loges, Sonja/ABE-9868-2021; Rolny, Charlotte/AET-0493-2022; ZACCHIGNA, SERENA/E-9496-2017	Carmeliet, Peter/0000-0001-7961-1821; Morales-Ruiz, Manuel/0000-0002-9074-2272; Cuervo, Henar/0000-0001-8293-9377; Giacca, Mauro/0000-0003-2927-7225; Maxwell, Patrick H/0000-0002-0338-2679; Morales-Ruiz, Manuel/0000-0002-9074-2272; Bonnin, Philippe/0000-0003-3184-3740; Schmidt, Thomas/0000-0002-7166-3675; Loges, Sonja/0000-0002-7650-8527; Heindryckx, Femke/0000-0002-1987-7676; Van Vlierberghe, Hans/0000-0003-0647-9238; Jimenez, Wladimiro/0000-0002-9376-0214; Vilar, Jose/0000-0002-9136-7726; geerts, anja/0000-0002-2218-9081; Noel, Agnes/0000-0002-7670-6179; ZACCHIGNA, SERENA/0000-0001-6705-3076; Rolny, Charlotte/0000-0003-4979-9266	TG; Methusalem funding; NCCR Molecular Oncology; Swiss Science Foundation; FWO [G. 0229.04, G. 0500.08, SCIE2006-3, OT/08/ 37]; NIH [CA69184, EY017164]; Swiss Science Foundation [3100A0108207]; DFG; DKH;  [IUAP06/30];  [GOA2006/11];  [LSHG-CT-2004-503573];  [LSHC-CT-2005-518178];  [SAF 2007-63069];  [2009 SGR 1496]; NATIONAL CANCER INSTITUTE [R01CA069184] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017164] Funding Source: NIH RePORTER	TG; Methusalem funding; NCCR Molecular Oncology(Swiss National Science Foundation (SNSF)); Swiss Science Foundation(Swiss National Science Foundation (SNSF)); FWO(FWO); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss Science Foundation(Swiss National Science Foundation (SNSF)); DFG(German Research Foundation (DFG)); DKH; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	ThromboGenics (TG) NV and BioInvent AB developed PlGF inhibitors for antiangiogenic treatment under a license from VIB and K. U. Leuven. D. C. was the Founder and is Chairman of the Board of TG (indirectly holding 1% equity share); his participation relates to his scientific directorship of the VIB department (until October 2008) when most studies were ongoing. The research on anti-PlGF conducted in the lab of P. C. has been financed in small part by TG. This work was supported by K. U. Leuven, IUAP06/30, GOA2006/11, and Methusalem funding to P. C.; by LSHG-CT-2004-503573 to P. C., L. C.-W., and G. Christofori; by NCCR Molecular Oncology, Swiss Science Foundation to G. Christofori; by FWO G. 0229.04 and G. 0500.08, SCIE2006-3, and OT/08/ 37 to G. Carmeliet; by NIH grant CA69184, Swiss Science Foundation 3100A0108207, and LSHC-CT-2005-518178 to M. Detmar; by NIH EY017164 to S. A. V.; by SAF 2007-63069 and 2009 SGR 1496 to M. M.-R.; by DFG fellowship to T. S.; and by DKH fellowship to S. L.	Bais C, 2010, CELL, V141, P166, DOI 10.1016/j.cell.2010.01.033; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Davidoff AM, 2002, CANCER RES, V62, P3077; Dawson MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006525; Dupuy E, 2003, J HEPATOL, V38, P793, DOI 10.1016/S0168-8278(03)00086-2; Fernandez M, 2009, J HEPATOL, V50, P604, DOI 10.1016/j.jhep.2008.12.011; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; Gerber HP, 2007, P NATL ACAD SCI USA, V104, P3478, DOI 10.1073/pnas.0611492104; Gordon MS, 2001, J CLIN ONCOL, V19, P843, DOI 10.1200/JCO.2001.19.3.843; Hawighorst T, 2001, EMBO J, V20, P2631, DOI 10.1093/emboj/20.11.2631; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Ho MC, 2007, CANCER LETT, V250, P237, DOI 10.1016/j.canlet.2006.10.005; Johnson SJ, 1998, J GASTROEN HEPATOL, V13, P145, DOI 10.1111/j.1440-1746.1998.tb00629.x; Landgren E, 1998, ONCOGENE, V16, P359, DOI 10.1038/sj.onc.1201545; Lassen U, 2009, MOL CANCER THER, V8, DOI 10.1158/1535-7163.TARG-09-A111; Xu L, 2007, MOL CANCER RES, V5, P873, DOI 10.1158/1541-7786.MCR-06-0141; Loges S, 2009, CANCER CELL, V15, P167, DOI 10.1016/j.ccr.2009.02.007; Luttun A, 2002, BIOCHEM BIOPH RES CO, V295, P428, DOI 10.1016/S0006-291X(02)00677-0; Luttun A., 2002, NAT MED, V1, P1; Marcellini M, 2006, AM J PATHOL, V169, P643, DOI 10.2353/ajpath.2006.051041; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Oura H, 2003, BLOOD, V101, P560, DOI 10.1182/blood-2002-05-1516; Paternostro C, 2010, WORLD J GASTROENTERO, V16, P281, DOI 10.3748/wjg.v16.i3.281; Riisbro R, 2009, MOL CANCER THER, V8, DOI 10.1158/1535-7163.TARG-09-A3; Roncal C, 2010, CARDIOVASC RES, V86, P29, DOI 10.1093/cvr/cvp380; Taylor AP, 2007, MOL CANCER THER, V6, P524, DOI 10.1158/1535-7163.MCT-06-0461; Van Steenkiste C, 2009, GASTROENTEROLOGY, V137, P2112, DOI 10.1053/j.gastro.2009.08.068; Willett CG, 2005, J CLIN ONCOL, V23, P8136, DOI 10.1200/JCO.2005.02.5635; Wittko IM, 2009, J NEUROSCI, V29, P8704, DOI 10.1523/JNEUROSCI.5527-08.2009; Wu XZ, 2007, J GASTROEN HEPATOL, V22, P1178, DOI 10.1111/j.1440-1746.2007.04997.x	33	213	217	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2010	141	1					178	190		10.1016/j.cell.2010.02.039	http://dx.doi.org/10.1016/j.cell.2010.02.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	577GS	20371353	Green Submitted, Bronze			2022-12-28	WOS:000276211100022
J	Muraki, N; Nomata, J; Ebata, K; Mizoguchi, T; Shiba, T; Tamiaki, H; Kurisu, G; Fujita, Y				Muraki, Norifumi; Nomata, Jiro; Ebata, Kozue; Mizoguchi, Tadashi; Shiba, Tomoo; Tamiaki, Hitoshi; Kurisu, Genji; Fujita, Yuichi			X-ray crystal structure of the light-independent protochlorophyllide reductase	NATURE			English	Article							PYROCOCCUS-FURIOSUS; BCHN-BCHB; L-PROTEIN; IN-VITRO; OXIDOREDUCTASE; BIOSYNTHESIS; LIGAND; ENZYME; IDENTIFICATION; FERREDOXIN	Photosynthetic organisms adopt two different strategies for the reduction of the C17=C18 double bond of protochlorophyllide (Pchlide) to form chlorophyllide a, the direct precursor of chlorophyll a (refs 1-4). The first involves the activity of the light-dependent Pchlide oxidoreductase(5-9), and the second involves the light-independent (dark-operative) Pchlide oxidoreductase(10) (DPOR). DPOR is a nitrogenase-like enzyme consisting of two components, L-protein (a BchL dimer) and NB-protein (a BchN-BchB heterotetramer), which are structurally related to nitrogenase Fe protein and MoFe protein, respectively(10,11). Here we report the crystal structure of the NB-protein of DPOR from Rhodobacter capsulatus at a resolution of 2.3 angstrom. As expected, the overall structure is similar to that of nitrogenase MoFe protein: each catalytic BchN-BchB unit contains one Pchlide and one iron-sulphur cluster (NB-cluster) coordinated uniquely by one aspartate and three cysteines. Unique aspartate ligation is not necessarily needed for the cluster assembly but is essential for the catalytic activity. Specific Pchlide-binding accompanies the partial unwinding of an a-helix that belongs to the next catalytic BchN-BchB unit. We propose a unique trans-specific reduction mechanism in which the distorted C17-propionate of Pchlide and an aspartate from BchB serve as proton donors for C18 and C17 of Pchlide, respectively. Intriguingly, the spatial arrangement of the NB-cluster and Pchlide is almost identical to that of the P-cluster and FeMo-cofactor in nitrogenase MoFe-protein, illustrating that a common architecture exists to reduce chemically stable multibonds of porphyrin and dinitrogen.	[Muraki, Norifumi; Kurisu, Genji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Muraki, Norifumi; Shiba, Tomoo] Univ Tokyo, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan; [Nomata, Jiro; Ebata, Kozue; Fujita, Yuichi] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Mizoguchi, Tadashi; Tamiaki, Hitoshi] Ritsumeikan Univ, Dept Biosci & Biotechnol, Shiga 5258577, Japan; [Fujita, Yuichi] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	Osaka University; University of Tokyo; Nagoya University; Ritsumeikan University; Japan Science & Technology Agency (JST)	Kurisu, G (corresponding author), Osaka Univ, Inst Prot Res, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	gkurisu@protein.osaka-u.ac.jp; fujita@agr.nagoya-u.ac.jp	Muraki, Norifumi/AAW-2540-2020; KURISU, GENJI/AAD-7109-2022; KURISU, GENJI/ABA-5960-2020; Fujita, Yuichi/G-8908-2013; Nomata, Jiro/D-1813-2015	Muraki, Norifumi/0000-0003-4112-2955; KURISU, GENJI/0000-0002-5354-0807; KURISU, GENJI/0000-0002-5354-0807; Nomata, Jiro/0000-0001-9849-2426	Japan Society for the Promotion of Science (JSPS) [17687008, 18054308, 19570036, 20200063, 19750148, 19350088, 19010733, 2110614]; Japan Science and Technology Agency (JST); Kato Memorial Science Foundation; Toyoaki Scholarship Foundation; Japan Securities Scholarship Foundation	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Kato Memorial Science Foundation; Toyoaki Scholarship Foundation(Toyoaki Scholarship Foundation); Japan Securities Scholarship Foundation	We thank K. Fukuyama, T. Omata and K. Terauchi for discussions; J. Peters and R. Cogdell for a critical reading of the manuscript; H. Yamamoto for establishing the functional overexpression system in E. coli; J. Harimoto for technical help in the sequence confirmation of a series of expression vectors; C. E. Bauer for donating the broad host-range vector pBBR1MSC2 and the triparental mating system for R. capsulatus; and the staff at the Photon Factory, KEK, Japan, for support during data collection. This work was supported by Grants-in-Aid for Scientific Research numbers 17687008 and 18054308 (G. K.), 19570036, 14COEA2 and 20200063 (Y. F.), 19750148 (T. M.) and 19350088 (H. T.) from the Japan Society for the Promotion of Science (JSPS), Precursory Research for Embryonic Science and Technology of the Japan Science and Technology Agency (JST) (Y. F.), the Kato Memorial Science Foundation (G. K.), the Toyoaki Scholarship Foundation and the Japan Securities Scholarship Foundation (Y. F.). N. M and J. N. grateful for fellowships from the JSPS for Japanese Junior Scientists (numbers 19010733 and 2110614).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brocker MJ, 2008, J BIOL CHEM, V283, P10559, DOI 10.1074/jbc.M708010200; Buhr F, 2008, P NATL ACAD SCI USA, V105, P12629, DOI 10.1073/pnas.0803950105; CALZOLAI L, 1995, BIOCHEMISTRY-US, V34, P11373, DOI 10.1021/bi00036a010; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujita Y, 2000, J BIOL CHEM, V275, P23583, DOI 10.1074/jbc.M002904200; Fujita Y., 2003, PORPHYRIN HDB CHLORO, P109, DOI DOI 10.1016/B978-0-08-092387-1.50010-2; Heyes DJ, 2005, TRENDS BIOCHEM SCI, V30, P642, DOI 10.1016/j.tibs.2005.09.001; Imai T, 2001, J BIOCHEM, V130, P649, DOI 10.1093/oxfordjournals.jbchem.a003030; KIM JS, 1992, SCIENCE, V257, P1677, DOI 10.1126/science.1529354; Lebedev N, 1999, P NATL ACAD SCI USA, V96, P9954, DOI 10.1073/pnas.96.17.9954; Masuda T, 2004, PHOTOSYNTH RES, V81, P1, DOI 10.1023/B:PRES.0000028392.80354.7c; Masuda T, 2008, PHOTOCH PHOTOBIO SCI, V7, P1131, DOI 10.1039/b807210h; Mizoguchi T, 2009, ORG BIOMOL CHEM, V7, P2120, DOI 10.1039/b900802k; Nomata J, 2005, BBA-BIOENERGETICS, V1708, P229, DOI 10.1016/j.bbabio.2005.02.002; Nomata J, 2008, FEBS LETT, V582, P1346, DOI 10.1016/j.febslet.2008.03.018; Nomata J, 2006, FEBS LETT, V580, P6151, DOI 10.1016/j.febslet.2006.10.014; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Reinbothe S, 1996, CELL, V86, P703, DOI 10.1016/S0092-8674(00)80144-0; Ruediger Wolfhart, 2006, V25, P189; Sarma R, 2008, BIOCHEMISTRY-US, V47, P13004, DOI 10.1021/bi801058r; Schmid B, 2002, SCIENCE, V296, P352, DOI 10.1126/science.1070010; SHAH VK, 1977, P NATL ACAD SCI USA, V74, P3249, DOI 10.1073/pnas.74.8.3249; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; VON WETTSTEIN D, 1995, PLANT CELL, V7, P1039, DOI 10.1105/tpc.7.7.1039; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WILKS HM, 1995, P NATL ACAD SCI USA, V92, P724, DOI 10.1073/pnas.92.3.724; Yamamoto H, 2008, PHOTOCH PHOTOBIO SCI, V7, P1238, DOI 10.1039/b802427h	33	139	146	1	73	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 6	2010	465	7294					110	U124		10.1038/nature08950	http://dx.doi.org/10.1038/nature08950			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591OW	20400946				2022-12-28	WOS:000277311900041
J	Charron, S; Koechlin, E				Charron, Sylvain; Koechlin, Etienne			Divided Representation of Concurrent Goals in the Human Frontal Lobes	SCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; HUMAN PREFRONTAL CORTEX; DECISION-MAKING; REWARD; BRAIN; MOTIVATION; SELECTION; TASK	The anterior prefrontal cortex (APC) confers on humans the ability to simultaneously pursue several goals. How does the brain's motivational system, including the medial frontal cortex (MFC), drive the pursuit of concurrent goals? Using brain imaging, we observed that the left and right MFC, which jointly drive single-task performance according to expected rewards, divide under dual-task conditions: While the left MFC encodes the rewards driving one task, the right MFC concurrently encodes those driving the other task. The same dichotomy was observed in the lateral frontal cortex, whereas the APC combined the rewards driving both tasks. The two frontal lobes thus divide for representing simultaneously two concurrent goals coordinated by the APC. The human frontal function seems limited to driving the pursuit of two concurrent goals simultaneously.	[Charron, Sylvain; Koechlin, Etienne] INSERM, F-75654 Paris 13, France; [Charron, Sylvain] Ecole Polytech, F-91128 Palaiseau, France; [Koechlin, Etienne] Ecole Normale Super, F-75230 Paris 05, France; [Koechlin, Etienne] Univ Paris 06, CENIR, F-75651 Paris 13, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Polytechnique de Paris; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); UDICE-French Research Universities; Sorbonne Universite	Koechlin, E (corresponding author), INSERM, F-75654 Paris 13, France.	etienne.koechlin@upmc.fr	Koechlin, Etienne/E-5061-2016; Koechlin, Etienne/AAF-5717-2021	Koechlin, Etienne/0000-0002-6514-9311; Koechlin, Etienne/0000-0002-6514-9311; Charron, Sylvain/0000-0001-9511-9693	Bettencourt-Schueller Foundation; EURYI	Bettencourt-Schueller Foundation; EURYI(European Science Foundation (ESF))	Supported by the Bettencourt-Schueller Foundation and a EURYI award to E. K. We thank L. Sabarly for his help in conducting the behavioral experiment.	Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Hayden BY, 2009, SCIENCE, V324, P948, DOI 10.1126/science.1168488; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Kouneiher F, 2009, NAT NEUROSCI, V12, P939, DOI 10.1038/nn.2321; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Montague PR, 2006, ANNU REV NEUROSCI, V29, P417, DOI 10.1146/annurev.neuro.29.051605.112903; Pandya DN, 1996, RES PER NEUROSCI, P13; Petrides M, 2007, J NEUROSCI, V27, P11573, DOI 10.1523/JNEUROSCI.2419-07.2007; Ramnani N, 2003, CEREB CORTEX, V13, P318, DOI 10.1093/cercor/13.3.318; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Sakai K, 2002, NAT NEUROSCI, V5, P479, DOI 10.1038/nn846; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Stephan KE, 2003, SCIENCE, V301, P384, DOI 10.1126/science.1086025	21	100	107	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2010	328	5976					360	363		10.1126/science.1183614	http://dx.doi.org/10.1126/science.1183614			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583NR	20395509				2022-12-28	WOS:000276685000039
J	Lemery, J				Lemery, Jay			A Case for White Coat Diplomacy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH; CRISIS		Weill Cornell Med Coll, New York, NY 10065 USA	Cornell University	Lemery, J (corresponding author), Weill Cornell Med Coll, 525 E 68th St, New York, NY 10065 USA.	lemery@med.cornell.edu						FEINSILVER JM, COUNCIL HEMISPHERIC; Kishore SP, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000635; Merson MII, DRAMATIC EXPANSION U; Mullan F, 2007, JAMA-J AM MED ASSOC, V297, P744, DOI 10.1001/jama.297.7.744	4	4	5	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2010	303	13					1307	1308		10.1001/jama.2010.384	http://dx.doi.org/10.1001/jama.2010.384			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579FM	20371792				2022-12-28	WOS:000276353700033
J	Tao, X; Lee, A; Limapichat, W; Dougherty, DA; MacKinnon, R				Tao, Xiao; Lee, Alice; Limapichat, Walrati; Dougherty, Dennis A.; MacKinnon, Roderick			A Gating Charge Transfer Center in Voltage Sensors	SCIENCE			English	Article							DEPENDENT K+ CHANNEL; SHAKER POTASSIUM CHANNEL; FOCUSED ELECTRIC-FIELD; TRANSMEMBRANE MOVEMENT; WILD-TYPE; ACTIVATION; PORE; S4; DISPLACEMENT; TRANSITIONS	Voltage sensors regulate the conformations of voltage-dependent ion channels and enzymes. Their nearly switchlike response as a function of membrane voltage comes from the movement of positively charged amino acids, arginine or lysine, across the membrane field. We used mutations with natural and unnatural amino acids, electrophysiological recordings, and x-ray crystallography to identify a charge transfer center in voltage sensors that facilitates this movement. This center consists of a rigid cyclic "cap" and two negatively charged amino acids to interact with a positive charge. Specific mutations induce a preference for lysine relative to arginine. By placing lysine at specific locations, the voltage sensor can be stabilized in different conformations, which enables a dissection of voltage sensor movements and their relation to ion channel opening.	[Tao, Xiao; Lee, Alice; MacKinnon, Roderick] Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10065 USA; [Limapichat, Walrati; Dougherty, Dennis A.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	Howard Hughes Medical Institute; Rockefeller University; California Institute of Technology	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10065 USA.	mackinn@rockefeller.edu			NIH [GM43949, NS 34407]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034407, R37NS034407] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of D. Gadsby's laboratory (Rockefeller University) for assistance with oocyte preparation; members of the MacKinnon laboratory for assistance; the staff at beamline X29 (National Synchrotron Light Source, Brookhaven National Laboratory) for advice at the synchrotron; and A. Banerjee, J. A. Letts, G. von Heijne (Stockholm University), and J. Chen (Purdue University) for helpful discussions. R. M. is the Investigator in the Howard Hughes Medical Institute. D. A. D. is a George Grant Hoag Professor of Chemistry. Supported by NIH GM43949 to R. M and NS 34407 to D. A. D. The x-ray crystallographic coordinates and structure factor files have been deposited in the Protein Data Bank with accession ID 3LNM.	Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Ahern CA, 2005, NEURON, V48, P25, DOI 10.1016/j.neuron.2005.08.020; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; Banerjee A, 2008, J MOL BIOL, V381, P569, DOI 10.1016/j.jmb.2008.06.010; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Chanda B, 2005, NATURE, V436, P852, DOI 10.1038/nature03888; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HOSHI T, 1994, J GEN PHYSIOL, V103, P249, DOI 10.1085/jgp.103.2.249; Islas LD, 1999, J GEN PHYSIOL, V114, P723, DOI 10.1085/jgp.114.5.723; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Lee SY, 2009, PLOS BIOL, V7, P676, DOI 10.1371/journal.pbio.1000047; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Okamura Yasushi, 2006, Tanpakushitsu Kakusan Koso, V51, P18; Posson DJ, 2005, NATURE, V436, P848, DOI 10.1038/nature03819; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279	30	351	360	0	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	2010	328	5974					67	73		10.1126/science.1185954	http://dx.doi.org/10.1126/science.1185954			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577DR	20360102	Green Accepted			2022-12-28	WOS:000276202200035
J	Craddock, N; Hurles, ME; Cardin, N; Pearson, RD; Plagnol, V; Robson, S; Vukcevic, D; Barnes, C; Conrad, DF; Giannoulatou, E; Holmes, C; Marchini, JL; Stirrups, K; Tobin, MD; Wain, LV; Yau, C; Aerts, J; Ahmad, T; Andrews, TD; Arbury, H; Attwood, A; Auton, A; Ball, SG; Balmforth, AJ; Barrett, JC; Barroso, I; Barton, A; Bennett, AJ; Bhaskar, S; Blaszczyk, K; Bowes, J; Brand, OJ; Braund, PS; Bredin, F; Breen, G; Brown, MJ; Bruce, IN; Bull, J; Burren, OS; Burton, J; Byrnes, J; Caesar, S; Clee, CM; Coffey, AJ; Connell, JMC; Cooper, JD; Dominiczak, AF; Downes, K; Drummond, HE; Dudakia, D; Dunham, A; Ebbs, B; Eccles, D; Edkins, S; Edwards, C; Elliot, A; Emery, P; Evans, DM; Evans, G; Eyre, S; Farmer, A; Ferrier, IN; Feuk, L; Fitzgerald, T; Flynn, E; Forbes, A; Forty, L; Franklyn, JA; Freathy, RM; Gibbs, P; Gilbert, P; Gokumen, O; Gordon-Smith, K; Gray, E; Green, E; Groves, CJ; Grozeva, D; Gwilliam, R; Hall, A; Hammond, N; Hardy, M; Harrison, P; Hassanali, N; Hebaishi, H; Hines, S; Hinks, A; Hitman, GA; Hocking, L; Howard, E; Howard, P; Howson, JMM; Hughes, D; Hunt, S; Isaacs, JD; Jain, M; Jewell, DP; Johnson, T; Jolley, JD; Jones, IR; Jones, LA; Kirov, G; Langford, CF; Lango-Allen, H; Lathrop, GM; Lee, J; Lee, KL; Lees, C; Lewis, K; Lindgren, CM; Maisuria-Armer, M; Maller, J; Mansfield, J; Martin, P; Massey, DCO; McArdle, WL; McGuffin, P; McLay, KE; Mentzer, A; Mimmack, ML; Morgan, AE; Morris, AP; Mowat, C; Myers, S; Newman, W; Nimmo, ER; O'Donovan, MC; Onipinla, A; Onyiah, I; Ovington, NR; Owen, MJ; Palin, K; Parnell, K; Pernet, D; Perry, JRB; Phillips, A; Pinto, D; Prescott, NJ; Prokopenko, I; Quail, MA; Rafelt, S; Rayner, NW; Redon, R; Reid, DM; Renwick, A; Ring, SM; Robertson, N; Russell, E; St Clair, D; Sambrook, JG; Sanderson, JD; Schuilenburg, H; Scott, CE; Scott, R; Seal, S; Shaw-Hawkins, S; Shields, BM; Simmonds, MJ; Smyth, DJ; Somaskantharajah, E; Spanova, K; Steer, S; Stephens, J; Stevens, HE; Stone, MA; Su, Z; Symmons, DPM; Thompson, JR; Thomson, W; Travers, ME; Turnbull, C; Valsesia, A; Walker, M; Walker, NM; Wallace, C; Warren-Perry, M; Watkins, NA; Webster, J; Weedon, MN; Wilson, AG; Woodburn, M; Wordsworth, BP; Young, AH; Zeggini, E; Carter, NP; Frayling, TM; Lee, C; McVean, G; Munroe, PB; Palotie, A; Sawcer, SJ; Scherer, SW; Strachan, DP; Tyler-Smith, C; Brown, MA; Burton, PR; Caulfield, MJ; Compston, A; Farrall, M; Gough, SCL; Hall, AS; Hattersley, AT; Hill, AVS; Mathew, CG; Pembrey, M; Satsangi, J; Stratton, MR; Worthington, J; Deloukas, P; Duncanson, A; Kwiatkowski, DP; McCarthy, MI; Ouwehand, WH; Parkes, M; Rahman, N; Todd, JA; Samani, NJ; Donnelly, P				Craddock, Nick; Hurles, Matthew E.; Cardin, Niall; Pearson, Richard D.; Plagnol, Vincent; Robson, Samuel; Vukcevic, Damjan; Barnes, Chris; Conrad, Donald F.; Giannoulatou, Eleni; Holmes, Chris; Marchini, Jonathan L.; Stirrups, Kathy; Tobin, Martin D.; Wain, Louise V.; Yau, Chris; Aerts, Jan; Ahmad, Tariq; Andrews, T. Daniel; Arbury, Hazel; Attwood, Anthony; Auton, Adam; Ball, Stephen G.; Balmforth, Anthony J.; Barrett, Jeffrey C.; Barroso, Ines; Barton, Anne; Bennett, Amanda J.; Bhaskar, Sanjeev; Blaszczyk, Katarzyna; Bowes, John; Brand, Oliver J.; Braund, Peter S.; Bredin, Francesca; Breen, Gerome; Brown, Morris J.; Bruce, Ian N.; Bull, Jaswinder; Burren, Oliver S.; Burton, John; Byrnes, Jake; Caesar, Sian; Clee, Chris M.; Coffey, Alison J.; Connell, John M. C.; Cooper, Jason D.; Dominiczak, Anna F.; Downes, Kate; Drummond, Hazel E.; Dudakia, Darshna; Dunham, Andrew; Ebbs, Bernadette; Eccles, Diana; Edkins, Sarah; Edwards, Cathryn; Elliot, Anna; Emery, Paul; Evans, David M.; Evans, Gareth; Eyre, Steve; Farmer, Anne; Ferrier, I. Nicol; Feuk, Lars; Fitzgerald, Tomas; Flynn, Edward; Forbes, Alistair; Forty, Liz; Franklyn, Jayne A.; Freathy, Rachel M.; Gibbs, Polly; Gilbert, Paul; Gokumen, Omer; Gordon-Smith, Katherine; Gray, Emma; Green, Elaine; Groves, Chris J.; Grozeva, Detelina; Gwilliam, Rhian; Hall, Anita; Hammond, Naomi; Hardy, Matt; Harrison, Pile; Hassanali, Neelam; Hebaishi, Husam; Hines, Sarah; Hinks, Anne; Hitman, Graham A.; Hocking, Lynne; Howard, Eleanor; Howard, Philip; Howson, Joanna M. M.; Hughes, Debbie; Hunt, Sarah; Isaacs, John D.; Jain, Mahim; Jewell, Derek P.; Johnson, Toby; Jolley, Jennifer D.; Jones, Ian R.; Jones, Lisa A.; Kirov, George; Langford, Cordelia F.; Lango-Allen, Hana; Lathrop, G. Mark; Lee, James; Lee, Kate L.; Lees, Charlie; Lewis, Kevin; Lindgren, Cecilia M.; Maisuria-Armer, Meeta; Maller, Julian; Mansfield, John; Martin, Paul; Massey, Dunecan C. O.; McArdle, Wendy L.; McGuffin, Peter; McLay, Kirsten E.; Mentzer, Alex; Mimmack, Michael L.; Morgan, Ann E.; Morris, Andrew P.; Mowat, Craig; Myers, Simon; Newman, William; Nimmo, Elaine R.; O'Donovan, Michael C.; Onipinla, Abiodun; Onyiah, Ifejinelo; Ovington, Nigel R.; Owen, Michael J.; Palin, Kimmo; Parnell, Kirstie; Pernet, David; Perry, John R. B.; Phillips, Anne; Pinto, Dalila; Prescott, Natalie J.; Prokopenko, Inga; Quail, Michael A.; Rafelt, Suzanne; Rayner, Nigel W.; Redon, Richard; Reid, David M.; Renwick, Anthony; Ring, Susan M.; Robertson, Neil; Russell, Ellie; St Clair, David; Sambrook, Jennifer G.; Sanderson, Jeremy D.; Schuilenburg, Helen; Scott, Carol E.; Scott, Richard; Seal, Sheila; Shaw-Hawkins, Sue; Shields, Beverley M.; Simmonds, Matthew J.; Smyth, Debbie J.; Somaskantharajah, Elilan; Spanova, Katarina; Steer, Sophia; Stephens, Jonathan; Stevens, Helen E.; Stone, Millicent A.; Su, Zhan; Symmons, Deborah P. M.; Thompson, John R.; Thomson, Wendy; Travers, Mary E.; Turnbull, Clare; Valsesia, Armand; Walker, Mark; Walker, Neil M.; Wallace, Chris; Warren-Perry, Margaret; Watkins, Nicholas A.; Webster, John; Weedon, Michael N.; Wilson, Anthony G.; Woodburn, Matthew; Wordsworth, B. Paul; Young, Allan H.; Zeggini, Eleftheria; Carter, Nigel P.; Frayling, Timothy M.; Lee, Charles; McVean, Gil; Munroe, Patricia B.; Palotie, Aarno; Sawcer, Stephen J.; Scherer, Stephen W.; Strachan, David P.; Tyler-Smith, Chris; Brown, Matthew A.; Burton, Paul R.; Caulfield, Mark J.; Compston, Alastair; Farrall, Martin; Gough, Stephen C. L.; Hall, Alistair S.; Hattersley, Andrew T.; Hill, Adrian V. S.; Mathew, Christopher G.; Pembrey, Marcus; Satsangi, Jack; Stratton, Michael R.; Worthington, Jane; Deloukas, Panos; Duncanson, Audrey; Kwiatkowski, Dominic P.; McCarthy, Mark I.; Ouwehand, Willem H.; Parkes, Miles; Rahman, Nazneen; Todd, John A.; Samani, Nilesh J.; Donnelly, Peter		Wellcome Trust Case Control	Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls	NATURE			English	Article							COPY-NUMBER VARIATION; LARGE-SCALE; SUSCEPTIBILITY; POLYMORPHISMS; DELETION; HERITABILITY; HEALTH	Copy number variants (CNVs) account for a major proportion of human genetic polymorphism and have been predicted to have an important role in genetic susceptibility to common disease. To address this we undertook a large, direct genome-wide study of association between CNVs and eight common human diseases. Using a purpose-designed array we typed,19,000 individuals into distinct copy-number classes at 3,432 polymorphic CNVs, including an estimated similar to 50% of all common CNVs larger than 500 base pairs. We identified several biological artefacts that lead to false-positive associations, including systematic CNV differences between DNAs derived from blood and cell lines. Association testing and follow-up replication analyses confirmed three loci where CNVs were associated with disease-IRGM for Crohn's disease, HLA for Crohn's disease, rheumatoid arthritis and type 1 diabetes, and TSPAN8 for type 2 diabetes-although in each case the locus had previously been identified in single nucleotide polymorphism (SNP)-based studies, reflecting our observation that most common CNVs that are well-typed on our array are well tagged by SNPs and so have been indirectly explored through SNP studies. We conclude that common CNVs that can be typed on existing platforms are unlikely to contribute greatly to the genetic basis of common human diseases.	[Craddock, Nick; Forty, Liz; Green, Elaine; Grozeva, Detelina; Jones, Ian R.; Kirov, George; O'Donovan, Michael C.; Owen, Michael J.; Russell, Ellie] Cardiff Univ, MRC, Ctr Neuropsychiat Genet & Genom, Sch Med, Cardiff CF14 4XN, Wales; [Hurles, Matthew E.; Robson, Samuel; Barnes, Chris; Conrad, Donald F.; Stirrups, Kathy; Aerts, Jan; Andrews, T. Daniel; Arbury, Hazel; Attwood, Anthony; Barrett, Jeffrey C.; Barroso, Ines; Bhaskar, Sanjeev; Burton, John; Clee, Chris M.; Coffey, Alison J.; Dunham, Andrew; Edkins, Sarah; Fitzgerald, Tomas; Gray, Emma; Gwilliam, Rhian; Hammond, Naomi; Hebaishi, Husam; Howard, Eleanor; Hunt, Sarah; Langford, Cordelia F.; Lewis, Kevin; McLay, Kirsten E.; Mimmack, Michael L.; Onyiah, Ifejinelo; Palin, Kimmo; Quail, Michael A.; Redon, Richard; Scott, Carol E.; Somaskantharajah, Elilan; Valsesia, Armand; Zeggini, Eleftheria; Carter, Nigel P.; Palotie, Aarno; Tyler-Smith, Chris; Stratton, Michael R.; Deloukas, Panos; Kwiatkowski, Dominic P.; Ouwehand, Willem H.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Cardin, Niall; Giannoulatou, Eleni; Holmes, Chris; Marchini, Jonathan L.; Yau, Chris; Auton, Adam; Myers, Simon; Su, Zhan; McVean, Gil; Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Pearson, Richard D.; Vukcevic, Damjan; Byrnes, Jake; Jain, Mahim; Lindgren, Cecilia M.; Maller, Julian; Morris, Andrew P.; Prokopenko, Inga; Rayner, Nigel W.; Robertson, Neil; Zeggini, Eleftheria; Hill, Adrian V. S.; Kwiatkowski, Dominic P.; McCarthy, Mark I.; Donnelly, Peter] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Plagnol, Vincent; Burren, Oliver S.; Cooper, Jason D.; Downes, Kate; Hardy, Matt; Howson, Joanna M. M.; Maisuria-Armer, Meeta; Ovington, Nigel R.; Schuilenburg, Helen; Smyth, Debbie J.; Stevens, Helen E.; Walker, Neil M.; Wallace, Chris; Woodburn, Matthew; Todd, John A.] Univ Cambridge, Cambridge Inst Med Res, Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab,Dept Med Ge, Cambridge CB2 0XY, England; [Tobin, Martin D.; Wain, Louise V.; Thompson, John R.; Burton, Paul R.] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [Tobin, Martin D.; Wain, Louise V.; Thompson, John R.; Burton, Paul R.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Ahmad, Tariq; Freathy, Rachel M.; Lango-Allen, Hana; Parnell, Kirstie; Perry, John R. B.; Shields, Beverley M.; Weedon, Michael N.; Frayling, Timothy M.; Hattersley, Andrew T.] Univ Exeter, Peninsula Coll Med & Dent, Exeter EX1 2LU, Devon, England; [Attwood, Anthony; Jolley, Jennifer D.; Sambrook, Jennifer G.; Stephens, Jonathan; Watkins, Nicholas A.; Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge CB2 0PT, England; [Attwood, Anthony; Jolley, Jennifer D.; Sambrook, Jennifer G.; Stephens, Jonathan; Watkins, Nicholas A.; Ouwehand, Willem H.] Cambridge Ctr, Natl Hlth Serv Blood & Transplant, Cambridge CB2 0PT, England; [Ball, Stephen G.; Balmforth, Anthony J.; Hall, Alistair S.] Univ Leeds, LIGHT, MCRC, Leeds LS2 9JT, W Yorkshire, England; [Barton, Anne; Bowes, John; Bruce, Ian N.; Eyre, Steve; Flynn, Edward; Gilbert, Paul; Hinks, Anne; Martin, Paul; Symmons, Deborah P. M.; Thomson, Wendy; Worthington, Jane] Univ Manchester, Arc Epidemiol Unit, Manchester M13 9PT, Lancs, England; [Bennett, Amanda J.; Groves, Chris J.; Hassanali, Neelam; Lindgren, Cecilia M.; Prokopenko, Inga; Rayner, Nigel W.; Robertson, Neil; Travers, Mary E.; McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Med, Oxford OX3 7LJ, England; [Blaszczyk, Katarzyna; Prescott, Natalie J.; Mathew, Christopher G.] Kings Coll London, Sch Med, Dept Med & Mol Genet, Guys Hosp, London SE1 9RT, England; [Brand, Oliver J.; Franklyn, Jayne A.; Simmonds, Matthew J.; Gough, Stephen C. L.] Univ Birmingham, Inst Biomed Res, Ctr Endocrinol Diabet & Metab, Birmingham B15 2TT, W Midlands, England; [Braund, Peter S.; Rafelt, Suzanne; Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Bredin, Francesca; Lee, James; Massey, Dunecan C. O.; Parkes, Miles] Addenbrookes Hosp, IBD Genet Res Grp, Cambridge CB2 0QQ, England; [Breen, Gerome; St Clair, David] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Breen, Gerome; Farmer, Anne; McGuffin, Peter] Kings Coll London, Inst Psychiat, SGDP, London SE5 8AF, England; [Brown, Morris J.] Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 2QQ, England; [Bull, Jaswinder; Dudakia, Darshna; Ebbs, Bernadette; Elliot, Anna; Gibbs, Polly; Hall, Anita; Hines, Sarah; Hughes, Debbie; Pernet, David; Renwick, Anthony; Scott, Richard; Seal, Sheila; Spanova, Katarina; Turnbull, Clare; Warren-Perry, Margaret; Stratton, Michael R.; Rahman, Nazneen] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; [Caesar, Sian; Gordon-Smith, Katherine; Jones, Lisa A.] Univ Birmingham, Natl Ctr Mental Hlth, Dept Psychiat, Birmingham B15 2FG, W Midlands, England; [Connell, John M. C.; Dominiczak, Anna F.] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland; [Drummond, Hazel E.; Lees, Charlie; Nimmo, Elaine R.; Satsangi, Jack] Univ Edinburgh, Western Gen Hosp, Gastrointestinal Unit, Div Med Sci,Sch Mol & Clin Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Eccles, Diana] Univ Southampton, Acad Unit Genet Med, Southampton SO16 5YA, Hants, England; [Edwards, Cathryn] Torbay Hosp, Endoscopy Reg Training Unit, Torquay TQ2 7AA, England; [Emery, Paul] Univ Leeds, Chapel Allerton Hosp, Acad Unit Musculoskeletal Dis, Leeds LS7 4SA, W Yorkshire, England; [Evans, David M.] Univ Bristol, MRC, Ctr Causal Analyses Translat Epidemiol, Dept Social Med, Bristol BS8 2BN, Avon, England; [Evans, Gareth; Newman, William] Univ Manchester, MAHSC, Dept Med Genet, Manchester M13 0JH, Lancs, England; [Ferrier, I. Nicol; Young, Allan H.] Royal Victoria Infirm, Sch Neurol Neurobiol & Psychiat, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Feuk, Lars; Pinto, Dalila; Scherer, Stephen W.] Hosp Sick Children, MaRS Ctr, Ctr Appl Genom, Toronto, ON M5G 1L7, Canada; [Feuk, Lars; Pinto, Dalila; Scherer, Stephen W.] Hosp Sick Children, MaRS Ctr, Program Genet & Genom Biol, Toronto, ON M5G 1L7, Canada; [Feuk, Lars] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, S-75185 Uppsala, Sweden; [Forbes, Alistair] Univ Coll London Hosp Trust, Inst Digest Dis, London NW1 2BU, England; [Franklyn, Jayne A.; Gough, Stephen C. L.] Univ Hosp Birmingham NHS Fdn Trust, Birmingham B15 2TT, W Midlands, England; [Gokumen, Omer; Lee, Charles] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Gokumen, Omer; Lee, Charles] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Harrison, Pile] Univ Oxford, Inst Musculoskeletal Sci, Botnar Res Ctr, Oxford OX3 7LD, England; [Hitman, Graham A.] Barts & London Royal London Hosp, Ctr Diabet & Metab Med, London E1 1BB, England; [Hocking, Lynne; Reid, David M.] Univ Aberdeen, Bone Res Grp, Dept Med & Therapeut, Aberdeen AB25 2ZD, Scotland; [Howard, Philip; Johnson, Toby; Lee, Kate L.; Onipinla, Abiodun; Shaw-Hawkins, Sue; Munroe, Patricia B.; Caulfield, Mark J.] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Clin Pharmacol & Barts & London Genome Ctr, London EC1M 6BQ, England; [Isaacs, John D.] Sch Med, Musculoskeletal Res Grp, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Jewell, Derek P.] Univ Oxford, Gastroenterol Unit, Radcliffe Infirm, Oxford OX2 6HE, England; [Lathrop, G. Mark] Ctr Natl Genotypage, F-91057 Paris, France; [Mansfield, John] Newcastle Univ, Royal Victoria Infirm, Dept Gastroenterol & Hepatol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [McArdle, Wendy L.; Ring, Susan M.] Univ Bristol, Dept Social Med, ALSPAC Lab, Bristol BS8 2BN, Avon, England; [Mentzer, Alex; Sanderson, Jeremy D.] Kings Coll London, Sch Biomed & Hlth Sci, Div Nutr Sci, London SE1 9NH, England; [Morgan, Ann E.] Univ Leeds, Chapel Allerton Hosp, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds LS7 4SA, W Yorkshire, England; [Mowat, Craig; Phillips, Anne] Univ Dundee, Ninewells Hosp & Med Sch, Dept Gen Internal Med, Dundee DD1 9SY, Scotland; [Redon, Richard] INSERM, UMR915, Inst Thorax, F-44035 Nantes, France; [Steer, Sophia] Kings Coll Hosp Natl Hlth Serv Fdn Trust, London SE5 9RS, England; [Stone, Millicent A.] Univ Toronto, St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Stone, Millicent A.] Univ Bath, Bath BA2 7AY, Somerset, England; [Walker, Mark] Newcastle Univ, Diabet Res Grp, Sch Clin Med Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Webster, John] Aberdeen Royal Infirm, Aberdeen AB9 2ZB, Grampian, Scotland; [Wilson, Anthony G.] Univ Sheffield, Sch Med & Biomed Sci, Sheffield S10 2JF, S Yorkshire, England; [Wordsworth, B. Paul; Brown, Matthew A.] Univ Oxford, Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England; [Young, Allan H.] Univ British Columbia, Inst Mental Hlth, Vancouver, BC V6T 1Z3, Canada; [Sawcer, Stephen J.; Compston, Alastair] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England; [Scherer, Stephen W.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Strachan, David P.] Univ London, Div Community Hlth Sci, London SW17 0RE, England; [Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld 4102, Australia; [Farrall, Martin] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Hattersley, Andrew T.] Univ Exeter, Peninsula Coll Med & Dent, Exeter EX2 5DW, Devon, England; [Pembrey, Marcus] UCL, Inst Child Hlth, Clin & Mol Genet Unit, London WC1N 1EH, England; [Duncanson, Audrey] Wellcome Trust Res Labs, London NW1 2BE, England; [McCarthy, Mark I.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford OX3 7LJ, England; [Samani, Nilesh J.] Glenfield Hosp, Leicester NIHR Biomed Res Unit Cardiovasc Dis, Leicester LE3 9QP, Leics, England	Cardiff University; Wellcome Trust Sanger Institute; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Cambridge; University of Leicester; University of Leicester; University of Exeter; University of Plymouth; University of Cambridge; NHS Blood & Transplant (NHSBT); University of Leeds; University of Manchester; University of Oxford; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Birmingham; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Aberdeen; University of London; King's College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; Institute of Cancer Research - UK; University of Birmingham; University of Glasgow; University of Edinburgh; University of Southampton; Chapel Allerton Hospital; University of Leeds; University of Bristol; University of Manchester; Newcastle University - UK; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Uppsala University; University of London; University College London; University of Birmingham; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Oxford; Barts Health NHS Trust; Royal London Hospital; University of Aberdeen; University of London; Queen Mary University London; Newcastle University - UK; Radcliffe Infirmary; University of Oxford; CEA; Newcastle University - UK; University of Bristol; University of London; King's College London; Chapel Allerton Hospital; Leeds Biomedical Research Centre; University of Leeds; University of Dundee; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Bath; Newcastle University - UK; University of Aberdeen; University of Sheffield; Nuffield Orthopaedic Centre; University of Oxford; University of British Columbia; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Toronto; University of London; University of Queensland; University of Oxford; Wellcome Centre for Human Genetics; University of Exeter; University of Plymouth; University of London; University College London; University of Oxford; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	Craddock, N (corresponding author), Cardiff Univ, MRC, Ctr Neuropsychiat Genet & Genom, Sch Med, Heath Pk, Cardiff CF14 4XN, Wales.		Turnbull, Clare/AAA-6596-2019; Scherer, Stephen W./B-3785-2013; McGuffin, Peter/A-1565-2012; Worthington, Jane/M-9770-2014; Brown, Matthew A/E-5749-2010; Pinto, Dalila/C-4218-2016; Evans, David M/H-6325-2013; Prokopenko, Inga/AAU-9895-2020; Yau, Christopher/G-2896-2012; Aerts, Jan/AAQ-6949-2020; Andrews, Dan/ABG-4815-2020; Hall, Alistair/K-1953-2019; St Clair, David/AAN-2412-2021; Pillay, Nischalan/F-9536-2012; Palin, Kimmo/ABG-5710-2020; Rahman, Nazneen/B-8890-2012; Myers, Simon R/A-6792-2015; Deloukas, Panos/B-2922-2013; Marchini, Jonathan/ABE-9024-2020; Eccles, Diana/K-6327-2019; O'Donovan, Michael C/P-7005-2018; Valsesia, Armand/F-1724-2010; Breen, Gerome D/A-5540-2010; Evans, D Gareth/AAB-4308-2022; Lee, James/ABD-5920-2020; Quail, michael/ABE-6131-2020; Burton, Paul R/H-7527-2016; Bowes, John/B-3472-2015; Breen, Gerome/Y-2706-2019; eyre, stephen/K-3776-2017; Jones, Ian R/B-4925-2009; Prescott, Natalie J/F-6490-2011; emery, paul/B-3560-2013; Prokopenko, Inga/H-3241-2014; Hinks, Anne/E-1853-2015; Plagnol, Vincent/A-5667-2011; Mowat, Craig/AAD-1851-2019; Redon, Richard/F-3303-2014; Mathew, Christopher G/G-3434-2015; Dominiczak, Anna F/P-9390-2017; Rahman, Nazneen/D-2802-2013; Holmes, Christopher/C-7108-2011; McCarthy, Mark/M-3763-2015; Barton, Anne/N-2053-2014; Todd, John/A-3542-2010	Scherer, Stephen W./0000-0002-8326-1999; McGuffin, Peter/0000-0002-9888-2907; Worthington, Jane/0000-0003-0544-042X; Brown, Matthew A/0000-0003-0538-8211; Pinto, Dalila/0000-0002-8769-0846; Evans, David M/0000-0003-0663-4621; Yau, Christopher/0000-0001-7615-8523; Aerts, Jan/0000-0002-6416-2717; Palin, Kimmo/0000-0002-4621-6128; Myers, Simon R/0000-0002-2585-9626; Deloukas, Panos/0000-0001-9251-070X; Marchini, Jonathan/0000-0003-0610-8322; Eccles, Diana/0000-0002-9935-3169; O'Donovan, Michael C/0000-0001-7073-2379; Breen, Gerome D/0000-0003-2053-1792; Evans, D Gareth/0000-0002-8482-5784; Lee, James/0000-0001-5711-9385; Bowes, John/0000-0003-4659-031X; Breen, Gerome/0000-0003-2053-1792; eyre, stephen/0000-0002-1251-6974; Jones, Ian R/0000-0001-5821-5889; Prescott, Natalie J/0000-0002-5901-7371; Prokopenko, Inga/0000-0003-1624-7457; Hinks, Anne/0000-0001-8843-3967; Mowat, Craig/0000-0002-5021-415X; Redon, Richard/0000-0001-7751-2280; Mathew, Christopher G/0000-0003-4178-1838; Dominiczak, Anna F/0000-0003-4913-3608; Donnelly, Peter/0000-0001-9495-3408; Hall, Alistair/0000-0003-0306-7887; Isaacs, John/0000-0002-6103-7056; bennett, amanda/0000-0003-2140-8710; Rahman, Nazneen/0000-0003-4376-0440; Walker, Neil/0000-0001-9796-7688; Holmes, Christopher/0000-0001-9021-3760; Symmons, Deborah/0000-0002-8625-1200; Hocking, Lynne J/0000-0002-2414-2826; Forbes, Alastair/0000-0001-7416-9843; Wain, Louise/0000-0003-4951-1867; Kirov, George/0000-0002-3427-3950; s, hema/0000-0002-3440-9475; Edkins, Sarah/0000-0003-0717-1972; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Wilson, Anthony Gerard/0000-0003-4855-3926; Vukcevic, Damjan/0000-0001-7780-9586; Hunt, Sarah/0000-0002-8350-1235; Munroe, Patricia/0000-0002-4176-2947; Weedon, Michael/0000-0002-6174-6135; Johnson, Toby/0000-0002-5998-3270; Caulfield, Mark/0000-0001-9295-3594; McCarthy, Mark/0000-0002-4393-0510; Grozeva, Detelina/0000-0003-3239-8415; Hattersley, Andrew/0000-0001-5620-473X; Lee, Kathryn/0000-0001-6848-4767; Barnes, Chris/0000-0002-9459-1395; Fitzgerald, Tomas/0000-0002-2370-8496; Martin, Paul/0000-0002-1016-6851; Wallace, Chris/0000-0001-9755-1703; Newman, William/0000-0002-6382-4678; Jones, Lisa/0000-0002-5122-8334; Thomson, Wendy/0000-0002-9022-5179; Palotie, Aarno/0000-0002-2527-5874; Simmonds, Matt/0000-0003-3154-3510; Bruce, Ian/0000-0003-3047-500X; Barton, Anne/0000-0003-3316-2527; Gordon-Smith, Katherine/0000-0003-4083-1143; Harrison, Pille/0000-0003-4117-6910; Burren, Oliver/0000-0002-3388-5760; Parkes, Miles/0000-0002-6467-0631; Lango Allen, Hana/0000-0002-7803-8688; Massey, Dunecan/0000-0002-7144-4579; Tobin, Martin/0000-0002-3596-7874; Mentzer, Alexander/0000-0002-4502-2209; Andrews, Dan/0000-0003-3922-6376; Valsesia, Armand/0000-0003-0746-9664; Young, Allan/0000-0003-2291-6952; Morgan, Ann/0000-0003-1109-624X; Howson, Joanna/0000-0001-7618-0050; Zeggini, Eleftheria/0000-0003-4238-659X; Maller, Julian/0000-0002-1565-9559; Todd, John/0000-0003-2740-8148; Plagnol, Vincent/0000-0002-5597-9215; Morris, Andrew/0000-0002-6805-6014; Lindgren, Cecilia/0000-0002-4903-9374; Turnbull, Clare/0000-0002-1734-5772; Giannoulatou, Eleni/0000-0002-7084-6736; Kwiatkowski, Dominic/0000-0002-5023-0176	Wellcome Trust; MRC [G0800675, G0701420, G0701810, G0800383, G0400874, G90/106, G0700491, G0501942, G0800759, G19/9, MC_UP_A390_1107, G0800509, G0600329, G0000934, G0701003, G0500115, G0600705, G9521010] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067, RG/09/012/28096] Funding Source: researchfish; Medical Research Council [G0000934, G9817803B, G0701003, G9521010, G0501942, G90/106, G0400874, G0600718B, G0500115, G0701420, G0800509, G0800759, G0801418B, G19/9, G0600329, G0701810, G0600705, G0800675, G0800383, MC_UP_A390_1107, G0700491] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10299, NF-SI-0508-10335] Funding Source: researchfish; Versus Arthritis [18475] Funding Source: researchfish; Chief Scientist Office [CZB/4/540] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis); Chief Scientist Office	The principal funder of this project was the Wellcome Trust. Many individuals, groups, consortia, organizations and funding bodies have made important contributions to sample collections and coordination of the scientific analyses. Details are provided in Supplementary Information Section 11. We are indebted to all those who participated within the sample collections.	Barnes C, 2008, NAT GENET, V40, P1245, DOI 10.1038/ng.206; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; CONRAD DF, 2009, NATURE          1007, DOI DOI 10.1038/NATURE08516; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Field SF, 2009, NAT MED, V15, P1115, DOI 10.1038/nm1009-1115; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Horton R, 2008, IMMUNOGENETICS, V60, P1, DOI 10.1007/s00251-007-0262-2; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Koch S, 2005, GENES IMMUN, V6, P445, DOI 10.1038/sj.gene.6364187; Levy Samuel, 2007, PLoS Biol, V5, pe254, DOI 10.1371/journal.pbio.0050254; Lieber MR, 2006, DNA REPAIR, V5, P1234, DOI 10.1016/j.dnarep.2006.05.013; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Mamtani M, 2008, ANN RHEUM DIS, V67, P1076, DOI 10.1136/ard.2007.078048; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; McKinney C, 2008, ANN RHEUM DIS, V67, P409, DOI 10.1136/ard.2007.075028; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Stankiewicz P, 2007, CURR OPIN GENET DEV, V17, P182, DOI 10.1016/j.gde.2007.04.009; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; WILCOXON F, 1945, BIOMETRICS BULL, V1, P80, DOI 10.1093/jee/39.2.269; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217	33	599	625	0	118	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 1	2010	464	7289					713	U86		10.1038/nature08979	http://dx.doi.org/10.1038/nature08979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577EO	20360734	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000276205000036
J	Baker, M				Baker, M.			RNA interference Micrornas as biomarkers	NATURE			English	Editorial Material																			0	15	16	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 22	2010	464	7292					1227	1227						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20414310	Bronze			2022-12-28	WOS:000276891100047
J	Baker, M				Baker, Monya			RNA interference From tools to therapies	NATURE			English	Editorial Material																			0	0	0	2	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 22	2010	464	7292					1225	1225						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20414309	Bronze			2022-12-28	WOS:000276891100046
J	Nicoli, S; Standley, C; Walker, P; Hurlstone, A; Fogarty, KE; Lawson, ND				Nicoli, Stefania; Standley, Clive; Walker, Paul; Hurlstone, Adam; Fogarty, Kevin E.; Lawson, Nathan D.			MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis	NATURE			English	Article							DEVELOPING ZEBRAFISH; TIP CELLS; FORCES; EXPRESSION	Within the circulatory system, blood flow regulates vascular remodelling(1), stimulates blood stem cell formation(2), and has a role in the pathology of vascular disease(3). During vertebrate embryogenesis, vascular patterning is initially guided by conserved genetic pathways that act before circulation(4). Subsequently, endothelial cells must incorporate the mechanosensory stimulus of blood flow with these early signals to shape the embryonic vascular system(4). However, few details are known about how these signals are integrated during development. To investigate this process, we focused on the aortic arch (AA) blood vessels, which are known to remodel in response to blood flow(1). By using two-photon imaging of live zebrafish embryos, we observe that flow is essential for angiogenesis during AA development. We further find that angiogenic sprouting of AA vessels requires a flow-induced genetic pathway in which the mechano-sensitive zinc finger transcription factor klf2a(5-7) induces expression of an endothelial-specific microRNA, mir-126, to activate Vegf signalling. Taken together, our work describes a novel genetic mechanism in which a microRNA facilitates integration of a physiological stimulus with growth factor signalling in endothelial cells to guide angiogenesis.	[Nicoli, Stefania; Lawson, Nathan D.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Standley, Clive; Fogarty, Kevin E.] Univ Massachusetts, Sch Med, Program Mol Med, Biomed Imaging Grp, Worcester, MA 01605 USA; [Walker, Paul; Hurlstone, Adam] Univ Manchester, Fac Life Sci, Mol Canc Studies Grp, Manchester M13 9PT, Lancs, England	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Manchester	Lawson, ND (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA.	nathan.lawson@umassmed.edu	Nicoli, Stefania/P-8627-2019	Walker, Paul/0000-0002-7840-9709; Lawson, Nathan/0000-0001-7788-9619; Hurlstone, Adam/0000-0001-5260-9457	National Heart, Lung, and Blood Institute and National Cancer Institute; National Institute of Diabetes and Digestive and Kidney Diseases, Diabetes Endocrinology Research Center (DERC) [DK32520]; NATIONAL CANCER INSTITUTE [R01CA107454] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute and National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases, Diabetes Endocrinology Research Center (DERC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank B. Roman, V. Ambros and C. Sagerstrom for critical review of the manuscript. We thank J.-N. Chen for providing the Tg(kdrl:egfp)<SUP>la116</SUP> zebrafish line. We appreciate the assistance of T. Stork and M. Freeman for help in performing laser assisted microsurgery. We also thank C. Grabher for the gift of gata1 morpholino. We are grateful to M. Beltrame for providing the cdh5 plasmid and T. Smith and S. Sheppard for technical assistance. We thank M. Green and N. Wajapeyee for the Ras-transformed NIH3T3 cell line. This work was supported in part by grants from the National Heart, Lung, and Blood Institute and National Cancer Institute (N. D. L.). The Bioimaging Group (C. S. and K. E. F.) is a core resource supported by a Diabetes Endocrinology Research Center (DERC) grant DK32520 from the National Institute of Diabetes and Digestive and Kidney Diseases. N. D. L and K. E. F are members of the UMass DERC (DK32520). We apologize to researchers whose work we were unable to cite due to space constraints.	Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073; Anderson MJ, 2008, DEV BIOL, V318, P258, DOI 10.1016/j.ydbio.2008.03.022; Covassin LD, 2009, DEV BIOL, V329, P212, DOI 10.1016/j.ydbio.2009.02.031; Covassin LD, 2006, P NATL ACAD SCI USA, V103, P6554, DOI 10.1073/pnas.0506886103; Dekker RJ, 2002, BLOOD, V100, P1689, DOI 10.1182/blood-2002-01-0046; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Gimbrone MA, 2000, ANN NY ACAD SCI, V902, P230; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3; le Noble F, 2008, CARDIOVASC RES, V78, P232, DOI 10.1093/cvr/cvn058; Lee JS, 2006, DEV CELL, V11, P845, DOI 10.1016/j.devcel.2006.09.006; Meadows SM, 2009, DEVELOPMENT, V136, P1115, DOI 10.1242/dev.029538; Nasevicius A, 2000, YEAST, V17, P294, DOI 10.1002/1097-0061(200012)17:4<294::AID-YEA54>3.0.CO;2-5; Nicoli S, 2007, CANCER RES, V67, P2927, DOI 10.1158/0008-5472.CAN-06-4268; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Roman BL, 2002, DEVELOPMENT, V129, P3009; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Serluca FC, 2002, CURR BIOL, V12, P492, DOI 10.1016/S0960-9822(02)00694-2; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Siekmann AF, 2009, GENE DEV, V23, P2272, DOI 10.1101/gad.1813509; Vermot J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000246; Villefranc JA, 2007, DEV DYNAM, V236, P3077, DOI 10.1002/dvdy.21354; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Westerfield M, 1993, ZEBRAFISH BOOK; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Yashiro K, 2007, NATURE, V450, P285, DOI 10.1038/nature06254	30	341	365	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2010	464	7292					1196	U118		10.1038/nature08889	http://dx.doi.org/10.1038/nature08889			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20364122	Green Accepted, Green Submitted			2022-12-28	WOS:000276891100038
J	Stillman, MD				Stillman, Michael D.			For Those on Whom We Rely	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												michael.stillman@bmc.org							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2010	303	15					1458	1459		10.1001/jama.2010.452	http://dx.doi.org/10.1001/jama.2010.452			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585SJ	20407047				2022-12-28	WOS:000276849000001
J	Karras, GI; Jentsch, S				Karras, Georgios I.; Jentsch, Stefan			The RAD6 DNA Damage Tolerance Pathway Operates Uncoupled from the Replication Fork and Is Functional Beyond S Phase	CELL			English	Article							UBIQUITIN-CONJUGATING-ENZYME; RADIATION-SENSITIVE STRAINS; SACCHAROMYCES-CEREVISIAE; POSTREPLICATION REPAIR; POLYMERASE-DELTA; TRANSLESION SYNTHESIS; RECQ HELICASE; HOMOLOGOUS RECOMBINATION; DISTINCT MECHANISMS; PCNA UBIQUITINATION	Damaged DNA templates provide an obstacle to the replication fork and can cause genome instability. In eukaryotes, tolerance to damaged DNA is mediated largely by the RAD6 pathway involving ubiquitylation of the DNA polymerase processivity factor PCNA. Whereas monoubiquitylation of PCNA mediates error-prone translesion synthesis (TLS), polyubiquitylation triggers an error-free pathway. Both branches of this pathway are believed to occur in S phase in order to ensure replication completion. However, we found that limiting TLS or the error-free pathway to the G2/M phase of the cell-cycle efficiently promote lesion tolerance. Thus, our findings indicate that both branches of the DNA damage tolerance pathway operate effectively after chromosomal replication, outside S phase. We therefore propose that the RAD6 pathway acts on single-stranded gaps left behind newly restarted replication forks.	[Karras, Georgios I.; Jentsch, Stefan] Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Jentsch, S (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	jentsch@biochem.mpg.de		Karras, Georgios/0000-0003-2933-1535; Karras, Georgios/0000-0002-6169-5569	Max Planck Society; Deutsche Forschungsgemeinschaft; Fonds der chemischen Industrie; Center for Integrated Protein Science Munich; RUBICON EU Network of Excellence	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Center for Integrated Protein Science Munich; RUBICON EU Network of Excellence	We thank M. Raghuraman and B. Brewer for generously hosting G. I. K. for experiments, W. Feng for demonstrating 2D gel analysis for replication intermediates, and G. Alvino and W. Feng for help with quantification. We also thank B. Le Tallec, S. Muller, I. Psakhye, M. Raschle, and Z. Storchova for comments on the manuscript, K. Schorpp and M. Schwarz for help with the robot-based screen, S. Moertl and B. Johansson for PFGE protocols, M. Kupiec for the cdc2-2 mutant strain, and A. Strasser for technical assistance. This work is supported (to S.J.) by the Max Planck Society, Deutsche Forschungsgemeinschaft, Fonds der chemischen Industrie, Center for Integrated Protein Science Munich, and RUBICON EU Network of Excellence.	Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Alvino GM, 2007, MOL CELL BIOL, V27, P6396, DOI 10.1128/MCB.00719-07; Andersen PL, 2008, CELL RES, V18, P162, DOI 10.1038/cr.2007.114; Arakawa H, 2006, PLOS BIOL, V4, P1947, DOI 10.1371/journal.pbio.0040366; Bachrati CZ, 2008, CHROMOSOMA, V117, P219, DOI 10.1007/s00412-007-0142-4; Barbour L, 2003, MUTAT RES-FUND MOL M, V532, P137, DOI 10.1016/j.mrfmmm.2003.08.014; Bi XH, 2006, MOL CELL BIOL, V26, P3527, DOI 10.1128/MCB.26.9.3527-3540.2006; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Blastyak A, 2007, MOL CELL, V28, P167, DOI 10.1016/j.molcel.2007.07.030; Branzei D, 2002, MOL GENET GENOMICS, V268, P371, DOI 10.1007/s00438-002-0757-3; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Branzei D, 2008, NATURE, V456, P915, DOI 10.1038/nature07587; BREWER BJ, 1980, P NATL ACAD SCI-BIOL, V77, P5380, DOI 10.1073/pnas.77.9.5380; Broomfield S, 1998, P NATL ACAD SCI USA, V95, P5678, DOI 10.1073/pnas.95.10.5678; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; Chang DJ, 2009, NAT CHEM BIOL, V5, P82, DOI 10.1038/nchembio.139; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; Courcelle J, 2003, ANNU REV GENET, V37, P611, DOI 10.1146/annurev.genet.37.110801.142616; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Davies AA, 2008, MOL CELL, V29, P625, DOI 10.1016/j.molcel.2007.12.016; Edmunds CE, 2008, MOL CELL, V30, P519, DOI 10.1016/j.molcel.2008.03.024; Feng WY, 2006, NAT CELL BIOL, V8, P148, DOI 10.1038/ncb1358; Frei C, 2000, GENE DEV, V14, P81; Friedberg EC, 2005, NAT REV MOL CELL BIO, V6, P943, DOI 10.1038/nrm1781; Fukui T, 2004, GENES CELLS, V9, P179, DOI 10.1111/j.1356-9597.2004.00716.x; Gangavarapu V, 2007, MOL CELL BIOL, V27, P7758, DOI 10.1128/MCB.01331-07; Gangavarapu V, 2006, MOL CELL BIOL, V26, P7783, DOI 10.1128/MCB.01260-06; Gerik KJ, 1998, J BIOL CHEM, V273, P19747, DOI 10.1074/jbc.273.31.19747; Giot L, 1997, GENETICS, V146, P1239; HASTINGS PJ, 1976, NATURE, V264, P719, DOI 10.1038/264719a0; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hood JK, 2001, J CELL SCI, V114, P589; HOWARDFL.P, 1968, ANNU REV BIOCHEM, V37, P175, DOI 10.1146/annurev.bi.37.070168.001135; Huang ME, 1997, YEAST, V13, P1181, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1181::AID-YEA169>3.3.CO;2-F; Huang ME, 1999, MOL GEN GENET, V260, P541, DOI 10.1007/s004380050927; Huang ME, 2000, CURR GENET, V38, P178, DOI 10.1007/s002940000149; Jansen JG, 2009, DNA REPAIR, V8, P1444, DOI 10.1016/j.dnarep.2009.09.006; Jansen JG, 2009, MOL CELL BIOL, V29, P3113, DOI 10.1128/MCB.00071-09; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; JOHNSON RE, 1994, J BIOL CHEM, V269, P28259; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kunz BA, 2000, MUTAT RES-FUND MOL M, V451, P169, DOI 10.1016/S0027-5107(00)00048-8; LAWRENCE CW, 1974, J MOL BIOL, V85, P137, DOI 10.1016/0022-2836(74)90134-X; LAWRENCE CW, 1976, GENETICS, V82, P207; Leach CA, 2005, J CELL BIOL, V171, P947, DOI 10.1083/jcb.200508100; Lee KY, 2008, MOL CELLS, V26, P5; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Lehmann AR, 2006, DNA REPAIR, V5, P1495, DOI 10.1016/j.dnarep.2006.07.002; LEMONTT JF, 1971, GENETICS, V68, P21; Lengronne A, 2001, NUCLEIC ACIDS RES, V29, P1433, DOI 10.1093/nar/29.7.1433; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; Lundin C, 2005, NUCLEIC ACIDS RES, V33, P3799, DOI 10.1093/nar/gki681; Ma WJ, 2009, MOL CELL BIOL, V29, P1212, DOI 10.1128/MCB.01499-08; McDonald JP, 1997, GENETICS, V147, P1557; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; Mimitou EP, 2009, TRENDS BIOCHEM SCI, V34, P264, DOI 10.1016/j.tibs.2009.01.010; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; MORRISON A, 1989, J BACTERIOL, V171, P5659, DOI 10.1128/jb.171.10.5659-5667.1989; Motlagh NDV, 2006, DNA REPAIR, V5, P1459, DOI 10.1016/j.dnarep.2006.07.006; Nakayama H, 2002, ONCOGENE, V21, P9008, DOI 10.1038/sj.onc.1205959; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Pages V, 2009, GENE DEV, V23, P1438, DOI 10.1101/gad.1793409; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Paulovich AG, 1998, GENETICS, V150, P75; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Sabbioneda S, 2005, J BIOL CHEM, V280, P38657, DOI 10.1074/jbc.M507638200; Sabbioneda S, 2007, DNA REPAIR, V6, P121, DOI 10.1016/j.dnarep.2006.09.002; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Sidorova JM, 2008, CELL CYCLE, V7, P796, DOI 10.4161/cc.7.6.5566; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Stewart E, 1997, EMBO J, V16, P2682, DOI 10.1093/emboj/16.10.2682; Torres-Ramos CA, 2002, MOL CELL BIOL, V22, P2419, DOI 10.1128/MCB.22.7.2419-2426.2002; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Ulrich HD, 2009, DNA REPAIR, V8, P461, DOI 10.1016/j.dnarep.2009.01.006; Ward TR, 2000, MOL CELL BIOL, V20, P4948, DOI 10.1128/MCB.20.13.4948-4957.2000; Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Waters LS, 2006, P NATL ACAD SCI USA, V103, P8971, DOI 10.1073/pnas.0510167103; Weinert T, 2007, SCIENCE, V315, P1374, DOI 10.1126/science.1140759; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Yang XH, 2009, CELL CYCLE, V8, P191, DOI 10.4161/cc.8.2.7357; Zhang HS, 2005, P NATL ACAD SCI USA, V102, P15954, DOI 10.1073/pnas.0504586102	87	226	228	2	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2010	141	2					255	267		10.1016/j.cell.2010.02.028	http://dx.doi.org/10.1016/j.cell.2010.02.028			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	584GF	20403322	Bronze			2022-12-28	WOS:000276738400016
J	Morgan, DO				Morgan, David O.			The Hidden Rhythms of the Dividing Cell	CELL			English	Editorial Material							CYCLE; YEAST		Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Morgan, DO (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94158 USA.	david.morgan@ucsf.edu		Morgan, David/0000-0001-8753-4416				Drapkin BJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.78; Haase SB, 1999, NATURE, V401, P394, DOI 10.1038/43930; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; McCleland ML, 2008, CURR BIOL, V18, P245, DOI 10.1016/j.cub.2008.01.041; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; Nasmyth K, 1996, TRENDS GENET, V12, P405, DOI 10.1016/0168-9525(96)10041-X; Stern Bodo, 1996, Trends in Genetics, V12, P345, DOI 10.1016/0168-9525(96)10036-6; Visintin C, 2008, GENE DEV, V22, P79, DOI 10.1101/gad.1601308	8	7	7	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2010	141	2					224	226		10.1016/j.cell.2010.03.042	http://dx.doi.org/10.1016/j.cell.2010.03.042			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	584GF	20403319	Bronze			2022-12-28	WOS:000276738400012
J	Trenberth, KE; Fasullo, JT				Trenberth, Kevin E.; Fasullo, John T.			CLIMATE CHANGE Tracking Earth's Energy	SCIENCE			English	Editorial Material									[Trenberth, Kevin E.; Fasullo, John T.] Natl Ctr Atmospher Res, Boulder, CO 80307 USA	National Center Atmospheric Research (NCAR) - USA	Trenberth, KE (corresponding author), Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA.	trenbert@ucar.edu	Trenberth, Kevin Edward/A-5683-2012; Fasullo, John/H-4552-2019; Keyes, Dennis/AAZ-9285-2021	Trenberth, Kevin Edward/0000-0002-1445-1000; Fasullo, John/0000-0003-1216-892X; 				Cazenave A, 2009, GLOBAL PLANET CHANGE, V65, P83, DOI 10.1016/j.gloplacha.2008.10.004; Chen JL, 2009, NAT GEOSCI, V2, P859, DOI 10.1038/ngeo694; Leuliette EW, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036010; Levitt Steven D., 2009, SUPERFREAKONOMICS GL; Levitus S, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037155; Loeb NG, 2009, J CLIMATE, V22, P748, DOI 10.1175/2008JCLI2637.1; Murphy DM, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD012105; Perlwitz J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL041188; Solomon S., 2007, PHYS SCI BASIS WORKI; Trenberth KE, 1998, J GEOPHYS RES-OCEANS, V103, P14291, DOI 10.1029/97JC01444; Trenberth KE, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000298; Trenberth KE, 2009, CURR OPIN ENV SUST, V1, P19, DOI 10.1016/j.cosust.2009.06.001; Trenberth KE, 2009, B AM METEOROL SOC, V90, P311, DOI 10.1175/2008BAMS2634.1; van den Broeke M, 2009, SCIENCE, V326, P984, DOI 10.1126/science.1178176; Wong T, 2009, B AM METEOROL SOC, V90, pS33, DOI DOI 10.1175/BAMS-90-8-STATEOFTHECLIMATE	15	137	146	0	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2010	328	5976					316	317		10.1126/science.1187272	http://dx.doi.org/10.1126/science.1187272			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583NR	20395501				2022-12-28	WOS:000276685000025
J	Niewoehner, DE				Niewoehner, Dennis E.			Outpatient Management of Severe COPD.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; ELDERLY PERSONS; OXYGEN-THERAPY; HEALTH; BRONCHODILATOR; EXACERBATIONS; MORTALITY; SURVIVAL; TRIAL		[Niewoehner, Dennis E.] Vet Adm Med Ctr, Pulm Sect, Minneapolis, MN 55417 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Niewoehner, DE (corresponding author), Vet Adm Med Ctr, Pulm Sect 111N, 1 Vet Dr, Minneapolis, MN 55417 USA.	niewo001@umn.edu			Boehringer Ingelheim; Adams Respiratory Therapeutics; GlaxoSmithKline; AstraZeneca; Nycomed; Forest Research Institute; Pfizer; Sepracor	Boehringer Ingelheim(Boehringer Ingelheim); Adams Respiratory Therapeutics; GlaxoSmithKline(GlaxoSmithKline); AstraZeneca(AstraZeneca); Nycomed; Forest Research Institute; Pfizer(Pfizer); Sepracor	Dr. Niewoehner reports receiving consulting fees from Boehringer Ingelheim, Adams Respiratory Therapeutics, GlaxoSmithKline, AstraZeneca, Nycomed, and Forest Research Institute and speaking fees from Boehringer Ingelheim, Pfizer, Sepracor, and Nycomed. No other potential conflicts of interest relevant to this article were reported.	Aaron SD, 2003, NEW ENGL J MED, V348, P2618, DOI 10.1056/NEJMoa023161; Adams SG, 2007, ARCH INTERN MED, V167, P551, DOI 10.1001/archinte.167.6.551; Advisory Committee on Immunization Practices, 2009, Ann Intern Med, V150, P40; Agusti AGN, 2003, EUR RESPIR J, V21, P347, DOI 10.1183/09031936.03.00405703; [Anonymous], 1980, Ann Intern Med, V93, P391; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; Balmes J, 2003, AM J RESP CRIT CARE, V167, P787, DOI 10.1164/rccm.167.5.787; Bradley JM, 2005, COCHRANE DB SYST REV, V4; Brooks D, 2007, CAN RESPIR J, V14, P87, DOI 10.1155/2007/951498; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Calverley PMA, 2003, THORAX, V58, P659, DOI 10.1136/thorax.58.8.659; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Chaouat A, 1999, EUR RESPIR J, V14, P1002, DOI 10.1183/09031936.99.14510029; Dirksen A, 1999, AM J RESP CRIT CARE, V160, P1468, DOI 10.1164/ajrccm.160.5.9901055; Drummond MB, 2009, JAMA-J AM MED ASSOC, V301, P1024; Drummond MB, 2008, JAMA-J AM MED ASSOC, V300, P2407, DOI 10.1001/jama.2008.717; Ezzati M, 2005, LANCET, V366, P104, DOI 10.1016/S0140-6736(05)66845-6; Ferguson GT, 2000, CHEST, V117, P1146, DOI 10.1378/chest.117.4.1146; Fiore MC, 2009, TREATING TOBACCO USE; Fishman A, 2003, NEW ENGL J MED, V348, P2059; FLENLEY DC, 1981, LANCET, V1, P681; Gorecka D, 1997, THORAX, V52, P674, DOI 10.1136/thx.52.8.674; GRANGER R, 2006, COCHRANE DB SYST REV, V4; Griffiths TL, 2000, LANCET, V355, P362, DOI 10.1016/S0140-6736(99)07042-7; GUYATT GH, 1988, ARCH INTERN MED, V148, P1949, DOI 10.1001/archinte.148.9.1949; Hendeles L, 2007, NEW ENGL J MED, V356, P1344, DOI 10.1056/NEJMra050380; HOLLEMAN DR, 1995, JAMA-J AM MED ASSOC, V273, P313, DOI 10.1001/jama.273.4.313; Jackson LA, 2003, NEW ENGL J MED, V348, P1747, DOI 10.1056/NEJMoa022678; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; Kanner RE, 2001, AM J RESP CRIT CARE, V164, P358, DOI 10.1164/ajrccm.164.3.2010017; Kotz D, 2009, EUR RESPIR J, V33, P754, DOI 10.1183/09031936.00116308; Lacasse Y, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003793.pub2; MAHLER DA, 1988, CHEST, V93, P580, DOI 10.1378/chest.93.3.580; Mannino David M, 2002, Respir Care, V47, P1184; McCrory D C, 2002, Cochrane Database Syst Rev, pCD003900; Nichol KL, 1999, ARCH INTERN MED, V159, P2437, DOI 10.1001/archinte.159.20.2437; Nichol KL, 1999, ANN INTERN MED, V130, P397, DOI 10.7326/0003-4819-130-5-199903020-00003; Niewoehner DE, 1999, NEW ENGL J MED, V340, P1941, DOI 10.1056/NEJM199906243402502; Niewoehner DE, 2007, CHEST, V131, P20, DOI 10.1378/chest.06-1316; Nonoyama ML, 2007, AM J RESP CRIT CARE, V176, P343, DOI 10.1164/rccm.200702-308OC; Parkes G, 2008, BMJ-BRIT MED J, V336, P598, DOI 10.1136/bmj.39503.582396.25; Poole PJ, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD002733.PUB2; Qaseem A, 2007, ANN INTERN MED, V147, P633, DOI 10.7326/0003-4819-147-9-200711060-00008; RAM FS, 2006, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD004403.PUB2; Salpeter SR, 2006, J GEN INTERN MED, V21, P1011, DOI 10.1111/j.1525-1497.2006.00507.x; Schane RE, 2008, J GEN INTERN MED, V23, P1757, DOI 10.1007/s11606-008-0749-z; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Sin DD, 2003, JAMA-J AM MED ASSOC, V290, P2301, DOI 10.1001/jama.290.17.2301; Singh S, 2009, JAMA-J AM MED ASSOC, V301, P1227; Singh S, 2008, JAMA-J AM MED ASSOC, V300, P1439, DOI 10.1001/jama.300.12.1439; Stavem K, 2006, J HEART LUNG TRANSPL, V25, P75, DOI 10.1016/j.healun.2005.06.025; Strassels SA, 2001, CHEST, V119, P344, DOI 10.1378/chest.119.2.344; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Wilt T, 2005, USE SPIROMETRY CASE; Wilt TJ, 2007, NICOTINE TOB RES, V9, P21, DOI 10.1080/14622200601078509	57	40	44	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 15	2010	362	15					1407	1416		10.1056/NEJMcp0912556	http://dx.doi.org/10.1056/NEJMcp0912556			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582XY	20393177				2022-12-28	WOS:000276635300009
J	Seol, JH; Jo, I; Moore, AL; Lindsay, L; Aitken, ZH; Pettes, MT; Li, XS; Yao, Z; Huang, R; Broido, D; Mingo, N; Ruoff, RS; Shi, L				Seol, Jae Hun; Jo, Insun; Moore, Arden L.; Lindsay, Lucas; Aitken, Zachary H.; Pettes, Michael T.; Li, Xuesong; Yao, Zhen; Huang, Rui; Broido, David; Mingo, Natalio; Ruoff, Rodney S.; Shi, Li			Two-Dimensional Phonon Transport in Supported Graphene	SCIENCE			English	Article							THERMAL-CONDUCTIVITY; FILMS; GRAPHITE; SIO2	The reported thermal conductivity (kappa) of suspended graphene, 3000 to 5000 watts per meter per kelvin, exceeds that of diamond and graphite. Thus, graphene can be useful in solving heat dissipation problems such as those in nanoelectronics. However, contact with a substrate could affect the thermal transport properties of graphene. Here, we show experimentally that k of monolayer graphene exfoliated on a silicon dioxide support is still as high as about 600 watts per meter per kelvin near room temperature, exceeding those of metals such as copper. It is lower than that of suspended graphene because of phonons leaking across the graphene-support interface and strong interface-scattering of flexural modes, which make a large contribution to k in suspended graphene according to a theoretical calculation.	[Seol, Jae Hun; Moore, Arden L.; Pettes, Michael T.; Li, Xuesong; Ruoff, Rodney S.; Shi, Li] Univ Texas Austin, Dept Mech Engn, Austin, TX 78712 USA; [Jo, Insun; Yao, Zhen] Univ Texas Austin, Dept Phys, Austin, TX 78712 USA; [Lindsay, Lucas; Broido, David] Boston Coll, Dept Phys, Chestnut Hill, MA 02467 USA; [Lindsay, Lucas] Christopher Newport Univ, Dept Phys Comp Sci & Engn, Newport News, VA 23606 USA; [Aitken, Zachary H.; Huang, Rui] Univ Texas Austin, Dept Aerosp Engn & Engn Mech, Austin, TX 78712 USA; [Li, Xuesong; Ruoff, Rodney S.; Shi, Li] Univ Texas Austin, Texas Mat Inst, Austin, TX 78712 USA; [Mingo, Natalio] CEA, Lab Innovat Technol Energies Nouvelles & Nanomat, F-38054 Grenoble, France	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Boston College; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; CEA	Shi, L (corresponding author), Univ Texas Austin, Dept Mech Engn, Austin, TX 78712 USA.	lishi@mail.utexas.edu	Shi, Li/C-8123-2013; Ruoff, Rodney/ABE-6532-2020; Pettes, Michael T/D-3572-2012; Huang, Rui/T-3017-2017; Jo, Insun/B-4944-2011; Lindsay, Lucas/C-9221-2012; Huang, Rui/B-1627-2008; Ruoff, Rodney S/B-7605-2009; Moore, Arden L/G-9227-2014	Shi, Li/0000-0002-5401-6839; Ruoff, Rodney/0000-0002-6599-6764; Pettes, Michael T/0000-0001-6862-6841; Lindsay, Lucas/0000-0001-9645-7993; Huang, Rui/0000-0003-0328-3862; Ruoff, Rodney S/0000-0002-6599-6764; Moore, Arden L/0000-0002-9217-7510; Seol, Jae Hun/0000-0003-3180-9155	National Science Foundation [CBET-0553649, 0933454, CBET 0651381, 0651310, CMMI-0926851]; Office of Naval Research [N00014-08-1-1168]; Department of Energy Office of Science [DE-FG02-07ER46377]; University of Texas at Austin; Div Of Civil, Mechanical, & Manufact Inn [0926851] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Department of Energy Office of Science(United States Department of Energy (DOE)); University of Texas at Austin; Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work is supported in part by National Science Foundation awards CBET-0553649 and 0933454 (J.H.S. and L. S.), CBET 0651381 (D. A. B. and L. L.), 0651310 (N.M.), and CMMI-0926851 (Z.H.A. and R. H.); Office of Naval Research award N00014-08-1-1168 (A. L. M. and L. S.); Department of Energy Office of Science award DE-FG02-07ER46377(M. T. P. and L. S.); and The University of Texas at Austin (R. S. R.).	Balandin AA, 2008, NANO LETT, V8, P902, DOI 10.1021/nl0731872; Berger C, 2004, J PHYS CHEM B, V108, P19912, DOI 10.1021/jp040650f; Bolotin KI, 2008, SOLID STATE COMMUN, V146, P351, DOI 10.1016/j.ssc.2008.02.024; Chen JH, 2008, NAT NANOTECHNOL, V3, P206, DOI 10.1038/nnano.2008.58; DOVE MT, 1993, CAMBRIDGE TOPICS MIN, V4, P29; Geringer V, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.076102; Hwang EH, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.235415; Ishigami M, 2007, NANO LETT, V7, P1643, DOI 10.1021/nl070613a; Ju YS, 1999, APPL PHYS LETT, V74, P3005, DOI 10.1063/1.123994; Kim KS, 2009, NATURE, V457, P706, DOI 10.1038/nature07719; Kim P, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.215502; KLEMENS PG, 1994, CARBON, V32, P735, DOI 10.1016/0008-6223(94)90096-5; Klemens PG, 2001, INT J THERMOPHYS, V22, P265, DOI 10.1023/A:1006776107140; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Lindsay L, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.125407; Malard LM, 2009, PHYS REP, V473, P51, DOI 10.1016/j.physrep.2009.02.003; Mariani E, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.076801; Nika DL, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.155413; Nika DL, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3136860; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Pop E, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.155505; Prasher R, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3075065; SLACK GA, 1962, PHYS REV, V127, P694, DOI 10.1103/PhysRev.127.694; SLACK GA, 1964, J APPL PHYS, V35, P3460, DOI 10.1063/1.1713251; Tan YW, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.246803; Yang Y, 2004, APPL PHYS LETT, V84, P3121, DOI 10.1063/1.1713033; Yu CH, 2005, NANO LETT, V5, P1842, DOI 10.1021/nl051044e	28	1344	1380	33	920	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 9	2010	328	5975					213	216		10.1126/science.1184014	http://dx.doi.org/10.1126/science.1184014			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580OU	20378814				2022-12-28	WOS:000276459600038
J	Barbier, E				Barbier, Edward			How is the Global Green New Deal going?	NATURE			English	Editorial Material									Univ Wyoming, Laramie, WY 82071 USA	University of Wyoming	Barbier, E (corresponding author), Univ Wyoming, Laramie, WY 82071 USA.	ebarbier@uwyo.edu						Barbier E. B., 2009, GLOBAL GREEN NEW DEA; Barbier Edward.B., 2010, GLOBAL GREEN NEW DEA; Goulder L. H., 2004, INDUCED TECHNOLOGICA; Podesta J., 2007, CAPTURING ENERGY OPP; UNEP (United Nations Environment Program), 2022, UNEP UN ENV PROGR RE; World Bank, 2009, GLOBAL ECONOMIC PROSPECTS: COMMODITIES AT THE CROSSROADS, P1, DOI 10.1596/978-0-8213-7799-4	6	59	60	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 8	2010	464	7290					832	833		10.1038/464832a	http://dx.doi.org/10.1038/464832a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	579TM	20376129				2022-12-28	WOS:000276397300016
J	Hafner, M; Landthaler, M; Burger, L; Khorshid, M; Hausser, J; Berninger, P; Rothballer, A; Ascano, M; Jungkamp, AC; Munschauer, M; Ulrich, A; Wardle, GS; Dewell, S; Zavolan, M; Tuschl, T				Hafner, Markus; Landthaler, Markus; Burger, Lukas; Khorshid, Mohsen; Hausser, Jean; Berninger, Philipp; Rothballer, Andrea; Ascano, Manuel, Jr.; Jungkamp, Anna-Carina; Munschauer, Mathias; Ulrich, Alexander; Wardle, Greg S.; Dewell, Scott; Zavolan, Mihaela; Tuschl, Thomas			Transcriptome-wide Identification of RNA-Binding Protein and MicroRNA Target Sites by PAR-CLIP	CELL			English	Article							HETEROGENEOUS NUCLEAR-RNA; MAMMALIAN MESSENGER-RNAS; CROSS-LINKING; RIBONUCLEOPROTEIN COMPLEXES; ULTRAVIOLET-LIGHT; GENE-EXPRESSION; C. ELEGANS; CELLS; TRANSLATION; FAMILY	RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.	[Burger, Lukas; Khorshid, Mohsen; Hausser, Jean; Berninger, Philipp; Zavolan, Mihaela] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Hafner, Markus; Landthaler, Markus; Rothballer, Andrea; Ascano, Manuel, Jr.; Jungkamp, Anna-Carina; Munschauer, Mathias; Ulrich, Alexander; Wardle, Greg S.; Tuschl, Thomas] Rockefeller Univ, Lab RNA Mol Biol, Howard Hughes Med Inst, New York, NY 10065 USA; [Burger, Lukas; Khorshid, Mohsen; Hausser, Jean; Berninger, Philipp; Zavolan, Mihaela] SIB, CH-4056 Basel, Switzerland; [Dewell, Scott] Rockefeller Univ, Genom Resource Ctr, New York, NY 10065 USA	University of Basel; Howard Hughes Medical Institute; Rockefeller University; Swiss Institute of Bioinformatics; Rockefeller University	Zavolan, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	mihaela.zavolan@unibas.ch; ttuschl@rockefeller.edu	Hafner, Markus/O-7100-2018; Munschauer, Mathias/AAK-2789-2020; Landthaler, Markus/A-1427-2010; Ascano, Manuel/ABA-3586-2020; Zavolan, Mihaela/S-3888-2016	Hafner, Markus/0000-0002-4336-6518; Munschauer, Mathias/0000-0001-6143-4548; Landthaler, Markus/0000-0002-1075-8734; Ascano, Manuel/0000-0002-9370-5493; Zavolan, Mihaela/0000-0002-8832-2041; Ulrich, Alexander Konstantin Christian/0000-0003-4255-4856; Hausser, Jean/0000-0002-3321-7199	Deutscher Akademischer Austauschdienst (DAAD); Swiss National Fund [3100A0-114001]; NIH [GM073047]; Starr Foundation [MH08442]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM073047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080442] Funding Source: NIH RePORTER	Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Swiss National Fund(Swiss National Science Foundation (SNSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank V. Hovestadt for his help with the analysis of the crosslinking positions within miRNAs. We are grateful to W. Zhang and C. Zhao (Genomics Resource Center) for mRNA array analysis and Solexa sequencing. We thank Millipore for the antibodies. We thank members of the Tuschl laboratory for comments on the manuscript. M. H. is supported by the Deutscher Akademischer Austauschdienst (DAAD). This work was supported by the Swiss National Fund Grant # 3100A0-114001 to M. Z.; T. T. is an HHMI investigator, and work in his laboratory was supported by NIH grants GM073047 and MH08442 and the Starr Foundation.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boyerinas B, 2008, CANCER RES, V68, P2587, DOI 10.1158/0008-5472.CAN-08-0264; Chenard CA, 2008, J NEUROSCI RES, V86, P233, DOI 10.1002/jnr.21485; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Dimitriadis E, 2007, INT J CANCER, V121, P486, DOI 10.1002/ijc.22716; DREYFUSS G, 1984, MOL CELL BIOL, V4, P1104, DOI 10.1128/MCB.4.6.1104; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; FAVRE A, 1986, BIOCHEM BIOPH RES CO, V141, P847, DOI 10.1016/S0006-291X(86)80250-9; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Galgano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003164; Gerber AP, 2006, P NATL ACAD SCI USA, V103, P4487, DOI 10.1073/pnas.0509260103; Granneman S, 2009, P NATL ACAD SCI USA, V106, P9613, DOI 10.1073/pnas.0901997106; GREENBERG JR, 1979, NUCLEIC ACIDS RES, V6, P715, DOI 10.1093/nar/6.2.715; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Hausser J, 2009, GENOME RES, V19, P2009, DOI 10.1101/gr.091181.109; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kirino Y, 2008, RNA, V14, P2254, DOI 10.1261/rna.1133808; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; MAYRAND S, 1981, J CELL BIOL, V90, P380, DOI 10.1083/jcb.90.2.380; McKee AE, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-14; Meisenheimer KM, 1997, CRIT REV BIOCHEM MOL, V32, P101, DOI 10.3109/10409239709108550; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Sanford JR, 2009, GENOME RES, V19, P381, DOI 10.1101/gr.082503.108; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; WAGENMAKERS AJM, 1980, EUR J BIOCHEM, V112, P323, DOI 10.1111/j.1432-1033.1980.tb07207.x; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Yisraeli JK, 2005, BIOL CELL, V97, P87; Zisoulis DG, 2010, NAT STRUCT MOL BIOL, V17, P173, DOI 10.1038/nsmb.1745	59	2022	2094	13	242	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2010	141	1					129	141		10.1016/j.cell.2010.03.009	http://dx.doi.org/10.1016/j.cell.2010.03.009			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	577GS	20371350	Green Accepted, Bronze			2022-12-28	WOS:000276211100018
J	Snow, RW; Marsh, K				Snow, Robert W.; Marsh, Kevin			Malaria in Africa: progress and prospects in the decade since the Abuja Declaration	LANCET			English	Editorial Material							TRANSMISSION; MORTALITY		[Snow, Robert W.; Marsh, Kevin] Ctr Geog Med, Wellcome Trust Collaborat Programme, Kenya Med Res Inst, Nairobi, Kenya; [Snow, Robert W.; Marsh, Kevin] Ctr Geog Med, Wellcome Trust Collaborat Programme, Kenya Med Res Inst, Kilifi, Kenya; [Snow, Robert W.; Marsh, Kevin] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, CCVTM, Oxford, England	Kenya Medical Research Institute; Kenya Medical Research Institute; University of Oxford	Snow, RW (corresponding author), KEMRI Univ Oxford Wellcome Trust Collaborat Progr, Kenyatta Natl Hosp Grounds, Malaria Publ Hlth & Epidemiol Grp, Ctr Geog Med, POB 43640-00100, Nairobi, Kenya.	rsnow@nairobi.kemri-wellcome.org	Snow, Robert William/AFR-1436-2022	Snow, Robert William/0000-0003-3725-6088	Wellcome Trust [079080, 077092] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], GLOB MAL ACT PLAN MA; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Feachem RGA, 2006, LANCET, V368, P537, DOI 10.1016/S0140-6736(06)69163-0; *GLOB FUND FIGHT A, 2009, TUB MAL COMM DISB; Kidson Chev, 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P635; Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882; Molineaux L, 1997, ANN TROP MED PARASIT, V91, P811, DOI 10.1080/00034989760572; Narasimhan V, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-8; Noor AM, 2009, LANCET, V373, P58, DOI 10.1016/S0140-6736(08)61596-2; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Okiro Emelda A, 2009, BMC Med, V7, P75, DOI 10.1186/1741-7015-7-75; Roberts L, 2007, SCIENCE, V318, P1544, DOI 10.1126/science.318.5856.1544; Sachs JD, 2005, LANCET, V365, P347, DOI 10.1016/S0140-6736(05)70201-4; Snow RW, 2008, PLOS MED, V5, P1068, DOI 10.1371/journal.pmed.0050142; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Teklehaimanot A, 2007, AM J TROP MED HYG, V77, P138, DOI 10.4269/ajtmh.2007.77.138; White NJ, 1999, LANCET, V353, P1965, DOI 10.1016/S0140-6736(98)07367-X; *WHO, WORLD MAL REP 2009; WHO, 2000, AB DECL PLAN ACT EXT; Zanzibar Malaria Control Program, 2009, MAL EL ZANZ FEAS ASS	20	69	69	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 10	2010	376	9735					137	139		10.1016/S0140-6736(10)60577-6	http://dx.doi.org/10.1016/S0140-6736(10)60577-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	626CJ	20417552	Green Accepted			2022-12-28	WOS:000279943200029
J	Suchy, FJ; Brannon, PM; Carpenter, TO; Fernandez, JR; Gilsanz, V; Gould, JB; Hall, K; Hui, SL; Lupton, J; Mennella, J; Miller, NJ; Osganian, SK; Sellmeyer, DE; Wolf, MA				Suchy, Frederick J.; Brannon, Patsy M.; Carpenter, Thomas O.; Fernandez, Jose R.; Gilsanz, Vicente; Gould, Jeffrey B.; Hall, Karen; Hui, Siu L.; Lupton, Joanne; Mennella, Julie; Miller, Natalie J.; Osganian, Stavroula Kalis; Sellmeyer, Deborah E.; Wolf, Marshall A.			National Institutes of Health Consensus Development Conference: Lactose Intolerance and Health	ANNALS OF INTERNAL MEDICINE			English	Article								National Institutes of Health (NIH) consensus and state-of-the-science statements are prepared by independent panels of health professionals and public representatives on the basis of 1) the results of a systematic literature review prepared under contract with the Agency for Healthcare Research and Quality; 2) presentations by investigators working in areas relevant to the conference questions during a 2-day public session; 3) questions and statements from conference attendees during open discussion periods that are part of the public session; and 4) closed deliberations by the panel during the remainder of the second day and morning of the third. This statement is an independent report of the panel and is not a policy statement of the National Institutes of Health or the U. S. government. The following statement is an abridged version of the panel's report, which is available in full at http: //consensus.nih.gov/2010/lactosestatement.htm.	[Suchy, Frederick J.] NYU, Mt Sinai Sch Med, Mt Sinai Kravis Childrens Hosp, New York, NY 10016 USA; Cornell Univ, Ithaca, NY USA; Yale Univ, Sch Med, Yale Ctr X Linked Hypophosphatemia, New Haven, CT USA; Univ Alabama Birmingham, Birmingham, AL USA; Univ So Calif, Childrens Hosp Los Angeles, Childrens Imaging Res Program, Los Angeles, CA USA; Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA; Univ Michigan, Sch Med, Ann Arbor, MI USA; Vet Affairs Ann Arbor Healthcare Syst, Ctr Geriatr Res Educ & Clin, Ann Arbor, MI USA; Indiana Univ, Sch Med, Ctr Aging Res, Indianapolis, IN USA; Regenstrief Inst Hlth Care, Indianapolis, IN 46202 USA; Texas A&M Univ, College Stn, TX USA; Univ Penn, Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; Harvard Univ, Childrens Hosp, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Johns Hopkins Bay View Med Ctr, Metab Bone Ctr, Baltimore, MD USA	Icahn School of Medicine at Mount Sinai; New York University; Cornell University; Yale University; University of Alabama System; University of Alabama Birmingham; Children's Hospital Los Angeles; University of Southern California; University of Southern California; Stanford University; University of Michigan System; University of Michigan; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; Texas A&M University System; Texas A&M University College Station; Monell Chemical Senses Center; University of Pennsylvania; University of Pennsylvania; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Johns Hopkins University; Johns Hopkins Medicine	Suchy, FJ (corresponding author), NYU, Mt Sinai Sch Med, Mt Sinai Kravis Childrens Hosp, New York, NY 10016 USA.			Mennella, Julie/0000-0002-8855-0204					0	76	80	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 15	2010	152	12					792	+		10.7326/0003-4819-152-12-201006150-00248	http://dx.doi.org/10.7326/0003-4819-152-12-201006150-00248			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611OP	20404261				2022-12-28	WOS:000278827700005
J	Nair, H; Nokes, DJ; Gessner, BD; Dherani, M; Madhi, SA; Singleton, RJ; O'Brien, KL; Roca, A; Wright, PF; Bruce, N; Chandran, A; Theodoratou, E; Sutanto, A; Sedyaningsih, ER; Ngama, M; Munywoki, PK; Kartasasmita, C; Simoes, EAF; Rudan, I; Weber, MW; Campbell, H				Nair, Harish; Nokes, D. James; Gessner, Bradford D.; Dherani, Mukesh; Madhi, Shabir A.; Singleton, Rosalyn J.; O'Brien, Katherine L.; Roca, Anna; Wright, Peter F.; Bruce, Nigel; Chandran, Aruna; Theodoratou, Evropi; Sutanto, Agustinus; Sedyaningsih, Endang R.; Ngama, Mwanajuma; Munywoki, Patrick K.; Kartasasmita, Cissy; Simoes, Eric A. F.; Rudan, Igor; Weber, Martin W.; Campbell, Harry			Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis	LANCET			English	Article							HUMAN METAPNEUMOVIRUS; TRACT INFECTIONS; INFLUENZA-VIRUS; DISEASE; PNEUMONIA; RSV; EPIDEMIOLOGY; POPULATION; AGE; BRONCHIOLITIS	Background The global burden of disease attributable to respiratory syncytial virus (RSV) remains unknown. We aimed to estimate the global incidence of and mortality from episodes of acute lower respiratory infection (ALRI) due to RSV in children younger than 5 years in 2005. Methods We estimated the incidence of RSV-associated ALRI in children younger than 5 years, stratified by age, using data from a systematic review of studies published between January, 1995, and June, 2009, and ten unpublished population-based studies. We estimated possible boundaries for RSV-associated ALRI mortality by combining case fatality ratios with incidence estimates from hospital-based reports from published and unpublished studies and identifying studies with population-based data for RSV seasonality and monthly ALRI mortality. Findings In 2005, an estimated 33.8 (95% CI 19.3-46-2) million new episodes of RSV-associated ALRI occurred worldwide in children younger than 5 years (22% of ALRI episodes), with at least 3.4 (2.8-4.3) million episodes representing severe RSV-associated ALRI necessitating hospital admission. We estimated that 66 000-199 000 children younger than 5 years died from RSV-associated ALRI in 2005, with 99% of these deaths occurring in developing countries. Incidence and mortality can vary substantially from year to year in any one setting. Interpretation Globally, RSV is the most common cause of childhood ALRI and a major cause of admission to hospital as a result of severe ALRI. Mortality data suggest that RSV is an important cause of death in childhood from ALRI, after pneumococcal pneumonia and Haemophilus influenzae type b. The development of novel prevention and treatment strategies should be accelerated as a priority.	[Campbell, Harry] Univ Edinburgh, Ctr Populat Hlth Sci, Sch Med, Global Hlth Acad, Edinburgh EH8 9AG, Midlothian, Scotland; [Nair, Harish] Publ Hlth Fdn India, New Delhi, India; [Nokes, D. James; Ngama, Mwanajuma; Munywoki, Patrick K.] Ctr Geog Med Res Coast, KEMRI, Kilifi, Kenya; [Nokes, D. James] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Gessner, Bradford D.] Agence Med Prevent, Paris, France; [Dherani, Mukesh; Bruce, Nigel] Univ Liverpool, Div Publ Hlth, Liverpool L69 3BX, Merseyside, England; [Madhi, Shabir A.] Univ Witwatersrand, MRC, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa; [Madhi, Shabir A.] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn Vaccine Preventable Dis, Johannesburg, South Africa; [Singleton, Rosalyn J.] Alaska Native Tribal Hlth Consortium, Anchorage, AK USA; [Singleton, Rosalyn J.] CDC, Arctic Invest Program, Natl Ctr Preparedness Detect & Control Infect Dis, Anchorage, AK USA; [O'Brien, Katherine L.; Chandran, Aruna] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Amer Indian Hlth, Baltimore, MD USA; [Roca, Anna] Univ Barcelona, Hosp Clin, IDIBAPS, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Roca, Anna] Minist Saude, CISM, Maputo, Mozambique; [Wright, Peter F.] Dartmouth Med Sch, Div Infect Dis & Int Hlth, Lebanon, NH USA; [Sutanto, Agustinus] W Nusa Tenggara Prov Govt, Lombok, Indonesia; [Sedyaningsih, Endang R.] Indonesian Minist Hlth, Jakarta, Indonesia; [Kartasasmita, Cissy] Padjadjaran State Univ, Hasan Sadikin Gen Hosp, Fac Med, Bandung, Indonesia; [Simoes, Eric A. F.] Univ Colorado, Denver, CO 80202 USA; [Simoes, Eric A. F.] Childrens Hosp, Denver, CO 80218 USA; [Rudan, Igor] Univ Split, Fac Med, Croatian Ctr Global Hlth, Split, Croatia; [Weber, Martin W.] WHO, Indonesia Country Off, Jakarta, Indonesia	University of Edinburgh; Public Health Foundation of India; University of Warwick; Agence de Medecine Preventive; University of Liverpool; University of Witwatersrand; National Research Foundation - South Africa; University of Witwatersrand; Alaska Native Tribal Health Consortium; Centers for Disease Control & Prevention - USA; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Centro de Investigacao em Saude de Manhica; Dartmouth College; Ministry of Health - Indonesia; Dr Hasan Sadikin General Hospital; Universitas Padjadjaran; University of Colorado System; University of Colorado Denver; Children's Hospital Colorado; University of Split; World Health Organization	Campbell, H (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Sch Med, Global Hlth Acad, Teviot Pl, Edinburgh EH8 9AG, Midlothian, Scotland.	Harry.Campbell@ed.ac.uk	Weber, Martin/GPW-6095-2022; Munywoki, Patrick K./GQP-4775-2022; Theodoratou, Evropi/C-3430-2014; Rudan, Igor/I-1467-2012; Campbell, Harry/E-2959-2010; Nair, Harish/E-7431-2010	Munywoki, Patrick K./0000-0001-9419-7155; Theodoratou, Evropi/0000-0001-5887-9132; Rudan, Igor/0000-0001-6993-6884; Campbell, Harry/0000-0002-6169-6262; Nair, Harish/0000-0002-9432-9100; Dherani, Mukesh/0000-0002-3055-9636; O'Brien, Katherine/0000-0002-0164-4030	WHO CAH [WHO OD/AP-07-04680]; Bill & Melinda Gates Foundation [R41202]; Wellcome Trust [061584, 076278]; Spanish Ministry of Education and Science (Ramon y Cajal) [RYC-2008-02777]	WHO CAH; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Wellcome Trust(Wellcome TrustEuropean Commission); Spanish Ministry of Education and Science (Ramon y Cajal)(Spanish Government)	This work was done as part of the wider programme of the Child Epidemiology Reference Group (CHERG) to establish the major causes of global childhood disease burden. We thank Emelda A Okiro, Ann Bett, John Abwao (KEMRI-Wellcome Trust Research Programme, Kenya); Dana Bruden (Arctic Investigations Program, National Center for Preparedness, Detection and Control of Infectious Disease, CDC, Anchorage, AK, USA); Byron Arana (Center for Health Studies, Universidad del Valle de Guatemala, Guatemala City, Guatemala); Keith P Kingman (University of the Witwatersrand/Medical Research Council: Respiratory and Meningeal Pathogens Research Unit and Hubert Department of Global Health, Rollins School of Public Health and Division of Infectious Diseases, School of Medicine, Emory University, Atlanta, GA, USA); Pedro Alonso (Barcelona Centre for International Health Research (CRESIB), Hospital Clinic/IDIBAPS, Universitat de Barcelona, Spain and Centro de Investigacao em Saude da Manhica (CISM), Ministerio de Sande, Mozambique); Llorenc Quinto (Barcelona Centre for International Health Research (CRESIB), Hospital Clinic/IDIBAPS, Universitat de Barcelona, Spain); Kuswandewi Mutyara (Medical Faculty, Padjadjaran University, Hasan Sadikin General Hospital, Bandung, Indonesia); Lesley C McGoohan (Centre for Population Studies, Global Health Academy, The University of Edinburgh) assistance with some of the illustrations in this report; and Douglas Holtzman (Bill & Melinda Gates Foundation, Seattle, WA, USA) for participating in the expert group meeting in Edinburgh and reviewing the report. Financial support for this work was provided by WHO CAH (grant number WHO OD/AP-07-04680) and the Bill & Melinda Gates Foundation (R41202). Studies from Kilifi, Kenya received Wellcome Trust funding (061584, 076278). AR was supported by a grant from the Spanish Ministry of Education and Science (Ramon y Cajal: RYC-2008-02777). MWW is a WHO staff member; he is responsible for the views expressed in this publication and they do not necessarily represent the decisions or the policies of WHO.	Boyce TG, 2000, J PEDIATR-US, V137, P865, DOI 10.1067/mpd.2000.110531; Broor S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000491; Bruce N, 2007, B WORLD HEALTH ORGAN, V85, P535, DOI 10.2471/BLT.06.035832; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; BURTON GG, 1997, RESP CARE GUIDE CLIN; Chan PKS, 1999, EPIDEMIOL INFECT, V123, P257, DOI 10.1017/S0950268899002824; Deshpande SA, 2003, ARCH DIS CHILD, V88, P1065, DOI 10.1136/adc.88.12.1065; Djelantik IGG, 2003, J TROP PEDIATRICS, V49, P327, DOI 10.1093/tropej/49.6.327; Duke T, 2008, LANCET, V372, P1328, DOI 10.1016/S0140-6736(08)61164-2; Eriksson M, 2002, ACTA PAEDIATR, V91, P593, DOI 10.1080/080352502753711740; Forster J, 2004, EUR J PEDIATR, V163, P709, DOI 10.1007/s00431-004-1523-9; Foulongne V, 2006, PEDIATR INFECT DIS J, V25, P354, DOI 10.1097/01.inf.0000207480.55201.f6; Gomez M, 2009, PEDIATR INFECT DIS J, V28, P655, DOI 10.1097/INF.0b013e318199c3b1; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hamelin ME, 2004, CLIN INFECT DIS, V38, P983, DOI 10.1086/382536; Hasan K, 2006, SCAND J INFECT DIS, V38, P690, DOI 10.1080/00365540600606473; Henrickson KJ, 2007, PEDIATR INFECT DIS J, V26, pS36, DOI 10.1097/INF.0b013e318157da6f; Henrickson KJ, 2004, PEDIATR INFECT DIS J, V23, pS11, DOI 10.1097/01.inf.0000108188.37237.48; Holman RC, 2004, PEDIATRICS, V114, pE437, DOI 10.1542/peds.2004-0049; Iwane MK, 2004, PEDIATRICS, V113, P1758, DOI 10.1542/peds.113.6.1758; Jansen AGSC, 2007, EUR RESPIR J, V30, P1158, DOI 10.1183/09031936.00034407; Karron RA, 2005, J INFECT DIS, V191, P1093, DOI 10.1086/427813; Law BJ, 2002, RESP MED, V96, pS1, DOI 10.1053/rmed.2002.1294; Leader S, 2003, J PEDIATR-US, V143, pS127, DOI 10.1067/S0022-3476(03)00510-9; Madhi SA, 2007, PEDIATR INFECT DIS J, V26, P693, DOI 10.1097/INF.0b013e3180621192; Muller-Pebody B, 2002, EPIDEMIOL INFECT, V129, P99, DOI 10.1017/S095026880200729X; Mullins JA, 2003, PEDIATR INFECT DIS J, V22, P857, DOI 10.1097/01.inf.0000090921.21313.d3; Nokes DJ, 2008, CLIN INFECT DIS, V46, P50, DOI 10.1086/524019; Nokes DJ, 2009, CLIN INFECT DIS, V49, P1341, DOI 10.1086/606055; Nokes DJ, 2007, RESP SYNCYTIAL VIRUS; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; ONYANGO FE, 1993, BRIT MED J, V306, P612, DOI 10.1136/bmj.306.6878.612; Resch B, 2002, INFECTION, V30, P193, DOI 10.1007/s15010-002-2122-1; Robertson SE, 2004, B WORLD HEALTH ORGAN, V82, P914; Rudan I, 2004, B WORLD HEALTH ORGAN, V82, P895; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Schickli JH, 2009, HUM VACCINES, V5, P582, DOI 10.4161/hv.9131; Simoes EAF, 1999, LANCET, V354, P847, DOI 10.1016/S0140-6736(99)80040-3; Simoes EAF, 2002, RESP MED, V96, pS15, DOI 10.1053/rmed.2002.1296; Singleton RJ, 2007, PEDIATR INFECT DIS J, V26, pS46, DOI 10.1097/INF.0b013e318157da9b; Strutton DR, 2003, J PEDIATR-US, V143, pS157, DOI 10.1067/S0022-3476(03)00512-2; Sutanto A, 2002, AM J TROP MED HYG, V66, P175, DOI 10.4269/ajtmh.2002.66.175; SUTMOLLER F, 1995, CLIN INFECT DIS, V20, P854, DOI 10.1093/clinids/20.4.854; Suwanjutha Subharee, 2002, Journal of the Medical Association of Thailand, V85, pS1111; UNICEF, 2007, STAT WORLDS CHILDR 2; Vicente D, 2003, EPIDEMIOL INFECT, V131, P867, DOI 10.1017/S0950268803008926; Watt JP, 2009, LANCET, V374, P903, DOI 10.1016/S0140-6736(09)61203-4; Weber MW, 2002, B WORLD HEALTH ORGAN, V80, P562; Weber MW, 1998, TROP MED INT HEALTH, V3, P268, DOI 10.1046/j.1365-3156.1998.00213.x; Weber MW, 1998, PEDIATR INFECT DIS J, V17, P224, DOI 10.1097/00006454-199803000-00010; Weigl JAI, 2002, KLIN PADIATR, V214, P334, DOI 10.1055/s-2002-35365; Whitehall JS, 2001, J PAEDIATR CHILD H, V37, P416, DOI 10.1046/j.1440-1754.2001.0720f.x; Wolf DG, 2006, PEDIATR INFECT DIS J, V25, P320, DOI 10.1097/01.inf.0000207395.80657.cf; World Health Organization, 1991, TECHN BAS WHO REC MA; WRIGHT PF, 2000, GENERIC PROTOCOL EXA, P34; Yorita KL, 2007, PEDIATR INFECT DIS J, V26, P1081, DOI 10.1097/INF.0b013e31812e62c2	56	1839	1960	4	244	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2010	375	9725					1545	1555		10.1016/S0140-6736(10)60206-1	http://dx.doi.org/10.1016/S0140-6736(10)60206-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	596AH	20399493	Green Published			2022-12-28	WOS:000277655100027
J	Greenberg, JO; Dudley, JC; Ferris, TG				Greenberg, Jeffrey O.; Dudley, Jessica C.; Ferris, Timothy G.			Engaging Specialists in Performance-Incentive Programs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Greenberg, Jeffrey O.; Dudley, Jessica C.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Greenberg, Jeffrey O.; Dudley, Jessica C.] Brigham & Womens Phys Org, Boston, MA USA; [Ferris, Timothy G.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Ferris, Timothy G.] Massachusetts Gen Phys Org, Boston, MA USA; [Greenberg, Jeffrey O.; Dudley, Jessica C.; Ferris, Timothy G.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Greenberg, JO (corresponding author), Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA.							DesRoches CM, 2008, NEW ENGL J MED, V359, P50, DOI 10.1056/NEJMsa0802005; Ferris TG, 2007, HEALTH AFFAIR, V26, P1712, DOI 10.1377/hlthaff.26.6.1712; National Center for Health Statistics, 2009, HLTH US 2008 CHARTB; Reschovsky James, 2007, Issue Brief Cent Stud Health Syst Change, P1; Resnic FS, 2009, J AM COLL CARDIOL, V53, P825, DOI 10.1016/j.jacc.2008.11.034	5	20	20	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 29	2010	362	17					1558	1560		10.1056/NEJMp1000650	http://dx.doi.org/10.1056/NEJMp1000650			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	589AX	20410500				2022-12-28	WOS:000277117400003
J	Dahut, WL; Madan, RA				Dahut, William L.; Madan, Ravi A.			Revisiting the ultimate target of treatment for prostate cancer	LANCET			English	Editorial Material							ANTIANDROGEN WITHDRAWAL; ABIRATERONE ACETATE; MITOXANTRONE; PREDNISONE; ANDROGEN; DOCETAXEL; TRIAL; CYP17		[Dahut, William L.; Madan, Ravi A.] NCI, Div Clin Sci, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Dahut, WL (corresponding author), NCI, Div Clin Sci, Bethesda, MD 20892 USA.	dahutw@mail.nih.gov			NATIONAL CANCER INSTITUTE [ZIASC010098] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Attard G, 2008, J CLIN ONCOL, V26, P4563, DOI 10.1200/JCO.2007.15.9749; Attard G, 2009, J CLIN ONCOL, V27, P3742, DOI 10.1200/JCO.2008.20.0642; FURR BJA, 1989, HORM RES, V32, P69, DOI 10.1159/000181315; MOORE MJ, 1994, J CLIN ONCOL, V12, P689, DOI 10.1200/JCO.1994.12.4.689; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Sartor AO, 2008, CANCER-AM CANCER SOC, V112, P2393, DOI 10.1002/cncr.23473; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; Sharifi N, 2005, JAMA-J AM MED ASSOC, V294, P238, DOI 10.1001/jama.294.2.238; Sharifi N, 2008, CLIN CANCER RES, V14, P4691, DOI 10.1158/1078-0432.CCR-08-0453; Small EJ, 2004, J CLIN ONCOL, V22, P1025, DOI 10.1200/JCO.2004.06.037; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720	11	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 24	2010	375	9724					1409	1410		10.1016/S0140-6736(10)60400-X	http://dx.doi.org/10.1016/S0140-6736(10)60400-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	590FL	20398924				2022-12-28	WOS:000277210000004
J	Zeng, WW; Sun, LJ; Jiang, XM; Chen, X; Hou, FJ; Adhikari, A; Xu, M; Chen, ZJJ				Zeng, Wenwen; Sun, Lijun; Jiang, Xiaomo; Chen, Xiang; Hou, Fajian; Adhikari, Anirban; Xu, Ming; Chen, Zhijian J.			Reconstitution of the RIG-I Pathway Reveals a Signaling Role of Unanchored Polyubiquitin Chains in Innate Immunity	CELL			English	Article							TUMOR-SUPPRESSOR CYLD; DOUBLE-STRANDED-RNA; ANTIVIRAL RESPONSES; ADAPTER PROTEIN; UBIQUITIN; ACTIVATION; DOMAIN; RECOGNITION; KINASES; SENSOR	RIG-I detects invading viral RNA and activates the transcription factors NF-kappa B and IRF3 through the mitochondrial protein MAVS. Here we show that RNA bearing 5'-triphosphate strongly activates the RIG-I-IRF3 signaling cascade in a reconstituted system composed of RIG-I, mitochondria, and cytosol. Activation of RIG-I requires not only RNA but also polyubiquitin chains linked through lysine 63 (K63) of ubiquitin. RIG-I binds specifically to K63-polyubiquitin chains through its tandem CARD domains in a manner that depends on RNA and ATP. Mutations in the CARD domains that abrogate ubiquitin binding also impair RIG-I activation. Remarkably, unanchored K63-ubiquitin chains, which are not conjugated to any target protein, potently activate RIG-I. These ubiquitin chains function as an endogenous ligand of RIG-I in human cells. Our results delineate the mechanism of RIG-I activation, identify CARD domains as a ubiquitin sensor, and demonstrate that unanchored K63-polyubiquitin chains are signaling molecules in antiviral innate immunity.	[Zeng, Wenwen; Sun, Lijun; Jiang, Xiaomo; Chen, Xiang; Hou, Fajian; Adhikari, Anirban; Xu, Ming; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Sun, Lijun; Chen, Xiang; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, ZJJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	zhijian.chen@utsouthwestern.edu	xu, ming/E-5524-2012; Sun, Lijun/ABD-4470-2021; Chen, Zhijian/C-6039-2012; Zeng, Wenwen/D-7276-2017	Chen, Zhijian/0000-0002-8475-8251; Zeng, Wenwen/0000-0001-8544-3318	NIH [RO1-AI09919, RO1-GM63692]; Welch Foundation [I-1389]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI009919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063692] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Francesco Melandri and Dr. Kal Lapan (Boston Biochem) for generously providing some of the ubiquitin chains and Dr. Jae Jung (University of Southern California) for the mammalian expression plasmids of GST-RIG-I(N), K172R, K172-only, and 6KR mutants. We also thank Brian Skaug for reading the manuscript. This work was supported by grants from NIH (RO1-AI09919 and RO1-GM63692) and the Welch Foundation (I-1389). Z.J.C. is an Investigator of Howard Hughes Medical Institute.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Frias-Staheli N, 2007, CELL HOST MICROBE, V2, P404, DOI 10.1016/j.chom.2007.09.014; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Fujita T, 2009, IMMUNITY, V31, P4, DOI 10.1016/j.immuni.2009.06.014; Gack MU, 2008, P NATL ACAD SCI USA, V105, P16743, DOI 10.1073/pnas.0804947105; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Nakhaei P, 2009, SEMIN IMMUNOL, V21, P215, DOI 10.1016/j.smim.2009.05.001; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; XU M, 2009, CELL, V36, P302; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2002, J INTERF CYTOK RES, V22, P73, DOI 10.1089/107999002753452674; Zeng WW, 2009, MOL CELL, V36, P315, DOI 10.1016/j.molcel.2009.09.037; Zhang MY, 2008, J BIOL CHEM, V283, P18621, DOI 10.1074/jbc.M801451200	28	461	486	5	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2010	141	2					315	330		10.1016/j.cell.2010.03.029	http://dx.doi.org/10.1016/j.cell.2010.03.029			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	584GF	20403326	Green Accepted, Bronze			2022-12-28	WOS:000276738400021
J	Blake, RE; Chang, SJ; Lepland, A				Blake, Ruth E.; Chang, Sae Jung; Lepland, Aivo			Phosphate oxygen isotopic evidence for a temperate and biologically active Archaean ocean	NATURE			English	Article							BARBERTON GREENSTONE-BELT; SWAZILAND SUPERGROUP; BIOGENIC APATITES; MOUNTAIN LAND; EARLY-LIFE; PHOSPHORUS; IRON; CHERTS; WATER; ADSORPTION	Oxygen and silicon isotope compositions of cherts(1-3) and studies of protein evolution(4) have been interpreted to reflect ocean temperatures of 55-85 degrees C during the early Palaeoarchaean era (similar to 3.5 billion years ago). A recent study combining oxygen and hydrogen isotope compositions of cherts, however, makes a case for Archaean ocean temperatures being no greater than 40 degrees C (ref. 5). Ocean temperature can also be assessed using the oxygen isotope composition of phosphate. Recent studies show that O-18:O-16 ratios of dissolved inorganic phosphate (delta O-18(P)) reflect ambient seawater temperature as well as biological processing that dominates marine phosphorus cycling at low temperature(6,7). All forms of life require and concentrate phosphorus, and as a result of biological processing, modern marine phosphates have delta O-18(P) values typically between 19-26 parts per thousand (VSMOW)(7,8), highly evolved from presumed source values of similar to 6-8 parts per thousand that are characteristic of apatite in igneous rocks(9,10) and meteorites(11). Here we report oxygen isotope compositions of phosphates in sediments from the 3.2-3.5-billion-year-old Barberton Greenstone Belt in South Africa. We find that delta O-18(P) values range from 9.3 parts per thousand to 19.9 parts per thousand and include the highest values reported for Archaean rocks. The temperatures calculated from our highest delta O-18(P) values and assuming equilibrium with sea water with delta O-18=0% (ref. 12) range from 26 degrees C to 35 degrees C. The higher delta O-18(P) values are similar to those of modern marine phosphate and suggest a well-developed phosphorus cycle and evolved biologic activity on the Archaean Earth.	[Blake, Ruth E.; Chang, Sae Jung] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Lepland, Aivo] Geol Survey Norway, N-7491 Trondheim, Norway; [Lepland, Aivo] Tallinn Univ Technol, Inst Geol, EE-19086 Tallinn, Estonia	Yale University; Geological Survey of Norway; Tallinn University of Technology	Blake, RE (corresponding author), Yale Univ, Dept Geol & Geophys, POB 6666, New Haven, CT 06520 USA.	ruth.blake@yale.edu		Lepland, Aivo/0000-0002-0248-1405	Division Of Ocean Sciences [0928247] Funding Source: National Science Foundation	Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		BERNER RA, 1973, EARTH PLANET SC LETT, V18, P77, DOI 10.1016/0012-821X(73)90037-X; Bjerrum CJ, 2002, NATURE, V417, P159, DOI 10.1038/417159a; Blake RE, 2005, AM J SCI, V305, P596, DOI 10.2475/ajs.305.6-8.596; BYERLY GR, 1986, NATURE, V319, P489, DOI 10.1038/319489a0; Colman AS, 2005, P NATL ACAD SCI USA, V102, P13023, DOI 10.1073/pnas.0506455102; COLMAN SA, 2002, THESIS YALE U; Furnes H, 2004, SCIENCE, V304, P578, DOI 10.1126/science.1095858; Gaucher EA, 2008, NATURE, V451, P704, DOI 10.1038/nature06510; Greenwood JP, 2003, GEOCHIM COSMOCHIM AC, V67, P2289, DOI 10.1016/S0016-7037(03)00130-3; Hofmann A, 2007, ASTROBIOLOGY, V7, P355, DOI 10.1089/ast.2005.0288; Hofmann A, 2008, CHEM GEOL, V257, P224, DOI 10.1016/j.chemgeo.2008.09.015; Hren MT, 2009, NATURE, V462, P205, DOI 10.1038/nature08518; Jaffres JBD, 2007, EARTH-SCI REV, V83, P83, DOI 10.1016/j.earscirev.2007.04.002; Kappler A, 2005, GEOLOGY, V33, P865, DOI 10.1130/G21658.1; KARHU J, 1986, GEOCHIM COSMOCHIM AC, V50, P1745, DOI 10.1016/0016-7037(86)90136-5; KARL DM, 1992, LIMNOL OCEANOGR, V37, P105, DOI 10.4319/lo.1992.37.1.0105; Knauth LP, 2003, GEOL SOC AM BULL, V115, P566, DOI 10.1130/0016-7606(2003)115<0566:HACTIF>2.0.CO;2; KOLODNY Y, 1983, EARTH PLANET SC LETT, V64, P398, DOI 10.1016/0012-821X(83)90100-0; Liang Y., 2005, THESIS YALE U; LILJESTRAND FL, 1999, GEOL S AM S, P83, DOI 10.1130/0-8137-2329-9.83; LONGINELLI A, 1973, EARTH PLANET SC LETT, V19, P373, DOI 10.1016/0012-821X(73)90088-5; Lowe DR, 2007, DEV PREC G, V15, P481, DOI 10.1016/S0166-2635(07)15053-2; Markel Doron, 1994, Israel Journal of Earth Sciences, V43, P165; MUEHLENBACHS K, 1976, J GEOPHYS RES, V81, P4365, DOI 10.1029/JB081i023p04365; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Poulton SW, 2005, CHEM GEOL, V214, P209, DOI 10.1016/j.chemgeo.2004.09.003; Robert F, 2006, NATURE, V443, P969, DOI 10.1038/nature05239; RUTTENBERG KC, 1992, LIMNOL OCEANOGR, V37, P1460, DOI 10.4319/lo.1992.37.7.1460; SHEMESH A, 1983, EARTH PLANET SC LETT, V64, P405, DOI 10.1016/0012-821X(83)90101-2; SMITH HS, 1984, ARCHAEAN GEOCHEMISTR, P115, DOI DOI 10.1007/978-3-642-70001-9_6; TAYLOR HP, 1962, GEOL SOC AM BULL, V73, P461, DOI 10.1130/0016-7606(1962)73[461:RBORIC]2.0.CO;2; Tice MM, 2004, GEOLOGY, V32, P37, DOI 10.1130/G19915.1; TUDGE AP, 1960, GEOCHIM COSMOCHIM AC, V18, P81, DOI 10.1016/0016-7037(60)90019-3; van den Boorn SHJM, 2007, GEOLOGY, V35, P939, DOI 10.1130/G24096A.1; Vennemann TW, 2002, CHEM GEOL, V185, P321, DOI 10.1016/S0009-2541(01)00413-2; WALSH MM, 1985, NATURE, V314, P530, DOI 10.1038/314530a0; WIDDEL F, 1993, NATURE, V362, P834, DOI 10.1038/362834a0	37	137	144	10	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2010	464	7291					1029	U89		10.1038/nature08952	http://dx.doi.org/10.1038/nature08952			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20393560				2022-12-28	WOS:000276635000036
J	Klass, P				Klass, Perri			Disconnected.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NYU, New York, NY 10016 USA	New York University	Klass, P (corresponding author), NYU, New York, NY 10016 USA.								0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 15	2010	362	15					1358	1361		10.1056/NEJMp0911193	http://dx.doi.org/10.1056/NEJMp0911193			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	582XY	20393174				2022-12-28	WOS:000276635300003
J	Chen, MIC; Lee, VJM; Lim, WY; Barr, IG; Lin, RTP; Koh, GCH; Yap, J; Cui, L; Cook, AR; Laurie, K; Tan, LWL; Tan, BH; Loh, J; Shaw, R; Durrant, C; Chow, VTK; Kelso, A; Chia, KS; Leo, YS				Chen, Mark I. C.; Lee, Vernon J. M.; Lim, Wei-Yen; Barr, Ian G.; Lin, Raymond T. P.; Koh, Gerald C. H.; Yap, Jonathan; Cui, Lin; Cook, Alex R.; Laurie, Karen; Tan, Linda W. L.; Tan, Boon Huan; Loh, Jimmy; Shaw, Robert; Durrant, Chris; Chow, Vincent T. K.; Kelso, Anne; Chia, Kee Seng; Leo, Yee Sin			2009 Influenza A(H1N1) Seroconversion Rates and Risk Factors Among Distinct Adult Cohorts in Singapore	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROPHYLAXIS; HOUSEHOLDS	Context Singapore experienced a single epidemic wave of 2009 influenza A(H1N1) with epidemic activity starting in late June 2009 and peaking in early August before subsiding within a month. Objective To compare the risk and factors associated with H1N1 seroconversion in different adult cohorts. Design, Setting, and Participants A study with serial serological samples from 4 distinct cohorts: general population (n=838), military personnel (n=1213), staff from an acute care hospital (n=558), and staff as well as residents from long-term care facilities (n=300) from June 22, 2009, to October 15, 2009. Hemagglutination inhibition results of serum samples taken before, during, and after the epidemic and data from symptom questionnaires are presented. Main Outcome Measures A 4-fold or greater increase in titer between any of the 3 serological samples was defined as evidence of H1N1 seroconversion. Results Baseline titers of 40 or more were observed in 22 members (2.6%; 95% confidence interval [CI], 1.7%-3.9%) of the community, 114 military personnel (9.4%; 95% CI, 7.9%-11.2%), 37 hospital staff (6.6%; 95% CI, 4.8%-9.0%), and 20 participants from long-term care facilities (6.7%; 95% CI, 4.4%-10.1%). In participants with 1 or more follow-up serum samples, 312 military personnel (29.4%; 95% CI, 26.8%-32.2%) seroconverted compared with 98 community members (13.5%; 95% CI, 11.2%-16.2%), 35 hospital staff (6.5%; 95% CI, 4.7%-8.9%), and only 3 longterm care participants (1.2%; 95% CI, 0.4%-3.5%). Increased frequency of seroconversion was observed for community participants from households in which 1 other member seroconverted (adjusted odds ratio [OR], 3.32; 95% CI, 1.50-7.33), whereas older age was associated with reduced odds of seroconversion (adjusted OR, 0.77 per 10 years; 95% CI, 0.64-0.93). Higher baseline titers were associated with decreased frequency of seroconversion in community (adjusted OR for every doubling of baseline titer, 0.48; 95% CI, 0.27-0.85), military (adjusted OR, 0.71; 95% CI, 0.61-0.81), and hospital staff cohorts (adjusted OR, 0.50; 95% CI, 0.26-0.93). Conclusion Following the June-September 2009 wave of 2009 influenza A(H1N1), 13% of the community participants seroconverted, and most of the adult population likely remained susceptible. JAMA. 2010; 303(14): 1383-1391	[Chen, Mark I. C.] Tan Tock Seng Hosp, Dept Clin Epidemiol, Singapore 308433, Singapore; [Chen, Mark I. C.; Lee, Vernon J. M.; Lim, Wei-Yen; Koh, Gerald C. H.; Chia, Kee Seng] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore; [Chen, Mark I. C.] Duke NUS Grad Med Sch, Singapore, Singapore; [Lee, Vernon J. M.; Yap, Jonathan] Minist Def, Biodef Ctr, Singapore, Singapore; [Lee, Vernon J. M.] Australian Natl Univ, Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia; [Lee, Vernon J. M.; Koh, Gerald C. H.] Natl Univ Singapore, Ctr Hlth Serv Res, Singapore 117548, Singapore; [Barr, Ian G.; Laurie, Karen; Shaw, Robert; Durrant, Chris; Kelso, Anne] World Hlth Org Collaborating Ctr Reference & Res, Melbourne, Vic, Australia; [Lin, Raymond T. P.; Cui, Lin] Minist Hlth, Natl Publ Hlth Lab, Singapore, Singapore; [Cook, Alex R.] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Loh, Jimmy] DSO Natl Labs, Detect & Diagnost Lab, Singapore, Singapore; [Chow, Vincent T. K.] Natl Univ Singapore, Dept Microbiol, Singapore 117548, Singapore; [Leo, Yee Sin] Tan Tock Seng Hosp, Dept Infect Dis, Communicable Dis Ctr, Singapore 308433, Singapore	Tan Tock Seng Hospital; National University of Singapore; National University of Singapore; Australian National University; National University of Singapore; World Health Organization; Ministry of Health-Singapore; National University of Singapore; National University of Singapore; Tan Tock Seng Hospital	Chen, MIC (corresponding author), Tan Tock Seng Hosp, Dept Clin Epidemiol, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.	mark_chen@ttsh.com.sg	Cook, Alex/B-5941-2011; Chen, Mark/AGC-5338-2022; Chen, Mark/CAG-2949-2022; Yap, Jonathan/AAJ-7266-2020; Cook, Alex/S-3576-2019; Tan, Boon Huan/ABB-8381-2021; CHIA, Kee Seng/C-5790-2011	Cook, Alex/0000-0002-6271-5832; Chen, Mark/0000-0001-9369-5830; Chen, Mark/0000-0001-9369-5830; Yap, Jonathan/0000-0002-5227-8536; Tan, Boon Huan/0000-0002-4976-7988; Kelso, Anne/0000-0002-3166-3267; Chow, Vincent/0000-0003-2634-6213; Laurie, Karen/0000-0001-5186-8342; Koh, Choon Huat Gerald/0000-0002-6453-6897; Barr, Ian/0000-0002-7351-418X	National University of Singapore; GlaxoSmithKline; National Medical Research Council of Singapore [NMRC/H1N1O/005/2009]; Australian Government Department of Health and Ageing; Ministry of Defence, Singapore	National University of Singapore(National University of Singapore); GlaxoSmithKline(GlaxoSmithKline); National Medical Research Council of Singapore(National Medical Research Council, Singapore); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Ministry of Defence, Singapore(Ministry of Defence, Singapore)	Dr Cook reported that he has received research funding from the National University of Singapore. Dr Lee reported that he has received unrelated research funding from GlaxoSmithKline. No other financial disclosures were reported.; Funding/Support: This project was funded by grant NMRC/H1N1O/005/2009 from the National Medical Research Council of Singapore. The Melbourne World Health Organization Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health and Ageing; the Centre has collaborative projects with vaccine companies unrelated to this study. The military cohort study was funded by the Ministry of Defence, Singapore.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Chen HL, 2009, EMERG INFECT DIS, V15, P1849, DOI 10.3201/eid1511.090868; Chow A, 2006, EMERG INFECT DIS, V12, P114, DOI 10.3201/eid1201.050826; CUTTER J, 2009, EPIDEMIOLOGICAL NEWS, V35, P39; Dan YY, 2009, EMERG INFECT DIS, V15, P1909, DOI 10.3201/eid1512.090902; DORAISINGHAM S, 1986, Annals Academy of Medicine Singapore, V15, P9; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; Hong CY, 2004, FAM PRACT, V21, P317, DOI 10.1093/fampra/cmh319; Kendal AP, 1982, CONCEPTS PROCEDURES; Leo YS, 2010, EMERG INFECT DIS, V16, P103, DOI 10.3201/eid1601.091164; Liang M, 2009, SINGAP MED J, V50, P581; LIM KA, 1957, LANCET, V2, P791; Lipsitch M, 2009, LANCET, V374, P1209, DOI 10.1016/S0140-6736(09)61377-5; Marchand-Austin A, 2009, EMERG INFECT DIS, V15, P2001, DOI 10.3201/eid1512.091022; MEDLOCK J, 2009, PLOS CURR INFLUENZA; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Monto AS, 2002, J INFECT DIS, V186, P1582, DOI 10.1086/345722; Mukherjee P, 2010, EMERG INFECT DIS, V16, P21, DOI 10.3201/eid1601.091376; Ong AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008453; ONG JBS, PLOS ONE IN PRESS; Vynnycky E, 2007, INT J EPIDEMIOL, V36, P881, DOI 10.1093/ije/dym071; Wald A, 1943, T AM MATH SOC, V54, P426, DOI 10.2307/1990256; WHO, 2009, WKLY EPIDEMIOL REC, V84, P185; *WHO, WHO INFL LIK ILLN US; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774	28	138	139	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2010	303	14					1383	1391		10.1001/jama.2010.404	http://dx.doi.org/10.1001/jama.2010.404			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582KX	20388894	Bronze			2022-12-28	WOS:000276597300023
J	Bennett, WL; Gilson, MM; Jamshidi, R; Burke, AE; Segal, JB; Steele, KE; Makary, MA; Clark, JM				Bennett, Wendy L.; Gilson, Marta M.; Jamshidi, Roxanne; Burke, Anne E.; Segal, Jodi B.; Steele, Kimberley E.; Makary, Martin A.; Clark, Jeanne M.			Impact of bariatric surgery on hypertensive disorders in pregnancy: retrospective analysis of insurance claims data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MATERNAL OBESITY; UNITED-STATES; RISK; PREECLAMPSIA; OVERWEIGHT; DIAGNOSES; ACCURACY; WEIGHT	Objective To determine whether women who had a delivery after bariatric surgery have lower rates of hypertensive disorders in pregnancy compared with women who had a delivery before bariatric surgery. Design Retrospective cohort study. Setting Claims data for 2002-6 from seven insurance plans in the United States. Participants 585 women aged 16-45 who had undergone bariatric surgery, had at least one pregnancy and delivery, and had continuous insurance coverage during pregnancy plus two weeks after delivery. Main outcome measure Hypertensive disorders in pregnancy defined with ICD-9 codes. The independent variable was the timing of delivery in relation to bariatric surgery, classified as deliveries before and after surgery. We used logistic regression to calculate odds ratios and confidence intervals for each type of hypertensive disorder in pregnancy. Results Among the 585 women who had undergone bariatric surgery and had a delivery, 269 delivered before surgery and 316 delivered after surgery. Gastric bypass was the surgery in 82% (477) of all women. Women who delivered before surgery were younger at the time of delivery (mean age 31.3 v 32.5) but had higher rates of pre-existing diabetes and gestational diabetes mellitus. Compared with women who delivered before surgery, women who delivered after surgery had substantially lower rates of pre-eclampsia and eclampsia (odds ratio 0.20, 95% confidence interval 0.09 to 0.44), chronic hypertension complicating pregnancy (0.39, 0.20 to 0.74), and gestational hypertension (0.16, 0.07 to 0.37), even after adjustment for age at delivery, multiple pregnancy (that is, twins or more), surgical procedure, pre-existing diabetes, and insurance plan. Conclusion In this retrospective analysis of US women, bariatric surgery was associated with lower rates of hypertensive disorders in subsequent pregnancy.	[Bennett, Wendy L.; Segal, Jodi B.; Clark, Jeanne M.] Johns Hopkins Univ, Sch Med, Div Gen Internal Med, Dept Med, Baltimore, MD 21205 USA; [Gilson, Marta M.; Steele, Kimberley E.; Makary, Martin A.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Jamshidi, Roxanne; Burke, Anne E.] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Bennett, WL (corresponding author), Johns Hopkins Univ, Sch Med, Div Gen Internal Med, Dept Med, 2024 E Monument St,Room 2-611, Baltimore, MD 21205 USA.	wbennet5@jhmi.edu	Burke, Anne/AHE-9713-2022; Clark, Jeanne/AGG-8199-2022	Clark, Jeanne/0000-0003-1194-0092; Bennett, Wendy/0000-0001-9828-0706	Ethicon Endo-Surgery; Pfizer; GlaxoSmithKline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER	Ethicon Endo-Surgery; Pfizer(Pfizer); GlaxoSmithKline(GlaxoSmithKline); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The dataset used in this study was created for a research project on the patterns of obesity care within selected BlueCross BlueShield plans. The original development of the dataset was funded by unrestricted research grants from Ethicon Endo-Surgery, Pfizer, and GlaxoSmithKline. Data and database development support were provided by the BlueCross BlueShield Association (Tennessee, Hawaii, Michigan, North Carolina), Highmark (Pennsylvania), Independence BlueCross (Pennsylvania), and Wellmark BlueCross BlueShield (Iowa and South Dakota). The BlueCross BlueShield plans were invited to review the manuscript but they did not have any direct role in the design and conduct of the study, data management or analysis, interpretation of the data, or preparation of the manuscript.	ACOG, 2009, OBSTET GYNECOL, V113, P1405, DOI [10.1097/AOG.0b013e3181ac0544, DOI 10.1097/AOG.0B013E3181AC0544]; [Anonymous], 2001, OBSTET GYNECOL, V98, P177; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Bodnar LM, 2005, ANN EPIDEMIOL, V15, P475, DOI 10.1016/j.annepidem.2004.12.008; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; BURKE AE, J AM COLL S IN PRESS; CALLAWAY LK, 2009, HYPERTENS PREGNANCY, V4, P1; Chang Jeani, 2003, MMWR Surveill Summ, V52, P1; Chu SY, 2007, OBES REV, V8, P385, DOI 10.1111/j.1467-789X.2007.00397.x; Chu SY, 2008, NEW ENGL J MED, V358, P1444, DOI 10.1056/NEJMoa0706786; Chu SY, 2007, DIABETES CARE, V30, P2070, DOI 10.2337/dc06-2559a; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; Eerdekens A, 2010, EUR J PEDIATR, V169, P191, DOI 10.1007/s00431-009-1005-1; Fortner RT, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.021; Freedman DS, 2002, JAMA-J AM MED ASSOC, V288, P1758, DOI 10.1001/jama.288.14.1758; Geller SE, 2004, AM J OBSTET GYNECOL, V190, P1629, DOI 10.1016/j.ajog.2004.03.061; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; GRUNDY SM, 1991, ANN INTERN MED, V115, P956; Klemmensen AK, 2007, AM J EPIDEMIOL, V166, P117, DOI 10.1093/aje/kwm139; Lydon-Rochelle MT, 2005, AM J OBSTET GYNECOL, V193, P125, DOI 10.1016/j.ajog.2005.02.096; Lynch CS, 2007, J GEN INTERN MED, V22, P908, DOI 10.1007/s11606-007-0218-0; Maggard MA, 2008, JAMA-J AM MED ASSOC, V300, P2286, DOI 10.1001/jama.2008.641; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; RICHARDS DS, 1987, J REPROD MED, V32, P172; Roberts CL, 2008, HYPERTENS PREGNANCY, V27, P285, DOI 10.1080/10641950701826695; Salas M, 1999, AM J EPIDEMIOL, V149, P981; Samuels-Kalow ME, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.04.043; Segal JB, 2009, OBES SURG, V19, P1646, DOI 10.1007/s11695-009-9960-1; Stothard KJ, 2009, JAMA-J AM MED ASSOC, V301, P636, DOI 10.1001/jama.2009.113; Stotland NE, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2450; Vikse BE, 2008, NEW ENGL J MED, V359, P800, DOI 10.1056/NEJMoa0706790; Weintraub AY, 2008, INT J GYNECOL OBSTET, V103, P246, DOI 10.1016/j.ijgo.2008.07.008; *WHO, 2006, 311 WHO; Yasmeen S, 2006, AM J OBSTET GYNECOL, V194, P992, DOI 10.1016/j.ajog.2005.08.058; Zhang J, 2003, HYPERTENS PREGNANCY, V22, P203, DOI 10.1081/PRG-120021066	35	65	65	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 13	2010	340								c1662	10.1136/bmj.c1662	http://dx.doi.org/10.1136/bmj.c1662			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	586JZ	20388692	Green Published, hybrid			2022-12-28	WOS:000276904800002
J	Madariaga, R; Metois, M; Vigny, C; Campos, J				Madariaga, Raul; Metois, Marianne; Vigny, Christophe; Campos, Jaime			Central Chile Finally Breaks	SCIENCE			English	Editorial Material							INTERSEISMIC STRAIN ACCUMULATION; SEISMIC GAP; EARTHQUAKES; GPS; DEFORMATION		[Madariaga, Raul; Metois, Marianne; Vigny, Christophe] CNRS, Geol Lab, F-75231 Paris 05, France; [Madariaga, Raul; Metois, Marianne; Vigny, Christophe] CNRS, LIA Montessus Ballore, F-75231 Paris 05, France; [Madariaga, Raul; Metois, Marianne; Vigny, Christophe] Ecole Normale Super, F-75231 Paris 05, France; [Campos, Jaime] Univ Chile, LIA Montessus Ballore, Dept Geofis, FCFM, Santiago, Chile	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universidad de Chile	Madariaga, R (corresponding author), CNRS, Geol Lab, F-75231 Paris 05, France.	madariag@geologie.ens.fr	CAMPOS, Jaime/K-7358-2014; Métois, Marianne/D-7019-2017; Madariaga, Raul/D-5304-2011	CAMPOS, Jaime/0000-0002-5924-9009; Métois, Marianne/0000-0002-1489-0513; 				Barrientos S., 1990, SEISMOL RES LETT, V61, P43; Beck S, 1998, J S AM EARTH SCI, V11, P115, DOI 10.1016/S0895-9811(98)00005-4; Brooks BA, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2003GC000505; Campos J, 2002, PHYS EARTH PLANET IN, V132, P177, DOI 10.1016/S0031-9201(02)00051-1; Campos J., 1990, SEISMOL RES LETT, V61, P1; DARWIN C, 1845, J RES NATURAL HIST; Hough S, 2010, PREDICTING THE UNPREDICTABLE: THE TUMULTUOUS SCIENCE OF EARTHQUAKE PREDICTION, P1; KELLEHER JA, 1972, J GEOPHYS RES, V77, P2087, DOI 10.1029/JB077i011p02087; Klotz J, 2001, EARTH PLANET SC LETT, V193, P437, DOI 10.1016/S0012-821X(01)00532-5; Lomnitz C, 1971, GEOFIS PANAMERICANA, V1, P151; MADARIAGA R, 1998, FIS TIERRA, V10, P221; Montessus de Ballore F, 1911, HIST SISMICA ANDES M, V2, P162; Moreno MS, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002198; NISHENKO SP, 1985, J GEOPHYS RES-SOLID, V90, P3589, DOI 10.1029/JB090iB05p03589; Ruegg JC, 2009, PHYS EARTH PLANET IN, V175, P78, DOI 10.1016/j.pepi.2008.02.015; Ruegg JC, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013438; Vigny C, 2009, PHYS EARTH PLANET IN, V175, P86, DOI 10.1016/j.pepi.2008.02.013	17	71	74	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2010	328	5975					181	182		10.1126/science.1189197	http://dx.doi.org/10.1126/science.1189197			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580OU	20378806				2022-12-28	WOS:000276459600030
J	Scolari, F; Ravani, P				Scolari, Francesco; Ravani, Pietro			Atheroembolic renal disease	LANCET			English	Article							CHOLESTEROL CRYSTAL EMBOLIZATION; PERIPHERAL VASCULAR COMPLICATIONS; ATHEROMATOUS EMBOLIZATION; EMBOLIC DISEASE; CUTANEOUS MANIFESTATIONS; CARDIAC-CATHETERIZATION; MYOCARDIAL-INFARCTION; CORONARY ANGIOGRAPHY; SPINAL-CORD; FAILURE	Atheroembolic renal disease develops when atheromatous aortic plaques rupture, releasing cholesterol crystals into the small renal arteries. Embolisation often affects other organs, such as the skin, gastrointestinal system, and brain. Although the disease can develop spontaneously, it usually develops after vascular surgery, catheterisation, or anticoagulation. The systemic nature of atheroembolism makes diagnosis difficult. The classic triad of a precipitating event, acute or subacute renal failure, and skin lesions, are strongly suggestive of the disorder. Eosinophilia further supports the diagnosis, usually confirmed by biopsy of an affected organ or by the fundoscopic finding of cholesterol crystals in the retinal circulation. Renal and patient prognosis are poor. Treatment is mostly preventive, based on avoidance of further precipitating factors, and symptomatic, aimed to the optimum treatment of hypertension and cardiac and renal failure. Statins, which stabilise atherosclerotic plaques, should be offered to all patients. Steroids might have a role in acute or subacute progressive forms with systemic inflammation.	[Scolari, Francesco] Univ Brescia, Fac Med, Brescia, Italy; [Scolari, Francesco] Azienda Osped Spedali Civili Brescia, Div Nefrol & Dialisi 2, Presidio Di Montichiari, Italy; [Ravani, Pietro] Univ Calgary, Dept Med, Div Nephrol, Calgary, AB T2N 1N4, Canada; [Ravani, Pietro] Univ Calgary, Dept Community Hlth Sci, Div Nephrol, Calgary, AB T2N 1N4, Canada	University of Brescia; Hospital Spedali Civili Brescia; University of Calgary; University of Calgary	Scolari, F (corresponding author), Osped Montichiari Brescia, Div Nephrol, Via Ciotti 154, I-25018 Brescia, Italy.	fscolar@tin.it	scolari, francesco/AAC-5957-2022; Ravani, Pietro/J-3050-2015	Ravani, Pietro/0000-0001-6973-8570; Scolari, Francesco/0000-0003-0233-9705				Ackoundou-N'Guessan C, 2008, Saudi J Kidney Dis Transpl, V19, P631; ANDERSON WR, 1968, ARCH PATHOL, V86, P535; Arroyo LH, 1999, CARDIOVASC RES, V41, P369, DOI 10.1016/S0008-6363(98)00308-3; BEAL MF, 1981, NEUROLOGY, V31, P860, DOI 10.1212/WNL.31.7.860; Belenfant X, 1999, AM J KIDNEY DIS, V33, P840, DOI 10.1016/S0272-6386(99)70415-4; Ben-Horin S, 2003, AM J GASTROENTEROL, V98, P1471, DOI 10.1016/S0002-9270(03)00361-7; Benson RL, 1926, ARCH PATHOL LAB MED, V2, P876; BLANKENSHIP JC, 1989, AM J MED, V87, P239; Carroccio A, 2004, J VASC SURG, V40, P424, DOI 10.1016/j.jvs.2004.06.036; COGAN E, 1995, J ALLERGY CLIN IMMUN, V96, P427, DOI 10.1016/S0091-6749(95)70065-X; COSIO FG, 1985, LANCET, V2, P118; CROSS SS, 1991, J CLIN PATHOL, V44, P859, DOI 10.1136/jcp.44.10.859; DAHLBERG PJ, 1989, SURGERY, V105, P737; DESNUELLE C, 1992, REV NEUROL, V148, P715; deTakats DLP, 1996, NEPHROL DIAL TRANSPL, V11, P1325; Donohue KG, 2003, J EUR ACAD DERMATOL, V17, P504, DOI 10.1046/j.1468-3083.2003.00710.x; DROST H, 1984, BRIT HEART J, V52, P339; ELIOT RS, 1964, CIRCULATION, V30, P611, DOI 10.1161/01.CIR.30.4.611; FALANGA V, 1986, ARCH DERMATOL, V122, P1194, DOI 10.1001/archderm.122.10.1194; FEDER W, 1961, ANN INTERN MED, V55, P911, DOI 10.7326/0003-4819-55-6-911; FINE MJ, 1987, ANGIOLOGY, V38, P769, DOI 10.1177/000331978703801007; FLORY CM, 1945, AM J PATHOL, V21, P549; Frock J, 1994, Nebr Med J, V79, P317; Fukumoto Y, 2003, J AM COLL CARDIOL, V42, P211, DOI 10.1016/S0735-1097(03)00579-5; GORE I, 1960, AM J CLIN PATHOL, V33, P416; GORE I, 1964, J ATHEROSCLER RES, V4, P527, DOI 10.1016/S0368-1319(64)80055-7; Greenberg A, 1997, AM J KIDNEY DIS, V29, P334, DOI 10.1016/S0272-6386(97)90193-1; Haqqie SS, 1996, AM J KIDNEY DIS, V28, P493, DOI 10.1016/S0272-6386(96)90458-8; Henry M, 2003, CATHETER CARDIO INTE, V60, P299, DOI 10.1002/ccd.10669; Hitti WA, 2008, AM J CARDIOVASC DRUG, V8, P27, DOI 10.2165/00129784-200808010-00004; HOLLENHORST R, 1961, JAMA-J AM MED ASSOC, V178, P23, DOI 10.1001/jama.1961.03040400025005; JENNINGS WC, 1990, TRANSPLANT P, V22, P279; JOHNSON LW, 1994, CATHETER CARDIO DIAG, V31, P165, DOI 10.1002/ccd.1810310302; JONES DB, 1975, AM J PATHOL, V78, P261; Jucgla A, 2006, J AM ACAD DERMATOL, V55, P786, DOI 10.1016/j.jaad.2006.05.012; KASINATH BS, 1987, AM J NEPHROL, V7, P173, DOI 10.1159/000167459; KASSIRER JP, 1969, NEW ENGL J MED, V280, P812, DOI 10.1056/NEJM196904102801506; KEALY WF, 1978, J CLIN PATHOL, V31, P984, DOI 10.1136/jcp.31.10.984; KEEN RR, 1995, J VASC SURG, V21, P773, DOI 10.1016/S0741-5214(05)80008-4; KEON WJ, 1982, J THORAC CARDIOV SUR, V84, P849; Lai CK, 2007, AM J SURG PATHOL, V31, P536, DOI 10.1097/PAS.0b013e31802b30e3; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; LIE JT, 1992, PATHOL ANNU, V27, P17; Liew YP, 2005, VASC MED, V10, P309, DOI 10.1191/1358863x05vm640ra; LYE WC, 1993, AM J NEPHROL, V13, P489, DOI 10.1159/000168669; Mann SJ, 2001, AM J HYPERTENS, V14, P831, DOI 10.1016/S0895-7061(01)02183-5; MASUDA J, 1994, NEUROLOGY, V44, P1231, DOI 10.1212/WNL.44.7.1231; Matchett WJ, 2000, J VASC INTERV RADIOL, V11, P585, DOI 10.1016/S1051-0443(07)61610-8; Mayo RR, 1996, AM J MED, V100, P524, DOI 10.1016/S0002-9343(95)00059-3; Meyrier A, 2006, KIDNEY INT, V69, P1308, DOI 10.1038/sj.ki.5000263; Mittal BV, 2008, KIDNEY INT, V73, P126, DOI 10.1038/sj.ki.5002433; Modi KS, 2001, J AM SOC NEPHROL, V12, P1781, DOI 10.1681/ASN.V1281781; MOLDVEEN.M, 1967, CIRCULATION, V35, P946, DOI 10.1161/01.CIR.35.5.946; MOOLENAAR W, 1995, J CLIN GASTROENTEROL, V21, P220, DOI 10.1097/00004836-199510000-00011; Moolenaar W, 1996, DIGEST DIS SCI, V41, P1819, DOI 10.1007/BF02088752; MOOLENAAR W, 1991, SCAND J GASTROENTERO, V26, P69, DOI 10.3109/00365529109111232; Moolenaar W, 1996, ARCH INTERN MED, V156, P653, DOI 10.1001/archinte.156.6.653; Moolenaar W, 1996, GUT, V38, P196, DOI 10.1136/gut.38.2.196; Nakayama M, 2006, CLIN NEPHROL, V66, P232; NASSER TK, 1995, CLIN CARDIOL, V18, P609, DOI 10.1002/clc.4960181105; Ott U, 2008, CLIN TRANSPLANT, V22, P677, DOI 10.1111/j.1399-0012.2008.00836.x; PANUM PL, 1862, VIRCHOWS ARCH PATHOL, V25, P308; Paraf F, 2001, AM J GASTROENTEROL, V96, P3301; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; Polu KR, 2006, NEW ENGL J MED, V354, P68, DOI 10.1056/NEJMcps051939; PRESTON RA, 1990, J AM GERIATR SOC, V38, P669, DOI 10.1111/j.1532-5415.1990.tb01427.x; PRICE DL, 1970, NEUROLOGY, V20, P1209, DOI 10.1212/WNL.20.12.1209; RAMIREZ G, 1978, ARCH INTERN MED, V138, P1430, DOI 10.1001/archinte.138.9.1430; Reich M P, 1968, Vasc Surg, V2, P230, DOI 10.1177/153857446800200408; Reimers B, 2001, CIRCULATION, V104, P12, DOI 10.1161/hc2601.092495; Ripple MG, 2000, TRANSPLANTATION, V69, P2221, DOI 10.1097/00007890-200005270-00050; ROBINSON RJ, 1993, POSTGRAD MED J, V69, P947, DOI 10.1136/pgmj.69.818.947; Rocha-Singh KJ, 2008, CIRCULATION, V118, P2873, DOI 10.1161/CIRCULATIONAHA.108.191178; RUDNICK MR, 1994, AM J KIDNEY DIS, V24, P713, DOI 10.1016/S0272-6386(12)80235-6; Sabatine MS, 1997, CHEST, V112, P1687, DOI 10.1378/chest.112.6.1687; SAKLAYEN MG, 1989, AM J NEPHROL, V9, P87, DOI 10.1159/000167942; Saklayen MG, 1997, ANGIOLOGY, V48, P609, DOI 10.1177/000331979704800707; Schonermarck U, 2006, CLIN NEPHROL, V66, P386; Scoble JE, 1996, NEPHROL DIAL TRANSPL, V11, P1516; Scoble JE, 1999, AM J KIDNEY DIS, V33, P975, DOI 10.1016/S0272-6386(99)70436-1; Scolari F, 2003, J AM SOC NEPHROL, V14, P1584, DOI 10.1097/01.ASN.0000069220.60954.F1; Scolari F, 2000, AM J KIDNEY DIS, V36, P1089, DOI 10.1053/ajkd.2000.19809; Scolari F, 2003, J NEPHROL, V16, P139; Scolari F, 2007, CIRCULATION, V116, P298, DOI 10.1161/CIRCULATIONAHA.106.680991; Shappell HW, 2000, AM J KIDNEY DIS, V35, P997, DOI 10.1016/S0272-6386(00)70279-4; SIEMONS L, 1987, CLIN NEPHROL, V28, P205; SINGH I, 1995, J AM SOC NEPHROL, V6, P165; SLAVIN RE, 1975, STROKE, V6, P411, DOI 10.1161/01.STR.6.4.411; Smyth John S., 2002, Curr Treat Options Cardiovasc Med, V4, P255, DOI 10.1007/s11936-002-0006-4; SNYDER HE, 1961, SURGERY, V49, P195; STONE W, 1992, HYPERTENSION RENAL D; TEJA K, 1985, AM HEART J, V110, P168, DOI 10.1016/0002-8703(85)90533-2; THADHANI RI, 1995, MEDICINE, V74, P350, DOI 10.1097/00005792-199511000-00005; Theriault J, 2003, NEPHRON CLIN PRACT, V94, pC11, DOI 10.1159/000070819; THURLBECK WM, 1957, NEW ENGL J MED, V257, P442, DOI 10.1056/NEJM195709052571002; VacherCoponat H, 1997, NEPHROL DIAL TRANSPL, V12, P1977, DOI 10.1093/ndt/12.9.1977; Walton TJ, 2002, POSTGRAD MED J, V78, P288, DOI 10.1136/pmj.78.919.288; WARREN BA, 1973, BRIT J EXP PATHOL, V54, P469; Woolfson RG, 1998, LANCET, V351, P1331, DOI 10.1016/S0140-6736(05)79058-9; Yucel AE, 2006, RHEUMATOL INT, V26, P454, DOI 10.1007/s00296-005-0012-4; ZUCCHELLI P, 1993, AM J KIDNEY DIS, V21, P87, DOI 10.1016/0272-6386(93)70100-D; 1996, N ENGL J MED, V334, P973	102	102	108	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 8	2010	375	9726					1650	1660		10.1016/S0140-6736(09)62073-0	http://dx.doi.org/10.1016/S0140-6736(09)62073-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	597CX	20381857	Green Submitted			2022-12-28	WOS:000277734700031
J	Pratley, RE; Nauck, M; Bailey, T; Montanya, E; Cuddihy, R; Filetti, S; Thomsen, AB; Sondergaard, RE; Davies, M				Pratley, Richard E.; Nauck, Michael; Bailey, Timothy; Montanya, Eduard; Cuddihy, Robert; Filetti, Sebastiano; Thomsen, Anne Bloch; Sondergaard, Rie Elvang; Davies, Melanie		1860-LIRA-DPP-4 Study Grp	Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial	LANCET			English	Article							DIPEPTIDYL PEPTIDASE-4 INHIBITOR; HUMAN GLP-1 ANALOG; EXENATIDE EXENDIN-4; TREATED PATIENTS; THERAPY; EFFICACY; SAFETY; PLACEBO; WEIGHT; SULFONYLUREA	Background Agonists of the glucagon-like peptide-1 (GLP-1) receptor provide pharmacological levels of GLP-1 activity, whereas dipeptidyl peptidase-4 (DPP-4) inhibitors increase concentrations of endogenous GLP-1 and glucose-dependent insulinotropic polypeptide. We aimed to assess the efficacy and safety of the human GLP-1 analogue liraglutide versus the DPP-4 inhibitor sitagliptin, as adjunct treatments to metformin, in individuals with type 2 diabetes who did not achieve adequate glycaemic control with metformin alone. Methods In this parallel-group, open-label trial, participants (aged 18-80 years) with type 2 diabetes mellitus who had inadequate glycaemic control (glycosylated haemoglobin [HbA(1c)] 7.5-10.0%) on metformin (>= 1500 mg daily for >= 3 months) were enrolled and treated at office-based sites in Europe, the USA, and Canada. Participants were randomly allocated to receive 26 weeks' treatment with 1.2 mg (n=225) or 1.8 mg (n=221) subcutaneous liraglutide once daily, or 100 mg oral sitagliptin once daily (n=219). The primary endpoint was change in HbA(1c) from baseline to week 26. The efficacy of liraglutide versus sitagliptin was assessed hierarchically by a non-inferiority comparison, with a margin of 0.4%, followed by a superiority comparison. Analyses were done on the full analysis set with missing values imputed by last observation carried forward; seven patients assigned to liraglutide did not receive treatment and thus did not meet criteria for inclusion in the full analysis set. This trial is registered with ClinicalTrials. gov, number NCT00700817. Findings Greater lowering of mean HbA(1c) (8.5% at baseline) was achieved with 1.8 mg liraglutide (-1.50%, 95% CI -1.63 to -1.37, n=218) and 1.2 mg liraglutide (-1.24%, -1.37 to -1.11, n=221) than with sitagliptin (-0.90%, -1.03 to -0.77, n=219). Estimated mean treatment differences for liraglutide versus sitagliptin were -0.60% (95% CI -0.77 to -0.43, p<0.0001) for 1.8 mg and -0.34% (-0.51 to -0.16, p<0.0001) for 1.2 mg liraglutide. Nausea was more common with liraglutide (59 [27%] patients on 1.8 mg; 46 [21%] on 1.2 mg) than with sitagliptin (10 [5%]). Minor hypoglycaemia was recorded in about 5% of participants in each treatment group. Interpretation Liraglutide was superior to sitagliptin for reduction of HbA(1c), and was well tolerated with minimum risk of hypoglycaemia. These findings support the use of liraglutide as an effective GLP-1 agent to add to metformin.	[Pratley, Richard E.] Univ Vermont, Coll Med, Diabet & Metab Translat Med Unit, Burlington, VT 05401 USA; [Nauck, Michael] Diabet Zentrum Bad Lauterberg, Bad Lauterberg im Harz, Germany; [Bailey, Timothy] AMCR Inst, Escondido, CA USA; [Montanya, Eduard] Univ Barcelona, Hosp Univ Bellvitge IDIBELL, CIBER Diabet & Enfermedades Metab Asociadas, Barcelona, Spain; [Cuddihy, Robert] Int Diabet Ctr, Minneapolis, MN USA; [Cuddihy, Robert] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Filetti, Sebastiano] Univ Roma La Sapienza, Dept Clin Sci, Rome, Italy; [Thomsen, Anne Bloch; Sondergaard, Rie Elvang] Novo Nordisk AS, Soborg, Denmark; [Davies, Melanie] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England	University of Vermont; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; International Diabetes Center; University of Minnesota System; University of Minnesota Twin Cities; Sapienza University Rome; Novo Nordisk; University of Leicester	Pratley, RE (corresponding author), Univ Vermont, Coll Med, Diabet & Metab Translat Med Unit, Burlington, VT 05401 USA.	richard.pratley@uvm.edu	Torre, Edelmiro Menéndez/G-1547-2013; Dotta, Francesco/H-3788-2012; Byrne, Maria/A-8310-2017; Nauck, Michael Albrecht/ABA-9752-2021; Pijl, Hanno/W-8719-2018	Torre, Edelmiro Menéndez/0000-0002-9548-7821; Byrne, Maria/0000-0002-9394-8698; Nauck, Michael Albrecht/0000-0002-5749-6954; Davies, Melanie/0000-0002-9987-9371; Montanya, Eduard/0000-0003-2518-9076; Pijl, Hanno/0000-0002-3076-1551	Novo Nordisk, Bagsvaerd, Denmark	Novo Nordisk, Bagsvaerd, Denmark(Novo Nordisk)	This study was funded by Novo Nordisk, Bagsvaerd, Denmark. We thank the 1860 investigators and their staff for participation in this study; research volunteers; Mette Hammer of Novo Nordisk for design of the treatment satisfaction substudy and data interpretation; John Smith of Novo Nordisk for writing assistance; and Watermeadow Medical UK (supported by Novo Nordisk) for additional writing support and assistance with the collation of author comments.	*AM PHARM, 2009, BYETT EX INJ; Aschner P, 2006, DIABETES CARE, V29, P2632, DOI 10.2337/dc06-0703; BERGENSTAL R, 2009, DURATION 2 EXENATIDE; Bradley C., 1994, HDB PSYCHOL DIABETES, P111; Buse JB, 2004, DIABETES CARE, V27, P2628, DOI 10.2337/diacare.27.11.2628; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; Charbonnel B, 2006, DIABETES CARE, V29, P2638, DOI 10.2337/dc06-0706; DeFronzo RA, 2005, DIABETES CARE, V28, P1092, DOI 10.2337/diacare.28.5.1092; Degn KB, 2004, DIABETES, V53, P1187, DOI 10.2337/diabetes.53.5.1187; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Garber A, 2009, LANCET, V373, P473, DOI 10.1016/S0140-6736(08)61246-5; Goldstein BJ, 2007, DIABETES CARE, V30, P1979, DOI 10.2337/dc07-0627; Herman GA, 2005, CLIN PHARMACOL THER, V78, P675, DOI 10.1016/j.clpt.2005.09.002; Hermansen K, 2007, DIABETES OBES METAB, V9, P733, DOI 10.1111/j.1463-1326.2007.00744.x; Hoerger TJ, 2008, DIABETES CARE, V31, P81, DOI 10.2337/dc07-1572; *INT DIAB FDN, 2009, DIAB ATL; Kendall DM, 2009, AM J MED, V122, P37, DOI 10.1016/j.amjmed.2009.03.015; Marre M, 2009, DIABETIC MED, V26, P268, DOI 10.1111/j.1464-5491.2009.02666.x; McGill JB, 2009, POSTGRAD MED, V121, P16, DOI 10.3810/pgm.2009.05.1998; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Nauck M, 2009, DIABETES CARE, V32, P84, DOI 10.2337/dc08-1355; Nauck MA, 2009, AM J MED, V122, P3, DOI 10.1016/j.amjmed.2009.03.012; Noel RA, 2009, DIABETES CARE, V32, P834, DOI 10.2337/dc08-1755; Peyrot M, 2009, DIABETES CARE, V32, P1411, DOI 10.2337/dc08-2256; Schmidt WE, 2009, DIABETOLOGIA, V52, pS289; Scott R, 2008, DIABETES OBES METAB, V10, P959, DOI 10.1111/j.1463-1326.2007.00839.x; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; U.S. Centers for Disease Control and Prevention (CDC), 2007, NAT DIAB FACT SHEET; US Food and Drug Administration, GUID IND DIAB MELL D; US Food and Drug Administration, 2009, INF HEALTHC PROF AC; Zinman B, 2007, ANN INTERN MED, V146, P477, DOI 10.7326/0003-4819-146-7-200704030-00003	31	462	499	2	50	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 24	2010	375	9724					1447	1456		10.1016/S0140-6736(10)60307-8	http://dx.doi.org/10.1016/S0140-6736(10)60307-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	590FL	20417856				2022-12-28	WOS:000277210000031
J	Tshefu, AK; Gaye, O; Kayentao, K; Thompson, R; Bhatt, KM; Sesay, SSS; Bustos, DG; Tjitra, E; Bedu-Addo, G; Borghini-Fuhrer, I; Duparc, S; Shin, CS; Fleckenstein, L				Tshefu, Antoinette K.; Gaye, Oumar; Kayentao, Kassoum; Thompson, Ricardo; Bhatt, Kirana M.; Sesay, Sanie S. S.; Bustos, Dorina G.; Tjitra, Emiliana; Bedu-Addo, George; Borghini-Fuhrer, Isabelle; Duparc, Stephan; Shin, Chang Sik; Fleckenstein, Lawrence		Pyronaridine-Artesunate Study Team	Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial	LANCET			English	Article							IN-VITRO; PHARMACOKINETICS; BENFLUMETOL; AMODIAQUINE; THERAPIES; PAPUA	Background There is a need for new artemisinin-based combination therapies that are convenient, effective, and safe. We compared the efficacy and safety of pyronaridine-artesunate with that of artemether-lumefantrine for treatment of uncomplicated P falciparum malaria. Methods This phase 3, parallel-group, double-blind, randomised, non-inferiority trial was undertaken in seven sites in Africa and three sites in southeast Asia. In a double-dummy design, patients aged 3-60 years with uncomplicated P. falciparum malaria were randomly assigned in a 2:1 ratio to receive pyronaridine-artesunate once a day or artemether-lumefantrine twice a day, orally for 3 days, plus respective placebo. Randomisation was done by computer-generated randomisation sequence in blocks of nine by study centre. Intervention tablets contained 180 mg pyronaridine and 60 mg artesunate; control tablets contained 20 mg artemether and 120 mg lumefantrine. Both treatments were given according to bodyweight. The primary efficacy outcome was PCR-corrected adequate clinical and parasitological response (ACPR) rate at day 28 in the per-protocol population. Non-inferiority was shown if the lower limit of the two-sided 95% CI for the difference between groups was greater than -5%. This study is registered with ClinicalTrials.gov, number NCT00422084. Findings 1272 patients were randomly assigned to treatment (pyronaridine-artesunate, n=849; artemether-lumefantrine, n=423). The per-protocol population consisted of 784 patients in the pyronaridine-artesunate group and 386 patients in the artemether-lumefantrine group. PCR-corrected ACPR rate at day 28 was 99.5% (780 patients; 95% CI 98.7-99.9) in the pyronaridine-artesunate group and 99.2% (383 patients; 95% CI 97.7-99.8) in the artemether-lumefantrine group (treatment difference 0.3%, 95% CI -0.7 to 1.8; p=0.578). There were 509 (60.0%) adverse events in 849 patients assigned to pyronaridine-artesunate and 241 (57.0%) in 423 patients assigned to artemether-lumefantrine. The most frequent drug-related adverse event was eosinophilia (pyronaridine-artesunate, 53 events [6.2%]; artemether-lumefantrine 24 events [5.7%]). 21(2.5%) patients in the pyronaridine-artesunate group and seven (1.7%) in the artemether-lumefantrine group discontinued study drugs or were withdrawn from the study. Mild and transient increases in alanine aminotransferase and aspartate aminotransferase concentrations were seen in the pyronaridine-artesunate group but not in the artemether-lumefantrine group. Interpretation Efficacy of pyronaridine-artesunate was non-inferior to that of artemether-lumefantrine for treatment of uncomplicated falciparum malaria. Pyronaridine-artesunate should be considered for inclusion in malaria treatment programmes.	[Tshefu, Antoinette K.] Univ Kinshasa, Fac Med, Ecole Sante Publ, Kinshasa, DEM REP CONGO; [Gaye, Oumar] Univ Cheikh Anta Diop, Fac Med, Serv Parasitol, Dakar, Senegal; [Kayentao, Kassoum] Fac Med Pharm & Odontostomatol, Malaria Res & Training Ctr, Bamako, Mali; [Thompson, Ricardo] Natl Inst Hlth, Chokwe Hlth Res & Training Ctr, Chokwe, Mozambique; [Bhatt, Kirana M.] Univ Nairobi, UNITID Coll Hlth Sci, Nairobi, Kenya; [Sesay, Sanie S. S.] MRC Labs, Farafenni Field Stn, Fajara, Gambia; [Bustos, Dorina G.] Res Inst Trop Med, Manila, Philippines; [Tjitra, Emiliana] Minist Hlth, Natl Inst Hlth Res & Dev, Jakarta, Indonesia; [Bedu-Addo, George] Komfo Anokye Teaching Hosp, Kumasi, Ghana; [Shin, Chang Sik] Shin Poong Pharmaceut, Seoul, South Korea; [Fleckenstein, Lawrence] Univ Iowa, Iowa City, IA USA	Universite de Kinshasa; University Cheikh Anta Diop Dakar; University of Nairobi; MRC Laboratory Molecular Biology; Research Institute for Tropical Medicine - Philippines; Ministry of Health - Indonesia; National Institute of Health Research & Development - Indonesia; Kwame Nkrumah University Science & Technology; University of Iowa	Borghini-Fuhrer, I (corresponding author), Int Ctr Cointrin, Route Prebois 20,POB 1826, CH-1215 Geneva 15, Switzerland.	borghinii@mmv.org	Duparc, Stephan/AAH-8758-2020; Sesay, Sanie Samuel Sogoyan/M-2982-2014	Duparc, Stephan/0000-0002-9649-4847; Sesay, Sanie Samuel Sogoyan/0000-0001-6233-7854; Enosse, Sonia Maria Mauricio/0000-0002-2586-2083; Fleckenstein, Lawrence/0000-0001-5320-4531; Ndiaye, Jean/0000-0003-0450-5551; Arnaldo, Paulo/0000-0001-8747-5209; Bojang, Kalifa/0000-0001-7506-0938; Beck, Hans-Peter/0000-0001-8326-4834	Medicines for Malaria Venture; Shin Poong Pharmaceutical	Medicines for Malaria Venture; Shin Poong Pharmaceutical	The Medicines for Malaria Venture sponsored this trial as part of the clinical development programme of pyronaridine-artesunate. Shin Poong Pharmaceutical co-sponsored the trial. Naomi Richardson of Magenta Communications developed a first draft of this report from the approved study report and collated author contributions and was funded by the Medicines for Malaria Venture. We thank the study population and local staff, who made this study possible. We thank the following individuals for their assistance during the trial: Abdoulaye Djimde, Ogobara K Doumbo, and Moussa Niangaly from Mali; Paulo Arnaldo, Jeronimo Langa, Sergio Chicumbe, and Mbate Pedro Matandalasse from Mozambique; and Ignatius Baldeh from The Gambia. We would also like to acknowledge the contributions of Ghiorghis Belai, David Asante, and Pongphaya Choosakulchart (Family Health International), who were in charge of the study monitoring; Sarah Arbe-Bames, Eric Didillon, Audrey Mulder (Fulcrum Pharma, UK), and Claude Oeuvray (Medicines for Malaria Venture) for their dedicated work in the set-up and execution of this trial; and Hanspeter Marti and Hans-Peter Beck (Swiss Tropical Institute), who undertook central reading of the slides and PCR analysis. We thank Stephen Allen (Swansea University, UK), Robert Miller (Fulcrum Pharma, UK), J Carl Craft (Libertyville, USA), and Frank Stephen Wignall (Family Health International) for their participation in the Safety Monitoring Board. Statistical analysis was undertaken by Averion (Basel, Switzerland) and we acknowledge the dedicated work of Mikael Saulay and Arnaud Demange.	Abdulla S, 2008, LANCET, V372, P1819, DOI 10.1016/S0140-6736(08)61492-0; Adjei GO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-127; [Anonymous], 2003, ASS MON ANT DRUG EFF; Ezzet F, 2000, ANTIMICROB AGENTS CH, V44, P697, DOI 10.1128/AAC.44.3.697-704.2000; Ezzet F, 1998, BRIT J CLIN PHARMACO, V46, P553, DOI 10.1046/j.1365-2125.1998.00830.x; Faye B, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-80; Felger Ingrid, 2002, Methods Mol Med, V72, P117, DOI 10.1385/1-59259-271-6:117; Karunajeewa HA, 2008, NEW ENGL J MED, V359, P2545, DOI 10.1056/NEJMoa0804915; Kurth F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-79; Martensson A, 2005, CLIN INFECT DIS, V41, P1079, DOI 10.1086/444460; *MED MAL VENT WHO, 2008, METH TECHN CLIN TRIA; Price R, 1999, AM J TROP MED HYG, V60, P547, DOI 10.4269/ajtmh.1999.60.547; Ramharter M, 2008, J INFECT DIS, V198, P911, DOI 10.1086/591096; Ratcliff A, 2007, LANCET, V369, P757, DOI 10.1016/S0140-6736(07)60160-3; Ribeiro I R, 1998, Med Trop (Mars), V58, P50; Ringwald P, 1998, CLIN INFECT DIS, V26, P946, DOI 10.1086/513942; Ringwald P, 1996, LANCET, V347, P24, DOI 10.1016/S0140-6736(96)91558-5; Sagara I, 2008, AM J TROP MED HYG, V79, P655, DOI 10.4269/ajtmh.2008.79.655; Sinclair D, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007483.pub2; Suputtamongkol Y, 2001, BRIT J CLIN PHARMACO, V52, P655, DOI 10.1046/j.1365-2125.2001.01458.x; van den Broek I, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-113; Vivas L, 2008, ACTA TROP, V105, P222, DOI 10.1016/j.actatropica.2007.12.005; Whitty CJM, 2005, CLIN INFECT DIS, V41, P1087, DOI 10.1086/444464; WHO, 2006, GUID TREATM MAL	24	91	92	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 24	2010	375	9724					1457	1467		10.1016/S0140-6736(10)60322-4	http://dx.doi.org/10.1016/S0140-6736(10)60322-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	590FL	20417857				2022-12-28	WOS:000277210000032
J	Hines, PJ; Wible, B; McCartney, M				Hines, Pamela J.; Wible, Brad; McCartney, Melissa			Learning to Read, Reading to Learn INTRODUCTION	SCIENCE			English	Editorial Material																			0	11	12	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 23	2010	328	5977					447	447		10.1126/science.328.5977.447	http://dx.doi.org/10.1126/science.328.5977.447			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	586YR	20413486				2022-12-28	WOS:000276952400026
J	Poulsen, CJ; Ehlers, TA; Insel, N				Poulsen, Christopher J.; Ehlers, Todd A.; Insel, Nadja			Onset of Convective Rainfall During Gradual Late Miocene Rise of the Central Andes	SCIENCE			English	Article							SUMMERTIME PRECIPITATION; BOLIVIAN ALTIPLANO; CLIMATE; UPLIFT; PALEOALTIMETRY; SIMULATION; ELEVATION; ISOTOPES; PALEOSOL; REMOVAL	A decrease in the ratio of O-18 to O-16 (delta O-18) of sedimentary carbonate from the Bolivian Altiplano has been interpreted to indicate rapid surface uplift of the late Miocene Andean plateau (AP). Here we report on paleoclimate simulations of Andean surface uplift with an atmospheric general circulation model (GCM) that tracks oxygen isotopes in vapor. The GCM predicts changes in atmospheric circulation and rainfall that influence AP isotopic source and amount effects. On eastern AP slopes, summer convective precipitation increases by up to 6 millimeters per day (>500%) for plateau elevations that are greater than about 2000 meters. High precipitation rates enhance the isotope amount effect, leading to a decrease in precipitation delta O-18 at high elevations and an increase in delta O-18 lapse rate. Our results indicate that late Miocene delta O-18 depletion reflects initiation and intensification of convective rainfall.	[Poulsen, Christopher J.; Ehlers, Todd A.; Insel, Nadja] Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA; [Ehlers, Todd A.] Univ Tubingen, Inst Geowissensch, D-72074 Tubingen, Germany	University of Michigan System; University of Michigan; Eberhard Karls University of Tubingen	Poulsen, CJ (corresponding author), Univ Michigan, Dept Geol Sci, 1006 CC Little Bldg, Ann Arbor, MI 48109 USA.	poulsen@umich.edu	Ehlers, Todd A/A-9582-2012; Poulsen, Christopher J/C-6213-2009	Ehlers, Todd A/0000-0001-9436-0303; Poulsen, Christopher J/0000-0001-5104-4271	NSF [0738822, 0907817]; University of Michigan's Graham Environmental Sustainability Institute; Alexander von Humboldt Foundation; Directorate For Geosciences [0907817] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); University of Michigan's Graham Environmental Sustainability Institute; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	D. Pollard and J. Poulsen provided support with the GENESIS AGCM and data analyses, respectively. This work was funded by grants to C. J. P. and T. A. E. from NSF (EAR Awards 0738822 and 0907817) and the University of Michigan's Graham Environmental Sustainability Institute. C. J. P. also received support from the Alexander von Humboldt Foundation.	Barnes JB, 2009, EARTH-SCI REV, V97, P105, DOI 10.1016/j.earscirev.2009.08.003; Blisniuk PM, 2005, AM J SCI, V305, P1033, DOI 10.2475/ajs.305.10.1033; Campetella CM, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015451; DANSGAARD W, 1964, TELLUS, V16, P436; Ehlers TA, 2009, EARTH PLANET SC LETT, V281, P238, DOI 10.1016/j.epsl.2009.02.026; Eiler J, 2006, SCIENCE, V314, DOI 10.1126/science.1133131; Garcia M., 1998, ISOTOPE TECHNIQUES S, P127; Garreaud RD, 1999, MON WEATHER REV, V127, P901, DOI 10.1175/1520-0493(1999)127<0901:MAOTSP>2.0.CO;2; Garzione CN, 2006, EARTH PLANET SC LETT, V241, P543, DOI 10.1016/j.epsl.2005.11.026; Gat JR, 1996, ANNU REV EARTH PL SC, V24, P225, DOI 10.1146/annurev.earth.24.1.225; Ghosh P, 2006, SCIENCE, V311, P511, DOI 10.1126/science.1119365; Gonfiantini R, 2001, CHEM GEOL, V181, P147, DOI 10.1016/S0009-2541(01)00279-0; Gregory-Wodzicki KM, 2002, PALAEOGEOGR PALAEOCL, V180, P331, DOI 10.1016/S0031-0182(01)00434-5; Hartley AJ, 2007, EARTH PLANET SC LETT, V259, P625, DOI 10.1016/j.epsl.2007.04.012; IAEA/WMO, GLOB NETW IS PREC GN; Insel N, 2010, CLIM DYNAM, V35, P1477, DOI 10.1007/s00382-009-0637-1; Kleinert K, 2001, GEOL SOC AM BULL, V113, P728, DOI 10.1130/0016-7606(2001)113<0728:CCIRTO>2.0.CO;2; Kowalski EA, 2002, PALAEOGEOGR PALAEOCL, V188, P141, DOI 10.1016/S0031-0182(02)00550-3; Lenters JD, 1995, J CLIMATE, V8, P2988, DOI 10.1175/1520-0442(1995)008<2988:SADOTR>2.0.CO;2; Mamani M, 2010, GEOL SOC AM BULL, V122, P162, DOI 10.1130/B26538.1; Mathieu R, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD900255; Mulch A, 2010, EARTH PLANET SC LETT, V290, P173, DOI 10.1016/j.epsl.2009.12.019; Poage MA, 2001, AM J SCI, V301, P1, DOI 10.2475/ajs.301.1.1; Sepulchre P, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P211; Starck D, 2001, J S AM EARTH SCI, V14, P763, DOI 10.1016/S0895-9811(01)00066-9; Stern LA, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002509; Uba CE, 2007, GEOLOGY, V35, P979, DOI 10.1130/G224025A.1; Zhou J, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2008PA001596	28	124	126	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2010	328	5977					490	493		10.1126/science.1185078	http://dx.doi.org/10.1126/science.1185078			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YR	20360069	Green Submitted			2022-12-28	WOS:000276952400040
J	Schleicher, A				Schleicher, Andreas			EDUCATION Assessing Literacy Across a Changing World	SCIENCE			English	Editorial Material									Directorate Educ Org Econ Cooperat & Dev, F-75775 Paris, France	Organisation for Economic Co-operation & Development (OECD)	Schleicher, A (corresponding author), Directorate Educ Org Econ Cooperat & Dev, F-75775 Paris, France.	andreas.schleicher@oecd.org						Adams R.J., 2010, 46 OECD; [Anonymous], ED ACHIEVEMENT 13 YE; Autor DH, 2003, Q J ECON, V118, P1279, DOI 10.1162/003355303322552801; Butler Jayne, 2007, J Appl Meas, V8, P279; *IRA, 2009, IRA POS STAT NEW LIT; Jensen T. P., 2006, NO LIGHTS PISA 2003, P239; Levy F., 2010, 45 OECD; OECD, 2010, PATHW SUCC KNOWL SKI; OECD, 2009, PISA 2006 TECHN REP, DOI DOI 10.1787/9789264048096-EN; OECD, 2010, PISA 2009 ASS FRAM K; OECD, 2007, PISA 2006 SCI COMPET, V1, DOI 10.1787/9789264040014-en; OECD (Organization for Economic Cooperation and Development), 2009, ED GLANC 2009 OECD I; *OECD STAT CAN, 2000, LIT INF AG FIN REP I	13	11	11	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 23	2010	328	5977					433	434		10.1126/science.1183092	http://dx.doi.org/10.1126/science.1183092			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	586YR	20413478				2022-12-28	WOS:000276952400018
J	Komiyama, T; Sato, TR; O'Connor, DH; Zhang, YX; Huber, D; Hooks, BM; Gabitto, M; Svoboda, K				Komiyama, Takaki; Sato, Takashi R.; O'Connor, Daniel H.; Zhang, Ying-Xin; Huber, Daniel; Hooks, Bryan M.; Gabitto, Mariano; Svoboda, Karel			Learning-related fine-scale specificity imaged in motor cortex circuits of behaving mice	NATURE			English	Article							IN-VIVO; CELLULAR RESOLUTION; PREFRONTAL CORTEX; CROSS-CORRELATION; TRANSGENIC MICE; RAT; ORGANIZATION; NEURONS; NETWORKS; CHANNELRHODOPSIN-2	Cortical neurons form specific circuits(1), but the functional structure of this microarchitecture and its relation to behaviour are poorly understood. Two-photon calcium imaging can monitor activity of spatially defined neuronal ensembles in the mammalian cortex(2-5). Here we applied this technique to the motor cortex of mice performing a choice behaviour. Head-fixed mice were trained to lick in response to one of two odours, and to withhold licking for the other odour(6,7). Mice routinely showed significant learning within the first behavioural session and across sessions. Microstimulation(8,9) and trans-synaptic tracing(10,11) identified two non-overlapping candidate tongue motor cortical areas. Inactivating either area impaired voluntary licking. Imaging in layer 2/3 showed neurons with diverse response types in both areas. Activity in approximately half of the imaged neurons distinguished trial types associated with different actions. Many neurons showed modulation coinciding with or preceding the action, consistent with their involvement in motor control. Neurons with different response types were spatially intermingled. Nearby neurons (within similar to 150 mm) showed pronounced coincident activity. These temporal correlations increased with learning within and across behavioural sessions, specifically for neuron pairs with similar response types. We propose that correlated activity in specific ensembles of functionally related neurons is a signature of learning-related circuit plasticity. Our findings reveal a fine-scale and dynamic organization of the frontal cortex that probably underlies flexible behaviour.	[Komiyama, Takaki; Sato, Takashi R.; O'Connor, Daniel H.; Zhang, Ying-Xin; Huber, Daniel; Hooks, Bryan M.; Svoboda, Karel] HHMI, Ashburn, VA 20147 USA; [Gabitto, Mariano] Univ Calif San Diego, HHMI, La Jolla, CA 92093 USA; [Gabitto, Mariano] Univ Calif San Diego, Dept Neurobiol, La Jolla, CA 92093 USA; [Gabitto, Mariano] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Komiyama, T (corresponding author), HHMI, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	komiyamat@janelia.hhmi.org	Huber, Daniel/C-2932-2013	Huber, Daniel/0000-0002-0744-7679; Komiyama, Takaki/0000-0001-9609-4600	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank D. Rinberg for help with experiments; F. Collman, D. Tank, C. Zuker, T. O'Connor and V. Iyer for help with analysis and imaging software; L. W. Enquist for pseudorabies vectors; W. Denk for help with mechanical design; D. Dombeck, M. Andermann, A. Kerlin and C. Reid for discussions about imaging awake mice; B. Shields, A. Hu and S. Michael for help with histology; A. Arnold for help with imaging; J. Osborne and S. Bassin for machining; L. Luo, Z. Mainen and D. Rinberg for comments on the manuscript; A. C. Gontang for illustration. Supported by Howard Hughes Medical Institute. T. K. is a Helen Hay Whitney Foundation postdoctoral fellow.	AERTSEN AMHJ, 1985, BRAIN RES, V340, P341, DOI 10.1016/0006-8993(85)90931-X; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Ayling OGS, 2009, NAT METHODS, V6, P219, DOI [10.1038/NMETH.1303, 10.1038/nmeth.1303]; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Bodyak N, 1999, CHEM SENSES, V24, P637, DOI 10.1093/chemse/24.6.637; Brecht M, 2004, J COMP NEUROL, V479, P360, DOI 10.1002/cne.20306; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; Constantinidis C, 2001, J NEUROSCI, V21, P3646, DOI 10.1523/JNEUROSCI.21-10-03646.2001; DOBBINS EG, 1995, J COMP NEUROL, V357, P376, DOI 10.1002/cne.903570305; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dombeck DA, 2009, J NEUROSCI, V29, P13751, DOI 10.1523/JNEUROSCI.2985-09.2009; Doucette W, 2008, PLOS BIOL, V6, P2266, DOI 10.1371/journal.pbio.0060258; Fay RA, 1997, BRAIN RES REV, V25, P291, DOI 10.1016/S0165-0173(97)00028-3; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; GEORGOPOULOS AP, 1993, SCIENCE, V260, P47, DOI 10.1126/science.8465199; Hira R, 2009, J NEUROSCI METH, V179, P258, DOI 10.1016/j.jneumeth.2009.02.001; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Kerr JND, 2007, J NEUROSCI, V27, P13316, DOI 10.1523/JNEUROSCI.2210-07.2007; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; LI CX, 1991, CAN J NEUROL SCI, V18, P28, DOI 10.1017/S0317167100031267; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; Rathelot JA, 2006, P NATL ACAD SCI USA, V103, P8257, DOI 10.1073/pnas.0602933103; Sato TR, 2007, PLOS BIOL, V5, P1440, DOI 10.1371/journal.pbio.0050189; Shepherd GMG, 2005, NAT NEUROSCI, V8, P782, DOI 10.1038/nn1447; Slotnick B, 2005, CURR PROTOC NEUROSCI; Smith BN, 2000, P NATL ACAD SCI USA, V97, P9264, DOI 10.1073/pnas.97.16.9264; Song CK, 2005, VIRUS RES, V111, P235, DOI 10.1016/j.virusres.2005.04.012; Song J, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-13; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; TANJI J, 1976, J NEUROPHYSIOL, V39, P1062, DOI 10.1152/jn.1976.39.5.1062; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Travers JB, 1997, NEUROSCI BIOBEHAV R, V21, P631, DOI 10.1016/S0149-7634(96)00045-0; TSO DY, 1986, J NEUROSCI, V6, P1160; Verhagen JV, 2007, NAT NEUROSCI, V10, P631, DOI 10.1038/nn1892; Yaksi E, 2007, PLOS BIOL, V5, P1453, DOI 10.1371/journal.pbio.0050178; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	38	299	301	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 22	2010	464	7292					1182	U99		10.1038/nature08897	http://dx.doi.org/10.1038/nature08897			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20376005				2022-12-28	WOS:000276891100035
J	Zewail, AH				Zewail, Ahmed H.			Science in Diplomacy	CELL			English	Editorial Material									[Zewail, Ahmed H.] CALTECH, Pasadena, CA 91125 USA	California Institute of Technology	Zewail, AH (corresponding author), CALTECH, Pasadena, CA 91125 USA.	zewail@caltech.edu		gaber, sarah/0000-0002-5995-7291					0	5	5	1	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 16	2010	141	2					204	207		10.1016/j.cell.2010.04.002	http://dx.doi.org/10.1016/j.cell.2010.04.002			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	584GF	20403314	Bronze			2022-12-28	WOS:000276738400006
J	Deer, B				Deer, Brian			Autism Research Wakefield's "autistic enterocolitis" under the microscope	BRITISH MEDICAL JOURNAL			English	Editorial Material							DIAGNOSIS; PATTERNS; DISORDER; CHILDREN; COLON											BARR R, 1996, PROPOSED PROTOCOL CO; BARTRAM CI, 1994, BAILLIERE CLIN GAST, V8, P108; Buie T, 2010, PEDIATRICS, V125, pS1, DOI 10.1542/peds.2009-1878C; BUNTING C, 2004, INDEPENDENT     0221; Carpenter HA, 2000, AM J GASTROENTEROL, V95, P878; DEER B, 2009, SUNDAY TIMES    0208; DEER B, 2004, SUNDAY TIMES    0222; Fernell E, 2007, ACTA PAEDIATR, V96, P1076, DOI 10.1111/j.1651-2227.2007.00298.x; General Medical Council, 2010, FITN PRACT PAN HEAR; Jenkins D, 1997, J CLIN PATHOL, V50, P93, DOI 10.1136/jcp.50.2.93; JEPSON B, C PRESENTATIONS; LEVINE DS, 1989, AM J SURG PATHOL, V13, P966, DOI 10.1097/00000478-198911000-00008; MACDONALD TT, 2007, IMMUNOLOGY DIS GUT; MOLAVI DM, 2008, PRACTICE SURG PATHOL, P65; Montgommery EA, 2005, BIOPSY INTERPRETATIO, P213; Murch S, 1998, LANCET, V351, P908, DOI 10.1016/S0140-6736(05)70323-8; Murch SH, 2004, LANCET, V363, P750, DOI 10.1016/S0140-6736(04)15715-2; *ROYAL FREE HAMP N, 1996, ETH PRACT SUBC PROT; Sandhu B, 2009, ARCH DIS CHILD, V94, P497, DOI 10.1136/adc.2008.148866; WAKEFIELD A, COMPLAINT PRESS COMP; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Walker-Smith JA, 1983, PRACTICAL PAEDIAT GA; [No title captured]	23	11	11	0	21	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 15	2010	340								c1127	10.1136/bmj.c1127	http://dx.doi.org/10.1136/bmj.c1127			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	586KC	20395277	Bronze			2022-12-28	WOS:000276905500001
J	Mokalla, MM				Mokalla, Mani McDonald			Letter to a Father in Jail	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												mani.mokalla@childrensmn.org							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2010	303	14					1347	1348		10.1001/jama.2010.385	http://dx.doi.org/10.1001/jama.2010.385			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582KX	20388882				2022-12-28	WOS:000276597300001
J	Hansen, SG; Powers, CJ; Richards, R; Ventura, AB; Ford, JC; Siess, D; Axthelm, MK; Nelson, JA; Jarvis, MA; Picker, LJ; Fruh, K				Hansen, Scott G.; Powers, Colin J.; Richards, Rebecca; Ventura, Abigail B.; Ford, Julia C.; Siess, Don; Axthelm, Michael K.; Nelson, Jay A.; Jarvis, Michael A.; Picker, Louis J.; Frueh, Klaus			Evasion of CD8(+) T Cells Is Critical for Superinfection by Cytomegalovirus	SCIENCE			English	Article							CLASS-I MOLECULES; GENE; INFECTION; IMMUNITY; MEMORY; VIRUS; CHALLENGE; PRODUCTS; PROTECTS; STRAINS	Cytomegalovirus (CMV) can superinfect persistently infected hosts despite CMV-specific humoral and cellular immunity; however, how it does so remains undefined. We have demonstrated that superinfection of rhesus CMV-infected rhesus macaques (RM) requires evasion of CD8(+) T cell immunity by virally encoded inhibitors of major histocompatibility complex class I (MHC-I) antigen presentation, particularly the homologs of human CMV US2, 3, 6, and 11. In contrast, MHC-I interference was dispensable for primary infection of RM, or for the establishment of a persistent secondary infection in CMV-infected RM transiently depleted of CD8(+) lymphocytes. These findings demonstrate that US2-11 glycoproteins promote evasion of CD8(+) T cells in vivo, thus supporting viral replication and dissemination during superinfection, a process that complicates the development of preventive CMV vaccines but that can be exploited for CMV-based vector development.	[Hansen, Scott G.; Powers, Colin J.; Richards, Rebecca; Ventura, Abigail B.; Ford, Julia C.; Axthelm, Michael K.; Nelson, Jay A.; Jarvis, Michael A.; Picker, Louis J.; Frueh, Klaus] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA; [Siess, Don; Axthelm, Michael K.; Nelson, Jay A.; Picker, Louis J.; Frueh, Klaus] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center	Picker, LJ (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, 505 NW 185th Ave, Beaverton, OR 97006 USA.	pickerl@ohsu.edu; fruehk@ohsu.edu		Jarvis, Michael A/0000-0002-0124-4061; Frueh, Klaus/0000-0001-8014-3877	Centocor, Inc [AI040101, RR016001]; National Institutes of Health [RO1 AI059457, RO1 AI060392]; International AIDS Vaccine Initiative; National Center for Research Resources [RR016025, RR18107, RR00163]; Ruth L. Kirschstein National Research Service [T32 AI007472, T32 HL007781]; OHSU Tartar Trust fellowship; Achievement Reward for College Scientists; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR018107, P51RR000163, R24RR016001, U42RR016025, K01RR000163] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059457, R01AI060392, R01AI021640, R01AI040101, T32AI007472] Funding Source: NIH RePORTER	Centocor, Inc(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OHSU Tartar Trust fellowship; Achievement Reward for College Scientists; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to P. Barry for providing the RhCMV-GFP and RhCMV-BAC and M. Messerle for plasmid ori6k-F5. The NIH Nonhuman Primate Reagent Resource Program provided the CD8a-specific antibody cM-T807 used in this work (contracts AI040101 and RR016001), which was originally obtained from Centocor, Inc. We thank A. Townsend for help with the graphics. We thank D. Drummond, L. Coyne-Johnson, M. Spooner Lewis, C. Hughes, N. Whizin, M. Giday, J. Clock, J. Cook, J. Edgar, J. Dewane, and A. Legasse for technical assistance. This research was supported by the National Institutes of Health (RO1 AI059457 to K. F. and RO1 AI060392 to L. J. P.), the International AIDS Vaccine Initiative (to L. J. P.), the National Center for Research Resources (RR016025 and RR18107 to M. K. A.; RR00163 supporting the Oregon National Primate Research Center), the Ruth L. Kirschstein National Research Service Awards T32 AI007472 (to C. J. P.) and T32 HL007781 (to R. R.), the OHSU Tartar Trust fellowship (to C. J. P.), and the Achievement Reward for College Scientists (to R. R.). The CMV vector technology has been patented by Oregon Health and Science University (US2008/0199493A1) with L. J. P., J. A. N., and M. A. J. as coinventors. This patent has been licensed to the International AIDS Vaccine Initiative. The comparative genome sequencing data shown in fig. S5 were deposited in the Gene Expression Omnibus database (accession number GSE20308).	ADLER SP, 1995, J INFECT DIS, V171, P26, DOI 10.1093/infdis/171.1.26; Boppana SB, 2001, NEW ENGL J MED, V344, P1366, DOI 10.1056/NEJM200105033441804; Furman MH, 2002, J VIROL, V76, P11753, DOI 10.1128/JVI.76.22.11753-11756.2002; Gorman S, 2006, J GEN VIROL, V87, P1123, DOI 10.1099/vir.0.81583-0; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hewitt EW, 2001, EMBO J, V20, P387, DOI 10.1093/emboj/20.3.387; Krmpotic A, 1999, J EXP MED, V190, P1285, DOI 10.1084/jem.190.9.1285; Liu Z, 2009, INT J BIOCHEM CELL B, V41, P503, DOI 10.1016/j.biocel.2008.10.012; Meyer-Konig U, 1998, LANCET, V352, P1280, DOI 10.1016/S0140-6736(05)70487-6; Pande NT, 2005, J VIROL, V79, P5786, DOI 10.1128/JVI.79.9.5786-5798.2005; Pass RF, 2009, NEW ENGL J MED, V360, P1191, DOI 10.1056/NEJMoa0804749; Pinto AK, 2005, VIRAL IMMUNOL, V18, P434, DOI 10.1089/vim.2005.18.434; PLOTKIN SA, 1989, J INFECT DIS, V159, P860, DOI 10.1093/infdis/159.5.860; Powers C, 2008, CURR TOP MICROBIOL, V325, P333; Powers CJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000150; Selin LK, 2006, IMMUNOL REV, V211, P164, DOI 10.1111/j.0105-2896.2006.00394.x; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Tirabassi RS, 2002, J VIROL, V76, P6832, DOI 10.1128/JVI.76.13.6832-6835.2002; van der Wal FJ, 2002, CURR TOP MICROBIOL, V269, P37; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603	20	199	222	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 2	2010	328	5974					102	106		10.1126/science.1185350	http://dx.doi.org/10.1126/science.1185350			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577DR	20360110	Green Accepted			2022-12-28	WOS:000276202200045
J	Tolstoy, M				Tolstoy, Maya			What Lies Beneath	SCIENCE			English	Editorial Material							HEAT-FLOW; DEPTH ANOMALIES; AGE; OCEAN; TOPOGRAPHY; PACIFIC		Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Columbia University	Tolstoy, M (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	tolstoy@ldeo.colum-bia.edu						Adam C, 2010, SCIENCE, V328, P83, DOI 10.1126/science.1185906; ANDERSON RN, 1976, J GEOPHYS RES, V81, P2968, DOI 10.1029/JB081i017p02968; DAVIS EE, 1974, EARTH PLANET SC LETT, V21, P405, DOI 10.1016/0012-821X(74)90180-0; Doin MP, 2000, GEOPHYS J INT, V143, P582, DOI 10.1046/j.1365-246X.2000.00229.x; HAYES DE, 1988, J GEOPHYS RES-SOLID, V93, P2937, DOI 10.1029/JB093iB04p02937; Humler E, 1999, EARTH PLANET SC LETT, V173, P7, DOI 10.1016/S0012-821X(99)00218-6; PARKER RL, 1973, NATURE, V242, P384; PARSONS B, 1978, J GEOPHYS RES, V83, P4485, DOI 10.1029/JB083iB09p04485; PARSONS B, 1977, J GEOPHYS RES, V82, P803, DOI 10.1029/JB082i005p00803; SCHROEDER W, 1984, J GEOPHYS RES, V89, P9873, DOI 10.1029/JB089iB12p09873; STEIN CA, 1992, NATURE, V359, P123, DOI 10.1038/359123a0; TURCOTTE T, 2002, GEODYNAMICS; VINE FJ, 1963, NATURE, V199, P947, DOI 10.1038/199947a0	13	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 2	2010	328	5974					54	55		10.1126/science.1188090	http://dx.doi.org/10.1126/science.1188090			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577DR	20360099				2022-12-28	WOS:000276202200030
J	dos Santos, MC; Alecrim, MGC				dos Santos, Marcelo Cordeiro; Costa Alecrim, Maria G.			Varicella Pneumonia in an Adult.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[dos Santos, Marcelo Cordeiro; Costa Alecrim, Maria G.] Amazonas State Univ, Manaus, Amazonas, Brazil	Universidade do Estado do Amazonas	dos Santos, MC (corresponding author), Amazonas State Univ, Manaus, Amazonas, Brazil.	marcelo_cordeiro@uol.com.br							0	3	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 1	2010	362	13					1227	1227		10.1056/NEJMicm0902199	http://dx.doi.org/10.1056/NEJMicm0902199			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	577QQ	20357285				2022-12-28	WOS:000276239500013
J	Kesselheim, AS; Solomon, DH				Kesselheim, Aaron S.; Solomon, Daniel H.			Incentives for Drug Development - The Curious Case of Colchicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GOUT		[Kesselheim, Aaron S.] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Solomon, Daniel H.] Brigham & Womens Hosp, Div Rheumatol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				AHERN MJ, 1987, AUST NZ J MED, V17, P301, DOI 10.1111/j.1445-5994.1987.tb01232.x; Terkeltaub RA, 2010, ARTHRITIS RHEUM-US, V62, P1060, DOI 10.1002/art.27327; Zhang W, 2006, ANN RHEUM DIS, V65, P1312, DOI 10.1136/ard.2006.055269	3	56	57	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 3	2010	362	22					2045	2047		10.1056/NEJMp1003126	http://dx.doi.org/10.1056/NEJMp1003126			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	603XU	20393164				2022-12-28	WOS:000278242200001
J	Holden, DJ; Jonas, DE; Porterfield, DS; Reuland, D; Harris, R				Holden, Debra J.; Jonas, Daniel E.; Porterfield, Deborah S.; Reuland, Daniel; Harris, Russell			Systematic Review: Enhancing the Use and Quality of Colorectal Cancer Screening	ANNALS OF INTERNAL MEDICINE			English	Review							FECAL OCCULT BLOOD; RANDOMIZED CONTROLLED-TRIAL; PATIENT-PROVIDER COMMUNICATION; PRIMARY-CARE PHYSICIANS; COLON-CANCER; PREVENTIVE SERVICES; ADENOMA DETECTION; NATIONAL-SURVEY; DECISION AID; SURVEILLANCE COLONOSCOPY	Background: National guideline groups recommend screening and discussion of screening options for persons at average risk for colorectal cancer (CRC). However, emerging evidence suggests that CRC screening is simultaneously underused, overused, and misused and that adequate patient-provider discussions about screening are infrequent. Purpose: To summarize evidence on factors that influence CRC screening and strategies that increase the appropriate use and quality of CRC screening and CRC screening discussions. Data Sources: MEDLINE, the Cochrane Library, and the Cochrane Central Register of Controlled Trials were searched for English-language publications describing studies conducted in the United States from January 1998 through September 2009. Study Selection: Two reviewers independently selected studies that addressed the study questions and met eligibility criteria. Data Extraction: Information on study design, setting, intervention, outcomes, and quality were extracted by one reviewer and double-checked by another. Reviewers assigned a strength-of-evidence grade for intervention categories by using criteria plus a consensus process. Data Synthesis: Reviewers found evidence of simultaneous underuse, overuse, and misuse of CRC screening as well as inadequate clinical discussions about CRC screening. Several patient-level factors were independently associated with lower screening rates, including having low income or less education, being uninsured, being Hispanic or Asian, being less acculturated into the United States, or having limited access to care. Evidence that interventions that included patient reminders or one-on-one interactions (that is, between patients and nonphysician clinic staff), eliminated structural barriers (for example, simplifying access to fecal occult blood test cards), or made system-level changes (for example, using systematic screening as opposed to opportunistic screening) were effective in enhancing use of CRC screening was strong. Evidence on how best to enhance discussions about CRC screening options is limited. No studies focused on reducing overuse, and very few focused on misuse. Limitations: Reporting and publication bias may have affected our findings. The independent effect of individual elements of multicomponent interventions was often uncertain. Conclusion: Although CRC screening is underused overall, important problems of overuse and misuse also exist. System-and policy-level interventions that target vulnerable populations are needed to reduce underuse. Interventions aimed at reducing barriers by making the screening process easier are likely to be effective. Studies aimed at reducing overuse and misuse and at enhancing the quality and frequency of discussions about CRC screening options are needed.	[Holden, Debra J.] RTI Int, Community Hlth Promot Res Program, Res Triangle Pk, NC 27709 USA; Univ N Carolina, Chapel Hill, NC USA	Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill	Holden, DJ (corresponding author), RTI Int, Community Hlth Promot Res Program, 3040 Cornwallis Rd,POB 12194, Res Triangle Pk, NC 27709 USA.	debra@rti.org	Wilkins, Thad/G-2541-2010	Reuland, Daniel/0000-0002-7839-6581	Agency for Healthcare Research and Quality [290200710056I]; U.S. Department of Health and Human Services; American Cancer Society [CCCDA-09-215-01]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); U.S. Department of Health and Human Services; American Cancer Society(American Cancer Society)	Grant Support: This project was funded under contract 290200710056I from the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services. Dr. Reuland was supported by a Cancer Control Career Development Award for Primary Care Physicians from the American Cancer Society (CCCDA-09-215-01).	Afable-Munsuz A, 2009, J GEN INTERN MED, V24, P963, DOI 10.1007/s11606-009-1022-9; Agency for Healthcare Research and Quality, 2007, METH GUID COMP EFF R; Ata A, 2006, CANCER DETECT PREV, V30, P134, DOI 10.1016/j.cdp.2006.02.003; Ayanian JZ, 2008, J GEN INTERN MED, V23, P762, DOI 10.1007/s11606-008-0576-2; Baig N, 2003, AM J GASTROENTEROL, V98, P2078, DOI 10.1016/S0002-9270(03)00424-6; Bao YH, 2007, HEALTH SERV RES, V42, P950, DOI 10.1111/j.1475-6773.2006.00638.x; Barclay RL, 2008, CLIN GASTROENTEROL H, V6, P1091, DOI 10.1016/j.cgh.2008.04.018; Barclay RL, 2006, NEW ENGL J MED, V355, P2533, DOI 10.1056/NEJMoa055498; Basch CE, 2006, AM J PUBLIC HEALTH, V96, P2246, DOI 10.2105/AJPH.2005.067223; Berkowitz Z, 2008, J AM GERIATR SOC, V56, P307, DOI 10.1111/j.1532-5415.2007.01547.x; Boolchand V, 2006, ANN INTERN MED, V145, P654, DOI 10.7326/0003-4819-145-9-200611070-00007; Braun KL, 2005, PREV MED, V40, P619, DOI 10.1016/j.ypmed.2004.09.005; Breen N, 2001, J NATL CANCER I, V93, P1704, DOI 10.1093/jnci/93.22.1704; Bressler B, 2007, GASTROENTEROLOGY, V132, P96, DOI 10.1053/j.gastro.2006.10.027; Cairns CP, 2006, CANCER CAUSE CONTROL, V17, P1115, DOI 10.1007/s10552-006-0046-2; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Campbell MK, 2004, HEALTH PSYCHOL, V23, P492, DOI 10.1037/0278-6133.23.5.492; Carcaise-Edinboro P, 2008, MED CARE, V46, P738, DOI 10.1097/MLR.0b013e318178935a; Carlos RC, 2005, ACAD RADIOL, V12, P451, DOI 10.1016/j.acra.2004.12.024; *CDCP, 2006, MMWR-MORBID MORTAL W, V55, P308; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P193; Chen SC, 2007, AM J GASTROENTEROL, V102, P856, DOI 10.1111/j.1572-0241.2006.01054.x; Church TR, 2004, JNCI-J NATL CANCER I, V96, P770, DOI 10.1093/jnci/djh134; Collins JF, 2005, ANN INTERN MED, V142, P81, DOI 10.7326/0003-4819-142-2-200501180-00006; Costanza ME, 2007, CANCER DETECT PREV, V31, P191, DOI 10.1016/j.cdp.2007.04.008; Coughlin SS, 2005, HEALTH PROMOT PRACT, V6, P369, DOI 10.1177/1524839905278742; de Bosset V, 2008, CANCER EPIDEM BIOMAR, V17, P834, DOI 10.1158/1055-9965.EPI-07-2760; Denberg TD, 2006, ANN INTERN MED, V145, P895, DOI 10.7326/0003-4819-145-12-200612190-00006; Diaz JA, 2008, CANCER EPIDEM BIOMAR, V17, P2169, DOI 10.1158/1055-9965.EPI-07-2692; Dietrich AJ, 2006, ANN INTERN MED, V144, P563, DOI 10.7326/0003-4819-144-8-200604180-00006; Dietrich AJ, 2007, ANN FAM MED, V5, P320, DOI 10.1370/afm.701; Dolan JG, 2002, MED DECIS MAKING, V22, P125, DOI 10.1177/02729890222063017; Etzioni DA, 2004, CANCER-AM CANCER SOC, V101, P2523, DOI 10.1002/cncr.20692; Etzioni DA, 2006, DIS COLON RECTUM, V49, P1002, DOI 10.1007/s10350-006-0533-2; Fenton JJ, 2008, AM J PREV MED, V35, P194, DOI 10.1016/j.amepre.2008.05.029; Fenton JJ, 2007, ARCH INTERN MED, V167, P580, DOI 10.1001/archinte.167.6.580; Fenton JJ, 2009, J AM GERIATR SOC, V57, P412, DOI 10.1111/j.1532-5415.2008.02143.x; Fisher DA, 2005, AM J GASTROENTEROL, V100, P2526, DOI 10.1111/j.1572-0241.2005.00322.x; Fisher DA, 2007, CLIN GASTROENTEROL H, V5, P991, DOI 10.1016/j.cgh.2007.04.010; Fisher DA, 2006, CANCER EPIDEM BIOMAR, V15, P1232, DOI 10.1158/1055-9965.EPI-05-0916; Fox SA, 2009, PATIENT EDUC COUNS, V75, P178, DOI 10.1016/j.pec.2008.09.010; Gilbert A, 2005, PREV MED, V41, P367, DOI 10.1016/j.ypmed.2005.01.008; Goel MS, 2003, J GEN INTERN MED, V18, P1028, DOI 10.1111/j.1525-1497.2003.20807.x; Harewood GC, 2004, CLIN GASTROENTEROL H, V2, P72, DOI 10.1016/S1542-3565(03)00294-5; Haseman JH, 1997, GASTROINTEST ENDOSC, V45, P451, DOI 10.1016/S0016-5107(97)70172-X; Holden DJ, 2010, AHRQ PUBLICATION; Hudson SV, 2007, CANCER DETECT PREV, V31, P417, DOI 10.1016/j.cdp.2007.08.004; Imperiale TF, 2009, GASTROINTEST ENDOSC, V69, P1288, DOI 10.1016/j.gie.2007.11.043; Jandorf L, 2005, J URBAN HEALTH, V82, P216, DOI 10.1093/jurban/jti046; Janz NK, 2003, PREV MED, V37, P627, DOI 10.1016/j.ypmed.2003.09.016; Jerant AF, 2008, ARCH INTERN MED, V168, P1317, DOI 10.1001/archinte.168.12.1317; Joseph D. A., 2008, Morbidity and Mortality Weekly Report, V57, P253; Katz ML, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-62; Kim DH, 2007, NEW ENGL J MED, V357, P1403, DOI 10.1056/NEJMoa070543; Klabunde CN, 2009, AM J PREV MED, V37, P8, DOI 10.1016/j.amepre.2009.03.008; Klabunde CN, 2004, AM J MANAG CARE, V10, P273; Klabunde CN, 2005, MED CARE, V43, P939, DOI 10.1097/01.mlr.0000173599.67470.ba; Koroukian SM, 2005, MED CARE, V43, P445, DOI 10.1097/01.mlr.0000160376.42562.79; Krist AH, 2007, AM J PREV MED, V33, P471, DOI 10.1016/j.amepre.2007.07.039; Lafata JE, 2005, CANCER, V104, P1356, DOI 10.1002/cncr.21333; Lafata JE, 2006, AM J PREV MED, V31, P202, DOI 10.1016/j.amepre.2006.04.010; Laiyemo AO, 2009, CLIN GASTROENTEROL H, V7, P562, DOI 10.1016/j.cgh.2008.12.009; Laiyemo AO, 2009, CLIN GASTROENTEROL H, V7, P497; Leaper M, 2004, ENDOSCOPY, V36, P499, DOI 10.1055/s-2004-814399; Lemon S, 2001, AM J PUBLIC HEALTH, V91, P1264, DOI 10.2105/AJPH.91.8.1264; Levin B, 1997, ARCH INTERN MED, V157, P970, DOI 10.1001/archinte.157.9.970; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Levine JS, 2006, NEW ENGL J MED, V355, P2551, DOI 10.1056/NEJMcp063038; Levy BT, 2006, AM J PREV MED, V31, P193, DOI 10.1016/j.amepre.2006.04.008; Ling BS, 2008, MED CARE, V46, pS23, DOI 10.1097/MLR.0b013e31817dc496; Ling BS, 2009, ARCH INTERN MED, V169, P47, DOI 10.1001/archinternmed.2008.519; McQueen A, 2006, CANCER EPIDEM BIOMAR, V15, P782, DOI 10.1158/1055-9965.EPI-05-0629; McQueen A, 2009, J GEN INTERN MED, V24, P1228, DOI 10.1007/s11606-009-1108-4; Meissner HI, 2006, CANCER EPIDEM BIOMAR, V15, P389, DOI 10.1158/1055-9965.EPI-05-0678; Messina CR, 2009, PUBLIC HEALTH REP, V124, P568, DOI 10.1177/003335490912400414; Miglioretti DL, 2008, MED CARE, V46, pS91, DOI 10.1097/MLR.0b013e31817946c8; Myers RE, 2007, CANCER-AM CANCER SOC, V110, P2083, DOI 10.1002/cncr.23022; Mysliwiec PA, 2004, ANN INTERN MED, V141, P264, DOI 10.7326/0003-4819-141-4-200408170-00006; Nadel MR, 2005, ANN INTERN MED, V142, P86, DOI 10.7326/0003-4819-142-2-200501180-00007; Nash D, 2006, J URBAN HEALTH, V83, P231, DOI 10.1007/s11524-006-9029-6; OWENS DK, 2009, J CLIN EPIDEMIOL; Pabby A, 2005, GASTROINTEST ENDOSC, V61, P385, DOI 10.1016/S0016-5107(04)02765-8; Peterson NB, 2007, J WOMENS HEALTH, V16, P57, DOI 10.1089/jwh.2006.0131; Pham HH, 2005, JAMA-J AM MED ASSOC, V294, P473, DOI 10.1001/jama.294.4.473; Pignone M, 2000, ANN INTERN MED, V133, P761, DOI 10.7326/0003-4819-133-10-200011210-00008; Potter MB, 2009, ANN FAM MED, V7, P17, DOI 10.1370/afm.934; Prajapati DN, 2003, AM J GASTROENTEROL, V98, P194; Rao SK, 2009, J GEN INTERN MED, V24, P356, DOI 10.1007/s11606-008-0893-5; Rex DK, 1997, GASTROENTEROLOGY, V112, P24, DOI 10.1016/S0016-5085(97)70214-2; Rex DK, 2005, AM J GASTROENTEROL, V100, P1903, DOI 10.1111/j.1572-0241.2005.50130_2.x; Robertson DJ, 2005, GASTROENTEROLOGY, V129, P34, DOI 10.1053/j.gastro.2005.05.012; Robertson RH, 2006, PREV MED, V42, P460, DOI 10.1016/j.ypmed.2006.01.014; Roetzheim RG, 2005, ANN FAM MED, V3, P109, DOI 10.1370/afm.240; Roetzheim RG, 2004, ANN FAM MED, V2, P294, DOI 10.1370/afm.101; Ruffin MT, 2007, PREV MED, V45, P267, DOI 10.1016/j.ypmed.2007.07.003; SCHENCK AP, 1998, AM J PREV MED, V1, P2005; Schumacher MC, 2008, CANCER CAUSE CONTROL, V19, P725, DOI 10.1007/s10552-008-9135-8; Seeff LC, 2004, CANCER-AM CANCER SOC, V100, P2093, DOI 10.1002/cncr.20276; Sequist TD, 2009, ARCH INTERN MED, V169, P364, DOI 10.1001/archinternmed.2008.564; Shah HA, 2007, GASTROENTEROLOGY, V132, P2297, DOI 10.1053/j.gastro.2007.03.032; Shapiro JA, 2008, CANCER EPIDEM BIOMAR, V17, P1623, DOI 10.1158/1055-9965.EPI-07-2838; Shields HM, 2001, AM J GASTROENTEROL, V96, P196; Shih YCT, 2008, J CANCER EDUC, V23, P18, DOI 10.1080/08858190701634623; Shih YCT, 2006, HEALTH AFFAIR, V25, P1153, DOI 10.1377/hlthaff.25.4.1153; Stokamer CL, 2005, J GEN INTERN MED, V20, P278, DOI 10.1111/j.1525-1497.2005.40023.x; Sun WY, 2004, PREV MED, V39, P323, DOI 10.1016/j.ypmed.2004.04.029; Thorpe LE, 2005, CANCER-AM CANCER SOC, V104, P1075, DOI 10.1002/cncr.21274; Trivers KF, 2008, AM J PREV MED, V35, P185, DOI 10.1016/j.amepre.2008.05.021; Tu SP, 2006, CANCER-AM CANCER SOC, V107, P959, DOI 10.1002/cncr.22091; Turner B, 2003, J GEN INTERN MED, V18, P357, DOI 10.1046/j.1525-1497.2003.20525.x; Wackerbarth SB, 2007, PATIENT EDUC COUNS, V66, P43, DOI 10.1016/j.pec.2006.10.003; Walter LC, 2009, ANN INTERN MED, V150, P465, DOI 10.7326/0003-4819-150-7-200904070-00006; Warren JL, 2009, ANN INTERN MED, V150, P849, DOI 10.7326/0003-4819-150-12-200906160-00008; Wee CC, 2005, PREV MED, V41, P23, DOI 10.1016/j.ypmed.2004.11.004; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245; Winawer SJ, 2006, GASTROENTEROLOGY, V130, P1872, DOI 10.1053/j.gastro.2006.03.012; Wolf MS, 2007, J GEN INTERN MED, V22, P1493, DOI 10.1007/s11606-007-0289-y; Wong ST, 2005, CANCER-AM CANCER SOC, V104, P2940, DOI 10.1002/cncr.21521; Yano EM, 2007, HEALTH SERV RES, V42, P1130, DOI 10.1111/j.1475-6773.2006.00643.x; Young WF, 2007, J RURAL HEALTH, V23, P238, DOI 10.1111/j.1748-0361.2007.00096.x; Zapka JG, 2004, ANN INTERN MED, V141, P683, DOI 10.7326/0003-4819-141-9-200411020-00009; Zapka JG, 2002, AM J PREV MED, V23, P28, DOI 10.1016/S0749-3797(02)00444-0	122	221	222	0	30	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 18	2010	152	10					668	+		10.7326/0003-4819-152-10-201005180-00239	http://dx.doi.org/10.7326/0003-4819-152-10-201005180-00239			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	598RJ	20388703				2022-12-28	WOS:000277855500007
J	Niessing, J; Friedrich, RW				Niessing, Joern; Friedrich, Rainer W.			Olfactory pattern classification by discrete neuronal network states	NATURE			English	Article							BINARY ODOR MIXTURES; ANTENNAL LOBE; MITRAL CELLS; SENSORY INFORMATION; ATTRACTOR DYNAMICS; GLOMERULAR LAYER; BULB; REPRESENTATIONS; ZEBRAFISH; DISCRIMINATION	The categorial nature of sensory, cognitive and behavioural acts indicates that the brain classifies neuronal activity patterns into discrete representations. Pattern classification may be achieved by abrupt switching between discrete activity states of neuronal circuits, but few experimental studies have directly tested this. We gradually varied the concentration or molecular identity of odours and optically measured responses across output neurons of the olfactory bulb in zebrafish. Whereas population activity patterns were largely insensitive to changes in odour concentration, morphing of one odour into another resulted in abrupt transitions between odour representations. These transitions were mediated by coordinated response changes among small neuronal ensembles rather than by shifts in the global network state. The olfactory bulb therefore classifies odour-evoked input patterns into many discrete and defined output patterns, as proposed by attractor models. This computation is consistent with perceptual phenomena and may represent a general information processing strategy in the brain.	[Niessing, Joern; Friedrich, Rainer W.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Friedrich, RW (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	Rainer.Friedrich@fmi.ch		Friedrich, Rainer/0000-0001-9107-0482	Novartis Research Foundation; Max Planck Society; Deutsche Forschungsgemeinschaft [FOR 643]; Studienstiftung des deutschen Volkes	Novartis Research Foundation; Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Studienstiftung des deutschen Volkes	We thank A. Luthi, T. Oertner, G. Jacobson and M. Wiechert for comments on the manuscript, and members of the Friedrich laboratory for discussions. This work was funded by the Novartis Research Foundation, the Max Planck Society, the Deutsche Forschungsgemeinschaft (FOR 643) and a fellowship from the Studienstiftung des deutschen Volkes (J.N.).	Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Barnes DC, 2008, NAT NEUROSCI, V11, P1378, DOI 10.1038/nn.2217; Bathellier B, 2008, NEURON, V57, P586, DOI 10.1016/j.neuron.2008.02.011; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Carlson GC, 2000, J NEUROSCI, V20, P2011; Carr W.E.S., 1988, P3; Cleland TA, 2007, P NATL ACAD SCI USA, V104, P1953, DOI 10.1073/pnas.0608564104; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; FREEMAN WJ, 1978, ELECTROEN CLIN NEURO, V44, P586, DOI 10.1016/0013-4694(78)90126-8; FREEMAN WJ, 1987, BIOL CYBERN, V56, P139, DOI 10.1007/BF00317988; Friedrich RW, 2004, J NEUROPHYSIOL, V91, P2658, DOI 10.1152/jn.01143.2003; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Galan RF, 2004, NEURAL COMPUT, V16, P999, DOI 10.1162/089976604773135078; GROSSISSEROFF R, 1988, CHEM SENSES, V13, P191, DOI 10.1093/chemse/13.2.191; HASSELMO ME, 1990, COLD SPRING HARB SYM, V55, P599; Higashijima S, 2003, J NEUROPHYSIOL, V90, P3986, DOI 10.1152/jn.00576.2003; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; Khan AG, 2008, NEURON, V57, P571, DOI 10.1016/j.neuron.2008.01.008; Krone D, 2001, PHYTOTHER RES, V15, P135, DOI 10.1002/ptr.716; LAING DG, 1983, CHEM SENSES, V7, P249, DOI 10.1093/chemse/7.3-4.249; LAING DG, 1984, PHYSIOL BEHAV, V33, P309, DOI 10.1016/0031-9384(84)90118-5; Laing DG, 2003, CHEM SENSES, V28, P57, DOI 10.1093/chemse/28.1.57; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; Leutgeb JK, 2005, NEURON, V48, P345, DOI 10.1016/j.neuron.2005.09.007; Li J, 2005, J NEUROSCI, V25, P5784, DOI 10.1523/JNEUROSCI.0922-05.2005; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; MATHIESON WB, 1988, J COMP PHYSIOL A, V163, P489, DOI 10.1007/BF00604903; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Meister M, 2001, J NEUROSCI, V21, P1351; MICHEL WC, 1995, J COMP PHYSIOL A, V177, P191; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; MOZER MC, 2009, OXFORD COMPANION CON; Murphy GJ, 2004, J NEUROSCI, V24, P3023, DOI 10.1523/JNEUROSCI.5745-03.2004; Parker AJ, 2003, CURR OPIN NEUROBIOL, V13, P433, DOI 10.1016/S0959-4388(03)00099-0; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Sachse S, 2003, EUR J NEUROSCI, V18, P2119, DOI 10.1046/j.1460-9568.2003.02931.x; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Uchida N, 2008, FRONT SYST NEUROSCI, V1, DOI 10.3389/neuro.06.003.2007; Urban NN, 2002, J PHYSIOL-LONDON, V542, P355, DOI 10.1113/jphysiol.2001.013491; Valentincic T, 2000, J EXP BIOL, V203, P3307; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Wachowiak M, 2006, SEMIN CELL DEV BIOL, V17, P411, DOI 10.1016/j.semcdb.2006.04.007; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; Wiltrout C, 2003, BEHAV NEUROSCI, V117, P236, DOI 10.1037/0735-7044.117.2.236; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874; Yaksi E, 2007, PLOS BIOL, V5, P1453, DOI 10.1371/journal.pbio.0050178; Yaksi E, 2009, NAT NEUROSCI, V12, P474, DOI 10.1038/nn.2288	54	122	123	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 6	2010	465	7294					47	U53		10.1038/nature08961	http://dx.doi.org/10.1038/nature08961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591OW	20393466				2022-12-28	WOS:000277311900028
J	Rocks, O; Gerauer, M; Vartak, N; Koch, S; Huang, ZP; Pechlivanis, M; Kuhlmann, J; Brunsveld, L; Chandra, A; Ellinger, B; Waldmann, H; Bastiaens, PIH				Rocks, Oliver; Gerauer, Marc; Vartak, Nachiket; Koch, Sebastian; Huang, Zhi-Ping; Pechlivanis, Markos; Kuhlmann, Juergen; Brunsveld, Lucas; Chandra, Anchal; Ellinger, Bernhard; Waldmann, Herbert; Bastiaens, Philippe I. H.			The Palmitoylation Machinery Is a Spatially Organizing System for Peripheral Membrane Proteins	CELL			English	Article							CYSTEINE-RICH DOMAIN; PLASMA-MEMBRANE; STRUCTURAL DETERMINANTS; PALMITATE TURNOVER; H-RAS; GOLGI; TRAFFICKING; ACYLATION; PSD-95; FAMILY	Reversible S-palmitoylation of cysteine residues critically controls transient membrane tethering of peripheral membrane proteins. Little is known about how the palmitoylation machinery governs their defined localization and function. We monitored the spatially resolved reaction dynamics and substrate specificity of the core mammalian palmitoylation machinery using semisynthetic substrates. Palmitoylation is detectable only on the Golgi, whereas depalmitoylation occurs everywhere in the cell. The reactions are not stereoselective and lack any primary consensus sequence, demonstrating that substrate specificity is not essential for de-/repalmitoylation. Both palmitate attachment and removal require seconds to accomplish. This reaction topography and rapid kinetics allows the continuous redirection of mislocalized proteins via the post-Golgi sorting apparatus. Unidirectional secretion ensures the maintenance of a proper steady-state protein distribution between the Golgi and the plasma membrane, which are continuous with endosomes. This generic spatially organizing system differs from conventional receptor-mediated targeting mechanisms and efficiently counteracts entropy-driven redistribution of palmitoylated peripheral membrane proteins over all membranes.	[Gerauer, Marc; Koch, Sebastian; Huang, Zhi-Ping; Brunsveld, Lucas; Ellinger, Bernhard; Waldmann, Herbert] Max Planck Inst Mol Physiol, Dept Biol Chem, D-44227 Dortmund, Germany; [Rocks, Oliver; Bastiaens, Philippe I. H.] European Mol Biol Lab, D-69118 Heidelberg, Germany; [Rocks, Oliver; Vartak, Nachiket; Chandra, Anchal; Bastiaens, Philippe I. H.] Max Planck Inst Mol Physiol, Dept Syst Cell Biol, D-44227 Dortmund, Germany; [Pechlivanis, Markos; Kuhlmann, Juergen] Max Planck Inst Mol Physiol, Dept Biol Struct, D-44227 Dortmund, Germany; [Gerauer, Marc; Koch, Sebastian; Brunsveld, Lucas; Waldmann, Herbert; Bastiaens, Philippe I. H.] TU Dortmund, Fachbereich Chem, D-44227 Dortmund, Germany	Max Planck Society; European Molecular Biology Laboratory (EMBL); Max Planck Society; Max Planck Society; Dortmund University of Technology	Waldmann, H (corresponding author), Max Planck Inst Mol Physiol, Dept Biol Chem, Otto Hahn Str 11, D-44227 Dortmund, Germany.	herbert.waldmann@mpi-dortmund.mpg.de; philippe.bastiaens@mpi-dortmund.mpg.de	Vartak, Nachiket/A-2979-2009; Chandra, Anchal/AAT-5644-2021; Rocks, Oliver/ABG-3341-2020; Waldmann, Herbert/B-7406-2017; Rocks, Oliver/AFI-7418-2022	Vartak, Nachiket/0000-0002-2966-4631; Chandra, Anchal/0000-0003-4096-4771; Rocks, Oliver/0000-0001-6349-9193; Waldmann, Herbert/0000-0002-9606-7247; Brunsveld, Luc/0000-0001-5675-511X; Vartak, Nachiket/0000-0001-8813-4799; Ellinger, Bernhard/0000-0001-5703-3901	Human Frontier Science Program	Human Frontier Science Program(Human Frontier Science Program)	O.R. received funding from the Human Frontier Science Program (LT Fellowship). We are thankful to C. Nowak and J. Luig for technical support, J. Lippincott-Schwartz, R. Tsien, M. Frame, and M. Torti for providing plasmids, and J. Moffat and Y. Fedyshyn for providing lentiviruses.	Bader B, 2000, NATURE, V403, P223, DOI 10.1038/35003249; Baker TL, 2003, J BIOL CHEM, V278, P19292, DOI 10.1074/jbc.M206956200; Bano MC, 1998, BIOCHEM J, V330, P723, DOI 10.1042/bj3300723; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; Bizzozero OA, 2001, BBA-PROTEIN STRUCT M, V1545, P278, DOI 10.1016/S0167-4838(00)00291-0; Charollais J, 2009, MOL MEMBR BIOL, V26, P55, DOI 10.1080/09687680802620369; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Dighe SA, 2008, MOL BIOL CELL, V19, P4454, DOI 10.1091/mbc.E08-03-0252; DRAUZ K, 2002, ENZYME CATALYSIS ORG, V2; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Fishburn CS, 1999, J BIOL CHEM, V274, P18793, DOI 10.1074/jbc.274.26.18793; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Gerisch G, 2004, EUR J CELL BIOL, V83, P297, DOI 10.1078/0171-9335-00393; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Greaves J, 2009, MOL BIOL CELL, V20, P1845, DOI 10.1091/mbc.E08-09-0944; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Horton AC, 2003, J NEUROSCI, V23, P6188; Hou HT, 2009, TRAFFIC, V10, P1061, DOI 10.1111/j.1600-0854.2009.00925.x; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Jura N, 2006, MOL CELL, V21, P679, DOI 10.1016/j.molcel.2006.02.011; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kawase K, 2006, DEV CELL, V11, P411, DOI 10.1016/j.devcel.2006.07.008; Kuhn K, 2001, J AM CHEM SOC, V123, P1023, DOI 10.1021/ja002723o; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; LU JY, 1995, J BIOL CHEM, V270, P7251, DOI 10.1074/jbc.270.13.7251; MAGEE AI, 1987, EMBO J, V6, P3353, DOI 10.1002/j.1460-2075.1987.tb02656.x; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Nadolski MJ, 2009, J BIOL CHEM, V284, P17720, DOI 10.1074/jbc.M109.005447; Navarro-Lerida I, 2002, J CELL SCI, V115, P3119; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Paganini S, 2006, BIOCHIMIE, V88, P285, DOI 10.1016/j.biochi.2005.08.007; Perez-Sala D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008117; QUESNEL S, 1994, BIOCHEMISTRY-US, V33, P13340, DOI 10.1021/bi00249a021; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rocks O, 2006, CURR OPIN CELL BIOL, V18, P351, DOI 10.1016/j.ceb.2006.06.007; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Sato I, 2009, J CELL SCI, V122, P965, DOI 10.1242/jcs.034843; Seebach D, 2004, CHEM BIODIVERS, V1, P1111, DOI 10.1002/cbdv.200490087; SHAHINIAN S, 1995, BIOCHEMISTRY-US, V34, P3813, DOI 10.1021/bi00011a039; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Smyth P, 1997, ADV NEUR IN, V9, P648; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; Takaya A, 2007, MOL BIOL CELL, V18, P1850, DOI 10.1091/mbc.E06-08-0765; Tsutsumi R, 2008, PFLUG ARCH EUR J PHY, V456, P1199, DOI 10.1007/s00424-008-0465-x; vantHof W, 1997, J CELL BIOL, V136, P1023, DOI 10.1083/jcb.136.5.1023; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Zeidman R, 2009, MOL MEMBR BIOL, V26, P32, DOI 10.1080/09687680802629329	53	312	316	0	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2010	141	3					458	471		10.1016/j.cell.2010.04.007	http://dx.doi.org/10.1016/j.cell.2010.04.007			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	589UX	20416930	Bronze			2022-12-28	WOS:000277180800017
J	Zhang, X; Jin, L; Fang, Q; Hui, WH; Zhou, ZH				Zhang, Xing; Jin, Lei; Fang, Qin; Hui, Wong H.; Zhou, Z. Hong			3.3 angstrom Cryo-EM Structure of a Nonenveloped Virus Reveals a Priming Mechanism for Cell Entry	CELL			English	Article							GRASS CARP REOVIRUS; CAPSID PROTEIN MU-1; INFECTIOUS SUBVIRION PARTICLES; MEMBRANE-PENETRATION PROTEIN; ELECTRON CRYOMICROSCOPY; CRYOELECTRON MICROSCOPY; MAMMALIAN REOVIRUSES; PUTATIVE AUTOCLEAVAGE; IMAGE-RECONSTRUCTION; 3D RECONSTRUCTION	To achieve cell entry, many nonenveloped viruses must transform from a dormant to a primed state. In contrast to the membrane fusion mechanism of enveloped viruses (e.g., influenza virus), this membrane penetration mechanism is poorly understood. Here, using single-particle cryo-electron microscopy, we report a 3.3 angstrom structure of the primed, infectious subvirion particle of aquareovirus. The density map reveals side-chain densities of all types of amino acids (except glycine), enabling construction of a full-atom model of the viral particle. Our structure and biochemical results show that priming involves autocleavage of the membrane penetration protein and suggest that Lys84 and Glu76 may facilitate this autocleavage in a nucleophilic attack. We observe a myristoyl group, covalently linked to the N terminus of the penetration protein and embedded in a hydrophobic pocket. These results suggest a well-orchestrated process of nonenveloped virus entry involving autocleavage of the penetration protein prior to exposure of its membrane-insertion finger.	[Zhang, Xing; Jin, Lei; Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Fang, Qin] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Hubei, Peoples R China; [Hui, Wong H.; Zhou, Z. Hong] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; University of California System; University of California Los Angeles	Zhou, ZH (corresponding author), Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA.	hong.zhou@ucla.edu	fang, qin/GQA-8223-2022; Zhou, Z Hong/HDN-0747-2022		National Institutes of Health (NIH) [GM071940, AI069015, 1S10RR23057]; Abraxis BioScience; National Basic Research Program of China (973 Program) [2009CB118701]; National Natural Scientific Foundation of China [30671615, 30871940]; Chinese Academy of Sciences [KSCX2-YW-N-021]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071940] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abraxis BioScience; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Stan Schein for editing our manuscript, Xiaokang Zhang for assistance in programming, Xuekui Yu for advice in sample purification, Hongrong Liu and Lingpeng Cheng for assistance in film development, and Connie Huang for film digitization. This project is supported in part by grants from the National Institutes of Health (NIH; GM071940 and AI069015 to Z.H.Z.) and Abraxis BioScience. We acknowledge the use of the cryo-EM facility at the Electron Imaging Center for NanoMachines supported by the NIH (1S10RR23057 to Z.H.Z.). This project is also supported by the National Basic Research Program of China (973 Program, #2009CB118701 to Q.F.), the National Natural Scientific Foundation of China (# 30671615 and # 30871940 to Q.F.), and the Chinese Academy of Sciences (KSCX2-YW-N-021 to Q.F.).	Agosto MA, 2008, P NATL ACAD SCI USA, V105, P10571, DOI 10.1073/pnas.0802039105; Agosto MA, 2007, J VIROL, V81, P7400, DOI 10.1128/JVI.02720-06; Banerjee M, 2008, CURR PROTEIN PEPT SC, V9, P16; Bartlett GJ, 2002, J MOL BIOL, V324, P105, DOI 10.1016/S0022-2836(02)01036-7; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chandran K, 2003, TRENDS MICROBIOL, V11, P374, DOI 10.1016/S0966-842X(03)00178-1; Chandran K, 2002, J VIROL, V76, P9920, DOI 10.1128/JVI.76.19.9920-9933.2002; Chandran K, 1998, J VIROL, V72, P467, DOI 10.1128/JVI.72.1.467-475.1998; Cheng LP, 2008, J MOL BIOL, V382, P213, DOI 10.1016/j.jmb.2008.06.075; Cheng LP, 2010, J MOL BIOL, V397, P852, DOI 10.1016/j.jmb.2009.12.027; Clarke P, 2005, CURR TOP MICROBIOL, V289, P1; Danthi P, 2008, J VIROL, V82, P161, DOI 10.1128/JVI.01739-07; DeLano WL, 2002, PYMOL USERS MANUAL; DOWELL LG, 1960, NATURE, V188, P1144, DOI 10.1038/1881144a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang Q, 2008, ARCH VIROL, V153, P675, DOI 10.1007/s00705-008-0048-3; Fang Q, 2005, SCI CHINA SER C, V48, P593, DOI 10.1360/062004-105; FritzWolf K, 1996, NATURE, V381, P341, DOI 10.1038/381341a0; FURLONG DB, 1988, J VIROL, V62, P246, DOI 10.1128/JVI.62.1.246-256.1988; Greenleaf WB, 2008, J VIROL, V82, P6017, DOI 10.1128/JVI.00387-08; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; Ivanovic T, 2008, EMBO J, V27, P1289, DOI 10.1038/emboj.2008.60; Jiang W, 2008, NATURE, V451, P1130, DOI 10.1038/nature06665; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li YQ, 2009, PROTEINS, V76, P665, DOI 10.1002/prot.22380; Liang YY, 2002, J STRUCT BIOL, V137, P292, DOI 10.1016/S1047-8477(02)00014-X; Liemann S, 2002, CELL, V108, P283, DOI 10.1016/S0092-8674(02)00612-8; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Middleton JK, 2007, VIROLOGY, V361, P412, DOI 10.1016/j.virol.2006.11.024; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Nason EL, 2000, J VIROL, V74, P6546, DOI 10.1128/JVI.74.14.6546-6555.2000; Nibert ML, 2005, J MOL BIOL, V345, P461, DOI 10.1016/j.jmb.2004.10.026; NIBERT ML, 1991, J VIROL, V65, P1960, DOI 10.1128/JVI.65.4.1960-1967.1991; NIBERT ML, 1992, J VIROL, V66, P6408, DOI 10.1128/JVI.66.11.6408-6418.1992; Noad L, 2006, VIRUS RES, V116, P45, DOI 10.1016/j.virusres.2005.08.014; Odegard AL, 2004, J VIROL, V78, P8732, DOI 10.1128/JVI.78.16.8732-8745.2004; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; REDDY V, 2004, NODAVIRUS ENDOPEPTID, V1; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; Rivas C, 1998, AQUACULTURE, V160, P47, DOI 10.1016/S0044-8486(97)00239-1; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Shing M, 1996, VIRUS RES, V46, P19, DOI 10.1016/S0168-1702(96)01372-X; Taylor DJ, 2005, PROTEIN SCI, V14, P401, DOI 10.1110/ps.041054605; TILLOTSON L, 1992, J VIROL, V66, P2180, DOI 10.1128/JVI.66.4.2180-2186.1992; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69, DOI 10.1146/annurev.bi.57.070188.000441; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Wynne SA, 1999, MOL CELL, V3, P771, DOI 10.1016/S1097-2765(01)80009-5; Yu XK, 2008, NATURE, V453, P415, DOI 10.1038/nature06893; Zhang L, 2006, J VIROL, V80, P12367, DOI 10.1128/JVI.01343-06; Zhang X, 2005, VIROLOGY, V343, P25, DOI 10.1016/j.virol.2005.08.002; Zhang X, 2005, STRUCTURE, V13, P1545, DOI 10.1016/j.str.2005.07.012; Zhang X, 2008, P NATL ACAD SCI USA, V105, P1867, DOI 10.1073/pnas.0711623105; Zhou ZH, 2008, CURR OPIN STRUC BIOL, V18, P218, DOI 10.1016/j.sbi.2008.03.004	58	237	266	0	86	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2010	141	3					472	482		10.1016/j.cell.2010.03.041	http://dx.doi.org/10.1016/j.cell.2010.03.041			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	589UX	20398923	Green Accepted, Bronze			2022-12-28	WOS:000277180800018
J	Gruter, T; Carbon, CC				Grueter, Thomas; Carbon, Claus-Christian			Escaping attention. Some cognitive disorders can be overlooked	SCIENCE			English	Editorial Material							FACE RECOGNITION; PROSOPAGNOSIA; ABILITY		[Grueter, Thomas; Carbon, Claus-Christian] Otto Friedrich Univ Bamberg, Dept Gen Psychol & Methodol, D-96047 Bamberg, Germany	Otto Friedrich University Bamberg	Gruter, T (corresponding author), Otto Friedrich Univ Bamberg, Dept Gen Psychol & Methodol, Markuspl 3, D-96047 Bamberg, Germany.	tgrueter@comfood.com	Carbon, Claus-Christian/GLQ-6274-2022; Carbon, Claus-Christian/A-7494-2008	Carbon, Claus-Christian/0000-0002-3446-9347; Carbon, Claus-Christian/0000-0002-3446-9347; Gruter, Thomas/0000-0003-3529-9244				Anokhin AP, 2010, BEHAV GENET, V40, P178, DOI 10.1007/s10519-010-9337-1; Basso MR, 2002, CLIN NEUROPSYCHOL, V16, P57, DOI 10.1076/clin.16.1.57.8329; Behrmann M, 2005, TRENDS COGN SCI, V9, P180, DOI 10.1016/j.tics.2005.02.011; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; COLTHEART M, 1993, PSYCHOL REV, V100, P589, DOI 10.1037/0033-295X.100.4.589; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; Garrido L, 2009, NEUROPSYCHOLOGIA, V47, P123, DOI 10.1016/j.neuropsychologia.2008.08.003; Gobbini MI, 2007, NEUROPSYCHOLOGIA, V45, P32, DOI 10.1016/j.neuropsychologia.2006.04.015; Gruter T, 2008, J NEUROPSYCHOL, V2, P79, DOI 10.1348/174866407X231001; Hausknecht JP, 2007, J APPL PSYCHOL, V92, P373, DOI 10.1037/0021-9010.92.2.373; Kennerknecht I, 2006, AM J MED GENET A, V140A, P1617, DOI 10.1002/ajmg.a.31343; Nijboer TCW, 2007, NEUROPSYCHOLOGIA, V45, P1961, DOI 10.1016/j.neuropsychologia.2007.01.021; Siok WT, 2004, NATURE, V431, P71, DOI 10.1038/nature02865; Wilmer JB, 2010, P NATL ACAD SCI USA, V107, P5238, DOI 10.1073/pnas.0913053107; Zhu Q, 2010, CURR BIOL, V20, P137, DOI 10.1016/j.cub.2009.11.067	15	14	14	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 23	2010	328	5977					435	436		10.1126/science.1190432	http://dx.doi.org/10.1126/science.1190432			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	586YR	20413479				2022-12-28	WOS:000276952400019
J	Adesnik, H; Scanziani, M				Adesnik, Hillel; Scanziani, Massimo			Lateral competition for cortical space by layer-specific horizontal circuits	NATURE			English	Article							PRIMARY VISUAL-CORTEX; SOMATOSENSORY BARREL CORTEX; ACTION-POTENTIAL INITIATION; PYRAMIDAL NEURONS; IN-VIVO; ORIENTATION SELECTIVITY; GABAERGIC INTERNEURONS; SYNAPTIC CONNECTIONS; SENSORY RESPONSES; STRIATE CORTEX	The cerebral cortex constructs a coherent representation of the world by integrating distinct features of the sensory environment. Although these features are processed vertically across cortical layers, horizontal projections interconnecting neighbouring cortical domains allow these features to be processed in a context-dependent manner. Despite the wealth of physiological and psychophysical studies addressing the function of horizontal projections, how they coordinate activity among cortical domains remains poorly understood. We addressed this question by selectively activating horizontal projection neurons in mouse somatosensory cortex, and determined how the resulting spatial pattern of excitation and inhibition affects cortical activity. We found that horizontal projections suppress superficial layers while simultaneously activating deeper cortical output layers. This layer-specific modulation does not result from a spatial separation of excitation and inhibition, but from a layer-specific ratio between these two opposing conductances. Through this mechanism, cortical domains exploit horizontal projections to compete for cortical space.	[Adesnik, Hillel; Scanziani, Massimo] Univ Calif San Diego, Howard Hughes Med Inst, Ctr Neural Circuits & Behav, Neurobiol Sect, La Jolla, CA 92093 USA; [Adesnik, Hillel; Scanziani, Massimo] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Scanziani, M (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Ctr Neural Circuits & Behav, Neurobiol Sect, La Jolla, CA 92093 USA.	massimo@ucsd.edu			National Institute for Mental Health [R01 MH70058]; Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070058] Funding Source: NIH RePORTER	National Institute for Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank P. Abelkop for immunohistochemical labelling, J. Isaacson and R. Malinow for critical reading of the manuscript and the members of the Scanziani and Isaacson laboratory for advice during the course of the study. We thank K. Svoboda for pCAGGS-ChR2-Venus (Addgene 15753), C. Cepko for pCAG-GFP (Addgene 11150) and K. Deisseroth for sharing reagents. This work was supported in part by a grant from the National Institute for Mental Health (R01 MH70058). H. A. was supported by the Helen Hay Whitney Foundation. M. S. is an investigator of the Howard Hughes Medical Institute.	AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Bartos M, 2002, P NATL ACAD SCI USA, V99, P13222, DOI 10.1073/pnas.192233099; Benucci A, 2007, NEURON, V55, P103, DOI 10.1016/j.neuron.2007.06.017; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Bosking WH, 1997, J NEUROSCI, V17, P2112; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Carnevale NT, 2006, NEURON BOOK; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; Douglas R, 1998, SYNAPTIC ORG BRAIN, V4th; Feldmeyer D, 2006, J PHYSIOL-LONDON, V575, P583, DOI 10.1113/jphysiol.2006.105106; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Fukuda T, 2006, J NEUROSCI, V26, P3434, DOI 10.1523/JNEUROSCI.4076-05.2006; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; Gottlieb JP, 1997, EXP BRAIN RES, V115, P47, DOI 10.1007/PL00005684; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Helmstaedter M, 2009, CEREB CORTEX, V19, P926, DOI 10.1093/cercor/bhn141; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; Jones MS, 1997, BRAIN RES, V768, P167, DOI 10.1016/S0006-8993(97)00639-2; Kampa BM, 2006, NAT NEUROSCI, V9, P1472, DOI 10.1038/nn1798; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; Manns ID, 2004, J PHYSIOL-LONDON, V556, P601, DOI 10.1113/jphysiol.2003.053132; Meeks JP, 2007, J NEUROPHYSIOL, V97, P3460, DOI 10.1152/jn.01288.2006; MOUNTCASTLE VB, 1959, B JOHNS HOPKINS HOSP, V105, P201; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nase G, 2003, J NEUROPHYSIOL, V90, P1115, DOI 10.1152/jn.00480.2002; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Pouille F, 2009, NAT NEUROSCI, V12, P1577, DOI 10.1038/nn.2441; RAMACHANDRAN VS, 1991, NATURE, V350, P699, DOI 10.1038/350699a0; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Shimegi S, 1999, J NEUROSCI, V19, P10164; Shu YS, 2007, J NEUROPHYSIOL, V97, P746, DOI 10.1152/jn.00922.2006; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Tucker TR, 2003, J NEUROPHYSIOL, V89, P488, DOI 10.1152/jn.00869.2001	47	245	247	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2010	464	7292					1155	U71		10.1038/nature08935	http://dx.doi.org/10.1038/nature08935			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20414303	Green Accepted			2022-12-28	WOS:000276891100029
J	Iwai, M; Takizawa, K; Tokutsu, R; Okamuro, A; Takahashi, Y; Minagawa, J				Iwai, Masakazu; Takizawa, Kenji; Tokutsu, Ryutaro; Okamuro, Akira; Takahashi, Yuichiro; Minagawa, Jun			Isolation of the elusive supercomplex that drives cyclic electron flow in photosynthesis	NATURE			English	Article							CYTOCHROME B(6)F COMPLEX; CHLAMYDOMONAS-REINHARDTII; PHOTOSYSTEM-I; STATE TRANSITIONS; TRANSPORT; ARABIDOPSIS; PLANTS; PHOTOPHOSPHORYLATION; PLASTOCYANIN; ACCLIMATION	Photosynthetic light reactions establish electron flow in the chloroplast's thylakoid membranes, leading to the production of the ATP and NADPH that participate in carbon fixation. Two modes of electron flow exist-linear electron flow (LEF) from water to NADP 1 via photosystem (PS) II and PSI in series(1) and cyclic electron flow (CEF) around PSI (ref. 2). Although CEF is essential for satisfying the varying demand for ATP, the exact molecule(s) and operational site are as yet unclear. In the green alga Chlamydomonas reinhardtii, the electron flow shifts from LEF to CEF on preferential excitation of PSII (ref. 3), which is brought about by an energy balancing mechanism between PSII and PSI (state transitions(4)). Here, we isolated a protein super-complex composed of PSI with its own light-harvesting complex (LHCI), the PSII light-harvesting complex (LHCII), the cytochrome b(6)f complex (Cyt bf), ferredoxin (Fd)-NADPH oxidoreductase (FNR), and the integral membrane protein PGRL1 (ref. 5) from C. reinhardtii cells under PSII-favouring conditions. Spectroscopic analyses indicated that on illumination, reducing equivalents from downstream of PSI were transferred to Cyt bf, whereas oxidised PSI was re-reduced by reducing equivalents from Cyt bf, indicating that this supercomplex is engaged in CEF (Supplementary Fig. 1). Thus, formation and dissociation of the PSI-LHCI-LHCII-FNR-Cyt bf-PGRL1 supercomplex not only controlled the energy balance of the two photosystems, but also switched the mode of photosynthetic electron flow.	[Iwai, Masakazu; Takizawa, Kenji; Tokutsu, Ryutaro; Minagawa, Jun] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan; [Okamuro, Akira; Takahashi, Yuichiro] Okayama Univ, Fac Sci, Dept Biol, Okayama 7008530, Japan	Hokkaido University; Okayama University	Minagawa, J (corresponding author), Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan.	minagawa@lowtem.hokudai.ac.jp	Tokutsu, Ryutaro/V-7596-2019; Takahashi, Yuichiro/B-2062-2011; Tokutsu, Ryutaro/GRF-0208-2022	Tokutsu, Ryutaro/0000-0003-2037-255X; Takahashi, Yuichiro/0000-0001-6410-0447; Minagawa, Jun/0000-0002-3028-3203; Takizawa, Kenji/0000-0002-1060-5738; Iwai, Masakazu/0000-0002-0986-9015	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology [18GS0318, 2120006309, 2157003109]; Japan Science and Technology Agency; Natural Sciences by the Mitsubishi Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Natural Sciences by the Mitsubishi Foundation	We thank S. Ozawa and M. Kuwano for technical help with MS/ MS analysis, D. Kramer for valuable discussions, T. Shikanai, D. Leister and T. Hase for providing antibodies, and K. Redding for providing the PSI- His mutant. This study was supported by the Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science (M. I., R. T.), Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (Y. T., 18GS0318; J. M., 18GS0318, 2120006309, 2157003109), the Strategic International Cooperative Program by Japan Science and Technology Agency (J. M.), and a Research Grant in the Natural Sciences by the Mitsubishi Foundation (J. M.).	Allen JF, 2003, TRENDS PLANT SCI, V8, P15, DOI 10.1016/S1360-1385(02)00006-7; ARNON DI, 1958, SCIENCE, V127, P1026, DOI 10.1126/science.127.3305.1026; ARNON DI, 1954, NATURE, V174, P394, DOI 10.1038/174394a0; Avenson TJ, 2004, P NATL ACAD SCI USA, V101, P5530, DOI 10.1073/pnas.0401269101; BENDALL DS, 1995, BBA-BIOENERGETICS, V1229, P23, DOI 10.1016/0005-2728(94)00195-B; Breyton C, 2006, BIOCHEMISTRY-US, V45, P13465, DOI 10.1021/bi061439s; BULTE L, 1990, BIOCHIM BIOPHYS ACTA, V1020, P72, DOI 10.1016/0005-2728(90)90095-L; DalCorso G, 2008, CELL, V132, P273, DOI 10.1016/j.cell.2007.12.028; Finazzi G, 2002, EMBO REP, V3, P280, DOI 10.1093/embo-reports/kvf047; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Gulis G, 2008, PHOTOSYNTH RES, V96, P51, DOI 10.1007/s11120-007-9283-9; Hamel P, 2000, J BIOL CHEM, V275, P17072, DOI 10.1074/jbc.M001468200; Hippler M, 1997, BIOCHEMISTRY-US, V36, P6343, DOI 10.1021/bi970082c; Iwai M, 2008, PLANT CELL, V20, P2177, DOI 10.1105/tpc.108.059352; Joliot P, 2002, P NATL ACAD SCI USA, V99, P10209, DOI 10.1073/pnas.102306999; Kramer DM, 2004, TRENDS PLANT SCI, V9, P349, DOI 10.1016/j.tplants.2004.05.001; LAISK A, 1993, P ROY SOC B-BIOL SCI, V251, P243, DOI 10.1098/rspb.1993.0036; LAM E, 1982, FEBS LETT, V141, P98, DOI 10.1016/0014-5793(82)80024-0; LEMAIRE C, 1986, BIOCHIM BIOPHYS ACTA, V851, P229, DOI 10.1016/0005-2728(86)90130-1; MARKWELL JP, 1980, BIOCHIM BIOPHYS ACTA, V591, P391, DOI 10.1016/0005-2728(80)90170-X; Metzger SU, 1997, BBA-BIOENERGETICS, V1319, P233, DOI 10.1016/S0005-2728(96)00164-8; Munekage Y, 2002, CELL, V110, P361, DOI 10.1016/S0092-8674(02)00867-X; OGAWA T, 1991, P NATL ACAD SCI USA, V88, P4275, DOI 10.1073/pnas.88.10.4275; Pesaresi P, 2009, PLANT CELL, V21, P2402, DOI 10.1105/tpc.108.064964; RICH PR, 1987, BIOCHIM BIOPHYS ACTA, V892, P138, DOI 10.1016/0005-2728(87)90256-8; Rochaix JD, 2007, FEBS LETT, V581, P2768, DOI 10.1016/j.febslet.2007.04.038; Sacksteder CA, 2001, PHOTOSYNTH RES, V70, P231, DOI 10.1023/A:1017906626288; Shikanai T, 2007, ANNU REV PLANT BIOL, V58, P199, DOI 10.1146/annurev.arplant.58.091406.110525; TAGAWA K, 1963, P NATL ACAD SCI USA, V49, P567, DOI 10.1073/pnas.49.4.567; Takahashi H, 2006, P NATL ACAD SCI USA, V103, P477, DOI 10.1073/pnas.0509952103; VALLON O, 1991, P NATL ACAD SCI USA, V88, P8262, DOI 10.1073/pnas.88.18.8262; Zhang HM, 2001, J BIOL CHEM, V276, P38159	32	315	329	2	183	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2010	464	7292					1210	U134		10.1038/nature08885	http://dx.doi.org/10.1038/nature08885			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20364124				2022-12-28	WOS:000276891100041
J	Thorel, F; Nepote, V; Avril, I; Kohno, K; Desgraz, R; Chera, S; Herrera, PL				Thorel, Fabrizio; Nepote, Virginie; Avril, Isabelle; Kohno, Kenji; Desgraz, Renaud; Chera, Simona; Herrera, Pedro L.			Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss	NATURE			English	Article							DIPHTHERIA-TOXIN RECEPTOR; TRANSCRIPTION FACTOR; MOUSE PANCREAS; IN-VITRO; ECTOPIC EXPRESSION; GLUCAGON-SECRETION; ENDOCRINE PANCREAS; DIABETES-MELLITUS; PROGENITOR CELLS; REGENERATION	Pancreatic insulin-producing beta-cells have a long lifespan, such that in healthy conditions they replicate little during a lifetime. Nevertheless, they show increased self-duplication after increased metabolic demand or after injury (that is, beta-cell loss). It is not known whether adult mammals can differentiate (regenerate) new-beta-cells after extreme, total beta-cell loss, as in diabetes. This would indicate differentiation from precursors or another heterologous (non-beta-cell) source. Here we show beta-cell regeneration in a transgenicmodel of diphtheria-toxin-induced acute selective near-total beta-cell ablation. If given insulin, the mice survived and showed beta-cell mass augmentation with time. Lineage-tracing to label the glucagon-producing alpha-cells before beta-cell ablation tracked large fractions of regenerated beta-cells as deriving from alpha-cells, revealing a previously disregarded degree of pancreatic cell plasticity. Such inter-endocrine spontaneous adult cell conversion could be harnessed towards methods of producing beta-cells for diabetes therapies, either in differentiation settings in vitro or in induced regeneration.	[Thorel, Fabrizio; Nepote, Virginie; Avril, Isabelle; Desgraz, Renaud; Chera, Simona; Herrera, Pedro L.] Univ Geneva, Fac Med, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland; [Kohno, Kenji] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan	University of Geneva; Nara Institute of Science & Technology	Herrera, PL (corresponding author), Univ Geneva, Fac Med, Dept Cell Physiol & Metab, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	pedro.herrera@unige.ch	Kohno, Kenji/AAZ-6573-2020; CHERA, Simona/N-3207-2014	Kohno, Kenji/0000-0002-3503-6551; CHERA, Simona/0000-0001-6310-3486; Herrera Merino, Pedro Luis/0000-0003-0771-9504	NIH/NIDDK; JDRF; Swiss National Science Foundation; EU; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK072522] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); JDRF(Juvenile Diabetes Research Foundation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EU(European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to P. Vassalli and C. V. E. Wright for their comments and support. We also thank R. Stein, S. Kim and A. Ruiz i Altaba for discussions, and G. Flores, C. Gysler, O. Fazio, G. Philippin and C. Vesin for their technical help. We thank D. Melton for the RIP-CreER transgenic strain, and B. Thorens and C. V. E. Wright for anti-Glut2 and anti-Pdx1 antibodies, respectively. Work was funded with grants from the NIH/NIDDK ('Beta Cell Biology Consortium'), JDRF (Juvenile Diabetes Research Foundation), Swiss National Science Foundation (and the NCCR 'Frontiers in Genetics'), and 6FP EU Integrated Project 'Beta Cell Therapy for Diabetes' to P. L. H.	Baeyens L, 2005, DIABETOLOGIA, V48, P49, DOI 10.1007/s00125-004-1606-1; Bonal C, 2008, INT J DEV BIOL, V52, P823, DOI 10.1387/ijdb.072444cb; Bonal C, 2009, GASTROENTEROLOGY, V136, P309, DOI 10.1053/j.gastro.2008.10.015; Bonner-Weir S, 2005, NAT BIOTECHNOL, V23, P857, DOI 10.1038/nbt1115; BONNERWEIR S, 1993, DIABETES, V42, P1715, DOI 10.2337/diabetes.42.12.1715; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Cano DA, 2008, DIABETES, V57, P958, DOI 10.2337/db07-0913; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; Desgraz R, 2009, DEVELOPMENT, V136, P3567, DOI 10.1242/dev.039214; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214; Fodor A, 2007, DIABETOLOGIA, V50, P121, DOI 10.1007/s00125-006-0509-8; GERICH JE, 1975, JAMA-J AM MED ASSOC, V234, P159, DOI 10.1001/jama.234.2.159; Heimberg H, 1996, P NATL ACAD SCI USA, V93, P7036, DOI 10.1073/pnas.93.14.7036; HEIMBERG H, 1995, J BIOL CHEM, V270, P8971, DOI 10.1074/jbc.270.15.8971; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Herrera PL, 2000, DEVELOPMENT, V127, P2317; HERRERA PL, 1994, P NATL ACAD SCI USA, V91, P12999, DOI 10.1073/pnas.91.26.12999; Herrera PL, 2002, ENDOCRINE, V19, P267, DOI 10.1385/ENDO:19:3:267; Hogan B, 1994, MANIPULATING MOUSE E, P289; Karges B, 2004, DIABETES CARE, V27, P1207, DOI 10.2337/diacare.27.5.1207; Karges B, 2006, DIABETES-METAB RES, V22, P184, DOI 10.1002/dmrr.600; Li WC, 2005, MECH DEVELOP, V122, P835, DOI 10.1016/j.mod.2005.01.001; Matveyenko AV, 2008, DIABETES OBES METAB, V10, P23, DOI 10.1111/j.1463-1326.2008.00939.x; Meier JJ, 2006, DIABETOLOGIA, V49, P1838, DOI 10.1007/s00125-006-0308-2; Meier JJ, 2005, DIABETOLOGIA, V48, P2221, DOI 10.1007/s00125-005-1949-2; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; NGUYEN VX, 1989, ANTIMICROB AGENTS CH, V33, P434, DOI 10.1128/AAC.33.4.434; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Quoix N, 2007, FEBS LETT, V581, P4235, DOI 10.1016/j.febslet.2007.07.068; Rankin MM, 2009, DIABETES, V58, P1365, DOI 10.2337/db08-1198; Ritz-Laser B, 2003, DIABETOLOGIA, V46, P810, DOI 10.1007/s00125-003-1115-7; Rorsman P, 2008, TRENDS ENDOCRIN MET, V19, P277, DOI 10.1016/j.tem.2008.07.003; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Schisler JC, 2005, P NATL ACAD SCI USA, V102, P7297, DOI 10.1073/pnas.0502168102; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Thyssen S, 2006, ENDOCRINOLOGY, V147, P2346, DOI 10.1210/en.2005-0396; Trucco M, 2005, J CLIN INVEST, V115, P5, DOI 10.1172/JCI200523935; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; WANG RN, 1995, DIABETOLOGIA, V38, P1405, DOI 10.1007/BF00400600; Wang RN, 1996, DIABETOLOGIA, V39, P548, DOI 10.1007/BF00403301; Wang ZV, 2008, DIABETES, V57, P2137, DOI 10.2337/db07-1631; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	50	805	838	0	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2010	464	7292					1149	1154		10.1038/nature08894	http://dx.doi.org/10.1038/nature08894			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20364121	Green Accepted			2022-12-28	WOS:000276891100028
J	Wang, LB; Seidman, JG; Seidman, CE				Wang, Libin; Seidman, Jonathan G.; Seidman, Christine E.			Narrative Review: Harnessing Molecular Genetics for the Diagnosis and Management of Hypertrophic Cardiomyopathy	ANNALS OF INTERNAL MEDICINE			English	Review							MYOSIN HEAVY-CHAIN; CARDIAC TROPONIN-T; BINDING-PROTEIN-C; TRANSGENIC RABBIT MODEL; MOUSE MODEL; OBSTRUCTIVE CARDIOMYOPATHY; PROGNOSTIC IMPLICATIONS; MAGNETIC-RESONANCE; MEDICAL PROGRESS; HEART-FAILURE	Unexplained cardiac hypertrophy, the diagnostic criterion for hypertrophic cardiomyopathy (HCM), occurs in 1 in 500 adults. Insights into the genetic cause and molecular pathophysiology of HCM are reshaping clinical paradigms for diagnosis and treatment of this common myocardial disorder. Human genetic studies have established that dominant mutations in the proteins that make up the contractile apparatus ( the sarcomere) cause HCM. With the current availability of clinical gene-based diagnostics, pathogenic mutations in affected patients can be defined, which can suggest a clinical course and allow definitive preclinical identification of family members at risk for HCM. Genetic discoveries have also fostered mechanistic investigations in model organisms that are engineered to carry human HCM mutations. Novel therapeutic targets have emerged from these fundamental studies and are currently under clinical assessment in humans. The combination of contemporary gene-based diagnosis with new strategies to attenuate disease development and progression is changing the natural history of lifelong cardiac symptoms, arrhythmias, and heart failure from HCM.	[Seidman, Christine E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Seidman, CE (corresponding author), Harvard Univ, Sch Med, Dept Genet, Room 256 NRB,77 Louis Pasteur Ave, Boston, MA 02115 USA.	cseidman@genetics.med.harvard.edu			Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [PL1 HL092552-03, R01 HL084553, R01 HL084553-04, PL1 HL092552, R01 HL080494-03, R01 HL080494] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [PL1HL092552, R01HL084553, R01HL080494] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adabag AS, 2008, J AM COLL CARDIOL, V51, P1369, DOI 10.1016/j.jacc.2007.11.071; Ahmad F, 2005, ANNU REV GENOM HUM G, V6, P185, DOI 10.1146/annurev.genom.6.080604.162132; Alcalai R, 2008, J CARDIOVASC ELECTR, V19, P104, DOI 10.1111/j.1540-8167.2007.00965.x; ANAN R, 1994, J CLIN INVEST, V93, P280, DOI 10.1172/JCI116957; Arad M, 2005, CIRCULATION, V112, P2805, DOI 10.1161/CIRCULATIONAHA.105.547448; Arad M, 2005, NEW ENGL J MED, V352, P362, DOI 10.1056/NEJMoa033349; Arad M, 2002, J CLIN INVEST, V109, P357, DOI 10.1172/JCI200214571; Baudenbacher F, 2008, J CLIN INVEST, V118, P3893, DOI 10.1172/JCI36642; Blair E, 2001, HUM MOL GENET, V10, P1215, DOI 10.1093/hmg/10.11.1215; BROCK R, 1957, Guys Hosp Rep, V106, P221; Camici PG, 2007, NEW ENGL J MED, V356, P830, DOI 10.1056/NEJMra061889; Chandra M, 2005, AM J PHYSIOL-HEART C, V289, pH2112, DOI 10.1152/ajpheart.00571.2005; Dearani Joseph A, 2005, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, P86, DOI 10.1053/j.pcsu.2005.01.003; Debold EP, 2007, AM J PHYSIOL-HEART C, V293, pH284, DOI 10.1152/ajpheart.00128.2007; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; Elliott P, 2008, HEART, V94, P1269, DOI 10.1136/hrt.2008.154385; Elliott P, 2004, LANCET, V363, P1881, DOI 10.1016/S0140-6736(04)16358-7; Faber L, 1998, CIRCULATION, V98, P2415, DOI 10.1161/01.CIR.98.22.2415; Fatkin D, 2000, J CLIN INVEST, V106, P1351, DOI 10.1172/JCI11093; Fernandes VL, 2008, JACC-CARDIOVASC INTE, V1, P561, DOI 10.1016/j.jcin.2008.07.005; GeisterferLowrance AAT, 1996, SCIENCE, V272, P731, DOI 10.1126/science.272.5262.731; Georgakopoulos D, 1999, NAT MED, V5, P327, DOI 10.1038/6549; Gollob MH, 2001, NEW ENGL J MED, V344, P1823, DOI 10.1056/NEJM200106143442403; Haim TE, 2007, J MOL CELL CARDIOL, V42, P1098, DOI 10.1016/j.yjmcc.2007.03.906; Harris KM, 2006, CIRCULATION, V114, P216, DOI 10.1161/CIRCULATIONAHA.105.583500; Hershberger RE, 2009, CIRC-HEART FAIL, V2, P253, DOI 10.1161/CIRCHEARTFAILURE.108.817346; Ho CY, 2002, CIRCULATION, V105, P2992, DOI 10.1161/01.CIR.0000019070.70491.6D; Ingles J, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.033886; Keren A, 2008, NAT CLIN PRACT CARD, V5, P158, DOI 10.1038/ncpcardio1110; Kubo T, 2009, CIRC J, V73, P1599, DOI 10.1253/circj.CJ-09-0140; Kwon DH, 2008, JACC-CARDIOVASC INTE, V1, P432, DOI 10.1016/j.jcin.2008.05.009; Lim DS, 2001, CIRCULATION, V103, P789, DOI 10.1161/01.CIR.103.6.789; Lombardi R, 2009, CIRCULATION, V119, P1398, DOI 10.1161/CIRCULATIONAHA.108.790501; Marian AJ, 1999, J CLIN INVEST, V104, P1683, DOI 10.1172/JCI7956; Marian AJ, 2008, CURR OPIN CARDIOL, V23, P199, DOI 10.1097/HCO.0b013e3282fc27d9; Maron BJ, 2009, JAMA-J AM MED ASSOC, V301, P1253, DOI 10.1001/jama.2009.371; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Maron BJ, 2003, NEW ENGL J MED, V349, P1064, DOI 10.1056/NEJMra022783; Maron BJ, 2003, J AM COLL CARDIOL, V42, P882, DOI 10.1016/S0735-1097(03)00855-6; Maron BJ, 2000, NEW ENGL J MED, V342, P365, DOI 10.1056/NEJM200002103420601; McConnell BK, 2001, CIRC RES, V88, P383; Miller T, 2001, J BIOL CHEM, V276, P3743, DOI 10.1074/jbc.M006746200; Minamisawa S, 2004, EXP MOL MED, V36, P193, DOI 10.1038/emm.2004.27; Morita H, 2008, NEW ENGL J MED, V358, P1899, DOI 10.1056/NEJMoa075463; Niimura H, 2002, CIRCULATION, V105, P446, DOI 10.1161/hc0402.102990; Niimura H, 1998, NEW ENGL J MED, V338, P1248, DOI 10.1056/NEJM199804303381802; Nishimura RA, 2004, NEW ENGL J MED, V350, P1320, DOI 10.1056/NEJMcp030779; Oka K, 2008, J CARDIOL, V52, P146, DOI 10.1016/j.jjcc.2008.07.003; Olivotto I, 2008, MAYO CLIN PROC, V83, P630, DOI 10.4065/83.6.630; Ommen SR, 2008, HEART, V94, P1276, DOI 10.1136/hrt.2008.154435; Palmiter KA, 2000, J MUSCLE RES CELL M, V21, P609, DOI 10.1023/A:1005678905119; Penicka M, 2009, J MOL DIAGN, V11, P35, DOI 10.2353/jmoldx.2009.080082; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Semsarian C, 2002, J CLIN INVEST, V109, P1013, DOI 10.1172/JCI200214677; Spirito P, 1997, NEW ENGL J MED, V336, P775, DOI 10.1056/NEJM199703133361107; Spirito P, 2006, BMJ-BRIT MED J, V332, P1251, DOI 10.1136/bmj.332.7552.1251; Szczesna-Cordary D, 2007, FASEB J, V21, P3974, DOI 10.1096/fj.07-8630com; Tardiff JC, 1999, J CLIN INVEST, V104, P469, DOI 10.1172/JCI6067; TEARE D, 1958, BRIT HEART J, V20, P1; Varnava AM, 2001, AM J CARDIOL, V88, P275, DOI 10.1016/S0002-9149(01)01640-X; Wang SX, 2008, CLIN CARDIOL, V31, P114, DOI 10.1002/clc.20151; Watkins H, 2008, HEART, V94, P1264, DOI 10.1136/hrt.2008.154104; WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603; WATKINS H, 1992, NEW ENGL J MED, V326, P1108, DOI 10.1056/NEJM199204233261703; Wolf CM, 2005, P NATL ACAD SCI USA, V102, P18123, DOI 10.1073/pnas.0509145102; Woo A, 2003, HEART, V89, P1179, DOI 10.1136/heart.89.10.1179; Yamazaki T, 2007, INT HEART J, V48, P715, DOI 10.1536/ihj.48.715; Yang QL, 1998, J CLIN INVEST, V102, P1292, DOI 10.1172/JCI3880; Yano M, 2005, J CLIN INVEST, V115, P556, DOI 10.1172/JCI200524159	69	60	64	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 20	2010	152	8					513	U62		10.7326/0003-4819-152-8-201004200-00008	http://dx.doi.org/10.7326/0003-4819-152-8-201004200-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588FV	20404382	Green Accepted			2022-12-28	WOS:000277054400005
J	Ferris, P; Olson, BJSC; De Hoff, PL; Douglass, S; Casero, D; Prochnik, S; Geng, S; Rai, R; Grimwood, J; Schmutz, J; Nishii, I; Hamaji, T; Nozaki, H; Pellegrini, M; Umen, JG				Ferris, Patrick; Olson, Bradley J. S. C.; De Hoff, Peter L.; Douglass, Stephen; Casero, David; Prochnik, Simon; Geng, Sa; Rai, Rhitu; Grimwood, Jane; Schmutz, Jeremy; Nishii, Ichiro; Hamaji, Takashi; Nozaki, Hisayoshi; Pellegrini, Matteo; Umen, James G.			Evolution of an Expanded Sex-Determining Locus in Volvox	SCIENCE			English	Article							MINUS-DOMINANCE GENE; MATING-TYPE LOCUS; CHLAMYDOMONAS-REINHARDTII; CHROMOSOME EVOLUTION; Y-CHROMOSOME; ORIGIN; IDENTIFICATION; DIMORPHISM; REVEALS	Although dimorphic sexes have evolved repeatedly in multicellular eukaryotes, their origins are unknown. The mating locus (MT) of the sexually dimorphic multicellular green alga Volvox carteri specifies the production of eggs and sperm and has undergone a remarkable expansion and divergence relative to MT from Chlamydomonas reinhardtii, which is a closely related unicellular species that has equal-sized gametes. Transcriptome analysis revealed a rewired gametic expression program for Volvox MT genes relative to Chlamydomonas and identified multiple gender-specific and sex-regulated transcripts. The retinoblastoma tumor suppressor homolog MAT3 is a Volvox MT gene that displays sexually regulated alternative splicing and evidence of gender-specific selection, both of which are indicative of cooption into the sexual cycle. Thus, sex-determining loci affect the evolution of both sex-related and non-sex-related genes.	[Ferris, Patrick; Olson, Bradley J. S. C.; De Hoff, Peter L.; Geng, Sa; Rai, Rhitu; Umen, James G.] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Douglass, Stephen; Casero, David; Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Douglass, Stephen; Casero, David; Pellegrini, Matteo] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Prochnik, Simon] US DOE, JGI, Walnut Creek, CA 95498 USA; [Rai, Rhitu] Indian Agr Res Inst, Lab Plant Microbe Interact, Natl Res Ctr Plant Biotechnol, New Delhi 110012, India; [Grimwood, Jane; Schmutz, Jeremy] Hudson Alpha Inst Biotechnol, Genome Sequencing Ctr, Huntsville, AL 35806 USA; [Nishii, Ichiro] Nara Womens Univ, Dept Biol Sci, Nara 6308506, Japan; [Hamaji, Takashi; Nozaki, Hisayoshi] Univ Tokyo, Dept Biol Sci, Tokyo 1130033, Japan	Salk Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; United States Department of Energy (DOE); Joint Genome Institute - JGI; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; ICAR - National Institute For Plant Biotechnology (NIPB); Nara Womens University; University of Tokyo	Umen, JG (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	umen@salk.edu	Olson, Bradley J S C/A-4532-2013; Casero, David/E-7365-2010; NOZAKI, HISAYOSHI/G-4926-2014; Grimwood, Jane/ABD-5737-2021; Umen, James G/K-9120-2013; Schmutz, Jeremy/N-3173-2013	Olson, Bradley J S C/0000-0002-4751-8347; Casero, David/0000-0002-7347-3330; Umen, James G/0000-0003-4094-9045; Schmutz, Jeremy/0000-0001-8062-9172; Nozaki, Hisayoshi/0000-0002-9308-4498; Hamaji, Takashi/0000-0002-2801-2148; Pellegrini, Matteo/0000-0001-9355-9564	Coypu Foundation; NIH [R01 GM078376, F32 GM086037, T32-HG002536, DE-FC02-02ER63421]; Japan Society for the Promotion of Science [S05750/L06701]; Ministry of Education, Culture, Sports, Science and Technology, Japan [20247032]; AFOSR; DOE-JGI [776835]; DOE [DE-AC02-05CH11231]; DOE's Office of Science, Biological and Environmental Research; University of California, Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Los Alamos National Laboratory [DE-AC02-06NA25396]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078376, F32GM086037] Funding Source: NIH RePORTER	Coypu Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); DOE-JGI; DOE(United States Department of Energy (DOE)); DOE's Office of Science, Biological and Environmental Research; University of California, Lawrence Berkeley National Laboratory(University of California System); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Kirk for DNA from Volvox mapping populations. We thank V. Lundblad and S. Merchant for advice on the manuscript. This work was supported by the Coypu Foundation and from grants NIH R01 GM078376 to J.G.U.; NIH F32 GM086037 to B.O.; Japan Society for the Promotion of Science grant S05750/L06701 to P. F.; Grant-in-Aid for Scientific Research (20247032) from the Ministry of Education, Culture, Sports, Science and Technology, Japan to H.N.; NIH grant T32-HG002536 to S. D.; and DE-FC02-02ER63421 and AFOSR to M. P. DOE-JGI provided sequencing and analyses for algal mating loci under the Community Sequencing Program (776835) supported by the Office of Science of DOE under contract DE-AC02-05CH11231. Sequencing of the V. carteri genome was performed under the auspices of DOE's Office of Science, Biological and Environmental Research Program and by the University of California, Lawrence Berkeley National Laboratory under contract DE-AC02-05CH11231, Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344, and Los Alamos National Laboratory under contract DE-AC02-06NA25396. Sequences generated in this study have been deposited in GenBank under accession numbers GU814014, GU814015, GU784915, GU784916, and GU735444-GU735478. Materials used in this study will be made available upon request with the completion of a Materials Transfer Agreement from Salk Institute.	Bachtrog D, 2006, CURR OPIN GENET DEV, V16, P578, DOI 10.1016/j.gde.2006.10.007; BULL JJ, 1978, AM NAT, V112, P245, DOI 10.1086/283267; CHARLESWORTH B, 1978, J THEOR BIOL, V73, P347, DOI 10.1016/0022-5193(78)90195-9; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; Fang SC, 2006, PLOS GENET, V2, P1565, DOI 10.1371/journal.pgen.0020167; Ferris PJ, 1997, GENETICS, V146, P859; Ferris PJ, 2002, GENETICS, V160, P181; Fraser JA, 2004, PLOS BIOL, V2, P2243, DOI 10.1371/journal.pbio.0020384; Goodenough U, 2007, SEMIN CELL DEV BIOL, V18, P350, DOI 10.1016/j.semcdb.2007.02.006; Hamaji T, 2008, GENETICS, V178, P283, DOI 10.1534/genetics.107.078618; Hamaji T, 2009, J PHYCOL, V45, P1310, DOI 10.1111/j.1529-8817.2009.00744.x; Herron MD, 2009, P NATL ACAD SCI USA, V106, P3254, DOI 10.1073/pnas.0811205106; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; Idnurm A, 2008, NATURE, V451, P193, DOI 10.1038/nature06453; Kirk DL., 1998, VOLVOX MOL GENETIC O; KLIMAN RM, 1993, MOL BIOL EVOL, V10, P1239; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lin H, 2007, GENETICS, V176, P913, DOI 10.1534/genetics.106.066167; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Menkis A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000030; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Nozaki H, 1996, J PLANT RES, V109, P353, DOI 10.1007/BF02344484; Nozaki H, 2006, CURR BIOL, V16, pR1018, DOI 10.1016/j.cub.2006.11.019; PARKER GA, 1972, J THEOR BIOL, V36, P529, DOI 10.1016/0022-5193(72)90007-0; Umen JG, 2001, GENE DEV, V15, P1652, DOI 10.1101/gad.892101; Waters PD, 2007, SEMIN CELL DEV BIOL, V18, P389, DOI 10.1016/j.semcdb.2007.02.007; Williams TM, 2009, NAT REV GENET, V10, P797, DOI 10.1038/nrg2687; Yamato KT, 2007, P NATL ACAD SCI USA, V104, P6472, DOI 10.1073/pnas.0609054104	28	115	119	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2010	328	5976					351	354		10.1126/science.1186222	http://dx.doi.org/10.1126/science.1186222			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583NR	20395508	Green Accepted			2022-12-28	WOS:000276685000036
J	Macilwain, C				Macilwain, Colin			Moment of reckoning	NATURE			English	Editorial Material												cfmworldview@gmail.com							0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 15	2010	464	7291					975	975		10.1038/464975a	http://dx.doi.org/10.1038/464975a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	582XW	20393535	Bronze			2022-12-28	WOS:000276635000013
J	Trifiro, G; Gambassi, G; Sen, EF; Caputi, AP; Bagnardi, V; Brea, J; Sturkenboom, MCJM				Trifiro, Gianluca; Gambassi, Giovanni; Sen, Elif F.; Caputi, Achille P.; Bagnardi, Vincenzo; Brea, Jose; Sturkenboom, Miriam C. J. M.			Association of Community-Acquired Pneumonia With Antipsychotic Drug Use in Elderly Patients A Nested Case-Control Study	ANNALS OF INTERNAL MEDICINE			English	Article							OLDER-ADULTS; RISK; MORTALITY; AFFINITY; BINDING; EVENTS; RECORDS	Background: According to safety alerts from the U. S. Food and Drug Administration, pneumonia is one of the most frequently reported causes of death in elderly patients with dementia who are treated with antipsychotic drugs. However, epidemiologic evidence of the association between antipsychotic drug use and pneumonia is limited. Objective: To evaluate whether typical or atypical antipsychotic use is associated with fatal or nonfatal pneumonia in elderly persons. Design: Population-based, nested case-control study. Setting: Dutch Integrated Primary Care Information database. Patients: Cohort of persons who used an antipsychotic drug, were 65 years or older, and were registered in the IPCI database from 1996 to 2006. Case patients were all persons with incident community-acquired pneumonia. Up to 20 control participants were matched to each case patient on the basis of age, sex, and date of onset. Measurements: Risk for fatal or nonfatal community-acquired pneumonia with atypical and typical antipsychotic use. Antipsychotic exposure was categorized by type, timing, and daily dose, and the association with pneumonia was assessed by using conditional logistic regression. Results: 258 case patients with incident pneumonia were matched to 1686 control participants. Sixty-five (25%) of the case patients died in 30 days, and their disease was considered fatal. Current use of either atypical (odds ratio [OR], 2.61 [95% CI, 1.48 to 4.61]) or typical (OR, 1.76 [CI, 1.22 to 2.53]) antipsychotic drugs was associated with a dose-dependent increase in the risk for pneumonia compared with past use of antipsychotic drugs. Only atypical antipsychotic drugs were associated with an increase in the risk for fatal pneumonia (OR, 5.97 [CI, 1.49 to 23.98]). Limitations: Antipsychotic exposure was based on prescription files. Residual confounding due to unmeasured covariates or severity of disease was possible. Conclusion: The use of either atypical or typical antipsychotic drugs in elderly patients is associated in a dose-dependent manner with risk for community-acquired pneumonia.	[Trifiro, Gianluca] Erasmus Univ, Med Ctr, Dept Med Informat, NL-3800 DR Rotterdam, Netherlands; Univ Cattolica Sacro Cuore, I-00168 Rome, Italy; Univ Messina, I-98125 Messina, Italy; IRCCS, Ctr Neurolesi Bonino Pulejo, Messina, Italy; Univ Milano Bicocca, I-20126 Milan, Italy; European Inst Oncol, Milan, Italy; Univ Santiago Compostela, Santiago De Compostela 15782, Spain	Erasmus University Rotterdam; Erasmus MC; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Messina; IRCCS Bonino Pulejo; University of Milano-Bicocca; IRCCS European Institute of Oncology (IEO); Universidade de Santiago de Compostela	Trifiro, G (corresponding author), Erasmus Univ, Med Ctr, Dept Med Informat, POB 1738, NL-3800 DR Rotterdam, Netherlands.	g.trifiro@erasmusmc.nl	Brea, Jose/ABH-3260-2020; Trifiro, Gianluca/K-9744-2016	Trifiro, Gianluca/0000-0003-1147-7296; Brea, Jose/0000-0002-5523-1979				Alexopoulos GS, 2004, J CLIN PSYCHIAT, V65, P5; Alexopoulos GS, 2004, J CLIN PSYCHIAT, V65, P100; Barnett MJ, 2006, J CLIN PSYCHOPHARM, V26, P182, DOI 10.1097/01.jcp.0000203598.43314.34; BEAUMONT JJ, 1989, AM J EPIDEMIOL, V129, P212, DOI 10.1093/oxfordjournals.aje.a115111; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Gill SS, 2007, ANN INTERN MED, V146, P775, DOI 10.7326/0003-4819-146-11-200706050-00006; GOLDS PR, 1980, BRIT J PHARMACOL, V68, P541, DOI 10.1111/j.1476-5381.1980.tb14570.x; HORWITZ RI, 1980, AM J MED, V68, P255, DOI 10.1016/0002-9343(80)90363-0; Jeste DV, 1999, AM J GERIAT PSYCHIAT, V7, P70; Knol W, 2008, J AM GERIATR SOC, V56, P661, DOI 10.1111/j.1532-5415.2007.01625.x; Laheij RJF, 2004, JAMA-J AM MED ASSOC, V292, P1955, DOI 10.1001/jama.292.16.1955; LAMBERTS H, 1992, FAM PRACT, V9, P330, DOI 10.1093/fampra/9.3.330; Marder SR, 2003, J CLIN PSYCHIAT, V64, P3; Marrie TJ, 2000, CLIN INFECT DIS, V31, P1066, DOI 10.1086/318124; MOORE KA, 2005, Patent No. 2005035511; PALACIOS JM, 1978, EUR J PHARMACOL, V50, P443, DOI 10.1016/0014-2999(78)90151-6; Pierre JM, 2005, DRUG SAFETY, V28, P191, DOI 10.2165/00002018-200528030-00002; Psaty BM, 1999, J AM GERIATR SOC, V47, P749, DOI 10.1111/j.1532-5415.1999.tb01603.x; Rochon PA, 2008, ARCH INTERN MED, V168, P1090, DOI 10.1001/archinte.168.10.1090; Schindler JS, 2002, LARYNGOSCOPE, V112, P589, DOI 10.1097/00005537-200204000-00001; Sekine Y, 1999, EUR J CLIN PHARMACOL, V55, P583, DOI 10.1007/s002280050676; Silvestre JS, 2005, METHOD FIND EXP CLIN, V27, P289, DOI 10.1358/mf.2005.27.5.908643; Trifiro G, 2005, EUR J CLIN PHARMACOL, V61, P47, DOI 10.1007/s00228-004-0868-3; Trifiro G, 2007, PHARMACOEPIDEM DR S, V16, P538, DOI 10.1002/pds.1334; U.S. Food and Drug Administration, 2005, PUBL HLTH ADV DEATHS; van der Steen JT, 2006, J CLIN EPIDEMIOL, V59, P970, DOI 10.1016/j.jclinepi.2005.12.005; VANDERLEI J, 1993, ANN INTERN MED, V119, P1036, DOI 10.7326/0003-4819-119-10-199311150-00011; Vlug AE, 1999, METHOD INFORM MED, V38, P339; Wada H, 2001, GERONTOLOGY, V47, P271, DOI 10.1159/000052811; Wang PS, 2007, J CLIN PSYCHOPHARM, V27, P707, DOI 10.1097/JCP.0b013e31815a882b; Wang PS, 2005, NEW ENGL J MED, V353, P2335, DOI 10.1056/NEJMoa052827	31	109	111	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 6	2010	152	7					418	W140		10.7326/0003-4819-152-7-201004060-00006	http://dx.doi.org/10.7326/0003-4819-152-7-201004060-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579QI	20368647				2022-12-28	WOS:000276386900002
J	Bhutta, ZA; Chen, L; Cohen, J; Crisp, N; Evans, T; Fineberg, H; Frenk, J; Garcia, P; Horton, R; Ke, Y; Kelley, P; Kistnasamy, B; Meleis, A; Naylor, D; Pablos-Mendez, A; Reddy, S; Scrimshaw, S; Sepulveda, J; Serwadda, D; Zurayk, H				Bhutta, Zulfiqar A.; Chen, Lincoln; Cohen, Jordan; Crisp, Nigel; Evans, Tim; Fineberg, Harvey; Frenk, Julio; Garcia, Patricia; Horton, Richard; Ke, Yang; Kelley, Patrick; Kistnasamy, Barry; Meleis, Afaf; Naylor, David; Pablos-Mendez, Ariel; Reddy, Srinath; Scrimshaw, Susan; Sepulveda, Jaime; Serwadda, David; Zurayk, Huda			Education of health professionals for the 21st century: a global independent Commission	LANCET			English	Editorial Material									[Frenk, Julio] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Bhutta, Zulfiqar A.] Aga Khan Univ, Karachi, Pakistan; [Chen, Lincoln] China Med Board, Cambridge, MA USA; [Cohen, Jordan] George Washington Univ, Washington, DC USA; [Crisp, Nigel] House Lords, London, England; [Evans, Tim] WHO, CH-1211 Geneva, Switzerland; [Fineberg, Harvey; Kelley, Patrick] Natl Acad Sci, Inst Med, Washington, DC 20418 USA; [Garcia, Patricia] Cayetano Heredia Univ, Lima, Peru; [Horton, Richard] The Lancet, London NW1 7BY, England; [Ke, Yang] Peking Univ, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Kistnasamy, Barry] Natl Inst Occupat Hlth, Johannesburg, South Africa; [Meleis, Afaf] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; [Naylor, David] Univ Toronto, Toronto, ON, Canada; [Pablos-Mendez, Ariel] Rockefeller Fdn, New York, NY USA; [Reddy, Srinath] Publ Hlth Fdn India, New Delhi, India; [Scrimshaw, Susan] Sage Coll, Albany, NY USA; [Sepulveda, Jaime] Bill & Melinda Gates Fdn, Seattle, WA USA; [Serwadda, David] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Zurayk, Huda] Amer Univ Beirut, Beirut, Lebanon	Harvard University; Harvard T.H. Chan School of Public Health; Aga Khan University; George Washington University; World Health Organization; National Academies of Sciences, Engineering & Medicine; Universidad Peruana Cayetano Heredia; Peking University; University of Pennsylvania; University of Toronto; Public Health Foundation of India; Bill & Melinda Gates Foundation; Makerere University; American University of Beirut	Frenk, J (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	commission.global.health@gmail.com		Crisp, Nigel/0000-0002-9452-095X				Flexner A., 1910, MED ED US CANADA REP; ED HLTH PROFESSIONAL	2	83	85	1	22	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 3	2010	375	9721					1137	1138		10.1016/S0140-6736(10)60450-3	http://dx.doi.org/10.1016/S0140-6736(10)60450-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	585VL	20362799				2022-12-28	WOS:000276858200004
J	Monnereau, M; Calvet, M; Margerin, L; Souriau, A				Monnereau, Marc; Calvet, Marie; Margerin, Ludovic; Souriau, Annie			Lopsided Growth of Earth's Inner Core	SCIENCE			English	Article							DEPENDENT SEISMIC ATTENUATION; CONVECTION; ANISOTROPY; HETEROGENEITY; CONSTRAINTS; SCATTERING; PHASES	Hemispherical asymmetry is a prominent feature of Earth's inner core, but how this asymmetry relates to core growth is unknown. Based on multiple-scattering modeling of seismic velocity and attenuation measurements sampling the whole uppermost inner core, we propose that the growth of the solid core implies an eastward drift of the material, driven by crystallization in the Western Hemisphere and melting in the Eastern Hemisphere. This self-sustained translational motion generates an asymmetric distribution of sizes of iron crystals, which grow during their translation. The invoked dynamical process is still active today, which supports the idea of a young inner core.	[Monnereau, Marc; Calvet, Marie; Souriau, Annie] Univ Toulouse, CNRS, Observ Midi Pyrenees, F-31400 Toulouse, France; [Margerin, Ludovic] Univ Aix Marseille 3, CNRS, Ctr Europeen Rech & Enseignement Geosci Environm, F-13545 Aix En Provence 04, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Monnereau, M (corresponding author), Univ Toulouse, CNRS, Observ Midi Pyrenees, 14 Ave Edouard Belin, F-31400 Toulouse, France.	marc.monnereau@dtp.obs-mip.fr	Margerin, Ludovic/AAX-4542-2021; Calvet, Marie/AAS-3037-2020; Monnereau, Marc/A-3594-2014	Margerin, Ludovic/0000-0003-4848-3227; Calvet, Marie/0000-0001-9660-5079; Monnereau, Marc/0000-0002-4094-5581	Institut National des Sciences de l'Univers (INSU)-CNRS	Institut National des Sciences de l'Univers (INSU)-CNRS(Centre National de la Recherche Scientifique (CNRS))	We thank V. F. Cormier and two anonymous referees for helpful reviews; M. Toplis, T. Alboussiere, and R. Deguen for stimulating discussions; and the French group Structure, Evolution et Dynamique de l'Interieur de la Terre (SEDIT) Noyau for supporting interdisciplinary exchanges. We thank the institutions that provided data for this study through the Incorporated Research Institutions for Seismology. Financial support has been provided by Institut National des Sciences de l'Univers (INSU)-CNRS programs.	Aubert J, 2001, PHYS EARTH PLANET IN, V128, P51, DOI 10.1016/S0031-9201(01)00277-1; Aubert J, 2008, NATURE, V454, P758, DOI 10.1038/nature07109; Buffett BA, 2009, GEOPHYS J INT, V179, P711, DOI 10.1111/j.1365-246X.2009.04311.x; BUSSE FH, 1970, J FLUID MECH, V44, P441, DOI 10.1017/S0022112070001921; Calvet M, 2008, EARTH PLANET SC LETT, V267, P200, DOI 10.1016/j.epsl.2007.11.048; Cao A, 2004, EARTH PLANET SC LETT, V228, P243, DOI 10.1016/j.epsl.2004.09.032; CHRISTENSEN UR, 1985, J GEOPHYS RES-SOLID, V90, P291, DOI 10.1029/JB090iB12p10291; Cormier VF, 2007, EARTH PLANET SC LETT, V258, P442, DOI 10.1016/j.epsl.2007.04.003; Cormier VF, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2002JB001796; Deguen R, 2009, NAT GEOSCI, V2, P418, DOI 10.1038/NGEO522; Garcia R, 2002, GEOPHYS J INT, V150, P651, DOI 10.1046/j.1365-246X.2002.01717.x; JEANLOZ R, 1988, GEOPHYS RES LETT, V15, P72, DOI 10.1029/GL015i001p00072; Labrosse S, 2001, EARTH PLANET SC LETT, V190, P111, DOI 10.1016/S0012-821X(01)00387-9; Leyton F, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004370; Li X, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2002JB001795; Souriau A., 2007, TREATISE GEOPHYS, V11, P655, DOI DOI 10.1016/B978-044452748-6.00023-7; Stroujkova A, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB002976; Tkalcic H, 2008, AUST J EARTH SCI, V55, P419, DOI 10.1080/08120090801888578; Venet L, 2009, CR GEOSCI, V341, P513, DOI 10.1016/j.crte.2009.06.003; Vocadlo L, 2007, EARTH PLANET SC LETT, V254, P227, DOI 10.1016/j.epsl.2006.09.046; WEBER P, 1992, GEOPHYS RES LETT, V19, P2107, DOI 10.1029/92GL02148; Yoshida S, 1996, J GEOPHYS RES-SOL EA, V101, P28085, DOI 10.1029/96JB02700; Yu WC, 2006, EARTH PLANET SC LETT, V245, P581, DOI 10.1016/j.epsl.2006.03.043; Yu WC, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004868	24	154	155	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2010	328	5981					1014	1017		10.1126/science.1186212	http://dx.doi.org/10.1126/science.1186212			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598YW	20395477				2022-12-28	WOS:000277877100037
J	Schmidt, D; Wilson, MD; Ballester, B; Schwalie, PC; Brown, GD; Marshall, A; Kutter, C; Watt, S; Martinez-Jimenez, CP; Mackay, S; Talianidis, I; Flicek, P; Odom, DT				Schmidt, Dominic; Wilson, Michael D.; Ballester, Benoit; Schwalie, Petra C.; Brown, Gordon D.; Marshall, Aileen; Kutter, Claudia; Watt, Stephen; Martinez-Jimenez, Celia P.; Mackay, Sarah; Talianidis, Iannis; Flicek, Paul; Odom, Duncan T.			Five-Vertebrate ChIP-seq Reveals the Evolutionary Dynamics of Transcription Factor Binding	SCIENCE			English	Article							HUMAN GENOME; FUNCTIONAL ELEMENTS; SEQUENCE ALIGNMENTS; GENE-EXPRESSION; CONSERVATION; REGIONS; SITES; IDENTIFICATION; DISRUPTION; CONSTRAINT	Transcription factors (TFs) direct gene expression by binding to DNA regulatory regions. To explore the evolution of gene regulation, we used chromatin immunoprecipitation with high-throughput sequencing (ChIP-seq) to determine experimentally the genome-wide occupancy of two TFs, CCAAT/enhancer-binding protein alpha and hepatocyte nuclear factor 4 alpha, in the livers of five vertebrates. Although each TF displays highly conserved DNA binding preferences, most binding is species-specific, and aligned binding events present in all five species are rare. Regions near genes with expression levels that are dependent on a TF are often bound by the TF in multiple species yet show no enhanced DNA sequence constraint. Binding divergence between species can be largely explained by sequence changes to the bound motifs. Among the binding events lost in one lineage, only half are recovered by another binding event within 10 kilobases. Our results reveal large interspecies differences in transcriptional regulation and provide insight into regulatory evolution.	[Ballester, Benoit; Schwalie, Petra C.; Flicek, Paul] EBI, EMBL, Cambridge CB10 1SD, England; [Schmidt, Dominic; Wilson, Michael D.; Brown, Gordon D.; Marshall, Aileen; Kutter, Claudia; Watt, Stephen; Odom, Duncan T.] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Schmidt, Dominic; Wilson, Michael D.; Odom, Duncan T.] Univ Cambridge, Dept Oncol, Hutchison Med Res Council Res Ctr, Cambridge CB2 0XZ, England; [Marshall, Aileen] Addenbrookes Hosp, Cambridge Hepatobiliary Serv, Cambridge CB2 2QQ, England; [Martinez-Jimenez, Celia P.; Talianidis, Iannis] Biomed Sci Res Ctr Alexander Fleming, Vari 16672, Greece; [Mackay, Sarah] Univ Glasgow, Fac Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Flicek, Paul] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	European Molecular Biology Laboratory (EMBL); Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Alexander Fleming Biomedical Sciences Research Center; University of Glasgow; Wellcome Trust Sanger Institute	Flicek, P (corresponding author), EBI, EMBL, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England.	flicek@ebi.ac.uk; duncan.odom@cancer.org.uk	Martinez Jimenez, Celia P./K-8751-2012; Talianidis, Iannis/F-7556-2016; Kutter, Claudia/HHD-1391-2022; Ballester, Benoit/N-6127-2016; Pillay, Nischalan/F-9536-2012; Wilson, Michael D/K-6294-2014	Martinez Jimenez, Celia P./0000-0002-9534-6201; Talianidis, Iannis/0000-0002-1209-3609; Ballester, Benoit/0000-0002-0834-7135; Wilson, Michael D/0000-0002-4015-3066; Odom, Duncan/0000-0001-6201-5599; Flicek, Paul/0000-0002-3897-7955; Kutter, Claudia/0000-0002-8047-0058; Schwalie, Petra Catalina/0000-0002-6004-8095	European Research Council; European Molecular Biology Organization Young Investigator Award, Addenbrooke's Biomedical Research Centre, Hutchinson Whampoa; Swiss National Science Foundation; University of Cambridge; Cancer Research UK; Wellcome Trust [WT062023, WT079643]; European Molecular Biology Laboratory; Cancer Research UK [15603] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); European Molecular Biology Organization Young Investigator Award, Addenbrooke's Biomedical Research Centre, Hutchinson Whampoa; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Cambridge(University of Cambridge); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome Trust); European Molecular Biology Laboratory; Cancer Research UK(Cancer Research UK)	We thank N. Matthews and J. Hadfield at the Cambridge Research Institute (CRI) Genomics Core; the CRI Bioinformatics Core; W. Howat and the Histopathology Core; T. Davidge, S. Ballantyne (CRI); A. Enright, S. Wilder, and J. Herrero (European Bioinformatics Institute). This work was supported by the European Research Council Starting Grant, the European Molecular Biology Organization Young Investigator Award, Addenbrooke's Biomedical Research Centre, Hutchinson Whampoa (D.T.O.); Swiss National Science Foundation (C. K.); University of Cambridge (D. S., M. D. W., and D.T.O.); Cancer Research UK (D. S., M. D. W., G. B., C. K., and D.T.O.); the Wellcome Trust (grant nos. WT062023 and WT079643) (B. B. and P. F.); and European Molecular Biology Laboratory (P. C. S. and P. F.). ChIP-seq experiments were deposited into ArrayExpress under the accession number E-TABM-722. CEBPA knockout gene expression experiments were deposited into ArrayExpress under the accession number E-MTAB-178. Author contributions: D. S., M. D. W., and D.T.O. designed experiments; D. S., M. D. W, C. K., S. W., and C.P.M.-J. performed experiments; D. S., M. D. W., B. B., G. B., P. C. S., and P. F. analyzed the data; S. M., C.P.M.-J., I. T., and A. M. provided tissues; D. S., M. D. W., B. B., I. T., P. C. S., P. F., and D.T.O. wrote the manuscript. P. F. and D.T.O. oversaw the work.	Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blanchette M, 2006, GENOME RES, V16, P656, DOI 10.1101/gr.4866006; Boffelli D, 2003, SCIENCE, V299, P1391, DOI 10.1126/science.1081331; Boj SF, 2009, DIABETES, V58, P1245, DOI 10.2337/db08-0812; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Chan Esther T., 2009, Journal of Biology (London), V8, P33, DOI 10.1186/jbiol130; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Gordan R, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1166; Hatzis P, 2006, MOL CELL BIOL, V26, P7017, DOI 10.1128/MCB.00297-06; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Lee YH, 1997, MOL CELL BIOL, V17, P6014, DOI 10.1128/MCB.17.10.6014; Lenhard Boris, 2003, J Biol, V2, P13, DOI 10.1186/1475-4924-2-13; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; Margulies EH, 2005, P NATL ACAD SCI USA, V102, P4795, DOI 10.1073/pnas.0409882102; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Portales-Casamar E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r207; Taylor J, 2006, GENOME RES, V16, P1596, DOI 10.1101/gr.4537706; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104	29	518	528	1	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2010	328	5981					1036	1040		10.1126/science.1186176	http://dx.doi.org/10.1126/science.1186176			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598YW	20378774	Green Accepted			2022-12-28	WOS:000277877100043
J	Bayard, D				Bayard, Dominique			Haiti Earthquake Relief, Phase Two - Long-Term Needs and Local Resources	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Brennan RJ, 2006, NEW ENGL J MED, V354, P1769, DOI 10.1056/NEJMp068017; *PAN AM HLTH ORG, 2010, HAIT HLTH CLUST B EA; *UN OFF COORD HUM, 30 UN OFF COORD HUM; *UNICEF, HAIT EM RESP UPD MAR	4	21	21	1	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 20	2010	362	20					1858	1861		10.1056/NEJMp1003839	http://dx.doi.org/10.1056/NEJMp1003839			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	598EI	20393163				2022-12-28	WOS:000277815600003
J	Stadtfeld, M; Apostolou, E; Akutsu, H; Fukuda, A; Follett, P; Natesan, S; Kono, T; Shioda, T; Hochedlinger, K				Stadtfeld, Matthias; Apostolou, Effie; Akutsu, Hidenori; Fukuda, Atsushi; Follett, Patricia; Natesan, Sridaran; Kono, Tomohiro; Shioda, Toshi; Hochedlinger, Konrad			Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells	NATURE			English	Article							NUCLEAR TRANSFER; ES CELLS; EXPRESSION; MICE; METHYLATION; GENERATION; CLUSTER; DIFFERENTIATION; FIBROBLASTS; CLONING	Induced pluripotent stem cells (iPSCs) have been generated by enforced expression of defined sets of transcription factors in somatic cells. It remains controversial whether iPSCs are molecularly and functionally equivalent to blastocyst-derived embryonic stem (ES) cells. By comparing genetically identical mouse ES cells and iPSCs, we show here that their overall messenger RNA and microRNA expression patterns are indistinguishable with the exception of a few transcripts encoded within the imprinted Dlk1-Dio3 gene cluster on chromosome 12qF1, which were aberrantly silenced in most of the iPSC clones. Consistent with a developmental role of the Dlk1-Dio3 gene cluster, these iPSC clones contributed poorly to chimaeras and failed to support the development of entirely iPSC-derived animals ('all-iPSC mice'). In contrast, iPSC clones with normal expression of the Dlk1-Dio3 cluster contributed to high-grade chimaeras and generated viable all-iPSC mice. Notably, treatment of an iPSC clone that had silenced Dlk1-Dio3 with a histone deacetylase inhibitor reactivated the locus and rescued its ability to support full-term development of all-iPSC mice. Thus, the expression state of a single imprinted gene cluster seems to distinguish most murine iPSCs from ES cells and allows for the prospective identification of iPSC clones that have the full development potential of ES cells.	[Stadtfeld, Matthias; Apostolou, Effie; Follett, Patricia; Hochedlinger, Konrad] Massachusetts Gen Hosp, Howard Hughes Med Inst, Ctr Regenerat Med, Harvard Stem Cell Inst, Boston, MA 02114 USA; [Stadtfeld, Matthias; Apostolou, Effie; Shioda, Toshi; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Stadtfeld, Matthias; Apostolou, Effie; Shioda, Toshi; Hochedlinger, Konrad] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Stadtfeld, Matthias; Apostolou, Effie; Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Stadtfeld, Matthias; Apostolou, Effie; Hochedlinger, Konrad] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Akutsu, Hidenori] Natl Inst Child Hlth & Dev, Dept Reprod Biol, Tokyo 1578535, Japan; [Fukuda, Atsushi; Kono, Tomohiro] Tokyo Univ Agr, Dept Biosci, Tokyo 1568502, Japan; [Natesan, Sridaran] Sanofi Aventis, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; National Center for Child Health & Development - Japan; Tokyo University of Agriculture; Sanofi-Aventis	Hochedlinger, K (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Ctr Regenerat Med, Harvard Stem Cell Inst, 185 Cambridge St, Boston, MA 02114 USA.	khochedlinger@helix.mgh.harvard.edu	Apostolou, Effie/AAG-1559-2020	Stadtfeld, Matthias/0000-0002-5852-9906	Schering Foundation; Jane Coffin Childs postdoctoral fellowship; NIH; Harvard Stem Cell Institute; MGH; HHMI; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD003266] Funding Source: NIH RePORTER	Schering Foundation; Jane Coffin Childs postdoctoral fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; MGH; HHMI(Howard Hughes Medical Institute); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to H. Arnold for assistance with GeneSifter analysis; K. Coser, K. Claycomb and P. August for technical support on Affymetrix expression profiling; S. Sato and M. Machida for technical assistance; V. Greco for advice on keratinocyte isolation; and S. Schubert for advice on miRNA isolation. We thank members of the Hochedlinger laboratory for helpful suggestions and A. Umezawa for discussions and support. M. S. was supported by a postdoctoral fellowship from the Schering Foundation, E. A. was supported by a Jane Coffin Childs postdoctoral fellowship and K. H. was supported by a NIH Director's Innovator Award and by funds provided by the Harvard Stem Cell Institute, MGH and HHMI.	Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; Carr MS, 2007, GENOMICS, V89, P280, DOI 10.1016/j.ygeno.2006.10.005; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Coser KR, 2003, P NATL ACAD SCI USA, V100, P13994, DOI 10.1073/pnas.2235866100; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; da Rocha ST, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000392; Dean W, 1998, DEVELOPMENT, V125, P2273; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Lin SP, 2007, DEVELOPMENT, V134, P417, DOI 10.1242/dev.02726; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; NAGY A, 1990, DEVELOPMENT, V110, P815; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Ono Y, 2006, BIOL REPROD, V75, P210, DOI 10.1095/biolreprod.105.049171; Pick M, 2009, STEM CELLS, V27, P2686, DOI 10.1002/stem.205; Schmidt JV, 2000, GENE DEV, V14, P1997; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; Steshina EY, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-44; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi N, 2009, HUM MOL GENET, V18, P1879, DOI 10.1093/hmg/ddp108; Tevendale M, 2006, CYTOGENET GENOME RES, V113, P215, DOI 10.1159/000090835; Wakayama S, 2006, STEM CELLS, V24, P2023, DOI 10.1634/stemcells.2005-0537; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilson KD, 2009, STEM CELLS DEV, V18, P749, DOI 10.1089/scd.2008.0247; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	50	611	649	0	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 13	2010	465	7295					175	U55		10.1038/nature09017	http://dx.doi.org/10.1038/nature09017			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594SS	20418860	Green Accepted			2022-12-28	WOS:000277558500026
J	Gao, M; Nettles, RE; Belema, M; Snyder, LB; Nguyen, VN; Fridell, RA; Serrano-Wu, MH; Langley, DR; Sun, JH; O'Boyle, DR; Lemm, JA; Wang, CF; Knipe, JO; Chien, C; Colonno, RJ; Grasela, DM; Meanwell, NA; Hamann, LG				Gao, Min; Nettles, Richard E.; Belema, Makonen; Snyder, Lawrence B.; Nguyen, Van N.; Fridell, Robert A.; Serrano-Wu, Michael H.; Langley, David R.; Sun, Jin-Hua; O'Boyle, Donald R.; Lemm, Julie A.; Wang, Chunfu; Knipe, Jay O.; Chien, Caly; Colonno, Richard J.; Grasela, Dennis M.; Meanwell, Nicholas A.; Hamann, Lawrence G.			Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect	NATURE			English	Article							HEPATITIS-C VIRUS; NONSTRUCTURAL PROTEINS; DOMAIN; RNA	The worldwide prevalence of chronic hepatitis C virus (HCV) infection is estimated to be approaching 200 million people(1). Current therapy relies upon a combination of pegylated interferon-alpha and ribavirin, a poorly tolerated regimen typically associated with less than 50% sustained virological response rate in those infected with genotype 1 virus(2,3). The development of direct-acting antiviral agents to treat HCV has focused predominantly on inhibitors of the viral enzymes NS3 protease and the RNA-dependent-RNA polymerase NS5B(4). Here we describe the profile of BMS-790052, a small molecule inhibitor of the HCV NS5A protein that exhibits picomolar half-maximum effective concentrations (EC50) towards replicons expressing a broad range of HCV genotypes and the JFH-1 genotype 2a infectious virus in cell culture. In a phase I clinical trial in patients chronically infected with HCV, administration of a single 100-mg dose of BMS-790052 was associated with a 3.3 log(10) reduction in mean viral load measured 24 h post-dose that was sustained for an additional 120 h in two patients infected with genotype 1b virus. Genotypic analysis of samples taken at baseline, 24 and 144 h post-dose revealed that the major HCV variants observed had substitutions at amino-acid positions identified using the in vitro replicon system. These results provide the first clinical validation of an inhibitor of HCV NS5A, a protein with no known enzymatic function, as an approach to the suppression of virus replication that offers potential as part of a therapeutic regimen based on combinations of HCV inhibitors.	[Belema, Makonen; Snyder, Lawrence B.; Nguyen, Van N.; Serrano-Wu, Michael H.; Meanwell, Nicholas A.; Hamann, Lawrence G.] Bristol Myers Squibb Co, Res & Dev, Dept Discovery Chem, Wallingford, CT 06492 USA; [Nettles, Richard E.; Chien, Caly; Grasela, Dennis M.] Bristol Myers Squibb Co, Res & Dev, Dept Discovery Med & Clin Pharmacol, Princeton, NJ 08543 USA; [Langley, David R.] Bristol Myers Squibb Co, Res & Dev, Dept Comp Aided Drug Design, Wallingford, CT 06492 USA; [Knipe, Jay O.] Bristol Myers Squibb Co, Res & Dev, Dept Metab & Pharmacokinet, Wallingford, CT 06492 USA; [Gao, Min; Fridell, Robert A.; Sun, Jin-Hua; O'Boyle, Donald R.; Lemm, Julie A.; Wang, Chunfu; Colonno, Richard J.] Bristol Myers Squibb Co, Res & Dev, Dept Virol, Wallingford, CT 06492 USA	Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb	Meanwell, NA (corresponding author), Bristol Myers Squibb Co, Res & Dev, Dept Discovery Chem, 5 Res Pkwy, Wallingford, CT 06492 USA.	Nicholas.Meanwell@bms.com		Meanwell, Nicholas/0000-0002-8857-1515; Sun, Jin-hua/0000-0003-2813-3633; Langley, David/0000-0002-0820-3190				Appel N, 2006, J BIOL CHEM, V281, P9833, DOI 10.1074/jbc.R500026200; Bachand C., 2008, World Patent, Patent No. [WO 2008021927, 2008021927, WO-2008021927 A2/A3]; Bartenschlager R, 2005, P NATL ACAD SCI USA, V102, P9739, DOI 10.1073/pnas.0504296102; Bartenschlager R, 2002, NAT REV DRUG DISCOV, V1, P911, DOI 10.1038/nrd942; De Francesco R, 2005, NATURE, V436, P953, DOI 10.1038/nature04080; Fernandes F, 2007, HEPATOLOGY, V46, P1026, DOI 10.1002/hep.21809; Green N, 2008, EXPERT OPIN DRUG DIS, V3, P671, DOI 10.1517/17460441.3.6.671; Holler TP, 2009, EXPERT OPIN DRUG DIS, V4, P293, DOI 10.1517/17460440902762802; Hoofnagle JH, 2006, NEW ENGL J MED, V355, P2444, DOI 10.1056/NEJMct061675; Kim WR, 2002, MICROBES INFECT, V4, P1219, DOI 10.1016/S1286-4579(02)01649-0; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lemm JA, 2010, J VIROL, V84, P482, DOI 10.1128/JVI.01360-09; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Love RA, 2009, J VIROL, V83, P4395, DOI 10.1128/JVI.02352-08; Manns MP, 2007, NAT REV DRUG DISCOV, V6, P991, DOI 10.1038/nrd2411; O'Boyle DR, 2005, ANTIMICROB AGENTS CH, V49, P1346, DOI 10.1128/AAC.49.4.1346-1353.2005; Pearlman BL, 2008, WORLD J GASTROENTERO, V14, P3621, DOI 10.3748/wjg.14.3621; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Schmitz Uli, 2008, Recent Pat Antiinfect Drug Discov, V3, P77, DOI 10.2174/157489108784746597; Stockwell BR, 2004, NATURE, V432, P846, DOI 10.1038/nature03196; Sun JH, 2003, J VIROL, V77, P6753, DOI 10.1128/JVI.77.12.6753-6760.2003; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Yi MK, 2004, J VIROL, V78, P7904, DOI 10.1128/JVI.78.15.7904-7915.2004	23	768	834	0	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 6	2010	465	7294					96	U108		10.1038/nature08960	http://dx.doi.org/10.1038/nature08960			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	591OW	20410884	Green Published, Bronze			2022-12-28	WOS:000277311900038
J	Okamoto, K; Iwai, Y; Oh-hora, M; Yamamoto, M; Morio, T; Aoki, K; Ohya, K; Jetten, AM; Akira, S; Muta, T; Takayanagi, H				Okamoto, Kazuo; Iwai, Yoshiko; Oh-hora, Masatsugu; Yamamoto, Masahiro; Morio, Tomohiro; Aoki, Kazuhiro; Ohya, Keiichi; Jetten, Anton M.; Akira, Shizuo; Muta, Tatsushi; Takayanagi, Hiroshi			I kappa B zeta regulates T(H)17 development by cooperating with ROR nuclear receptors	NATURE			English	Article							TARGETED DISRUPTION; GAMMA-T; DIFFERENTIATION; TRANSCRIPTION; INDUCTION; PROTEIN; CELLS; EXPRESSION; APOPTOSIS; ROLES	Interleukin (IL)-17-producing helper T (T(H)17) cells are a distinct T-cell subset characterized by its pathological role in autoimmune diseases(1-3). IL-6 and transforming growth factor-beta (TGF-beta) induce TH17 development, in which the orphan nuclear receptors, ROR gamma t and ROR alpha, have an indispensable role(4-6). However, in the absence of IL-6 and TGF-beta, the ectopic expression of ROR gamma t or ROR alpha leads to only a modest IL-17 production(5,7,8). Here we identify a nuclear I kappa B family member, I kappa B zeta (encoded by the Nfkbiz gene), as a transcription factor required for TH17 development in mice. The ectopic expression of I kappa B zeta in naive CD4(+) T cells together with ROR gamma t or ROR alpha potently induces T(H)17 development, even in the absence of IL-6 and TGF-beta. Notably, Nfkbiz(-/-) mice have a defect in T(H)17 development and a resistance to experimental autoimmune encephalomyelitis (EAE). The T-cell-intrinsic function of I kappa B zeta was clearly demonstrated by the resistance to EAE of the Rag2(-/-) mice into which Nfkbiz(-/-) CD4(+) T cells were transferred. In cooperation with ROR gamma t and RORa, I kappa B zeta enhances Il17a expression by binding directly to the regulatory region of the Il17a gene. This study provides evidence for the transcriptional mechanisms underlying T(H)17 development and points to a molecular basis for a novel therapeutic strategy against autoimmune disease.	[Okamoto, Kazuo; Oh-hora, Masatsugu; Takayanagi, Hiroshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cell Signaling, Bunkyo Ku, Tokyo 1138549, Japan; [Okamoto, Kazuo; Oh-hora, Masatsugu; Takayanagi, Hiroshi] Int Res Ctr Mol Sci Tooth & Bone Dis, Global Ctr Excellence Program, Bunkyo Ku, Tokyo 1138549, Japan; [Okamoto, Kazuo; Takayanagi, Hiroshi] Japan Sci & Technol Agcy, ERATO, Takayanagi Osteonetwork Project, Bunkyo Ku, Tokyo 1138549, Japan; [Iwai, Yoshiko] Tokyo Med & Dent Univ, Med Res Inst, Med Top Track Program, Bunkyo Ku, Tokyo 1138510, Japan; [Yamamoto, Masahiro] Osaka Univ, Grad Sch Med, Dept Microbiol & Immunol, Lab Immune Regulat, Suita, Osaka 5650871, Japan; [Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Host Def Lab, Suita, Osaka 5650871, Japan; [Morio, Tomohiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Pediat & Dev Biol, Bunkyo Ku, Tokyo 1138519, Japan; [Aoki, Kazuhiro; Ohya, Keiichi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Hard Tissue Engn Pharmacol, Bunkyo Ku, Tokyo 1138549, Japan; [Jetten, Anton M.] NIEHS, Cell Biol Sect, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA; [Muta, Tatsushi] Tohoku Univ, Grad Sch Life Sci, Lab Cell Recognit & Response, Aoba Ku, Sendai, Miyagi 9808578, Japan	Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); Tokyo Medical & Dental University (TMDU); Osaka University; Osaka University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Tohoku University	Takayanagi, H (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cell Signaling, Bunkyo Ku, Yushima 1-5-45, Tokyo 1138549, Japan.	taka.csi@tmd.ac.jp	Akira, Shizuo/C-3134-2009; AOKI, Kazuhiro/GRO-6475-2022; Jetten, Anton/C-3736-2019	AOKI, Kazuhiro/0000-0001-6643-6315; Jetten, Anton/0000-0003-0954-4445; Morio, Tomohiro/0000-0002-9259-1025	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); ERATO; JST; NIEHS [Z01-ES-101586]; Takeda Life Science Foundation; Yokoyama Foundation; Ichiro Kanehara; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101586, ZIAES101586] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ERATO(Japan Science & Technology Agency (JST)); JST(Japan Science & Technology Agency (JST)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Takeda Life Science Foundation; Yokoyama Foundation; Ichiro Kanehara; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We are grateful to Y. Iwakura and T. Kitamura for providing Il17a<SUP>-/-</SUP> mice and retrovirus vectors, respectively. We also thank M. Shinohara, T. Negishi-Koga, M. Asagiri, T. Nakashima, N. Komatsu, M. Ohba, Y. Kunisawa, Y. Suzuki, S. Miyakoshi and T. Kunigami for discussion and assistance. This work was supported in part by Grant-in-Aid for Creative Scientific Research from the Japan Society for the Promotion of Science (JSPS), Grant-in-Aid for Challenging Exploratory Research from JSPS, Grant-in-Aid for JSPS Fellows, Grants-in-Aid for GCOE Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), and ERATO, Takayanagi Osteonetwork Project from JST. It was also supported by grants from the Intramural Research Program of the NIEHS (Z01-ES-101586) (to A. M. J.), Takeda Life Science Foundation and Yokoyama Foundation for Clinical Pharmacology and the Ichiro Kanehara	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Hamilton BA, 1996, NATURE, V379, P736, DOI 10.1038/379736a0; Huber M, 2008, P NATL ACAD SCI USA, V105, P20846, DOI 10.1073/pnas.0809077106; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jetten AM, 2006, AD DEV BIOL, V16, P313, DOI 10.1016/S1574-3349(06)16010-X; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kurebayashi S, 2000, P NATL ACAD SCI USA, V97, P10132, DOI 10.1073/pnas.97.18.10132; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Matsuo S, 2007, BIOCHEM J, V405, P605, DOI 10.1042/BJ20061797; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Muta T, 2006, VITAM HORM, V74, P301, DOI 10.1016/S0083-6729(06)74012-2; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; O'Shea JJ, 2009, MICROBES INFECT, V11, P599, DOI 10.1016/j.micinf.2009.04.007; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Shiina T, 2004, J BIOL CHEM, V279, P55493, DOI 10.1074/jbc.M409770200; Shinohara M, 2008, CELL, V132, P794, DOI 10.1016/j.cell.2007.12.037; Takeda K, 1998, J IMMUNOL, V161, P4652; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamamoto Masahiro, 2008, Journal of Infection and Chemotherapy, V14, P265, DOI 10.1007/s10156-008-0619-y; Yamazaki S, 2001, J BIOL CHEM, V276, P27657, DOI 10.1074/jbc.M103426200; Yamazaki S, 2005, J BIOL CHEM, V280, P1678, DOI 10.1074/jbc.M409983200; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663	35	194	204	3	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2010	464	7293					1381	U13		10.1038/nature08922	http://dx.doi.org/10.1038/nature08922			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20383124				2022-12-28	WOS:000277149000053
J	Doebeli, M; Ispolatov, I				Doebeli, Michael; Ispolatov, Iaroslav			Complexity and Diversity	SCIENCE			English	Article							NATURAL-POPULATIONS; GENETIC-VARIABILITY; GENIC HETEROZYGOSITY; POLYGENIC CHARACTER; MAINTENANCE; EVOLUTION; MUTATION; DIFFERENTIATION; ALLELES; MODEL	The mechanisms for the origin and maintenance of biological diversity are not fully understood. It is known that frequency-dependent selection, generating advantages for rare types, can maintain genetic variation and lead to speciation, but in models with simple phenotypes (that is, low-dimensional phenotype spaces), frequency dependence needs to be strong to generate diversity. However, we show that if the ecological properties of an organism are determined by multiple traits with complex interactions, the conditions needed for frequency-dependent selection to generate diversity are relaxed to the point where they are easily satisfied in high-dimensional phenotype spaces. Mathematically, this phenomenon is reflected in properties of eigenvalues of quadratic forms. Because all living organisms have at least hundreds of phenotypes, this casts the potential importance of frequency dependence for the origin and maintenance of diversity in a new light.	[Doebeli, Michael] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Math, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia	Doebeli, M (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	doebeli@zoology.ubc.ca; slava@math.ubc.ca	Doebeli, Michael/D-5391-2012; Ispolatov, Yaroslav/E-8544-2010	Ispolatov, Yaroslav/0000-0002-0201-3396	Natural Sciences and Engineering Research Council (Canada); European Union	Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); European Union(European Commission)	The order of authors is alphabetical. We thank K. Schneider for improving some of the mathematical arguments and D. Weigel, H. Metz, and S. Otto for discussions and comments. This research was supported by the Natural Sciences and Engineering Research Council (Canada) and by the Human Frontier Science Program (European Union).	Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; Burger R, 2009, THEOR POPUL BIOL, V76, P214, DOI 10.1016/j.tpb.2009.07.002; BURGER R, 1986, J MATH BIOL, V24, P341, DOI 10.1007/BF00275642; CHRISTIANSEN FB, 1987, THEOR POPUL BIOL, V31, P33, DOI 10.1016/0040-5809(87)90021-9; CLARKE BC, 1979, PROC R SOC SER B-BIO, V205, P453, DOI 10.1098/rspb.1979.0079; Coyne J.A., 2004, SPECIATION; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Dieckmann U., 2004, ADAPTIVE SPECIATION; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; Doebeli M, 2007, P ROY SOC B-BIOL SCI, V274, P347, DOI 10.1098/rspb.2006.3725; Durinx M, 2008, J MATH BIOL, V56, P673, DOI 10.1007/s00285-007-0134-2; Frantz A, 2009, BIOL J LINN SOC, V97, P718, DOI 10.1111/j.1095-8312.2009.01221.x; Gavrilets S, 2004, FITNESS LANDSCAPES O; Gyllenberg M, 2005, J MATH BIOL, V50, P133, DOI 10.1007/s00285-004-0283-5; Hernandez-Garcia E, 2009, PHILOS T R SOC A, V367, P3183, DOI 10.1098/rsta.2009.0086; HERNANDEZGARCIA E, 2009, THEOR ECOL, DOI DOI 10.1007/S12080-009-0056-2; HUBBY JL, 1966, GENETICS, V54, P577; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; KIMURA M, 1965, P NATL ACAD SCI USA, V54, P731, DOI 10.1073/pnas.54.3.731; Kimura M., 1983, NEUTRAL THEORY MOL E; Kirkpatrick M, 1997, AM NAT, V150, P1, DOI 10.1086/286054; Kondrashov AS, 1999, NATURE, V400, P351, DOI 10.1038/22514; LANDE R, 1975, GENET RES, V26, P221, DOI 10.1017/S0016672300016037; Le Gac M, 2008, GENETICS, V178, P1049, DOI 10.1534/genetics.107.082040; LEWONTIN RC, 1966, GENETICS, V54, P595; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Maharjan R, 2006, SCIENCE, V313, P514, DOI 10.1126/science.1129865; Matessi C, 2009, THEOR POPUL BIOL, V76, P1, DOI 10.1016/j.tpb.2009.02.007; Phillips PC, 2007, GENET RES, V89, P371, DOI 10.1017/S0016672308009567; Roughgarden J., 1979, THEORY POPULATION GE; Singer MC, 2010, EVOLUTION, V64, P921, DOI 10.1111/j.1558-5646.2009.00866.x; TAPER ML, 1985, ECOLOGY, V66, P355, DOI 10.2307/1940385; TURELLI M, 1984, THEOR POPUL BIOL, V25, P138, DOI 10.1016/0040-5809(84)90017-0; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	35	92	94	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2010	328	5977					494	497		10.1126/science.1187468	http://dx.doi.org/10.1126/science.1187468			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YR	20413499				2022-12-28	WOS:000276952400041
J	Gross, C; Zibold, T; Nicklas, E; Esteve, J; Oberthaler, MK				Gross, C.; Zibold, T.; Nicklas, E.; Esteve, J.; Oberthaler, M. K.			Nonlinear atom interferometer surpasses classical precision limit	NATURE			English	Article							STANDARD QUANTUM LIMIT; ENTANGLEMENT; STATES; SPECTROSCOPY	Interference is fundamental to wave dynamics and quantum mechanics. The quantum wave properties of particles are exploited in metrology using atom interferometers, allowing for high-precision inertia measurements(1,2). Furthermore, the state-of-the-art time standard is based on an interferometric technique known as Ramsey spectroscopy. However, the precision of an interferometer is limited by classical statistics owing to the finite number of atoms used to deduce the quantity of interest(3). Here we show experimentally that the classical precision limit can be surpassed using nonlinear atom interferometry with a Bose-Einstein condensate. Controlled interactions between the atoms lead to non-classical entangled states within the interferometer; this represents an alternative approach to the use of non-classical input states(4-8). Extending quantum interferometry(9) to the regime of large atom number, we find that phase sensitivity is enhanced by 15 per cent relative to that in an ideal classical measurement. Our nonlinear atomic beam splitter follows the 'one-axis-twisting' scheme(10) and implements interaction control using a narrow Feshbach resonance. We perform noise tomography of the quantum state within the interferometer and detect coherent spin squeezing with a squeezing factor of -8.2 dB (refs 11-15). The results provide information on the many-particle quantum state, and imply the entanglement of 170 atoms(16).	[Gross, C.; Zibold, T.; Nicklas, E.; Esteve, J.; Oberthaler, M. K.] Heidelberg Univ, Kirchhoff Inst Phys, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Oberthaler, MK (corresponding author), Heidelberg Univ, Kirchhoff Inst Phys, Neuenheimer Feld 227, D-69120 Heidelberg, Germany.	quantum.metrology@matterwave.de	Esteve, Jerome/G-1084-2014; Gross, Christian/P-5475-2014	Esteve, Jerome/0000-0002-1556-8120; Gross, Christian/0000-0003-2292-5234; Zibold, Tilman/0000-0003-0266-6650	Deutsche Forschungsgemeinschaft; German-Israeli Foundation; Heidelberg Center of Quantum Dynamics; ExtreMe Matter Institute; European Commission; Landesgraduiertenforderung Baden-Wurttemberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Heidelberg Center of Quantum Dynamics; ExtreMe Matter Institute; European Commission(European CommissionEuropean Commission Joint Research Centre); Landesgraduiertenforderung Baden-Wurttemberg	We thank J.-P. Ronzheimer for technical assistance throughout the realization of this project and acknowledge discussions with Y. Li and A. Sinatra. We gratefully acknowledge support from the Deutsche Forschungsgemeinschaft, the German-Israeli Foundation, the Heidelberg Center of Quantum Dynamics, the ExtreMe Matter Institute and the European Commission Future and Emerging Technologies Open Scheme project MIDAS ( Macroscopic Interference Devices for Atomic and Solid- State Systems). C. G. acknowledges support from the Landesgraduiertenforderung Baden-Wurttemberg.	Appel J, 2009, P NATL ACAD SCI USA, V106, P10960, DOI 10.1073/pnas.0901550106; Cronin AD, 2009, REV MOD PHYS, V81, P1051, DOI 10.1103/RevModPhys.81.1051; Erhard M, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.032705; Esteve J, 2008, NATURE, V455, P1216, DOI 10.1038/nature07332; Esteve J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.130403; Fernholz T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.073601; FERRINI G, 2009, ANOMALOUS DECOHERENC; Fixler JB, 2007, SCIENCE, V315, P74, DOI 10.1126/science.1135459; Giovannetti V, 2004, SCIENCE, V306, P1330, DOI 10.1126/science.1104149; Gustavson TL, 1997, PHYS REV LETT, V78, P2046, DOI 10.1103/PhysRevLett.78.2046; Hald J, 1999, PHYS REV LETT, V83, P1319, DOI 10.1103/PhysRevLett.83.1319; Kaufman AM, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.050701; KITAGAWA M, 1993, PHYS REV A, V47, P5138, DOI 10.1103/PhysRevA.47.5138; Kuzmich A, 2000, PHYS REV LETT, V85, P1594, DOI 10.1103/PhysRevLett.85.1594; Leibfried D, 2004, SCIENCE, V304, P1476, DOI 10.1126/science.1097576; Leroux ID, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.073602; Li Y, 2009, EUR PHYS J B, V68, P365, DOI 10.1140/epjb/e2008-00472-6; Li Y, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.210401; Meyer V, 2001, PHYS REV LETT, V86, P5870, DOI 10.1103/PhysRevLett.86.5870; Pezze L, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.100401; Reinaudi G, 2007, OPT LETT, V32, P3143, DOI 10.1364/OL.32.003143; Roos CF, 2006, NATURE, V443, P316, DOI 10.1038/nature05101; Santarelli C, 1999, PHYS REV LETT, V82, P4619, DOI 10.1103/PhysRevLett.82.4619; Sinatra A, 2000, EUR PHYS J D, V8, P319, DOI 10.1007/s100530050042; SORENSEN A, 2001, NATURE, V63, P409; Sorensen AS, 2001, PHYS REV LETT, V86, P4431, DOI 10.1103/PhysRevLett.86.4431; Steel MJ, 1998, PHYS REV A, V57, P2920, DOI 10.1103/PhysRevA.57.2920; Toth G, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.250405; Widera A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.160406; WINELAND DJ, 1994, PHYS REV A, V50, P67, DOI 10.1103/PhysRevA.50.67	30	603	607	4	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2010	464	7292					1165	1169		10.1038/nature08919	http://dx.doi.org/10.1038/nature08919			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20357767	Green Submitted			2022-12-28	WOS:000276891100031
J	Herman, JB				Herman, John B.			Increasing the Value of the State Medical License	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Herman, JB (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.								0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 22	2010	362	16					1459	1461		10.1056/NEJMp0912754	http://dx.doi.org/10.1056/NEJMp0912754			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	586GP	20410513				2022-12-28	WOS:000276894700003
J	Tan, LKK; Carlone, GM; Borrow, R				Tan, Lionel K. K.; Carlone, George M.; Borrow, Ray			CURRENT CONCEPTS Advances in the Development of Vaccines against Neisseria meningitidis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							FACTOR-H-BINDING; B MENINGOCOCCAL DISEASE; SEROGROUP-C; CONJUGATE VACCINE; PROTEIN VACCINE; VESICLE VACCINE; HUMAN IMMUNITY; GROUP-A; IMMUNOGENICITY; POLYSACCHARIDES		[Borrow, Ray] Manchester Royal Infirm, Hlth Protect Agcy, Manchester M13 9WZ, Lancs, England; [Tan, Lionel K. K.] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, London, England; [Carlone, George M.] Ctr Dis Control & Prevent, Immunol Labs, Atlanta, GA USA	Health Protection Agency; University of Manchester; Imperial College London; Centers for Disease Control & Prevention - USA	Borrow, R (corresponding author), Manchester Royal Infirm, Hlth Protect Agcy, Oxford Rd, Manchester M13 9WZ, Lancs, England.	ray.borrow@hpa.org.uk			Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	Supported by a grant from the Wellcome Trust (to Dr. Tan).	ANDERSON A, 2009, 10 EUR MEN DIS SOC M; [Anonymous], 2001, Wkly Epidemiol Rec, V76, P282; [Anonymous], 1805, J MED CHIR PHARM; Auckland C, 2006, J INFECT DIS, V194, P1745, DOI 10.1086/509619; Beernink PT, 2008, INFECT IMMUN, V76, P2568, DOI 10.1128/IAI.00033-08; BJUNE G, 1991, LANCET, V338, P1093, DOI 10.1016/0140-6736(91)91961-S; BOSLEGO J, 1995, VACCINE, V13, P821, DOI 10.1016/0264-410X(94)00037-N; Bruge J, 2004, VACCINE, V22, P1087, DOI 10.1016/j.vaccine.2003.10.005; Capecchi B, 2005, MOL MICROBIOL, V55, P687, DOI 10.1111/j.1365-2958.2004.04423.x; Cartwright K, 1999, VACCINE, V17, P2612, DOI 10.1016/S0264-410X(99)00044-4; COHN A, 2008, 48 INT C ANT AG CHEM; Comanducci M, 2004, INFECT IMMUN, V72, P4217, DOI 10.1128/IAI.72.7.4217-4223.2004; DEMORAES JC, 1992, LANCET, V340, P1074; FINDLOW J, 2009, 10 EUR MEN DIS SOC M; FINNE J, 1983, LANCET, V2, P355; Fletcher LD, 2004, INFECT IMMUN, V72, P2088, DOI 10.1128/IAI.72.4.2088-2100.2004; Franzoso S, 2008, J LEUKOCYTE BIOL, V83, P1100, DOI 10.1189/jlb.1207810; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307; GOTSCHLICH EC, 1969, J EXP MED, V129, P1367, DOI 10.1084/jem.129.6.1367; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Harrison LH, 2006, J INFECT DIS, V193, P1266, DOI 10.1086/501371; Howitz M, 2007, CLIN INFECT DIS, V45, P1327, DOI 10.1086/522190; Jarva H, 2005, J IMMUNOL, V174, P6299, DOI 10.4049/jimmunol.174.10.6299; Kelly DF, 2005, JAMA-J AM MED ASSOC, V294, P3019, DOI 10.1001/jama.294.23.3019; LaForce FM, 2009, VACCINE, V27, pB13, DOI 10.1016/j.vaccine.2009.04.062; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; Miller E, 2001, VACCINE, V20, pS58, DOI 10.1016/S0264-410X(01)00299-7; MILLER E, 2008, 26 ANN M EUR SOC PAE; Murphy E, 2009, J INFECT DIS, V200, P379, DOI 10.1086/600141; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; NEDELEC J, 1990, J NEUROIMMUNOL, V29, P49, DOI 10.1016/0165-5728(90)90146-E; Nissen M, 2008, 26 ANN M EUR SOC PAE; Nolan T, 2007, VACCINE, V25, P8487, DOI 10.1016/j.vaccine.2007.10.013; O'Hallahan J, 2009, NEW ZEAL MED J, V122, P48; Pace D, 2009, VACCINE, V27, pB30, DOI 10.1016/j.vaccine.2009.05.003; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Pollard AJ, 2009, NAT REV IMMUNOL, V9, P212, DOI 10.1038/nri2494; Ramsay ME, 2003, BRIT MED J, V326, P365, DOI 10.1136/bmj.326.7385.365; Rappuoli R, 2000, CURR OPIN MICROBIOL, V3, P445, DOI 10.1016/S1369-5274(00)00119-3; ROUGON G, 1986, J CELL BIOL, V103, P2429, DOI 10.1083/jcb.103.6.2429; SARDINAS G, 2009, 10 EUR MEN DIS SOC M; Schneider MC, 2007, TRENDS MICROBIOL, V15, P233, DOI 10.1016/j.tim.2007.03.005; Schneider MC, 2006, J IMMUNOL, V176, P7566, DOI 10.4049/jimmunol.176.12.7566; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; SIERRA G V G, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P195; Stephens DS, 2007, FEMS MICROBIOL REV, V31, P3, DOI 10.1111/j.1574-6976.2006.00051.x; Tappero JW, 1999, JAMA-J AM MED ASSOC, V281, P1520, DOI 10.1001/jama.281.16.1520; Tondella MLC, 2000, J CLIN MICROBIOL, V38, P3323, DOI 10.1128/JCM.38.9.3323-3328.2000; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1; van den Dobbelsteen GPJM, 2007, VACCINE, V25, P2491, DOI 10.1016/j.vaccine.2006.09.025; van Deuren M, 2000, CLIN MICROBIOL REV, V13, P144, DOI 10.1128/CMR.13.1.144-166.2000; Weynants V, 2009, INFECT IMMUN, V77, P2084, DOI 10.1128/IAI.01108-08; ZOLLINGER WD, 2008, 16 INT PATH NEISS C; 2008, YAOUNDE DECLARATION; 2009, WKLY EPIDEMIOL REC, V84, P117	58	165	190	2	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 22	2010	362	16					1511	1520		10.1056/NEJMra0906357	http://dx.doi.org/10.1056/NEJMra0906357			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	586GP	20410516	Bronze			2022-12-28	WOS:000276894700010
J	Glynn, RJ; Koenig, W; Nordestgaard, BG; Shepherd, J; Ridker, PM				Glynn, Robert J.; Koenig, Wolfgang; Nordestgaard, Borge G.; Shepherd, James; Ridker, Paul M.			Rosuvastatin for Primary Prevention in Older Persons With Elevated C-Reactive Protein and Low to Average Low-Density Lipoprotein Cholesterol Levels: Exploratory Analysis of a Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; LOWERING THERAPY; CLINICAL-TRIALS; PRAVASTATIN; METAANALYSIS; STATINS; WOMEN; MEN	Background: Randomized data on statins for primary prevention in older persons are limited, and the relative hazard of cardiovascular disease associated with an elevated cholesterol level weakens with advancing age. Objective: To assess the efficacy and safety of rosuvastatin in persons 70 years or older. Design: Secondary analysis of JUPITER ( Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin), a randomized, double-blind, placebo-controlled trial. Setting: 1315 sites in 26 countries randomly assigned participants in JUPITER. Participants: Among the 17 802 participants randomly assigned with low-density lipoprotein (LDL) cholesterol levels less than 3.37 mmol/L (< 130 mg/dL) and high-sensitivity C-reactive protein levels of 2.0 mg/L or more without cardiovascular disease, 5695 were 70 years or older. Intervention: Participants were randomly assigned in a 1: 1 ratio to receive 20 mg of rosuvastatin daily or placebo. Measurements: The primary end point was the occurrence of a first cardiovascular event ( myocardial infarction, stroke, arterial revascularization, hospitalization for unstable angina, or death from cardiovascular causes). Results: The 32% of trial participants 70 years or older accrued 49% (n = 194) of the 393 confirmed primary end points. The rates of the primary end point in this age group were 1.22 and 1.99 per 100 person-years of follow-up in the rosuvastatin and placebo groups, respectively ( hazard ratio, 0.61 [95% CI, 0.46 to 0.82]; P < 0.001). Corresponding rates of all-cause mortality in this age group were 1.63 and 2.04 ( hazard ratio, 0.80 [ CI, 0.62 to 1.04]; P = 0.090). Although no significant heterogeneity was found in treatment effects by age, absolute reductions in event rates associated with rosuvastatin were greater in older persons. The relative rate of any serious adverse event among older persons in the rosuvastatin versus placebo group was 1.05 ( CI, 0.93 to 1.17). Limitation: Effect estimates from this exploratory analysis with age cut-point chosen after trial completion should be viewed in the context of the overall trial results. Conclusion: In apparently healthy older persons without hyperlipidemia but with elevated high-sensitivity C-reactive protein levels, rosuvastatin reduces the incidence of major cardiovascular events.	[Glynn, Robert J.] Harvard Univ, Div Prevent Med, Brigham & Womens Hosp, Sch Med, Boston, MA 02215 USA; Univ Ulm, Ulm, Germany; Univ Copenhagen, Herlev Hosp, Copenhagen Univ Hosp, DK-2730 Herlev, Denmark; Univ Glasgow, Glasgow, Lanark, Scotland	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Ulm University; University of Copenhagen; Herlev & Gentofte Hospital; University of Glasgow	Glynn, RJ (corresponding author), Harvard Univ, Div Prevent Med, Brigham & Womens Hosp, Sch Med, 900 Commonwealth Ave, Boston, MA 02215 USA.	rglynn@rics.bwh.harvard.edu	Nordestgaard, Borge Gronne/ABF-1310-2020	Nordestgaard, Borge/0000-0002-1954-7220; Koenig, Wolfgang/0000-0002-2064-9603	AstraZeneca; NATIONAL INSTITUTE ON AGING [R01AG018833] Funding Source: NIH RePORTER	AstraZeneca(AstraZeneca); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Primary Funding Source: AstraZeneca.	Abramson J, 2007, LANCET, V369, P168, DOI 10.1016/S0140-6736(07)60084-1; Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Amarenco P, 2004, STROKE, V35, P2902, DOI 10.1161/01.STR.0000147965.52712.fa; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Corti MC, 1997, ANN INTERN MED, V126, P753, DOI 10.7326/0003-4819-126-10-199705150-00001; DeWilde S, 2003, HEART, V89, P417, DOI 10.1136/heart.89.4.417; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Everett BM, 2006, J AM COLL CARDIOL, V48, P2235, DOI 10.1016/j.jacc.2006.09.030; Freidlin B, 2009, CLIN TRIALS, V6, P119, DOI 10.1177/1740774509102310; Glynn RJ, 2009, NEW ENGL J MED, V360, P1851, DOI 10.1056/NEJMoa0900241; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hunt D, 2001, ANN INTERN MED, V134, P931, DOI 10.7326/0003-4819-134-10-200105150-00007; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Ko DT, 2004, JAMA-J AM MED ASSOC, V291, P1864, DOI 10.1001/jama.291.15.1864; Korn EL, 2009, J CLIN ONCOL, V27, P1712, DOI 10.1200/JCO.2008.19.5339; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lewis SJ, 1998, ANN INTERN MED, V129, P681, DOI 10.7326/0003-4819-129-9-199811010-00002; McAlister FA, 2007, PLOS MED, V4, P1325, DOI 10.1371/journal.pmed.0040250; Nakamura H, 2006, LANCET, V368, P1155, DOI 10.1016/S0140-6736(06)69472-5; *NAT CHOL ED PROG, 2001, NIH PUBL; Pletcher MJ, 2009, ANN INTERN MED, V150, P243, DOI 10.7326/0003-4819-150-4-200902170-00005; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Sargent D, 2009, J CLIN ONCOL, V27, P1543, DOI 10.1200/JCO.2008.20.8611; Setoguchi S, 2007, AM J CARDIOL, V100, P1061, DOI 10.1016/j.amjcard.2007.04.052; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Wenger NK, 2007, ANN INTERN MED, V147, P1, DOI 10.7326/0003-4819-147-1-200707030-00002	29	160	168	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 20	2010	152	8					488	U31		10.7326/0003-4819-152-8-201004200-00005	http://dx.doi.org/10.7326/0003-4819-152-8-201004200-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588FV	20404379	Green Accepted			2022-12-28	WOS:000277054400002
J	Sehgal, AR				Sehgal, Ashwini R.			The Role of Reputation in U.S. News & World Report's Rankings of the Top 50 American Hospitals	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY; CARE	Background: U. S. News & World Report's annual rankings of the top 50 American hospitals in 12 specialties are based on a combination of subjective and objective measures of quality. Although the rankings have been criticized for emphasizing the subjective reputation of hospitals too strongly, the role of reputation in determining the relative standings of the top 50 hospitals has not been quantified. Objective: To quantify the role of reputation in determining the relative standings of the top 50 hospitals in the 2009 edition of U. S. News & World Report's rankings. Design: Cross-sectional study. Setting: The top 50 hospitals in each of 12 specialties. Measurements: Rankings based on the total U. S. News score and on a subjective reputation score. Results: On average, rankings based on reputation score alone agreed with U. S. News & World Report's overall rankings 100% of the time for the top hospital in each specialty, 97% for the top 5 hospitals, 91% for the top 10 hospitals, and 89% for the top 20 hospitals. Hospital reputation was minimally associated with objective quality measures ( mean Spearman rho(2) = 0.03). Limitation: The findings apply primarily to interpretations about the relative standings of the 50 top-ranked hospitals in each specialty and not necessarily to the hundreds of unranked hospitals. Conclusion: The relative standings of the top 50 hospitals largely reflect the subjective reputations of those hospitals. Moreover, little relationship exists between subjective reputation and objective measures of hospital quality among the top 50 hospitals.	[Sehgal, Ashwini R.] Metrohlth Med Ctr, Div Nephrol, Cleveland, OH 44109 USA; [Sehgal, Ashwini R.] Case Western Reserve Univ, Cleveland, OH 44106 USA	MetroHealth System; Case Western Reserve University	Sehgal, AR (corresponding author), Metrohlth Med Ctr, Div Nephrol, 2500 MetroHlth Dr, Cleveland, OH 44109 USA.	axs81@cwru.edu						Chen J, 1999, NEW ENGL J MED, V340, P286, DOI 10.1056/NEJM199901283400407; Green J, 1997, JAMA-J AM MED ASSOC, V277, P1152, DOI 10.1001/jama.277.14.1152; Halasyamani LK, 2007, J HOSP MED, V2, P128, DOI 10.1002/jhm.176; Hill CA, 1997, INQUIRY-J HEALTH CAR, V34, P80; Larson RJ, 2005, ARCH INTERN MED, V165, P645, DOI 10.1001/archinte.165.6.645; MCFARLANE E, 2009 METHODOLOGY AM; Mueller J. H., 1977, STAT REASONING SOCIO; *NAT HLTH SERV, 2009, QUAL CAR COMM PERF R; Rosenthal GE, 1996, J GEN INTERN MED, V11, P366, DOI 10.1007/BF02600049; *US DEP HHS, HOSP QUAL COMP; Wennberg JE, 2004, BMJ-BRIT MED J, V328, P607, DOI 10.1136/bmj.328.7440.607; Williams SC, 2006, CIRCULATION, V114, P558, DOI 10.1161/CIRCULATIONAHA.105.600973; 2009, US NEWS WORLD R 0312	13	69	69	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 20	2010	152	8					521	525		10.7326/0003-4819-152-8-201004200-00009	http://dx.doi.org/10.7326/0003-4819-152-8-201004200-00009			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588FV	20404383				2022-12-28	WOS:000277054400006
J	Stechmann, B; Bai, SK; Gobbo, E; Lopez, R; Merer, G; Pinchard, S; Panigai, L; Tenza, D; Raposo, G; Beaumelle, B; Sauvaire, D; Gillet, D; Johannes, L; Barbier, J				Stechmann, Bahne; Bai, Siau-Kun; Gobbo, Emilie; Lopez, Roman; Merer, Goulven; Pinchard, Suzy; Panigai, Laetitia; Tenza, Daniele; Raposo, Graca; Beaumelle, Bruno; Sauvaire, Didier; Gillet, Daniel; Johannes, Ludger; Barbier, Julien			Inhibition of Retrograde Transport Protects Mice from Lethal Ricin Challenge	CELL			English	Article							GOLGI NETWORK; EARLY/RECYCLING ENDOSOMES; SNARE COMPLEX; RECEPTOR; TOXIN; CELLS; IDENTIFICATION; TRAFFICKING; MEMBRANE; SYNTAXIN-5	Bacterial Shiga-like toxins are virulence factors that constitute a significant public health threat worldwide, and the plant toxin ricin is a potential bioterror weapon. To gain access to their cytosolic target, ribosomal RNA, these toxins follow the retrograde transport route from the plasma membrane to the endoplasmic reticulum, via endosomes and the Golgi apparatus. Here, we used high-throughput screening to identify small molecule inhibitors that protect cells from ricin and Shiga-like toxins. We identified two compounds that selectively block retrograde toxin trafficking at the early endosome-TGN interface, without affecting compartment morphology, endogenous retrograde cargos, or other trafficking steps, demonstrating an unexpected degree of selectivity and lack of toxicity. In mice, one compound clearly protects from lethal nasal exposure to ricin. Our work discovers the first small molecule that shows efficacy against ricin in animal experiments and identifies the retrograde route as a potential therapeutic target.	[Gobbo, Emilie; Gillet, Daniel; Barbier, Julien] Commissariat Energie Atom & Energies Alternat, Direct Sci Vivant, Inst Biol & Technol Saclay, Serv Ingn Mol Prot,Lab Toxinol Mol & Biotechnol, F-91191 Gif Sur Yvette, France; [Stechmann, Bahne; Bai, Siau-Kun; Johannes, Ludger] Inst Curie, Ctr Rech, Traff Signaling & Delivery Lab, F-75248 Paris 05, France; [Tenza, Daniele; Raposo, Graca] Inst Curie, Ctr Rech, Struct & Membrane Compartments Lab, F-75248 Paris 05, France; [Tenza, Daniele; Raposo, Graca] Inst Curie, Ctr Rech, Cell & Tissue Imaging Facil Infrastruct Biol Sant, F-75248 Paris 05, France; [Stechmann, Bahne; Bai, Siau-Kun; Tenza, Daniele; Raposo, Graca; Johannes, Ludger] CNRS, UMR 144, F-75700 Paris, France; [Lopez, Roman; Merer, Goulven] Commissariat Energie Atom & Energies Alternat, Direct Sci Vivant, Inst Biol & Technol Saclay, Lab Chim Bioorgan,Serv Chim Bioorgan & Marquage, F-91191 Gif Sur Yvette, France; [Pinchard, Suzy; Panigai, Laetitia; Sauvaire, Didier] French Hlth Prod Safety Agcy, Afssaps French Official Med Control Lab, Direct Labs & Controles, Unite Controles Bioact & Radioanal, F-34740 Vendargues, France; [Beaumelle, Bruno] Univ Montpellier 2, CNRS, Ctr Etud Agents Pathogenes & Biotechnol Sante, UMR 5236, F-34095 Montpellier, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Gillet, D (corresponding author), Commissariat Energie Atom & Energies Alternat, Direct Sci Vivant, Inst Biol & Technol Saclay, Serv Ingn Mol Prot,Lab Toxinol Mol & Biotechnol, F-91191 Gif Sur Yvette, France.	daniel.gillet@cea.fr; ludger.johannes@curie.fr	Gillet, Daniel/C-5592-2008; Johannes, Ludger/W-8593-2019; Johannes, Ludger/M-9778-2017	Gillet, Daniel/0000-0003-0477-3599; Johannes, Ludger/0000-0002-2168-0004; Johannes, Ludger/0000-0002-2168-0004; Beaumelle, Bruno/0000-0002-4912-9134; barbier, julien/0000-0003-2187-4973; Stechmann, Bahne/0000-0003-2759-5924; Stechmann, Bahne/0000-0003-1440-1545; Raposo, graca/0000-0001-9590-1298	European Union; Commissariat a l'Energie Atomique et aux Energies Alternatives; Association pour la Recherche sur le Cancer	European Union(European Commission); Commissariat a l'Energie Atomique et aux Energies Alternatives; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by grants from the European Union (Cancerimmunotherapy), Project ToxScreen, and the Commissariat a l'Energie Atomique et aux Energies Alternatives. B. S. was supported by Association pour la Recherche sur le Cancer. We are grateful to Francois Becher, Elodie Duriez and Eric Ezan for measurement of the enzymatic activity of ricin, Annie El Zaouk, Philippe Chabert, and Emmanuel Intsaby for technical help with mouse experiments, Anne Bonhoure for help with ricin purification, Severine Hebbe for chemical synthesis of Retro-2, and Jennifer Martinez and Michel Petitjean for technical help. The following colleagues kindly provided us with reagents ( further details are in the Extended Experimental Procedures): Georges Bismuth, Juan Bonifacino, Michel Bornens, Frances Brodsky, Paul Gleeson, Jennifer Hirst, Bernard Hoflack, Wanjin Hong, Michael Marks, Kazuhisa Nakayama, Andrew Peden, Franck Perez, Suzanne Pfeffer, Lynne Roberts, and Harald Stenmark.	Amessou M, 2006, CURR PROTOC CELL BIO, P15, DOI [10.1002/0471143030.cb1510s32, DOI 10.1002/0471143030.CB1510S32]; Amessou M, 2007, J CELL SCI, V120, P1457, DOI 10.1242/jcs.03436; Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Astoul E, 2001, TRENDS IMMUNOL, V22, P490, DOI 10.1016/S1471-4906(01)01973-1; Audi J, 2005, JAMA-J AM MED ASSOC, V294, P2342, DOI 10.1001/jama.294.18.2342; BEAUMELLE B, 1993, J BIOL CHEM, V268, P23661; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Cook DL, 2006, TOXICOLOGY, V223, P61, DOI 10.1016/j.tox.2006.03.010; DONTA ST, 1995, J INFECT DIS, V171, P721, DOI 10.1093/infdis/171.3.721; Feng Y, 2004, EMBO REP, V5, P596, DOI 10.1038/sj.embor.7400152; Fraser T R, 1872, Br Med J, V2, P457; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Ghosh RN, 1998, J CELL BIOL, V142, P923, DOI 10.1083/jcb.142.4.923; GLICKMAN JN, 1989, EMBO J, V8, P1041, DOI 10.1002/j.1460-2075.1989.tb03471.x; Hay JC, 1998, J CELL BIOL, V141, P1489, DOI 10.1083/jcb.141.7.1489; HOLMGREN J, 1973, INFECT IMMUN, V8, P208, DOI 10.1128/IAI.8.2.208-214.1973; Hunyady L, 2002, J CELL BIOL, V157, P1211, DOI 10.1083/jcb.200111013; JACEWICZ M, 1986, J EXP MED, V163, P1391, DOI 10.1084/jem.163.6.1391; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Liger D, 1997, FEBS LETT, V406, P157, DOI 10.1016/S0014-5793(97)00243-3; Lord Michael J., 2003, Toxicological Reviews, V22, P53, DOI 10.2165/00139709-200322010-00006; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; Nishimoto-Morita K, 2009, J BIOL CHEM, V284, P10583, DOI 10.1074/jbc.M900847200; Ponnambalam S, 1996, J CELL SCI, V109, P675; Pratt TS, 2007, EXP LUNG RES, V33, P459, DOI 10.1080/01902140701731805; Saenz JB, 2007, INFECT IMMUN, V75, P4552, DOI 10.1128/IAI.00442-07; Saenz JB, 2009, NAT CHEM BIOL, V5, P157, DOI 10.1038/nchembio.144; Sandvig K, 2004, INT J MED MICROBIOL, V293, P483, DOI 10.1078/1438-4221-00294; Sandvig K, 2005, GENE THER, V12, P865, DOI 10.1038/sj.gt.3302525; SNIDER MD, 1985, J CELL BIOL, V100, P826, DOI 10.1083/jcb.100.3.826; Spillsberg B, 2003, TRAFFIC, V4, P544, DOI 10.1034/j.1600-0854.2003.00111.x; Tai GH, 2004, MOL BIOL CELL, V15, P4011, DOI 10.1091/mbc.e03-12-0876; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Yeh PJ, 2009, NAT REV MICROBIOL, V7, P460, DOI 10.1038/nrmicro2133; Zhang T, 2001, J BIOL CHEM, V276, P27480, DOI 10.1074/jbc.M102786200	38	214	228	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2010	141	2					231	242		10.1016/j.cell.2010.01.043	http://dx.doi.org/10.1016/j.cell.2010.01.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	584GF	20403321	Bronze			2022-12-28	WOS:000276738400014
J	Gill, TM; Gahbauer, EA; Han, L; Allore, HG				Gill, Thomas M.; Gahbauer, Evelyne A.; Han, Ling; Allore, Heather G.			Trajectories of Disability in the Last Year of Life.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OLDER PERSONS; FUNCTIONAL DECLINE; SAS PROCEDURE; HEALTH; MORBIDITY; FRAILTY; STATES	Background: Despite the importance of functional status to older persons and their families, little is known about the course of disability at the end of life. Methods: We evaluated data on 383 decedents from a longitudinal study involving 754 community-dwelling older persons. None of the subjects had disability in essential activities of daily living at the beginning of the study, and the level of disability was ascertained during monthly interviews for more than 10 years. Information on the conditions leading to death was obtained from death certificates and comprehensive assessments that were completed at 18-month intervals after the baseline assessment. Results: In the last year of life, five distinct trajectories were identified, from no disability to the most severe disability: 65 subjects had no disability (17.0%), 76 had catastrophic disability (19.8%), 67 had accelerated disability (17.5%), 91 had progressive disability (23.8%), and 84 had persistently severe disability (21.9%). The most common condition leading to death was frailty (in 107 subjects [27.9%]), followed by organ failure (in 82 subjects [21.4%]), cancer (in 74 subjects [19.3%]), other causes (in 57 subjects [14.9%]), advanced dementia (in 53 subjects [13.8%]), and sudden death (in 10 subjects [2.6%]). When the distribution of the disability trajectories was evaluated according to the conditions leading to death, a predominant trajectory was observed only for subjects who died from advanced dementia (67.9% of these subjects had a trajectory of persistently severe disability) and sudden death (50.0% of these subjects had no disability). For the four other conditions leading to death, no more than 34% of the subjects had any of the disability trajectories. The distribution of disability trajectories was particularly heterogeneous among the subjects with organ failure (from 12.2 to 32.9% of the subjects followed a specific trajectory) and frailty (from 14.0 to 27.1% of the subjects followed a specific trajectory). Conclusions: In most of the decedents, the course of disability in the last year of life did not follow a predictable pattern based on the condition leading to death. N Engl J Med 2010;362:1173-80.	[Gill, Thomas M.] Yale Univ, Sch Med, Adler Geriatr Ctr, Dept Internal Med, New Haven, CT 06510 USA	Yale University	Gill, TM (corresponding author), Yale Univ, Sch Med, Adler Geriatr Ctr, Dept Internal Med, 874 Howard Ave, New Haven, CT 06510 USA.	thomas.gill@yale.edu	Maier, Andrea B./Q-5548-2019; Gill, Thomas M./H-7043-2019	Gill, Thomas M./0000-0002-6450-0368; Allore, Heather/0000-0001-7685-8175	National Institute on Aging [R37AG17560, R01AG022993, K24AG021507]; Yale Claude D. Pepper Older Americans Independence Center [P30AG21342]; NATIONAL INSTITUTE ON AGING [P30AG021342, R01AG022993, R37AG017560, K24AG021507] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Yale Claude D. Pepper Older Americans Independence Center; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from the National Institute on Aging (R37AG17560 and R01AG022993) and the Yale Claude D. Pepper Older Americans Independence Center (P30AG21342) and by a Midcareer Investigator Award in Patient-Oriented Research from the National Institute on Aging (K24AG021507, to Dr. Gill).	Bandeen-Roche K, 2006, J GERONTOL A-BIOL, V61, P262, DOI 10.1093/gerona/61.3.262; Chen JH, 2007, J GERONTOL A-BIOL, V62, P531, DOI 10.1093/gerona/62.5.531; Efron Bradley., 1993, INTRO BOOTSTRAP, DOI 10.1007/978-1-4899-4541-9; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freedman VA, 2002, JAMA-J AM MED ASSOC, V288, P3137, DOI 10.1001/jama.288.24.3137; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Gazelle G, 2007, NEW ENGL J MED, V357, P321, DOI 10.1056/NEJMp078067; Gill TM, 2008, J AM GERIATR SOC, V56, P436, DOI 10.1111/j.1532-5415.2007.01603.x; Gill TM, 2006, ARCH INTERN MED, V166, P418, DOI 10.1001/.418; Gill TM, 2002, J AM GERIATR SOC, V50, P1492, DOI 10.1046/j.1532-5415.2002.50403.x; Gill TM, 2001, ANN INTERN MED, V135, P313, DOI 10.7326/0003-4819-135-5-200109040-00007; GURALNIK JM, 1991, AM J PUBLIC HEALTH, V81, P443, DOI 10.2105/AJPH.81.4.443; Hardy SE, 2005, AM J EPIDEMIOL, V161, P575, DOI 10.1093/aje/kwi083; Hardy SE, 2004, JAMA-J AM MED ASSOC, V291, P1596, DOI 10.1001/jama.291.13.1596; Ives DG, 2009, J AM GERIATR SOC, V57, P133, DOI 10.1111/j.1532-5415.2008.02056.x; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364; Liao YL, 1999, AM J EPIDEMIOL, V149, P1097; Lunney JR, 2003, JAMA-J AM MED ASSOC, V289, P2387, DOI 10.1001/jama.289.18.2387; Lunney JR, 2002, J AM GERIATR SOC, V50, P1108, DOI 10.1046/j.1532-5415.2002.50268.x; Manton KG, 2006, P NATL ACAD SCI USA, V103, P18374, DOI 10.1073/pnas.0608483103; Nagin DS, 2005, GROUP BASED MODELING; Weiss CO, 2007, JAMA-J AM MED ASSOC, V298, P1160, DOI 10.1001/jama.298.10.1160-a	24	555	567	0	62	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 1	2010	362	13					1173	1180		10.1056/NEJMoa0909087	http://dx.doi.org/10.1056/NEJMoa0909087			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	577QQ	20357280	Bronze, Green Accepted			2022-12-28	WOS:000276239500007
J	Maisel, WH; Kohno, T				Maisel, William H.; Kohno, Tadayoshi			Improving the Security and Privacy of Implantable Medical Devices.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Maisel, William H.] Beth Israel Deaconess Med Ctr, Med Device Safety Inst, Boston, MA 02215 USA; [Kohno, Tadayoshi] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA	Harvard University; Beth Israel Deaconess Medical Center; University of Washington; University of Washington Seattle	Maisel, WH (corresponding author), Beth Israel Deaconess Med Ctr, Med Device Safety Inst, Boston, MA 02215 USA.							*FOOD DRUG ADM, 2007, GUID IND COMP SYST U; Halperin D, 2008, P IEEE S SECUR PRIV, P129, DOI 10.1109/SP.2008.31; HIGHFIELD R, 2008, HACKING FEARS WIRELE; MURRAY J, 2004, PREPARED STATEMENT S; Office of Civil Rights U. S. Deptartment of Health and Human Services, 2003, FED REGISTER, V68, P8334	5	43	44	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 1	2010	362	13					1164	1166		10.1056/NEJMp1000745	http://dx.doi.org/10.1056/NEJMp1000745			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	577QQ	20357279				2022-12-28	WOS:000276239500002
J	Weinberg, RA				Weinberg, Robert A.			Point: Hypotheses first	NATURE			English	Editorial Material									[Weinberg, Robert A.] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Weinberg, Robert A.] MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Weinberg, RA (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	weinberg@wi.mit.edu							0	65	73	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 1	2010	464	7289					678	678		10.1038/464678a	http://dx.doi.org/10.1038/464678a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	577EO	20360718				2022-12-28	WOS:000276205000020
J	Fazzari, P; Paternain, AV; Valiente, M; Pla, R; Lujan, R; Lloyd, K; Lerma, J; Marin, O; Rico, B				Fazzari, Pietro; Paternain, Ana V.; Valiente, Manuel; Pla, Ramon; Lujan, Rafael; Lloyd, Kent; Lerma, Juan; Marin, Oscar; Rico, Beatriz			Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling	NATURE			English	Article							GABAERGIC INTERNEURONS; NEUREGULIN-1; NEURONS; RAT; SCHIZOPHRENIA; RECEPTORS; SUSCEPTIBILITY; ORIGIN; CELLS; CAT	Schizophrenia is a complex disorder that interferes with the function of several brain systems required for cognition and normal social behaviour. Although the most notable clinical aspects of the disease only become apparent during late adolescence or early adulthood, many lines of evidence suggest that schizophrenia is a neurodevelopmental disorder with a strong genetic component(1,2). Several independent studies have identified neuregulin 1 (NRG1) and its receptor ERBB4 as important risk genes for schizophrenia(3,4), although their precise role in the disease process remains unknown. Here we show that Nrg1 and ErbB4 signalling controls the development of inhibitory circuitries in the mammalian cerebral cortex by cell-autonomously regulating the connectivity of specific GABA (gamma-aminobutyric acid)-containing interneurons. In contrast to the prevalent view, which supports a role for these genes in the formation and function of excitatory synapses between pyramidal cells, we found that ErbB4 expression in the mouse neocortex and hippocampus is largely confined to certain classes of interneurons. In particular, ErbB4 is expressed by many parvalbumin-expressing chandelier and basket cells, where it localizes to axon terminals and postsynaptic densities receiving glutamatergic input. Gain- and loss-of-function experiments, both in vitro and in vivo, demonstrate that ErbB4 cell-autonomously promotes the formation of axo-axonic inhibitory synapses over pyramidal cells, and that this function is probably mediated by Nrg1. In addition, ErbB4 expression in GABA-containing interneurons regulates the formation of excitatory synapses onto the dendrites of these cells. By contrast, ErbB4 is dispensable for excitatory transmission between pyramidal neurons. Altogether, our results indicate that Nrg1 and ErbB4 signalling is required for the wiring of GABA-mediated circuits in the postnatal cortex, providing a new perspective to the involvement of these genes in the aetiology of schizophrenia.	[Fazzari, Pietro; Paternain, Ana V.; Valiente, Manuel; Pla, Ramon; Lerma, Juan; Marin, Oscar; Rico, Beatriz] CSIC, Inst Neurociencias, Sant Joan dAlacant 03550, Spain; [Fazzari, Pietro; Paternain, Ana V.; Valiente, Manuel; Pla, Ramon; Lerma, Juan; Marin, Oscar; Rico, Beatriz] Univ Miguel Hernandez, Sant Joan dAlacant 03550, Spain; [Lujan, Rafael] Univ Castilla La Mancha, Fac Med, Dept Ciencias Med, Albacete 02006, Spain; [Lloyd, Kent] Univ Calif Davis, Dept Internal Med, Calif Natl Primate Res Ctr, Davis, CA 95616 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Universidad Miguel Hernandez de Elche; Universidad de Castilla-La Mancha; University of California System; University of California Davis	Marin, O (corresponding author), CSIC, Inst Neurociencias, Sant Joan dAlacant 03550, Spain.	o.marin@umh.es; brico@umh.es	Marin, Oscar/F-3856-2012; Ferriz, Ramon Pla/ABF-5635-2020; Fazzari, Pietro/ABE-9368-2020; Valiente, Manuel/J-9523-2014; Lujan, Rafael/G-2555-2015; Lerma, Juan/G-7907-2015; Pla, Ramon/AAA-9243-2020	Marin, Oscar/0000-0001-6264-7027; Fazzari, Pietro/0000-0003-3457-9201; Valiente, Manuel/0000-0002-0647-7542; Lerma, Juan/0000-0001-7838-5199; Pla, Ramon/0000-0003-4115-149X; Rico, Beatriz/0000-0002-0581-851X; Lujan Miras, Rafael/0000-0003-2001-9545	Spanish Ministry of Science and Innovation [SAF2008-00770, SAF2007-61904, BFU2006-07138, CSD2007-00023]; Consejeria de Educacion y Ciencia de la Junta de Comunidades de Castilla-La Mancha [PAI08-0174-6967]; fundacio la Caixa; EURYI; Marie Curie Intra-European Fellowship	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejeria de Educacion y Ciencia de la Junta de Comunidades de Castilla-La Mancha; fundacio la Caixa(La Caixa FoundationEuropean Commission); EURYI(European Science Foundation (ESF)); Marie Curie Intra-European Fellowship(European Commission)	We thank G. Fernandez for technical assistance, T. Gil and A. Casillas for general laboratory support, C. Lai for antibodies and plasmids, F. H. Gage for retroviral vectors, and K. Campbell (Dlx5/6-Cre-IRES-GFP), M. Gassmann (HER4<SUP>heart</SUP> and Erbb4<SUP>-</SUP>), S. Goebbels and K.-A. Nave (Nex Cre), and G. Szabo (GAD65-GFP) for mouse strains. We are grateful to L. Menendez de la Prida and P. Aivar for help with electrophysiological experiments, M. Maravall for critical reading of the manuscript, and members of the Borrell, Marin and Rico laboratories for stimulating discussions and ideas. This work was supported by grants from Spanish Ministry of Science and Innovation SAF2008-00770 (to O. M.), SAF2007-61904 (to B. R.), BFU2006-07138 (to J.L.), and CONSOLIDER CSD2007-00023 (to J. L., O. M. and B. R.), Consejeria de Educacion y Ciencia de la Junta de Comunidades de Castilla-La Mancha PAI08-0174-6967 (to R. L.), fundacio la Caixa (to B. R.) and the EURYI (see http://www.esf.org/euryi) scheme award (to O. M). P. F. is the recipient of a Marie Curie Intra-European Fellowship.	Addington AM, 2007, MOL PSYCHIATR, V12, P195, DOI 10.1038/sj.mp.4001906; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Barros CS, 2009, P NATL ACAD SCI USA, V106, P4507, DOI 10.1073/pnas.0900355106; Bjarnadottir M, 2007, J NEUROSCI, V27, P4519, DOI 10.1523/JNEUROSCI.4314-06.2007; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Christensen JK, 2004, J NEUROSCI, V24, P8986, DOI 10.1523/JNEUROSCI.2156-04.2004; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Garcia RAG, 2000, P NATL ACAD SCI USA, V97, P3596, DOI 10.1073/pnas.070042497; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Golub MS, 2004, BEHAV BRAIN RES, V153, P159, DOI 10.1016/j.bbr.2003.11.010; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Hall J, 2006, NAT NEUROSCI, V9, P1477, DOI 10.1038/nn1795; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Krivosheya D, 2008, J BIOL CHEM, V283, P32944, DOI 10.1074/jbc.M800073200; Kwon OB, 2005, J NEUROSCI, V25, P9378, DOI 10.1523/JNEUROSCI.2100-05.2005; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Li B, 2007, NEURON, V54, P583, DOI 10.1016/j.neuron.2007.03.028; Longart M, 2007, BRAIN RES BULL, V73, P210, DOI 10.1016/j.brainresbull.2007.02.014; Lopez-Bendito G, 2004, CEREB CORTEX, V14, P1122, DOI 10.1093/cercor/bhh072; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Owen MJ, 2004, MOL PSYCHIATR, V9, P14, DOI 10.1038/sj.mp.4001444; Pla R, 2006, J NEUROSCI, V26, P6924, DOI 10.1523/JNEUROSCI.0245-06.2006; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; SOMOGYI P, 1982, NEUROSCIENCE, V7, P2577, DOI 10.1016/0306-4522(82)90086-0; Spencer KM, 2003, J NEUROSCI, V23, P7407; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Stenman J, 2003, J NEUROSCI, V23, P167; Tamas G, 1997, J PHYSIOL-LONDON, V500, P715, DOI 10.1113/jphysiol.1997.sp022054; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Vullhorst D, 2009, J NEUROSCI, V29, P12255, DOI 10.1523/JNEUROSCI.2454-09.2009; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Woo RS, 2007, NEURON, V54, P599, DOI 10.1016/j.neuron.2007.04.009; Woo TU, 1998, P NATL ACAD SCI USA, V95, P5341, DOI 10.1073/pnas.95.9.5341; ZHU XJ, 1995, EMBO J, V14, P5842, DOI 10.1002/j.1460-2075.1995.tb00272.x	42	335	339	2	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2010	464	7293					1376	U11		10.1038/nature08928	http://dx.doi.org/10.1038/nature08928			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20393464				2022-12-28	WOS:000277149000052
J	French, C				French, Charles			ARCHAEOLOGY People, Societies, and Landscapes	SCIENCE			English	Editorial Material							EROSION; VALLEY		Univ Cambridge, Dept Archaeol, Cambridge CB2 3DZ, England	University of Cambridge	French, C (corresponding author), Univ Cambridge, Dept Archaeol, Downing St, Cambridge CB2 3DZ, England.	caif2@cam.ac.uk		French, Charles/0000-0001-7967-3248				Ayala G, 2005, GEOARCHAEOLOGY, V20, P149, DOI 10.1002/gea.20041; Barrett J., 1994, FRAGMENTS ANTIQUITY; Barton CM, 2010, AM ANTIQUITY, V75, P364, DOI 10.7183/0002-7316.75.2.364; Barton CM, 2004, J ARCHAEOL METHOD TH, V11, P253, DOI 10.1023/B:JARM.0000047315.57162.b7; Bintliff J, 2005, GEOARCHAEOLOGY, V20, P135, DOI 10.1002/gea.20040; Conolly J., 2006, GEOGRAPHICAL INFORM; FRENCH C, 2007, RECONSTRUCTING HUMAN, P252; French C, 2007, PREHISTORIC LANDSCAP; French CAI., 2003, GEOARCHAEOLOGY ACTIO; French C, 2009, CATENA, V78, P218, DOI 10.1016/j.catena.2009.02.010; Kwan M. P., 2004, SPATIALLY INTEGRATED; Llobera M, 2007, WORLD ARCHAEOL, V39, P51, DOI 10.1080/00438240601136496; Samarasundera E, 2007, PREHISTORIC LANDSCAP, P197; Wainwright J, 2008, GEOFORUM, V39, P659, DOI 10.1016/j.geoforum.2006.09.011; Wilkinson TJ, 2005, GEOARCHAEOLOGY, V20, P169, DOI 10.1002/gea.20042; [No title captured]	16	9	9	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 23	2010	328	5977					443	444		10.1126/science.1186019	http://dx.doi.org/10.1126/science.1186019			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	586YR	20413485				2022-12-28	WOS:000276952400025
J	Webb, P				Webb, Paul			Science Education and Literacy: Imperatives for the Developed and Developing World	SCIENCE			English	Editorial Material							LANGUAGE	This article explores current language-based research aimed at promoting scientific literacy and examines issues of language use in schools, particularly where science teaching and learning take place in teachers' and learners' second language. Literature supporting the premise that promoting reading, writing, and talking while "doing science" plays a vital role in effective teaching and learning of the subject is highlighted. A wide range of studies suggest that, whether in homogenous or language-diverse settings, science educators can make a significant contribution to both understanding science and promoting literacy.	Nelson Mandela Metropolitan Univ, Ctr Educ Res Technol & Innovat, ZA-6001 Port Elizabeth, South Africa	Nelson Mandela University	Webb, P (corresponding author), Nelson Mandela Metropolitan Univ, Ctr Educ Res Technol & Innovat, ZA-6001 Port Elizabeth, South Africa.		Webb, Paul/AAI-5861-2020					Alidou H. B., 2006, OPTIMIZING LEARNING; Amaral O.M., 2002, BILINGUAL RES J, V29, P213, DOI [DOI 10.1080/15235882.2002.10668709, 10.1080/15235882.2002.10668709]; Ballenger Cynthia, 1997, LANGUAGE ED, V11, P1, DOI DOI 10.1080/09500789708666715; Cervetti G., 2006, LINKING SCI LITERACY, P221; CUMMINS J, 1981, APPL LINGUIST, V2, P132, DOI 10.1093/applin/2.2.132; Department of Education, 2005, NAT ED QUAL IN ED SC; Fensham Peter., 2008, SCI ED POLICY MAKING; Gunel Murat, 2007, INT J SCI MATH EDUC, V5, P615, DOI [10.1007/s10763-007-9082-y, DOI 10.1007/S10763-007-9082-Y]; Hand B., 2007, SCI INQUIRY ARGUMENT; Hand B., 2001, WRITING LEARNING TOO, P105; Hodson D., 2009, TEACHING LEARNING SC, DOI [10.1163/9789460910531, DOI 10.1163/9789460910531]; MCDERMOTT MA, 2008, INT M ASS SCI TEACH; NESBIT CR, 2003, IMPLEMENTING SCI NOT; Norris SP, 2003, SCI EDUC, V87, P224, DOI 10.1002/sce.10066; REVAK M, 2008, INT M ASS SCI TEACH; Rodseth V., 1995, BILINGUALISM MULTILI; Romance N. R., 2006, LINKING SCI LITERACY, P391; ROMANCE NR, 1992, J RES SCI TEACH, V29, P545, DOI 10.1002/tea.3660290604; ROMANCE NR, 2008, 02283530014 NSFIERI; Setati M., 2002, LANG EDUC-UK, V16, P128; Shanahan T., 2006, DEV LITERACY 2 LANGU; Villanueva MG, 2008, AFR J RES MATH SCI T, V12, P3, DOI 10.1080/10288457.2008.10740631; Webb P., 2009, INT J ENV SCI ED, V4, P313; Webb P, 2008, AFRICAN J RES SMT ED, V12, P4; Webb P, 2006, RES SCI EDUC, V36, P381, DOI 10.1007/s11165-005-9011-4; Yore LD, 2006, INT J SCI EDUC, V28, P291, DOI 10.1080/09500690500336973; Yore LD, 2003, INT J SCI EDUC, V25, P689, DOI 10.1080/09500690305018	27	36	37	4	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2010	328	5977					448	450		10.1126/science.1182596	http://dx.doi.org/10.1126/science.1182596			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	586YR	20413487				2022-12-28	WOS:000276952400027
J	Schlosshan, D; Aggarwal, G; Mathur, G; Cranney, G; Giles, R				Schlosshan, Dominik; Aggarwal, Gunjan; Mathur, Gita; Cranney, Greg; Giles, Robert			Amorous overheating?	LANCET			English	Editorial Material							INFECTIONS; MANAGEMENT		[Schlosshan, Dominik; Aggarwal, Gunjan; Mathur, Gita; Cranney, Greg; Giles, Robert] Prince Wales Hosp, Dept Cardiol, Sydney, NSW, Australia		Schlosshan, D (corresponding author), Eastern Heart Clin, Level 3,Campus Ctr Bldg,Barker St, Randwick, NSW 2031, Australia.	dschlo1038@aol.com						Baddour LM, 2003, CIRCULATION, V108, P2015, DOI 10.1161/01.CIR.0000093201.57771.47; BLUHM G, 1985, ACTA MED SCAND, P1; Chamis AL, 2001, CIRCULATION, V104, P1029, DOI 10.1161/hc3401.095097; Chua JD, 2000, ANN INTERN MED, V133, P604, DOI 10.7326/0003-4819-133-8-200010170-00011; Klug D, 1997, CIRCULATION, V95, P2098, DOI 10.1161/01.CIR.95.8.2098	5	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 17	2010	375	9723					1406	1406		10.1016/S0140-6736(10)60137-7	http://dx.doi.org/10.1016/S0140-6736(10)60137-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588GW	20399980				2022-12-28	WOS:000277057800031
J	Astafiev, SV; Snyder, AZ; Shulman, GL; Corbetta, M				Astafiev, Serguei V.; Snyder, Abraham Z.; Shulman, Gordon L.; Corbetta, Maurizio			Comment on "Modafinil Shifts Human Locus Coeruleus to Low-Tonic, High-Phasic Activity During Functional MRI" and "Homeostatic Sleep Pressure and Responses to Sustained Attention in the Suprachiasmatic Area"	SCIENCE			English	Editorial Material							RECONSTRUCTION		[Astafiev, Serguei V.; Snyder, Abraham Z.; Corbetta, Maurizio] Washington Univ, Dept Radiol, St Louis, MO 63110 USA; [Snyder, Abraham Z.; Shulman, Gordon L.; Corbetta, Maurizio] Washington Univ, Dept Neurol, St Louis, MO 63110 USA; [Corbetta, Maurizio] Washington Univ, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Corbetta, M (corresponding author), Washington Univ, Dept Radiol, Box 8225, St Louis, MO 63110 USA.	mau@npg.wustl.edu	Corbetta, Maurizio/AAZ-5219-2020; Astafiev, Serguei/A-9734-2014	Astafiev, Serguei/0000-0003-3736-7095; CORBETTA, MAURIZIO/0000-0001-8295-3304	NIMH NIH HHS [R01 MH71920-06, R01 MH071920] Funding Source: Medline; NINDS NIH HHS [R01 NS048013] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048013] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Aston-Jones G, 2004, RAT NERVOUS SYSTEM, P259; BAKER KG, 1989, EXP BRAIN RES, V77, P257, DOI 10.1007/BF00274983; D'Ardenne K, 2008, SCIENCE, V319, P1264, DOI 10.1126/science.1150605; DeArmond SJ, 1989, STRUCTURE HUMAN BRAI; GERMAN DC, 1988, J NEUROSCI, V8, P1776; Ishimatsu M, 1996, J NEUROSCI, V16, P5196; Keren NI, 2009, NEUROIMAGE, V47, P1261, DOI 10.1016/j.neuroimage.2009.06.012; Minzenberg MJ, 2008, SCIENCE, V322, P1700, DOI 10.1126/science.1164908; Nakane Toshiki, 2008, Magn Reson Med Sci, V7, P205; Nieuwenhuys R., 2008, HUMAN CENTRAL NERVOU; Sasaki M, 2006, NEUROREPORT, V17, P1215, DOI 10.1097/01.wnr.0000227984.84927.a7; Sasaki M, 2008, NEUROREPORT, V19, P1649, DOI 10.1097/WNR.0b013e328315a637; Schmidt C, 2009, SCIENCE, V324, P516, DOI 10.1126/science.1167337; Shulman GL, 2009, J NEUROSCI, V29, P4392, DOI 10.1523/JNEUROSCI.5609-08.2009	15	49	49	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2010	328	5976								10.1126/science.1177200	http://dx.doi.org/10.1126/science.1177200			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583NR	20395497	Green Accepted, Green Submitted			2022-12-28	WOS:000276685000017
J	Montell, C				Montell, Craig			Preventing a Perm with TRPV3	CELL			English	Editorial Material							MUTATION; GROWTH; HEAT		[Montell, Craig] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Dept Biol Chem, Baltimore, MD 21205 USA; [Montell, Craig] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Montell, C (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Dept Biol Chem, Baltimore, MD 21205 USA.	cmontell@jhmi.edu	Montell, Craig/AAH-3357-2021	Montell, Craig/0000-0001-5637-1482				Asakawa M, 2006, J INVEST DERMATOL, V126, P2664, DOI 10.1038/sj.jid.5700468; Denda M, 2010, J INVEST DERMATOL, V130, P1942, DOI 10.1038/jid.2010.32; Grandl J, 2008, NAT NEUROSCI, V11, P1007, DOI 10.1038/nn.2169; Lee J, 2008, J DERMATOL SCI, V52, P160, DOI 10.1016/j.jdermsci.2008.06.007; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Schneider MR, 2008, AM J PATHOL, V173, P14, DOI 10.2353/ajpath.2008.070942; Xiao R, 2008, CELL CALCIUM, V43, P334, DOI 10.1016/j.ceca.2007.06.004; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218	9	4	7	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2010	141	2					218	220		10.1016/j.cell.2010.03.043	http://dx.doi.org/10.1016/j.cell.2010.03.043			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	584GF	20403316	Bronze			2022-12-28	WOS:000276738400009
J	Jennings, CC				Jennings, Christopher C.			Implementation and the Legacy of Health Care Reform.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Jennings Policy Strategies, Washington, DC USA		Jennings, CC (corresponding author), Jennings Policy Strategies, Washington, DC USA.								0	7	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 15	2010	362	15								10.1056/NEJMp1003709	http://dx.doi.org/10.1056/NEJMp1003709			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	582XY	20357274				2022-12-28	WOS:000276635300004
J	Phung, OJ; Scholle, JM; Talwar, M; Coleman, CI				Phung, Olivia J.; Scholle, Jennifer M.; Talwar, Mehak; Coleman, Craig I.			Effect of Noninsulin Antidiabetic Drugs Added to Metformin Therapy on Glycemic Control, Weight Gain, and Hypoglycemia in Type 2 Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							DIPEPTIDYL PEPTIDASE-4 INHIBITOR; DOUBLE-BLIND; COMBINATION THERAPY; TREATED PATIENTS; CLINICAL-TRIALS; PLUS METFORMIN; EFFICACY; SAFETY; VILDAGLIPTIN; MELLITUS	Context Metformin is the recommended initial drug therapy for patients with type 2 diabetes mellitus (DM). However, the optimal second-line drug when metformin monotherapy fails is unclear. Objective To determine the comparative efficacy, risk of weight gain, and hypoyglycemia associated with noninsulin antidiabetic drugs in patients with type 2 DM not controlled by metformin alone. Data Sources A literature search via MEDLINE (beginning in January 1950) and Cochrane CENTRAL through January 2010 and a manual search of references for additional relevant studies. Study Selection Randomized controlled trials (RCTs) with at least 3 months' duration, evaluating noninsulin antidiabetic drugs added to metformin in patients experiencing an inadequate response to maximized and stable (>= 4 weeks at >= 1500 mg or maximally tolerated dose) metformin therapy. Data Extraction Inclusion/exclusion criteria; duration of patient follow-up; drug, dose, and schedule used; use of concurrent lifestyle modification; and baseline characteristics (age, sex, anthropometrics, glycated hemoglobin A(1c) [HbA(1c)], duration of DM, and metformin dose). End points collected included mean change in HbA(1c), proportion of patients achieving HbA(1c) goal of less than 7%, change in weight, and incidence of hypoglycemia. Mixed-treatment comparison meta-analysis was used to calculate the weighted mean difference for changes from baseline in HbA(1c) and body weight and relative risk (RR) of HbA(1c) goal attainment and hypoglycemia, with associated 95% credible intervals. Data Synthesis Overall, 27 RCTs (n=11 198) were included. Mean (range) trial duration was 32 (12-52) weeks. The different classes of drugs were associated with similar HbA(1c) reductions (range, 0.64%-0.97%) compared with placebo. Although use of thiazolidinediones, sulfonylureas, and glinides were associated with weight gain (range, 1.77-2.08 kg), glucagon-like peptide-1 analogs, alpha-glucosidase inhibitors, and dipeptidyl peptidase-4 inhibitors were associated with weight loss or no weight change. Sulfonylureas and glinides were associated with higher rates of hypoglycemia than with placebo (RR range, 4.57-7.50). Conclusion When added to maximal metformin therapy, all noninsulin antidiabetic drugs were associated with similar HbA(1c) reductions but differed in their associations with weight gain and risk of hypoglycemia. JAMA. 2010; 303(14): 1410-1418	Univ Connecticut, Sch Pharm, Storrs, CT USA; Hartford Hosp, Drug Informat Ctr, Hartford, CT 06115 USA	University of Connecticut; Hartford Hospital	Coleman, CI (corresponding author), Univ Connecticut, Sch Pharm, 80 Seymour St, Hartford, CT 06102 USA.	ccolema@harthosp.org		Coleman, Craig/0000-0003-4868-7158	Hartford Hospital Research Foundation, Hartford, Connecticut	Hartford Hospital Research Foundation, Hartford, Connecticut	This work was supported financially by the Hartford Hospital Research Foundation, Hartford, Connecticut.	Ahren B, 2007, HORM METAB RES, V39, P826, DOI 10.1055/s-2007-991172; Ahren B, 2004, DIABETES CARE, V27, P2874, DOI 10.2337/diacare.27.12.2874; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; [Anonymous], 2009, BYETT EX; Bolli G, 2008, DIABETES OBES METAB, V10, P82, DOI 10.1111/j.1463-1326.2007.00820.x; Bolli G, 2009, DIABETES OBES METAB, V11, P589, DOI 10.1111/j.1463-1326.2008.01023.x; Bosi E, 2007, DIABETES CARE, V30, P890, DOI 10.2337/dc06-1732; Charbonnel B, 2006, DIABETES CARE, V29, P2638, DOI 10.2337/dc06-0706; Charpentier G, 2001, DIABETIC MED, V18, P828, DOI 10.1046/j.1464-5491.2001.00582.x; DeFronzo RA, 2005, DIABETES CARE, V28, P1092, DOI 10.2337/diacare.28.5.1092; DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902; DeFronzo RA, 2009, DIABETES CARE, V32, P1649, DOI 10.2337/dc08-1984; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Feinglos M, 2005, DIABETES RES CLIN PR, V68, P167, DOI 10.1016/j.diabres.2004.09.002; Ferrannini E, 2009, DIABETES OBES METAB, V11, P157, DOI 10.1111/j.1463-1326.2008.00994.x; FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q; Fonseca V, 2000, JAMA-J AM MED ASSOC, V283, P1695, DOI 10.1001/jama.283.13.1695; Frier BM, 2008, DIABETES-METAB RES, V24, P87, DOI 10.1002/dmrr.796; Garber A, 2006, DIABETES OBES METAB, V8, P156, DOI 10.1111/j.1463-1326.2005.00570.x; *GLAXOSMITHKLINE, 2009, AV ROS; Gomez-Perez FJ, 2002, DIABETES-METAB RES, V18, P127, DOI 10.1002/dmrr.264; Goodman M, 2009, HORM METAB RES, V41, P368, DOI 10.1055/s-0028-1104604; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Halimi S, 2000, DIABETES RES CLIN PR, V50, P49, DOI 10.1016/S0168-8227(00)00163-7; Hamann A, 2008, EXP CLIN ENDOCR DIAB, V116, P6, DOI 10.1055/s-2007-984441; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Holman RR, 2006, METABOLISM, V55, pS2, DOI 10.1016/j.metabol.2006.02.006; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Khanolkar MP, 2008, ATHEROSCLEROSIS, V197, P718, DOI 10.1016/j.atherosclerosis.2007.07.020; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Marre A, 2002, DIABETES OBES METAB, V4, P177, DOI 10.1046/j.1463-1326.2002.00196.x; Matthews DR, 2005, DIABETES-METAB RES, V21, P167, DOI 10.1002/dmrr.478; Monami M, 2008, DIABETES RES CLIN PR, V79, P196, DOI 10.1016/j.diabres.2007.08.024; Moses R, 1999, DIABETES CARE, V22, P119, DOI 10.2337/diacare.22.1.119; Moses R, 1999, EXP CLIN ENDOCR DIAB, V107, pS136, DOI 10.1055/s-0029-1212169; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Nathan DM, 2002, NEW ENGL J MED, V347, P1342, DOI 10.1056/NEJMcp021106; Nauck MA, 2007, DIABETES OBES METAB, V9, P194, DOI 10.1111/j.1463-1326.2006.00704.x; Nauck MA, 2009, INT J CLIN PRACT, V63, P46, DOI 10.1111/j.1742-1241.2008.01933.x; Nauck M, 2009, DIABETES CARE, V32, P84, DOI 10.2337/dc08-1355; Raz I, 2008, CURR MED RES OPIN, V24, P537, DOI [10.1185/030079908X260925, 10.1185/030079908X260925 ]; Ristic S, 2007, DIABETES OBES METAB, V9, P506, DOI 10.1111/j.1463-1326.2006.00632.x; Ristic S, 2006, DIABETIC MED, V23, P757, DOI 10.1111/j.1464-5491.2006.01914.x; Rosenstock J, 1998, DIABETES CARE, V21, P2050, DOI 10.2337/diacare.21.12.2050; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Scott R, 2008, DIABETES OBES METAB, V10, P959, DOI 10.1111/j.1463-1326.2007.00839.x; *TAK PHARM AM INC, 2008, ACT PIOGL; *THOMS, 2008, DRUG TOP RED BOOK; US Food and Drug Administration, GUID IND DIAB MELL D; Van Gaal L, 2001, DIABETES OBES METAB, V3, P326, DOI 10.1046/j.1463-1326.2001.00141.x	50	372	389	0	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2010	303	14					1410	1418		10.1001/jama.2010.405	http://dx.doi.org/10.1001/jama.2010.405			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582KX	20388897	Bronze			2022-12-28	WOS:000276597300026
J	Whitcomb, ME				Whitcomb, Michael E.			New Medical Schools in the United States.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									George Washington Univ, Sch Publ Hlth & Hlth Serv, Washington, DC 20052 USA	George Washington University	Whitcomb, ME (corresponding author), George Washington Univ, Sch Publ Hlth & Hlth Serv, Washington, DC 20052 USA.							Hurt MM, 2005, ACAD MED, V80, P973, DOI 10.1097/00001888-200511000-00002; Whitcomb M, 2009, NEW DEV MED SCH MOTI	2	13	13	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 8	2010	362	14					1255	1258		10.1056/NEJMp0912179	http://dx.doi.org/10.1056/NEJMp0912179			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	579SN	20375402				2022-12-28	WOS:000276393700002
J	Xavier, JB; Sander, C				Xavier, Joao B.; Sander, Chris			Principle of System Balance for Drug Interactions.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Xavier, Joao B.; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Xavier, JB (corresponding author), Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, 1275 York Ave, New York, NY 10021 USA.		Xavier, Joao/H-5471-2011	Xavier, Joao/0000-0003-3592-1689				Bollenbach T, 2009, CELL, V139, P707, DOI 10.1016/j.cell.2009.10.025; Chait R, 2007, NATURE, V446, P668, DOI 10.1038/nature05685; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890	3	7	7	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 8	2010	362	14					1339	1340		10.1056/NEJMcibr1001270	http://dx.doi.org/10.1056/NEJMcibr1001270			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	579SN	20375413				2022-12-28	WOS:000276393700016
J	Deyo, RA; Mirza, SK; Martin, BI; Kreuter, W; Goodman, DC; Jarvik, JG				Deyo, Richard A.; Mirza, Sohail K.; Martin, Brook I.; Kreuter, William; Goodman, David C.; Jarvik, Jeffrey G.			Trends, Major Medical Complications, and Charges Associated With Surgery for Lumbar Spinal Stenosis in Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOW-BACK-PAIN; UNITED-STATES TRENDS; RANDOMIZED CONTROLLED-TRIAL; FUSION SURGERY; REGIONAL-VARIATIONS; ARTHRODESIS; SPONDYLOLISTHESIS; DECOMPRESSION; OUTCOMES; INSTRUMENTATION	Context In recent decades, the fastest growth in lumbar surgery occurred in older patients with spinal stenosis. Trials indicate that for selected patients, decompressive surgery offers an advantage over nonoperative treatment, but surgeons often recommend more invasive fusion procedures. Comorbidity is common in older patients, so benefits and risks must be carefully weighed in the choice of surgical procedure. Objective To examine trends in use of different types of stenosis operations and the association of complications and resource use with surgical complexity. Design, Setting, and Patients Retrospective cohort analysis of Medicare claims for 2002-2007, focusing on 2007 to assess complications and resource use in US hospitals. Operations for Medicare recipients undergoing surgery for lumbar stenosis (n=32 152 in the first 11 months of 2007) were grouped into 3 gradations of invasiveness: decompression alone, simple fusion (1 or 2 disk levels, single surgical approach), or complex fusion (more than 2 disk levels or combined anterior and posterior approach). Main Outcome Measures Rates of the 3 types of surgery, major complications, postoperative mortality, and resource use. Results Overall, surgical rates declined slightly from 2002-2007, but the rate of complex fusion procedures increased 15-fold, from 1.3 to 19.9 per 100 000 beneficiaries. Life-threatening complications increased with increasing surgical invasiveness, from 2.3% among patients having decompression alone to 5.6% among those having complex fusions. After adjustment for age, comorbidity, previous spine surgery, and other features, the odds ratio (OR) of life-threatening complications for complex fusion compared with decompression alone was 2.95 (95% confidence interval [CI], 2.50-3.49). A similar pattern was observed for rehospitalization within 30 days, which occurred for 7.8% of patients undergoing decompression and 13.0% having a complex fusion (adjusted OR, 1.94; 95% CI, 1.74-2.17). Adjusted mean hospital charges for complex fusion procedures were US $80 888 compared with US $23 724 for decompression alone. Conclusions Among Medicare recipients, between 2002 and 2007, the frequency of complex fusion procedures for spinal stenosis increased while the frequency of decompression surgery and simple fusions decreased. In 2007, compared with decompression, simple fusion and complex fusion were associated with increased risk of major complications, 30-day mortality, and resource use. JAMA. 2010; 303(13): 1259-1265	[Deyo, Richard A.] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97239 USA; [Deyo, Richard A.] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97239 USA; [Deyo, Richard A.] Kaiser Permanente Ctr Hlth Res, Portland, OR USA; [Mirza, Sohail K.; Martin, Brook I.] Dartmouth Med Sch, Dept Orthopaed, Hanover, NH USA; [Kreuter, William] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Jarvik, Jeffrey G.] Univ Washington, Dept Radiol & Neurol Surg, Seattle, WA 98195 USA; [Goodman, David C.] Dartmouth Inst Hlth Policy & Clin Practice, Ctr Hlth Policy Res, Lebanon, NH USA	Oregon Health & Science University; Oregon Health & Science University; Kaiser Permanente; Dartmouth College; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Dartmouth College	Deyo, RA (corresponding author), Oregon Hlth & Sci Univ, Dept Family Med, Mail Code FM,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	deyor@ohsu.edu	Goodman, David/AAG-7497-2020; Martin, Brook/L-4698-2019; Jarvik, Jeffrey/AAL-4292-2021		National Institute of Arthritis, Musculoskeletal and Skin Diseases [1R01AR054912-01A2]; National Institute on Aging [1RC1AG036268-01]; National Center for Research Resources [1UL1RR024140-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC1AG036268, P01AG019783] Funding Source: NIH RePORTER	National Institute of Arthritis, Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding/Support: This study was supported in part by grants 1R01AR054912-01A2 from the National Institute of Arthritis, Musculoskeletal and Skin Diseases; 1RC1AG036268-01 from the National Institute on Aging; and 1UL1RR024140-01 from the National Center for Research Resources.	Abdu WA, 2009, SPINE, V34, P2351, DOI 10.1097/BRS.0b013e3181b8a829; BJARKE CF, 2002, SPINE, V27, P1269; Buntin MB, 2004, J HEALTH ECON, V23, P525, DOI 10.1016/j.jhealeco.2003.10.005; Carreon LY, 2003, J BONE JOINT SURG AM, V85A, P2089, DOI 10.2106/00004623-200311000-00004; CHERKIN DC, 1993, SPINE, V18, P1728, DOI 10.1097/00007632-199310000-00003; Chou R, 2005, ANN INTERN MED, V142, P1090, DOI 10.7326/0003-4819-142-12_Part_2-200506211-00009; Ciol MA, 1996, J AM GERIATR SOC, V44, P285, DOI 10.1111/j.1532-5415.1996.tb00915.x; Deyo RA, 2005, SPINE, V30, P1441, DOI 10.1097/01.brs.0000166503.37969.8a; DEYO RA, 1993, SPINE, V18, P1463; Deyo RA, 2004, NEW ENGL J MED, V350, P722, DOI 10.1056/NEJMsb031771; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Deyo RA, 2006, CLIN ORTHOP RELAT R, P139, DOI 10.1097/01.blo.0000198726.62514.75; DUAN N, 1983, J AM STAT ASSOC, V78, P605, DOI 10.2307/2288126; ESSES SI, 1993, SPINE, V18, P2231, DOI 10.1097/00007632-199311000-00015; Fischgrund JS, 1997, SPINE, V22, P2807, DOI 10.1097/00007632-199712150-00003; Fritzell P, 2001, SPINE, V26, P2521, DOI 10.1097/00007632-200112010-00002; Fritzell P, 2003, EUR SPINE J, V12, P178, DOI 10.1007/s00586-002-0493-8; Glassman SD, 2007, SPINE J, V7, P547, DOI 10.1016/j.spinee.2006.11.003; Glick H, 2007, EC EVALUATION CLIN T; GROB D, 1995, J BONE JOINT SURG AM, V77A, P1036, DOI 10.2106/00004623-199507000-00009; HERKOWITZ HN, 1991, J BONE JOINT SURG AM, V73A, P802, DOI 10.2106/00004623-199173060-00002; Irwin ZN, 2005, SPINE, V30, P2208, DOI 10.1097/01.brs.0000181057.60012.08; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Katz JN, 1997, SPINE, V22, P1123, DOI 10.1097/00007632-199705150-00012; Lawthers AG, 2000, MED CARE, V38, P785, DOI 10.1097/00005650-200008000-00003; Lumley T, 2002, ANNU REV PUBL HEALTH, V23, P151, DOI 10.1146/annurev.publhealth.23.100901.140546; Malmivaara A, 2007, SPINE, V32, P1, DOI 10.1097/01.brs.0000251014.81875.6d; Mirza SK, 2008, SPINE, V33, P2651, DOI 10.1097/BRS.0b013e31818dad07; Moller H, 2000, SPINE, V25, P1716, DOI 10.1097/00007632-200007010-00017; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Schermerhorn ML, 2008, NEW ENGL J MED, V358, P464, DOI 10.1056/NEJMoa0707348; TAYLOR VM, 1994, SPINE, V19, P1207, DOI 10.1097/00007632-199405310-00002; Thomsen K, 1997, SPINE, V22, P2813, DOI 10.1097/00007632-199712150-00004; Weinstein JN, 2008, NEW ENGL J MED, V358, P794, DOI 10.1056/NEJMoa0707136; Weinstein JN, 2006, SPINE, V31, P2707, DOI 10.1097/01.brs.0000248132.15231.fe	35	933	972	3	51	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2010	303	13					1259	1265		10.1001/jama.2010.338	http://dx.doi.org/10.1001/jama.2010.338			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579FM	20371784	Green Accepted, Bronze			2022-12-28	WOS:000276353700025
J	Liu, JG				Liu, Jianguo			China's Road to Sustainability	SCIENCE			English	Editorial Material									Michigan State Univ, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48823 USA	Michigan State University	Liu, JG (corresponding author), Michigan State Univ, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48823 USA.	jliu@panda.msu.edu	Liu, Jianguo/G-5211-2015	Liu, Jianguo/0000-0001-6344-0087				*CAEP, 2006, CHIN GREEN NAT ACC S; Cao SX, 2008, ENVIRON SCI TECHNOL, V42, P1826, DOI 10.1021/es0870597; *CHIN POP DEV RES, 2010, 1949 1998 TOT POP CH; Dietz T, 2009, P NATL ACAD SCI USA, V106, P18452, DOI 10.1073/pnas.0908738106; Liu JG, 2003, NATURE, V421, P530, DOI 10.1038/nature01359; Liu JG, 2005, NATURE, V435, P1179, DOI 10.1038/4351179a; Liu JG, 2008, P NATL ACAD SCI USA, V105, P9477, DOI 10.1073/pnas.0706436105; *MEP, 2009, B NAT ENV STAT 2008; National Development and Reform Commission, 2019, CHIN NAT CLIM CHANG; PAN Y, 2007, THOUGHTS CHINAS ENV; Shapiro Judith, 2001, MAOS WAR NATURE; TANG Q, 2009, J HUNAN ADM I, P9; *XINH NEWS AG, CHIN ANN TARG CARB E; Zhao J, 2007, LANDSCAPE RES, V32, P171, DOI 10.1080/01426390701231564; 2005 ENV SUSTAINABIL	15	116	126	4	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 2	2010	328	5974					50	50		10.1126/science.1186234	http://dx.doi.org/10.1126/science.1186234			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	577DR	20360095				2022-12-28	WOS:000276202200026
J	Moslemi, AR; Lindberg, C; Nilsson, J; Tajsharghi, H; Andersson, B; Oldfors, A				Moslemi, Ali-Reza; Lindberg, Christopher; Nilsson, Johanna; Tajsharghi, Homa; Andersson, Bert; Oldfors, Anders			Brief Report: Glycogenin-1 Deficiency and Inactivated Priming of Glycogen Synthesis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SKELETAL-MUSCLE GLYCOGENIN; SELF-GLUCOSYLATING PROTEIN; MESSENGER-RNA EXPRESSION; BIOSYNTHESIS; SYNTHASE; EXERCISE; CARDIOMYOPATHY; TYROSINE-194; INITIATOR; SUBUNIT	Glycogen, which serves as a major energy reserve in cells, is a large, branched polymer of glucose molecules. We describe a patient who had muscle weakness, associated with the depletion of glycogen in skeletal muscle, and cardiac arrhythmia, associated with the accumulation of abnormal storage material in the heart. The skeletal muscle showed a marked predominance of slow-twitch, oxidative muscle fibers and mitochondrial proliferation. Western blotting showed the presence of unglucosylated glycogenin-1 in the muscle and heart. Sequencing of the glycogenin-1 gene, GYG1, revealed a nonsense mutation in one allele and a missense mutation, Thr83Met, in the other. The missense mutation resulted in inactivation of the autoglucosylation of glycogenin-1 that is necessary for the priming of glycogen synthesis in muscle.	[Moslemi, Ali-Reza; Nilsson, Johanna; Tajsharghi, Homa; Oldfors, Anders] Univ Gothenburg, Dept Pathol, Inst Biomed, Gothenburg, Sweden; [Lindberg, Christopher] Univ Gothenburg, Dept Neurol, Inst Physiol & Neurol Sci, Gothenburg, Sweden; [Andersson, Bert] Univ Gothenburg, Dept Cardiol, Inst Med, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg	Oldfors, A (corresponding author), Univ Gothenburg, Dept Pathol, Inst Biomed, Sahlgrenska Univ Hosp, S-41345 Gothenburg, Sweden.	anders.oldfors@gu.se		Oldfors, Anders/0000-0002-5758-7397	Swedish Research Council [7122]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	Supported by a grant (7122, to Dr. Oldfors) from the Swedish Research Council.	ALONSO MD, 1994, FEBS LETT, V342, P38, DOI 10.1016/0014-5793(94)80580-6; ALONSO MD, 1994, FEBS LETT, V352, P222, DOI 10.1016/0014-5793(94)00962-7; Arad M, 2005, NEW ENGL J MED, V352, P362, DOI 10.1056/NEJMoa033349; Barbetti F, 1996, BIOCHEM BIOPH RES CO, V220, P72, DOI 10.1006/bbrc.1996.0359; CAO YJ, 1993, J BIOL CHEM, V268, P14687; Gibbons BJ, 2002, J MOL BIOL, V319, P463, DOI 10.1016/S0022-2836(02)00305-4; Hurley TD, 2005, J BIOL CHEM, V280, P23892, DOI 10.1074/jbc.M502344200; Hurley TD, 2006, BIOCHEM BIOPH RES CO, V348, P374, DOI 10.1016/j.bbrc.2006.07.106; Kollberg G, 2007, NEW ENGL J MED, V357, P1507, DOI 10.1056/NEJMoa066691; Lin A, 1999, ARCH BIOCHEM BIOPHYS, V363, P163, DOI 10.1006/abbi.1998.1073; Lomako J, 2004, BBA-GEN SUBJECTS, V1673, P45, DOI 10.1016/j.bbagen.2004.03.017; LOMAKO J, 1988, FASEB J, V2, P3097, DOI 10.1096/fasebj.2.15.2973423; Mccue ME, 2008, GENOMICS, V91, P458, DOI 10.1016/j.ygeno.2008.01.011; Mu J, 1997, J BIOL CHEM, V272, P27589, DOI 10.1074/jbc.272.44.27589; Pederson BA, 2005, DIABETES, V54, P3466, DOI 10.2337/diabetes.54.12.3466; Pederson BA, 2005, J BIOL CHEM, V280, P17260, DOI 10.1074/jbc.M410448200; PITCHER J, 1987, EUR J BIOCHEM, V169, P497, DOI 10.1111/j.1432-1033.1987.tb13637.x; Raben N, 2001, NEUROLOGY, V56, P1739, DOI 10.1212/WNL.56.12.1739; Shearer J, 2005, J APPL PHYSIOL, V99, P957, DOI 10.1152/japplphysiol.00275.2005; Silva AL, 2009, FEBS LETT, V583, P499, DOI 10.1016/j.febslet.2008.12.058; SKURAT AV, 2004, DIABETES MELLITUS FU, P317; SMYTHE C, 1988, EMBO J, V7, P2681, DOI 10.1002/j.1460-2075.1988.tb03121.x; Wilson RJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE1815, DOI 10.1152/ajpendo.00598.2006	23	71	72	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 1	2010	362	13					1203	1210		10.1056/NEJMoa0900661	http://dx.doi.org/10.1056/NEJMoa0900661			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	577QQ	20357282	Bronze			2022-12-28	WOS:000276239500010
J	Nussenzweig, A; Nussenzweig, MC				Nussenzweig, Andre; Nussenzweig, Michel C.			Origin of Chromosomal Translocations in Lymphoid Cancer	CELL			English	Review							CLASS-SWITCH RECOMBINATION; DOUBLE-STRAND BREAKS; INDUCED CYTIDINE DEAMINASE; END-JOINING PATHWAY; B-CELL LYMPHOMA; SOMATIC HYPERMUTATION; V(D)J RECOMBINATION; DNA-REPAIR; MAMMALIAN-CELLS; GENOMIC INSTABILITY	Aberrant fusions between heterologous chromosomes are among the most prevalent cytogenetic abnormalities found in cancer cells. Oncogenic chromosomal translocations provide cells with a proliferative or survival advantage. They may either initiate transformation or be acquired secondarily as a result of genomic instability. Here, we highlight recent advances toward understanding the origin of chromosomal translocations in incipient lymphoid cancers and how tumor-suppressive pathways normally limit the frequency of these aberrant recombination events. Deciphering the mechanisms that mediate chromosomal fusions will open new avenues for developing therapeutic strategies aimed at eliminating lesions that lead to the initiation, maintenance, and progression of cancer.	[Nussenzweig, Andre] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Labs Mol Immunol, New York, NY 10065 USA; [Nussenzweig, Michel C.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rockefeller University; Howard Hughes Medical Institute	Nussenzweig, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	andre_nussenzweig@nih.gov; nussen@mail.rockefeller.edu	Nussenzweig, Michel/AAE-7292-2019		National Institutes of Health (NIH) [AI037526]; NATIONAL CANCER INSTITUTE [ZIABC010283, ZIABC010959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037526, R37AI037526] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Callen for drawing the figures, and A. Bothmer, S. Bunting, J. Danial, E. Callen, S. Deroubaix, M. Di Virgilio, N. Feldhan, A. Gazumyan, M. Jankovic, I. Klein, K. McBride, R. Pavri, A. Ramiro, B. Reina San- Martin, and D. Robbiani for comments on the manuscript. M. C. N. is a Howard Hughes Medical Institute investigator and is supported by National Institutes of Health (NIH) grant AI037526. A. N. is supported by the Intramural Research program of the NIH, National Cancer Institute, Center for Cancer Research.	Arlt MF, 2006, DNA REPAIR, V5, P1126, DOI 10.1016/j.dnarep.2006.05.010; Bassing CH, 2004, CELL CYCLE, V3, P149; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Boboila C, 2010, P NATL ACAD SCI USA, V107, P3034, DOI 10.1073/pnas.0915067107; Boboila C, 2010, J EXP MED, V207, P417, DOI 10.1084/jem.20092449; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2007, J CLIN INVEST, V117, P2059, DOI 10.1172/JCI32577; Callen E, 2007, CELL, V130, P63, DOI 10.1016/j.cell.2007.06.016; Callen E, 2009, CELL CYCLE, V8, P2408, DOI 10.4161/cc.8.15.9085; Callen E, 2009, MOL CELL, V34, P285, DOI 10.1016/j.molcel.2009.04.025; Cao L, 2009, MOL CELL, V35, P534, DOI 10.1016/j.molcel.2009.06.037; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Curry JD, 2007, J EXP MED, V204, P2293, DOI 10.1084/jem.20070583; de Villartay JP, 2009, ADV EXP MED BIOL, V650, P46; Deriano L, 2009, MOL CELL, V34, P13, DOI 10.1016/j.molcel.2009.03.009; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Difilippantonio MJ, 2002, J EXP MED, V196, P469, DOI 10.1084/jem.20020851; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Dinkelmann M, 2009, NAT STRUCT MOL BIOL, V16, P808, DOI 10.1038/nsmb.1639; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Ferguson DO, 2000, P NATL ACAD SCI USA, V97, P6630, DOI 10.1073/pnas.110152897; Fernandez-Capetillo O, 2003, CELL CYCLE, V2, P426, DOI 10.4161/cc.2.5.509; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Franco S, 2008, J EXP MED, V205, P557, DOI 10.1084/jem.20080044; Franke ME, 2006, SMALL, V2, P36, DOI 10.1002/smll.200500261; GAUWERKY CE, 1989, P NATL ACAD SCI USA, V86, P8867, DOI 10.1073/pnas.86.22.8867; Gordon MS, 2003, P NATL ACAD SCI USA, V100, P4126, DOI 10.1073/pnas.0735266100; Gostissa M, 2009, NATURE, V462, P803, DOI 10.1038/nature08633; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Guidos CJ, 1996, GENE DEV, V10, P2038, DOI 10.1101/gad.10.16.2038; Haber JE, 2008, P NATL ACAD SCI USA, V105, P405, DOI 10.1073/pnas.0711334105; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Han L, 2008, J EXP MED, V205, P2745, DOI 10.1084/jem.20081623; Helmink BA, 2009, J EXP MED, V206, P669, DOI 10.1084/jem.20081326; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Jankovic M, 2004, ANNU REV IMMUNOL, V22, P485, DOI 10.1146/annurev.immunol.22.012703.104707; Jankovic M, 2007, NAT IMMUNOL, V8, P801, DOI 10.1038/ni1498; Jankovic M, 2010, P NATL ACAD SCI USA, V107, P187, DOI 10.1073/pnas.0908946107; Jones JM, 2004, IMMUNOL REV, V200, P233, DOI 10.1111/j.0105-2896.2004.00168.x; Karanjawala ZE, 1999, CURR BIOL, V9, P1501, DOI 10.1016/S0960-9822(00)80123-2; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Kuppers R, 2005, NAT REV CANCER, V5, P251, DOI 10.1038/nrc1589; Lenz G, 2007, J EXP MED, V204, P633, DOI 10.1084/jem.20062041; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Maser RS, 2007, MOL CELL BIOL, V27, P2253, DOI 10.1128/MCB.01354-06; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Meffre E, 2000, NAT IMMUNOL, V1, P379, DOI 10.1038/80816; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muschen M, 2000, J EXP MED, V192, P1833, DOI 10.1084/jem.192.12.1833; Muto T, 2006, P NATL ACAD SCI USA, V103, P2752, DOI 10.1073/pnas.0510970103; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pan-Hammarstrom Q, 2005, J EXP MED, V201, P189, DOI 10.1084/jem.20040772; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Raghavan SC, 2004, NATURE, V428, P88, DOI 10.1038/nature02355; Ramachandran S, 2010, P NATL ACAD SCI USA, V107, P809, DOI 10.1073/pnas.0913790107; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Rass E, 2009, NAT STRUCT MOL BIOL, V16, P819, DOI 10.1038/nsmb.1641; Reina-San-Martin B, 2007, EUR J IMMUNOL, V37, P235, DOI 10.1002/eji.200636789; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Robert I, 2009, J EXP MED, V206, P1047, DOI 10.1084/jem.20082468; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; ROTH DB, 1986, MOL CELL BIOL, V6, P4295, DOI 10.1128/MCB.6.12.4295; Santagata S, 1999, MOL CELL, V4, P935, DOI 10.1016/S1097-2765(00)80223-3; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Savic V, 2009, MOL CELL, V34, P298, DOI 10.1016/j.molcel.2009.04.012; Schatz DG, 2005, CURR TOP MICROBIOL, V290, P49; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Schrader CE, 2007, J IMMUNOL, V179, P6064, DOI 10.4049/jimmunol.179.9.6064; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Shen HM, 2008, MOL IMMUNOL, V45, P1883, DOI 10.1016/j.molimm.2007.10.041; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; SIMSEK D, 2010, NAT STRUCT MOL BIOL; Sleckman BR, 2005, IMMUNOL RES, V32, P253, DOI 10.1385/IR:32:1-3:253; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Soulas-Sprauel P, 2007, J EXP MED, V204, P1717, DOI 10.1084/jem.20070255; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Takeda S, 2007, MOL CELL, V28, P351, DOI 10.1016/j.molcel.2007.10.016; Takizawa M, 2008, J EXP MED, V205, P1949, DOI 10.1084/jem.20081007; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Tsai AG, 2008, CELL, V135, P1130, DOI 10.1016/j.cell.2008.10.035; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang JH, 2009, NATURE, V460, P231, DOI 10.1038/nature08159; Wang JH, 2008, J EXP MED, V205, P3079, DOI 10.1084/jem.20082271; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Wang X, 2008, MOL CELL, V31, P463, DOI 10.1016/j.molcel.2008.05.028; Weinstock David M, 2007, Nat Cell Biol, V9, P978; Weinstock DM, 2006, DNA REPAIR, V5, P1065, DOI 10.1016/j.dnarep.2006.05.028; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Xie AY, 2009, NAT STRUCT MOL BIOL, V16, P814, DOI 10.1038/nsmb.1640; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zha S, 2009, NAT STRUCT MOL BIOL, V16, P798, DOI 10.1038/nsmb0809-798; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	121	212	217	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 1	2010	141	1					27	38		10.1016/j.cell.2010.03.016	http://dx.doi.org/10.1016/j.cell.2010.03.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	577GS	20371343	Green Accepted, Bronze			2022-12-28	WOS:000276211100010
J	Janda, CY; Li, J; Oubridge, C; Hernandez, H; Robinson, CV; Nagai, K				Janda, Claudia Y.; Li, Jade; Oubridge, Chris; Hernandez, Helena; Robinson, Carol V.; Nagai, Kiyoshi			Recognition of a signal peptide by the signal recognition particle	NATURE			English	Article							ESCHERICHIA-COLI RIBONUCLEOPROTEIN; CRYSTAL-STRUCTURE; RIBOSOME; SEQUENCE; RNA; PROTEINS; TRANSLOCATION; CONTAINS; SUBUNIT; DOMAIN	Targeting of proteins to appropriate subcellular compartments is a crucial process in all living cells. Secretory and membrane proteins usually contain an amino-terminal signal peptide, which is recognized by the signal recognition particle (SRP) when nascent polypeptide chains emerge from the ribosome. The SRP-ribosome nascent chain complex is then targeted through its GTP-dependent interaction with SRP receptor to the protein-conducting channel on endoplasmic reticulum membrane in eukaryotes or plasma membrane in bacteria. A universally conserved component of SRP (refs 1, 2), SRP54 or its bacterial homologue, fifty-four homologue (Ffh), binds the signal peptides, which have a highly divergent sequence divisible into a positively charged n-region, an h-region commonly containing 8-20 hydrophobic residues and a polar c-region(3-5). No structure has been reported that exemplifies SRP54 binding of any signal sequence. Here we have produced a fusion protein between Sulfolobus solfataricus SRP54 (Ffh) and a signal peptide connected via a flexible linker. This fusion protein oligomerizes in solution through interaction between the SRP54 and signal peptide moieties belonging to different chains, and it is functional, as demonstrated by its ability to bind SRP RNA and SRP receptor FtsY. We present the crystal structure at 3.5 angstrom resolution of an SRP54-signal peptide complex in the dimer, which reveals how a signal sequence is recognized by SRP54.	[Janda, Claudia Y.; Li, Jade; Oubridge, Chris; Nagai, Kiyoshi] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Hernandez, Helena; Robinson, Carol V.] Univ Cambridge, Chem Labs, Cambridge CB2 1EW, England	MRC Laboratory Molecular Biology; University of Cambridge	Nagai, K (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	kn@mrc-lmb.cam.ac.uk		robinson, carol/0000-0001-7829-5505; Oubridge, Chris/0000-0001-8492-8305	Medical Research Council of the UK; HFSP; MRC [MC_U105184330] Funding Source: UKRI; Medical Research Council [MC_U105184330] Funding Source: researchfish	Medical Research Council of the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); HFSP(Human Frontier Science Program); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank members of the Nagai group for assisting with data collection, O. Daumke for help with the GTP binding and GTPase assays, and J. Kavran for discussion. This project was supported by the Medical Research Council of the UK. C. Y. J. was supported by a HFSP grant.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; CHOTHIA C, 1981, J MOL BIOL, V145, P215, DOI 10.1016/0022-2836(81)90341-7; DeLano W.L, PYMOL MOL GRAPHICS S; Doudna JA, 2004, ANNU REV BIOCHEM, V73, P539, DOI 10.1146/annurev.biochem.73.011303.074048; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Freymann DM, 1997, NATURE, V385, P361, DOI 10.1038/385361a0; GIERASCH LM, 1989, BIOCHEMISTRY-US, V28, P923, DOI 10.1021/bi00429a001; Gu SQ, 2003, RNA, V9, P566, DOI 10.1261/rna.2196403; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Halic M, 2006, NATURE, V444, P507, DOI 10.1038/nature05326; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Huber D, 2005, J BACTERIOL, V187, P2983, DOI 10.1128/JB.187.9.2983-2991.2005; Keenan RJ, 1998, CELL, V94, P181, DOI 10.1016/S0092-8674(00)81418-X; KENDALL DA, 1986, NATURE, V321, P706, DOI 10.1038/321706a0; Kuglstatter A, 2002, NAT STRUCT BIOL, V9, P740, DOI 10.1038/nsb843; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; LUIRINK J, 1992, NATURE, V359, P741, DOI 10.1038/359741a0; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Pool MR, 2002, SCIENCE, V297, P1345, DOI 10.1126/science.1072366; PORITZ MA, 1990, SCIENCE, V250, P1111, DOI 10.1126/science.1701272; Rosendal KR, 2003, P NATL ACAD SCI USA, V100, P14701, DOI 10.1073/pnas.2436132100; Schaffitzel C, 2006, NATURE, V444, P503, DOI 10.1038/nature05182; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WALTER P, 1982, NATURE, V299, P691, DOI 10.1038/299691a0; Wild K, 2004, NAT STRUCT MOL BIOL, V11, P1049, DOI 10.1038/nsmb853; ZOPF D, 1990, EMBO J, V9, P4511, DOI 10.1002/j.1460-2075.1990.tb07902.x	32	147	155	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 27	2010	465	7297					507	U139		10.1038/nature08870	http://dx.doi.org/10.1038/nature08870			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601FM	20364120	Green Accepted			2022-12-28	WOS:000278043700041
J	Drews, RE; Shulman, LN				Drews, Reed E.; Shulman, Lawrence N.			Update in Hematology and Oncology	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Drews, Reed E.] Harvard Univ, Div Hematol Oncol, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital	Drews, RE (corresponding author), Harvard Univ, Div Hematol Oncol, Beth Israel Deaconess Med Ctr, Sch Med, E-RA-430,330 Brookline Ave, Boston, MA 02215 USA.	rdrews@bidmc.harvard.edu						Albini A, 2010, JNCI-J NATL CANCER I, V102, P14, DOI 10.1093/jnci/djp440; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485	5	8	8	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 18	2010	152	10					655	W229		10.7326/0003-4819-152-10-201005180-00244	http://dx.doi.org/10.7326/0003-4819-152-10-201005180-00244			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	598RJ	20410447				2022-12-28	WOS:000277855500005
J	Schwenk, J; Metz, M; Zolles, G; Turecek, R; Fritzius, T; Bildl, W; Tarusawa, E; Kulik, A; Unger, A; Ivankova, K; Seddik, R; Tiao, JY; Rajalu, M; Trojanova, J; Rohde, V; Gassmann, M; Schulte, U; Fakler, B; Bettler, B				Schwenk, Jochen; Metz, Michaela; Zolles, Gerd; Turecek, Rostislav; Fritzius, Thorsten; Bildl, Wolfgang; Tarusawa, Etsuko; Kulik, Akos; Unger, Andreas; Ivankova, Klara; Seddik, Riad; Tiao, Jim Y.; Rajalu, Mathieu; Trojanova, Johana; Rohde, Volker; Gassmann, Martin; Schulte, Uwe; Fakler, Bernd; Bettler, Bernhard			Native GABA(B) receptors are heteromultimers with a family of auxiliary subunits	NATURE			English	Article							K+ CHANNELS; AMPA RECEPTORS; CULTURED-CELLS; HCN CHANNELS; PROTEIN; RAT; EXPRESSION; RESPONSES; INHIBITION; COMPLEXES	GABA(B) receptors are the G-protein-coupled receptors for gamma-aminobutyric acid (GABA), the main inhibitory neurotransmitter in the brain. They are expressed in almost all neurons of the brain, where they regulate synaptic transmission and signal propagation by controlling the activity of voltage-gated calcium (Ca-v) and inward-rectifier potassium (K-ir) channels(1). Molecular cloning revealed that functional GABA(B) receptors are formed by the heteromeric assembly of GABA(B1) with GABA(B2) subunits(2-5). However, cloned GABA(B(1,2)) receptors failed to reproduce the functional diversity observed with native GABA(B) receptors(6-8). Here we show by functional proteomics that GABA(B) receptors in the brain are high-molecular-mass complexes of GABA(B1), GABA(B2) and members of a subfamily of the KCTD (potassium channel tetramerization domain-containing) proteins. KCTD proteins 8, 12, 12b and 16 show distinct expression profiles in the brain and associate tightly with the carboxy terminus of GABA(B2) as tetramers. This co-assembly changes the properties of the GABA(B(1,2)) core receptor: the KCTD proteins increase agonist potency and markedly alter the G-protein signalling of the receptors by accelerating onset and promoting desensitization in a KCTD-subtype-specific manner. Taken together, our results establish the KCTD proteins as auxiliary subunits of GABA(B) receptors that determine the pharmacology and kinetics of the receptor response.	[Schwenk, Jochen; Zolles, Gerd; Bildl, Wolfgang; Schulte, Uwe; Fakler, Bernd] Univ Freiburg, Inst Physiol 2, D-79108 Freiburg, Germany; [Metz, Michaela; Turecek, Rostislav; Fritzius, Thorsten; Ivankova, Klara; Seddik, Riad; Tiao, Jim Y.; Rajalu, Mathieu; Gassmann, Martin; Bettler, Bernhard] Univ Basel, Inst Physiol, Pharmazentrum, Dept Biomed, CH-4056 Basel, Switzerland; [Rohde, Volker; Schulte, Uwe] Logopharm GmbH, D-79108 Freiburg, Germany; [Tarusawa, Etsuko; Kulik, Akos; Unger, Andreas] Univ Freiburg, Inst Anat & Cell Biol, D-79104 Freiburg, Germany; [Fakler, Bernd] Ctr Biol Signaling Studies Bioss, D-79104 Freiburg, Germany; [Turecek, Rostislav; Trojanova, Johana] Acad Sci Czech Republic, Inst Expt Med, Prague 14220 4, Czech Republic	University of Freiburg; University of Basel; University of Freiburg; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences	Fakler, B (corresponding author), Univ Freiburg, Inst Physiol 2, Engesserstr 4, D-79108 Freiburg, Germany.	bernd.fakler@physiologie.uni-freiburg.de; bernhard.bettler@unibas.ch	Turecek, Rostislav/H-2706-2014; bettler, bernhard/AAO-8018-2020; Turecek, Rostislav/AAL-3523-2020	Turecek, Rostislav/0000-0003-4978-7556; Schwenk, Jochen/0000-0003-3664-9795; Bettler, Bernhard/0000-0003-0842-8207; Tiao, Jim/0000-0001-6692-9697; Gassmann, Martin/0000-0001-6201-3032	Deutsche Forschungsgemeinschaft [SFB 746/TP16, SFB 780/A3, EXC294, SFB 780/A2]; Wellcome Trust (ISRF); EU Synapse; GACR [309/06/1304]; Swiss Science Foundation [3100A0-117816]; Fridericus Stiftung; European Community [FP7/2007-2013, 201714]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wellcome Trust (ISRF)(Wellcome Trust); EU Synapse; GACR(Grant Agency of the Czech Republic); Swiss Science Foundation(Swiss National Science Foundation (SNSF)); Fridericus Stiftung; European Community(European Commission)	We thank J. P. Adelman and H. R. Brenner for discussions and critical reading of the manuscript, and A. Haupt and K. Kaupmann for help with bioinformatics and shRNA experiments, respectively. This work was supported by grants from the Deutsche Forschungsgemeinschaft to B. F. (SFB 746/TP16; SFB 780/A3; EXC294) and to A. K. (SFB 780/A2), by grants from the Wellcome Trust (ISRF), the EU Synapse and the GACR (309/06/1304) to R. T., and by grants from the Swiss Science Foundation (3100A0-117816), the Fridericus Stiftung and the European Community's 7th Framework Programme (FP7/2007-2013) under Grant Agreement 201714 to B. B.	Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; BONANNO G, 1993, TRENDS PHARMACOL SCI, V14, P259, DOI 10.1016/0165-6147(93)90124-3; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cruz HG, 2004, NAT NEUROSCI, V7, P153, DOI 10.1038/nn1181; Deisz RA, 1997, SYNAPSE, V25, P62, DOI 10.1002/(SICI)1098-2396(199701)25:1<62::AID-SYN8>3.0.CO;2-D; Dittert I, 2006, J NEUROSCI METH, V151, P178, DOI 10.1016/j.jneumeth.2005.07.005; Duthey B, 2002, J BIOL CHEM, V277, P3236, DOI 10.1074/jbc.M108900200; Engle MP, 2006, NEUROSCIENCE, V138, P1277, DOI 10.1016/j.neuroscience.2005.11.064; Gassmann M, 2004, J NEUROSCI, V24, P6086, DOI 10.1523/JNEUROSCI.5635-03.2004; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kulik A, 2006, J NEUROSCI, V26, P4289, DOI 10.1523/JNEUROSCI.4178-05.2006; Kulik A, 2003, J NEUROSCI, V23, P11026; Masugi-Tokita M, 2007, J NEUROSCI, V27, P2135, DOI 10.1523/JNEUROSCI.2861-06.2007; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Nicoll RA, 2004, BIOCHEM PHARMACOL, V68, P1667, DOI 10.1016/j.bcp.2004.07.024; OTIS TS, 1993, J PHYSIOL-LONDON, V463, P391, DOI 10.1113/jphysiol.1993.sp019600; Price CJ, 2008, J NEUROSCI, V28, P6974, DOI 10.1523/JNEUROSCI.4673-07.2008; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Rivas G, 1999, METHODS, V19, P194, DOI 10.1006/meth.1999.0851; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schuler V, 2001, NEURON, V31, P47, DOI 10.1016/S0896-6273(01)00345-2; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; Sodickson DL, 1996, J NEUROSCI, V16, P6374; Tamas G, 2003, SCIENCE, V299, P1902, DOI 10.1126/science.1082053; Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Wischmeyer E, 1997, MOL CELL NEUROSCI, V9, P194, DOI 10.1006/mcne.1997.0614; Zolles G, 2006, NEURON, V52, P1027, DOI 10.1016/j.neuron.2006.12.005; Zolles G, 2009, NEURON, V62, P814, DOI 10.1016/j.neuron.2009.05.008	35	222	233	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 13	2010	465	7295					231	U121		10.1038/nature08964	http://dx.doi.org/10.1038/nature08964			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594SS	20400944				2022-12-28	WOS:000277558500038
J	Cutler, DM; Everett, W				Cutler, David M.; Everett, Wendy			Thinking Outside the Pillbox - Medication Adherence as a Priority for Health Care Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cutler, David M.] Harvard Univ, Cambridge, MA 02138 USA; [Everett, Wendy] New England Healthcare Inst, Cambridge, MA USA	Harvard University	Cutler, DM (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.			Cutler, David/0000-0002-4949-8917				Cutler DM, 2007, HEALTH AFFAIR, V26, P97, DOI 10.1377/hlthaff.26.1.97; Doshi JA, 2009, CIRCULATION, V119, P390, DOI 10.1161/CIRCULATIONAHA.108.783944; Mosen DM, 2007, J AMBUL CARE MANAG, V30, P21, DOI 10.1097/00004479-200701000-00005; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100	4	302	315	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 29	2010	362	17					1553	1555		10.1056/NEJMp1002305	http://dx.doi.org/10.1056/NEJMp1002305			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	589AX	20375400	Green Published			2022-12-28	WOS:000277117400001
J	Marshall, M; Heath, I; Sweeney, K				Marshall, Martin; Heath, Iona; Sweeney, Kieran			Clinical practice: when things go wrong	LANCET			English	Editorial Material							DOCTORS		[Marshall, Martin] Hlth Fdn, London WC2E 9RA, England; [Heath, Iona] Caversham Grp Practice, London, England; [Sweeney, Kieran] Univ Exeter, Exeter, Devon, England	University of Exeter	Marshall, M (corresponding author), Hlth Fdn, 90 Long Acre, London WC2E 9RA, England.	Martin.Marshall@health.org.uk						Department of Health, 2006, GOOD DOCT SAF PAT PR; Dibben MR, 2004, QUAL SAF HEALTH CARE, V13, P88, DOI 10.1136/qshc.2004.010173; *HEALTHC COMM, 2008, LEARN INV; *HELATHC COMM, 2009, SUMM INT BIRM CHILDR, P92502; *HELATHC COMM, 2009, INV MIDST NHS FDN TR, P92502; Hockey PM, 2009, J ROY SOC MED, V102, P173, DOI 10.1258/jrsm.2009.090065; KLEIN R, 1998, NEW POLITICS NATL HL, P92502; Klein R., 1996, MANAGING SCARCITY; Langley Gj., 1996, IMPROVEMENT GUIDE PR; Marshall M, 2005, QUAL SAF HEALTH CARE, V14, P4, DOI 10.1136/qshc.2004.013193; Schon D., 1984, REFLECTIVE PRACTITIO; The Bristol Royal Infirmary Inquiry, 2001, LEARN BRIST REP PUBL; Thome DC, 2009, MIDSTAFFORDSHIRE NHS	13	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 24	2010	375	9724					1491	1493		10.1016/S0140-6736(09)61868-7	http://dx.doi.org/10.1016/S0140-6736(09)61868-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	590FL	20417859				2022-12-28	WOS:000277210000035
J	Maxmen, A				Maxmen, Amy			Video Games and the Second Life of Science Class	CELL			English	Editorial Material																			0	6	6	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 16	2010	141	2					201	203		10.1016/j.cell.2010.03.045	http://dx.doi.org/10.1016/j.cell.2010.03.045			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	584GF	20403313	Bronze			2022-12-28	WOS:000276738400005
J	Kim, J; Lee, JE; Heynen-Genel, S; Suyama, E; Ono, K; Lee, K; Ideker, T; Aza-Blanc, P; Gleeson, JG				Kim, Joon; Lee, Ji Eun; Heynen-Genel, Susanne; Suyama, Eigo; Ono, Keiichiro; Lee, KiYoung; Ideker, Trey; Aza-Blanc, Pedro; Gleeson, Joseph G.			Functional genomic screen for modulators of ciliogenesis and cilium length	NATURE			English	Article							PHOSPHOLIPASE A(2); FIBROBLASTS; DISSECTION; MUTATIONS; PROTEINS; COMPLEX	Primary cilia are evolutionarily conserved cellular organelles that organize diverse signalling pathways(1,2). Defects in the formation or function of primary cilia are associated with a spectrum of human diseases and developmental abnormalities(3). Genetic screens in model organisms have discovered core machineries of cilium assembly and maintenance(4). However, regulatory molecules that coordinate the biogenesis of primary cilia with other cellular processes, including cytoskeletal organization, vesicle trafficking and cell-cell adhesion, remain to be identified. Here we report the results of a functional genomic screen using RNA interference (RNAi) to identify human genes involved in ciliogenesis control. The screen identified 36 positive and 13 negative ciliogenesis modulators, which include molecules involved in actin dynamics and vesicle trafficking. Further investigation demonstrated that blocking actin assembly facilitates ciliogenesis by stabilizing the pericentrosomal preciliary compartment (PPC), a previously uncharacterized compact vesiculotubular structure storing transmembrane proteins destined for cilia during the early phase of ciliogenesis. The PPC was labelled by recycling endosome markers. Moreover, knockdown of modulators that are involved in the endocytic recycling pathway affected the formation of the PPC as well as ciliogenesis. Our results uncover a critical regulatory step that couples actin dynamics and endocytic recycling with ciliogenesis, and also provides potential target molecules for future study.	[Kim, Joon; Lee, Ji Eun; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurosci, Inst Genom Med, La Jolla, CA 92093 USA; [Kim, Joon; Lee, Ji Eun; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Pediat, Inst Genom Med, La Jolla, CA 92093 USA; [Heynen-Genel, Susanne; Suyama, Eigo; Aza-Blanc, Pedro] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Ono, Keiichiro; Lee, KiYoung; Ideker, Trey] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Ono, Keiichiro; Lee, KiYoung; Ideker, Trey] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Lee, KiYoung] Ajou Univ, Sch Med, Dept Biomed Informat, Suwon 443749, South Korea	Howard Hughes Medical Institute; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Ajou University	Gleeson, JG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurosci, Inst Genom Med, La Jolla, CA 92093 USA.	jogleeson@ucsd.edu	Kim, Joon/C-1833-2011	Ideker, Trey/0000-0002-1708-8454	UCSD Microscopy Core [P30 NS047101, P30 CA23100]; NARSAD; NINDS [RO1 NS052455]; NIH [GM070743]; Korea Food and Drug Administration [10182KFDA992]; Brain Research Center [M103KV010008-07K2201-00810]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057096, R01NS052455, P30NS047101] Funding Source: NIH RePORTER	UCSD Microscopy Core; NARSAD(NARSAD); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Food and Drug Administration(Food & Drug Administration (KFDA), Republic of Korea); Brain Research Center; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The screen was performed at the Functional Genomics Core (LJINCC grant P30 NS057096 to S. Lipton) with technical assistance from A. Cortez and E. Sisman and with imaging support from the UCSD Microscopy Core (P30 NS047101 and P30 CA23100). We thank P. A. Beachy for the Smo-EGFP plasmid and J. F. Reiter for IFT88<SUP>orpk/orpk</SUP> MEFs. We thank C. Kintner, V. M. Fowler, S. J. Field and S. Ferro-Novick for discussion. This work was supported by grants from NARSAD (Young Investigator Award to J. K.), NINDS (RO1 NS052455 to J. G. G.), the NIH (GM070743 to T. I. and K. L.), the Korea Food and Drug Administration (10182KFDA992 to K. L.) and the Brain Research Center of the 21st Century Frontier Research Program (M103KV010008-07K2201-00810 to K. L.). J. G. G. is an investigator of the Howard Hughes Medical Institute.	ARCHER FL, 1971, J ANAT, V109, P277; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Brown WJ, 2003, TRAFFIC, V4, P214, DOI 10.1034/j.1600-0854.2003.00078.x; Christensen ST, 2008, CURR TOP DEV BIOL, V85, P261, DOI 10.1016/S0070-2153(08)00810-7; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Doyotte A, 2008, P NATL ACAD SCI USA, V105, P6308, DOI 10.1073/pnas.0707601105; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Fernandez-Gonzalez A, 2002, SCIENCE, V295, P1904, DOI 10.1126/science.1068912; Finetti F, 2009, NAT CELL BIOL, V11, P1332, DOI 10.1038/ncb1977; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; HOPE WC, 1993, AGENTS ACTIONS, V39, pC39, DOI 10.1007/BF01972714; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Inoue H, 2008, MOL BIOL CELL, V19, P4224, DOI 10.1091/mbc.E08-03-0290; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Sepulveda JL, 2006, CELL MOL LIFE SCI, V63, P25, DOI 10.1007/s00018-005-5355-1; Silacci P, 2004, CELL MOL LIFE SCI, V61, P2614, DOI 10.1007/s00018-004-4225-6; SOROKIN S, 1962, J CELL BIOL, V15, P363, DOI 10.1083/jcb.15.2.363; Valentin E, 2000, J BIOL CHEM, V275, P7492, DOI 10.1074/jbc.275.11.7492; Yoder BK, 2002, AM J PHYSIOL-RENAL, V282, pF541, DOI 10.1152/ajprenal.00273.2001; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047	25	369	380	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2010	464	7291					1048	U114		10.1038/nature08895	http://dx.doi.org/10.1038/nature08895			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20393563	Green Accepted, Green Published			2022-12-28	WOS:000276635000040
J	Benigni, A; Morigi, M; Remuzzi, G				Benigni, Ariela; Morigi, Marina; Remuzzi, Giuseppe			Renal Medicine 3 Kidney regeneration	LANCET			English	Article							MESENCHYMAL STEM-CELLS; MARROW-DERIVED CELLS; TUBULAR EPITHELIAL-CELLS; BONE-MARROW; PROGENITOR CELLS; ACE-INHIBITION; ANGIOTENSIN INHIBITION; POSTISCHEMIC KIDNEY; CHRONIC NEPHROPATHY; GLOMERULAR-LESIONS	Neonephrogenesis, the capacity to regenerate renal tissue, is a distinctive feature of fish but not usually of mammals. However, evidence exists for kidney repair in response to insulting agents for animals and human beings. Studies have therefore been designed in the past few years to clarify the cellular and molecular basis of renal repair, with the aim to investigate the potential regenerative capacity of animal and human kidneys. Three main questions are being addressed by this research: whether terminally differentiated cells in adult animal kidneys have regenerative capacity; whether multipotent progenitor cells exist in kidneys; and whether renal repair can be favoured or accelerated by cells of extrarenal origin migrating to the kidney in response to injury. In this Review, we describe evidence of cellular and molecular pathways related to renal repair and regeneration, and review data from animal and human studies that show that the kidney might have regenerative capacity.	[Benigni, Ariela; Morigi, Marina; Remuzzi, Giuseppe] Mario Negri Inst Pharmacol Res, I-24125 Bergamo, Italy; [Remuzzi, Giuseppe] Osped Riuniti Bergamo, Azienda Osped, Unit Nephrol & Dialysis, Bergamo, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Ospedali Riuniti di Bergamo	Benigni, A (corresponding author), Mario Negri Inst Pharmacol Res, Via Gavazzeni 11, I-24125 Bergamo, Italy.	ariela.benigni@marionegri.fr	Ariela, Benigni/ABH-3492-2020; Morigi, Marina/ABH-3131-2020; Remuzzi, Giuseppe/V-9766-2017	Ariela, Benigni/0000-0002-4721-5485; Morigi, Marina/0000-0001-8029-7382; Remuzzi, Giuseppe/0000-0002-6194-3446	European Community [FP7-HEALTH-2007-1.4-8]; Fondazione Cariplo (Milano, Italy) [2007-5549]	European Community(European Commission); Fondazione Cariplo (Milano, Italy)(Fondazione Cariplo)	We thank Irene van der Meer, Piero Ruggenenti, and Paola Rizzo for their assistance; Antonella Piccinelli for her work on figures and tables; and Manuela l'assera for her assistance with preparation of the report. This report was supported by grants front the European Community STAR-T REK (FP7-HEALTH-2007-1.4-8) and front Fondazione Cariplo (Milano, Italy; grant 2007-5549).	Abuelo JG, 2007, NEW ENGL J MED, V357, P797, DOI 10.1056/NEJMra064398; Adamczak M, 2004, J AM SOC NEPHROL, V15, P3063, DOI 10.1097/01.ASN.0000146121.72699.86; Adamczak M, 2003, J AM SOC NEPHROL, V14, P2833, DOI 10.1097/01.ASN.0000095248.91994.D3; Appel D, 2009, J AM SOC NEPHROL, V20, P333, DOI 10.1681/ASN.2008070795; Bedelbaeva K, 2010, P NATL ACAD SCI USA, V107, P5845, DOI 10.1073/pnas.1000830107; Bi B, 2007, J AM SOC NEPHROL, V18, P2486, DOI 10.1681/ASN.2007020140; Birnbaum KD, 2008, CELL, V132, P697, DOI 10.1016/j.cell.2008.01.040; Boffa JJ, 2003, J AM SOC NEPHROL, V14, P1132, DOI 10.1097/01.ASN.0000060574.38107.3B; Bonnet C, 1779, OEUVRES HIST NATUREL; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Bonventre JV, 2003, J AM SOC NEPHROL, V14, P2199, DOI 10.1097/01.ASN.0000079785.13922.F6; Boyle S, 2008, DEV BIOL, V313, P234, DOI 10.1016/j.ydbio.2007.10.014; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Brodie JC, 2005, PHARMACOL REV, V57, P299, DOI 10.1124/pr.57.3.3; Bruno S, 2009, STEM CELLS DEV, V18, P867, DOI 10.1089/scd.2008.0320; Bussolati B, 2005, AM J PATHOL, V166, P545, DOI 10.1016/S0002-9440(10)62276-6; Choi S, 2009, STEM CELLS DEV, V18, P521, DOI 10.1089/scd.2008.0097; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; De Broe ME, 2005, NEPHROL DIAL TRANSPL, V20, P2318, DOI 10.1093/ndt/gfi164; Dekel B, 2003, NAT MED, V9, P53, DOI 10.1038/nm812; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Duffield JS, 2005, J CLIN INVEST, V115, P1743, DOI 10.1172/JCI22593; Elger M, 2003, J AM SOC NEPHROL, V14, P1506, DOI 10.1097/01.ASN.0000067645.49562.09; Fang TC, 2005, J AM SOC NEPHROL, V16, P1723, DOI 10.1681/ASN.2004121089; Fioretto P, 1998, NEW ENGL J MED, V339, P69, DOI 10.1056/NEJM199807093390202; Fogo AB, 2005, CURR OPIN NEPHROL HY, V14, P201, DOI 10.1097/01.mnh.0000165883.08675.ab; Fujihara CK, 2005, KIDNEY INT, V67, P1913, DOI 10.1111/j.1523-1755.2005.00290.x; Gaspari F, 1998, J AM SOC NEPHROL, V9, P310; Gobe GC, 2007, INT J BIOCHEM CELL B, V39, P1551, DOI 10.1016/j.biocel.2007.04.025; Gupta S, 2002, KIDNEY INT, V62, P1285, DOI 10.1111/j.1523-1755.2002.kid569.x; Haller H, 2005, KIDNEY INT, V68, P1932, DOI 10.1111/j.1523-1755.2005.00622.x; Hartman HA, 2007, DEV BIOL, V310, P379, DOI 10.1016/j.ydbio.2007.08.021; Herrera MB, 2004, INT J MOL MED, V14, P1035; HERZLINGER D, 1992, DEVELOPMENT, V114, P565; Hopkins C, 2009, J PATHOL, V217, P265, DOI 10.1002/path.2477; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; IKOMA M, 1991, KIDNEY INT, V40, P195, DOI 10.1038/ki.1991.200; IMBERTI B, 2009, J AM SOC NEPHROL, V20, pA103; Imgrund M, 1999, KIDNEY INT, V56, P1423, DOI 10.1046/j.1523-1755.1999.00663.x; Ito T, 2001, J AM SOC NEPHROL, V12, P2625, DOI 10.1681/ASN.V12122625; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kellum JA, 2008, CRIT CARE MED, V36, pS141, DOI 10.1097/CCM.0b013e318168c4a4; KOBAYASHI A, 2009, J AM SOC NEPHROL, V20, pA103; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Kuure S, 2000, MECH DEVELOP, V92, P31, DOI 10.1016/S0925-4773(99)00323-8; Li B, 2006, KIDNEY INT, V69, P323, DOI 10.1038/sj.ki.5000083; Li JH, 2007, STEM CELLS, V25, P697, DOI 10.1634/stemcells.2006-0133; Lin SL, 2010, P NATL ACAD SCI USA, V107, P4194, DOI 10.1073/pnas.0912228107; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x; Ma LJ, 2000, KIDNEY INT, V58, P2425, DOI 10.1046/j.1523-1755.2000.00426.x; Ma LJ, 2005, J AM SOC NEPHROL, V16, P966, DOI 10.1681/ASN.2004060492; Macconi D, 2009, AM J PATHOL, V174, P797, DOI 10.2353/ajpath.2009.080227; Maeshima A, 2003, J AM SOC NEPHROL, V14, P3138, DOI 10.1097/01.ASN.0000098685.43700.28; Magnasco A, 2008, CELL TRANSPLANT, V17, P1157, DOI 10.3727/096368908787236567; MARINIDES GN, 1990, KIDNEY INT, V37, P749, DOI 10.1038/ki.1990.42; Mathur A, 2004, LANCET, V364, P183, DOI 10.1016/S0140-6736(04)16632-4; MAUER SM, 1975, DIABETES, V24, P280; Michalopoulos GK, 2011, INT J BIOCHEM CELL B, V43, P173, DOI 10.1016/j.biocel.2009.09.014; Morigi M, 2004, J AM SOC NEPHROL, V15, P1794, DOI 10.1097/01.ASN.0000128974.07460.34; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; Ninichuk V, 2006, KIDNEY INT, V70, P121, DOI 10.1038/sj.ki.5001521; Oliver JA, 2002, AM J PHYSIOL-RENAL, V283, pF799, DOI 10.1152/ajprenal.00375.2001; Oliver JA, 2004, J CLIN INVEST, V114, P795, DOI 10.1172/JCI200420921; Oliver JA, 2009, J AM SOC NEPHROL, V20, P2315, DOI 10.1681/ASN.2008111203; Perico N, 2008, NAT REV DRUG DISCOV, V7, P936, DOI 10.1038/nrd2685; Poulsom R, 2001, J PATHOL, V195, P229, DOI 10.1002/path.976; Prodromidi EI, 2006, STEM CELLS, V24, P2448, DOI 10.1634/stemcells.2006-0201; Remuzzi A, 2006, KIDNEY INT, V69, P1124, DOI 10.1038/sj.ki.5000060; Remuzzi A, 2002, KIDNEY INT, V62, P885, DOI 10.1046/j.1523-1755.2002.00526.x; Remuzzi A, 1999, AM J KIDNEY DIS, V34, P626, DOI 10.1016/S0272-6386(99)70385-9; Rogers SA, 1998, KIDNEY INT, V54, P27, DOI 10.1046/j.1523-1755.1998.00971.x; Ronconi E, 2009, J AM SOC NEPHROL, V20, P322, DOI 10.1681/ASN.2008070709; Ruggenenti P, 1999, J AM SOC NEPHROL, V10, P997; Ruggenenti P, 1997, LANCET, V349, P1857; Ruggenenti P, 1998, LANCET, V352, P1252, DOI 10.1016/S0140-6736(98)04433-X; Ruggenenti P, 2001, NEPHRON, V88, P254, DOI 10.1159/000045998; Ruggenenti P, 2001, LANCET, V357, P1601, DOI 10.1016/S0140-6736(00)04728-0; Ruggenenti P, 2008, J AM SOC NEPHROL, V19, P1213, DOI 10.1681/ASN.2007090970; Sagrinati C, 2006, J AM SOC NEPHROL, V17, P2443, DOI 10.1681/ASN.2006010089; Schrier RW, 2004, J CLIN INVEST, V114, P5, DOI 10.1172/JC1200422353; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Sena G, 2009, NATURE, V457, P1150, DOI 10.1038/nature07597; SPALLANZANI L, 1769, PRODROMO OPERA IMPRI; Swetha G, 2011, J CELL MOL MED, V15, P396, DOI 10.1111/j.1582-4934.2009.00937.x; Teles F, 2009, KIDNEY INT, V75, P72, DOI 10.1038/ki.2008.528; Trembley A., 1744, MEMOIRES SERVIR HIST; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Wilmer WA, 1999, AM J KIDNEY DIS, V34, P308, DOI 10.1016/S0272-6386(99)70360-4; WITZGALL R, 1994, J CLIN INVEST, V93, P2175, DOI 10.1172/JCI117214; Yamashita S, 2005, J AM SOC NEPHROL, V16, P2044, DOI 10.1681/ASN.2004080681; Yan L, 2007, STEM CELL REV, V3, P265, DOI 10.1007/s12015-007-9004-y	93	105	111	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 10	2010	375	9722					1310	1317		10.1016/S0140-6736(10)60237-1	http://dx.doi.org/10.1016/S0140-6736(10)60237-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585VN	20382327	Green Submitted			2022-12-28	WOS:000276858400033
J	Lai, YH; Tsai, JP; Kuo, JY; Hou, CJY; Yeh, HI; Hung, CL				Lai, Yau-Huei; Tsai, Jui-Peng; Kuo, Jen-Yuan; Hou, Charles Jia-Yin; Yeh, Hung-I; Hung, Chung-Lieh			A mimicker of acute myocardial infarction	LANCET			English	Editorial Material									[Lai, Yau-Huei; Tsai, Jui-Peng; Kuo, Jen-Yuan; Hou, Charles Jia-Yin; Yeh, Hung-I; Hung, Chung-Lieh] Mackay Mem Hosp, Dept Cardiovasc Med, Taipei 10449, Taiwan; [Tsai, Jui-Peng; Hou, Charles Jia-Yin; Hung, Chung-Lieh] Mackay Med Nursing & Management Coll, Taipei, Taiwan; [Kuo, Jen-Yuan] Natl Yang Ming Univ, Coll Med, Taipei 112, Taiwan; [Yeh, Hung-I] Mackay Med Coll, Taipei, Taiwan	Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; National Yang Ming Chiao Tung University; Mackay Medical College	Hung, CL (corresponding author), Mackay Mem Hosp, Dept Cardiovasc Med, 92,Sec 2,Zhongshan N Rd, Taipei 10449, Taiwan.	garak1109@gmail.com	Kuo, Jen-Yuan/AAX-5448-2021; 葉, 宏一/D-2033-2010					DCRUZ IA, 1994, ECHOCARDIOGR-J CARD, V11, P523, DOI 10.1111/j.1540-8175.1994.tb01093.x; Grebenc ML, 2000, RADIOGRAPHICS, V20, P1073, DOI 10.1148/radiographics.20.4.g00jl081073; Kiffer J D, 1999, Australas Radiol, V43, P58, DOI 10.1046/j.1440-1673.1999.00607.x; NICHOLS CR, 1991, CHEST, V99, P472, DOI 10.1378/chest.99.2.472; Tarin N, 1999, PACE, V22, P1264, DOI 10.1111/j.1540-8159.1999.tb00613.x	5	0	0	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 10	2010	375	9722					1318	1318		10.1016/S0140-6736(10)60136-5	http://dx.doi.org/10.1016/S0140-6736(10)60136-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585VN	20382328				2022-12-28	WOS:000276858400034
J	Weening, JJ; Remuzzi, G				Weening, Jan J.; Remuzzi, Giuseppe			Exciting times for renal medicine	LANCET			English	Editorial Material							KIDNEY-DISEASE		[Remuzzi, Giuseppe] Mario Negri Inst Pharmacol Res, I-24125 Bergamo, Italy; [Weening, Jan J.] Univ Amsterdam, Acad Med Ctr, Blaricum, Netherlands; [Weening, Jan J.] Tergooiziekenhuizen, Erasmus Med Ctr Rotterdam, Renal Pathol Unit, Blaricum, Netherlands; [Remuzzi, Giuseppe] Osped Riuniti Bergamo, Azienda Osped, Unit Nephrol & Dialysis, I-24100 Bergamo, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Amsterdam; Tergooi Blaricum; Ospedali Riuniti di Bergamo	Remuzzi, G (corresponding author), Mario Negri Inst Pharmacol Res, I-24125 Bergamo, Italy.	gremuzzi@marionegri.it	Remuzzi, Giuseppe/V-9766-2017	Remuzzi, Giuseppe/0000-0002-6194-3446				Anderson GF, 2007, NEW ENGL J MED, V356, P209, DOI 10.1056/NEJMp068182; Atkins RC, 2010, NAT REV NEPHROL, V6, P134, DOI 10.1038/nrneph.2010.10; Barsoum RS, 2006, NEW ENGL J MED, V354, P997, DOI 10.1056/NEJMp058318; Benigni A, 2010, LANCET, V375, P1310, DOI 10.1016/S0140-6736(10)60237-1; Brantsma AH, 2008, J AM SOC NEPHROL, V19, P1785, DOI 10.1681/ASN.2007101065; Cravedi P, 2008, KIDNEY INT, V74, pS2, DOI 10.1038/ki.2008.511; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Hildebrandt F, 2010, LANCET, V375, P1287, DOI 10.1016/S0140-6736(10)60236-X; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; James MT, 2010, LANCET, V375, P1296, DOI 10.1016/S0140-6736(09)62004-3; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Powe NR, 2009, AM J KIDNEY DIS, V53, pS64, DOI 10.1053/j.ajkd.2008.07.050; Ronconi E, 2009, J AM SOC NEPHROL, V20, P322, DOI 10.1681/ASN.2008070709	13	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 10	2010	375	9722					1227	1228		10.1016/S0140-6736(10)60283-8	http://dx.doi.org/10.1016/S0140-6736(10)60283-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585VN	20382312				2022-12-28	WOS:000276858400004
J	Parekh, AK; Barton, MB				Parekh, Anand K.; Barton, Mary B.			The Challenge of Multiple Comorbidity for the US Health Care System	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PREVALENCE; QUALITY		[Parekh, Anand K.] US Dept HHS, Off Assistant Secretary Hlth, Washington, DC 20201 USA; [Barton, Mary B.] US Dept HHS, Agcy Healthcare Res & Qual, Washington, DC 20201 USA	Agency for Healthcare Research & Quality	Parekh, AK (corresponding author), US Dept HHS, Off Assistant Secretary Hlth, 200 Independence Ave SW, Washington, DC 20201 USA.	anand.parekh@hhs.gov						Anderson G, CHRONIC CONDITIONS M; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Colton Craig W, 2006, Prev Chronic Dis, V3, pA42; Darer JD, 2004, ACAD MED, V79, P541, DOI 10.1097/00001888-200406000-00009; *DEP HLTH HUM SERV, OPT PREV HEALTHC MAN; Fortin M, 2006, ANN FAM MED, V4, P104, DOI 10.1370/afm.516; Lee TA, 2007, J GEN INTERN MED, V22, P403, DOI 10.1007/s11606-007-0277-2; Vogeli C, 2007, J GEN INTERN MED, V22, P391, DOI 10.1007/s11606-007-0322-1; Warshaw G, 2006, GENERATIONS, V30, P5; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269	10	169	170	2	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2010	303	13					1303	1304		10.1001/jama.2010.381	http://dx.doi.org/10.1001/jama.2010.381			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579FM	20371790				2022-12-28	WOS:000276353700031
J	Marinopoulos, SS; Coylewright, M; Auwaerter, PG; Flynn, JA				Marinopoulos, Spyridon S.; Coylewright, Megan; Auwaerter, Paul G.; Flynn, John A.			More Than Meets the Ear.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTIBODY-ASSOCIATED VASCULITIS; WEGENERS-GRANULOMATOSIS; RANDOMIZED-TRIAL; DISEASE; METHOTREXATE; MAINTENANCE		[Marinopoulos, Spyridon S.; Coylewright, Megan; Auwaerter, Paul G.; Flynn, John A.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University	Marinopoulos, SS (corresponding author), 401 N Caroline St, Baltimore, MD 21231 USA.	smarino1@jhmi.edu			Abbott	Abbott(Abbott Laboratories)	Dr. Flynn reports receiving research support from Abbott. No other potential conflict of interest relevant to this article was reported.	Bacon PA, 2005, NEW ENGL J MED, V352, P330, DOI 10.1056/NEJMp048338; Bosch X, 2007, JAMA-J AM MED ASSOC, V298, P655, DOI 10.1001/jama.298.6.655; DCRUZ DP, 1989, BRIT MED J, V299, P419, DOI 10.1136/bmj.299.6696.419; de Groot K, 2005, ARTHRITIS RHEUM-US, V52, P2461, DOI 10.1002/art.21142; Finkielman JD, 2007, ANN INTERN MED, V147, P611, DOI 10.7326/0003-4819-147-9-200711060-00005; Finkielman JD, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.08.016; HOFFMAN GS, 1992, ANN INTERN MED, V116, P488, DOI 10.7326/0003-4819-116-6-488; Jayne D, 2003, NEW ENGL J MED, V349, P36, DOI 10.1056/NEJMoa020286; KORNBLUT AD, 1982, LARYNGOSCOPE, V92, P713, DOI 10.1288/00005537-198207000-00001; Mukhtyar C, 2008, ANN RHEUM DIS, V67, P1004, DOI 10.1136/ard.2007.071936; NISHINO H, 1993, ANN NEUROL, V33, P4, DOI 10.1002/ana.410330103; Pagnoux C, 2008, NEW ENGL J MED, V359, P2790, DOI 10.1056/NEJMoa0802311; Srouji IA, 2007, J LARYNGOL OTOL, V121, P653, DOI 10.1017/S0022215106005032; Stone JH, 2005, NEW ENGL J MED, V352, P351; Takagi D, 2002, LARYNGOSCOPE, V112, P1684, DOI 10.1097/00005537-200209000-00029	15	3	4	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 1	2010	362	13					1228	1233		10.1056/NEJMcps0808968	http://dx.doi.org/10.1056/NEJMcps0808968			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	577QQ	20357286				2022-12-28	WOS:000276239500015
J	Deyton, L; Sharfstein, J; Hamburg, M				Deyton, Lawrence; Sharfstein, Joshua; Hamburg, Margaret			Tobacco Product Regulation - A Public Health Approach	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Deyton, Lawrence] Ctr Tobacco Prod, Silver Spring, MD USA; [Sharfstein, Joshua; Hamburg, Margaret] US FDA, Dept Hlth & Human Serv, Silver Spring, MD USA	US Food & Drug Administration (FDA); FDA Center for Tobacco Products (CTP); US Food & Drug Administration (FDA)	Deyton, L (corresponding author), Ctr Tobacco Prod, Silver Spring, MD USA.							[Anonymous], 2008, MMWR SURVEILL SUMM, V57, P1; [Anonymous], 2008, MMWR MORB MORTAL WKL, V57, P1226; Centers for Disease Control and Prevention, SMOK TOB US CONS DAT; National Cancer Institute, 2001, MON NAT CANC I; *SUBST AB MENT HLT, 2009, PUBL SUBST AB MENT H	5	53	53	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 13	2010	362	19					1753	1756		10.1056/NEJMp1004152	http://dx.doi.org/10.1056/NEJMp1004152			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	594RQ	20410498	Bronze			2022-12-28	WOS:000277555500001
J	Kim, TK; Hemberg, M; Gray, JM; Costa, AM; Bear, DM; Wu, J; Harmin, DA; Laptewicz, M; Barbara-Haley, K; Kuersten, S; Markenscoff-Papadimitriou, E; Kuhl, D; Bito, H; Worley, PF; Kreiman, G; Greenberg, ME				Kim, Tae-Kyung; Hemberg, Martin; Gray, Jesse M.; Costa, Allen M.; Bear, Daniel M.; Wu, Jing; Harmin, David A.; Laptewicz, Mike; Barbara-Haley, Kellie; Kuersten, Scott; Markenscoff-Papadimitriou, Eirene; Kuhl, Dietmar; Bito, Haruhiko; Worley, Paul F.; Kreiman, Gabriel; Greenberg, Michael E.			Widespread transcription at neuronal activity-regulated enhancers	NATURE			English	Article							RNA-POLYMERASE-II; CHIP-SEQ EXPERIMENTS; SYNAPSE DEVELOPMENT; GENE; ARC/ARG3.1; EXPRESSION; REVEALS; IDENTIFICATION; PLASTICITY; PROMOTERS	We used genome-wide sequencing methods to study stimulus-dependent enhancer function in mouse cortical neurons. We identified similar to 12,000 neuronal activity-regulated enhancers that are bound by the general transcriptional co-activator CBP in an activity-dependent manner. A function of CBP at enhancers may be to recruit RNA polymerase II (RNAPII), as we also observed activity-regulated RNAPII binding to thousands of enhancers. Notably, RNAPII at enhancers transcribes bi-directionally a novel class of enhancer RNAs (eRNAs) within enhancer domains defined by the presence of histone H3 monomethylated at lysine 4. The level of eRNA expression at neuronal enhancers positively correlates with the level of messenger RNA synthesis at nearby genes, suggesting that eRNA synthesis occurs specifically at enhancers that are actively engaged in promoting mRNA synthesis. These findings reveal that a widespread mechanism of enhancer activation involves RNAPII binding and eRNA synthesis.	[Kim, Tae-Kyung; Gray, Jesse M.; Costa, Allen M.; Bear, Daniel M.; Harmin, David A.; Laptewicz, Mike; Markenscoff-Papadimitriou, Eirene; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Hemberg, Martin; Kreiman, Gabriel] Harvard Univ, Childrens Hosp Boston, Dept Ophthalmol, Ctr Brain Sci, Boston, MA 02115 USA; [Hemberg, Martin; Kreiman, Gabriel] Harvard Univ, Swartz Ctr Theoret Neurosci, Boston, MA 02115 USA; [Wu, Jing; Worley, Paul F.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Harmin, David A.] Harvard Mit Div Hlth Sci & Technol, Childrens Hosp Informat Program, Boston, MA 02115 USA; [Barbara-Haley, Kellie] Childrens Hosp, Mol Genet Core Facil, Boston, MA 02115 USA; [Kuersten, Scott] Epictr Biotechnol, Madison, WI 53713 USA; [Kuhl, Dietmar] Univ Med Ctr Hamburg Eppendorf UKE, Ctr Mol Neurobiol ZMNH, IMCC, D-20251 Hamburg, Germany; [Bito, Haruhiko] Univ Tokyo, Grad Sch Med, Dept Neurochem, Bunkyo Ku, Tokyo 1130033, Japan	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Johns Hopkins University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Tokyo	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	michael_greenberg@hms.harvard.edu	Kuhl, Dietmar/A-4689-2009; Kim, Tae-Kyung/AAX-4230-2020; Bito, Haruhiko/A-8635-2008	Kuhl, Dietmar/0000-0002-4772-6701; Kim, Tae-Kyung/0000-0001-5161-9864; Costa, Allen/0000-0002-4568-8449; Bito, Haruhiko/0000-0001-6315-9594	Nancy Lurie Marks Family Foundation; National Institutes of Health [NS028829, R21EY019710, DP2OD006461, MH-053608]; Lefler postdoctoral fellowship; Jane Coffin Childs Memorial Funds; Helen Hay Whitney postdoctoral fellowship; Children's Hospital Ophthalmology Foundation; Whitehall Foundation; Klingenstein Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY019710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028829, R01NS028829] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006461] Funding Source: NIH RePORTER	Nancy Lurie Marks Family Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lefler postdoctoral fellowship; Jane Coffin Childs Memorial Funds; Helen Hay Whitney postdoctoral fellowship; Children's Hospital Ophthalmology Foundation; Whitehall Foundation; Klingenstein Fund(Klingenstein Philanthropies); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Greenberg laboratory for discussions and for critical reading of the manuscript. We thank S. Vasquez for preparing dissociated mouse cortical neurons. We thank L. Hu for generating antibodies. We thank the Molecular Genetics Core Facility at Children's Hospital Boston, including H. Schneider and S. Burgess, for operation of their SOLiD 3.0 sequencer (I. D. D. R. C). We thank the support and R&D teams at Life Technologies including S. Ranade, R. David, J. Ni, C. Barbacioru, M. Barker, G. Costa and K. McKernan. M. E. G. acknowledges the support of the Nancy Lurie Marks Family Foundation. We thank M. Dehoff for technical support in the Arc knockout experiments. This work was supported by the National Institutes of Health grants NS028829 (M. E. G.), R21EY019710 (G. K.), DP2OD006461 (G. K.) and MH-053608 (P. F. W.). This work was also supported by The Lefler postdoctoral fellowship (T-K. K.) and The Jane Coffin Childs Memorial Funds (T-K. K.), The Helen Hay Whitney postdoctoral fellowship (J. M. G.), The Children's Hospital Ophthalmology Foundation (G. K.), The Whitehall Foundation (G. K.), and The Klingenstein Fund (G. K.)	Abeel T, 2008, BIOINFORMATICS, V24, pI24, DOI 10.1093/bioinformatics/btn172; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brodsky AS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r64; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Couttet P, 1997, P NATL ACAD SCI USA, V94, P5628, DOI 10.1073/pnas.94.11.5628; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Efron B, 2008, STAT SCI, V23, P1, DOI 10.1214/07-STS236; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Gerber M, 2003, J BIOL CHEM, V278, P26303, DOI 10.1074/jbc.R300014200; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kawashima T, 2009, P NATL ACAD SCI USA, V106, P316, DOI 10.1073/pnas.0806518106; Kee BL, 1996, J BIOL CHEM, V271, P2373, DOI 10.1074/jbc.271.5.2373; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Koch F, 2008, TRENDS BIOCHEM SCI, V33, P265, DOI 10.1016/j.tibs.2008.04.006; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Ling JH, 2004, J BIOL CHEM, V279, P51704, DOI 10.1074/jbc.M404039200; Ooe N, 2004, MOL CELL BIOL, V24, P608, DOI 10.1128/MCB.24.2.608-616.2004; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Pintchovski SA, 2009, J NEUROSCI, V29, P1525, DOI 10.1523/JNEUROSCI.5575-08.2009; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Robertson AG, 2008, GENOME RES, V18, P1906, DOI 10.1101/gr.078519.108; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; SKELLAM JG, 1946, J ROY STAT SOC A STA, V109, P296, DOI 10.2307/2981372; Szutorisz H, 2005, TRENDS BIOCHEM SCI, V30, P593, DOI 10.1016/j.tibs.2005.08.006; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Waltereit R, 2001, J NEUROSCI, V21, P5484, DOI 10.1523/JNEUROSCI.21-15-05484.2001; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136; Zhao H, 2004, NUCLEIC ACIDS RES, V32, P4903, DOI 10.1093/nar/gkh832	37	1599	1655	2	195	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 13	2010	465	7295					182	U65		10.1038/nature09033	http://dx.doi.org/10.1038/nature09033			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594SS	20393465	Green Accepted			2022-12-28	WOS:000277558500027
J	Anttila, A; Kotaniemi-Talonen, L; Leinonen, M; Hakama, M; Laurila, P; Tarkkanen, J; Malila, N; Nieminen, P				Anttila, Ahti; Kotaniemi-Talonen, Laura; Leinonen, Maarit; Hakama, Matti; Laurila, Pekka; Tarkkanen, Jussi; Malila, Nea; Nieminen, Pekka			Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HUMAN-PAPILLOMAVIRUS; CONVENTIONAL CYTOLOGY; FINLAND	Objective To assess the performance and impact of primary human papillomavirus (HPV) DNA screening with cytology triage compared with conventional cytology on cervical cancer and severe pre-cancerous lesions. Design Randomised trial. Setting Population based screening programme for cervical cancer in southern Finland in 2003-5. Participants 58 076 women, aged 30-60, invited to the routine population based screening programme for cervical cancer. Interventions Primary HPV DNA test (hybrid capture II) with cytology triage if the result was positive or conventional cytological screening (reference). Main outcome measures Rate of cervical cancer, cervical intraepithelial neoplasia (CIN) grade III, and adenocarcinoma in situ (as a composite outcome referred to as CIN III+) during 2003-7 through record linkage between files from the screening registry and the national cancer registry. Results In the HPV and conventional arms there were 95 600 and 95 700 woman years of follow-up and 76 and 53 cases of CIN III+, respectively (of which six and eight were cervical cancers). The relative rate of CIN III+ in the HPV arm versus the conventional arm was 1.44 (95% confidence interval 1.01 to 2.05) among all women invited for screening and 1.77 (1.16 to 2.74) among those who attended. Among women with a normal or negative test result, the relative rate of subsequent CIN III+ was 0.28 (0.04 to 1.17). The rate of cervical cancer between arms was 0.75 (0.25 to 2.16) among women invited for screening and 1.98 (0.52 to 9.38) among those who attended. Conclusions When incorporated into a well established organised screening programme, primary HPV screening with cytology triage was more sensitive than conventional cytology in detecting CIN III+ lesions. The number of cases of cervical cancer was small, but considering the high probability of progression of CIN III the findings are of importance regarding cancer prevention.	[Anttila, Ahti; Kotaniemi-Talonen, Laura; Leinonen, Maarit; Hakama, Matti; Malila, Nea] Finnish Canc Registry, Mass Screening Registry, FIN-00130 Helsinki, Finland; [Laurila, Pekka; Tarkkanen, Jussi] HUSLAB Katiloopisto Pathol Lab, Helsinki, Finland; [Malila, Nea] Univ Tampere, Sch Publ Hlth, FIN-33101 Tampere, Finland; [Nieminen, Pekka] Univ Helsinki, Cent Hosp, Dept Obstet & Gynaecol, Helsinki, Finland; [Nieminen, Pekka] Finnish Canc Soc, Pathol Lab, Helsinki, Finland	Finnish Cancer Registry; Tampere University; University of Helsinki; Helsinki University Central Hospital	Anttila, A (corresponding author), Finnish Canc Registry, Mass Screening Registry, Pieni Roobertinkatu 9, FIN-00130 Helsinki, Finland.	ahti.anttila@cancer.fi	Leinonen, Maarit/AAP-7165-2020; Leinonen, Maarit/AAX-3832-2020; Nieminen, Pekka/W-8570-2019	Leinonen, Maarit/0000-0002-7631-4749; Kotaniemi-Talonen, Laura/0000-0001-5696-2469	European Commission; Academy of Finland; Cancer Organisation of Finland	European Commission(European CommissionEuropean Commission Joint Research Centre); Academy of Finland(Academy of Finland); Cancer Organisation of Finland	The study was partially financed by grants from the European Commission, Europe Against Cancer action programme through European Cervical Cancer Screening Network; the Academy of Finland; and the Cancer Organisation of Finland.	Anttila A, 2000, EUR J CANCER, V36, P2209, DOI 10.1016/S0959-8049(00)00311-7; Anttila A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-252; Arbyn M, 2008, EUROPEAN GUIDELINES; Bulkmans NWJ, 2007, LANCET, V370, P1764, DOI 10.1016/S0140-6736(07)61450-0; Dillner J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1754; *FINN CANC REG I S, 2009, CANC SOC FINL PUBL, V76; *INT AG RES CANC, 2007, IARC MON EV CARC RIS, V90; International Agency for Research on Cancer, 2005, IARC WHO HDB CANC PR, V10; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; Kitchener HC, 2009, LANCET ONCOL, V10, P672, DOI 10.1016/S1470-2045(09)70156-1; Kotaniemi-Talonen L, 2005, BRIT J CANCER, V93, P862, DOI 10.1038/sj.bjc.6602799; Leinonen M, 2008, INT J CANCER, V123, P1344, DOI 10.1002/ijc.23670; Leinonen M, 2009, JNCI-J NATL CANCER I, V101, P1612, DOI 10.1093/jnci/djp367; Monto K, 2005, SUOM LAAKARILEHTI, V60, P2093; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; Niemi-Talonen LK, 2008, EUR J CANCER, V44, P565, DOI 10.1016/j.ejca.2007.12.002; Ronco G, 2008, J NATL CANCER I, V100, P492, DOI 10.1093/jnci/djn065; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; VANOORTMARSSEN GJ, 1991, BRIT J CANCER, V64, P559, DOI 10.1038/bjc.1991.350; 1986, IARC SCI PUBL, V76, P1	20	120	125	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 27	2010	340								c1804	10.1136/bmj.c1804	http://dx.doi.org/10.1136/bmj.c1804			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591PM	20423964	Green Published, hybrid			2022-12-28	WOS:000277314100001
J	Nosten, FH				Nosten, Francois Henri			Pyronaridine-artesunate for uncomplicated falciparum malaria	LANCET			English	Editorial Material							BIOAVAILABILITY		Mahidol Oxford Univ, Trop Med Res Programme, Shoklo Malaria Res Unit, Mae Sot 63110, Tak, Thailand	Mahidol University	Nosten, FH (corresponding author), Mahidol Oxford Univ, Trop Med Res Programme, Shoklo Malaria Res Unit, Mae Sot 63110, Tak, Thailand.	SMRU@tropmedres.ac	Nosten, Francois/AAC-5509-2019	Nosten, Francois/0000-0002-7951-0745				Ashley EA, 2007, TROP MED INT HEALTH, V12, P195, DOI [10.1111/j.1365-3165.2006.01784.x, 10.1111/j.1365-3156.2006.01784.x]; Borrmann S, 2010, TROP MED INT HEALTH, V15, P434, DOI 10.1111/j.1365-3156.2010.02477.x; Ramharter M, 2008, J INFECT DIS, V198, P911, DOI 10.1086/591096; Ringwald P, 1996, LANCET, V347, P24, DOI 10.1016/S0140-6736(96)91558-5; Stepniewska K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-127; Tshefu AK, 2010, LANCET, V375, P1457, DOI 10.1016/S0140-6736(10)60322-4	6	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 24	2010	375	9724					1413	1414		10.1016/S0140-6736(10)60582-X	http://dx.doi.org/10.1016/S0140-6736(10)60582-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	590FL	20417841				2022-12-28	WOS:000277210000006
J	Pearson, PD; Moje, E; Greenleaf, C				Pearson, P. David; Moje, Elizabeth; Greenleaf, Cynthia			Literacy and Science: Each in the Service of the Other	SCIENCE			English	Review							INSTRUCTION; CURRICULUM; KNOWLEDGE; EDUCATION; STRATEGY; SCHOOL; TEXTS; MODEL	We use conceptual and empirical lenses to examine synergies between inquiry science and literacy teaching and learning of K-12 (kindergarten through high school) curriculum. We address two questions: (i) how can reading and writing be used as tools to support inquiry-based science, and (ii) how do reading and writing benefit when embedded in an inquiry-based science setting? After elaborating the theoretical and empirical support for integrated approaches, we discuss how to support their implementation in today's complicated curricular landscape.	[Pearson, P. David] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Moje, Elizabeth] Univ Michigan, Ann Arbor, MI 48109 USA; [Greenleaf, Cynthia] WestEd, Oakland, CA 94612 USA	University of California System; University of California Berkeley; University of Michigan System; University of Michigan	Pearson, PD (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	ppearson@berkeley.edu	Pearson, P. David/W-3851-2019					Anderson CW, 1999, J RES SCI TEACH, V36, P973, DOI 10.1002/(SICI)1098-2736(199911)36:9<973::AID-TEA1>3.3.CO;2-3; Anderson TH, 1997, J CURRICULUM STUD, V29, P711, DOI 10.1080/002202797183847; [Anonymous], 2002, READING UNDERSTANDIN; Baker L., 1991, SCI LEARNING PROCESS, P2; Ball D.L., 2015, EDUC RESEARCHER, V25, p6, DOI [10.12691/education-3-2-10, DOI 10.12691/EDUCATION-3-2-10, 10.3102/0013189X025009006, DOI 10.3102/0013189X025009006]; BARBER J, 2010, SEEDS SCI ROOTS READ, pA11; Bransford J. D., 2005, STUDENTS LEARN HIST, P397, DOI DOI 10.17226/10126; Braunger J., 2004, RETHINKING PREPARATI; Calfee R, 2005, CEN IM E R, P215; Cervetti G., 2006, LINKING SCI LITERACY, P221; Cervetti G. N., 2007, SHAPING LITERACY ACH, P157; *COMM SCI ENG PUBL, 2007, RIS GATH STORM EN EM; Davis EA., 2005, ED RES, V34, P3, DOI [10.3102/0013189X034003003, DOI 10.3102/0013189X034003003]; DIGISI LL, 1995, J RES SCI TEACH, V32, P123, DOI 10.1002/tea.3660320204; Dillon DR, 2001, CONSTRUCTIONS OF LITERACY, P51; Donahue D, 2003, J ADOLESC ADULT LIT, V47, P24; Dorph R., 2007, STATUS SCI ED BAY AR; DOUGLAS R, 2006, LINKING SCI LITERACY, P261; Duke NK, 2000, READ RES QUART, V35, P202, DOI 10.1598/RRQ.35.2.1; Eisenhart M, 1996, AM EDUC RES J, V33, P261, DOI 10.2307/1163285; Eisner E. W., 1987, CURRICULUM REV, V26, P11; Goldman SR, 2002, PSYCHOLOGY OF SCIENCE TEXT COMPREHENSION, P19; GOLDSCHMIDT P, 2009, EVALUATION SEEDS SCI; Gomez LM, 2007, PHI DELTA KAPPAN, V89, P224, DOI 10.1177/003172170708900313; Greenleaf C., 2004, BRIDGING LITERACY AC, P200; Greenleaf C., 2004, IMPROVING READING AC, P97; Greenleaf C., 2009, INTEGRATING LITERACY; Guthrie JT, 2004, J EDUC PSYCHOL, V96, P403, DOI 10.1037/0022-0663.96.3.403; Guthrie JT, 1999, ELEM SCHOOL J, V99, P343, DOI 10.1086/461929; GUTHRIE JT, 2002, COMPREHENSION INSTRU, P275; Lee C.D., 2010, READING DISCIPLINES; McMahon MM, 1998, LEARNING FROM TEXT ACROSS CONCEPTUAL DOMAINS, P227; MCMURRER J, 2008, INSTRUCTIONAL TIME E; McNeill KL, 2006, J LEARN SCI, V15, P153, DOI 10.1207/s15327809jls1502_1; MILLER RG, 2004, SCI CHILDREN, V42, P20; Moje E. B., 2010, INTEGRATING LITERACY; Moje E. B., 2009, TEACHER ED DISCIPLIN; MOJE EB, 2004, BRIDGING GAP IMPROVI, P227; Moje EB, 2007, REV RES EDUC, V31, P1, DOI 10.3102/0091732X07300046001; *NAT RES COUNC, 1990, FULF PROM BIOL ED NA; Norris SP, 2003, SCI EDUC, V87, P224, DOI 10.1002/sce.10066; OBRIEN DG, 1995, READ RES QUART, V30, P442, DOI 10.2307/747625; Osborne J, 2010, SCIENCE, V328, P463, DOI 10.1126/science.1183944; Palincsar AS, 2001, CARN S COGN, P151; Pappas C.C., 2002, LINGUIST EDUC, V13, P435, DOI [10.1016/S0898-5898(03)00004-4, DOI 10.1016/S0898-5898(03)00004-4]; ROMANCE NR, 1992, J RES SCI TEACH, V29, P545, DOI 10.1002/tea.3660290604; Romance NR, 2001, INT J SCI EDUC, V23, P373, DOI 10.1080/09500690116738; ROMANCE NR, 2008, COMMITTEE ED WORKSHO; Rutherford F.J., 1990, SCI ALL AM; Schleppegrell M.J., 2004, LANGUAGE SCH FUNCTIO, DOI DOI 10.4324/9781410610317; Shepard L., 2009, STANDARDS ASSESSMENT; SHOENBACH R, 2009, HDB ADOLESCENT LITER, pCH7; Sizer T., 2004, HORACES COMPROMISE D; Snow CE, 2010, SCIENCE, V328, P450, DOI 10.1126/science.1182597; van den Broek P, 2010, SCIENCE, V328, P453, DOI 10.1126/science.1182594; Wang J., 2005, EVALUATION SEEDS SCI; Weiss I. R., 2003, HIGHLIGHTS REPORT LO; YORE LD, 1991, J RES SCI TEACH, V28, P55, DOI 10.1002/tea.3660280106; YORE LD, 2009, P INT SCI ED C 2009, P2393	59	203	205	4	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2010	328	5977					459	463		10.1126/science.1182595	http://dx.doi.org/10.1126/science.1182595			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	586YR	20413491				2022-12-28	WOS:000276952400031
J	Rutten, G				Rutten, Guy			Screening for type 2 diabetes-where are we now?	LANCET			English	Editorial Material							COST-EFFECTIVENESS; RISK; STRATEGIES; VALIDATION; PEOPLE		Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Rutten, G (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	g.e.h.m.rutten@umcutrecht.nl						[Anonymous], 2010, DIABETES CARE S1, V33, pS4, DOI DOI 10.2337/DC10-S004; Borch-Johnsen K, 2003, DIABETIC MED, V20, P175, DOI 10.1046/j.1464-5491.2003.00842.x; Christensen J, 2004, DIABETOLOGIA, V47, P1566, DOI 10.1007/s00125-004-1496-2; Eddy DM, 2003, DIABETES CARE, V26, P3102, DOI 10.2337/diacare.26.11.3102; Eddy DM, 2005, ANN INTERN MED, V143, P251, DOI 10.7326/0003-4819-143-4-200508160-00006; Gillies CL, 2008, BMJ-BRIT MED J, V336, P1180, DOI 10.1136/bmj.39545.585289.25; Glumer C, 2006, DIABETOLOGIA, V49, P1536, DOI 10.1007/s00125-006-0248-x; Janssen PGH, 2007, FAM PRACT, V24, P555, DOI 10.1093/fampra/cmm052; Janssen PGH, 2009, BRIT J GEN PRACT, V59, P43, DOI 10.3399/bjgp09X394851; Kahn R, 2010, LANCET, V375, P1365, DOI 10.1016/S0140-6736(09)62162-0; Sandbaek A, 2008, DIABETOLOGIA, V51, P1127, DOI 10.1007/s00125-008-1013-0; Stern M, 2008, DIABETES CARE, V31, P1670, DOI 10.2337/dc08-0521; Wareham NJ, 2001, BMJ-BRIT MED J, V322, P986, DOI 10.1136/bmj.322.7292.986; Wilson JMG, 1968, PRINCIPLES PRACTICES	14	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 17	2010	375	9723					1324	1326		10.1016/S0140-6736(10)60455-2	http://dx.doi.org/10.1016/S0140-6736(10)60455-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	588GW	20356620				2022-12-28	WOS:000277057800006
J	Matsuda, K; Miura, E; Miyazaki, T; Kakegawa, W; Emi, K; Narumi, S; Fukazawa, Y; Ito-Ishida, A; Kondo, T; Shigemoto, R; Watanabe, M; Yuzaki, M				Matsuda, Keiko; Miura, Eriko; Miyazaki, Taisuke; Kakegawa, Wataru; Emi, Kyoichi; Narumi, Sakae; Fukazawa, Yugo; Ito-Ishida, Aya; Kondo, Tetsuro; Shigemoto, Ryuichi; Watanabe, Masahiko; Yuzaki, Michisuke			Cbln1 Is a Ligand for an Orphan Glutamate Receptor delta 2, a Bidirectional Synapse Organizer	SCIENCE			English	Article							CEREBELLAR PURKINJE-CELLS; EXCITATORY SYNAPSES; TERMINAL DOMAIN; IN-VIVO; GLUR-DELTA-2; FAMILY; PLASTICITY; DIFFERENTIATION; SYNAPTOGENESIS; EXPRESSION	Cbln1, secreted from cerebellar granule cells, and the orphan glutamate receptor delta 2 (GluD2), expressed by Purkinje cells, are essential for synapse integrity between these neurons in adult mice. Nevertheless, no endogenous binding partners for these molecules have been identified. We found that Cbln1 binds directly to the N-terminal domain of GluD2. GluD2 expression by postsynaptic cells, combined with exogenously applied Cbln1, was necessary and sufficient to induce new synapses in vitro and in the adult cerebellum in vivo. Further, beads coated with recombinant Cbln1 directly induced presynaptic differentiation and indirectly caused clustering of postsynaptic molecules via GluD2. These results indicate that the Cbln1-GluD2 complex is a unique synapse organizer that acts bidirectionally on both pre- and postsynaptic components.	[Matsuda, Keiko; Miura, Eriko; Kakegawa, Wataru; Emi, Kyoichi; Narumi, Sakae; Ito-Ishida, Aya; Kondo, Tetsuro; Yuzaki, Michisuke] Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan; [Miyazaki, Taisuke; Watanabe, Masahiko] Hokkaido Univ, Grad Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan; [Fukazawa, Yugo; Shigemoto, Ryuichi] Natl Inst Physiol Sci, Div Cerebral Struct, Okazaki, Aichi 4448787, Japan; [Ito-Ishida, Aya] Univ Tokyo, Grad Sch Med, Dept Cellular Neurobiol, Tokyo 1130033, Japan; [Kondo, Tetsuro] Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki 3058566, Japan	Keio University; Hokkaido University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST)	Yuzaki, M (corresponding author), Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan.	myuzaki@a5.keio.jp	Watanabe, Masahiko/S-3614-2019; Yuzaki, Michisuke/K-5328-2013; Ito-Ishida, Aya/AEP-0189-2022; Kakegawa, Wataru/G-5569-2016; Shigemoto, Ryuichi/E-3628-2013; Kakegawa, Wataru/L-4900-2013; Miyazaki, Taisuke/C-8685-2012; Kondo, Tetsuro/L-7044-2018; WATANABE, Masahiko/A-4055-2012; Matsuda, Keiko/L-5778-2013; Fukazawa, Yugo/H-9899-2012	Watanabe, Masahiko/0000-0001-5037-7138; Yuzaki, Michisuke/0000-0002-5750-3544; Shigemoto, Ryuichi/0000-0001-8761-9444; Kondo, Tetsuro/0000-0002-0055-3292; WATANABE, Masahiko/0000-0001-5037-7138; Fukazawa, Yugo/0000-0001-7436-8797; Ito-Ishida, Aya/0000-0001-5531-2480	Japanese Government Ministry of Education, Culture, Sports, Science and Technology (MEXT); Takeda Science Foundation; Naito Memorial Grant for Female Researchers; Core Research for Evolutional Science and Technology from the Japanese Science and Technology Agency	Japanese Government Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Memorial Grant for Female Researchers; Core Research for Evolutional Science and Technology from the Japanese Science and Technology Agency	We thank J. Motohashi for excellent technical support. This work was supported by a grant-in-aid from Japanese Government Ministry of Education, Culture, Sports, Science and Technology (MEXT) (M.Y.), the Takeda Science Foundation (M.Y.), the Naito Memorial Grant for Female Researchers (K. M.), and the Core Research for Evolutional Science and Technology from the Japanese Science and Technology Agency (M.Y.).	Bao DS, 2005, J NEUROCHEM, V95, P618, DOI 10.1111/j.1471-4159.2005.03385.x; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Hirai H, 2005, NAT NEUROSCI, V8, P1534, DOI 10.1038/nn1576; Iijima T, 2009, J NEUROSCI, V29, P5425, DOI 10.1523/JNEUROSCI.4473-08.2009; Ito-Ishida A, 2008, J NEUROSCI, V28, P5920, DOI 10.1523/JNEUROSCI.1030-08.2008; Kakegawa W, 2008, J NEUROSCI, V28, P1460, DOI 10.1523/JNEUROSCI.2553-07.2008; Kakegawa W, 2009, J NEUROSCI, V29, P5738, DOI 10.1523/JNEUROSCI.6013-08.2009; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Kayser MS, 2006, J NEUROSCI, V26, P12152, DOI 10.1523/JNEUROSCI.3072-06.2006; Kuroyanagi T, 2009, P NATL ACAD SCI USA, V106, P4912, DOI 10.1073/pnas.0900892106; LOMELI H, 1993, FEBS LETT, V315, P318, DOI 10.1016/0014-5793(93)81186-4; Masugi-Tokita M, 2007, J NEUROSCI, V27, P2135, DOI 10.1523/JNEUROSCI.2861-06.2007; Miura E, 2006, EUR J NEUROSCI, V24, P750, DOI 10.1111/j.1460-9568.2006.04950.x; Miura E, 2009, EUR J NEUROSCI, V29, P693, DOI 10.1111/j.1460-9568.2009.06632.x; Roche KW, 1999, J NEUROSCI, V19, P3926; Takeuchi T, 2005, J NEUROSCI, V25, P2146, DOI 10.1523/JNEUROSCI.4740-04.2005; Uemura T, 2004, MOL CELL NEUROSCI, V26, P330, DOI 10.1016/j.mcn.2004.02.007; Uemura T, 2008, BIOCHEM BIOPH RES CO, V377, P1315, DOI 10.1016/j.bbrc.2008.10.170; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Wei P, 2009, MOL CELL NEUROSCI, V41, P258, DOI 10.1016/j.mcn.2009.03.005; Woo J, 2009, NAT NEUROSCI, V12, P428, DOI 10.1038/nn.2279; Yuzaki M, 2008, CELL MOL LIFE SCI, V65, P1698, DOI 10.1007/s00018-008-7550-3; Yuzaki M, 2009, NEUROSCIENCE, V162, P633, DOI 10.1016/j.neuroscience.2008.12.002	24	236	241	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2010	328	5976					363	368		10.1126/science.1185152	http://dx.doi.org/10.1126/science.1185152			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583NR	20395510				2022-12-28	WOS:000276685000040
J	Sancak, Y; Bar-Peled, L; Zoncu, R; Markhard, AL; Nada, S; Sabatini, DM				Sancak, Yasemin; Bar-Peled, Liron; Zoncu, Roberto; Markhard, Andrew L.; Nada, Shigeyuki; Sabatini, David M.			Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids	CELL			English	Article							GTP-BINDING-PROTEINS; MEMBRANE LOCALIZATION; MAMMALIAN TARGET; RHEB; SCAFFOLD; MP1; AKT; PHOSPHORYLATION; PARTNER; PATHWAY	The mTORC1 kinase promotes growth in response to growth factors, energy levels, and amino acids, and its activity is often deregulated in disease. The Rag GTPases interact with mTORC1 and are proposed to activate it in response to amino acids by promoting mTORC1 translocation to a membrane-bound compartment that contains the mTORC1 activator, Rheb. We show that amino acids induce the movement of mTORC1 to lysosomal membranes, where the Rag proteins reside. A complex encoded by the MAPKSP1, ROBLD3, and c11orf59 genes, which we term Ragulator, interacts with the Rag GTPases, recruits them to lysosomes, and is essential for mTORC1 activation. Constitutive targeting of mTORC1 to the lysosomal surface is sufficient to render the mTORC1 pathway amino acid insensitive and independent of Rag and Ragulator, but not Rheb, function. Thus, Rag-Ragulator-mediated translocation of mTORC1 to lysosomal membranes is the key event in amino acid signaling to mTORC1.	[Sancak, Yasemin; Bar-Peled, Liron; Zoncu, Roberto; Markhard, Andrew L.; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Sancak, Yasemin; Bar-Peled, Liron; Zoncu, Roberto; Markhard, Andrew L.; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Sancak, Yasemin; Bar-Peled, Liron; Zoncu, Roberto; Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Nada, Shigeyuki] Osaka Univ, Microbial Dis Res Inst, Dept Oncogene Res, Suita, Osaka 5650871, Japan; [Sabatini, David M.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Osaka University; Howard Hughes Medical Institute	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu		/0000-0002-1446-7256	National Institutes of Health [CA103866, AI47389]; Department of Defense [W81XWH-07-0448]; W. M. Keck Foundation; LAM Foundation; Jane Coffin Childs Memorial Fund; NATIONAL CANCER INSTITUTE [R01CA103866, R01CA129105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047389, R01AI047389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); W. M. Keck Foundation(W.M. Keck Foundation); LAM Foundation; Jane Coffin Childs Memorial Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all members of the Sabatini Lab for helpful suggestions and Eric Spooner for the mass spectrometric analysis of samples. We thank Lukas A. Huber for providing p14 null and control cells and Christoph Klein for providing patient-derived and healthy donor-derived cells. This work was supported by grants from the National Institutes of Health (CA103866 and AI47389) and Department of Defense (W81XWH-07-0448) to D. M. S., awards from the W. M. Keck Foundation and LAM Foundation to D. M. S, and fellowship support from the LAM Foundation and from the Jane Coffin Childs Memorial Fund for Medical Research to R.Z. D.M.S. is an investigator of the Howard Hughes Medical Institute.	Berchtold D, 2009, MOL BIOL CELL, V20, P1565, DOI 10.1091/mbc.E08-10-1001; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Bohn G, 2007, NAT MED, V13, P38, DOI 10.1038/nm1528; Buerger C, 2006, BIOCHEM BIOPH RES CO, V344, P869, DOI 10.1016/j.bbrc.2006.03.220; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Clark GJ, 1997, J BIOL CHEM, V272, P10608; Dard N, 2006, BIOESSAYS, V28, P146, DOI 10.1002/bies.20351; Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Gao MG, 2006, NAT CELL BIOL, V8, P657, DOI 10.1038/ncb1419; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hirose E, 1998, J CELL SCI, V111, P11; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Koonin EV, 2000, CURR BIOL, V10, pR774, DOI 10.1016/S0960-9822(00)00774-0; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Lunin VV, 2004, J BIOL CHEM, V279, P23422, DOI 10.1074/jbc.M401648200; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308; PIZON V, 1994, J CELL SCI, V107, P1661; Roccio M, 2006, ONCOGENE, V25, P657, DOI 10.1038/sj.onc.1209106; Saito K, 2005, J BIOCHEM, V137, P423, DOI 10.1093/jb/mvi046; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schaeffer HJ, 1998, SCIENCE, V281, P1668, DOI 10.1126/science.281.5383.1668; SCHURMANN A, 1995, J BIOL CHEM, V270, P28982, DOI 10.1074/jbc.270.48.28982; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Takahashi K, 2005, J BIOL CHEM, V280, P32768, DOI 10.1074/jbc.M506280200; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; Wunderlich W, 2001, J CELL BIOL, V152, P765, DOI 10.1083/jcb.152.4.765; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	35	1599	1660	3	126	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2010	141	2					290	303		10.1016/j.cell.2010.02.024	http://dx.doi.org/10.1016/j.cell.2010.02.024			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	584GF	20381137	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000276738400019
J	Handyside, A				Handyside, Alan			Let parents decide	NATURE			English	Editorial Material									London Bridge Fertil, Gynaecol & Genet Ctr, London SE1 9RY, England		Handyside, A (corresponding author), London Bridge Fertil, Gynaecol & Genet Ctr, London SE1 9RY, England.	ahandyside@thebridgecentre.co.uk							0	11	12	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 15	2010	464	7291					978	979		10.1038/464978a	http://dx.doi.org/10.1038/464978a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20393539				2022-12-28	WOS:000276635000017
J	Meyer, G; Roy, PM; Gilberg, S; Perrier, A				Meyer, Guy; Roy, Pierre-Marie; Gilberg, Serge; Perrier, Arnaud			Easily Missed? Pulmonary embolism	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VENOUS THROMBOEMBOLISM; DIAGNOSIS; MANAGEMENT		[Meyer, Guy; Gilberg, Serge] Univ Paris 05, Paris, France; [Meyer, Guy] Hop Europeen Georges Pompidou, Serv Pneumol & Soins Intensifs, APHP, Paris, France; [Meyer, Guy] INSERM, U765, Paris, France; [Roy, Pierre-Marie] Univ Angers, IFR 132, Angers, France; [Roy, Pierre-Marie] Ctr Hosp Univ, Serv Accueil & Traitement Urgences, Angers, France; [Perrier, Arnaud] Univ Hosp Geneva, Div Gen Internal Med, Geneva, Switzerland	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; University of Geneva	Meyer, G (corresponding author), Hop Europeen Georges Pompidou, Serv Pneumol, 20 Rue Leblanc, F-75015 Paris, France.	guy.meyer@egp.aphp.fr	Perrier, Arnaud/M-2263-2014; Roy, Pierre-Marie/AAA-7737-2022					Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Le Gal G, 2006, ANN INTERN MED, V144, P165, DOI 10.7326/0003-4819-144-3-200602070-00004; Le Gal G, 2005, BRIT MED J, V330, P452, DOI 10.1136/bmj.38331.602384.8F; Meyer G, 2008, CURR OPIN HEMATOL, V15, P499, DOI 10.1097/MOH.0b013e3283063a51; Nordstrom M, 1998, APMIS, V106, P378, DOI 10.1111/j.1699-0463.1998.tb01360.x; Oger E, 2000, THROMB HAEMOSTASIS, V83, P657; Pineda LA, 2001, CHEST, V120, P791, DOI 10.1378/chest.120.3.791; Righini M, 2008, LANCET, V371, P1343, DOI 10.1016/S0140-6736(08)60594-2; Roy PM, 2006, ANN INTERN MED, V144, P157, DOI 10.7326/0003-4819-144-3-200602070-00003; Roy PM, 2005, BMJ-BRIT MED J, V331, P259, DOI 10.1136/bmj.331.7511.259; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; Torbicki A, 2008, EUR HEART J, V29, P2276, DOI 10.1093/eurheartj/ehn310; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172	13	12	12	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 13	2010	340								c1421	10.1136/bmj.c1421	http://dx.doi.org/10.1136/bmj.c1421			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	586JZ	20388676				2022-12-28	WOS:000276904800001
J	Kogan, SC				Kogan, Scott C.			Poisonous Contacts	SCIENCE			English	Editorial Material							ACUTE PROMYELOCYTIC LEUKEMIA; INITIATING CELLS; ARSENIC TRIOXIDE; PML; DEGRADATION; EFFICACY; PROTEIN		Univ Calif San Francisco, Ctr Canc, Lab Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Kogan, SC (corresponding author), Univ Calif San Francisco, Ctr Canc, Lab Med, San Francisco, CA 94143 USA.	scott.kogan@ucsf.edu		Kogan, Scott/0000-0002-2395-8479				Haupt S, 2009, CANCER RES, V69, P4818, DOI 10.1158/0008-5472.CAN-08-4010; Hu J, 2009, P NATL ACAD SCI USA, V106, P3342, DOI 10.1073/pnas.0813280106; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Nasr R, 2008, NAT MED, V14, P1333, DOI 10.1038/nm.1891; Shao WL, 1998, J NATL CANCER I, V90, P124, DOI 10.1093/jnci/90.2.124; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; SUN H, 1992, CHIN J INTEGRAT TRAD, V12, P1701; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; ZHANG P, 1996, CHIN J HEMATOL, V17, P58; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424; Zhu J, 2002, NAT REV CANCER, V2, P705, DOI 10.1038/nrc887; Zhu J, 1997, P NATL ACAD SCI USA, V94, P3978, DOI 10.1073/pnas.94.8.3978	14	9	10	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 9	2010	328	5975					184	185		10.1126/science.1189198	http://dx.doi.org/10.1126/science.1189198			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580OU	20378808				2022-12-28	WOS:000276459600032
J	Chang, VW; Asch, DA; Werner, RM				Chang, Virginia W.; Asch, David A.; Werner, Rachel M.			Quality of Care Among Obese Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COLORECTAL-CANCER; MEDICARE BENEFICIARIES; PREVENTIVE SERVICES; BODY-WEIGHT; HEALTH-CARE; CLAIMS DATA; SELF-REPORT; US ADULTS; WOMEN; MAMMOGRAPHY	Context Clinicians often have negative attitudes toward obesity and express dissatisfaction in caring for obese patients. Moreover, obese patients often feel that clinicians are biased or disrespectful because of their weight. These observations raise the concern that obese patients may receive lower quality of care. Objective To determine whether performance on common outpatient quality measures differs by patient weight status. Design, Setting, and Participants Eight different performance measures were examined in 2 national-level patient populations: (1) Medicare beneficiaries (n=36 122) using data from the Medicare Beneficiary Survey (1994-2006); and (2) recipients of care from the Veterans Health Administration (VHA) (n=33 550) using data from an ongoing performance-evaluation program (2003-2004). Main Outcome Measures Performance measures among eligible patients for diabetes care (eye examination, glycated hemoglobin [HbA(1c)] testing, and lipid screening), pneumococcal vaccination, influenza vaccination, screening mammography, colorectal cancer screening, and cervical cancer screening. Measures were based on a combination of administrative claims, survey, and chart review data. Results We found no evidence that obese or overweight patients were less likely to receive recommended care relative to normal-weight patients. Moreover, success rates were marginally higher for obese and/or overweight patients on several measures. The most notable differentials were observed for recommended diabetes care among Medicare beneficiaries: comparing obese vs normal-weight patients with diabetes, obese patients were more likely to receive recommended care on lipid screening (72% vs 65%; odds ratio, 1.37 [95% confidence interval, 1.09-1.73]) and HbA(1c) testing (74% vs 62%; odds ratio, 1.73 [95% confidence interval, 1.41-2.11]). All analyses were adjusted for sociodemographic factors, health status, clinical complexity, and visit frequency. Conclusions Among samples of patients from the Medicare and VHA populations, there was no evidence across 8 performance measures that obese or overweight patients received inferior care when compared with normal-weight patients. Being obese or overweight was associated with a marginally higher rate of recommended care on several measures. JAMA. 2010;303(13):1274-1281	[Chang, Virginia W.; Asch, David A.; Werner, Rachel M.] Univ Penn, Sch Med, Dept Med, Ctr Hlth Equ Res & Promot,Philadelphia VA Med Ctr, Philadelphia, PA 19104 USA; [Chang, Virginia W.; Asch, David A.; Werner, Rachel M.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Chang, Virginia W.] Univ Penn, Dept Sociol, Philadelphia, PA 19104 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; University of Pennsylvania	Chang, VW (corresponding author), Univ Penn, Sch Med, Dept Med, Ctr Hlth Equ Res & Promot,Philadelphia VA Med Ctr, 1233 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	vwchang@mail.med.upenn.edu		Werner, Rachel/0000-0003-3435-4221; Asch, David/0000-0002-7970-286X	Veterans Administration Health Services [IIR 06-096]; Robert Wood Johnson Foundation	Veterans Administration Health Services; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	This work was supported by a Veterans Administration Health Services Research and Development Merit Award (IIR 06-096); the Robert Wood Johnson Foundation Physician Faculty Scholars Program; and a Veterans Administration Health Services Research and Development Career Development Award (to Dr Werner).	[Anonymous], 1991, MMWR Recomm Rep, V40, P1; [Anonymous], 1997, MMWR Recomm Rep, V46, P1; Arday DR, 2002, DIABETES CARE, V25, P2230, DOI 10.2337/diacare.25.12.2230; Asch SM, 2000, JAMA-J AM MED ASSOC, V284, P2325, DOI 10.1001/jama.284.18.2325; Baier M, 2000, CANCER EPIDEM BIOMAR, V9, P229; Chao A, 2004, AM J PUBLIC HEALTH, V94, P1775, DOI 10.2105/AJPH.94.10.1775; Cohen SS, 2008, CANCER-AM CANCER SOC, V112, P1892, DOI 10.1002/cncr.23408; Das SR, 2005, AM J PREV MED, V28, P291, DOI 10.1016/j.amepre.2004.12.007; Doshi JA, 2007, HEALTH AFFAIR, V26, P1111, DOI 10.1377/hlthaff.26.4.1111; Ellis RP, 1996, HEALTH CARE FINANC R, V17, P101; Ferrante JM, 2006, CANCER DETECT PREV, V30, P459, DOI 10.1016/j.cdp.2006.09.003; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Fleming BB, 2001, DIABETES CARE, V24, P1815, DOI 10.2337/diacare.24.10.1815; Fontaine KR, 1998, ARCH FAM MED, V7, P381, DOI 10.1001/archfami.7.4.381; Freeman JL, 2002, MED CARE, V40, P36; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; Hebert P L, 1999, Am J Med Qual, V14, P270, DOI 10.1177/106286069901400607; Higashi T, 2007, NEW ENGL J MED, V356, P2496, DOI 10.1056/NEJMsa066253; Holt K, 2006, MED CARE, V44, P513, DOI 10.1097/01.mlr.0000215884.81143.da; Jencks SF, 2000, JAMA-J AM MED ASSOC, V284, P1670, DOI 10.1001/jama.284.13.1670; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; KLEIN D, 1982, J FAM PRACTICE, V14, P881; LUBITZ RM, 1995, AM J MED, V98, P491, DOI 10.1016/S0002-9343(99)80350-7; Mac Donald R, 1999, AM J PREV MED, V16, P173, DOI 10.1016/S0749-3797(98)00159-7; NHLBI Obesity Education Initiative Expert Panel on the Identification Evaluation and Treatment of Obesity in Adults (US), 1998, CLIN GUID ID EV TREA; *OFF QUAL PERF, 2004, FY 2004 TECHN MAN VH; Ostbye T, 2005, AM J PUBLIC HEALTH, V95, P1623, DOI 10.2105/AJPH.2004.047803; Peytremann-Bridevaux I, 2007, J GEN INTERN MED, V22, P923, DOI 10.1007/s11606-007-0181-9; Pham HH, 2005, JAMA-J AM MED ASSOC, V294, P473, DOI 10.1001/jama.294.4.473; Puhl R, 2001, OBES RES, V9, P788, DOI 10.1038/oby.2001.108; Puhl RM, 2006, OBESITY, V14, P1802, DOI 10.1038/oby.2006.208; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rosen AB, 2004, J GEN INTERN MED, V19, P332, DOI 10.1111/j.1525-1497.2004.30339.x; Smith-Bindman R, 2006, MED CARE, V44, P463, DOI 10.1097/01.mlr.0000207436.07513.79; STEVENS J, 1990, AM J EPIDEMIOL, V132, P1156, DOI 10.1093/oxfordjournals.aje.a115758; Thompson BL, 2001, HEALTH SERV RES, V36, P813; US Preventive Services Task Force. Screening for Cervical Cancer: Recommendations and Rationale. Agency for Healthcare Research and Quality, 2003, SCREEN CERV CANC REC; Wee CC, 2000, ANN INTERN MED, V132, P697, DOI 10.7326/0003-4819-132-9-200005020-00003; Werner RM, 2008, J GEN INTERN MED, V23, P1729, DOI 10.1007/s11606-008-0734-6	40	65	66	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2010	303	13					1274	1281		10.1001/jama.2010.339	http://dx.doi.org/10.1001/jama.2010.339			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	579FM	20371786	Bronze			2022-12-28	WOS:000276353700027
J	[Anonymous]				[Anonymous]			Frustrations With Hospitalist Care: Need to Improve Transitions and Communication	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																		Ault MJ, 2010, ANN INTERN MED, V152, P475, DOI 10.7326/0003-4819-152-7-201004060-00018; Beckman Howard, 2009, Ann Intern Med, V151, P890, DOI 10.7326/0003-4819-151-12-200912150-00011; Coffman J, 2005, MED CARE RES REV, V62, P379, DOI 10.1177/1077558705277379; Harrison Jeffrey P, 2009, J Health Care Finance, V35, P22; Kumar PD, 2010, ANN INTERN MED, V152, P476, DOI 10.7326/0003-4819-152-7-201004060-00020; Lo B, 2001, AM J MED, V111, P48, DOI 10.1016/S0002-9343(01)00972-X; Meltzer D, 2002, ANN INTERN MED, V137, P866, DOI 10.7326/0003-4819-137-11-200212030-00007; Reynolds CH, 2010, ANN INTERN MED, V152, P474, DOI 10.7326/0003-4819-152-7-201004060-00017; Stillman MD, 2010, ANN INTERN MED, V152, P475, DOI 10.7326/0003-4819-152-7-201004060-00019; Wachter RM, 2010, ANN INTERN MED, V152, P474, DOI 10.7326/0003-4819-152-7-201004060-00016	10	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 6	2010	152	7					469	469		10.7326/0003-4819-152-7-201004060-00013	http://dx.doi.org/10.7326/0003-4819-152-7-201004060-00013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	579QI	20368654				2022-12-28	WOS:000276386900009
J	Hengel, H; Koszinowski, UH				Hengel, Hartmut; Koszinowski, Ulrich H.			A Vaccine Monkey Wrench?	SCIENCE			English	Editorial Material							ANTIGEN PRESENTATION; CYTOMEGALOVIRUS-INFECTION; T-CELLS; VIRUS		[Hengel, Hartmut] Univ Dusseldorf, Inst Virol, Dusseldorf, Germany; [Koszinowski, Ulrich H.] Univ Munich, Max Von Pettenkofer Inst, Munich, Germany	Heinrich Heine University Dusseldorf; University of Munich	Hengel, H (corresponding author), Univ Dusseldorf, Inst Virol, Dusseldorf, Germany.	koszinowski@mvp.uni-muenchen.de						Arvin AM, 2004, CLIN INFECT DIS, V39, P233, DOI 10.1086/421999; Atalay R, 2002, J VIROL, V76, P8596, DOI 10.1128/JVI.76.17.8596-8608.2002; DELVAL M, 1992, J EXP MED, V176, P729, DOI 10.1084/jem.176.3.729; Hansen SG, 2010, SCIENCE, V328, P102, DOI 10.1126/science.1185350; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Holtappels R, 2004, J EXP MED, V199, P131, DOI 10.1084/jem.20031582; JONJIC S, 1994, J EXP MED, V179, P1713, DOI 10.1084/jem.179.5.1713; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Lilley BN, 2005, IMMUNOL REV, V207, P126, DOI 10.1111/j.0105-2896.2005.00318.x; Nigro G, 2005, NEW ENGL J MED, V353, P1350, DOI 10.1056/NEJMoa043337; Pinto AK, 2005, VIRAL IMMUNOL, V18, P434, DOI 10.1089/vim.2005.18.434; Powers C, 2008, CURR TOP MICROBIOL, V325, P333; Ross SA, 2010, J INFECT DIS, V201, P386, DOI 10.1086/649903	13	3	3	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 2	2010	328	5974					51	52		10.1126/science.1188578	http://dx.doi.org/10.1126/science.1188578			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577DR	20360096				2022-12-28	WOS:000276202200027
J	Bais, C; Wu, XM; Yao, J; Yang, SY; Crawford, Y; McCutcheon, K; Tan, C; Kolumam, G; Vernes, JM; Eastham-Anderson, J; Haughney, P; Kowanetz, M; Hagenbeek, T; Kasman, I; Reslan, HB; Ross, J; Van Bruggen, N; Carano, RAD; Meng, YJG; Hongo, JA; Stephan, JP; Shibuya, M; Ferrara, N				Bais, Carlos; Wu, Xiumin; Yao, Jenny; Yang, Suya; Crawford, Yongping; McCutcheon, Krista; Tan, Christine; Kolumam, Ganesh; Vernes, Jean-Michel; Eastham-Anderson, Jeffrey; Haughney, Peter; Kowanetz, Marcin; Hagenbeek, Thijs; Kasman, Ian; Reslan, Hani Bou; Ross, Jed; Van Bruggen, Nick; Carano, Richard A. D.; Meng, Yu-Ju Gloria; Hongo, Jo-Anne; Stephan, Jean-Philippe; Shibuya, Masabumi; Ferrara, Napoleone			PlGF Blockade Does Not Inhibit Angiogenesis during Primary Tumor Growth	CELL			English	Article							VEGFR1-ACTIVITY-INDEPENDENT METASTASIS FORMATION; HIGH-AFFINITY BINDING; FACTOR RECEPTOR-1; TYROSINE KINASE; IN-VIVO; VEGF; FLT-1; ANTIBODY; TARGETS; CANCER	It has been recently reported that treatment with an anti-placenta growth factor (PlGF) antibody inhibits metastasis and primary tumor growth. Here we show that, although anti-PlGF treatment inhibited wound healing, extravasation of B16F10 cells, and growth of a tumor engineered to overexpress the PlGF receptor (VEGFR-1), neutralization of PlGF using four novel blocking antibodies had no significant effect on tumor angiogenesis in 15 models. Also, genetic ablation of the tyrosine kinase domain of VEGFR-1 in the host did not result in growth inhibition of the anti-VEGF-A sensitive or resistant tumors tested. Furthermore, combination of anti-PlGF with anti-VEGF-A antibodies did not result in greater antitumor efficacy than anti-VEGF-A monotherapy. In conclusion, our data argue against an important role of PlGF during primary tumor growth in most models and suggest that clinical evaluation of anti-PlGF antibodies may be challenging.	[Bais, Carlos; Wu, Xiumin; Yao, Jenny; Yang, Suya; Crawford, Yongping; McCutcheon, Krista; Tan, Christine; Kolumam, Ganesh; Vernes, Jean-Michel; Eastham-Anderson, Jeffrey; Haughney, Peter; Kowanetz, Marcin; Hagenbeek, Thijs; Kasman, Ian; Reslan, Hani Bou; Ross, Jed; Van Bruggen, Nick; Carano, Richard A. D.; Meng, Yu-Ju Gloria; Hongo, Jo-Anne; Stephan, Jean-Philippe; Shibuya, Masabumi; Ferrara, Napoleone] Genentech Inc, San Francisco, CA 94080 USA; [Shibuya, Masabumi] Tokyo Med & Dent Univ, Grad Sch Med & Dent, Dept Mol Oncol, Tokyo 1138510, Japan	Roche Holding; Genentech; Tokyo Medical & Dental University (TMDU)	Bais, C (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	bais@gene.com; nf@gene.com						Autiero M, 2003, J THROMB HAEMOST, V1, P1356, DOI 10.1046/j.1538-7836.2003.00263.x; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Cao YH, 1996, J BIOL CHEM, V271, P3154, DOI 10.1074/jbc.271.6.3154; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Cianfarani F, 2006, AM J PATHOL, V169, P1167, DOI 10.2353/ajpath.2006.051314; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; DavisSmyth T, 1996, EMBO J, V15, P4919, DOI 10.1002/j.1460-2075.1996.tb00872.x; Dawson MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006525; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Eriksson A, 2002, CANCER CELL, V1, P99, DOI 10.1016/S1535-6108(02)00028-4; Ferrara N, 1998, NAT MED, V4, P336, DOI 10.1038/nm0398-336; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 2010, CYTOKINE GROWTH F R, V21, P21, DOI 10.1016/j.cytogfr.2009.11.003; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Gerber HP, 2000, CANCER RES, V60, P6253; Gluzman-Poltorak Z, 2000, J BIOL CHEM, V275, P29922; HATTORI K, 2002, NAT MED, V1, P1; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Hiratsuka S, 2001, CANCER RES, V61, P1207; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kaplan RN, 2009, NATURE, V461, pE5, DOI 10.1038/nature08261; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kerber M, 2008, CANCER RES, V68, P7342, DOI 10.1158/0008-5472.CAN-07-6241; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Luttun A., 2002, NAT MED, V1, P1; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; MAGLIONE D, 1991, P NATL ACAD SCI USA, V88, P9267, DOI 10.1073/pnas.88.20.9267; Marcellini M, 2006, AM J PATHOL, V169, P643, DOI 10.2353/ajpath.2006.051041; Murakami M, 2006, BLOOD, V108, P1849, DOI 10.1182/blood-2006-04-016030; Odorisio T, 2002, J CELL SCI, V115, P2559; Oflazoglu E, 2007, BLOOD, V110, P4370, DOI 10.1182/blood-2007-06-097014; PARK JE, 1994, J BIOL CHEM, V269, P25646; Samuelsson A, 2001, SCIENCE, V291, P484, DOI 10.1126/science.291.5503.484; Schomber T, 2007, CANCER RES, V67, P10840, DOI 10.1158/0008-5472.CAN-07-1034; Shibuya M, 2001, CELL STRUCT FUNCT, V26, P25, DOI 10.1247/csf.26.25; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Wu Y, 2006, CLIN CANCER RES, V12, P6573, DOI 10.1158/1078-0432.CCR-06-0831; Wu Y, 2006, INT J CANCER, V119, P1519, DOI 10.1002/ijc.21865; Ziche M, 1997, LAB INVEST, V76, P517	49	124	131	1	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 1	2010	141	1					166	177		10.1016/j.cell.2010.01.033	http://dx.doi.org/10.1016/j.cell.2010.01.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	577GS	20371352	Bronze			2022-12-28	WOS:000276211100021
J	Prokopakis, EP; Panagiotaki, IE; Papadakis, IA; Vardouniotis, AS; Lagoudianakis, GM; Velegrakis, GA				Prokopakis, Emmanuel P.; Panagiotaki, Irene E.; Papadakis, Ioannis A.; Vardouniotis, Alexios S.; Lagoudianakis, George M.; Velegrakis, George A.			Picture Quiz Immunocompromised patient with an ulcerated nasolabial skin lesion	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CUTANEOUS LEISHMANIASIS; GREECE		[Prokopakis, Emmanuel P.; Panagiotaki, Irene E.; Papadakis, Ioannis A.; Vardouniotis, Alexios S.; Lagoudianakis, George M.; Velegrakis, George A.] Univ Crete, Sch Med, Dept Otorhinolaryngol, Iraklion, Greece	University of Crete	Papadakis, IA (corresponding author), Univ Crete, Sch Med, Dept Otorhinolaryngol, Iraklion, Greece.	ioannispapadakis2003@yahoo.gr						Aliaga L, 2003, MEDICINE, V82, P147, DOI 10.1097/00005792-200305000-00001; Berens-Riha N, 2009, J TRAVEL MED, V16, P220, DOI 10.1111/j.1708-8305.2008.00291.x; Chaudhry IA, 1998, ARCH OPHTHALMOL-CHIC, V116, P1244, DOI 10.1001/archopht.116.9.1244; Di Lella F, 2006, INT J ORAL MAX SURG, V35, P870, DOI 10.1016/j.ijom.2006.02.015; GARIFALLOU A, 1984, ANN TROP MED PARASIT, V78, P369, DOI 10.1080/00034983.1984.11811834; Motta ACF, 2007, ORAL DIS, V13, P335, DOI 10.1111/j.1601-0825.2006.01296.x; Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8; SOM PM, 1991, RADIOLOGY, V178, P831, DOI 10.1148/radiology.178.3.1994427; Tzanetou K, 2005, ARCH HELL MED, V22, P239	9	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2010	340								c1444	10.1136/bmj.c1444	http://dx.doi.org/10.1136/bmj.c1444			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579VL	20356960				2022-12-28	WOS:000276404400001
J	Hall, CB				Hall, Caroline Breese			Respiratory syncytial virus in young children	LANCET			English	Editorial Material							DEVELOPING-COUNTRIES; EPIDEMIOLOGY; PNEUMONIA		[Hall, Caroline Breese] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA; [Hall, Caroline Breese] Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Hall, CB (corresponding author), Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA.	caroline_hall@urmc.rochester.edu						BERMAN S, 1991, REV INFECT DIS, V13, pS454; DICKENS C, 1858, HOUSEHOLD WORDS WEEK, V18, P379; MONTO AS, 1986, NEW VACCINE DEV ESTA, V2, P299; MURPHY BR, 1994, VIRUS RES, V32, P13, DOI 10.1016/0168-1702(94)90059-0; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; *NIH, 2002, JORD REP 20 ANN ACC; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Scott JAG, 2008, J CLIN INVEST, V118, P1291, DOI 10.1172/JCI33947; United Nations, 2009, MILL DEV GOALS REP 2; United Nations Population Division, WORLD POP PROSP 2008; Weber MW, 1998, TROP MED INT HEALTH, V3, P268, DOI 10.1046/j.1365-3156.1998.00213.x; Wright PF, 2000, GENERIC PROTOCOL EXA; You D, 2010, LANCET, V375, P100, DOI 10.1016/S0140-6736(09)61601-9	13	28	31	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 1	2010	375	9725					1500	1502		10.1016/S0140-6736(10)60401-1	http://dx.doi.org/10.1016/S0140-6736(10)60401-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	596AH	20399494				2022-12-28	WOS:000277655100006
J	Castera, L; Pinzani, M				Castera, Laurent; Pinzani, Massimo			Non-invasive assessment of liver fibrosis: are we ready?	LANCET			English	Editorial Material							CHRONIC HEPATITIS-C; TRANSIENT ELASTOGRAPHY; STIFFNESS MEASUREMENT; GENERAL-POPULATION; FIBROTEST; CIRRHOSIS		[Castera, Laurent] Ctr Hosp Univ Bordeaux, Hop Haut Leveque, Serv Hepatogastroenterol, F-33604 Bordeaux, France; [Castera, Laurent] Ctr Hosp Univ Bordeaux, Hop St Andre, F-33604 Bordeaux, France; [Pinzani, Massimo] Univ Florence, Dipartimento Med Interna, Florence, Italy; [Pinzani, Massimo] Univ Florence, Ctr Res High Educ & Transfer DENOThe, Florence, Italy	CHU Bordeaux; CHU Bordeaux; University of Florence; University of Florence	Castera, L (corresponding author), Ctr Hosp Univ Bordeaux, Hop Haut Leveque, Serv Hepatogastroenterol, F-33604 Bordeaux, France.	laurent.castera@chu-bordeaux.fr		Castera, laurent/0000-0002-6715-8588				Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Hezode C, 2009, J HEPATOL, V50, pS226, DOI 10.1016/S0168-8278(09)60617-6; Pinzani M, 2008, NAT CLIN PRACT GASTR, V5, P95, DOI 10.1038/ncpgasthep1025; Poynard T, 2009, J HEPATOL, V50, pS369, DOI 10.1016/S0168-8278(09)61023-0; Poynard T, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-40; Roulot D, 2009, J HEPATOL, V50, pS89, DOI 10.1016/S0168-8278(09)60221-X; Shaheen AAM, 2007, HEPATOLOGY, V46, P912, DOI 10.1002/hep.21835; Vizzutti F, 2007, HEPATOLOGY, V45, P1290, DOI 10.1002/hep.21665; *WHO, MORT DAT 2006, P92502	12	90	95	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 24	2010	375	9724					1419	1420		10.1016/S0140-6736(09)62195-4	http://dx.doi.org/10.1016/S0140-6736(09)62195-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	590FL	20417845				2022-12-28	WOS:000277210000010
J	James, CD; Bayarsaikhan, D; Bekedam, H				James, Chris D.; Bayarsaikhan, Dorjsuren; Bekedam, Henk			Health-financing strategy for WHO's Asia-Pacific Region	LANCET			English	Editorial Material									[James, Chris D.; Bayarsaikhan, Dorjsuren; Bekedam, Henk] WHO, Western Pacific Reg Off, Manila 1000, Philippines	WHO Western Pacific Regional Office; World Health Organization	James, CD (corresponding author), WHO, Western Pacific Reg Off, Manila 1000, Philippines.	jamesc@wpro.who.int						[Anonymous], 2001, MACR HLTH INV HLTH E; Bauer A, 2008, WORLD BANKS NEW POVE; Bloom DE, 2000, SCIENCE, V287, P1207, DOI 10.1126/science.287.5456.1207; Carrin G, 2005, ACHIEVING UNIVERSAL; Carrin G, 2008, B WORLD HEALTH ORGAN, V86, P857, DOI 10.2471/BLT.07.049387; Docteur E, 2003, HLTH CARE SYSTEMS LE; Garrett L, 2009, LANCET, V374, P1294, DOI 10.1016/S0140-6736(09)61503-8; Savedoff W, 2003, MUCH SHOULD COUNTRIE; *WHO, WHO HLTH FIN STRAT A, P92502; World Health Organization, 2005, SUST HLTH FIN UN COV; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972; DATA ASIAN DEV OUTLO, P92502	12	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 24	2010	375	9724					1417	1419		10.1016/S0140-6736(10)60552-1	http://dx.doi.org/10.1016/S0140-6736(10)60552-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	590FL	20417844				2022-12-28	WOS:000277210000009
J	Scher, HI; Beer, TM; Higano, CS; Anand, A; Taplin, ME; Efstathiou, E; Rathkopf, D; Shelkey, J; Yu, EY; Alumkal, J; Hung, D; Hirmand, M; Seely, L; Morris, MJ; Danila, DC; Humm, J; Larson, S; Fleisher, M; Sawyers, CL				Scher, Howard I.; Beer, Tomasz M.; Higano, Celestia S.; Anand, Aseem; Taplin, Mary-Ellen; Efstathiou, Eleni; Rathkopf, Dana; Shelkey, Julia; Yu, Evan Y.; Alumkal, Joshi; Hung, David; Hirmand, Mohammad; Seely, Lynn; Morris, Michael J.; Danila, Daniel C.; Humm, John; Larson, Steve; Fleisher, Martin; Sawyers, Charles L.		Prostate Canc Fdn	Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study	LANCET			English	Article							CIRCULATING TUMOR-CELLS; HORMONAL-THERAPY; CLINICAL-TRIALS; SURVIVAL; PROGRESSION; MUTATIONS; IMATINIB; GENE; TESTOSTERONE; ANTIANDROGEN	Background MDV3100 is an androgen-receptor antagonist that blocks androgens from binding to the androgen receptor and prevents nuclear translocation and co-activator recruitment of the ligand-receptor complex. It also induces tumour cell apoptosis, and has no agonist activity. Because growth of castration-resistant prostate cancer is dependent on continued androgen-receptor signalling, we assessed the antitumour activity and safety of MDV3100 in men with this disease. Methods This phase 1-2 study was undertaken in five US centres in 140 patients. Patients with progressive, metastatic, castration-resistant prostate cancer were enrolled in dose-escalation cohorts of three to six patients and given an oral daily starting dose of MDV3100 30 mg. The final daily doses studied were 30 mg (n=3), 60 mg (27), 150 mg (28), 240 mg (29), 360 mg (28), 480 mg (22), and 600 mg (3). The primary objective was to identify the safety and tolerability profile of MDV3100 and to establish the maximum tolerated dose. The trial is registered with ClinicalTrials.gov, number NCT00510718. Findings We noted antitumour effects at all doses, including decreases in serum prostate-specific antigen of 50% or more in 78 (56%) patients, responses in soft tissue in 13 (22%) of 59 patients, stabilised bone disease in 61 (56%) of 109 patients, and conversion from unfavourable to favourable circulating tumour cell counts in 25 (49%) of the 51 patients. PET imaging of 22 patients to assess androgen-receptor blockade showed decreased F-18-fluoro-5 alpha-dihydrotestosterone binding at doses from 60 mg to 480 mg per day (range 20-100%). The median time to progression was 47 weeks (95% CI 34 not reached) for radiological progression. The maximum tolerated dose for sustained treatment (>28 days) was 240 mg. The most common grade 3-4 adverse event was dose-dependent fatigue (16 [11%] patients), which generally resolved after dose reduction. Interpretation We recorded encouraging antitumour activity with MDV3100 in patients with castration-resistant prostate cancer. The results of this phase 1-2 trial validate in man preclinical studies implicating sustained androgen-receptor signalling as a driver in this disease.	[Scher, Howard I.] Mem Sloan Kettering Canc Ctr, Dept Med, Genitourinary Oncol Serv, Sidney Kimmel Ctr Prostate & Urol Canc, New York, NY 10021 USA; [Larson, Steve] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA; [Humm, John] Mem Sloan Kettering Canc Ctr, Nucl Med Serv, Dept Med Imaging, New York, NY 10021 USA; [Fleisher, Martin] Mem Sloan Kettering Canc Ctr, Dept Clin Labs, New York, NY 10021 USA; [Sawyers, Charles L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Beer, Tomasz M.; Alumkal, Joshi] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Sawyers, Charles L.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Higano, Celestia S.; Yu, Evan Y.] Univ Washington, Seattle, WA 98195 USA; [Taplin, Mary-Ellen] Dana Farber Canc Inst, Boston, MA 02115 USA; [Efstathiou, Eleni] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Hung, David; Hirmand, Mohammad; Seely, Lynn] Medivation, San Francisco, CA USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Oregon Health & Science University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Harvard University; Dana-Farber Cancer Institute; University of Texas System; UTMD Anderson Cancer Center	Scher, HI (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Genitourinary Oncol Serv, Sidney Kimmel Ctr Prostate & Urol Canc, 1275 York Ave, New York, NY 10021 USA.	scherh@mskcc.org	Anand, Aseem/P-1214-2014; Sawyers, Charles/G-5327-2016	Anand, Aseem/0000-0002-3606-540X; Morris, Michael J./0000-0002-9454-0096; Rathkopf, Dana/0000-0002-4503-7582	Medivation; National Cancer Institute [P50-CA92629, P50-CA97186, P50-CA086438]; Howard Hughes Medical Institute; Doris Duke Charitable Foundation; Department of Defense Prostate Cancer Research Program Clinical Consortium [W81XWH-06-2-0011, W81XWH-06-1-0237, W81XWH-07-1-0097, W81XWH-06-1-0261, W81XWH-06-1-0203]; NATIONAL CANCER INSTITUTE [P50CA086438, P50CA092629, P50CA097186] Funding Source: NIH RePORTER	Medivation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Department of Defense Prostate Cancer Research Program Clinical Consortium(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support for this research came from Medivation; the Prostate Cancer Foundation, P50-CA92629 MSKCC Specialized Program in Research Excellence in Prostate Cancer grant from the National Cancer Institute; P50-CA97186 The University of Washington and Oregon Health and Science University Knight Cancer Institute Specialized Program in Research Excellence in Prostate Cancer Grant from the National Cancer Institute; P50-CA086438 MSKCC Center for Molecular Imaging in Cancer from the National Cancer Institute; the Howard Hughes Medical Institute; Doris Duke Charitable Foundation; and Department of Defense Prostate Cancer Research Program Clinical Consortium (Memorial Sloan-Kettering Cancer Center W81XWH-06-2-0011; Oregon Health and Science University Knight Cancer Institute: W81XWH-06-1-0237; The University of Washington: W81XWH-07-1-0097; Dana-Farber Cancer Institute: W81XWH-06-1-0261; MD Anderson Cancer Center W81XWH-06-1-0203). We thank Janet Novak of Helix Editing for editing of the report. Janet Novak was paid for her work by Memorial Sloan-Kettering Cancer Center.	Antonescu CR, 2005, CLIN CANCER RES, V11, P4182, DOI 10.1158/1078-0432.CCR-04-2245; Basch EM, 2007, J CLIN ONCOL, V25, P5313, DOI 10.1200/JCO.2007.13.4536; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Chen L, 2004, NEW ASTRON, V10, P39, DOI 10.1016/j.newast.2004.04.008; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Cortes J, 2007, BLOOD, V110, P4005, DOI 10.1182/blood-2007-03-080838; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Danila DC, 2007, CLIN CANCER RES, V13, P7053, DOI 10.1158/1078-0432.CCR-07-1506; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Demetri GD, 2009, CLIN CANCER RES, V15, P5902, DOI 10.1158/1078-0432.CCR-09-0482; Gajiwala KS, 2009, P NATL ACAD SCI USA, V106, P1542, DOI 10.1073/pnas.0812413106; Holzbeierlein J, 2004, AM J PATHOL, V164, P217, DOI 10.1016/S0002-9440(10)63112-4; Linardou H, 2008, LANCET ONCOL, V9, P962, DOI 10.1016/S1470-2045(08)70206-7; Linja MJ, 2001, CANCER RES, V61, P3550; Morris MJ, 2009, CLIN GENITOURIN CANC, V7, P51, DOI 10.3816/CGC.2009.n.009; Morris MJ, 2005, CLIN CANCER RES, V11, P3210, DOI 10.1158/1078-0432.CCR-04-2034; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pomerantz M, 2007, ANNU REV MED, V58, P205, DOI 10.1146/annurev.med.58.101505.115650; Scher HI, 1997, EUR UROL, V31, P3; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Scher HI, 1997, J CLIN ONCOL, V15, P2928, DOI 10.1200/JCO.1997.15.8.2928; Scher HI, 2008, J CLIN ONCOL, V26, P1148, DOI 10.1200/JCO.2007.12.4487; Scher HI, 2007, CLIN CANCER RES, V13, P1488, DOI 10.1158/1078-0432.CCR-06-1885; Shah NP, 2007, J CLIN INVEST, V117, P2562, DOI 10.1172/JCI30890; Small EJ, 1997, J CLIN ONCOL, V15, P382, DOI 10.1200/JCO.1997.15.1.382; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; VERIDEX LLC, 2008, CELLSEARCH CIRCULATI	30	819	862	4	71	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 24	2010	375	9724					1437	1446		10.1016/S0140-6736(10)60172-9	http://dx.doi.org/10.1016/S0140-6736(10)60172-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	590FL	20398925	Green Accepted			2022-12-28	WOS:000277210000030
J	Hanaguri, T; Niitaka, S; Kuroki, K; Takagi, H				Hanaguri, T.; Niitaka, S.; Kuroki, K.; Takagi, H.			Unconventional s-Wave Superconductivity in Fe(Se,Te)	SCIENCE			English	Article							QUASI-PARTICLE INTERFERENCE	The superconducting state is characterized by a pairing of electrons with a superconducting gap on the Fermi surface. In iron-based superconductors, an unconventional pairing state has been argued for theoretically. We used scanning tunneling microscopy on Fe(Se,Te) single crystals to image the quasi-particle scattering interference patterns in the superconducting state. By applying a magnetic field to break the time-reversal symmetry, the relative sign of the superconducting gap can be determined from the magnetic-field dependence of quasi-particle scattering amplitudes. Our results indicate that the sign is reversed between the hole and the electron Fermi-surface pockets (s(+/-)-wave), favoring the unconventional pairing mechanism associated with spin fluctuations.	[Hanaguri, T.; Niitaka, S.; Takagi, H.] RIKEN, Adv Sci Inst, Magnet Mat Lab, Wako, Saitama 3510198, Japan; [Hanaguri, T.; Niitaka, S.; Kuroki, K.; Takagi, H.] Japan Sci & Technol Agcy, Transformat Res Project Iron Pnictides, Tokyo 1020075, Japan; [Kuroki, K.] Univ Electrocommun, Dept Appl Phys & Chem, Tokyo 1828585, Japan; [Takagi, H.] Univ Tokyo, Dept Adv Mat, Kashiwa, Chiba 2778561, Japan	RIKEN; Japan Science & Technology Agency (JST); University of Electro-Communications - Japan; University of Tokyo	Hanaguri, T (corresponding author), RIKEN, Adv Sci Inst, Magnet Mat Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	hanaguri@riken.jp	TAKAGI, HIDENORI/Q-1041-2019; Takagi, Hidenori/B-2935-2010; Hanaguri, Tetsuo/I-6710-2012	TAKAGI, HIDENORI/0000-0001-5700-3761; Hanaguri, Tetsuo/0000-0003-2896-0081	RIKEN; Ministry of Education, Culture, Sports, Science and Technology of Japan	RIKEN; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank H. Aoki, R. Arita, P. Coleman, Y. Kato, Y. Kohsaka, Y. Matsuda, I. I. Mazin, Y. Nagai, M. Ogata, T. Shibauchi, T. Shimojima, and S. Shin for valuable discussions and comments. This work has been supported by an Incentive Research Grant from RIKEN and Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Cvetkovic V, 2009, EPL-EUROPHYS LETT, V85, DOI 10.1209/0295-5075/85/37002; Ding H, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/47001; Fletcher JD, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.147001; Fujita K, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.054510; Graser S, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/2/025016; Hanaguri T, 2007, NAT PHYS, V3, P865, DOI 10.1038/nphys753; Hanaguri T, 2009, SCIENCE, V323, P923, DOI 10.1126/science.1166138; Hashimoto K, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.017002; Hoffman JE, 2002, SCIENCE, V297, P1148, DOI 10.1126/science.1072640; Hsu FC, 2008, P NATL ACAD SCI USA, V105, P14262, DOI 10.1073/pnas.0807325105; Kamihara Y, 2008, J AM CHEM SOC, V130, P3296, DOI 10.1021/ja800073m; Kato T, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.180507; Kohsaka Y, 2007, SCIENCE, V315, P1380, DOI 10.1126/science.1138584; Kondo T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.147003; Kuroki K, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.024501; Kuroki K, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.224511; Kuroki K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.087004; Lynn JW, 2009, PHYSICA C, V469, P469, DOI 10.1016/j.physc.2009.03.046; Maltseva M, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.144514; Massee F, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.140507; Mazin II, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.057003; Pereg-Barnea T, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.020509; Ren ZA, 2008, CHINESE PHYS LETT, V25, P2215, DOI 10.1088/0256-307X/25/6/080; Singh DJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.237003; Wang F, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.047005; Wang F, 2009, EPL-EUROPHYS LETT, V85, DOI 10.1209/0295-5075/85/37005; Zhang YY, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.094528	27	426	430	8	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 23	2010	328	5977					474	476		10.1126/science.1187399	http://dx.doi.org/10.1126/science.1187399			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YR	20413495	Green Submitted			2022-12-28	WOS:000276952400035
J	McKenney, RJ; Vershinin, M; Kunwar, A; Vallee, RB; Gross, SP				McKenney, Richard J.; Vershinin, Michael; Kunwar, Ambarish; Vallee, Richard B.; Gross, Steven P.			LIS1 and NudE Induce a Persistent Dynein Force-Producing State	CELL			English	Article							MOTOR-BASED TRANSPORT; COILED-COIL DOMAIN; CYTOPLASMIC DYNEIN; MYOSIN-V; NEURONAL MIGRATION; HEAVY-CHAIN; ASPERGILLUS-NIDULANS; LISSENCEPHALY GENE; ATPASE ACTIVITY; PROTEIN	Cytoplasmic dynein is responsible for many aspects of cellular and subcellular movement. LIS1, NudE, and NudEL are dynein interactors initially implicated in brain developmental disease but now known to be required in cell migration, nuclear, centrosomal, and microtubule transport, mitosis, and growth cone motility. Identification of a specific role for these proteins in cytoplasmic dynein motor regulation has remained elusive. We find that NudE stably recruits LIS1 to the dynein holoenzyme molecule, where LIS1 interacts with the motor domain during the pre-powerstroke state of the dynein crossbridge cycle. NudE abrogates dynein force production, whereas LIS1 alone or with NudE induces a persistent-force dynein state that improves ensemble function of multiple dyneins for transport under high-load conditions. These results likely explain the requirement for LIS1 and NudE in the transport of nuclei, centrosomes, chromosomes, and the microtubule cytoskeleton as well as the particular sensitivity of migrating neurons to reduced LIS1 expression.	[McKenney, Richard J.; Vallee, Richard B.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Vershinin, Michael; Gross, Steven P.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Kunwar, Ambarish] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA	Columbia University; University of California System; University of California Irvine; University of California System; University of California Davis	Vallee, RB (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA.	rv2025@columbia.edu; sgross@uci.edu	Kunwar, Ambarish/AAD-3618-2022	Kunwar, Ambarish/0000-0002-8671-7816; Vershinin, Michael/0000-0002-8207-1376	 [GM47434];  [HD40182];  [1RO1GM070676];  [GM079156];  [GM068952]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068952, R01GM070676, R01GM047434, R37GM047434, R01GM079156] Funding Source: NIH RePORTER	; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge Drs. Jing Xu, Silvia Cermelli, and Peter Hook for helpful discussions and Shahrnaz Kemal, Kassandra Ori-McKenney, and Z. Shu for technical help. This work was supported by grants GM47434 and HD40182 to R. B. V. and grants 1RO1GM070676 and GM079156 to S. P. G. A. K. was supported by grant GM068952.	Bremner KH, 2009, CELL HOST MICROBE, V6, P523, DOI 10.1016/j.chom.2009.11.006; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Chen BY, 2007, STRUCTURE, V15, P429, DOI 10.1016/j.str.2007.02.007; Coquelle FM, 2002, MOL CELL BIOL, V22, P3089, DOI 10.1128/MCB.22.9.3089-3102.2002; Derewenda U, 2007, STRUCTURE, V15, P1467, DOI 10.1016/j.str.2007.09.015; Dietrich KA, 2008, P NATL ACAD SCI USA, V105, P8938, DOI 10.1073/pnas.0803575105; Dobyns W B, 1987, Birth Defects Orig Artic Ser, V23, P225; Dujardin DL, 2003, J CELL BIOL, V163, P1205, DOI 10.1083/jcb.200310097; Efimov VP, 2000, J CELL BIOL, V150, P681, DOI 10.1083/jcb.150.3.681; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; Gebhardt JCM, 2006, P NATL ACAD SCI USA, V103, P8680, DOI 10.1073/pnas.0510191103; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Grabham PW, 2007, J NEUROSCI, V27, P5823, DOI 10.1523/JNEUROSCI.1135-07.2007; Guo J, 2006, MOL BIOL CELL, V17, P680, DOI 10.1091/mbc.E05-04-0360; Han GS, 2001, CURR BIOL, V11, P719, DOI 10.1016/S0960-9822(01)00200-7; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Hook P, 2005, J BIOL CHEM, V280, P33045, DOI 10.1074/jbc.M504693200; Imamula K, 2007, P NATL ACAD SCI USA, V104, P16134, DOI 10.1073/pnas.0702370104; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Kon T, 2009, NAT STRUCT MOL BIOL, V16, P325, DOI 10.1038/nsmb.1555; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Kunwar A, 2008, CURR BIOL, V18, P1173, DOI 10.1016/j.cub.2008.07.027; Liang Y, 2004, J CELL BIOL, V164, P557, DOI 10.1083/jcb.200308058; Liang Y, 2007, MOL BIOL CELL, V18, P2656, DOI 10.1091/mbc.E06-04-0345; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Mesngon MT, 2006, J NEUROSCI, V26, P2132, DOI 10.1523/JNEUROSCI.5095-05.2006; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; PASCHAL BM, 1987, J CELL BIOL, V105, P1273, DOI 10.1083/jcb.105.3.1273; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Sapir T, 1997, EMBO J, V16, P6977, DOI 10.1093/emboj/16.23.6977; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; SCHOLEY JM, 1980, NATURE, V287, P233, DOI 10.1038/287233a0; SCHROEDER HW, 2008, MOL BIOL CELL S, V19; Shen YD, 2008, DEV CELL, V14, P342, DOI 10.1016/j.devcel.2008.01.001; SHIMIZU T, 1983, J BIOL CHEM, V258, P3841; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; Siller KH, 2005, MOL BIOL CELL, V16, P5127, DOI 10.1091/mbc.E05-04-0338; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Stehman SA, 2007, J CELL BIOL, V178, P583, DOI 10.1083/jcb.200610112; Stock MF, 1999, J BIOL CHEM, V274, P14617, DOI 10.1074/jbc.274.21.14617; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Tai CY, 2002, J CELL BIOL, V156, P959, DOI 10.1083/jcb.200109046; Tarricone C, 2004, NEURON, V44, P809, DOI 10.1016/S0896-6273(04)00751-2; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Vergnolle MAS, 2007, CURR BIOL, V17, P1173, DOI 10.1016/j.cub.2007.05.077; Vershinin M, 2008, TRAFFIC, V9, P882, DOI 10.1111/j.1600-0854.2008.00741.x; Vershinin M, 2007, P NATL ACAD SCI USA, V104, P87, DOI 10.1073/pnas.0607919104; Vogel SK, 2009, PLOS BIOL, V7, P918, DOI 10.1371/journal.pbio.1000087; Wang F, 2004, J BIOL CHEM, V279, P2333, DOI 10.1074/jbc.C300488200; XIANG X, 1995, MOL BIOL CELL, V6, P297, DOI 10.1091/mbc.6.3.297; Yamada M, 2008, EMBO J, V27, P2471, DOI 10.1038/emboj.2008.182; Yan XM, 2003, MOL CELL BIOL, V23, P1239, DOI 10.1128/MCB.23.4.1239-1250.2003	60	255	256	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2010	141	2					304	314		10.1016/j.cell.2010.02.035	http://dx.doi.org/10.1016/j.cell.2010.02.035			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	584GF	20403325	Green Accepted, Bronze			2022-12-28	WOS:000276738400020
J	Pironio, S; Acin, A; Massar, S; de la Giroday, AB; Matsukevich, DN; Maunz, P; Olmschenk, S; Hayes, D; Luo, L; Manning, TA; Monroe, C				Pironio, S.; Acin, A.; Massar, S.; de la Giroday, A. Boyer; Matsukevich, D. N.; Maunz, P.; Olmschenk, S.; Hayes, D.; Luo, L.; Manning, T. A.; Monroe, C.			Random numbers certified by Bell's theorem	NATURE			English	Article								Randomness is a fundamental feature of nature and a valuable resource for applications ranging from cryptography and gambling to numerical simulation of physical and biological systems. Random numbers, however, are difficult to characterize mathematically(1), and their generation must rely on an unpredictable physical process(2-6). Inaccuracies in the theoretical modelling of such processes or failures of the devices, possibly due to adversarial attacks, limit the reliability of random number generators in ways that are difficult to control and detect. Here, inspired by earlier work on non-locality-based(7-9) and device-independent(10-14) quantum information processing, we show that the non-local correlations of entangled quantum particles can be used to certify the presence of genuine randomness. It is thereby possible to design a cryptographically secure random number generator that does not require any assumption about the internal working of the device. Such a strong form of randomness generation is impossible classically and possible in quantum systems only if certified by a Bell inequality violation(15). We carry out a proof-of-concept demonstration of this proposal in a system of two entangled atoms separated by approximately one metre. The observed Bell inequality violation, featuring near perfect detection efficiency, guarantees that 42 new random numbers are generated with 99 per cent confidence. Our results lay the groundwork for future device-independent quantum information experiments and for addressing fundamental issues raised by the intrinsic randomness of quantum theory.	[Acin, A.] ICREA, Barcelona 08010, Spain; [Acin, A.] ICFO, Barcelona 08860, Spain; [Pironio, S.; Massar, S.] Univ Libre Bruxelles, Lab Informat Quant, B-1050 Brussels, Belgium; [Pironio, S.] Univ Geneva, Appl Phys Grp, CH-1211 Geneva, Switzerland; [de la Giroday, A. Boyer] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [Matsukevich, D. N.; Maunz, P.; Olmschenk, S.; Hayes, D.; Luo, L.; Manning, T. A.; Monroe, C.] Univ Maryland, Dept Phys, Joint Quantum Inst, College Pk, MD 20742 USA; [Matsukevich, D. N.; Maunz, P.; Olmschenk, S.; Hayes, D.; Luo, L.; Manning, T. A.; Monroe, C.] NIST, College Pk, MD 20742 USA	ICREA; Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); Universite Libre de Bruxelles; University of Geneva; University of Cambridge; University System of Maryland; University of Maryland College Park; National Institute of Standards & Technology (NIST) - USA	Acin, A (corresponding author), ICFO, Mediterranean Technol Pk, Barcelona 08860, Spain.	antonio.acin@icfo.es	Luo, Le/E-3225-2010; Monroe, Christopher R/G-8105-2011; Matsukevich, Dzmitry/C-9134-2009; Luo, Le/I-6459-2013; Olmschenk, Steven/D-4960-2011	Matsukevich, Dzmitry/0000-0002-7679-0569; Luo, Le/0000-0002-8375-6326; Olmschenk, Steven/0000-0003-0105-7714	Swiss NCCR Quantum Photonics; European ERC-AG QORE; European projects QAP and COM-PAS; Spanish MEC [FIS2007-60182]; Consolider-Ingenio QOIT projects; Generalitat de Catalunya; Caixa Manresa; Fundacio Cellex Barcelona; Interuniversity Attraction Poles Photonics@ be Programme (Belgian Science Policy); Brussels-Capital Region; BB2B Grant; US Army Research Office; IARPA; National Science Foundation (NSF), Physics Frontier Center; ICREA Funding Source: Custom	Swiss NCCR Quantum Photonics(Swiss National Science Foundation (SNSF)); European ERC-AG QORE; European projects QAP and COM-PAS; Spanish MEC(Spanish Government); Consolider-Ingenio QOIT projects; Generalitat de Catalunya(Generalitat de Catalunya); Caixa Manresa; Fundacio Cellex Barcelona(Foundation CELLEXEuropean Commission); Interuniversity Attraction Poles Photonics@ be Programme (Belgian Science Policy)(Belgian Federal Science Policy Office); Brussels-Capital Region; BB2B Grant; US Army Research Office; IARPA; National Science Foundation (NSF), Physics Frontier Center(National Science Foundation (NSF)); ICREA(ICREA)	We thank R. Colbeck for sharing his PhD thesis with us. This work was supported by the Swiss NCCR Quantum Photonics, the European ERC-AG QORE, the European projects QAP and COM-PAS, the ERC starting grant PERCENT, the Spanish MEC FIS2007-60182 and Consolider-Ingenio QOIT projects, Generalitat de Catalunya, Caixa Manresa, Fundacio Cellex Barcelona, the Interuniversity Attraction Poles Photonics@ be Programme (Belgian Science Policy), the Brussels-Capital Region through the project CRYPTASC and a BB2B Grant, the US Army Research Office with funds from IARPA, the National Science Foundation (NSF) Physics at the Information Frontier Program, and the NSF Physics Frontier Center at JQI.	Acin A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.230501; [Anonymous], 2008, MARSAGLIA RANDOM NUM; Barrett J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.010503; Bell J.S., 2004, SPEAKABLE UNSPEAKABL, P14; Colbeck R., 2007, THESIS U CAMBRIDGE; Dynes JF, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2961000; EKERT AK, 1991, PHYS REV LETT, V67, P661, DOI 10.1103/PhysRevLett.67.661; FINE A, 1982, PHYS REV LETT, V48, P291, DOI 10.1103/PhysRevLett.48.291; Fiorentino M, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.032334; Gill R. D., 2003, MATH MODEL PHYS ENG, V2, P179; Jennewein T, 2000, REV SCI INSTRUM, V71, P1675, DOI 10.1063/1.1150518; Knuth D. E, 1981, ART COMPUTER PROGRAM, V2; Konig R, 2009, IEEE T INFORM THEORY, V55, P4337, DOI 10.1109/TIT.2009.2025545; Luo L, 2009, FORTSCHR PHYS, V57, P1133, DOI 10.1002/prop.200900093; Magniez F, 2006, LECT NOTES COMPUT SC, V4051, P72, DOI 10.1007/11786986_8; Masanes L, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.140501; Matsukevich DN, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.150404; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; Mayers D, 1998, ANN IEEE SYMP FOUND, P503, DOI 10.1109/SFCS.1998.743501; Navascues M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.010401; Navascues M, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/7/073013; Nisan N, 1999, J COMPUT SYST SCI, V58, P148, DOI 10.1006/jcss.1997.1546; Olmschenk S, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.052314; Pironio S, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/4/045021; Rowe MA, 2001, NATURE, V409, P791, DOI 10.1038/35057215; Rukhin A, 2008, SPECIAL PUBLICATION, V800-22; Stefanov A, 2000, J MOD OPTIC, V47, P595, DOI 10.1080/09500340008233380; Uchida A, 2008, NAT PHOTONICS, V2, P728, DOI 10.1038/nphoton.2008.227	29	835	841	4	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2010	464	7291					1021	1024		10.1038/nature09008	http://dx.doi.org/10.1038/nature09008			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20393558	Green Submitted			2022-12-28	WOS:000276635000034
J	Corrigan, P				Corrigan, Paul			Can the NHS cut costs without substantially damaging the quality of health care? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material									NHS London, London, England		Corrigan, P (corresponding author), NHS London, London, England.	corriganpauld@yahoo.co.uk							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 14	2010	340								c1999	10.1136/bmj.c1999	http://dx.doi.org/10.1136/bmj.c1999			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	586KB	20392776				2022-12-28	WOS:000276905400013
J	Nagy, M; Akos, Z; Biro, D; Vicsek, T				Nagy, Mate; Akos, Zsuzsa; Biro, Dora; Vicsek, Tamas			Hierarchical group dynamics in pigeon flocks	NATURE			English	Article							COLLECTIVE BEHAVIOR; LEADERSHIP; TRANSITION	Animals that travel together in groups display a variety of fascinating motion patterns thought to be the result of delicate local interactions among group members(1-3). Although the most informative way of investigating and interpreting collective movement phenomena would be afforded by the collection of high-resolution spatio-temporal data from moving individuals, such data are scarce(4-7) and are virtually non-existent for long-distance group motion within a natural setting because of the associated technological difficulties(8). Here we present results of experiments in which track logs of homing pigeons flying in flocks of up to 10 individuals have been obtained by high-resolution lightweight GPS devices and analysed using a variety of correlation functions inspired by approaches common in statistical physics. We find a well-defined hierarchy among flock members from data concerning leading roles in pairwise interactions, defined on the basis of characteristic delay times between birds' directional choices. The average spatial position of a pigeon within the flock strongly correlates with its place in the hierarchy, and birds respond more quickly to conspecifics perceived primarily through the left eye-both results revealing differential roles for birds that assume different positions with respect to flock-mates. From an evolutionary perspective, our results suggest that hierarchical organization of group flight may be more efficient than an egalitarian one, at least for those flock sizes that permit regular pairwise interactions among group members, during which leader-follower relationships are consistently manifested.	[Nagy, Mate; Akos, Zsuzsa; Vicsek, Tamas] Eotvos Lorand Univ, Dept Biol Phys, H-1117 Budapest, Hungary; [Biro, Dora] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Vicsek, Tamas] Hungarian Acad Sci, Stat & Biol Phys Res Grp, H-1117 Budapest, Hungary	Eotvos Lorand University; University of Oxford; Hungarian Academy of Sciences	Vicsek, T (corresponding author), Eotvos Lorand Univ, Dept Biol Phys, Pazmany Peter Setany 1A, H-1117 Budapest, Hungary.	vicsek@hal.elte.hu	Nagy, Máté/B-3180-2011	Nagy, Máté/0000-0001-8817-087X; Biro, Dora/0000-0002-3408-6274	EU; Royal Society; Somerville College, Oxford	EU(European Commission); Royal Society(Royal Society of London); Somerville College, Oxford	We thank the Hungarian Racing Pigeon Sports Federation-in particular I. Bardos-for support. We are grateful to J. Pato for allowing his pigeons to participate in the present research, and for his technical help throughout the experiments. This research was partially supported by the EU ERC COLLMOT and the EU FP6 STARFLAG projects. D. B. was supported by a Royal Society University Research Fellowship and by Somerville College, Oxford.	Akos Z, 2008, P NATL ACAD SCI USA, V105, P4139, DOI 10.1073/pnas.0707711105; Bajec IL, 2009, ANIM BEHAV, V78, P777, DOI 10.1016/j.anbehav.2009.07.007; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Becco C, 2006, PHYSICA A, V367, P487, DOI 10.1016/j.physa.2005.11.041; Biro D, 2004, P NATL ACAD SCI USA, V101, P17440, DOI 10.1073/pnas.0406984101; Biro D, 2006, CURR BIOL, V16, P2123, DOI 10.1016/j.cub.2006.08.087; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; Conradt L, 2009, AM NAT, V173, P304, DOI 10.1086/596532; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; de Perera TB, 1999, ANIM BEHAV, V57, P715; Dell'Ariccia G, 2008, ANIM BEHAV, V76, P1165, DOI 10.1016/j.anbehav.2008.05.022; Dennis TE, 2007, P ROY SOC B-BIOL SCI, V274, P1153, DOI 10.1098/rspb.2007.3768; Fischhoff IR, 2007, ANIM BEHAV, V73, P825, DOI 10.1016/j.anbehav.2006.10.012; Freeman R, 2009, J NAVIGATION, V62, P33, DOI 10.1017/S0373463308005080; Gregoire G, 2003, PHYSICA D, V181, P157, DOI 10.1016/S0167-2789(03)00102-7; Gunturkun O, 2009, LANGUAGE LATERALIZATION AND PSYCHOSIS, P19, DOI 10.1017/CBO9780511576744.003; Krause J, 2000, FISH FISH, V1, P82, DOI 10.1111/j.1467-2979.2000.tb00001.x; Lipp HP, 2004, CURR BIOL, V14, P1239, DOI 10.1016/j.cub.2004.07.024; Parrish J., 1997, ANIMAL GROUPS 3 DIME; PARTRIDGE BL, 1980, BEHAV ECOL SOCIOBIOL, V6, P277, DOI 10.1007/BF00292770; POMEROY H, 1977, ANIM BEHAV, V25, P720, DOI 10.1016/0003-3472(77)90121-X; Prior H, 2004, BEHAV BRAIN RES, V154, P301, DOI 10.1016/j.bbr.2004.02.018; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Reynolds C.W., 1987, ACM SIGGRAPH COMPUTE, V21, P25, DOI DOI 10.1145/37402.37406; Tien JH, 2004, EVOL ECOL RES, V6, P555; VALLORTIGARA G, 1994, BEHAV PROCESS, V33, P41, DOI 10.1016/0376-6357(94)90059-0; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; WOLFER DP, 2005, 2005 C ROYAL I NAV R	30	634	661	7	293	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					890	U99		10.1038/nature08891	http://dx.doi.org/10.1038/nature08891			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20376149	Green Submitted			2022-12-28	WOS:000276397300037
J	Horvath, K; Koch, K; Jeitler, K; Matyas, E; Bender, R; Bastian, H; Lange, S; Siebenhofer, A				Horvath, Karl; Koch, Klaus; Jeitler, Klaus; Matyas, Eva; Bender, Ralf; Bastian, Hilda; Lange, Stefan; Siebenhofer, Andrea			Effects of treatment in women with gestational diabetes mellitus: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIAL; IMPAIRED GLUCOSE-TOLERANCE; PREGNANCY OUTCOMES; BLOOD-GLUCOSE; THERAPEUTIC APPROACH; GLYCEMIC CONTROL; MANAGEMENT; INSULIN; EXERCISE; HETEROGENEITY	Objective To summarise the benefits and harms of treatments for women with gestational diabetes mellitus. Design Systematic review and meta-analysis of randomised controlled trials. Data sources Embase, Medline, AMED, BIOSIS, CCMed, CDMS, CDSR, CENTRAL, CINAHL, DARE, HTA, NHS EED, Heclinet, SciSearch, several publishers' databases, and reference lists of relevant secondary literature up to October 2009. Review methods Included studies were randomised controlled trials of specific treatment for gestational diabetes compared with usual care or "intensified" compared with "less intensified" specific treatment. Results Five randomised controlled trials matched the inclusion criteria for specific versus usual treatment. All studies used a two step approach with a 50 g glucose challenge test or screening for risk factors, or both, and a subsequent 75 g or 100 g oral glucose tolerance test. Meta- analyses did not show significant differences for most single end points judged to be of direct clinical importance. In women specifically treated for gestational diabetes, shoulder dystocia was significantly less common (odds ratio 0.40, 95% confidence interval 0.21 to 0.75), and one randomised controlled trial reported a significant reduction of pre-eclampsia (2.5 v 5.5%, P=0.02). For the surrogate end point of large for gestational age infants, the odds ratio was 0.48 (0.38 to 0.62). In the 13 randomised controlled trials of different intensities of specific treatments, meta-analysis showed a significant reduction of shoulder dystocia in women with more intensive treatment (0.31, 0.14 to 0.70). Conclusions Treatment for gestational diabetes, consisting of treatment to lower blood glucose concentration alone or with special obstetric care, seems to lower the risk for some perinatal complications. Decisions regarding treatment should take into account that the evidence of benefit is derived from trials for which women were selected with a two step strategy (glucose challenge test/screening for risk factors and oral glucose tolerance test).	[Horvath, Karl; Jeitler, Klaus; Matyas, Eva; Siebenhofer, Andrea] Med Univ Graz, EBM Review Ctr, A-8036 Graz, Austria; [Horvath, Karl] Med Univ Graz, Dept Internal Med, Div Endocrinol & Nucl Med, A-8036 Graz, Austria; [Koch, Klaus; Bender, Ralf; Bastian, Hilda; Lange, Stefan] Inst Qual & Efficiency Hlth Care IQWiG, D-51105 Cologne, Germany; [Siebenhofer, Andrea] Goethe Univ Frankfurt, Inst Gen Practice, Frankfurt, Germany	Medical University of Graz; Medical University of Graz; Goethe University Frankfurt	Horvath, K (corresponding author), Med Univ Graz, EBM Review Ctr, A-8036 Graz, Austria.	Karl.Horvath@medunigraz.at		Jeitler, Klaus/0000-0002-1520-8061; Siebenhofer-Kroitzsch, Andrea/0000-0002-6980-2103	German Federal Joint Committee	German Federal Joint Committee	This study was commissioned by the German Federal Joint Committee. KH, KJ, EM, and AS acted as consultants for the preparation of the review. For this they were reimbursed by IQWiG. KK, RB, HB, and SL (as well as PTS, SD, SW, AS, MM, YZ, EV, CS, and SS) are employees of IQWiG.	Athukorala C, 2007, AUST NZ J OBSTET GYN, V47, P37, DOI 10.1111/j.1479-828X.2006.00676.x; Bancroft K, 2000, BRIT J OBSTET GYNAEC, V107, P959, DOI 10.1111/j.1471-0528.2000.tb10396.x; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Bevier WC, 1999, AM J PERINAT, V16, P269, DOI 10.1055/s-2007-993871; Bonomo M, 2005, DIABETIC MED, V22, P1536, DOI 10.1111/j.1464-5491.2005.01690.x; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; BUNG P, 1993, J PERINAT MED, V21, P125, DOI 10.1515/jpme.1993.21.2.125; BUNG P, 1991, DIABETES, V40, P182, DOI 10.2337/diab.40.2.S182; BUNG P, 1993, GEBURTSH FRAUENHEILK, V53, P188, DOI 10.1055/s-2007-1023663; Canadian Diabetes Association Expert Panel Committee, 2003, CAN J DIABETES, V27, pS1; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DEVECIANA M, 1995, NEW ENGL J MED, V333, P1237, DOI 10.1056/NEJM199511093331901; *DTSCH GES GYN GEB, 2001, DIAGN THER GEST GDM; Elnour AA, 2008, J EVAL CLIN PRACT, V14, P131, DOI 10.1111/j.1365-2753.2007.00819.x; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; Garner P, 1997, AM J OBSTET GYNECOL, V177, P190, DOI 10.1016/S0002-9378(97)70461-7; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hillier TA, 2008, ANN INTERN MED, V148, P766, DOI 10.7326/0003-4819-148-10-200805200-00009; Homko CJ, 2007, DIABETES TECHNOL THE, V9, P297, DOI 10.1089/dia.2006.0034; Homko CJ, 2002, DIABETES EDUCATOR, V28, P435, DOI 10.1177/014572170202800313; *I QUAL WIRTSCH GE, 2007, S0701 IQWIG; Jackson D, 2006, STAT MED, V25, P2688, DOI 10.1002/sim.2481; Jovanovic L, 1999, DIABETES CARE, V22, P1422, DOI 10.2337/diacare.22.9.1422; Keely EJ, 2008, PEDIATR DIABETES, V9, P53; Kestila KK, 2007, DIABETES RES CLIN PR, V77, P174, DOI 10.1016/j.diabres.2006.12.012; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Langer O, 2005, AM J OBSTET GYNECOL, V192, P989, DOI 10.1016/j.ajog.2004.11.039; LANGER O, 1989, AM J OBSTET GYNECOL, V161, P646, DOI 10.1016/0002-9378(89)90371-2; Langer O, 2000, NEW ENGL J MED, V343, P1134, DOI 10.1056/NEJM200010193431601; Lao T, 2001, BRIT J OBSTET GYNAEC, V108, P769; Malcolm JC, 2006, DIABETIC MED, V23, P565, DOI 10.1111/j.1464-5491.2006.01840.x; Metzger BE, 1998, DIABETES CARE, V21, pB161; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Montori Victor M, 2005, ACP J Club, V143, pA8; Moss John R, 2007, BMC Pregnancy Childbirth, V7, P27, DOI 10.1186/1471-2393-7-27; Mugglestone MA, 2008, BRIT MED J, V336, P714, DOI 10.1136/bmj.39505.641273.AD; Nachum Z, 1999, BRIT MED J, V319, P1223, DOI 10.1136/bmj.319.7219.1223; National Collaborating Centre for Women's and Children's Health, 2008, ANT CAR ROUT CAR HLT; Nicholson Wanda K, 2008, Evid Rep Technol Assess (Full Rep), P1; OSULLIVAN JB, 1966, OBSTET GYNECOL, V27, P683; Persson B, 1985, Diabetes, V34 Suppl 2, P101; Rae A, 2000, AUST NZ J OBSTET GYN, V40, P416, DOI 10.1111/j.1479-828X.2000.tb01172.x; Rey E, 1997, OBSTET GYNECOL, V89, P981, DOI 10.1016/S0029-7844(97)00141-5; Rossi G, 2000, ACTA OBSTET GYN SCAN, V79, P649; W.H. Organization, 1999, DEFINITION DIAGNOSIS; Yang X, 2003, DIABETIC MED, V20, P687, DOI 10.1046/j.1464-5491.2003.09282.x; Yang XL, 2003, DIABETES CARE, V26, P254, DOI 10.2337/diacare.26.1.254; Yogev Y, 2009, SEMIN FETAL NEONAT M, V14, P94, DOI 10.1016/j.siny.2009.01.001; [No title captured]	51	190	196	0	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2010	340								c1395	10.1136/bmj.c1395	http://dx.doi.org/10.1136/bmj.c1395			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579VM	20360215	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000276404500005
J	Mulder, DW; Boyd, ES; Sarma, R; Lange, RK; Endrizzi, JA; Broderick, JB; Peters, JW				Mulder, David W.; Boyd, Eric S.; Sarma, Ranjana; Lange, Rachel K.; Endrizzi, James A.; Broderick, Joan B.; Peters, John W.			Stepwise [FeFe]-hydrogenase H-cluster assembly revealed in the structure of HydA(Delta EFG)	NATURE			English	Article							HYDROGENASE; PROTEIN; MATURATION; BIOSYNTHESIS; EVOLUTION; INFERENCE; COFACTORS; ENZYMES; MRBAYES; LIGAND	Complex enzymes containing Fe-S clusters are ubiquitous in nature, where they are involved in a number of fundamental processes including carbon dioxide fixation, nitrogen fixation and hydrogen metabolism(1,2). Hydrogen metabolism is facilitated by the activity of three evolutionarily and structurally unrelated enzymes: the [NiFe]-hydrogenases, [FeFe]-hydrogenases and [Fe]-hydrogenases(3,4) (Hmd). The catalytic core of the [FeFe]-hydrogenase (HydA), termed the H-cluster, exists as a [4Fe-4S] subcluster linked by a cysteine thiolate to a modified 2Fe subcluster with unique non-protein ligands(5,6). The 2Fe subcluster and non-protein ligands are synthesized by the hydrogenase maturation enzymes HydE, HydF and HydG; however, the mechanism, synthesis and means of insertion of H-cluster components remain unclear(7-10). Here we show the structure of HydA(Delta EFG) (HydA expressed in a genetic background devoid of the active site H-cluster biosynthetic genes hydE, hydF and hydG) revealing the presence of a [4Fe-4S] cluster and an open pocket for the 2Fe subcluster. The structure indicates that H-cluster synthesis occurs in a stepwise manner, first with synthesis and insertion of the [4Fe-4S] subcluster by generalized host-cell machinery(11,12) and then with synthesis and insertion of the 2Fe subcluster by specialized hydE-, hydF- and hydG-encoded maturation machinery(7-10). Insertion of the 2Fe subcluster presumably occurs through a cationically charged channel that collapses following incorporation, as a result of conformational changes in two conserved loop regions. The structure, together with phylogenetic analysis, indicates that HydA emerged within bacteria most likely from a Nar1-like ancestor lacking the 2Fe subcluster, and that this was followed by acquisition in several unicellular eukaryotes.	[Mulder, David W.; Boyd, Eric S.; Sarma, Ranjana; Lange, Rachel K.; Endrizzi, James A.; Broderick, Joan B.; Peters, John W.] Montana State Univ, Astrobiol Biogeocatalysis Res Ctr, Bozeman, MT 59717 USA; [Mulder, David W.; Boyd, Eric S.; Sarma, Ranjana; Lange, Rachel K.; Endrizzi, James A.; Broderick, Joan B.; Peters, John W.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Peters, JW (corresponding author), Montana State Univ, Astrobiol Biogeocatalysis Res Ctr, Bozeman, MT 59717 USA.	john.peters@chemistry.montana.edu	Mulder, David/AHC-0138-2022	Mulder, David/0000-0003-0559-0145; Peters, John/0000-0001-9117-9568; Broderick, Joan/0000-0001-7057-9124; Spietz, Rachel/0000-0001-5277-0734	US Air Force Office of Scientific Research Multidisciplinary University Research Initiative [FA9550-05-01-0365]; NASA Astrobiology Institute (NAI) [NNA08C-N85A]; NAI; US Department of Energy, Office of Biological and Environmental Research; US National Institutes of Health, National Center for Research Resources; US National Institute of General Medical Sciences	US Air Force Office of Scientific Research Multidisciplinary University Research Initiative; NASA Astrobiology Institute (NAI); NAI; US Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); US National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a US Air Force Office of Scientific Research Multidisciplinary University Research Initiative Award (FA9550-05-01-0365, J.W.P.) and the NASA Astrobiology Institute (NAI)-funded Astrobiology Biogeocatalysis Research Center (NNA08C-N85A, J.B.B. and J.W.P.). E. S. B. was supported by a NAI postdoctoral fellowship. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL), a national user facility operated by Stanford University on behalf of the US Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology programme is supported by the US Department of Energy, Office of Biological and Environmental Research, the US National Institutes of Health, National Center for Research Resources, Biomedical Technology programme, and the US National Institute of General Medical Sciences.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Brazzolotto X, 2006, J BIOL CHEM, V281, P769, DOI 10.1074/jbc.M510310200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL VIEWER; Drennan CL, 2003, CURR OPIN STRUC BIOL, V13, P220, DOI 10.1016/S0959-440X(03)00038-1; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fani R, 2000, J MOL EVOL, V51, P1; Fontecilla-Camps JC, 2009, NATURE, V460, P814, DOI 10.1038/nature08299; GEORGIADIS MM, 1992, SCIENCE, V257, P1653, DOI 10.1126/science.1529353; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hug LA, 2010, MOL BIOL EVOL, V27, P311, DOI 10.1093/molbev/msp237; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; McGlynn SE, 2008, FEBS LETT, V582, P2183, DOI 10.1016/j.febslet.2008.04.063; McGlynn SE, 2009, DALTON T, P4274, DOI 10.1039/b821432h; Meyer J, 2007, CELL MOL LIFE SCI, V64, P1063, DOI 10.1007/s00018-007-6477-4; Mulder DW, 2009, BIOCHEMISTRY-US, V48, P6240, DOI 10.1021/bi9000563; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicolet Y, 1999, STRUCTURE, V7, P13, DOI 10.1016/S0969-2126(99)80005-7; Nicolet Y, 2008, J BIOL CHEM, V283, P18861, DOI 10.1074/jbc.M801161200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandey AS, 2008, J AM CHEM SOC, V130, P4533, DOI 10.1021/ja711187e; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Peters JW, 1997, BIOCHEMISTRY-US, V36, P1181, DOI 10.1021/bi9626665; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Peters JW, 2006, FEBS LETT, V580, P363, DOI 10.1016/j.febslet.2005.12.040; Pilet E, 2009, FEBS LETT, V583, P506, DOI 10.1016/j.febslet.2009.01.004; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rubach JK, 2005, FEBS LETT, V579, P5055, DOI 10.1016/j.febslet.2005.07.092; Rubio LM, 2008, ANNU REV MICROBIOL, V62, P93, DOI 10.1146/annurev.micro.62.081307.162737; Schmid B, 2002, SCIENCE, V296, P352, DOI 10.1126/science.1070010; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Shima S, 2007, CHEM REC, V7, P37, DOI 10.1002/tcr.20111; Silakov A, 2009, PHYS CHEM CHEM PHYS, V11, P6592, DOI 10.1039/b905841a; TENEYCK LF, 1973, ACTA CRYSTALLOGR A, VA 29, P183, DOI 10.1107/S0567739473000458; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r	45	230	235	3	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 13	2010	465	7295					248	U143		10.1038/nature08993	http://dx.doi.org/10.1038/nature08993			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594SS	20418861				2022-12-28	WOS:000277558500042
J	Navon, N; Nascimbene, S; Chevy, F; Salomon, C				Navon, N.; Nascimbene, S.; Chevy, F.; Salomon, C.			The Equation of State of a Low-Temperature Fermi Gas with Tunable Interactions	SCIENCE			English	Article							GROUND-STATE; SYSTEM	Interacting fermions are ubiquitous in nature, and understanding their thermodynamics is an important problem. We measured the equation of state of a two-component ultracold Fermi gas for a wide range of interaction strengths at low temperature. A detailed comparison with theories including Monte-Carlo calculations and the Lee-Huang-Yang corrections for low-density bosonic and fermionic superfluids is presented. The low-temperature phase diagram of the spin-imbalanced gas reveals Fermi liquid behavior of the partially polarized normal phase for all but the weakest interactions. Our results provide a benchmark for many-body theories and are relevant to other fermionic systems such as the crust of neutron stars.	[Navon, N.; Nascimbene, S.; Chevy, F.; Salomon, C.] Univ Paris 06, Ecole Normale Super, CNRS, Lab Kastler Brossel, F-75231 Paris, France	UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS)	Navon, N (corresponding author), Univ Paris 06, Ecole Normale Super, CNRS, Lab Kastler Brossel, 24 Rue Lhomond, F-75231 Paris, France.	navon@ens.fr	Nascimbene, Sylvain/L-7595-2016; Salomon, Carlos F/L-2167-2013	Nascimbene, Sylvain/0000-0002-3931-9436; Salomon, Carlos F/0000-0003-4474-0046; Navon, Nir/0000-0002-8917-3463	European Research Council; European Science Foundation (Euroquam); SCALA (Scalable Quantum Computing with Light and Atoms); Agence Nationale de la Recherche FABIOLA (Fermions and Bosons in Optical Lattices); Region Ile de France Institut Francilien de Recherche sur les Atomes Froids; Institut Universitaire de France	European Research Council(European Research Council (ERC)European Commission); European Science Foundation (Euroquam)(European Science Foundation (ESF)); SCALA (Scalable Quantum Computing with Light and Atoms); Agence Nationale de la Recherche FABIOLA (Fermions and Bosons in Optical Lattices)(French National Research Agency (ANR)); Region Ile de France Institut Francilien de Recherche sur les Atomes Froids(Region Ile-de-France); Institut Universitaire de France	We thank K. Jiang for participation in the early phase of the experimental work. We are grateful to X. Leyronas, C. Mora, Y. Castin, F. Werner, R. Combescot, J. Dalibard, F. Gerbier, and G. Shlyapnikov for stimulating discussions and critical comments on the manuscript. We thank S. Giorgini, P. Drummond, J. Drut, R. Haussmann, and W. Zwerger for providing us with their data. We acknowledge support from European Research Council, European Science Foundation (Euroquam), SCALA (Scalable Quantum Computing with Light and Atoms), Agence Nationale de la Recherche FABIOLA (Fermions and Bosons in Optical Lattices), Region Ile de France Institut Francilien de Recherche sur les Atomes Froids, and Institut Universitaire de France.	Altmeyer A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.040401; Astrakharchik GE, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.200404; BAKER GA, 1971, REV MOD PHYS, V43, P479, DOI 10.1103/RevModPhys.43.479; Braaten E, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.040401; Bulgac A, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.023625; Chang SY, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.043602; Combescot R, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/60007; Combescot R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.180402; Diener RB, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.023626; Haussmann R, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.023610; Ho TL, 2010, NAT PHYS, V6, P131, DOI 10.1038/NPHYS1477; Hu H, 2006, EUROPHYS LETT, V74, P574, DOI 10.1209/epl/i2006-10023-y; HU H, 2010, UNIVERSAL STRUCTURE; Inguscio M., 2008, ULTRACOLD FERMI GASE; LEE TD, 1957, PHYS REV, V105, P1119, DOI 10.1103/PhysRev.105.1119; Leggett A. J., 1980, Modern Trends in the Theory of Condensed Matter. Proceedings of the XVIth Karpacz Winter School of Theoretical Physics, P13; Leyronas X, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.170402; Lobo C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.200403; Lobo C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.100405; Nascimbene S, 2010, NATURE, V463, P1057, DOI 10.1038/nature08814; Nascimbene S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.170402; Pilati S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.030401; Prokof'ev N, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.020408; Schirotzek A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.230402; Schirotzek A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.140403; Shin Y, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.030401; Shin YI, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.070404; Shin YI, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.041603; Tan S, 2008, ANN PHYS-NEW YORK, V323, P2971, DOI 10.1016/j.aop.2008.03.005; Tan S, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.013636; WU TT, 1959, PHYS REV, V115, P1390, DOI 10.1103/PhysRev.115.1390	31	293	295	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 7	2010	328	5979					729	732		10.1126/science.1187582	http://dx.doi.org/10.1126/science.1187582			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592DZ	20395472	Green Submitted			2022-12-28	WOS:000277357100033
J	Chmiola, J; Largeot, C; Taberna, PL; Simon, P; Gogotsi, Y				Chmiola, John; Largeot, Celine; Taberna, Pierre-Louis; Simon, Patrice; Gogotsi, Yury			Monolithic Carbide-Derived Carbon Films for Micro-Supercapacitors	SCIENCE			English	Article							DOUBLE-LAYER CAPACITORS; ENERGY-STORAGE; ELECTROCHEMICAL CAPACITORS; SUBNANOMETER PORES; ELECTROLYTES; BATTERIES; DEVICES	Microbatteries with dimensions of tens to hundreds of micrometers that are produced by common microfabrication techniques are poised to provide integration of power sources onto electronic devices, but they still suffer from poor cycle lifetime, as well as power and temperature range of operation issues that are alleviated with the use of supercapacitors. There have been a few reports on thin-film and other micro-supercapacitors, but they are either too thin to provide sufficient energy or the technology is not scalable. By etching supercapacitor electrodes into conductive titanium carbide substrates, we demonstrate that monolithic carbon films lead to a volumetric capacity exceeding that of micro-and macroscale supercapacitors reported thus far, by a factor of 2. This study also provides the framework for integration of high-performance micro-supercapacitors onto a variety of devices.	[Chmiola, John; Gogotsi, Yury] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA; [Chmiola, John; Gogotsi, Yury] Univ Penn, AJ Drexel Nanotechnol Inst, Philadelphia, PA 19104 USA; [Largeot, Celine; Taberna, Pierre-Louis; Simon, Patrice] Univ Toulouse 3, CNRS, UMR 5085, Inter Univ Res & Engn Ctr Mat CIRIMAT, F-31062 Toulouse 4, France	University of Pennsylvania; Drexel University; University of Pennsylvania; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Gogotsi, Y (corresponding author), Univ Penn, Dept Mat Sci & Engn, 3231 Walnut St, Philadelphia, PA 19104 USA.	gogotsi@drexel.edu	SIMON, Patrice/N-6777-2016; Gogotsi, Yury/B-2167-2008	SIMON, Patrice/0000-0002-0461-8268; Gogotsi, Yury/0000-0001-9423-4032	NSF; Delegation Generale pour l'Armement; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [ER46473]; Partnership University Fund grant	NSF(National Science Foundation (NSF)); Delegation Generale pour l'Armement; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); Partnership University Fund grant	Electron microscopy and Raman spectroscopy analyses were conducted with the use of instruments in the Centralized Research Facility of the College of Engineering, Drexel University and Universite Paul Sabatier de Toulouse. J.C. was supported by Integrative Graduate Education and Research Traineeship (IGERT) and Graduate Research fellowships from the NSF, C. L. was supported by Delegation Generale pour l'Armement, and Y.G. was supported by the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under award ER46473. Collaboration between the participating universities was supported by a Partnership University Fund grant. Y.G. is also Founder and Chief Science Officer, Y-Carbon. The authors also have a related patent application no. 61/025058.	Ahn HJ, 2008, ELECTROCHEM COMMUN, V10, P1284, DOI 10.1016/j.elecom.2008.06.018; Arico AS, 2005, NAT MATER, V4, P366, DOI 10.1038/nmat1368; Armand M, 2008, NATURE, V451, P652, DOI 10.1038/451652a; Brodd RJ, 2004, J ELECTROCHEM SOC, V151, pK1, DOI 10.1149/1.1641042; Cambaz ZG, 2006, J AM CERAM SOC, V89, P509, DOI 10.1111/j.1551-2916.2005.00780.x; Chmiola J, 2006, SCIENCE, V313, P1760, DOI [10.1126/science.1132195, 10.1126/science/1132195]; Chmiola J, 2008, ANGEW CHEM INT EDIT, V47, P3392, DOI 10.1002/anie.200704894; Dash RK, 2005, MICROPOR MESOPOR MAT, V86, P50, DOI 10.1016/j.micromeso.2005.05.047; Ersoy DA, 2001, MATER RES INNOV, V5, P55, DOI 10.1007/s100190100136; Hoffman EN, 2008, MATER CHEM PHYS, V112, P587, DOI 10.1016/j.matchemphys.2008.06.006; Janes A, 2006, J ELECTROCHEM SOC, V153, pA113, DOI 10.1149/1.2135212; Kaempgen M, 2009, NANO LETT, V9, P1872, DOI 10.1021/nl8038579; Lee MJ, 2006, J ELECTROCERAM, V17, P639, DOI 10.1007/s10832-006-7777-z; Lee SW, 2009, J AM CHEM SOC, V131, P671, DOI 10.1021/ja807059k; Leis J, 2006, CARBON, V44, P2122, DOI 10.1016/j.carbon.2006.04.022; Lin R, 2009, J ELECTROCHEM SOC, V156, pA7, DOI 10.1149/1.3002376; Linden D., 2001, HDB BATTERIES; Long JW, 2004, CHEM REV, V104, P4463, DOI 10.1021/cr020740l; Miller JR, 2008, ELECTROCHEM SOC INTE, V17, P53; Mysyk R, 2009, ELECTROCHEM COMMUN, V11, P554, DOI 10.1016/j.elecom.2008.12.035; Naoi K, 2008, ELECTROCHEM SOC INTE, V17, P44; Pech D, 2010, J POWER SOURCES, V195, P1266, DOI 10.1016/j.jpowsour.2009.08.085; Pushparaj VL, 2007, P NATL ACAD SCI USA, V104, P13574, DOI 10.1073/pnas.0706508104; Ricketts BW, 2000, J POWER SOURCES, V89, P64, DOI 10.1016/S0378-7753(00)00387-6; Simon P, 2008, NAT MATER, V7, P845, DOI 10.1038/nmat2297; Sun W, 2009, MICROELECTRON ENG, V86, P1307, DOI 10.1016/j.mee.2008.12.010; Tanimura A, 2003, CHEM PHYS LETT, V378, P638, DOI 10.1016/S0009-2614(03)01336-8; Wang J, 2007, J PHYS CHEM C, V111, P14925, DOI 10.1021/jp074464w; Zheng JP, 1997, J ELECTROCHEM SOC, V144, P2417, DOI 10.1149/1.1837829	29	1104	1136	17	1066	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 23	2010	328	5977					480	483		10.1126/science.1184126	http://dx.doi.org/10.1126/science.1184126			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YR	20413497				2022-12-28	WOS:000276952400037
J	Proshkin, S; Rahmouni, AR; Mironov, A; Nudler, E				Proshkin, Sergey; Rahmouni, A. Rachid; Mironov, Alexander; Nudler, Evgeny			Cooperation Between Translating Ribosomes and RNA Polymerase in Transcription Elongation	SCIENCE			English	Article							CODON USAGE; ESCHERICHIA-COLI; EXPRESSION; MECHANISM; GROWTH; ATTENUATION; TERMINATION; GENOME; GENE; DNA	During transcription of protein-coding genes, bacterial RNA polymerase (RNAP) is closely followed by a ribosome that translates the newly synthesized transcript. Our in vivo measurements show that the overall elongation rate of transcription is tightly controlled by the rate of translation. Acceleration and deceleration of a ribosome result in corresponding changes in the speed of RNAP. Moreover, we found an inverse correlation between the number of rare codons in a gene, which delay ribosome progression, and the rate of transcription. The stimulating effect of a ribosome on RNAP is achieved by preventing its spontaneous backtracking, which enhances the pace and also facilitates readthrough of roadblocks in vivo. Such a cooperative mechanism ensures that the transcriptional yield is always adjusted to translational needs at different genes and under various growth conditions.	[Proshkin, Sergey; Nudler, Evgeny] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; [Proshkin, Sergey; Mironov, Alexander] State Res Inst Genet & Select Ind Microorganisms, Moscow 117545, Russia; [Rahmouni, A. Rachid] CNRS, Ctr Biophys Mol, F-45071 Orleans, France	New York University; National Research Centre - Kurchatov Institute; Institute of Genetics & Selection of Industrial Microorganisms; Centre National de la Recherche Scientifique (CNRS)	Nudler, E (corresponding author), NYU, Sch Med, Dept Biochem, New York, NY 10016 USA.	evgeny.nudler@nyumc.org	Proshkin, Sergey/G-2733-2017; Mironov, Alexander/G-8531-2013	Proshkin, Sergey/0000-0002-6116-4637; Nudler, Evgeny/0000-0002-8811-3071; Mironov, Alexander/0000-0003-3914-1380	NIH; Dynasty Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058750] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dynasty Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Hughes for the CH184 (SmP) strain. This work was supported by grants from the NIH and Dynasty Foundation (E.N.).	ADHYA S, 1978, ANNU REV BIOCHEM, V47, P967, DOI 10.1146/annurev.bi.47.070178.004535; Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; BOHMAN K, 1984, MOL GEN GENET, V198, P90, DOI 10.1007/BF00328706; CHAN CL, 1993, J MOL BIOL, V233, P25, DOI 10.1006/jmbi.1993.1482; Depken M, 2009, BIOPHYS J, V96, P2189, DOI 10.1016/j.bpj.2008.12.3918; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Elf J, 2003, SCIENCE, V300, P1718, DOI 10.1126/science.1083811; Epshtein V, 2003, EMBO J, V22, P4719, DOI 10.1093/emboj/cdg452; Epshtein V, 2003, SCIENCE, V300, P801, DOI 10.1126/science.1083219; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Henkin TM, 2002, BIOESSAYS, V24, P700, DOI 10.1002/bies.10125; Jansen R, 2003, NUCLEIC ACIDS RES, V31, P2242, DOI 10.1093/nar/gkg306; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Lavner Y, 2005, GENE, V345, P127, DOI 10.1016/j.gene.2004.11.035; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Nudler E, 2009, ANNU REV BIOCHEM, V78, P335, DOI 10.1146/annurev.biochem.76.052705.164655; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; RICHARDSON JP, 1991, CELL, V64, P1047, DOI 10.1016/0092-8674(91)90257-Y; RUUSALA T, 1984, EMBO J, V3, P2575, DOI 10.1002/j.1460-2075.1984.tb02176.x; Saeki H, 2009, MOL CELL, V35, P191, DOI 10.1016/j.molcel.2009.06.009; Steitz TA, 2008, NAT REV MOL CELL BIO, V9, P242, DOI 10.1038/nrm2352; Svetlov V, 2007, NUCLEIC ACIDS RES, V35, P5694, DOI 10.1093/nar/gkm600; VARENNE S, 1984, J MOL BIOL, V180, P549, DOI 10.1016/0022-2836(84)90027-5; VOGEL U, 1994, J BACTERIOL, V176, P2807, DOI 10.1128/JB.176.10.2807-2813.1994; YANOFSKY C, 1981, NATURE, V289, P751, DOI 10.1038/289751a0; Zhang G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005036	27	355	358	3	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 23	2010	328	5977					504	508		10.1126/science.1184939	http://dx.doi.org/10.1126/science.1184939			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YR	20413502	Green Accepted			2022-12-28	WOS:000276952400044
J	Reyes-Lamothe, R; Sherratt, DJ; Leake, MC				Reyes-Lamothe, Rodrigo; Sherratt, David J.; Leake, Mark C.			Stoichiometry and Architecture of Active DNA Replication Machinery in Escherichia coli	SCIENCE			English	Article							CLAMP-LOADER COMPLEX; POLYMERASE-III; PLASMA-MEMBRANE; TWEEZERS ASSAY; IN-VIVO; SINGLE; REPLISOME; PROTEIN; ELASTICITY; DYNAMICS	The multiprotein replisome complex that replicates DNA has been extensively characterized in vitro, but its composition and architecture in vivo is unknown. Using millisecond single-molecule fluorescence microscopy in living cells expressing fluorescent derivatives of replisome components, we have examined replisome stoichiometry and architecture. Active Escherichia coli replisomes contain three molecules of the replicative polymerase, rather than the historically accepted two. These are associated with three molecules of tau, a clamp loader component that trimerizes polymerase. Only two of the three sliding clamps are always associated with the core replisome. Single-strand binding protein has a broader spatial distribution than the core components, with 5 to 11 tetramers per replisome. This in vivo technique could provide single-molecule insight into other molecular machines.	[Reyes-Lamothe, Rodrigo; Sherratt, David J.; Leake, Mark C.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Leake, Mark C.] Univ Oxford, Dept Phys, Oxford OX1 3PU, England	University of Oxford; University of Oxford	Leake, MC (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.	m.leake1@physics.ox.ac.uk	Leake, Mark/C-1245-2011	Leake, Mark/0000-0002-1715-1249	Wellcome Trust; Royal Society; Conacyt; Clarendon postgraduate award	Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Clarendon postgraduate award	Supported by the Wellcome Trust and the Royal Society. M. C. L. is a Royal Society University Fellow and research fellow of Hertford College Oxford. R. R.-L. is a research fellow of New College Oxford and was supported by Conacyt and a Clarendon postgraduate award. We thank C. Possoz and C. Lesterlin for stimulating discussions, and we acknowledge National BioResource Project (NIG, Japan): E. coli for the provision of the holC and holD deletion strains.	ALBERTS BM, 1982, COLD SPRING HARB SYM, V47, P655, DOI 10.1101/SQB.1983.047.01.077; Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; BLINKOVA A, 1993, J BACTERIOL, V175, P6018, DOI 10.1128/JB.175.18.6018-6027.1993; BLINKOWA AL, 1990, NUCLEIC ACIDS RES, V18, P1725, DOI 10.1093/nar/18.7.1725; CHUNG SH, 1991, J NEUROSCI METH, V40, P71, DOI 10.1016/0165-0270(91)90118-J; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kazmirski SL, 2004, P NATL ACAD SCI USA, V101, P16750, DOI 10.1073/pnas.0407904101; Lamers MH, 2006, CELL, V126, P881, DOI 10.1016/j.cell.2006.07.028; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Leake MC, 2004, BIOPHYS J, V87, P1112, DOI 10.1529/biophysj.103.033571; Leake MC, 2003, FEBS LETT, V535, P55, DOI 10.1016/S0014-5793(02)03857-7; Lenn T, 2008, BIOCHEM SOC T, V36, P1032, DOI 10.1042/BST0361032; Lenn T, 2008, MOL MICROBIOL, V70, P1397, DOI 10.1111/j.1365-2958.2008.06486.x; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; McInerney P, 2007, MOL CELL, V27, P527, DOI 10.1016/j.molcel.2007.06.019; McInerney P, 2007, J BIOL CHEM, V282, P25903, DOI 10.1074/jbc.M703777200; Nossal NG, 2007, J BIOL CHEM, V282, P1098, DOI 10.1074/jbc.M606772200; Plank M, 2009, INTEGR BIOL-UK, V1, P602, DOI 10.1039/b907837a; Reyes-Lamothe R, 2008, CELL, V133, P90, DOI 10.1016/j.cell.2008.01.044; Simonetta KR, 2009, CELL, V137, P659, DOI 10.1016/j.cell.2009.03.044; Smith DA, 1998, PHILOS T R SOC B, V353, P1969, DOI 10.1098/rstb.1998.0348; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Xie XS, 2006, SCIENCE, V312, P228, DOI 10.1126/science.1127566; Yao NY, 2009, P NATL ACAD SCI USA, V106, P13236, DOI 10.1073/pnas.0906157106; Yuzhakov A, 1999, CELL, V96, P153, DOI 10.1016/S0092-8674(00)80968-X	27	259	265	2	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 23	2010	328	5977					498	501		10.1126/science.1185757	http://dx.doi.org/10.1126/science.1185757			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YR	20413500	Green Accepted			2022-12-28	WOS:000276952400042
J	Welsh, JA; Sharma, A; Abramson, JL; Vaccarino, V; Gillespie, C; Vos, MB				Welsh, Jean A.; Sharma, Andrea; Abramson, Jerome L.; Vaccarino, Viola; Gillespie, Cathleen; Vos, Miriam B.			Caloric Sweetener Consumption and Dyslipidemia Among US Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SUGARS; BEVERAGES; FOODS; DIET; NUTRIENTS; NUTRITION; FRUCTOSE; CHILDREN; HEALTH; LIPIDS	Context Dietary carbohydrates have been associated with dyslipidemia, a lipid profile known to increase cardiovascular disease risk. Added sugars (caloric sweeteners used as ingredients in processed or prepared foods) are an increasing and potentially modifiable component in the US diet. No known studies have examined the association between the consumption of added sugars and lipid measures. Objective To assess the association between consumption of added sugars and blood lipid levels in US adults. Design, Setting, and Participants Cross-sectional study among US adults (n=6113) from the National Health and Nutrition Examination Survey (NHANES) 1999-2006. Respondents were grouped by intake of added sugars using limits specified in dietary recommendations (<5% [reference group], 5%-<10%, 10%-<17.5%, 17.5%-<25%, and >= 25% of total calories). Linear regression was used to estimate adjusted mean lipid levels. Logistic regression was used to determine adjusted odds ratios of dyslipidemia. Interactions between added sugars and sex were evaluated. Main Outcome Measures Adjusted mean high-density lipoprotein cholesterol (HDL-C), geometric mean triglycerides, and mean low-density lipoprotein cholesterol (LDL-C) levels and adjusted odds ratios of dyslipidemia, including low HDL-C levels (<40 mg/dL for men; <50 mg/dL for women), high triglyceride levels (>= 150 mg/dL), high LDL-C levels (>130 mg/dL), or high ratio of triglycerides to HDL-C (>3.8). Results were weighted to be representative of the US population. Results A mean of 15.8% of consumed calories was from added sugars. Among participants consuming less than 5%, 5% to less than 17.5%, 17.5% to less than 25%, and 25% or greater of total energy as added sugars, adjusted mean HDL-C levels were, respectively, 58.7, 57.5, 53.7, 51.0, and 47.7 mg/dL (P<.001 for linear trend), geometric mean triglyceride levels were 105, 102, 111, 113, and 114 mg/dL (P<.001 for linear trend), and LDL-C levels modified by sex were 116, 115, 118, 121, and 123 mg/dL among women (P=.047 for linear trend). There were no significant trends in LDL-C levels among men. Among higher consumers (>= 10% added sugars) the odds of low HDL-C levels were 50% to more than 300% greater compared with the reference group (<5% added sugars). Conclusion In this study, there was a statistically significant correlation between dietary added sugars and blood lipid levels among US adults. JAMA. 2010; 303(15): 1490-1497	[Welsh, Jean A.; Sharma, Andrea; Vaccarino, Viola; Vos, Miriam B.] Emory Univ, Nutr & Hlth Sci Program, Grad Div Biol & Biomed Sci, Atlanta, GA 30322 USA; [Abramson, Jerome L.; Vaccarino, Viola] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Vaccarino, Viola] Emory Univ, Div Cardiol, Sch Med, Atlanta, GA 30322 USA; [Vos, Miriam B.] Emory Univ, Dept Pediat Gastroenterol Hepatol & Nutr, Sch Med, Atlanta, GA 30322 USA; [Welsh, Jean A.; Vos, Miriam B.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Sharma, Andrea] Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Atlanta, GA USA; [Gillespie, Cathleen] Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Atlanta, GA USA	Emory University; Emory University; Rollins School Public Health; Emory University; Emory University; Children's Healthcare of Atlanta (CHOA); Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Vos, MB (corresponding author), Emory Univ, Nutr & Hlth Sci Program, Grad Div Biol & Biomed Sci, 2015 Uppergate Dr NE, Atlanta, GA 30322 USA.	mvos@emory.edu	, Viola/AAW-5600-2020	Sharma, Andrea/0000-0003-0385-0011	National Institute of Diabetes and Digestive and Kidney Diseases [K23DK080953]; Children's Digestive Health and Nutrition Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK080953] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Children's Digestive Health and Nutrition Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr Vos reported that she is the author of and receives royalties from a book about childhood obesity and that she is supported in part by a career award from the National Institute of Diabetes and Digestive and Kidney Diseases (K23DK080953) and from the Children's Digestive Health and Nutrition Foundation. No other authors reported disclosures.	[Anonymous], 2005, DIETARY REFERENCE IN; BALLINGER RA, 1978, 382 USDA; CARLETON RA, 1991, CIRCULATION, V83, P2154, DOI 10.1161/01.CIR.83.6.2154; Centers for Disease Control and Prevention, NCHS RES ETH REV BOA; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention, KEY CONC NHANES SURV; Cleveland LE, 1997, AM J CLIN NUTR, V65, P1254; Cooney MT, 2009, J AM COLL CARDIOL, V54, P1209, DOI 10.1016/j.jacc.2009.07.020; Couillard B, 1999, ARTERIOSCL THROM VAS, V19, P2448; Dodd KW, 2006, J AM DIET ASSOC, V106, P1640, DOI 10.1016/j.jada.2006.07.011; *EUFIC, SUG OUR DIET; Frary CD, 2004, J ADOLESCENT HEALTH, V34, P56, DOI 10.1016/S1054-139X(03)00248-9; GLINSMANN WH, 1986, J NUTR, V116, pS1, DOI 10.1093/jn/116.suppl_11.S1; Grundy S. M., 1982, CIRCULATION, V65, P839, DOI DOI 10.1161/01.CIR.65.5.839; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; HALEY S, SUGAR BACKGROUNDER; Hanak V, 2004, AM J CARDIOL, V94, P219, DOI 10.1016/j.amjcard.2004.03.069; Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627; Johnson RK, 2001, J NUTR, V131, p2766S, DOI 10.1093/jn/131.10.2766S; Krebs-Smith SM, 2000, EUR J CLIN NUTR, V54, P281, DOI 10.1038/sj.ejcn.1600936; Krebs-Smith SM, 2001, J NUTR, V131, p527S, DOI 10.1093/jn/131.2.527S; Marshall TA, 2007, J AM DENT ASSOC, V138, P39, DOI 10.14219/jada.archive.2007.0019; Montonen J, 2007, J NUTR, V137, P1447, DOI 10.1093/jn/137.6.1447; *NCHS, LAB PROC MAN; Nishida C, 2004, PUBLIC HEALTH NUTR, V7, P245, DOI 10.1079/PHN2003592; Obarzanek E, 2001, AM J CLIN NUTR, V74, P80; Stanhope KL, 2009, J NUTR, V139, pS1236, DOI 10.3945/jn.109.106641; Thompson FE, 2009, J AM DIET ASSOC, V109, P1376, DOI 10.1016/j.jada.2009.05.002; US Department of Health and Human Services and US Department of Agriculture, 2005, DIET GUID AM; *USDA, NAT AGR LIB NAT NUTR; *USDA, 2006, MYPYRAMID EQ DAT USD; *USDA AGR RES SERV, 2005, USDA DAT ADD SUG CON; *USDA EC RES SERV, NAT AGR LIB NAT NUTR; VANHORN LV, 1991, AM J EPIDEMIOL, V133, P9, DOI 10.1093/oxfordjournals.aje.a115807; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Wells H.F., 2008, EC INFORM B; Willett W., 2012, NUTR EPIDEMIOLOGY	37	178	184	1	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2010	303	15					1490	1497		10.1001/jama.2010.449	http://dx.doi.org/10.1001/jama.2010.449			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585SJ	20407058	Green Accepted, Bronze			2022-12-28	WOS:000276849000025
J	Boppana, SB; Ross, SA; Novak, Z; Shimamura, M; Tolan, RW; Palmer, AL; Ahmed, A; Michaels, MG; Sanchez, PJ; Bernstein, DI; Britt, WJ; Fowler, KB				Boppana, Suresh B.; Ross, Shannon A.; Novak, Zdenek; Shimamura, Masako; Tolan, Robert W., Jr.; Palmer, April L.; Ahmed, Amina; Michaels, Marian G.; Sanchez, Pablo J.; Bernstein, David I.; Britt, William J.; Fowler, Karen B.		Natl Inst Deafness Other Commun; CMV Hearing Multictr Screening	Dried Blood Spot Real-time Polymerase Chain Reaction Assays to Screen Newborns for Congenital Cytomegalovirus Infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SENSORINEURAL HEARING-LOSS; CMV INFECTION; DNA DETECTION; FILTER-PAPER; RAPID DETECTION; VIRAL-LOAD; CHILDREN; DISEASE; VIRUS; PREVALENCE	Context Reliable methods to screen newborns for congenital cytomegalovirus (CMV) infection are needed for identification of infants at increased risk of hearing loss. Since dried blood spots (DBS) are routinely collected for metabolic screening from all newborns in the United States, there has been interest in using DBS polymerase chain reaction (PCR)-based methods for newborn CMV screening. Objective To determine the diagnostic accuracy of DBS real-time PCR assays for newborn CMV screening. Design, Setting, and Participants Between March 2007 and May 2008, infants born at 7 US medical centers had saliva specimens tested by rapid culture for early antigen fluorescent foci. Results of saliva rapid culture were compared with a single-primer (March 2007-December 2007) and a 2-primer DBS real-time PCR (January 2008-May 2008). Infants whose specimens screened positive on rapid culture or PCR had congenital infection confirmed by the reference standard method with rapid culture testing on saliva or urine. Main Outcome Measures Sensitivity, specificity, and positive and negative likelihood ratios (LRs) of single-primer and 2-primer DBS real-time PCR assays for identifying infants with confirmed congenital CMV infection. Results Congenital CMV infection was confirmed in 92 of 20 448 (0.45%; 95% confidence interval [CI], 0.36%-0.55%) infants. Ninety-one of 92 infants had positive results on saliva rapid culture. Of the 11 422 infants screened using the single-primer DBS PCR, 17 of 60 (28%) infants had positive results with this assay, whereas, among the 9026 infants screened using the 2-primer DBS PCR, 11 of 32 (34%) screened positive. The single-primer DBS PCR identified congenital CMV infection with a sensitivity of 28.3% (95% CI, 17.4%-41.4%), specificity of 99.9% (95% CI, 99.9%-100%), positive LR of 803.7 (95% CI, 278.7-2317.9), and negative LR of 0.7 (95% CI, 0.60.8). The positive and negative predictive values of the single-primer DBS PCR were 80.9% (95% CI, 58.1%-94.5%) and 99.6% (95% CI, 99.5%-99.7%), respectively. The 2-primer DBS PCR assay identified infants with congenital CMV infection with a sensitivity of 34.4% (95% CI, 18.6%-53.2%), specificity of 99.9% (95% CI, 99.9%100.0%), positive LR of 3088.9 (95% CI, 410.8-23 226.7), and negative LR of 0.7 (95% CI, 0.5-0.8). The positive and negative predictive values of the 2-primer DBS PCR were 91.7% (95% CI, 61.5%-99.8%) and 99.8% (95% CI, 99.6%-99.9%), respectively. Conclusion Among newborns, CMV testing with DBS real-time PCR compared with saliva rapid culture had low sensitivity, limiting its value as a screening test. JAMA. 2010; 303(14): 1375-1382	[Boppana, Suresh B.; Ross, Shannon A.; Novak, Zdenek; Shimamura, Masako; Britt, William J.; Fowler, Karen B.] UAB, Dept Pediat, Birmingham, AL 35233 USA; [Fowler, Karen B.] UAB, Dept Epidemiol, Birmingham, AL 35233 USA; [Boppana, Suresh B.; Britt, William J.] UAB, Dept Microbiol, Birmingham, AL 35233 USA; [Britt, William J.] UAB, Dept Neurobiol, Birmingham, AL 35233 USA; [Tolan, Robert W., Jr.] St Peters Univ Hosp, Dept Pediat, New Brunswick, NJ USA; [Palmer, April L.] Univ Mississippi, Med Ctr, Dept Pediat, Jackson, MS USA; [Ahmed, Amina] Carolinas Med Ctr, Dept Pediat, Charlotte, NC 28203 USA; [Michaels, Marian G.] Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15260 USA; [Michaels, Marian G.] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; [Sanchez, Pablo J.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Bernstein, David I.] Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH USA; [Bernstein, David I.] Univ Cincinnati, Cincinnati, OH USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Saint Peter's University Hospital; University of Mississippi; University of Mississippi Medical Center; Carolinas Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Southwestern Medical Center Dallas; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Boppana, SB (corresponding author), UAB, Dept Pediat, CHB 114,1600 6th Ave S, Birmingham, AL 35233 USA.	sboppana@peds.uab.edu	Mejias, Maria Asuncion/E-3659-2011; Mejias, Asuncion/AAC-5998-2019	Mejias, Asuncion/0000-0002-5983-8006; Arora, Nitin/0000-0001-6840-4333	National Institute on Deafness and Other Communication Disorders [N01 DC50008]	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by a contract from the National Institute on Deafness and Other Communication Disorders (N01 DC50008).	BALCAREK KB, 1993, J INFECT DIS, V167, P1433, DOI 10.1093/infdis/167.6.1433; Barbi M, 2006, PEDIATR INFECT DIS J, V25, P156, DOI 10.1097/01.inf.0000199261.98769.29; Barbi M, 1998, EUR J EPIDEMIOL, V14, P791, DOI 10.1023/A:1007554726449; Barbi M, 2000, J CLIN VIROL, V17, P159, DOI 10.1016/S1386-6532(00)00089-5; Barbi M, 1996, CLIN DIAGN VIROL, V6, P27, DOI 10.1016/0928-0197(96)00228-0; Barbi M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-2; Boppana SB, 2005, J PEDIATR-US, V146, P817, DOI 10.1016/j.jpeds.2005.01.059; BOPPANA SB, 1992, PEDIATR INFECT DIS J, V11, P93, DOI 10.1097/00006454-199202000-00007; BOPPANA SB, 1992, J CLIN MICROBIOL, V30, P721, DOI 10.1128/JCM.30.3.721-723.1992; Bradford RD, 2005, J INFECT DIS, V191, P227, DOI 10.1086/426456; Busa J, 2007, PEDIATRICS, V120, P898, DOI 10.1542/peds.2007-2333; Dahle A J, 2000, J Am Acad Audiol, V11, P283; DEMMLER GJ, 1991, REV INFECT DIS, V13, P315, DOI 10.1093/clinids/13.2.315; Emery VC, 2000, LANCET, V355, P2032, DOI 10.1016/S0140-6736(00)02350-3; Engman ML, 2008, SCAND J INFECT DIS, V40, P935, DOI 10.1080/00365540802308431; FOWLER KB, 1993, J INFECT DIS, V168, P552, DOI 10.1093/infdis/168.3.552; Fowler KB, 1997, J PEDIATR-US, V130, P624, DOI 10.1016/S0022-3476(97)70248-8; GLEAVES CA, 1985, J CLIN MICROBIOL, V21, P217, DOI 10.1128/JCM.21.2.217-221.1985; Johansson PJH, 1997, SCAND J INFECT DIS, V29, P465, DOI 10.3109/00365549709011855; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Kimberlin DW, 2008, J INFECT DIS, V197, P836, DOI 10.1086/528376; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Mussi-Pinhata MM, 2009, CLIN INFECT DIS, V49, P522, DOI 10.1086/600882; *NAT I DEAFN OTH C, 2002, REP REC NIDCD WORKSH; Ogawa H, 2007, J INFECT DIS, V195, P782, DOI 10.1086/511981; Ross SA, 2006, J PEDIATR-US, V148, P332, DOI 10.1016/j.jpeds.2005.09.003; Ross SA, 2009, PEDIATR INFECT DIS J, V28, P588, DOI 10.1097/INF.0b013e3181979a27; Scanga L, 2006, J MOL DIAGN, V8, P240, DOI 10.2353/jmoldx.2006.050075; SHIBATA M, 1994, J VIROL METHODS, V46, P279, DOI 10.1016/0166-0934(94)90111-2; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Soetens O, 2008, J CLIN MICROBIOL, V46, P943, DOI 10.1128/JCM.01391-07; Spector SA, 1999, J VIROL, V73, P7027, DOI 10.1128/JVI.73.8.7027-7030.1999; Stagno SBW, 2006, INFECT DIS FETUS NEW, P389; Stehel EK, 2008, PEDIATRICS, V121, P970, DOI 10.1542/peds.2006-3441; THIELE GM, 1987, J VIROL METHODS, V16, P327, DOI 10.1016/0166-0934(87)90018-8; WILLIAMSON WD, 1992, PEDIATRICS, V90, P862; Yamagishi Y, 2006, J MED VIROL, V78, P923, DOI 10.1002/jmv.20642; Yamamoto AY, 2006, J CLIN VIROL, V36, P228, DOI 10.1016/j.jcv.2006.03.011; Yamamoto AY, 2001, J VIROL METHODS, V97, P159, DOI 10.1016/S0166-0934(01)00347-0	39	236	245	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2010	303	14					1375	1382		10.1001/jama.2010.423	http://dx.doi.org/10.1001/jama.2010.423			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582KX	20388893	Green Accepted, Bronze			2022-12-28	WOS:000276597300022
J	Prasher, R				Prasher, Ravi			Graphene Spreads the Heat	SCIENCE			English	Editorial Material							FILMS		Intel Corp, Chandler, AZ 85226 USA	Intel Corporation	Prasher, R (corresponding author), Intel Corp, 5000 W Chandler Blvd, Chandler, AZ 85226 USA.	ravi.s.prasher@intel.com						BALANDIN AA, 2009, IEEE SPECTRUM    OCT; Balandin AA, 2008, NANO LETT, V8, P902, DOI 10.1021/nl0731872; Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877; Geringer V, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.076102; Klemens PG, 2001, INT J THERMOPHYS, V22, P265, DOI 10.1023/A:1006776107140; Lin YM, 2010, SCIENCE, V327, P662, DOI 10.1126/science.1184289; Mahajan R, 2006, P IEEE, V94, P1476, DOI 10.1109/JPROC.2006.879800; Majumdar A, 2009, NAT NANOTECHNOL, V4, P214, DOI 10.1038/nnano.2009.65; Nika DL, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3136860; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Prasher R, 2006, P IEEE, V94, P1571, DOI 10.1109/JPROC.2006.879796; Seol JH, 2010, SCIENCE, V328, P213, DOI 10.1126/science.1184014; Yang Y, 2004, APPL PHYS LETT, V84, P3121, DOI 10.1063/1.1713033; Yu CH, 2005, NANO LETT, V5, P1842, DOI 10.1021/nl051044e	14	186	195	1	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 9	2010	328	5975					185	186		10.1126/science.1188998	http://dx.doi.org/10.1126/science.1188998			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580OU	20378809				2022-12-28	WOS:000276459600033
J	Whiting, PF; Smidt, N; Sterne, JAC; Harbord, R; Burton, A; Burke, M; Beynon, R; Ben-Shlomo, Y; Axford, J; Dieppe, P				Whiting, Penny F.; Smidt, Nynke; Sterne, Jonathan A. C.; Harbord, Roger; Burton, Anya; Burke, Margaret; Beynon, Rebecca; Ben-Shlomo, Yoav; Axford, John; Dieppe, Paul			Systematic Review: Accuracy of Anti-Citrullinated Peptide Antibodies for Diagnosing Rheumatoid Arthritis	ANNALS OF INTERNAL MEDICINE			English	Review							JUVENILE IDIOPATHIC ARTHRITIS; PRIMARY SJOGRENS-SYNDROME; CCP ANTIBODIES; ANTIKERATIN ANTIBODIES; CLINICAL-SIGNIFICANCE; PREDICTIVE-VALUE; POLYMYALGIA-RHEUMATICA; PSORIATIC-ARTHRITIS; UNDIFFERENTIATED ARTHRITIS; FILAGGRIN ANTIBODIES	Background: Early recognition and treatment of rheumatoid arthritis is important to prevent irreversible joint damage. Anti-citrullinated peptide antibodies (ACPA) have been suggested for early diagnosis. Purpose: To compare the accuracy of ACPA and rheumatoid factor in diagnosing rheumatoid arthritis in patients with early symptoms of the disease. Data Sources: 10 medical databases from inception to September 2009, with no language or publication restrictions, and references of included studies. Study Selection: Two independent reviewers screened searches. Full articles were assessed by one reviewer and checked by a second reviewer to identify studies that reported 2 x 2 data on ACPA for the diagnosis of rheumatoid arthritis (by 1987 American College of Rheumatology criteria). Data Extraction: One reviewer abstracted data on patient characteristics, ACPA details, and 2 x 2 data and assessed study quality by using the QUADAS tool. A second reviewer checked extractions. Data Synthesis: 151 studies were included, with considerable heterogeneity in sensitivity (range, 12% to 93%) and specificity (range, 63% to 100%). In cohort studies that investigated second-generation anti-cyclic citrullinated peptide antibodies (anti-CCP2) in patients with early rheumatoid arthritis (<2 years), summary sensitivity and specificity were 57% (95% CI, 51% to 63%) and 96% (CI, 93% to 97%), respectively. Case-control and cross-sectional studies and studies of patients with established rheumatoid arthritis all overestimated sensitivity. Anti-CCP2 had greater specificity than rheumatoid factor (96% vs. 86%), with similar sensitivity. Evidence was insufficient to ascertain whether the combination of anti-CCP2 and rheumatoid factor provides additional benefit over anti-CCP2 alone. Limitations: Most studies used a diagnostic case-control design, which overestimated sensitivity. Items relating to study quality were rarely reported. Publication bias could not be assessed. Conclusion: Anti-CCP2 should be included in the work-up of patients with early symptoms of rheumatoid arthritis.	[Whiting, Penny F.] Univ Bristol, Dept Social Med, Bristol BS8 2PS, Avon, England; Univ Exeter, Exeter EX1 2LU, Devon, England; St Georges Univ London, London SW17 0QT, England; St Georges Healthcare Trust, Sir Joseph Hotung Ctr, London SW17 0QT, England; Leiden Univ, Med Ctr, NL-2300 RC Leiden, Netherlands	University of Bristol; University of Exeter; St Georges University London; St Georges University London; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Whiting, PF (corresponding author), Univ Bristol, Dept Social Med, Canynge Hall,39 Whatley Rd, Bristol BS8 2PS, Avon, England.	penny.whiting@bristol.ac.uk	Sterne, Jonathan/Z-3106-2019; Harbord, Roger M/A-8699-2008; Ben-Shlomo, Yoav/ABD-2004-2021	Sterne, Jonathan/0000-0001-8496-6053; Harbord, Roger M/0000-0002-2257-8271; Ben-Shlomo, Yoav/0000-0001-6648-3007; Whiting, Penny/0000-0003-1138-5682; Burton, Anya/0000-0002-4416-0538	United Kingdom Medical Research Council; Medical Research Council [G0801405] Funding Source: researchfish; MRC [G0801405] Funding Source: UKRI	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Grant Support: By the United Kingdom Medical Research Council.	Abdel-Nasser AM, 2008, SCAND J RHEUMATOL, V37, P329, DOI 10.1080/03009740802116208; Aho K, 1999, SCAND J RHEUMATOL, V28, P113; Aigner E, 2007, ANN RHEUM DIS, V66, P1249, DOI 10.1136/ard.2007.071621; Aleksandrova EN, 2004, TERAPEVT ARKH, V76, P64; Alexiou I, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-37; Amezcua-Guerra LM, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2036; Anzilotti C, 2007, RHEUMATOLOGY, V46, P1579, DOI 10.1093/rheumatology/kem193; Aotsuka S, 2005, CLIN EXP RHEUMATOL, V23, P475; Aridogan BC, 2008, MIKROBIYOL BUL, V42, P669; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Ates A, 2007, CLIN RHEUMATOL, V26, P499, DOI 10.1007/s10067-006-0309-z; Atta AM, 2007, J AUTOIMMUN, V28, P55, DOI 10.1016/j.jaut.2006.12.001; Baeten D, 2004, ARTHRITIS RHEUM, V50, P2931, DOI 10.1002/art.20476; BAKY MSA, 2006, ARTHRITIS RHEUM, V54, pS631; Banal F, 2009, ANN RHEUM DIS, V68, P1184, DOI 10.1136/ard.2008.093187; Bang H, 2007, ARTHRITIS RHEUM-US, V56, P2503, DOI 10.1002/art.22817; Bas S, 2000, RHEUMATOLOGY, V39, P1082, DOI 10.1093/rheumatology/39.10.1082; Bas S, 2003, RHEUMATOLOGY, V42, P677, DOI 10.1093/rheumatology/keg184; Bas S, 2002, RHEUMATOLOGY, V41, P809, DOI 10.1093/rheumatology/41.7.809; Bassyouni IH, 2009, CLIN CHEM LAB MED, V47, P842, DOI 10.1515/CCLM.2009.189; Bizzaro N, 2001, CLIN CHEM, V47, P1089; Boer A K, 2008, Ned Tijdschr Geneeskd, V152, P91; Bongi SM, 2004, AUTOIMMUNITY, V37, P495, DOI 10.1080/08916930400011965; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Candia L, 2006, JCR-J CLIN RHEUMATOL, V12, P226, DOI 10.1097/rhu.0000242779.73390.51; Caro-Oleas JL, 2007, CLIN CHEM LAB MED, V45, P1396, DOI 10.1515/CCLM.2007.294; Ceccato F, 2006, CLIN RHEUMATOL, V25, P854, DOI 10.1007/s10067-005-0188-8; Chibnik LB, 2009, J RHEUMATOL, V36, P706, DOI 10.3899/jrheum.080895; Cho SY, 2008, KOREAN J LAB MED, V28, P39, DOI 10.3343/kjlm.2008.28.1.39; Choi KH, 2005, EXP MOL MED, V37, P546, DOI 10.1038/emm.2005.67; Choi SW, 2005, J KOREAN MED SCI, V20, P473, DOI 10.3346/jkms.2005.20.3.473; Coenen D, 2007, CLIN CHEM, V53, P498, DOI 10.1373/clinchem.2006.078063; Combe B, 2007, ANN RHEUM DIS, V66, P34, DOI 10.1136/ard.2005.044354; Cruyssen BV, 2008, ANN RHEUM DIS, V67, P542, DOI 10.1136/ard.2007.071654; DAMJANOVSKA L, 2007, J MED BIOCHEM, V26, P285; De Rycke L, 2004, ANN RHEUM DIS, V63, P1587, DOI 10.1136/ard.2003.017574; de Seny D, 2005, ARTHRITIS RHEUM-US, V52, P3801, DOI 10.1002/art.21607; Dejaco C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2008; Devauchelle-Pensec V, 2001, JOINT BONE SPINE, V68, P306, DOI 10.1016/S1297-319X(01)00287-1; DOSSANTOS W, 1997, REV BRAS REUMATOL, V37, P251; Dubucquoi S, 2004, ANN RHEUM DIS, V63, P415, DOI 10.1136/ard.2003.008623; dos Anjos LME, 2009, CLIN RHEUMATOL, V28, P153, DOI 10.1007/s10067-008-0999-5; ERRE GL, 2006, TRENDS MED, V6, P105; Fernandez-Suarez A, 2005, CLIN CHEM LAB MED, V43, P1234, DOI 10.1515/CCLM.2005.214; Ferraro-Peyret C, 2002, J RHEUMATOL, V29, P276; Fusconi M, 2005, ALIMENT PHARM THER, V22, P951, DOI 10.1111/j.1365-2036.2005.02686.x; Galati S, 2008, ANN BIOL CLIN-PARIS, V66, P157, DOI 10.1684/abc.2008.0216; Gao IK, 2005, ANN RHEUM DIS, V64, P1516, DOI 10.1136/ard.2005.035444; Garcia-Berrocal B, 2005, CLIN CHIM ACTA, V354, P123, DOI 10.1016/j.cccn.2004.11.025; Girelli F, 2004, Eur Ann Allergy Clin Immunol, V36, P127; Goldbach-Mansky R, 2000, ARTHRITIS RES, V2, P236, DOI 10.1186/ar93; Grillo ICC, 2003, ARTHRITIS RHEUM, V48, P3633; [郭雨凡 GUO Yufan], 2006, [江苏医药, Jiangsu medical Journal], V32, P112; Gupta Rajiva, 2009, Indian J Med Sci, V63, P92; Gyorgy B, 2006, INT J BIOCHEM CELL B, V38, P1662, DOI 10.1016/j.biocel.2006.03.008; Harbord RM, 2008, J CLIN EPIDEMIOL, V61, P1095, DOI 10.1016/j.jclinepi.2007.09.013; Harbord RM, 2007, BIOSTATISTICS, V8, P239, DOI 10.1093/biostatistics/kxl004; Harbord RM, 2009, STATA J, V9, P211, DOI 10.1177/1536867X0900900203; Havemose-Poulsen A, 2006, J PERIODONTOL, V77, P280, DOI 10.1902/jop.2006.050051; Hayashi Nobuhide, 2003, Rinsho Byori, V51, P1030; Heidari B, 2007, RHEUMATOLOGY, V46, pI142; Heidari B, 2006, RHEUMATOLOGY, V45, pI103; Herold M, 2005, Clin Dev Immunol, V12, P131, DOI 10.1080/14767050500134217; Hill JA, 2006, J RHEUMATOL, V33, P2115; Hitchon CA, 2004, J RHEUMATOL, V31, P2336; Hoffman IEA, 2005, CLIN CHEM, V51, P261; Hyrich KL, 2008, BRIT MED J, V336, P215, DOI 10.1136/bmj.39381.597454.AE; Inanc N, 2007, CLIN RHEUMATOL, V26, P17, DOI 10.1007/s10067-006-0214-5; Innala L, 2008, J RHEUMATOL, V35, P1002; Ioan-Facsinay A, 2008, ARTHRITIS RHEUM-US, V58, P3000, DOI 10.1002/art.23763; JIANG Z, 2009, ZHONGGUO WUZHEN XUE, V1, P6; Jorgensen KT, 2008, ANN RHEUM DIS, V67, P860, DOI 10.1136/ard.2007.073825; Kamali S, 2005, CLIN RHEUMATOL, V24, P673, DOI 10.1007/s10067-005-1104-y; Karayev D, 2003, ARTHRITIS RHEUM, V48, P3654; Kastbom A, 2004, ANN RHEUM DIS, V63, P1085, DOI 10.1136/ard.2003.016808; Kelly P, 2007, CLIN CHEM, V53, pA148; Kim KE, 2008, KOREAN J LAB MED, V28, P457, DOI 10.3343/kjlm.2008.28.6.457; Kitahara K, 2008, ANN RHEUM DIS, V67, P1059, DOI 10.1136/ard.2007.082826; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Koivula MK, 2008, RHEUMATOLOGY, V47, P656, DOI 10.1093/rheumatology/ken092; Koivula MK, 2007, ANN RHEUM DIS, V66, P1450, DOI 10.1136/ard.2006.062919; Korkmaz C, 2006, CLIN BIOCHEM, V39, P961, DOI 10.1016/j.clinbiochem.2006.06.004; Kudo-Tanaka E, 2007, CLIN RHEUMATOL, V26, P1627, DOI 10.1007/s10067-007-0558-5; Kvien TK, 2004, PHARMACOECONOMICS, V22, P1, DOI 10.2165/00019053-200422001-00002; Kwok JSY, 2005, SCAND J RHEUMATOL, V34, P359, DOI 10.1080/03009740510026634; KYRIAZIS NC, 2005, ANN RHEUM DIS, V64, P172; Lee DM, 2003, ANN RHEUM DIS, V62, P870, DOI 10.1136/ard.62.9.870; Leeflang MMG, 2006, J CLIN EPIDEMIOL, V59, P234, DOI 10.1016/j.jclinepi.2005.07.014; Lemos A, 2007, ACTA REUMATOL PORT, V32, P345; Levesque MC, 2009, ARTHRITIS RHEUM-US, V60, P2211, DOI 10.1002/art.24720; Liao KP, 2008, ANN RHEUM DIS, V67, P1557, DOI 10.1136/ard.2007.082339; Lim MK, 2009, J RHEUMATOL, V36, P712, DOI 10.3899/jrheum.080653; Limaye S, 2005, JCR-J CLIN RHEUMATOL, V11, P150, DOI 10.1097/01.rhu.0000164818.98410.2f; Liu FC, 2008, CLIN RHEUMATOL, V27, P463, DOI 10.1007/s10067-007-0729-4; Liu X, 2009, J RHEUMATOL, V36, P1136, DOI 10.3899/jrheum.080796; Lopez-Hoyos M, 2004, RHEUMATOLOGY, V43, P655, DOI 10.1093/rheumatology/keh143; Lopez-Longo FJ, 2006, J RHEUMATOL, V33, P1476; Lundberg K, 2008, ARTHRITIS RHEUM-US, V58, P3009, DOI 10.1002/art.23936; Marrone M, 2007, REUMATISMO, V59, P20, DOI 10.4081/reumatismo.2007.20; Merlini G, 2005, ANN NY ACAD SCI, V1050, P243, DOI 10.1196/annals.1313.025; Mettler S, 2003, ANN RHEUM DIS, V62, P385; Miyamura Tomoya, 2009, Nihon Rinsho Meneki Gakkai Kaishi, V32, P102; Mori S, 2009, CLIN RHEUMATOL, V28, P277, DOI 10.1007/s10067-008-1035-5; Mutlu N, 2009, J RHEUMATOL, V36, P491, DOI 10.3899/jrheum.080656; Nakamura H, 2005, SCAND J RHEUMATOL, V34, P489, DOI 10.1080/03009740510026706; Narvaez J, 2008, SEMIN ARTHRITIS RHEU, V38, P101, DOI 10.1016/j.semarthrit.2007.10.012; Nell VPK, 2005, ANN RHEUM DIS, V64, P1731, DOI 10.1136/ard.2005.035691; Nicoloudi A, 2007, IMMUNO-ANAL BIOL SPE, V22, P167, DOI 10.1016/j.immbio.2007.02.007; Nielen MM, 2004, ARTHRITIS RHEUM, V50, pS162; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; NIENHUIS RL, 1964, ANN RHEUM DIS, V23, P302, DOI 10.1136/ard.23.4.302; Nikolaisen C, 2007, SCAND J RHEUMATOL, V36, P97, DOI 10.1080/03009740600958538; Nishimura K, 2007, ANN INTERN MED, V146, P797, DOI 10.7326/0003-4819-146-11-200706050-00008; Novikov A. A., 2008, Klinicheskaya Laboratornaya Diagnostika, P27; Panchagnula R, 2006, JCR-J CLIN RHEUMATOL, V12, P172, DOI 10.1097/01.rhu.0000230483.66042.28; Parodi A, 2005, ACTA DERM-VENEREOL, V85, P253, DOI 10.1080/00015550510025560; PENGFEI C, 2005, WUHAN DAXUE XUEBAO Y, V26, P529; Perez T, 2002, LETT PEPT SCI, V9, P291, DOI 10.1023/A:1024651830455; Pikner R, 2008, CHEM LISTY, V102, P997; Qing YF, 2009, LUPUS, V18, P713, DOI 10.1177/0961203309102817; Quinn MA, 2006, RHEUMATOLOGY, V45, P478, DOI 10.1093/rheumatology/kei203; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Raza K, 2005, J RHEUMATOL, V32, P231; Reitsma JB., 2009, COCHRANE HDB SYSTEMA; Ribeiro SLE, 2008, BRAZ J MED BIOL RES, V41, P1005, DOI 10.1590/S0100-879X2008001100010; Riedemann JP, 2005, CLIN EXP RHEUMATOL, V23, pS69; Riley RD, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-3; Rodriguez-Mahou M, 2006, ARTHRIT RHEUM-ARTHR, V55, P657, DOI 10.1002/art.22089; Roland PN, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2570; Rutjes Anne W S, 2006, CMAJ, V174, P469, DOI 10.1503/cmaj.050090; Salvador G, 2003, RHEUMATOLOGY, V42, P972, DOI 10.1093/rheumatology/keg268; Samanci N, 2005, J NATL MED ASSOC, V97, P1120; Santiago M, 2008, CLIN RHEUMATOL, V27, P77, DOI 10.1007/s10067-007-0656-4; Sauerland U, 2005, ANN NY ACAD SCI, V1050, P314, DOI 10.1196/annals.1313.033; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; Schellekens GA, 2000, ARTHRITIS RHEUM-US, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3; SEDOVA L, 2005, CESKA REVMATOLOGIE, V13, P79; Sene D, 2006, ANN RHEUM DIS, V65, P394, DOI 10.1136/ard.2005.038042; Sghiri R, 2008, RHEUMATOL INT, V29, P59, DOI 10.1007/s00296-008-0614-8; Sghiri R, 2007, RHEUMATOL INT, V27, P1125, DOI 10.1007/s00296-007-0351-4; SHARIF SK, 2007, APLAR J RHEUMATOL, V10, P121; Shibata S, 2009, J DERMATOL SCI, V53, P34, DOI 10.1016/j.jdermsci.2008.06.008; Shmerling RH, 2009, ARCH INTERN MED, V169, P9, DOI 10.1001/archinternmed.2008.522; Silva Aldifran Ferreira da, 2006, Rev. Bras. Reumatol., V46, P174, DOI 10.1590/S0482-50042006000300003; Silveira IG, 2007, CLIN RHEUMATOL, V26, P1883, DOI 10.1007/s10067-007-0601-6; SIMON M, 1993, J CLIN INVEST, V92, P1387, DOI 10.1172/JCI116713; Snijders GF, 2008, SCAND J RHEUMATOL, V37, P151, DOI 10.1080/03009740701867331; Soriano ER, 2008, RHEUMATOLOGY, V47, pII107; Spadaro A, 2006, REUMATISMO, V58, P116, DOI 10.4081/reumatismo.2006.116; Sutton AJ, 2008, MED DECIS MAKING, V28, P650, DOI 10.1177/0272989X08324036; Suzuki K, 2003, SCAND J RHEUMATOL, V32, P197, DOI 10.1080/03009740310003677; Takasaki Yoshinari, 2004, Mod Rheumatol, V14, P367, DOI 10.1007/s10165-004-0325-2; Tamai M, 2006, ANN RHEUM DIS, V65, P134, DOI 10.1136/ard.2005.043075; Tamai M, 2009, ARTHRIT RHEUM-ARTHR, V61, P772, DOI 10.1002/art.24711; Tampoia M, 2005, CLIN CHIM ACTA, V355, P137, DOI 10.1016/j.cccn.2004.12.017; Tobon GJ, 2005, ANN RHEUM DIS, V64, P791, DOI 10.1136/ard.2004.029603; Tuchocka-Piotrowska A, 2005, ANN RHEUM DIS, V64, P554; Union A, 2002, ARTHRITIS RHEUM, V46, P1185, DOI 10.1002/art.10229; VALLADARES GC, 2003, QUIMICA CLIN, V22, P397; Vallbracht I, 2003, ANN RHEUM DIS, V62, P159; van der Linden MPM, 2009, ARTHRITIS RHEUM-US, V60, P2232, DOI 10.1002/art.24716; van Gaalen FA, 2005, ANN RHEUM DIS, V64, P1510, DOI 10.1136/ard.2004.035089; Vasiliauskiene L, 2001, ANN RHEUM DIS, V60, P459, DOI 10.1136/ard.60.5.459; Garcia VV, 2009, REUMATOL CLIN, V5, P115, DOI 10.1016/j.reuma.2008.09.001; Vincent C, 1999, ANN RHEUM DIS, V58, P42, DOI 10.1136/ard.58.1.42; Vincent C, 2002, ARTHRITIS RHEUM, V46, P2051, DOI 10.1002/art.10436; Vittecoq O, 2001, JOINT BONE SPINE, V68, P144, DOI 10.1016/S1297-319X(00)00244-X; Vossenaar ER, 2004, ARTHRITIS RHEUM-US, V50, P3485, DOI 10.1002/art.20584; Wagner E, 2009, RHEUMATOL INT, V29, P1315, DOI 10.1007/s00296-009-0854-2; WANG Y, 2004, ZHONGGUO LINCHUANG K, V8, P1616; Wei Guo-lan, 2008, Chinese Journal of Biologicals, V21, P421; Wild N, 2008, BIOMARKERS, V13, P88, DOI 10.1080/13547500701669410 ; Wu R, 2007, CLIN REV ALLERG IMMU, V32, P47, DOI 10.1007/BF02686081; Yamane T, 2008, J RHEUMATOL, V35, P414; Yazdani-Biuki BJ, 2006, ANN RHEUM DIS, V65, P159; YOUNG BJJ, 1979, BRIT MED J, V2, P97, DOI 10.1136/bmj.2.6182.97; Zeng XF, 2003, J RHEUMATOL, V30, P1451	182	132	137	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 6	2010	152	7					456	W166		10.7326/0003-4819-152-7-201004060-00010	http://dx.doi.org/10.7326/0003-4819-152-7-201004060-00010			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579QI	20368651				2022-12-28	WOS:000276386900006
J	Andriole, GL; Bostwick, DG; Brawley, OW; Gomella, LG; Marberger, M; Montorsi, F; Pettaway, CA; Tammela, TL; Teloken, C; Tindall, DJ; Somerville, MC; Wilson, TH; Fowler, IL; Rittmaster, RS				Andriole, Gerald L.; Bostwick, David G.; Brawley, Otis W.; Gomella, Leonard G.; Marberger, Michael; Montorsi, Francesco; Pettaway, Curtis A.; Tammela, Teuvo L.; Teloken, Claudio; Tindall, Donald J.; Somerville, Matthew C.; Wilson, Timothy H.; Fowler, Ivy L.; Rittmaster, Roger S.		REDUCE Study Grp	Effect of Dutasteride on the Risk of Prostate Cancer.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							5-ALPHA-REDUCTASE INHIBITOR DUTASTERIDE; PREVENTION TRIAL; MODELING APPROACH; FINASTERIDE; GRADE; SENSITIVITY; HYPERPLASIA; PROGRESSION; THERAPY; DESIGN	Background: We conducted a study to determine whether dutasteride reduces the risk of incident prostate cancer, as detected on biopsy, among men who are at increased risk for the disease. Methods: In this 4-year, multicenter, randomized, double-blind, placebo-controlled, parallel-group study, we compared dutasteride, at a dose of 0.5 mg daily, with placebo. Men were eligible for inclusion in the study if they were 50 to 75 years of age, had a prostate-specific antigen (PSA) level of 2.5 to 10.0 ng per milliliter, and had had one negative prostate biopsy (6 to 12 cores) within 6 months before enrollment. Subjects underwent a 10-core transrectal ultrasound-guided biopsy at 2 and 4 years. Results: Among 6729 men who underwent a biopsy or prostate surgery, cancer was detected in 659 of the 3305 men in the dutasteride group, as compared with 858 of the 3424 men in the placebo group, representing a relative risk reduction with dutasteride of 22.8% (95% confidence interval, 15.2 to 29.8) over the 4-year study period (P<0.001). Overall, in years 1 through 4, among the 6706 men who underwent a needle biopsy, there were 220 tumors with a Gleason score of 7 to 10 among 3299 men in the dutasteride group and 233 among 3407 men in the placebo group (P=0.81). During years 3 and 4, there were 12 tumors with a Gleason score of 8 to 10 in the dutasteride group, as compared with only 1 in the placebo group (P=0.003). Dutasteride therapy, as compared with placebo, resulted in a reduction in the rate of acute urinary retention (1.6% vs. 6.7%, a 77.3% relative reduction). The incidence of adverse events was similar to that in studies of dutasteride therapy for benign prostatic hyperplasia, except that in our study, as compared with previous studies, the relative incidence of the composite category of cardiac failure was higher in the dutasteride group than in the placebo group (0.7% [30 men] vs. 0.4% [16 men], P=0.03). Conclusions: Over the course of the 4-year study period, dutasteride reduced the risk of incident prostate cancer detected on biopsy and improved the outcomes related to benign prostatic hyperplasia. (ClinicalTrials.gov number, NCT00056407.) N Engl J Med 2010;362:1192-202.	[Andriole, Gerald L.] Washington Univ, Sch Med, Dept Surg, Div Urol, St Louis, MO 63110 USA; [Bostwick, David G.] Bostwick Labs, Glen Allen, VA USA; [Brawley, Otis W.] Emory Univ, Sch Med, Atlanta, GA USA; [Brawley, Otis W.] Amer Canc Soc, Atlanta, GA 30329 USA; [Gomella, Leonard G.] Thomas Jefferson Univ, Dept Urol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Marberger, Michael] Med Univ Vienna, Vienna, Austria; [Montorsi, Francesco] Univ Vita Salute San Raffaele, Milan, Italy; [Pettaway, Curtis A.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Tammela, Teuvo L.] Tampere Univ Hosp, Dept Urol, Tampere, Finland; [Teloken, Claudio] Univ Fed Ciencias Saude Porto Alegre, Porto Alegre, RS, Brazil; [Tindall, Donald J.] Mayo Clin, Rochester, MN USA; [Somerville, Matthew C.; Wilson, Timothy H.; Fowler, Ivy L.; Rittmaster, Roger S.] GlaxoSmithKline Inc, Res Triangle Pk, NC USA	Washington University (WUSTL); Emory University; American Cancer Society; Jefferson University; Medical University of Vienna; Vita-Salute San Raffaele University; University of Texas System; UTMD Anderson Cancer Center; Tampere University; Tampere University Hospital; Universidade Federal de Ciencias da Saude de Porto Alegre; Mayo Clinic; GlaxoSmithKline	Andriole, GL (corresponding author), Washington Univ, Sch Med, Dept Surg, Div Urol, St Louis, MO 63110 USA.	andrioleg@wustl.edu	Teloken, Claudio/A-4280-2013; Montorsi, Francesco/AAN-2473-2020; Mulders, Peter F.A./H-8076-2014; Roslan, Marek R/A-9140-2015; VILLERS, Arnauld/K-6629-2016	Teloken, Claudio/0000-0002-1888-4786; Roslan, Marek R/0000-0001-9794-3539; Taari, Kimmo/0000-0002-0077-4896; Jarzemski, Piotr/0000-0002-9451-7320; colombel, marc/0000-0002-0152-8021; VILLERS, Arnauld/0000-0002-6298-7758; Somerville, Matthew/0000-0001-5315-3164; Lacombe, Louis/0000-0003-4811-0308	GlaxoSmithKline; Aeterna Zentaris; Accuray; Bioniche; Endo; Capstone; Dendreon; EDAP; Gilead; GlobeImmune; GTx; Protox Therapeutics; SanofiAventis; Schering-Plough; Spectrum Pharmaceuticals; Stiefel Laboratories; Cougar Biotechnology; VIVUS; GE Healthcare; Photocure; Antigenics; AstraZeneca; EDAP Technomed and Prostate Conditions Education Council; T. J. Martell Foundation	GlaxoSmithKline(GlaxoSmithKline); Aeterna Zentaris; Accuray; Bioniche; Endo; Capstone; Dendreon; EDAP; Gilead(Gilead Sciences); GlobeImmune; GTx; Protox Therapeutics; SanofiAventis(Sanofi-Aventis); Schering-Plough(Merck & CompanySchering Plough Corporation); Spectrum Pharmaceuticals; Stiefel Laboratories; Cougar Biotechnology; VIVUS; GE Healthcare(General ElectricGE Healthcare); Photocure; Antigenics; AstraZeneca(AstraZeneca); EDAP Technomed and Prostate Conditions Education Council; T. J. Martell Foundation	Supported by GlaxoSmithKline.; Dr. Rittmaster, Ms. Fowler, and Messrs. Somerville and Wilson report being employees of and owning stock and stock options in GlaxoSmithKline; Dr. Andriole, receiving consulting or advisory fees from Aeterna Zentaris, Ferring Pharmaceuticals, EMD Serono, Gen-Probe, Onconome, Veridex, Amgen, GlaxoSmithKline, Steba Biotech, and the France Foundation, lecture fees from GlaxoSmithKline, and grant support from Aeterna Zentaris, owning stock in Cambridge Endo and Envisioneering Medical Technologies, and holding stock options in Viking Medical; Dr. Bostwick, receiving consulting or advisory fees from GlaxoSmithKline, lecture fees from GlaxoSmithKline, and grant support from Accuray, Bioniche, Endo, Capstone, Dendreon, EDAP, Gilead, GlobeImmune, GlaxoSmithKline, GTx, Protox Therapeutics, SanofiAventis, Schering-Plough, Spectrum Pharmaceuticals, and Stiefel Laboratories, and owning stock in GlaxoSmithKline and stock and stock options in Bostwick Laboratories; Dr. Brawley, receiving consulting or advisory fees from GlaxoSmithKline and Sanofi-Aventis; Dr. Gomella, receiving consulting or advisory fees from GlaxoSmithKline, Sanofi-Aventis, Watson Pharmaceuticals, Ferring, and AstraZeneca, lecture fees from the France Foundation, and grant support from Cougar Biotechnology, VIVUS, GE Healthcare, GlaxoSmithKline, Photocure, Dendreon, Antigenics, AstraZeneca, EDAP Technomed and Prostate Conditions Education Council; Dr. Marberger, receiving consulting or advisory fees from Antigenics, Allergan, GlaxoSmithKline, GP Pharm, Merck, Rottapharm-Madaus, and Astellas, and lecture fees from Astellas, Ferring, GE Healthcare, GlaxoSmithKline, and Merck; Dr. Montorsi, receiving consulting or advisory fees from Bayer Schering, GlaxoSmithKline, Pierre Fabre Medicament, and Recordati; Dr. Pettaway, receiving consulting or advisory fees from Ferring Pharmaceuticals and GlaxoSmithKline and lecture fees from Takeda-Abbott Pharmaceuticals; Dr. Tammela, receiving consulting or advisory fees from GlaxoSmithKline, Orion Pharma, and Astellas and lecture fees from GlaxoSmithKline, Orion Pharma, and Astellas; Dr. Teloken, receiving consulting or advisory fees from GlaxoSmithKline and Pfizer; Dr. Tindall, receiving grant support from T. J. Martell Foundation and GlaxoSmithKline; and Dr. Rittmaster, being listed as an inventor on a patent application for the use of dutasteride and testosterone for the treatment of prostate cancer. No other potential conflict of interest relevant to this article was reported.	Andriole G, 2004, J UROLOGY, V172, P1314, DOI 10.1097/01.ju.0000139320.78673.2a; Bramson HN, 1997, J PHARMACOL EXP THER, V282, P1496; Choo R, 2007, PROSTATE, V67, P1614, DOI 10.1002/pros.20648; Cohen YC, 2007, J NATL CANCER I, V99, P1366, DOI 10.1093/jnci/djm130; Debruyne F, 2004, EUR UROL, V46, P488, DOI 10.1016/j.eururo.2004.05.008; Gleave M, 2006, PROSTATE, V66, P1674, DOI 10.1002/pros.20499; Goodman PJ, 2006, J UROLOGY, V175, P2234, DOI 10.1016/S0022-5347(06)00284-9; IEHLE C, 1995, J STEROID BIOCHEM, V54, P273, DOI 10.1016/0960-0760(95)00134-L; Kaplan SA, 2009, UROLOGY, V73, P935, DOI 10.1016/j.urology.2008.09.079; Kramer BS, 2009, J UROLOGY, V181, P1642, DOI 10.1016/j.juro.2009.01.071; McConnell JD, 2003, NEW ENGL J MED, V349, P2387, DOI 10.1056/NEJMoa030656; Pinsky P, 2008, CANCER PREV RES, V1, P182, DOI 10.1158/1940-6207.CAPR-07-0007; Redman MW, 2008, CANCER PREV RES, V1, P174, DOI 10.1158/1940-6207.CAPR-08-0092; Serfling R, 2007, J UROLOGY, V177, P2352, DOI 10.1016/j.juro.2007.01.116; Stokes ME, 2000, CATEGORICAL DATA ANA; Thomas LN, 2005, PROSTATE, V63, P231, DOI 10.1002/pros.20188; Thompson IM, 2007, J UROLOGY, V177, P1749, DOI 10.1016/j.juro.2007.01.071; Thompson IM, 2006, J NATL CANCER I, V98, P1128, DOI 10.1093/jnci/djj307; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660	19	780	805	3	86	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 1	2010	362	13					1192	1202		10.1056/NEJMoa0908127	http://dx.doi.org/10.1056/NEJMoa0908127			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	577QQ	20357281				2022-12-28	WOS:000276239500009
J	Warren, WC; Clayton, DF; Ellegren, H; Arnold, AP; Hillier, LW; Kunstner, A; Searle, S; White, S; Vilella, AJ; Fairley, S; Heger, A; Kong, LS; Ponting, CP; Jarvis, ED; Mello, CV; Minx, P; Lovell, P; Velho, TAF; Ferris, M; Balakrishnan, CN; Sinha, S; Blatti, C; London, SE; Li, Y; Lin, YC; George, J; Sweedler, J; Southey, B; Gunaratne, P; Watson, M; Nam, K; Backstrom, N; Smeds, L; Nabholz, B; Itoh, Y; Whitney, O; Pfenning, AR; Howard, J; Voelker, M; Skinner, BM; Griffin, DK; Ye, L; McLaren, WM; Flicek, P; Quesada, V; Velasco, G; Lopez-Otin, C; Puente, XS; Olender, T; Lancet, D; Smit, AFA; Hubley, R; Konkel, MK; Walker, JA; Batzer, MA; Gu, WJ; Pollock, DD; Chen, L; Cheng, Z; Eichler, EE; Stapley, J; Slate, J; Ekblom, R; Birkhead, T; Burke, T; Burt, D; Scharff, C; Adam, I; Richard, H; Sultan, M; Soldatov, A; Lehrach, H; Edwards, SV; Yang, SP; Li, XC; Graves, T; Fulton, L; Nelson, J; Chinwalla, A; Hou, SF; Mardis, ER; Wilson, RK				Warren, Wesley C.; Clayton, David F.; Ellegren, Hans; Arnold, Arthur P.; Hillier, LaDeana W.; Kuenstner, Axel; Searle, Steve; White, Simon; Vilella, Albert J.; Fairley, Susan; Heger, Andreas; Kong, Lesheng; Ponting, Chris P.; Jarvis, Erich D.; Mello, Claudio V.; Minx, Pat; Lovell, Peter; Velho, Tarciso A. F.; Ferris, Margaret; Balakrishnan, Christopher N.; Sinha, Saurabh; Blatti, Charles; London, Sarah E.; Li, Yun; Lin, Ya-Chi; George, Julia; Sweedler, Jonathan; Southey, Bruce; Gunaratne, Preethi; Watson, Michael; Nam, Kiwoong; Backstroem, Niclas; Smeds, Linnea; Nabholz, Benoit; Itoh, Yuichiro; Whitney, Osceola; Pfenning, Andreas R.; Howard, Jason; Voelker, Martin; Skinner, Bejamin M.; Griffin, Darren K.; Ye, Liang; McLaren, William M.; Flicek, Paul; Quesada, Victor; Velasco, Gloria; Lopez-Otin, Carlos; Puente, Xose S.; Olender, Tsviya; Lancet, Doron; Smit, Arian F. A.; Hubley, Robert; Konkel, Miriam K.; Walker, Jerilyn A.; Batzer, Mark A.; Gu, Wanjun; Pollock, David D.; Chen, Lin; Cheng, Ze; Eichler, Evan E.; Stapley, Jessica; Slate, Jon; Ekblom, Robert; Birkhead, Tim; Burke, Terry; Burt, David; Scharff, Constance; Adam, Iris; Richard, Hugues; Sultan, Marc; Soldatov, Alexey; Lehrach, Hans; Edwards, Scott V.; Yang, Shiaw-Pyng; Li, XiaoChing; Graves, Tina; Fulton, Lucinda; Nelson, Joanne; Chinwalla, Asif; Hou, Shunfeng; Mardis, Elaine R.; Wilson, Richard K.			The genome of a songbird	NATURE			English	Article							GENE-EXPRESSION; DOSAGE COMPENSATION; LEARNED BIRDSONG; BRAIN; EVOLUTION; NUCLEUS; CHICKEN; MECHANISMS; REVEALS; RNA	The zebra finch is an important model organism in several fields(1,2) with unique relevance to human neuroscience(3,4). Like other songbirds, the zebra finch communicates through learned vocalizations, an ability otherwise documented only in humans and a few other animals and lacking in the chicken(5)-the only bird with a sequenced genome until now(6). Here we present a structural, functional and comparative analysis of the genome sequence of the zebra finch (Taeniopygia guttata), which is a songbird belonging to the large avian order Passeriformes(7). We find that the overall structures of the genomes are similar in zebra finch and chicken, but they differ in many intrachromosomal rearrangements, lineage-specific gene family expansions, the number of long-terminal-repeat-based retrotransposons, and mechanisms of sex chromosome dosage compensation. We show that song behaviour engages gene regulatory networks in the zebra finch brain, altering the expression of long non-coding RNAs, microRNAs, transcription factors and their targets. We also show evidence for rapid molecular evolution in the songbird lineage of genes that are regulated during song experience. These results indicate an active involvement of the genome in neural processes underlying vocal communication and identify potential genetic substrates for the evolution and regulation of this behaviour.	[Warren, Wesley C.; Hillier, LaDeana W.; Minx, Pat; Ye, Liang; Graves, Tina; Fulton, Lucinda; Nelson, Joanne; Chinwalla, Asif; Hou, Shunfeng; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Genome Ctr, Sch Med, St Louis, MO 63108 USA; [Clayton, David F.; Ferris, Margaret; Balakrishnan, Christopher N.; Sinha, Saurabh; Blatti, Charles; London, Sarah E.; Li, Yun; Lin, Ya-Chi; George, Julia; Sweedler, Jonathan; Southey, Bruce] Univ Illinois, Urbana, IL 61801 USA; [Ellegren, Hans; Kuenstner, Axel; Nam, Kiwoong; Backstroem, Niclas; Smeds, Linnea; Nabholz, Benoit] Uppsala Univ, Inst Evolut & Genet Syst, S-75236 Uppsala, Sweden; [Arnold, Arthur P.; Itoh, Yuichiro] Univ Calif Los Angeles, Los Angeles, CA 90056 USA; [Searle, Steve; White, Simon; Fairley, Susan] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Vilella, Albert J.; McLaren, William M.] EMBL EBI, Cambridge CB10 1SD, England; [Heger, Andreas; Kong, Lesheng; Ponting, Chris P.] Univ Oxford, Funct Genom Unit, MRC, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; [Jarvis, Erich D.; Whitney, Osceola; Pfenning, Andreas R.; Howard, Jason] Duke Univ, Med Ctr, Dept Neurobiol, Howard Hughes Med Inst, Durham, NC 27710 USA; [Mello, Claudio V.; Lovell, Peter; Velho, Tarciso A. F.; Flicek, Paul] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97239 USA; [Gunaratne, Preethi] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Watson, Michael; Voelker, Martin] Inst Anim Hlth, Dept Bioinformat, Compton RG20 7NN, Berks, England; [Skinner, Bejamin M.; Griffin, Darren K.] Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England; [Quesada, Victor; Velasco, Gloria; Lopez-Otin, Carlos; Puente, Xose S.] Univ Oviedo, Dept Bioquim & Biol Mol, Inst Univ Oncol, E-33006 Oviedo, Spain; [Olender, Tsviya; Lancet, Doron] Weizmann Inst Sci, Dept Mol Genet, Crown Human Genome Ctr, IL-76100 Rehovot, Israel; [Smit, Arian F. A.; Hubley, Robert] Inst Syst Biol, Seattle, WA 98103 USA; [Konkel, Miriam K.; Walker, Jerilyn A.; Batzer, Mark A.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Gu, Wanjun; Pollock, David D.] Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Chen, Lin; Cheng, Ze; Eichler, Evan E.; Stapley, Jessica] Univ Washington, Seattle, WA 98195 USA; [Slate, Jon; Ekblom, Robert; Birkhead, Tim; Burke, Terry] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Scharff, Constance; Adam, Iris] Free Univ Berlin, Inst Biol, D-14195 Berlin, Germany; [Burt, David] Univ Edinburgh, Roslin Inst, Edinburgh EH25 9OS, Midlothian, Scotland; [Burt, David] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH25 9OS, Midlothian, Scotland; [Richard, Hugues; Sultan, Marc; Soldatov, Alexey; Lehrach, Hans] Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-14195 Berlin, Germany; [Edwards, Scott V.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Yang, Shiaw-Pyng] Monsanto Co, St Louis, MO 63167 USA; [Li, XiaoChing] Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci, New Orleans, LA 70112 USA	Washington University (WUSTL); University of Illinois System; University of Illinois Urbana-Champaign; Uppsala University; University of California System; University of California Los Angeles; Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); University of Oxford; Duke University; Howard Hughes Medical Institute; Oregon Health & Science University; University of Houston System; University of Houston; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Kent; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Weizmann Institute of Science; Institute for Systems Biology (ISB); Louisiana State University System; Louisiana State University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Washington; University of Washington Seattle; University of Sheffield; Free University of Berlin; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Max Planck Society; Harvard University; Monsanto; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Warren, WC (corresponding author), Washington Univ, Genome Ctr, Sch Med, Campus Box 8501,4444 Forest Pk Ave, St Louis, MO 63108 USA.	wwarren@watson.wustl.edu; dclayton@illinois.edu; hans.ellegren@ebc.uu.se; arnold@ucla.edu	Sweedler, Jonathan V/A-9405-2009; Pollock, David D/M-4740-2016; Scharff, Constance/HHN-0673-2022; Burke, Terry/B-3196-2011; Wilson, Richard K./AAF-4139-2019; Clayton, David/B-2190-2008; Quesada, Víctor/B-6557-2014; Ponting, Chris/AAV-2621-2021; George, Julia M/B-2169-2008; Jarvis, Erich D/A-2319-2008; Skinner, Benjamin M/A-5265-2010; Puente, Xosé S./ADB-0672-2022; Nabholz, Benoit/AAE-2864-2021; López-Otín, Carlos/AAB-2106-2020; Gu, Wanjun/P-5389-2019; Backström, Niclas/C-8425-2012; Velasco, Gloria/AAS-5842-2021; Kong, Lesheng/O-8933-2015; Mardis, Elaine/W-2202-2019; Slate, Jon/D-2925-2012; Burt, David W/C-7802-2013; Edwards, Scott V./D-9071-2018; Gu, Wanjun/B-3998-2010; Soldatov, Alexey/V-2383-2019; Stapley, Jessica/B-3858-2010; Lin, Ya-Chi/B-8223-2009; Balakrishnan, Christopher/A-3043-2014	Sweedler, Jonathan V/0000-0003-3107-9922; Pollock, David D/0000-0002-7627-4214; Burke, Terry/0000-0003-3848-1244; Wilson, Richard K./0000-0002-1992-1358; Clayton, David/0000-0002-6395-3488; Quesada, Víctor/0000-0002-8398-3457; George, Julia M/0000-0001-6194-6914; Jarvis, Erich D/0000-0001-8931-5049; Skinner, Benjamin M/0000-0002-7152-1167; Puente, Xosé S./0000-0001-9525-1483; López-Otín, Carlos/0000-0001-6964-1904; Gu, Wanjun/0000-0003-4501-0539; Velasco, Gloria/0000-0001-8032-5056; Kong, Lesheng/0000-0002-9225-3421; Slate, Jon/0000-0003-3356-5123; Burt, David W/0000-0002-9991-1028; Edwards, Scott V./0000-0003-2535-6217; Stapley, Jessica/0000-0002-9138-5684; Lin, Ya-Chi/0000-0003-1240-7011; Balakrishnan, Christopher/0000-0002-0788-0659; Heger, Andreas/0000-0001-7720-0447; McLaren, William/0000-0001-6218-1116; Whitney, Osceola/0000-0002-5701-7722; Richard, Hugues/0000-0001-7776-1340; Fairley, Susan/0000-0001-9425-0788; /0000-0002-3447-9801; Adam, Iris/0000-0001-7561-7636; Mello, Claudio/0000-0002-9826-8421; Kunstner, Axel/0000-0003-0692-2105; Flicek, Paul/0000-0002-3897-7955; Smeds, Linnea/0000-0002-8415-9259; White, Simon/0000-0001-6375-2363; Chinwalla, Asif/0000-0001-7831-3996; Ponting, Chris/0000-0003-0202-7816; Howard, Jason/0000-0003-3265-5127; Nam, Kiwoong/0000-0003-3194-8673; Ferris, Margaret/0000-0001-7767-0705; Southey, Bruce/0000-0002-8959-7709; Watson, Mick/0000-0003-4211-0358; London, Sarah/0000-0002-7839-2644; Vilella, Albert/0000-0002-2005-2516; Arnold, Arthur/0000-0002-9908-9767	National Human Genome Research Institute (NHGRI); NIH [RO1 NS045264, RO1 NS051820, R01 DC007218, RO1 GM59290]; Swedish Research Council; Knut and Alice Wallenberg Foundation; Biotechnology and Biological Sciences Research Council [BBE0175091]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002939, U54HG003079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085233, R01GM059290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045264, R01NS051820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310] Funding Source: NIH RePORTER; BBSRC [BB/E017509/1, BB/E010652/1, BB/D013704/2, BB/D013704/1, BB/F007590/1, BBS/E/I/00001425] Funding Source: UKRI; MRC [MC_U137761446] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E017509/1, BB/F007590/1, BB/E010652/1, BB/D013704/2, BBS/E/I/00001425, BB/D013704/1] Funding Source: researchfish; Medical Research Council [MC_U137761446] Funding Source: researchfish	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The sequencing of zebra finch was funded by the National Human Genome Research Institute (NHGRI). Further research support included grants to D. F. C. (NIH RO1 NS045264 and RO1 NS051820), H. E. (Swedish Research Council and Knut and Alice Wallenberg Foundation), E. D. J. (HHMI, NIH Directors Pioneer Award and R01 DC007218), M. A. B. (NIH Ro1 GM59290) and J. S. (Biotechnology and Biological Sciences Research Council grant number BBE0175091). Resources for exploring the sequence and annotation data are available on browser displays available at UCSC (http://genome.ucsc.edu), Ensembl (http://www.ensembl.org), the NCBI (http://www.ncbi.nlm.nih.gov) and http://aviangenomes.org. We thank K. Lindblad-Toh for permission to use the green anole lizard genome assembly, the Production Sequencing Group of The Genome Center at Washington University School of Medicine for generating all the sequence reads used for genome assembly, and the Clemson University Genome Institute for the construction of the BAC library. We would like to recognize all the important published work that we were unable to cite owing to space limitations.	Agate RJ, 2009, P NATL ACAD SCI USA, V106, P17963, DOI 10.1073/pnas.0909139106; Arnold AP, 2008, ANNU REV GENOM HUM G, V9, P109, DOI 10.1146/annurev.genom.9.081307.164220; Clayton DF, 2009, CURR BIOL, V19, pR865, DOI 10.1016/j.cub.2009.07.006; Clayton DF, 2000, NEUROBIOL LEARN MEM, V74, P185, DOI 10.1006/nlme.2000.3967; Cooper EC, 1999, P NATL ACAD SCI USA, V96, P4759, DOI 10.1073/pnas.96.9.4759; Dong S, 2009, P NATL ACAD SCI USA, V106, P11364, DOI 10.1073/pnas.0812998106; Dong S, 2009, NEUROBIOL LEARN MEM, V92, P183, DOI 10.1016/j.nlm.2008.09.009; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Ellegren H, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-40; GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Itoh Yuichiro, 2007, Journal of Biology, V6, pUnpaginated, DOI 10.1186/jbiol53; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; KONISHI M, 1985, NATURE, V315, P145, DOI 10.1038/315145a0; London SE, 2009, FRONT NEUROENDOCRIN, V30, P302, DOI 10.1016/j.yfrne.2009.05.001; Lovell PV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003440; Makeyev EV, 2008, SCIENCE, V319, P1789, DOI 10.1126/science.1152326; Mattick JS, 2004, NAT REV GENET, V5, P316, DOI 10.1038/nrg1321; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; Mooney R, 2009, LEARN MEMORY, V16, P655, DOI 10.1101/lm.1065209; Nottebohm F, 2004, ANN NY ACAD SCI, V1016, P628, DOI 10.1196/annals.1298.027; NOTTEBOHM F, 1985, HOPE NEW NEUROLOGY; Ovcharenko I, 2004, GENOME RES, V14, P472, DOI 10.1101/gr.2129504; Replogle K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-131; Stapley J, 2008, GENETICS, V179, P651, DOI 10.1534/genetics.107.086264; Teranishi M, 2001, CHROMOSOME RES, V9, P147, DOI 10.1023/A:1009235120741; Wada K, 2004, J COMP NEUROL, V476, P44, DOI 10.1002/cne.20201; Wada K, 2006, P NATL ACAD SCI USA, V103, P15212, DOI 10.1073/pnas.0607098103; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Woolley SC, 2008, PLOS BIOL, V6, P525, DOI 10.1371/journal.pbio.0060062; Zann RA., 1996, ZEBRA FINCH SYNTHESI; Zeigler H. P., 2004, BEHAV NEUROBIOLOGY B, V1016	35	600	818	2	222	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 1	2010	464	7289					757	762		10.1038/nature08819	http://dx.doi.org/10.1038/nature08819			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577EO	20360741	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000276205000045
J	Gregor, T; Fujimoto, K; Masaki, N; Sawai, S				Gregor, Thomas; Fujimoto, Koichi; Masaki, Noritaka; Sawai, Satoshi			The Onset of Collective Behavior in Social Amoebae	SCIENCE			English	Article							DICTYOSTELIUM-DISCOIDEUM; CHEMICAL OSCILLATORS; SIGNAL PROPAGATION; QUORUM; SYNCHRONIZATION; POPULATIONS; DYNAMICS; CIRCUIT; CLOCKS; RELAY	In the social amoebae Dictyostelium discoideum, periodic synthesis and release of extracellular cyclic adenosine 3',5'-monophosphate (cAMP) guide cell aggregation and commitment to form fruiting bodies. It is unclear whether these oscillations are an intrinsic property of individual cells or if they exist only as a population-level phenomenon. Here, we showed by live-cell imaging of intact cell populations that pulses originate from a discrete location despite constant exchange of cells to and from the region. In a perfusion chamber, both isolated single cells and cell populations switched from quiescence to rhythmic activity depending on the concentration of extracellular cAMP. A quantitative analysis showed that stochastic pulsing of individual cells below the threshold concentration of extracellular cAMP plays a critical role in the onset of collective behavior.	[Gregor, Thomas; Sawai, Satoshi] Univ Tokyo, Grad Sch Arts & Sci, Tokyo 1538902, Japan; [Fujimoto, Koichi; Masaki, Noritaka; Sawai, Satoshi] Japan Sci & Technol Agcy JST, Exploratory Res Adv Technol ERATO Complex Syst Bi, Tokyo 1538902, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Sawai, S (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Tokyo 1538902, Japan.	cssawai@mail.ecc.u-tokyo.ac.jp	Fujimoto, Koichi/J-8454-2013; Sawai, Satoshi/AAX-8536-2020	Fujimoto, Koichi/0000-0001-6473-7990; Gregor, Thomas/0000-0001-9460-139X; Sawai, Satoshi/0000-0003-3764-219X	Japan Society for the Promotion of Science (JSPS); ERATO-JST; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098407, P50GM071508] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22680024] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ERATO-JST(Japan Science & Technology Agency (JST)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank V. O. Nikolaev and M. J. Lohse for providing vector containing Epac1-camps; M. Kitahara and E. Hada for technical help, E. C. Cox, S. Ishihara, K. Kaneko, H. Kori, and J. Teramae for discussions and suggestions; and the Japan Society for the Promotion of Science (JSPS) postdoctoral fellowship (T. G.), K. Kaneko, and the ERATO-JST for support.	Bosgraaf L, 2008, J CELL SCI, V121, P3589, DOI 10.1242/jcs.031781; BUCK J, 1968, SCIENCE, V159, P1319, DOI 10.1126/science.159.3821.1319; Corner FI, 2005, CURR BIOL, V15, P134, DOI 10.1016/j.cub.2005.01.007; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; De Monte S, 2007, P NATL ACAD SCI USA, V104, P18377, DOI 10.1073/pnas.0706089104; DEVREOTES PN, 1979, J CELL BIOL, V80, P291, DOI 10.1083/jcb.80.2.291; DINAUER MC, 1980, J CELL BIOL, V86, P537, DOI 10.1083/jcb.86.2.537; Garcia-Ojalvo J, 2004, P NATL ACAD SCI USA, V101, P10955, DOI 10.1073/pnas.0307095101; GERISCH G, 1975, BIOCHEM BIOPH RES CO, V65, P364, DOI 10.1016/S0006-291X(75)80102-1; Goldbeter A., 1996, BIOCH OSCILLATIONS C; GROSS JD, 1976, J CELL SCI, V22, P645; Iranfar N, 2003, EUKARYOT CELL, V2, P664, DOI 10.1128/EC.2.4.664-670.2003; JOHNSON RL, 1992, J BIOL CHEM, V267, P4600; Kim L, 2002, DEV CELL, V3, P523, DOI 10.1016/S1534-5807(02)00269-1; Kiss IZ, 2002, SCIENCE, V296, P1676, DOI 10.1126/science.1070757; Maeda M, 2004, SCIENCE, V304, P875, DOI 10.1126/science.1094647; McMillen D, 2002, P NATL ACAD SCI USA, V99, P679, DOI 10.1073/pnas.022642299; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Riedel-Kruse IH, 2007, SCIENCE, V317, P1911, DOI 10.1126/science.1142538; Sawai S, 2005, NATURE, V433, P323, DOI 10.1038/nature03228; SIEGERT F, 1989, J CELL SCI, V93, P325; Taylor AF, 2009, SCIENCE, V323, P614, DOI 10.1126/science.1166253; Thomason PA, 1998, EMBO J, V17, P2838, DOI 10.1093/emboj/17.10.2838; TOMCHIK KJ, 1981, SCIENCE, V212, P443, DOI 10.1126/science.6259734; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Wiesenfeld K, 1996, PHYS REV LETT, V76, P404, DOI 10.1103/PhysRevLett.76.404; WINFREE AT, 1980, BIOMATHEMATICS SERIE; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287	28	215	216	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2010	328	5981					1021	1025		10.1126/science.1183415	http://dx.doi.org/10.1126/science.1183415			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598YW	20413456	Green Accepted			2022-12-28	WOS:000277877100039
J	Gao, ZH; Liu, HL; Daxinger, L; Pontes, O; He, XJ; Qian, WQ; Lin, HX; Xie, MT; Lorkovic, ZJ; Zhang, SD; Miki, D; Zhan, XQ; Pontier, D; Lagrange, T; Jin, HL; Matzke, AJM; Matzke, M; Pikaard, CS; Zhu, JK				Gao, Zhihuan; Liu, Hai-Liang; Daxinger, Lucia; Pontes, Olga; He, Xinjian; Qian, Weiqiang; Lin, Huixin; Xie, Mingtang; Lorkovic, Zdravko J.; Zhang, Shoudong; Miki, Daisuke; Zhan, Xiangqiang; Pontier, Dominique; Lagrange, Thierry; Jin, Hailing; Matzke, Antonius J. M.; Matzke, Marjori; Pikaard, Craig S.; Zhu, Jian-Kang			An RNA polymerase II- and AGO4-associated protein acts in RNA-directed DNA methylation	NATURE			English	Article							ARABIDOPSIS-THALIANA; PROCESSING CENTER; BINDING PROTEIN; ARGONAUTE4; GLYCOSYLASE/LYASE; TRANSCRIPTION; RESOLUTION; PATHWAYS; PATTERNS; BODIES	DNA methylation is an important epigenetic mark in many eukaryotes(1-5). In plants, 24-nucleotide small interfering RNAs (siRNAs) bound to the effector protein, Argonaute 4 (AGO4), can direct de novo DNA methylation by the methyltransferase DRM2 (refs 2, 4-6). Here we report a new regulator of RNA-directed DNA methylation (RdDM) in Arabidopsis: RDM1. Loss-of-function mutations in the RDM1 gene impair the accumulation of 24-nucleotide siRNAs, reduce DNA methylation, and release transcriptional gene silencing at RdDM target loci. RDM1 encodes a small protein that seems to bind single-stranded methyl DNA, and associates and co-localizes with RNA polymerase II (Pol II, also known as NRPB), AGO4 and DRM2 in the nucleus. Our results indicate that RDM1 is a component of the RdDM effector complex and may have a role in linking siRNA production with pre-existing or de novo cytosine methylation. Our results also indicate that, although RDM1 and Pol V (also known as NRPE) may function together at some RdDM target sites in the peri-nucleolar siRNA processing centre, Pol II rather than Pol Vis associated with the RdDM effector complex at target sites in the nucleoplasm.	[Gao, Zhihuan; Liu, Hai-Liang; He, Xinjian; Qian, Weiqiang; Lin, Huixin; Xie, Mingtang; Zhang, Shoudong; Miki, Daisuke; Zhan, Xiangqiang; Jin, Hailing; Zhu, Jian-Kang] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Gao, Zhihuan; Liu, Hai-Liang; He, Xinjian; Qian, Weiqiang; Lin, Huixin; Xie, Mingtang; Zhang, Shoudong; Miki, Daisuke; Zhan, Xiangqiang; Zhu, Jian-Kang] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Liu, Hai-Liang] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Daxinger, Lucia; Matzke, Antonius J. M.; Matzke, Marjori] Austrian Acad Sci, Gregor Mendel Inst Mol Plant Biol, A-1030 Vienna, Austria; [Pontes, Olga] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [He, Xinjian; Zhang, Shoudong; Zhan, Xiangqiang; Zhu, Jian-Kang] 4700 King Abdullah Univ Sci & Technol, Ctr Plant Stress Genom & Technol, Thuwal 239556900, Saudi Arabia; [Lorkovic, Zdravko J.] Med Univ Vienna, Max F Perutz Lab, A-1030 Vienna, Austria; [Pontier, Dominique; Lagrange, Thierry] Univ Perpignan, CNRS, IRD, LGDP,UMR 5096, F-66806 Perpignan, France; [Jin, Hailing] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; [Pikaard, Craig S.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Pikaard, Craig S.] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; Tongji University; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); Washington University (WUSTL); King Abdullah University of Science & Technology; Medical University of Vienna; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut de Recherche pour le Developpement (IRD); Universite Perpignan Via Domitia; University of California System; University of California Riverside; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Zhu, JK (corresponding author), Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA.	jian-kang.zhu@ucr.edu	Pontes, Olga MF/F-9768-2011; Zhang, Shoudong/ABC-5471-2021; Pikaard, Craig S/K-8772-2012; Matzke, Antonius/H-8698-2015; Zhan, Xiangqiang/B-6073-2018; Jin, Hailing/Z-1168-2019; Zhu, Jian-Kang/F-7658-2011; Daxinger, Lucia/A-6840-2013	Pontes, Olga MF/0000-0003-3316-1145; Zhang, Shoudong/0000-0001-7332-7627; Pikaard, Craig S/0000-0001-8204-7459; Jin, Hailing/0000-0001-5778-5193; Zhu, Jian-Kang/0000-0001-5134-731X; Miki, Daisuke/0000-0001-6066-3357; Zhan, Xiangqiang/0000-0003-2682-5310; Lagrange, Thierry/0000-0003-3090-0918; Xie, Mingtang/0000-0002-2797-0598; Lorkovic, Zdravko/0000-0002-3074-7258; Daxinger, Lucia/0000-0001-6557-6201; Pontier, Dominique/0000-0001-9032-4620	National Institutes of Health; Austrian Fonds zur Forderung der wissenschaftlichen Forschung; National Science Foundation Career Award; Edward Mallinckrodt Foundation Award; Agence Nationale de la Recherche; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059138, R01GM077590, R01GM093008, R01GM070795] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Fonds zur Forderung der wissenschaftlichen Forschung(Austrian Science Fund (FWF)); National Science Foundation Career Award(National Science Foundation (NSF)); Edward Mallinckrodt Foundation Award; Agence Nationale de la Recherche(French National Research Agency (ANR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants (J.-K.Z.), Austrian Fonds zur Forderung der wissenschaftlichen Forschung ( M. M. and Z.J.L.), National Science Foundation Career Award (H.J.), Edward Mallinckrodt Foundation Award (O.P.), and Agence Nationale de la Recherche ( T. L.). We thank E. Richards for his gift of methylated DNA oligonucleotides, B. Stevenson for technical assistance and T. Kanno for discussions.	Allard STM, 2005, ACTA CRYSTALLOGR F, V61, P647, DOI 10.1107/S1744309105019743; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Chan SWL, 2006, PLOS BIOL, V4, P1923, DOI 10.1371/journal.pbio.0040363; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Dorweiler JE, 2000, PLANT CELL, V12, P2101, DOI 10.1105/tpc.12.11.2101; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; He XJ, 2009, CELL, V137, P498, DOI 10.1016/j.cell.2009.04.028; He XJ, 2009, GENE DEV, V23, P318, DOI 10.1101/gad.1765209; Huettel B, 2006, EMBO J, V25, P2828, DOI 10.1038/sj.emboj.7601150; Ishitani M, 1997, PLANT CELL, V9, P1935, DOI 10.1105/tpc.9.11.1935; Jasencakova Z, 2000, PLANT CELL, V12, P2087, DOI 10.1105/tpc.12.11.2087; Kapoor A, 2005, CURR BIOL, V15, P1912, DOI 10.1016/j.cub.2005.09.013; LAW JA, CURR BIOL IN PRESS; Li CF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040027; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; MARTIENSSEN RA, 1995, CURR OPIN GENET DEV, V5, P234, DOI 10.1016/0959-437X(95)80014-X; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Tariq M, 2004, TRENDS GENET, V20, P244, DOI 10.1016/j.tig.2004.04.005; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Woo HR, 2007, GENE DEV, V21, P267, DOI 10.1101/gad.1512007; Zheng BL, 2009, GENE DEV, V23, P2850, DOI 10.1101/gad.1868009; Zhu JH, 2007, CURR BIOL, V17, P54, DOI 10.1016/j.cub.2006.10.059; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055	30	183	194	8	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 6	2010	465	7294					106	U118		10.1038/nature09025	http://dx.doi.org/10.1038/nature09025			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591OW	20410883	Green Accepted, Green Submitted			2022-12-28	WOS:000277311900040
J	Tsuchimatsu, T; Suwabe, K; Shimizu-Inatsugi, R; Isokawa, S; Pavlidis, P; Stadler, T; Suzuki, G; Takayama, S; Watanabe, M; Shimizu, KK				Tsuchimatsu, Takashi; Suwabe, Keita; Shimizu-Inatsugi, Rie; Isokawa, Sachiyo; Pavlidis, Pavlos; Staedler, Thomas; Suzuki, Go; Takayama, Seiji; Watanabe, Masao; Shimizu, Kentaro K.			Evolution of self-compatibility in Arabidopsis by a mutation in the male specificity gene	NATURE			English	Article							S-LOCUS GENES; BRASSICA-NAPUS; INCOMPATIBILITY; THALIANA; HAPLOTYPES; TRANSITION; BREAKDOWN; DISTANCE; RNA	Ever since Darwin's pioneering research, the evolution of self-fertilisation (selfing) has been regarded as one of the most prevalent evolutionary transitions in flowering plants(1,2). A major mechanism to prevent selfing is the self-incompatibility (SI) recognition system, which consists of male and female specificity genes at the S-locus and SI modifier genes(2-4). Under conditions that favour selfing, mutations disabling the male recognition component are predicted to enjoy a relative advantage over those disabling the female component, because male mutations would increase through both pollen and seeds whereas female mutations would increase only through seeds(5,6). Despite many studies on the genetic basis of loss of SI in the predominantly selfing plant Arabidopsis thaliana(7-15), it remains unknown whether selfing arose through mutations in the female specificity gene (S-receptor kinase, SRK), male specificity gene (S-locus cysteine-rich protein, SCR; also known as S-locus protein 11, SP11) or modifier genes, and whether any of them rose to high frequency across large geographic regions. Here we report that a disruptive 213-base-pair (bp) inversion in the SCR gene (or its derivative haplotypes with deletions encompassing the entire SCR-A and a large portion of SRK-A) is found in 95% of European accessions, which contrasts with the genome-wide pattern of polymorphism in European A. thaliana(16,17). Importantly, interspecific crossings using Arabidopsis halleri as a pollen donor reveal that some A. thaliana accessions, including Wei-1, retain the female SI reaction, suggesting that all female components including SRK are still functional. Moreover, when the 213-bp inversion in SCR was inverted and expressed in transgenic Wei-1 plants, the functional SCR restored the SI reaction. The inversion within SCR is the first mutation disrupting SI shown to be nearly fixed in geographically wide samples, and its prevalence is consistent with theoretical predictions regarding the evolutionary advantage of mutations in male components.	[Tsuchimatsu, Takashi; Shimizu-Inatsugi, Rie; Shimizu, Kentaro K.] Univ Zurich, Inst Plant Biol, Univ Res Prior Program Syst Biol, Funct Genom & Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland; [Tsuchimatsu, Takashi] Univ Tokyo, Dept Gen Syst Studies, Meguro Ku, Tokyo 1538902, Japan; [Suwabe, Keita; Isokawa, Sachiyo; Watanabe, Masao] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 9808577, Japan; [Suwabe, Keita] Mie Univ, Grad Sch Bioresources, Tsu, Mie 5148507, Japan; [Isokawa, Sachiyo; Watanabe, Masao] Tohoku Univ, Fac Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Pavlidis, Pavlos] Univ Munich LMU, Bioctr, Sect Evolutionary Biol, D-82152 Planegg Martinsried, Germany; [Staedler, Thomas] ETH, Inst Integrat Biol, CH-8092 Zurich, Switzerland; [Suzuki, Go] Osaka Kyoiku Univ, Div Nat Sci, Kashiwara 5828582, Japan; [Takayama, Seiji] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma 6300101, Japan	University of Zurich; University of Tokyo; Tohoku University; Mie University; Tohoku University; University of Munich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Osaka University of Education; Nara Institute of Science & Technology	Shimizu, KK (corresponding author), Univ Zurich, Inst Plant Biol, Univ Res Prior Program Syst Biol, Funct Genom & Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland.	nabe@ige.tohoku.ac.jp; shimizu@botinst.uzh.ch	Watanabe, Masao/N-1465-2019; Tsuchimatsu, Takashi/A-9218-2017; Städler, Thomas/B-7286-2009; Watanabe, Masao/E-6300-2011; Tsuchimatsu, Takashi/T-7402-2019	Watanabe, Masao/0000-0002-9419-5149; Tsuchimatsu, Takashi/0000-0003-1241-9338; Städler, Thomas/0000-0003-4513-8583; Watanabe, Masao/0000-0002-9419-5149; Tsuchimatsu, Takashi/0000-0003-1241-9338; Shimizu, Kentaro K./0000-0002-6483-1781; Shimizu Inatsugi, Rie/0000-0002-9899-591X	University of Zurich; Swiss National Science Foundation (SNF); Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); Japan Society for the Promotion of Science (JSPS); Volkswagen Foundation; Deutscher Akademischer Austauschdienst (DAAD)	University of Zurich; Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Volkswagen Foundation(Volkswagen); Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	We thank P. Awadalla, C. Bustamante, A. Caicedo, G. Coop, U. Grossniklaus, T.-h. Kao, C. Mays, R. Moore, K. Olsen, M. Purugganan, J. Reininga, L. Rose, S. Ruzsa and W. Stephan for discussions or technical advice. This work was supported by grants from the University Research Priority Program in Systems Biology/Functional Genomics of the University of Zurich and from the Swiss National Science Foundation (SNF) to K. K. S., and by Grants-in-Aid for Special Research on Priority Areas to S. T., M. W. and K. K. S.; by a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) and by a Grant-in-Aid for Creative Scientific Research to S. T.; by a Young Scientific Research (S) grant to M. W.; and by a grant from the Japan Society for the Promotion of Science (JSPS). P. P. is the recipient of a grant from the Volkswagen Foundation and a STIBET scholarship of the Deutscher Akademischer Austauschdienst (DAAD). T. T. and K. S. are recipients of a Research Fellowship for Young Scientists from JSPS.	ABBOTT RJ, 1989, HEREDITY, V62, P411, DOI 10.1038/hdy.1989.56; BAKER HG, 1955, EVOLUTION, V9, P347, DOI 10.2307/2405656; Bechsgaard JS, 2006, MOL BIOL EVOL, V23, P1741, DOI 10.1093/molbev/msl042; Boggs NA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000426; Busch JW, 2008, TRENDS PLANT SCI, V13, P128, DOI 10.1016/j.tplants.2008.01.002; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Darwin CR, 1876, EFFECTS CROSS SELF F; Fisher RA, 1941, ANN EUGENIC, V11, P53, DOI 10.1111/j.1469-1809.1941.tb02272.x; Francois O, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000075; Goodwillie C, 2005, ANNU REV ECOL EVOL S, V36, P47, DOI 10.1146/annurev.ecolsys.36.091704.175539; GORING DR, 1993, PLANT CELL, V5, P531, DOI 10.1105/tpc.5.5.531; Guo YL, 2009, P NATL ACAD SCI USA, V106, P5246, DOI 10.1073/pnas.0808012106; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; Igic B, 2008, INT J PLANT SCI, V169, P93, DOI 10.1086/523362; Karkkainen K, 1999, EVOLUTION, V53, P1354, DOI [10.2307/2640882, 10.1111/j.1558-5646.1999.tb05400.x]; Kusaba M, 2001, PLANT CELL, V13, P627, DOI 10.1105/tpc.13.3.627; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu P, 2007, CURR BIOL, V17, P734, DOI 10.1016/j.cub.2007.03.022; Mable BK, 2008, GENET RES, V90, P47, DOI 10.1017/S0016672307008907; Nasrallah ME, 2002, SCIENCE, V297, P247, DOI 10.1126/science.1072205; Nettancourt, 2001, INCOMPATIBILITY INCO; NOU IS, 1993, SEX PLANT REPROD, V6, P79, DOI 10.1007/BF00227652; Okamoto S, 2007, PLANT J, V50, P391, DOI 10.1111/j.1365-313X.2007.03058.x; Park JI, 2006, GENES GENET SYST, V81, P355, DOI 10.1266/ggs.81.355; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; Sharbel TF, 2000, MOL ECOL, V9, P2109, DOI 10.1046/j.1365-294X.2000.01122.x; Sherman-Broyles S, 2007, PLANT CELL, V19, P94, DOI 10.1105/tpc.106.048199; SHIBA H, 1995, P JPN ACAD B-PHYS, V71, P81, DOI 10.2183/pjab.71.81; Shimizu KK, 2008, MOL ECOL, V17, P704, DOI 10.1111/j.1365-294X.2007.03605.x; Shimizu KK, 2002, POPUL ECOL, V44, P221, DOI 10.1007/s101440200025; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Stebbins G.L., 1974, FLOWERING PLANTS EVO, DOI 10.4159/harvard.9780674864856; Takasaki T, 2000, NATURE, V403, P913, DOI 10.1038/35002628; Takayama S, 2005, ANNU REV PLANT BIOL, V56, P467, DOI 10.1146/annurev.arplant.56.032604.144249; Takayama S, 2001, NATURE, V413, P534, DOI 10.1038/35097104; Tang CL, 2007, SCIENCE, V317, P1070, DOI 10.1126/science.1143153; Uyenoyama MK, 2001, GENETICS, V157, P1805	37	98	106	2	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2010	464	7293					1342	1346		10.1038/nature08927	http://dx.doi.org/10.1038/nature08927			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20400945	Green Accepted			2022-12-28	WOS:000277149000045
J	Morin, SA; Bierman, MJ; Tong, J; Jin, S				Morin, Stephen A.; Bierman, Matthew J.; Tong, Jonathan; Jin, Song			Mechanism and Kinetics of Spontaneous Nanotube Growth Driven by Screw Dislocations	SCIENCE			English	Article							ZINC-OXIDE; ESHELBY TWIST; ZNO; NANOWIRES; NANORODS; CRYSTALS; ARRAYS	Single-crystal nanotubes are commonly observed, but their formation is often not understood. We show that nanotube growth can be driven by axial screw dislocations: Self-perpetuating growth spirals enable anisotropic growth, and the dislocation strain energy overcomes the surface energy required for creating a new inner surface forming hollow tubes spontaneously. This was demonstrated through solution-grown zinc oxide nanotubes and nanowires by controlling supersaturation using a flow reactor and confirmed using microstructural characterization. The agreement between experimental growth kinetics and those predicted from fundamental crystal growth theories confirms that the growth of these nanotubes is driven by dislocations.	[Morin, Stephen A.; Bierman, Matthew J.; Tong, Jonathan; Jin, Song] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Bierman, Matthew J.] CALTECH, Pasadena, CA 91125 USA	University of Wisconsin System; University of Wisconsin Madison; California Institute of Technology	Jin, S (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	jin@chem.wisc.edu	Bierman, Matthew J/C-2657-2013; Jin, Song/B-4300-2008	Bierman, Matthew J/0000-0002-9053-6356; Jin, Song/0000-0001-8693-7010	NSF [CAREER DMR-0548232]; UW-Madison NSEC [NSF DMR 0425880, NSF DMR 0832760]; Research Corporation; DuPont Young Professor Grant; Sloan Research Fellowship; 3M Graduate Research Fellowship	NSF(National Science Foundation (NSF)); UW-Madison NSEC; Research Corporation(Research Corporation for Science Advancement); DuPont Young Professor Grant; Sloan Research Fellowship(Alfred P. Sloan Foundation); 3M Graduate Research Fellowship(3M)	S.J. thanks NSF (CAREER DMR-0548232), UW-Madison NSEC (NSF DMR 0425880 and 0832760), Research Corporation Cottrell Scholar Award, DuPont Young Professor Grant, and Sloan Research Fellowship for support. S. A. M. was partially supported by a 3M Graduate Research Fellowship.	BATEMAN TB, 1962, J APPL PHYS, V33, P3309, DOI 10.1063/1.1931160; Bierman MJ, 2008, SCIENCE, V320, P1060, DOI 10.1126/science.1157131; BURTON WK, 1951, PHILOS T R SOC S-A, V243, P299, DOI 10.1098/rsta.1951.0006; Dhanaraj G, 2006, J CRYST GROWTH, V297, P74, DOI 10.1016/j.jcrysgro.2006.09.025; Ding F, 2009, P NATL ACAD SCI USA, V106, P2506, DOI 10.1073/pnas.0811946106; DRUM CM, 1965, J APPL PHYS, V36, P824, DOI 10.1063/1.1714226; ESHELBY JD, 1958, PHILOS MAG, V3, P440, DOI 10.1080/14786435808236832; ESHELBY JD, 1953, J APPL PHYS, V24, P176, DOI 10.1063/1.1721234; FRANK FC, 1951, ACTA CRYSTALLOGR, V4, P497, DOI 10.1107/S0365110X51001690; Govender K, 2004, J MATER CHEM, V14, P2575, DOI 10.1039/b404784b; Heindl J, 1997, PHYS STATUS SOLIDI A, V162, P251, DOI 10.1002/1521-396X(199707)162:1<251::AID-PSSA251>3.0.CO;2-7; Huang MH, 2001, SCIENCE, V292, P1897, DOI 10.1126/science.1060367; Lau YKA, 2009, J AM CHEM SOC, V131, P16461, DOI 10.1021/ja906499a; Law M, 2005, NAT MATER, V4, P455, DOI 10.1038/nmat1387; Li QC, 2005, CHEM MATER, V17, P1001, DOI 10.1021/cm048144q; Markov I. V., 2003, CRYSTAL GROWTH BEGIN; Morales AM, 1998, SCIENCE, V279, P208, DOI 10.1126/science.279.5348.208; Nabarro FRN, 1967, THEORY CRYSTAL DISLO; Patzke GR, 2002, ANGEW CHEM INT EDIT, V41, P2446, DOI 10.1002/1521-3773(20020715)41:14<2446::AID-ANIE2446>3.0.CO;2-K; Penn RL, 1998, SCIENCE, V281, P969, DOI 10.1126/science.281.5379.969; SEARS GW, 1955, ACTA METALL MATER, V3, P361, DOI 10.1016/0001-6160(55)90041-9; Sun Y, 2005, ADV MATER, V17, P2477, DOI 10.1002/adma.200500726; Teng HH, 2000, GEOCHIM COSMOCHIM AC, V64, P2255, DOI 10.1016/S0016-7037(00)00341-0; Vayssieres L, 2001, J PHYS CHEM B, V105, P3350, DOI 10.1021/jp010026s; WAGNER RS, 1964, APPL PHYS LETT, V4, P89, DOI 10.1063/1.1753975; Wang ZL, 2006, SCIENCE, V312, P242, DOI 10.1126/science.1124005; Xia YN, 2003, ADV MATER, V15, P353, DOI 10.1002/adma.200390087; Zhu J, 2008, NAT NANOTECHNOL, V3, P477, DOI 10.1038/nnano.2008.179	28	259	261	13	303	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 23	2010	328	5977					476	480		10.1126/science.1182977	http://dx.doi.org/10.1126/science.1182977			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YR	20413496				2022-12-28	WOS:000276952400036
J	Hawkins, JL				Hawkins, Joy L.			Epidural Analgesia for Labor and Delivery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; INTERVILLOUS BLOOD-FLOW; CESAREAN DELIVERY; PAIN RELIEF; INTRAVENOUS ANALGESIA; NEURAXIAL ANALGESIA; RISK; BUPIVACAINE; MANAGEMENT; WOMEN	A 30-year-old nulliparous woman at 39 weeks' gestation is undergoing induction of labor because of premature rupture of membranes. She is currently receiving an oxytocin infusion, and her cervical dilatation is 1 cm. Her obstetrician has ordered intermittent intravenous administration of fentanyl for pain relief, but she feels nauseated, has been unable to rest, and describes her pain as 9 on a scale of 10. The patient strongly prefers a vaginal delivery to cesarean delivery and is concerned that epidural analgesia may alter the progress of labor. The anesthesiologist is consulted to discuss the use of epidural analgesia during labor and delivery.	Univ Colorado, Denver Sch Med, Dept Anesthesiol, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Hawkins, JL (corresponding author), Univ Colorado, Denver Sch Med, Dept Anesthesiol, 12631 E 17th Ave,Mail Stop 8203, Aurora, CO 80045 USA.	joy.hawkins@ucdenver.edu						ABBOUD TK, 1983, ANESTHESIOLOGY, V59, P1, DOI 10.1097/00000542-198307000-00001; Abrao KC, 2009, OBSTET GYNECOL, V113, P41, DOI 10.1097/AOG.0b013e31818f5eb6; American College of Obstetricians and Gynecologists Committee on Obstetric Practice, 2006, Obstet Gynecol, V107, P1487; Anim-Somuah M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000331.pub2; [Anonymous], 2004, Obstet Gynecol, V104, P213; [Anonymous], 2007, ANESTHESIOLOGY, V106, P843; Arzola C, 2007, ANESTH ANALG, V104, P1188, DOI 10.1213/01.ane.0000250912.66057.41; Ayad S, 2003, REGION ANESTH PAIN M, V28, P512, DOI 10.1016/S1098-7339(03)00393-6; Beilin Y, 2005, ANESTHESIOLOGY, V103, P1211, DOI 10.1097/00000542-200512010-00016; Capogna G, 2007, INT J OBSTET ANESTH, V16, P110, DOI 10.1016/j.ijoa.2006.08.009; Catterall W. A., 2006, GOODMAN GILMANS PHAR, P369; Cluett ER, 2004, BMJ-BRIT MED J, V328, P314, DOI 10.1136/bmj.37963.606412.EE; Dickinson JE, 2003, AUST NZ J OBSTET GYN, V43, P463, DOI 10.1046/j.0004-8666.2003.00152.x; EIDELMAN AI, 1993, OBSTET GYNECOL, V81, P764; Fanning RA, 2008, ANESTH ANALG, V107, P1303, DOI 10.1213/ane.0b013e3181804245; Goetzl L, 2007, OBSTET GYNECOL, V109, P687, DOI 10.1097/01.AOG.0000255976.14297.f6; Grondin LS, 2009, ANESTHESIOLOGY, V111, P165, DOI 10.1097/ALN.0b013e3181a4c6f2; Halpern SH, 2004, ANESTH ANALG, V99, P1532, DOI 10.1213/01.ANE.0000136850.08972.07; Halpern SH, 1999, BIRTH-ISS PERINAT C, V26, P83, DOI 10.1046/j.1523-536x.1999.00083.x; Harvey M, 2009, ANESTHESIOLOGY, V111, P467, DOI 10.1097/ALN.0b013e3181afe083; Hebl JR, 2006, REGION ANESTH PAIN M, V31, P311, DOI 10.1016/j.rapm.2006.04.004; Hiltunen P, 2004, ACTA OBSTET GYN SCAN, V83, P257, DOI 10.1111/j.0001-6349.2004.0302.x; HOLLMEN AI, 1982, BRIT J ANAESTH, V54, P837, DOI 10.1093/bja/54.8.837; Horlocker TT, 2010, ANESTHESIOLOGY, V112, P530, DOI 10.1097/ALN.0b013e3181c4c7d8; Horlocker TT, 2010, REGION ANESTH PAIN M, V35, P64, DOI 10.1097/AAP.0b013e3181c15c70; Horlocker TT, 2009, ANESTHESIOLOGY, V110, P218, DOI 10.1097/ALN.0b013e31818ec946; Howell CJ, 2002, BMJ-BRIT MED J, V325, P580; Howell CJ, 2002, BMJ-BRIT MED J, V325, P357, DOI 10.1136/bmj.325.7360.357; Huang C, 2002, PHARMACOECONOMICS, V20, P305, DOI 10.2165/00019053-200220050-00002; Huntley AL, 2004, AM J OBSTET GYNECOL, V191, P36, DOI 10.1016/j.ajog.2003.12.008; Impey LWM, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.011; JOUPPILA P, 1982, OBSTET GYNECOL, V59, P158; Lee H, 2004, AM J OBSTET GYNECOL, V191, P1573, DOI 10.1016/j.ajog.2004.05.027; Lieberman E, 1997, PEDIATRICS, V99, P415, DOI 10.1542/peds.99.3.415; Lim Y, 2008, ANESTH ANALG, V107, P1968, DOI 10.1213/ane.0b013e3181887ffb; Liu EHC, 2004, BMJ-BRIT MED J, V328, P1410, DOI 10.1136/bmj.38097.590810.7C; Mazoit JX, 2009, ANESTHESIOLOGY, V110, P380, DOI 10.1097/ALN.0b013e318194b252; MELZACK R, 1984, PAIN, V19, P321, DOI 10.1016/0304-3959(84)90079-4; Miro M, 2008, INT J OBSTET ANESTH, V17, P15, DOI 10.1016/j.ijoa.2007.07.003; Nielsen PE, 1996, ANESTH ANALG, V83, P742, DOI 10.1097/00000539-199610000-00014; Ohel G, 2006, AM J OBSTET GYNECOL, V194, P600, DOI 10.1016/j.ajog.2005.10.821; RAMIN SM, 1995, OBSTET GYNECOL, V86, P783, DOI 10.1016/0029-7844(95)00269-W; Ruppen W, 2006, ANESTHESIOLOGY, V105, P394, DOI 10.1097/00000542-200608000-00023; Scott KD, 1999, AM J OBSTET GYNECOL, V180, P1054, DOI 10.1016/S0002-9378(99)70594-6; Seyb ST, 1999, OBSTET GYNECOL, V94, P600, DOI 10.1016/S0029-7844(99)00377-4; Sharma SK, 2004, ANESTHESIOLOGY, V100, P142, DOI 10.1097/00000542-200401000-00023; SHNIDER SM, 1979, ANESTHESIOLOGY, V50, P524; Soet JE, 2003, BIRTH-ISS PERINAT C, V30, P36, DOI 10.1046/j.1523-536X.2003.00215.x; van der Vyver M, 2002, BRIT J ANAESTH, V89, P459, DOI 10.1093/bja/aef217; Wiklund I, 2009, MIDWIFERY, V25, pE31, DOI 10.1016/j.midw.2007.07.005; Wilson MJA, 2009, BRIT J ANAESTH, V102, P97, DOI 10.1093/bja/aen313; Wong CA, 2005, NEW ENGL J MED, V352, P655, DOI 10.1056/NEJMoa042573; Wong CA, 2009, OBSTET GYNECOL, V113, P1066, DOI 10.1097/AOG.0b013e3181a1a9a8; 2002, OBSTET GYNECOL, V100, P177	54	135	162	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 22	2010	362	16					1503	1510		10.1056/NEJMct0909254	http://dx.doi.org/10.1056/NEJMct0909254			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	586GP	20410515				2022-12-28	WOS:000276894700009
J	Chen, HC; Vermulst, M; Wang, YE; Chomyn, A; Prolla, TA; McCaffery, JM; Chan, DC				Chen, Hsiuchen; Vermulst, Marc; Wang, Yun E.; Chomyn, Anne; Prolla, Tomas A.; McCaffery, J. Michael; Chan, David C.			Mitochondrial Fusion Is Required for mtDNA Stability in Skeletal Muscle and Tolerance of mtDNA Mutations	CELL			English	Article							DOMINANT OPTIC ATROPHY; DYNAMIN-RELATED GTPASE; SUBSTANTIA-NIGRA NEURONS; DNA DELETIONS; FUNCTIONAL MITOCHONDRIA; MEMBRANE FUSION; MICE; DISEASE; FIBERS; OPA1	Mitochondria are highly mobile and dynamic organelles that continually fuse and divide. These processes allow mitochondria to exchange contents, including mitochondrial DNA (mtDNA). Here we examine the functions of mitochondrial fusion in differentiated skeletal muscle through conditional deletion of the mitofusins Mfn1 and Mfn2, mitochondrial GTPases essential for fusion. Loss of the mitofusins causes severe mitochondrial dysfunction, compensatory mitochondrial proliferation, and muscle atrophy. Mutant mice have severe mtDNA depletion in muscle that precedes physiological abnormalities. Moreover, the mitochondrial genomes of the mutant muscle rapidly accumulate point mutations and deletions. In a related experiment, we find that disruption of mitochondrial fusion strongly increases mitochondrial dysfunction and lethality in a mouse model with high levels of mtDNA mutations. With its dual function in safeguarding mtDNA integrity and preserving mtDNA function in the face of mutations, mitochondrial fusion is likely to be a protective factor in human disorders associated with mtDNA mutations.	[Chen, Hsiuchen; Vermulst, Marc; Wang, Yun E.; Chomyn, Anne; Chan, David C.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Chomyn, Anne; Chan, David C.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Prolla, Tomas A.] Univ Wisconsin, Dept Genet & Med Genet, Madison, WI 53706 USA; [McCaffery, J. Michael] Johns Hopkins Univ, Dept Biol, Integrated Imaging Ctr, Baltimore, MD 21218 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; Johns Hopkins University	Chan, DC (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	dchan@caltech.edu			Ellison Medical Foundation; NCRR [1 S10 RR023454-01];  [R01 GM062967]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062967] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. S. Burden and P. Soriano for generously providing the MLC-Cre and Meox2-Cre mouse strains. We are grateful to Igor Antoshechkin, director of the Caltech Genomics Facility, for help with analysis of Solexa sequence data. This work was supported by grants to D. C. C. (R01 grant GM062967 and an Ellison Medical Foundation Senior Scholar Award) and J.M.M. (NCRR grant 1 S10 RR023454-01).	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chomyn A, 2003, BIOCHEM BIOPH RES CO, V304, P519, DOI 10.1016/S0006-291X(03)00625-9; CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Duan S, 2003, J BIOL CHEM, V278, P1346, DOI 10.1074/jbc.M209269200; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gilkerson RW, 2008, J CELL BIOL, V181, P1117, DOI 10.1083/jcb.200712101; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Krishnan KJ, 2007, ANN NY ACAD SCI, V1100, P227, DOI 10.1196/annals.1395.024; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; LYONS GE, 1990, J CELL BIOL, V111, P1465, DOI 10.1083/jcb.111.4.1465; Meeusen S, 2004, SCIENCE, V305, P1747, DOI 10.1126/science.1100612; Meeusen S, 2006, CELL, V127, P383, DOI 10.1016/j.cell.2006.09.021; Nakada K, 2001, BIOCHEM BIOPH RES CO, V288, P743, DOI 10.1006/bbrc.2001.5838; Nakada K, 2009, INT J BIOCHEM CELL B, V41, P1907, DOI 10.1016/j.biocel.2009.05.010; Ogata T, 1997, ANAT REC, V248, P214; Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116; Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150; Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; Vermulst M, 2008, METHODS, V46, P263, DOI 10.1016/j.ymeth.2008.10.008; Villani G, 2001, METHOD CELL BIOL, V65, P119, DOI 10.1016/S0091-679X(01)65007-6; Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com; Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	48	772	790	0	75	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 16	2010	141	2					280	289		10.1016/j.cell.2010.02.026	http://dx.doi.org/10.1016/j.cell.2010.02.026			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	584GF	20403324	Green Accepted, Bronze			2022-12-28	WOS:000276738400018
J	Fontana, L; Partridge, L; Longo, VD				Fontana, Luigi; Partridge, Linda; Longo, Valter D.			Extending Healthy Life Span-From Yeast to Humans	SCIENCE			English	Review							DIETARY RESTRICTION; CALORIE RESTRICTION; DROSOPHILA-MELANOGASTER; STRESS RESISTANCE; I RECEPTOR; EXTENSION; LONGEVITY; TOR; DISRUPTION; MECHANISM	When the food intake of organisms such as yeast and rodents is reduced (dietary restriction), they live longer than organisms fed a normal diet. A similar effect is seen when the activity of nutrient-sensing pathways is reduced by mutations or chemical inhibitors. In rodents, both dietary restriction and decreased nutrient-sensing pathway activity can lower the incidence of age-related loss of function and disease, including tumors and neurodegeneration. Dietary restriction also increases life span and protects against diabetes, cancer, and cardiovascular disease in rhesus monkeys, and in humans it causes changes that protect against these age-related pathologies. Tumors and diabetes are also uncommon in humans with mutations in the growth hormone receptor, and natural genetic variants in nutrient-sensing pathways are associated with increased human life span. Dietary restriction and reduced activity of nutrient-sensing pathways may thus slow aging by similar mechanisms, which have been conserved during evolution. We discuss these findings and their potential application to prevention of age-related disease and promotion of healthy aging in humans, and the challenge of possible negative side effects.	[Fontana, Luigi] Washington Univ, Sch Med, Div Geriatr & Nutr Sci, St Louis, MO 63110 USA; [Fontana, Luigi] Ist Super Sanita, Div Nutr & Aging, I-00161 Rome, Italy; [Partridge, Linda] UCL, Inst Healthy Aging & GEE, London WC1E 6BT, England; [Longo, Valter D.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Longo, Valter D.] Univ So Calif, Andrus Gerontol Ctr, Los Angeles, CA 90089 USA	Washington University (WUSTL); Istituto Superiore di Sanita (ISS); University of London; University College London; University of Southern California; University of Southern California	Fontana, L (corresponding author), Washington Univ, Sch Med, Div Geriatr & Nutr Sci, St Louis, MO 63110 USA.	lfontana@dom.wustl.edu; l.partridge@ucl.ac.uk; vlongo@usc.edu	Partridge, Linda/A-5501-2010; Fontana, Luigi/K-4773-2013; Partridge, Linda/E-7342-2015; Fontana, Luigi/A-8371-2013	Partridge, Linda/0000-0001-9615-0094; Fontana, Luigi/0000-0001-8500-5537	American Federation for Aging Research, Bakewell Foundation; NIH [AG20642, AG025135, GM075308]; National Center for Research Resources [UL1 RR024992]; National Institute of Diabetes and Digestive and Kidney Diseases [P30DK056341]; Istituto Superiore di Sanita/National Institutes of Health Collaboration Program, Ministero della Salute; Longer Life Foundation; Bakewell Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020642, R01AG025135] Funding Source: NIH RePORTER	American Federation for Aging Research, Bakewell Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Istituto Superiore di Sanita/National Institutes of Health Collaboration Program, Ministero della Salute(Ministry of Health, Italy); Longer Life Foundation; Bakewell Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Wei for careful reading of the manuscript. This work was supported in part by a grant from the American Federation for Aging Research, Bakewell Foundation, and by NIH grants AG20642, AG025135, and GM075308 (to V. D. L.). Support was also provided by the National Center for Research Resources (grant UL1 RR024992) and the National Institute of Diabetes and Digestive and Kidney Diseases (grant P30DK056341); by grants from Istituto Superiore di Sanita/National Institutes of Health Collaboration Program, Ministero della Salute, the Longer Life Foundation (an RGA/Washington University Partnership), and the Bakewell Foundation; and by a donation from the Scott and Annie Appleby Charitable Trust (to L. F.).	Amador-Noguez D, 2007, AGING CELL, V6, P453, DOI 10.1111/j.1474-9726.2007.00300.x; Anderson RM, 2009, TOXICOL PATHOL, V37, P47, DOI 10.1177/0192623308329476; Bartke A, 2005, ENDOCRINOLOGY, V146, P3718, DOI 10.1210/en.2005-0411; Bass TM, 2007, J GERONTOL A-BIOL, V62, P1071, DOI 10.1093/gerona/62.10.1071; Bass TM, 2007, MECH AGEING DEV, V128, P546, DOI 10.1016/j.mad.2007.07.007; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Bonafe M, 2003, J CLIN ENDOCR METAB, V88, P3299, DOI 10.1210/jc.2002-021810; Bonkowski MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004567; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Brown-Borg HM, 2007, AGEING RES REV, V6, P28, DOI 10.1016/j.arr.2007.02.005; Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287; Chapman T, 1996, P ROY SOC B-BIOL SCI, V263, P755, DOI 10.1098/rspb.1996.0113; Chen D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000486; Cohen E, 2009, CELL, V139, P1157, DOI 10.1016/j.cell.2009.11.014; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808; Enns LC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005963; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101; Fontana L, 2008, AGING CELL, V7, P681, DOI 10.1111/j.1474-9726.2008.00417.x; Fontana L, 2007, JAMA-J AM MED ASSOC, V297, P986, DOI 10.1001/jama.297.9.986; Garcia AM, 2008, MECH AGEING DEV, V129, P528, DOI 10.1016/j.mad.2008.04.013; Giannakou ME, 2008, AGING CELL, V7, P187, DOI 10.1111/j.1474-9726.2007.00362.x; GOURMELEN M, 1991, ACTA PAEDIATR SCAND, P115; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Ikeno Y, 2009, J GERONTOL A-BIOL, V64, P522, DOI 10.1093/gerona/glp017; Johnson TE, 2008, EXP GERONTOL, V43, P1, DOI 10.1016/j.exger.2007.09.008; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kristan DM, 2008, AGE, V30, P147, DOI 10.1007/s11357-008-9056-1; Kuningas M, 2007, EUR J HUM GENET, V15, P294, DOI 10.1038/sj.ejhg.5201766; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Longo VD, 1997, J CELL BIOL, V137, P1581, DOI 10.1083/jcb.137.7.1581; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; McElwee JJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r132; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; Mehta R, 2009, SCIENCE, V324, P1196, DOI 10.1126/science.1173507; Min KJ, 2008, AGING CELL, V7, P199, DOI 10.1111/j.1474-9726.2008.00373.x; Oliveira JLM, 2007, J CLIN ENDOCR METAB, V92, P4664, DOI 10.1210/jc.2007-1636; Pan Y, 2009, AGING-US, V1, P131, DOI 10.18632/aging.100016; Patel NV, 2005, NEUROBIOL AGING, V26, P995, DOI 10.1016/j.neurobiolaging.2004.09.014; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Pearson KJ, 2008, P NATL ACAD SCI USA, V105, P2325, DOI 10.1073/pnas.0712162105; Piper MDW, 2008, J INTERN MED, V263, P179, DOI 10.1111/j.1365-2796.2007.01906.x; Piper MDW, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030057; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Raffaghello L, 2008, P NATL ACAD SCI USA, V105, P8215, DOI 10.1073/pnas.0708100105; Reed MJ, 1996, MECH AGEING DEV, V89, P21, DOI 10.1016/0047-6374(96)01737-X; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Shevah O, 2007, GROWTH HORM IGF RES, V17, P54, DOI 10.1016/j.ghir.2006.10.007; SHIMOKAWA I, 1993, J GERONTOL, V48, pB27, DOI 10.1093/geronj/48.1.B27; Smith DL, 2007, AGING CELL, V6, P649, DOI 10.1111/j.1474-9726.2007.00326.x; Smith ED, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-49; Steffen KK, 2008, CELL, V133, P292, DOI 10.1016/j.cell.2008.02.037; Steinkraus KA, 2008, AGING CELL, V7, P394, DOI 10.1111/j.1474-9726.2008.00385.x; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Wei M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040013; Wei M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000467; Wong R, 2008, NAT METHODS, V5, P214, DOI 10.1038/nmeth0308-214; Yan L, 2007, CELL, V130, P247, DOI 10.1016/j.cell.2007.05.038	69	1903	1971	14	586	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2010	328	5976					321	326		10.1126/science.1172539	http://dx.doi.org/10.1126/science.1172539			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583NR	20395504	Green Accepted			2022-12-28	WOS:000276685000028
J	McClellan, J; King, MC				McClellan, Jon; King, Mary-Claire			Genetic Heterogeneity in Human Disease	CELL			English	Article							COLORECTAL-CANCER; ASSOCIATION; SCHIZOPHRENIA; AUTISM; VARIANTS; PATHWAYS; RISK; STRATIFICATION; DISORDERS; RS6983267		[McClellan, Jon] Univ Washington, Dept Psychiat, Seattle, WA 98195 USA; [King, Mary-Claire] Univ Washington, Dept Med, Seattle, WA 98195 USA; [King, Mary-Claire] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	McClellan, J (corresponding author), Univ Washington, Dept Psychiat, Seattle, WA 98195 USA.	drjack@uw.edu; mcking@uw.edu		King, Mary-Claire/0000-0001-9426-1743				Bird TD, 2005, NEW ENGL J MED, V352, P862, DOI 10.1056/NEJMp058027; Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Coop G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000500; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Dror AA, 2009, ANNU REV GENET, V43, P411, DOI 10.1146/annurev-genet-102108-134135; Fahmi S, 2008, HUM MOL GENET, V17, P2101, DOI 10.1093/hmg/ddn108; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Galton F., 1872, P R SOC LONDON, V20, P394, DOI DOI 10.1098/RSPL.1871.0075; Geschwind DH, 2008, CELL, V135, P391, DOI 10.1016/j.cell.2008.10.016; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Guilmatre A, 2009, ARCH GEN PSYCHIAT, V66, P947, DOI 10.1001/archgenpsychiatry.2009.80; Gurwitz D, 2007, PHARMACOGENOMICS, V8, P1479, DOI 10.2217/14622416.8.11.1479; Kristiansson K, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-109; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Moser KL, 2009, GENES IMMUN, V10, P373, DOI 10.1038/gene.2009.39; Nachman MW, 2000, GENETICS, V156, P297; OLSON MV, 1995, SCIENCE, V270, P394, DOI 10.1126/science.270.5235.394; Patrinos GR, 2005, HUM MUTAT, V26, P399, DOI 10.1002/humu.20225; Paynter NP, 2010, JAMA-J AM MED ASSOC, V303, P631, DOI 10.1001/jama.2010.119; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinlan RJ, 2008, CURR TOP DEV BIOL, V84, P249, DOI 10.1016/S0070-2153(08)00605-4; RISCH N, 1996, SCIENCE, V273, P1517; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Serre D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001382; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Wright S, 1934, GENETICS, V19, P0537; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162	50	699	729	0	63	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 16	2010	141	2					210	217		10.1016/j.cell.2010.03.032	http://dx.doi.org/10.1016/j.cell.2010.03.032			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	584GF	20403315	Bronze			2022-12-28	WOS:000276738400008
J	Payne, D				Payne, David			US Medical Injury Claims Farewell, 12 good men and true	BRITISH MEDICAL JOURNAL			English	Editorial Material							REFORM		BMJ, London W12 9JR, England		Payne, D (corresponding author), BMJ, London W12 9JR, England.	dpayne@bmj.com						*COMM GOOD, 2009, NEW NAT POLL FINDS M; Elliott ED, 2008, J HEALTH POLIT POLIC, V33, P761, DOI 10.1215/03616878-2008-015; HOWARD TK, 4 WAYS FIX BROKEN LE; Mello MM, 2009, NEW ENGL J MED, V361, P1, DOI 10.1056/NEJMp0903765; Tanne JH, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1176	5	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 16	2010	340								c1881	10.1136/bmj.c1881	http://dx.doi.org/10.1136/bmj.c1881			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	586KE	20400484				2022-12-28	WOS:000276905700002
J	Jacobson, PD; Gostin, LO				Jacobson, Peter D.; Gostin, Lawrence O.			Reducing Distracted Driving Regulation and Education to Avert Traffic Injuries and Fatalities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; [Jacobson, Peter D.] Univ Michigan, Sch Publ Hlth, Dept Hlth Law & Policy, Ann Arbor, MI 48109 USA; [Jacobson, Peter D.] Univ Michigan, Sch Publ Hlth, Ctr Law Eth & Hlth, Ann Arbor, MI 48109 USA	Georgetown University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Drews FA, 2009, HUM FACTORS, V51, P762, DOI 10.1177/0018720809353319; Federal Motor Carrier Safety Administration, 2009, FED MOT CARR SAF ADM; Highway Loss Data Institute, 2009, HAND HELD CELLPH LAW; Hosking S, 2006, 246 MON U ACC RES CT; *INS I HIGHW SAF, CELLPH LAWS; McCartt Anne T, 2006, Traffic Inj Prev, V7, P89, DOI 10.1080/15389580600651103; National Highway Traffic Safety Administration, 2009, 811216 DOT HS NAT HI 811216 DOT HS NAT HI; Virginia Tech Transportation Institute Research, 2009, NEW DAT VTTI PROV IN; 2010, FED REG, V75, P4305; 2009, FED REG, V74, P51225	10	36	36	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2010	303	14					1419	1420		10.1001/jama.2010.414	http://dx.doi.org/10.1001/jama.2010.414			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582KX	20388898				2022-12-28	WOS:000276597300027
J	Lei, Y; Mehmood, F; Lee, S; Greeley, J; Lee, B; Seifert, S; Winans, RE; Elam, JW; Meyer, RJ; Redfern, PC; Teschner, D; Schlogl, R; Pellin, MJ; Curtiss, LA; Vajda, S				Lei, Y.; Mehmood, F.; Lee, S.; Greeley, J.; Lee, B.; Seifert, S.; Winans, R. E.; Elam, J. W.; Meyer, R. J.; Redfern, P. C.; Teschner, D.; Schlogl, R.; Pellin, M. J.; Curtiss, L. A.; Vajda, S.			Increased Silver Activity for Direct Propylene Epoxidation via Subnanometer Size Effects	SCIENCE			English	Article							SELECTIVE PROPENE EPOXIDATION; MOLECULAR-OXYGEN; PARTICLE-SIZE; CATALYSTS; CLUSTERS; SURFACE; REACTIVITY; ETHYLENE; HYDROGEN; TITANIA	Production of the industrial chemical propylene oxide is energy-intensive and environmentally unfriendly. Catalysts based on bulk silver surfaces with direct propylene epoxidation by molecular oxygen have not resolved these problems because of substantial formation of carbon dioxide. We found that unpromoted, size-selected Ag(3) clusters and similar to 3.5-nanometer Ag nanoparticles on alumina supports can catalyze this reaction with only a negligible amount of carbon dioxide formation and with high activity at low temperatures. Density functional calculations show that, relative to extended silver surfaces, oxidized silver trimers are more active and selective for epoxidation because of the open-shell nature of their electronic structure. The results suggest that new architectures based on ultrasmall silver particles may provide highly efficient catalysts for propylene epoxidation.	[Lei, Y.; Lee, S.; Redfern, P. C.; Curtiss, L. A.; Vajda, S.] Argonne Natl Lab, Chem Sci & Engn Div, Argonne, IL 60439 USA; [Lei, Y.; Meyer, R. J.] Univ Illinois, Dept Chem Engn, Chicago, IL 60607 USA; [Mehmood, F.; Pellin, M. J.; Curtiss, L. A.] Argonne Natl Lab, Div Mat Sci, Argonne, IL 60439 USA; [Greeley, J.; Vajda, S.] Argonne Natl Lab, Ctr Nanoscale Mat, Argonne, IL 60439 USA; [Lee, B.; Seifert, S.; Winans, R. E.] Argonne Natl Lab, Xray Sci Div, Argonne, IL 60439 USA; [Elam, J. W.] Argonne Natl Lab, Div Energy Syst, Argonne, IL 60439 USA; [Teschner, D.; Schlogl, R.] Max Planck Gesell, Fritz Haber Inst, Dept Inorgan Chem, D-14195 Berlin, Germany; [Vajda, S.] Yale Univ, Dept Chem Engn, New Haven, CT 06520 USA	United States Department of Energy (DOE); Argonne National Laboratory; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; Max Planck Society; Fritz Haber Institute of the Max Planck Society; Yale University	Curtiss, LA (corresponding author), Argonne Natl Lab, Chem Sci & Engn Div, 9700 S Cass Ave, Argonne, IL 60439 USA.	curtiss@anl.gov; vajda@anl.gov	Pellin, Michael J/B-5897-2008; Vajda, Stefan/U-1865-2019; Lei, Yu/A-2863-2010	Pellin, Michael J/0000-0002-8149-9768; Vajda, Stefan/0000-0002-1879-2099; Lei, Yu/0000-0002-4161-5568; Lee, Sungsik/0000-0002-1425-9852; Winans, Randall/0000-0002-7080-7673	U.S. Department of Energy, Office of Basic Energy (Chemical Sciences, Materials Sciences, and Scientific User Facilities) [DE-AC-02-06CH11357]; American Chemical Society; U.S. Air Force Office of Scientific Research	U.S. Department of Energy, Office of Basic Energy (Chemical Sciences, Materials Sciences, and Scientific User Facilities)(United States Department of Energy (DOE)); American Chemical Society(American Chemical Society); U.S. Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	Work at Argonne National Laboratory was supported by the U.S. Department of Energy, Office of Basic Energy Sciences (Chemical Sciences, Materials Sciences, and Scientific User Facilities), under contract DE-AC-02-06CH11357. We thank the BESSY staff for their support. Also supported by the American Chemical Society Petroleum Research Fund (Y.L. and R.J.M.) and the U.S. Air Force Office of Scientific Research (S. V.). We acknowledge grants of computer time at the Molecular Science Computing Facility at Pacific Northwest National Laboratory and the Laboratory Computing Resource Center at Argonne National Laboratory. A Full Utility Patent Application was filed by Argonne in March 2009, entitled "Subnanometer and Nanometer Catalysts, Method for Preparing Size-Selected Catalyst" (Application 12/402,948).	BARTEAU MA, 1983, J AM CHEM SOC, V105, P344, DOI 10.1021/ja00341a008; Bell AT, 2003, SCIENCE, V299, P1688, DOI 10.1126/science.1083671; Benz L, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1859271; Chen MS, 2004, SCIENCE, V306, P252, DOI 10.1126/science.1102420; de Oliveira AL, 2001, CATAL LETT, V73, P157, DOI 10.1023/A:1016641708074; Dietsche R, 2008, APPL PHYS A-MATER, V90, P395, DOI 10.1007/s00339-007-4344-7; DIETSCHE R, 2009, THESIS U KONSTANZ; Egelhoff WF, 1987, SURF SCI REP, V6, P253, DOI 10.1016/0167-5729(87)90007-0; Elam JW, 2002, THIN SOLID FILMS, V414, P43, DOI 10.1016/S0040-6090(02)00427-3; Gamallo P, 2007, PHYS CHEM CHEM PHYS, V9, P5112, DOI 10.1039/b705452a; Hayashi T, 1998, J CATAL, V178, P566, DOI 10.1006/jcat.1998.2157; Kaden WE, 2009, SCIENCE, V326, P826, DOI 10.1126/science.1180297; Kim DH, 2005, CATAL LETT, V105, P259, DOI 10.1007/s10562-005-8700-y; Lambert RM, 2005, J MOL CATAL A-CHEM, V228, P27, DOI 10.1016/j.molcata.2004.09.077; Lee S, 2009, ANGEW CHEM INT EDIT, V48, P1467, DOI 10.1002/anie.200804154; Lemire C, 2004, ANGEW CHEM INT EDIT, V43, P118, DOI 10.1002/anie.200352538; Linic S, 2003, J AM CHEM SOC, V125, P4034, DOI 10.1021/ja029076g; Lu JQ, 2005, J CATAL, V232, P85, DOI 10.1016/j.jcat.2005.02.013; Luo K, 2005, J PHYS CHEM B, V109, P4064, DOI 10.1021/jp045948k; Luo MF, 2003, CATAL LETT, V86, P43, DOI 10.1023/A:1022650723251; Nijhuis TAR, 2005, ANGEW CHEM INT EDIT, V44, P1115, DOI 10.1002/anie.200462043; Palmer RE, 2003, NAT MATER, V2, P443, DOI 10.1038/nmat897; Serafin JG, 1998, J MOL CATAL A-CHEM, V131, P157, DOI 10.1016/S1381-1169(97)00263-X; Socaciu LD, 2004, J CHEM PHYS, V120, P2078, DOI 10.1063/1.1644103; Takahashi A, 2005, APPL CATAL A-GEN, V294, P34, DOI 10.1016/j.apcata.2005.06.026; Tao F, 2008, SCIENCE, V322, P932, DOI 10.1126/science.1164170; Torres D, 2007, ANGEW CHEM INT EDIT, V46, P2055, DOI 10.1002/anie.200603803; Vajda S, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3237158; Vajda S, 2009, NAT MATER, V8, P213, DOI [10.1038/nmat2384, 10.1038/NMAT2384]; Weissermel K., 2003, IND ORGANIC CHEM, V4th; Winans RE, 2006, TOP CATAL, V39, P145, DOI 10.1007/s11244-006-0050-5; Wodiunig S, 2003, CATAL LETT, V87, P1, DOI 10.1023/A:1022821630812; XU Z, 1994, NATURE, V372, P346, DOI 10.1038/372346a0; Yao W, 2007, CATAL LETT, V119, P185, DOI 10.1007/s10562-007-9220-8; Zemichael FW, 2002, CATAL LETT, V80, P93, DOI 10.1023/A:1015484121891; ZONNEVYLLE MC, 1989, SURF SCI, V223, P233, DOI 10.1016/0039-6028(89)90736-X	36	660	674	20	714	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 9	2010	328	5975					224	228		10.1126/science.1185200	http://dx.doi.org/10.1126/science.1185200			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	580OU	20378815				2022-12-28	WOS:000276459600041
J	Iheanacho, I				Iheanacho, Ike			Rosiglitazone in the UK: down but not out	BRITISH MEDICAL JOURNAL			English	Editorial Material												iiheanacho@bmjgroup.com							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 7	2010	340								c1849	10.1136/bmj.c1849	http://dx.doi.org/10.1136/bmj.c1849			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582ZF	20375092				2022-12-28	WOS:000276639400007
J	Xu, M; Long, CZ; Chen, XZ; Huang, C; Chen, S; Zhu, B				Xu, Mo; Long, Chengzu; Chen, Xiuzhen; Huang, Chang; Chen, She; Zhu, Bing			Partitioning of Histone H3-H4 Tetramers During DNA Replication-Dependent Chromatin Assembly	SCIENCE			English	Article							NEWLY SYNTHESIZED HISTONES; HYBRID NUCLEOSOMES; H3; SEGREGATION; DEPOSITION; H4; METHYLATION; PATHWAYS	Semiconservative DNA replication ensures the faithful duplication of genetic information during cell divisions. However, how epigenetic information carried by histone modifications propagates through mitotic divisions remains elusive. To address this question, the DNA replication-dependent nucleosome partition pattern must be clarified. Here, we report significant amounts of H3.3-H4 tetramers split in vivo, whereas most H3.1-H4 tetramers remained intact. Inhibiting DNA replication-dependent deposition greatly reduced the level of splitting events, which suggests that (i) the replication-independent H3.3 deposition pathway proceeds largely by cooperatively incorporating two new H3.3-H4 dimers and (ii) the majority of splitting events occurred during replication-dependent deposition. Our results support the idea that "silent" histone modifications within large heterochromatic regions are maintained by copying modifications from neighboring preexisting histones without the need for H3-H4 splitting events.	[Xu, Mo; Long, Chengzu; Chen, Xiuzhen; Huang, Chang; Chen, She; Zhu, Bing] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Xu, Mo] Peking Union Med Coll, Grad Program, Beijing 100730, Peoples R China; [Xu, Mo] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Chen, Xiuzhen] Beijing Normal Univ, Life Sci Coll, Beijing 100875, Peoples R China; [Huang, Chang] China Agr Univ, Coll Biol Sci, Dept Biochem, Beijing 100094, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Beijing Normal University; China Agricultural University	Chen, S (corresponding author), Natl Inst Biol Sci, 7 Sci Pk Rd,Zhong Guan Cun Life Sci Pk, Beijing 102206, Peoples R China.	chenshe@nibs.ac.cn; zhubing@nibs.ac.cn		Chen, Xiuzhen/0000-0002-3027-6441	Chinese Ministry of Science and Technology [2007AA02Z1A6, 2007AA02Z1A3]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China)	We thank X. Wang from the Howard Hughes Medical Institute/University of Texas Southwestern Medical Center for critical comments on the manuscript. We thank N. Yang and J. Ni for color illustration. We thank P. Mortensen from the University of Southern Denmark for developing and supporting the MSQuant software. This work was supported by the Chinese Ministry of Science and Technology 863 projects 2007AA02Z1A6 (to B. Z.) and 2007AA02Z1A3 (to S. C.).	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Allis C. D., 2006, EPIGENETICS; ANNUNZIATO AT, 1982, J BIOL CHEM, V257, P8507; Benson LJ, 2006, J BIOL CHEM, V281, P9287, DOI 10.1074/jbc.M512956200; BESTOR TH, 1992, EMBO J, V11, P2611, DOI 10.1002/j.1460-2075.1992.tb05326.x; English CM, 2005, BIOCHEMISTRY-US, V44, P13673, DOI 10.1021/bi051333h; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; JACKSON V, 1981, CELL, V23, P121, DOI 10.1016/0092-8674(81)90277-4; JACKSON V, 1988, BIOCHEMISTRY-US, V27, P2109, DOI 10.1021/bi00406a044; JACKSON V, 1990, BIOCHEMISTRY-US, V29, P719, DOI 10.1021/bi00455a019; JACKSON V, 1981, J BIOL CHEM, V256, P5095; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; LEFFAK IM, 1977, CELL, V12, P837, DOI 10.1016/0092-8674(77)90282-3; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Nakatani Y, 2004, COLD SPRING HARB SYM, V69, P273, DOI 10.1101/sqb.2004.69.273; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; PRIOR CP, 1980, CELL, V20, P597, DOI 10.1016/0092-8674(80)90306-2; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; RUSSEV G, 1981, NUCLEIC ACIDS RES, V9, P4129, DOI 10.1093/nar/9.16.4129; SEALE RL, 1976, CELL, V9, P423, DOI 10.1016/0092-8674(76)90087-8; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; YAMASU K, 1990, J BIOCHEM-TOKYO, V107, P15, DOI 10.1093/oxfordjournals.jbchem.a122999	27	228	233	14	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	2010	328	5974					94	98		10.1126/science.1178994	http://dx.doi.org/10.1126/science.1178994			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577DR	20360108				2022-12-28	WOS:000276202200043
J	Uchida, M; Tonomura, A				Uchida, Masaya; Tonomura, Akira			Generation of electron beams carrying orbital angular momentum	NATURE			English	Article							PHASE PLATE; SCREW DISLOCATIONS; WAVE-FRONTS; LASER-BEAMS; MICROSCOPY; HOLOGRAPHY; PARTICLES; VORTICES; CONTRAST; PHOTONS	All forms of waves can contain phase singularities(1-4). In the case of optical waves, a light beam with a phase singularity carries orbital angular momentum, and such beams have found a range of applications in optical manipulation, quantum information and astronomy(3-9). Here we report the generation of an electron beam with a phase singularity propagating in free space, which we achieve by passing a plane electron wave through a spiral phase plate constructed naturally from a stack of graphite thin films. The interference pattern between the final beam and a plane electron wave in a transmission electron microscope shows the 'Y'-like defect pattern characteristic of a beam carrying a phase singularity with a topological charge equal to one. This fundamentally new electron degree of freedom could find application in a number of research areas, as is the case for polarized electron beams.	[Uchida, Masaya; Tonomura, Akira] RIKEN, Inst Phys & Chem Res, Adv Sci Inst, Wako, Saitama 3510198, Japan	RIKEN	Uchida, M (corresponding author), RIKEN, Inst Phys & Chem Res, Adv Sci Inst, Wako, Saitama 3510198, Japan.	masaya1.uchida@gmail.com						ALLEN L, 1992, PHYS REV A, V45, P8185, DOI 10.1103/PhysRevA.45.8185; Allen L., 2003, OPTICAL ANGULAR MOME; Allen LJ, 2001, ULTRAMICROSCOPY, V88, P85, DOI 10.1016/S0304-3991(01)00072-9; Angelsky OV, 1997, OPT APPL, V27, P273; BASISTIY IV, 1993, OPT COMMUN, V103, P422, DOI 10.1016/0030-4018(93)90168-5; BAZHENOV VY, 1990, JETP LETT+, V52, P429; BEIJERSBERGEN MW, 1993, OPT COMMUN, V96, P123, DOI 10.1016/0030-4018(93)90535-D; BEIJERSBERGEN MW, 1994, OPT COMMUN, V112, P321, DOI 10.1016/0030-4018(94)90638-6; Bliokh KY, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.190404; FUKUHARA A, 1983, PHYS REV B, V27, P1839, DOI 10.1103/PhysRevB.27.1839; Furhapter S, 2005, OPT EXPRESS, V13, P689, DOI 10.1364/OPEX.13.000689; HE H, 1995, PHYS REV LETT, V75, P826, DOI 10.1103/PhysRevLett.75.826; HECKENBERG NR, 1992, OPT LETT, V17, P221, DOI 10.1364/OL.17.000221; KHONINA SN, 1992, J MOD OPTIC, V39, P1147, DOI 10.1080/09500349214551151; Kim GH, 1997, APPL OPTICS, V36, P8614, DOI 10.1364/AO.36.008614; Kotlyar VV, 2006, OPT LETT, V31, P1597, DOI 10.1364/OL.31.001597; Leach J, 2004, NEW J PHYS, V6, DOI 10.1088/1367-2630/6/1/071; Mair A, 2001, NATURE, V412, P313, DOI 10.1038/35085529; Majorovits E, 2007, ULTRAMICROSCOPY, V107, P213, DOI 10.1016/j.ultramic.2006.07.006; Molina-Terriza G, 2007, NAT PHYS, V3, P305, DOI 10.1038/nphys607; NYE JF, 1974, P ROY SOC LOND A MAT, V336, P165, DOI 10.1098/rspa.1974.0012; Nye JF, 1999, NATURAL FOCUSING FIN; Padgett M, 2004, PHYS TODAY, V57, P35, DOI 10.1063/1.1768672; Paterson L, 2001, SCIENCE, V292, P912, DOI 10.1126/science.1058591; SANCHEZ A, 1985, J PHYS C SOLID STATE, V18, P33, DOI 10.1088/0022-3719/18/1/011; Schattschneider P, 2008, ULTRAMICROSCOPY, V109, P91, DOI 10.1016/j.ultramic.2008.08.004; TONOMURA A, 1987, REV MOD PHYS, V59, P639, DOI 10.1103/RevModPhys.59.639; Tonomura A., 1999, ELECT HOLOGRAPHY, Vsecond; Uchida M, 2006, SCIENCE, V311, P359, DOI 10.1126/science.1120639; VOLKL E, 1995, J MICROSC-OXFORD, V180, P39, DOI 10.1111/j.1365-2818.1995.tb03655.x	30	501	521	6	227	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 1	2010	464	7289					737	739		10.1038/nature08904	http://dx.doi.org/10.1038/nature08904			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577EO	20360737				2022-12-28	WOS:000276205000040
J	Hagan, CL; Kim, S; Kahne, D				Hagan, Christine L.; Kim, Seokhee; Kahne, Daniel			Reconstitution of Outer Membrane Protein Assembly from Purified Components	SCIENCE			English	Article							BETA-BARREL PROTEINS; ESCHERICHIA-COLI; YAET COMPLEX; IN-VITRO; TRANSLOCATION; SURA; PROTEOLIPOSOMES; IDENTIFICATION; BIOGENESIS; SECA	beta-barrel membrane proteins in Gram-negative bacteria, mitochondria, and chloroplasts are assembled by highly conserved multi-protein complexes. The mechanism by which these molecular machines fold and insert their substrates is poorly understood. It has not been possible to dissect the folding and insertion pathway because the process has not been reproduced in a biochemical system. We purified the components that fold and insert Escherichia coli outer membrane proteins and reconstituted beta-barrel protein assembly in proteoliposomes using the enzymatic activity of a protein substrate to report on its folding state. The assembly of this protein occurred without an energy source but required a soluble chaperone in addition to the multi-protein assembly complex.	[Hagan, Christine L.; Kim, Seokhee; Kahne, Daniel] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Kahne, Daniel] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School	Kahne, D (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	kahne@chemistry.harvard.edu	Kim, Seokhee/C-2303-2018	Kim, Seokhee/0000-0003-0806-583X	NIH [AI081059]; NSF; Amherst College; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081059] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Amherst College; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Biophysics Resource of the Keck Facility at Yale University performed the size exclusion-light scattering analysis and amino acid analysis. This work is supported by NIH grant AI081059. C. L. H. is supported by a NSF Graduate Research Fellowship and a Kellogg fellowship from Amherst College.	AKIMARU J, 1991, P NATL ACAD SCI USA, V88, P6545, DOI 10.1073/pnas.88.15.6545; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; Burgess NK, 2008, J BIOL CHEM, V283, P26748, DOI 10.1074/jbc.M802754200; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Eggert US, 2001, SCIENCE, V294, P361, DOI 10.1126/science.1063611; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Hennecke G, 2005, J BIOL CHEM, V280, P23540, DOI 10.1074/jbc.M413742200; Ieva R, 2009, P NATL ACAD SCI USA, V106, P19120, DOI 10.1073/pnas.0907912106; Jansen C, 2000, EUR J BIOCHEM, V267, P3792, DOI 10.1046/j.1432-1327.2000.01417.x; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Kleinschmidt JH, 2006, CHEM PHYS LIPIDS, V141, P30, DOI 10.1016/j.chemphyslip.2006.02.004; Kramer RA, 2000, EUR J BIOCHEM, V267, P885, DOI 10.1046/j.1432-1327.2000.01073.x; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; Malinverni JC, 2006, MOL MICROBIOL, V61, P151, DOI 10.1111/j.1365-2958.2006.05211.x; Mogensen JE, 2005, MOL MICROBIOL, V57, P326, DOI 10.1111/j.1365-2958.2005.04674.x; NICCHITTA CV, 1990, CELL, V60, P259, DOI 10.1016/0092-8674(90)90741-V; Onufryk C, 2005, J BACTERIOL, V187, P4552, DOI 10.1128/JB.187.13.4552-4561.2005; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Reumann S, 1999, P NATL ACAD SCI USA, V96, P784, DOI 10.1073/pnas.96.2.784; Rizzitello AE, 2001, J BACTERIOL, V183, P6794, DOI 10.1128/JB.183.23.6794-6800.2001; Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104; Ureta AR, 2007, J BACTERIOL, V189, P446, DOI 10.1128/JB.01103-06; Vertommen D, 2009, PROTEOMICS, V9, P2432, DOI 10.1002/pmic.200800794; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753; Wimley WC, 2003, CURR OPIN STRUC BIOL, V13, P404, DOI 10.1016/S0959-440X(03)00099-X; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Xu XH, 2007, J MOL BIOL, V373, P367, DOI 10.1016/j.jmb.2007.07.069; Yakushi T, 2000, NAT CELL BIOL, V2, P212, DOI 10.1038/35008635	31	195	205	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 14	2010	328	5980					890	892		10.1126/science.1188919	http://dx.doi.org/10.1126/science.1188919			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20378773	Green Accepted			2022-12-28	WOS:000277618800048
J	Brongersma, ML; Shalaev, VM				Brongersma, Mark L.; Shalaev, Vladimir M.			APPLIED PHYSICS The Case for Plasmonics	SCIENCE			English	Editorial Material							SCALE; NANOWIRES; LIGHT		[Brongersma, Mark L.] Stanford Univ, Geballe Lab Adv Mat, Stanford, CA 94305 USA; [Brongersma, Mark L.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA; [Shalaev, Vladimir M.] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; [Shalaev, Vladimir M.] Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA	Stanford University; Stanford University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Brongersma, ML (corresponding author), Stanford Univ, Geballe Lab Adv Mat, Stanford, CA 94305 USA.	brongersma@stanford.edu; shalaev@purdue.edu	Brongersma, Mark L/R-6099-2016; Shalaev, Vladimir M./B-9331-2019	Brongersma, Mark L/0000-0003-1777-8970; Shalaev, Vladimir M./0000-0001-8976-1102				Akimov AV, 2007, NATURE, V450, P402, DOI 10.1038/nature06230; Bergman DJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.027402; BRONGERSMA ML, 1999, MAT RES SOC S P, V502; Cai WS, 2009, NANO LETT, V9, P4403, DOI 10.1021/nl902701b; Cao LY, 2007, NANO LETT, V7, P3523, DOI 10.1021/nl0722370; Challener WA, 2009, NAT PHOTONICS, V3, P220, DOI 10.1038/NPHOTON.2009.26; Ebbesen TW, 1998, NATURE, V391, P667, DOI 10.1038/35570; Engheta N, 2007, SCIENCE, V317, P1698, DOI 10.1126/science.1133268; FLEISCHMANN M, 1974, CHEM PHYS LETT, V26, P163, DOI 10.1016/0009-2614(74)85388-1; Hill MT, 2007, NAT PHOTONICS, V1, P589, DOI 10.1038/nphoton.2007.171; Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100; Hryciw A, 2010, NAT MATER, V9, P3, DOI 10.1038/nmat2598; JEANMAIRE DL, 1977, J ELECTROANAL CHEM, V1, P84, DOI DOI 10.1016/S0022-0728(77)80224-6; MOSKOVITS M, 1978, J CHEM PHYS, V69, P4159, DOI 10.1063/1.437095; Noginov MA, 2009, NATURE, V460, P1110, DOI 10.1038/nature08318; Oulton RF, 2009, NATURE, V461, P629, DOI 10.1038/nature08364; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Shalaev VM, 2008, SCIENCE, V322, P384, DOI 10.1126/science.1166079; Stockman MI, 2010, J OPTICS-UK, V12, DOI 10.1088/2040-8978/12/2/024004; Takahara J, 1997, OPT LETT, V22, P475, DOI 10.1364/OL.22.000475; Tang L, 2008, NAT PHOTONICS, V2, P226, DOI 10.1038/nphoton.2008.30; Zia R, 2006, MATER TODAY, V9, P20, DOI 10.1016/S1369-7021(06)71572-3	22	461	477	6	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 23	2010	328	5977					440	441		10.1126/science.1186905	http://dx.doi.org/10.1126/science.1186905			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YR	20413483				2022-12-28	WOS:000276952400023
J	Krajcik, JS; Sutherland, LM				Krajcik, Joseph S.; Sutherland, LeeAnn M.			Supporting Students in Developing Literacy in Science	SCIENCE			English	Review							MIDDLE SCHOOL; TEXT	Reading, writing, and oral communication are critical literacy practices for participation in a global society. In the context of science inquiry, literacy practices support learners by enabling them to grapple with ideas, share their thoughts, enrich understanding, and solve problems. Here we suggest five instructional and curricular features that can support students in developing literacy in the context of science: (i) linking new ideas to prior knowledge and experiences, (ii) anchoring learning in questions that are meaningful in the lives of students, (iii) connecting multiple representations, (iv) providing opportunities for students to use science ideas, and (v) supporting students' engagement with the discourses of science. These five features will promote students' ability to read, write, and communicate about science so that they can engage in inquiry throughout their lives.	[Krajcik, Joseph S.; Sutherland, LeeAnn M.] Univ Michigan, Sch Educ, Ann Arbor, MI 48109 USA; [Krajcik, Joseph S.] Ewha Womans Univ, Inst Global Sci Technol & Soc Educ, Seoul, South Korea	University of Michigan System; University of Michigan; Ewha Womans University	Krajcik, JS (corresponding author), Univ Michigan, Sch Educ, 610 E Univ Ave, Ann Arbor, MI 48109 USA.	krajcik@umich.edu			NSF [ESI 0439352, ESI 0439494]	NSF(National Science Foundation (NSF))	The opinions expressed are those of the authors. The work was partially funded by grants from the NSF (ESI 0439352 and ESI 0439494).	*AM ASS ADV SCI, 1990, SCI ALL AM PROJ 2061; Blumenfeld PC, 2006, CAMB HANDB PSYCHOL, P475; Bransford J. D, 1999, PEOPLE LEARN BRAIN M; Cervetti G., 2006, LINKING SCI LITERACY, P221; Duschl R. A., 2007, TAKING SCI SCH LEARN, DOI DOI 10.17226/11625; Fox E, 2009, REV EDUC RES, V79, P197, DOI 10.3102/0034654308324654; Gee J. P, 1990, SOCIAL LINGUISTICS L; Hammer D., 2008, TEACHING SCI INQUIRY, P138; Ivey G, 1999, READ RES QUART, V34, P172, DOI 10.1598/RRQ.34.2.3; Kesidou S, 2002, J RES SCI TEACH, V39, P522, DOI 10.1002/tea.10035; KRAJCIK J, 2008, INVESTIGATING QUESTI; Lee HS, 2010, J RES SCI TEACH, V47, P71, DOI 10.1002/tea.20304; Lemke J., 1990, TALKING SCI LANGUAGE; Lemke JL, 1998, HDB LITERACY TECHNOL, P283; Linn M.C., 2006, HDB ED PSYCHOL, P511, DOI [10.4324/9780203874790, DOI 10.4324/9780203874790]; LORCH RF, 1993, J EDUC PSYCHOL, V85, P281, DOI 10.1037/0022-0663.85.2.281; MAGNUSSON SJ, 1995, THEOR PRACT, V34, P43, DOI 10.1080/00405849509543656; Mayer RE, 2009, MULTIMEDIA LEARNING, 2ND EDITION, P1, DOI 10.1017/CBO9780511811678; McNeill K.L., 2007, THINKING DATA P 33 C, P233; McNeill KL, 2009, J LEARN SCI, V18, P416, DOI 10.1080/10508400903013488; *NAT RES COUNC, 1986, NAT SCI ED STAND; Norris SP, 2003, SCI EDUC, V87, P224, DOI 10.1002/sce.10066; Shwartz Y, 2008, ELEM SCHOOL J, V109, P199, DOI 10.1086/590526; Sutherland, 2006, LINKING SCI LITERACY, P163; Sutherland LM, 2008, ELEM SCHOOL J, V109, P162, DOI 10.1086/590524; Wellington J., 2001, LANGUAGE LITERACY SC; Yager R. E., 2004, CROSSING BORDERS LIT, P95	27	99	105	5	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2010	328	5977					456	459		10.1126/science.1182593	http://dx.doi.org/10.1126/science.1182593			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	586YR	20413490				2022-12-28	WOS:000276952400030
J	Schroder, GF; Levitt, M; Brunger, AT				Schroeder, Gunnar F.; Levitt, Michael; Brunger, Axel T.			Super-resolution biomolecular crystallography with low-resolution data	NATURE			English	Article							STRUCTURE REFINEMENT; ENERGY MINIMIZATION; PHASE DETERMINATION; NORMAL-MODES; PROTEIN; LIKELIHOOD; RIBONUCLEASE; DYNAMICS	X-ray diffraction plays a pivotal role in the understanding of biological systems by revealing atomic structures of proteins, nucleic acids and their complexes, with much recent interest in very large assemblies like the ribosome. As crystals of such large assemblies often diffract weakly (resolution worse than 4 angstrom), we need methods that work at such low resolution. In macromolecular assemblies, some of the components may be known at high resolution, whereas others are unknown: current refinement methods fail as they require a high-resolution starting structure for the entire complex(1). Determining the structure of such complexes, which are often of key biological importance, should be possible in principle as the number of independent diffraction intensities at a resolution better than 5 angstrom generally exceeds the number of degrees of freedom. Here we introduce a method that adds specific information from known homologous structures but allows global and local deformations of these homology models. Our approach uses the observation that local protein structure tends to be conserved as sequence and function evolve. Cross-validation with R-free ( the free R-factor) determines the optimum deformation and influence of the homology model. For test cases at 3.5-5 angstrom resolution with known structures at high resolution, our method gives significant improvements over conventional refinement in the model as monitored by coordinate accuracy, the definition of secondary structure and the quality of electron density maps. For re-refinements of a representative set of 19 low-resolution crystal structures from the Protein Data Bank, we find similar improvements. Thus, a structure derived from low-resolution diffraction data can have quality similar to a high-resolution structure. Our method is applicable to the study of weakly diffracting crystals using X-ray micro-diffraction(2) as well as data from new X-ray light sources(3). Use of homology information is not restricted to X-ray crystallography and cryo-electron microscopy: as optical imaging advances to subnanometre resolution(4,5), it can use similar tools.	[Schroeder, Gunnar F.] Forschungszentrum Julich, Inst Strukturbiol & Biophys ISB 3, D-52425 Julich, Germany; [Schroeder, Gunnar F.; Levitt, Michael; Brunger, Axel T.] Stanford Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Brunger, Axel T.] Stanford Univ, Howard Hughes Med Inst, James H Clark Ctr E300, Stanford, CA 94305 USA; [Brunger, Axel T.] Stanford Univ, Dept Mol & Cellular Physiol, James H Clark Ctr E300, Stanford, CA 94305 USA; [Brunger, Axel T.] Stanford Univ, Dept Neurol & Neurol Sci, James H Clark Ctr E300, Stanford, CA 94305 USA; [Brunger, Axel T.] Stanford Univ, Dept Photon Sci, James H Clark Ctr E300, Stanford, CA 94305 USA	Helmholtz Association; Research Center Julich; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University	Schroder, GF (corresponding author), Forschungszentrum Julich, Inst Strukturbiol & Biophys ISB 3, D-52425 Julich, Germany.	gu.schroeder@fz-juelich.de; brunger@stanford.edu	Schröder, Gunnar F/H-5261-2013; Levitt, Michael/E-4582-2012	Schröder, Gunnar F/0000-0003-1803-5431; Levitt, Michael/0000-0002-8414-7397; Brunger, Axel/0000-0001-5121-2036	National Science Foundation [CNS-0619926]; National Institutes of Health [PN2 (EY016525), GM63718]; Deutsche Forschungsgemeinschaft (DFG); NATIONAL EYE INSTITUTE [PN1EY016525, PN2EY016525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063817, U54GM072970] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. D. Adams, S. C. Harrison and T. D. Fenn for discussions. We also thank the National Science Foundation for computing resources (CNS-0619926), the National Institutes of Health for both Roadmap Grant PN2 (EY016525) and grant GM63718 to M. L., and the Deutsche Forschungsgemeinschaft (DFG) for support for G. F. S.	Adams PD, 1999, ACTA CRYSTALLOGR D, V55, P181, DOI 10.1107/S0907444998006635; BRICOGNE G, 1990, ACTA CRYSTALLOGR A, V46, P284, DOI 10.1107/S0108767389012882; BRUNGER AT, 1988, J MOL BIOL, V203, P803, DOI 10.1016/0022-2836(88)90211-2; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Davies JM, 2008, STRUCTURE, V16, P715, DOI 10.1016/j.str.2008.02.010; DeLano W.L, PYMOL MOL GRAPHICS S; Delarue M, 2004, P NATL ACAD SCI USA, V101, P6957, DOI 10.1073/pnas.0400301101; DIAMOND R, 1990, ACTA CRYSTALLOGR A, V46, P425, DOI 10.1107/S0108767390002082; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; GIBSON KD, 1967, P NATL ACAD SCI USA, V58, P420, DOI 10.1073/pnas.58.2.420; JACK A, 1978, ACTA CRYSTALLOGR A, V34, P931, DOI 10.1107/S0567739478001904; JAMES MNG, 1983, J MOL BIOL, V163, P299, DOI 10.1016/0022-2836(83)90008-6; KARLE J, 1956, ACTA CRYSTALLOGR, V9, P635, DOI 10.1107/S0365110X56001741; KONNERT JH, 1980, ACTA CRYSTALLOGR A, V36, P344, DOI 10.1107/S0567739480000794; LEVITT M, 1983, J MOL BIOL, V170, P723, DOI 10.1016/S0022-2836(83)80129-6; LEVITT M, 1969, J MOL BIOL, V46, P269, DOI 10.1016/0022-2836(69)90421-5; LEVITT M, 1985, J MOL BIOL, V181, P423, DOI 10.1016/0022-2836(85)90230-X; LEVITT M, 1992, J MOL BIOL, V226, P507, DOI 10.1016/0022-2836(92)90964-L; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; Moerner WE, 2007, P NATL ACAD SCI USA, V104, P12596, DOI 10.1073/pnas.0610081104; Pannu NS, 1998, ACTA CRYSTALLOGR D, V54, P1285, DOI 10.1107/S0907444998004119; Pannu NS, 1996, ACTA CRYSTALLOGR A, V52, P659, DOI 10.1107/S0108767396004370; PEARL L, 1984, FEBS LETT, V174, P96, DOI 10.1016/0014-5793(84)81085-6; PERTSINIDIS A, NATURE UNPUB; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; Raines KS, 2010, NATURE, V463, P214, DOI 10.1038/nature08705; RICE LM, 1994, PROTEINS, V19, P277, DOI 10.1002/prot.340190403; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanishvili R, 2008, ACTA CRYSTALLOGR D, V64, P425, DOI 10.1107/S0907444908001741; Schroder GF, 2007, STRUCTURE, V15, P1630, DOI 10.1016/j.str.2007.09.021; SUSSMAN JL, 1977, ACTA CRYSTALLOGR A, V33, P800, DOI 10.1107/S0567739477001958; Tama F, 2004, J STRUCT BIOL, V147, P315, DOI 10.1016/j.jsb.2004.03.002; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	39	232	235	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2010	464	7292					1218	U146		10.1038/nature08892	http://dx.doi.org/10.1038/nature08892			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20376006	Green Accepted			2022-12-28	WOS:000276891100043
J	Kanji, JN; Anglin, RES; Hunt, DL; Panju, A				Kanji, Jamil N.; Anglin, Rebecca E. S.; Hunt, Dereck L.; Panju, Akbar			Does This Patient With Diabetes Have Large-Fiber Peripheral Neuropathy?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; CLINICAL EXAMINATION; DISTAL POLYNEUROPATHY; DIAGNOSTIC-CRITERIA; FOOT ULCERATION; SENSATION; POPULATION; PREVALENCE; VALIDATION; ULCERS	Context Diabetic peripheral neuropathy predisposes patients to foot ulceration that heals poorly and too often leads to amputation. Large-fiber peripheral neuropathy (LFPN), one common form of diabetic neuropathy, when detected early prompts aggressive measures to prevent progression to foot ulceration and its associated morbidity and mortality. Objective To systematically review the literature to determine the clinical examination findings predictive of asymptomatic LFPN before foot ulceration develops. Data Sources, Study Selection, and Data Extraction MEDLINE (January 1966-November 2009) and EMBASE (1980-2009 [week 50]) databases were searched for articles on bedside diagnosis of diabetic peripheral neuropathy. Included studies compared elements of history or physical examination with nerve conduction testing as the reference standard. Data Synthesis Of 1388 articles, 9 on diagnostic accuracy and 3 on precision met inclusion criteria. The prevalence of diabetic LFPN ranged from 23% to 79%. A score greater than 4 on a symptom questionnaire developed by the Italian Society of Diabetology increases the likelihood of LFPN (likelihood ratio [LR], 4.0; 95% confidence interval [CI], 2.9-5.6; negative LR, 0.19; 95% CI, 0.10-0.38). The most useful examination findings were vibration perception with a 128-Hz tuning fork (LR range, 1635) and pressure sensation with a 5.07 Semmes-Weinstein monofilament (LR range, 11-16). Normal results on vibration testing (LR range, 0.33-0.51) or monofilament (LR range, 0.09-0.54) make LFPN less likely. Combinations of signs did not perform better than these 2 individual findings. Conclusions Physical examination is most useful in evaluating for LFPN in patients with diabetes. Abnormal results on monofilament testing and vibratory perception (alone or in combination with the appearance of the feet, ulceration, and ankle reflexes) are the most helpful signs. JAMA. 2010;303(15):1526-1532 www.jama.com	[Kanji, Jamil N.; Hunt, Dereck L.; Panju, Akbar] McMaster Univ, Dept Med, Hamilton, ON L8V 1C3, Canada; [Anglin, Rebecca E. S.] McMaster Univ, Dept Psychiat & Behav Sci, Hamilton, ON L8V 1C3, Canada; [Hunt, Dereck L.; Panju, Akbar] Hamilton Hlth Sci, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Panju, A (corresponding author), McMaster Univ, Dept Med, Hamilton Hlth Sci Henderson Site,711 Concess St, Hamilton, ON L8V 1C3, Canada.	panju@hhsc.ca		Kanji, Jamil/0000-0002-1043-6807; Anglin, Rebecca/0000-0001-9926-1881	Physician Services Inc; Hamilton Health Sciences New Investigator Fund	Physician Services Inc; Hamilton Health Sciences New Investigator Fund	Dr Anglin reports having received grants from Physician Services Inc and the Hamilton Health Sciences New Investigator Fund; however, these funds were not used toward this research. Dr Panju reports having received honoraria and served on advisory boards for Bayer, Sanofi-Aventis, AstraZeneca, and Boehringer Ingelheim. No other disclosures were reported.	[Anonymous], 2007, EVIDENCE BASED PHYS; BEGHI E, 1988, ITAL J NEUROL SCI, V9, P577, DOI 10.1007/BF02337012; BIRKE JA, 1986, LEPROSY REV, V57, P261; BOULTON AJ, 2000, CAN J DIABETES CA S2, V24, P67; BRIL V, 2000, CAN J DIABETES CA S2, V24, P67; Butalia S, 2008, JAMA-J AM MED ASSOC, V299, P806, DOI 10.1001/jama.299.7.806; Coffey JT, 2002, DIABETES CARE, V25, P2238, DOI 10.2337/diacare.25.12.2238; Cornblath DR, 1999, NEUROLOGY, V53, P1660, DOI 10.1212/WNL.53.8.1660; Costa LA, 2006, DIABETES RES CLIN PR, V73, P292, DOI 10.1016/j.diabres.2006.02.005; Currie CJ, 2006, DIABETOLOGIA, V49, P2272, DOI 10.1007/s00125-006-0380-7; DYCK PJ, 1991, NEUROLOGY, V41, P799, DOI 10.1212/WNL.41.6.799; DYCK PJ, 1980, ANN NEUROL, V8, P590, DOI 10.1002/ana.410080608; DYCK PJ, 1988, MUSCLE NERVE, V11, P21, DOI 10.1002/mus.880110106; GENTILE S, 1995, ACTA DIABETOL, V32, P7, DOI 10.1007/BF00581037; Hoitsma E, 2004, J NEUROL SCI, V227, P119, DOI 10.1016/j.jns.2004.08.012; Hsu WC, 2005, NEUROEPIDEMIOLOGY, V25, P1, DOI 10.1159/000085306; International Working Group on the Diabetic Foot, 2012, PRACT GUID MAN PREV; KUMAR S, 1994, DIABETIC MED, V11, P480, DOI 10.1111/j.1464-5491.1994.tb00310.x; Lee SY, 2003, J KOREAN MED SCI, V18, P103; MASER RE, 1989, DIABETES CARE, V12, P270, DOI 10.2337/diacare.12.4.270; McIntosh A, 2003, CLIN GUIDELINES TYPE; Moghtaderi A, 2006, CLIN NEUROL NEUROSUR, V108, P477, DOI 10.1016/j.clineuro.2005.08.003; *NAT DIAB ED PROGR, FEET CAN LAST LIF HL; O'Neill J, 2006, INT J CLIN PRACT, V60, P174, DOI 10.1111/j.1368-5031.2005.00650.x; Papanas N, 2007, J DIABETES COMPLICAT, V21, P353, DOI 10.1016/j.jdiacomp.2006.08.003; Park TS, 2004, DIABETES RES CLIN PR, V66, pS53, DOI 10.1016/j.diabres.2003.12.009; PECORARO RE, 1990, DIABETES CARE, V13, P513, DOI 10.2337/diacare.13.5.513; Perkins BA, 2003, CLIN NEUROPHYSIOL, V114, P1167, DOI 10.1016/S1388-2457(03)00025-7; Perkins BA, 2001, DIABETES CARE, V24, P250, DOI 10.2337/diacare.24.2.250; Ramsey SD, 1999, DIABETES CARE, V22, P382, DOI 10.2337/diacare.22.3.382; Saltzman CL, 2004, J BONE JOINT SURG AM, V86A, P717, DOI 10.2106/00004623-200404000-00008; Scadding J, 2003, ACNR, V3, P8; Shin JB, 2000, J KOREAN MED SCI, V15, P78, DOI 10.3346/jkms.2000.15.1.78; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217; Smieja M, 1999, J GEN INTERN MED, V14, P418, DOI 10.1046/j.1525-1497.1999.05208.x; Tavee J, 2009, CLEV CLIN J MED, V76, P297, DOI 10.3949/ccjm.76a.08070; YOUNG MJ, 1994, DIABETES CARE, V17, P557, DOI 10.2337/diacare.17.6.557	38	39	41	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2010	303	15					1526	1532		10.1001/jama.2010.428	http://dx.doi.org/10.1001/jama.2010.428			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585SJ	20407062				2022-12-28	WOS:000276849000029
J	Koek, MBG; Sigurdsson, V; van Weelden, H; Steegmans, PHA; Bruijnzeel-Koomen, CAFM; Buskens, E				Koek, Mayke B. G.; Sigurdsson, Vigfus; van Weelden, Huib; Steegmans, Paul H. A.; Bruijnzeel-Koomen, Carla A. F. M.; Buskens, Erik			Cost effectiveness of home ultraviolet B phototherapy for psoriasis: economic evaluation of a randomised controlled trial (PLUTO study)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EARLY MYCOSIS-FUNGOIDES; UVB PHOTOTHERAPY; HEALTH-CARE; PATIENT; PRODUCTIVITY; GUIDELINES; MANAGEMENT; ACITRETIN; SEVERITY; MODERATE	Objective To assess the costs and cost effectiveness of phototherapy with ultraviolet B light provided at home compared with outpatient ultraviolet B phototherapy for psoriasis. Design Cost utility, cost effectiveness, and cost minimisation analyses performed alongside a pragmatic randomised clinical trial (the PLUTO study) at the end of phototherapy (mean 17.6 weeks) and at one year after the end of phototherapy (mean 68.4 weeks). Setting Secondary care, provided by a dermatologist in the Netherlands. Participants 196 adults with psoriasis who were clinically eligible for narrowband (TL-01) ultraviolet B phototherapy were recruited from the dermatology departments of 14 hospitals and were followed until the end of phototherapy. From the end of phototherapy onwards, follow-up was continued for an unselected, consecutive group of 105 patients for one year after end of phototherapy. Interventions Ultraviolet B phototherapy provided at home (intervention) and conventional outpatient ultraviolet B phototherapy (control) in a setting reflecting routine practice in the Netherlands. Both treatments used narrowband ultraviolet B lamps (TL-01). Main outcome measures Total costs to society, quality adjusted life years (QALYs) as calculated using utilities measured by the EQ-5D questionnaire, and the number of days with a relevant treatment effect (>= 50% improvement of the baseline self administered psoriasis area and severity index (SAPASI)). Results Home phototherapy is at least as effective and safe as outpatient phototherapy, therefore allowing cost minimisation analyses (simply comparing costs). The average total costs by the end of phototherapy were (sic)800 for home treatment and (sic)752 for outpatient treatment, showing an incremental cost per patient of (sic)48 (95% CI (sic)-77 to (sic)174). The average total costs by one year after the end of phototherapy were (sic)1272 and (sic)1148 respectively (difference (sic)124, 95% CI (sic)-155 to (sic)403). Cost utility analyses revealed that patients experienced equal health benefits-that is, a gain of 0.296 versus 0.291 QALY (home v outpatient) by the end of phototherapy (difference 0.0052, -0.0244 to 0.0348) and 1.153 versus 1.126 QALY by one year after the end of phototherapy (difference 0.0267, -0.024 to 0.078). Incremental costs per QALY gained were (sic)9276 and (sic)4646 respectively, both amounts well below the normally accepted standard of (sic)20 000 per QALY. Cost effectiveness analyses indicated that the mean number of days with a relevant treatment effect was 42.4 versus 55.3 by the end of phototherapy (difference -12.9, -23.4 to -2.4). By one year after the end of phototherapy the number of days with a relevant treatment effect were 216.5 and 210.4 respectively (6.1, -41.1 to 53.2), yielding an incremental cost of (sic)20 per additional day with a relevant treatment effect. Conclusions Home ultraviolet B phototherapy for psoriasis is not more expensive than phototherapy in an outpatient setting and proved to be cost effective. As both treatments are at least equally effective and patients express a preference for home treatment, the authors conclude that home phototherapy should be the primary treatment option for patients who are eligible for phototherapy with ultraviolet B light.	[Koek, Mayke B. G.; Sigurdsson, Vigfus; van Weelden, Huib; Bruijnzeel-Koomen, Carla A. F. M.] Univ Med Ctr Utrecht, Dept Dermatol Allergol G02 124, NL-3584 CX Utrecht, Netherlands; [Steegmans, Paul H. A.] St Antonius Hosp, Dept Dermatol, NL-3435 CM Nieuwegein, Netherlands; [Buskens, Erik] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9713 GZ Groningen, Netherlands; [Buskens, Erik] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; St. Antonius Hospital Utrecht; University of Groningen; Utrecht University; Utrecht University Medical Center	Koek, MBG (corresponding author), Univ Med Ctr Utrecht, Dept Dermatol Allergol G02 124, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	author@koek.com			Netherlands Organisation for Health Research and Development (ZonMW) [945-02-017]	Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	This study was supported by grant 945-02-017 from the Netherlands Organisation for Health Research and Development (ZonMW). ZonMW had no role in the study design; collection, analysis, and interpretation of data; production of the manuscript; or the decision to submit the article for publication. The researchers are independent from the funders.	ABEL EA, 1985, CUTIS, V35, P127; Anstey A, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b607; Barbagallo J, 2001, CUTIS, V68, P345; Bilsland D, 1997, BRIT J DERMATOL, V137, P327, DOI 10.1046/j.1365-2133.1997.18441939.x; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Brazier J, 2004, HEALTH ECON, V13, P873, DOI 10.1002/hec.866; Cameron H, 2002, BRIT J DERMATOL, V147, P957, DOI 10.1046/j.1365-2133.2002.04860.x; de Rie MA, 2001, DERMATOLOGY, V202, P38, DOI 10.1159/000051583; *DUTCH HLTH CAR IN, 2003, MED GUID 2003; Feldman SR, 1996, J INVEST DERMATOL, V106, P183, DOI 10.1111/1523-1747.ep12329912; Feldman SR, 2003, EXPERT OPIN PHARMACO, V4, P1525, DOI 10.1517/eoph.4.9.1525.21059; Feldman SR, 1996, CUTIS, V58, P71; Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903; FLEISCHER AB, 1994, J INVEST DERMATOL, V102, P967, DOI 10.1111/1523-1747.ep12384205; Fleischer Alan B. Jr., 1999, Journal of Dermatology (Tokyo), V26, P210; FREDRIKSSON T, 1978, DERMATOLOGICA, V157, P238, DOI 10.1159/000250839; Ibbotson SH, 2004, BRIT J DERMATOL, V151, P283, DOI 10.1111/j.1365-2133.2004.06128.x; Jacob-Tacken KHM, 2005, HEALTH ECON, V14, P435, DOI 10.1002/hec.948; JORDAN WP, 1981, J AM ACAD DERMATOL, V4, P584, DOI 10.1016/S0190-9622(81)70061-6; Koek Mayke B G, 2006, BMC Med Res Methodol, V6, P39, DOI 10.1186/1471-2288-6-39; Koek MBG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1542; Koek MBG, 2006, BRIT J DERMATOL, V154, P701, DOI 10.1111/j.1365-2133.2006.07136.x; LARKO O, 1979, BRIT J DERMATOL, V101, P13, DOI 10.1111/j.1365-2133.1979.tb15286.x; LOWE NJ, 1992, SEMIN DERMATOL, V11, P284; MATTO DM, 2003, MED CONTACT, V58, P950; MILSTEIN HJ, 1982, J AM ACAD DERMATOL, V6, P355, DOI 10.1016/S0190-9622(82)70029-5; Naldi L, 2005, BRIT J DERMATOL, V152, P597, DOI 10.1111/j.1365-2133.2005.06563.x; *NAT HLTH TAR AUTH, 2006, ONL PRIC LISTS; Oostenbrink JB, 2004, MANUAL COSTING METHO; RESNIK KS, 1993, J AM ACAD DERMATOL, V29, P73, DOI 10.1016/0190-9622(93)70155-M; *ROYAL DUTCH ASS A, 2006, PRIC REIMB SYST MED; Severens JL, 1998, ALIMENT PHARM THERAP, V12, P919, DOI 10.1046/j.1365-2036.1998.00376.x; Simpson GL, 2006, J DERMATOL TREAT, V17, P359, DOI 10.1080/09546630601028786; Spuls PI, 1998, ARCH DERMATOL, V134, P1591, DOI 10.1001/archderm.134.12.1591; *STAT NETH CBS, 2006, ZORGR KEMC UITG CONF; *TASK FORC PSOR NE, 2004, GUID PHOT SYST THER; van Vloten W A, 1993, Ned Tijdschr Geneeskd, V137, P2525; vanRoijen L, 1996, INT J TECHNOL ASSESS, V12, P405, DOI 10.1017/S0266462300009764; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Yelverton CB, 2008, ARCH DERMATOL, V144, P1224, DOI 10.1001/archderm.144.9.1224; Simpson Jason F, 2006, Manag Care Interface, V19, P39; Yentzer BA, 2008, J AM ACAD DERMATOL, V59, P577, DOI 10.1016/j.jaad.2008.06.007; *ZORG ZEK, 2008, ONL LIST TAR REIMB; 1991, NATL PSORIASIS FDN B, V22, P15	44	35	35	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 20	2010	340								c1490	10.1136/bmj.c1490	http://dx.doi.org/10.1136/bmj.c1490			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	589HM	20406865	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000277137700002
J	Bennett, EJ; Harper, JW				Bennett, Eric J.; Harper, J. Wade			Ubiquitin Gets CARDed	CELL			English	Editorial Material									[Bennett, Eric J.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Harper, JW (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	wade_harper@hms.harvard.edu		Harper, Jeffrey/0000-0002-6944-7236	NIA NIH HHS [R01 AG011085] Funding Source: Medline; NIGMS NIH HHS [R01 GM070565] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Moore CB, 2008, IMMUNITY, V28, P735, DOI 10.1016/j.immuni.2008.05.005; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yoneyama M, 2008, IMMUNITY, V29, P178, DOI 10.1016/j.immuni.2008.07.009; Zeng WW, 2009, MOL CELL, V36, P315, DOI 10.1016/j.molcel.2009.09.037	7	3	3	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2010	141	2					220	222		10.1016/j.cell.2010.03.047	http://dx.doi.org/10.1016/j.cell.2010.03.047			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	584GF	20403317	Bronze			2022-12-28	WOS:000276738400010
J	Saito, M; Sakaguchi, M; Tajima, T; Ishimura, K; Nagase, S; Hada, M				Saito, Masaichi; Sakaguchi, Masafumi; Tajima, Tomoyuki; Ishimura, Kazuya; Nagase, Shigeru; Hada, Masahiko			Dilithioplumbole: A Lead-Bearing Aromatic Cyclopentadienyl Analog	SCIENCE			English	Article							INDEPENDENT CHEMICAL-SHIFTS; HEAVIER GROUP-14 ELEMENTS; MOLECULAR-ORBITAL METHODS; PROJECTION OPERATORS; BASIS-SET; DIANIONS; SYSTEM; STABILIZATION; METALLOLES; COMPOUND	Although the concept of aromaticity has long played an important role in carbon chemistry, it has been unclear how applicable the stabilizing framework is to the heaviest elements. Here we report the synthesis of dilithiotetraphenylplumbole by reduction of hexaphenylplumbole. X-ray crystallography revealed a planar structure with no alternation of carbon-carbon bond lengths in the five-membered ring core. Nuclear magnetic resonance spectra and relativistic theoretical calculations show considerable aromatic character in the molecule, thus extending aromaticity to carbon's heaviest congener.	[Saito, Masaichi; Sakaguchi, Masafumi; Tajima, Tomoyuki] Saitama Univ, Grad Sch Sci & Engn, Dept Chem, Sakura Ku, Saitama 3388570, Japan; [Ishimura, Kazuya; Nagase, Shigeru] Inst Mol Sci, Dept Theoret Mol & Computat Sci, Okazaki, Aichi 4448585, Japan; [Hada, Masahiko] Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Dept Chem, Tokyo 1920397, Japan	Saitama University; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Tokyo Metropolitan University	Saito, M (corresponding author), Saitama Univ, Grad Sch Sci & Engn, Dept Chem, Sakura Ku, Saitama 3388570, Japan.	masaichi@chem.saitama-u.ac.jp	Tajima, Tomoyuki/B-1844-2011; Hada, Masahiko/AAJ-8931-2020; Saito, Masaichi/N-9607-2013	Tajima, Tomoyuki/0000-0002-9078-7577; Hada, Masahiko/0000-0003-2752-2442; Saito, Masaichi/0000-0001-6176-3034; Ishimura, Kazuya/0000-0003-0855-9303	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20038010, 18066017, 19029037]; Toray Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Toray Science Foundation(Toray Industries, Inc.)	This work was partially supported by Grants-in-Aid for Scientific Research (no. 20038010 to M. S., no. 18066017 to S.N., and no. 19029037 to M. H.) in Priority Areas "Molecular Theory for Real Systems" and by the Nanotechnology Support Project from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. M. S. acknowledges a research grant from Toray Science Foundation. Deposition nos. CCDC-750458 and 750459 contain the supplementary crystallographic data for compounds 1 and 4, respectively. These data can be obtained free of charge at www.ccdc.cam.ac.uk/conts/retrieving. html (or from the Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax, 44-1223-336-033; e-mail, deposit@ccdc.cam.ac.uk).	ASHE AJ, 1982, J AM CHEM SOC, V104, P5693, DOI 10.1021/ja00385a024; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Chen ZF, 2005, CHEM REV, V105, P3842, DOI 10.1021/cr030088+; DOUGLAS M, 1974, ANN PHYS-NEW YORK, V82, P89, DOI 10.1016/0003-4916(74)90333-9; Dubac J., 1998, CHEM ORGANIC SILICON, P1961; Dunning Jr T. H., 1977, METHODS ELECT STRUCT, V2; EDLUND U, 1987, J AM CHEM SOC, V109, P5982, DOI 10.1021/ja00254a015; Frisch M.J., 2016, GAUSSIAN16 REV B01; Goldfuss B, 1997, ORGANOMETALLICS, V16, P1543, DOI 10.1021/om960994v; Goldfuss B, 1996, ORGANOMETALLICS, V15, P1755, DOI 10.1021/om9503306; HEHRE WJ, 1972, J CHEM PHYS, V56, P2257, DOI 10.1063/1.1677527; HESS BA, 1985, PHYS REV A, V32, P756, DOI 10.1103/PhysRevA.32.756; HESS BA, 1986, PHYS REV A, V33, P3742, DOI 10.1103/PhysRevA.33.3742; HONG JH, 1994, ORGANOMETALLICS, V13, P3387, DOI 10.1021/om00021a005; Ichinohe M, 2005, J AM CHEM SOC, V127, P9978, DOI 10.1021/ja053202+; Igarashi M, 2007, J AM CHEM SOC, V129, P12660, DOI 10.1021/ja075740n; KRISHNAN R, 1980, J CHEM PHYS, V72, P650, DOI 10.1063/1.438955; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lee VY, 2007, ANGEW CHEM INT EDIT, V46, P6596, DOI 10.1002/anie.200604869; Lee VY, 2005, J AM CHEM SOC, V127, P13142, DOI 10.1021/ja054398g; Lee VY, 2004, J AM CHEM SOC, V126, P4758, DOI 10.1021/ja030662z; LI XW, 1995, J AM CHEM SOC, V117, P7578, DOI 10.1021/ja00133a045; Mizuhata Y, 2006, J AM CHEM SOC, V128, P1050, DOI 10.1021/ja057531d; Roos BO, 2004, J PHYS CHEM A, V108, P2851, DOI 10.1021/jp031064+; Saito M, 2005, ANGEW CHEM INT EDIT, V44, P6553, DOI 10.1002/anie.200501632; Saito M, 2005, COORDIN CHEM REV, V249, P765, DOI 10.1016/j.ccr.2004.08.004; Saito M, 2010, PHOSPHORUS SULFUR, V185, P1068, DOI 10.1080/10426501003773399; Schleyer PV, 1996, J AM CHEM SOC, V118, P6317, DOI 10.1021/ja960582d; Sekiguchi A, 1997, SCIENCE, V275, P60, DOI 10.1126/science.275.5296.60; Tokitoh N, 2004, B CHEM SOC JPN, V77, P429, DOI 10.1246/bcsj.77.429; Tokitoh N, 2004, ACCOUNTS CHEM RES, V37, P86, DOI 10.1021/ar020093k; WADT WR, 1985, J CHEM PHYS, V82, P284, DOI 10.1063/1.448800; Yasuda H, 2009, J AM CHEM SOC, V131, P6352, DOI 10.1021/ja901881z	33	82	82	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 16	2010	328	5976					339	342		10.1126/science.1183648	http://dx.doi.org/10.1126/science.1183648			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	583NR	20395505				2022-12-28	WOS:000276685000032
J	Colombel, JF; Sandborn, WJ; Reinisch, W; Mantzaris, GJ; Kornbluth, A; Rachmilewitz, D; Lichtiger, S; D'Haens, G; Diamond, RH; Broussard, DL; Tang, KL; van der Woude, CJ; Rutgeerts, P				Colombel, Jean Frederic; Sandborn, William J.; Reinisch, Walter; Mantzaris, Gerassimos J.; Kornbluth, Asher; Rachmilewitz, Daniel; Lichtiger, Simon; D'Haens, Geert; Diamond, Robert H.; Broussard, Delma L.; Tang, Kezhen L.; van der Woude, C. Janneke; Rutgeerts, Paul		SONIC Study Grp	Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MAINTENANCE INFLIXIMAB; ORAL BUDESONIDE; LONG-TERM; 6-MERCAPTOPURINE; PLACEBO; MANAGEMENT; EFFICACY; TRIAL; IMMUNOMODULATORS; ASSOCIATION	Background: The comparative efficacy and safety of infliximab and azathioprine therapy alone or in combination for Crohn's disease are unknown. Methods: In this randomized, double-blind trial, we evaluated the efficacy of infliximab monotherapy, azathioprine monotherapy, and the two drugs combined in 508 adults with moderate-to-severe Crohn's disease who had not undergone previous immunosuppressive or biologic therapy. Patients were randomly assigned to receive an intravenous infusion of 5 mg of infliximab per kilogram of body weight at weeks 0, 2, and 6 and then every 8 weeks plus daily oral placebo capsules; 2.5 mg of oral azathioprine per kilogram daily plus a placebo infusion on the standard schedule; or combination therapy with the two drugs. Patients received study medication through week 30 and could continue in a blinded study extension through week 50. Results: Of the 169 patients receiving combination therapy, 96 (56.8%) were in corticosteroid-free clinical remission at week 26 (the primary end point), as compared with 75 of 169 patients (44.4%) receiving infliximab alone (P=0.02) and 51 of 170 patients (30.0%) receiving azathioprine alone (P<0.001 for the comparison with combination therapy and P=0.006 for the comparison with infliximab). Similar numerical trends were found at week 50. At week 26, mucosal healing had occurred in 47 of 107 patients (43.9%) receiving combination therapy, as compared with 28 of 93 patients (30.1%) receiving infliximab (P=0.06) and 18 of 109 patients (16.5%) receiving azathioprine (P<0.001 for the comparison with combination therapy and P=0.02 for the comparison with infliximab). Serious infections developed in 3.9% of patients in the combination-therapy group, 4.9% of those in the infliximab group, and 5.6% of those in the azathioprine group. Conclusions: Patients with moderate-to-severe Crohn's disease who were treated with infliximab plus azathioprine or infliximab monotherapy were more likely to have a corticosteroid-free clinical remission than those receiving azathioprine monotherapy.	[Colombel, Jean Frederic] Univ Lille Nord France, CHU Lille, Hop Claude Huriez, F-59037 Lille, France; [Colombel, Jean Frederic] Univ Lille Nord France, CHU Lille, Ctr Invest Clin, F-59037 Lille, France; [Sandborn, William J.] Mayo Clin, Rochester, MN USA; [Reinisch, Walter] Univ Hosp Vienna, Vienna, Austria; [Mantzaris, Gerassimos J.] Evangelismos Med Ctr, Athens, Greece; [Kornbluth, Asher; Lichtiger, Simon] Mt Sinai Med Ctr, New York, NY 10029 USA; [Rachmilewitz, Daniel] Shaare Zedek Med Ctr, Jerusalem, Israel; [D'Haens, Geert] Imelda Ziekenhuis, Bonheiden, Belgium; [Rutgeerts, Paul] Univ Hosp Gasthuisberg, B-3000 Leuven, Belgium; [Diamond, Robert H.; Broussard, Delma L.; Tang, Kezhen L.] Centocor Ortho Biotech, Malvern, PA USA; [van der Woude, C. Janneke] Erasmus MC, Rotterdam, Netherlands	Universite de Lille - ISITE; CHU Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; Mayo Clinic; University Hospital Vienna; Evangelismos Hospital; Icahn School of Medicine at Mount Sinai; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Imeldaziekenhuis; KU Leuven; University Hospital Leuven; Johnson & Johnson; Johnson & Johnson USA; Erasmus University Rotterdam; Erasmus MC	Colombel, JF (corresponding author), Univ Lille Nord France, CHU Lille, Hop Claude Huriez, Rue Michel Polonovski, F-59037 Lille, France.	jfcolombel@chru-lille.fr; sandborn.william@mayo.edu	Sandborn, William/ABE-8342-2020	Menchen, Luis/0000-0001-9490-3726; Dahlerup, Jens Frederik/0000-0002-1587-7636	Centocor Ortho Biotech; Schering-Plough; ActoGeniX; AstraZeneca; BayerSchering Pharma; Biogen Idec; Boehringer Ingelheim; BristolMyers Squibb; Cellerix; ChemoCentryx; Cosmo Technologies; Danone France; Elan Pharmaceuticals; Genentech; Giuliani SPA; Given Imaging; GlaxoSmithKline; Merck; Millennium Pharmaceuticals; Neovacs; Ocera Therapeutics; Otsuka America Pharmaceuticals; PDL Biopharma; Pfizer; RiboVacs Biotech; Shire Pharmaceutical; Synta Pharmaceutical; Teva Pharmaceuticals; Therakos; UCB Pharma; Wyeth; Elan; Falk Pharma; Ferring Pharmaceuticals; Shire Pharmaceuticals; Synta Pharma; Bristol-Myers Squibb; Chiltem; Lesaffre; Danisco; Roquette; Mapi Naxis; Dysphar; AGI Therapeutics; Alba Therapeutics; Albireo; M-Pharma; Amgen; Ardea Biosciences; Aspreva Pharmaceuticals; Astellas Pharma; Athersys; Atlantic Healthcare Limited; Axcan Pharma; BioBalance; Celgene; Celek Pharmaceuticals; Cerimon Pharmaceutical; CombinatoRx; CoMentis; Cytokine Pharmasciences; Eagle Pharmaceuticals; Eisai Medical Genome Sciences; Hutchison Medipharma; Ironwood Pharmaceuticals; KaloBios Pharmaceuticals; Merck Research Laboratories; MerckSerono; Nisshin Kyorin Pharmaceutical; Novo Nordisk; Procter Gamble; Prometheus Laboratories; Purgenesis Technologies; Salient Pharmaceuticals; Salix Pharmaceuticals; Santarus; Sigmoid Pharma; Sirtris Pharmaceuticals; S.L.A. Pharma; Tillotts Pharma; Tioga Pharmaceuticals; Vascular Biogenics; Ventech; Viamet Pharmaceuticals; Celltech; Novartis; Robarts Research Institute; Abbott Laboratories; Osiris Pharmaceuticals; Ferring; Tramedico; Ely Broad Foundation; Erasmus Medical Center; Italifarmako	Centocor Ortho Biotech; Schering-Plough(Merck & CompanySchering Plough Corporation); ActoGeniX; AstraZeneca(AstraZeneca); BayerSchering Pharma(Bayer AG); Biogen Idec(Biogen); Boehringer Ingelheim(Boehringer Ingelheim); BristolMyers Squibb(Bristol-Myers Squibb); Cellerix; ChemoCentryx; Cosmo Technologies; Danone France(Danone Nutricia); Elan Pharmaceuticals; Genentech(Roche HoldingGenentech); Giuliani SPA; Given Imaging; GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Millennium Pharmaceuticals(Takeda Pharmaceutical Company Ltd); Neovacs; Ocera Therapeutics; Otsuka America Pharmaceuticals(Otsuka Pharmaceutical); PDL Biopharma; Pfizer(Pfizer); RiboVacs Biotech; Shire Pharmaceutical; Synta Pharmaceutical(Johnson & Johnson); Teva Pharmaceuticals(Teva Pharmaceutical Industries); Therakos; UCB Pharma(UCB Pharma SA); Wyeth(Wyeth); Elan; Falk Pharma; Ferring Pharmaceuticals(Ferring Pharmaceuticals); Shire Pharmaceuticals; Synta Pharma(Dexcel Pharma); Bristol-Myers Squibb(Bristol-Myers Squibb); Chiltem; Lesaffre; Danisco; Roquette; Mapi Naxis; Dysphar; AGI Therapeutics; Alba Therapeutics; Albireo; M-Pharma; Amgen(Amgen); Ardea Biosciences; Aspreva Pharmaceuticals; Astellas Pharma(Astellas Pharmaceuticals); Athersys; Atlantic Healthcare Limited; Axcan Pharma(Dexcel Pharma); BioBalance; Celgene(Bristol-Myers SquibbCelgene Corporation); Celek Pharmaceuticals; Cerimon Pharmaceutical(Johnson & Johnson); CombinatoRx; CoMentis; Cytokine Pharmasciences; Eagle Pharmaceuticals; Eisai Medical Genome Sciences; Hutchison Medipharma; Ironwood Pharmaceuticals; KaloBios Pharmaceuticals; Merck Research Laboratories(Merck & Company); MerckSerono(Merck & Company); Nisshin Kyorin Pharmaceutical; Novo Nordisk(Novo Nordisk); Procter Gamble(Procter & Gamble); Prometheus Laboratories; Purgenesis Technologies; Salient Pharmaceuticals; Salix Pharmaceuticals; Santarus; Sigmoid Pharma; Sirtris Pharmaceuticals; S.L.A. Pharma; Tillotts Pharma(Dexcel Pharma); Tioga Pharmaceuticals; Vascular Biogenics; Ventech; Viamet Pharmaceuticals; Celltech; Novartis(Novartis); Robarts Research Institute; Abbott Laboratories(Abbott Laboratories); Osiris Pharmaceuticals; Ferring(Ferring Pharmaceuticals); Tramedico; Ely Broad Foundation; Erasmus Medical Center; Italifarmako	Supported by research grants from Centocor Ortho Biotech and Schering-Plough.; Dr. Colombel reports receiving consulting or advisory board fees from Abbott Laboratories, ActoGeniX, AstraZeneca, BayerSchering Pharma, Biogen Idec, Boehringer Ingelheim, BristolMyers Squibb, Cellerix, ChemoCentryx, Centocor Ortho Biotech, Cosmo Technologies, Danone France, Elan Pharmaceuticals, Genentech, Giuliani SPA, Given Imaging, GlaxoSmithKline, Merck, Millennium Pharmaceuticals, Neovacs, Ocera Therapeutics, Otsuka America Pharmaceuticals, PDL Biopharma, Pfizer, RiboVacs Biotech, Schering-Plough, Shire Pharmaceutical, Synta Pharmaceutical, Teva Pharmaceuticals, Therakos, UCB Pharma, and Wyeth, lecture fees from Abbott Laboratories, Centocor Ortho Biotech, Elan, Falk Pharma, Ferring Pharmaceuticals, Given Imaging, Otsuka America Pharmaceuticals, PDL Biopharma, Schering-Plough, Shire Pharmaceuticals, and UCB Pharma, grant support from Abbott Laboratories, Centocor Ortho Biotech, Synta Pharma, Otsuka America Pharmaceuticals, Bristol-Myers Squibb, PDL Biopharma, Chiltem, AstraZeneca, Pfizer, Teva Pharmaceuticals, Lesaffre, Giuliani SPA, Danisco, Ocera Therapeutics, Danone France, Roquette, Mapi Naxis, Dysphar, Ferring Pharmaceuticals, Schering-Plough, and UCB Pharma, and having an equity interest in Intestinal Biotech Development; Dr. Sandborn, receiving consulting or advisory board fees from Abbott Laboratories (fees paid to the Mayo Clinic), ActoGeniX, AGI Therapeutics, Alba Therapeutics, Albireo, AM-Pharma, Amgen, Ardea Biosciences, Aspreva Pharmaceuticals, Astellas Pharma, Athersys, Atlantic Healthcare Limited, Axcan Pharma, BioBalance, Bristol-Myers Squibb, Celgene, Celek Pharmaceuticals, Cellerix, Centocor Ortho Biotech (fees paid to the Mayo Clinic), Cerimon Pharmaceutical, ChemoCentryx, CombinatoRx, CoMentis, Cosmo Technologies, Cytokine Pharmasciences, Eagle Pharmaceuticals, Eisai Medical Genome Sciences, Hutchison Medipharma, Ironwood Pharmaceuticals, KaloBios Pharmaceuticals, Merck Research Laboratories, MerckSerono, Millennium Pharmaceuticals, Nisshin Kyorin Pharmaceutical, Novo Nordisk, Ocera Therapeutics, Pfizer, Procter & Gamble (fees paid to the Mayo Clinic), Prometheus Laboratories, Purgenesis Technologies, Salient Pharmaceuticals, Salix Pharmaceuticals, Santarus, Schering-Plough, Shire Pharmaceuticals (fees paid to the Mayo Clinic), Sigmoid Pharma, Sirtris Pharmaceuticals, S.L.A. Pharma, Teva Pharmaceuticals, Tillotts Pharma, Tioga Pharmaceuticals, UCB Pharma (fees paid to the Mayo Clinic), Vascular Biogenics, Ventech, Viamet Pharmaceuticals, and Wyeth, and research support from Abbott Laboratories, Bristol-Myers Squibb, Celltech, Centocor Ortho Biotech, Genentech, Millennium Pharmaceuticals, Novartis, Otsuka America Pharmaceuticals, PDL Biopharma, Pfizer, Procter & Gamble, Robarts Research Institute, Shire Pharmaceuticals, and UCB Pharma; Dr. Reinisch, receiving consulting or advisory board fees from Abbott Laboratories, Centocor Ortho Biotech, Schering-Plough, and Genentech and lecture fees from Abbott Laboratories, Otsuka America Pharmaceuticals, and Schering-Plough; Dr. Mantzaris, receiving advisory board fees from Centocor Ortho Biotech, Schering-Plough, Abbott Immunology, Schering-Plough Hellas, and Abbott Hellas and lecture fees from Ferring International, Schering-Plough Hellas, and Abbott Hellas; Dr. Kornbluth, receiving consulting or advisory board fees from Abbott Laboratories, Elan-Biogen, Centocor Ortho Biotech, and UCB Pharma, lecture fees from Abbott Laboratories and UCB Pharma, and grant support from Centocor Ortho Biotech and Abbott Laboratories; Dr.; Lichtiger, receiving consulting or advisory boad fees from Abbott Laboratories, Centocor Ortho Biotech, Shire Pharmaceuticals, Prometheus Laboratories, and UCB Pharma, lecture fees from Abbott Laboratories, Procter & Gamble, Prometheus Laboratories, and Shire Pharmaceuticals, and grant support from Abbott Laboratories, Bristol-Myers Pharmaceuticals, Celgene, Centocor Ortho Biotech, Osiris Pharmaceuticals, Procter & Gamble, and UCB Pharma; Dr. D'Haens, receiving consulting fees from Centocor Ortho Biotech, Schering-Plough, UCB Pharma, and Abbott and lecture fees from Schering-Plough, Abbott Laboratories, and UCB Pharma; Drs. Diamond, Broussard, and Tang, being employed by Centocor Ortho Biotech and having an equity interest in Johnson & Johnson; Dr. van der Woude, receiving consulting or advisory board fees from Schering-Plough and Abbott Laboratories, lecture fees from Ferring, Tramedico, Schering-Plough, and Abbott, and grant support from Ely Broad Foundation, Erasmus Medical Center, Schering-Plough, and Abbott Laboratories; and Dr. Rutgeerts, receiving consulting or advisory board fees from Centocor Ortho Biotech, Schering-Plough, UCB Pharma, Abbott, Millennium, Genetech, NovImmune, ChemoCentryx, GlaxoSmithKline, and Italifarmako, lecture fees from Centocor Ortho Biotech, Schering-Plough, UCB Pharma, and Abbott, and research support from Centocor Ortho Biotech, Schering-Plough, UCB Pharma, and Abbott. No other potential conflict of interest relevant to this article was reported.	BEST WR, 1976, GASTROENTEROLOGY, V70, P439; Black AJ, 1998, ANN INTERN MED, V129, P716, DOI 10.7326/0003-4819-129-9-199811010-00007; CANDY S, 1995, GUT, V37, P674, DOI 10.1136/gut.37.5.674; Mackey AC, 2007, J PEDIATR GASTR NUTR, V44, P265, DOI 10.1097/MPG.0b013e31802f6424; Cosnes J, 2002, INFLAMM BOWEL DIS, V8, P244, DOI 10.1097/00054725-200207000-00002; Dubinsky MC, 2000, GASTROENTEROLOGY, V118, P705, DOI 10.1016/S0016-5085(00)70140-5; Faubion WA, 2001, GASTROENTEROLOGY, V121, P255, DOI 10.1053/gast.2001.26279; Greenberg GR, 1996, GASTROENTEROLOGY, V110, P45, DOI 10.1053/gast.1996.v110.pm8536887; GREENBERG GR, 1994, NEW ENGL J MED, V331, P836, DOI 10.1056/NEJM199409293311303; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Hanauer SB, 2004, CLIN GASTROENTEROL H, V2, P542, DOI 10.1016/S1542-3565(04)00238-1; IRVINE EJ, 1994, GASTROENTEROLOGY, V106, P287, DOI 10.1016/0016-5085(94)90585-1; Lemann M, 2006, GASTROENTEROLOGY, V130, P1054, DOI 10.1053/j.gastro.2006.02.014; Lewis JD, 2008, AM J GASTROENTEROL, V103, P1428, DOI 10.1111/j.1572-0241.2008.01836.x; Lichtenstein GR, 2009, ALIMENT PHARM THER, V30, P210, DOI 10.1111/j.1365-2036.2009.04027.x; Lichtenstein GR, 2009, AM J GASTROENTEROL, V104, P465, DOI 10.1038/ajg.2008.168; Lichtenstein GR, 2006, CLIN GASTROENTEROL H, V4, P621, DOI 10.1016/j.cgh.2006.03.002; Lichtenstein GR, 2006, GASTROENTEROLOGY, V130, P940, DOI 10.1053/j.gastro.2006.01.048; Marehbian J, 2009, AM J GASTROENTEROL, V104, P2524, DOI 10.1038/ajg.2009.322; Markowitz J, 2000, GASTROENTEROLOGY, V119, P895, DOI 10.1053/gast.2000.18144; PEARSON DC, 1995, ANN INTERN MED, V123, P132, DOI 10.7326/0003-4819-123-2-199507150-00009; Peyrin-Biroulet L, 2008, CLIN GASTROENTEROL H, V6, P644, DOI 10.1016/j.cgh.2008.03.014; PRESENT DH, 1980, NEW ENGL J MED, V302, P981, DOI 10.1056/NEJM198005013021801; Reinisch W, 2008, AM J GASTROENTEROL, V103, P2284, DOI 10.1111/j.1572-0241.2008.02024.x; Sandborn WJ, 1999, GASTROENTEROLOGY, V117, P527, DOI 10.1016/S0016-5085(99)70445-2; Sandborn WJ, 2002, GASTROENTEROLOGY, V122, P512, DOI 10.1053/gast.2002.31072; SUMMERS RW, 1979, GASTROENTEROLOGY, V77, P847; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; ten Hove T, 2002, GUT, V50, P206, DOI 10.1136/gut.50.2.206; Tiede I, 2003, J CLIN INVEST, V111, P1133, DOI 10.1172/JCI200316432; Travis SPL, 2006, GUT, V55, DOI 10.1136/gut.2005.081950b; Van Assche G, 2008, GASTROENTEROLOGY, V134, P1861, DOI 10.1053/j.gastro.2008.03.004	32	2144	2234	2	116	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 15	2010	362	15					1383	1395		10.1056/NEJMoa0904492	http://dx.doi.org/10.1056/NEJMoa0904492			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582XY	20393175				2022-12-28	WOS:000276635300007
J	Zhang, XW; Yan, XJ; Zhou, ZR; Yang, FF; Wu, ZY; Sun, HB; Liang, WX; Song, AX; Lallemand-Breitenbach, V; Jeanne, M; Zhang, QY; Yang, HY; Huang, QH; Zhou, GB; Tong, JH; Zhang, Y; Wu, JH; Hu, HY; de The, H; Chen, SJ; Chen, Z				Zhang, Xiao-Wei; Yan, Xiao-Jing; Zhou, Zi-Ren; Yang, Fei-Fei; Wu, Zi-Yu; Sun, Hong-Bin; Liang, Wen-Xue; Song, Ai-Xin; Lallemand-Breitenbach, Valerie; Jeanne, Marion; Zhang, Qun-Ye; Yang, Huai-Yu; Huang, Qiu-Hua; Zhou, Guang-Biao; Tong, Jian-Hua; Zhang, Yan; Wu, Ji-Hui; Hu, Hong-Yu; de The, Hugues; Chen, Sai-Juan; Chen, Zhu			Arsenic Trioxide Controls the Fate of the PML-RAR alpha Oncoprotein by Directly Binding PML	SCIENCE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; TRANS-RETINOIC ACID; INITIATING CELLS; DEGRADATION; RECEPTOR; THERAPY; PROTEINS; EFFICACY; DOMAIN; AS2O3	Arsenic, an ancient drug used in traditional Chinese medicine, has attracted worldwide interest because it shows substantial anticancer activity in patients with acute promyelocytic leukemia (APL). Arsenic trioxide (As2O3) exerts its therapeutic effect by promoting degradation of an oncogenic protein that drives the growth of APL cells, PML-RAR alpha (a fusion protein containing sequences from the PML zinc finger protein and retinoic acid receptor alpha). PML and PML-RAR alpha degradation is triggered by their SUMOylation, but the mechanism by which As2O3 induces this posttranslational modification is unclear. Here we show that arsenic binds directly to cysteine residues in zinc fingers located within the RBCC domain of PML-RAR alpha and PML. Arsenic binding induces PML oligomerization, which increases its interaction with the small ubiquitin-like protein modifier (SUMO)-conjugating enzyme UBC9, resulting in enhanced SUMOylation and degradation. The identification of PML as a direct target of As2O3 provides new insights into the drug's mechanism of action and its specificity for APL.	[Zhang, Xiao-Wei; Yan, Xiao-Jing; Liang, Wen-Xue; Zhang, Qun-Ye; Huang, Qiu-Hua; Tong, Jian-Hua; Zhang, Yan; Chen, Sai-Juan; Chen, Zhu] Shanghai Jiao Tong Univ, Rui Jin Hosp, Shanghai Inst Hematol, State Key Lab Med Genom,Sch Med, Shanghai 200025, Peoples R China; [Zhou, Zi-Ren; Song, Ai-Xin; Hu, Hong-Yu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Yang, Fei-Fei; Wu, Zi-Yu] Univ Sci & Technol China, Natl Synchrotron Radiat Lab, Beijing 10004, Peoples R China; [Yang, Fei-Fei; Wu, Zi-Yu] CAS, Inst High Energy Phys, Beijing Synchrotron Radiat Facil, Beijing 10004, Peoples R China; [Sun, Hong-Bin; Wu, Ji-Hui] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Sun, Hong-Bin; Wu, Ji-Hui] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Lallemand-Breitenbach, Valerie; Jeanne, Marion; de The, Hugues] Univ Paris 07, INSERM, CNRS,Hop St Louis, Equipe Labellisee Ligue Natl Canc 11,UMR 944 7151, F-75475 Paris 10, France; [Yang, Huai-Yu] CAS, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; [Zhou, Guang-Biao] CAS, Lab Mol Carcinogenesis & Targeted Therapy Canc, State Key Lab Biomembrane & Membrane Biotechnol, Beijing, Peoples R China; [Zhou, Guang-Biao] CAS, Inst Zool, Key Lab Stem Cell Dev, Beijing, Peoples R China; [de The, Hugues; Chen, Sai-Juan; Chen, Zhu] Hop Rui Jin, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Zoology, CAS	Chen, SJ (corresponding author), Shanghai Jiao Tong Univ, Rui Jin Hosp, Shanghai Inst Hematol, State Key Lab Med Genom,Sch Med, 197 Rui Jin Rd 2, Shanghai 200025, Peoples R China.	sjchen@stn.sh.cn; zchen@stn.sh.cn	Yang, Fang/AAF-3024-2019; Sun, Hongbin/C-9721-2015; Zhou, Guang-Biao/ABG-5795-2021; Chou, Steven Ziren/M-1995-2014; Hu, Hong-Yu/AAQ-2633-2020; Zhou, Guangbiao/J-6575-2017	Sun, Hongbin/0000-0002-7712-0655; Zhou, Guangbiao/0000-0002-6327-2316; Zhou, Guang-Biao/0000-0001-6778-7133; Jeanne, Marion/0000-0001-7334-3061; Lallemand, Valerie/0000-0001-9852-204X	863 Program [2006AA02A405]; 973 Project [2010CB529201, 2006CB910305]; National Natural Science Foundation of China [30801372, 30623010, 30772744, 30830119, 10734070]; Shanghai Municipal Commission for Science and Technology [07DZ05908, 08DZ2200100]; Samuel Waxman Cancer Research Foundation	863 Program(National High Technology Research and Development Program of China); 973 Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission for Science and Technology; Samuel Waxman Cancer Research Foundation	We thank E.-D. Wang, K.-K. Wang, J. Zhu, and X.-J. Sun for constructive comments on the work; Y.-Y. Shi, H.-L. Jiang, J.-H. Mao, C.-F. Wu, Y.-Y. Xie, Y.-G. Chang, Y.-J. Jiang, and W.-S. Chu for experimental assistance; X.-D. Xi, N. Kieffer, and J. Zhu for critical reading of the manuscript; and all members of Shanghai Institute of Hematology for their encouragement. This work was supported in part by 863 Program (2006AA02A405), 973 Project (2010CB529201, 2006CB910305), the National Natural Science Foundation of China (30801372, 30623010, 30772744, 30830119, 10734070), the Shanghai Municipal Commission for Science and Technology (07DZ05908 and 08DZ2200100), and the Samuel Waxman Cancer Research Foundation Co-Principal Investigator Program.	Benfatto M, 2003, J SYNCHROTRON RADIAT, V10, P51, DOI 10.1107/S0909049502018137; Bhattacharjee H, 1996, J BIOL CHEM, V271, P24465, DOI 10.1074/jbc.271.40.24465; Borden KLB, 1996, P NATL ACAD SCI USA, V93, P1601, DOI 10.1073/pnas.93.4.1601; BORDEN KLB, 1995, EMBO J, V14, P1532, DOI 10.1002/j.1460-2075.1995.tb07139.x; Chen GQ, 1997, BLOOD, V89, P3345; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; Duprez E, 1999, J CELL SCI, V112, P381; Hu J, 2009, P NATL ACAD SCI USA, V106, P3342, DOI 10.1073/pnas.0813280106; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Jiang GF, 2003, CHEM RES TOXICOL, V16, P873, DOI 10.1021/tx034053g; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lu J, 2007, P NATL ACAD SCI USA, V104, P12288, DOI 10.1073/pnas.0701549104; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; Nasr R, 2008, NAT MED, V14, P1333, DOI 10.1038/nm.1891; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Spuches AM, 2005, INORG CHEM, V44, P2964, DOI 10.1021/ic048694q; Spuches AM, 2008, J AM CHEM SOC, V130, P8148, DOI 10.1021/ja802179p; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Zhang XY, 2007, CANCER LETT, V255, P95, DOI 10.1016/j.canlet.2007.03.025; Zhou GB, 2007, PHILOS T R SOC B, V362, P959, DOI 10.1098/rstb.2007.2026; Zhu J, 1999, P NATL ACAD SCI USA, V96, P14807, DOI 10.1073/pnas.96.26.14807; Zhu J, 2002, NAT REV CANCER, V2, P705, DOI 10.1038/nrc887; Zhu J, 1997, P NATL ACAD SCI USA, V94, P3978, DOI 10.1073/pnas.94.8.3978	28	550	628	15	344	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2010	328	5975					240	243		10.1126/science.1183424	http://dx.doi.org/10.1126/science.1183424			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580OU	20378816				2022-12-28	WOS:000276459600045
J	Brousseau, DC; Owens, PL; Mosso, AL; Panepinto, JA; Steiner, CA				Brousseau, David C.; Owens, Pamela L.; Mosso, Andrew L.; Panepinto, Julie A.; Steiner, Claudia A.			Acute Care Utilization and Rehospitalizations for Sickle Cell Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTORS; HOSPITAL READMISSION; VASOOCCLUSIVE CRISES; HEART-FAILURE; CHILDREN; QUALITY; LENGTH; STATE	Context Published rates of health care utilization and rehospitalization by people with sickle cell disease have had limited generalizability and are not population based. Objective To provide benchmark data for rates of acute care utilization and rehospitalizations for patients with sickle cell disease. Design Retrospective cohort of sickle cell disease-related emergency department (ED) visits and hospitalizations from select states in the 2005 and 2006 Healthcare Cost and Utilization Project (HCUP) State Inpatient Databases and State Emergency Department Databases. Setting Eight geographically dispersed states (Arizona, California, Florida, Massachusetts, Missouri, New York, South Carolina, and Tennessee) that provide encrypted identifiers and have sufficient numbers of patients with sickle cell disease; together these states have 33% of the US population with sickle cell disease. Patients A total of 21 112 patients with sickle cell-related treat-and-release ED visits or inpatient hospitalizations. Main Outcome Measures Rates of acute care utilization and rehospitalizations. Population-based utilization rates were also calculated. Results The 21 112 people with sickle cell disease had 109 344 encounters, a mean of 2.59 (95% confidence interval [CI], 2.53-2.65) encounters per patient per year, 1.52 (95% CI, 1.48-1.55) encounters for hospitalizations and 1.08 (95% CI, 1.04-1.11) for treat-and-release ED visits. Utilization was highest for 18- to 30-year-olds, 3.61 (95% CI, 3.47-3.75) encounters per patient per year, and those with public insurance, 3.22 (95% CI, 3.13-3.31) encounters per patient per year. Publicly insured 18- to 30-year-olds had 4.80 (95% CI, 4.58-5.02) encounters per patient per year. Approximately 29% of the population had no encounters while 16.9% had 3 or more encounters per year. The 30-day and 14-day rehospitalization rates were 33.4% (95% CI, 33.0%-33.8%) and 22.1% (95% CI, 21.8%-22.4%), respectively. The rehospitalization rate was highest for 18- to 30-year-olds, with 41.1% (95% CI, 40.5%-41.7%) rehospitalized within 30 days and 28.4% (95% CI, 27.8%-29.0%) within 14 days. Rehospitalizations were also highest for publicly insured patients. Conclusion Among patients with sickle cell disease, acute care encounters and rehospitalizations were frequent, particularly for 18- to 30-year-olds. JAMA. 2010; 303(13): 1288-1294	[Brousseau, David C.] Med Coll Wisconsin, Dept Pediat, Sect Emergency Med, Milwaukee, WI 53226 USA; [Panepinto, Julie A.] Med Coll Wisconsin, Sect Hematol Oncol Bone Marrow Transplant, Milwaukee, WI 53226 USA; [Owens, Pamela L.; Steiner, Claudia A.] Agcy Healthcare Res & Qual, Healthcare Cost & Utilizat Project, Rockville, MD USA; [Owens, Pamela L.; Steiner, Claudia A.] Agcy Healthcare Res & Qual, Ctr Delivery Org & Markets, Rockville, MD USA; [Owens, Pamela L.] Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO 63110 USA; [Mosso, Andrew L.] Social & Sci Syst Inc, Silver Spring, MD USA; [Brousseau, David C.; Panepinto, Julie A.] Childrens Res Inst, Milwaukee, WI USA	Medical College of Wisconsin; Medical College of Wisconsin; Agency for Healthcare Research & Quality; Agency for Healthcare Research & Quality; Washington University (WUSTL); Social & Scientific Systems	Brousseau, DC (corresponding author), Med Coll Wisconsin, Dept Pediat, Sect Emergency Med, 999 N 92nd St,CCC 550, Milwaukee, WI 53226 USA.	dbrousse@mcw.edu			Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Work on this study was funded in part by a Career Development Award (D.C.B.) from the Agency for Healthcare Research and Quality.	*AG HEALTHC RES QU, CLIN CALSS SOFTW CCS; Agency for Healthcare Research and Quality, OV STAT INP DAT SID; [Anonymous], OV STAT EM DEP DAT S; Ashley-Koch A, 2000, AM J EPIDEMIOL, V151, P839; Ballas SK, 2005, AM J HEMATOL, V79, P17, DOI 10.1002/ajh.20336; Basu J, 2007, MED CARE RES REV, V64, P544, DOI 10.1177/1077558707301955; Brousseau DC, 2010, AM J HEMATOL, V85, P77, DOI 10.1002/ajh.21570; CASTRO O, 1994, BLOOD, V84, P643, DOI 10.1182/blood.V84.2.643.643; *CTR MED MED SERV, 2007, MED SCHIP QUAL IMPR; Ellison AM, 2007, J NATL MED ASSOC, V99, P192; Fosdal Marian B, 2007, J Pediatr Nurs, V22, P342; Frei-Jones MJ, 2009, PEDIATR BLOOD CANCER, V52, P481, DOI 10.1002/pbc.21854; Guice KS, 2007, J TRAUMA, V63, pS68, DOI 10.1097/TA.0b013e31815acbb6; Harjai KJ, 2001, AM J CARDIOL, V87, P234, DOI 10.1016/S0002-9149(00)01328-X; Jasti H, 2008, CLIN INFECT DIS, V46, P550, DOI 10.1086/526526; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Johnson RW, 2000, HEALTH SERV RES, V35, P911; Lorey FW, 1996, GENET EPIDEMIOL, V13, P501, DOI 10.1002/(SICI)1098-2272(1996)13:5<501::AID-GEPI6>3.0.CO;2-4; Panepinto JA, 2005, PEDIATR BLOOD CANCER, V44, P182, DOI 10.1002/pbc.20180; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; Quinn CT, 2009, PEDIATR BLOOD CANCER, V52, P435, DOI 10.1002/pbc.21904; Reznik M, 2006, J ASTHMA, V43, P37, DOI 10.1080/02770900500446997; Robbins JM, 2006, MED CARE, V44, P292, DOI 10.1097/01.mlr.0000199639.20342.87; Ross JS, 2006, JAMA-J AM MED ASSOC, V295, P2027, DOI 10.1001/jama.295.17.2027; Scanlon DP, 2008, HEALTH SERV RES, V43, P1849, DOI 10.1111/j.1475-6773.2008.00889.x; Schwalenstocker E, 2009, PEDIATR BLOOD CANCER, V53, P1361, DOI 10.1002/pbc.22212; Shankar SM, 2005, AM J HEMATOL, V80, P262, DOI 10.1002/ajh.20485; Taylor A K, 2001, Health Serv Res, V36, P16; VanSuch M, 2006, QUAL SAF HEALTH CARE, V15, P414, DOI 10.1136/qshc.2005.017640	29	391	393	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2010	303	13					1288	1294		10.1001/jama.2010.378	http://dx.doi.org/10.1001/jama.2010.378			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	579FM	20371788	Bronze			2022-12-28	WOS:000276353700029
J	Finegold, JA; Belcher, R; Noor, S; Mort, D				Finegold, Judith A.; Belcher, Rosemary; Noor, Shahid; Mort, Dominic			Picture Quiz A pain in the neck	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CERVICAL-ARTERY DISSECTION; VERTEBRAL ARTERIES; RISK-FACTORS; HEADACHE		[Finegold, Judith A.; Belcher, Rosemary; Noor, Shahid; Mort, Dominic] Chase Farm Hosp, London EN2 8JL, England	University of London; University College London; Royal Free London NHS Foundation Trust	Finegold, JA (corresponding author), Chase Farm Hosp, London EN2 8JL, England.	judyfinegold@doctors.org.uk						Arnold M, 2009, J NEUROL NEUROSUR PS, V80, P232, DOI 10.1136/jnnp.2008.151324; Arnold M, 2006, STROKE, V37, P2499, DOI 10.1161/01.STR.0000240493.88473.39; Bassetti C, 1996, STROKE, V27, P1804, DOI 10.1161/01.STR.27.10.1804; Benninger DH, 2009, CEREBROVASC DIS, V27, P241, DOI 10.1159/000196822; Bin Saeed A, 2000, CAN J NEUROL SCI, V27, P292, DOI 10.1017/S0317167100001025; CAPLAN LR, 1985, STROKE, V16, P1030, DOI 10.1161/01.STR.16.6.1030; Coward LJ, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000516.pub2; Debette S, 2009, LANCET NEUROL, V8, P668, DOI 10.1016/S1474-4422(09)70084-5; Garry D, 2009, EMERG MED J, V26, P384, DOI 10.1136/emj.2008.066928; Grau AJ, 1999, ARCH NEUROL-CHICAGO, V56, P851, DOI 10.1001/archneur.56.7.851; Greener J, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000425; HOSOYA T, 1994, AM J NEURORADIOL, V15, P1161; Legg LA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003585.pub2; Menon R, 2008, J NEUROL NEUROSUR PS, V79, P1122, DOI 10.1136/jnnp.2007.138800; National Institute for Health and Clinical Excellence, 2008, STROK NAT CLIN GUID; Opeskin K, 1998, AM J FOREN MED PATH, V19, P206, DOI 10.1097/00000433-199809000-00002; Pezzini A, 2006, J NEUROL NEUROSUR PS, V77, P95, DOI 10.1136/jnnp.2005.063107; Pollock A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001920.pub2; Rubinstein SM, 2005, STROKE, V36, P1575, DOI 10.1161/01.STR.0000169919.73219.30; SCHIEVINK WI, 1994, NEW ENGL J MED, V330, P393, DOI 10.1056/NEJM199402103300604; Schievink WI, 1996, STROKE, V27, P622, DOI 10.1161/01.STR.27.4.622; SCHIEVINK WI, 1994, STROKE, V25, P889, DOI 10.1161/01.STR.25.4.889; Schievink WI, 2001, NEW ENGL J MED, V344, P898, DOI 10.1056/NEJM200103223441206; SILBERT PL, 1995, NEUROLOGY, V45, P1517, DOI 10.1212/WNL.45.8.1517; Tinel D., 2008, Annales de Readaptation et de Medecine Physique, V51, P403, DOI 10.1016/j.annrmp.2008.04.010; Tzourio C, 1997, CIRCULATION, V95, P2351, DOI 10.1161/01.CIR.95.10.2351; Vertinsky AT, 2008, AM J NEURORADIOL, V29, P1753, DOI 10.3174/ajnr.A1189	27	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2010	340								c1001	10.1136/bmj.c1001	http://dx.doi.org/10.1136/bmj.c1001			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582ZF	20375085				2022-12-28	WOS:000276639400001
J	Moore, J; McKnight, AJ; Simmonds, MJ; Courtney, AE; Hanvesakul, R; Brand, OJ; Briggs, D; Ball, S; Cockwell, P; Patterson, CC; Maxwell, AP; Gough, SCL; Borrows, R				Moore, Jason; McKnight, Amy Jayne; Simmonds, Matthew J.; Courtney, Aisling E.; Hanvesakul, Rajesh; Brand, Oliver J.; Briggs, David; Ball, Simon; Cockwell, Paul; Patterson, Christopher C.; Maxwell, Alexander P.; Gough, Stephen C. L.; Borrows, Richard			Association of Caveolin-1 Gene Polymorphism With Kidney Transplant Fibrosis and Allograft Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CELLS	Context Caveolin-1 (CAV1) is an inhibitor of tissue fibrosis. Objective To study the association of CAV1 gene variation with kidney transplant outcome, using kidney transplantation as a model of accelerated fibrosis. Design, Setting, and Patients Candidate gene association and validation study. Genomic DNA from 785 white kidney transplant donors and their respective recipients (transplantations in Birmingham, England, between 1996 and 2006; median followup, 81 months) were analyzed for common variation in CAV1 using a single-nucleotide polymorphism (SNP) tagging approach. Validation of positive findings was sought in an independent kidney transplant donor-recipient cohort (transplantations in Belfast, Northern Ireland, between 1986 and 2005; n=697; median follow-up, 69 months). Association between genotype and allograft failure was initially assessed by Kaplan-Meier analysis, then in an adjusted Cox model. Main Outcome Measure Death-censored allograft failure, defined as a return to dialysis or retransplantation. Results The presence of donor AA genotype for the CAV1 rs4730751 SNP was associated with increased risk of allograft failure in the Birmingham group (donor AA vs non-AA genotype in adjusted Cox model, hazard ratio [HR], 1.97; 95% confidence interval [CI], 1.29-3.16; P=.002). No other tag SNPs showed a significant association. This finding was validated in the Belfast cohort (in adjusted Cox model, HR, 1.56; 95% CI, 1.07-2.27; P=.02). Overall graft failure rates were as follows: for the Birmingham cohort, donor genotype AA, 22 of 57 (38.6%); genotype CC, 96 of 431 (22.3%); and genotype AC, 66 of 297 (22.2%); and for the Belfast cohort, donor genotype AA, 32 of 48 (67%); genotype CC, 150 of 358 (42%); and genotype AC, 119 of 273 (44%). Conclusion Among kidney transplant donors, the CAV1 rs4730751 SNP was significantly associated with allograft failure in 2 independent cohorts. JAMA. 2010;303(13):1282-1287	[Moore, Jason; Hanvesakul, Rajesh; Ball, Simon; Cockwell, Paul; Borrows, Richard] Univ Hosp Birmingham, Renal Inst Birmingham, Dept Nephrol & Transplantat, Birmingham, W Midlands, England; [Simmonds, Matthew J.; Brand, Oliver J.; Gough, Stephen C. L.] Univ Birmingham, Inst Biomed Res, Sch Clin & Expt Med, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Briggs, David] Natl Blood Serv, Birmingham, W Midlands, England; [McKnight, Amy Jayne; Courtney, Aisling E.; Patterson, Christopher C.; Maxwell, Alexander P.] Queens Univ Belfast, Nephrol Res Grp, Belfast, Antrim, North Ireland	University of Birmingham; University of Birmingham; Queens University Belfast	Borrows, R (corresponding author), Queen Elizabeth Hosp, Univ Hosp Birmingham, Dept Nephrol & Kidney Transplantat, Birmingham B15 2TH, W Midlands, England.	richard.borrows@uhb.nhs.uk	McKnight, Amy Jayne/ABF-4492-2020; McKnight, AJ/B-2450-2009	McKnight, Amy Jayne/0000-0002-7482-709X; Ball, Simon/0000-0001-7410-5268; Cockwell, Paul/0000-0003-1975-266X; Briggs, David/0000-0002-6796-7086; Maxwell, Alexander P./0000-0002-6110-7253; Simmonds, Matt/0000-0003-3154-3510	University Hospital Birmingham Charities; Novartis Pharmaceuticals; ESRC [ES/G007438/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish; Public Health Agency [STL/3714/07] Funding Source: researchfish	University Hospital Birmingham Charities; Novartis Pharmaceuticals(Novartis); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Public Health Agency	Funding was provided by the University Hospital Birmingham Charities. Dr Moore is funded by an unrestricted educational grant from Novartis Pharmaceuticals.	Clarke GM, 2007, AM J HUM GENET, V81, P995, DOI 10.1086/521952; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; El-Zoghby ZM, 2009, AM J TRANSPLANT, V9, P527, DOI 10.1111/j.1600-6143.2008.02519.x; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; Park HC, 2010, AM J PHYSIOL-RENAL, V298, pF357, DOI 10.1152/ajprenal.00542.2009; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Rienstra H, 2009, AM J TRANSPLANT, V9, P463, DOI 10.1111/j.1600-6143.2008.02534.x; Saidi RF, 2007, AM J TRANSPLANT, V7, P2769, DOI 10.1111/j.1600-6143.2007.01993.x; Schwencke C, 2006, CARDIOVASC RES, V70, P42, DOI 10.1016/j.cardiores.2005.11.029; Thomas CM, 2008, J CELL MOL MED, V12, P796, DOI 10.1111/j.1582-4934.2008.00295.x; Wang L, 2008, PROG CHEM, V20, P713	12	64	65	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2010	303	13					1282	1287		10.1001/jama.2010.356	http://dx.doi.org/10.1001/jama.2010.356			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579FM	20371787	Bronze			2022-12-28	WOS:000276353700028
J	Kessenbrock, K; Plaks, V; Werb, Z				Kessenbrock, Kai; Plaks, Vicki; Werb, Zena			Matrix Metalloproteinases: Regulators of the Tumor Microenvironment	CELL			English	Review							SYNERGISTIC UP-REGULATION; EXTRACELLULAR-MATRIX; CELL-ADHESION; CANCER-CELLS; TGF-BETA; CHEMOKINE RECEPTOR; ENDOTHELIAL-CELLS; ANGIOGENIC SWITCH; BASEMENT-MEMBRANE; NECROSIS-FACTOR	Extracellular proteolysis mediates tissue homeostasis. In cancer, altered proteolysis leads to unregulated tumor growth, tissue remodeling, inflammation, tissue invasion, and metastasis. The matrix metalloproteinases (MMPs) represent the most prominent family of proteinases associated with tumorigenesis. Recent technological developments have markedly advanced our understanding of MMPs as modulators of the tumor microenvironment. In addition to their role in extracellular matrix turnover and cancer cell migration, MMPs regulate signaling pathways that control cell growth, inflammation, or angiogenesis and may even work in a nonproteolytic manner. These aspects of MMP function are reorienting our approaches to cancer therapy.	[Kessenbrock, Kai; Plaks, Vicki; Werb, Zena] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Kessenbrock, Kai; Plaks, Vicki; Werb, Zena] Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Werb, Z (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	zena.werb@ucsf.edu	Kessenbrock, Kai/B-6936-2011		National Cancer Institute [CA057621, CA072006]; Susan G. Komen Foundation; Israeli Science Foundation; Machiah Foundation; NATIONAL CANCER INSTITUTE [P01CA072006, R01CA057621] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Israeli Science Foundation(Israel Science Foundation); Machiah Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge support by grants (CA057621 and CA072006) from the National Cancer Institute and by fellowships from the Susan G. Komen Foundation, the Israeli Science Foundation, and the Machiah Foundation.	Agrawal S, 2006, J EXP MED, V203, P1007, DOI 10.1084/jem.20051342; Ahn GO, 2008, CANCER CELL, V13, P193, DOI 10.1016/j.ccr.2007.11.032; Alexander CM, 2001, J CELL BIOL, V152, P693, DOI 10.1083/jcb.152.4.693; Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; Ardi VC, 2009, J BIOL CHEM, V284, P25854, DOI 10.1074/jbc.M109.033472; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Bond M, 1998, FEBS LETT, V435, P29, DOI 10.1016/S0014-5793(98)01034-5; Bremer C, 2001, NAT MED, V7, P743, DOI 10.1038/89126; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Bruyere F, 2008, NAT METHODS, V5, P431, DOI [10.1038/nmeth.1205, 10.1038/NMETH.1205]; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050; Conant K, 2004, J BIOL CHEM, V279, P8056, DOI 10.1074/jbc.M307051200; Cornelius LA, 1998, J IMMUNOL, V161, P6845; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cox JH, 2008, J BIOL CHEM, V283, P19389, DOI 10.1074/jbc.M800266200; Crawford HC, 2002, J CLIN INVEST, V109, P1437, DOI 10.1172/JCI200215051; Cuniasse P, 2005, BIOCHIMIE, V87, P393, DOI 10.1016/j.biochi.2004.09.025; Dahl KDC, 2008, CANCER RES, V68, P4606, DOI 10.1158/0008-5472.CAN-07-5046; Dallas SL, 2002, J BIOL CHEM, V277, P21352, DOI 10.1074/jbc.M111663200; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Dufour A, 2008, J CELL PHYSIOL, V217, P643, DOI 10.1002/jcp.21535; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Egeblad M, 2008, DIS MODEL MECH, V1, P155, DOI 10.1242/dmm.000596; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Friedl P, 2008, CANCER RES, V68, P7247, DOI 10.1158/0008-5472.CAN-08-0784; Fu XY, 2003, J BIOL CHEM, V278, P28403, DOI 10.1074/jbc.M304739200; Furumoto S, 2003, NUCL MED BIOL, V30, P119, DOI 10.1016/S0969-8051(02)00393-1; Galvez BG, 2001, J BIOL CHEM, V276, P37491, DOI 10.1074/jbc.M104094200; Glasheen BM, 2009, P NATL ACAD SCI USA, V106, P2659, DOI 10.1073/pnas.0804171106; GROSS J, 1962, P NATL ACAD SCI USA, V48, P1014, DOI 10.1073/pnas.48.6.1014; Gutierrez-Fernandez A, 2008, CANCER RES, V68, P2755, DOI 10.1158/0008-5472.CAN-07-5154; Gutierrez-Fernandez A, 2007, FASEB J, V21, P2580, DOI 10.1096/fj.06-7860com; Hamano Y, 2003, CANCER CELL, V3, P589, DOI 10.1016/S1535-6108(03)00133-8; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Haro H, 2000, J CLIN INVEST, V105, P143, DOI 10.1172/JCI7091; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Heljasvaara R, 2005, EXP CELL RES, V307, P292, DOI 10.1016/j.yexcr.2005.03.021; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Houghton AM, 2006, CANCER RES, V66, P6149, DOI 10.1158/0008-5472.CAN-04-0297; Houghton AM, 2009, NATURE, V460, P637, DOI 10.1038/nature08181; Houghton AM, 2006, J CLIN INVEST, V116, P753, DOI 10.1172/JCI25617; Huang YJ, 2009, CANCER RES, V69, P7529, DOI 10.1158/0008-5472.CAN-08-4382; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Islekel H, 2007, CELL BIOCHEM FUNCT, V25, P433, DOI 10.1002/cbf.1325; Jastrzebska B, 2009, J MED CHEM, V52, P1576, DOI 10.1021/jm801411h; Jiang T, 2004, P NATL ACAD SCI USA, V101, P17867, DOI 10.1073/pnas.0408191101; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Langenskiold M, 2005, INT J COLORECTAL DIS, V20, P245, DOI 10.1007/s00384-004-0667-4; Le Maux Chansac B, 2008, INT IMMUNOL, V20, P801, DOI 10.1093/intimm/dxn038; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Lijnen HR, 2001, BBA-PROTEIN STRUCT M, V1547, P206, DOI 10.1016/S0167-4838(01)00186-8; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; Littlepage LE, 2010, CANCER RES, V70, P2224, DOI 10.1158/0008-5472.CAN-09-3515; Liu H, 2008, CANCER SCI, V99, P2185, DOI 10.1111/j.1349-7006.2008.00922.x; Liu S, 2008, J BIOL CHEM, V283, P529, DOI 10.1074/jbc.M707419200; Liu Z, 2000, CELL, V102, P647, DOI 10.1016/S0092-8674(00)00087-8; Lochter A, 1997, J CELL BIOL, V139, P1861, DOI 10.1083/jcb.139.7.1861; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Lu X, 2009, GENE DEV, V23, P1882, DOI 10.1101/gad.1824809; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Lynch CC, 2005, CANCER CELL, V7, P485, DOI 10.1016/j.ccr.2005.04.013; Manicone AM, 2008, SEMIN CELL DEV BIOL, V19, P34, DOI 10.1016/j.semcdb.2007.07.003; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; McQuibban GA, 2002, BLOOD, V100, P1160, DOI 10.1182/blood.V100.4.1160.h81602001160_1160_1167; Mentzel T, 2001, VIRCHOWS ARCH, V438, P13, DOI 10.1007/s004280000327; Mitsiades N, 2001, CANCER RES, V61, P577; Motrescu ER, 2008, BIOL CHEM, V389, P1037, DOI 10.1515/BC.2008.110; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nakamura ES, 2004, CANCER SCI, V95, P25, DOI 10.1111/j.1349-7006.2004.tb03166.x; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Olson ES, 2009, INTEGR BIOL-UK, V1, P382, DOI 10.1039/b904890a; Packard BZ, 2009, MATRIX BIOL, V28, P3, DOI 10.1016/j.matbio.2008.10.001; Padera TP, 2002, SCIENCE, V296, P1883, DOI 10.1126/science.1071420; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Palavalli LH, 2009, NAT GENET, V41, P518, DOI 10.1038/ng.340; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Patterson BC, 1997, J BIOL CHEM, V272, P28823, DOI 10.1074/jbc.272.46.28823; Pinilla S, 2009, CANCER LETT, V284, P80, DOI 10.1016/j.canlet.2009.04.013; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Redondo-Munoz J, 2010, CANCER CELL, V17, P160, DOI 10.1016/j.ccr.2009.12.044; Ribatti D, 2009, LEUKEMIA RES, V33, P638, DOI 10.1016/j.leukres.2008.11.019; Rocks N, 2008, CANCER RES, V68, P9541, DOI 10.1158/0008-5472.CAN-08-0548; Rozanov DV, 2004, J BIOL CHEM, V279, P50321, DOI 10.1074/jbc.M409174200; Rupp PA, 2008, MOL BIOL CELL, V19, P5529, DOI 10.1091/mbc.E07-05-0480; Rutkowski JM, 2009, FEBS J, V276, P5738, DOI 10.1111/j.1742-4658.2009.07303.x; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Sakamoto T, 2009, GENES CELLS, V14, P617, DOI 10.1111/j.1365-2443.2009.01293.x; Schafers M, 2004, CIRCULATION, V109, P2554, DOI 10.1161/01.CIR.0000129088.49276.83; Scherer RL, 2008, MOL IMAGING, V7, P118, DOI 10.2310/7290.2008.00010; Scherer RL, 2008, CANCER METAST REV, V27, P679, DOI 10.1007/s10555-008-9152-9; Schulte M, 2007, CELL DEATH DIFFER, V14, P1040, DOI 10.1038/sj.cdd.4402101; Smith ML, 2007, PLOS BIOL, V5, P2243, DOI 10.1371/journal.pbio.0050268; SOUNNI NE, 2010, DIS MODEL MECH, DOI DOI 10.1242/DMM.00386.3; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Struyf S, 2009, EUR J IMMUNOL, V39, P843, DOI 10.1002/eji.200838660; Tatti O, 2008, EXP CELL RES, V314, P2501, DOI 10.1016/j.yexcr.2008.05.018; Temma T, 2009, BIOL PHARM BULL, V32, P1272, DOI 10.1248/bpb.32.1272; Van den Steen PE, 2000, BLOOD, V96, P2673, DOI 10.1182/blood.V96.8.2673.h8002673_2673_2681; Waldhauer I, 2008, CANCER RES, V68, P6368, DOI 10.1158/0008-5472.CAN-07-6768; Weathington NM, 2006, NAT MED, V12, P317, DOI 10.1038/nm1361; WEISS SJ, 1985, SCIENCE, V227, P747, DOI 10.1126/science.2982211; Witters L, 2008, CANCER RES, V68, P7083, DOI 10.1158/0008-5472.CAN-08-0739; Woessner J.F., 2000, PROTEIN PROFILE SER; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Wu Y, 2008, AM J PHYSIOL-ENDOC M, V295, pE205, DOI 10.1152/ajpendo.90316.2008; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Yeh WL, 2009, GLIA, V57, P454, DOI 10.1002/glia.20773; Yu Q, 2000, GENE DEV, V14, P163; Zhang XH, 2009, SCIENCE, V324, P1330, DOI 10.1126/science.1170905	132	3352	3501	40	1017	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2010	141	1					52	67		10.1016/j.cell.2010.03.015	http://dx.doi.org/10.1016/j.cell.2010.03.015			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	577GS	20371345	Green Accepted, Bronze			2022-12-28	WOS:000276211100012
J	Liu, X; Tonegawa, S				Liu, Xu; Tonegawa, Susumu			Optogenetics 3.0	CELL			English	Editorial Material							HALORHODOPSIN		[Liu, Xu; Tonegawa, Susumu] MIT, Dept Biol, RIKEN MIT Ctr Neural Circuit Genet, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Liu, Xu; Tonegawa, Susumu] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Massachusetts Institute of Technology (MIT)	Tonegawa, S (corresponding author), MIT, Dept Biol, RIKEN MIT Ctr Neural Circuit Genet, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tonegawa@mit.edu						Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; DUSCHL A, 1990, J BIOL CHEM, V265, P1261; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Liu X, 2006, CURR OPIN NEUROBIOL, V16, P679, DOI 10.1016/j.conb.2006.09.003; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhao SL, 2008, BRAIN CELL BIOL, V36, P141, DOI 10.1007/s11068-008-9034-7	9	20	55	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2010	141	1					22	24		10.1016/j.cell.2010.03.019	http://dx.doi.org/10.1016/j.cell.2010.03.019			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	577GS	20371341	Bronze, Green Published			2022-12-28	WOS:000276211100008
J	Pauwels, L; Barbero, GF; Geerinck, J; Tilleman, S; Grunewald, W; Perez, AC; Chico, JM; Vanden Bossche, R; Sewell, J; Gil, E; Garcia-Casado, G; Witters, E; Inze, D; Long, JA; De Jaeger, G; Solano, R; Goossens, A				Pauwels, Laurens; Barbero, Gemma Fernandez; Geerinck, Jan; Tilleman, Sofie; Grunewald, Wim; Perez, Amparo Cuellar; Chico, Jose Manuel; Vanden Bossche, Robin; Sewell, Jared; Gil, Eduardo; Garcia-Casado, Gloria; Witters, Erwin; Inze, Dirk; Long, Jeff A.; De Jaeger, Geert; Solano, Roberto; Goossens, Alain			NINJA connects the co-repressor TOPLESS to jasmonate signalling	NATURE			English	Article							TANDEM AFFINITY PURIFICATION; FUNCTIONAL GENOMICS; STRESS-RESPONSE; PROTEIN FAMILY; ARABIDOPSIS; DEGRADATION; DEFENSE; GENES; BIOSYNTHESIS; METABOLISM	Jasmonoyl-isoleucine (JA-Ile) is a plant hormone that regulates a broad array of plant defence and developmental processes(1-5). JA-Ile-responsive gene expression is regulated by the transcriptional activator MYC2 that interacts physically with the jasmonate ZIM-domain (JAZ) repressor proteins. On perception of JA-Ile, JAZ proteins are degraded and JA-Ile-dependent gene expression is activated(6,7). The molecular mechanisms by which JAZ proteins repress gene expression remain unknown. Here we show that the Arabidopsis JAZ proteins recruit the Groucho/Tup1-type corepressor TOPLESS (TPL)(8) and TPL-related proteins (TPRs) through a previously uncharacterized adaptor protein, designated Novel Interactor of JAZ (NINJA). NINJA acts as a transcriptional repressor whose activity is mediated by a functional TPL-binding EAR repression motif. Accordingly, both NINJA and TPL proteins function as negative regulators of jasmonate responses. Our results point to TPL proteins as general co-repressors that affect multiple signalling pathways through the interaction with specific adaptor proteins. This new insight reveals how stress-related and growth-related signalling cascades use common molecular mechanisms to regulate gene expression in plants.	[Pauwels, Laurens; Geerinck, Jan; Tilleman, Sofie; Grunewald, Wim; Perez, Amparo Cuellar; Vanden Bossche, Robin; Inze, Dirk; De Jaeger, Geert; Goossens, Alain] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Pauwels, Laurens; Geerinck, Jan; Tilleman, Sofie; Grunewald, Wim; Perez, Amparo Cuellar; Vanden Bossche, Robin; Inze, Dirk; De Jaeger, Geert; Goossens, Alain] Univ Ghent, Dept Plant Biotechnol & Genet, B-9052 Ghent, Belgium; [Barbero, Gemma Fernandez; Chico, Jose Manuel; Solano, Roberto] Ctr Nacl Biotecnol CSIC, Dept Genet Mol Plantas, Madrid 28049, Spain; [Gil, Eduardo; Garcia-Casado, Gloria; Solano, Roberto] Ctr Nacl Biotecnol CSIC, Genom Unit, Madrid 28049, Spain; [Grunewald, Wim] Univ Ghent, Dept Mol Biotechnol, Fac Biosci Engn, B-9000 Ghent, Belgium; [Sewell, Jared; Long, Jeff A.] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Witters, Erwin] Univ Antwerp, EBT CEPROMA, Dept Biol, B-2020 Antwerp, Belgium; [Witters, Erwin] VITO MANT, Flemish Inst Technol Res, B-2400 Mol, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Ghent University; Salk Institute; University of Antwerp; VITO	Goossens, A (corresponding author), Univ Ghent VIB, Dept Plant Syst Biol, Technol Pk 927, B-9052 Ghent, Belgium.	alain.goossens@psb.vib-ugent.be	Pauwels, Laurens/Y-4080-2019; Inzé, Dirk/AAW-6381-2021; Solano, Roberto/O-5908-2017	Pauwels, Laurens/0000-0002-0221-9052; Inzé, Dirk/0000-0002-3217-8407; Solano, Roberto/0000-0001-5459-2417; Sewell, Jared/0000-0003-3229-2645; Goossens, Alain/0000-0002-1599-551X; Gil, Eduardo/0000-0002-0423-9794; De Jaeger, Geert/0000-0001-6558-5669	Research Foundation-Flanders; Agency for Innovation by Science and Technology in Flanders ('Generisch Basisonderzoek aan de Universiteiten'); Ghent University; National Institutes of Health; Spanish Ministerio de Ciencia y Tecnologia; Comunidad de Madrid; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072764] Funding Source: NIH RePORTER	Research Foundation-Flanders(FWO); Agency for Innovation by Science and Technology in Flanders ('Generisch Basisonderzoek aan de Universiteiten'); Ghent University(Ghent University); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid(Comunidad de Madrid); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Lammertyn and all colleagues of the Functional Proteomics group at VIB and Ecophysiology-Biochemistry-Toxicology, Centre for Proteome Analysis and Mass Spectrometry (EBT-CEPROMA) at Antwerp University for technical assistance; M. I. Puga and J. Paz-Ares for providing the prey cDNA library for Y2H screens; V. Storme for help with statistical analysis; J. Van Leene and M. Karimi for discussions; and M. De Cock for help in preparing the manuscript. This work was supported by the Research Foundation-Flanders (predoctoral fellowship to L. P.), the Agency for Innovation by Science and Technology in Flanders ('Generisch Basisonderzoek aan de Universiteiten', and predoctoral fellowships to S. T. and J. G.), the Special Research Fund of Ghent University (postdoctoral fellowship to W. G.), the National Institutes of Health (to J. L.) and the Spanish Ministerio de Ciencia y Tecnologia and the Comunidad de Madrid (to R. S.).	Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Browse J, 2008, PLANT PHYSIOL, V146, P832, DOI 10.1104/pp.107.115683; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Chico JM, 2008, CURR OPIN PLANT BIOL, V11, P486, DOI 10.1016/j.pbi.2008.06.003; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chini A, 2009, PLANT J, V59, P77, DOI 10.1111/j.1365-313X.2009.03852.x; Chung HS, 2009, PLANT CELL, V21, P131, DOI 10.1105/tpc.108.064097; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; De Sutter V, 2005, PLANT J, V44, P1065, DOI 10.1111/j.1365-313X.2005.02586.x; Devoto A, 2002, PLANT J, V32, P457, DOI 10.1046/j.1365-313X.2002.01432.x; Dreher KA, 2006, PLANT CELL, V18, P699, DOI 10.1105/tpc.105.039172; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Garcia ME, 2008, PLANT MOL BIOL, V67, P643, DOI 10.1007/s11103-008-9344-2; Goda H, 2008, PLANT J, V55, P526, DOI 10.1111/j.1365-313X.2008.03510.x; Goossens A, 2003, P NATL ACAD SCI USA, V100, P8595, DOI 10.1073/pnas.1032967100; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Grunewald W, 2009, EMBO REP, V10, P923, DOI 10.1038/embor.2009.103; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Hilson P, 2004, GENOME RES, V14, P2176, DOI 10.1101/gr.2544504; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Karimi M, 2007, PLANT PHYSIOL, V145, P1144, DOI 10.1104/pp.107.106989; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Kazan K, 2006, TRENDS PLANT SCI, V11, P109, DOI 10.1016/j.tplants.2006.01.004; Kazan K, 2008, PLANT PHYSIOL, V146, P1459, DOI 10.1104/pp.107.115717; Long JA, 2002, DEVELOPMENT, V129, P2797; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Ohta M, 2000, PLANT J, V22, P29, DOI 10.1046/j.1365-313x.2000.00709.x; Pauwels L, 2009, TRENDS PLANT SCI, V14, P87, DOI 10.1016/j.tplants.2008.11.005; Pauwels L, 2008, P NATL ACAD SCI USA, V105, P1380, DOI 10.1073/pnas.0711203105; Salmon J, 2008, PLANT J, V54, P118, DOI 10.1111/j.1365-313X.2007.03396.x; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Van Leene J, 2008, TRENDS PLANT SCI, V13, P517, DOI 10.1016/j.tplants.2008.08.002; Van Leene J, 2007, MOL CELL PROTEOMICS, V6, P1226, DOI 10.1074/mcp.M700078-MCP200; Vanholme B, 2007, TRENDS PLANT SCI, V12, P239, DOI 10.1016/j.tplants.2007.04.004; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; White DWR, 2006, P NATL ACAD SCI USA, V103, P13238, DOI 10.1073/pnas.0604349103; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708	41	638	701	9	261	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 1	2010	464	7289					788	U169		10.1038/nature08854	http://dx.doi.org/10.1038/nature08854			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577EO	20360743	Green Accepted			2022-12-28	WOS:000276205000051
J	Qian, BZ; Pollard, JW				Qian, Bin-Zhi; Pollard, Jeffrey W.			Macrophage Diversity Enhances Tumor Progression and Metastasis	CELL			English	Review							COLONY-STIMULATING FACTOR; ENDOTHELIAL GROWTH-FACTOR; NF-KAPPA-B; MONOCYTE CHEMOATTRACTANT PROTEIN-1; GENE-EXPRESSION ANALYSIS; LYMPH-NODE METASTASIS; MYELOID CELLS; PROMOTE TUMOR; MOUSE MODEL; ANGIOGENIC SWITCH	There is persuasive clinical and experimental evidence that macrophages promote cancer initiation and malignant progression. During tumor initiation, they create an inflammatory environment that is mutagenic and promotes growth. As tumors progress to malignancy, macrophages stimulate angiogenesis, enhance tumor cell migration and invasion, and suppress antitumor immunity. At metastatic sites, macrophages prepare the target tissue for arrival of tumor cells, and then a different subpopulation of macrophages promotes tumor cell extravasation, survival, and subsequent growth. Specialized subpopulations of macrophages may represent important new therapeutic targets.	[Qian, Bin-Zhi; Pollard, Jeffrey W.] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Pollard, Jeffrey W.] Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10461 USA; [Pollard, Jeffrey W.] Albert Einstein Coll Med, Cooperat Ctr Study Reprod & Infertil Res, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Pollard, JW (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA.	jeffrey.pollard@einstein.yu.edu		Qian, Binzhi/0000-0002-5796-1078	National Institutes of Health [NIH PO1 CA100324, U01CA143233, RO1 CA131270]; Albert Einstein Cancer Center [P30 CA 13330]; NATIONAL CANCER INSTITUTE [R01CA131270, P01CA100324, U01CA143233, P30CA013330] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health to J.W.P. (NIH PO1 CA100324, U01CA143233, and RO1 CA131270) and Albert Einstein Cancer Center Core grant P30 CA 13330. J.W.P. is the Louis Goldstein Swan Chair in Women's Cancer Research.	Abraham D, 2010, INT J CANCER, V126, P1339, DOI 10.1002/ijc.24859; Aharinejad Seyedhossein, 2009, V487, P243, DOI 10.1007/978-1-60327-547-7_12; Almholt K, 2005, INT J CANCER, V113, P525, DOI 10.1002/ijc.20631; Bailey C, 2007, CLIN EXP METASTAS, V24, P121, DOI 10.1007/s10585-007-9060-3; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Beck AH, 2009, CLIN CANCER RES, V15, P778, DOI 10.1158/1078-0432.CCR-08-1283; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Biswas SK, 2006, BLOOD, V107, P2112, DOI 10.1182/blood-2005-01-0428; Chen JJW, 2005, J CLIN ONCOL, V23, P953, DOI 10.1200/JCO.2005.12.172; Cheng JS, 2007, CANCER RES, V67, P5141, DOI 10.1158/0008-5472.CAN-06-4763; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dawson MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006525; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Deng L, 2010, AM J PATHOL, V176, P952, DOI 10.2353/ajpath.2010.090622; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Enzler T, 2003, J EXP MED, V197, P1213, DOI 10.1084/jem.20021258; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Espinosa I, 2009, AM J PATHOL, V174, P2347, DOI 10.2353/ajpath.2009.081037; Eubank TD, 2009, CANCER RES, V69, P2133, DOI 10.1158/0008-5472.CAN-08-1405; Farinha P, 2005, BLOOD, V106, P2169, DOI 10.1182/blood-2005-04-1565; FIDLER IJ, 1988, BIOCHIM BIOPHYS ACTA, V948, P151, DOI 10.1016/0304-419X(88)90009-1; Fujimoto H, 2009, INT J CANCER, V125, P1276, DOI 10.1002/ijc.24378; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gazzaniga S, 2007, J INVEST DERMATOL, V127, P2031, DOI 10.1038/sj.jid.5700827; Giraudo E, 2004, J CLIN INVEST, V114, P623, DOI 10.1172/JCI200422087; Gligorijevic Bojana, 2009, J Vis Exp, DOI 10.3791/1278; Gocheva V, 2006, GENE DEV, V20, P543, DOI 10.1101/gad.1407406; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Green CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006713; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grimshaw MJ, 2002, EUR J IMMUNOL, V32, P2393, DOI 10.1002/1521-4141(200209)32:9<2393::AID-IMMU2393>3.0.CO;2-4; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Groblewska M, 2007, CLIN CHEM LAB MED, V45, P30, DOI 10.1515/CCLM.2007.025; Guiducci C, 2005, CANCER RES, V65, P3437, DOI 10.1158/0008-5472.CAN-04-4262; Hagemann T, 2005, J IMMUNOL, V175, P1197, DOI 10.4049/jimmunol.175.2.1197; Halin S, 2009, NEOPLASIA, V11, P177, DOI 10.1593/neo.81338; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hanahan D, 1996, EUR J CANCER, V32A, P2386, DOI 10.1016/S0959-8049(96)00401-7; Hernandez L, 2009, CANCER RES, V69, P3221, DOI 10.1158/0008-5472.CAN-08-2871; HEUFF G, 1993, CANCER IMMUNOL IMMUN, V37, P125, DOI 10.1007/BF01517045; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Ingman WV, 2006, DEV DYNAM, V235, P3222, DOI 10.1002/dvdy.20972; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kim DW, 2008, BRIT J CANCER, V98, P1118, DOI 10.1038/sj.bjc.6604256; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kimura YN, 2007, CANCER SCI, V98, P2009, DOI 10.1111/j.1349-7006.2007.00633.x; Kitamura T, 2007, NAT GENET, V39, P467, DOI 10.1038/ng1997; Kuang DM, 2009, J EXP MED, V206, P1327, DOI 10.1084/jem.20082173; Kubota Y, 2009, J EXP MED, V206, P1089, DOI 10.1084/jem.20081605; Lacy-Hulbert A, 2007, P NATL ACAD SCI USA, V104, P15823, DOI 10.1073/pnas.0707421104; Leek RD, 2000, J PATHOL, V190, P430, DOI 10.1002/(SICI)1096-9896(200003)190:4<430::AID-PATH538>3.0.CO;2-6; Leek RD, 2002, J MAMMARY GLAND BIOL, V7, P177, DOI 10.1023/A:1020304003704; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Lewis CE, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1679; Lin EY, 2007, MOL ONCOL, V1, P288, DOI 10.1016/j.molonc.2007.10.003; Lin EY, 2007, CANCER RES, V67, P5064, DOI 10.1158/0008-5472.CAN-07-0912; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Lin EY, 2002, J MAMMARY GLAND BIOL, V7, P147, DOI 10.1023/A:1020399802795; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; MANTOVANI A, 2010, CURR OPIN I IN PRESS; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; Meira LB, 2008, J CLIN INVEST, V118, P2516, DOI 10.1172/JCI35073; Moghaddam SJ, 2009, AM J RESP CELL MOL, V40, P443, DOI 10.1165/rcmb.2008-0198OC; Mroczko B, 2007, CLIN CHIM ACTA, V380, P208, DOI 10.1016/j.cca.2007.02.037; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Oguma K, 2008, EMBO J, V27, P1671, DOI 10.1038/emboj.2008.105; Ojalvo LS, 2010, J IMMUNOL, V184, P702, DOI 10.4049/jimmunol.0902360; Ojalvo LS, 2009, AM J PATHOL, V174, P1048, DOI 10.2353/ajpath.2009.080676; Oosterling SJ, 2005, J PATHOL, V207, P147, DOI 10.1002/path.1830; Pahler J, 2008, NEOPLASIA, V10, P329, DOI 10.1593/neo.07871; Pang B, 2007, CARCINOGENESIS, V28, P1807, DOI 10.1093/carcin/bgm037; Patsialou A, 2009, CANCER RES, V69, P9498, DOI 10.1158/0008-5472.CAN-09-1868; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Pucci F, 2009, BLOOD, V114, P901, DOI 10.1182/blood-2009-01-200931; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Robinson BD, 2009, CLIN CANCER RES, V15, P2433, DOI 10.1158/1078-0432.CCR-08-2179; Robinson-Smith TM, 2007, CANCER RES, V67, P5708, DOI 10.1158/0008-5472.CAN-06-4375; Ryder M, 2008, ENDOCR-RELAT CANCER, V15, P1069, DOI 10.1677/ERC-08-0036; Saccani A, 2006, CANCER RES, V66, P11432, DOI 10.1158/0008-5472.CAN-06-1867; Saji H, 2001, CANCER, V92, P1085, DOI 10.1002/1097-0142(20010901)92:5<1085::AID-CNCR1424>3.0.CO;2-K; Sangaletti S, 2008, CANCER RES, V68, P9050, DOI 10.1158/0008-5472.CAN-08-1327; Sapi E, 1999, P SOC EXP BIOL MED, V220, P1, DOI 10.1046/j.1525-1373.1999.d01-1.x; SCHOLL SM, 1994, JNCI-J NATL CANCER I, V86, P120, DOI 10.1093/jnci/86.2.120; Sharma M, 2010, BREAST CANCER RES TR, V123, P397, DOI 10.1007/s10549-009-0654-0; SMITH HO, 1995, CLIN CANCER RES, V1, P313; Stockmann C, 2008, NATURE, V456, P814, DOI 10.1038/nature07445; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Swann JB, 2008, P NATL ACAD SCI USA, V105, P652, DOI 10.1073/pnas.0708594105; Tanaka K, 2009, THYROID, V19, P21, DOI 10.1089/thy.2008.0237; Torroella-Kouri M, 2009, CANCER RES, V69, P4800, DOI 10.1158/0008-5472.CAN-08-3427; Varney ML, 2005, MELANOMA RES, V15, P417, DOI 10.1097/00008390-200510000-00010; Vasiljeva O, 2006, CANCER RES, V66, P5242, DOI 10.1158/0008-5472.CAN-05-4463; Wang S, 2009, P NATL ACAD SCI USA, V106, P151, DOI 10.1073/pnas.0808703105; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Yoshidome H, 2009, INT J ONCOL, V34, P923, DOI 10.3892/ijo_00000218; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Zabuawala T, 2010, CANCER RES, V70, P1323, DOI 10.1158/0008-5472.CAN-09-1474; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240; Zhu P, 2006, CELL, V124, P615, DOI 10.1016/j.cell.2005.12.032; Zhu XD, 2008, J CLIN ONCOL, V26, P2707, DOI 10.1200/JCO.2007.15.6521; Zijlmans HJMAA, 2006, J PATHOL, V208, P507, DOI 10.1002/path.1918; Zumsteg A, 2009, CURR OPIN ONCOL, V21, P60, DOI 10.1097/CCO.0b013e32831bed7e	128	3204	3339	26	574	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2010	141	1					39	51		10.1016/j.cell.2010.03.014	http://dx.doi.org/10.1016/j.cell.2010.03.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	577GS	20371344	Green Accepted, Bronze			2022-12-28	WOS:000276211100011
J	Greenhalgh, RM; Brown, LC; Powell, JT; Thompson, SG; Epstein, D; Sculpher, MJ				Greenhalgh, Roger M.; Brown, Louise C.; Powell, Janet T.; Thompson, Simon G.; Epstein, David; Sculpher, Mark J.		United Kingdom EVAR Trial Investi	Endovascular versus Open Repair of Abdominal Aortic Aneurysm	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OUTCOMES; EVAR	BACKGROUND Few data are available on the long-term outcome of endovascular repair of abdominal aortic aneurysm as compared with open repair. METHODS From 1999 through 2004 at 37 hospitals in the United Kingdom, we randomly assigned 1252 patients with large abdominal aortic aneurysms (>= 5.5 cm in diameter) to undergo either endovascular or open repair; 626 patients were assigned to each group. Patients were followed for rates of death, graft-related complications, reinterventions, and resource use until the end of 2009. Logistic regression and Cox regression were used to compare outcomes in the two groups. RESULTS The 30-day operative mortality was 1.8% in the endovascular-repair group and 4.3% in the open-repair group (adjusted odds ratio for endovascular repair as compared with open repair, 0.39; 95% confidence interval [CI], 0.18 to 0.87; P=0.02). The endovascular-repair group had an early benefit with respect to aneurysm-related mortality, but the benefit was lost by the end of the study, at least partially because of fatal endo-graft ruptures (adjusted hazard ratio, 0.92; 95% CI, 0.57 to 1.49; P=0.73). By the end of follow-up, there was no significant difference between the two groups in the rate of death from any cause (adjusted hazard ratio, 1.03; 95% CI, 0.86 to 1.23; P=0.72). The rates of graft-related complications and reinterventions were higher with endovascular repair, and new complications occurred up to 8 years after randomization, contributing to higher overall costs. CONCLUSIONS In this large, randomized trial, endovascular repair of abdominal aortic aneurysm was associated with a significantly lower operative mortality than open surgical repair. However, no differences were seen in total mortality or aneurysm-related mortality in the long term. Endovascular repair was associated with increased rates of graft-related complications and reinterventions and was more costly. (Current Controlled Trials number, ISRCTN55703451.)	[Greenhalgh, Roger M.; Brown, Louise C.; Powell, Janet T.] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Thompson, Simon G.] MRC, Biostat Unit, Cambridge CB2 2BW, England; [Epstein, David; Sculpher, Mark J.] Univ York, York YO10 5DD, N Yorkshire, England	Imperial College London; MRC Biostatistics Unit; University of York - UK	Greenhalgh, RM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Vasc Surg Res Grp, Charing Cross Hosp, Fulham Palace Rd, London W6 8RF, England.	r.greenhalgh@imperial.ac.uk	Powell, Janet/AAW-8669-2021; Epstein, David/I-2839-2019; Russell, Ian T/H-1181-2012; Morgan, Robert Anthony/AAH-9104-2021	Powell, Janet/0000-0002-3905-1468; Epstein, David/0000-0002-2275-0916; Morgan, Robert Anthony/0000-0002-8108-5258; Sculpher, Mark/0000-0003-3746-9913; Halliday, Alison/0000-0001-9828-3579	National Institute for Health Research in the United Kingdom; Medtronic; MRC [MC_U105260792] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MC_U105260792] Funding Source: researchfish	National Institute for Health Research in the United Kingdom; Medtronic(Medtronic); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by the Health Technology Assessment Programme of the National Institute for Health Research in the United Kingdom.; Dr. Greenhalgh reports serving as a salaried medical director of BIBA Medical and having an equity interest in the company, serving as a director of and having an equity interest in Space-form Holdings, and serving as an expert witness on behalf of patients with vascular disease; Mr. Epstein, receiving fellowship support from Medtronic; and Dr. Sculpher, receiving consulting fees from Medtronic. No other potential conflict of interest relevant to this article was reported. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.	Blankensteijn JD, 2005, NEW ENGL J MED, V352, P2398, DOI 10.1056/NEJMoa051255; Brown LC, 2004, EUR J VASC ENDOVASC, V27, P372, DOI 10.1016/j.ejvs.2003.12.019; Chaikof EL, 2002, J VASC SURG, V35, P1048, DOI 10.1067/mva.2002.123763; Conrad MF, 2007, J VASC SURG, V46, P669, DOI 10.1016/j.jvs.2007.05.046; DUBOST C, 1951, Mem Acad Chir (Paris), V77, P381; Greenhalgh RM, 2005, LANCET, V365, P2179, DOI 10.1016/S0140-6736(05)66627-5; Greenhalgh RM, 2004, LANCET, V364, P843, DOI 10.1016/S0140-6736(04)16979-1; Greenhalgh RM, 2010, NEW ENGL J MED, V362, P1872, DOI 10.1056/NEJMoa0911056; Hallett JW, 1997, J VASC SURG, V25, P277, DOI 10.1016/S0741-5214(97)70349-5; Kertai MD, 2004, AM J MED, V116, P96, DOI 10.1016/j.amjmed.2003.08.029; Lederle FA, 2009, JAMA-J AM MED ASSOC, V302, P1535, DOI 10.1001/jama.2009.1426; Leurs LJ, 2007, ARCH SURG-CHICAGO, V142, P33, DOI 10.1001/archsurg.142.1.33; McCulloch P, 2009, LANCET, V374, P1105, DOI 10.1016/S0140-6736(09)61116-8; Prinssen M, 2004, NEW ENGL J MED, V351, P1607, DOI 10.1056/NEJMoa042002; Reise JA, 2010, EUR J VASC ENDOVASC, V39, P55, DOI 10.1016/j.ejvs.2009.08.008; Schermerhorn ML, 2008, NEW ENGL J MED, V358, P464, DOI 10.1056/NEJMoa0707348; VOLODOS NL, 1986, VESTN KHIR IM GREKOV, V137, P123; Winterborn RJ, 2009, J VASC SURG, V49, P576, DOI 10.1016/j.jvs.2008.09.012	18	1018	1076	1	84	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 20	2010	362	20					1863	1871		10.1056/NEJMoa0909305	http://dx.doi.org/10.1056/NEJMoa0909305			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	598EI	20382983	Green Published			2022-12-28	WOS:000277815600004
J	Pires, D; Hedrick, JL; De Silva, A; Frommer, J; Gotsmann, B; Wolf, H; Despont, M; Duerig, U; Knoll, AW				Pires, David; Hedrick, James L.; De Silva, Anuja; Frommer, Jane; Gotsmann, Bernd; Wolf, Heiko; Despont, Michel; Duerig, Urs; Knoll, Armin W.			Nanoscale Three-Dimensional Patterning of Molecular Resists by Scanning Probes	SCIENCE			English	Article							ATOMIC-FORCE MICROSCOPY; ELECTRON-BEAM; VAPOR-DEPOSITION; GLASS RESISTS; HIGH-SPEED; LITHOGRAPHY; NANOLITHOGRAPHY; NANOFABRICATION; NANOSTRUCTURES; RESOLUTION	For patterning organic resists, optical and electron beam lithography are the most established methods; however, at resolutions below 30 nanometers, inherent problems result from unwanted exposure of the resist in nearby areas. We present a scanning probe lithography method based on the local desorption of a glassy organic resist by a heatable probe. We demonstrate patterning at a half pitch down to 15 nanometers without proximity corrections and with throughputs approaching those of Gaussian electron beam lithography at similar resolution. These patterns can be transferred to other substrates, and material can be removed in successive steps in order to fabricate complex three-dimensional structures.	[Pires, David; Gotsmann, Bernd; Wolf, Heiko; Despont, Michel; Duerig, Urs; Knoll, Armin W.] IBM Res Zurich, CH-8803 Ruschlikon, Switzerland; [Hedrick, James L.; Frommer, Jane] IBM Res Almaden, San Jose, CA 95120 USA; [De Silva, Anuja] IBM Res Watson, TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA	International Business Machines (IBM); International Business Machines (IBM); International Business Machines (IBM)	Knoll, AW (corresponding author), IBM Res Zurich, Saumerstr 4, CH-8803 Ruschlikon, Switzerland.	ark@zurich.ibm.com	Wolf, Heiko/D-7541-2014; Gotsmann, Bernd/K-3923-2018; Despont, Michel/U-4263-2018; Knoll, Armin W/F-3553-2011	Wolf, Heiko/0000-0002-7218-5759; Gotsmann, Bernd/0000-0001-8978-7468; Despont, Michel/0000-0003-3759-2161; Knoll, Armin W/0000-0003-2301-3149; Frommer, Jane/0000-0002-5198-6127; Duerig, Urs/0000-0003-4017-1894				CHANG THP, 1975, J VAC SCI TECHNOL, V12, P1271, DOI 10.1116/1.568515; Dai JY, 2006, CHEM MATER, V18, P3404, DOI 10.1021/cm052452m; De Silva A, 2008, CHEM MATER, V20, P1606, DOI 10.1021/cm702613n; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; Fenwick O, 2009, NAT NANOTECHNOL, V4, P664, DOI 10.1038/nnano.2009.254; Garcia R, 2006, CHEM SOC REV, V35, P29, DOI 10.1039/b501599p; GOTSMANN B, 2009, NANOTECHNOLOGY, V6, P121; Gotsmann B, 2006, ADV FUNCT MATER, V16, P1499, DOI 10.1002/adfm.200500724; Harth E, 2002, J AM CHEM SOC, V124, P8653, DOI 10.1021/ja026208x; Iwata F, 1999, J VAC SCI TECHNOL B, V17, P2452, DOI 10.1116/1.591110; Levinson H. J., 2005, PRINCIPLES LITHOGRAP; Liddle JA, 2003, MATER RES SOC SYMP P, V739, P19; Marrian CRK, 2003, J VAC SCI TECHNOL A, V21, pS207, DOI 10.1116/1.1600446; Martin C, 2005, NANOTECHNOLOGY, V16, P1016, DOI 10.1088/0957-4484/16/8/003; Martinez RV, 2007, NANO LETT, V7, P1846, DOI 10.1021/nl070328r; Menon R, 2005, MATER TODAY, V8, P26, DOI 10.1016/S1369-7021(05)00699-1; Milner AA, 2008, NANO LETT, V8, P2017, DOI 10.1021/nl801203c; Pantazi A, 2008, IBM J RES DEV, V52, P493, DOI 10.1147/rd.524.0493; PARK SW, 1995, APPL PHYS LETT, V67, P2415, DOI 10.1063/1.114565; Pfeiffer F, 2007, ADV FUNCT MATER, V17, P2336, DOI 10.1002/adfm.200600717; Rolandi M, 2007, ANGEW CHEM INT EDIT, V46, P7477, DOI 10.1002/anie.200701496; SOHN LL, 1995, APPL PHYS LETT, V67, P1552, DOI 10.1063/1.114731; Szoszkiewicz R, 2007, NANO LETT, V7, P1064, DOI 10.1021/nl070300f; Tseng AA, 2005, J VAC SCI TECHNOL B, V23, P877, DOI 10.1116/1.1926293; Watanabe K, 2004, J VAC SCI TECHNOL B, V22, P22, DOI 10.1116/1.1633281; Wilder K, 1998, J VAC SCI TECHNOL B, V16, P3864, DOI 10.1116/1.590425; Wouters D, 2004, ANGEW CHEM INT EDIT, V43, P2480, DOI 10.1002/anie.200300609; Xia YN, 1999, CHEM REV, V99, P1823, DOI 10.1021/cr980002q	28	268	276	8	155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 7	2010	328	5979					732	735		10.1126/science.1187851	http://dx.doi.org/10.1126/science.1187851			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592DZ	20413457				2022-12-28	WOS:000277357100034
J	Malleshaiah, MK; Shahrezaei, V; Swain, PS; Michnick, SW				Malleshaiah, Mohan K.; Shahrezaei, Vahid; Swain, Peter S.; Michnick, Stephen W.			The scaffold protein Ste5 directly controls a switch-like mating decision in yeast	NATURE			English	Article							MAP KINASE; MULTISITE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; PATHWAY; MECHANISM; DYNAMICS	Evolution has resulted in numerous innovations that allow organisms to increase their fitness by choosing particular mating partners, including secondary sexual characteristics, behavioural patterns, chemical attractants and corresponding sensory mechanisms(1). The haploid yeast Saccharomyces cerevisiae selects mating partners by interpreting the concentration gradient of pheromone secreted by potential mates through a network of mitogen-activated protein kinase (MAPK) signalling proteins(2,3). The mating decision in yeast is an all-or-none, or switch-like, response that allows cells to filter weak pheromone signals, thus avoiding inappropriate commitment to mating by responding only at or above critical concentrations when a mate is sufficiently close(4). The molecular mechanisms that govern the switch-like mating decision are poorly understood. Here we show that the switching mechanism arises from competition between the MAPK Fus3 and a phosphatase Ptc1 for control of the phosphorylation state of four sites on the scaffold protein Ste5. This competition results in a switch-like dissociation of Fus3 from Ste5 that is necessary to generate the switch-like mating response. Thus, the decision to mate is made at an early stage in the pheromone pathway and occurs rapidly, perhaps to prevent the loss of the potential mate to competitors. We argue that the architecture of the Fus3Ste5- Ptc1 circuit generates a novel ultrasensitivity mechanism, which is robust to variations in the concentrations of these proteins. This robustness helps assure that mating can occur despite stochastic or genetic variation between individuals. The role of Ste5 as a direct modulator of a cell-fate decision expands the functional repertoire of scaffold proteins beyond providing specificity and efficiency of information processing(5,6). Similar mechanisms may govern cellular decisions in higher organisms and be disrupted in cancer.	[Malleshaiah, Mohan K.; Michnick, Stephen W.] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada; [Michnick, Stephen W.] Univ Montreal, Ctr Robert Cedergren Bioinformat & Genom, Montreal, PQ H3C 3J7, Canada; [Shahrezaei, Vahid] Univ London Imperial Coll Sci Technol & Med, Dept Math, London SW7 2AZ, England; [Swain, Peter S.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Swain, Peter S.] Univ Edinburgh, Ctr Syst Biol, Edinburgh EH9 3JD, Midlothian, Scotland	Universite de Montreal; Universite de Montreal; Imperial College London; McGill University; University of Edinburgh	Michnick, SW (corresponding author), Univ Montreal, Dept Biochim, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	peter.swain@ed.ac.uk; stephen.michnick@umontreal.ca	Swain, Peter S/AAW-3265-2020	Shahrezaei, Vahid/0000-0002-4013-5458; Swain, Peter/0000-0001-7489-8587; Malleshaiah, Mohan/0000-0003-2896-8585	Canadian Institutes of Health Research [MOP-GMX-152556]; Canada Research Chair in Integrative Genomics; Canada Research Chair in Systems Biology	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Integrative Genomics; Canada Research Chair in Systems Biology	We thank J. Ferrell Jr, W. Lim, M. Babu, E. Stefan, C. Landry, F.-X. Campbell-Valois and E. Levy for comments on the manuscript; W. Lim and J. Vogel for providing plasmids and yeast strains; N. Paquin for assistance with the in vitro kinase assay; and J. Ollivier, O. Dushek and our laboratory members for discussions. This work was supported by grants from the Canadian Institutes of Health Research (MOP-GMX-152556) and a Canada Research Chair in Integrative Genomics to S. W. M. P. S. S. was supported by a Canada Research Chair in Systems Biology and currently holds a Scottish Universities Life Sciences Alliance Professorship, also in systems biology.	Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Darwin C., 1871, P475; Elion EA, 2000, CURR OPIN MICROBIOL, V3, P573, DOI 10.1016/S1369-5274(00)00143-0; Erdman S, 2001, GENETICS, V159, P919; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Good M, 2009, CELL, V136, P1085, DOI 10.1016/j.cell.2009.01.049; Haario H, 2006, STAT COMPUT, V16, P339, DOI 10.1007/s11222-006-9438-0; Hao N, 2008, MOL CELL, V30, P649, DOI 10.1016/j.molcel.2008.04.016; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; JACKSON CL, 1990, CELL, V63, P1039, DOI 10.1016/0092-8674(90)90507-B; Lawrence MC, 2008, CELL RES, V18, P436, DOI 10.1038/cr.2008.37; Lenz P, 2006, CURR BIOL, V16, P2150, DOI 10.1016/j.cub.2006.09.013; McClean MN, 2007, NAT GENET, V39, P409, DOI 10.1038/ng1957; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PETER M, 1994, SCIENCE, V265, P1228, DOI 10.1126/science.8066461; Salazar C, 2007, FEBS J, V274, P1046, DOI 10.1111/j.1742-4658.2007.05653.x; Serber Z, 2007, CELL, V128, P441, DOI 10.1016/j.cell.2007.01.018; Siso-Nadal F, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-36; Stefan E, 2007, P NATL ACAD SCI USA, V104, P16916, DOI 10.1073/pnas.0704257104; Strickfaden SC, 2007, CELL, V128, P519, DOI 10.1016/j.cell.2006.12.032; Swain PS, 2002, BIOPHYS J, V82, P2928, DOI 10.1016/S0006-3495(02)75633-6; van Drogen F, 2001, NAT CELL BIOL, V3, P1051, DOI 10.1038/ncb1201-1051; Warmka J, 2001, MOL CELL BIOL, V21, P51, DOI 10.1128/MCB.21.1.51-60.2001	30	133	139	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 6	2010	465	7294					101	105		10.1038/nature08946	http://dx.doi.org/10.1038/nature08946			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591OW	20400943				2022-12-28	WOS:000277311900039
J	Schulli, TU; Daudin, R; Renaud, G; Vaysset, A; Geaymond, O; Pasturel, A				Schuelli, T. U.; Daudin, R.; Renaud, G.; Vaysset, A.; Geaymond, O.; Pasturel, A.			Substrate-enhanced supercooling in AuSi eutectic droplets	NATURE			English	Article							LIQUID-SOLID GROWTH; MOLECULAR-DYNAMICS; NANOWIRE GROWTH; ALLOY; ORDER; INTERFACE; CRYSTALLIZATION; EPITAXY; METALS; GOLD	The phenomenon of supercooling in metals-that is, the preservation of a disordered, fluid phase in a metastable state well below the melting point(1)-has led to speculation that local atomic structure configurations of dense, symmetric, but non-periodic packing act as the main barrier for crystal nucleation(2,3). For liquids in contact with solids, crystalline surfaces induce layering of the adjacent atoms in the liquid(4,5) and may prevent or lower supercooling(6). This seed effect is supposed to depend on the local lateral order adopted in the last atomic layers of the liquid in contact with the crystal. Although it has been suggested that there might be a direct coupling between surface-induced lateral order and supercooling(6), no experimental observation of such lateral ordering at interfaces is available(6). Here we report supercooling in gold-silicon (AuSi) eutectic droplets, enhanced by a Au-induced (6 x 6) reconstruction of the Si(111) substrate. In situ X-ray scattering and ab initio molecular dynamics reveal that pentagonal atomic arrangements of Au atoms at this interface favour a lateral-ordering stabilization process of the liquid phase. This interface-enhanced stabilization of the liquid state shows the importance of the solid-liquid interaction for the structure of the adjacent liquid layers. Such processes are important for present and future technologies, as fluidity and crystallization play a key part in soldering and casting, as well as in processing and controlling chemical reactions for microfluidic devices or during the vapour-liquid-solid growth of semiconductor nanowires.	[Schuelli, T. U.; Daudin, R.; Renaud, G.; Vaysset, A.; Pasturel, A.] CEA, Inst Nanosci & Cryogenie, SP2M, F-38054 Grenoble, France; [Schuelli, T. U.] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Geaymond, O.] Inst Neel, CNRS, F-38042 Grenoble, France; [Pasturel, A.] SIMAP INPG, F-38402 St Martin Dheres, France	CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); European Synchrotron Radiation Facility (ESRF); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS)	Schulli, TU (corresponding author), CEA, Inst Nanosci & Cryogenie, SP2M, 17 Rue Martyrs, F-38054 Grenoble, France.	schulli@esrf.fr	Renaud, Gilles/C-2073-2017	Daudin, Remi/0000-0001-8922-2555				Adhikari H, 2006, NANO LETT, V6, P318, DOI 10.1021/nl052231f; CHEN HS, 1967, J APPL PHYS, V38, P3646, DOI 10.1063/1.1710186; FRANK FC, 1952, PROC R SOC LON SER-A, V215, P43, DOI 10.1098/rspa.1952.0194; Greer AL, 2006, NAT MATER, V5, P13, DOI 10.1038/nmat1557; Grozea D, 1998, SURF SCI, V418, P32, DOI 10.1016/S0039-6028(98)00660-8; Hannon JB, 2006, NATURE, V440, P69, DOI 10.1038/nature04574; Heni M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.021501; Hofmann S, 2008, NAT MATER, V7, P372, DOI 10.1038/nmat2140; HONEYCUTT JD, 1987, J PHYS CHEM-US, V91, P4950, DOI 10.1021/j100303a014; Jakse N, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.195501; Kim BJ, 2008, SCIENCE, V322, P1070, DOI 10.1126/science.1163494; Kodambaka S, 2007, SCIENCE, V316, P729, DOI 10.1126/science.1139105; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Oh SH, 2005, SCIENCE, V310, P661, DOI 10.1126/science.1118611; Pinardi AL, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.045416; Reichert H, 2000, NATURE, V408, P839, DOI 10.1038/35048537; Schenk T, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.075507; Schubert L, 2004, APPL PHYS LETT, V84, P4968, DOI 10.1063/1.1762701; Sheng HW, 2006, NATURE, V439, P419, DOI 10.1038/nature04421; Shpyrko OG, 2006, SCIENCE, V313, P77, DOI 10.1126/science.1128314; SPAEPEN F, 1975, ACTA METALL MATER, V23, P729, DOI 10.1016/0001-6160(75)90056-5; STEINHARDT PJ, 1981, PHYS REV LETT, V47, P1297, DOI 10.1103/PhysRevLett.47.1297; Sutter E, 2008, NANO LETT, V8, P411, DOI 10.1021/nl0719630; Sutter PW, 2007, NAT MATER, V6, P363, DOI 10.1038/nmat1894; Torquato S, 2009, NATURE, V460, P876, DOI 10.1038/nature08239; TURNBULL D, 1952, J CHEM PHYS, V20, P411, DOI 10.1063/1.1700435; Vlieg E, 2000, J APPL CRYSTALLOGR, V33, P401, DOI 10.1107/S0021889899013655; WAGNER RS, 1964, APPL PHYS LETT, V4, P89, DOI 10.1063/1.1753975; Wochner P, 2009, P NATL ACAD SCI USA, V106, P11511, DOI 10.1073/pnas.0905337106	29	93	97	6	172	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 22	2010	464	7292					1174	1177		10.1038/nature08986	http://dx.doi.org/10.1038/nature08986			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20414305				2022-12-28	WOS:000276891100033
J	Siston, AM; Rasmussen, SA; Honein, MA; Fry, AM; Seib, K; Callaghan, WM; Louie, J; Doyle, TJ; Crockett, M; Lynfield, R; Moore, Z; Wiedeman, C; Anand, M; Tabony, L; Nielsen, CF; Waller, K; Page, S; Thompson, JM; Avery, C; Springs, CB; Jones, T; Williams, JL; Newsome, K; Finelli, L; Jamieson, DJ				Siston, Alicia M.; Rasmussen, Sonja A.; Honein, Margaret A.; Fry, Alicia M.; Seib, Katherine; Callaghan, William M.; Louie, Janice; Doyle, Timothy J.; Crockett, Molly; Lynfield, Ruth; Moore, Zack; Wiedeman, Caleb; Anand, Madhu; Tabony, Laura; Nielsen, Carrie F.; Waller, Kirsten; Page, Shannon; Thompson, Jeannie M.; Avery, Catherine; Springs, Chasisity Brown; Jones, Timothy; Williams, Jennifer L.; Newsome, Kim; Finelli, Lyn; Jamieson, Denise J.		Pandemic H1N1 Influenza Pregnancy	Pandemic 2009 Influenza A(H1N1) Virus Illness Among Pregnant Women in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							A H1N1 VIRUS; CRITICALLY-ILL PATIENTS; OSELTAMIVIR TREATMENT; ASIAN INFLUENZA; INFECTION; IMPACT; SAFETY; SENSITIVITY; VACCINATION; PREVENTION	Context Early data on pandemic 2009 influenza A(H1N1) suggest pregnant women are at increased risk of hospitalization and death. Objective To describe the severity of 2009 influenza A(H1N1) illness and the association with early antiviral treatment among pregnant women in the United States. Design, Setting, and Patients Surveillance of 2009 influenza A(H1N1) in pregnant women reported to the Centers for Disease Control and Prevention (CDC) with symptom onset from April through December 2009. Main Outcome Measures Severity of illness (hospitalizations, intensive care unit [ICU] admissions, and deaths) due to 2009 influenza A(H1N1) among pregnant women, stratified by timing of antiviral treatment and pregnancy trimester at symptom onset. Results We received reports on 788 pregnant women in the United States with 2009 influenza A(H1N1) with symptom onset from April through August 2009. Among those, 30 died (5% of all reported 2009 influenza A[ H1N1] influenza deaths in this period). Among 509 hospitalized women, 115 (22.6%) were admitted to an ICU. Pregnant women with treatment more than 4 days after symptom onset were more likely to be admitted to an ICU (56.9% vs 9.4%; relative risk [RR], 6.0; 95% confidence interval [CI], 3.5-10.6) than those treated within 2 days after symptom onset. Only 1 death occurred in a patient who received treatment within 2 days of symptom onset. Updating these data with the CDC's continued surveillance of ICU admissions and deaths among pregnant women with symptom onset through December 31, 2009, identified an additional 165 women for a total of 280 women who were admitted to ICUs, 56 of whom died. Among the deaths, 4 occurred in the first trimester (7.1%), 15 in the second (26.8%), and 36 in the third (64.3%); Conclusions Pregnant women had a disproportionately high risk of mortality due to 2009 influenza A(H1N1). Among pregnant women with 2009 influenza A(H1N1) influenza reported to the CDC, early antiviral treatment appeared to be associated with fewer admissions to an ICU and fewer deaths. JAMA. 2010;303(15):1517-1525 www.jama.com	[Rasmussen, Sonja A.; Honein, Margaret A.] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA; [Siston, Alicia M.; Nielsen, Carrie F.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA; [Siston, Alicia M.; Fry, Alicia M.; Finelli, Lyn] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Callaghan, William M.; Jamieson, Denise J.] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA; [Louie, Janice] Calif Dept Publ Hlth, Richmond, CA USA; [Doyle, Timothy J.] Florida Dept Hlth, Tallahassee, FL USA; [Crockett, Molly] Massachusetts Dept Publ Hlth, Boston, MA USA; [Lynfield, Ruth] Minnesota Dept Hlth, St Paul, MN USA; [Moore, Zack] N Carolina Dept Hlth & Human Serv, Raleigh, NC USA; [Wiedeman, Caleb] Arizona Dept Hlth Serv, Phoenix, AZ 85007 USA; [Anand, Madhu] New York State Dept Hlth, Albany, NY 12237 USA; [Tabony, Laura] Texas Dept State Hlth Serv, Austin, TX USA; [Nielsen, Carrie F.] Wisconsin Dept Hlth Serv, Madison, WI USA; [Waller, Kirsten] Penn Dept Hlth, Harrisburg, PA 17108 USA; [Page, Shannon] Ohio Dept Hlth, Columbus, OH 43266 USA; [Thompson, Jeannie M.] Oklahoma Dept Hlth, Oklahoma City, OK USA; [Avery, Catherine] New Mexico Dept Hlth, Santa Fe, NM USA; [Springs, Chasisity Brown] S Carolina Dept Hlth & Environm Control, Columbia, SC 29201 USA; [Jones, Timothy] Tennessee Dept Hlth, Nashville, TN USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; California Department of Public Health; Florida Department of Health; Massachusetts Department of Public Health; Minnesota Department of Health (MHD); Arizona Department of Health Services; State University of New York (SUNY) System; Texas Department of State Health Services; New Mexico Department of Health; Tennessee Department Health	Honein, MA (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, 1600 Clifton Rd,MS E-86, Atlanta, GA 30333 USA.	mhonein@cdc.gov	Doyle, Timothy/AAM-3263-2021; Finelli, Lyn/AAK-2360-2020	Jamieson, Denise/0000-0003-2597-1201; Doyle, Timothy/0000-0002-4501-9157	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		ACOG Committee on Obstetric Practice, 2004, Obstet Gynecol, V104, P1125; Aoki FY, 2003, J ANTIMICROB CHEMOTH, V51, P123, DOI 10.1093/jac/dkg007; Balish A., 2009, Morbidity and Mortality Weekly Report, V58, P826; *CDC HLTH AL NETW, REC EARL EMP ANT TRE; *CDCP, SEAS INFL FLUV; *CDCP, H1N1 FLU SWIN FLU RE; Centers for Disease Control and Prevention, 2009, MMWR-MORBID MORTAL W, V58, P431; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1029; Chan KH, 2009, J CLIN VIROL, V45, P205, DOI 10.1016/j.jcv.2009.05.034; Creanga AA, 2010, OBSTET GYNECOL, V115, P717, DOI 10.1097/AOG.0b013e3181d57947; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Dodds L, 2007, CAN MED ASSOC J, V176, P463, DOI 10.1503/cmaj.061435; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; FREEMAN DW, 1959, AM J OBSTET GYNECOL, V78, P1172, DOI 10.1016/0002-9378(59)90570-8; Ginocchio CC, 2009, J CLIN VIROL, V45, P191, DOI 10.1016/j.jcv.2009.06.005; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Goodnight William H, 2005, Crit Care Med, V33, pS390, DOI 10.1097/01.CCM.0000182483.24836.66; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hamilton B. E., 2009, NATL VITAL STAT REP, V57, P1; Hanshaoworakul W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006051; HARDY JM, 1961, AM J PUBLIC HEALTH N, V51, P1182, DOI 10.2105/AJPH.51.8.1182; Harris JW, 1919, J AMER MED ASSOC, V72, P978, DOI 10.1001/jama.1919.02610140008002; Hewagama S, 2010, CLIN INFECT DIS, V50, P686, DOI 10.1086/650460; Hurt AC, 2009, INFLUENZA OTHER RESP, V3, P171, DOI 10.1111/j.1750-2659.2009.00086.x; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Kaiser L, 2003, ARCH INTERN MED, V163, P1667, DOI 10.1001/archinte.163.14.1667; Kelly H, 2009, EUROSURVEILLANCE, V14, P33; Kimura A. C., 2005, Morbidity and Mortality Weekly Report, V54, P196; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Langenegger E, 2009, SAMJ S AFR MED J, V99, P713; LIM ML, 2010, BJOG; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Lu PJ, 2008, VACCINE, V26, P1786, DOI 10.1016/j.vaccine.2008.01.040; Martinez Gustavo, 2009, Journal of Taphonomy, V7, P1; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; Naleway AL, 2006, EPIDEMIOL REV, V28, P47, DOI 10.1093/epirev/mxj002; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Nuzum JW, 1918, J AMER MED ASSOC, V71, P1562, DOI 10.1001/jama.1918.26020450009011a; *PUBL HLTH AG CAN, 2009, FLU WATCH AUG 16 23; Rasmussen SA, 2009, AM J PUBLIC HEALTH, V99, pS248, DOI 10.2105/AJPH.2008.152900; Schrag SJ, 2003, OBSTET GYNECOL, V101, P704, DOI 10.1016/S0029-7844(03)00010-3; Singleton J. A., 2010, Morbidity and Mortality Weekly Report, V59, P44; Tamma PD, 2009, AM J OBSTET GYNECOL, V201, P547, DOI 10.1016/j.ajog.2009.09.034; Tanaka T, 2009, CAN MED ASSOC J, V181, P55, DOI 10.1503/cmaj.090866; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; Woolston WJ, 1918, J AMER MED ASSOC, V71, P1898, DOI 10.1001/jama.1918.02600490030008; Zarocostas J, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2425	53	639	684	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2010	303	15					1517	1525		10.1001/jama.2010.479	http://dx.doi.org/10.1001/jama.2010.479			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585SJ	20407061	Green Accepted, Bronze			2022-12-28	WOS:000276849000028
J	Chhem, RK; Meghzifene, A; Czarwinski, R; Holmberg, O; Lou, L; Kesner, A				Chhem, Rethy K.; Meghzifene, Ahmed; Czarwinski, Renate; Holmberg, Ola; Lou, Lawrence; Kesner, Adam			Towards better and safer use of radiation in medicine	LANCET			English	Editorial Material							DIAGNOSTIC-RADIOLOGY; EXPOSURE; CHILDREN; CT		[Chhem, Rethy K.; Meghzifene, Ahmed; Kesner, Adam] IAEA, Div Human Hlth, A-1400 Vienna, Austria; [Czarwinski, Renate; Holmberg, Ola] IAEA, Div Radiat Transport & Waste Safety, A-1400 Vienna, Austria; [Lou, Lawrence] Int Radiol Qual Network, Sydney, NSW 2000, Australia	International Atomic Energy Agency; International Atomic Energy Agency	Chhem, RK (corresponding author), IAEA, Div Human Hlth, A-1400 Vienna, Austria.	R.Chhem@iaea.org	Meghzifene, Ahmed/S-6990-2019	Holmberg, Ola/0000-0001-6036-2319				*AM COLL RAD, 2009, ACR APPR CRIT; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Fenton JJ, 2003, J AM BOARD FAM PRACT, V16, P494, DOI 10.3122/jabfm.16.6.494; Frush DP, 2009, RADIOLOGY, V252, P4, DOI 10.1148/radiol.2521090661; Huda W, 2008, MED PHYS, V35, P5713, DOI 10.1118/1.3013604; *IAEA, 2002, MEAS STRENGTH INT CO; *IAEA, MISS STAT; IAEA, 1996, VIENNA SAFETY SERIES, V115; IAEA, 2009, P INT WORKSH JUST ME; International Atomic Energy Agency (IAEA), 2010, COMPR CLIN AUD DIAGN; Kleinerman RA, 2006, PEDIATR RADIOL, V36, P121, DOI 10.1007/s00247-006-0191-5; Lau Ls, 2007, Biomed Imaging Interv J, V3, pe21, DOI 10.2349/biij.3.3.e21; Malone JF, 2008, RADIAT PROT DOSIM, V129, P6, DOI 10.1093/rpd/ncn012; Oikarinen H, 2009, EUR RADIOL, V19, P1161, DOI 10.1007/s00330-008-1256-7; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609; The Royal College of Radiologists, 2007, MAK BEST US CLIN RAD; United Nations, 2008, REP UN SCI COMM EFF	17	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 17	2010	375	9723					1328	1330		10.1016/S0140-6736(10)60555-7	http://dx.doi.org/10.1016/S0140-6736(10)60555-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	588GW	20399968				2022-12-28	WOS:000277057800008
J	Fredrick, K; Ibba, M				Fredrick, Kurt; Ibba, Michael			How the Sequence of a Gene Can Tune Its Translation	CELL			English	Review							TRANSFER-RNA-SYNTHETASE; GENOME-WIDE ANALYSIS; MESSENGER-RNA; COMPLEX; RESOLUTION; CELLS		[Fredrick, Kurt; Ibba, Michael] Ohio State Univ, Dept Microbiol, Ohio State Biochem Program, Columbus, OH 43210 USA; [Fredrick, Kurt; Ibba, Michael] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Fredrick, K (corresponding author), Ohio State Univ, Dept Microbiol, Ohio State Biochem Program, 484 W 12th Ave, Columbus, OH 43210 USA.	fredrick.5@osu.edu; ibba.1@osu.edu			National Institutes of Health [GM 072528, GM 065183]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072528, R01GM065183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (GM 072528 to K. F.; GM 065183 to M. I.).	Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Chandra G, 2008, ANTON LEEUW INT J G, V94, P111, DOI 10.1007/s10482-008-9231-5; de Smit MH, 2003, J MOL BIOL, V331, P737, DOI 10.1016/S0022-2836(03)00809-X; DEUTSCHER MP, 1984, J CELL BIOL, V99, P373, DOI 10.1083/jcb.99.2.373; Dittmar KA, 2005, EMBO REP, V6, P151, DOI 10.1038/sj.embor.7400341; Ehrenberg M, 2010, BIOCHIMIE, V92, P12, DOI 10.1016/j.biochi.2009.10.002; EHRENBERG M, 2010, SCIENCE, V300, P1718; Elf J, 2003, SCIENCE, V300, P1718, DOI 10.1126/science.1083811; Geslain R, 2010, J MOL BIOL, V396, P821, DOI 10.1016/j.jmb.2009.12.018; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kaminska M, 2009, J BIOL CHEM, V284, P13746, DOI 10.1074/jbc.M900480200; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Kyriacou SV, 2008, MOL CELL, V29, P419, DOI 10.1016/j.molcel.2007.11.038; MIRANDE M, 1985, EUR J BIOCHEM, V147, P281, DOI 10.1111/j.1432-1033.1985.tb08748.x; Studer SM, 2006, MOL CELL, V22, P105, DOI 10.1016/j.molcel.2006.02.014; Zaborske JM, 2009, J BIOL CHEM, V284, P25254, DOI 10.1074/jbc.M109.000877; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554	17	118	120	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 16	2010	141	2					227	229		10.1016/j.cell.2010.03.033	http://dx.doi.org/10.1016/j.cell.2010.03.033			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	584GF	20403320	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000276738400013
J	Lapen, TJ; Righter, M; Brandon, AD; Debaille, V; Beard, BL; Shafer, JT; Peslier, AH				Lapen, T. J.; Righter, M.; Brandon, A. D.; Debaille, V.; Beard, B. L.; Shafer, J. T.; Peslier, A. H.			A Younger Age for ALH84001 and Its Geochemical Link to Shergottite Sources in Mars	SCIENCE			English	Article							MARTIAN METEORITE ALH84001; ALLAN HILLS 84001; LU-HF; DIFFERENTIATION; CONSTRAINTS; HISTORY; MANTLE; SYSTEMATICS; CHONDRITES	Martian meteorite ALH84001 (ALH) is the oldest known igneous rock from Mars and has been used to constrain its early history. Lutetium-hafnium (Lu-Hf) isotope data for ALH indicate an igneous age of 4.091 +/- 0.030 billion years, nearly coeval with an interval of heavy bombardment and cessation of the martian core dynamo and magnetic field. The calculated Lu/Hf and Sm/Nd (samarium/neodymium) ratios of the ALH parental magma source indicate that it must have undergone extensive igneous processing associated with the crystallization of a deep magma ocean. This same mantle source region also produced the shergottite magmas (dated 150 to 570 million years ago), possibly indicating uniform igneous processes in Mars for nearly 4 billion years.	[Lapen, T. J.; Righter, M.; Brandon, A. D.; Shafer, J. T.] Univ Houston, Dept Earth & Atmospher Sci, Houston, TX 77204 USA; [Peslier, A. H.] NASA, Lyndon B Johnson Space Ctr, ARES, Houston, TX 77058 USA; [Debaille, V.] Univ Libre Bruxelles, Dept Sci Terre & Environm, B-1050 Brussels, Belgium; [Beard, B. L.] Univ Wisconsin, Dept Geosci, Madison, WI 53706 USA; [Beard, B. L.] Univ Wisconsin, NASA, Astrobiol Inst, Madison, WI 53706 USA; [Peslier, A. H.] Engn & Sci Contract Grp, Houston, TX 77058 USA; [Shafer, J. T.] Lunar & Planetary Inst, Houston, TX 77058 USA	University of Houston System; University of Houston; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Universite Libre de Bruxelles; University of Wisconsin System; University of Wisconsin Madison; National Aeronautics & Space Administration (NASA); University of Wisconsin System; University of Wisconsin Madison	Lapen, TJ (corresponding author), Univ Houston, Dept Earth & Atmospher Sci, Houston, TX 77204 USA.	tjlapen@uh.edu	Peslier, Anne/F-3956-2010	Debaille, Vinciane/0000-0002-6544-4564	NASA; University of Houston Institute for Space Systems Operations; Belgian Fund for Scientific Research	NASA(National Aeronautics & Space Administration (NASA)); University of Houston Institute for Space Systems Operations; Belgian Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS)	Supported by NASA Cosmochemistry grants (T.J.L. and A. D. B.), a NASA Astrobiology grant (B. L. B.), the University of Houston Institute for Space Systems Operations (T.J.L.), and the Belgian Fund for Scientific Research (V. D.). We thank three anonymous reviewers for improving the clarity of the manuscript.	BARRAT JA, 2009, METEORIT PLANET SC S, V44; Blichert-Toft J, 1999, EARTH PLANET SC LETT, V173, P25, DOI 10.1016/S0012-821X(99)00222-8; Bogard DD, 1999, METEORIT PLANET SCI, V34, P451, DOI 10.1111/j.1945-5100.1999.tb01353.x; Borg LE, 1997, GEOCHIM COSMOCHIM AC, V61, P4915, DOI 10.1016/S0016-7037(97)00276-7; Borg LE, 1999, SCIENCE, V286, P90, DOI 10.1126/science.286.5437.90; Borg LE, 2003, METEORIT PLANET SCI, V38, P1713, DOI 10.1111/j.1945-5100.2003.tb00011.x; Borg LE, 2003, GEOCHIM COSMOCHIM AC, V67, P3519, DOI 10.1016/S0016-7037(03)00094-2; Bouvier A, 2005, EARTH PLANET SC LETT, V240, P221, DOI 10.1016/j.epsl.2005.09.007; Bouvier A, 2008, EARTH PLANET SC LETT, V273, P48, DOI 10.1016/j.epsl.2008.06.010; Bouvier A, 2008, EARTH PLANET SC LETT, V266, P105, DOI 10.1016/j.epsl.2007.11.006; Bouvier A, 2007, GEOCHIM COSMOCHIM AC, V71, P1583, DOI 10.1016/j.gca.2006.12.005; Bouvier A, 2009, EARTH PLANET SC LETT, V280, P285, DOI 10.1016/j.epsl.2009.01.042; Brandon AD, 2000, GEOCHIM COSMOCHIM AC, V64, P4083, DOI 10.1016/S0016-7037(00)00482-8; Debaille V, 2008, EARTH PLANET SC LETT, V269, P186, DOI 10.1016/j.epsl.2008.02.008; Debaille V, 2007, NATURE, V450, P525, DOI 10.1038/nature06317; Frey H, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033515; Ilg S, 1997, METEORIT PLANET SCI, V32, pA65; JAGOUTZ E, 1994, METEORITICS, V29, P478; JAGOUTZ E, 2009, LUNAR PLANET SCI C, V40, P1662; JONES JH, 1989, P LUNAR PLANET SCI C, V19, P465; Kleine T, 2009, GEOCHIM COSMOCHIM AC, V73, P5150, DOI 10.1016/j.gca.2008.11.047; LAPEN TJ, 2009, LUNAR PLANET SCI C, V40, P2376; Lillis RJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034338; Ludwig K. R., 2003, BERKLELEY GEOCHRON A, V1a, P59; MEYER C, 2008, 27672 NASAARES JSC; Nyquist LE, 2001, SPACE SCI REV, V96, P105, DOI 10.1023/A:1011993105172; NYQUIST LE, 1995, LUNAR PLANET SCI, V26, P1065; Roberts JH, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2008JE003287; RUMBLE D, 2009, LUNAR PLANET SCI C, V40, P2293; Scherer E, 2001, SCIENCE, V293, P683, DOI 10.1126/science.1061372; Shih C.-Y., 2009, LUNAR PLANET SCI C, P1360; Terada K, 2003, METEORIT PLANET SCI, V38, P1697, DOI 10.1111/j.1945-5100.2003.tb00009.x; Thomas-Keprta KL, 2009, GEOCHIM COSMOCHIM AC, V73, P6631, DOI 10.1016/j.gca.2009.05.064; Treiman AH, 1998, METEORIT PLANET SCI, V33, P753, DOI 10.1111/j.1945-5100.1998.tb01681.x; Turner G, 1997, GEOCHIM COSMOCHIM AC, V61, P3835, DOI 10.1016/S0016-7037(97)00285-8; Wadhwa M., 1996, METEORIT PLANET SCI, V31, pA145; WADHWA M, 1998, METEORIT PLANET SCI, V33, P1713; Weiss BP, 2002, EARTH PLANET SC LETT, V201, P449, DOI 10.1016/S0012-821X(02)00728-8	38	151	152	3	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 16	2010	328	5976					347	351		10.1126/science.1185395	http://dx.doi.org/10.1126/science.1185395			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583NR	20395507				2022-12-28	WOS:000276685000035
J	Venna, N; Gonzalez, RG; Camelo-Piragua, SI				Venna, Nagagopal; Gonzalez, R. Gilberto; Camelo-Piragua, Sandra I.			A Woman with Lethargy, Confusion, and Abnormalities on Brain Imaging Progressive multifocal leukoencephalopathy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RHEUMATIC-DISEASES; ENCEPHALOPATHY; ENCEPHALITIS; DIAGNOSIS; THERAPY; ADULTS; LUPUS		[Venna, Nagagopal] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Gonzalez, R. Gilberto] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Camelo-Piragua, Sandra I.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Venna, Nagagopal] Harvard Univ, Sch Med, Dept Neurol, Cambridge, MA 02138 USA; [Gonzalez, R. Gilberto] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Camelo-Piragua, Sandra I.] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Venna, N (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.			Camelopiragua, Sandra/0000-0002-9606-9402				Aksamit AJ, 2008, CURR TREAT OPTION NE, V10, P178, DOI 10.1007/s11940-008-0019-8; Boren EJ, 2008, J AUTOIMMUN, V30, P90, DOI 10.1016/j.jaut.2007.11.013; Brickelmaier M, 2009, ANTIMICROB AGENTS CH, V53, P1840, DOI 10.1128/AAC.01614-08; Calabrese LH, 2007, ARTHRITIS RHEUM-US, V56, P2116, DOI 10.1002/art.22657; Carson KR, 2009, BLOOD, V113, P4834, DOI 10.1182/blood-2008-10-186999; Cettomai D, 2009, ARCH NEUROL-CHICAGO, V66, P255, DOI 10.1001/archneurol.2008.557; Cinque P, 2003, J NEUROVIROL, V9, P73, DOI 10.1080/13550280390195351; Cunha BA, 2001, INFECT DIS CLIN N AM, V15, P567, DOI 10.1016/S0891-5520(05)70160-4; Elphick GF, 2004, SCIENCE, V306, P1380, DOI 10.1126/science.1103492; FONG IW, 1995, J CLIN MICROBIOL, V33, P484, DOI 10.1128/JCM.33.2.484-486.1995; Fong TG, 2009, NAT REV NEUROL, V5, P210, DOI 10.1038/nrneurol.2009.24; Hunt Matthew A, 2006, Neurosurg Focus, V21, pE3; Joseph FG, 2007, NEUROLOGY, V69, P644, DOI 10.1212/01.wnl.0000267320.48939.d0; Kappos L, 2007, LANCET NEUROL, V6, P431, DOI 10.1016/S1474-4422(07)70078-9; Khanna N, 2009, CLIN INFECT DIS, V48, P1459, DOI 10.1086/598335; Meierkord H, 2007, LANCET NEUROL, V6, P329, DOI 10.1016/S1474-4422(07)70074-1; Peretti-Viton P, 2002, J NEURO-ONCOL, V59, P249, DOI 10.1023/A:1019934901750; Schiess N, 2008, ANN NY ACAD SCI, V1142, P254, DOI 10.1196/annals.1444.018; Sechi G, 2007, LANCET NEUROL, V6, P442, DOI 10.1016/S1474-4422(07)70104-7; Seeley WW, 2007, NEUROLOGY, V69, P156, DOI 10.1212/01.wnl.0000265591.10200.d7; Vendrely A, 2005, ACTA NEUROPATHOL, V109, P449, DOI 10.1007/s00401-005-0983-y; 2006, N ENGL J MED, V355, P2678	22	5	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 15	2010	362	15					1431	1437		10.1056/NEJMcpc0910931	http://dx.doi.org/10.1056/NEJMcpc0910931			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582XY	20393180				2022-12-28	WOS:000276635300013
J	Taylor, CE				Taylor, Carl E.			What would Jim Grant say now?	LANCET			English	Editorial Material							PRIMARY HEALTH-CARE					nkureshy@usaid.gov						Altobelli L, 2008, CASE STUDY CLAS PERU; Grant J P, 1981, UNICEF News, P30; Jolly R, 2001, J GRANT UNICEF VISIO; KRISTOF ND, 2008, NY TIMES        0306; Lawn JE, 2008, LANCET, V372, P917, DOI 10.1016/S0140-6736(08)61402-6; SEIPP C, 1963, HLTH CARE COMMUNITY, P169; TAYLOR C, 1988, SOC SCI MED, V26, P971, DOI 10.1016/0277-9536(88)90418-2; Taylor C. E., 1987, Health Policy and Planning, V2, P150, DOI 10.1093/heapol/2.2.150; TAYLORIDE D, 2002, JUST LASTING CHANGE, P130; WISNER B, 1988, SOC SCI MED, V26, P963, DOI 10.1016/0277-9536(88)90417-0; World Health Organization, 1978, DECL ALM AT INT C PR	11	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 10	2010	375	9722					1236	1237		10.1016/S0140-6736(10)60449-7	http://dx.doi.org/10.1016/S0140-6736(10)60449-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	585VN	20382313				2022-12-28	WOS:000276858400010
J	Kloppenborg, B; Stencel, R; Monnier, JD; Schaefer, G; Zhao, M; Baron, F; McAlister, H; ten Brummelaar, T; Che, X; Farrington, C; Pedretti, E; Sallave-Goldfinger, PJ; Sturmann, J; Sturmann, L; Thureau, N; Turner, N; Carroll, SM				Kloppenborg, Brian; Stencel, Robert; Monnier, John D.; Schaefer, Gail; Zhao, Ming; Baron, Fabien; McAlister, Hal; ten Brummelaar, Theo; Che, Xiao; Farrington, Chris; Pedretti, Ettore; Sallave-Goldfinger, P. J.; Sturmann, Judit; Sturmann, Laszlo; Thureau, Nathalie; Turner, Nils; Carroll, Sean M.			Infrared images of the transiting disk in the epsilon Aurigae system	NATURE			English	Article							ECLIPSE	Epsilon Aurigae (epsilon Aur) is a visually bright, eclipsing binary star system with a period of 27.1 years. The cause of each 18-month-long eclipse has been a subject of controversy for nearly 190 years(1) because the companion has hitherto been undetectable. The orbital elements imply that the opaque object has roughly the same mass as the visible component, which for much of the last century was thought to be an F-type supergiant star with a mass of similar to 15M(circle dot) (M(circle dot), mass of the Sun). The high mass-to-luminosity ratio of the hidden object was originally explained by supposing it to be a hyperextended infrared star(2) or, later, a black hole(3) with an accretion disk, although the preferred interpretation was as a disk of opaque material(4,5) at a temperature of 500 K, tilted to the line of sight(6,7) and with a central opening(8). Recent work implies that the system consists of a low-mass (2.2M(circle dot)-3.3M(circle dot)) visible F-type star, with a disk at 550K that enshrouds a single B5V-type star(9). Here we report interferometric images that show the eclipsing body moving in front of the F star. The body is an opaque disk and appears tilted as predicted(7). Adopting a mass of 5.9M(circle dot) for the B star, we derive a mass of similar to(3.6 +/- 0.7)M(circle dot) for the F star. The disk mass is dynamically negligible; we estimate it to contain similar to 0.07M(circle plus) (M(circle plus), mass of the Earth) if it consists purely of dust.	[Kloppenborg, Brian; Stencel, Robert] Univ Denver, Dept Phys & Astron, Denver, CO 80208 USA; [Monnier, John D.; Baron, Fabien; Che, Xiao] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA; [Schaefer, Gail; McAlister, Hal; ten Brummelaar, Theo; Farrington, Chris; Sallave-Goldfinger, P. J.; Sturmann, Judit; Sturmann, Laszlo; Turner, Nils] Georgia State Univ, Ctr High Angular Resolut Astron, Atlanta, GA 30302 USA; [Zhao, Ming] Jet Prop Lab, Pasadena, CA 91101 USA; [Pedretti, Ettore; Thureau, Nathalie] Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland; [Carroll, Sean M.] CALTECH, Dept Phys, Pasadena, CA 91125 USA	University of Denver; University of Michigan System; University of Michigan; University System of Georgia; Georgia State University; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of St Andrews; California Institute of Technology	Kloppenborg, B (corresponding author), Univ Denver, Dept Phys & Astron, 2112 E Wesley Ave, Denver, CO 80208 USA.	bkloppen@du.edu; rstencel@du.edu	Carroll, Sean/C-5972-2015	Carroll, Sean/0000-0002-4226-5758	US National Science Foundation (NSF); Georgia State University; W. M. Keck Foundation; David and Lucile Packard Foundation; office of the Dean of the College of Arts and Science at Georgia State University; University of Michigan	US National Science Foundation (NSF)(National Science Foundation (NSF)); Georgia State University; W. M. Keck Foundation(W.M. Keck Foundation); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); office of the Dean of the College of Arts and Science at Georgia State University; University of Michigan(University of Michigan System)	We are grateful to the firefighters who defended Mount Wilson Observatory from the Station Fire, and L. Webster and the staff at Mount Wilson Observatory for facilitating our observations. We acknowledge with thanks the variable-star observations from the AAVSO International Database contributed by observers worldwide and used in this research. The CHARA Array, operated by Georgia State University, was built with funding provided by the US National Science Foundation (NSF), Georgia State University, the W. M. Keck Foundation and the David and Lucile Packard Foundation. CHARA is operated under continuing support from the NSF. This research is supported by the NSF as well as by funding from the office of the Dean of the College of Arts and Science at Georgia State University. J.D.M. acknowledges funding from the University of Michigan and the NSF. MIRC was supported by funds from the NSF. B. K. and R. S. thank J. Hopkins for ongoing photometry and are grateful for the bequest of William Herschel Womble in support of astronomy at the University of Denver.	BARON F, 2008, SPIE C SER, V7013; CAMERON AGW, 1971, NATURE, V229, P178, DOI 10.1038/229178a0; CARROLL SM, 1991, ASTROPHYS J, V367, P278, DOI 10.1086/169626; Guinan EF, 2002, ASTR SOC P, V279, P121; HOARD DW, ASTROPHYS J IN PRESS; HUANG S, 1965, ASTROPHYS J, V141, P976, DOI 10.1086/148191; Ireland M. J., 2006, SPIE C SER, V6268; KEMP JC, 1986, ASTROPHYS J, V300, pL11, DOI 10.1086/184593; Kuiper GP, 1937, ASTROPHYS J, V86, P570, DOI 10.1086/143888; Lawson P. R., 2006, SPIE C SER, V6268; Lissauer JJ, 1996, ASTROPHYS J, V465, P371, DOI 10.1086/177426; Monnier JD, 2006, SPIE C SER, V6268; Monnier JD, 2007, SCIENCE, V317, P342, DOI 10.1126/science.1143205; Pauls TA, 2005, PUBL ASTRON SOC PAC, V117, P1255, DOI 10.1086/444523; Stefanik RP, 2010, ASTRON J, V139, P1254, DOI 10.1088/0004-6256/139/3/1254; STENCEL RE, 1985, NASA C PUBL, V2384; Stencel RE, 2008, ASTROPHYS J LETT, V689, pL137, DOI 10.1086/595877; ten Brummelaar TA, 2005, ASTROPHYS J, V628, P453, DOI 10.1086/430729; WILSON RE, 1971, ASTROPHYS J, V170, P529, DOI 10.1086/151237; Zhao M, 2008, ASTROPHYS J LETT, V684, pL95, DOI 10.1086/592146; [No title captured]	21	132	132	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 8	2010	464	7290					870	872		10.1038/nature08968	http://dx.doi.org/10.1038/nature08968			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20376144	Green Submitted			2022-12-28	WOS:000276397300032
J	Wolf, B; Zheng, XH; Brueggemann, N; Chen, WW; Dannenmann, M; Han, XG; Sutton, MA; Wu, HH; Yao, ZS; Butterbach-Bahl, K				Wolf, Benjamin; Zheng, Xunhua; Brueggemann, Nicolas; Chen, Weiwei; Dannenmann, Michael; Han, Xingguo; Sutton, Mark A.; Wu, Honghui; Yao, Zhisheng; Butterbach-Bahl, Klaus			Grazing-induced reduction of natural nitrous oxide release from continental steppe	NATURE			English	Article							CARBON-DIOXIDE; SOIL-WATER; N2O; EMISSIONS; FLUXES; METHANE; GRASSLAND	Atmospheric concentrations of the greenhouse gas nitrous oxide (N2O) have increased significantly since pre-industrial times owing to anthropogenic perturbation of the global nitrogen cycle(1,2), with animal production being one of the main contributors(3). Grasslands cover about 20 per cent of the temperate land surface of the Earth and are widely used as pasture. It has been suggested that high animal stocking rates and the resulting elevated nitrogen input increase N2O emissions(4-7). Internationally agreed methods to upscale the effect of increased livestock numbers on N2O emissions are based directly on per capita nitrogen inputs(8). However, measurements of grassland N2O fluxes are often performed over short time periods(9), with low time resolution and mostly during the growing season. In consequence, our understanding of the daily and seasonal dynamics of grassland N2O fluxes remains limited. Here we report year-round N2O flux measurements with high and low temporal resolution at ten steppe grassland sites in Inner Mongolia, China. We show that short-lived pulses of N2O emission during spring thaw dominate the annual N2O budget at our study sites. The N2O emission pulses are highest in ungrazed steppe and decrease with increasing stocking rate, suggesting that grazing decreases rather than increases N2O emissions. Our results show that the stimulatory effect of higher stocking rates on nitrogen cycling(4,7) and, hence, on N2O emission is more than offset by the effects of a parallel reduction in microbial biomass, inorganic nitrogen production and wintertime water retention. By neglecting these freeze-thaw interactions, existing approaches may have systematically overestimated N2O emissions over the last century for semi-arid, cool temperate grasslands by up to 72 per cent.	[Wolf, Benjamin; Brueggemann, Nicolas; Dannenmann, Michael; Butterbach-Bahl, Klaus] Karlsruhe Inst Technol, Inst Meteorol & Climate Res, D-82467 Garmisch Partenkirchen, Germany; [Zheng, Xunhua; Chen, Weiwei; Yao, Zhisheng] Chinese Acad Sci, Inst Atmospher Phys, State Key Lab Atmospher Boundary Layer Phys & Atm, Beijing 100029, Peoples R China; [Han, Xingguo; Wu, Honghui] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing 100093, Peoples R China; [Sutton, Mark A.] Ctr Ecol & Hydrol, Penicuik EH26 0QB, Midlothian, Scotland	Helmholtz Association; Karlsruhe Institute of Technology; Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; UK Centre for Ecology & Hydrology (UKCEH)	Butterbach-Bahl, K (corresponding author), Karlsruhe Inst Technol, Inst Meteorol & Climate Res, Kreuzeckbahnstr 19, D-82467 Garmisch Partenkirchen, Germany.	klaus.butterbach-bahl@kit.edu	Butterbach-Bahl, Klaus/A-8081-2013; Han, Xingguo/K-7552-2016; Dannenmann, Michael/A-7278-2013; Han, Xingguo/B-3980-2012; LAPC, IAP/AAI-6991-2020; Zheng, Xunhua/D-3048-2017; Sutton, Mark/K-2700-2012; Zheng, Xunhua/AAH-8172-2019; Yao, Zhisheng/A-5749-2015; Brueggemann, Nicolas/C-4263-2014; Wu, Honghui/AAF-5696-2019	Butterbach-Bahl, Klaus/0000-0001-9499-6598; Han, Xingguo/0000-0002-1836-975X; LAPC, IAP/0000-0002-0025-3484; Zheng, Xunhua/0000-0002-4138-7470; Sutton, Mark/0000-0002-1342-2072; Zheng, Xunhua/0000-0002-4138-7470; Yao, Zhisheng/0000-0001-6242-2426; Brueggemann, Nicolas/0000-0003-3851-2418; Dannenmann, Michael/0000-0001-5924-7612	German Research Foundation (DFG) [536]; National Natural Science Foundation of China [40805061]; European Commission; Natural Environment Research Council [ceh010023] Funding Source: researchfish	German Research Foundation (DFG)(German Research Foundation (DFG)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work has been supported by the German Research Foundation (DFG research group 536, 'Matter fluxes in grasslands of Inner Mongolia as influenced by stocking rate') and the National Natural Science Foundation of China (grant number 40805061), with co-funding from the NitroEurope Integrated Project of the European Commission. We thank K. K. Goldewijk for providing livestock data for the years before 1961, and Z. Yu, K. Muller, L. Lin, P. Schoenbach, G. Willibald, R. Kiese, C. Werner and C. Liu for support with field measurements.	Brooks PD, 1998, BIOGEOCHEMISTRY, V43, P1, DOI 10.1023/A:1005947511910; Crutzen PJ, 2008, ATMOS CHEM PHYS, V8, P389, DOI 10.5194/acp-8-389-2008; Dannenmann M, 2006, PLANT SOIL, V287, P279, DOI 10.1007/s11104-006-9077-4; Davidson EA, 2009, NAT GEOSCI, V2, P659, DOI 10.1038/NGEO608; Eggleston H.S., 2006, 2006 IPCC GUIDELINES; Essery R, 2004, J HYDROMETEOROL, V5, P735, DOI 10.1175/1525-7541(2004)005<0735:VATCOW>2.0.CO;2; *FERTISTAT, 2007, FERT US CROP STAT; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Groffman PM, 2006, GLOBAL CHANGE BIOL, V12, P1748, DOI 10.1111/j.1365-2486.2006.01194.x; Hoffmann C, 2008, J ARID ENVIRON, V72, P792, DOI 10.1016/j.jaridenv.2007.09.004; Koponen HT, 2004, NUTR CYCL AGROECOSYS, V69, P213, DOI 10.1023/B:FRES.0000035172.37839.24; Ma XZ, 2006, NEW ZEAL J AGR RES, V49, P285, DOI 10.1080/00288233.2006.9513719; Matzner E, 2008, EUR J SOIL SCI, V59, P274, DOI 10.1111/j.1365-2389.2007.00992.x; Mitchell B.R., 1995, INT HIST STAT AFRICA; MITCHELL BR, 1992, INT HIST STAT EUROPE, P325; Mitchell Brian R, 1993, INT HIST STAT AM 175; Mosier A, 1998, NUTR CYCL AGROECOSYS, V52, P225, DOI 10.1023/A:1009740530221; Mosier AR, 1997, GLOBAL BIOGEOCHEM CY, V11, P29, DOI 10.1029/96GB03612; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Oenema O, 1997, SOIL USE MANAGE, V13, P288, DOI 10.1111/j.1475-2743.1997.tb00600.x; Papen H, 1999, J GEOPHYS RES-ATMOS, V104, P18487, DOI 10.1029/1999JD900293; Ramankutty N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002952; Rivkina EM, 2000, APPL ENVIRON MICROB, V66, P3230, DOI 10.1128/AEM.66.8.3230-3233.2000; Rover M, 1998, SOIL BIOL BIOCHEM, V30, P1859, DOI 10.1016/S0038-0717(98)00080-7; Saggar S, 2007, AGR ECOSYST ENVIRON, V122, P357, DOI 10.1016/j.agee.2007.02.006; Sharma S, 2006, APPL ENVIRON MICROB, V72, P2148, DOI 10.1128/AEM.72.3.2148-2154.2006; Teepe R, 2004, EUR J SOIL SCI, V55, P357, DOI 10.1111/j.1365-2389.2004.00602.x; Yamulki S, 1998, SOIL BIOL BIOCHEM, V30, P491, DOI 10.1016/S0038-0717(97)00145-4	28	216	237	23	477	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					881	884		10.1038/nature08931	http://dx.doi.org/10.1038/nature08931			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20376147				2022-12-28	WOS:000276397300035
J	Judd, O; Colvin, IB				Judd, O.; Colvin, I. B.			10 Minute Consultation Hoarse voice	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Judd, O.] Derbyshire Royal Infirm, Dept Otolaryngol, Derby DE1 2QY, England; [Colvin, I. B.] Elizabeth Ave Grp Practice, London N1 3BX, England		Judd, O (corresponding author), Derbyshire Royal Infirm, Dept Otolaryngol, Derby DE1 2QY, England.	owenjudd@doctors.org.uk		Judd, Owen/0000-0003-3112-931X					0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 7	2010	340								c522	10.1136/bmj.c522	http://dx.doi.org/10.1136/bmj.c522			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582ZF	20375088				2022-12-28	WOS:000276639400014
J	Dannenberg, JH; Berns, A				Dannenberg, Jan-Hermen; Berns, Anton			Drugging Drug Resistance	CELL			English	Editorial Material							LUNG-CANCER; MECHANISMS		[Dannenberg, Jan-Hermen; Berns, Anton] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Berns, A (corresponding author), Netherlands Canc Inst, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	a.berns@nki.nl						Ahmed S, 2004, MOL CELL BIOL, V24, P3660, DOI 10.1128/MCB.24.9.3660-3669.2004; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Frank NY, 2010, J CLIN INVEST, V120, P41, DOI 10.1172/JCI41004; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Redmond KM, 2008, FRONT BIOSCI-LANDMRK, V13, P5138, DOI 10.2741/3070	7	21	22	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2010	141	1					18	20		10.1016/j.cell.2010.03.020	http://dx.doi.org/10.1016/j.cell.2010.03.020			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	577GS	20371339	Bronze			2022-12-28	WOS:000276211100006
J	Storlazzi, A; Gargano, S; Ruprich-Robert, G; Falque, M; David, M; Kleckner, N; Zickler, D				Storlazzi, Aurora; Gargano, Silvana; Ruprich-Robert, Gwenael; Falque, Matthieu; David, Michelle; Kleckner, Nancy; Zickler, Denise			Recombination Proteins Mediate Meiotic Spatial Chromosome Organization and Pairing	CELL			English	Article							SYNAPTONEMAL COMPLEX-FORMATION; DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE MER3; CROSSING-OVER; CROSSOVER CONTROL; MEIOSIS; ARABIDOPSIS; INITIATION; PROPHASE; TRANSITION	Meiotic chromosome pairing involves not only recognition of homology but also juxtaposition of entire chromosomes in a topologically regular way. Analysis of filamentous fungus Sordaria macrospora reveals that recombination proteins Mer3, Msh4, and Mlh1 play direct roles in all of these aspects, in advance of their known roles in recombination. Absence of Mer3 helicase results in interwoven chromosomes, thereby revealing the existence of features that specifically ensure "entanglement avoidance." Entanglements that remain at zygotene, i.e., "interlockings," require Mlh1 for resolution, likely to eliminate constraining recombinational connections. Patterns of Mer3 and Msh4 foci along aligned chromosomes show that the double-strand breaks mediating homologous alignment have spatially separated ends, one localized to each partner axis, and that pairing involves interference among developing interhomolog interactions. We propose that Mer3, Msh4, and Mlh1 execute all of these roles during pairing by modulating the state of nascent double-strand break/partner DNA contacts within axis-associated recombination complexes.	[Storlazzi, Aurora; Ruprich-Robert, Gwenael; David, Michelle; Zickler, Denise] Univ Paris 11, Inst Genet & Microbiol, UMR 8621, F-91405 Orsay, France; [Storlazzi, Aurora; Gargano, Silvana] CNR, Ist Genet & Biofis A Buzzati Traverso, I-80131 Naples, Italy; [Falque, Matthieu] UMR Genet Vegetale Moulon, F-91190 Gif Sur Yvette, France; [Kleckner, Nancy] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02139 USA	UDICE-French Research Universities; Universite Paris Saclay; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); Harvard University	Zickler, D (corresponding author), Univ Paris 11, Inst Genet & Microbiol, UMR 8621, F-91405 Orsay, France.	denise.zickler@igmors.u-psud.fr		Falque, Matthieu/0000-0002-6444-858X; Ruprich-Robert, Gwenael/0000-0003-3679-428X	Centre National de la Recherche Scientifique [UMR 8621]; National Institutes of Health [GM025326, GM044794]; Regione campania Legge [28/03/2002 n.5]; CNR; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044794, R37GM025326, R01GM025326] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Regione campania Legge(Regione Campania); CNR(Consiglio Nazionale delle Ricerche (CNR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Stefanie Poggeler for the recombinant ku70 plasmid and Olivier Martin for his advice in the statistical analyses. D. Z., A. S. and G. R.-R. were supported by grants from the Centre National de la Recherche Scientifique (UMR 8621), and from the National Institutes of Health (GM025326 and GM044794) to N. K. S. G. was supported by Regione campania Legge 28/03/2002 n.5, and together with A. S. by CNR.	ALBINI SM, 1987, CHROMOSOMA, V95, P324, DOI 10.1007/BF00293179; Anderson LK, 2005, CYTOGENET GENOME RES, V109, P198, DOI 10.1159/000082400; Argueso JL, 2003, MOL CELL BIOL, V23, P873, DOI 10.1128/MCB.23.3.873-886.2003; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; de Boer E, 2006, P NATL ACAD SCI USA, V103, P9607, DOI 10.1073/pnas.0600418103; Franklin AE, 1999, PLANT CELL, V11, P809, DOI 10.1105/tpc.11.5.809; Franklin FCH, 2006, BIOCHEM SOC T, V34, P542, DOI 10.1042/BST0340542; Guillon H, 2005, MOL CELL, V20, P563, DOI 10.1016/j.molcel.2005.09.021; Henderson KA, 2005, BIOESSAYS, V27, P995, DOI 10.1002/bies.20310; Higgins JD, 2004, GENE DEV, V18, P2557, DOI 10.1101/gad.317504; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Hunter N., 2006, MOL GENETICS RECOMBI, P381, DOI 10.1007/978-3-540-71021-9_14; Jackson N, 2006, EMBO J, V25, P1315, DOI 10.1038/sj.emboj.7600992; KLECKNER N, 1993, COLD SPRING HARB SYM, V58, P553, DOI 10.1101/SQB.1993.058.01.062; Koszul R, 2008, CELL, V133, P1188, DOI 10.1016/j.cell.2008.04.050; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Mazina OM, 2004, CELL, V117, P47, DOI 10.1016/S0092-8674(04)00294-6; Moens PB, 2007, J CELL SCI, V120, P1017, DOI 10.1242/jcs.03394; Nakagawa T, 1999, EMBO J, V18, P5714, DOI 10.1093/emboj/18.20.5714; Nakagawa T, 2002, MOL CELL BIOL, V22, P3281, DOI 10.1128/MCB.22.10.3281-3291.2002; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Oliver-Bonet M, 2007, MOL HUM REPROD, V13, P837, DOI 10.1093/molehr/gam076; Page SL, 2004, ANNU REV CELL DEV BI, V20, P525, DOI 10.1146/annurev.cellbio.19.111301.155141; Robine N, 2007, MOL CELL BIOL, V27, P1868, DOI 10.1128/MCB.02063-06; Scherthan H, 2007, P NATL ACAD SCI USA, V104, P16934, DOI 10.1073/pnas.0704860104; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Storlazzi A, 2003, GENE DEV, V17, P2675, DOI 10.1101/gad.275203; Storlazzi A, 2008, GENE DEV, V22, P796, DOI 10.1101/gad.459308; Tesse S, 2003, P NATL ACAD SCI USA, V100, P12865, DOI 10.1073/pnas.2034282100; van Heemst D, 1999, CELL, V98, P261, DOI 10.1016/S0092-8674(00)81020-X; VONWETTSTEIN D, 1984, ANNU REV GENET, V18, P331, DOI 10.1146/annurev.ge.18.120184.001555; Wang CJR, 2009, GENETICS, V183, P905, DOI 10.1534/genetics.109.108688; Wang KJ, 2009, J CELL SCI, V122, P2055, DOI 10.1242/jcs.049080; WU TC, 1995, GENETICS, V140, P55; Zickler D, 2006, CHROMOSOMA, V115, P158, DOI 10.1007/s00412-006-0048-6; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; ZICKLER D, 1992, GENETICS, V132, P135	38	110	110	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2010	141	1					94	106		10.1016/j.cell.2010.02.041	http://dx.doi.org/10.1016/j.cell.2010.02.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	577GS	20371348	Bronze, Green Accepted			2022-12-28	WOS:000276211100015
J	Yu, XJ; McGourty, K; Liu, M; Unsworth, KE; Holden, DW				Yu, Xiu-Jun; McGourty, Kieran; Liu, Mei; Unsworth, Kate E.; Holden, David W.			pH Sensing by Intracellular Salmonella Induces Effector Translocation	SCIENCE			English	Article							III SECRETION SYSTEM; PATHOGENICITY ISLAND 2; YERSINIA-PESTIS; APPARATUS	Salmonella enterica is an important intracellular bacterial pathogen of humans and animals. It replicates within host-cell vacuoles by delivering virulence (effector) proteins through a vacuolar membrane pore made by the Salmonella pathogenicity island 2 (SPI-2) type III secretion system (T3SS). T3SS assembly follows vacuole acidification, but when bacteria are grown at low pH, effector secretion is negligible. We found that effector secretion was activated at low pH from mutant strains lacking a complex of SPI-2-encoded proteins SsaM, SpiC, and SsaL. Exposure of wild-type bacteria to pH 7.2 after growth at pH 5.0 caused dissociation and degradation of SsaM/SpiC/SsaL complexes and effector secretion. In infected cells, loss of the pH 7.2 signal through acidification of host-cell cytosol prevented complex degradation and effector translocation. Thus, intravacuolar Salmonella senses host cytosolic pH, resulting in the degradation of regulatory complex proteins and effector translocation.	[Yu, Xiu-Jun; McGourty, Kieran; Liu, Mei; Unsworth, Kate E.; Holden, David W.] Univ London Imperial Coll Sci Technol & Med, Microbiol Sect, Ctr Mol Microbiol & Infect, London SW7 2AZ, England	Imperial College London	Holden, DW (corresponding author), Univ London Imperial Coll Sci Technol & Med, Microbiol Sect, Ctr Mol Microbiol & Infect, Armstrong Rd, London SW7 2AZ, England.	d.holden@imperial.ac.uk		Liu, Mei/0000-0002-4319-3063	Medical Research Council [G0800148, 074553/Z/04/Z]; Wellcome Trust; MRC [G0800148] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank J. Mota, C. Tang, and members of the Holden laboratory for comments on the manuscript. This research was supported by grants G0800148 and 074553/Z/04/Z to D. W. H. from the Medical Research Council and Wellcome Trust.	Beuzon CR, 1999, MOL MICROBIOL, V33, P806, DOI 10.1046/j.1365-2958.1999.01527.x; Chakravortty D, 2005, EMBO J, V24, P2043, DOI 10.1038/sj.emboj.7600676; Coombes BK, 2004, J BIOL CHEM, V279, P49804, DOI 10.1074/jbc.M404299200; Drecktrah D, 2007, TRAFFIC, V8, P212, DOI 10.1111/j.1600-0854.2006.00529.x; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Kenjale R, 2005, J BIOL CHEM, V280, P42929, DOI 10.1074/jbc.M508377200; Pallen MJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-9; Rappl C, 2003, FEMS MICROBIOL LETT, V226, P363, DOI 10.1016/S0378-1097(03)00638-4; Schubot FD, 2005, J MOL BIOL, V346, P1147, DOI 10.1016/j.jmb.2004.12.036; Torruellas J, 2005, MOL MICROBIOL, V57, P1719, DOI 10.1111/j.1365-2958.2005.04790.x; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Yu XJ, 2004, MOL MICROBIOL, V54, P604, DOI 10.1111/j.1365-2958.2004.04297.x	12	134	138	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 21	2010	328	5981					1040	1043		10.1126/science.1189000	http://dx.doi.org/10.1126/science.1189000			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598YW	20395475	Green Accepted, Green Submitted			2022-12-28	WOS:000277877100044
J	Zemach, A; McDaniel, IE; Silva, P; Zilberman, D				Zemach, Assaf; McDaniel, Ivy E.; Silva, Pedro; Zilberman, Daniel			Genome-Wide Evolutionary Analysis of Eukaryotic DNA Methylation	SCIENCE			English	Article								Eukaryotic cytosine methylation represses transcription but also occurs in the bodies of active genes, and the extent of methylation biology conservation is unclear. We quantified DNA methylation in 17 eukaryotic genomes and found that gene body methylation is conserved between plants and animals, whereas selective methylation of transposons is not. We show that methylation of plant transposons in the CHG context extends to green algae and that exclusion of histone H2A.Z from methylated DNA is conserved between plants and animals, and we present evidence for RNA-directed DNA methylation of fungal genes. Our data demonstrate that extant DNA methylation systems are mosaics of conserved and derived features, and indicate that gene body methylation is an ancient property of eukaryotic genomes.	[Zemach, Assaf; McDaniel, Ivy E.; Silva, Pedro; Zilberman, Daniel] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Zilberman, D (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, 211 Koshland Hall, Berkeley, CA 94720 USA.	danielz@berkeley.edu	Silva, Pedro/H-9497-2012	Silva, Pedro/0000-0002-9889-3075; Zilberman, Daniel/0000-0002-0123-8649; Zemach, Assaf/0000-0003-3282-4445				Bestor TH, 1999, GENETICA, V107, P289, DOI 10.1023/A:1003990818251; Feil R, 2007, TRENDS GENET, V23, P192, DOI 10.1016/j.tig.2007.02.004; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Galagan JE, 2004, TRENDS GENET, V20, P417, DOI 10.1016/j.tig.2004.07.007; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Lewis ZA, 2009, GENOME RES, V19, P427, DOI 10.1101/gr.086231.108; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; PATEL CV, 1987, ANAL BIOCHEM, V164, P164, DOI 10.1016/0003-2697(87)90381-2; Simmen MW, 1999, SCIENCE, V283, P1164, DOI 10.1126/science.283.5405.1164; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	16	1120	1164	11	308	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2010	328	5980					916	919		10.1126/science.1186366	http://dx.doi.org/10.1126/science.1186366			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20395474				2022-12-28	WOS:000277618800056
J	Burmann, BM; Schweimer, K; Luo, X; Wahl, MC; Stitt, BL; Gottesman, ME; Rosch, P				Burmann, Bjoern M.; Schweimer, Kristian; Luo, Xiao; Wahl, Markus C.; Stitt, Barbara L.; Gottesman, Max E.; Roesch, Paul			A NusE:NusG Complex Links Transcription and Translation	SCIENCE			English	Article							ESCHERICHIA-COLI; ANTITERMINATION COMPLEX; RNA-TRANSCRIPTION; PHAGE-LAMBDA; FACTOR-NUSG; N-PROTEIN; BOXA RNA; ELONGATION; TERMINATION; RHO	Bacterial NusG is a highly conserved transcription factor that is required for most Rho activity in vivo. We show by nuclear magnetic resonance spectroscopy that Escherichia coli NusG carboxy-terminal domain forms a complex alternatively with Rho or with transcription factor NusE, a protein identical to 30S ribosomal protein S10. Because NusG amino-terminal domain contacts RNA polymerase and the NusG carboxyl-terminal domain interaction site of NusE is accessible in the ribosomal 30S subunit, NusG may act as a link between transcription and translation. Uncoupling of transcription and translation at the ends of bacterial operons enables transcription termination by Rho factor, and competition between ribosomal NusE and Rho for NusG helps to explain why Rho cannot terminate translated transcripts.	[Burmann, Bjoern M.; Schweimer, Kristian; Roesch, Paul] Univ Bayreuth, Lehrstuhl Biopolymere, D-95447 Bayreuth, Germany; [Burmann, Bjoern M.; Schweimer, Kristian; Roesch, Paul] Univ Bayreuth, Forschungszentrum BioMakromol, D-95447 Bayreuth, Germany; [Luo, Xiao; Wahl, Markus C.] Free Univ Berlin, Fachbereich Biol Chem Pharm, Inst Chem & Biochem, AG Strukturbiochem, D-14195 Berlin, Germany; [Stitt, Barbara L.] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; [Stitt, Barbara L.] Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA; [Gottesman, Max E.] Columbia Univ, Dept Microbiol, Med Ctr, New York, NY 10032 USA; [Gottesman, Max E.] Columbia Univ, Inst Canc Res, Med Ctr, New York, NY 10032 USA	University of Bayreuth; University of Bayreuth; Free University of Berlin; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Columbia University; Columbia University	Rosch, P (corresponding author), Univ Bayreuth, Lehrstuhl Biopolymere, Univ Str 30, D-95447 Bayreuth, Germany.	roesch@unibt.de	Wahl, Markus C./D-6365-2017; Burmann, Björn/M-8913-2015; Rösch, Paul/I-5445-2014; Burmann, Björn M./AAI-7760-2021; Burmann, Björn M./AAR-7399-2020	Wahl, Markus C./0000-0002-2811-5307; Burmann, Björn/0000-0002-3135-7964; Rösch, Paul/0000-0003-3330-2446; Burmann, Björn M./0000-0002-3135-7964; Schweimer, Kristian/0000-0002-3837-8442	Deutsche Forschungsgemeinschaft [Ro617/16-1, Wa1126/3-1, NSF MCB-0744422]; NIH [GM037219]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037219, R56GM037219] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Heissmann for excellent technical assistance. Financial support by the Deutsche Forschungsgemeinschaft to P. R. (Ro617/16-1), M. C. W. (Wa1126/3-1), and B. L. S. (NSF MCB-0744422) as well as by the NIH to M. E. G. (GM037219) is gratefully acknowledged.	ADHYA S, 1978, ANNU REV BIOCHEM, V47, P967, DOI 10.1146/annurev.bi.47.070178.004535; Belogurov GA, 2009, EMBO J, V28, P112, DOI 10.1038/emboj.2008.268; Burmann BM, 2010, NUCLEIC ACIDS RES, V38, P314, DOI 10.1093/nar/gkp736; Cardinale CJ, 2008, SCIENCE, V320, P935, DOI 10.1126/science.1152763; DAS A, 1985, P NATL ACAD SCI USA, V82, P4070, DOI 10.1073/pnas.82.12.4070; DOWNING WL, 1990, J BACTERIOL, V172, P1621, DOI 10.1128/jb.172.3.1621-1627.1990; GREENBLATT J, 1993, NATURE, V364, P401, DOI 10.1038/364401a0; Greive SJ, 2005, J BIOL CHEM, V280, P36397, DOI 10.1074/jbc.M507146200; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; KELLER EB, 1979, P NATL ACAD SCI USA, V76, P6186, DOI 10.1073/pnas.76.12.6186; Knowlton JR, 2003, BIOCHEMISTRY-US, V42, P2275, DOI 10.1021/bi0272508; Kyrpides NC, 1996, TRENDS BIOCHEM SCI, V21, P425, DOI 10.1016/S0968-0004(96)30036-4; Kyrpides NC, 1999, P NATL ACAD SCI USA, V96, P8545, DOI 10.1073/pnas.96.15.8545; Luo X, 2008, MOL CELL, V32, P791, DOI 10.1016/j.molcel.2008.10.028; MASON SW, 1991, GENE DEV, V5, P1504, DOI 10.1101/gad.5.8.1504; Mooney RA, 2009, MOL CELL, V33, P97, DOI 10.1016/j.molcel.2008.12.021; Mooney RA, 2009, J MOL BIOL, V391, P341, DOI 10.1016/j.jmb.2009.05.078; Pasman Z, 2000, BIOCHEMISTRY-US, V39, P5573, DOI 10.1021/bi992658z; Peters JM, 2009, P NATL ACAD SCI USA, V106, P15406, DOI 10.1073/pnas.0903846106; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Squires CL, 2000, ANNU REV MICROBIOL, V54, P775, DOI 10.1146/annurev.micro.54.1.775; Steiner T, 2002, EMBO J, V21, P4641, DOI 10.1093/emboj/cdf455; SULLIVAN SL, 1992, J BACTERIOL, V174, P1339, DOI 10.1128/jb.174.4.1339-1344.1992; SULLIVAN SL, 1992, CELL, V68, P989, DOI 10.1016/0092-8674(92)90041-A; Torres M, 2001, EMBO J, V20, P3811, DOI 10.1093/emboj/20.14.3811; VOGEL U, 1994, J BIOL CHEM, V269, P16236; Zellars M, 1999, MOL MICROBIOL, V32, P1296, DOI 10.1046/j.1365-2958.1999.01442.x; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	28	235	237	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 23	2010	328	5977					501	504		10.1126/science.1184953	http://dx.doi.org/10.1126/science.1184953			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YR	20413501				2022-12-28	WOS:000276952400043
J	Dowell, RD; Ryan, O; Jansen, A; Cheung, D; Agarwala, S; Danford, T; Bernstein, DA; Rolfe, PA; Heisler, LE; Chin, B; Nislow, C; Giaever, G; Phillips, PC; Fink, GR; Gifford, DK; Boone, C				Dowell, Robin D.; Ryan, Owen; Jansen, An; Cheung, Doris; Agarwala, Sudeep; Danford, Timothy; Bernstein, Douglas A.; Rolfe, P. Alexander; Heisler, Lawrence E.; Chin, Brian; Nislow, Corey; Giaever, Guri; Phillips, Patrick C.; Fink, Gerald R.; Gifford, David K.; Boone, Charles			Genotype to Phenotype: A Complex Problem	SCIENCE			English	Article							GENOME; CELL		[Dowell, Robin D.; Danford, Timothy; Rolfe, P. Alexander; Gifford, David K.] MIT, Dept Elect Engn & Comp Sci, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Ryan, Owen; Cheung, Doris; Heisler, Lawrence E.; Nislow, Corey; Boone, Charles] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Ryan, Owen; Cheung, Doris; Heisler, Lawrence E.; Nislow, Corey; Giaever, Guri; Boone, Charles] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Ryan, Owen; Cheung, Doris; Heisler, Lawrence E.; Nislow, Corey; Giaever, Guri; Boone, Charles] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Jansen, An; Agarwala, Sudeep; Bernstein, Douglas A.; Chin, Brian; Fink, Gerald R.; Gifford, David K.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Giaever, Guri] Univ Toronto, Dept Pharm, Toronto, ON M5S 3E1, Canada; [Phillips, Patrick C.] 5289 Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA; [Fink, Gerald R.; Gifford, David K.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); University of Toronto; University of Toronto; University of Toronto; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Toronto; University of Oregon; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Gifford, DK (corresponding author), MIT, Dept Elect Engn & Comp Sci, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA.	gifford@mit.edu; charlie.boone@utoronto.ca	Young, Richard A/F-6495-2012; Jansen, An/T-9228-2018	Young, Richard A/0000-0001-8855-8647; Jansen, An/0000-0003-2412-0456; DOWELL, ROBIN/0000-0001-7665-9985; Heisler, Lawrence/0000-0002-1332-1802	NIH [DK076284, GM035010, GM069676, P01 NS055923, ACS PF-09-072-01-MBC]; NSF [DEB-0614588]; Ellison Medical Foundation; Natural Sciences and Engineering Research Council (NSERC) of Canada; Howard Hughes Medical Institute (HHMI); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK076284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035010, R01GM069676, R37GM035010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS055923] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Ellison Medical Foundation(Lawrence Ellison Foundation); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by NIH grants DK076284 (R. D. D.), GM035010 (G. R. F.), GM069676 (D. K. G.), P01 NS055923 (D. K. G.), ACS PF-09-072-01-MBC (D. A. B.); NSF grant DEB-0614588; a Senior Scholar Award in Aging from the Ellison Medical Foundation (P. C. P.); the Natural Sciences and Engineering Research Council (NSERC) of Canada; and Howard Hughes Medical Institute (HHMI) (C. B.). Sequence and assembly data has been deposited at DNA Data Bank of Japan/European Molecular Biology Laboratory/GenBank, project accession ACVY00000000.	Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484	6	273	274	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 23	2010	328	5977					469	469		10.1126/science.1189015	http://dx.doi.org/10.1126/science.1189015			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YR	20413493	Green Accepted			2022-12-28	WOS:000276952400033
J	Lyratzopoulos, G; Barbiere, JM; Greenberg, DC; Wright, KA; Neal, DE				Lyratzopoulos, Georgios; Barbiere, Josephine M.; Greenberg, David C.; Wright, Karen A.; Neal, David E.			Population based time trends and socioeconomic variation in use of radiotherapy and radical surgery for prostate cancer in a UK region: continuous survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SOCIAL-CLASS; SURVIVAL; MORTALITY; CARE; DEPRIVATION; DIAGNOSIS; PATTERNS; QUALITY; ENGLAND; RACE/ETHNICITY	Objective To examine variation in the management of prostate cancer in patients with different socioeconomic status. Design Survey using UK regional cancer registry data. Setting Regional population based cancer registry. Participants 35 171 patients aged >= 51 with a diagnosis of prostate cancer, 1995-2006. Main outcome measures Use of radiotherapy and radical surgery. Socioeconomic status according to fifths of small area deprivation index. Results Over nine years of the study, information on stage at diagnosis was available for 15 916 of 27 970 patients (57%). During the study period, the proportion of patients treated with radiotherapy remained at about 25%, while use of radical surgery increased significantly (from 2.9% (212/7201) during 1995-7 to 8.4% (854/10 211) during 2004-6, P<0.001). Both treatments were more commonly used in least deprived compared with most deprived patients (28.5% v 21.0% for radiotherapy and 8.4% v 4.0% for surgery). In multivariable analysis, increasing deprivation remained strongly associated with lower odds of radiotherapy or surgery (odds ratio 0.92 (95% confidence interval 0.90 to 0.94), P<0.001, and 0.91 (0.87 to 0.94), P<0.001, respectively, per incremental deprivation group). There were consistently concordant findings with multilevel models for clustering of observations by hospital of diagnosis, with restriction of the analysis to patients with information on stage, and with sequential restriction of the analysis to different age, stage, diagnosis period, and morphology groups. Conclusions After a diagnosis of prostate cancer, men from lower socioeconomic groups were substantially less likely to be treated with radical surgery or radiotherapy. The causes and impact on survival of such differences remain uncertain.	[Lyratzopoulos, Georgios; Barbiere, Josephine M.] Univ Cambridge, Sch Clin Med, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 0SR, England; [Greenberg, David C.; Wright, Karen A.] Eastern Canc Registrat & Informat Ctr, Cambridge CB22 3AD, England; [Neal, David E.] Addenbrookes Hosp, Univ Dept Oncol, Cambridge CB2 OQQ, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital	Lyratzopoulos, G (corresponding author), Univ Cambridge, Sch Clin Med, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 0SR, England.	gl290@medschl.cam.ac.uk	Lyratzopoulos, Georgios/B-6301-2012; Lyratzopoulos, Georgios/O-8260-2019	Lyratzopoulos, Georgios/0000-0002-2873-7421; Neal, David/0000-0002-6033-5086	MRC [G0900871] Funding Source: UKRI; Medical Research Council [G0900871] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Albain KS, 2009, JNCI-J NATL CANCER I, V101, P984, DOI 10.1093/jnci/djp175; [Anonymous], 1997, J CLIN PATHOL; Bentley R, 2008, CANCER CAUSE CONTROL, V19, P183, DOI 10.1007/s10552-007-9084-7; Bill-Axelson A, 2008, J NATL CANCER I, V100, P1144, DOI 10.1093/jnci/djn255; Bolla M, 2002, LANCET, V360, P103, DOI 10.1016/S0140-6736(02)09408-4; Bott SRJ, 2005, BJU INT, V95, P34, DOI 10.1111/j.1464-410X.2005.05245.x; *BRIT ASS UR SURG, 2007, AN MIN DAT SET UR CA; CARSTAIRS V, 1989, COMMUNITY MED, V11, P210, DOI 10.1093/oxfordjournals.pubmed.a042469; Clarke NW, 2008, BRIT J CANCER, V99, pS78, DOI 10.1038/sj.bjc.6604596; *COMM LOC GOV, IND DEPR 2004; Davison BJ, 2004, BJU INT, V93, P47, DOI 10.1111/j.1464-410X.2004.04553.x; Fairley L, 2009, BRIT J CANCER, V101, P1839, DOI 10.1038/sj.bjc.6605424; Hall SE, 2005, BJU INT, V95, P51, DOI 10.1111/j.1464-410X.2005.05248.x; Harlan LC, 2001, J NATL CANCER I, V93, P1864, DOI 10.1093/jnci/93.24.1864; Hayen A, 2008, AUST NZ J PUBL HEAL, V32, P417, DOI 10.1111/j.1753-6405.2008.00272.x; Hoffman RM, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-27; Jeffreys M, 2009, CANCER EPIDEM BIOMAR, V18, P915, DOI 10.1158/1055-9965.EPI-08-0685; Kim SP, 2001, CANCER INVEST, V19, P684, DOI 10.1081/CNV-100106143; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; Krupski TL, 2005, J CLIN ONCOL, V23, P7881, DOI 10.1200/JCO.2005.08.755; LIBERATOS P, 1988, EPIDEMIOL REV, V10, P87, DOI 10.1093/oxfordjournals.epirev.a036030; Lyratzopoulos G, 2008, J CLIN EPIDEMIOL, V61, P261, DOI 10.1016/j.jclinepi.2007.05.020; Marsa K, 2008, EUR J CANCER, V44, P2018, DOI 10.1016/j.ejca.2008.06.012; Melia J, 2004, BJU INT, V94, P51, DOI 10.1111/j.1464-4096.2004.04832.x; *NAT CANC INT NETW, 2002, ENGL CANC INC SURV M; *NAT CANC INT NETW, 1995, CANC INC DEPR ENGL; National Institute for Health and Clinical Excellence, 2008, PROST CANC DIAGN TRE; *NHS CONN HLTH, 2010, OPCS 4 INT CLASS; *OFF NAT STAT, 2010, EST POP EST ETHN GRO; Oliver SE, 2003, BJU INT, V91, P331, DOI 10.1046/j.1464-410X.2003.04083.x; Penson DF, 2005, J CLIN ONCOL, V23, P7783, DOI 10.1200/JCO.2005.03.0353; Quinn M, 2002, BJU INT, V90, P162, DOI 10.1046/j.1464-410X.2002.2822.x; Quinn MJ, 2001, STUDIES MED POPULATI; Rachet B, 2009, LANCET ONCOL, V10, P351, DOI 10.1016/S1470-2045(09)70028-2; Rapiti E, 2009, CANCER-AM CANCER SOC, V115, P5556, DOI 10.1002/cncr.24607; Richstone L, 2008, BJU INT, V101, P541, DOI 10.1111/j.1464-410X.2007.07410.x; ROWAN S, 2008, BR J CANC S1, V99, P75; Shavers VL, 2004, MED CARE, V42, P239, DOI 10.1097/01.mlr.0000117361.61444.71; Shavers VL, 2004, J GEN INTERN MED, V19, P146, DOI 10.1111/j.1525-1497.2004.30209.x; Shohaimi S, 2004, EUR RESPIR J, V24, P157, DOI 10.1183/09031936.04.00088303; Sloggett A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-20; Smith DP, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4817; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P399, DOI 10.1136/jech.52.6.399; Smith JA, 2007, J UROLOGY, V178, P2385, DOI 10.1016/j.juro.2007.08.008; SWORDS K, 2008, UROL ONCOL      1211; *U BRIST, 2009, PROTECT STUD PROST T; Wilt TJ, 2008, J UROLOGY, V180, P820, DOI 10.1016/j.juro.2008.05.010; Woods LM, 2005, BRIT J CANCER, V92, P1279, DOI 10.1038/sj.bjc.6602506	48	38	38	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2010	340								c1928	10.1136/bmj.c1928	http://dx.doi.org/10.1136/bmj.c1928			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589HO	20413566	hybrid, Green Published			2022-12-28	WOS:000277138000001
J	Taylor, PG; Townsend, AR				Taylor, Philip G.; Townsend, Alan R.			Stoichiometric control of organic carbon-nitrate relationships from soils to the sea	NATURE			English	Article							N-P STOICHIOMETRY; GROWTH EFFICIENCY; NITROGEN; DENITRIFICATION; ECOSYSTEMS; TRENDS; RATIO; CYCLE; LAND; FATE	The production of artificial fertilizers, fossil fuel use and leguminous agriculture worldwide has increased the amount of reactive nitrogen in the natural environment by an order of magnitude since the Industrial Revolution(1). This reorganization of the nitrogen cycle has led to an increase in food production(2), but increasingly causes a number of environmental problems(1,3). One such problem is the accumulation of nitrate in both freshwater and coastal marine ecosystems. Here we establish that ecosystem nitrate accrual exhibits consistent and negative nonlinear correlations with organic carbon availability along a hydrologic continuum from soils, through freshwater systems and coastal margins, to the open ocean. The trend also prevails in ecosystems subject to substantial human alteration. Across this diversity of environments, we find evidence that resource stoichiometry ( organic carbon: nitrate) strongly influences nitrate accumulation by regulating a suite of microbial processes that couple dissolved organic carbon and nitrate cycling. With the help of a meta-analysis we show that heterotrophic microbes maintain low nitrate concentrations when organic carbon: nitrate ratios match the stoichiometric demands of microbial anabolism. When resource ratios drop below the minimum carbon: nitrogen ratio of microbial biomass(4), however, the onset of carbon limitation appears to drive rapid nitrate accrual, which may then be further enhanced by nitrification. At low organic carbon: nitrate ratios, denitrification appears to constrain the extent of nitrate accretion, once organic carbon and nitrate availability approach the 1: 1 stoichiometry(5) of this catabolic process. Collectively, these microbial processes express themselves on local to global scales by restricting the threshold ratios underlying nitrate accrual to a constrained stoichiometric window. Our findings indicate that ecological stoichiometry can help explain the fate of nitrate across disparate environments and in the face of human disturbance.	[Taylor, Philip G.; Townsend, Alan R.] Univ Colorado, INSTAAR, Boulder, CO 80309 USA; [Taylor, Philip G.; Townsend, Alan R.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Taylor, PG (corresponding author), Univ Colorado, INSTAAR, Boulder, CO 80309 USA.	philip.taylor@colorado.edu	Townsend, Alan/AAE-9602-2019					Allen AP, 2009, ECOL LETT, V12, P369, DOI 10.1111/j.1461-0248.2009.01302.x; Anderson TR, 2005, AM NAT, V165, P1, DOI 10.1086/426598; Apple JK, 2007, ISME J, V1, P729, DOI 10.1038/ismej.2007.86; Arango CP, 2008, J N AM BENTHOL SOC, V27, P90, DOI 10.1899/07-024.1; BARNES RT, ECOL APPL IN PRESS, DOI DOI 10.1890/08-1328; Bohlke JK, 2009, BIOGEOCHEMISTRY, V93, P117, DOI 10.1007/s10533-008-9282-8; Cebrian J, 1999, AM NAT, V154, P449, DOI 10.1086/303244; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; Evans CD, 2006, ECOSYSTEMS, V9, P453, DOI 10.1007/s10021-006-0051-z; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Goodale CL, 2005, ECOSYSTEMS, V8, P334, DOI 10.1007/s10021-003-0162-8; Hedin LO, 1998, ECOLOGY, V79, P684, DOI 10.2307/176963; Hill AR, 2000, BIOGEOCHEMISTRY, V51, P193, DOI 10.1023/A:1006476514038; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; JAHNKE RA, 1995, LIMNOL OCEANOGR, V40, P436, DOI 10.4319/lo.1995.40.2.0436; Manzoni S, 2010, ECOL MONOGR, V80, P89, DOI 10.1890/09-0179.1; McGroddy ME, 2004, ECOLOGY, V85, P2390, DOI 10.1890/03-0351; Monteith DT, 2007, NATURE, V450, P537, DOI 10.1038/nature06316; Mulholland MR, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P303, DOI 10.1016/B978-0-12-372522-6.00007-4; Mulholland PJ, 2008, NATURE, V452, P202, DOI 10.1038/nature06686; Perakis SS, 2002, NATURE, V415, P416, DOI 10.1038/415416a; Raymond PA, 2001, ORG GEOCHEM, V32, P469, DOI 10.1016/S0146-6380(00)00190-X; Richards F. A., 1965, CHEM OCEANOGR, V1, P611; Sarmiento J.L., 2013, OCEAN BIOGEOCHEMICAL, DOI [DOI 10.2307/J.CTT3FGXQX, 10.1515/9781400849079, DOI 10.1515/9781400849079]; Smil V, 1999, GLOBAL BIOGEOCHEM CY, V13, P647, DOI 10.1029/1999GB900015; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; TEZUKA Y, 1990, MICROBIAL ECOL, V19, P227, DOI 10.1007/BF02017167; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494	30	273	288	18	455	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2010	464	7292					1178	1181		10.1038/nature08985	http://dx.doi.org/10.1038/nature08985			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20414306				2022-12-28	WOS:000276891100034
J	Wojcicki, JM; Heyman, MB				Wojcicki, Janet M.; Heyman, Melvin B.			Let's Move - Childhood Obesity Prevention from Pregnancy and Infancy Onward	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wojcicki, Janet M.; Heyman, Melvin B.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Wojcicki, JM (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.				NIDDK NIH HHS [T32 DK007762, K24 DK060617, K24 DK060617-08] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007762, K24DK060617] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Horta BL, 2007, EVIDENCE LONG TERM E; Skinner AC, 2010, PEDIATRICS      0301; Sullivan EL, 2010, FORUM NUTR, V63, P186, DOI 10.1159/000264406; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Wrotniak BH, 2008, AM J CLIN NUTR, V87, P1818, DOI 10.1093/ajcn/87.6.1818	5	69	71	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 22	2010	362	16					1457	1459		10.1056/NEJMp1001857	http://dx.doi.org/10.1056/NEJMp1001857			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	586GP	20393165	Green Accepted			2022-12-28	WOS:000276894700002
J	Buldyrev, SV; Parshani, R; Paul, G; Stanley, HE; Havlin, S				Buldyrev, Sergey V.; Parshani, Roni; Paul, Gerald; Stanley, H. Eugene; Havlin, Shlomo			Catastrophic cascade of failures in interdependent networks	NATURE			English	Article								Complex networks have been studied intensively for a decade, but research still focuses on the limited case of a single, non-interacting network(1-14). Modern systems are coupled together(15-19) and therefore should be modelled as interdependent networks. A fundamental property of interdependent networks is that failure of nodes in one network may lead to failure of dependent nodes in other networks. This may happen recursively and can lead to a cascade of failures. In fact, a failure of a very small fraction of nodes in one network may lead to the complete fragmentation of a system of several interdependent networks. A dramatic real-world example of a cascade of failures ('concurrent malfunction') is the electrical blackout that affected much of Italy on 28 September 2003: the shutdown of power stations directly led to the failure of nodes in the Internet communication network, which in turn caused further breakdown of power stations(20). Here we develop a framework for understanding the robustness of interacting networks subject to such cascading failures. We present exact analytical solutions for the critical fraction of nodes that, on removal, will lead to a failure cascade and to a complete fragmentation of two interdependent networks. Surprisingly, a broader degree distribution increases the vulnerability of interdependent networks to random failure, which is opposite to how a single network behaves. Our findings highlight the need to consider interdependent network properties in designing robust networks.	[Buldyrev, Sergey V.] Yeshiva Univ, Dept Phys, New York, NY 10033 USA; [Buldyrev, Sergey V.; Paul, Gerald; Stanley, H. Eugene] Boston Univ, Dept Phys, Boston, MA 02215 USA; [Buldyrev, Sergey V.; Paul, Gerald; Stanley, H. Eugene] Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA; [Parshani, Roni; Havlin, Shlomo] Bar Ilan Univ, Dept Phys, IL-52900 Ramat Gan, Israel; [Parshani, Roni; Havlin, Shlomo] Bar Ilan Univ, Minerva Ctr, IL-52900 Ramat Gan, Israel	Yeshiva University; Boston University; Boston University; Bar Ilan University; Bar Ilan University	Buldyrev, SV (corresponding author), Yeshiva Univ, Dept Phys, 500 W 185th St, New York, NY 10033 USA.	buldyrev@yu.edu	Buldyrev, Sergey V/I-3933-2015; Havlin, Shlomo/ABF-1527-2020	Stanley, H./0000-0003-2800-4495; Buldyrev, Sergey/0000-0002-3008-1070	Office of Academic Affairs of Yeshiva University; Office of Naval Research; European EPIWORK project; Israel Science Foundation	Office of Academic Affairs of Yeshiva University; Office of Naval Research(Office of Naval Research); European EPIWORK project; Israel Science Foundation(Israel Science Foundation)	We thank R. Burk for discussions that led the authors to focus on the interesting new scientific principles governing the catastrophic collapse of coupled networks. We also thank V. Rosato for providing the Italy 2003 blackout data. S. V. B. thanks the Office of Academic Affairs of Yeshiva University for funding the Yeshiva University high-performance computer cluster and acknowledges the partial support of this research through the Dr. Bernard W. Gamson Computational Science Center at Yeshiva College. S. V. B., G. P. and H. E. S. thank the Office of Naval Research for support. S. H. thanks the European EPIWORK project and the Israel Science Foundation for financial support. We thank E. Leicht and R. de Souza for discussing their unpublished work with us.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A., 2009, DYNAMICAL PROCESSES; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; BOLLOBAS B., 2001, RANDOM GRAPHS, V73, DOI 10.1017/CBO9780511814068.008; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; ERDOS P, 1960, B INT STATIST INST, V38, P343; Erdos P., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Goh KI, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.278701; Kurant M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.138701; Laprie JC, 2007, LECT NOTES COMPUT SC, V4680, P54; Motter AE, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.065102; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.016131; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Panzieri S, 2008, INT J MODEL IDENTIF, V3, P69, DOI 10.1504/IJMIC.2008.018186; PASTORSATORRAS R, 2006, EVOLUTION STRUCTURE; Peerenboom J., 2001, P CRIS DRM IIIT NSF; Rinaldi SA, 2001, IEEE CONTR SYST MAG, V21, P11, DOI 10.1109/37.969131; Rosato V, 2008, INT J CRIT INFRASTRU, V4, P63, DOI 10.1504/IJCIS.2008.016092; Shao J, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.036105; Shao J, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/48004; Song CM, 2005, NATURE, V433, P392, DOI 10.1038/nature03248; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	26	2652	2844	73	704	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 15	2010	464	7291					1025	1028		10.1038/nature08932	http://dx.doi.org/10.1038/nature08932			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20393559	Green Submitted			2022-12-28	WOS:000276635000035
J	Shimomura, Y; Agalliu, D; Vonica, A; Luria, V; Wajid, M; Baumer, A; Belli, S; Petukhova, L; Schinzel, A; Brivanlou, AH; Barres, BA; Christiano, AM				Shimomura, Yutaka; Agalliu, Dritan; Vonica, Alin; Luria, Victor; Wajid, Muhammad; Baumer, Alessandra; Belli, Serena; Petukhova, Lynn; Schinzel, Albert; Brivanlou, Ali H.; Barres, Ben A.; Christiano, Angela M.			APCDD1 is a novel Wnt inhibitor mutated in hereditary hypotrichosis simplex	NATURE			English	Article							AUTOSOMAL DOMINANT INHERITANCE; PROTEIN-COUPLED RECEPTOR; HAIR-FOLLICLE; ANDROGENETIC ALOPECIA; SPEMANN ORGANIZER; DEPENDENT MANNER; NEURAL-TUBE; IN-VITRO; EXPRESSION; XENOPUS	Hereditary hypotrichosis simplex is a rare autosomal dominant form of hair loss characterized by hair follicle miniaturization(1,2). Using genetic linkage analysis, we mapped a new locus for the disease to chromosome 18p11.22, and identified a mutation (Leu9Arg) in the adenomatosis polyposis down-regulated 1 (APCDD1) gene in three families. We show that APCDD1 is a membrane-bound glycoprotein that is abundantly expressed in human hair follicles, and can interact in vitro with WNT3A and LRP5-two essential components of Wnt signalling. Functional studies show that APCDD1 inhibits Wnt signalling in a cell-autonomous manner and functions upstream of beta-catenin. Moreover, APCDD1 represses activation of Wnt reporters and target genes, and inhibits the biological effects of Wnt signalling during both the generation of neurons from progenitors in the developing chick nervous system, and axis specification in Xenopus laevis embryos. The mutation Leu9Arg is located in the signal peptide of APCDD1, and perturbs its translational processing from the endoplasmic reticulum to the plasma membrane. APCDD1(L9R) probably functions in a dominant-negative manner to inhibit the stability and membrane localization of the wild-type protein. These findings describe a novel inhibitor of the Wnt signalling pathway with an essential role in human hair growth. As APCDD1 is expressed in a broad repertoire of cell types(3), our findings indicate that APCDD1 may regulate a diversity of biological processes controlled by Wnt signalling.	[Shimomura, Yutaka; Luria, Victor; Wajid, Muhammad; Petukhova, Lynn; Christiano, Angela M.] Columbia Univ Coll Phys & Surg, Dept Dermatol, New York, NY 10032 USA; [Luria, Victor; Christiano, Angela M.] Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; [Agalliu, Dritan; Barres, Ben A.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Vonica, Alin; Brivanlou, Ali H.] Rockefeller Univ, Lab Vertebrate Embryol, New York, NY 10065 USA; [Baumer, Alessandra; Schinzel, Albert] Univ Zurich, Inst Med Genet, CH-8603 Schwerzenbach, Switzerland; [Belli, Serena] Struttura Semplice Genet Med APSS, I-138100 Trento, Italy	Columbia University; Columbia University; Stanford University; Rockefeller University; University of Zurich	Christiano, AM (corresponding author), Columbia Univ Coll Phys & Surg, Dept Dermatol, 630 W 168th St,VC15 204A, New York, NY 10032 USA.	amc65@columbia.edu	Wajid, Muhammad/F-5087-2015; Petukhova, Lynn/W-6858-2019	Luria, Victor/0000-0003-0558-0983	USPHS NIH, NIH/NIAMS [R01AR44924]; Dermatology Foundation; Myelin Repair Foundation; National Multiple Sclerosis Society [RG 3936A7/1]; NIH [R01 HD032105, R03HD057334]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD057334, R01HD032105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044924] Funding Source: NIH RePORTER	USPHS NIH, NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Dermatology Foundation; Myelin Repair Foundation; National Multiple Sclerosis Society(National Multiple Sclerosis Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to the family members for their participation in this study, and to H. Lam and M. Zhang for technical assistance. We appreciate the collaboration and discussions with R. M. Bernstein, R. M. Trueb and members of the A. M. C. laboratory. We thank S. Ishii and J. Miyazaki for supplying the pCXN2.1 vector. We thank C. Jahoda, A. Tomlinson, A. Salic, C. Extavour, L. Shapiro, B. Honig, D. Petrey, R. Vallee, G. Di Paolo and G. Karsenty for discussions and comments on the manuscript, and P. Ducy for sharing reagents. This work was supported in part by USPHS NIH grant R01AR44924 from NIH/NIAMS (A. M. C.). Y. S. is supported by a Research Career Development Award from the Dermatology Foundation. The work in B. A. B.'s laboratory (D. A. and B. A. B.) was supported by grants from the Myelin Repair Foundation and the National Multiple Sclerosis Society (grant RG 3936A7/1). The work in A. H. B.' s laboratory (A. V. and A. H. B.) was supported by NIH grants R01 HD032105 (A. H. B.) and R03HD057334 (A. V.).	Agalliu D, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-2; Aoki N, 2001, J INVEST DERMATOL, V116, P359, DOI 10.1046/j.1523-1747.2001.01226.x; Baumer A, 2000, EUR J HUM GENET, V8, P443, DOI 10.1038/sj.ejhg.5200506; Bazzi H, 2006, DIFFERENTIATION, V74, P129, DOI 10.1111/j.1432-0436.2006.00061.x; Bazzi H, 2007, DEV BIOL, V305, P498, DOI 10.1016/j.ydbio.2007.02.035; Betz RC, 2000, AM J HUM GENET, V66, P1979, DOI 10.1086/302934; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Hillmer AM, 2008, AM J HUM GENET, V82, P737, DOI 10.1016/j.ajhg.2007.11.014; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; IBSEN HHW, 1991, ACTA DERM-VENEREOL, V71, P349; Jukkola T, 2004, GENE EXPR PATTERNS, V4, P755, DOI 10.1016/j.modgep.2004.03.006; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kishimoto J, 2000, GENE DEV, V14, P1181; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; Lei QB, 2006, DEV CELL, V11, P325, DOI 10.1016/j.devcel.2006.06.013; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Luria V, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-13; Luria V, 2008, NEURON, V60, P1039, DOI 10.1016/j.neuron.2008.11.011; Martinez-Mir A, 2007, AM J HUM GENET, V80, P316, DOI 10.1086/511442; Megason SG, 2002, DEVELOPMENT, V129, P2087; Nakamura T, 2008, J CELL MOL MED, V12, P391, DOI 10.1111/j.1582-4934.2007.00201.x; Niehrs C, 2004, NAT REV GENET, V5, P425, DOI 10.1038/nrg1347; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; O'Shaughnessy RFL, 2004, J INVEST DERMATOL, V123, P613, DOI 10.1111/j.0022-202X.2004.23410.x; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Pidasheva S, 2005, HUM MOL GENET, V14, P1679, DOI 10.1093/hmg/ddi176; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Shimomura Y, 2003, J DERMATOL SCI, V31, P43, DOI 10.1016/S0923-1811(02)00140-8; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Takahashi M, 2002, CANCER RES, V62, P5651; Taylor MF, 1996, J BIOL CHEM, V271, P17445, DOI 10.1074/jbc.271.29.17445; TORIBIO J, 1974, BRIT J DERMATOL, V91, P687, DOI 10.1111/j.1365-2133.1974.tb12455.x; Trueb RM, 2002, EXP GERONTOL, V37, P981, DOI 10.1016/S0531-5565(02)00093-1; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Vonica A, 2002, DEV BIOL, V250, P112, DOI 10.1006/dbio.2002.0786; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; WILSON PA, 1994, CURR BIOL, V4, P676, DOI 10.1016/S0960-9822(00)00152-4; Yu WY, 2008, DEVELOPMENT, V135, P3687, DOI 10.1242/dev.021899	47	161	175	2	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2010	464	7291					1043	U109		10.1038/nature08875	http://dx.doi.org/10.1038/nature08875			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20393562	Green Accepted			2022-12-28	WOS:000276635000039
J	Patorno, E; Bohn, RL; Wahl, PM; Avorn, J; Patrick, AR; Liu, J; Schneeweiss, S				Patorno, Elisabetta; Bohn, Rhonda L.; Wahl, Peter M.; Avorn, Jerry; Patrick, Amanda R.; Liu, Jun; Schneeweiss, Sebastian			Anticonvulsant Medications and the Risk of Suicide, Attempted Suicide, or Violent Death	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANTIEPILEPTIC DRUGS; AGGRESSIVE-BEHAVIOR; BIPOLAR DISORDER; EPILEPSY; LITHIUM; DIVALPROEX; GABAPENTIN; LAMOTRIGINE; DEPRESSION; MANAGEMENT	Context In 2008, the US Food and Drug Administration mandated warning labeling for anticonvulsant medications regarding the increased risk of suicidal thoughts and behaviors. The decision was based on a meta-analysis not sufficiently large to investigate individual drugs. Objective To evaluate the risk of suicidal acts and combined suicidal acts or violent death associated with individual anticonvulsants. Design A cohort study of the risk of suicidal acts and combined suicidal acts or violent death in patients beginning use of anticonvulsant medications compared with patients initiating a reference anticonvulsant drug. Setting and Patients Patients 15 years and older from the HealthCore Integrated Research Database (HIRD) who began taking an anticonvulsant between July 2001 and December 2006. Main Outcome Measures Cox proportional hazards models and propensity score-matched analyses were used to evaluate risk of attempted or completed suicide and combined suicidal acts or violent death, controlling for psychiatric comorbidities and other risk factors, among individual anticonvulsants compared with topiramate and secondarily carbamazepine. Results The study identified 26 completed suicides, 801 attempted suicides, and 41 violent deaths in 297 620 new episodes of treatment with an anticonvulsant (overall median follow-up, 60 days). The incidence of the composite outcomes of completed suicides, attempted suicides, and violent deaths for anticonvulsants used in at least 100 treatment episodes ranged from 6.2 per 1000 person-years for primidone to 34.3 per 1000 person-years for oxcarbazepine. The risk of suicidal acts was increased for gabapentin (hazard ratio [HR], 1.42; 95% confidence interval [CI], 1.11-1.80), lamotrigine (HR, 1.84; 95% CI, 1.43-2.37), oxcarbazepine (HR, 2.07; 95% CI, 1.522.80), tiagabine (HR, 2.41; 95% CI, 1.65-3.52), and valproate (HR, 1.65; 95% CI, 1.25-2.19), compared with topiramate. The analyses including violent death produced similar results. Gabapentin users had increased risk in subgroups of younger and older patients, patients with mood disorders, and patients with epilepsy or seizure when compared with carbamazepine. Conclusion This exploratory analysis suggests that the use of gabapentin, lamotrigine, oxcarbazepine, and tiagabine, compared with the use of topiramate, may be associated with an increased risk of suicidal acts or violent deaths. JAMA. 2010; 303(14): 1401-1409	[Patorno, Elisabetta; Bohn, Rhonda L.; Avorn, Jerry; Patrick, Amanda R.; Liu, Jun; Schneeweiss, Sebastian] Harvard Univ, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med,Med Sch, Boston, MA 02120 USA; [Bohn, Rhonda L.; Wahl, Peter M.] HealthCore Inc, Wilmington, DE USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; HealthCore, Inc	Patorno, E (corresponding author), Harvard Univ, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med,Med Sch, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	epatorno@partners.org	Schneeweiss, Sebastian/C-2125-2013	Schneeweiss, Sebastian/0000-0003-2575-467X	HealthCore Fellowship in Pharmacoepidemiology; Harvard School of Public Health	HealthCore Fellowship in Pharmacoepidemiology; Harvard School of Public Health	Funding/Support: This study was supported by the HealthCore Fellowship in Pharmacoepidemiology and the Pharmacoepidemiology Research and Training Fund of the Harvard School of Public Health (Dr Patorno).	[Anonymous], 1989, PHYS CURR PROC TERM; Austin PC, 2009, PHARMACOEPIDEM DR S, V18, P469, DOI 10.1002/pds.1733; Avorn J, 2008, NEW ENGL J MED, V359, P991, DOI 10.1056/NEJMp0805922; BARABAS G, 1988, PEDIATRICS, V82, P284; Beran RG, 1998, EPILEPSIA, V39, P280, DOI 10.1111/j.1528-1157.1998.tb01373.x; Clark DE, 2004, J AM GERIATR SOC, V52, P2023, DOI 10.1111/j.1532-5415.2004.52560.x; Collins JC, 2008, J AFFECT DISORDERS, V107, P23, DOI 10.1016/j.jad.2007.07.014; CURRAN HV, 1993, EUR J CLIN PHARMACOL, V44, P529, DOI 10.1007/BF02440853; Elger CE, 2008, EPILEPSY BEHAV, V12, P501, DOI 10.1016/j.yebeh.2008.01.003; Ettinger AB, 1998, EPILEPSIA, V39, P874, DOI 10.1111/j.1528-1157.1998.tb01183.x; Ettinger AB, 2007, NEUROTHERAPEUTICS, V4, P75, DOI 10.1016/j.nurt.2006.10.003; Ettinger AB, 2006, NEUROLOGY, V67, P1916, DOI 10.1212/01.wnl.0000247045.85646.c0; *FDA PUBL HLTH ADV, SUIC THOUGHTS BEH AN; French JA, 2008, NEW ENGL J MED, V359, P166, DOI 10.1056/NEJMcp0801738; Goodwin FK, 2003, JAMA-J AM MED ASSOC, V290, P1467, DOI 10.1001/jama.290.11.1467; Grabowska-Grzyb A, 2006, EPILEPSY BEHAV, V8, P411, DOI 10.1016/j.yebeh.2005.12.005; Hamer Ann M, 2002, J Manag Care Pharm, V8, P266; Iribarren C, 2000, SOC PSYCH PSYCH EPID, V35, P288, DOI 10.1007/s001270050241; Kalinin VV, 2007, DRUG SAFETY, V30, P123, DOI 10.2165/00002018-200730020-00003; Ketter TA, 1999, NEUROLOGY, V53, pS53; Landmark CJ, 2008, CNS DRUGS, V22, P27; Lee DO, 1996, EPILEPSIA, V37, P87, DOI 10.1111/j.1528-1157.1996.tb00517.x; MOYER LA, 1989, AM J EPIDEMIOL, V130, P1024, DOI 10.1093/oxfordjournals.aje.a115403; Mula M, 2007, DRUG SAFETY, V30, P555, DOI 10.2165/00002018-200730070-00001; Ohberg A, 1998, ACTA PSYCHIAT SCAND, V98, P214, DOI 10.1111/j.1600-0447.1998.tb10069.x; Parsons LS, P 26 ANN SAS US GROU, DOI www2. sas. com/ proceedings/ sugi26/ p214- 26. pdf.; PATRICK AR, 2009, PHARMACOEPIDEM DR S, V18, pS1; PEREIRA J, 2002, COCHRANE DB SYST REV, V3; PHILLIPS DP, 1993, SUICIDE LIFE-THREAT, V23, P307; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Reijs R, 2004, EPILEPSY BEHAV, V5, pS66, DOI 10.1016/j.yebeh.2003.11.009; Rosenberg JM, 2007, CNS SPECTRUMS, V12, P831, DOI 10.1017/S1092852900015571; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Schmitz B, 2006, EPILEPSIA, V47, P28, DOI 10.1111/j.1528-1167.2006.00684.x; Spina E, 2004, EPILEPTIC DISORD, V6, P57; Tallian KB, 1996, EPILEPSIA, V37, P501, DOI 10.1111/j.1528-1157.1996.tb00598.x; U.S. Department of Health and Human Services Food and Drug Administration Center for Evaluation and Research, 2008, STAT REV EVALUATION; *US DEP HHS, 1988, INT CLASS DIS 9 REV; Vandenbroucke JP, 2008, PLOS MED, V5, P339, DOI 10.1371/journal.pmed.0050067; WOLF SM, 1995, EPILEPSIA, V36, P1203, DOI 10.1111/j.1528-1157.1995.tb01063.x; World Health Organization, 1992, INT STAT CLASS DIS 1; Yerevanian BI, 2007, J AFFECT DISORDERS, V103, P5, DOI 10.1016/j.jad.2007.05.019; 2008, JOINT M PER CENTR NE; UPDATE SUICIDAL BEHA	45	150	154	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2010	303	14					1401	1409		10.1001/jama.2010.410	http://dx.doi.org/10.1001/jama.2010.410			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582KX	20388896				2022-12-28	WOS:000276597300025
J	McHutchison, JG; Manns, MP; Muir, AJ; Terrault, NA; Jacobson, IM; Afdhal, NH; Heathcote, EJ; Zeuzem, S; Reesink, HW; Garg, J; Bsharat, M; George, S; Kauffman, RS; Adda, N; Di Bisceglie, AM				McHutchison, John G.; Manns, Michael P.; Muir, Andrew J.; Terrault, Norah A.; Jacobson, Ira M.; Afdhal, Nezam H.; Heathcote, E. Jenny; Zeuzem, Stefan; Reesink, Hendrik W.; Garg, Jyotsna; Bsharat, Mohammad; George, Shelley; Kauffman, Robert S.; Adda, Nathalie; Di Bisceglie, Adrian M.		PROVE3 Study Team	Telaprevir for Previously Treated Chronic HCV Infection.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC HEPATITIS-C; SUSTAINED VIROLOGICAL RESPONSE; HEPATOCELLULAR-CARCINOMA; RIBAVIRIN; PEGINTERFERON-ALPHA-2A; COMBINATION; THERAPY	Background: Patients with genotype 1 hepatitis C virus (HCV) who do not have a sustained response to therapy with peginterferon alfa and ribavirin have a low likelihood of success with retreatment. Methods: We randomly assigned patients with HCV genotype 1 who had not had a sustained virologic response after peginterferon alfa-ribavirin therapy to one of four treatment groups: 115 patients to the T12PR24 group, receiving telaprevir (1125-mg loading dose, then 750 mg every 8 hours) for 12 weeks and peginterferon alfa-2a (180 microg per week) and ribavirin (1000 or 1200 mg per day, according to body weight) for 24 weeks; 113 patients to the T24PR48 group, receiving telaprevir for 24 weeks and peginterferon alfa-2a and ribavirin for 48 weeks (at the same doses as in the T12PR24 group); 111 patients to the T24P24 group, receiving telaprevir and peginterferon alfa-2a for 24 weeks (at the same doses as in the T12PR24 group); and 114 patients to the PR48 (or control) group, receiving peginterferon alfa-2a and ribavirin for 48 weeks (at the same doses as in the T12PR24 group). The primary end point was sustained virologic response (undetectable HCV RNA levels 24 weeks after the last dose of study drugs). Results: The rates of sustained virologic response in the three telaprevir groups -- 51% in the T12PR24 group, 53% in the T24PR48 group, and 24% in the T24P24 group -- were significantly higher than the rate in the control group (14%; P<0.001, P<0.001, and P=0.02, respectively). Response rates were higher among patients who had previously had relapses than among nonresponders. One of the most common adverse events in the telaprevir groups was rash (overall, occurring in 51% of patients, with severe rash in 5%). Discontinuation of study drugs because of adverse events was more frequent in the telaprevir groups than in the control group (15% vs. 4%). Conclusions: In HCV-infected patients in whom initial peginterferon alfa and ribavirin treatment failed, retreatment with telaprevir in combination with peginterferon alfa-2a and ribavirin was more effective than retreatment with peginterferon alfa-2a and ribavirin alone. (ClinicalTrials.gov number, NCT00420784.) N Engl J Med 2010;362:1292-303.	[McHutchison, John G.; Muir, Andrew J.; Garg, Jyotsna] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27715 USA; [Manns, Michael P.] Hannover Med Sch, D-3000 Hannover, Germany; [Terrault, Norah A.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Jacobson, Ira M.] Weill Cornell Med Coll, New York, NY USA; [Afdhal, Nezam H.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Heathcote, E. Jenny] Univ Toronto, Toronto, ON, Canada; [Zeuzem, Stefan] Goethe Univ Frankfurt, Med Ctr, Frankfurt, Germany; [Reesink, Hendrik W.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Bsharat, Mohammad; George, Shelley; Kauffman, Robert S.; Adda, Nathalie] Vertex Pharmaceut, Cambridge, MA USA; [Di Bisceglie, Adrian M.] St Louis Univ, Sch Med, St Louis, MO 63103 USA	Duke University; Hannover Medical School; University of California System; University of California San Francisco; Cornell University; Harvard University; Beth Israel Deaconess Medical Center; University of Toronto; Goethe University Frankfurt; University of Amsterdam; Academic Medical Center Amsterdam; Vertex Pharmaceuticals; Saint Louis University	McHutchison, JG (corresponding author), Duke Univ, Med Ctr, Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	mchut001@mc.duke.edu	Zeuzem, Stefan/AAE-7435-2019; Yang, Chen/G-1379-2010	Afdhal, Nezam/0000-0002-7342-6593	Vertex Pharmaceuticals; Roche; Pharmasset; SciClone; Geneva Foundation; Idenix Pharmaceuticals; Gilead Sciences	Vertex Pharmaceuticals(Vertex Pharmaceuticals); Roche(Roche Holding); Pharmasset; SciClone; Geneva Foundation; Idenix Pharmaceuticals; Gilead Sciences(Gilead Sciences)	Supported by Vertex Pharmaceuticals.Dr. McHutchison reports receiving consulting fees from Vertex Pharmaceuticals and Schering-Plough, travel and accommodation fees from Schering-Plough and Roche, lecture fees from Schering-Plough, and grant support from Vertex Pharmaceuticals, Schering-Plough, and Hoffmann-La Roche; Dr. Manns, consulting fees from Vertex Pharmaceuticals, Roche, ScheringPlough, Gilead Sciences, Bristol-Myers Squibb, and Boehringer Ingelheim, lecture fees from Schering-Plough, Vertex Pharmaceuticals, Roche, Gilead Sciences, Bristol-Myers Squibb, and Boehringer Ingelheim, and grant support from Vertex Pharmaceuticals, Roche, Schering-Plough, Gilead Sciences, BristolMyers Squibb, and Boehringer Ingelheim; Dr. Muir, consulting fees from Vertex Pharmaceuticals and Schering-Plough and grant support from Vertex Pharmaceuticals; Dr. Terrault, consulting fees from Roche and Schering-Plough and grant support from Roche and Vertex Pharmaceuticals; Dr. Jacobson, consulting fees from Bristol-Myers Squibb, Novartis, Gilead Sciences, Schering-Plough, Pfizer, Vertex Pharmaceuticals, GlobeImmune, Human Genome Sciences, Merck, Boehringer Ingelheim, Pharmasset, Zymogenetics, Tibotec, Abbott, Roche, Anadys, and Progenics, lecture fees from Schering-Plough, Gilead Sciences, BristolMyers Squibb, and Novartis, and grant support from Vertex Pharmaceuticals, Schering-Plough, Valeant, Gilead Sciences, GlobeImmune, Human Genome Sciences, Novartis, Boehringer Ingelheim, Anadys, Pharmasset, Roche, Merck, Tibotec, and Romark; Dr. Afdhal, consulting fees from Vertex Pharmaceuticals, Schering-Plough, GlaxoSmithKline, and Idenix Pharmaceuticals, lecture fees from Schering-Plough, Gilead Sciences, and Bristol-Myers Squibb, and grant support from Schering-Plough, Gilead Sciences, and Vertex Pharmaceuticals; Dr. Heathcote, consulting fees from Roche, Gilead Sciences, Merck, Axcan Pharma, Hoffmann-La Roche, Schering-Plough and Tibotec, lecture fees from Axcan Pharma, Gilead Sciences, Roche, Hoffmann-La Roche, Schering-Plough, and Tibotec, and grant support from Vertex Pharmaceuticals, Roche, Schering-Plough (Canada), Axcan Pharma, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Hoffmann-La Roche, Intercept, Tibotec, and Debiopharm; Dr. Zeuzem, consulting fees from Vertex Pharmaceuticals, Tibotec, Roche, and Schering-Plough and lecture fees from Vertex Pharmaceuticals and Roche; Dr. Reesink, consulting fees from PRA International, Tibotec, Merck, Anadys, Schering-Plough, Roche, Roche Molecular Diagnostics, and Novartis Chiron, lecture fees from Roche, and grant support from Vertex Pharmaceuticals, Schering-Plough, Japan Tobacco International, Phenomix, Anadys, Roche, Gilead-UCB, Tibotec, PRA International, and Boehringer Ingelheim; and Ms. Garg, grant support from Vertex Pharmaceuticals. Dr. Bsharat reports being an employee of Vertex Pharmaceuticals and owning stock options in the company; Drs. George, Kauffman, and Adda report being employees of Vertex Pharmaceuticals, owning stock options in the company, and receiving reimbursement for travel and accommodation expenses from the company. Dr. Di Bisceglie reports receiving consulting fees from Vertex Pharmaceuticals, Roche, Idenix Pharmaceuticals, Bristol-Myers Squibb, Schering-Plough, Anadys, GlobeImmune, and Pharmasset, lecture fees from Novartis and Clinical Care Options, and grant support from Vertex Pharmaceuticals, Roche, Pharmasset, SciClone, Geneva Foundation, Idenix Pharmaceuticals, and Gilead Sciences.; No other potential conflict of interest relevant to this articl was reported.	Bruno S, 2007, HEPATOLOGY, V45, P579, DOI 10.1002/hep.21492; Camma C, 2004, HEPATOLOGY, V39, P333, DOI 10.1002/hep.20073; Di Bisceglie AM, 2003, AM J GASTROENTEROL, V98, P2060, DOI 10.1111/j.1572-0241.2003.t01-1-07641.x; Global surveillance and control of hepatitis C, 1999, J VIRAL HEPAT, V6, P35; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Jensen DM, 2009, ANN INTERN MED, V150, P528, DOI 10.7326/0003-4819-150-8-200904210-00007; Kasahara A, 2004, J VIRAL HEPATITIS, V11, P148, DOI 10.1046/j.1365-2893.2003.00481.x; Lin C., 2006, Infectious Disorders - Drug Targets, V6, P3, DOI 10.2174/187152606776056706; McHutchison JG, 2009, NEW ENGL J MED, V361, P1516; McHutchison JG, 2001, J HEPATOL, V34, P140, DOI 10.1016/S0168-8278(00)00026-X; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; *ORG PROC TRANSPL, US LIV TRANSPL PERF; Poynard T, 2009, GASTROENTEROLOGY, V136, P1618, DOI 10.1053/j.gastro.2009.01.039; Veldt BJ, 2007, ANN INTERN MED, V147, P677, DOI 10.7326/0003-4819-147-10-200711200-00003; Yoshida H, 1999, ANN INTERN MED, V131, P174, DOI 10.7326/0003-4819-131-3-199908030-00003	16	567	597	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 8	2010	362	14					1292	1303		10.1056/NEJMoa0908014	http://dx.doi.org/10.1056/NEJMoa0908014			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579SN	20375406	Green Published			2022-12-28	WOS:000276393700008
J	Mukamal, KJ				Mukamal, Kenneth J.			A 42-Year-Old Man Considering Whether to Drink Alcohol for His Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; MYOCARDIAL-INFARCTION; RISK-FACTORS; POSTMENOPAUSAL WOMEN; BREAST-CANCER; RED WINE; CARDIOVASCULAR-DISEASE; INSULIN SENSITIVITY; POOLED ANALYSIS	Alcohol consumption is widespread and, in excess, a leading cause of morbidity and mortality worldwide. At the same time, a consistent body of observational evidence has found that individuals who consume alcohol within recommended limits have a lower risk of coronary heart disease than do abstainers. These observations have led many to consider small amounts of alcohol as a cardioprotective strategy. Mr Q, a 42-year-old man who has consistently sought ways to preserve his health, is at a crossroads in his discussions with his physicians about the health effects of his regular, limited alcohol intake. The discussion reviews the epidemiology of drinking in the United States, the established effects of moderate alcohol intake on key pathophysiological biomarkers and pathways, the strengths and limitations of observational evidence linking alcohol intake to lower risk of coronary heart disease, other chronic diseases linked to moderate alcohol intake, and a framework in which MrQcan discuss the potential risks and benefits of alcohol consumption with his physicians. JAMA. 2010;303(20):2065-2073 www.jama.com	[Mukamal, Kenneth J.] Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; [Mukamal, Kenneth J.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Mukamal, KJ (corresponding author), Beth Israel Deaconess Med Ctr, 1309 Beacon St,2nd Floor, Brookline, MA 02446 USA.	kmukamal@bidmc.harvard.edu	Mukamal, Kenneth/GVR-7978-2022					Allen NE, 2009, JNCI-J NATL CANCER I, V101, P296, DOI 10.1093/jnci/djn514; Bagnardi V, 2001, BRIT J CANCER, V85, P1700, DOI 10.1054/bjoc.2001.2140; BALLIN JC, 1986, JAMA-J AM MED ASSOC, V255, P522; Baraona E, 2001, ALCOHOL CLIN EXP RES, V25, P502, DOI 10.1097/00000374-200104000-00004; Berg KM, 2008, AM J MED, V121, P406, DOI 10.1016/j.amjmed.2007.12.012; Beulens JWJ, 2008, EUR J CLIN NUTR, V62, P1098, DOI 10.1038/sj.ejcn.1602821; Beulens JWJ, 2008, DIABETES CARE, V31, P2050, DOI 10.2337/dc08-0814; Brand-Miller JC, 2007, AM J CLIN NUTR, V85, P1545, DOI 10.1093/ajcn/85.6.1545; Briel M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b92; CHERPITEL CJ, 1995, ACCIDENT ANAL PREV, V27, P651, DOI 10.1016/0001-4575(95)00011-N; Cho EY, 2004, ANN INTERN MED, V140, P603, DOI 10.7326/0003-4819-140-8-200404200-00007; Cleophas TJ, 1999, BIOMED PHARMACOTHER, V53, P417, DOI 10.1016/S0753-3322(99)80121-8; Colditz GA, 2004, JNCI-J NATL CANCER I, V96, P218, DOI 10.1093/jnci/djh025; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Corrao G, 2000, ADDICTION, V95, P1505, DOI 10.1046/j.1360-0443.2000.951015056.x; Corrao G, 1998, ALCOHOL ALCOHOLISM, V33, P381; CORRAO G, 1993, J CLIN EPIDEMIOL, V46, P601, DOI 10.1016/0895-4356(93)90032-V; Davies MJ, 2002, JAMA-J AM MED ASSOC, V287, P2559, DOI 10.1001/jama.287.19.2559; Di Castelnuovo A, 2002, CIRCULATION, V105, P2836, DOI 10.1161/01.CIR.0000018653.19696.01; Di Castelnuovo A, 2006, ARCH INTERN MED, V166, P2437, DOI 10.1001/archinte.166.22.2437; Ding JZ, 2004, STROKE, V35, P16, DOI 10.1161/01.STR.0000105929.88691.8E; Dorn JM, 2007, ADDICTION, V102, P730, DOI 10.1111/j.1360-0443.2007.01765.x; Dudley R, 2004, INTEGR COMP BIOL, V44, P315, DOI 10.1093/icb/44.4.315; Ellison RC, 1999, AM J EPIDEMIOL, V150, P910; ELMER O, 1984, HAEMOSTASIS, V14, P223; Estruch R, 2004, ATHEROSCLEROSIS, V175, P117, DOI 10.1016/j.atherosclerosis.2004.03.006; Fillmore KM, 2006, ADDICT RES THEORY, V14, P101, DOI 10.1080/16066350500497983; Ford MM, 2008, ALCOHOL CLIN EXP RES, V32, P1408, DOI 10.1111/j.1530-0277.2008.00718.x; Frank D, 2008, J GEN INTERN MED, V23, P781, DOI 10.1007/s11606-008-0594-0; Freudenheim JL, 2005, AM J CLIN NUTR, V82, P657, DOI 10.1093/ajcn/82.3.657; Goldberg DA, 2003, CLIN BIOCHEM, V36, P79, DOI 10.1016/S0009-9120(02)00397-1; Goldberg IJ, 2003, NEW ENGL J MED, V348, P163, DOI 10.1056/NEJMe020163; Gronbaek M, 2004, EPIDEMIOLOGY, V15, P222, DOI 10.1097/01.ede.0000112219.01955.56; Gruenewald PJ, 2006, J STUD ALCOHOL, V67, P738, DOI 10.15288/jsa.2006.67.738; HANKINSON SE, 1995, J NATL CANCER I, V87, P1297, DOI 10.1093/jnci/87.17.1297; Hansen AS, 2005, EUR J CLIN NUTR, V59, P449, DOI 10.1038/sj.ejcn.1602107; Hassan MM, 2002, HEPATOLOGY, V36, P1206, DOI 10.1053/jhep.2002.36780; Heidemann C, 2008, ANN INTERN MED, V149, P307, DOI 10.7326/0003-4819-149-5-200809020-00005; Hines LM, 2000, CANCER EPIDEM BIOMAR, V9, P1099; Hines LM, 2001, NEW ENGL J MED, V344, P549, DOI 10.1056/NEJM200102223440802; Johansen D, 2006, BMJ-BRIT MED J, V332, P519, DOI 10.1136/bmj.38694.568981.80; Johansen D, 2003, ALCOHOL CLIN EXP RES, V27, P1305, DOI 10.1097/01.ALC.0000081642.14093.C6; Joosten MM, 2008, DIABETOLOGIA, V51, P1375, DOI 10.1007/s00125-008-1031-y; King DE, 2008, AM J MED, V121, P201, DOI 10.1016/j.amjmed.2007.12.004; KLATSKY AL, 1974, ANN INTERN MED, V81, P294, DOI 10.7326/0003-4819-81-3-294; Klatsky AL, 1997, AM J CARDIOL, V80, P416, DOI 10.1016/S0002-9149(97)00388-3; Klatsky AL, 2001, AM J CARDIOL, V88, P703, DOI 10.1016/S0002-9149(01)01824-0; Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719; Kuller LH, 2007, NEUROBIOL AGING, V28, P1307, DOI 10.1016/j.neurobiolaging.2006.06.010; Kuller LH, 2003, NEUROEPIDEMIOLOGY, V22, P13, DOI 10.1159/000067109; LAPORTE RE, 1980, PREV MED, V9, P22, DOI 10.1016/0091-7435(80)90057-2; Lauer MS, 2009, J NATL CANCER I, V101, P282, DOI 10.1093/jnci/djp006; Leary T, 1931, NEW ENGL J MED, V205, P231, DOI 10.1056/NEJM193107302050504; Lew JQ, 2009, AM J EPIDEMIOL, V170, P308, DOI 10.1093/aje/kwp120; Lim U, 2007, AM J EPIDEMIOL, V166, P697, DOI 10.1093/aje/kwm122; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; MACLURE M, 1993, EPIDEMIOL REV, V15, P328, DOI 10.1093/oxfordjournals.epirev.a036124; Mahabir S, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-11; Marfella R, 2006, DIABETIC MED, V23, P974, DOI 10.1111/j.1464-5491.2006.01886.x; MarquesVidal P, 1996, AM J EPIDEMIOL, V143, P1089, DOI 10.1093/oxfordjournals.aje.a008683; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Mosher JF, 2005, J PUBLIC HEALTH POL, V26, P326, DOI 10.1057/palgrave.jphp.3200037; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; Mukamal KJ, 2007, OSTEOPOROSIS INT, V18, P593, DOI 10.1007/s00198-006-0287-7; Mukamal KJ, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-118; Mukamal KJ, 2006, ARCH INTERN MED, V166, P2145, DOI 10.1001/archinte.166.19.2145; Mukamal KJ, 2005, CIRCULATION, V112, P1406, DOI 10.1161/CIRCULATIONAHA.105.537704; Mukamal KJ, 2003, NEW ENGL J MED, V348, P109, DOI 10.1056/NEJMoa022095; Mukamal KJ, 2001, CIRCULATION, V104, P1367, DOI 10.1161/hc3701.096067; Mukamal KJ, 2001, STROKE, V32, P1939, DOI 10.1161/hs0901.095723; *NAT I ALC AB ALC, FAQ GEN PUBL; Paul CA, 2008, ARCH NEUROL-CHICAGO, V65, P1363, DOI 10.1001/archneur.65.10.1363; Pedersen JO, 2008, EUR HEART J, V29, P204, DOI 10.1093/eurheartj/ehm574; PFEFFERBAUM A, 1995, ALCOHOL CLIN EXP RES, V19, P1177, DOI 10.1111/j.1530-0277.1995.tb01598.x; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Rehm J, 2003, EUR ADDICT RES, V9, P157, DOI 10.1159/000072222; REICHMAN ME, 1993, J NATL CANCER I, V85, P722, DOI 10.1093/jnci/85.9.722; Reynolds K, 2003, JAMA-J AM MED ASSOC, V289, P579, DOI 10.1001/jama.289.5.579; Rimm EB, 1996, BRIT MED J, V312, P731, DOI 10.1136/bmj.312.7033.731; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Rohrmann S, 2008, CANCER EPIDEM BIOMAR, V17, P1282, DOI 10.1158/1055-9965.EPI-07-2888; Saha TD, 2006, PSYCHOL MED, V36, P931, DOI 10.1017/S003329170600746X; Sesso HD, 2000, ARCH INTERN MED, V160, P2605, DOI 10.1001/archinte.160.17.2605; Shai I, 2007, DIABETES CARE, V30, P3011, DOI 10.2337/dc07-1103; Shaper AG, 1998, NOVART FDN SYMP, V216, P173; Sierksma A, 2004, ALCOHOL CLIN EXP RES, V28, P780, DOI 10.1097/01.ALC.0000125356.70824.81; Sierksma A, 2004, DIABETES CARE, V27, P184, DOI 10.2337/diacare.27.1.184; Sierksma A, 2002, EUR J CLIN NUTR, V56, P1130, DOI 10.1038/sj.ejcn.1601459; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Smith-Warner SA, 1998, JAMA-J AM MED ASSOC, V279, P535, DOI 10.1001/jama.279.7.535; *SUBST AB MENT HLT, 2007, RES 2006 NAT SURV DR, V7; Thun MJ, 1997, NEW ENGL J MED, V337, P1705, DOI 10.1056/NEJM199712113372401; Tjonneland A, 1999, AM J CLIN NUTR, V69, P49; Tolstrup J, 2006, BMJ-BRIT MED J, V332, P1244, DOI 10.1136/bmj.38831.503113.7C; US Department of Agriculture, NAT NUTR DAT STAND R; van der Gaag MS, 2001, J LIPID RES, V42, P2077; Wannamethee SG, 2002, HEART, V87, P32, DOI 10.1136/heart.87.1.32; Weathermon R, 1999, ALCOHOL RES HEALTH, V23, P40; Wellmann J, 2004, EUR J CARDIOV PREV R, V11, P48, DOI 10.1097/01.hjr.0000118174.70522.20; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; 2009, 2007 TOP PRODUCTS US	102	10	10	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2010	303	20					2065	2073		10.1001/jama.2010.550	http://dx.doi.org/10.1001/jama.2010.550			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	600VY	20407040				2022-12-28	WOS:000278018200031
J	Ye, SX; Zaitseva, E; Caltabiano, G; Schertler, GFX; Sakmar, TP; Deupi, X; Vogel, R				Ye, Shixin; Zaitseva, Ekaterina; Caltabiano, Gianluigi; Schertler, Gebhard F. X.; Sakmar, Thomas P.; Deupi, Xavier; Vogel, Reiner			Tracking G-protein-coupled receptor activation using genetically encoded infrared probes	NATURE			English	Article							INDUCED CONFORMATIONAL-CHANGES; BETA(2) ADRENERGIC-RECEPTOR; MECHANICAL CALCULATIONS; RHODOPSIN ACTIVATION; IONIC LOCK; CRYSTALLOGRAPHY; SPECTROSCOPY; DISCOVERY; SEGMENT-6; SWITCHES	Rhodopsin is a prototypical heptahelical family A G-protein-coupled receptor (GPCR) responsible for dim-light vision(1,2). Light isomerizes rhodopsin's retinal chromophore and triggers concerted movements of transmembrane helices, including an outward tilting of helix 6 (H6) and a smaller movement of H5, to create a site for G-protein binding and activation(3,4). However, the precise temporal sequence and mechanism underlying these helix rearrangements is unclear. We used site-directed non-natural amino acid mutagenesis to engineer rhodopsin with p-azido-L-phenylalanine residues incorporated at selected sites(5), and monitored the azido vibrational signatures using infrared spectroscopy as rhodopsin proceeded along its activation pathway. Here we report significant changes in electrostatic environments of the azido probes even in the inactive photoproduct Meta I, well before the active receptor state was formed. These early changes suggest a significant rotation of H6 and movement of the cytoplasmic part of H5 away from H3. Subsequently, a large outward tilt of H6 leads to opening of the cytoplasmic surface to form the active receptor photoproduct Meta II3. Thus, our results reveal early conformational changes that precede larger rigid-body helix movements, and provide a basis to interpret recent GPCR crystal structures(6,7) and to understand conformational sub-states observed during the activation of other GPCRs(8).	[Zaitseva, Ekaterina; Vogel, Reiner] Univ Freiburg, Inst Mol Med & Cell Res, Biophys Sect, D-79104 Freiburg, Germany; [Ye, Shixin; Sakmar, Thomas P.] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA; [Caltabiano, Gianluigi; Deupi, Xavier] Univ Autonoma Barcelona, Unitat Bioestadist, Lab Med Computac, Bellaterra 08193, Catalunya, Spain; [Schertler, Gebhard F. X.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Schertler, Gebhard F. X.] Paul Scherrer Inst, Dept Biol & Chem, Lab Biomol Res, CH-5232 Villigen, Switzerland	University of Freiburg; Rockefeller University; Autonomous University of Barcelona; MRC Laboratory Molecular Biology; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Vogel, R (corresponding author), Univ Freiburg, Inst Mol Med & Cell Res, Biophys Sect, Hermann Herder Str 9, D-79104 Freiburg, Germany.	sakmar@mail.rockefeller.edu; xavier.deupi@uab.cat; reiner.vogel@biophysik.uni-freiburg.de	Schertler, Gebhard/M-9512-2014; Deupi, Xavier/B-2424-2009; Sakmar, Thomas P/D-1833-2015; Caltabiano, Gianluigi/F-4654-2010	Deupi, Xavier/0000-0003-4572-9316; Sakmar, Thomas P/0000-0002-2836-8953; Caltabiano, Gianluigi/0000-0002-2929-7069; Schertler, Gebhard F.X./0000-0002-5846-6810; Ye, Shixin/0000-0002-9254-9409	DFG [Vo 811/4-1, Za 566/2]; C. H. Li Memorial Scholar Award; NIH; Ministerio de Educacion y Ciencia; Instituto de Salud Carlos III	DFG(German Research Foundation (DFG)); C. H. Li Memorial Scholar Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Educacion y Ciencia(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by DFG grants (Vo 811/4-1 to R. V. and Za 566/2 to E. Z.), a C. H. Li Memorial Scholar Award ( to S. Y.), an NIH grant ( to T. P. S.), the Ministerio de Educacion y Ciencia (Ramon y Cajal Program) and the Instituto de Salud Carlos III ( to X. D.).	Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; [Anonymous], 2008, AMBER 10; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Bublitz GU, 1997, ANNU REV PHYS CHEM, V48, P213, DOI 10.1146/annurev.physchem.48.1.213; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Crocker E, 2006, J MOL BIOL, V357, P163, DOI 10.1016/j.jmb.2005.12.046; DeLano W.L, PYMOL MOL GRAPHICS S; Deupi X, 2007, ADV PROTEIN CHEM, V74, P137, DOI 10.1016/S0065-3231(07)74004-4; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESWAR XN, 2006, CURRENT PROTOCOLS S, V15, P20403; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Hubbell WL, 2003, ADV PROTEIN CHEM, V63, P243; Jensen AD, 2001, J BIOL CHEM, V276, P9279, DOI 10.1074/jbc.M004871200; Kenakin T, 2007, TRENDS PHARMACOL SCI, V28, P407, DOI 10.1016/j.tips.2007.06.009; Knierim B, 2007, P NATL ACAD SCI USA, V104, P20290, DOI 10.1073/pnas.0710393104; Kobilka B, 2008, TRENDS PHARMACOL SCI, V29, P79, DOI 10.1016/j.tips.2007.11.009; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Mahalingam M, 2008, P NATL ACAD SCI USA, V105, P17795, DOI 10.1073/pnas.0804541105; Menon ST, 2001, PHYSIOL REV, V81, P1659, DOI 10.1152/physrev.2001.81.4.1659; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Oh KI, 2008, J PHYS CHEM B, V112, P10352, DOI 10.1021/jp801558k; Pieffet G, 2009, J MOL MODEL, V15, P1291, DOI 10.1007/s00894-009-0488-z; Ruprecht JJ, 2004, EMBO J, V23, P3609, DOI 10.1038/sj.emboj.7600374; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; Vogel R, 2005, BIOCHEMISTRY-US, V44, P11684, DOI 10.1021/bi0508587; Vogel R, 2005, BIOCHEMISTRY-US, V44, P12914, DOI 10.1021/bi058026w; Vogel R, 2003, BIOPOLYMERS, V72, P133, DOI 10.1002/bip.10407; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Vogel R, 2006, J AM CHEM SOC, V128, P10503, DOI 10.1021/ja0627848; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; Ye SX, 2008, J BIOL CHEM, V283, P1525, DOI 10.1074/jbc.M707355200; Ye SX, 2009, NAT CHEM BIOL, V5, P397, DOI 10.1038/nchembio.167	41	202	203	0	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2010	464	7293					1386	U14		10.1038/nature08948	http://dx.doi.org/10.1038/nature08948			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20383122				2022-12-28	WOS:000277149000054
J	Roberts, SA; Strande, N; Burkhalter, MD; Strom, C; Havener, JM; Hasty, P; Ramsden, DA				Roberts, Steven A.; Strande, Natasha; Burkhalter, Martin D.; Strom, Christina; Havener, Jody M.; Hasty, Paul; Ramsden, Dale A.			Ku is a 5 '-dRP/AP lyase that excises nucleotide damage near broken ends	NATURE			English	Article							DOUBLE-STRAND BREAKS; DNA-POLYMERASE-BETA; REPAIR IN-VITRO; PHOSPHATE LYASE; URACIL EXCISION; PROTEIN-KINASE; CELLS; IDENTIFICATION; DEPENDENCE; ROLES	Mammalian cells require non-homologous end joining (NHEJ) for the efficient repair of chromosomal DNA double-strand breaks(1). A key feature of biological sources of strand breaks is associated nucleotide damage, including base loss (abasic or apurinic/apyrimidinic (AP) sites)(2). At single-strand breaks, 5'-terminal abasic sites are excised by the 5'-deoxyribose-5-phosphate (5'-dRP) lyase activity of DNA polymerase beta (pol beta)(3-6): here we show, in vitro and in cells, that accurate and efficient repair by NHEJ of double-strand breaks with such damage similarly requires 5'-dRP/AP lyase activity. Classically defined NHEJ is moreover uniquely effective at coupling this end-cleaning step to joining in cells, helping to distinguish this pathway from otherwise robust alternative NHEJ pathways. The NHEJ factor Ku can be identified as an effective 5'-dRP/AP lyase. In a similar manner to other lyases(7), Ku nicks DNA 3' of an abasic site by a mechanism involving a Schiff-base covalent intermediate with the abasic site. We show by using cell extracts that Ku is essential for the efficient removal of AP sites near double-strand breaks and, consistent with this result, that joining of such breaks is specifically decreased in cells complemented with a lyase-attenuated Ku mutant. Ku had previously been presumed only to recognize ends and recruit other factors that process ends; our data support an unexpected direct role for Ku in end-processing steps as well.	[Roberts, Steven A.; Strande, Natasha; Burkhalter, Martin D.; Strom, Christina; Havener, Jody M.; Ramsden, Dale A.] Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Roberts, Steven A.; Strande, Natasha; Burkhalter, Martin D.; Strom, Christina; Havener, Jody M.; Ramsden, Dale A.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Hasty, Paul] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, San Antonio, TX 78245 USA; [Hasty, Paul] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78245 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Ramsden, DA (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	dale_ramsden@med.unc.edu	Strande, Natasha T./H-9894-2019	Strande, Natasha T./0000-0001-5148-9772; Hasty, Paul/0000-0003-3046-0131; Burkhalter, Martin/0000-0002-8646-3131; Ramsden, Dale/0000-0003-1575-4748	Public Health Service (PHS) [CA 84442, R01 CA76317-05A1, P01 AG17242]; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [R01CA084442, R01CA076317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017242] Funding Source: NIH RePORTER	Public Health Service (PHS)(United States Department of Health & Human ServicesUnited States Public Health Service); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Gellert, T. Kunkel, M. Garcia-Diaz, T. Traut, L. Harrison and K. Meek for helpful comments. This work was supported by Public Health Service (PHS) grant CA 84442 and a Leukemia and Lymphoma Society scholar award to D. A. R., and by PHS grants R01 CA76317-05A1 and P01 AG17242 to P. H.	AHNSTROM G, 1982, INT J RADIAT BIOL, V41, P671, DOI 10.1080/09553008214550761; Allinson SL, 2001, EMBO J, V20, P6919, DOI 10.1093/emboj/20.23.6919; Anderson Carl W., 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P283; Bebenek K, 2005, J BIOL CHEM, V280, P20051, DOI 10.1074/jbc.M501981200; Daley JM, 2008, DNA REPAIR, V7, P67, DOI 10.1016/j.dnarep.2007.07.018; Davis BJ, 2008, NUCLEIC ACIDS RES, V36, P3085, DOI 10.1093/nar/gkn164; Di Noia JM, 2007, J EXP MED, V204, P3209, DOI 10.1084/jem.20071768; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Garcia-Diaz M, 2001, J BIOL CHEM, V276, P34659, DOI 10.1074/jbc.M106336200; Guirouilh-Barbat J, 2007, P NATL ACAD SCI USA, V104, P20902, DOI 10.1073/pnas.0708541104; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Ilina ES, 2008, BBA-PROTEINS PROTEOM, V1784, P1777, DOI 10.1016/j.bbapap.2008.08.001; JEGGO PA, 1990, MUTAT RES, V239, P1, DOI 10.1016/0165-1110(90)90028-A; Kabotyanski EB, 1998, NUCLEIC ACIDS RES, V26, P5333, DOI 10.1093/nar/26.23.5333; Li H, 2009, ONCOGENE, V28, P1875, DOI 10.1038/onc.2009.57; Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; McElhinny SAN, 2005, MOL CELL, V19, P357, DOI 10.1016/j.molcel.2005.06.012; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Piersen CE, 1996, J BIOL CHEM, V271, P17811, DOI 10.1074/jbc.271.30.17811; Pogozelski WK, 1998, CHEM REV, V98, P1089, DOI 10.1021/cr960437i; Prasad R, 1998, J BIOL CHEM, V273, P11121, DOI 10.1074/jbc.273.18.11121; Prasad R, 1998, J BIOL CHEM, V273, P15263, DOI 10.1074/jbc.273.24.15263; Prasad R, 2009, NUCLEIC ACIDS RES, V37, P1868, DOI 10.1093/nar/gkp035; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Schulte-Uentrop L, 2008, NUCLEIC ACIDS RES, V36, P2561, DOI 10.1093/nar/gkn094; Sobol RW, 2000, NATURE, V405, P807, DOI 10.1038/35015598; Stewart RD, 2001, RADIAT RES, V156, P365, DOI 10.1667/0033-7587(2001)156[0365:TLKMOD]2.0.CO;2; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; WARD JF, 1994, INT J RADIAT BIOL, V66, P427, DOI 10.1080/09553009414551401; Yang N, 2004, DNA REPAIR, V3, P1323, DOI 10.1016/j.dnarep.2004.04.014	31	141	147	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2010	464	7292					1214	U139		10.1038/nature08926	http://dx.doi.org/10.1038/nature08926			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20383123	Green Accepted, Green Submitted			2022-12-28	WOS:000276891100042
J	Croswell, JM; Baker, SG; Marcus, PM; Clapp, JD; Kramer, BS				Croswell, Jennifer M.; Baker, Stuart G.; Marcus, Pamela M.; Clapp, Jonathan D.; Kramer, Barnett S.			Cumulative Incidence of False-Positive Test Results in Lung Cancer Screening A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							SPIRAL COMPUTED-TOMOGRAPHY; FOLLOW-UP; INTRAOBSERVER VARIABILITY; PULMONARY NODULES; CHEST RADIOGRAPH; BREAST-CANCER; CT-SCAN; RADIATION; RISK; INTEROBSERVER	Background: Direct-to-consumer promotion of lung cancer screening has increased, especially low-dose computed tomography (CT). However, screening exposes healthy persons to potential harms, and cumulative false-positive rates for low-dose CT have never been formally reported. Objective: To quantify the cumulative risk that a person who participated in a 1- or 2-year lung cancer screening examination would receive at least 1 false-positive result, as well as rates of unnecessary diagnostic procedures. Design: Randomized, controlled trial of low-dose CT versus chest radiography. (ClinicalTrials.govregistration number: NCT00006382) Setting: Feasibility study for the ongoing National Lung Screening Trial. Patients: Current or former smokers, aged 55 to 74 years, with a smoking history of 30 pack-years or more and no history of lung cancer (n = 3190). Intervention: Random assignment to low-dose CT or chest radiography with baseline and 1 repeated annual screening; 1-year follow-up after the final screening. Randomization was centralized and stratified by age, sex, and study center. Measurements: False-positive screenings, defined as a positive screening with a completed negative work-up or 12 months or more of follow-up with no lung cancer diagnosis. Results: By using a Kaplan-Meier analysis, a person's cumulative probability of 1 or more false-positive low-dose CT examinations was 21% (95% CI, 19% to 23%) after 1 screening and 33% ( CI, 31% to 35%) after 2. The rates for chest radiography were 9% ( CI, 8% to 11%) and 15% ( CI, 13% to 16%), respectively. A total of 7% of participants with a false-positive low-dose CT examination and 4% with a false-positive chest radiography had a resulting invasive procedure. Limitations: Screening was limited to 2 rounds. Follow-up after the second screening was limited to 12 months. The false-negative rate is probably an underestimate. Conclusion: Risks for false-positive results on lung cancer screening tests are substantial after only 2 annual examinations, particularly for low-dose CT. Further study of resulting economic, psychosocial, and physical burdens of these methods is warranted.	[Croswell, Jennifer M.] NCI, Off Med Applicat Res, NIH, Bethesda, MD 20892 USA; Informat Management Serv Inc, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Information Management Services, Inc.	Croswell, JM (corresponding author), NCI, Off Med Applicat Res, NIH, 6100 Execut Blvd,Suite 2B-03, Bethesda, MD 20892 USA.	croswellj@od.nih.gov		Clapp, Jonathan/0000-0002-8058-5808	National Cancer Institute	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Primary Funding Source: National Cancer Institute.	BAECKE E, 2009, LUNG CANC; Baker Stuart G, 2003, BMC Med Res Methodol, V3, P11, DOI 10.1186/1471-2288-3-11; Black WC, 2000, J NATL CANCER I, V92, P1280, DOI 10.1093/jnci/92.16.1280; Blanchon T, 2007, LUNG CANCER, V58, P50, DOI 10.1016/j.lungcan.2007.05.009; Bogot NR, 2005, ACAD RADIOL, V12, P948, DOI 10.1016/j.acra.2005.04.009; BONNIE J, AWARENESS CAMPAIGN L; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2004, RADIOLOGY, V231, P440, DOI 10.1148/radiol.2312030880; Brewer NT, 2007, ANN INTERN MED, V146, P502, DOI 10.7326/0003-4819-146-7-200704030-00006; Chong SM, 2005, J KOREAN MED SCI, V20, P402, DOI 10.3346/jkms.2005.20.3.402; Christiansen CL, 2000, JNCI-J NATL CANCER I, V92, P1657, DOI 10.1093/jnci/92.20.1657; Croswell JM, 2009, ANN FAM MED, V7, P212, DOI 10.1370/afm.942; CZAJA R, 1994, ANN INTERN MED, V120, P602, DOI 10.7326/0003-4819-120-7-199404010-00012; Diederich S, 2004, EUR RADIOL, V14, P691, DOI 10.1007/s00330-003-2200-5; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Erasmus JJ, 2003, J CLIN ONCOL, V21, P2574, DOI 10.1200/JCO.2003.01.144; Ford ME, 2003, CANCER EPIDEM BIOMAR, V12, P28; Garg K, 2002, RADIOLOGY, V225, P506, DOI 10.1148/radiol.2252011851; Gierada DS, 2008, RADIOLOGY, V246, P265, DOI 10.1148/radiol.2461062097; Gilbert FJ, 1998, EUR J CANCER, V34, P2010, DOI 10.1016/S0959-8049(98)00294-9; Gohagan J, 2004, CHEST, V126, P114, DOI 10.1378/chest.126.1.114; Gohagan JK, 2005, LUNG CANCER, V47, P9, DOI 10.1016/j.lungcan.2004.06.007; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Hofvind S, 2004, CANCER-AM CANCER SOC, V101, P1501, DOI 10.1002/cncr.20528; Jett JR, 2008, ONCOLOGIST, V13, P439, DOI 10.1634/theoncologist.2008-0027; Lafata JE, 2004, CANCER EPIDEM BIOMAR, V13, P2126; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; MacRedmond R, 2006, THORAX, V61, P54, DOI 10.1136/thx.2004.037580; Marcus PM, 2006, J NATL CANCER I, V98, P748, DOI 10.1093/jnci/djj207; McWilliams Annette, 2008, Proc Am Thorac Soc, V5, P900, DOI 10.1513/pats.200809-111QC; Njor SH, 2007, J MED SCREEN, V14, P94, DOI 10.1258/096914107781261891; Oken MM, 2005, JNCI-J NATL CANCER I, V97, P1832, DOI 10.1093/jnci/dji430; Pastorino U, 2003, LANCET, V362, P593, DOI 10.1016/S0140-6736(03)14188-8; Pierce DA, 2003, RADIAT RES, V159, P511, DOI 10.1667/0033-7587(2003)159[0511:JEORAS]2.0.CO;2; Pinsky PF, 2007, AM J EPIDEMIOL, V165, P874, DOI 10.1093/aje/kwk075; Sone S, 2001, BRIT J CANCER, V84, P25, DOI 10.1054/bjoc.2000.1531; STEELE MF, 2008, NY TIMES        0304; Swensen SJ, 2003, RADIOLOGY, V226, P756, DOI 10.1148/radiol.2263020036; Swensen SJ, 2005, RADIOLOGY, V235, P259, DOI 10.1148/radiol.2351041662; Taylor KL, 2004, JNCI-J NATL CANCER I, V96, P1083, DOI 10.1093/jnci/djh194; Tokarskaya ZB, 2002, HEALTH PHYS, V83, P833, DOI 10.1097/00004032-200212000-00011; van den Bergh KAM, 2008, CANCER, V113, P396, DOI 10.1002/cncr.23590; van Klaveren RV, 2008, J CLIN ONCOL, V26; Wilson DO, 2008, AM J RESP CRIT CARE, V178, P956, DOI 10.1164/rccm.200802-336OC; Yau G, 2007, LUNG CANCER, V58, P161, DOI 10.1016/j.lungcan.2007.07.006	45	103	108	1	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 20	2010	152	8					505	U53		10.7326/0003-4819-152-8-201004200-00007	http://dx.doi.org/10.7326/0003-4819-152-8-201004200-00007			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588FV	20404381				2022-12-28	WOS:000277054400004
J	Duval, X; Iung, B; Klein, I; Brochet, E; Thabut, G; Arnoult, F; Lepage, L; Laissy, JP; Wolff, M; Leport, C				Duval, Xavier; Iung, Bernard; Klein, Isabelle; Brochet, Eric; Thabut, Gabriel; Arnoult, Florence; Lepage, Laurent; Laissy, Jean-Pierre; Wolff, Michel; Leport, Catherine		IMAGE Resonance Magnetic Imaging	Effect of Early Cerebral Magnetic Resonance Imaging on Clinical Decisions in Infective Endocarditis A Prospective Study	ANNALS OF INTERNAL MEDICINE			English	Article							CEREBROVASCULAR COMPLICATIONS; PROGNOSTIC VALUE; MICROBLEEDS; ECHOCARDIOGRAPHY; DIAGNOSIS; EMBOLISM; DEATH; RISK	Background: Neurologic complications of endocarditis can influence diagnosis, therapeutic plans, and prognosis. Objective: To describe how early cerebral magnetic resonance imaging (MRI) affects the diagnosis and management of endocarditis in hospitalized adults. Design: Single-center prospective study between June 2005 and October 2008. (ClinicalTrials.govregistration number: NCT00144885) Setting: Tertiary care university hospital in France. Patients: 130 patients with endocarditis. Intervention: Cerebral MRI with angiography performed up to 7 days after admission and before any surgical intervention. Measurements: 2 experts jointly established the endocarditis diagnostic classification ( according to Duke-modified criteria) and therapeutic plans just before and after MRI and then compared them. Results: Endocarditis was initially classified as definite in 77 patients and possible in 50 and was excluded in 3. Sixteen patients (12%) had acute neurologic symptoms. Cerebral lesions were detected by MRI in 106 patients (82% [95% CI, 75% to 89%]), including ischemic lesions in 68, microhemorrhages in 74, and silent aneurysms in 10. Solely on the basis of MRI results and excluding microhemorrhages, diagnostic classification of 17 of 53 (32%) cases of nondefinite endocarditis was upgraded to either definite ( 14 patients) or possible ( 3 patients). Endocarditis therapeutic plans were modified for 24 (18%) of the 130 patients, including surgical plan modifications for 18 (14%). Overall, early MRI led to modifications of diagnosis or therapeutic plan in 36 patients (28% [CI, 20% to 36%]). Limitation: Investigators did not assess whether the MRI-related changes in diagnosis and therapeutic plans improved patient outcomes or led to unnecessary procedures and increased costs. Conclusion: Cerebral lesions were identified by MRI in many patients with endocarditis but no neurologic symptoms. The MRI findings affected both diagnostic classifications and clinical management plans.	Univ Paris 07, Bichat Univ Hosp, AP HP, Sch Med, Paris, France; INSERM, CIC 007, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Duval, X (corresponding author), Hop Bichat Claude Bernard, Ctr Invest Clin, 46 Rue Henri Huchard, F-75877 Paris 18, France.	xavier.duval@bch.aphp.fr	Ruimy, Raymond/P-6068-2016; Essig, Marie/Q-5770-2016; Iung, Bernard/AAQ-9004-2020	Essig, Marie/0000-0002-2030-5616; Iung, Bernard/0000-0002-9127-348X; Ravaud, Philippe/0000-0001-8264-9206; MOURVILLIER, BRUNO/0000-0001-5227-1468; Vrtovsnik, Francois/0000-0003-1554-314X; patrick, nataf/0000-0002-8412-6182	French Ministry of Health	French Ministry of Health	Primary Funding Source: French Ministry of Health.	Baddour LM, 2005, CIRCULATION, V111, pE394, DOI 10.1161/CIRCULATIONAHA.105.165564; Bannay A, 2009, EUR HEART J; Chu VH, 2004, CIRCULATION, V109, P1745, DOI 10.1161/01.CIR.0000124719.61827.7F; Cooper HA, 2009, CIRCULATION, V120, P585, DOI 10.1161/CIRCULATIONAHA.108.834432; Cordonnier C, 2007, BRAIN, V130, P1988, DOI 10.1093/brain/awl387; Di Salvo G, 2001, J AM COLL CARDIOL, V37, P1069, DOI 10.1016/S0735-1097(00)01206-7; Dixon AK, 1997, LANCET, V350, P509, DOI 10.1016/S0140-6736(97)06100-X; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Heiro M, 2000, ARCH INTERN MED, V160, P2781, DOI 10.1001/archinte.160.18.2781; Hoen B, 2002, JAMA-J AM MED ASSOC, V288, P75, DOI 10.1001/jama.288.1.75; Imaizumi T, 2004, J NEUROIMAGING, V14, P251, DOI 10.1177/1051228404265714; Klein I, 2007, NEUROLOGY, V68, P2043, DOI 10.1212/01.wnl.0000266965.04112.bc; Klein I, 2009, STROKE, V40, P3461, DOI 10.1161/STROKEAHA.109.562546; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; PANKEY GA, 1961, ANN INTERN MED, V55, P550, DOI 10.7326/0003-4819-55-4-550; Provenchere S, 2003, ANESTH ANALG, V96, P1258, DOI 10.1213/01.ANE.0000055803.92191.69; PRUITT AA, 1978, MEDICINE, V57, P329, DOI 10.1097/00005792-197807000-00004; Snygg-Martin U, 2008, CLIN INFECT DIS, V47, P23, DOI 10.1086/588663; STECKELBERG JM, 1991, ANN INTERN MED, V114, P635, DOI 10.7326/0003-4819-114-8-635; Subramaniam S, 2006, NEUROLOGY, V67, P1697, DOI 10.1212/01.wnl.0000229143.28230.ce; Thuny F, 2005, CIRCULATION, V112, P69, DOI 10.1161/CIRCULATIONAHA.104.493155; Thuny F, 2007, EUR HEART J, V28, P1155, DOI 10.1093/eurheartj/ehm005	24	177	181	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 20	2010	152	8					497	U40		10.7326/0003-4819-152-8-201004200-00006	http://dx.doi.org/10.7326/0003-4819-152-8-201004200-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588FV	20404380				2022-12-28	WOS:000277054400003
J	Bunting, SF; Callen, E; Wong, N; Chen, HT; Polato, F; Gunn, A; Bothmer, A; Feldhahn, N; Fernandez-Capetillo, O; Cao, L; Xu, XL; Deng, CX; Finkel, T; Nussenzweig, M; Stark, JM; Nussenzweig, A				Bunting, Samuel F.; Callen, Elsa; Wong, Nancy; Chen, Hua-Tang; Polato, Federica; Gunn, Amanda; Bothmer, Anne; Feldhahn, Niklas; Fernandez-Capetillo, Oscar; Cao, Liu; Xu, Xiaoling; Deng, Chu-Xia; Finkel, Toren; Nussenzweig, Michel; Stark, Jeremy M.; Nussenzweig, Andre			53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA Breaks	CELL			English	Article							DOUBLE-STRAND BREAKS; DAMAGE-RESPONSE; POLY(ADP-RIBOSE) POLYMERASE; GENOMIC INSTABILITY; CHROMOSOMAL BREAKS; DIRECTED REPAIR; BRCA1 FUNCTION; C-MYC; PATHWAY; CYCLE	Defective DNA repair by homologous recombination (HR) is thought to be a major contributor to tumorigenesis in individuals carrying Brca1 mutations. Here, we show that DNA breaks in Brca1-deficient cells are aberrantly joined into complex chromosome rearrangements by a process dependent on the nonhomologous end-joining (NHEJ) factors 53BP1 and DNA ligase 4. Loss of 53BP1 alleviates hypersensitivity of Brca1 mutant cells to PARP inhibition and restores error-free repair by HR. Mechanistically, 53BP1 deletion promotes ATM-dependent processing of broken DNA ends to produce recombinogenic single-stranded DNA competent for HR. In contrast, Lig4 deficiency does not rescue the HR defect in Brca1 mutant cells but prevents the joining of chromatid breaks into chromosome rearrangements. Our results illustrate that HR and NHEJ compete to process DNA breaks that arise during DNA replication and that shifting the balance between these pathways can be exploited to selectively protect or kill cells harboring Brca1 mutations.	[Bunting, Samuel F.; Callen, Elsa; Wong, Nancy; Chen, Hua-Tang; Polato, Federica; Nussenzweig, Andre] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Cao, Liu; Finkel, Toren] NHLBI, Translat Med Branch, NIH, Bethesda, MD 20892 USA; [Xu, Xiaoling; Deng, Chu-Xia] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Gunn, Amanda; Stark, Jeremy M.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA; [Gunn, Amanda; Stark, Jeremy M.] City Hope Natl Med Ctr, Beckman Res Inst, Irell & Manella Grad Sch Biol Sci, Duarte, CA 91010 USA; [Bothmer, Anne; Feldhahn, Niklas; Nussenzweig, Michel] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Nussenzweig, Michel] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Fernandez-Capetillo, Oscar] Spanish Natl Canc Res Ctr CNIO, Genom Instabil Grp, Madrid 28029, Spain	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Centro Nacional de Investigaciones Oncologicas (CNIO)	Nussenzweig, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	andre_nussenzweig@nih.gov	deng, chuxia/N-6713-2016; Polato, Federica/Q-1803-2018; Nussenzweig, Michel/AAE-7292-2019; Fernandez-Capetillo, Oscar/H-3508-2015	Fernandez-Capetillo, Oscar/0000-0002-2690-6885	National Institutes of Health (NIH) [AI037526]; NIH/National Cancer Institute [RO1CA120954]; NATIONAL CANCER INSTITUTE [ZICBC009255, ZIABC010283, ZIABC010959, R01CA120954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI037526, R01AI037526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056004, ZIADK056011, ZIADK056009, ZIADK056010, ZIADK056001] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank Richard Baer for the CtIP antibody, Davide Robbiani for the CtIP shRNA, Junjie Chen and Peter McKinnon for mice, Susan Sharrow and Larry Granger for flow cytometry, and Jeremy Daniel and Jaqueline Barlow for comments on the manuscript. M.C.N. is a Howard Hughes Medical Institute investigator. N.F. is a fellow of the Leukemia and Lymphoma society. This research was supported in part by National Institutes of Health (NIH) grant AI037526 to M.C.N., NIH/National Cancer Institute grant RO1CA120954 to J.M.S., and the Intramural Research Program of the NIH.	Andreassen PR, 2006, CARCINOGENESIS, V27, P883, DOI 10.1093/carcin/bgi319; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Brodie SG, 2001, ONCOGENE, V20, P7514, DOI 10.1038/sj.onc.1204929; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Callen E, 2007, CELL, V130, P63, DOI 10.1016/j.cell.2007.06.016; Cao L, 2006, EMBO J, V25, P2167, DOI 10.1038/sj.emboj.7601115; Cao L, 2009, MOL CELL, V35, P534, DOI 10.1016/j.molcel.2009.06.037; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Cousineau I, 2007, CELL CYCLE, V6, P962, DOI 10.4161/cc.6.8.4105; Deng CX, 2006, NUCLEIC ACIDS RES, V34, P1416, DOI 10.1093/nar/gkl010; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Holstege H, 2009, CANCER RES, V69, P3625, DOI 10.1158/0008-5472.CAN-08-3426; Inagaki S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000613; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Lazzaro F, 2008, EMBO J, V27, P1502, DOI 10.1038/emboj.2008.81; Lee JH, 2010, EMBO J, V29, P574, DOI 10.1038/emboj.2009.372; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Li S, 2000, NATURE, V406, P210, DOI 10.1038/35018134; Liu N, 1998, MOL CELL, V1, P783, DOI 10.1016/S1097-2765(00)80078-7; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Martin RW, 2007, CANCER RES, V67, P9658, DOI 10.1158/0008-5472.CAN-07-0290; McBride KM, 2006, P NATL ACAD SCI USA, V103, P8798, DOI 10.1073/pnas.0603272103; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Nagaraju G, 2009, MOL CELL BIOL, V29, P4283, DOI 10.1128/MCB.01406-08; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Postow L, 2008, J CELL BIOL, V182, P467, DOI 10.1083/jcb.200802146; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Reid LJ, 2008, P NATL ACAD SCI USA, V105, P20876, DOI 10.1073/pnas.0811203106; Reina-San-Martin B, 2007, EUR J IMMUNOL, V37, P235, DOI 10.1002/eji.200636789; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Saberi A, 2007, MOL CELL BIOL, V27, P2562, DOI 10.1128/MCB.01243-06; Sakai W, 2008, NATURE, V451, P1116, DOI 10.1038/nature06633; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schlegel BP, 2006, CANCER RES, V66, P5181, DOI 10.1158/0008-5472.CAN-05-3209; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Venkitaraman AR, 2004, NAT REV CANCER, V4, P266, DOI 10.1038/nrc1321; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Watanabe K, 2009, NUCLEIC ACIDS RES, V37, P2176, DOI 10.1093/nar/gkp082; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Xu XL, 2001, NAT GENET, V28, P266, DOI 10.1038/90108; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Yun MH, 2009, BIOCHEM SOC T, V37, P597, DOI 10.1042/BST0370597; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zhang Y, 2007, NAT STRUCT MOL BIOL, V14, P639, DOI 10.1038/nsmb1261	66	1128	1165	3	92	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2010	141	2					243	254		10.1016/j.cell.2010.03.012	http://dx.doi.org/10.1016/j.cell.2010.03.012			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	584GF	20362325	Bronze, Green Accepted			2022-12-28	WOS:000276738400015
J	Tuller, T; Carmi, A; Vestsigian, K; Navon, S; Dorfan, Y; Zaborske, J; Pan, T; Dahan, O; Furman, I; Pilpel, Y				Tuller, Tamir; Carmi, Asaf; Vestsigian, Kalin; Navon, Sivan; Dorfan, Yuval; Zaborske, John; Pan, Tao; Dahan, Orna; Furman, Itay; Pilpel, Yitzhak			An Evolutionarily Conserved Mechanism for Controlling the Efficiency of Protein Translation	CELL			English	Article							GENOME-WIDE ANALYSIS; CODON USAGE BIAS; GENE-EXPRESSION; SELECTION	Recent years have seen intensive progress in measuring protein translation. However, the contributions of coding sequences to the efficiency of the process remain unclear. Here, we identify a universally conserved profile of translation efficiency along mRNAs computed based on adaptation between coding sequences and the tRNA pool. In this profile, the first similar to 30-50 codons are, on average, translated with a low efficiency. Additionally, in eukaryotes, the last similar to 50 codons show the highest efficiency over the full coding sequence. The profile accurately predicts position-dependent ribosomal density along yeast genes. These data suggest that translation speed and, as a consequence, ribosomal density are encoded by coding sequences and the tRNA pool. We suggest that the slow "ramp'' at the beginning of mRNAs serves as a late stage of translation initiation, forming an optimal and robust means to reduce ribosomal traffic jams, thus minimizing the cost of protein expression.	[Tuller, Tamir; Carmi, Asaf; Navon, Sivan; Dorfan, Yuval; Dahan, Orna; Furman, Itay; Pilpel, Yitzhak] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Tuller, Tamir] Weizmann Inst Sci, Fac Math & Comp Sci, IL-76100 Rehovot, Israel; [Vestsigian, Kalin] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Zaborske, John; Pan, Tao] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	Weizmann Institute of Science; Weizmann Institute of Science; Harvard University; Harvard Medical School; University of Chicago	Pilpel, Y (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	pilpel@weizmann.ac.il		Tuller, Tamir/0000-0003-4194-7068; Dorfan, Yuval/0000-0003-3236-0572	European Research Council; European Commission; FP6 Programme; Ben May Charitable Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007183] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); FP6 Programme(European Commission); Ben May Charitable Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Pilpel lab and Chaim Kahana, Ran Kafri, Ron Milo, Uri Alon, Michael Springer, Jeremy Gunawardena, Eytan Ruppin, and Martin Kupiec for stimulating discussions and Orna Man for critically reading the manuscript. We thank the "Ideas'' program of the European Research Council, EMBRACE Network of Excellence grant of the European Commission within its FP6 Programme, and the Ben May Charitable Trust for grant support. T. T. is a Koshland Scholar at the Weizmann Institute of Science.	Akashi H, 2003, GENETICS, V164, P1291; Alberts B., 2008, MOL BIOL CEL, V5th ed.; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; GRAY NK, 1994, MOL BIOL REP, V19, P195, DOI 10.1007/BF00986961; Hirschman JE, 2006, NUCLEIC ACIDS RES, V34, pD442, DOI 10.1093/nar/gkj117; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kaczanowska M, 2007, MICROBIOL MOL BIOL R, V71, P477, DOI 10.1128/MMBR.00013-07; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; KURLAND CG, 1992, ANNU REV GENET, V26, P29, DOI 10.1146/annurev.ge.26.120192.000333; Li X, 2006, RNA, V12, P248, DOI 10.1261/rna.2212606; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Man O, 2007, NAT GENET, V39, P415, DOI 10.1038/ng1967; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; MILO R, 2009, NUCLEIC ACIDS RES, V23, P23; Pavon-Eternod M, 2010, RNA, V16, P267, DOI 10.1261/rna.1928110; Percudani R, 1997, J MOL BIOL, V268, P322, DOI 10.1006/jmbi.1997.0942; Qin H, 2004, GENETICS, V168, P2245, DOI 10.1534/genetics.104.030866; Schnitzer MJ, 1995, COLD SPRING HARB SYM, V60, P793, DOI 10.1101/SQB.1995.060.01.085; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SVOBODA K, 1994, P NATL ACAD SCI USA, V91, P11782, DOI 10.1073/pnas.91.25.11782; Tirosh I, 2009, SCIENCE, V324, P659, DOI 10.1126/science.1169766; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Tuller T, 2007, PLOS COMPUT BIOL, V3, P2510, DOI 10.1371/journal.pcbi.0030248; Vetsigian K, 2009, P NATL ACAD SCI USA, V106, P215, DOI 10.1073/pnas.0810122106; Wang DY, 2007, GENOME RES, V17, P1161, DOI 10.1101/gr.6328907; Widmann M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-207; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Zaborske JM, 2009, J BIOL CHEM, V284, P25254, DOI 10.1074/jbc.M109.000877; ZHANG SP, 1994, J THEOR BIOL, V170, P339, DOI 10.1006/jtbi.1994.1196; Zhu J, 1997, J STRUCT BIOL, V118, P197, DOI 10.1006/jsbi.1997.3845	36	561	572	2	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2010	141	2					344	354		10.1016/j.cell.2010.03.031	http://dx.doi.org/10.1016/j.cell.2010.03.031			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	584GF	20403328	Bronze			2022-12-28	WOS:000276738400023
J	Uemura, S; Aitken, CE; Korlach, J; Flusberg, BA; Turner, SW; Puglisi, JD				Uemura, Sotaro; Aitken, Colin Echeverria; Korlach, Jonas; Flusberg, Benjamin A.; Turner, Stephen W.; Puglisi, Joseph D.			Real-time tRNA transit on single translating ribosomes at codon resolution	NATURE			English	Article							ALLOSTERIC 3-SITE MODEL; ELONGATION-FACTOR G; L1 STALK; POLYMERASE MOLECULES; ANTIBIOTICS; MECHANISMS; SELECTION; MOVEMENT; DYNAMICS; GUIDES	Translation by the ribosome occurs by a complex mechanism involving the coordinated interaction of multiple nucleic acid and protein ligands. Here we use zero-mode waveguides (ZMWs) and sophisticated detection instrumentation to allow real-time observation of translation at physiologically relevant micromolar ligand concentrations. Translation at each codon is monitored by stable binding of transfer RNAs (tRNAs)-labelled with distinct fluorophores-to translating ribosomes, which allows direct detection of the identity of tRNA molecules bound to the ribosome and therefore the underlying messenger RNA (mRNA) sequence. We observe the transit of tRNAs on single translating ribosomes and determine the number of tRNA molecules simultaneously bound to the ribosome, at each codon of an mRNA molecule. Our results show that ribosomes are only briefly occupied by two tRNA molecules and that release of deacylated tRNA from the exit (E) site is uncoupled from binding of aminoacyl-tRNA site (A-site) tRNA and occurs rapidly after translocation. The methods outlined here have broad application to the study of mRNA sequences, and the mechanism and regulation of translation.	[Uemura, Sotaro; Aitken, Colin Echeverria; Puglisi, Joseph D.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Uemura, Sotaro] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Aitken, Colin Echeverria; Puglisi, Joseph D.] Stanford Univ, Sch Med, Biophys Program, Stanford, CA 94305 USA; [Korlach, Jonas; Flusberg, Benjamin A.; Turner, Stephen W.] Pacific Biosci Inc, Menlo Pk, CA 94025 USA	Stanford University; Japan Science & Technology Agency (JST); Stanford University	Puglisi, JD (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	puglisi@stanford.edu	Turner, Stephen/GXM-4654-2022		National Institutes of Health [GM51266]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM51266 (to J. D. P.). We thank T. Funatsu, A. Tsai and A. Petrov for encouragement and discussions. We thank J. Gray for performing ellipsometry experiments.	Agirrezabala X, 2008, MOL CELL, V32, P190, DOI 10.1016/j.molcel.2008.10.001; AITKEN CE, NAT STRUCT IN PRESS; Aitken CE, 2008, BIOPHYS J, V94, P1826, DOI 10.1529/biophysj.107.117689; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; BODLEY JW, 1972, BIOCHEM BIOPH RES CO, V46, P871, DOI 10.1016/S0006-291X(72)80222-5; Chan V, 1995, BIOPHYS J, V69, P2243, DOI 10.1016/S0006-3495(95)80095-0; Cornish PV, 2009, P NATL ACAD SCI USA, V106, P2571, DOI 10.1073/pnas.0813180106; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Fei J, 2008, MOL CELL, V30, P348, DOI 10.1016/j.molcel.2008.03.012; Fei JY, 2009, P NATL ACAD SCI USA, V106, P15702, DOI 10.1073/pnas.0908077106; Foquet M, 2008, J APPL PHYS, V103, DOI 10.1063/1.2831366; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; HAUSNER TP, 1988, J BIOL CHEM, V263, P13103; Korlach J, 2008, P NATL ACAD SCI USA, V105, P1176, DOI 10.1073/pnas.0710982105; Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700; LILL R, 1987, J MOL BIOL, V196, P137, DOI 10.1016/0022-2836(87)90516-X; Lundquist PM, 2008, OPT LETT, V33, P1026, DOI 10.1364/OL.33.001026; Marshall RA, 2008, ANNU REV BIOCHEM, V77, P177, DOI 10.1146/annurev.biochem.77.070606.101431; Marshall RA, 2009, MOL CELL, V35, P37, DOI 10.1016/j.molcel.2009.06.008; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Rodnina MV, 2001, ANNU REV BIOCHEM, V70, P415, DOI 10.1146/annurev.biochem.70.1.415; Sanders CL, 2007, RNA, V13, P1483, DOI 10.1261/rna.638707; Semenkov YP, 1996, P NATL ACAD SCI USA, V93, P12183, DOI 10.1073/pnas.93.22.12183; Tenson T, 2003, J MOL BIOL, V330, P1005, DOI 10.1016/S0022-2836(03)00662-4; Underwood KA, 2005, BIOTECHNOL BIOENG, V91, P425, DOI 10.1002/bit.20529	28	273	282	3	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2010	464	7291					1012	U73		10.1038/nature08925	http://dx.doi.org/10.1038/nature08925			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20393556	Green Accepted			2022-12-28	WOS:000276635000032
J	Schreiber, BE; Agrup, C; Haskard, DO; Luxon, LM				Schreiber, Benjamin E.; Agrup, Charlotte; Haskard, Dorian O.; Luxon, Linda M.			Sudden sensorineural hearing loss	LANCET			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; RESONANCE-IMAGING FINDINGS; MITRAL-VALVE-PROLAPSE; INNER-EAR DISEASE; OF-THE-LITERATURE; INTRATYMPANIC DEXAMETHASONE; COGANS-SYNDROME; RISK-FACTORS; MULTIPLE-SCLEROSIS; DOUBLE-BLIND	Sudden sensorineural hearing loss is usually unilateral and can be associated with tinnitus and vertigo. In most cases the cause is not identified, although various infective, vascular, and immune causes have been proposed. A careful examination is needed to exclude life threatening or treatable causes such as vascular events and malignant diseases, and patients should be referred urgently for further assessment. About half of patients completely recover, usually in about 2 weeks. Many treatments are used, including corticosteroids, antiviral drugs, and vasoactive and oxygen-based treatments. Although no treatment is proven, we recommend a short course of oral high-dose corticosteroids. There is much to learn about pathogenesis of sudden sensorineural hearing loss, and more clinical trials are needed to establish evidence-based management.	[Luxon, Linda M.] Natl Hosp Neurol & Neurosurg, Dept Neurootol, London WC1N 3BG, England; [Schreiber, Benjamin E.] Royal Free Hampstead NHS Trust, London, England; [Agrup, Charlotte] UCL Inst Neurol, Dept Neuroimmunol, London, England; [Haskard, Dorian O.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, London, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Imperial College London	Luxon, LM (corresponding author), Natl Hosp Neurol & Neurosurg, Dept Neurootol, Queen Sq, London WC1N 3BG, England.	l.luxon@ucl.ac.uk	Haberkamp, Thomas John/A-8895-2010		British Heart Foundation; National Institute for Health Research; UCLH/UCL	British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR)); UCLH/UCL	DOH is funded by the British Heart Foundation. LML is supported by the National Institute for Health Research, UCLH/UCL Comprehensive Biomedical Research Centre.	Aarnisalo AA, 2004, OTOL NEUROTOL, V25, P245, DOI 10.1097/00129492-200405000-00008; Acar GO, 2007, EUR ARCH OTO-RHINO-L, V264, P1513, DOI 10.1007/s00405-007-0382-1; Ahmad M, 2007, INT UROL NEPHROL, V39, P963, DOI 10.1007/s11255-007-9230-x; Ahn JH, 2008, LARYNGOSCOPE, V118, P279, DOI 10.1097/MLG.0b013e3181585428; Aimoni C, 2010, AUDIOL NEURO-OTOL, V15, P111, DOI 10.1159/000231636; [Anonymous], 1944, ACTA OTO-LARYNGOL, V32, P407; Asherson RA, 2008, AUTOIMMUN REV, V7, P164, DOI 10.1016/j.autrev.2007.11.009; Assimakopoulos D, 2001, DIABETES RES CLIN PR, V53, P201, DOI 10.1016/S0168-8227(01)00268-6; Bachmeyer C, 1998, AM J GASTROENTEROL, V93, P2565, DOI 10.1016/S0002-9270(98)00601-7; Ballesteros F, 2009, AUDIOL NEURO-OTOL, V14, P139, DOI 10.1159/000171475; Ban JH, 2006, OTOLARYNG HEAD NECK, V134, P970, DOI 10.1016/j.otohns.2005.11.045; BARRATT HJ, 1988, SCAND AUDIOL, V17, P67, DOI 10.3109/01050398809070694; Battaglia A, 2008, OTOL NEUROTOL, V29, P453, DOI 10.1097/MAO.0b013e318168da7a; BENNETT K, 2007, COCHRANE DATABASE SP, V1; Berrocal JRG, 2000, J LARYNGOL OTOL, V114, P101; Bigelow DC, 1998, ARCH OTOLARYNGOL, V124, P707, DOI 10.1001/archotol.124.6.707; Bitner-Glindzicz M, 2002, BRIT MED BULL, V63, P73, DOI 10.1093/bmb/63.1.73; *BRIT ASS OT, 2002, 5 BAONHS; Broughton SS, 2004, SEMIN ARTHRITIS RHEU, V34, P544, DOI 10.1016/j.semarthrit.2004.07.001; Cadoni G, 2006, J OTOLARYNGOL, V35, P310, DOI 10.2310/7070.2006.0066; Capaccio P, 2005, AM J OTOLARYNG, V26, P383, DOI 10.1016/j.amjoto.2005.05.001; Capaccio P, 2005, GENET MED, V7, P206, DOI 10.1097/01.GIM.0000157817.92509.45; Casano RAMS, 1999, AM J OTOLARYNG, V20, P151, DOI 10.1016/S0196-0709(99)90062-5; Chen CY, 2003, OTOL NEUROTOL, V24, P728, DOI 10.1097/00129492-200309000-00006; Cinamon U, 2001, EUR ARCH OTO-RHINO-L, V258, P477, DOI 10.1007/s004050100366; Conlin AE, 2007, ARCH OTOLARYNGOL, V133, P582, DOI 10.1001/archotol.133.6.582; Conlin AE, 2007, ARCH OTOLARYNGOL, V133, P573, DOI 10.1001/archotol.133.6.573; COOK TG, 1981, ANESTHESIOLOGY, V54, P421, DOI 10.1097/00000542-198105000-00015; CUMMINS D, 1990, JAMA-J AM MED ASSOC, V264, P2093; Cundiff J, 2006, AM J OTOLARYNG, V27, P68, DOI 10.1016/j.amjoto.2005.07.006; Dalmau J, 2000, REV NEUROLOGIA, V31, P1213, DOI 10.33588/rn.3112.2000090; Davies R, 2004, J NEUROL NEUROSUR PS, V75, P32, DOI 10.1136/jnnp.2004.054478; DAVIS AC, 1989, INT J EPIDEMIOL, V18, P911, DOI 10.1093/ije/18.4.911; de Seze J, 2001, REV NEUROL-FRANCE, V157, P1403; Deroee AF, 2009, OTOL NEUROTOL, V30, P277, DOI 10.1097/MAO.0b013e31819bda52; Escada PA, 2004, J LARYNGOL OTOL, V118, P143, DOI 10.1258/002221504772784612; Federspil P, 1981, Adv Otorhinolaryngol, V27, P144; Formann E, 2004, AM J GASTROENTEROL, V99, P873, DOI 10.1111/j.1572-0241.2004.30372.x; Free RH, 2009, OTOL NEUROTOL, V30, P691, DOI 10.1097/MAO.0b013e3181ab3380; Fukuda S, 2001, AURIS NASUS LARYNX, V28, pS3, DOI 10.1016/S0385-8146(01)00081-5; Fukui M, 2004, DIABETES RES CLIN PR, V63, P205, DOI 10.1016/j.diabres.2003.09.013; Garcia Berrocal J R, 1997, Acta Otorrinolaringol Esp, V48, P565; Garcia-Berrocal JR, 2006, ACTA OTO-LARYNGOL, V126, P679, DOI 10.1080/00016480500491994; Gedlicka C, 2009, AM J OTOLARYNG, V30, P157, DOI 10.1016/j.amjoto.2008.04.003; GLASSCOCK ME, 2003, OTOSCLEROSIS STAPEDE, P137; Gluth MB, 2006, MAYO CLIN PROC, V81, P483, DOI 10.4065/81.4.483; Grasland A, 2004, RHEUMATOLOGY, V43, P1007, DOI 10.1093/rheumatology/keh228; Green L, 2001, CLIN RHEUMATOL, V20, P220, DOI 10.1007/s100670170069; Gross M, 2007, AUDIOL NEURO-OTOL, V12, P179, DOI 10.1159/000099021; Guyot JP, 2000, SCHWEIZ MED WSCHR, V130, p93S; Hamid M, 2008, CURR OPIN OTOLARYNGO, V16, P434, DOI 10.1097/MOO.0b013e32830ce796; Hardin Monte F, 2003, J Ark Med Soc, V99, P327; Harris JP, 2003, JAMA-J AM MED ASSOC, V290, P1875, DOI 10.1001/jama.290.14.1875; HENDRIX RA, 1990, OTOLARYNG HEAD NECK, V103, P593, DOI 10.1177/019459989010300411; Herraiz C, 2007, AM J OTOLARYNG, V28, P225, DOI 10.1016/j.amjoto.2006.09.004; Hiraumi H, 2007, ACTA OTO-LARYNGOL, V127, P3, DOI 10.1080/03655230601065142; Ho GM, 2004, LARYNGOSCOPE, V114, P1184; HOLLANDERS D, 1986, POSTGRAD MED J, V62, P753, DOI 10.1136/pgmj.62.730.753; Hore I, 1999, J LARYNGOL OTOL, V113, P1098, DOI 10.1017/S0022215100157998; HUGHES GB, 1984, LARYNGOSCOPE, V94, P758; Hultcrantz M, 2006, ACTA OTO-LARYNGOL, V126, P10, DOI 10.1080/00016480510038617; Huy PTB, 2005, OTOL NEUROTOL, V26, P896, DOI 10.1097/01.mao.0000185071.35328.6d; Iguchi Y, 2008, CEREBROVASC DIS, V26, P409, DOI 10.1159/000151682; Inoue Y, 2000, J LARYNGOL OTOL, V114, P589; Ioannis P, 2009, EUR ARCH OTO-RHINO-L, V266, P1857, DOI 10.1007/s00405-009-0983-y; Jacobs W, 2001, AM J MED SCI, V321, P401; Janecke AR, 2002, HUM GENET, V111, P145, DOI 10.1007/s00439-002-0762-y; Keilmann A, 2009, J INHERIT METAB DIS, V32, P739, DOI 10.1007/s10545-009-1290-x; KEMPF HG, 1989, CLIN OTOLARYNGOL, V14, P451, DOI 10.1111/j.1365-2273.1989.tb00403.x; Klemm E, 2009, LARYNGO RHINO OTOL, V88, P524, DOI 10.1055/s-0028-1128133; Kumakiri K, 2005, AURIS NASUS LARYNX, V32, P71, DOI 10.1016/j.anl.2004.09.012; Kutz JW, 2006, ARCH OTOLARYNGOL, V132, P941, DOI 10.1001/archotol.132.9.941; Lee H, 2005, J NEUROL SCI, V228, P99, DOI 10.1016/j.jns.2004.10.016; Lee H, 2002, STROKE, V33, P2807, DOI 10.1161/01.STR.0000038692.17290.24; Lee HS, 2008, J OTOLARYNGOL-HEAD N, V37, P263, DOI 10.2310/7070.2008.0055; Lin HC, 2008, STROKE, V39, P2744, DOI 10.1161/STROKEAHA.108.519090; Loughran S, 2000, J LARYNGOL OTOL, V114, P837; Lunardi C, 2002, LANCET, V360, P915, DOI 10.1016/S0140-6736(02)11028-2; Luo Ren-han, 2009, Zhongguo Zhen Jiu, V29, P185; Maddox PT, 2009, LARYNGOSCOPE, V119, P1586, DOI 10.1002/lary.20511; Maier W, 2008, ENT-EAR NOSE THROAT, V87, P438, DOI 10.1177/014556130808700809; Marcucci R, 2005, J THROMB HAEMOST, V3, P929, DOI 10.1111/j.1538-7836.2005.01310.x; Maruyoshi H, 2005, INTERNAL MED, V44, P124, DOI 10.2169/internalmedicine.44.124; MASLAN MJ, 1985, AM J OTOL, V6, P435; Matthies C, 1997, NEUROSURGERY, V40, P1; MATTOX DE, 1977, ANN OTO RHINOL LARYN, V86, P463, DOI 10.1177/000348947708600406; MCCABE BF, 1979, ANN OTO RHINOL LARYN, V88, P585, DOI 10.1177/000348947908800501; Mentel R, 2004, J MED VIROL, V72, P625, DOI 10.1002/jmv.20014; Merchant SN, 2008, ORL-J OTO-RHIN-LARYN, V70, P52, DOI 10.1159/000111048; Merchant SN, 2005, OTOL NEUROTOL, V26, P151, DOI 10.1097/00129492-200503000-00004; Merchant SN, 2005, OTOL NEUROTOL, V26, P74, DOI 10.1097/00129492-200501000-00013; MILLER DH, 1988, BRAIN, V111, P927, DOI 10.1093/brain/111.4.927; Moon IS, 2009, EUR ARCH OTO-RHINO-L, V266, P1391, DOI 10.1007/s00405-009-0932-9; MORA P, 2005, INT TINNITUS J, V11, P181; Mort DJ, 2006, CURR OPIN NEUROL, V19, P1, DOI 10.1097/01.wco.0000196155.92856.a1; Nageris BI, 2004, ANN OTO RHINOL LARYN, V113, P672, DOI 10.1177/000348940411300814; Narvaez J, 1998, REV RHUM, V65, P63; National Institutes of Health, 2000, NIH PUBL; Ni Yusu, 2004, Lin Chuang Er Bi Yan Hou Ke Za Zhi, V18, P414; Nosrati-Zarenoe R, 2007, ACTA OTO-LARYNGOL, V127, P1168, DOI 10.1080/00016480701242477; Oh JH, 2007, OTOLARYNG HEAD NECK, V136, P87, DOI 10.1016/j.otohns.2006.05.015; OKEEFFE LJ, 1991, J LARYNGOL OTOL, V105, P653, DOI 10.1017/S0022215100116949; Parnes LS, 1999, LARYNGOSCOPE, V109, P1, DOI 10.1097/00005537-199907001-00001; Patterson JH, 1997, TOXICOLOGY, V121, P29, DOI 10.1016/S0300-483X(97)03653-6; Pawlak-Osinska K, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.09.880; Peltomaa M, 2000, EUR ARCH OTO-RHINO-L, V257, P317, DOI 10.1007/s004059900206; Penido NO, 2009, BRAZ J MED BIOL RES, V42, P712, DOI 10.1590/S0100-879X2009000800004; Pirodda A, 2001, ARCH OTOLARYNGOL, V127, P1049, DOI 10.1001/archotol.127.9.1049; Pitkaranta A, 1998, OTOLARYNG HEAD NECK, V118, P397, DOI 10.1016/S0194-5998(98)70324-9; PLONTKE SK, 2009, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD008080; Plontke SK, 2007, OTOL NEUROTOL, V28, P753, DOI 10.1097/MAO.0b013e31811515ae; Plontke SK, 2009, LARYNGOSCOPE, V119, P359, DOI 10.1002/lary.20074; Pollak L, 2001, J LARYNGOL OTOL, V115, P522; Pothier D. D, 2009, COCHRANE DB SYST REV, V4; Punj J, 2009, ANAESTHESIA, V64, P226, DOI [10.1111/j.1365-2044.2008.05847.x, 10.1111/j.1365-2044.2008.05846.x]; Ramos Hugo Valter Lisboa, 2005, Rev. Bras. Otorrinolaringol., V71, P422, DOI 10.1590/S0034-72992005000400004; RASMUSSEN HELMER, 1949, ACTA OTO LARYNGOL [STOCKHOLM], V37, P65, DOI 10.3109/00016484909120217; Roverano S, 2006, JCR-J CLIN RHEUMATOL, V12, P217, DOI 10.1097/01.rhu.0000242777.71604.69; ROWEJONES JM, 1990, J LARYNGOL OTOL, V104, P562, DOI 10.1017/S0022215100113179; Rozsasi A, 2003, OTOL NEUROTOL, V24, P195, DOI 10.1097/00129492-200303000-00011; RUBEN RJ, 1969, J AMER MED ASSOC, V209, P1364, DOI 10.1001/jama.209.9.1364; Ruben R, 2008, ACTA OTO-LARYNGOL, V128, P388, DOI 10.1080/00016480701663425; Rudack C, 2006, THROMB HAEMOSTASIS, V95, P454, DOI 10.1160/TH05-08-0554; Rudack C, 2004, HEARING RES, V191, P41, DOI 10.1016/j.heares.2004.01.002; Sakata T, 2006, ACTA OTO-LARYNGOL, V126, P828, DOI 10.1080/00016480500527268; Sauvaget E, 2004, LARYNGOSCOPE, V114, P327, DOI 10.1097/00005537-200402000-00028; SCHEIN JD, 2005, GERIATRICS AGEING, V8, P67; Segal S, 2003, OTOL NEUROTOL, V24, P734, DOI 10.1097/00129492-200309000-00007; SHI J, 2004, TRADIT CHIN MED, V40, P24; Sil A, 2006, J LARYNGOL OTOL, V120, P416, DOI 10.1017/S0022215106000405; Stenner M, 2009, LARYNGOSCOPE, V119, P2441, DOI 10.1002/lary.20711; Sugaya F, 1996, SARCOIDOSIS VASC DIF, V13, P54; Susac JO, 2007, J NEUROL SCI, V257, P270, DOI 10.1016/j.jns.2007.01.036; Teranishi M, 2007, ACTA OTO-LARYNGOL, V127, P1259, DOI 10.1080/00016480701242410; TIMON CI, 1989, J LARYNGOL OTOL, V103, P1071, DOI 10.1017/S0022215100111028; Touma Z, 2007, RHEUMATOL INT, V27, P995, DOI 10.1007/s00296-007-0373-y; Uppal HS, 2001, J LARYNGOL OTOL, V115, P907, DOI 10.1258/0022215011909323; VAN DISHOECK H A, 1957, Ann Otol Rhinol Laryngol, V66, P963; Vazquez R, 2008, INT J CARDIOL, V124, P370, DOI 10.1016/j.ijcard.2006.11.240; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Viirre ES, 1996, HEADACHE, V36, P24, DOI 10.1046/j.1526-4610.1996.3601024.x; Wackym PA, 1997, LARYNGOSCOPE, V107, P1165, DOI 10.1097/00005537-199709000-00003; Wei BP, 2006, COCHRANE DB SYST REV; Wiles Natasha M, 2006, Haematologica, V91, pECR46; WILSON WR, 1983, OTOLARYNG HEAD NECK, V91, P653, DOI 10.1177/019459988309100612; WILSON WR, 1980, ARCH OTOLARYNGOL, V106, P772; WOLFOVITZ E, 1987, J RHEUMATOL, V14, P384; Wu CS, 2006, AUDIOL NEURO-OTOL, V11, P151, DOI 10.1159/000091198; Xenellis J, 2007, ORL-J OTO-RHIN-LARYN, V69, P306, DOI 10.1159/000107435; Yehudai D, 2006, AUTOIMMUNITY, V39, P153, DOI 10.1080/08916930500499599; Yorgason JG, 2006, EXPERT OPIN DRUG SAF, V5, P383, DOI 10.1517/14740338.5.3.383; Young YH, 1999, J LARYNGOL OTOL, V113, P815, DOI 10.1017/S0022215100145281; Yue WL, 2003, AM J OTOLARYNG, V24, P328, DOI 10.1016/S0196-0709(03)00066-8; ZHANG S, 2006, CLIN REHABIL, V27, P22; Zhuo XL, 2008, J INT MED RES, V36, P467, DOI 10.1177/147323000803600310	155	297	356	3	59	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 3	2010	375	9721					1203	1211		10.1016/S0140-6736(09)62071-7	http://dx.doi.org/10.1016/S0140-6736(09)62071-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585VL	20362815				2022-12-28	WOS:000276858200032
J	Muser, MH; Shakhvorostov, D				Mueser, Martin H.; Shakhvorostov, Dmitry			Why Thick Can Be Slick	SCIENCE			English	Editorial Material									[Mueser, Martin H.; Shakhvorostov, Dmitry] Univ Saarland, D-66123 Saarbrucken, Germany	Saarland University	Muser, MH (corresponding author), Univ Saarland, Campus C6 3, D-66123 Saarbrucken, Germany.	martin.mueser@mx.uni-saarland.de; dshakh@mx.uni-saarland.de	Müser, Martin/ABH-4626-2020	Müser, Martin/0000-0003-0919-0843				Coulomb C. A., 1785, MEM MATH PHYS ACAD S, V10, P161; Donnet C, 2004, SURF COAT TECH, V180, P76, DOI 10.1016/j.surfcoat.2003.10.022; Filleter T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.086102; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; HARDY WB, 1923, COLLECTED WORKS; Lee C, 2010, SCIENCE, V328, P76, DOI 10.1126/science.1184167; Maboudian R, 2002, TRIBOL LETT, V12, P95, DOI 10.1023/A:1014044207344; Muser MH, 2004, EUROPHYS LETT, V66, P97, DOI 10.1209/epl/i2003-10139-6; Prandtl L, 1928, Z ANGEW MATH MECH, V8, P85, DOI 10.1002/zamm.19280080202	9	9	9	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 2	2010	328	5974					52	53		10.1126/science.1188086	http://dx.doi.org/10.1126/science.1188086			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577DR	20360097				2022-12-28	WOS:000276202200028
J	Nadjm, B; Amos, B; Mtove, G; Ostermann, J; Chonya, S; Wangai, H; Kimera, J; Msuya, W; Mtei, F; Dekker, D; Malahiyo, R; Olomi, R; Crump, JA; Whitty, CJM; Reyburn, H				Nadjm, Behzad; Amos, Ben; Mtove, George; Ostermann, Jan; Chonya, Semkini; Wangai, Hannah; Kimera, Juma; Msuya, Walii; Mtei, Frank; Dekker, Denise; Malahiyo, Rajabu; Olomi, Raimos; Crump, John A.; Whitty, Christopher J. M.; Reyburn, Hugh			WHO guidelines for antimicrobial treatment in children admitted to hospital in an area of intense Plasmodium falciparum transmission: prospective study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BLOOD-STREAM INFECTIONS; COMMUNITY-ACQUIRED BACTEREMIA; MALAWIAN CHILDREN; SEVERE MALARIA; SALMONELLA INFECTIONS; AFRICAN CHILDREN; CASE DEFINITIONS; FEBRILE ILLNESS; KENYAN CHILDREN; TANZANIA	Objectives To assess the performance of WHO's "Guidelines for care at the first-referral level in developing countries" in an area of intense malaria transmission and identify bacterial infections in children with and without malaria. Design Prospective study. Setting District hospital in Muheza, northeast Tanzania. Participants Children aged 2 months to 13 years admitted to hospital for febrile illness. Main outcome measures Sensitivity and specificity of WHO guidelines in diagnosing invasive bacterial disease; susceptibility of isolated organisms to recommended antimicrobials. Results Over one year, 3639 children were enrolled and 184 (5.1%) died; 2195 (60.3%) were blood slide positive for Plasmodium falciparum, 341 (9.4%) had invasive bacterial disease, and 142 (3.9%) were seropositive for HIV. The prevalence of invasive bacterial disease was lower in slide positive children (100/2195, 4.6%) than in slide negative children (241/1444, 16.7%). Non-typhi Salmonella was the most frequently isolated organism (52/100 (52%) of organisms in slide positive children and 108/241 (45%) in slide negative children). Mortality among children with invasive bacterial disease was significantly higher (58/341, 17%) than in children without invasive bacterial disease (126/3298, 3.8%) (P<0.001), and this was true regardless of the presence of P falciparum parasitaemia. The sensitivity and specificity of WHO criteria in identifying invasive bacterial disease in slide positive children were 60.0% (95% confidence interval 58.0% to 62.1%) and 53.5% (51.4% to 55.6%), compared with 70.5% (68.2% to 72.9%) and 48.1% (45.6% to 50.7%) in slide negative children. In children with WHO criteria for invasive bacterial disease, only 99/211(47%) of isolated organisms were susceptible to the first recommended antimicrobial agent. Conclusions In an area exposed to high transmission of malaria, current WHO guidelines failed to identify almost a third of children with invasive bacterial disease, and more than half of the organisms isolated were not susceptible to currently recommended antimicrobials. Improved diagnosis and treatment of invasive bacterial disease are needed to reduce childhood mortality.	[Nadjm, Behzad; Whitty, Christopher J. M.; Reyburn, Hugh] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Amos, Ben; Kimera, Juma; Msuya, Walii; Malahiyo, Rajabu] Hosp Teule, Muheza, Tanga, Tanzania; [Ostermann, Jan] Duke Univ, Ctr Hlth Policy, Durham, NC 27705 USA; [Chonya, Semkini; Wangai, Hannah; Mtei, Frank; Dekker, Denise; Olomi, Raimos] Kilimanjaro Christian Med Ctr, Joint Malaria Programme, Moshi, Tanzania; [Crump, John A.] Duke Univ, Med Ctr, Div Infect Dis & Int Hlth, Durham, NC 27710 USA	University of London; London School of Hygiene & Tropical Medicine; Duke University; Kilimanjaro Christian Medical Centre; Duke University	Reyburn, H (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	Hugh.reyburn@lshtm.ac.uk	Amos, Ben/AAG-6934-2022; Crump, John A./AAZ-6412-2020; Whitty, Christopher/C-7740-2012; Crump, John A./AAZ-6289-2020; Amos, Ben/AFL-6820-2022; Ostermann, Jan/GQB-4743-2022	Amos, Ben/0000-0002-8569-1650; Crump, John A./0000-0002-4529-102X; Crump, John A./0000-0002-4529-102X; Amos, Ben/0000-0002-8569-1650; Nadjm, Behzad/0000-0002-7704-3629; Mtove, George/0000-0001-5173-0829; Whitty, Christopher/0000-0002-6076-5027; Ostermann, Jan/0000-0002-8236-9500	European Commission [SANTE/2004/078-607]; Berkeley Fellowship; Sir Halley Stewart Trust; Pfizer Pharmaceuticals; Netspear; National Institute for Health Research [CL-2008-20-001] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); Berkeley Fellowship; Sir Halley Stewart Trust; Pfizer Pharmaceuticals(Pfizer); Netspear; National Institute for Health Research(National Institute for Health Research (NIHR))	Funding: Core funding for the study was provided by European Commission (Europaid) grant code SANTE/2004/078-607. BN was supported by grants from the Berkeley Fellowship, Sir Halley Stewart Trust, and Pfizer Pharmaceuticals. Pfizer Pharmaceuticals provided equipment and consumables for microbiology. Abbott Pharmaceuticals provided reagents for HIV testing. Netspear (www.netspear.org) funded the E-tests, which were performed at the KEMRI/Wellcome Trust Centre for Geographic Medicine (Coast), Kilifi, Kenya. None of the funders had a role in the design, analysis, or interpretation of results.	Archibald LK, 2003, J INFECT DIS, V188, P202, DOI 10.1086/376507; Bahwere P, 2001, Int J Infect Dis, V5, P180, DOI 10.1016/S1201-9712(01)90067-0; Bassat Q, 2009, TROP MED INT HEALTH, V14, P1011, DOI 10.1111/j.1365-3156.2009.02326.x; Bejon P, 2005, J ANTIMICROB CHEMOTH, V56, P232, DOI 10.1093/jac/dki145; Berkley J, 1999, T ROY SOC TROP MED H, V93, P283, DOI 10.1016/S0035-9203(99)90024-X; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Berkley JA, 2004, PEDIATRICS, V114, P1737, DOI 10.1542/peds.2004-1263; Berkley JA, 1999, QJM-INT J MED, V92, P151, DOI 10.1093/qjmed/92.3.151; Berkley JA, 2005, BMJ-BRIT MED J, V330, P995, DOI 10.1136/bmj.38408.471991.8F; Berkley JA, 2009, CLIN INFECT DIS, V49, P336, DOI 10.1086/600299; Blomberg B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-43; Brent AJ, 2006, PEDIATR INFECT DIS J, V25, P230, DOI 10.1097/01.inf.0000202066.02212.ff; Brent AJ, 2006, LANCET, V367, P482, DOI 10.1016/S0140-6736(06)68180-4; Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Calis JCJ, 2008, NEW ENGL J MED, V358, P888, DOI 10.1056/NEJMoa072727; Chandler CIR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-53; Chandler CIR, 2006, TROP MED INT HEALTH, V11, P1178, DOI 10.1111/j.1365-3156.2006.01672.x; Clinical and Laboratory Standards Institute, 2009, M100S19 CLIN LAB STA, V29; Cockerill FR, 2004, CLIN INFECT DIS, V38, P1724, DOI 10.1086/421087; Edmonds S, 2009, HIV MED, V10, P26; English M, 1996, T ROY SOC TROP MED H, V90, P658, DOI 10.1016/S0035-9203(96)90423-X; Evans JA, 2004, QJM-INT J MED, V97, P591, DOI 10.1093/qjmed/hch093; FIERER J, 1990, ANTIMICROB AGENTS CH, V34, P343, DOI 10.1128/AAC.34.2.343; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Graham SM, 2000, T ROY SOC TROP MED H, V94, P310, DOI 10.1016/S0035-9203(00)90337-7; Graham SM, 2000, T ROY SOC TROP MED H, V94, P227, DOI 10.1016/S0035-9203(00)90286-4; Graham SM, 2009, LANCET, V373, P267, DOI 10.1016/S0140-6736(09)60073-8; KIHLSTROM E, 1985, J ANTIMICROB CHEMOTH, V15, P723, DOI 10.1093/jac/15.6.723; Lee A, 2007, J CLIN MICROBIOL, V45, P3546, DOI 10.1128/JCM.01555-07; LEPAGE P, 1987, LANCET, V1, P1458; MABEY DCW, 1987, J INFECT DIS, V155, P1319, DOI 10.1093/infdis/155.6.1319; Maxwell CA, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-28; Mayhood MK, 2008, J CLIN MICROBIOL, V46, P3946, DOI 10.1128/JCM.01045-08; ONWUBALILI JK, 1983, J INFECTION, V7, P2, DOI 10.1016/S0163-4453(83)90863-0; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Reyburn H, 2008, B WORLD HEALTH ORGAN, V86, P132, DOI 10.2471/BLT.07.041723; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; ROUX CM, 2010, INFECT IMMUN; Scott JAG, 2005, ANTIMICROB AGENTS CH, V49, P3021, DOI 10.1128/AAC.49.7.3021-3024.2005; Shaw AV, 2008, 46 ANN M INF DIS SOC; Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d; SMITH T, 1994, STAT MED, V13, P2345, DOI 10.1002/sim.4780132206; Walsh AL, 2000, PEDIATR INFECT DIS J, V19, P312, DOI 10.1097/00006454-200004000-00010; WHO, 2006, GUID TREATM MAL; World Health Organization, 2000, MAN CHILD SER INF SE; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C	47	115	115	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2010	340								c1350	10.1136/bmj.c1350	http://dx.doi.org/10.1136/bmj.c1350			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579VJ	20354024	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000276404100004
J	Zachariah, MA; Cyster, JG				Zachariah, Marcus A.; Cyster, Jason G.			Neural Crest-Derived Pericytes Promote Egress of Mature Thymocytes at the Corticomedullary Junction	SCIENCE			English	Article							LYMPHOCYTE EGRESS; T-CELLS; LYMPHATIC VESSELS; THYMIC EMIGRATION; MOUSE THYMUS; BLOOD; MIGRATION; RETENTION; EMIGRANTS; S1P(1)	T cell egress from the thymus is essential for adaptive immunity, yet the requirements for and sites of egress are incompletely understood. We have shown that transgenic expression of sphingosine-1-phosphate receptor-1 (S1P1) in immature thymocytes leads to their perivascular accumulation and premature release into circulation. Using an intravascular procedure to label emigrating cells, we found that mature thymocytes exit via blood vessels at the corticomedullary junction. By deleting sphingosine kinases in neural crest-derived pericytes, we provide evidence that these specialized vessel-ensheathing cells contribute to the S1P that promotes thymic egress. Lymphatic endothelial cell-derived S1P was not required. These studies identify the major thymic egress route and suggest a role for pericytes in promoting reverse transmigration of cells across blood vessel endothelium.	[Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 513 Parnassus Ave,HSE1001, San Francisco, CA 94143 USA.	Jason.Cyster@ucsf.edu			UCSF; NIH [AI74847]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074847] Funding Source: NIH RePORTER	UCSF; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Lingrel for making KLF2<SUP>f/f</SUP> mice available and K. Hogquist for sending these mice; S. Coughlin for Sphk1<SUP>f/-</SUP>2<SUP>-/-</SUP> mice; T. Nakayama for CD69<SUP>-/-</SUP>; B. Black for providing Wnt1-Cre mice; T. Pham, Y. Xu, and J. An for technical help; F. Schaufele of the Diabetes Endocrinology Research Center Imaging Core for help with the confocal microscope core; N. Killeen for help generating the S1P1 transgenic mice; and O. Bannard, S. Coughlin, M. Anderson, and A. Weiss for comments on the manuscript. M.A.Z. was supported by the UCSF Medical Scientist Training Program. J. G. C. is an investigator of the Howard Hughes Medical Institute. This work was supported in part by NIH grant AI74847.	BEARMAN RM, 1975, ANAT REC, V183, P485, DOI 10.1002/ar.1091830402; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Chai Y, 2000, DEVELOPMENT, V127, P1671; Drumea-Mirancea M, 2006, J CELL SCI, V119, P1396, DOI 10.1242/jcs.02840; Foster K, 2008, J IMMUNOL, V180, P3183, DOI 10.4049/jimmunol.180.5.3183; Iritani BM, 1997, EMBO J, V16, P7019, DOI 10.1093/emboj/16.23.7019; Ji RC, 2006, ANAT SCI INT, V81, P201, DOI 10.1111/j.1447-073x.2006.00145.x; Kato S, 1997, MICROSC RES TECHNIQ, V38, P287, DOI 10.1002/(SICI)1097-0029(19970801)38:3<287::AID-JEMT9>3.0.CO;2-J; KATO S, 1988, CELL TISSUE RES, V253, P181; Komatsu N, 2007, P NATL ACAD SCI USA, V104, P8959, DOI 10.1073/pnas.0702004104; KOTANI M, 1967, Okajimas Folia Anatomica Japonica, V43, P61; Krueger M, 2010, GLIA, V58, P1, DOI 10.1002/glia.20898; Kuwata N, 1999, J IMMUNOL, V163, P6355; Lauzurica P, 2000, BLOOD, V95, P2312, DOI 10.1182/blood.V95.7.2312.007k16_2312_2320; Le Borgne M, 2009, NAT IMMUNOL, V10, P823, DOI 10.1038/ni.1761; Liu GW, 2009, NAT IMMUNOL, V10, P769, DOI 10.1038/ni.1743; McCaughtry TM, 2007, J EXP MED, V204, P2513, DOI 10.1084/jem.20070601; McGettrick HM, 2009, J LEUKOCYTE BIOL, V85, P98, DOI 10.1189/jlb.0508301; MIYASAKA M, 1990, THYMUS, V16, P29; Mori K, 2007, INT IMMUNOL, V19, P745, DOI 10.1093/intimm/dxm041; Muller SM, 2008, J IMMUNOL, V180, P5344, DOI 10.4049/jimmunol.180.8.5344; Murata K, 2003, INT IMMUNOL, V15, P987, DOI 10.1093/intimm/dxg102; Odaka C, 2006, CELL TISSUE RES, V325, P13, DOI 10.1007/s00441-005-0139-3; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pereira JP, 2009, NAT IMMUNOL, V10, P403, DOI 10.1038/ni.1710; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619; RAVIOLA E, 1972, J EXP MED, V136, P466, DOI 10.1084/jem.136.3.466; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; SAINTEMARIE G, 1964, BLOOD, V23, P275, DOI 10.1182/blood.V23.3.275.275; SCOLLAY RG, 1980, EUR J IMMUNOL, V10, P210, DOI 10.1002/eji.1830100310; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; SMITH ME, 1983, IMMUNOLOGY, V49, P83; TORO I, 1967, J ULTRA MOL STRUCT R, V17, P439, DOI 10.1016/S0022-5320(67)80134-5; USHIKI T, 1986, CELL TISSUE RES, V244, P285; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Weinreich MA, 2008, J IMMUNOL, V181, P2265, DOI 10.4049/jimmunol.181.4.2265; Zachariah Marcus A, 2009, F1000 Biol Rep, V1, P60, DOI 10.3410/B1-60	40	151	158	2	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2010	328	5982					1129	1135		10.1126/science.1188222	http://dx.doi.org/10.1126/science.1188222			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20413455	Green Accepted			2022-12-28	WOS:000278104700036
J	Greenhalgh, RM; Brown, LC; Powell, JT; Thompson, SG; Epstein, D				Greenhalgh, Roger M.; Brown, Louise C.; Powell, Janet T.; Thompson, Simon G.; Epstein, David		United Kingdom EVAR Trial Investig	Endovascular Repair of Aortic Aneurysm in Patients Physically Ineligible for Open Repair	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RUPTURE RATE; EVENTS	BACKGROUND Endovascular repair of abdominal aortic aneurysm was originally developed for patients who were considered to be physically ineligible for open surgical repair. Data are lacking on the question of whether endovascular repair reduces the rate of death among these patients. METHODS From 1999 through 2004 at 33 hospitals in the United Kingdom, we randomly assigned 404 patients with large abdominal aortic aneurysms (>= 5.5 cm in diameter) who were considered to be physically ineligible for open repair to undergo either endovascular repair or no repair; 197 patients were assigned to undergo endovascular repair, and 207 were assigned to have no intervention. Patients were followed for rates of death, graft-related complications and reinterventions, and costs until the end of 2009. Cox regression was used to compare outcomes in the two groups. RESULTS The 30-day operative mortality was 7.3% in the endovascular-repair group. The overall rate of aneurysm rupture in the no-intervention group was 12.4 (95% confidence interval [CI], 9.6 to 16.2) per 100 person-years. Aneurysm-related mortality was lower in the endovascular-repair group (adjusted hazard ratio, 0.53; 95% CI, 0.32 to 0.89; P=0.02). This advantage did not result in any benefit in terms of total mortality (adjusted hazard ratio, 0.99; 95% CI, 0.78 to 1.27; P=0.97). A total of 48% of patients who survived endovascular repair had graft-related complications, and 27% required reintervention within the first 6 years. During 8 years of follow-up, endovascular repair was considerably more expensive than no repair (cost difference, 9,826 pound [U. S. $14,867]; 95% CI, 7,638 to 12,013 [11,556 to 18,176]). CONCLUSIONS In this randomized trial involving patients who were physically ineligible for open repair, endovascular repair of abdominal aortic aneurysm was associated with a significantly lower rate of aneurysm-related mortality than no repair. However, endovascular repair was not associated with a reduction in the rate of death from any cause. The rates of graft-related complications and reinterventions were higher with endovascular repair, and it was more costly. (Current Controlled Trials number, ISRCTN55703451.)	[Greenhalgh, Roger M.; Brown, Louise C.; Powell, Janet T.] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Thompson, Simon G.] MRC, Biostat Unit, Cambridge CB2 2BW, England; [Epstein, David] Univ York, York YO10 5DD, N Yorkshire, England	Imperial College London; MRC Biostatistics Unit; University of York - UK	Greenhalgh, RM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Vasc Surg Res Grp, Charing Cross Hosp, Fulham Palace Rd, London W6 8RF, England.	r.greenhalgh@imperial.ac.uk	Russell, Ian T/H-1181-2012; Epstein, David/I-2839-2019; Powell, Janet/AAW-8669-2021; Morgan, Robert Anthony/AAH-9104-2021	Epstein, David/0000-0002-2275-0916; Powell, Janet/0000-0002-3905-1468; Morgan, Robert Anthony/0000-0002-8108-5258; Sculpher, Mark/0000-0003-3746-9913; Halliday, Alison/0000-0001-9828-3579	National Institute for Health Research in the United Kingdom; MRC [MC_U105260792] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MC_U105260792] Funding Source: researchfish	National Institute for Health Research in the United Kingdom; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by the Health Technology Assessment Programme of the National Institute for Health Research in the United Kingdom.	Brown LC, 2004, EUR J VASC ENDOVASC, V27, P372, DOI 10.1016/j.ejvs.2003.12.019; Brown LC, 1999, ANN SURG, V230, P289, DOI 10.1097/00000658-199909000-00002; BROWN LC, BR J SURG IN PRESS; BROWN LC, 2010, EUR J VASC ENDO 0120; Durazzo AES, 2004, J VASC SURG, V39, P967, DOI 10.1016/j.jvs.2004.01.004; Egorova N, 2009, J VASC SURG, V50, P1271, DOI 10.1016/j.jvs.2009.06.061; Greenhalgh RM, 2005, LANCET, V365, P2187, DOI 10.1016/S0140-6736(05)66628-7; Greenhalgh RM, 2010, NEW ENGL J MED, V362, P1863, DOI 10.1056/NEJMoa0909305; Lederle FA, 2002, JAMA-J AM MED ASSOC, V287, P2968, DOI 10.1001/jama.287.22.2968; Parodi J C, 1991, Ann Vasc Surg, V5, P491, DOI 10.1007/BF02015271; Poldermans D, 2009, EUR HEART J, V30, P2769, DOI 10.1093/eurheartj/ehp337; Powell JT, 2008, ANN SURG, V247, P173, DOI 10.1097/SLA.0b013e3181557d2a; Schouten O, 2009, NEW ENGL J MED, V361, P980, DOI 10.1056/NEJMoa0808207; Zannetti S, 2001, EUR J VASC ENDOVASC, V21, P334, DOI 10.1053/ejvs.2001.1345	14	211	220	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 20	2010	362	20					1872	1880		10.1056/NEJMoa0911056	http://dx.doi.org/10.1056/NEJMoa0911056			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	598EI	20382982	Bronze			2022-12-28	WOS:000277815600005
J	Kesselheim, AS; Mello, MM				Kesselheim, Aaron S.; Mello, Michelle M.			Gene Patenting - Is the Pendulum Swinging Back?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kesselheim, Aaron S.] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Kesselheim, Aaron S.] Harvard Univ, Sch Med, Boston, MA USA; [Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Care Policy & Management, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666; Mello, Michelle/0000-0003-2877-4270				MYRIAD GENETICS APPL	1	15	16	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 20	2010	362	20					1855	1858		10.1056/NEJMp1004026	http://dx.doi.org/10.1056/NEJMp1004026			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	598EI	20375396				2022-12-28	WOS:000277815600002
J	Pham, MX; Teuteberg, JJ; Kfoury, AG; Starling, RC; Deng, MC; Cappola, TP; Kao, A; Anderson, AS; Cotts, WG; Ewald, GA; Baran, DA; Bogaev, RC; Elashoff, B; Baron, H; Yee, J; Valantine, HA				Pham, Michael X.; Teuteberg, Jeffrey J.; Kfoury, Abdallah G.; Starling, Randall C.; Deng, Mario C.; Cappola, Thomas P.; Kao, Andrew; Anderson, Allen S.; Cotts, William G.; Ewald, Gregory A.; Baran, David A.; Bogaev, Roberta C.; Elashoff, Barbara; Baron, Helen; Yee, James; Valantine, Hannah A.		IMAGE Study Grp	Gene-Expression Profiling for Rejection Surveillance after Cardiac Transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOMYOCARDIAL BIOPSY; ALLOGRAFT-REJECTION; HEART; RECIPIENTS; UTILITY	BACKGROUND Endomyocardial biopsy is the standard method of monitoring for rejection in recipients of a cardiac transplant. However, this procedure is uncomfortable, and there are risks associated with it. Gene-expression profiling of peripheral-blood specimens has been shown to correlate with the results of an endomyocardial biopsy. METHODS We randomly assigned 602 patients who had undergone cardiac transplantation 6 months to 5 years previously to be monitored for rejection with the use of gene-expression profiling or with the use of routine endomyocardial biopsies, in addition to clinical and echocardiographic assessment of graft function. We performed a noninferiority comparison of the two approaches with respect to the composite primary outcome of rejection with hemodynamic compromise, graft dysfunction due to other causes, death, or retransplantation. RESULTS During a median follow-up period of 19 months, patients who were monitored with gene-expression profiling and those who underwent routine biopsies had similar 2-year cumulative rates of the composite primary outcome (14.5% and 15.3%, respectively; hazard ratio with gene-expression profiling, 1.04; 95% confidence interval, 0.67 to 1.68). The 2-year rates of death from any cause were also similar in the two groups (6.3% and 5.5%, respectively; P = 0.82). Patients who were monitored with the use of gene-expression profiling underwent fewer biopsies per person-year of follow-up than did patients who were monitored with the use of endomyocardial biopsies (0.5 vs. 3.0, P<0.001). CONCLUSIONS Among selected patients who had received a cardiac transplant more than 6 months previously and who were at a low risk for rejection, a strategy of monitoring for rejection that involved gene-expression profiling, as compared with routine biopsies, was not associated with an increased risk of serious adverse outcomes and resulted in the performance of significantly fewer biopsies. (ClinicalTrials.gov number, NCT00351559.)	[Valantine, Hannah A.] Stanford Univ, Sch Med, Div Cardiovasc Med, Falk CVRB, Stanford, CA 94305 USA; [Pham, Michael X.] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Teuteberg, Jeffrey J.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Kfoury, Abdallah G.] Intermt Med Ctr & Intermt Healthcare, Salt Lake City, UT USA; [Starling, Randall C.] Cleveland Clin, Cleveland, OH USA; [Deng, Mario C.] Columbia Univ, Med Ctr, New York, NY USA; [Cappola, Thomas P.] Hosp Univ Penn, Philadelphia, PA 19104 USA; [Kao, Andrew] St Lukes Hosp, Mid Amer Heart Inst, Kansas City, MO 64111 USA; [Anderson, Allen S.] Univ Chicago, Med Ctr, Chicago, IL 60637 USA; [Cotts, William G.] Northwestern Univ, Chicago, IL 60611 USA; [Ewald, Gregory A.] Washington Univ, Sch Med, St Louis, MO 63130 USA; [Baran, David A.] Newark Beth Israel Med Ctr, Newark, NJ USA; [Bogaev, Roberta C.] Texas Heart Inst, Houston, TX 77025 USA; [Elashoff, Barbara; Baron, Helen; Yee, James] XDx, Brisbane, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Intermountain Healthcare; Intermountain Medical Center; Cleveland Clinic Foundation; Columbia University; University of Pennsylvania; Pennsylvania Medicine; Saint Luke's Hospital - Missouri; Saint Luke's Mid America Heart Institute; University of Chicago; University of Chicago Medical Center; Northwestern University; Washington University (WUSTL); Newark Beth Israel Medical Center; Texas Heart Institute	Valantine, HA (corresponding author), Stanford Univ, Sch Med, Div Cardiovasc Med, Falk CVRB, 300 Pasteur Dr, Stanford, CA 94305 USA.	hvalantine@stanford.edu	Baran, David A./AAI-3795-2020; Mattos, Beatriz A/D-2432-2011	Baran, David A./0000-0002-7754-9953; Anderson, Allen/0000-0001-7216-2613	Stanford University	Stanford University(Stanford University)	Supported by XDx, maker of the AlloMap test. Stanford University holds equity in XDx.	BARALDIJUNKINS C, 1993, J HEART LUNG TRANSPL, V12, P63; BHAT G, 1993, AM HEART J, V125, P1180, DOI 10.1016/0002-8703(93)90138-Y; Brunner-La Rocca HP, 1998, TRANSPLANTATION, V65, P538, DOI 10.1097/00007890-199802270-00015; Deng MC, 2006, AM J TRANSPLANT, V6, P150, DOI 10.1111/j.1600-6143.2005.01175.x; Gradek WQ, 2001, J HEART LUNG TRANSPL, V20, P497, DOI 10.1016/S1053-2498(01)00236-4; Hamour IM, 2008, TRANSPLANTATION, V85, P969, DOI 10.1097/TP.0b013e318168d571; Heimansohn DA, 1997, ANN THORAC SURG, V64, P1231, DOI 10.1016/S0003-4975(97)00732-7; Hershberger RE, 2005, NEW ENGL J MED, V352, P2705, DOI 10.1056/NEJMoa032953; Horwitz PA, 2004, CIRCULATION, V110, P3815, DOI 10.1161/01.CIR.0000150539.72783.BF; Marboe CC, 2005, J HEART LUNG TRANSPL, V24, pS219, DOI 10.1016/j.healun.2005.04.001; Mills RM, 1997, J HEART LUNG TRANSPL, V16, P813; OLDHAM N, 1991, CATHETER CARDIO DIAG, V23, P300, DOI 10.1002/ccd.1810230415; Pham MX, 2007, J HEART LUNG TRANSPL, V26, P808, DOI 10.1016/j.healun.2007.05.017; Radovancevic B, 2005, J HEART LUNG TRANSPL, V24, P156, DOI 10.1016/j.healun.2003.11.399; Raichlin E, 2009, J HEART LUNG TRANSPL, V28, P320, DOI 10.1016/j.healun.2009.01.006; Starling, 2007, J HEART LUNG TRANSPL, V26, P204, DOI 10.1016/j.healun.2007.01.016; Starling RC, 2006, J HEART LUNG TRANSPL, V25, P1389, DOI 10.1016/j.healun.2006.10.002; Stehlik J, 2006, J HEART LUNG TRANSPL, V25, P1402, DOI 10.1016/j.healun.2006.10.003; Taylor DO, 2009, J HEART LUNG TRANSPL, V28, P1007, DOI 10.1016/j.healun.2009.08.014; Trulock EP, 2005, J HEART LUNG TRANSPL, V24, P956, DOI 10.1016/j.healun.2005.05.019; White JA, 1995, J HEART LUNG TRANSPL, V14, P1052; Williams MJA, 1996, AM J CARDIOL, V77, P1339, DOI 10.1016/S0002-9149(96)00202-0; WINTERS GL, 1995, CIRCULATION, V91, P1975, DOI 10.1161/01.CIR.91.7.1975	23	317	320	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 20	2010	362	20					1890	1900		10.1056/NEJMoa0912965	http://dx.doi.org/10.1056/NEJMoa0912965			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	598EI	20413602				2022-12-28	WOS:000277815600007
J	Horton, R				Horton, Richard			Maternal mortality: surprise, hope, and urgent action	LANCET			English	Editorial Material							HEALTH		The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.	richard.horton@lancet.com						[Anonymous], 2010, LANCET, V375, P865, DOI 10.1016/S0140-6736(10)60366-2; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Gill K, 2007, LANCET, V370, P1347, DOI 10.1016/S0140-6736(07)61577-3; Grange J, 2010, INT J GYNECOL OBSTET, V108, P181, DOI 10.1016/j.ijgo.2009.12.005; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; HOGAN MC, 2010, LANCET, DOI DOI 10.1016/SO140-6736(10)60518-1; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Shiffman J, 2007, LANCET, V370, P1370, DOI 10.1016/S0140-6736(07)61579-7	8	24	25	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 8	2010	375	9726					1581	1582		10.1016/S0140-6736(10)60547-8	http://dx.doi.org/10.1016/S0140-6736(10)60547-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	597CX	20382418				2022-12-28	WOS:000277734700004
J	Buonocore, S; Ahern, PP; Uhlig, HH; Ivanov, II; Littman, DR; Maloy, KJ; Powrie, F				Buonocore, Sofia; Ahern, Philip P.; Uhlig, Holm H.; Ivanov, Ivaylo I.; Littman, Dan R.; Maloy, Kevin J.; Powrie, Fiona			Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology	NATURE			English	Article							ROR-GAMMA-T; DIFFERENTIATION; MUCOSAL; IL-23; MICE; POPULATIONS	The key role of interleukin (IL)-23 in the pathogenesis of autoimmune and chronic inflammatory disorders is supported by the identification of IL-23 receptor (IL-23R) susceptibility alleles associated with inflammatory bowel disease, psoriasis and ankylosing spondylitis. IL-23-driven inflammation has primarily been linked to the actions of T-helper type 17 (T(H)17) cells(1). Somewhat overlooked, IL-23 also has inflammatory effects on innate immune cells(2) and can drive T-cell-independent colitis. However, the downstream cellular and molecular pathways involved in this innate intestinal inflammatory response are poorly characterized. Here we show that bacteria-driven innate colitis is associated with an increased production of IL-17 and interferon-gamma in the colon. Stimulation of colonic leukocytes with IL-23 induced the production of IL-17 and interferon-gamma exclusively by innate lymphoid cells expressing Thy1, stem cell antigen 1 (SCA-1), retinoic-acid-related orphan receptor (ROR)-gamma t and IL-23R, and these cells markedly accumulated in the inflamed colon. IL-23-responsive innate intestinal cells are also a feature of T-cell-dependent models of colitis. The transcription factor ROR-gamma t, which controls IL-23R expression, has a functional role, because Rag(-/-) Rorc(-/-) mice failed to develop innate colitis. Last, depletion of Thy1(+) innate lymphoid cells completely abrogated acute and chronic innate colitis. These results identify a previously unrecognized IL-23-responsive innate lymphoid population that mediates intestinal immune pathology and may therefore represent a target in inflammatory bowel disease.	[Buonocore, Sofia; Ahern, Philip P.; Maloy, Kevin J.; Powrie, Fiona] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Powrie, Fiona] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Translat Gastroenterol Unit, Oxford OX3 9DU, England; [Uhlig, Holm H.] Univ Childrens Hosp, D-04317 Leipzig, Germany; [Ivanov, Ivaylo I.; Littman, Dan R.] NYU, Sch Med, Kimmel Ctr Biol & Med,Skirball Inst, Mol Pathogenesis Program,Howard Hughes Med Inst, New York, NY 10016 USA	University of Oxford; University of Oxford; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Howard Hughes Medical Institute; New York University	Powrie, F (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	kevin.maloy@path.ox.ac.uk; fiona.powrie@path.ox.ac.uk		Maloy, Kevin/0000-0001-5795-7688; Uhlig, Holm/0000-0002-6111-7355	Wellcome Trust; Marie-Curie Network [MRTN-CT2004-006532]; Philippe Wiener-Maurice Anspach; European Crohn's & Colitis Organisation (ECCO); European Commission [223151]; Howard Hughes Medical Institute Exchange Programme; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK085329] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Marie-Curie Network(European Commission); Philippe Wiener-Maurice Anspach; European Crohn's & Colitis Organisation (ECCO); European Commission(European CommissionEuropean Commission Joint Research Centre); Howard Hughes Medical Institute Exchange Programme; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank N. Rust for cell sorting; R. Stillion and M. Ziegler for histology; J. Langhorne for providing the AN18 hybridoma; S. Cobbold and H. Waldmann for the gift of the depleting anti-Thy1 and isotype control antibodies; UCB Celltech for providing the blocking anti-IL-17 and isotype control antibodies; O. Boulard and S. Kirchberger for technical assistance; and C. Arancibia for critically reading the manuscript. This work was supported by the Wellcome Trust (F. P. and K. J. M.), the Marie-Curie Network fellowship (IMDEMI, MRTN-CT2004-006532) (S. B., P. A.), the Philippe Wiener-Maurice Anspach foundation (S. B.), European Crohn's & Colitis Organisation (ECCO) (S. B.), the European Commission research programme INFLA-CARE (EC contract no. 223151) (S. B. and P. A.) and a Wellcome Trust and Howard Hughes Medical Institute Exchange Programme grant (P. A., F. P. and D. R. L.).	Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Finke D, 2005, CURR OPIN IMMUNOL, V17, P144, DOI 10.1016/j.coi.2005.01.006; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kaiserling E, 2001, LYMPHOLOGY, V34, P22; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Marchesi F, 2009, MUCOSAL IMMUNOL, V2, P486, DOI 10.1038/mi.2009.113; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; SCHOENHAUT DS, 1992, J IMMUNOL, V148, P3433; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Yeung MMW, 2000, GUT, V47, P215, DOI 10.1136/gut.47.2.215; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	27	822	872	0	106	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 29	2010	464	7293					1371	1375		10.1038/nature08949	http://dx.doi.org/10.1038/nature08949			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20393462	Green Accepted			2022-12-28	WOS:000277149000051
J	Casalino, LP; Rittenhouse, DR; Gillies, RR; Shortell, SM				Casalino, Lawrence P.; Rittenhouse, Diane R.; Gillies, Robin R.; Shortell, Stephen M.			Specialist Physician Practices as Patient-Centered Medical Homes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Casalino, Lawrence P.] Weill Cornell Med Coll, New York, NY 10065 USA; [Rittenhouse, Diane R.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Gillies, Robin R.; Shortell, Stephen M.] Univ Calif Berkeley, Berkeley, CA 94720 USA	Cornell University; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Casalino, LP (corresponding author), Weill Cornell Med Coll, New York, NY 10065 USA.		Casalino, Lawrence/ABE-1245-2020	Casalino, Lawrence/0000-0002-7927-7859				*AM AC FAM PHYS AM, 2007, JOINT PRINC PAT CTR; *AM COLL PHYS, 2009, CLAR DOC REG PAT CTR; Berenson RA, 2010, CHEST, V137, P10, DOI 10.1378/chest.09-2502; Rittenhouse DR, 2008, HEALTH AFFAIR, V27, P1246, DOI 10.1377/hlthaff.27.5.1246	4	46	46	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 29	2010	362	17					1555	1558		10.1056/NEJMp1001232	http://dx.doi.org/10.1056/NEJMp1001232			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	589AX	20410499				2022-12-28	WOS:000277117400002
J	Baker, M				Baker, Monya			Homing in on delivery	NATURE			English	Editorial Material							RNA											Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105	6	54	56	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 22	2010	464	7292					1225	1230		10.1038/4641225a	http://dx.doi.org/10.1038/4641225a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20414308	Bronze			2022-12-28	WOS:000276891100044
J	Han, ZF; Niu, TH; Chang, JB; Lei, XG; Zhao, MY; Wang, Q; Cheng, W; Wang, JJ; Feng, Y; Chai, JJ				Han, Zhifu; Niu, Tianhui; Chang, Junbiao; Lei, Xiaoguang; Zhao, Mingyan; Wang, Qiang; Cheng, Wei; Wang, Jinjing; Feng, Yi; Chai, Jijie			Crystal structure of the FTO protein reveals basis for its substrate specificity	NATURE			English	Article							URACIL-DNA GLYCOSYLASE; REPAIR ENZYME ALKB; OXIDATIVE DEMETHYLATION; ESCHERICHIA-COLI; ALKYLATION DAMAGE; ADULT OBESITY; RNA; GENE; METHYLATION; MITOCHONDRIAL	Recent studies(1-5) have unequivocally associated the fat mass and obesity-associated (FTO) gene with the risk of obesity. In vitro FTO protein is an AlkB-like DNA/RNA demethylase with a strong preference for 3-methylthymidine (3-meT) in single-stranded DNA or 3-methyluracil (3-meU) in single-stranded RNA(6-8). Here we report the crystal structure of FTO in complex with the mononucleotide 3-meT. FTO comprises an amino-terminal AlkB-like domain and a carboxy-terminal domain with a novel fold. Biochemical assays show that these two domains interact with each other, which is required for FTO catalytic activity. In contrast with the structures of other AlkB members, FTO possesses an extra loop covering one side of the conserved jelly-roll motif. Structural comparison shows that this loop selectively competes with the unmethylated strand of the DNA duplex for binding to FTO, suggesting that it has an important role in FTO selection against double-stranded nucleic acids. The ability of FTO to distinguish 3-meT or 3-meU from other nucleotides is conferred by its hydrogen-bonding interaction with the two carbonyl oxygen atoms in 3-meT or 3-meU. Taken together, these results provide a structural basis for understanding FTO substrate-specificity, and serve as a foundation for the rational design of FTO inhibitors.	[Han, Zhifu; Niu, Tianhui; Lei, Xiaoguang; Zhao, Mingyan; Cheng, Wei; Wang, Jinjing; Feng, Yi; Chai, Jijie] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Niu, Tianhui] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Chang, Junbiao; Wang, Qiang] Zhengzhou Univ, Dept Chem, Zhengzhou 450001, Peoples R China; [Lei, Xiaoguang] Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin 300072, Peoples R China; [Chai, Jijie] Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China	National Institute of Biological Sciences, Beijing; China Agricultural University; Zhengzhou University; Tianjin University; Tsinghua University	Chai, JJ (corresponding author), Natl Inst Biol Sci, 7 Sci Pk Rd, Beijing 102206, Peoples R China.	chaijijie@nibs.ac.cn	chang, junbiao/P-1095-2014	chang, junbiao/0000-0001-6236-1256; Wang, Qiang/0000-0002-7366-5674; Chai, Jijie/0000-0001-7591-3873	Chinese Ministry of Science and Technology [2008AA022305, 2006CB806704, 2008AA022317]; National Natural Science Foundation of China [30825043]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Y. Yamada at Photon Factory of Japan for assistance with data collection. This research was funded by Chinese Ministry of Science and Technology '863' grant no. 2008AA022305 and '973' grant no. 2006CB806704 to J. Chai, '863' grant no. 2008AA022317 to X. L. and the National Outstanding Young Scholar Science Foundation of National Natural Science Foundation of China grant no. 30825043 to J. Chang.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P6260, DOI 10.1093/nar/gkh964; Fan JS, 2003, NUCLEIC ACIDS RES, V31, P769, DOI 10.1093/nar/gkg144; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; KLAGSBRUN M, 1973, J BIOL CHEM, V248, P2606; Koivisto P, 2003, J BIOL CHEM, V278, P44348, DOI 10.1074/jbc.M307361200; Meyre D, 2010, DIABETES, V59, P311, DOI 10.2337/db09-0703; Micura R, 2001, NUCLEIC ACIDS RES, V29, P3997, DOI 10.1093/nar/29.19.3997; MOL CD, 1995, CELL, V80, P869, DOI 10.1016/0092-8674(95)90290-2; NEGRE D, 1989, P NATL ACAD SCI USA, V86, P4902, DOI 10.1073/pnas.86.13.4902; Ougland R, 2004, MOL CELL, V16, P107, DOI 10.1016/j.molcel.2004.09.002; Sanchez-Pulido Luis, 2007, BMC Biochemistry, V8, P23, DOI 10.1186/1471-2091-8-23; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; Sundheim O, 2008, DNA REPAIR, V7, P1916, DOI 10.1016/j.dnarep.2008.07.015; Sundheim O, 2006, EMBO J, V25, P3389, DOI 10.1038/sj.emboj.7601219; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561; Yu B, 2009, P NATL ACAD SCI USA, V106, P14315, DOI 10.1073/pnas.0812938106	30	273	287	7	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2010	464	7292					1205	U129		10.1038/nature08921	http://dx.doi.org/10.1038/nature08921			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20376003				2022-12-28	WOS:000276891100040
J	Kradin, RL; Digumarthy, SR; Baggish, AL; Mark, EJ				Kradin, Richard L.; Digumarthy, Subba R.; Baggish, Aaron L.; Mark, Eugene J.			A Man with Progressive Dyspnea Pulmonary asbestosis, evolving into an accelerated phase. Pleural hyaline plaque	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LUNG-DISEASE; EXPOSURE; CRITERIA; CT		[Kradin, Richard L.] Massachusetts Gen Hosp, Dept Med, Pulm & Crit Care Unit, Boston, MA 02114 USA; [Kradin, Richard L.; Mark, Eugene J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Digumarthy, Subba R.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Baggish, Aaron L.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Kradin, Richard L.; Mark, Eugene J.] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA; [Digumarthy, Subba R.] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Kradin, Richard L.; Baggish, Aaron L.] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Kradin, RL (corresponding author), Massachusetts Gen Hosp, Dept Med, Pulm & Crit Care Unit, Boston, MA 02114 USA.							ABERLE DR, 1988, AM J ROENTGENOL, V151, P883, DOI 10.2214/ajr.151.5.883; Agusti C, 2002, AM J RESP CRIT CARE, V166, P426; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; BELLIS D, 1989, HUM PATHOL, V20, P102, DOI 10.1016/0046-8177(89)90172-X; Churg A, 2007, AM J SURG PATHOL, V31, P277, DOI 10.1097/01.pas.0000213341.70852.9d; COTES JE, 1988, THORAX, V43, P777, DOI 10.1136/thx.43.10.777; CRAIGHEAD JE, 1982, ARCH PATHOL LAB MED, V106, P544; Gevenois PA, 1998, EUR RESPIR J, V11, P1021, DOI 10.1183/09031936.98.11051021; Guidotti TL, 2005, AM J RESP CRIT CARE, V171, P528, DOI 10.1164/ajrccm.171.5.952; HUUSKONEN MS, 1978, SCAND J WORK ENV HEA, V4, P265, DOI 10.5271/sjweh.2699; KLAAS VE, 1993, AM J IND MED, V23, P801, DOI 10.1002/ajim.4700230513; Mandal RV, 2008, HUM PATHOL, V39, P1234, DOI 10.1016/j.humpath.2008.01.002; Mossman BT, 1998, AM J RESP CRIT CARE, V157, P1666, DOI 10.1164/ajrccm.157.5.9707141; NDIMBIE OK, 1987, ARCH PATHOL LAB MED, V111, P1062; PRIMACK SL, 1993, RADIOLOGY, V189, P681, DOI 10.1148/radiology.189.3.8234691; Ramazzini C, 1999, J OCCUP ENVIRON MED, V41, P830, DOI 10.1097/00043764-199910000-00003; Schattner A, 2003, J INTERN MED, V254, P193, DOI 10.1046/j.1365-2796.2003.01144.x; Setta JH, 2008, AM J IND MED, V51, P186, DOI 10.1002/ajim.20546	18	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 22	2010	362	16					1522	1531		10.1056/NEJMcpc0910930	http://dx.doi.org/10.1056/NEJMcpc0910930			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	586GP	20410518				2022-12-28	WOS:000276894700014
J	Stevenson, KB; Harrington, J; Nymeyer, S; Madhusudhan, N; Seager, S; Bowman, WC; Hardy, RA; Deming, D; Rauscher, E; Lust, NB				Stevenson, Kevin B.; Harrington, Joseph; Nymeyer, Sarah; Madhusudhan, Nikku; Seager, Sara; Bowman, William C.; Hardy, Ryan A.; Deming, Drake; Rauscher, Emily; Lust, Nate B.			Possible thermochemical disequilibrium in the atmosphere of the exoplanet GJ 436b	NATURE			English	Article							HOT NEPTUNE; CHEMICAL-EQUILIBRIUM; EMISSION-SPECTRUM; GIANT PLANETS; DWARF; SPITZER; TEMPERATURE; TRANSIT; GJ-436; CARBON	The nearby extrasolar planet GJ 436b-which has been labelled as a 'hot Neptune'-reveals itself by the dimming of light as it crosses in front of and behind its parent star as seen from Earth. Respectively known as the primary transit and secondary eclipse, the former constrains the planet's radius and mass(1,2), and the latter constrains the planet's temperature(3,4) and, with measurements at multiple wavelengths, its atmospheric composition. Previous work(5) using transmission spectroscopy failed to detect the 1.4-mu m-water vapour band, leaving the planet's atmospheric composition poorly constrained. Here we report the detection of planetary thermal emission from the dayside of GJ 436b at multiple infrared wavelengths during the secondary eclipse. The best-fit compositional models contain a high CO abundance and a substantial methane (CH4) deficiency relative to thermochemical equilibrium models(6) for the predicted hydrogen-dominated atmosphere(7,8). Moreover, we report the presence of some H2O and traces of CO2. Because CH4 is expected to be the dominant carbon-bearing species, disequilibrium processes such as vertical mixing(9) and polymerization of methane(10) into substances such as ethylene may be required to explain the hot Neptune's small CH4-to-CO ratio, which is at least 10(5) times smaller than predicted(6).	[Stevenson, Kevin B.; Harrington, Joseph; Nymeyer, Sarah; Bowman, William C.; Hardy, Ryan A.; Lust, Nate B.] Univ Cent Florida, Dept Phys, Planetary Sci Grp, Orlando, FL 32816 USA; [Madhusudhan, Nikku; Seager, Sara] MIT, Dept Phys, Cambridge, MA 02139 USA; [Madhusudhan, Nikku; Seager, Sara] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Deming, Drake] NASA, Goddard Space Flight Ctr, Planetary Syst Lab, Greenbelt, MD 20771 USA; [Rauscher, Emily] Columbia Univ, Dept Astron, New York, NY 10027 USA	State University System of Florida; University of Central Florida; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Columbia University	Stevenson, KB (corresponding author), Univ Cent Florida, Dept Phys, Planetary Sci Grp, Orlando, FL 32816 USA.	kevin218@knights.ucf.edu	Harrington, Joseph/E-6250-2011; Stevenson, Kevin/AAC-8222-2019	Stevenson, Kevin/0000-0002-7352-7941; Harrington, Joseph/0000-0002-8955-8531; Hardy, Ryan/0000-0002-3849-9551; Rauscher, Emily/0000-0003-3963-9672	US NSF; US NASA; JPL/Caltech	US NSF(National Science Foundation (NSF)); US NASA(National Aeronautics & Space Administration (NASA)); JPL/Caltech	We thank the Spitzer staff for rapid scheduling; M. Gillon, A. Lanotte and T. Loredo for discussions; D. Wilson for contributed code; and A. Wright for manuscript comments. We thank the following for software: the Free Software Foundation, W. Landsman and other contributors to the Interactive Data Language Astronomy Library, contributors to SciPy, Matplotlib and the Python programming language, and the open-source community. This work is based on observations made with the Spitzer Space Telescope, which is operated by the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. This material is based on work supported by the US NSF and by the US NASA through an award issued by JPL/Caltech.	Alonso R, 2008, ASTRON ASTROPHYS, V487, pL5, DOI 10.1051/0004-6361:200810007; Bean JL, 2006, ASTROPHYS J, V653, pL65, DOI 10.1086/510527; Burrows A, 1999, ASTROPHYS J, V512, P843, DOI 10.1086/306811; Caceres C, 2009, ASTRON ASTROPHYS, V507, P481, DOI 10.1051/0004-6361/200810908; Castelli F., 2004, NEW GRIDS ATLAS9 MOD; Cho JYK, 2008, ASTROPHYS J, V675, P817, DOI 10.1086/524718; Deming D, 2005, NATURE, V434, P740, DOI 10.1038/nature03507; Deming D, 2007, ASTROPHYS J, V667, pL199, DOI 10.1086/522496; Demory BO, 2007, ASTRON ASTROPHYS, V475, P1125, DOI 10.1051/0004-6361:20078354; Figueira P, 2009, ASTRON ASTROPHYS, V493, P671, DOI 10.1051/0004-6361:20078951; Ford EB, 2005, ASTRON J, V129, P1706, DOI 10.1086/427962; Gillon M, 2007, ASTRON ASTROPHYS, V472, pL13, DOI 10.1051/0004-6361:20077799; Harrington J, 2007, NATURE, V447, P691, DOI 10.1038/nature05863; LODDERS K, 1994, ICARUS, V112, P368, DOI 10.1006/icar.1994.1190; Lodders K, 2002, ICARUS, V155, P393, DOI 10.1006/icar.2001.6740; Madhusudhan N, 2009, ASTROPHYS J, V707, P24, DOI 10.1088/0004-637X/707/1/24; Mandel K, 2002, ASTROPHYS J, V580, pL171, DOI 10.1086/345520; Maness HL, 2007, PUBL ASTRON SOC PAC, V119, P90, DOI 10.1086/510689; Pont F, 2009, MON NOT R ASTRON SOC, V393, pL6, DOI 10.1111/j.1745-3933.2008.00582.x; Reiners A, 2009, ASTRON ASTROPHYS, V498, P853, DOI 10.1051/0004-6361/200810257; Rogers LA, 2010, ASTROPHYS J, V712, P974, DOI 10.1088/0004-637X/712/2/974; Saumon D, 2006, ASTROPHYS J, V647, P552, DOI 10.1086/505419; Swain MR, 2009, ASTROPHYS J LETT, V690, pL114, DOI 10.1088/0004-637X/690/2/L114; Swain MR, 2010, NATURE, V463, P637, DOI 10.1038/nature08775; Torres G, 2007, ASTROPHYS J LETT, V671, pL65, DOI 10.1086/524886; Zahnle K, 2009, ASTROPHYS J LETT, V701, pL20, DOI 10.1088/0004-637X/701/1/L20; ZAHNLE K, 2009, THERMOMETRIC SOOTS H	30	192	192	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2010	464	7292					1161	1164		10.1038/nature09013	http://dx.doi.org/10.1038/nature09013			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20414304	Green Submitted			2022-12-28	WOS:000276891100030
J	Barnett, H; Burrill, P; Iheanacho, I				Barnett, Helen; Burrill, Peter; Iheanacho, Ike			Change Page Don't use aspirin for primary prevention of cardiovascular disease	BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIALS; COLLABORATIVE METAANALYSIS; EVENTS; RISK		[Barnett, Helen; Iheanacho, Ike] BMJ Grp, London WC1H 9JR, England; [Burrill, Peter] NHS Derbyshire Cty, Derbyshire Cty Primary Care Trust, Chesterfield S41 7PF, England		Barnett, H (corresponding author), BMJ Grp, London WC1H 9JR, England.	hbarnett@bmjgroup.com						[Anonymous], 2009, Drug Ther Bull, V47, P122, DOI 10.1136/dtb.2009.10.0045; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Berger JS, 2006, JAMA-J AM MED ASSOC, V295, P306, DOI 10.1001/jama.295.3.306; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; De Berardis G, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4531; Derry S, 2000, BMJ-BRIT MED J, V321, P1183, DOI 10.1136/bmj.321.7270.1183; Fowkes FGR, 2010, JAMA-J AM MED ASSOC, V303, P841, DOI 10.1001/jama.2010.221; Lip GYH, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003186.pub2, DOI 10.1002/14651858.CD003186.PUB2]; *NAT COLL CTR CHRO, 2008, TYP 2 DIAB NAT CLIN; Scottish Intercollegiate Guidelines Network, 2010, MAN DIAB NAT CLIN GU; Scottish Intercollegiate Guidelines Network, RISK EST PREV CARD D; Sever PS, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1183; von Haehling S, 2005, HEART, V91, P1, DOI 10.1136/hrt.2004.042515; 2007, EUR J CARDIO PREV RE, V14, pS1	14	20	20	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 21	2010	340								c1805	10.1136/bmj.c1805	http://dx.doi.org/10.1136/bmj.c1805			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589HN	20410163				2022-12-28	WOS:000277137900001
J	Craig, JC; Williams, GJ; Jones, M; Codarini, M; Macaskill, P; Hayen, A; Irwig, L; Fitzgerald, DA; Isaacs, D; McCaskill, M				Craig, Jonathan C.; Williams, Gabrielle J.; Jones, Mike; Codarini, Miriam; Macaskill, Petra; Hayen, Andrew; Irwig, Les; Fitzgerald, Dominic A.; Isaacs, David; McCaskill, Mary			The accuracy of clinical symptoms and signs for the diagnosis of serious bacterial infection in young febrile children: prospective cohort study of 15 781 febrile illnesses	BMJ-BRITISH MEDICAL JOURNAL			English	Article							URINARY-TRACT-INFECTION; LOW-RISK; INFANTS; BACTEREMIA; PREDICTORS; VARIABLES; PARENTS; PLACEBO; FEVER; MODEL	Objectives To evaluate current processes by which young children presenting with a febrile illness but suspected of having serious bacterial infection are diagnosed and treated, and to develop and test a multivariable model to distinguish serious bacterial infections from self limiting non-bacterial illnesses. Design Two year prospective cohort study. Setting The emergency department of The Children's Hospital at Westmead, Westmead, Australia. Participants Children aged less than 5 years presenting with a febrile illness between 1 July 2004 and 30 June 2006. Intervention A standardised clinical evaluation that included mandatory entry of 40 clinical features into the hospital's electronic record keeping system was performed by physicians. Serious bacterial infections were confirmed or excluded using standard radiological and microbiological tests and follow-up. Main outcome measures Diagnosis of one of three key types of serious bacterial infection (urinary tract infection, pneumonia, and bacteraemia), and the accuracy of both our clinical decision making model and clinician judgment in making these diagnoses. Results We had follow-up data for 93% of the 15781 instances of febrile illnesses recorded during the study period. The combined prevalence of any of the three infections of interest (urinary tract infection, pneumonia, or bacteraemia) was 7.2% (1120/15 781, 95% confidence interval (CI) 6.7% to 7.5%), with urinary tract infection the diagnosis in 543 (3.4%) cases of febrile illness (95% CI 3.2% to 3.7%), pneumonia in 533 (3.4%) cases (95% CI 3.1% to 3.7%), and bacteraemia in 64 (0.4%) cases (95% CI 0.3% to 0.5%). Almost all (>94%) of the children with serious bacterial infections had the appropriate test (urine culture, chest radiograph, or blood culture). Antibiotics were prescribed acutely in 66% (359/543) of children with urinary tract infection, 69% (366/533) with pneumonia, and 81% (52/64) with bacteraemia. However, 20% (2686/13 557) of children without bacterial infection were also prescribed antibiotics. On the basis of the data from the clinical evaluations and the confirmed diagnosis, a diagnostic model was developed using multinomial logistic regression methods. Physicians' diagnoses of bacterial infection had low sensitivity (10-50%) and high specificity (90-100%), whereas the clinical diagnostic model provided a broad range of values for sensitivity and specificity. Conclusions Emergency department physicians tend to underestimate the likelihood of serious bacterial infection in young children with fever, leading to undertreatment with antibiotics. A clinical diagnostic model could improve decision making by increasing sensitivity for detecting serious bacterial infection, thereby improving early treatment.	[Craig, Jonathan C.; Williams, Gabrielle J.; Jones, Mike; Codarini, Miriam; Macaskill, Petra; Hayen, Andrew; Irwig, Les] Univ Sydney, Sch Publ Hlth, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia; [Craig, Jonathan C.] Childrens Hosp Westmead, Dept Nephrol, Westmead, NSW, Australia; [Jones, Mike] Macquarie Univ, Dept Psychol, N Ryde, NSW, Australia; [Fitzgerald, Dominic A.] Childrens Hosp Westmead, Dept Resp Med, Westmead, NSW, Australia; [Isaacs, David] Childrens Hosp Westmead, Dept Infect Dis, Westmead, NSW, Australia; [McCaskill, Mary] Childrens Hosp Westmead, Dept Emergency Med, Westmead, NSW, Australia	University of Sydney; University of Sydney; Macquarie University; University of Sydney; University of Sydney; University of Sydney	Williams, GJ (corresponding author), Univ Sydney, Sch Publ Hlth, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia.	gabriew4@chw.edu.au	Jones, Michael/A-9013-2013; Williams, Gabrielle J/B-1348-2013; Craig, Jonathan/E-2813-2013	Jones, Michael/0000-0003-0565-4938; Craig, Jonathan/0000-0002-2548-4035; Hayen, Andrew/0000-0003-4046-8030; Macaskill, Petra/0000-0001-5879-6193	National Health and Medical Research Council of Australia [211205, 402764]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This trial was funded by the National Health and Medical Research Council of Australia (programme grant numbers 211205 and 402764). The funding source had no influence on study design, data collection, analysis, interpretation of data, writing of the report, or on the decision to submit the paper for publication.	Alpern ER, 2006, PEDIATR EMERG CARE, V22, P689, DOI 10.1097/01.pec.0000236830.39194.c0; Bachur RG, 2001, PEDIATRICS, V108, P311, DOI 10.1542/peds.108.2.311; BONADIO WA, 1993, PEDIATR INFECT DIS J, V12, P111, DOI 10.1097/00006454-199302000-00001; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Christiaens TCM, 2002, BRIT J GEN PRACT, V52, P729; DAGAN R, 1985, J PEDIATR-US, V107, P855, DOI 10.1016/S0022-3476(85)80175-X; Ferry SA, 2004, SCAND J INFECT DIS, V36, P296, DOI 10.1080/00365540410019642; Hay AD, 2005, FAM PRACT, V22, P367, DOI 10.1093/fampra/cmi035; Heffernan R, 2004, EMERG INFECT DIS, V10, P858, DOI 10.3201/eid1005.030646; Hewson PH, 2000, J PAEDIATR CHILD H, V36, P221, DOI 10.1046/j.1440-1754.2000.00483.x; Hsiao AL, 2006, PEDIATRICS, V117, P1695, DOI 10.1542/peds.2005-1673; JASKIEWICZ JA, 1994, PEDIATRICS, V94, P390; Kondratovich MV, 2008, J BIOPHARM STAT, V18, P145, DOI 10.1080/10543400701668308; Kuppermann N, 1998, ANN EMERG MED, V31, P679, DOI 10.1016/S0196-0644(98)70225-2; Massin MM, 2006, ACTA CLIN BELG, V61, P161, DOI 10.1179/acb.2006.027; MCCARTHY PL, 1982, PEDIATRICS, V70, P802; MCGOWAN JE, 1973, NEW ENGL J MED, V288, P1309, DOI 10.1056/NEJM197306212882501; *NAT I HLTH CLIN E, 2007, FEV ILLN ASS IN MAN; Newman-Toker DE, 2009, JAMA-J AM MED ASSOC, V301, P1060, DOI 10.1001/jama.2009.249; Nyquist AC, 1998, JAMA-J AM MED ASSOC, V279, P875, DOI 10.1001/jama.279.11.875; Pantell RH, 2004, JAMA-J AM MED ASSOC, V291, P1203, DOI 10.1001/jama.291.10.1203; Perz JF, 2002, JAMA-J AM MED ASSOC, V287, P3103, DOI 10.1001/jama.287.23.3103; Royston P, 2003, STAT MED, V22, P639, DOI 10.1002/sim.1310; SACKETT DL, 1992, JAMA-J AM MED ASSOC, V267, P2650, DOI 10.1001/jama.267.19.2650; Sauerbrei W, 1999, J ROY STAT SOC C-APP, V48, P313, DOI 10.1111/1467-9876.00155; SAUERBREI W, 1992, STAT MED, V11, P2093, DOI 10.1002/sim.4780111607; SCHMITT BD, 1980, AM J DIS CHILD, V134, P176, DOI 10.1001/archpedi.1980.02130140050015; Simpkins D, 2009, PEDIATR INFECT DIS J, V28, P1119, DOI 10.1097/INF.0b013e3181accde8; Steyerberg E., 2009, CLIN PREDICTION MODE; TEACH SJ, 1995, J PEDIATR-US, V126, P877, DOI 10.1016/S0022-3476(95)70200-8; Trainor JL, 2001, ACAD EMERG MED, V8, P781, DOI 10.1111/j.1553-2712.2001.tb00207.x; *US BUR CENS, 2010, POP FIND US; Van den Bruel A, 2007, BRIT J GEN PRACT, V57, P538; Whiting Penny, 2005, BMC Pediatr, V5, P4	34	204	216	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 20	2010	340								c1594	10.1136/bmj.c1594	http://dx.doi.org/10.1136/bmj.c1594			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589HM	20406860	Green Published, hybrid			2022-12-28	WOS:000277137700003
J	Lu, Y; Cross, FR				Lu, Ying; Cross, Frederick R.			Periodic Cyclin-Cdk Activity Entrains an Autonomous Cdc14 Release Oscillator	CELL			English	Article							POLO KINASE CDC5; CELL-CYCLE; MITOTIC EXIT; BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; PHOSPHATASE CDC14; GENE-EXPRESSION; PROTEIN-KINASE; MITOSIS; LOCALIZATION	One oscillation of Cyclin-dependent kinase (Cdk) activity, largely driven by periodic synthesis and destruction of cyclins, is tightly coupled to a single complete eukaryotic cell division cycle. Tight linkage of different steps in diverse cell-cycle processes to Cdk activity has been proposed to explain this coupling. Here, we demonstrate an intrinsically oscillatory module controlling nucleolar release and resequestration of the Cdc14 phosphatase, which is essential for mitotic exit in budding yeast. We find that this Cdc14 release oscillator functions at constant and physiological cyclin-Cdk levels, and is therefore independent of the Cdk oscillator. However, the frequency of the release oscillator is regulated by cyclin-Cdk activity. This observation together with its mechanism suggests that the intrinsically autonomous Cdc14 release cycles are locked at once-per-cell-cycle through entrainment by the Cdk oscillator in wild-type cells. This concept may have broad implications for the structure and evolution of eukaryotic cell-cycle control.	[Lu, Ying; Cross, Frederick R.] Rockefeller Univ, New York, NY 10065 USA	Rockefeller University	Cross, FR (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.	fcross@rockefeller.edu	Lu, Ying/B-4925-2011		National Institutes of Health [GM078153, GM47238]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047238, R01GM078153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Special thanks go to B. Drapkin for developing and characterizing the quantitative Clb2kd-GFP-loading method and for communicating results before publication. We thank A. Amon, B. Drapkin, A. Geoghegan, K. Lee, D. Morgan, K. Nasmyth, J. Robbins, E. Schiebel, J. Skotheim, and R. Visintin for providing strains and plasmids. We thank L. Bai, N. Buchler, B. Drapkin, H. Funabiki, J. Robbins, W. Shou, E. Siggia, and J. Skotheim for comments on the manuscript. We thank R. Visintin for sharing unpublished data. We also thank E. Siggia for extended discussion. This work was supported by grants from the National Institutes of Health GM078153 and GM47238 to F. C.	Alexandru G, 1999, EMBO J, V18, P2707, DOI 10.1093/emboj/18.10.2707; [Anonymous], 1861, ORIGIN SPECIES MEANS; Azzam R, 2004, SCIENCE, V305, P516, DOI 10.1126/science.1099402; Bardin AJ, 2000, CELL, V102, P21, DOI 10.1016/S0092-8674(00)00007-6; Bean JM, 2006, MOL CELL, V21, P3, DOI 10.1016/j.molcel.2005.10.035; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; Brede M, 2008, PHYS LETT A, V372, P5305, DOI 10.1016/j.physleta.2008.06.017; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Charvin G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001468; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Drapkin BJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.78; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Fesquet D, 1999, EMBO J, V18, P2424, DOI 10.1093/emboj/18.9.2424; FITCH I, 1992, MOL BIOL CELL, V3, P805, DOI 10.1091/mbc.3.7.805; GARD DL, 1990, J CELL BIOL, V110, P2033, DOI 10.1083/jcb.110.6.2033; Glass L, 2001, NATURE, V410, P277, DOI 10.1038/35065745; Haase SB, 1999, NATURE, V401, P394, DOI 10.1038/43930; Haase SB, 2001, NAT CELL BIOL, V3, P38, DOI 10.1038/35050543; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; HARTWELL LH, 1974, BACTERIOL REV, V38, P164, DOI 10.1128/MMBR.38.2.164-198.1974; Jaspersen SL, 2000, CURR BIOL, V10, P615, DOI 10.1016/S0960-9822(00)00491-7; Jensen S, 2002, J CELL SCI, V115, P4977, DOI 10.1242/jcs.00189; Kearsey SE, 2003, MOL CELL, V12, P1067, DOI 10.1016/S1097-2765(03)00441-6; Krylov DM, 2003, CURR BIOL, V13, P173, DOI 10.1016/S0960-9822(03)00008-3; Kuramoto, 1975, LECT NOTE PHYS, V30, P420, DOI DOI 10.1007/BFB0013365; Lu Y, 2009, MOL BIOL CELL, V20, P1576, DOI 10.1091/mbc.E08-10-1042; Mateus C, 2000, YEAST, V16, P1313, DOI 10.1002/1097-0061(200010)16:14<1313::AID-YEA626>3.0.CO;2-O; McCleland ML, 2008, CURR BIOL, V18, P245, DOI 10.1016/j.cub.2008.01.041; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; NASMYTH K, 1995, PHILOS T ROY SOC B, V349, P271, DOI 10.1098/rstb.1995.0113; Nasmyth K, 1996, TRENDS GENET, V12, P405, DOI 10.1016/0168-9525(96)10041-X; Orlando DA, 2008, NATURE, V453, P944, DOI 10.1038/nature06955; Pereira G, 2000, MOL CELL, V6, P1, DOI 10.1016/S1097-2765(05)00017-1; Pfleger CM, 2000, GENE DEV, V14, P655; PRINGLE JR, 1981, MOL BIOL YEAST SACCH, P97; Queralt E, 2006, CELL, V125, P719, DOI 10.1016/j.cell.2006.03.038; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Sendina-Nadal I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002644; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; SLUDER G, 1990, J CELL BIOL, V110, P2025, DOI 10.1083/jcb.110.6.2025; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Stern B, 1996, TRENDS GENET, V12, P345; Sullivan M, 2001, NAT CELL BIOL, V3, P771, DOI 10.1038/ncb0901-771; SURANA U, 1993, EMBO J, V12, P1969, DOI 10.1002/j.1460-2075.1993.tb05846.x; Toyn JH, 1997, GENETICS, V145, P85; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Visintin C, 2008, GENE DEV, V22, P79, DOI 10.1101/gad.1601308; Visintin R, 2003, MOL BIOL CELL, V14, P4486, DOI 10.1091/mbc.E03-02-0095; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3; Wittenberg C, 2005, ONCOGENE, V24, P2746, DOI 10.1038/sj.onc.1208606; WITTENBERG C, 1990, CELL, V62, P225, DOI 10.1016/0092-8674(90)90361-H; Xu SC, 2000, CURR BIOL, V10, P329, DOI 10.1016/S0960-9822(00)00382-1; Yeong FM, 2000, MOL CELL, V5, P501, DOI 10.1016/S1097-2765(00)80444-X; Yoshida S, 2001, GENES GENET SYST, V76, P141, DOI 10.1266/ggs.76.141	63	70	71	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2010	141	2					268	279		10.1016/j.cell.2010.03.021	http://dx.doi.org/10.1016/j.cell.2010.03.021			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	584GF	20403323	Green Accepted, Bronze			2022-12-28	WOS:000276738400017
J	Stuart, SN; Wilson, EO; McNeely, JA; Mittermeier, RA; Rodriguez, JP				Stuart, S. N.; Wilson, E. O.; McNeely, J. A.; Mittermeier, R. A.; Rodriguez, J. P.			The Barometer of Life	SCIENCE			English	Editorial Material							IUCN RED LIST		[Stuart, S. N.] IUCN, Species Survival Commiss, CH-1196 Gland, Switzerland; [Stuart, S. N.] UN Environm Program, World Conservat Monitoring Ctr, Al Ain, U Arab Emirates; [Stuart, S. N.] Univ Bath, Dept Chem & Biol Chem, Bath BA2 7AY, Avon, England; [Wilson, E. O.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Mittermeier, R. A.] Conservat Int, Arlington, VA 22202 USA; [Rodriguez, J. P.] Inst Venezolano Invest Cient, Ctr Ecol, Caracas 1020A, Venezuela; [Rodriguez, J. P.] Provita, Caracas 1040A, Venezuela	United Nations Environment Programme; University of Bath; Harvard University; Conservation International; Venezuelan Institute Science Research	Stuart, SN (corresponding author), IUCN, Species Survival Commiss, CH-1196 Gland, Switzerland.	simon.stuart@iucn.org	Rodriguez, Jon P/G-7224-2012; Rodriguez, Jon P/A-1491-2009	Rodriguez, Jon P/0000-0001-5019-2870				BISBY FA, 2009, CATALOGUE LIFE 2009; Chapman A, 2009, NUMBERS LIVING SPECI; Mace G., 2005, ECOSYSTEMS HUMAN WEL, V1, P77; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Rodriguez Jon Paul, 2008, Endangered Species Research, V6, P193, DOI 10.3354/esr006193; Vie J-C, 2009, WILDLIFE CHANGING WO; VIE JC, COMMUNICATION; Wheeler QD, 2004, SCIENCE, V303, P285, DOI 10.1126/science.303.5656.285; Wilson EO, 2003, TRENDS ECOL EVOL, V18, P77, DOI 10.1016/S0169-5347(02)00040-X; ZAMIN TJ, CONSERV BIO IN PRESS	10	110	117	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 9	2010	328	5975					177	177		10.1126/science.1188606	http://dx.doi.org/10.1126/science.1188606			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580OU	20378803				2022-12-28	WOS:000276459600027
J	Cooke, M				Cooke, Molly			Cost Consciousness in Patient Care -- What is Medical Education's Responsibility?.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH-CARE		Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Cooke, M (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.							Abbo ED, 2006, AM J BIOETHICS, V6, P33, DOI 10.1080/15265160600755540; Beach MC, 2005, ANN FAM MED, V3, P53, DOI 10.1370/afm.257; Blumenthal D, 2001, NEW ENGL J MED, V344, P766, DOI 10.1056/NEJM200103083441012; HIATT HH, 1975, NEW ENGL J MED, V293, P235, DOI 10.1056/NEJM197507312930506; Shortell SM, 1998, JAMA-J AM MED ASSOC, V280, P1102, DOI 10.1001/jama.280.12.1102	5	118	119	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 8	2010	362	14					1253	1255		10.1056/NEJMp0911502	http://dx.doi.org/10.1056/NEJMp0911502			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	579SN	20357275				2022-12-28	WOS:000276393700001
J	Li, XY; Wei, YJ; Lu, L; Lu, K; Gao, HJ				Li, Xiaoyan; Wei, Yujie; Lu, Lei; Lu, Ke; Gao, Huajian			Dislocation nucleation governed softening and maximum strength in nano-twinned metals	NATURE			English	Article							MOLECULAR-DYNAMICS SIMULATION; NANOCRYSTALLINE MATERIALS; MECHANICAL-PROPERTIES; NANOTWINNED COPPER; DEFORMATION; PLASTICITY; NANOSCALE; DUCTILITY; CRYSTALS; NICKEL	In conventional metals, there is plenty of space for dislocations-line defects whose motion results in permanent material deformation-to multiply, so that the metal strengths are controlled by dislocation interactions with grain boundaries(1,2) and other obstacles(3,4). For nano-structured materials, in contrast, dislocation multiplication is severely confined by the nanometre-scale geometries so that continued plasticity can be expected to be source-controlled. Nano-grained polycrystalline materials were found to be strong but brittle(5-9), because both nucleation and motion of dislocations are effectively suppressed by the nanoscale crystallites. Here we report a dislocation-nucleation-controlled mechanism in nano-twinned metals(10,11) in which there are plenty of dislocation nucleation sites but dislocation motion is not confined. We show that dislocation nucleation governs the strength of such materials, resulting in their softening below a critical twin thickness. Large-scale molecular dynamics simulations and a kinetic theory of dislocation nucleation in nano-twinned metals show that there exists a transition in deformation mechanism, occurring at a critical twin-boundary spacing for which strength is maximized. At this point, the classical Hall-Petch type of strengthening due to dislocation pile-up and cutting through twin planes switches to a dislocation-nucleation-controlled softening mechanism with twin-boundary migration resulting from nucleation and motion of partial dislocations parallel to the twin planes. Most previous studies(12,13) did not consider a sufficient range of twin thickness and therefore missed this strength-softening regime. The simulations indicate that the critical twin-boundary spacing for the onset of softening in nano-twinned copper and the maximum strength depend on the grain size: the smaller the grain size, the smaller the critical twin-boundary spacing, and the higher the maximum strength of the material.	[Li, Xiaoyan; Gao, Huajian] Brown Univ, Div Engn, Providence, RI 02912 USA; [Wei, Yujie] Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA; [Lu, Lei; Lu, Ke] Chinese Acad Sci, Shenyang Natl Lab Mat Sci, Inst Met Res, Shenyang 110016, Peoples R China	Brown University; University of Alabama System; University of Alabama Tuscaloosa; Chinese Academy of Sciences; Institute of Metal Research, CAS	Wei, YJ (corresponding author), Chinese Acad Sci, Inst Mech, State Key Lab Nonlinear Mech, Beijing 100190, Peoples R China.	yujie_wei@lnm.imech.ac.cn; huajian_gao@brown.edu	Gao, Huajian/F-9360-2010; Wei, Yujie/A-3770-2009; Li, Xiaoyan/B-7325-2008; Lu, Lei/E-3864-2012; Wei, Yujie/AAO-7639-2021	Gao, Huajian/0000-0002-8656-846X; Wei, Yujie/0000-0002-3213-7891; Li, Xiaoyan/0000-0002-2953-9267; 	NSF [DMR-0520651]; Brown University [CMMI-0758535]; NSFC [50621091, 50725103, 50890171]; MOST of China [2005CB623604]; Directorate For Engineering [0758535] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Brown University; NSFC(National Natural Science Foundation of China (NSFC)); MOST of China(Ministry of Science and Technology, China); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	X. L. and H. G. acknowledge financial support by the NSF through the MRSEC Program (award number DMR-0520651) and grant CMMI-0758535 at Brown University. The simulations reported were performed on NSF TeraGrid resources provided by NICS under MSS090036 (H. G.) and DMR090083 (Y.W.), with additional support from the Computational Mechanics Research Facility at Brown University and the Alabama Supercomputer Center. Helpful discussions with J. D. Embury, W. D. Nix, H. Mughrabi, M. A. Meyers and R. Taylor are gratefully acknowledged. L. L. and K. L. acknowledge financial support by the NSFC (grant numbers 50621091, 50725103 and 50890171) and the MOST of China (grant number 2005CB623604).	Cao AJ, 2007, J APPL PHYS, V102, DOI 10.1063/1.2794884; CHOKSHI AH, 1989, SCRIPTA METALL MATER, V23, P1679, DOI 10.1016/0036-9748(89)90342-6; CHRISTIAN JW, 1995, PROG MATER SCI, V39, P1, DOI 10.1016/0079-6425(94)00007-7; Devincre B, 2008, SCIENCE, V320, P1745, DOI 10.1126/science.1156101; Froseth A, 2004, ACTA MATER, V52, P2259, DOI 10.1016/j.actamat.2004.01.017; Greer JR, 2005, ACTA MATER, V53, P1821, DOI 10.1016/j.actamat.2004.12.031; HALL EO, 1951, P PHYS SOC LOND B, V64, P747, DOI 10.1088/0370-1301/64/9/303; Hemker KJ, 2008, NAT MATER, V7, P97, DOI 10.1038/nmat2103; HIRTH JP, 1982, THEORY DISLOCATIONS, P764; Kulkarni Y, 2009, ACTA MATER, V57, P4835, DOI 10.1016/j.actamat.2009.06.047; Kumar KS, 2003, ACTA MATER, V51, P387, DOI 10.1016/S1359-6454(02)00421-4; Lu L, 2004, SCIENCE, V304, P422, DOI 10.1126/science.1092905; Lu L, 2009, SCIENCE, V323, P607, DOI 10.1126/science.1167641; Meyers MA, 2006, PROG MATER SCI, V51, P427, DOI 10.1016/j.pmatsci.2005.08.003; Mishin Y, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.224106; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; PETCH NJ, 1953, J IRON STEEL I, V174, P25; Schiotz J, 2003, SCIENCE, V301, P1357, DOI 10.1126/science.1086636; Schiotz J, 1998, NATURE, V391, P561, DOI 10.1038/35328; Shabib I, 2009, ACTA MATER, V57, P4364, DOI 10.1016/j.actamat.2009.05.028; Shan ZW, 2008, NAT MATER, V7, P115, DOI 10.1038/nmat2085; Shan ZW, 2004, SCIENCE, V305, P654, DOI 10.1126/science.1098741; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Uchic MD, 2004, SCIENCE, V305, P986, DOI 10.1126/science.1098993; Van Swygenhoven H, 2000, PHYS REV B, V62, P831, DOI 10.1103/PhysRevB.62.831; Van Swygenhoven H, 2004, NAT MATER, V3, P399, DOI 10.1038/nmat1136; Van Swygenhoven H, 1999, PHYS REV B, V60, P22, DOI 10.1103/PhysRevB.60.22; Wang YB, 2007, PHIL MAG LETT, V87, P935, DOI 10.1080/09500830701591493; Wolf D, 2005, ACTA MATER, V53, P1, DOI 10.1016/j.actamat.2004.08.045; Yamakov V, 2002, ACTA MATER, V50, P5005, DOI 10.1016/S1359-6454(02)00318-X; Yip S, 1998, NATURE, V391, P532, DOI 10.1038/35254; Zhu T, 2007, P NATL ACAD SCI USA, V104, P3031, DOI 10.1073/pnas.0611097104	32	839	861	68	1298	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					877	880		10.1038/nature08929	http://dx.doi.org/10.1038/nature08929			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20376146	Green Published			2022-12-28	WOS:000276397300034
J	Stein, PD; Chenevert, TL; Fowler, SE; Goodman, LR; Gottschalk, A; Hales, CA; Hull, RD; Jablonski, KA; Leeper, KV; Naidich, DP; Sak, DJ; Sostman, D; Tapson, VF; Weg, JG; Woodard, PK				Stein, Paul D.; Chenevert, Thomas L.; Fowler, Sarah E.; Goodman, Lawrence R.; Gottschalk, Alexander; Hales, Charles A.; Hull, Russell D.; Jablonski, Kathleen A.; Leeper, Kenneth V., Jr.; Naidich, David P.; Sak, Daniel J.; Sostman, Dirk; Tapson, Victor F.; Weg, John G.; Woodard, Pamela K.		PIOPED III Investigators	Gadolinium-Enhanced Magnetic Resonance Angiography for Pulmonary Embolism A Multicenter Prospective Study (PIOPED III)	ANNALS OF INTERNAL MEDICINE			English	Article							TOTAL HIP-REPLACEMENT; MR-ANGIOGRAPHY; PERFUSION SCINTIGRAPHY; VENOUS THROMBOSIS; DIAGNOSTIC-TEST; CLINICAL-MODEL; DOUBLE-BLIND; ENOXAPARIN; THROMBOPROPHYLAXIS; SENSITIVITY	Background: The accuracy of gadolinium-enhanced magnetic resonance pulmonary angiography and magnetic resonance venography for diagnosing pulmonary embolism has not been determined conclusively. Objective: To investigate performance characteristics of magnetic resonance angiography, with or without magnetic resonance venography, for diagnosing pulmonary embolism. Design: Prospective, multicenter study from 10 April 2006 to 30 September 2008. (ClinicalTrials.gov registration number: NCT00241826) Setting: 7 hospitals and their emergency services. Patients: 371 adults with diagnosed or excluded pulmonary embolism. Measurements: Sensitivity, specificity, and likelihood ratios were measured by comparing independently read magnetic resonance imaging with the reference standard for diagnosing pulmonary embolism. Reference standard diagnosis or exclusion was made by using various tests, including computed tomographic angiography and venography, ventilation-perfusion lung scan, venous ultrasonography, D-dimer assay, and clinical assessment. Results: Magnetic resonance angiography, averaged across centers, was technically inadequate in 25% of patients (92 of 371). The proportion of technically inadequate images ranged from 11% to 52% at various centers. Including patients with technically inadequate images, magnetic resonance angiography identified 57% (59 of 104) with pulmonary embolism. Technically adequate magnetic resonance angiography had a sensitivity of 78% and a specificity of 99%. Technically adequate magnetic resonance angiography and venography had a sensitivity of 92% and a specificity of 96%, but 52% of patients (194 of 370) had technically inadequate results. Limitation: A high proportion of patients with suspected embolism was not eligible or declined to participate. Conclusion: Magnetic resonance pulmonary angiography should be considered only at centers that routinely perform it well and only for patients for whom standard tests are contraindicated. Magnetic resonance pulmonary angiography and magnetic resonance venography combined have a higher sensitivity than magnetic resonance pulmonary angiography alone in patients with technically adequate images, but it is more difficult to obtain technically adequate images with the 2 procedures.	[Stein, Paul D.] Michigan State Univ, Coll Osteopath Med, Venous Thromboembolism Res Unit, Dept Internal Med,St Joseph Mercy Oakland Hosp, Pontiac, MI 48341 USA; Michigan State Univ, Coll Osteopath Med, E Lansing, MI 48824 USA; Univ Michigan, Ann Arbor, MI 48109 USA; George Washington Univ, Rockville, MD USA; Med Coll Wisconsin, Milwaukee, WI 53226 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Univ Calgary, Calgary, AB, Canada; Emory Univ, Atlanta, GA 30322 USA; NYU, Med Ctr, New York, NY 10016 USA; Weill Cornell Med Coll, Houston, TX USA; Methodist Hosp, Houston, TX 77030 USA; Duke Univ, Durham, NC USA; Washington Univ, St Louis, MO USA	Michigan State University; Michigan State University College of Osteopathic Medicine; Saint Joseph Mercy Health System (SJMHS); Michigan State University; Michigan State University College of Osteopathic Medicine; University of Michigan System; University of Michigan; George Washington University; Medical College of Wisconsin; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Calgary; Emory University; New York University; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston; Duke University; Washington University (WUSTL)	Stein, PD (corresponding author), Michigan State Univ, Coll Osteopath Med, Venous Thromboembolism Res Unit, Dept Internal Med,St Joseph Mercy Oakland Hosp, 44405 Woodward Ave, Pontiac, MI 48341 USA.	steinp@trinity-health.org	Staff, Roger T/G-1826-2011; Woodard, Pamela/AAC-3892-2020	Staff, Roger T/0000-0003-0620-8673; naidich, david/0000-0003-3751-5836; Chenevert, Thomas/0000-0003-1476-4274	U.S. Department of Health and Human Service, Public Health Service, National Heart, Lung, and Blood Institute (NHLBI), Bethesda, Maryland [HL081593, HL177150, HL077149, HL077151, HL077154, HL081594, HL077358, HL077155, HL077153]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL077151, U01HL077358, U01HL077153, U01HL077149, U01HL081593, U01HL077155, U01HL081594, U01HL077154] Funding Source: NIH RePORTER	U.S. Department of Health and Human Service, Public Health Service, National Heart, Lung, and Blood Institute (NHLBI), Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Grant Support: By the U.S. Department of Health and Human Service, Public Health Service, National Heart, Lung, and Blood Institute (NHLBI), Bethesda, Maryland (grants HL081593, HL177150, HL077149, HL077151, HL077154, HL081594, HL077358, HL077155, and HL077153).	*AG HEALTHC RES QU, 2003, 68 AG HEALTHC RES QU; Blum A, 2005, THROMB HAEMOSTASIS, V93, P503, DOI 10.1160/TH04-08-0495; Bossuyt PM, 2003, ANN CLIN BIOCHEM, V40, P357, DOI 10.1258/000456303766476986; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; COWPER SE, 2001, NEPHROGENIC FIBROSIN; Eriksson BI, 2008, NEW ENGL J MED, V358, P2765, DOI 10.1056/NEJMoa0800374; Eriksson BI, 2007, LANCET, V370, P949, DOI 10.1016/S0140-6736(07)61445-7; Ersoy H, 2007, AM J ROENTGENOL, V188, P1246, DOI 10.2214/AJR.06.0901; Fisher L, 1993, BIOSTATISTICS METHOD, P206; Goodman LR, 2005, RADIOLOGY, V234, P654, DOI 10.1148/radiol.2343041326; GOTTSCHALK A, 1993, J NUCL MED, V34, P1119; Gottschalk A, 2002, SEMIN NUCL MED, V32, P173, DOI 10.1053/snuc.2002.124177; Gupta A, 1999, RADIOLOGY, V210, P353, DOI 10.1148/radiology.210.2.r99fe53353; Hadizadeh DR, 2008, RADIOLOGY, V249, P701, DOI 10.1148/radiol.2492072033; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Kluge A, 2006, AM J ROENTGENOL, V186, P1686, DOI 10.2214/AJR.05.0756; Kluge Alexander, 2006, AJR Am J Roentgenol, V187, pW7, DOI 10.2214/AJR.04.1814; Krishnam MS, 2008, INVEST RADIOL, V43, P411, DOI 10.1097/RLI.0b013e3181690179; LOUBEYRE P, 1994, AM J ROENTGENOL, V162, P1035, DOI 10.2214/ajr.162.5.8165977; Meaney JFM, 1997, NEW ENGL J MED, V336, P1422, DOI 10.1056/NEJM199705153362004; Ohno Y, 2004, AM J ROENTGENOL, V183, P91, DOI 10.2214/ajr.183.1.1830091; Oser RF, 1996, RADIOLOGY, V199, P31, DOI 10.1148/radiology.199.1.8633168; Planes A, 1996, LANCET, V348, P224, DOI 10.1016/S0140-6736(96)01453-5; Pleszewski B, 2006, CLIN IMAG, V30, P166, DOI 10.1016/j.clinimag.2005.10.005; QUINN MF, 1987, AM J ROENTGENOL, V149, P469, DOI 10.2214/ajr.149.3.469; Sampson FC, 2007, EUR RADIOL, V17, P175, DOI 10.1007/s00330-006-0178-5; Sanson BJ, 2000, THROMB HAEMOSTASIS, V83, P199; SHELLOCK FG, 2004, MANUAL MAGNETIC RESO; SIMEL DL, 1987, MED DECIS MAKING, V7, P107, DOI 10.1177/0272989X8700700208; Sostman HD, 2008, J NUCL MED, V49, P1741, DOI 10.2967/jnumed.108.052217; Sox HC, 2004, ANN INTERN MED, V140, P602, DOI 10.7326/0003-4819-140-8-200404200-00005; Stein PD, 2008, SEMIN NUCL MED, V38, P462, DOI 10.1053/j.semnuclmed.2008.06.003; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; Stein PD, 1997, CHEST, V111, P1246, DOI 10.1378/chest.111.5.1246; Turpie AGG, 2009, LANCET, V373, P1673, DOI 10.1016/S0140-6736(09)60734-0; *US FDA, 2006, INF HEALTHC PROF GAD; Wells PS, 1998, ANN INTERN MED, V129, P997, DOI 10.7326/0003-4819-129-12-199812150-00002; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010	39	254	273	1	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 6	2010	152	7					434	W143		10.7326/0003-4819-152-7-201004060-00008	http://dx.doi.org/10.7326/0003-4819-152-7-201004060-00008			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579QI	20368649	Green Accepted			2022-12-28	WOS:000276386900004
J	Narbonne, GM				Narbonne, Guy M.			Ocean Chemistry and Early Animals	SCIENCE			English	Editorial Material									Queens Univ, Dept Geol Sci & Geol Engn, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Narbonne, GM (corresponding author), Queens Univ, Dept Geol Sci & Geol Engn, Kingston, ON K7L 3N6, Canada.	narbonne@geol.queensu.ca	Narbonne, Guy M/I-7518-2012					Canfield DE, 2007, SCIENCE, V315, P92, DOI 10.1126/science.1135013; Canfield DE, 2008, SCIENCE, V321, P949, DOI 10.1126/science.1154499; Cohen PA, 2009, P NATL ACAD SCI USA, V106, P6519, DOI 10.1073/pnas.0902322106; Condon D, 2005, SCIENCE, V308, P95, DOI 10.1126/science.1107765; Fike DA, 2006, NATURE, V444, P744, DOI 10.1038/nature05345; Johnston DT, 2010, EARTH PLANET SC LETT, V290, P64, DOI 10.1016/j.epsl.2009.11.059; Laflamme M, 2009, P NATL ACAD SCI USA, V106, P14438, DOI 10.1073/pnas.0904836106; Li C, 2010, SCIENCE, V328, P80, DOI 10.1126/science.1182369; Narbonne GM, 2005, ANNU REV EARTH PL SC, V33, P421, DOI 10.1146/annurev.earth.33.092203.122519; Rothman DH, 2003, P NATL ACAD SCI USA, V100, P8124, DOI 10.1073/pnas.0832439100; Sperling EA, 2007, GEOL SOC SPEC PUBL, V286, P355, DOI 10.1144/SP286.25; Xiao SH, 2009, TRENDS ECOL EVOL, V24, P31, DOI 10.1016/j.tree.2008.07.015; Yin LM, 2007, NATURE, V446, P661, DOI 10.1038/nature05682	13	25	26	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 2	2010	328	5974					53	54		10.1126/science.1188688	http://dx.doi.org/10.1126/science.1188688			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577DR	20360098				2022-12-28	WOS:000276202200029
J	Klibanski, A				Klibanski, Anne			Prolactinomas	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TERM-FOLLOW-UP; VALVULAR HEART-DISEASE; SECRETING PITUITARY-ADENOMAS; CARDIAC-VALVE REGURGITATION; DOPAMINE AGONISTS; CABERGOLINE THERAPY; HYPERPROLACTINEMIC AMENORRHEA; TRANSSPHENOIDAL SURGERY; BROMOCRIPTINE; WITHDRAWAL	A 42-year-old man presents with decreased libido, erectile dysfunction, and headaches. He reports no weight change, gynecomastia, fatigue, or other symptoms. He takes no medications. Testicular size is decreased on examination. His prolactin level is 648 mu g per liter (normal value, <15). Magnetic resonance imaging (MRI) reveals a sellar mass (2.5 by 1.5 by 2.0 cm) that is 5 mm below the optic chiasm and that extends bilaterally into the cavernous sinuses. What are the diagnostic and therapeutic considerations?	[Klibanski, Anne] Massachusetts Gen Hosp, Neuroendocrine Unit, Boston, MA 02114 USA; [Klibanski, Anne] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Klibanski, A (corresponding author), Massachusetts Gen Hosp, Neuroendocrine Unit, 55 Fruit St,BUL457B, Boston, MA 02114 USA.	aklibanski@partners.org			Novartis; Pfizer	Novartis(Novartis); Pfizer(Pfizer)	Dr. Klibanski reports receiving grant support from Novartis and Pfizer. No other potential conflict of interest relevant to this article was reported.	Acharya SV, 2009, PITUITARY, V12, P186, DOI 10.1007/s11102-008-0149-8; Barker FG, 2003, J CLIN ENDOCR METAB, V88, P4709, DOI 10.1210/jc.2003-030461; BERGH T, 1985, ACTA ENDOCRINOL-COP, V110, P440, DOI 10.1530/acta.0.1100440; Biller BMK, 1996, J CLIN ENDOCR METAB, V81, P2338, DOI 10.1210/jc.81.6.2338; Biswas M, 2005, CLIN ENDOCRINOL, V63, P26, DOI 10.1111/j.1365-2265.2005.02293.x; Bogazzi F, 2008, J ENDOCRINOL INVEST, V31, P1119, DOI 10.1007/BF03345662; CARTER JN, 1978, NEW ENGL J MED, V299, P847, DOI 10.1056/NEJM197810192991602; Casanueva FF, 2006, CLIN ENDOCRINOL, V65, P265, DOI 10.1111/j.1365-2265.2006.02562.x; Colao A, 2003, NEW ENGL J MED, V349, P2023, DOI 10.1056/NEJMoa022657; Colao A, 1997, J CLIN ENDOCR METAB, V82, P876, DOI 10.1210/jc.82.3.876; Colao A, 2008, J CLIN ENDOCR METAB, V93, P3777, DOI 10.1210/jc.2007-1403; Colao A, 2008, CLIN ENDOCRINOL, V68, P66, DOI 10.1111/j.1365-2265.2007.03000.x; Colao A, 2007, CLIN ENDOCRINOL, V67, P426, DOI 10.1111/j.1365-2265.2007.02905.x; CORENBLUM B, 1993, FERTIL STERIL, V59, P671; Correll CU, 2006, J AM ACAD CHILD PSY, V45, P771, DOI 10.1097/01.chi.0000220851.94392.30; Dekkers OM, 2010, J CLIN ENDOCR METAB, V95, P43, DOI 10.1210/jc.2009-1238; Di Sarno A, 2001, J CLIN ENDOCR METAB, V86, P5256, DOI 10.1210/jc.86.11.5256; Gibney J, 2005, J CLIN ENDOCR METAB, V90, P3927, DOI 10.1210/jc.2004-2234; GREENSPAN SL, 1986, ANN INTERN MED, V104, P777, DOI 10.7326/0003-4819-104-6-777; Herring N, 2009, CLIN ENDOCRINOL, V70, P104, DOI 10.1111/j.1365-2265.2008.03458.x; Jeffcoate WJ, 1996, CLIN ENDOCRINOL, V45, P299, DOI 10.1046/j.1365-2265.1996.00824.x; Jezkova J, 2009, CLIN ENDOCRINOL, V70, P732, DOI 10.1111/j.1365-2265.2008.03384.x; Karunakaran S, 2001, CLIN ENDOCRINOL, V54, P295, DOI 10.1046/j.1365-2265.2001.01190.x; Kinon BJ, 2003, PSYCHONEUROENDOCRINO, V28, P55, DOI 10.1016/S0306-4530(02)00127-0; KLIBANSKI A, 1988, J CLIN ENDOCR METAB, V67, P124, DOI 10.1210/jcem-67-1-124; KLIBANSKI A, 1986, NEW ENGL J MED, V315, P542, DOI 10.1056/NEJM198608283150903; KRUPP P, 1987, KLIN WOCHENSCHR, V65, P823, DOI 10.1007/BF01727477; MARCH CM, 1981, AM J OBSTET GYNECOL, V139, P835, DOI 10.1016/0002-9378(81)90553-6; Melmed S., 2002, PITUITARY; MOLITCH ME, 1985, NEW ENGL J MED, V312, P1364, DOI 10.1056/NEJM198505233122106; Molitch ME, 2005, MAYO CLIN PROC, V80, P1050, DOI 10.4065/80.8.1050; MOLITCH ME, 1985, J CLIN ENDOCR METAB, V60, P698, DOI 10.1210/jcem-60-4-698; MORI H, 1985, CANCER, V56, P230, DOI 10.1002/1097-0142(19850715)56:2<230::AID-CNCR2820560204>3.0.CO;2-8; Nachtigall LB, 2010, CLIN ENDOCRINOL, V72, P53, DOI 10.1111/j.1365-2265.2009.03608.x; NUNLEY WC, 1991, J CLIN ENDOCR METAB, V72, P287, DOI 10.1210/jcem-72-2-287; Passos VQ, 2002, J CLIN ENDOCR METAB, V87, P3578, DOI 10.1210/jc.87.8.3578; RASMUSSEN C, 1985, FERTIL STERIL, V44, P31; REDFIELD MM, 1992, ANN INTERN MED, V117, P50, DOI 10.7326/0003-4819-117-1-50; Roth BL, 2007, NEW ENGL J MED, V356, P6, DOI 10.1056/NEJMp068265; Schade R, 2007, NEW ENGL J MED, V356, P29, DOI 10.1056/NEJMoa062222; SCHLECHTE J, 1989, J CLIN ENDOCR METAB, V68, P412, DOI 10.1210/jcem-68-2-412; SERRI O, 1983, NEW ENGL J MED, V309, P280, DOI 10.1056/NEJM198308043090505; StJean E, 1996, CLIN ENDOCRINOL, V44, P305, DOI 10.1046/j.1365-2265.1996.663486.x; Thomson JA, 2002, NEUROSURGERY, V50, P36, DOI 10.1097/00006123-200201000-00007; VALASSI E, 2010, J CLIN ENDOCRIN 0203; Verhelst J, 1999, J CLIN ENDOCR METAB, V84, P2518, DOI 10.1210/jc.84.7.2518; Vestergaard P, 2002, CLIN ENDOCRINOL, V56, P159, DOI 10.1046/j.0300-0664.2001.01464.x; WEBSTER J, 1994, NEW ENGL J MED, V331, P904, DOI 10.1056/NEJM199410063311403; Zanettini R, 2007, NEW ENGL J MED, V356, P39, DOI 10.1056/NEJMoa054830; 1983, FERTIL STERIL, V39, P753	50	141	151	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 1	2010	362	13					1219	1226		10.1056/NEJMcp0912025	http://dx.doi.org/10.1056/NEJMcp0912025			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	577QQ	20357284				2022-12-28	WOS:000276239500012
J	Sigurdsson, T; Stark, KL; Karayiorgou, M; Gogos, JA; Gordon, JA				Sigurdsson, Torfi; Stark, Kimberly L.; Karayiorgou, Maria; Gogos, Joseph A.; Gordon, Joshua A.			Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia	NATURE			English	Article							22Q11 DELETION SYNDROME; FUNCTIONAL CONNECTIVITY; WORKING-MEMORY; DEFICITS; CONTRIBUTES; MECHANISMS; CHILDREN; CORTEX; RISK	Abnormalities in functional connectivity between brain areas have been postulated as an important pathophysiological mechanism underlying schizophrenia(1,2). In particular, macroscopic measurements of brain activity in patients suggest that functional connectivity between the frontal and temporal lobes may be altered(3,4). However, it remains unclear whether such dysconnectivity relates to the aetiology of the illness, and how it is manifested in the activity of neural circuits. Because schizophrenia has a strong genetic component(5), animal models of genetic risk factors are likely to aid our understanding of the pathogenesis and pathophysiology of the disease. Here we study Df(16)A(+/-) mice, which model a microdeletion on human chromosome 22 (22q11.2) that constitutes one of the largest known genetic risk factors for schizophrenia(6). To examine functional connectivity in these mice, we measured the synchronization of neural activity between the hippocampus and the prefrontal cortex during the performance of a task requiring working memory, which is one of the cognitive functions disrupted in the disease. In wild-type mice, hippocampal-prefrontal synchrony increased during working memory performance, consistent with previous reports in rats(7). Df(16)A(+/-) mice, which are impaired in the acquisition of the task, showed drastically reduced synchrony, measured both by phase-locking of prefrontal cells to hippocampal theta oscillations and by coherence of prefrontal and hippocampal local field potentials. Furthermore, the magnitude of hippocampal-prefrontal coherence at the onset of training could be used to predict the time it took the Df(16)A(+/-) mice to learn the task and increased more slowly during task acquisition. These data suggest how the deficits in functional connectivity observed in patients with schizophrenia may be realized at the single-neuron level. Our findings further suggest that impaired long-range synchrony of neural activity is one consequence of the 22q11.2 deletion and may be a fundamental component of the pathophysiology underlying schizophrenia.	[Sigurdsson, Torfi; Stark, Kimberly L.; Karayiorgou, Maria; Gordon, Joshua A.] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Stark, Kimberly L.; Gogos, Joseph A.] Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Gogos, Joseph A.] Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA; [Karayiorgou, Maria; Gordon, Joshua A.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute	Gordon, JA (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA.	jag90@columbia.edu; jg343@columbia.edu	Gordon, Joshua A/E-6778-2012	Gordon, Joshua A/0000-0002-5488-8266	Simons Foundation; US National Institute of Mental Health [MH67068, MH081968]; Lieber Center for Schizophrenia Research and Treatment; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067068, R01MH081968] Funding Source: NIH RePORTER	Simons Foundation; US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Lieber Center for Schizophrenia Research and Treatment; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank M. Topiwala, A. Adhikari and Y. Sun for technical assistance. We also thank A. Adhikari, L. Drew and A. Arguello for comments on the manuscript. This work was supported by the Simons Foundation (J. A. Gogos), US National Institute of Mental Health grants MH67068 (M. K. and J. A. Gogos) and MH081968 (J. A. Gordon), and the Lieber Center for Schizophrenia Research and Treatment.	Bertolino A, 2006, BIOL PSYCHIAT, V60, P1250, DOI 10.1016/j.biopsych.2006.03.078; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; Esslinger C, 2009, SCIENCE, V324, P605, DOI 10.1126/science.1167768; Floresco SB, 1997, J NEUROSCI, V17, P1880; Forbes NF, 2009, PSYCHOL MED, V39, P889, DOI 10.1017/S0033291708004558; Ford JM, 2002, BIOL PSYCHIAT, V51, P485, DOI 10.1016/S0006-3223(01)01335-X; GOTTESMAN II, 1967, P NATL ACAD SCI USA, V58, P199, DOI 10.1073/pnas.58.1.199; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Karayiorgou M, 2004, MOL BRAIN RES, V132, P95, DOI 10.1016/j.molbrainres.2004.09.029; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Kates WR, 2007, NEUROPSYCHOLOGIA, V45, P2863, DOI 10.1016/j.neuropsychologia.2007.05.007; Kelly RC, 2007, J NEUROSCI, V27, P261, DOI 10.1523/JNEUROSCI.4906-06.2007; Lawrie SM, 2002, BIOL PSYCHIAT, V51, P1008, DOI 10.1016/S0006-3223(02)01316-1; Lewandowski KE, 2007, AM J MED GENET B, V144B, P27, DOI 10.1002/ajmg.b.30379; Liu H, 2002, P NATL ACAD SCI USA, V99, P16859, DOI 10.1073/pnas.232186099; Meyer-Lindenberg AS, 2005, ARCH GEN PSYCHIAT, V62, P379, DOI 10.1001/archpsyc.62.4.379; Mukai J, 2004, NAT GENET, V36, P725, DOI 10.1038/ng1375; Mukai J, 2008, NAT NEUROSCI, V11, P1302, DOI 10.1038/nn.2204; Paterlini M, 2005, NAT NEUROSCI, V8, P1586, DOI 10.1038/nn1562; Raux G, 2007, HUM MOL GENET, V16, P83, DOI 10.1093/hmg/ddl443; Schroll S, 2005, REGUL PEPTIDES, V131, P1, DOI 10.1016/j.regpep.2005.03.001; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sobin C, 2005, CHILD NEUROPSYCHOL, V11, P39, DOI 10.1080/09297040590911167; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stephan KE, 2009, SCHIZOPHRENIA BULL, V35, P509, DOI 10.1093/schbul/sbn176; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; WERNICKE C, 1906, GRUNDRISSE PSYCHIAT; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Yavich L, 2007, J NEUROSCI, V27, P10196, DOI 10.1523/JNEUROSCI.0665-07.2007	30	463	468	1	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 1	2010	464	7289					763	U139		10.1038/nature08855	http://dx.doi.org/10.1038/nature08855			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577EO	20360742	Green Accepted			2022-12-28	WOS:000276205000046
J	Walker, MM; Diebel, CE; Haugh, CV; Pankhurst, PM; Montgomery, JC; Green, CR				Walker, MM; Diebel, CE; Haugh, CV; Pankhurst, PM; Montgomery, JC; Green, CR			Structure and function of the vertebrate magnetic sense	NATURE			English	Article							GEOMAGNETIC-FIELD; HOMING PIGEONS; BEHAVIORAL EVIDENCE; BIOGENIC MAGNETITE; ATMOSPHERIC ODORS; MIGRATORY BIRDS; SOCKEYE SALMON; HONEYBEES; MAGNETORECEPTION; DISCRIMINATION	Some vertebrates can navigate over long distances using the Earth's magnetic field, but the sensory system that they use to do so has remained a mystery. Here we describe the key components of a magnetic sense underpinning this navigational ability in a single species, the rainbow trout (Oncorhynchus mykiss), We report behavioural and electrophysiological responses to magnetic fields and identify an area in the nose of the trout where candidate magnetoreceptor cells are located. We have tracked the sensory pathway from these newly identified candidate magnetoreceptor cells to the brain and associated the system with a learned response to magnetic fields.	UNIV AUCKLAND,SCH MED,DEPT ANAT RADIOL,AUCKLAND,NEW ZEALAND	University of Auckland	Walker, MM (corresponding author), UNIV AUCKLAND,SCH BIOL SCI,EXPT BIOL RES GRP,PRIVATE BAG 92019,AUCKLAND 1,NEW ZEALAND.		Green, Colin R/B-5663-2012; Montgomery, John C/D-4310-2009	Green, Colin R/0000-0003-3459-6298; Montgomery, John C/0000-0002-7451-3541; Walker, Michael/0000-0001-9631-9128				BEASON RC, 1995, J EXP BIOL, V198, P141; Beason RC, 1996, J EXP BIOL, V199, P1241; BENVENUTI S, 1985, J COMP PHYSIOL A, V156, P737, DOI 10.1007/BF00610827; BLAKEMORE R, 1975, SCIENCE, V190, P377, DOI 10.1126/science.170679; CARMAN GJ, 1987, ANIM LEARN BEHAV, V15, P124, DOI 10.3758/BF03204957; GOULD JL, 1978, SCIENCE, V201, P1026, DOI 10.1126/science.201.4360.1026; KALMIJN AJ, 1981, IEEE T MAGN, V17, P1113, DOI 10.1109/TMAG.1981.1061156; KIRSCHVINK JL, 1989, BIOELECTROMAGNETICS, V10, P239, DOI 10.1002/bem.2250100304; KIRSCHVINK JL, 1981, BIOSYSTEMS, V13, P181, DOI 10.1016/0303-2647(81)90060-5; KIRSCHVINK JL, 1986, J EXP BIOL, V120, P1; KIRSCHVINK JL, 1985, MAGNETITE BIOMINERAL, P243; KREITHEN ML, 1974, J COMP PHYSIOL, V91, P355, DOI 10.1007/BF00694466; LEASK MJM, 1977, NATURE, V267, P144, DOI 10.1038/267144a0; Lohmann KJ, 1996, NATURE, V380, P59, DOI 10.1038/380059a0; LOHMANN KJ, 1995, J EXP BIOL, V198, P2041; MANN S, 1988, J EXP BIOL, V140, P35; MOENCH TT, 1978, ARCH MICROBIOL, V119, P203, DOI 10.1007/BF00964274; MOORE A, 1990, PHILOS T ROY SOC B, V329, P11, DOI 10.1098/rstb.1990.0145; PAPI F, 1989, ETHOL ECOL EVOL, V1, P219, DOI 10.1080/08927014.1989.9525511; PHILLIPS JB, 1992, NATURE, V359, P142, DOI 10.1038/359142a0; PUZDROWSKI RL, 1988, J MORPHOL, V198, P131, DOI 10.1002/jmor.1051980202; QUINN TP, 1981, J EXP ZOOL, V217, P137, DOI 10.1002/jez.1402170114; SEMM P, 1990, BRAIN RES BULL, V25, P735, DOI 10.1016/0361-9230(90)90051-Z; Sidman M., 1960, TACTICS SCI RES; WALCOTT C, 1979, SCIENCE, V205, P1027, DOI 10.1126/science.472725; WALCOTT C, 1980, IEEE T MAGN, V16, P1008, DOI 10.1109/TMAG.1980.1060868; WALKER MM, 1989, J COMP PSYCHOL, V103, P62; WALKER MM, 1984, J COMP PHYSIOL, V155, P673, DOI 10.1007/BF00610853; WALKER MM, 1989, J EXP BIOL, V145, P489; WALKER MM, 1992, J EXP BIOL, V171, P67; WALKER MM, 1985, J COMP PHYSIOL A, V157, P67, DOI 10.1007/BF00611096; WALKER MM, 1989, J EXP BIOL, V141, P447; WALLRAFF HG, 1983, COMP BIOCHEM PHYS A, V76, P643, DOI 10.1016/0300-9629(83)90126-3; Wiltschko R., 1995, TIEROSYCHOL; WILTSCHKO W, 1994, EXPERIENTIA, V50, P697, DOI 10.1007/BF01952877; WOODARD WT, 1974, BEHAV RES METH INSTR, V6, P389, DOI 10.3758/BF03200385; YORKE ED, 1979, J THEOR BIOL, V89, P533	37	316	330	4	171	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	NOV 27	1997	390	6658					371	376		10.1038/37057	http://dx.doi.org/10.1038/37057			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YH549	20358649				2022-12-28	WOS:A1997YH54900053
J	Nattinger, AB				Nattinger, A. B.			In the Clinic: Breast Cancer Screening and Prevention (vol 152, ITC4-2, 2010)	ANNALS OF INTERNAL MEDICINE			English	Correction														Nattinger, Ann/0000-0002-8189-3300				Nattinger AB, 2010, ANN INTERN MED, V152, P832, DOI [10.7326/0003-4819-152-12-201006150-00027, 10.7326/0003-4819-152-7-201004060-01004]	1	10	10	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 15	2010	152	12					832	832		10.7326/0003-4819-152-12-201006150-00027	http://dx.doi.org/10.7326/0003-4819-152-12-201006150-00027			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611OP	20368645				2022-12-28	WOS:000278827700022
J	Muirhead, N				Muirhead, Norman			Update in Nephrology	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CHRONIC KIDNEY-DISEASE; ANEMIA		[Muirhead, Norman] Univ Western Ontario, London, ON N6A 5A5, Canada	Western University (University of Western Ontario)	Muirhead, N (corresponding author), Univ Western Ontario, Univ Hosp, London Hlth Sci Ctr, 339 Windermere Rd, London, ON N6A 5A5, Canada.	norman.muirhead@lhsc.on.ca	Muirhead, Norman/G-3337-2011					Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Kovesdy CP, 2009, NEPHROL DIAL TRANSPL, V24, P1232, DOI 10.1093/ndt/gfn633; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545	4	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 1	2010	152	11					721	725		10.7326/0003-4819-152-11-201006010-00243	http://dx.doi.org/10.7326/0003-4819-152-11-201006010-00243			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608CT	20410450				2022-12-28	WOS:000278560000005
J	Abdo, AA; Ackermann, M; Ajello, M; Atwood, WB; Baldini, L; Ballet, J; Barbiellini, G; Bastieri, D; Baughman, BM; Bechtol, K; Bellazzini, R; Berenji, B; Blandford, RD; Bloom, ED; Bonamente, E; Borgland, AW; Bregeon, J; Brez, A; Brigida, M; Bruel, P; Burnett, TH; Buson, S; Caliandro, GA; Cameron, RA; Caraveo, PA; Casandjian, JM; Cavazzuti, E; Cecchi, C; Celik, O; Chekhtman, A; Cheung, CC; Chiang, J; Ciprini, S; Claus, R; Cohen-Tanugi, J; Colafrancesco, S; Cominsky, LR; Conrad, J; Costamante, L; Cutini, S; Davis, DS; Dermer, CD; de Angelis, A; de Palma, F; Digel, SW; Silva, EDE; Drell, PS; Dubois, R; Dumora, D; Famier, C; Favuzzi, C; Fegan, SJ; Finke, J; Focke, WB; Fortin, P; Fukazawa, Y; Funk, S; Fusco, P; Gargano, F; Gasparrini, D; Gehrels, N; Georganopoulos, M; Germani, S; Giebels, B; Giglietto, N; Giordano, F; Giroletti, M; Glanzman, T; Godfrey, G; Grenier, IA; Grove, JE; Guillemot, L; Guiriec, S; Hanabata, Y; Harding, AK; Hayashida, M; Hays, E; Hughes, RE; Jackson, MS; Johannesson, G; Johnson, AS; Johnson, TJ; Johnson, WN; Kamae, T; Katagiri, H; Kataoka, J; Kawai, N; Kerr, M; Knodlseder, J; Kocian, ML; Kuss, M; Lande, J; Latronico, L; Lemoine-Goumard, M; Longo, F; Loparco, F; Lott, B; Lovellette, MN; Lubrano, P; Madejski, GM; Makeev, A; Mazziotta, MN; McConville, W; McEnery, JE; Meurer, C; Michelson, PF; Mitthumsiri, W; Mizuno, T; Moiseev, AA; Monte, C; Monzani, ME; Morselli, A; Moskalenko, IV; Murgia, S; Nolan, PL; Norris, JP; Nuss, E; Ohsugi, T; Omodei, N; Orlando, E; Ormes, JF; Paneque, D; Parent, D; Pelassa, V; Pepe, M; Pesce-Rollins, M; Piron, F; Porter, TA; Raino, S; Rando, R; Razzano, M; Razzaque, S; Reimer, A; Reimer, O; Reposeur, T; Ritz, S; Rochester, S; Rodriguez, AY; Romani, RW; Roth, M; Ryde, F; Sadrozinski, HFW; Sambruna, R; Sanchez, D; Sander, A; Parkinson, PMS; Scargle, JD; Sgro, C; Siskind, EJ; Smith, DA; Smith, PD; Spandre, G; Spinelli, P; Starck, JL; Stawarz, L; Strickman, MS; Suson, DJ; Tajima, H; Takahashi, H; Takahashi, T; Tanaka, T; Thayer, JB; Thayer, JG; Thompson, DJ; Tibaldo, L; Torres, DF; Tosti, G; Tramacere, A; Uchiyama, Y; Usher, TL; Vasileiou, V; Vilchez, N; Vitale, V; Waite, AP; Wallace, E; Wang, P; Winer, BL; Wood, KS; Ylinen, T; Ziegler, M; Hardcastle, MJ; Kazanas, D				Abdo, A. A.; Ackermann, M.; Ajello, M.; Atwood, W. B.; Baldini, L.; Ballet, J.; Barbiellini, G.; Bastieri, D.; Baughman, B. M.; Bechtol, K.; Bellazzini, R.; Berenji, B.; Blandford, R. D.; Bloom, E. D.; Bonamente, E.; Borgland, A. W.; Bregeon, J.; Brez, A.; Brigida, M.; Bruel, P.; Burnett, T. H.; Buson, S.; Caliandro, G. A.; Cameron, R. A.; Caraveo, P. A.; Casandjian, J. M.; Cavazzuti, E.; Cecchi, C.; Celik, Oe; Chekhtman, A.; Cheung, C. C.; Chiang, J.; Ciprini, S.; Claus, R.; Cohen-Tanugi, J.; Colafrancesco, S.; Cominsky, L. R.; Conrad, J.; Costamante, L.; Cutini, S.; Davis, D. S.; Dermer, C. D.; de Angelis, A.; de Palma, F.; Digel, S. W.; do Couto e Silva, E.; Drell, P. S.; Dubois, R.; Dumora, D.; Famier, C.; Favuzzi, C.; Fegan, S. J.; Finke, J.; Focke, W. B.; Fortin, P.; Fukazawa, Y.; Funk, S.; Fusco, P.; Gargano, F.; Gasparrini, D.; Gehrels, N.; Georganopoulos, M.; Germani, S.; Giebels, B.; Giglietto, N.; Giordano, F.; Giroletti, M.; Glanzman, T.; Godfrey, G.; Grenier, I. A.; Grove, J. E.; Guillemot, L.; Guiriec, S.; Hanabata, Y.; Harding, A. K.; Hayashida, M.; Hays, E.; Hughes, R. E.; Jackson, M. S.; Johannesson, G.; Johnson, A. S.; Johnson, T. J.; Johnson, W. N.; Kamae, T.; Katagiri, H.; Kataoka, J.; Kawai, N.; Kerr, M.; Knoedlseder, J.; Kocian, M. L.; Kuss, M.; Lande, J.; Latronico, L.; Lemoine-Goumard, M.; Longo, F.; Loparco, F.; Lott, B.; Lovellette, M. N.; Lubrano, P.; Madejski, G. M.; Makeev, A.; Mazziotta, M. N.; McConville, W.; McEnery, J. E.; Meurer, C.; Michelson, P. F.; Mitthumsiri, W.; Mizuno, T.; Moiseev, A. A.; Monte, C.; Monzani, M. E.; Morselli, A.; Moskalenko, I. V.; Murgia, S.; Nolan, P. L.; Norris, J. P.; Nuss, E.; Ohsugi, T.; Omodei, N.; Orlando, E.; Ormes, J. F.; Paneque, D.; Parent, D.; Pelassa, V.; Pepe, M.; Pesce-Rollins, M.; Piron, F.; Porter, T. A.; Raino, S.; Rando, R.; Razzano, M.; Razzaque, S.; Reimer, A.; Reimer, O.; Reposeur, T.; Ritz, S.; Rochester, S.; Rodriguez, A. Y.; Romani, R. W.; Roth, M.; Ryde, F.; Sadrozinski, H. F. -W.; Sambruna, R.; Sanchez, D.; Sander, A.; Parkinson, P. M. Saz; Scargle, J. D.; Sgro, C.; Siskind, E. J.; Smith, D. A.; Smith, P. D.; Spandre, G.; Spinelli, P.; Starck, J. -L.; Stawarz, L.; Strickman, M. S.; Suson, D. J.; Tajima, H.; Takahashi, H.; Takahashi, T.; Tanaka, T.; Thayer, J. B.; Thayer, J. G.; Thompson, D. J.; Tibaldo, L.; Torres, D. F.; Tosti, G.; Tramacere, A.; Uchiyama, Y.; Usher, T. L.; Vasileiou, V.; Vilchez, N.; Vitale, V.; Waite, A. P.; Wallace, E.; Wang, P.; Winer, B. L.; Wood, K. S.; Ylinen, T.; Ziegler, M.; Hardcastle, M. J.; Kazanas, D.		Fermi-LAT Collaboration	Fermi Gamma-Ray Imaging of a Radio Galaxy	SCIENCE			English	Article							ENERGY PARTICLE-ACCELERATION; X-RAY; SYNCHROTRON RADIATION; CENTAURUS-A; LOBES; EMISSION; ELECTRONS; DISCOVERY	The Fermi Gamma-ray Space Telescope has detected the gamma-ray glow emanating from the giant radio lobes of the radio galaxy Centaurus A. The resolved gamma-ray image shows the lobes clearly separated from the central active source. In contrast to all other active galaxies detected so far in high-energy gamma-rays, the lobe flux constitutes a considerable portion (greater than one-half) of the total source emission. The gamma-ray emission from the lobes is interpreted as inverse Compton-scattered relic radiation from the cosmic microwave background, with additional contribution at higher energies from the infrared-to-optical extragalactic background light. These measurements provide gamma-ray constraints on the magnetic field and particle energy content in radio galaxy lobes, as well as a promising method to probe the cosmic relic photon fields.	[Abdo, A. A.; Chekhtman, A.; Cheung, C. C.; Dermer, C. D.; Finke, J.; Grove, J. E.; Johnson, W. N.; Lovellette, M. N.; Makeev, A.; Razzaque, S.; Strickman, M. S.; Wood, K. S.] USN, Res Lab, Div Space Sci, Washington, DC 20375 USA; [Abdo, A. A.; Cheung, C. C.; Finke, J.; Razzaque, S.] Natl Acad Sci, Natl Res Council Res Associate, Washington, DC 20001 USA; [Ackermann, M.; Ajello, M.; Bechtol, K.; Berenji, B.; Blandford, R. D.; Bloom, E. D.; Borgland, A. W.; Cameron, R. A.; Chiang, J.; Claus, R.; Costamante, L.; Digel, S. W.; do Couto e Silva, E.; Drell, P. S.; Dubois, R.; Focke, W. B.; Funk, S.; Glanzman, T.; Godfrey, G.; Hayashida, M.; Johannesson, G.; Johnson, A. S.; Kamae, T.; Kocian, M. L.; Lande, J.; Madejski, G. M.; Michelson, P. F.; Mitthumsiri, W.; Monzani, M. E.; Moskalenko, I. V.; Murgia, S.; Nolan, P. L.; Paneque, D.; Reimer, A.; Reimer, O.; Rochester, S.; Romani, R. W.; Stawarz, L.; Tajima, H.; Tanaka, T.; Thayer, J. B.; Thayer, J. G.; Tramacere, A.; Uchiyama, Y.; Usher, T. L.; Waite, A. P.; Wang, P.] Stanford Univ, SLAC Natl Accelerator Lab, Stanford, CA 94305 USA; [Ackermann, M.; Ajello, M.; Bechtol, K.; Berenji, B.; Blandford, R. D.; Bloom, E. D.; Borgland, A. W.; Cameron, R. A.; Chiang, J.; Claus, R.; Costamante, L.; Digel, S. W.; do Couto e Silva, E.; Drell, P. S.; Dubois, R.; Focke, W. B.; Funk, S.; Glanzman, T.; Godfrey, G.; Hayashida, M.; Johannesson, G.; Johnson, A. S.; Kamae, T.; Kocian, M. L.; Lande, J.; Madejski, G. M.; Michelson, P. F.; Mitthumsiri, W.; Monzani, M. E.; Moskalenko, I. V.; Murgia, S.; Nolan, P. L.; Paneque, D.; Reimer, A.; Reimer, O.; Rochester, S.; Romani, R. W.; Stawarz, L.; Tajima, H.; Tanaka, T.; Thayer, J. B.; Thayer, J. G.; Tramacere, A.; Uchiyama, Y.; Usher, T. L.; Waite, A. P.; Wang, P.] Stanford Univ, WW Hansen Expt Phys Lab, Kavli Inst Particle Astrophys & Cosmol, Dept Phys, Stanford, CA 94305 USA; [Atwood, W. B.; Porter, T. A.; Ritz, S.; Sadrozinski, H. F. -W.; Parkinson, P. M. Saz; Ziegler, M.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Atwood, W. B.; Porter, T. A.; Ritz, S.; Sadrozinski, H. F. -W.; Parkinson, P. M. Saz; Ziegler, M.] Univ Calif Santa Cruz, Dept Phys, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Baldini, L.; Bellazzini, R.; Bregeon, J.; Brez, A.; Kuss, M.; Latronico, L.; Omodei, N.; Pesce-Rollins, M.; Razzano, M.; Sgro, C.; Spandre, G.] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy; [Ballet, J.; Casandjian, J. M.; Grenier, I. A.; Starck, J. -L.; Tibaldo, L.] Univ Paris Diderot, Lab AIM, CEA Saclay, CEA IRFU,CNRS,Serv Astrophys, F-91191 Gif Sur Yvette, France; [Barbiellini, G.; Longo, F.] Ist Nazl Fis Nucl, Sez Trieste, I-34127 Trieste, Italy; [Barbiellini, G.; Longo, F.] Univ Trieste, Dipartimento Fis, I-34127 Trieste, Italy; [Bastieri, D.; Rando, R.; Tibaldo, L.] Univ Trieste, Sez Padova, I-35131 Padua, Italy; [Bastieri, D.; Buson, S.; Rando, R.; Tibaldo, L.] Univ Padua, Dipartimento Fis G Galilei, I-35131 Padua, Italy; [Baughman, B. M.; Hughes, R. E.; Sander, A.; Smith, P. D.; Winer, B. L.] Ohio State Univ, Dept Phys, Ctr Cosmol & Astroparticle Phys, Columbus, OH 43210 USA; [Bonamente, E.; Cecchi, C.; Germani, S.; Lubrano, P.; Pepe, M.; Tosti, G.] Ist Nazl Fis Nucl, Sez Perugia, I-06123 Perugia, Italy; [Bonamente, E.; Cecchi, C.; Ciprini, S.; Germani, S.; Lubrano, P.; Pepe, M.; Tosti, G.] Univ Perugia, Dipartimento Fis, I-06123 Perugia, Italy; [Brigida, M.; de Palma, F.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Monte, C.; Raino, S.; Spinelli, P.] Politecn Bari, I-70126 Bari, Italy; [Brigida, M.; de Palma, F.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Monte, C.; Raino, S.; Spinelli, P.] Univ Bari, Dipartimento Fis M Merlin, I-70126 Bari, Italy; [Brigida, M.; de Palma, F.; Favuzzi, C.; Fusco, P.; Gargano, F.; Giglietto, N.; Giordano, F.; Loparco, F.; Mazziotta, M. N.; Monte, C.; Raino, S.; Spinelli, P.] Ist Nazl Fis Nucl, Sez Bari, I-70126 Bari, Italy; [Bruel, P.; Fegan, S. J.; Fortin, P.; Giebels, B.; Sanchez, D.] Ecole Polytech, CNRS, IN2P3, Lab Leprince Ringuet, F-91128 Palaiseau, France; [Burnett, T. H.; Kerr, M.; Roth, M.; Wallace, E.] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Caliandro, G. A.; Rodriguez, A. Y.; Torres, D. F.] Inst Ciencies Espai IEEC CSIC, Barcelona 08193, Spain; [Caraveo, P. A.] Ist Astrofis Spaziale & Fis Cosm, INAF, I-20133 Milan, Italy; [Cavazzuti, E.; Colafrancesco, S.; Cutini, S.; Gasparrini, D.] Agenzia Spaziale Italiana Sci Data Ctr, I-00044 Frascati, Roma, Italy; [Celik, Oe; Cheung, C. C.; Davis, D. S.; Gehrels, N.; Harding, A. K.; Hays, E.; Johnson, T. J.; McConville, W.; McEnery, J. E.; Moiseev, A. A.; Sambruna, R.; Thompson, D. J.; Vasileiou, V.; Kazanas, D.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Celik, Oe; Moiseev, A. A.; Vasileiou, V.] Ctr Res & Explorat Space Sci & Technol, Greenbelt, MD 20771 USA; [Celik, Oe; Davis, D. S.; Georganopoulos, M.; Vasileiou, V.] Univ Maryland Baltimore Cty, Dept Phys, Baltimore, MD 21250 USA; [Celik, Oe; Davis, D. S.; Georganopoulos, M.; Vasileiou, V.] Univ Maryland Baltimore Cty, Ctr Space Sci & Technol, Baltimore, MD 21250 USA; [Chekhtman, A.; Makeev, A.] George Mason Univ, Fairfax, VA 22030 USA; [Cohen-Tanugi, J.; Famier, C.; Nuss, E.; Pelassa, V.; Piron, F.] Univ Montpellier 2, CNRS, IN2P3, Lab Phys Theor & Astroparticules, Montpellier, France; [Cominsky, L. R.] Sonoma State Univ, Dept Phys & Astron, Rohnert Pk, CA 94928 USA; [Conrad, J.; Meurer, C.] Stockholm Univ, Dept Phys, SE-10691 Stockholm, Sweden; [Conrad, J.; Jackson, M. S.; Meurer, C.; Ryde, F.; Ylinen, T.] Oskar Klein Ctr Cosmoparticle Phys, SE-10691 Stockholm, Sweden; [de Angelis, A.] Univ Udine, Dipartimento Fis, I-33100 Udine, Italy; [de Angelis, A.] Ist Nazl Fis Nucl, Sez Trieste, Grp Collegato Udine, I-33100 Udine, Italy; [Dumora, D.; Lemoine-Goumard, M.; Lott, B.; Parent, D.; Reposeur, T.; Smith, D. A.] Univ Bordeaux, UMR 5797, Ctr Etud Nucl Bordeaux Gradignan, F-33175 Gradignan, France; [Dumora, D.; Lemoine-Goumard, M.; Lott, B.; Parent, D.; Reposeur, T.; Smith, D. A.] Ctr Etud Nucl Bordeaux Gradignan, UMR 5797, CNRS, IN2P3, F-33175 Gradignan, France; [Fukazawa, Y.; Katagiri, H.; Mizuno, T.; Ohsugi, T.; Takahashi, H.] Hiroshima Univ, Dept Phys Sci, Hiroshima 7398526, Japan; [Gehrels, N.] Penn State Univ, Dept Astron & Astrophys, University Pk, PA 16802 USA; [Gehrels, N.; Johnson, T. J.; McConville, W.; McEnery, J. E.; Moiseev, A. A.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Gehrels, N.; Johnson, T. J.; McConville, W.; McEnery, J. E.; Moiseev, A. A.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Giroletti, M.] INAF Ist Radioastron, I-40129 Bologna, Italy; [Guillemot, L.] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Guiriec, S.; Hanabata, Y.] Univ Alabama, Ctr Space Plasma & Aeron Res, Huntsville, AL 35899 USA; [Jackson, M. S.; Ryde, F.; Ylinen, T.] Royal Inst Technol, Dept Phys, SE-10691 Stockholm, Sweden; [Kataoka, J.] Waseda Univ, Shinjuku Ku, Tokyo 1698050, Japan; [Kawai, N.] Tokyo Inst Technol, Dept Phys, Meguro, Tokyo 1528551, Japan; [Kawai, N.] RIKEN, Inst Phys & Chem Res, Cosm Radiat Lab, Wako, Saitama 3510198, Japan; [Knoedlseder, J.; Vilchez, N.] UPS, CNRS, Ctr Etud Spatiale Rayonnements, F-31028 Toulouse 4, France; [Morselli, A.; Vitale, V.] Ist Nazl Fis Nucl, Sez Roma Tor Vergata, I-00133 Rome, Italy; [Norris, J. P.; Ormes, J. F.] Univ Denver, Dept Phys & Astron, Denver, CO 80208 USA; [Orlando, E.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Reimer, A.; Reimer, O.] Leopold Franzens Univ Innsbruck, Inst Astro & Teilchenphys, A-6020 Innsbruck, Austria; [Reimer, A.; Reimer, O.] Leopold Franzens Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria; [Scargle, J. D.] NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA; [Siskind, E. J.] NYCB Real Time Comp, Lattingtown, NY 11560 USA; [Stawarz, L.] Jagiellonian Univ, Astron Observ, PL-30244 Krakow, Poland; [Suson, D. J.] Purdue Univ Calumet, Dept Chem & Phys, Hammond, IN 46323 USA; [Takahashi, T.] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan; [Torres, D. F.] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; [Tramacere, A.] Consorzio Interuniv Fis Spaziale, I-10133 Turin, Italy; [Vitale, V.] Univ Roma Tor Vergata, Dipartimento Fis, I-00133 Rome, Italy; [Ylinen, T.] Univ Kalmar, Sch Pure & Appl Nat Sci, SE-39182 Kalmar, Sweden; [Hardcastle, M. J.] Univ Hertfordshire, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England	United States Department of Defense; United States Navy; Naval Research Laboratory; National Academies of Sciences, Engineering & Medicine; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Istituto Nazionale di Fisica Nucleare (INFN); UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; Istituto Nazionale di Fisica Nucleare (INFN); University of Trieste; University of Trieste; University of Padua; University System of Ohio; Ohio State University; Istituto Nazionale di Fisica Nucleare (INFN); University of Perugia; Politecnico di Bari; Universita degli Studi di Bari Aldo Moro; Istituto Nazionale di Fisica Nucleare (INFN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Institut Polytechnique de Paris; University of Washington; University of Washington Seattle; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); Istituto Nazionale Astrofisica (INAF); Agenzia Spaziale Italiana (ASI); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore County; George Mason University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Montpellier; California State University System; Sonoma State University; Stockholm University; Oskar Klein Centre; University of Udine; Istituto Nazionale di Fisica Nucleare (INFN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux; Hiroshima University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Istituto Nazionale Astrofisica (INAF); Max Planck Society; University of Alabama System; University of Alabama Huntsville; Royal Institute of Technology; Waseda University; Tokyo Institute of Technology; RIKEN; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Istituto Nazionale di Fisica Nucleare (INFN); University of Denver; Max Planck Society; University of Innsbruck; University of Innsbruck; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Jagiellonian University; Purdue University System; Purdue University; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); ICREA; University of Rome Tor Vergata; Linnaeus University; University of Kalmar; University of Hertfordshire	Cheung, CC (corresponding author), USN, Res Lab, Div Space Sci, Washington, DC 20375 USA.	Teddy.Cheung.ctr@nrl.navy.mil; fukazawa@hep01.hepl.hiroshima-u.ac.jp; jurgen.knodlseder@cesr.fr; stawarz@slac.stanford.edu	Nolan, Patrick L/A-5582-2009; Tosti, Gino/E-9976-2013; Gasparrini, Dario/X-6699-2019; Jóhannesson, Guðlaugur/ABC-7216-2020; Sgrò, Carmelo/K-3395-2016; Giglietto, Nicola/Y-2425-2019; Caraveo, Patrizia/AAL-5708-2020; Reimer, Olaf/A-3117-2013; Gargano, Fabio/AAD-5121-2021; cohen-tanugi, Johann/ABB-1481-2021; Torres, Diego F/ABD-7940-2020; Torres, Diego F./AAF-7931-2019; Gargano, Fabio/O-8934-2015; Rando, Riccardo/O-1302-2019; Morselli, Aldo/G-6769-2011; Funk, Stefan/B-7629-2015; Baldini, Luca/E-5396-2012; Hardcastle, Martin/AAM-1395-2020; Mazziotta, Mario N/O-8867-2015; Cutini, Sara/ABB-1787-2020; Jóhannesson, Guðlaugur/O-8741-2015; lubrano, pasquale/F-7269-2012; giglietto, nicola/I-8951-2012; Moskalenko, Igor V/A-1301-2007; Reimer, Anita/K-5822-2015; Tajima, Hiroyasu/I-6228-2014; Funk, Stefan/AAI-1568-2021; Ryde, Felix/AAE-1086-2021; Harding, Alice K/D-3160-2012; tramacere, andrea/B-9424-2012; Loparco, Francesco/O-8847-2015; Hardcastle, Martin J/E-2264-2012; Starck, Jean-Luc/D-9467-2011; Thompson, David J/D-2939-2012; Rando, Riccardo/M-7179-2013; Hays, Elizabeth/D-3257-2012; Fukazawa, Yasushi/G-2081-2017; Orlando, Elena/R-5594-2016; McEnery, Julie E/D-6612-2012; Parkinson, Pablo Miguel Saz/I-7980-2013; Johnson, Neil/G-3309-2014; Takahashi, Hiromitsu H/T-2713-2017; Gehrels, Neil/D-2971-2012; Kuss, Michael W/H-8959-2012; Bastieri, Denis/AAC-5917-2020; Torres, Diego F./O-9422-2016	Gasparrini, Dario/0000-0002-5064-9495; Jóhannesson, Guðlaugur/0000-0003-1458-7036; Giglietto, Nicola/0000-0002-9021-2888; Caraveo, Patrizia/0000-0003-2478-8018; Reimer, Olaf/0000-0001-6953-1385; Gargano, Fabio/0000-0002-5055-6395; cohen-tanugi, Johann/0000-0001-9022-4232; Torres, Diego F./0000-0002-1522-9065; Gargano, Fabio/0000-0002-5055-6395; Rando, Riccardo/0000-0001-6992-818X; Morselli, Aldo/0000-0002-7704-9553; Funk, Stefan/0000-0002-2012-0080; Mazziotta, Mario N/0000-0001-9325-4672; Cutini, Sara/0000-0002-1271-2924; Jóhannesson, Guðlaugur/0000-0003-1458-7036; lubrano, pasquale/0000-0003-0221-4806; giglietto, nicola/0000-0002-9021-2888; Moskalenko, Igor V/0000-0001-6141-458X; Reimer, Anita/0000-0001-8604-7077; Tajima, Hiroyasu/0000-0002-1721-7252; Funk, Stefan/0000-0002-2012-0080; Ryde, Felix/0000-0002-9769-8016; tramacere, andrea/0000-0002-8186-3793; Loparco, Francesco/0000-0002-1173-5673; Hardcastle, Martin J/0000-0003-4223-1117; Starck, Jean-Luc/0000-0003-2177-7794; Thompson, David J/0000-0001-5217-9135; Fukazawa, Yasushi/0000-0002-0921-8837; Orlando, Elena/0000-0001-6406-9910; Takahashi, Hiromitsu H/0000-0001-6314-5897; Bastieri, Denis/0000-0002-6954-8862; Torres, Diego F./0000-0002-1522-9065; Cecchi, Claudia/0000-0002-2192-8233; Sgro', Carmelo/0000-0001-5676-6214; Grenier, Isabelle/0000-0003-3274-674X; Porter, Troy/0000-0002-2621-4440; Cavazzuti, Elisabetta/0000-0001-7150-9638; Costamante, Luigi/0000-0002-8120-5272; Pesce-Rollins, Melissa/0000-0003-1790-8018; Giordano, Francesco/0000-0002-8651-2394; Johnson, Tyrel/0000-0002-2771-472X; Buson, Sara/0000-0002-3308-324X; Omodei, Nicola/0000-0002-5448-7577; RAZZANO, MASSIMILIANO/0000-0003-4825-1629; Cameron, Robert/0000-0003-0942-2747; Ackermann, Markus/0000-0001-8952-588X; Katagiri, Hideaki/0000-0003-2347-8819; SANCHEZ, David/0000-0002-7210-4496; Kerr, Matthew/0000-0002-0893-4073; Tanaka, Takaaki/0000-0002-4383-0368; De Angelis, Alessandro/0000-0002-3288-2517; Tibaldo, Luigi/0000-0001-7523-570X; Ciprini, Stefano/0000-0002-0712-2479; Casandjian, Jean-Marc/0000-0003-1404-0524; de Palma, Francesco/0000-0001-5898-2834; Baldini, Luca/0000-0002-9785-7726; Spandre, Gloria/0000-0003-0802-3453; Razzaque, Soebur/0000-0002-0130-2460; Fusco, Piergiorgio/0000-0002-9383-2425; Cheung, Chi (Teddy)/0000-0002-4377-0174; Sadrozinski, Hartmut/0000-0003-0019-5410; Tosti, Gino/0000-0002-0839-4126; Pepe, Monica/0000-0001-5624-4010; Giroletti, Marcello/0000-0002-8657-8852; Monzani, Maria Elena/0000-0002-8254-5308; Murgia, Simona/0000-0003-0516-9422	U.S. Department of Energy in the United States; Commissariat a l'Energie Atomique; Centre National de la Recherche Scientifique/Institut National de Physique Nuclaire et de Physique des Particules in France; Agenzia Spaziale Italiana; Istituto Nazionale de Fisica Nucleare in Italy; Ministry of Education, Culture, Sports, Science and Technology (MEXT); High Energy Accelerator Research Organization (KEK); Japan Aerospace Exploration Agency (JAXA) in Japan; K. A. Wallenberg Foundation; Swedish Research Council; National Space Board in Sweden; Istituto Nazionale di Astrofisica in Italy; Centre National d'Etudes Spatiales in France; NASA; Royal Swedish Academy of Sciences; ICREA Funding Source: Custom; STFC [ST/G002630/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/G002630/1] Funding Source: researchfish	U.S. Department of Energy in the United States(United States Department of Energy (DOE)); Commissariat a l'Energie Atomique(French Atomic Energy Commission); Centre National de la Recherche Scientifique/Institut National de Physique Nuclaire et de Physique des Particules in France(Centre National de la Recherche Scientifique (CNRS)); Agenzia Spaziale Italiana(Agenzia Spaziale Italiana (ASI)); Istituto Nazionale de Fisica Nucleare in Italy; Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); High Energy Accelerator Research Organization (KEK)(High Energy Accelerator Research Organization (KEK)); Japan Aerospace Exploration Agency (JAXA) in Japan; K. A. Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); National Space Board in Sweden; Istituto Nazionale di Astrofisica in Italy(Istituto Nazionale Astrofisica (INAF)); Centre National d'Etudes Spatiales in France(Centre National D'etudes Spatiales); NASA(National Aeronautics & Space Administration (NASA)); Royal Swedish Academy of Sciences; ICREA(ICREA); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	The Fermi-LAT Collaboration acknowledges support from a number of agencies and institutes for both the development and operation of the LAT, as well as for scientific data analysis. These organizations include NASA and the U.S. Department of Energy in the United States; Commissariat a l'Energie Atomique and the Centre National de la Recherche Scientifique/Institut National de Physique Nuclaire et de Physique des Particules in France; the Agenzia Spaziale Italiana and the Istituto Nazionale de Fisica Nucleare in Italy; the Ministry of Education, Culture, Sports, Science and Technology (MEXT), High Energy Accelerator Research Organization (KEK), and Japan Aerospace Exploration Agency (JAXA) in Japan; and the K. A. Wallenberg Foundation, the Swedish Research Council, and the National Space Board in Sweden. Additional support from Istituto Nazionale di Astrofisica in Italy and Centre National d'Etudes Spatiales in France for science analysis during the operations phase is also gratefully acknowledged. C. C. C. was supported by the NASA Postdoctoral Program at Goddard Space Flight Center, administered by Oak Ridge Associated Universities through a contract with NASA. J. Conrad is a Royal Swedish Academy of Sciences research fellow (funded by a grant from the K.A. Wallenberg Foundation). We thank N. Odegard for providing the WMAP image.	Alvarez H, 2000, ASTRON ASTROPHYS, V355, P863; Atwood WB, 2009, ASTROPHYS J, V697, P1071, DOI 10.1088/0004-637X/697/2/1071; BLUMENTHAL GR, 1970, REV MOD PHYS, V42, P237, DOI 10.1103/RevModPhys.42.237; BOLTON JG, 1949, NATURE, V164, P101, DOI 10.1038/164101b0; Cheung CC, 2007, AIP CONF PROC, V921, P325; Croston JH, 2009, MON NOT R ASTRON SOC, V395, P1999, DOI 10.1111/j.1365-2966.2009.14715.x; Croston JH, 2005, ASTROPHYS J, V626, P733, DOI 10.1086/430170; CRUSIUS A, 1986, ASTRON ASTROPHYS, V164, pL16; Dermer CD, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/6/065016; Feain IJ, 2009, ASTROPHYS J, V707, P114, DOI 10.1088/0004-637X/707/1/114; FEIGELSON ED, 1995, ASTROPHYS J, V449, pL149, DOI 10.1086/309642; Ferrarese L, 2007, ASTROPHYS J, V654, P186, DOI 10.1086/506612; Georganopoulos M, 2008, ASTROPHYS J LETT, V686, pL5, DOI 10.1086/592833; Hardcastle MJ, 2009, MON NOT R ASTRON SOC, V393, P1041, DOI 10.1111/j.1365-2966.2008.14265.x; HARRIS DE, 1979, MON NOT R ASTRON SOC, V188, P25, DOI 10.1093/mnras/188.1.25; Hartman RC, 1999, ASTROPHYS J SUPPL S, V123, P79, DOI 10.1086/313231; Hauser MG, 2001, ANNU REV ASTRON ASTR, V39, P249, DOI 10.1146/annurev.astro.39.1.249; Hinshaw G, 2009, ASTROPHYS J SUPPL S, V180, P225, DOI 10.1088/0067-0049/180/2/225; JUNKES N, 1993, ASTRON ASTROPHYS, V269, P29; Kataoka J, 2005, ASTROPHYS J, V622, P797, DOI 10.1086/428083; Marconi A, 2006, ASTRON ASTROPHYS, V448, P921, DOI 10.1051/0004-6361:20053853; MARSHALL FJ, 1981, ASTROPHYS J, V245, P840, DOI 10.1086/158859; Mattox JR, 1996, ASTROPHYS J, V461, P396, DOI 10.1086/177068; Raue M, 2008, INT J MOD PHYS D, V17, P1515, DOI 10.1142/S0218271808013091; Shain C. A., 1958, AUST J PHYS, V11, P517; Sheridan K. V., 1958, AUST J PHYS, V11, P400	26	177	177	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2010	328	5979					725	729		10.1126/science.1184656	http://dx.doi.org/10.1126/science.1184656			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592DZ	20360067	Green Submitted			2022-12-28	WOS:000277357100032
J	Sharma, S; Liao, SL				Sharma, Shikha; Liao, Steve L.			Chest pain? Bridging the gap in diagnosis	LANCET			English	Editorial Material							MYOCARDIAL BRIDGE		[Sharma, Shikha; Liao, Steve L.] James J Peters VA Med Ctr, Dept Med, Cardiol Sect, Bronx, NY 10468 USA; [Liao, Steve L.] Mt Sinai Sch Med, Ctr Cardiovasc Hlth, Zena & Michael A Wiener Cardiovasc Inst, New York, NY USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai	Liao, SL (corresponding author), James J Peters VA Med Ctr, Dept Med, Cardiol Sect, 130 W Kingsbridge Rd, Bronx, NY 10468 USA.	Steve.Liao@va.gov						Duygu H, 2007, J AM SOC ECHOCARDIOG, V20, P717, DOI 10.1016/j.echo.2006.11.013; Ishikawa Y, 2009, CIRCULATION, V120, P376, DOI 10.1161/CIRCULATIONAHA.108.820720; Kunamneni PB, 2008, CATHETER CARDIO INTE, V71, P185, DOI 10.1002/ccd.21358; Mohlenkamp S, 2002, CIRCULATION, V106, P2616, DOI 10.1161/01.CIR.0000038420.14867.7A; Reyman H., 1737, THESIS U GOTTINGEN, P1	5	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 24	2010	375	9724					1494	1494		10.1016/S0140-6736(10)60281-4	http://dx.doi.org/10.1016/S0140-6736(10)60281-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	590FL	20417860				2022-12-28	WOS:000277210000036
J	Lu, K				Lu, K.			The Future of Metals	SCIENCE			English	Editorial Material							BOUNDARIES; COPPER; STEEL		Chinese Acad Sci, Shenyang Natl Lab Mat Sci, Inst Met Res, Shenyang 110016, Peoples R China	Chinese Academy of Sciences; Institute of Metal Research, CAS	Lu, K (corresponding author), Chinese Acad Sci, Shenyang Natl Lab Mat Sci, Inst Met Res, Shenyang 110016, Peoples R China.	lu@imr.ac.cn						Ashby M. F., 2005, MAT SELECTION MECH D; Chen KC, 2008, SCIENCE, V321, P1066, DOI 10.1126/science.1160777; Kimura Y, 2008, SCIENCE, V320, P1057, DOI 10.1126/science.1156084; King A, 2008, SCIENCE, V321, P382, DOI 10.1126/science.1156211; Lu K, 2009, SCIENCE, V324, P349, DOI 10.1126/science.1159610; Lu L, 2004, SCIENCE, V304, P422, DOI 10.1126/science.1092905; Meyers MA, 2006, PROG MATER SCI, V51, P427, DOI 10.1016/j.pmatsci.2005.08.003; Perepezko JH, 2009, SCIENCE, V326, P1068, DOI 10.1126/science.1179327; Si X, 2009, J MATER SCI TECHNOL, V25, P433; Yamamoto Y, 2007, SCIENCE, V316, P433, DOI 10.1126/science.1137711; [No title captured]	11	477	514	36	601	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 16	2010	328	5976					319	320		10.1126/science.1185866	http://dx.doi.org/10.1126/science.1185866			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583NR	20395503				2022-12-28	WOS:000276685000027
J	Ploeg, J; Brazil, K; Hutchison, B; Kaczorowski, J; Dalby, DM; Goldsmith, CH; Furlong, W				Ploeg, Jenny; Brazil, Kevin; Hutchison, Brian; Kaczorowski, Janusz; Dalby, Dawn M.; Goldsmith, Charles H.; Furlong, William			Effect of preventive primary care outreach on health related quality of life among older adults at risk of functional decline: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HOME VISITS; ELDERLY-PEOPLE; CONSTRUCT-VALIDITY; COMMUNITY; OUTCOMES; POPULATION; MANAGEMENT; PROMOTION; PROGRAM; SYSTEM	Objective To evaluate the impact of a provider initiated primary care outreach intervention compared with usual care among older adults at risk of functional decline. Design Randomised controlled trial. Setting Patients enrolled with 35 family physicians in five primary care networks in Hamilton, Ontario, Canada. Participants Patients were eligible if they were 75 years of age or older and were not receiving home care services. Of 3166 potentially eligible patients, 2662 (84%) completed the validated postal questionnaire used to determine risk of functional decline. Of 1724 patients who met the risk criteria, 769 (45%) agreed to participate and 719 were randomised. Intervention The 12 month intervention, provided by experienced home care nurses in 2004-6, consisted of a comprehensive initial assessment using the resident assessment instrument for home care; collaborative care planning with patients, their families, and family physicians; health promotion; and referral to community health and social support services. Main outcome measures Quality adjusted life years (QALYs), use and costs of health and social services, functional status, self rated health, and mortality. Results The mean difference in QALYs between intervention and control patients during the study period was not statistically significant (0.017, 95% confidence interval -0.022 to 0.056; P=0.388). The mean difference in overall cost of prescription drugs and services between the intervention and control groups was not statistically significant, (-$C165 (107; pound (sic)118; $162), 95% confidence interval -$C16 545 to $C16 214; P=0.984). Changes over 12 months in functional status and self rated health were not significantly different between the intervention and control groups. Ten patients died in each group. Conclusions The results of this study do not support adoption of this preventive primary care intervention for this target population of high risk older adults.	[Ploeg, Jenny] McMaster Univ, Fac Hlth Sci, Sch Nursing, Hamilton, ON L8N 3Z5, Canada; [Brazil, Kevin] McMaster Univ, Fac Hlth Sci, Dept Family Med, Dept Clin Epidemiol & Biostat,Div Palliat Care, Hamilton, ON L8N 3Z5, Canada; [Brazil, Kevin] St Josephs Hlth Syst Res Network, Hamilton, ON L8N 1G6, Canada; [Hutchison, Brian] McMaster Univ, Fac Hlth Sci, Ctr Hlth Econ & Policy Anal, Hamilton, ON L8N 3Z5, Canada; [Kaczorowski, Janusz] Univ British Columbia, Dept Family Practice, Child & Family Res Inst, Vancouver, BC V6T 1Z3, Canada; [Dalby, Dawn M.] Wilfrid Laurier Univ, Dept Kinesiol & Phys Educ, Waterloo, ON N2L 3C5, Canada; [Goldsmith, Charles H.] St Josephs Healthcare Hamilton, Biostat Unit, Hamilton, ON L8N 4A6, Canada; [Furlong, William] McMaster Univ, Dept Clin Epidemiol & Biostat, Ctr Hlth Econ & Policy Anal, Hlth Util Grp, Hamilton, ON L8N 3Z5, Canada	McMaster University; McMaster University; McMaster University; McMaster University; Child & Family Research Institute; University of British Columbia; Wilfrid Laurier University; McMaster University; McMaster University	Ploeg, J (corresponding author), McMaster Univ, Fac Hlth Sci, Sch Nursing, 1200 Main St W,Room HSc 3N28G, Hamilton, ON L8N 3Z5, Canada.	ploegj@mcmaster.ca	Campos, Caroline/AAT-5847-2021	Ploeg, Jenny/0000-0001-8168-8449	Ontario Ministry of Health and Long Term Care, Primary Health Care Transition Fund; Canadian Institutes of Health Research/St Joseph's Healthcare Hamilton	Ontario Ministry of Health and Long Term Care, Primary Health Care Transition Fund; Canadian Institutes of Health Research/St Joseph's Healthcare Hamilton(Canadian Institutes of Health Research (CIHR))	This study was supported by a grant from the Ontario Ministry of Health and Long Term Care, Primary Health Care Transition Fund. The views expressed in this paper are the views of the authors and do not necessarily reflect those of the Ontario Ministry of Health and Long Term Care. JP was supported by a Canadian Institutes of Health Research/St Joseph's Healthcare Hamilton investigator award while conducting this study. The funding agency played no role in the design and conduct of the study; in the collection, management, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript. The researchers were independent from the funders.	AKKI S, 1991, J AM GERIATR SOC, V39, pA22; Bergman H, 2002, AGING CLIN EXP RES, V14, P223; Bouman A, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-74; BROWNE G, 2001, 014 MCMAST U; BROWNE G, 2001, HLTH SOCIAL SERVICE; Brummell K, 2001, BRIT MED J, V323, P1; Byles JE, 2000, AUST NZ J PUBL HEAL, V24, P117, DOI 10.1111/j.1467-842X.2000.tb00131.x; Canadian Agency for Drugs and Technologies in Health (CADTH), 2017, GUID EC EV HLTH TECH; Coleman EA, 2002, AGING CLIN EXP RES, V14, P233; Dalby DM, 2000, CAN MED ASSOC J, V162, P497; Duke University Center for the Study of Aging and Human Development, 1978, MULT FUNCT ASS OARS; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Feeny D, 2005, J CLIN EPIDEMIOL, V58, P138, DOI 10.1016/j.jclinepi.2004.08.005; Feeny D, 2002, MED CARE, V40, P113, DOI 10.1097/00005650-200202000-00006; FEENY D, 2005, ASSESSING QUALITY LI; Feeny D., 2005, PRO NEWSLETTER, V34, P2; Fryback DG, 2007, MED CARE, V45, P1162, DOI 10.1097/MLR.0b013e31814848f1; Furlong WJ, 2001, ANN MED, V33, P375, DOI 10.3109/07853890109002092; Grootendorst P, 2000, MED CARE, V38, P290, DOI 10.1097/00005650-200003000-00006; HALL N, 1992, CAN J AGING, V11, P72, DOI 10.1017/S0714980800014537; Hay WI, 1998, CAN FAM PHYSICIAN, V44, P2677; Hebert R, 1996, AGE AGEING, V25, P159; Hebert R, 1997, CAN MED ASSOC J, V157, P1037; Hebert R, 2001, AGE AGEING, V30, P265, DOI 10.1093/ageing/30.3.265; HIRDES JP, 1994, CAN J AGING, V13, P499, DOI 10.1017/S0714980800006358; Horsman John, 2003, Health Qual Life Outcomes, V1, P54, DOI 10.1186/1477-7525-1-54; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Kendall M. G., 1955, ECONOMICA, V22, P365; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Little R.J.A., 2002, STAT ANAL MISSING DA; Markle-Reid M, 2006, MED CARE RES REV, V63, P531, DOI 10.1177/1077558706290941; Miller JD, 2006, ANN THORAC SURG, V81, P314, DOI 10.1016/j.athoracsur.2005.07.055; Morris JN, 2002, RAI HOME CARE RAI HC; *ONT MIN HLTH LONG, 2001, EV PRIM CAR REF PIL; *ONT MIN HLTH LONT, 2005, 39 ONT MIN HLTH LONG; Ploeg Jenny, 2005, Can Fam Physician, V51, P1244; Raynauld JP, 2002, OSTEOARTHR CARTILAGE, V10, P506, DOI 10.1053/joca.2002.0798; RUBENSTEIN LZ, 1991, J AM GERIATR SOC, V39, P37; *SAS I, 2008, KOLM SMIRN TEST KUIP; Stuck AE, 2002, JAMA-J AM MED ASSOC, V287, P1022, DOI 10.1001/jama.287.8.1022; STUCK AE, 1993, LANCET, V342, P1032, DOI 10.1016/0140-6736(93)92884-V; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Tu K, 2009, CAN FAM PHYSICIAN, V55, P719; van Haastregt JCM, 2000, BMJ-BRIT MED J, V320, P754, DOI 10.1136/bmj.320.7237.754; Vickrey BG, 2006, ANN INTERN MED, V145, P713, DOI 10.7326/0003-4819-145-10-200611210-00004; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE, 1993, SF36 HLTH SURVEY MAN; Wexler DJ, 2006, DIABETOLOGIA, V49, P1489, DOI 10.1007/s00125-006-0249-9	48	25	25	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2010	340								c1480	10.1136/bmj.c1480	http://dx.doi.org/10.1136/bmj.c1480			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	586KE	20400483	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000276905700001
J	Ehrenreich, IM; Torabi, N; Jia, Y; Kent, J; Martis, S; Shapiro, JA; Gresham, D; Caudy, AA; Kruglyak, L				Ehrenreich, Ian M.; Torabi, Noorossadat; Jia, Yue; Kent, Jonathan; Martis, Stephen; Shapiro, Joshua A.; Gresham, David; Caudy, Amy A.; Kruglyak, Leonid			Dissection of genetically complex traits with extremely large pools of yeast segregants	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; LOCI; IDENTIFICATION; ARCHITECTURE; MICROARRAYS; MUTATION; DISEASES	Most heritable traits, including many human diseases(1), are caused by multiple loci. Studies in both humans and model organisms, such as yeast, have failed to detect a large fraction of the loci that underlie such complex traits(2,3). A lack of statistical power to identify multiple loci with small effects is undoubtedly one of the primary reasons for this problem. We have developed a method in yeast that allows the use of much larger sample sizes than previously possible and hence permits the detection of multiple loci with small effects. The method involves generating very large numbers of progeny from a cross between two Saccharomyces cerevisiae strains and then phenotyping and genotyping pools of these offspring. We applied the method to 17 chemical resistance traits and mitochondrial function, and identified loci for each of these phenotypes. We show that the level of genetic complexity underlying these quantitative traits is highly variable, with some traits influenced by one major locus and others by at least 20 loci. Our results provide an empirical demonstration of the genetic complexity of a number of traits and show that it is possible to identify many of the underlying factors using straightforward techniques. Our method should have broad applications in yeast and can be extended to other organisms.	[Ehrenreich, Ian M.; Torabi, Noorossadat; Jia, Yue; Kent, Jonathan; Martis, Stephen; Shapiro, Joshua A.; Gresham, David; Caudy, Amy A.; Kruglyak, Leonid] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08540 USA; [Ehrenreich, Ian M.; Shapiro, Joshua A.; Kruglyak, Leonid] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08540 USA; [Ehrenreich, Ian M.; Jia, Yue; Shapiro, Joshua A.; Kruglyak, Leonid] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08540 USA; [Torabi, Noorossadat] Princeton Univ, Dept Mol Biol, Princeton, NJ 08540 USA	Princeton University; Princeton University; Howard Hughes Medical Institute; Princeton University; Princeton University	Kruglyak, L (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08540 USA.	leonid@genomics.princeton.edu	Shapiro, Joshua/B-5948-2008	Shapiro, Joshua/0000-0002-6224-0347; Caudy, Amy/0000-0001-6307-8137	NIH [R37 MH59520, F32 HG51762, P50 GM071508]; James S. McDonnell Centennial Fellowship; Howard Hughes Medical Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG005176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059520] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Centennial Fellowship; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors are grateful to members of the Kruglyak laboratory for comments on this manuscript; D. Botstein, J. Gerke, G. Lang and E. Perlstein for input regarding experiments; J. Bloom, L. Parsons, D. Sangurdekar and J. Storey for advice regarding analyses; and E. Alani for sharing the EAY1467 strain. This work was supported by NIH grant R37 MH59520, a James S. McDonnell Centennial Fellowship, and the Howard Hughes Medical Institute (L. K.), a NIH postdoctoral fellowship F32 HG51762 (I. M. E.), and NIH grant P50 GM071508 to the Center for Quantitative Biology at the Lewis-Sigler Institute of Princeton University.	Brauer MJ, 2006, GENETICS, V173, P1813, DOI 10.1534/genetics.106.057927; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Demogines A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000123; Deutschbauer AM, 2005, NAT GENET, V37, P1333, DOI 10.1038/ng1674; Dimitrov LN, 2009, GENETICS, V183, P365, DOI 10.1534/genetics.109.104497; Foss EJ, 2007, NAT GENET, V39, P1369, DOI 10.1038/ng.2007.22; Gaisne M, 1999, CURR GENET, V36, P195, DOI 10.1007/s002940050490; Gresham D, 2010, P NATL ACAD SCI USA, V107, P1482, DOI 10.1073/pnas.0913883107; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Kim HS, 2009, GENETICS, V183, P1141, DOI 10.1534/genetics.109.108068; Lai CQ, 2007, NAT METHODS, V4, P839, DOI 10.1038/NMETH1084; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Mackay TFC, 2005, PHILOS T R SOC B, V360, P1513, DOI 10.1098/rstb.2005.1672; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Perlstein EO, 2007, NAT GENET, V39, P496, DOI 10.1038/ng1991; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; Schneeberger K, 2009, NAT METHODS, V6, P550, DOI 10.1038/nmeth0809-550; Segre AV, 2006, PLOS BIOL, V4, P1372, DOI 10.1371/journal.pbio.0040256; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tong AHY, 2007, METHOD MICROBIOL, V36, P369, DOI 10.1016/S0580-9517(06)36016-3; Visscher PM, 2008, NAT GENET, V40, P489, DOI 10.1038/ng0508-489; Wolyn DJ, 2004, GENETICS, V167, P907, DOI 10.1534/genetics.103.024810; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	29	293	300	0	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2010	464	7291					1039	U101		10.1038/nature08923	http://dx.doi.org/10.1038/nature08923			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20393561	Green Submitted, Green Accepted			2022-12-28	WOS:000276635000038
J	Serabyn, E; Mawet, D; Burruss, R				Serabyn, E.; Mawet, D.; Burruss, R.			An image of an exoplanet separated by two diffraction beamwidths from a star	NATURE			English	Article							OPTICAL VORTEX CORONAGRAPH; PHASE-MASK CORONAGRAPH; HR 8799; TELESCOPE; PLANETS	Three exoplanets around the star HR8799 have recently been discovered by means of differential imaging with large telescopes(1). Bright scattered starlight limits high-contrast imaging to large angular offsets, currently of the order of ten diffraction beamwidths, 10 lambda/D, of the star (where lambda is the wavelength and D is the aperture diameter(1-5)). Imaging faint planets at smaller angles calls for reducing the starlight and associated photon and speckle noise before detection, while efficiently transmitting nearby planet light. To carry out initial demonstrations of reduced-angle high-contrast coronagraphy, we installed a vortex coronagraph(6-9) capable of reaching small angles behind a small, well-corrected telescope subaperture that provides low levels of scattered starlight(10,11). Here we report the detection of all three HR8799 planets with the resultant small-aperture (1.5 m) system, for which only 2 lambda/D separate the innermost planet from the star, with a final noise level within a factor of two of that given by photon statistics. Similar well-corrected small-angle coronagraphs should thus be able to detect exoplanets located even closer to their host stars with larger ground-based telescopes(12-15), and also allow a reduction in the size of potential space telescopes aimed at the imaging of very faint terrestrial planets.	[Serabyn, E.; Mawet, D.; Burruss, R.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Serabyn, E (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	gene.serabyn@jpl.nasa.gov						Beuzit J.-L., 2008, P SPIE, V7014; Bikkannavar S., 2008, P SPIE, V7015; Biller BA, 2007, ASTROPHYS J SUPPL S, V173, P143, DOI 10.1086/519925; Boccaletti A, 2008, ASTRON ASTROPHYS, V482, P939, DOI 10.1051/0004-6361:20079294; BOUCHEZ AH, 2008, P SPIE, V7015; Foo G, 2005, OPT LETT, V30, P3308, DOI 10.1364/OL.30.003308; Fukagawa M, 2009, ASTROPHYS J LETT, V696, pL1, DOI 10.1088/0004-637X/696/1/L1; Guyon O, 2006, ASTROPHYS J SUPPL S, V167, P81, DOI 10.1086/507630; HODAPP KW, 2008, P SPIE, V7014; Jenkins C, 2008, MON NOT R ASTRON SOC, V384, P515, DOI 10.1111/j.1365-2966.2007.12744.x; Lafreniere D, 2007, ASTROPHYS J, V660, P770, DOI 10.1086/513180; Lafreniere D, 2009, ASTROPHYS J LETT, V694, pL148, DOI 10.1088/0004-637X/694/2/L148; Macintosh B. A., 2008, P SPIE, V7015; MALBET F, 1995, PUBL ASTRON SOC PAC, V107, P386, DOI 10.1086/133563; Mawet D, 2005, ASTROPHYS J, V633, P1191, DOI 10.1086/462409; Mawet D, 2010, ASTROPHYS J, V709, P53, DOI 10.1088/0004-637X/709/1/53; Mawet D, 2009, ASTROPHYS J LETT, V702, pL47, DOI 10.1088/0004-637X/702/1/L47; Mawet D, 2009, OPT EXPRESS, V17, P1902, DOI 10.1364/OE.17.001902; Metchev S, 2009, ASTROPHYS J LETT, V705, pL204, DOI 10.1088/0004-637X/705/2/L204; Serabyn E, 2007, ASTROPHYS J, V658, P1386, DOI 10.1086/511949; Serabyn E, 2009, ASTROPHYS J, V696, P40, DOI 10.1088/0004-637X/696/1/40; Swartzlander GA, 2008, OPT EXPRESS, V16, P10200, DOI 10.1364/OE.16.010200	23	160	163	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 15	2010	464	7291					1018	1020		10.1038/nature09007	http://dx.doi.org/10.1038/nature09007			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20393557				2022-12-28	WOS:000276635000033
J	Wu, Y; Cain-Hom, C; Choy, L; Hagenbeek, TJ; de Leon, GP; Chen, YM; Finkle, D; Venook, R; Wu, XM; Ridgway, J; Schahin-Reed, D; Dow, GJ; Shelton, A; Stawicki, S; Watts, RJ; Zhang, J; Choy, R; Howard, P; Kadyk, L; Yan, MH; Zha, JP; Callahan, CA; Hymowitz, SG; Siebel, CW				Wu, Yan; Cain-Hom, Carol; Choy, Lisa; Hagenbeek, Thijs J.; de Leon, Gladys P.; Chen, Yongmei; Finkle, David; Venook, Rayna; Wu, Xiumin; Ridgway, John; Schahin-Reed, Dorreyah; Dow, Graham J.; Shelton, Amy; Stawicki, Scott; Watts, Ryan J.; Zhang, Jeff; Choy, Robert; Howard, Peter; Kadyk, Lisa; Yan, Minhong; Zha, Jiping; Callahan, Christopher A.; Hymowitz, Sarah G.; Siebel, Christian W.			Therapeutic antibody targeting of individual Notch receptors	NATURE			English	Article							INHIBITS TUMOR-GROWTH; GAMMA-SECRETASE; ANTI-P185HER2 ANTIBODY; MALIGNANT-MELANOMA; REGULATORY REGION; CANCER-THERAPY; B-CELLS; MUTATIONS; LEUKEMIA; ANGIOGENESIS	The four receptors of the Notch family are widely expressed transmembrane proteins that function as key conduits through which mammalian cells communicate to regulate cell fate and growth(1,2). Ligand binding triggers a conformational change in the receptor negative regulatory region (NRR) that enables ADAM protease cleavage(3,4) at a juxtamembrane site that otherwise lies buried within the quiescent NRR5,6. Subsequent intramembrane proteolysis catalysed by the c-secretase complex liberates the intracellular domain (ICD) to initiate the downstream Notch transcriptional program. Aberrant signalling through each receptor has been linked to numerous diseases, particularly cancer(7), making the Notch pathway a compelling target for new drugs. Although gamma-secretase inhibitors (GSIs) have progressed into the clinic(8), GSIs fail to distinguish individual Notch receptors, inhibit other signalling pathways(9) and cause intestinal toxicity(10), attributed to dual inhibition of Notch1 and 2 (ref. 11). To elucidate the discrete functions of Notch1 and Notch2 and develop clinically relevant inhibitors that reduce intestinal toxicity, we used phage display technology to generate highly specialized antibodies that specifically antagonize each receptor paralogue and yet cross-react with the human and mouse sequences, enabling the discrimination of Notch1 versus Notch2 function in human patients and rodent models. Our co-crystal structure shows that the inhibitory mechanism relies on stabilizing NRR quiescence. Selective blocking of Notch1 inhibits tumour growth in pre-clinical models through two mechanisms: inhibition of cancer cell growth and deregulation of angiogenesis. Whereas inhibition of Notch1 plus Notch2 causes severe intestinal toxicity, inhibition of either receptor alone reduces or avoids this effect, demonstrating a clear advantage over pan-Notch inhibitors. Our studies emphasize the value of paralogue-specific antagonists in dissecting the contributions of distinct Notch receptors to differentiation and disease and reveal the therapeutic promise in targeting Notch1 and Notch2 independently.	[Cain-Hom, Carol; Choy, Lisa; Hagenbeek, Thijs J.; Dow, Graham J.; Shelton, Amy; Siebel, Christian W.] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Wu, Yan; Chen, Yongmei; Stawicki, Scott] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Zha, Jiping; Callahan, Christopher A.] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Finkle, David; Venook, Rayna] Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA; [Wu, Xiumin; Ridgway, John; Yan, Minhong] Genentech Inc, Dept Tumor Biol & Angiogenesis, San Francisco, CA 94080 USA; [Schahin-Reed, Dorreyah; Watts, Ryan J.] Genentech Inc, Dept Neurodegenerat, San Francisco, CA 94080 USA; [de Leon, Gladys P.; Hymowitz, Sarah G.] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA; [Zhang, Jeff; Choy, Robert; Howard, Peter; Kadyk, Lisa] Exelixis Inc, San Francisco, CA 94083 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Exelixis, Inc.	Siebel, CW (corresponding author), Genentech Inc, Dept Mol Biol, 1 DNA Way, San Francisco, CA 94080 USA.	csiebel@gene.com	Kadyk, Lisa/W-5243-2019	Dow, Graham/0000-0003-2986-9677	Department of Energy, National Institutes of Health; National Institute of General Medical Sciences	Department of Energy, National Institutes of Health(United States Department of Energy (DOE)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the Notch scientists at Genentech and Exelixis for support throughout this project. In particular, we thank the following contributors at Exelixis: S.-H. Lin, L. Doukhan, S. Weiss, N. Benin and R. Mercer for protein production, purification and analysis, R. Funke for cloning and sequencing and D. Buckley and J. Greve for scientific discussions and guidance. We thank the Genentech protein expression group, R. Vij and J.-A. Hongo for help with antibody characterization, F. Bazan and C. Sanchez-Irizarry for stimulating discussions and critically reading the manuscript, J. Eastham-Anderson for morphometric analysis of the intestines, Y. Shang for making mutant Notch1 expression plasmids, S. Seshagiri for MT-3 sequencing, E. Quan for initial work with T-ALL lines, S. Chaudhuri for cloning and antibody characterization, and G. Plowman for insights and guidance. We appreciate the important contributions of F. de Sauvage, who helped initiate this collaborative project and provided guidance throughout. The Advanced Light Source and Berkeley Center for Structural Biology are supported by the Department of Energy, National Institutes of Health, and the National Institute of General Medical Sciences.	Aster JC, 2008, ANNU REV PATHOL-MECH, V3, P587, DOI 10.1146/annurev.pathmechdis.3.121806.154300; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; EIGENBROT C, 1993, J MOL BIOL, V229, P969, DOI 10.1006/jmbi.1993.1099; Ettinger R, 1996, P NATL ACAD SCI USA, V93, P13102, DOI 10.1073/pnas.93.23.13102; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; Gordon WR, 2009, BLOOD, V113, P4381, DOI 10.1182/blood-2008-08-174748; Hagenbeek TJ, 2008, LEUKEMIA, V22, P608, DOI 10.1038/sj.leu.2405056; Hagenbeek TJ, 2004, J EXP MED, V200, P883, DOI 10.1084/jem.20040495; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Jonsson G, 2007, ONCOGENE, V26, P4738, DOI 10.1038/sj.onc.1210252; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; Koch U, 2007, CELL MOL LIFE SCI, V64, P2746, DOI 10.1007/s00018-007-7164-1; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lee CV, 2004, J MOL BIOL, V340, P1073, DOI 10.1016/j.jmb.2004.05.051; Lee SY, 2009, CANCER SCI, V100, P920, DOI 10.1111/j.1349-7006.2009.01130.x; Leong KG, 2006, BLOOD, V107, P2223, DOI 10.1182/blood-2005-08-3329; Li K, 2008, J BIOL CHEM, V283, P8046, DOI 10.1074/jbc.M800170200; Liang WC, 2007, J MOL BIOL, V366, P815, DOI 10.1016/j.jmb.2006.11.021; Malecki MJ, 2006, MOL CELL BIOL, V26, P4642, DOI 10.1128/MCB.01655-05; Massi D, 2006, MODERN PATHOL, V19, P246, DOI 10.1038/modpathol.3800526; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Qin JZ, 2004, MOL CANCER THER, V3, P895; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Shih IM, 2007, CANCER RES, V67, P1879, DOI 10.1158/0008-5472.CAN-06-3958; Sidhu SS, 2004, J MOL BIOL, V338, P299, DOI 10.1016/j.jmb.2004.02.050; Troen G, 2008, HAEMATOL-HEMATOL J, V93, P1107, DOI 10.3324/haematol.11635; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Witt CM, 2003, J IMMUNOL, V171, P2783, DOI 10.4049/jimmunol.171.6.2783	38	537	605	3	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2010	464	7291					1052	U122		10.1038/nature08878	http://dx.doi.org/10.1038/nature08878			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20393564	Bronze			2022-12-28	WOS:000276635000041
J	Appleby, J				Appleby, John			Can the NHS cut costs without substantially damaging the quality of health care? No	BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, London W1G 0AN, England		Appleby, J (corresponding author), Kings Fund, London W1G 0AN, England.	j.appleby@kingsfund.org.uk						Appleby J, 2009, COLD WILL IT BE PROS; Department of Health, 2010, PAYM RES GUID 2010 1; Francis R, 2005, HC3751, V1; *HLTH SEL COMM, 2010, PUBL EXP HL IN PRESS; Nicholson D., 2009, NHS CHIEF EXECUTIVES	5	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 14	2010	340								c1959	10.1136/bmj.c1959	http://dx.doi.org/10.1136/bmj.c1959			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	586KB	20392772				2022-12-28	WOS:000276905400008
J	Carr, BG; Addyson, DK; Kahn, JM				Carr, Brendan G.; Addyson, Daniel K.; Kahn, Jeremy M.			Variation in Critical Care Beds Per Capita in the United States: Implications for Pandemic and Disaster Planning	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							2009 INFLUENZA A(H1N1); SERVICES		[Carr, Brendan G.] Univ Penn, Sch Med, Dept Emergency Med, Philadelphia, PA 19104 USA; [Addyson, Daniel K.] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Kahn, Jeremy M.] Univ Penn, Sch Med, Div Pulm Allergy & Crit Care, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Carr, BG (corresponding author), Univ Penn, Sch Med, Dept Emergency Med, Philadelphia, PA 19104 USA.	jmkahn@mail.med.upenn.edu		Kahn, Jeremy/0000-0001-9688-5576	AHRQ HHS [K08HS017960, K08 HS017960] Funding Source: Medline; NHLBI NIH HHS [K23 HL082650, K23HL082650] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS017960] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL082650] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Barnato AE, 2007, CRIT CARE MED, V35, P1003, DOI 10.1097/01.CCM.0000259535.06205.B4; Farmer JC, 2006, CRIT CARE MED, V34, pS56, DOI 10.1097/01.CCM.0000199989.44467.2E; Institute of Medicine, 2007, HOSP BAS EM CAR BREA; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; White DB, 2009, JAMA-J AM MED ASSOC, V302, P1905, DOI 10.1001/jama.2009.1539; Wunsch H, 2008, CRIT CARE MED, V36, P2787, DOI 10.1097/CCM.0b013e318186aec8	6	52	53	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2010	303	14					1371	1372		10.1001/jama.2010.394	http://dx.doi.org/10.1001/jama.2010.394			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582KX	20388892	Green Accepted			2022-12-28	WOS:000276597300021
J	Borghetti, J; Snider, GS; Kuekes, PJ; Yang, JJ; Stewart, DR; Williams, RS				Borghetti, Julien; Snider, Gregory S.; Kuekes, Philip J.; Yang, J. Joshua; Stewart, Duncan R.; Williams, R. Stanley			'Memristive' switches enable 'stateful' logic operations via material implication	NATURE			English	Article							NM HALF-PITCH; MOLECULAR ELECTRONICS; NANOIMPRINT LITHOGRAPHY; CROSSBAR CIRCUITS; DEVICES; ARCHITECTURE; FABRICATION; ELEMENT	The authors of the International Technology Roadmap for Semiconductors(1)-the industry consensus set of goals established for advancing silicon integrated circuit technology-have challenged the computing research community to find new physical state variables (other than charge or voltage), new devices, and new architectures that offer memory and logic functions(1-6) beyond those available with standard transistors. Recently, ultra-dense resistive memory arrays built from various two-terminal semiconductor or insulator thin film devices have been demonstrated(7-12). Among these, bipolar voltage-actuated switches have been identified as physical realizations of 'memristors' or memristive devices, combining the electrical properties of a memory element and a resistor(13,14). Such devices were first hypothesized by Chua in 1971 (ref. 15), and are characterized by one or more state variables(16) that define the resistance of the switch depending upon its voltage history. Here we show that this family of nonlinear dynamical memory devices can also be used for logic operations: we demonstrate that they can execute material implication (IMP), which is a fundamental Boolean logic operation on two variables p and q such that pIMPq is equivalent to (NOTp)ORq. Incorporated within an appropriate circuit(17,18), memristive switches can thus perform 'stateful' logic operations for which the same devices serve simultaneously as gates (logic) and latches(19) (memory) that use resistance instead of voltage or charge as the physical state variable.	[Borghetti, Julien; Snider, Gregory S.; Kuekes, Philip J.; Yang, J. Joshua; Stewart, Duncan R.; Williams, R. Stanley] Hewlett Packard Labs, Palo Alto, CA 94304 USA	Hewlett-Packard	Stewart, DR (corresponding author), Natl Res Council Canada, Steacie Inst Mol Sci, 100 Sussex Dr, Ottawa, ON K1A OR6, Canada.	duncan.stewart@nrc.gc.ca; stan.williams@hp.com	borghetti, julien/B-1568-2009; Williams, R. Stanley/A-8281-2009; Yang, J. Joshua/B-3358-2010	Williams, R. Stanley/0000-0003-0213-4259; Yang, J. Joshua/0000-0001-8242-7531				Allwood DA, 2005, SCIENCE, V309, P1688, DOI 10.1126/science.1108813; Borghetti J, 2009, J APPL PHYS, V106, DOI 10.1063/1.3264621; Borghetti J, 2009, P NATL ACAD SCI USA, V106, P1699, DOI 10.1073/pnas.0806642106; Chen Y, 2003, NANOTECHNOLOGY, V14, P462, DOI 10.1088/0957-4484/14/4/311; Chen Y, 2003, APPL PHYS LETT, V82, P1610, DOI 10.1063/1.1559439; CHUA LO, 1976, P IEEE, V64, P209, DOI 10.1109/PROC.1976.10092; CHUA LO, 1971, IEEE T CIRCUITS SYST, VCT18, P507, DOI 10.1109/TCT.1971.1083337; DeHon A, 2003, IEEE T NANOTECHNOL, V2, P23, DOI 10.1109/TNANO.2003.808508; Dery H, 2007, NATURE, V447, P573, DOI 10.1038/nature05833; Green JE, 2007, NATURE, V445, P414, DOI 10.1038/nature05462; Heath JR, 2003, PHYS TODAY, V56, P43, DOI 10.1063/1.1583533; ITRS 2009 Edition, 2009, EM RES DEV; Jung GY, 2004, NANO LETT, V4, P1225, DOI 10.1021/nl049487q; Jung GY, 2006, NANO LETT, V6, P351, DOI 10.1021/nl052110f; Kimura H, 2004, IEEE J SOLID-ST CIRC, V39, P919, DOI 10.1109/JSSC.2004.827802; Kuekes PJ, 2005, J APPL PHYS, V97, DOI 10.1063/1.1823026; LIKHAREV KK, 2005, LECT NOTES PHYS, V680; Luo Y, 2002, CHEMPHYSCHEM, V3, P519, DOI 10.1002/1439-7641(20020617)3:6<519::AID-CPHC519>3.0.CO;2-2; Ney A, 2003, NATURE, V425, P485, DOI 10.1038/nature02014; Shannon C. E., 1940, THESIS, P1; Snider G, 2005, APPL PHYS A-MATER, V80, P1183, DOI 10.1007/s00339-004-3154-4; Snider G, 2005, APPL PHYS A-MATER, V80, P1165, DOI 10.1007/s00339-004-3149-1; Stan MR, 2003, P IEEE, V91, P1940, DOI 10.1109/JPROC.2003.818327; Strukov DB, 2008, NATURE, V453, P80, DOI 10.1038/nature06932; Wang JG, 2005, J APPL PHYS, V97, DOI 10.1063/1.1857655; Waser R, 2009, ADV MATER, V21, P2632, DOI 10.1002/adma.200900375; Whitehead A. N., 1910, PRINCIPIA MATH, P7; Yang JJ, 2008, NAT NANOTECHNOL, V3, P429, DOI 10.1038/nnano.2008.160; Yang JJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/21/215201	29	1280	1330	28	672	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					873	876		10.1038/nature08940	http://dx.doi.org/10.1038/nature08940			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20376145				2022-12-28	WOS:000276397300033
J	Oakeshott, P; Kerry, S; Aghaizu, A; Atherton, H; Hay, S; Taylor-Robinson, D; Simms, I; Hay, P				Oakeshott, Pippa; Kerry, Sally; Aghaizu, Adamma; Atherton, Helen; Hay, Sima; Taylor-Robinson, David; Simms, Ian; Hay, Phillip			Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BACTERIAL VAGINOSIS; WOMEN; DIAGNOSIS	Objective To determine whether screening and treating women for chlamydial infection reduces the incidence of pelvic inflammatory disease over the subsequent 12 months. Design Randomised controlled trial. Setting Common rooms, lecture theatres, and student bars at universities and further education colleges in London. Participants 2529 sexually active female students, mean age 21 years (range 16-27). Intervention Participants completed a questionnaire and provided self taken vaginal swabs, with follow-up after one year. Samples were randomly allocated to immediate testing and treatment for chlamydial infection, or storage and analysis after a year (deferred screening controls). Main outcome measure Incidence of clinical pelvic inflammatory disease over 12 months. Results Baseline prevalence of chlamydia was 5.4% (68/1254) in screened women and 5.9% (75/1265) in controls. 94% (2377/2529) of women were followed up after 12 months. The incidence of pelvic inflammatory disease was 1.3% (15/1191) in screened women compared with 1.9% (23/1186) in controls (relative risk 0.65, 95% confidence interval 0.34 to 1.22). Seven of 74 control women (9.5%, 95% confidence interval 4.7% to 18.3%) who tested positive for chlamydial infection at baseline developed pelvic inflammatory disease over 12 months compared with one of 63 (1.6%) screened women (relative risk 0.17, 0.03 to 1.01). However, most episodes of pelvic inflammatory disease occurred in women who tested negative for chlamydia at baseline (79%, 30/38). 22% (527/2377) of women reported being tested independently for chlamydia during the trial. Conclusion Although some evidence suggests that screening for chlamydia reduces rates of pelvic inflammatory disease, especially in women with chlamydial infection at baseline, the effectiveness of a single chlamydia test in preventing pelvic inflammatory disease over 12 months may have been overestimated.	[Oakeshott, Pippa; Kerry, Sally; Aghaizu, Adamma] Univ London, Div Community Hlth Sci, London SW17 0RE, England; [Atherton, Helen] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Social Med, London SW7 2AZ, England; [Hay, Sima] Kings Coll London, Florence Nightingale Sch Nursing & Midwifery, London WC2R 2LS, England; [Taylor-Robinson, David] Univ London Imperial Coll Sci Technol & Med, Div Med, London SW7 2AZ, England; [Simms, Ian] Hlth Protect Agcy, Ctr Infect, London, England; [Hay, Phillip] St George Hosp, Dept Genitourinary Med, London, England	University of London; Imperial College London; University of London; King's College London; Imperial College London; Health Protection Agency; St Georges University London	Oakeshott, P (corresponding author), Univ London, Div Community Hlth Sci, London SW17 0RE, England.	oakeshot@sgul.ac.uk	Simms, Ian/AAA-8740-2019; Simms, Ian/P-1454-2019; Atherton, Helen/AFK-5296-2022	Simms, Ian/0000-0003-4519-5684; Atherton, Helen/0000-0002-7072-1925; Oakeshott, Pippa/0000-0003-2568-8211	BUPA Foundation [684/GB14B]	BUPA Foundation	This study was supported by the BUPA Foundation ( grant No 684/GB14B). TMA sample collecting kits were provided by Gen-Probe (San Diego, CA).	Abter EIM, 1996, NEW ENGL J MED, V335, P1531; Adams EJ, 2007, SEX TRANSM INFECT, V83, DOI 10.1136/sti.2006.024364; Atherton H, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-41; *CDC, 2006, MMWR-MORBID MORTAL W, V55, P56; *EUR CTR DIS PREV, 2009, CHALM CONTR EUR; Gaydos CA, 2008, SEX TRANSM DIS, V35, P233, DOI 10.1097/OLQ.0b013e31815c11fe; HAGER WD, 1983, OBSTET GYNECOL, V61, P113; Ivaz S, 2006, FAM PRACT, V23, P188, DOI 10.1093/fampra/cmi109; Low N, 2006, SEX TRANSM INFECT, V82, P212, DOI 10.1136/sti.2005.017186; Low N, 2007, SEX TRANSM INFECT, V83, DOI 10.1136/sti.2007.026898; Low N, 2009, INT J EPIDEMIOL, V38, P435, DOI 10.1093/ije/dyn222; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; *NAT I HLTH CLIN E, 2006, REV RAP REV EV EFF S; Ness RB, 2004, OBSTET GYNECOL, V104, P761, DOI 10.1097/01.AOG.0000139512.37582.17; Ness RB, 2002, AM J OBSTET GYNECOL, V186, P929, DOI 10.1067/mob.2002.121625; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Oakeshott P, 2002, BRIT MED J, V325, P1334, DOI 10.1136/bmj.325.7376.1334; Oakeshott Pippa, 2008, Trials, V9, P73, DOI 10.1186/1745-6215-9-73; Ostergaard L, 2000, CLIN INFECT DIS, V31, P951, DOI 10.1086/318139; Peterman TA, 2009, INT J EPIDEMIOL, V38, P449, DOI 10.1093/ije/dyn345; Pittrof R, 1996, NEW ENGL J MED, V335, P1532; Schachter J, 2005, SEX TRANSM DIS, V32, P725, DOI 10.1097/01.olq.0000190092.59482.96; Scholes D, 1996, NEW ENGL J MED, V334, P1362, DOI 10.1056/NEJM199605233342103; Sellors J, 1996, NEW ENGL J MED, V335, P1531; Simms I, 2008, INT J STD AIDS, V19, P285, DOI 10.1258/ijsa.2007.007316; Simms I, 1999, INT J STD AIDS, V10, P448, DOI 10.1258/0956462991914447	26	126	134	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2010	340								c1642	10.1136/bmj.c1642	http://dx.doi.org/10.1136/bmj.c1642			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582ZG	20378636	Green Accepted, Green Published, hybrid, Green Submitted			2022-12-28	WOS:000276639500001
J	Reeves, D; Doran, T; Valderas, JM; Kontopantelis, E; Trueman, P; Sutton, M; Campbell, S; Lester, H				Reeves, David; Doran, Tim; Valderas, Jose M.; Kontopantelis, Evangelos; Trueman, Paul; Sutton, Matt; Campbell, Stephen; Lester, Helen			How to identify when a performance indicator has run its course	BRITISH MEDICAL JOURNAL			English	Editorial Material							QUALITY IMPROVEMENT; PRIMARY-CARE; PAY; ENGLAND		[Lester, Helen] Natl Inst Hlth, Res Sch Primary Care Res, Manchester M13 9PL, Lancs, England; [Valderas, Jose M.; Kontopantelis, Evangelos] Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England; [Trueman, Paul] Univ York, York Hlth Econ Consortium, York YO10 5NH, N Yorkshire, England; [Sutton, Matt] Hlth Methodol Res Grp, Manchester M13 9PL, Lancs, England	University of Manchester; University of Manchester; University of York - UK; University of Manchester	Lester, H (corresponding author), Natl Inst Hlth, Res Sch Primary Care Res, Manchester M13 9PL, Lancs, England.	Helen.lester@manchester.ac.uk	Valderas, Jose M/G-7967-2014; Reeves, David/H-6203-2014; Valderas, Jose M/Y-9814-2019; Kontopantelis, Evangelos/H-2966-2019	Valderas, Jose M/0000-0002-9299-1555; Reeves, David/0000-0001-6377-6859; Kontopantelis, Evangelos/0000-0001-6450-5815; Campbell, Stephen/0000-0002-2328-4136; Sutton, Matt/0000-0002-6635-2127	Medical Research Council [MR/K006665/1, MC_PC_13042] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], QUAL OUTC FRAM; Campbell S, 2007, NEW ENGL J MED, V357, P181, DOI 10.1056/NEJMsr065990; Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; *DEP HLTH, 2008, DEV QUAL OUTC FRAM P; Ganz DA, 2007, MED CARE, V45, P8, DOI 10.1097/01.mlr.0000241115.31531.15; Giuffrida A, 1999, BRIT MED J, V319, P94, DOI 10.1136/bmj.319.7202.94; Hartzband P, 2009, NEW ENGL J MED, V360, P101, DOI 10.1056/NEJMp0806369; LESTER HE, 2009, BRIT MED J, V338, P5; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; *NAT I CLIN EXC, 2006, CLIN GUID NAT I CLIN, V38; National Patient Safety Agency, 2009, SAF LITH THER; *NHS INF CTR, GEN PRACT EXTR SERV	12	28	28	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 6	2010	340								c1717	10.1136/bmj.c1717	http://dx.doi.org/10.1136/bmj.c1717			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582ZC	20371570	Green Submitted			2022-12-28	WOS:000276639100001
J	Iwabu, M; Yamauchi, T; Okada-Iwabu, M; Sato, K; Nakagawa, T; Funata, M; Yamaguchi, M; Namiki, S; Nakayama, R; Tabata, M; Ogata, H; Kubota, N; Takamoto, I; Hayashi, YK; Yamauchi, N; Waki, H; Fukayama, M; Nishino, I; Tokuyama, K; Ueki, K; Oike, Y; Ishii, S; Hirose, K; Shimizu, T; Touhara, K; Kadowaki, T				Iwabu, Masato; Yamauchi, Toshimasa; Okada-Iwabu, Miki; Sato, Koji; Nakagawa, Tatsuro; Funata, Masaaki; Yamaguchi, Mamiko; Namiki, Shigeyuki; Nakayama, Ryo; Tabata, Mitsuhisa; Ogata, Hitomi; Kubota, Naoto; Takamoto, Iseki; Hayashi, Yukiko K.; Yamauchi, Naoko; Waki, Hironori; Fukayama, Masashi; Nishino, Ichizo; Tokuyama, Kumpei; Ueki, Kohjiro; Oike, Yuichi; Ishii, Satoshi; Hirose, Kenzo; Shimizu, Takao; Touhara, Kazushige; Kadowaki, Takashi			Adiponectin and AdipoR1 regulate PGC-1 alpha and mitochondria by Ca2+ and AMPK/SIRT1	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; MUSCLE FIBER-TYPE; SKELETAL-MUSCLE; INSULIN-RESISTANCE; RECEPTOR ACTIVATION; PHOSPHORYLATION; CLONING; DISEASE; OBESITY	Adiponectin is an anti-diabetic adipokine. Its receptors possess a seven-transmembrane topology with the amino terminus located intracellularly, which is the opposite of G-protein-coupled receptors. Here we provide evidence that adiponectin induces extracellular Ca2+ influx by adiponectin receptor 1 (AdipoR1), which was necessary for subsequent activation of Ca2+/calmodulin-dependent protein kinase kinase beta (CaMKK beta), AMPK and SIRT1, increased expression and decreased acetylation of peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha), and increased mitochondria in myocytes. Moreover, muscle-specific disruption of AdipoR1 suppressed the adiponectin-mediated increase in intracellular Ca2+ concentration, and decreased the activation of CaMKK, AMPK and SIRT1 by adiponectin. Suppression of AdipoR1 also resulted in decreased PGC-1 alpha expression and deacetylation, decreased mitochondrial content and enzymes, decreased oxidative type I myofibres, and decreased oxidative stress-detoxifying enzymes in skeletal muscle, which were associated with insulin resistance and decreased exercise endurance. Decreased levels of adiponectin and AdipoR1 in obesity may have causal roles in mitochondrial dysfunction and insulin resistance seen in diabetes.	[Iwabu, Masato; Yamauchi, Toshimasa; Okada-Iwabu, Miki; Funata, Masaaki; Yamaguchi, Mamiko; Nakayama, Ryo; Kubota, Naoto; Takamoto, Iseki; Waki, Hironori; Ueki, Kohjiro; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo 1130033, Japan; [Iwabu, Masato; Yamauchi, Toshimasa; Okada-Iwabu, Miki] Univ Tokyo, Dept Integrated Mol Sci Metab Dis, Century Med & Res Ctr 22, Tokyo 1130033, Japan; [Namiki, Shigeyuki; Hirose, Kenzo] Univ Tokyo, Grad Sch Med, Dept Neurobiol, Tokyo 1130033, Japan; [Yamauchi, Naoko; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo 1130033, Japan; [Ishii, Satoshi; Shimizu, Takao] Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Tokyo 1130033, Japan; [Sato, Koji; Touhara, Kazushige] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan; [Nakagawa, Tatsuro; Touhara, Kazushige] Univ Tokyo, Dept Integrated Biosci, Chiba 2778562, Japan; [Tabata, Mitsuhisa] Kumamoto Univ, Grad Sch Med Sci, Dept Mol Genet, Kumamoto 8600811, Japan; [Ogata, Hitomi; Tokuyama, Kumpei] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058577, Japan; [Hayashi, Yukiko K.; Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Kodaira, Tokyo 1878502, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Kumamoto University; University of Tsukuba; National Center for Neurology & Psychiatry - Japan	Yamauchi, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo 1130033, Japan.	tyamau-tky@umin.net; kadowaki-3im@h.u-tokyo.ac.jp	Waki, Hironori/AAE-3942-2020; Namiki, Shigeyuki/AAF-6157-2019; Shimizu, Takao/AAV-7052-2021; Kubota, Naoto/N-7892-2015; Nishino, Ichizo/G-2676-2010	Waki, Hironori/0000-0002-5302-9793; Namiki, Shigeyuki/0000-0003-1520-8261; Nishino, Ichizo/0000-0001-9452-112X; xing zhi, zuo teng/0000-0001-6198-6406	Ministry of Education, Culture, Sports, Science and Technology of Japan [20229008, 20390254]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank B. M. Spiegelman for critical discussions and reading of the manuscript; T. Yokomizo for discussion and support; A. Tsuchida, K. Hara, Y. Hada, Y. Nio, T. Maki, T. Takazawa, Y. Iwata, M. Kobayashi, S. Kawamoto, K. Kobayashi, K. Hirota, Y. Shiomi, T. Mitsumatsu, L. Hirose, Y. Sea, M. Nakamura and K. Take for technical help and support; and S. Suzuki, K. Miyata, C. Ueda, A. Itoh and A. Okano for technical assistance. This work was supported by Grant-in-aid for Scientific Research (S) (20229008) (to T. K.), (B) (20390254) (to T. Y.), Targeted Proteins Research Program (to T. K.), the Global COE Research Program (to T. K.) and Translational Systems Biology and Medicine Initiative (to T. K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Anderson KA, 1998, J BIOL CHEM, V273, P31880, DOI 10.1074/jbc.273.48.31880; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nakano Y, 1996, J BIOCHEM-TOKYO, V120, P803; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Scheer A, 1996, EMBO J, V15, P3566, DOI 10.1002/j.1460-2075.1996.tb00726.x; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shkryl VM, 2006, J BIOL CHEM, V281, P1547, DOI 10.1074/jbc.M505024200; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Toth A, 1998, AM J PHYSIOL-HEART C, V275, pH1652, DOI 10.1152/ajpheart.1998.275.5.H1652; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wang CH, 2007, J BIOL CHEM, V282, P7991, DOI 10.1074/jbc.M700098200; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506	45	691	727	3	149	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 29	2010	464	7293					1313	1319		10.1038/nature08991	http://dx.doi.org/10.1038/nature08991			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20357764				2022-12-28	WOS:000277149000038
J	Chamnan, P; Simmons, RK; Khaw, KT; Wareham, NJ; Griffin, SJ				Chamnan, Parinya; Simmons, Rebecca K.; Khaw, Kay-Tee; Wareham, Nicholas J.; Griffin, Simon J.			Estimating the population impact of screening strategies for identifying and treating people at high risk of cardiovascular disease: modelling study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; PRIMARY PREVENTION; EPIC-NORFOLK; PRIMARY-CARE; MYOCARDIAL-INFARCTION; VEGETABLE INTAKE; NON-ATTENDANCE; DIABETES RISK; MEN; MORTALITY	Objective To estimate the potential population impact of different screening strategies for identifying and treating people at high risk of cardiovascular disease, including strategies using routine data for cardiovascular risk stratification, in light of the UK government's recommended national strategy to screen all adults aged 40-74 for cardiovascular risk. Design Modelling study using data from a prospective cohort, EPIC-Norfolk (European Prospective Investigation of Cancer-Norfolk). Setting An English county. Participants 16 970 men and women aged 40-74 and free from cardiovascular disease and diabetes at baseline. Main outcome measures The main outcomes were the population attributable fraction, the number needed to screen to prevent one new case of cardiovascular disease, the number needed to treat to prevent one new case of cardiovascular disease, and the number of new cardiovascular events that could be prevented. Relative risk reductions for estimated treatment effects were derived from meta-analyses of clinical trials or guidelines from the National Institute for Health and Clinical Excellence. Results 1362 cardiovascular events occurred over 183 586 person years of follow-up. Compared with the recommended government strategy, a stepwise screening approach using a simple risk score incorporating routine data could prevent a similar number (lower to upper estimates) of new cardiovascular events annually in the United Kingdom (26 789, 20 778 to 36 239) and 25 134 (19 450 to 34 134), respectively) but requiring only 60% of the population to be invited to attend a vascular risk assessment. A similar number of cardiovascular events (25 016, 19 563 to 33 372) could also be prevented by inviting everyone aged 50-74 for a vascular assessment. Using a participant completed Finnish diabetes risk score questionnaire or anthropometric cut-off points for risk prestratification was less effective. Conclusions Compared with the UK government's recommended national strategy to screen all adults aged 40-74 for cardiovascular risk, an approach using routine data for cardiovascular risk stratification before inviting people at high risk for a vascular risk assessment may be similarly effective at preventing new cases of cardiovascular disease, with potential cost savings.	[Khaw, Kay-Tee; Griffin, Simon J.] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 2SR, England; [Chamnan, Parinya; Simmons, Rebecca K.; Wareham, Nicholas J.; Griffin, Simon J.] Addenbrookes Hosp, Inst Metab Sci, MRC Epidemiol Unit, Cambridge CB2 0QQ, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Griffin, SJ (corresponding author), Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 2SR, England.	simon.griffin@mrc-epid.cam.ac.uk	Griffin, Simon J/K-3106-2013; Khaw, Kay-Tee/AAZ-3209-2021; Chamnan, Parinya/J-6712-2017	Griffin, Simon J/0000-0002-2157-4797; Chamnan, Parinya/0000-0002-5202-4149; Simmons, Rebecca/0000-0002-7726-8529	Medical Research Council [G950223]; Cancer Research UK [C8648A3883]; European Union; Royal Thai Government; National Institute for Health [RP-PG-0606-1259]; MRC [MC_U106179474] Funding Source: UKRI; Medical Research Council [MC_U106179471, MC_U106179474, G0401527] Funding Source: researchfish; National Institute for Health Research [RP-PG-0606-1259] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); European Union(European Commission); Royal Thai Government; National Institute for Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by the Medical Research Council (grant No G950223), Cancer Research UK (grant No C8648A3883), and European Union (Europe Against Cancer Programme No 6438). PC is supported by a Royal Thai Government scholarship. SJG receives support from the National Institute for Health Research programme grant funding scheme (RP-PG-0606-1259). The views expressed in this publication are those of the authors and not necessarily those of the NHS, National Institute for Health Research, or Department of Health. The sponsors did not participate in the design or conduct of this study; in the collection, management, analysis, or interpretation of data; in the writing of the manuscript; or in the preparation, review, approval, or decision to submit this manuscript for publication.	Baillargeon J, 2001, OCCUP MED-STATE ART, V16, P359; Bingham S, 2008, INT J EPIDEMIOL, V37, P978, DOI 10.1093/ije/dyn111; Boekholdt MS, 2004, AM J MED, V117, P390, DOI 10.1016/j.amjmed.2004.04.010; *BRIT HEART FDN, 2008, HLTH CAR EC COSTS CV; Capewell Simon, 2008, BMJ, V337, pa1395, DOI 10.1136/bmj.a1395; Chiuve SE, 2006, CIRCULATION, V114, P160, DOI 10.1161/CIRCULATIONAHA.106.621417; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; DAVIES G, 1994, BRIT MED J, V309, P1553, DOI 10.1136/bmj.309.6968.1553; Day N, 1999, BRIT J CANCER, V80, P95; Department of Health, 2008, EC MOD VASC CHECKS; Department of Health, 2008, PUTT PREV 1 VASC CHE; Echouffo-Tcheugui JB, 2008, DIABETIC MED, V25, P1433, DOI 10.1111/j.1464-5491.2008.02600.x; Gemmell I, 2006, QUAL SAF HEALTH CARE, V15, P339, DOI 10.1136/qshc.2005.017061; Griffin SJ, 2000, DIABETES-METAB RES, V16, P164, DOI 10.1002/1520-7560(200005/06)16:3<164::AID-DMRR103>3.0.CO;2-R; Hardoon SL, 2008, CIRCULATION, V117, P598, DOI 10.1161/CIRCULATIONAHA.107.705947; Heller RF, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-7; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Jackson Rod, 2008, BMJ, V337, pa1371, DOI 10.1136/bmj.a1371; Joshipura KJ, 1999, JAMA-J AM MED ASSOC, V282, P1233, DOI 10.1001/jama.282.13.1233; Joshipura KJ, 2001, ANN INTERN MED, V134, P1106, DOI 10.7326/0003-4819-134-12-200106190-00010; Kahn R, 2008, CIRCULATION, V118, P576, DOI 10.1161/CIRCULATIONAHA.108.190186; Khaw KT, 2006, INT J EPIDEMIOL, V35, P1034, DOI 10.1093/ije/dyl079; Knops-Dullens T, 2007, EUR J CANCER PREV, V16, P436, DOI 10.1097/01.cej.0000236250.71113.7c; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; MANT J, 1995, BMJ-BRIT MED J, V311, P793, DOI 10.1136/bmj.311.7008.793; Marshall T, 2002, BMJ-BRIT MED J, V325, P197, DOI 10.1136/bmj.325.7357.197; National Collaborating Centre for Chronic Conditions, 2006, HYP MAN HYP AD PRIM; National Institute for Health and Clinical Excellence, 2006, STAT PREV CARD EV PA; *OFF NAT STAT, DEATHS HLTH AR US RE; Office for National Statistics, 2008, MID 2007 UK ENGL WAL; PETERSON S, 2005, CORONARY HEART DIS S; Pignone M, 2006, ANN INTERN MED, V144, P326, DOI 10.7326/0003-4819-144-5-200603070-00007; Shaw C, 1999, SOC SCI MED, V49, P1571, DOI 10.1016/S0277-9536(99)00244-0; Simmons RK, 2007, DIABETIC MED, V24, P830, DOI 10.1111/j.1464-5491.2007.02173.x; Sliventoinen K, 2005, EUR J CARDIOV PREV R, V12, P451, DOI 10.1097/01.hjr.0000174793.31812.21; Spanjersberg MQI, 2007, FOOD CHEM TOXICOL, V45, P49, DOI 10.1016/j.fct.2006.07.018; Spijkerman A, 2002, J MED SCREEN, V9, P187, DOI 10.1136/jms.9.4.187; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Thomas MC, 2002, J PUBLIC HEALTH MED, V24, P285, DOI 10.1093/pubmed/24.4.285; *UK NAT SCREEN COM, 2008, HDB VASC RISK ASS RI; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; WOOD PD, 1991, NEW ENGL J MED, V325, P461, DOI 10.1056/NEJM199108153250703	44	64	67	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 25	2010	340								c1693	10.1136/bmj.c1693	http://dx.doi.org/10.1136/bmj.c1693			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589HS	20418545	Green Published, hybrid			2022-12-28	WOS:000277138400002
J	Parkhurst, J; Weller, I; Kemp, J				Parkhurst, Justin; Weller, Ian; Kemp, Julia			Getting research into policy, or out of practice, in HIV?	LANCET			English	Editorial Material							COUNTRIES		[Parkhurst, Justin] Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England; [Weller, Ian] UCL, Sch Med, Ctr Sexual Hlth & HIV Res, London W1N 8AA, England; [Weller, Ian] Camden Provider Serv, London, England; [Kemp, Julia] British Embassy, Dept Int Dev, Yangon, Myanmar	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; UCL Medical School	Parkhurst, J (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England.	justin.parkhurst@lshtm.ac.uk	Parkhurst, Justin/AAP-3615-2021					Ainsworth M, 2000, LANCET, V356, P55, DOI 10.1016/S0140-6736(00)02440-5; Alliance for Health Policy and Systems Research, 2007, SOUND CHOIC ENH CAP; [Anonymous], 2003, EVIDENCE BASED HLTH; Bonell C, 2001, BRIT MED BULL, V58, P155, DOI 10.1093/bmb/58.1.155; Garner P, 1998, BRIT MED J, V317, P531; Global Health Council, GETT RES POL PRACT G; Harries AD, 2002, B WORLD HEALTH ORGAN, V80, P464; Pawson R., 2006, EVIDENCE BASED POLIC, DOI DOI 10.4135/9781849209120; UNAIDS, 1999, SEX BEH CHANG HIV HA; Walley J, 2007, B WORLD HEALTH ORGAN, V85, P424, DOI 10.2471/BLT.07.042531; World Health Organization, 2007, TASK SHIFT TACKL HLT; World Health Organization, 2004, WORLD HLTH REP 2004	12	14	14	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 24	2010	375	9724					1414	1415		10.1016/S0140-6736(10)60585-5	http://dx.doi.org/10.1016/S0140-6736(10)60585-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	590FL	20417842				2022-12-28	WOS:000277210000007
J	Osborne, J				Osborne, Jonathan			Arguing to Learn in Science: The Role of Collaborative, Critical Discourse	SCIENCE			English	Review							SCHOOL SCIENCE; SCIENTIFIC ARGUMENTATION; 2 WRONGS; THINKING; EXPLANATION; INSTRUCTION; ELEMENTARY; ENGAGEMENT; KNOWLEDGE; STUDENTS	Argument and debate are common in science, yet they are virtually absent from science education. Recent research shows, however, that opportunities for students to engage in collaborative discourse and argumentation offer a means of enhancing student conceptual understanding and students' skills and capabilities with scientific reasoning. As one of the hallmarks of the scientist is critical, rational skepticism, the lack of opportunities to develop the ability to reason and argue scientifically would appear to be a significant weakness in contemporary educational practice. In short, knowing what is wrong matters as much as knowing what is right. This paper presents a summary of the main features of this body of research and discusses its implications for the teaching and learning of science.	Stanford Univ, Sch Educ, Stanford, CA 94305 USA	Stanford University	Osborne, J (corresponding author), Stanford Univ, Sch Educ, 485 Lasuen Mall, Stanford, CA 94305 USA.	osbornej@stanford.edu						Alexander R., 2005, DIALOGIC TEACHING RE; American Association for the Advancement of Science, 1989, SCI ALL AM PROJ 2061; AMES GJ, 1982, DEV PSYCHOL, V18, P894, DOI 10.1037/0012-1649.18.6.894; Asterhan CSC, 2007, J EDUC PSYCHOL, V99, P626, DOI 10.1037/0022-0663.99.3.626; Bachelard G, 1968, PHILOS NO PHILOS NEW; Bao L, 2009, SCIENCE, V323, P586, DOI 10.1126/science.1167740; Barron B, 2003, J LEARN SCI, V12, P307, DOI 10.1207/S15327809JLS1203_1; Berland LK, 2009, SCI EDUC, V93, P26, DOI 10.1002/sce.20286; Billig M., 1996, ARGUING THINKING RHE; Blatchford P., 2003, INT J EDUC RES, V39, P153, DOI [10.1016/S0883-0355(03)00078-8, DOI 10.1016/S0883-0355(03)00078-8]; Chi MTH, 2009, TOP COGN SCI, V1, P73, DOI 10.1111/j.1756-8765.2008.01005.x; Driver R, 2000, SCI EDUC, V84, P287, DOI 10.1002/(SICI)1098-237X(200005)84:3<287::AID-SCE1>3.3.CO;2-1; Hake RR, 1998, AM J PHYS, V66, P64, DOI 10.1119/1.18809; Halliday M. A. K., 1993, LINGUIST EDUC, V5, P93, DOI [10.1016/0898-5898(93)90026-7, DOI 10.1016/0898-5898(93)90026-7]; Herrenkohl LR, 1998, COGNITION INSTRUCT, V16, P431, DOI 10.1207/s1532690xci1604_3; HOWE C, 1992, BRIT J DEV PSYCHOL, V10, P113, DOI 10.1111/j.2044-835X.1992.tb00566.x; HYND C, 1986, J READING, V29, P440; Inhelder B, 1958, GROWTH LOGICAL THINK; Jermann P., 2003, ARGUING LEARN CONFRO, P205, DOI DOI 10.1007/978-94-017-0781-7_8; Klahr D, 2004, PSYCHOL SCI, V15, P661, DOI 10.1111/j.0956-7976.2004.00737.x; Koslowski B, 2008, COGNITIVE DEV, V23, P472, DOI 10.1016/j.cogdev.2008.09.007; KUHN D, 1992, HARVARD EDUC REV, V62, P155, DOI 10.17763/haer.62.2.9r424r0113t670l1; Latour B., 1986, LAB LIFE CONSTRUCTIO; Lemke J., 1990, TALKING SCI LANGUAGE; Longino H. E., 1990, SCI SOCIAL KNOWLEDGE, DOI [10.1515/9780691209753, DOI 10.2307/J.CTVX5WBFZ]; Mercer N, 2004, BRIT EDUC RES J, V30, P359, DOI 10.1080/01411920410001689689; Mercer N., 1999, BRIT EDUC RES J, V25, P95, DOI [10.1080/0141192990250107, DOI 10.1080/0141192990250107]; Mercer N., 2007, DIALOGUE DEV CHILDRE; METZ KE, 1995, REV EDUC RES, V65, P93, DOI 10.3102/00346543065002093; *NAT RES COUNC, 2008, RES FUT SKILL DEM; National Academy of Science, 1995, NAT SCI ED STAND; National Research Council, 2000, INQ NAT SCI ED STAND; Newton P, 1999, INT J SCI EDUC, V21, P553, DOI 10.1080/095006999290570; Nolen SB, 2003, J RES SCI TEACH, V40, P347, DOI 10.1002/tea.10080; Norris SP, 2008, SCI EDUC, V92, P765, DOI 10.1002/sce.20266; Osborne J, 2004, J RES SCI TEACH, V41, P994, DOI 10.1002/tea.20035; Osborne J, 2001, INT J SCI EDUC, V23, P441, DOI 10.1080/09500690010006518; Popper K. R., 1963, CONJECTURES REFUTAT; Reddy Michael J., 1993, METAPHOR THOUGHT, P182; Sampson V, 2009, SCI EDUC, V93, P448, DOI 10.1002/sce.20306; Schwarz BB, 2000, COGNITION INSTRUCT, V18, P461, DOI 10.1207/S1532690XCI1804_2; SHAYER M, 1993, J RES SCI TEACH, V30, P351, DOI 10.1002/tea.3660300404; Toulmin Stephen, 1958, USES ARGUMENT; Webb NM, 2009, BRIT J EDUC PSYCHOL, V79, P1, DOI 10.1348/000709908X380772; Wertsch J.V., 2009, VOICES MIND SOCIOCUL; Zimmerman C, 2007, DEV REV, V27, P172, DOI 10.1016/j.dr.2006.12.001; Zohar A, 2002, J RES SCI TEACH, V39, P35, DOI 10.1002/tea.10008; Zohar A, 2008, METACOGN LEARN, V3, P59, DOI 10.1007/s11409-007-9019-4	48	435	444	14	241	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 23	2010	328	5977					463	466		10.1126/science.1183944	http://dx.doi.org/10.1126/science.1183944			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	586YR	20413492				2022-12-28	WOS:000276952400032
J	Wahl, ER; Morrill, C				Wahl, Eugene R.; Morrill, Carrie			CLIMATE CHANGE Toward Understanding and Predicting Monsoon Patterns	SCIENCE			English	Editorial Material									[Wahl, Eugene R.] NOAA, Natl Climat Data Ctr, Paleoclimatol Branch, World Data Ctr Paleoclimatol, Boulder, CO 80305 USA; [Morrill, Carrie] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA	National Center Atmospheric Research (NCAR) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder	Wahl, ER (corresponding author), NOAA, Natl Climat Data Ctr, Paleoclimatol Branch, World Data Ctr Paleoclimatol, 325 Broadway, Boulder, CO 80305 USA.	eugene.r.wahl@noaa.gov		Morrill, Carrie/0000-0002-1635-5469				Cook ER, 2007, EARTH-SCI REV, V81, P93, DOI 10.1016/j.earscirev.2006.12.002; Cook ER, 2010, SCIENCE, V328, P486, DOI 10.1126/science.1185188; Davis Mike., 2001, LATE VICTORIAN HOLOC; Graham NE, 2007, CLIMATIC CHANGE, V83, P241, DOI [10.1007/s10584-007-9239-2, 10.1007/s 10584-007-9239-2]; Kumar KK, 1999, SCIENCE, V284, P2156, DOI 10.1126/science.284.5423.2156; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Webster PJ, 1998, J GEOPHYS RES-OCEANS, V103, P14451, DOI 10.1029/97JC02719; Zhang PZ, 2008, SCIENCE, V322, P940, DOI 10.1126/science.1163965	8	32	32	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2010	328	5977					437	438		10.1126/science.1188926	http://dx.doi.org/10.1126/science.1188926			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YR	20413481				2022-12-28	WOS:000276952400021
J	Ribet, D; Hamon, M; Gouin, E; Nahori, MA; Impens, F; Neyret-Kahn, H; Gevaert, K; Vandekerckhove, J; Dejean, A; Cossart, P				Ribet, David; Hamon, Melanie; Gouin, Edith; Nahori, Marie-Anne; Impens, Francis; Neyret-Kahn, Helene; Gevaert, Kris; Vandekerckhove, Joel; Dejean, Anne; Cossart, Pascale			Listeria monocytogenes impairs SUMOylation for efficient infection	NATURE			English	Article							GROWTH-FACTOR-BETA; HISTONE MODIFICATIONS; SUMO PATHWAY; PROTEIN; CELLS; HOST; PROTEOMICS; FAMILY; ENTRY; MICE	During infection, pathogenic bacteria manipulate the host cell in various ways to allow their own replication, propagation and escape from host immune responses. Post-translational modifications are unique mechanisms that allow cells to rapidly, locally and specifically modify activity or interactions of key proteins. Some of these modifications, including phosphorylation and ubiquitylation(1,2), can be induced by pathogens. However, the effects of pathogenic bacteria on SUMOylation, an essential post-translational modification in eukaryotic cells(3), remain largely unknown. Here we show that infection with Listeria monocytogenes leads to a decrease in the levels of cellular SUMO-conjugated proteins. This event is triggered by the bacterial virulence factor listeriolysin O (LLO), which induces a proteasome-independent degradation of Ubc9, an essential enzyme of the SUMOylation machinery, and a proteasome-dependent degradation of some SUMOylated proteins. The effect of LLO on Ubc9 is dependent on the pore-forming capacity of the toxin and is shared by other bacterial pore-forming toxins like perfringolysin O(PFO) and pneumolysin (PLY). Ubc9 degradation was also observed in vivo in infected mice. Furthermore, we show that SUMO overexpression impairs bacterial infection. Together, our results reveal that Listeria, and probably other pathogens, dampen the host response by decreasing the SUMOylation level of proteins critical for infection.	[Ribet, David; Hamon, Melanie; Gouin, Edith; Nahori, Marie-Anne; Cossart, Pascale] Inst Pasteur, Dept Biol Cellulaire & Infect, Unite Interact Bacteries Cellules, F-75015 Paris, France; [Ribet, David; Hamon, Melanie; Gouin, Edith; Nahori, Marie-Anne; Cossart, Pascale] INRA, USC2020, F-75015 Paris, France; [Ribet, David; Hamon, Melanie; Gouin, Edith; Nahori, Marie-Anne; Cossart, Pascale] INSERM, U604, F-75015 Paris, France; [Impens, Francis; Gevaert, Kris; Vandekerckhove, Joel] VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Impens, Francis; Gevaert, Kris; Vandekerckhove, Joel] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Neyret-Kahn, Helene; Dejean, Anne] Inst Pasteur, Dept Biol Cellulaire & Infect, Unite Org Nucl & Oncogenese, F-75015 Paris, France; [Neyret-Kahn, Helene; Dejean, Anne] INSERM, U579, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Flanders Institute for Biotechnology (VIB); Ghent University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Cossart, P (corresponding author), Inst Pasteur, Dept Biol Cellulaire & Infect, Unite Interact Bacteries Cellules, F-75015 Paris, France.	pascale.cossart@pasteur.fr	Hamon, Melanie/B-3501-2013; Gevaert, Kris/AAE-4212-2019; Gevaert, Kris/H-3637-2013; Ribet, David/AAA-6659-2020; Impens, Francis/C-3335-2009; Dejean, Anne/L-5145-2018; Gevaert, Kris/D-6489-2017	Gevaert, Kris/0000-0002-4237-0283; Gevaert, Kris/0000-0002-4237-0283; Ribet, David/0000-0003-1175-6471; Gevaert, Kris/0000-0002-4237-0283; Hamon, Melanie/0000-0001-5078-4083; Marie-Anne, Nahori/0000-0002-4066-4528; Impens, Francis/0000-0003-2886-9616; NEYRET-KAHN, Helene/0000-0002-5660-4941	Institut Pasteur; INSERM; INRA; European Research Council (ERC) [233348]; Fund for Scientific Research Flanders (Belgium) [G.0042.07]; Concerted Research Actions [BOF07/GOA/012]; Ghent University; Inter University Attraction Poles [IUAP06]; Association pour la Recherche sur le Cancer; Research Assistant of the Research Foundation - Flanders (Fonds Wetenschappelijk Onderzoek - Vlaanderen)	Institut Pasteur(European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); INRA; European Research Council (ERC)(European Research Council (ERC)European Commission); Fund for Scientific Research Flanders (Belgium)(FWO); Concerted Research Actions; Ghent University(Ghent University); Inter University Attraction Poles(Belgian Federal Science Policy Office); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Research Assistant of the Research Foundation - Flanders (Fonds Wetenschappelijk Onderzoek - Vlaanderen)(FWO)	We thank V. Villiers for technical assistance. Work in the P. C. laboratory received financial support from Institut Pasteur, INSERM, INRA and European Research Council (ERC, Advanced Grant 233348). We further acknowledge support by research grants from the Fund for Scientific Research Flanders (Belgium) (project number G.0042.07), the Concerted Research Actions (project BOF07/GOA/012) from Ghent University and the Inter University Attraction Poles (IUAP06). D. R. is supported by a fellowship from the Association pour la Recherche sur le Cancer, F. I. is a Research Assistant of the Research Foundation - Flanders (Fonds Wetenschappelijk Onderzoek - Vlaanderen) and P. C. is an international research scholar of the Howard Hughes Medical Institute.	Bischof O, 2006, MOL CELL, V22, P783, DOI 10.1016/j.molcel.2006.05.016; Boggio R, 2004, MOL CELL, V16, P549, DOI 10.1016/j.molcel.2004.11.007; Boggio R, 2007, J BIOL CHEM, V282, P15376, DOI 10.1074/jbc.M700889200; Boggio R, 2006, CURR OPIN MICROBIOL, V9, P430, DOI 10.1016/j.mib.2006.06.008; Bonazzi M, 2008, CELL MICROBIOL, V10, P2208, DOI 10.1111/j.1462-5822.2008.01200.x; Cossart P, 2008, MICROBES INFECT, V10, P1041, DOI 10.1016/j.micinf.2008.07.043; DRAMSI S, 1995, MOL MICROBIOL, V16, P251, DOI 10.1111/j.1365-2958.1995.tb02297.x; Dramsi S, 2003, INFECT IMMUN, V71, P3614, DOI 10.1128/IAI.71.6.3614-3618.2003; Fitzpatrick DR, 1999, TRENDS MICROBIOL, V7, P232, DOI 10.1016/S0966-842X(99)01498-5; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gevaert K, 2008, PROTEOMICS, V8, P4873, DOI 10.1002/pmic.200800421; Glomski IJ, 2002, J CELL BIOL, V156, P1029, DOI 10.1083/jcb.200201081; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Hamon MA, 2008, CELL HOST MICROBE, V4, P100, DOI 10.1016/j.chom.2008.07.009; Hamon MA, 2007, P NATL ACAD SCI USA, V104, P13467, DOI 10.1073/pnas.0702729104; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hotze EM, 2002, J BIOL CHEM, V277, P11597, DOI 10.1074/jbc.M111039200; Kang JS, 2008, NAT CELL BIOL, V10, P654, DOI 10.1038/ncb1728; Lin X, 2003, J BIOL CHEM, V278, P31043, DOI 10.1074/jbc.C300112200; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; MICHEL E, 1990, MOL MICROBIOL, V4, P2167, DOI 10.1111/j.1365-2958.1990.tb00578.x; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Nakane A, 1996, INFECT IMMUN, V64, P3901, DOI 10.1128/IAI.64.9.3901-3904.1996; NATO F, 1991, INFECT IMMUN, V59, P4641, DOI 10.1128/IAI.59.12.4641-4646.1991; Rytkonen A, 2007, CELL HOST MICROBE, V1, P13, DOI 10.1016/j.chom.2007.02.003; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Schnupf P, 2007, MICROBES INFECT, V9, P1176, DOI 10.1016/j.micinf.2007.05.005; Tang P, 1996, INFECT IMMUN, V64, P2359, DOI 10.1128/IAI.64.6.2359-2361.1996; Veiga E, 2005, NAT CELL BIOL, V7, P894, DOI 10.1038/ncb1292; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4	32	147	153	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2010	464	7292					1192	U111		10.1038/nature08963	http://dx.doi.org/10.1038/nature08963			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20414307	Green Accepted			2022-12-28	WOS:000276891100037
J	Brook, RH; Young, RT				Brook, Robert H.; Young, Roy T.			The Primary Care Physician and Health Care Reform	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Brook, Robert H.] RAND Corp, Santa Monica, CA 90407 USA; [Young, Roy T.] Eisenhower Med Ctr, Rancho Mirage, CA USA	RAND Corporation	Brook, RH (corresponding author), RAND Corp, 1776 Main St, Santa Monica, CA 90407 USA.	robert_brook@rand.org						*AM MED ASS, 2009, PHYS CHAR DISTR US C; *AM MED GROUP ASS, 2009, MED GROUP COMP FIN S; Cherry D.K., 2008, NATL AMBULATORY MED; Larson EB, 2004, J GEN INTERN MED, V19, P69, DOI 10.1111/j.1525-1497.2004.31337.x; Rittenhouse DR, 2009, NEW ENGL J MED, V361, P2301, DOI 10.1056/NEJMp0909327; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Steinbrook R, 2009, NEW ENGL J MED, V360, P2696, DOI 10.1056/NEJMp0903460; Wennberg JE, 2008, TRACKING CARE PATIEN	8	11	11	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2010	303	15					1535	1536		10.1001/jama.2010.472	http://dx.doi.org/10.1001/jama.2010.472			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585SJ	20407064				2022-12-28	WOS:000276849000031
J	Hudson, TJ; Anderson, W; Aretz, A; Barker, AD; Bell, C; Bernabe, RR; Bhan, MK; Calvo, F; Eerola, I; Gerhard, DS; Guttmacher, A; Guyer, M; Hemsley, FM; Jennings, JL; Kerr, D; Klatt, P; Kolar, P; Kusuda, J; Lane, DP; Laplace, F; Lu, YY; Nettekoven, G; Ozenberger, B; Peterson, J; Rao, TS; Remacle, J; Schafer, AJ; Shibata, T; Stratton, MR; Vockley, JG; Watanabe, K; Yang, HM; Yuen, MMF; Knoppers, M; Bobrow, M; Cambon-Thomsen, A; Dressler, LG; Dyke, SOM; Joly, Y; Kato, K; Kennedy, KL; Nicolas, P; Parker, MJ; Rial-Sebbag, E; Romeo-Casabona, CM; Shaw, KM; Wallace, S; Wiesner, GL; Zeps, N; Lichter, P; Biankin, AV; Chabannon, C; Chin, L; Clement, B; de Alava, E; Degos, F; Ferguson, ML; Geary, P; Hayes, DN; Johns, AL; Nakagawa, H; Penny, R; Piris, MA; Sarin, R; Scarpa, A; van de Vijver, M; Futreal, PA; Aburatani, H; Bayes, M; Bowtell, DDL; Campbell, PJ; Estivill, X; Grimmond, SM; Gut, I; Hirst, M; Lopez-Otin, C; Majumder, P; Marra, M; Ning, ZM; Puente, XS; Ruan, YJ; Stunnenberg, HG; Swerdlow, H; Velculescu, VE; Wilson, RK; Xue, HH; Yang, L; Spellman, PT; Bader, GD; Boutros, PC; Flicek, P; Getz, G; Guigo, R; Guo, GW; Haussler, D; Heath, S; Hubbard, TJ; Jiang, T; Jones, SM; Li, QB; Lopez-Bigas, N; Luo, RB; Pearson, JV; Quesada, V; Raphael, BJ; Sander, C; Speed, TP; Stuart, JM; Teague, JW; Totoki, Y; Tsunoda, T; Valencia, A; Wheeler, DA; Wu, HL; Zhao, SC; Zhou, GY; Stein, LD; Lathrop, M; Ouellette, BFF; Thomas, G; Yoshida, T; Axton, M; Gunter, C; McPherson, JD; Miller, LJ; Kasprzyk, A; Zhang, JJ; Haider, SA; Wang, JX; Yung, CK; Cross, A; Liang, Y; Gnaneshan, S; Guberman, J; Hsu, J; Chalmers, DRC; Hasel, KW; Kaan, TSH; Knoppers, BM; Lowrance, WW; Masui, T; Rodriguez, LL; Vergely, C; Cloonan, N; Defazio, A; Eshleman, JR; Etemadmoghadam, D; Gardiner, BA; Kench, JG; Sutherland, RL; Tempero, MA; Waddell, NJ; Wilson, PJ; Gallinger, S; Tsao, MS; Shaw, PA; Petersen, GM; Mukhopadhyay, D; DePinho, RA; Thayer, S; Muthuswamy, L; Shazand, K; Beck, T; Sam, M; Timms, L; Ballin, V; Ji, JF; Zhang, XQ; Chen, F; Hu, XD; Yang, Q; Tian, G; Zhang, LH; Xing, XF; Li, XH; Zhu, ZG; Yu, YY; Yu, J; Tost, J; Brennan, P; Holcatova, I; Zaridze, D; Brazma, A; Egevad, L; Prokhortchouk, E; Banks, RE; Uhlen, M; Viksna, J; Ponten, F; Skryabin, K; Birney, E; Borg, A; Borresen-Dale, AL; Caldas, C; Foekens, JA; Martin, S; Reis-Filho, JS; Richardson, AL; Sotiriou, C; van't Veer, L; Birnbaum, D; Blanche, H; Boucher, P; Boyault, S; Masson-Jacquemier, JD; Pauporte, I; Pivot, X; Vincent-Salomon, A; Tabone, E; Theillet, C; Treilleux, I; Bioulac-Sage, P; Decaens, T; Franco, D; Gut, M; Samuel, D; Zucman-Rossi, J; Eils, R; Brors, B; Korbel, JO; Korshunov, A; Landgraf, P; Lehrach, H; Pfister, S; Radlwimmer, B; Reifenberger, G; Taylor, MD; von Kalle, C; Majumder, PP; Pederzoli, P; Lawlor, RT; Delledonne, M; Bardelli, A; Gress, T; Klimstra, D; Zamboni, G; Nakamura, Y; Miyano, S; Fujimoto, A; Campo, E; de Sanjose, S; Montserrat, E; Gonzalez-Diaz, M; Jares, P; Himmelbaue, H; Bea, S; Aparicio, S; Easton, DF; Collins, FS; Compton, CC; Lander, ES; Burke, W; Green, AR; Hamilton, SR; Kallioniemi, OP; Ley, TJ; Liu, ET; Wainwright, BJ				Hudson, Thomas J.; Anderson, Warwick; Aretz, Axel; Barker, Anna D.; Bell, Cindy; Bernabe, Rosa R.; Bhan, M. K.; Calvo, Fabien; Eerola, Iiro; Gerhard, Daniela S.; Guttmacher, Alan; Guyer, Mark; Hemsley, Fiona M.; Jennings, Jennifer L.; Kerr, David; Klatt, Peter; Kolar, Patrik; Kusuda, Jun; Lane, David P.; Laplace, Frank; Lu, Youyong; Nettekoven, Gerd; Ozenberger, Brad; Peterson, Jane; Rao, T. S.; Remacle, Jacques; Schafer, Alan J.; Shibata, Tatsuhiro; Stratton, Michael R.; Vockley, Joseph G.; Watanabe, Koichi; Yang, Huanming; Yuen, Matthew M. F.; Knoppers, M.; Bobrow, Martin; Cambon-Thomsen, Anne; Dressler, Lynn G.; Dyke, Stephanie O. M.; Joly, Yann; Kato, Kazuto; Kennedy, Karen L.; Nicolas, Pilar; Parker, Michael J.; Rial-Sebbag, Emmanuelle; Romeo-Casabona, Carlos M.; Shaw, Kenna M.; Wallace, Susan; Wiesner, Georgia L.; Zeps, Nikolajs; Lichter, Peter; Biankin, Andrew V.; Chabannon, Christian; Chin, Lynda; Clement, Bruno; de Alava, Enrique; Degos, Francoise; Ferguson, Martin L.; Geary, Peter; Hayes, D. Neil; Johns, Amber L.; Nakagawa, Hidewaki; Penny, Robert; Piris, Miguel A.; Sarin, Rajiv; Scarpa, Aldo; van de Vijver, Marc; Futreal, P. Andrew; Aburatani, Hiroyuki; Bayes, Monica; Bowtell, David D. L.; Campbell, Peter J.; Estivill, Xavier; Grimmond, Sean M.; Gut, Ivo; Hirst, Martin; Lopez-Otin, Carlos; Majumder, Partha; Marra, Marco; Ning, Zemin; Puente, Xose S.; Ruan, Yijun; Stunnenberg, Hendrik G.; Swerdlow, Harold; Velculescu, Victor E.; Wilson, Richard K.; Xue, Hong H.; Yang, Liu; Spellman, Paul T.; Bader, Gary D.; Boutros, Paul C.; Flicek, Paul; Getz, Gad; Guigo, Roderic; Guo, Guangwu; Haussler, David; Heath, Simon; Hubbard, Tim J.; Jiang, Tao; Jones, Steven M.; Li, Qibin; Lopez-Bigas, Nuria; Luo, Ruibang; Pearson, John V.; Quesada, Victor; Raphael, Benjamin J.; Sander, Chris; Speed, Terence P.; Stuart, Joshua M.; Teague, Jon W.; Totoki, Yasushi; Tsunoda, Tatsuhiko; Valencia, Alfonso; Wheeler, David A.; Wu, Honglong; Zhao, Shancen; Zhou, Guangyu; Stein, Lincoln D.; Lathrop, Mark; Ouellette, B. F. Francis; Thomas, Gilles; Yoshida, Teruhiko; Axton, Myles; Gunter, Chris; McPherson, John D.; Miller, Linda J.; Kasprzyk, Arek; Zhang, Junjun; Haider, Syed A.; Wang, Jianxin; Yung, Christina K.; Cross, Anthony; Liang, Yong; Gnaneshan, Saravanamuttu; Guberman, Jonathan; Hsu, Jack; Chalmers, Don R. C.; Hasel, Karl W.; Kaan, Terry S. H.; Knoppers, Bartha M.; Lowrance, William W.; Masui, Tohru; Rodriguez, Laura Lyman; Vergely, Catherine; Cloonan, Nicole; Defazio, Anna; Eshleman, James R.; Etemadmoghadam, Dariush; Gardiner, Brooke A.; Kench, James G.; Sutherland, Robert L.; Tempero, Margaret A.; Waddell, Nicola J.; Wilson, Peter J.; Gallinger, Steve; Tsao, Ming-Sound; Shaw, Patricia A.; Petersen, Gloria M.; Mukhopadhyay, Debabrata; DePinho, Ronald A.; Thayer, Sarah; Muthuswamy, Lakshmi; Shazand, Kamran; Beck, Timothy; Sam, Michelle; Timms, Lee; Ballin, Vanessa; Ji, Jiafu; Zhang, Xiuqing; Chen, Feng; Hu, Xueda; Yang, Qi; Tian, Geng; Zhang, Lianhai; Xing, Xiaofang; Li, Xianghong; Zhu, Zhenggang; Yu, Yingyan; Yu, Jun; Tost, Joerg; Brennan, Paul; Holcatova, Ivana; Zaridze, David; Brazma, Alvis; Egevad, Lars; Prokhortchouk, Egor; Banks, Rosamonde Elizabeth; Uhlen, Mathias; Viksna, Juris; Ponten, Fredrik; Skryabin, Konstantin; Birney, Ewan; Borg, Ake; Borresen-Dale, Anne-Lise; Caldas, Carlos; Foekens, John A.; Martin, Sancha; Reis-Filho, Jorge S.; Richardson, Andrea L.; Sotiriou, Christos; van't Veer, Laura; Birnbaum, Daniel; Blanche, Helene; Boucher, Pascal; Boyault, Sandrine; Masson-Jacquemier, Jocelyne D.; Pauporte, Iris; Pivot, Xavier; Vincent-Salomon, Anne; Tabone, Eric; Theillet, Charles; Treilleux, Isabelle; Bioulac-Sage, Paulette; Decaens, Thomas; Franco, Dominique; Gut, Marta; Samuel, Didier; Zucman-Rossi, Jessica; Eils, Roland; Brors, Benedikt; Korbel, Jan O.; Korshunov, Andrey; Landgraf, Pablo; Lehrach, Hans; Pfister, Stefan; Radlwimmer, Bernhard; Reifenberger, Guido; Taylor, Michael D.; von Kalle, Christof; Majumder, Partha P.; Pederzoli, Paolo; Lawlor, Rita T.; Delledonne, Massimo; Bardelli, Alberto; Gress, Thomas; Klimstra, David; Zamboni, Giuseppe; Nakamura, Yusuke; Miyano, Satoru; Fujimoto, Akihiro; Campo, Elias; de Sanjose, Silvia; Montserrat, Emili; Gonzalez-Diaz, Marcos; Jares, Pedro; Himmelbaue, Heinz; Bea, Silvia; Aparicio, Samuel; Easton, Douglas F.; Collins, Francis S.; Compton, Carolyn C.; Lander, Eric S.; Burke, Wylie; Green, Anthony R.; Hamilton, Stanley R.; Kallioniemi, Olli P.; Ley, Timothy J.; Liu, Edison T.; Wainwright, Brandon J.		Int Canc Genome Consortium	International network of cancer genome projects	NATURE			English	Article							SOMATIC MUTATIONS; MYELOID-LEUKEMIA; BREAST-CANCER; GENE; PATHWAYS; LANDSCAPES	The International Cancer Genome Consortium (ICGC) was launched to coordinate large-scale cancer genome studies in tumours from 50 different cancer types and/or subtypes that are of clinical and societal importance across the globe. Systematic studies of more than 25,000 cancer genomes at the genomic, epigenomic and transcriptomic levels will reveal the repertoire of oncogenic mutations, uncover traces of the mutagenic influences, define clinically relevant subtypes for prognosis and therapeutic management, and enable the development of new cancer therapies.	[Jennings, Jennifer L.; Boutros, Paul C.; Stein, Lincoln D.; Ouellette, B. F. Francis; McPherson, John D.; Kasprzyk, Arek; Zhang, Junjun; Wang, Jianxin; Yung, Christina K.; Cross, Anthony; Liang, Yong; Gnaneshan, Saravanamuttu; Guberman, Jonathan; Hsu, Jack; Muthuswamy, Lakshmi; Shazand, Kamran; Beck, Timothy; Sam, Michelle; Timms, Lee; Ballin, Vanessa] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A1, Canada; Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada; [Hudson, Thomas J.; Anderson, Warwick] Natl Hlth & Med Res Council, Canberra, ACT 2601, Australia; [Aretz, Axel] German Aerosp Ctr DLR, Project Management Agcy, D-53175 Bonn, Germany; [Barker, Anna D.; Gerhard, Daniela S.; Vockley, Joseph G.; Shaw, Kenna M.; Compton, Carolyn C.] NCI, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Bell, Cindy; Hasel, Karl W.] Genome Canada, Ottawa, ON K2P 1P1, Canada; [Bernabe, Rosa R.; Klatt, Peter] Minist Sci & Innovat, Secretariat State Res, Madrid 28027, Spain; [Bhan, M. K.; Rao, T. S.] Govt India, Minist Sci & Technol, Dept Biotechnol, New Delhi 110003, India; [Calvo, Fabien; Chabannon, Christian; Boucher, Pascal; Pauporte, Iris] Natl Canc Inst, F-92513 Boulogne, France; [Eerola, Iiro; Kolar, Patrik; Remacle, Jacques] European Commiss, Hlth Res Directorate, Genom & Syst Biol Unit, B-1049 Brussels, Belgium; [Guttmacher, Alan] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Guyer, Mark; Ozenberger, Brad; Peterson, Jane; Rodriguez, Laura Lyman] NHGRI, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Hemsley, Fiona M.; Lane, David P.] Canc Res UK, London WC2A 3PX, England; [Kerr, David] Qatar Fdn, Sidra Med & Res Ctr, Doha, Qatar; Univ Oxford, Dept Clin Pharmacol, Oxford OX2 6HE, England; [Kusuda, Jun; Masui, Tohru] Natl Inst Biomed Innovat, Osaka 5670085, Japan; [Laplace, Frank] Fed Minist Educ & Res, Div Mol Life Sci, D-11055 Berlin, Germany; [Lu, Youyong; Ji, Jiafu; Chen, Feng; Zhang, Lianhai; Xing, Xiaofang; Li, Xianghong] Peking Univ, Sch Oncol, Beijing Canc Inst & Hosp, Beijing 100142, Peoples R China; [Nettekoven, Gerd] German Canc Aid, D-53113 Bonn, Germany; [Schafer, Alan J.] Wellcome Trust Res Labs, London NW1 2BE, England; [Shibata, Tatsuhiro; Totoki, Yasushi; Yoshida, Teruhiko; Zaridze, David] Natl Canc Ctr, Chuo Ku, Tokyo 1040045, Japan; [Stratton, Michael R.; Dyke, Stephanie O. M.; Kennedy, Karen L.; Futreal, P. Andrew; Campbell, Peter J.; Ning, Zemin; Swerdlow, Harold; Hubbard, Tim J.; Teague, Jon W.; Martin, Sancha] Hinxton, Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Watanabe, Koichi] RIKEN, Yokohama Inst, Kanagawa, Japan; [Yang, Huanming; Guo, Guangwu; Jiang, Tao; Li, Qibin; Luo, Ruibang; Wu, Honglong; Zhao, Shancen; Zhou, Guangyu; Zhang, Xiuqing; Hu, Xueda; Yang, Qi; Tian, Geng] BGI Shenzhen, Shenzhen 518083, Guangdong, Peoples R China; [Yuen, Matthew M. F.] Hong Kong Univ Sci & Technol, Hong Kong, Hong Kong, Peoples R China; [Knoppers, M.; Joly, Yann; Wallace, Susan; Knoppers, Bartha M.] McGill Univ, Ctr Genom & Policy, Montreal, PQ H3A 1A4, Canada; [Knoppers, M.; Wallace, Susan] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; [Bobrow, Martin] Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England; [Cambon-Thomsen, Anne; Rial-Sebbag, Emmanuelle] Fac Med Toulouse, INSERM, U558, F-31073 Toulouse, France; [Dressler, Lynn G.] Univ N Carolina, Sch Pharm, Div Pharmaceut Outcomes & Policy, Inst Pharmacogen & Individualized Therapy, Chapel Hill, NC 27599 USA; [Kato, Kazuto] Kyoto Univ, Grad Sch Biostudies, Inst Integrated Cell Mat Sci, Inst Res Humanities, Kyoto 6068501, Japan; [Nicolas, Pilar; Romeo-Casabona, Carlos M.] Univ Deusto, Interuniv Chair Law & Human Genome, Bizkaia 48007, Spain; [Parker, Michael J.] Univ Oxford, Ethox Ctr, Oxford OX3 7LF, England; [Wiesner, Georgia L.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Wiesner, Georgia L.] Univ Hosp Cleveland, Case Med Ctr, Ctr Human Genet, Cleveland, OH 44106 USA; St John God Pathol, Subiaco, WA 6008, Australia; Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia; [Zeps, Nikolajs] Univ Western Australia, Sch Surg, Nedlands, WA 6009, Australia; [Lichter, Peter; Eils, Roland; Brors, Benedikt; Pfister, Stefan; Radlwimmer, Bernhard] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Biankin, Andrew V.; Johns, Amber L.; Kench, James G.; Sutherland, Robert L.] Univ New S Wales, Garvan Inst Med Res, Sydney, NSW 2010, Australia; Bankstown Hosp, Dept Surg, Sydney, NSW 2200, Australia; [Birnbaum, Daniel; Masson-Jacquemier, Jocelyne D.] Inst J Paoli I Calmettes, F-13273 Marseille, France; [Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Chin, Lynda] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Clement, Bruno] INSERM, U991, F-35043 Rennes, France; [de Alava, Enrique; Gonzalez-Diaz, Marcos] Univ Salamanca, Ctr Invest Canc, Univ Hosp, Dept Hematol, Salamanca 37007, Spain; [Degos, Francoise] Hop Beaujon, F-92110 Clichy, France; [Ferguson, Martin L.] MLF Consulting, Arlington, MA 02474 USA; [Geary, Peter] Canadian Tumour Repository Network, Winnipeg, MB R3M 0V5, Canada; [Hayes, D. Neil] Univ N Carolina, Div Med Oncol, Lineberger Comprehens Canc Ctr, Dept Internal Med, Chapel Hill, NC 27599 USA; [Nakagawa, Hidewaki; Tsunoda, Tatsuhiko; Nakamura, Yusuke; Fujimoto, Akihiro] RIKEN, Ctr Genom Med, Kanagawa 2300045, Japan; [Penny, Robert] Int Genom Consortium, Phoenix, AZ 85004 USA; [Piris, Miguel A.] Spanish Natl Canc Res Ctr, Mol Pathol Programme, Madrid 28029, Spain; [Sarin, Rajiv] Tata Mem Hosp, Adv Ctr Treatment, Res & Educ Canc, Navi Mumbai 41021, Maharashtra, India; [Scarpa, Aldo; Zamboni, Giuseppe] Univ Verona, Dept Pathol, I-37134 Verona, Italy; [Scarpa, Aldo; Lawlor, Rita T.] Verona Univ Hosp, Ctr Appl Res Canc ARC NET, I-37134 Verona, Italy; [van de Vijver, Marc; van't Veer, Laura] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [van de Vijver, Marc] Acad Med Ctr, NL-1015 AZ Amsterdam, Netherlands; [Aburatani, Hiroyuki] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan; [Bayes, Monica; Estivill, Xavier; Himmelbaue, Heinz] Pompeu Fabra Univ, Ctr Genom Regulat, Barcelona 08003, Spain; [Bayes, Monica] Biomed Res Ctr CIBERESP, Publ Hlth & Epidemiol Network, Barcelona 08003, Catalonia, Spain; [Bowtell, David D. L.; Etemadmoghadam, Dariush] Peter MacCallum Canc Ctr, Melbourne, Vic 3002, Australia; [Etemadmoghadam, Dariush] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; Univ Cambridge, Dept Haematol, Cambridge CB2 2XY, England; [Grimmond, Sean M.; Pearson, John V.; Cloonan, Nicole; Gardiner, Brooke A.; Waddell, Nicola J.] Univ Queensland, Inst Mol Biosci, Queensland Ctr Med Genom, Brisbane, Qld 4067, Australia; [Gut, Ivo; Heath, Simon; Lathrop, Mark; Tost, Joerg] CEA, DSV, IG Ctr Natl Genotypage, F-91057 Evry, France; [Hirst, Martin; Marra, Marco; Jones, Steven M.] British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Lopez-Otin, Carlos; Puente, Xose S.; Quesada, Victor] Univ Oviedo, Inst Univ Oncol, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain; [Majumder, Partha; Majumder, Partha P.] Natl Inst Biomed Genom, Kalyani 741251, W Bengal, India; [McPherson, John D.] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A1, Canada; [Ruan, Yijun; Liu, Edison T.] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore 138672, Singapore; [Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Velculescu, Victor E.] Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA; [Wilson, Richard K.; Ley, Timothy J.] Washington Univ, Sch Med, Genome Ctr, St Louis, MO 63108 USA; Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63108 USA; [Xue, Hong H.] HKUST, Appl Genom Ctr, Fok Ying Grad Sch, Hong Kong, Hong Kong, Peoples R China; [Xue, Hong H.] Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Yang, Liu] Zhejiang Univ, Inst Canc, Hangzhou 310009, Zhejiang, Peoples R China; [Spellman, Paul T.] Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94510 USA; [Bader, Gary D.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Bader, Gary D.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Flicek, Paul; Brazma, Alvis; Birney, Ewan; Korbel, Jan O.] Hinxton, European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; [Getz, Gad; Lander, Eric S.] MIT, Cambridge, MA 02142 USA; [Getz, Gad] Broad Inst Harvard, Cambridge, MA 02142 USA; [Guigo, Roderic] Univ Pompeu Fabra, Spanish Natl Bioinformat Inst, Barcelona 08003, Spain; Univ Pompeu Fabra, Ctr Genom Regulat, Barcelona 08003, Spain; [Haussler, David] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; [Haussler, David] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Lopez-Bigas, Nuria] Pompeu Fabra Univ, Dept Expt & Hlth Sci, Res Unit Biomed Informat, Barcelona 08003, Spain; [Raphael, Benjamin J.] Brown Univ, Ctr Computat Mol Biol, Providence, RI 02912 USA; [Raphael, Benjamin J.] Brown Univ, Dept Comp Sci, Providence, RI 02912 USA; [Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA; [Speed, Terence P.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Speed, Terence P.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Stuart, Joshua M.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Valencia, Alfonso] Spanish Natl Canc Res Ctr CNIO, Spanish Natl Bioinformat Inst, Madrid 28029, Spain; [Valencia, Alfonso] Spanish Natl Canc Res Ctr CNIO, Struct Biol & Biocomputing Programme, Madrid 28029, Spain; [Wheeler, David A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Blanche, Helene; Gut, Marta] Ctr Etud Polymorphisme Humain, Fdn Jean Dausset, F-75010 Paris, France; [Thomas, Gilles] Univ Lyon 1, F-69622 Villeurbanne, France; Fdn Synergie Lyon Canc, F-69008 Lyon, France; [Axton, Myles] Natl Genet, New York, NY 10013 USA; [Gunter, Chris] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Miller, Linda J.] Nat & Nat Res Journals, New York, NY 10013 USA; [Haider, Syed A.] Univ Cambridge, Comp Lab, Cambridge CB3 0FD, England; [Chalmers, Don R. C.] Univ Tasmania, Fac Law, Hobart, Tas 7001, Australia; [Kaan, Terry S. H.] Natl Univ Singapore, Fac Law, Singapore 259776, Singapore; [Lowrance, William W.] Consultant Hlth Res Eth & Policy, F-34280 La Grande Motte, France; [Vergely, Catherine] Inst Gustave Roussy, ISIS 39, F-94805 Villejuif, France; [Defazio, Anna] Westmead Hosp, Dept Gynaecol Oncol, Westmead, NSW 2145, Australia; [Defazio, Anna] Univ Sydney, Westmead Millennium Inst, Westmead Inst Canc Res, Westmead, NSW 2145, Australia; [Eshleman, James R.] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21231 USA; [Kench, James G.] Univ Sydney, Royal Prince Alfred Hosp, Dept Anat Pathol, Sydney, NSW 2050, Australia; [Tempero, Margaret A.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94115 USA; [Gallinger, Steve] Toronto Gen Hosp, Dept Gen Surg, Toronto, ON M5G 2C4, Canada; [Gallinger, Steve] Samuel Lunenfeld Res Inst, Toronto, ON M5S 1A1, Canada; [Tsao, Ming-Sound] Ontario Canc Inst, Univ Hlth Network, Toronto, ON M5G 2M9, Canada; [Tsao, Ming-Sound] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A1, Canada; [Shaw, Patricia A.] Univ Hlth Network, Dept Pathol, Toronto, ON M5G 2C4, Canada; [Petersen, Gloria M.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Mukhopadhyay, Debabrata] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Med & Genet, Boston, MA 02115 USA; [Thayer, Sarah] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Zhu, Zhenggang; Yu, Yingyan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Ruijin Hosp, Shanghai 200025, Peoples R China; [Yu, Jun] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Brennan, Paul] Int Agcy Res Canc, F-69372 Lyon, France; [Holcatova, Ivana] Charles Univ Prague, Fac Med 1, Inst Hyg & Epidemiol, Prague 12108, Czech Republic; [Zaridze, David] NN Blokhin Russian Canc Res Ctr, Dept Epidemiol & Prevent, Moscow 115478, Russia; [Egevad, Lars] Karolinska Univ Hosp, Karolinska Inst, SE-17176 Stockholm, Sweden; [Prokhortchouk, Egor] Russian Acad Sci, Ctr Bioengn, Moscow 117312, Russia; [Banks, Rosamonde Elizabeth] St James Univ Hosp, Leeds Inst Mol Med, Canc Res UK Ctr, Leeds LS9 7TF, W Yorkshire, England; [Uhlen, Mathias] KTH Royal Inst Technol, Sci Life Lab, SE-10044 Stockholm, Sweden; [Viksna, Juris] Univ Latvia, Inst Math & Comp Sci, LV-1459 Riga, Latvia; [Ponten, Fredrik] Uppsala Univ, SE-75105 Uppsala, Sweden; [Skryabin, Konstantin] Kurchatov Sci Ctr, Moscow 123182, Russia; [Borg, Ake] Lund Univ, Dept Oncol, SE-22185 Lund, Sweden; [Borresen-Dale, Anne-Lise] Oslo Univ Hosp, Radiumhosp, Inst Canc Res, N-0310 Oslo, Norway; [Borresen-Dale, Anne-Lise] Univ Oslo, Fac Med, N-0316 Oslo, Norway; [Caldas, Carlos] Univ Cambridge, Dept Oncol, Cambridge CB2 0RE, England; [Caldas, Carlos] Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Cambridge CB2 0RE, England; [Foekens, John A.] Josephine Nefkens Inst, Erasmus MC Rotterdam, Dept Med Oncol, NL-3015 CE Rotterdam, Netherlands; [Foekens, John A.] Canc Genom Ctr, NL-3015 CE Rotterdam, Netherlands; [Reis-Filho, Jorge S.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Richardson, Andrea L.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Richardson, Andrea L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Boyault, Sandrine; Tabone, Eric; Treilleux, Isabelle] Ctr Leon Berard, F-69373 Lyon, France; [Sotiriou, Christos] Inst Jules Bordet, B-1000 Brussels, Belgium; [Pivot, Xavier] Hop Jean Minjoz, F-25030 Besancon, France; [Vincent-Salomon, Anne] Inst Curie, F-75231 Paris, France; [Theillet, Charles] Ctr Val Aurelle, F-34298 Montpellier, France; [Bioulac-Sage, Paulette] Hop Pellegrin, F-33076 Bordeaux, France; [Decaens, Thomas] Hop Henri Mondor, F-94010 Creteil, France; [Decaens, Thomas] INSERM, U955, F-94000 Creteil, France; [Franco, Dominique] Hop Antoine Beclere, F-92141 Clamart, France; [Samuel, Didier] Hop Paul Brousse, AP HP, Ctr Hepatobilaire, F-94800 Villejuif, France; [Samuel, Didier] INSERM, U785, F-94800 Villejuif, France; [Zucman-Rossi, Jessica] INSERM, U674, F-75010 Paris, France; [Eils, Roland] Heidelberg Univ, D-69120 Heidelberg, Germany; [Korbel, Jan O.] European Mol Biol Lab, Genome Biol Unit, D-69126 Heidelberg, Germany; [Korshunov, Andrey] Univ Heidelberg Hosp, Dept Neuropathol, D-69120 Heidelberg, Germany; [Landgraf, Pablo] Univ Dusseldorf, Clin Pediat Oncol Hematol & Immunol, D-40225 Dusseldorf, Germany; [Lehrach, Hans] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Pfister, Stefan] Univ Heidelberg Hosp, Dept Pediat Hematol & Oncol, D-69120 Heidelberg, Germany; [Reifenberger, Guido] Univ Dusseldorf, Inst Neuropathol, D-40001 Dusseldorf, Germany; [Taylor, Michael D.] Hosp Sick Children, Div Neurosurg, Toronto, ON M5G 1X8, Canada; [Taylor, Michael D.] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON M5G 1X8, Canada; [von Kalle, Christof] Natl Ctr Tumor Dis, D-69120 Heidelberg, Germany; [von Kalle, Christof] German Canc Res Ctr, Div Translat Oncol, D-69120 Heidelberg, Germany; [Pederzoli, Paolo] Univ Hosp Trust Verona, Dept Surg, I-37134 Verona, Italy; [Delledonne, Massimo] Univ Verona, Dept Biotechnol, Funct Genom Ctr, I-37134 Verona, Italy; [Bardelli, Alberto] Univ Torino, Inst Canc Res & Treatment, Mol Genet Lab, I-10060 Turin, Italy; [Bardelli, Alberto] FIRC Inst Mol Oncol, I-20139 Milan, Italy; [Gress, Thomas] Univ Marburg, Dept Gastroenterol Endocrinol Metab & Infectiol, D-35043 Marburg, Germany; [Klimstra, David] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Nakamura, Yusuke; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Minato Ku, Tokyo 1088639, Japan; Univ Barcelona, Hosp Clin, E-08036 Barcelona, Spain; [Wilson, Peter J.; de Sanjose, Silvia] Hosp Llobregat, Inst Catala Oncol IDIBELL, Unit Infect & Canc,CIBER Epidemiol & Salud Publ, Canc Epidemiol Res Programme, Lhospitalet De Llobregat 08907, Spain; [Aparicio, Samuel] British Columbia Canc Agcy, BC Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada; [Easton, Douglas F.] Univ Cambridge, Dept Primary Care & Oncol, Dept Publ Hlth, Cambridge CB1 8RN, England; [Collins, Francis S.] US Natl Inst Hlth, Bethesda, MD 20892 USA; [Burke, Wylie] Univ Washington, Dept Bioeth & Humanities, Seattle, WA 98195 USA; [Green, Anthony R.] Univ Cambridge, Dept Haematol, Cambridge CB2 2XY, England; [Green, Anthony R.] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 2XY, England; [Hamilton, Stanley R.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Kallioniemi, Olli P.] Univ Helsinki, Inst Mol Med Finland, FIN-00290 Helsinki, Finland; [Ley, Timothy J.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Ley, Timothy J.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Wainwright, Brandon J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University of Toronto; Helmholtz Association; German Aerospace Centre (DLR); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Department of Biotechnology (DBT) India; Institut National du Cancer (INCA) France; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Cancer Research UK; Qatar Foundation (QF); Sidra Medical & Research Center; University of Oxford; National Institute of Health Sciences - Japan; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking University; National Cancer Center - Japan; Wellcome Trust Sanger Institute; RIKEN; Beijing Genomics Institute (BGI); Hong Kong University of Science & Technology; McGill University; University of Cambridge; Institut National de la Sante et de la Recherche Medicale (Inserm); University of North Carolina; University of North Carolina Chapel Hill; Kyoto University; University of Deusto; University of Oxford; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; St John of God Health Care; University of Western Australia; University of Western Australia; Helmholtz Association; German Cancer Research Center (DKFZ); Garvan Institute of Medical Research; University of New South Wales Sydney; UNICANCER; Institut Paoli-Calmette (IPC); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; University of North Carolina; University of North Carolina Chapel Hill; RIKEN; International Genomics Consortium; Centro Nacional de Investigaciones Oncologicas (CNIO); Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; University of Verona; Netherlands Cancer Institute; University of Amsterdam; Academic Medical Center Amsterdam; University of Tokyo; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Peter Maccallum Cancer Center; University of Melbourne; University of Cambridge; University of Queensland; CEA; British Columbia Cancer Agency; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Department of Biotechnology (DBT) India; National Institute of Biomedical Genomics (NIBMG); University of Toronto; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Radboud University Nijmegen; Johns Hopkins University; Johns Hopkins Medicine; Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Zhejiang University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Toronto; University of Toronto; European Molecular Biology Laboratory (EMBL); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Pompeu Fabra University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Pompeu Fabra University; Brown University; Brown University; Memorial Sloan Kettering Cancer Center; Walter & Eliza Hall Institute; University of California System; University of California Berkeley; University of California System; University of California Santa Cruz; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Baylor College of Medicine; Baylor College of Medicine; Foundation Jean Dausset-CEPH; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; HudsonAlpha Institute for Biotechnology; University of Cambridge; University of Tasmania; National University of Singapore; UNICANCER; Gustave Roussy; University of Sydney; University of Sydney; Westmead Institute for Medical Research; Johns Hopkins University; Johns Hopkins Medicine; University of Sydney; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Mayo Clinic; Mayo Clinic; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Shanghai Jiao Tong University; Chinese University of Hong Kong; World Health Organization; International Agency for Research on Cancer (IARC); Charles University Prague; N.N. Blokhin Russian Cancer Research Center; Karolinska Institutet; Karolinska University Hospital; Research Center of Biotechnology RAS; Russian Academy of Sciences; Cancer Research UK; Saint James's University Hospital; University of Leeds; Royal Institute of Technology; University of Latvia; Uppsala University; National Research Centre - Kurchatov Institute; Lund University; University of Oslo; University of Oslo; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; Erasmus University Rotterdam; Erasmus MC; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; UNICANCER; Centre Leon Berard; Institut Jules Bordet; Universite de Franche-Comte; CHU Besancon; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg; Heinrich Heine University Dusseldorf; Max Planck Society; Ruprecht Karls University Heidelberg; Heinrich Heine University Dusseldorf; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Turin; IFOM - FIRC Institute of Molecular Oncology; Philipps University Marburg; Memorial Sloan Kettering Cancer Center; University of Tokyo; University of Barcelona; Hospital Clinic de Barcelona; Catalan Institute of Oncology; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); British Columbia Cancer Agency; University of Cambridge; National Institutes of Health (NIH) - USA; University of Washington; University of Washington Seattle; University of Cambridge; University of Cambridge; University of Texas System; UTMD Anderson Cancer Center; University of Helsinki; Washington University (WUSTL); Washington University (WUSTL); University of Queensland	Hudson, TJ (corresponding author), Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada.	tom.hudson@oicr.on.ca	j, zucman-rossi/AAV-3594-2021; zucman-rossi, Jessica/B-5098-2009; Theillet, Charles/O-7634-2018; Chalmers, Don R/J-7658-2014; Tuluc, Petronel/C-2527-2011; de Sanjosé Llongueras, Silvia/H-6339-2014; Waddell, Nicola/H-4929-2015; Zaridze, David/K-5605-2013; Ning, Zemin/D-2411-2013; Delledonne, Massimo/O-8685-2017; DeFazio, Anna/O-2385-2019; Grimmond, Sean M/J-5304-2016; Puente, Xosé S./ADB-0672-2022; Yu, Jun/D-8569-2015; Lopez-Bigas, Nuria/F-6193-2011; Wheeler, David A/M-9740-2018; Tsao, Ming Sound/AFQ-7332-2022; Sander, Chris/H-1452-2011; Gunter, Chris/AHA-7271-2022; Korbel, Jan O/G-6470-2012; scarpa, aldo/K-6832-2016; Gill, Anthony/D-4215-2015; Wilson, Richard K./AAF-4139-2019; Bowtell, David/H-1007-2016; Uhlen, Mathias/AAV-8746-2021; Ouellette, Francis/G-1684-2010; Gallinger, Steven/E-4575-2013; Eils, Roland/B-6121-2009; Speed, Terence P/B-8085-2009; Hirst, Martin/B-7684-2016; yang, liu/GVU-8760-2022; deFazio, Anna/D-3939-2013; Decaens, Thomas/L-9483-2013; Kallioniemi, Olli P/H-5111-2011; Uhlen, Mathias/B-3262-2016; Marra, Marco A/B-5987-2008; Gasull, Martina/J-4076-2019; Pfister, Stefan M/F-6860-2013; wei, jiang/GRX-7907-2022; Shibata, Tatsuhiro/AAO-1278-2021; Jones, Steven J/C-3621-2009; Tsunoda, Tatsuhiko/K-2061-2014; Pearson, John/AAT-4211-2020; McPherson, John D/D-2633-2017; Gardiner, Brooke B/C-7773-2011; Shibata, Tatsuhiro/ABA-8234-2020; Heath, Simon C/J-4138-2012; Estivill, Xavier/A-3125-2013; de Alava, Enrique/GOH-0368-2022; Giuseppe, Zamboni/L-6029-2019; bea, silvia/K-7699-2014; Velculescu, Victor/ABF-4846-2020; López-Otín, Carlos/AAB-2106-2020; Guigo, Roderic/D-1303-2010; Stunnenberg, Hendrik G./D-6875-2012; Piris, Miguel A/AAP-1445-2020; Gut, Ivo/ABF-3188-2020; IBIS, SARCOMAS/O-1893-2015; Pearson, John V/F-2249-2011; Holcatova, Ivana/C-8327-2017; Viksna, Juris/ABD-2482-2021; Campo, Elias/AAC-5593-2019; Yuen, Matthew M.F./E-5621-2011; Zeps, Nikolajs/C-4180-2013; Quesada, Víctor/B-6557-2014; Reifenberger, Guido/AAE-3599-2019; Axton, Myles/AAZ-4093-2020; IBSAL, Secretaría/H-3719-2011; Jares, Pedro/T-3778-2019; Zeps, Nikolajs/AAF-3186-2021; Gnaneshan, Saravanamuttu/D-2305-2012; Tost, Joerg/H-7129-2019; Prokhortchouk, Egor/I-9108-2014; Valencia, Alfonso/I-3127-2015; Caldas, Carlos/U-7250-2019; Tsao, Ming-Sound/M-3503-2017; Hubbard, Tim J/C-2567-2008; Grimmond, Sean/K-3246-2019; Brors, Benedikt/E-5620-2013; Cloonan, Nicole/B-5272-2008; Caldas, Carlos/A-7543-2008; Radlwimmer, Bernhard F/I-3229-2013; Clement, Bruno/E-5546-2016; Sutherland, Robert L/A-8378-2008; Hubbard, Tim J.P./AAT-4571-2020; Liu, Edison/C-4141-2008; Estivill, Xavier/E-2957-2012; Piris, Miguel A/B-7067-2008; Bader, Gary/C-1176-2009; BARDELLI, Alberto/J-9721-2018	j, zucman-rossi/0000-0002-5687-0334; zucman-rossi, Jessica/0000-0002-5687-0334; Chalmers, Don R/0000-0002-7925-8818; Waddell, Nicola/0000-0002-3950-2476; DeFazio, Anna/0000-0003-0057-4744; Grimmond, Sean M/0000-0002-8102-7998; Puente, Xosé S./0000-0001-9525-1483; Yu, Jun/0000-0001-5008-2153; Lopez-Bigas, Nuria/0000-0003-4925-8988; Wheeler, David A/0000-0002-9056-6299; Tsao, Ming Sound/0000-0002-9160-5405; Sander, Chris/0000-0001-6059-6270; Korbel, Jan O/0000-0002-2798-3794; scarpa, aldo/0000-0003-1678-739X; Gill, Anthony/0000-0002-9447-1967; Wilson, Richard K./0000-0002-1992-1358; Bowtell, David/0000-0001-9089-7525; Eils, Roland/0000-0002-0034-4036; Speed, Terence P/0000-0002-5403-7998; deFazio, Anna/0000-0003-0057-4744; Decaens, Thomas/0000-0003-0928-0048; Kallioniemi, Olli P/0000-0002-3231-0332; Uhlen, Mathias/0000-0002-4858-8056; Marra, Marco A/0000-0001-7146-7175; Pfister, Stefan M/0000-0002-5447-5322; Jones, Steven J/0000-0003-3394-2208; Tsunoda, Tatsuhiko/0000-0002-5439-7918; McPherson, John D/0000-0001-8049-9347; Gardiner, Brooke B/0000-0003-3740-3244; Heath, Simon C/0000-0002-9550-0897; Estivill, Xavier/0000-0002-0723-2256; de Alava, Enrique/0000-0001-8400-046X; Giuseppe, Zamboni/0000-0001-7428-4673; bea, silvia/0000-0001-7192-2385; Velculescu, Victor/0000-0003-1195-438X; López-Otín, Carlos/0000-0001-6964-1904; Guigo, Roderic/0000-0002-5738-4477; Stunnenberg, Hendrik G./0000-0002-0066-1576; Piris, Miguel A/0000-0001-5839-3634; Gut, Ivo/0000-0001-7219-632X; Pearson, John V/0000-0003-0904-4598; Holcatova, Ivana/0000-0002-1366-0337; Campo, Elias/0000-0001-9850-9793; Yuen, Matthew M.F./0000-0002-6773-328X; Zeps, Nikolajs/0000-0002-6404-6839; Quesada, Víctor/0000-0002-8398-3457; Axton, Myles/0000-0002-8042-4131; Zeps, Nikolajs/0000-0002-6404-6839; Gnaneshan, Saravanamuttu/0000-0002-0455-8701; Tost, Joerg/0000-0002-2683-0817; Valencia, Alfonso/0000-0002-8937-6789; Caldas, Carlos/0000-0003-3547-1489; Hubbard, Tim J/0000-0002-1767-9318; Grimmond, Sean/0000-0002-8102-7998; Brors, Benedikt/0000-0001-5940-3101; Cloonan, Nicole/0000-0001-7802-6647; Radlwimmer, Bernhard F/0000-0002-4553-7800; Clement, Bruno/0000-0001-8827-146X; Hubbard, Tim J.P./0000-0002-1767-9318; Piris, Miguel A/0000-0001-5839-3634; Boutros, Paul/0000-0003-0553-7520; Wainwright, Brandon/0000-0003-0406-2092; Gress, Thomas/0000-0002-9333-5461; Miyano, Satoru/0000-0002-1753-6616; Gonzalez Diaz, Marcos/0000-0001-6637-1072; Bader, Gary/0000-0003-0185-8861; Yung, Christina/0000-0003-2958-150X; Lane, David/0000-0003-0551-3545; Anderson, Warwick Peter/0000-0002-7130-3530; Hayes, D. Neil/0000-0001-6203-7771; Ouellette, B. F. Francis/0000-0003-4676-675X; Viksna, Juris/0000-0003-2283-2978; Theillet, Charles/0000-0001-5555-2759; Birnbaum, Daniel/0000-0001-7920-9883; Aparicio, Samuel/0000-0002-0487-9599; Stuart, Joshua/0000-0002-2171-565X; Kench, James Geoffrey/0000-0001-8687-4988; Flicek, Paul/0000-0002-3897-7955; Sarin, Rajiv/0000-0002-6405-8282; Martin, Sancha/0000-0001-6213-5259; Swerdlow, Harold/0000-0002-9510-160X; Egevad, Lars/0000-0001-8531-222X; Himmelbauer, Heinz/0000-0001-8897-2928; NICOLAS JIMENEZ, MARIA PILAR/0000-0003-4166-5941; Delledonne, Massimo/0000-0002-7100-4581; Luo, Ruibang/0000-0001-9711-6533; JARES, PEDRO/0000-0002-8401-579X; Banks, Rosamonde/0000-0002-0042-8715; DePinho, Ronald/0000-0002-5625-577X; calvo, fabien/0000-0002-0298-7633; Taylor, Michael/0000-0001-7009-3466; Ning, Zemin/0000-0003-4359-776X; Brazma, Alvis/0000-0001-5988-7409; Green, Anthony/0000-0002-9795-0218; lawlor, Rita/0000-0003-3160-0634; BARDELLI, Alberto/0000-0003-1647-5070; Biankin, Andrew/0000-0002-0362-5597; Gunter, Chris/0000-0001-9369-7537; JI, JIAFU/0000-0001-6878-5543; Beck, Timothy/0000-0003-0145-3557; Kato, Kazuto/0000-0001-9006-9551; Birney, Ewan/0000-0001-8314-8497; Xue, Hong/0000-0002-8133-9828	NATIONAL CANCER INSTITUTE [R21CA094510, P50CA102701, P01CA117969, P50CA127003] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK071329] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA127003, P50 CA127003-04, R21 CA094510, P01 CA117969-04S1, P50 CA102701, P50 CA127003-05, P01 CA117969, P01 CA117969-05, P50 CA102701-08] Funding Source: Medline; NHGRI NIH HHS [R01 HG001806-02] Funding Source: Medline; NIDDK NIH HHS [K08 DK071329-05, K08 DK071329, K08 DK071329-04] Funding Source: Medline; Wellcome Trust [077198, 093867, 088340] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission)		Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chin L, 2008, NATURE, V452, P553, DOI 10.1038/nature06914; Collins FS, 2007, SCI AM, V296, P50, DOI 10.1038/scientificamerican0307-50; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dickson D, 1999, NATURE, V401, P729, DOI 10.1038/44413; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; DRUKER BJ, 2001, NEW ENGL J MED, V344, P1037; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2009, SCIENCE, V324, P217, DOI 10.1126/science.1171202; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Toronto Int Data Release Workshop, 2009, NATURE, V461, P168, DOI 10.1038/461168a; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	35	1514	1538	7	359	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 15	2010	464	7291					993	998		10.1038/nature08987	http://dx.doi.org/10.1038/nature08987			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20393554	Green Accepted, Green Published, Bronze, Green Submitted			2022-12-28	WOS:000276635000029
J	Thomson, JP; Skene, PJ; Selfridge, J; Clouaire, T; Guy, J; Webb, S; Kerr, ARW; Deaton, A; Andrews, R; James, KD; Turner, DJ; Illingworth, R; Bird, A				Thomson, John P.; Skene, Peter J.; Selfridge, Jim; Clouaire, Thomas; Guy, Jacky; Webb, Shaun; Kerr, Alastair R. W.; Deaton, Aimee; Andrews, Rob; James, Keith D.; Turner, Daniel J.; Illingworth, Robert; Bird, Adrian			CpG islands influence chromatin structure via the CpG-binding protein Cfp1	NATURE			English	Article							H3-LYS(4) METHYLTRANSFERASE COMPLEX; EMBRYONIC STEM-CELLS; DE-NOVO METHYLATION; DNA METHYLATION; HUMAN TRITHORAX; HISTONE H3; GENOME; MECP2; IDENTIFICATION; DOMAIN	CpG islands (CGIs) are prominent in the mammalian genome owing to their GC-rich base composition and high density of CpG dinucleotides(1,2). Most human gene promoters are embedded within CGIs that lack DNA methylation and coincide with sites of histone H3 lysine 4 trimethylation (H3K4me3), irrespective of transcriptional activity(3,4). In spite of these intriguing correlations, the functional significance of non-methylated CGI sequences with respect to chromatin structure and transcription is unknown. By performing a search for proteins that are common to all CGIs, here we show high enrichment for Cfp1, which selectively binds to nonmethylated CpGs in vitro(5,6). Chromatin immunoprecipitation of a mono-allelically methylated CGI confirmed that Cfp1 specifically associates with non-methylated CpG sites in vivo. High throughput sequencing of Cfp1-bound chromatin identified a notable concordance with non-methylated CGIs and sites of H3K4me3 in the mouse brain. Levels of H3K4me3 at CGIs were markedly reduced in Cfp1-depleted cells, consistent with the finding that Cfp1 associates with the H3K4 methyltransferase Setd1 (refs 7, 8). To test whether non-methylated CpG-dense sequences are sufficient to establish domains of H3K4me3, we analysed artificial CpG clusters that were integrated into the mouse genome. Despite the absence of promoters, the insertions recruited Cfp1 and created new peaks of H3K4me3. The data indicate that a primary function of non-methylated CGIs is to genetically influence the local chromatin modification state by interaction with Cfp1 and perhaps other CpG-binding proteins.	[Thomson, John P.; Skene, Peter J.; Selfridge, Jim; Clouaire, Thomas; Guy, Jacky; Webb, Shaun; Kerr, Alastair R. W.; Deaton, Aimee; Illingworth, Robert; Bird, Adrian] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Andrews, Rob; James, Keith D.; Turner, Daniel J.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	University of Edinburgh; Wellcome Trust Sanger Institute	Bird, A (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Michael Swann Bldg,Mayfield Rd, Edinburgh EH9 3JR, Midlothian, Scotland.	a.bird@ed.ac.uk	CLOUAIRE, THOMAS/L-7396-2017; Kerr, Alastair/B-3272-2010	CLOUAIRE, THOMAS/0000-0003-3238-1496; Bird, Adrian/0000-0002-8600-0372; SELFRIDGE, JIM/0000-0003-2473-4386; Kerr, Alastair/0000-0001-9207-6050; Guy, Jacky/0000-0002-8440-5667; Illingworth, Rob/0000-0001-9275-1933; Deaton, Aimee/0000-0003-0365-3077	Cancer Research UK studentship; Wellcome Trust; Medical Research Council; European Union; Medical Research Council [G0800026] Funding Source: researchfish; MRC [G0800026] Funding Source: UKRI	Cancer Research UK studentship(Cancer Research UK); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to D. Skalnik for the gift of a Cfp1 antibody, I. Chambers for the T beta C44 ES cell line, R. Klose for discussions, E. Sheridan for testing the DNA sequencing protocol, and K. Auger and J. Parkhill for coordinating the DNA sequencing. We also thank R. Ekiert and J. Connelly for comments on the manuscript. This work was funded by a Cancer Research UK studentship to J. P. T. and by grants from the Wellcome Trust, the Medical Research Council and the European Union 'Epigenome' Network of Excellence.	Araki K, 1997, NUCLEIC ACIDS RES, V25, P868, DOI 10.1093/nar/25.4.868; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Klose RJ, 2004, J BIOL CHEM, V279, P46490, DOI 10.1074/jbc.M408284200; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Lee JH, 2002, J BIOL CHEM, V277, P42259, DOI 10.1074/jbc.M205054200; Lee JH, 2001, J BIOL CHEM, V276, P44669, DOI 10.1074/jbc.M107179200; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Lorincz MC, 2001, MOL CELL BIOL, V21, P7913, DOI 10.1128/MCB.21.23.7913-7922.2001; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; McDonald LE, 1998, GENOMICS, V54, P379, DOI 10.1006/geno.1998.5570; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nan XS, 1996, MOL CELL BIOL, V16, P414; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Schmiedeberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004636; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; TAZI J, 1990, CELL, V60, P909, DOI 10.1016/0092-8674(90)90339-G; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Voo KS, 2000, MOL CELL BIOL, V20, P2108; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yang TT, 1996, NUCLEIC ACIDS RES, V24, P4592, DOI 10.1093/nar/24.22.4592	33	464	469	0	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2010	464	7291					1082	U162		10.1038/nature08924	http://dx.doi.org/10.1038/nature08924			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20393567	Green Accepted			2022-12-28	WOS:000276635000047
J	Ishiyama, N; Lee, SH; Liu, S; Li, GY; Smith, MJ; Reichardt, LF; Ikura, M				Ishiyama, Noboru; Lee, Seung-Hye; Liu, Shuang; Li, Guang-Yao; Smith, Matthew J.; Reichardt, Louis F.; Ikura, Mitsuhiko			Dynamic and Static Interactions between p120 Catenin and E-Cadherin Regulate the Stability of Cell-Cell Adhesion	CELL			English	Article							TYROSINE-KINASE FER; BETA-CATENIN; CYTOPLASMIC DOMAIN; ALPHA-CATENIN; ADHERENS JUNCTIONS; ENDOTHELIAL-CELLS; DILEUCINE MOTIF; COMPLEX; P120-CATENIN; BINDING	The association of p120 catenin (p120) with the juxta-membrane domain (JMD) of the cadherin cytoplasmic tail is critical for the surface stability of cadherin-catenin cell-cell adhesion complexes. Here, we present the crystal structure of p120 isoform 4A in complex with the JMD core region (JMD(core)) of E-cadherin. The p120 armadillo repeat domain contains modular binding pockets that are complementary to electrostatic and hydrophobic properties of the JMD(core). Single-residue mutations within the JMD(core)-binding site of p120 abolished its interaction with E-and N-cadherins in vitro and in cultured cells. These mutations of p120 enabled us to clearly differentiate between N-cadherin-dependent and -independent steps of neuronal dendritic spine morphogenesis crucial for synapse development. NMR studies revealed that p120 regulates the stability of cadherin-mediated cell-cell adhesion by associating with the majority of the JMD, including residues implicated in clathrin-mediated endocytosis and Hakai-dependent ubiquitination of E-cadherin, through its discrete "dynamic" and "static" binding sites.	[Ishiyama, Noboru; Liu, Shuang; Li, Guang-Yao; Smith, Matthew J.; Ikura, Mitsuhiko] Ontario Canc Inst, Div Signaling Biol, Toronto, ON M5G 1L7, Canada; [Ikura, Mitsuhiko] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Lee, Seung-Hye; Reichardt, Louis F.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of California System; University of California San Francisco	Ikura, M (corresponding author), Ontario Canc Inst, Div Signaling Biol, MaRS Toronto Med Discovery Tower,Room 4-804,101 C, Toronto, ON M5G 1L7, Canada.	mikura@uhnres.utoronto.ca	Smith, Matthew J/AAI-8060-2020	Smith, Matthew J/0000-0003-2896-9350; Ishiyama, Noboru/0000-0002-1426-6083	Canadian Cancer Society; Simons Foundation; Canadian Institutes of Health; Larry L. Hillblom Foundation	Canadian Cancer Society(Canadian Cancer Society (CCS)); Simons Foundation; Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Larry L. Hillblom Foundation	We are grateful to M. Takeichi for valuable discussion and encouragement. We thank P. B. Stathopulos for assistance with circular dichroism spectroscopy and fluorescence microscopy and for critical reading of the manuscript. We thank S. Oliveri for assistance with crystallization. We are grateful to P. L. Howell and Y. Lobsanov for assistance with crystal screening. We are grateful to the staff of the APS beamline 19BM for help with data collection. We thank S. Ng for assistance with site-directed mutagenesis and biochemical experiments in 293T cells. This work was supported by the grants from the Canadian Cancer Society (M. I.) and the Simons Foundation (L. F. R.). N. I. is a recipient of a Canadian Institutes of Health Research postdoctoral fellowship. S.-H. L. was supported by a Larry L. Hillblom Foundation fellowship. M. I. holds a Canada Research Chair in Cancer Structural Biology.	Al-Amoudi A, 2007, NATURE, V450, P832, DOI 10.1038/nature05994; Anastasiadis PZ, 2000, J CELL SCI, V113, P1319; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Castano J, 2007, MOL CELL BIOL, V27, P1745, DOI 10.1128/MCB.01974-06; Chen HY, 1997, J CELL SCI, V110, P345; Choi HJ, 2005, J MOL BIOL, V346, P367, DOI 10.1016/j.jmb.2004.11.048; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; DANIEL JM, 1995, MOL CELL BIOL, V15, P4819; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Elia LP, 2006, NEURON, V51, P43, DOI 10.1016/j.neuron.2006.05.018; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Huber AH, 2001, J BIOL CHEM, V276, P12301, DOI 10.1074/jbc.M010377200; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Lampugnani MG, 1997, J CELL SCI, V110, P2065; Lee SH, 2008, J CELL BIOL, V183, P893, DOI 10.1083/jcb.200807188; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Miyashita Y, 2007, J CELL SCI, V120, P4395, DOI 10.1242/jcs.03489; Miyashita Y, 2007, J BIOL CHEM, V282, P11540, DOI 10.1074/jbc.M608351200; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Myster SH, 2003, J CELL BIOL, V160, P433, DOI 10.1083/jcb.200211083; Nishimura T, 2009, CURR TOP DEV BIOL, V89, P33, DOI 10.1016/S0070-2153(09)89002-9; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peifer M, 2003, J CELL BIOL, V163, P437, DOI 10.1083/jcb.200310090; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; REYNOLDS AB, 1992, ONCOGENE, V7, P2439; Riehl R, 1996, NEURON, V17, P837, DOI 10.1016/S0896-6273(00)80216-0; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; Thoreson MA, 2002, DIFFERENTIATION, V70, P583, DOI 10.1046/j.1432-0436.2002.700911.x; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Xu G, 2004, J CELL SCI, V117, P3207, DOI 10.1242/jcs.01174; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yamada S, 2007, ANNU REV BIOCHEM, V76, P267, DOI 10.1146/annurev.biochem.75.103004.142811; Yanagisawa M, 2008, J BIOL CHEM, V283, P18344, DOI 10.1074/jbc.M801192200; Yang J, 2001, EMBO J, V20, P3645, DOI 10.1093/emboj/20.14.3645; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0	45	228	238	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2010	141	1					117	128		10.1016/j.cell.2010.01.017	http://dx.doi.org/10.1016/j.cell.2010.01.017			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	577GS	20371349	Bronze			2022-12-28	WOS:000276211100017
J	Reynolds, AB				Reynolds, Albert B.			Exposing p120 Catenin's Most Intimate Affair	CELL			English	Editorial Material							CELL-ADHESION; ROLES; P120-CATENIN		Vanderbilt Univ, Dept Canc Biol, Sch Med, Nashville, TN 37232 USA	Vanderbilt University	Reynolds, AB (corresponding author), Vanderbilt Univ, Dept Canc Biol, Sch Med, 221 Kirkland Hall, Nashville, TN 37232 USA.	al.reynolds@vanderbilt.edu						Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Reynolds AB, 2004, ONCOGENE, V23, P7947, DOI 10.1038/sj.onc.1208161; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P629, DOI 10.1128/MCB.9.2.629; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Troyanovsky RB, 2007, MOL BIOL CELL, V18, P4343, DOI 10.1091/mbc.E07-01-0084; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001	7	11	11	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 1	2010	141	1					20	22		10.1016/j.cell.2010.03.022	http://dx.doi.org/10.1016/j.cell.2010.03.022			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	577GS	20371340	Bronze			2022-12-28	WOS:000276211100007
J	Le Fanu, J				Le Fanu, James			Is modern genetics a blind alley? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							MEDICINE; DISEASE; GENOME		Mawbey Brough Hlth Ctr, London SW8 2UD, England		Le Fanu, J (corresponding author), Mawbey Brough Hlth Ctr, London SW8 2UD, England.	james.lefanu@btinternet.com						Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; HILL DE, 2001, NAT GENET, V27, P93; JONES S, 2009, DAILY TELEGRAPH 0420; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Mittra I, 2009, PERSPECT BIOL MED, V52, P500, DOI 10.1353/pbm.0.0131; Moses H, 2005, JAMA-J AM MED ASSOC, V294, P1333, DOI 10.1001/jama.294.11.1333; POLLACK A, 2007, NY TIMES        0211; Rees J, 2002, SCIENCE, V296, P698, DOI 10.1126/science.296.5568.698; Savill J, 1997, BRIT MED J, V314, P43, DOI 10.1136/bmj.314.7073.43; Steel M, 2005, J ROY SOC MED, V98, P197, DOI 10.1258/jrsm.98.5.197; 2008, NATURE, V455, pR7	11	4	4	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 30	2010	340								c1156	10.1136/bmj.c1156	http://dx.doi.org/10.1136/bmj.c1156			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579VJ	20354021				2022-12-28	WOS:000276404100002
J	Edvinsson, L; Linde, M				Edvinsson, Lars; Linde, Mattias			New drugs in migraine treatment and prophylaxis: telcagepant and topiramate	LANCET			English	Article							GENE-RELATED-PEPTIDE; CORTICAL SPREADING DEPRESSION; RECEPTOR-LIKE RECEPTOR; ORAL CGRP ANTAGONIST; DOUBLE-BLIND; CONTROLLED-TRIAL; TRIGEMINOVASCULAR SYSTEM; 5-HT1B/1D AGONISTS; BLOOD-FLOW; CALCITONIN	Although the triptan drugs provide effective relief from migraine for many patients, a substantial number of affected individuals are unresponsive to these compounds, and such therapy can also lead to a range of adverse effects. Telcagepant represents a new class of antimigraine drug-the calcitonin gene-related peptide receptor blockers. This compound exerts its effects by blocking receptors for the calcitonin-gene-related peptide at several sites in the trigeminal and central nervous systems, resulting in pain relief. Telcagepant does not cause vasoconstriction, a major limitation in the use of triptans. Comparisons with triptans in clinical trials for acute treatment of migraine attacks revealed clinical effects similar to those of triptans but better than those of placebo. Telcagepant might provide hope for those who have a poor response to, or are unable to use, older drugs. In patients who need prophylaxis because of frequent attacks of migraine, topiramate is a first-line drug for migraine prevention in many countries; it is generally safe and reasonably well tolerated. Data suggest that topiramate could aid reversion of chronic migraine to episodic migraine.	[Edvinsson, Lars] Univ Lund Hosp, Dept Internal Med, S-22185 Lund, Sweden; [Linde, Mattias] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [Linde, Mattias] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden; [Linde, Mattias] St Olavs Hosp, Div Neurol & Neurophysiol, Trondheim, Norway	Lund University; Skane University Hospital; Norwegian University of Science & Technology (NTNU); University of Gothenburg; Norwegian University of Science & Technology (NTNU)	Edvinsson, L (corresponding author), Univ Lund Hosp, Dept Internal Med, S-22185 Lund, Sweden.	lars.edvinsson@med.lu.se		Edvinsson, Lars/0000-0002-1805-1346	Swedish Research Council [5958]; Swedish Heart and Lung Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation)	We are supported by grants from the Swedish Research Council (no 5958), and the Swedish Heart and Lung Foundation.	Adelman J, 2008, PAIN MED, V9, P175, DOI 10.1111/j.1526-4637.2007.00389.x; Agrawal N, 2007, CEPHALALGIA, V27, P738; Akerman S, 2005, BRIT J PHARMACOL, V146, P7, DOI 10.1038/sj.bjp.0706290; Akerman S, 2008, BRAIN RES, V1229, P27, DOI 10.1016/j.brainres.2008.07.014; Andlin-Sobocki P, 2005, EUR J NEUROL, V12, P1, DOI 10.1111/j.1468-1331.2005.01202.x; Artemenko AR, 2008, CEPHALALGIA, V28, P203, DOI 10.1111/j.1468-2982.2007.01491.x; Ashtari F, 2008, ACTA NEUROL SCAND, V118, P301, DOI 10.1111/j.1600-0404.2008.01087.x; Aurora SK, 2010, CEPHALALGIA, V30, P648, DOI 10.1111/j.1468-2982.2009.01998.x; Ayata C, 2006, ANN NEUROL, V59, P652, DOI 10.1002/ana.20778; Bartolini M, 2005, CLIN NEUROPHARMACOL, V28, P277, DOI 10.1097/01.wnf.0000192136.46145.44; Becker WJ, 2006, HEADACHE, V46, P1424, DOI 10.1111/j.1526-4610.2006.00531.x; Bialer M, 2004, CLIN PHARMACOKINET, V43, P763, DOI 10.2165/00003088-200443120-00001; Brandes JL, 2004, JAMA-J AM MED ASSOC, V291, P965, DOI 10.1001/jama.291.8.965; Cady RK, 2009, HEADACHE, V49, P1258, DOI 10.1111/j.1526-4610.2009.01523.x; Connor KM, 2009, NEUROLOGY, V73, P970, DOI 10.1212/WNL.0b013e3181b87942; Coppola F, 2008, HEADACHE, V48, P86, DOI 10.1111/j.1526-4610.2007.00860.x; Cruciani F, 2009, CLIN TER, V160, P215; Cruz MJ, 2009, PEDIATR NEUROL, V41, P167, DOI 10.1016/j.pediatrneurol.2009.04.020; Cumberbatch MJ, 1997, EUR J PHARMACOL, V328, P37, DOI 10.1016/S0014-2999(97)83024-5; De Ciantis A, 2008, NEUROL SCI, V29, pS141, DOI 10.1007/s10072-008-0906-5; de Hoon J, 2007, CEPHALALGIA, V27, P738; de Hoon J, 2009, CEPHALALGIA, V29, P1349; Diener HC, 2007, CEPHALALGIA, V27, P814, DOI 10.1111/j.1468-2982.2007.01326.x; Diener HC, 2009, CEPHALALGIA, V29, P1021, DOI 10.1111/j.1468-2982.2009.01859.x; Diener HC, 2007, LANCET NEUROL, V6, P1054, DOI 10.1016/S1474-4422(07)70272-7; Diener HC, 2004, J NEUROL, V251, P943, DOI 10.1007/s00415-004-0464-6; Dodick D, 2004, HEADACHE, V44, P414, DOI 10.1111/j.1526-4610.2004.04078.x; Dodick DW, 2009, CLIN THER, V31, P542, DOI 10.1016/j.clinthera.2009.03.020; Doods H, 2007, TRENDS PHARMACOL SCI, V28, P580, DOI 10.1016/j.tips.2007.10.005; Durham PL, 2009, CEPHALALGIA, V29, P1, DOI 10.1111/j.1468-2982.2009.01976.x; Edvinsson L, 2005, CLIN SCI, V109, P335, DOI 10.1042/CS20050016; Edvinsson L, 2005, BRAIN RES REV, V48, P438, DOI 10.1016/j.brainresrev.2004.09.007; EDVINSSON L, CEPHALALGIA IN PRESS; Edvinsson L, 2008, LANCET, V372, P2089, DOI 10.1016/S0140-6736(08)61710-9; Edwards K. R., 2000, Cephalalgia, V20, P316; Eftekhari S, 2009, CEPHALALGIA, V29, P113; Ergun H, 2007, EUR NEUROL, V58, P215, DOI 10.1159/000107942; Evans BN, 2000, J BIOL CHEM, V275, P31438, DOI 10.1074/jbc.M005604200; Evans RW, 2009, HEADACHE, V49, P1054, DOI 10.1111/j.1526-4610.2009.01471.x; Evers S, 2009, EUR J NEUROL, V16, P968, DOI 10.1111/j.1468-1331.2009.02748.x; Ferrari MD, 2001, LANCET, V358, P1668, DOI 10.1016/S0140-6736(01)06711-3; Galletti F, 2009, PROG NEUROBIOL, V89, P176, DOI 10.1016/j.pneurobio.2009.07.005; GOADSBY PJ, 1993, ANN NEUROL, V33, P48, DOI 10.1002/ana.410330109; GOADSBY PJ, 1990, ANN NEUROL, V28, P183, DOI 10.1002/ana.410280213; Han TH, 2010, J CLIN PHARMACOL, V50, P1367, DOI 10.1177/0091270010361741; HAN TH, 2009, CLIN PHARM THER S1, V85; Hauge AW, 2009, LANCET NEUROL, V8, P718, DOI 10.1016/S1474-4422(09)70135-8; Hay DL, 2008, PHARMACOL REV, V60, P143, DOI 10.1124/pr.108.00372; Ho AP, 2009, CEPHALALGIA, V29, P1354; Ho TW, 2008, NEUROLOGY, V70, P1304, DOI 10.1212/01.WNL.0000286940.29755.61; Ho TW, 2008, LANCET, V372, P2115, DOI 10.1016/S0140-6736(08)61626-8; HO TW, 2009, CEPHALALGIA S1, V29, P1354; *JANSS CIL, 2009, TOP PROD INF LIF RES; Kececi H, 2009, J CLIN NEUROSCI, V16, P1588, DOI 10.1016/j.jocn.2009.03.025; Lainez MJA, 2009, CNS DRUGS, V23, P727, DOI 10.2165/11314380-000000000-00000; Lakshmi CVS, 2007, J CHILD NEUROL, V22, P829, DOI 10.1177/0883073807304201; Langtry HD, 1997, DRUGS, V54, P752, DOI 10.2165/00003495-199754050-00009; Lennerz JK, 2008, J COMP NEUROL, V507, P1277, DOI 10.1002/cne.21607; Levy D, 2005, ANN NEUROL, V58, P698, DOI 10.1002/ana.20619; Lewis D, 2009, PEDIATRICS, V123, P924, DOI 10.1542/peds.2008-0642; Luykx J, 2009, CLIN PHARMACOL THER, V85, P283, DOI 10.1038/clpt.2008.203; Martella G, 2008, CEPHALALGIA, V28, P1315, DOI 10.1111/j.1468-2982.2008.01682.x; Mathew NT, 2009, HEADACHE, V49, P1466, DOI 10.1111/j.1526-4610.2009.01566.x; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Mei D, 2004, NEUROL SCI, V25, P245, DOI 10.1007/s10072-004-0350-0; Mulleners WM, 2008, CEPHALALGIA, V28, P585, DOI 10.1111/j.1468-2982.2008.01571.x; Nelles G, 2009, HEADACHE, V49, P1454, DOI 10.1111/j.1526-4610.2009.01522.x; Olesen J, 2004, NEW ENGL J MED, V350, P1104, DOI 10.1056/NEJMoa030505; Olesen J, 2009, LANCET NEUROL, V8, P679, DOI 10.1016/S1474-4422(09)70090-0; Oliver KR, 2002, J CEREBR BLOOD F MET, V22, P620, DOI 10.1097/00004647-200205000-00014; Panday Vasudha A, 2007, Compr Ophthalmol Update, V8, P271; Paone DV, 2007, J MED CHEM, V50, P5564, DOI 10.1021/jm070668p; Privitera MD, 1997, ANN PHARMACOTHER, V31, P1164, DOI 10.1177/106002809703101010; Reuter U, 2010, CEPHALALGIA, V30, P543, DOI 10.1111/j.1468-2982.2009.01999.x; Roller S, 2009, XENOBIOTICA, V39, P33, DOI [10.1080/00498250802546861, 10.1080/00498250802546861 ]; Salvatore CA, 2009, CEPHALALGIA, V29, P139; Salvatore CA, 2008, J PHARMACOL EXP THER, V324, P416, DOI 10.1124/jpet.107.130344; Schoenen J, 2006, NEUROL SCI, V27, pS77, DOI 10.1007/s10072-006-0575-1; SEXTON PM, 1991, MOL NEUROBIOL, V5, P251, DOI 10.1007/BF02935550; Shank RP, 2008, CNS NEUROSCI THER, V14, P120, DOI 10.1111/j.1527-3458.2008.00041.x; Shaygannejad V, 2006, HEADACHE, V46, P642, DOI 10.1111/j.1526-4610.2006.00413.x; Silberstein SD, 2004, ARCH NEUROL-CHICAGO, V61, P490, DOI 10.1001/archneur.61.4.490; Silberstein SD, 2007, HEADACHE, V47, P170, DOI 10.1111/j.1526-4610.2006.00684.x; Storey JR, 2001, HEADACHE, V41, P968, DOI 10.1046/j.1526-4610.2001.01190.x; Taylor FR, 2008, CLIN THER, V30, P1069, DOI 10.1016/j.clinthera.2008.06.005; Vollono C, 2010, CEPHALALGIA, V30, P17, DOI 10.1111/j.1468-2982.2009.01892.x; Welch KM, 2005, HEADACHE, V45, pS25, DOI 10.1111/j.1526-4610.2005.4501008.x; Wertz DA, 2009, CURR MED RES OPIN, V25, P499, DOI [10.1185/03007990802664199, 10.1185/03007990802664199 ]; White RA, 2000, CYTOMETRY, V41, P1; Williams TM, 2006, BIOORG MED CHEM LETT, V16, P2595, DOI 10.1016/j.bmcl.2006.02.051; Winner P, 2005, HEADACHE, V45, P1304, DOI 10.1111/j.1526-4610.2005.00262.x; Winner P, 2006, HEADACHE, V46, P1503, DOI 10.1111/j.1526-4610.2006.00610.x	92	86	96	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 21	2010	376	9741					645	655		10.1016/S0140-6736(10)60323-6	http://dx.doi.org/10.1016/S0140-6736(10)60323-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643PB	20416945				2022-12-28	WOS:000281309100035
J	Doherty, RB				Doherty, Robert B.			The Certitudes and Uncertainties of Health Care Reform	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								The Patient Protection and Affordable Care Act (PPACA) of 2010 was signed into law by President Obama on March 23. This legislation has elicited much debate among policy experts and the public alike. No one knows exactly how this new complex law will play out, and objective evaluation of its effects is important. The American College of Physicians hopes that the legislation will advance key priorities on coverage, workforce, and payment and delivery system reform. The goal of the PPACA is to help provide affordable health insurance coverage to most Americans, improve access to primary care, and lower costs. This article discusses what the chances are that it will accomplish these objectives. It also explains many of the key provisions in the legislation and how they will affect both physicians and patients. Despite considerable uncertainty about the effects of this act, when compared with the status quo, it is an extraordinary achievement that will continue to evolve through its implementation.	[Doherty, Robert B.] Amer Coll Physicians, Philadelphia, PA USA	American College of Physicians	Doherty, RB (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave NW, Washington, DC 20001 USA.							*AARP PUBL POL I, 2008, COST DOING NOTH WHAT; *AM COLL PHYS, 2010, FIN HLTH REF PACK CO; BROWNSTEIN R, 2009, ATLANTIC MONTHL 1121; Collwill JM, 2008, HEALTH AFFAIR, V27, pW232, DOI 10.1377/hlthaff.27.3.w232; DOWNING L, 2010, CHRISTIAN SCI M 0323; GINSBURG J, 2010, ACP ADVOCATE BL 0813; Kaiser Family Foundation, 2010, EXPL HLTH CAR REF D; MERTENS M, 2010, KAISER HLTH NEW 0322; *NAT C STAT LEG, 2010, COV YOUNG AD THEIR P; REINHARDT U, 2008, NY TIMES EC BLO 1107; SAMUELSON R, 2010, REALCLEARPOLITI 1214; Senkeeto N, 2008, ACHIEVING AFFORDABLE; *US CENS BUR, HLTH INS COV 2007; *US DEP HHS, 2009 HHS POV GUID	14	26	26	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 18	2010	152	10					679	682		10.7326/0003-4819-153-1-201007060-00235	http://dx.doi.org/10.7326/0003-4819-153-1-201007060-00235			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	598RJ	20378676				2022-12-28	WOS:000277855500009
J	Lo, AC; Guarino, PD; Richards, LG; Haselkorn, JK; Wittenberg, GF; Federman, DG; Ringer, RJ; Wagner, TH; Krebs, HI; Volpe, BT; Bever, CT; Bravata, DM; Duncan, PW; Corn, BH; Maffucci, AD; Nadeau, SE; Conroy, SS; Powell, JM; Huang, GD; Peduzzi, P				Lo, Albert C.; Guarino, Peter D.; Richards, Lorie G.; Haselkorn, Jodie K.; Wittenberg, George F.; Federman, Daniel G.; Ringer, Robert J.; Wagner, Todd H.; Krebs, Hermano I.; Volpe, Bruce T.; Bever, Christopher T., Jr.; Bravata, Dawn M.; Duncan, Pamela W.; Corn, Barbara H.; Maffucci, Alysia D.; Nadeau, Stephen E.; Conroy, Susan S.; Powell, Janet M.; Huang, Grant D.; Peduzzi, Peter			Robot-Assisted Therapy for Long-Term Upper-Limb Impairment after Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONSTRAINT-INDUCED MOVEMENT; RANDOMIZED CONTROLLED-TRIAL; CLINICAL-TRIALS; UPPER EXTREMITY; SINGLE-BLIND; FORCED USE; REHABILITATION; INFORMATION; RECOVERY; IMPACT	BACKGROUND Effective rehabilitative therapies are needed for patients with long-term deficits after stroke. METHODS In this multicenter, randomized, controlled trial involving 127 patients with moderate-to-severe upper-limb impairment 6 months or more after a stroke, we randomly assigned 49 patients to receive intensive robot-assisted therapy, 50 to receive intensive comparison therapy, and 28 to receive usual care. Therapy consisted of 36 1-hour sessions over a period of 12 weeks. The primary outcome was a change in motor function, as measured on the Fugl-Meyer Assessment of Sensorimotor Recovery after Stroke, at 12 weeks. Secondary outcomes were scores on the Wolf Motor Function Test and the Stroke Impact Scale. Secondary analyses assessed the treatment effect at 36 weeks. RESULTS At 12 weeks, the mean Fugl-Meyer score for patients receiving robot-assisted therapy was better than that for patients receiving usual care (difference, 2.17 points; 95% confidence interval [CI], -0.23 to 4.58) and worse than that for patients receiving intensive comparison therapy (difference, -0.14 points; 95% CI, -2.94 to 2.65), but the differences were not significant. The results on the Stroke Impact Scale were significantly better for patients receiving robot-assisted therapy than for those receiving usual care (difference, 7.64 points; 95% CI, 2.03 to 13.24). No other treatment comparisons were significant at 12 weeks. Secondary analyses showed that at 36 weeks, robot-assisted therapy significantly improved the Fugl-Meyer score (difference, 2.88 points; 95% CI, 0.57 to 5.18) and the time on the Wolf Motor Function Test (difference, -8.10 seconds; 95% CI, -13.61 to -2.60) as compared with usual care but not with intensive therapy. No serious adverse events were reported. CONCLUSIONS In patients with long-term upper-limb deficits after stroke, robot-assisted therapy did not significantly improve motor function at 12 weeks, as compared with usual care or intensive therapy. In secondary analyses, robot-assisted therapy improved outcomes over 36 weeks as compared with usual care but not with intensive therapy. (ClinicalTrials.gov number, NCT00372411.)	[Lo, Albert C.] Brown Univ, Providence Vet Affairs Med Ctr, Providence, RI 02909 USA; [Lo, Albert C.] Brown Univ, Ctr Restorat & Regenerat Med, VA Res & Dev Ctr Excellence, Providence, RI 02909 USA; [Guarino, Peter D.; Corn, Barbara H.; Maffucci, Alysia D.; Peduzzi, Peter] VA Cooperat Studies Program Coordinating Ctr, West Haven, CT USA; [Federman, Daniel G.] VA Connecticut Healthcare Syst, West Haven, CT USA; [Federman, Daniel G.] Yale Univ, New Haven, CT USA; [Richards, Lorie G.; Nadeau, Stephen E.] N Florida S Georgia Vet Hlth Syst, Gainesville, FL USA; [Richards, Lorie G.; Nadeau, Stephen E.] Univ Florida, Gainesville, FL USA; [Haselkorn, Jodie K.; Powell, Janet M.] VA Puget Sound Healthcare Syst, Seattle, WA USA; [Haselkorn, Jodie K.; Powell, Janet M.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Wittenberg, George F.] VAMC Baltimore Geriatr Res Educ & Clin Ctr, Baltimore, MD USA; [Wittenberg, George F.; Bever, Christopher T., Jr.] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA; [Bever, Christopher T., Jr.] VA Maryland Healthcare Syst, Res Serv, Baltimore, MD USA; [Conroy, Susan S.] VAMC, Baltimore, MD USA; [Ringer, Robert J.] Clin Res Pharm Coordinating Ctr, VA Cooperat Studies Program, Albuquerque, NM USA; [Wagner, Todd H.] VA Palo Alto Healthcare Syst, Hlth Econ Resource Ctr, Menlo Pk, CA USA; [Krebs, Hermano I.] MIT, Cambridge, MA 02139 USA; [Volpe, Bruce T.] Cornell Univ, Weill Med Coll, Burke Med Res Inst, White Plains, NY USA; [Bravata, Dawn M.] Richard L Roudebush VAMC, Indianapolis, IN USA; [Duncan, Pamela W.] Duke Univ, Doctor Phys Therapy Program, Duke Div, Durham, NC USA; [Huang, Grant D.] VA Off Res & Dev Serv, Cooperat Studies Program Cent Off, Washington, DC USA	Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; State University System of Florida; University of Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; Geriatric Research Education & Clinical Center; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Massachusetts Institute of Technology (MIT); Cornell University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Duke University	Lo, AC (corresponding author), Brown Univ, Providence Vet Affairs Med Ctr, 830 Chalkstone Ave,111N, Providence, RI 02909 USA.	albert.lo@va.gov	Wittenberg, George/AAM-3428-2020; Wittenberg, George F/J-8698-2015; volpe, b/U-8409-2019	Wittenberg, George/0000-0001-5603-1197; Lo, Albert/0000-0002-6508-1361; Wagner, Todd/0000-0001-7625-3504; Volpe, Bruce/0000-0002-1098-1848; Duncan, Pamela/0000-0002-4838-3253	Veterans Affairs Cooperative Studies Program and Rehabilitation Research and Development Service; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028747, P30AG028740] Funding Source: NIH RePORTER	Veterans Affairs Cooperative Studies Program and Rehabilitation Research and Development Service; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by the Veterans Affairs Cooperative Studies Program and Rehabilitation Research and Development Service.	Atteya Abdul-Alim A, 2004, Neurosciences (Riyadh), V9, P24; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Broeks JG, 1999, DISABIL REHABIL, V21, P357; Dromerick AW, 2009, NEUROLOGY, V73, P195, DOI 10.1212/WNL.0b013e3181ab2b27; Dromerick AW, 2000, STROKE, V31, P2984, DOI 10.1161/01.STR.31.12.2984; Duncan PW, 2003, ARCH PHYS MED REHAB, V84, P950, DOI 10.1016/S0003-9993(03)00035-2; Fasoli SE, 2003, ARCH PHYS MED REHAB, V84, P477, DOI 10.1053/apmr.2003.50110; Ferraro M, 2003, NEUROLOGY, V61, P1604, DOI 10.1212/01.WNL.0000095963.00970.68; Feys HM, 1998, STROKE, V29, P785, DOI 10.1161/01.STR.29.4.785; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; JENNISON C, 1997, J AM STAT ASSOC, V92, P1330; Jennison C, 2000, GROUP SEQUENTIAL MET; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P406, DOI 10.1016/S0003-9993(95)80568-0; Krebs H I, 1998, IEEE Trans Rehabil Eng, V6, P75, DOI 10.1109/86.662623; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; LAN KKG, 1993, STAT MED, V12, P753, DOI 10.1002/sim.4780120804; Lang CE, 2009, ARCH PHYS MED REHAB, V90, P1692, DOI 10.1016/j.apmr.2009.04.005; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Lo AC, 2009, NEUROREHAB NEURAL RE, V23, P775, DOI 10.1177/1545968309338195; Lum PS, 2002, ARCH PHYS MED REHAB, V83, P952, DOI 10.1053/apmr.2001.33101; Mehta CR, 2001, DRUG INF J, V35, P1095, DOI 10.1177/009286150103500407; Page SJ, 2004, ARCH PHYS MED REHAB, V85, P14, DOI 10.1016/S0003-9993(03)00481-7; Page SJ, 2008, PHYS THER, V88, P333, DOI 10.2522/ptj.20060029; Rigler SK, 2002, CLIN REHABIL, V16, P420, DOI 10.1191/0269215502cr515oa; Scharfstein DO, 1997, J AM STAT ASSOC, V92, P1342, DOI 10.2307/2965404; Studenski SA, 2004, AGE AGEING, V33, P195, DOI 10.1093/ageing/afh056; Suputtitada Areerat, 2004, Journal of the Medical Association of Thailand, V87, P1482; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; van der Lee JH, 1999, STROKE, V30, P2369, DOI 10.1161/01.STR.30.11.2369; Volpe BT, 2008, NEUROREHAB NEURAL RE, V22, P305, DOI 10.1177/1545968307311102; WOLF SL, 1989, EXP NEUROL, V104, P125, DOI 10.1016/S0014-4886(89)80005-6; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095	32	837	888	11	275	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 13	2010	362	19					1772	1783		10.1056/NEJMoa0911341	http://dx.doi.org/10.1056/NEJMoa0911341			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594RQ	20400552	Green Accepted			2022-12-28	WOS:000277555500004
J	Sprinzak, D; Lakhanpal, A; LeBon, L; Santat, LA; Fontes, ME; Anderson, GA; Garcia-Ojalvo, J; Elowitz, MB				Sprinzak, David; Lakhanpal, Amit; LeBon, Lauren; Santat, Leah A.; Fontes, Michelle E.; Anderson, Graham A.; Garcia-Ojalvo, Jordi; Elowitz, Michael B.			Cis-interactions between Notch and Delta generate mutually exclusive signalling states	NATURE			English	Article							PATTERN-FORMATION; CELL FATE; DROSOPHILA; EXPRESSION; INDUCTION; FEEDBACK; TRANSACTIVATION; ACTIVATION; LIGANDS; DOMAIN	The Notch-Delta signalling pathway allows communication between neighbouring cells during development(1). It has a critical role in the formation of 'fine-grained' patterns, generating distinct cell fates among groups of initially equivalent neighbouring cells and sharply delineating neighbouring regions in developing tissues(2-5). The Delta ligand has been shown to have two activities: it transactivates Notch in neighbouring cells and cis-inhibits Notch in its own cell. However, it remains unclear how Notch integrates these two activities and how the resulting system facilitates pattern formation. Here we report the development of a quantitative time-lapse microscopy platform for analysing Notch-Delta signalling dynamics in individual mammalian cells, with the aim of addressing these issues. By controlling both cis- and trans-Delta concentrations, and monitoring the dynamics of a Notch reporter, we measured the combined cis-trans input-output relationship in the Notch-Delta system. The data revealed a striking difference between the responses of Notch to trans-and cis-Delta: whereas the response to trans-Delta is graded, the response to cis-Delta is sharp and occurs at a fixed threshold, independent of trans-Delta. We developed a simple mathematical model that shows how these behaviours emerge from the mutual inactivation of Notch and Delta proteins in the same cell. This interaction generates an ultrasensitive switch between mutually exclusive sending ( high Delta/low Notch) and receiving (high Notch/low Delta) signalling states. At the multicellular level, this switch can amplify small differences between neighbouring cells even without transcription-mediated feedback. This Notch-Delta signalling switch facilitates the formation of sharp boundaries and lateral-inhibition patterns in models of development, and provides insight into previously unexplained mutant behaviours.	[Sprinzak, David; Lakhanpal, Amit; LeBon, Lauren; Santat, Leah A.; Fontes, Michelle E.; Elowitz, Michael B.] CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA; [Sprinzak, David; Lakhanpal, Amit; LeBon, Lauren; Santat, Leah A.; Fontes, Michelle E.; Elowitz, Michael B.] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; [Anderson, Graham A.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Garcia-Ojalvo, Jordi] Univ Politecn Cataluna, Dept Fis & Engn Nucl, E-08222 Terrassa, Spain	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; Stanford University; Universitat Politecnica de Catalunya	Elowitz, MB (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	melowitz@caltech.edu	Garcia-Ojalvo, Jordi/A-4574-2009	Garcia-Ojalvo, Jordi/0000-0002-3716-7520; Sprinzak, David/0000-0001-6776-6957; LeBon, Lauren/0000-0003-3205-1948	US National Institutes of Health [F32GM77014, GM08042]; Caltech Center for Biological Circuit Design; Packard Foundation; Fannie and John Hertz Foundation; Ministerio de Ciencia e Innovacion (Spain) [FIS2009-13360]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042, F32GM077014] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caltech Center for Biological Circuit Design; Packard Foundation(The David & Lucile Packard Foundation); Fannie and John Hertz Foundation; Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank I. Bernstein for the IgG-Delta<SUP>ext</SUP>, U. Lendahl for the 12xCSL reporter construct, J. Aster for human NOTCH1 and other constructs, and G. Weinmaster for the rat DLL1 construct and advice. We also thank R. Tsien and K. Thorn for mCherry, S. Megason and S. Fraser for H2B- citrine and other constructs, R. Diamond and D. Perez for assistance with FACS, and F. Tan and J. Yong for help with cloning some of the constructs. We thank A. Eldar, J. Locke, G. Seelig, R. Kishony, B. Shraiman, A. C. Oates and members of the Elowitz laboratory for discussions and advice. This work was supported by the US National Institutes of Health Fellowship F32GM77014 (D. S.), the Caltech Center for Biological Circuit Design and the Packard Foundation. A. L. acknowledges support from the Fannie and John Hertz Foundation and the UCLA/Caltech Medical Scientist Training Program (NIH GM08042). J. G. O. acknowledges support from the Ministerio de Ciencia e Innovacion (Spain, project FIS2009-13360 and the I3 programme).	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Aster JC, 2000, MOL CELL BIOL, V20, P7505, DOI 10.1128/MCB.20.20.7505-7515.2000; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Buchler NE, 2008, J MOL BIOL, V384, P1106, DOI 10.1016/j.jmb.2008.09.079; Collier JR, 1996, J THEOR BIOL, V183, P429, DOI 10.1006/jtbi.1996.0233; Cordle J, 2008, NAT STRUCT MOL BIOL, V15, P849, DOI 10.1038/nsmb.1457; de Celis JF, 2000, DEVELOPMENT, V127, P1291; deCelis JF, 1997, DEVELOPMENT, V124, P1919; deCelis JF, 1997, DEVELOPMENT, V124, P3241; Goodyear R, 1997, J NEUROSCI, V17, P6289; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; Huppert SS, 1997, DEVELOPMENT, V124, P3283; Jacobsen TL, 1998, DEVELOPMENT, V125, P4531; KAKIDANI H, 1988, CELL, V52, P161, DOI 10.1016/0092-8674(88)90504-1; Klein T, 1997, DEV BIOL, V189, P123, DOI 10.1006/dbio.1997.8564; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Levine E, 2007, PLOS BIOL, V5, P1998, DOI 10.1371/journal.pbio.0050229; Matsuda M, 2009, DEVELOPMENT, V136, P197, DOI 10.1242/dev.027938; Melen GJ, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100036; Micchelli CA, 1997, DEVELOPMENT, V124, P1485; Miller AC, 2009, CURR BIOL, V19, P1378, DOI 10.1016/j.cub.2009.06.042; Plahte E, 2001, J MATH BIOL, V43, P411, DOI 10.1007/s002850100105; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Shaye DD, 2005, DEVELOPMENT, V132, P5081, DOI 10.1242/dev.02076; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Varnum-Finney B, 2000, J CELL SCI, V113, P4313; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Yang LT, 2005, MOL BIOL CELL, V16, P927, DOI 10.1091/mbc.e04-07-0614	29	406	416	2	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 6	2010	465	7294					86	U95		10.1038/nature08959	http://dx.doi.org/10.1038/nature08959			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591OW	20418862	Green Accepted			2022-12-28	WOS:000277311900036
J	Hawkes, N				Hawkes, Nigel			Hospital Performance Patient coding and the ratings game	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	23	23	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 25	2010	340								c2153	10.1136/bmj.c2153	http://dx.doi.org/10.1136/bmj.c2153			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589HS	20418546				2022-12-28	WOS:000277138400003
J	Moir, S; Fauci, AS				Moir, Susan; Fauci, Anthony S.			IMMUNOLOGY Salmonella Susceptibility	SCIENCE			English	Editorial Material							HIV-INFECTION; ACTIVATION		[Moir, Susan; Fauci, Anthony S.] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Moir, S (corresponding author), NIAID, Immunoregulat Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	smoir@niaid.nih.gov	Moir, Susan/AAC-3676-2020		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000825] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; *CDCP, 1993, MMWR-MORBID MORTAL W, V41, P1; Chimalizeni Y, 2010, ADV EXP MED BIOL, V659, P33, DOI 10.1007/978-1-4419-0981-7_3; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; MacLennan CA, 2008, J CLIN INVEST, V118, P1553, DOI 10.1172/JCI33998; MacLennan CA, 2010, SCIENCE, V328, P508, DOI 10.1126/science.1180346; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Santos RL, 2009, TRENDS MICROBIOL, V17, P498, DOI 10.1016/j.tim.2009.08.008	9	8	10	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 23	2010	328	5977					439	440		10.1126/science.1189088	http://dx.doi.org/10.1126/science.1189088			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YR	20413482				2022-12-28	WOS:000276952400022
J	Taylor, J; Roehrig, AD; Hensler, BS; Connor, CM; Schatschneider, C				Taylor, J.; Roehrig, A. D.; Hensler, B. Soden; Connor, C. M.; Schatschneider, C.			Teacher Quality Moderates the Genetic Effects on Early Reading	SCIENCE			English	Article							LITERACY DEVELOPMENT; PARENTAL EDUCATION; INSTRUCTION	Children's reading achievement is influenced by genetics as well as by family and school environments. The importance of teacher quality as a specific school environmental influence on reading achievement is unknown. We studied first-and second-grade students in Florida from schools representing diverse environments. Comparison of monozygotic and dizygotic twins, differentiating genetic similarities of 100% and 50%, provided an estimate of genetic variance in reading achievement. Teacher quality was measured by how much reading gain the non-twin classmates achieved. The magnitude of genetic variance associated with twins' oral reading fluency increased as the quality of their teacher increased. In circumstances where the teachers are all excellent, the variability in student reading achievement may appear to be largely due to genetics. However, poor teaching impedes the ability of children to reach their potential.	[Taylor, J.; Hensler, B. Soden; Connor, C. M.; Schatschneider, C.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; [Roehrig, A. D.] Florida State Univ, Dept Educ Psychol & Learning Syst, Tallahassee, FL 32306 USA; [Connor, C. M.; Schatschneider, C.] Florida Ctr Reading Res, Tallahassee, FL 32310 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Taylor, J (corresponding author), Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA.	taylor@psy.fsu.edu	Roehrig, Alysia/O-2630-2019	Schatschneider, Christopher/0000-0002-1700-7685; Roehrig, Alysia/0000-0002-2038-2865	NICHD [P50 HD052120]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD052120] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD062834, R01HD048539] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by NICHD P50 HD052120. The authors thank S. Kershaw, L. M. James, S. Pizzarello, and L. Bobadilla for their assistance with the project.	BRONFENBRENNER U, 1994, PSYCHOL REV, V101, P568, DOI 10.1037/0033-295X.101.4.568; Byrne B, 2010, J EDUC PSYCHOL, V102, P32, DOI 10.1037/a0017288; Byrne B, 2009, J NEUROLINGUIST, V22, P219, DOI 10.1016/j.jneuroling.2008.09.003; Connor CM, 2007, SCIENCE, V315, P464, DOI 10.1126/science.1134513; Connor CM, 2009, CHILD DEV, V80, P77, DOI 10.1111/j.1467-8624.2008.01247.x; Duncan A., 2009, COMMUNICATION   1022; Friend A, 2008, PSYCHOL SCI, V19, P1124, DOI 10.1111/j.1467-9280.2008.02213.x; Friend A, 2009, BEHAV GENET, V39, P427, DOI 10.1007/s10519-009-9263-2; Goe Laura., 2008, APPROACHES EVALUATIN; Good RH., 2001, DYNAMIC INDICATORS B; Johnson W, 2007, PSYCHOL REV, V114, P423, DOI 10.1037/0033-295X.114.2.423; Kremen WS, 2005, BEHAV GENET, V35, P417, DOI 10.1007/s10519-004-3876-2; May H, 2006, EDUC EVAL POLICY AN, V28, P231, DOI 10.3102/01623737028003231; MCLOYD VC, 1990, CHILD DEV, V61, P311, DOI 10.1111/j.1467-8624.1990.tb02781.x; *NAT READ PAN, 2000, NIH PUBL; Oliver BR, 2007, COGNITIVE DEV, V22, P77, DOI 10.1016/j.cogdev.2006.07.003; OLSON RK, 2008, SINGLE WORD READING, pCH12; Purcell S, 2005, BEHAV GENET, V35, P491, DOI 10.1007/s10519-004-1484-9; Purcell S, 2002, TWIN RES, V5, P554, DOI 10.1375/136905202762342026; Raudenbush SW, 2005, ANN AM ACAD POLIT SS, V602, P131, DOI 10.1177/0002716205280900; Reynolds AJ, 2002, EDUC EVAL POLICY AN, V24, P267, DOI 10.3102/01623737024004267; Roehrig AD, 2008, J SCHOOL PSYCHOL, V46, P343, DOI 10.1016/j.jsp.2007.06.006; Snow C., 2001, READING UNDERSTANDIN; Walker S. O., 2005, EDUC PSYCHOL-UK, V25, P55, DOI [DOI 10.1080/0144341042000294895, 10.1080/0144341042000294895]; 2007, FED REG, V72, P8685	25	98	103	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 23	2010	328	5977					512	514		10.1126/science.1186149	http://dx.doi.org/10.1126/science.1186149			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	586YR	20413504	Green Accepted			2022-12-28	WOS:000276952400046
J	Bachmann, S; Finger, C; Huss, A; Egger, M; Stuck, AE; Clough-Gorr, KM				Bachmann, Stefan; Finger, Christoph; Huss, Anke; Egger, Matthias; Stuck, Andreas E.; Clough-Gorr, Kerri M.			Inpatient rehabilitation specifically designed for geriatric patients: systematic review and meta-analysis of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HIP FRACTURE; ELDERLY-PEOPLE; OLDER-PEOPLE; FUNCTIONAL DECLINE; CLINICAL-TRIAL; HEALTH-CARE; INTERNATIONAL CLASSIFICATION; CONCEPTUAL DESCRIPTION; COMMUNITY HOSPITALS; EVALUATION UNIT	Objective To assess the effects of inpatient rehabilitation specifically designed for geriatric patients compared with usual care on functional status, admissions to nursing homes, and mortality. Design Systematic review and meta-analysis. Data sources Medline, Embase, Cochrane database, and reference lists from published literature. Review methods Only randomised controlled trials were included. Trials had to report on inpatient rehabilitation and report at least one of functional improvement, admission to nursing homes, or mortality. Trials of consultation or outpatient services, trials including patients aged <55, trials of non-multidisciplinary rehabilitation, and trials without a control group receiving usual care were excluded. Data were double extracted. Odds ratios and relative risks with 95% confidence intervals were calculated. Results 17 trials with 4780 people comparing the effects of general or orthopaedic geriatric rehabilitation programmes with usual care were included. Metaanalyses of effects indicated an overall benefit in outcomes at discharge (odds ratio 1.75 (95% confidence interval 1.31 to 2.35) for function, relative risk 0.64 (0.51 to 0.81) for nursing home admission, relative risk 0.72 (0.55 to 0.95) for mortality) and at end of follow-up (1.36 (1.07 to 1.71), 0.84 (0.72 to 0.99), 0.87 (0.77 to 0.97), respectively). Limited data were available on impact on health care or cost. Compared with those in control groups, weighted mean length of hospital stay after randomisation was longer in patients allocated to general geriatric rehabilitation (24.5 v 15.1 days) and shorter in patients allocated to orthopaedic rehabilitation (24.6 v 28.9 days). Conclusion Inpatient rehabilitation specifically designed for geriatric patients has the potential to improve outcomes related to function, admission to nursing homes, and mortality. Insufficient data are available for defining characteristics and cost effectiveness of successful programmes.	[Bachmann, Stefan; Stuck, Andreas E.] Univ Hosp Bern, Inselspital, Dept Geriatr, Robert Bosch Fdn, CH-3010 Bern, Switzerland; [Bachmann, Stefan] Rehabil Ctr Klin Valens, CH-7317 Valens, Switzerland; [Huss, Anke; Egger, Matthias; Clough-Gorr, Kerri M.] Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland; [Huss, Anke] Netherlands Utrecht Univ, Inst Risk Assessment Sci, NL-3508 TD Utrecht, Netherlands; [Egger, Matthias] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; [Clough-Gorr, Kerri M.] Boston Univ, Med Ctr, Sect Geriatr, Boston, MA 02118 USA	University of Bern; University Hospital of Bern; University of Bern; Utrecht University; University of Bristol; Boston University	Stuck, AE (corresponding author), Univ Hosp Bern, Inselspital, Dept Geriatr, Robert Bosch Fdn, Freiburgstr 10, CH-3010 Bern, Switzerland.	andreas.stuck@spitalnetzbern.ch	Bachmann, Stefan/AAE-8947-2022	Huss, Anke/0000-0001-9268-1867	Robert Bosch Foundation, Stuttgart, Germany [32.5.1141.0021.0]	Robert Bosch Foundation, Stuttgart, Germany	SB was supported by a Forschungskolleg Geriatrie Grant from the Robert Bosch Foundation, Stuttgart, Germany (grant No 32.5.1141.0021.0).	APPLEGATE WB, 1991, AM J PUBLIC HEALTH, V81, P1302, DOI 10.2105/AJPH.81.10.1302; APPLEGATE WB, 1990, NEW ENGL J MED, V322, P1572, DOI 10.1056/NEJM199005313222205; Baztan JJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b50; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Beswick AD, 2008, LANCET, V371, P725, DOI 10.1016/S0140-6736(08)60342-6; Cameron I D, 1993, Disabil Rehabil, V15, P29; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M; Cohen HJ, 2002, NEW ENGL J MED, V346, P905, DOI 10.1056/NEJMsa010285; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ellis G, 2004, BRIT MED BULL, V71, P45, DOI 10.1093/bmb/ldh033; Fleming SA, 2004, AGE AGEING, V33, P384, DOI 10.1093/ageing/afh126; Gaugler Joseph E, 2007, BMC Geriatr, V7, P13, DOI 10.1186/1471-2318-7-13; GILCHRIST WJ, 1988, BRIT MED J, V297, P1116, DOI 10.1136/bmj.297.6656.1116; Gill TM, 2002, NEW ENGL J MED, V347, P1068, DOI 10.1056/NEJMoa020423; Green J, 2005, BMJ-BRIT MED J, V331, P317, DOI 10.1136/bmj.38498.387569.8F; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; HASSELBLAD V, 1995, PSYCHOL BULL, V117, P167, DOI 10.1037/0033-2909.117.1.167; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huss A, 2008, J GERONTOL A-BIOL, V63, P298, DOI 10.1093/gerona/63.3.298; Huusko TM, 2002, ACTA ORTHOP SCAND, V73, P425, DOI 10.1080/00016470216324; Huusko TM, 2000, BRIT MED J, V321, P1107, DOI 10.1136/bmj.321.7269.1107; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Juni P, 2002, INT J EPIDEMIOL, V31, P115, DOI 10.1093/ije/31.1.115; KARPPI P, 1995, AGING-CLIN EXP RES, V7, P207, DOI 10.1007/BF03324317; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; KENNIE DC, 1988, BRIT MED J, V297, P1083, DOI 10.1136/bmj.297.6656.1083; MAHONEY F I, 1965, Md State Med J, V14, P61; Naglie G, 2002, CAN MED ASSOC J, V167, P25; O'Reilly J, 2008, AGE AGEING, V37, P513, DOI 10.1093/ageing/afn120; Ottenbacher KJ, 2004, JAMA-J AM MED ASSOC, V292, P1687, DOI 10.1001/jama.292.14.1687; Phibbs CS, 2006, MED CARE, V44, P91, DOI 10.1097/01.mlr.0000188981.06522.e0; REID J, 1989, BRIT MED J, V299, P25, DOI 10.1136/bmj.299.6690.25-a; RUBENSTEIN LZ, 1988, J CLIN EPIDEMIOL, V41, P441, DOI 10.1016/0895-4356(88)90045-5; RUBENSTEIN LZ, 1995, AGING-CLIN EXP RES, V7, P212, DOI 10.1007/BF03324318; RUBENSTEIN LZ, 1984, NEW ENGL J MED, V311, P1664, DOI 10.1056/NEJM198412273112604; Saltvedt I, 2004, AGING CLIN EXP RES, V16, P300; Saltvedt I, 2002, J AM GERIATR SOC, V50, P792, DOI 10.1046/j.1532-5415.2002.50202.x; Saltvedt I, 2006, GERONTOLOGY, V52, P223, DOI 10.1159/000093654; Shyu YIL, 2005, J AM GERIATR SOC, V53, P811, DOI 10.1111/j.1532-5415.2005.53253.x; Stenvall M, 2007, J REHABIL MED, V39, P232, DOI 10.2340/16501977-0045; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Stettler C, 2006, AM HEART J, V152, P27, DOI 10.1016/j.ahj.2005.09.015; Stuck AE, 2002, JAMA-J AM MED ASSOC, V287, P1022, DOI 10.1001/jama.287.8.1022; STUCK AE, 1993, LANCET, V342, P1032, DOI 10.1016/0140-6736(93)92884-V; Stucki G, 2003, DISABIL REHABIL, V25, P628, DOI 10.1080/09638280110070221; Stucki G, 2007, J REHABIL MED, V39, P279, DOI 10.2340/16501977-0041; Stucki G, 2007, J REHABIL MED, V39, P286, DOI 10.2340/16501977-0044; Swanson CE, 1998, MED J AUSTRALIA, V169, P515, DOI 10.5694/j.1326-5377.1998.tb123397.x; Vidan M, 2005, J AM GERIATR SOC, V53, P1476, DOI 10.1111/j.1532-5415.2005.53466.x; Wells JL, 2003, ARCH PHYS MED REHAB, V84, P890, DOI 10.1016/S0003-9993(02)04929-8; White S J, 1994, J Tenn Med Assoc, V87, P425; WHO, 1981, WHO TECH REP SER, V668, P1; Young J, 2007, J AM GERIATR SOC, V55, P1995, DOI 10.1111/j.1532-5415.2007.01456.x	54	188	194	1	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 20	2010	340								c1718	10.1136/bmj.c1718	http://dx.doi.org/10.1136/bmj.c1718			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	589HM	20406866	Green Published, Green Submitted			2022-12-28	WOS:000277137700004
J	Ooms, G; Decoster, K; Miti, K; Rens, S; Van Leemput, L; Vermeiren, P; Van Damme, W				Ooms, Gorik; Decoster, Kristof; Miti, Katabaro; Rens, Sabine; Van Leemput, Luc; Vermeiren, Peter; Van Damme, Wim			Crowding out: are relations between international health aid and government health funding too complex to be captured in averages only?	LANCET			English	Editorial Material									[Ooms, Gorik; Decoster, Kristof; Miti, Katabaro; Van Leemput, Luc; Vermeiren, Peter; Van Damme, Wim] Inst Trop Med, Dept Publ Hlth, Hlth Policy & Financing Unit, B-2000 Antwerp, Belgium; [Miti, Katabaro] Univ Pretoria, Dept Polit Sci, ZA-0002 Pretoria, South Africa	Institute of Tropical Medicine (ITM); University of Pretoria	Ooms, G (corresponding author), Inst Trop Med, Dept Publ Hlth, Hlth Policy & Financing Unit, Natl Str 155, B-2000 Antwerp, Belgium.	gooms@itg.be	Van Damme, Wim/F-7404-2011; Ooms, Gorik/A-2537-2015	Van Damme, Wim/0000-0002-6344-3007; Ooms, Gorik/0000-0002-9804-0128				[Anonymous], 2005, PARIS DECLARATION AI; BERNDT M, 2008, SPENDING ABSORPTION; *INT DEV ASS, 2007, IDA15 FIN FRAM; *INT HLTH PARTN, INT HLTH PARTN PLUS; *INT MON FUND, 2006, REG EC OUTL SUBS AFR; Lane C., 2008, SMOOTH PREDICTABLE A; LU C, 2010, LANCET; Ooms G, 2006, PLOS MED, V3, P2171, DOI 10.1371/journal.pmed.0030530; Smith RD, 2007, GLOBALIZATION HEALTH, V3, DOI 10.1186/1744-8603-3-9; van der Tol C, 2007, BIOGEOSCIENCES, V4, P137, DOI 10.5194/bg-4-137-2007; *WHO, PROGR PROJ NAT HLTH	11	29	29	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 17	2010	375	9723					1403	1405		10.1016/S0140-6736(10)60207-3	http://dx.doi.org/10.1016/S0140-6736(10)60207-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	588GW	20381858				2022-12-28	WOS:000277057800030
J	Hurst, JK				Hurst, James K.			CHEMISTRY In Pursuit of Water Oxidation Catalysts for Solar Fuel Production	SCIENCE			English	Editorial Material							OXYGEN-EVOLVING CATALYST; COMPLEXES; BOND		Washington State Univ, Dept Chem, Pullman, WA 99164 USA	Washington State University	Hurst, JK (corresponding author), Washington State Univ, Dept Chem, Pullman, WA 99164 USA.	hurst@wsu.edu						Concepcion JJ, 2009, ACCOUNTS CHEM RES, V42, P1954, DOI 10.1021/ar9001526; Duan LL, 2010, INORG CHEM, V49, P209, DOI 10.1021/ic9017486; Duan LL, 2009, J AM CHEM SOC, V131, P10397, DOI 10.1021/ja9034686; Geletii YV, 2008, ANGEW CHEM INT EDIT, V47, P3896, DOI 10.1002/anie.200705652; GHOSH PK, 1984, J AM CHEM SOC, V106, P4772, DOI 10.1021/ja00329a022; Hoertz PG, 2007, J PHYS CHEM B, V111, P6845, DOI 10.1021/jp070735r; Hurst JK, 2008, INORG CHEM, V47, P1753, DOI 10.1021/ic700724h; Jiao F, 2009, ANGEW CHEM INT EDIT, V48, P1841, DOI 10.1002/anie.200805534; Lutterman DA, 2009, J AM CHEM SOC, V131, P3838, DOI 10.1021/ja900023k; Muckerman JT, 2008, INORG CHEM, V47, P1787, DOI 10.1021/ic701892v; Romain S, 2009, J AM CHEM SOC, V131, P2768, DOI 10.1021/ja808166d; Sartorel A, 2008, J AM CHEM SOC, V130, P5006, DOI 10.1021/ja077837f; Tseng HW, 2008, INORG CHEM, V47, P11763, DOI 10.1021/ic8014817; Yin QS, 2010, SCIENCE, V328, P342, DOI 10.1126/science.1185372	14	173	174	0	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 16	2010	328	5976					315	316		10.1126/science.1187721	http://dx.doi.org/10.1126/science.1187721			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583NR	20395500				2022-12-28	WOS:000276685000024
J	Sandoval, DA; Seeley, RJ				Sandoval, Darleen A.; Seeley, Randy J.			The Microbes Made Me Eat It	SCIENCE			English	Editorial Material							GUT MICROBIOME; OBESITY		[Seeley, Randy J.] Univ Cincinnati, Metab Dis Inst, Cincinnati, OH 45237 USA; Univ Cincinnati, Dept Internal Med, Cincinnati, OH 45237 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Sandoval, DA (corresponding author), Univ Cincinnati, Metab Dis Inst, Cincinnati, OH 45237 USA.	randy.seeley@uc.edu		Seeley, Randy/0000-0002-3721-5625				Dhurandhar NV, 2004, DRUG NEWS PERSPECT, V17, P307, DOI 10.1358/dnp.2004.17.5.829034; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	6	16	17	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 9	2010	328	5975					179	180		10.1126/science.1188876	http://dx.doi.org/10.1126/science.1188876			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580OU	20378804				2022-12-28	WOS:000276459600028
J	Shlamovitz, GZ; Reardon, PC				Shlamovitz, Gil Zvi; Reardon, Patricia Caton			Persistent Pupillary Strands and Membranes.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Shlamovitz, Gil Zvi; Reardon, Patricia Caton] Windham Community Mem Hosp, Willimantic, CT USA		Shlamovitz, GZ (corresponding author), Windham Community Mem Hosp, Willimantic, CT USA.	gilshla@yahoo.com							0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 8	2010	362	14					1325	1325		10.1056/NEJMicm0906051	http://dx.doi.org/10.1056/NEJMicm0906051			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579SN	20375409				2022-12-28	WOS:000276393700011
J	Kettl, P				Kettl, Paul			One Vote for Death Panels	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												paul.kettl@va.gov							0	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2010	303	13					1234	1235		10.1001/jama.2010.376	http://dx.doi.org/10.1001/jama.2010.376			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579FM	20371773				2022-12-28	WOS:000276353700001
J	Sedgwick, P				Sedgwick, Philip			Statistical Question Per protocol analysis	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Ctr Med & Healthcare Educ, London WC1E 7HU, England	St Georges University London; University of London	Sedgwick, P (corresponding author), Univ London, Ctr Med & Healthcare Educ, London WC1E 7HU, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Johansson K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4609; Sedgwick P, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1705	2	7	7	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 7	2010	340								c1825	10.1136/bmj.c1825	http://dx.doi.org/10.1136/bmj.c1825			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	582ZF	20375086				2022-12-28	WOS:000276639400005
J	Wang, HP; Spencer, D; Fellous, JM; Sejnowski, TJ				Wang, Hsi-Ping; Spencer, Donald; Fellous, Jean-Marc; Sejnowski, Terrence J.			Synchrony of Thalamocortical Inputs Maximizes Cortical Reliability	SCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; PRIMARY VISUAL-CORTEX; NEOCORTICAL NEURONS; SPIKE TRAINS; FIRING RATE; INFORMATION; CAT; CELLS; INNERVATION; VARIABILITY	Thalamic inputs strongly drive neurons in the primary visual cortex, even though these neurons constitute only similar to 5% of the synapses on layer 4 spiny stellate simple cells. We modeled the feedforward excitatory and inhibitory inputs to these cells based on in vivo recordings in cats, and we found that the reliability of spike transmission increased steeply between 20 and 40 synchronous thalamic inputs in a time window of 5 milliseconds, when the reliability per spike was most energetically efficient. The optimal range of synchronous inputs was influenced by the balance of background excitation and inhibition in the cortex, which could gate the flow of information into the cortex. Ensuring reliable transmission by spike synchrony in small populations of neurons may be a general principle of cortical function.	[Wang, Hsi-Ping; Spencer, Donald; Sejnowski, Terrence J.] Salk Inst Biol Studies, Howard Hughes Med Inst, Computat Neurobiol Lab, La Jolla, CA 92037 USA; [Wang, Hsi-Ping; Sejnowski, Terrence J.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Fellous, Jean-Marc] Univ Arizona, Dept Psychol, Tucson, AZ 85721 USA; [Fellous, Jean-Marc] Univ Arizona, Program Appl Math, Tucson, AZ 85721 USA	Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego; University of Arizona; University of Arizona	Wang, HP (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Computat Neurobiol Lab, La Jolla, CA 92037 USA.	ping@salk.edu	Sejnowski, Terrence/AAV-5558-2021; Fellous, Jean-Marc/AAP-3117-2021		Howard Hughes Medical Institute; NSF Science of Learning Center [SBE-0542013]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NSF Science of Learning Center(National Science Foundation (NSF)NSF - Office of the Director (OD))	We thank P. Kara, P. Reinagel, and R. C. Reid for sharing in vivo recordings of simultaneously recorded retinal, thalamic, and cortical neurons. K. Martin provided invaluable anatomical data on thalamocortical connectivity. This research was supported by the Howard Hughes Medical Institute and the NSF Science of Learning Center SBE-0542013.	AHMED B, 1994, J COMP NEUROL, V341, P39, DOI 10.1002/cne.903410105; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Chatterjee S, 2007, VISUAL NEUROSCI, V24, P827, DOI 10.1017/S0952523807070757; Dan Y, 1998, NAT NEUROSCI, V1, P501, DOI 10.1038/2217; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; FREUND TF, 1985, J COMP NEUROL, V242, P263, DOI 10.1002/cne.902420208; HAMOS JE, 1987, J COMP NEUROL, V259, P165, DOI 10.1002/cne.902590202; HUMPHREY DR, 1970, SCIENCE, V170, P758, DOI 10.1126/science.170.3959.758; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; Kara P, 2003, J NEUROSCI, V23, P8547; Kumbhani RD, 2007, J NEUROPHYSIOL, V98, P2647, DOI 10.1152/jn.00900.2006; Lesica NA, 2007, NEURON, V55, P479, DOI 10.1016/j.neuron.2007.07.013; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; PETERS A, 1993, CEREB CORTEX, V3, P69, DOI 10.1093/cercor/3.1.69; Reich DS, 2000, J NEUROSCI, V20, P1964; Reinagel P, 2000, J NEUROSCI, V20, P5392, DOI 10.1523/JNEUROSCI.20-14-05392.2000; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Schreiber S, 2003, NEUROCOMPUTING, V52-4, P925, DOI 10.1016/S0925-2312(02)00838-X; SHARP AA, 1993, J NEUROPHYSIOL, V69, P992, DOI 10.1152/jn.1993.69.3.992; Tiesinga P, 2008, NAT REV NEUROSCI, V9, P97, DOI 10.1038/nrn2315; Usrey WM, 2002, PHILOS T ROY SOC B, V357, P1729, DOI 10.1098/rstb.2002.1157; Usrey WM, 2002, CURR OPIN NEUROBIOL, V12, P411, DOI 10.1016/S0959-4388(02)00339-2; Usrey WM, 1999, ANNU REV PHYSIOL, V61, P435, DOI 10.1146/annurev.physiol.61.1.435; Usrey WM, 2000, J NEUROSCI, V20, P5461, DOI 10.1523/JNEUROSCI.20-14-05461.2000; White E.L., 1989, CORTICAL CIRCUITS SY	30	101	101	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 2	2010	328	5974					106	109		10.1126/science.1183108	http://dx.doi.org/10.1126/science.1183108			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577DR	20360111	Green Accepted			2022-12-28	WOS:000276202200046
J	Kolokotrones, T; Savage, V; Deeds, EJ; Fontana, W				Kolokotrones, Tom; Savage, Van; Deeds, Eric J.; Fontana, Walter			Curvature in metabolic scaling	NATURE			English	Article							BODY-SIZE; ENERGY-METABOLISM; TEMPERATURE; POWER	For more than three-quarters of a century it has been assumed(1) that basal metabolic rate increases as body mass raised to some power p. However, there is no broad consensus regarding the value of p: whereas many studies have asserted that p is 3/4 (refs 1-4; 'Kleiber's law'), some have argued that it is 2/3 (refs 5-7), and others have found that it varies depending on factors like environment and taxonomy(6,8-16). Here we show that the relationship between mass and metabolic rate has convex curvature on a logarithmic scale, and is therefore not a pure power law, even after accounting for body temperature. This finding has several consequences. First, it provides an explanation for the puzzling variability in estimates of p, settling a long-standing debate. Second, it constitutes a stringent test for theories of metabolic scaling. A widely debated model(17) based on vascular system architecture fails this test, and we suggest modifications that could bring it into compliance with the observed curvature. Third, it raises the intriguing question of whether the scaling relation limits body size.	[Kolokotrones, Tom; Deeds, Eric J.; Fontana, Walter] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Savage, Van] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90024 USA	Harvard University; Harvard Medical School; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Fontana, W (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	walter@hms.harvard.edu			NATIONAL INSTITUTE ON AGING [R01AG034994] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alberts B., 2008, MOL BIOL CEL, V5th ed.; BARTELS H, 1982, EXP BIOL MED, V7, P1; Bokma F, 2004, FUNCT ECOL, V18, P184, DOI 10.1111/j.0269-8463.2004.00817.x; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Calder WAI., 1996, SIZE FUNCTION LIFE H; Dodds PS, 2001, J THEOR BIOL, V209, P9, DOI 10.1006/jtbi.2000.2238; FELDMAN HA, 1983, RESP PHYSIOL, V52, P149, DOI 10.1016/0034-5687(83)90002-6; Gillooly JF, 2007, BIOL LETTERS, V3, P99, DOI 10.1098/rsbl.2006.0576; GLAZIER DS, 2009, BIOL REV CAMB PHIL S, V85, P111; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; HEUSNER AA, 1982, RESP PHYSIOL, V48, P1, DOI 10.1016/0034-5687(82)90046-9; HEUSNER AA, 1991, J EXP BIOL, V160, P25; HEUSNER AA, 1982, RESP PHYSIOL, V48, P13, DOI 10.1016/0034-5687(82)90047-0; KLEIBER MAX, 1932, HILGARDIA, V6, P315; LINDSTEDT SL, 1981, Q REV BIOL, V56, P1, DOI 10.1086/412080; Lovegrove BG, 2003, J COMP PHYSIOL B, V173, P87, DOI 10.1007/s00360-002-0309-5; Lovegrove BG, 2000, AM NAT, V156, P201, DOI 10.1086/303383; McMahon T.A., 1983, SIZE LIFE; MCNAB BK, 1988, Q REV BIOL, V63, P25, DOI 10.1086/415715; Mcnab BK, 2008, COMP BIOCHEM PHYS A, V151, P5, DOI 10.1016/j.cbpa.2008.05.008; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; ROBINSON WR, 1983, CAN J ZOOL, V61, P281, DOI 10.1139/z83-037; Savage VM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000171; Savage VM, 2004, FUNCT ECOL, V18, P257, DOI 10.1111/j.0269-8463.2004.00856.x; SCHMIDTNIELSEN K, 1983, SCALING WHY IS ANIMA; Sieg AE, 2009, AM NAT, V174, P720, DOI 10.1086/606023; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; White CR, 2006, BIOL LETTERS, V2, P125, DOI 10.1098/rsbl.2005.0378; White CR, 2009, EVOLUTION, V63, P2658, DOI 10.1111/j.1558-5646.2009.00747.x	30	247	252	1	118	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 1	2010	464	7289					753	756		10.1038/nature08920	http://dx.doi.org/10.1038/nature08920			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577EO	20360740				2022-12-28	WOS:000276205000044
J	Crawley, J; Chu, C; Mtove, G; Nosten, F				Crawley, Jane; Chu, Cindy; Mtove, George; Nosten, Francois			Malaria in children	LANCET			English	Article							INTERMITTENT PREVENTIVE TREATMENT; SEVERE FALCIPARUM-MALARIA; TUMOR-NECROSIS-FACTOR; CHILDHOOD CEREBRAL MALARIA; SULFADOXINE-PYRIMETHAMINE; AFRICAN CHILDREN; UNCOMPLICATED MALARIA; VIVAX MALARIA; COST-EFFECTIVENESS; CLINICAL-FEATURES	The past decade has seen an unprecedented surge in political commitment and international funding for malaria control. Coverage with existing control methods (ie, vector control and artemisinin-based combination therapy) is increasing, and, in some Asian and African countries, childhood morbidity and mortality from malaria caused by Plasmodium falciparum are starting to decline. Consequently, there is now renewed interest in the possibility of malaria elimination. But the ability of the parasite to develop resistance to antimalarial drugs and increasing insecticide resistance of the vector threaten to reduce and even reverse current gains. Plasmodium vivax, with its dormant liver stage, will be particularly difficult to eliminate, and access to effective and affordable treatment at community level is a key challenge. New drugs and insecticides are needed urgently, while use of an effective vaccine as part of national malaria control programmes remains an elusive goal. This Seminar, which is aimed at clinicians who manage children with malaria, especially in resource-poor settings, discusses present knowledge and controversies in relation to the epidemiology, pathophysiology, diagnosis, treatment, and prevention of malaria in children.	[Chu, Cindy; Nosten, Francois] Mahidol Oxford Univ, Trop Med Res Programme, Shoklo Malaria Res Unit, Mae Sot 63110, Thailand; [Crawley, Jane] MRC, Clin Trials Unit, London, England; [Chu, Cindy; Nosten, Francois] Churchill Hosp, Ctr Vaccinol & Trop Med, Oxford OX3 7LJ, England; [Mtove, George] Amani Ctr, Natl Inst Med Res Tanzania, Tanga, Tanzania	Mahidol University; Medical Research Council Clinical Trials Unit; University of Oxford; National Institute of Medical Research	Nosten, F (corresponding author), Mahidol Oxford Univ, Trop Med Res Programme, Shoklo Malaria Res Unit, 68-30 Ban Tung Rd, Mae Sot 63110, Thailand.	SMRU@tropmedres.ac	Chu, Cindy S/E-3135-2014; Nosten, Francois/AAC-5509-2019	Chu, Cindy S/0000-0001-9465-8214; Nosten, Francois/0000-0002-7951-0745; Mtove, George/0000-0001-5173-0829	Wellcome Trust, UK	Wellcome Trust, UK(Wellcome Trust)	CC and FN are supported by the Wellcome Trust, UK.	Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773; ACHOKI R, 2009, J TROP PEDIATRICS, DOI DOI 10.1093/TROPEJ/FRNP109; Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Angulo I, 2002, CLIN DIAGN LAB IMMUN, V9, P1145, DOI 10.1128/CDLI.9.6.1145-1152.2002; [Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; [Anonymous], 2007, INS TREAT MOSQ NETS; [Anonymous], 2006, IND RES SPRAYING US; Aponte JJ, 2009, LANCET, V374, P1533, DOI 10.1016/S0140-6736(09)61258-7; Armah H, 2005, ANN TROP MED PARASIT, V99, P629, DOI 10.1179/136485905X51508; Artavanis-Tsakonas K, 2003, CLIN EXP IMMUNOL, V133, P145, DOI 10.1046/j.1365-2249.2003.02174.x; Baer K, 2007, PLOS PATHOG, V3, P1651, DOI 10.1371/journal.ppat.0030171; Barnes KI, 2008, TRENDS PARASITOL, V24, P127, DOI 10.1016/j.pt.2007.11.008; Barnes KI, 2006, CLIN PHARMACOL THER, V80, P582, DOI 10.1016/j.clpt.2006.08.016; Bassat Q, 2009, TROP MED INT HEALTH, V14, P1011, DOI 10.1111/j.1365-3156.2009.02326.x; Bate R, 2009, LANCET INFECT DIS, V9, P396, DOI 10.1016/S1473-3099(09)70158-6; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Beare NAV, 2006, AM J TROP MED HYG, V75, P790, DOI 10.4269/ajtmh.2006.75.790; Beare NAV, 2009, J INFECT DIS, V199, P263, DOI 10.1086/595735; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Berkley JA, 2003, BRIT MED J, V326, P361, DOI 10.1136/bmj.326.7385.361; Berkley JA, 2005, BMJ-BRIT MED J, V330, P995, DOI 10.1136/bmj.38408.471991.8F; Berkley JA, 2009, CLIN INFECT DIS, V49, P336, DOI 10.1086/600299; Boivin MJ, 2007, PEDIATRICS, V119, pE360, DOI 10.1542/peds.2006-2027; Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437; Buffet PA, 2009, CURR OPIN HEMATOL, V16, P157, DOI 10.1097/MOH.0b013e32832a1d4b; Butler D, 2009, NATURE, V462, P19, DOI 10.1038/462017a; Carrara VI, 2006, PLOS MED, V3, P856, DOI 10.1371/journal.pmed.0030183; Carter JA, 2005, J NEUROL NEUROSUR PS, V76, P476, DOI 10.1136/jnnp.2004.043893; Carter R, 2002, CLIN MICROBIOL REV, V15, P564, DOI 10.1128/CMR.15.4.564-594.2002; Caulfield LE, 2004, AM J TROP MED HYG, V71, P55, DOI 10.4269/ajtmh.2004.71.55; Chandramohan D, 2002, TROP MED INT HEALTH, V7, P45, DOI 10.1046/j.1365-3156.2002.00827.x; Cisse B, 2006, LANCET, V367, P659, DOI 10.1016/S0140-6736(06)68264-0; Cisse B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007164; Clark IA, 2003, PHARMACOL THERAPEUT, V99, P221, DOI 10.1016/S0163-7258(03)00060-3; Clark IA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-85; Clark IA, 2009, TRENDS PARASITOL, V25, P314, DOI 10.1016/j.pt.2009.04.003; Clarke SE, 2008, LANCET, V372, P127, DOI 10.1016/S0140-6736(08)61034-X; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; Cole-Tobian JL, 2009, INFECT IMMUN, V77, P4009, DOI 10.1128/IAI.00158-09; Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888; Crawley J, 2000, LANCET, V355, P701, DOI 10.1016/S0140-6736(99)07148-2; Crawley J, 2001, ARCH DIS CHILD, V84, P247, DOI 10.1136/adc.84.3.247; Day NPJ, 1999, J INFECT DIS, V180, P1288, DOI 10.1086/315016; Dicko A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-123; Dinglasan RR, 2008, TRENDS PARASITOL, V24, P364, DOI 10.1016/j.pt.2008.05.002; Dondorp AM, 2008, J INFECT DIS, V197, P79, DOI 10.1086/523762; Dondorp AM, 2004, ACTA TROP, V89, P309, DOI 10.1016/j.actatropica.2003.10.004; Dondorp AM, 2002, T ROY SOC TROP MED H, V96, P282, DOI 10.1016/S0035-9203(02)90100-8; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; EISENHUT M, 2005, COCHRANE DB SYST REV, V1; English M, 1996, AM J TROP MED HYG, V55, P525, DOI 10.4269/ajtmh.1996.55.525; English M, 1997, QJM-INT J MED, V90, P263, DOI 10.1093/qjmed/90.4.263; English M, 2002, LANCET, V359, P494, DOI 10.1016/S0140-6736(02)07666-3; English M, 2000, T ROY SOC TROP MED H, V94, P585, DOI 10.1016/S0035-9203(00)90197-4; Enwere G, 2005, TROP MED INT HEALTH, V10, P1171, DOI 10.1111/j.1365-3156.2005.01505.x; Faiz MA, 2005, LANCET, V366, P717; Falade C, 2007, TROP MED INT HEALTH, V12, P1279, DOI 10.1111/j.1365-3156.2007.01931.x; Feachem R, 2008, LANCET, V371, P1633, DOI 10.1016/S0140-6736(08)60424-9; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Gamble C, 2007, PLOS MED, V4, P506, DOI 10.1371/journal.pmed.0040107; Gasasira AF, 2008, CLIN INFECT DIS, V46, P985, DOI 10.1086/529192; German P, 2007, CLIN INFECT DIS, V44, P889, DOI 10.1086/511882; Gimenez F, 2003, CELL MOL LIFE SCI, V60, P1623, DOI 10.1007/s00018-003-2347-x; *GLOB FUND FIGHT A, AFF MED FAC MAL AMFM; Gomes MF, 2009, LANCET, V373, P557, DOI 10.1016/S0140-6736(08)61734-1; Gosling RD, 2009, LANCET, V374, P1521, DOI 10.1016/S0140-6736(09)60997-1; Graham SM, 2009, LANCET, V373, P267, DOI 10.1016/S0140-6736(09)60073-8; Grau GE, 2003, J INFECT DIS, V187, P461, DOI 10.1086/367960; Greenwood B, 2004, AM J TROP MED HYG, V70, P1; Greenwood B, 2009, PARASITE IMMUNOL, V31, P582, DOI 10.1111/j.1365-3024.2009.01140.x; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Iannotti LL, 2006, AM J CLIN NUTR, V84, P1261, DOI 10.1093/ajcn/84.6.1261; Idro R, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-57; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Idro R, 2007, JAMA-J AM MED ASSOC, V297, P2232, DOI 10.1001/jama.297.20.2232; Institute of Medicine (US) Committee on the Economics of Antimalarial Drugs, 2004, SAVING LIVES BUYING; Jurado RL, 1997, CLIN INFECT DIS, V25, P888, DOI 10.1086/515549; Kallander K, 2004, ACTA TROP, V90, P211, DOI 10.1016/j.actatropica.2003.11.013; KARUNAWEERA ND, 1992, P NATL ACAD SCI USA, V89, P3200, DOI 10.1073/pnas.89.8.3200; Kitchen AD, 2006, VOX SANG, V90, P77, DOI 10.1111/j.1423-0410.2006.00733.x; Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882; KRISHNA S, 1994, T ROY SOC TROP MED H, V88, P67, DOI 10.1016/0035-9203(94)90504-5; Kurtzhals JAL, 1998, LANCET, V351, P1768, DOI 10.1016/S0140-6736(97)09439-7; Kweku M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004000; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lovegrove FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004912; Lubell Y, 2009, TROP MED INT HEALTH, V14, P332, DOI 10.1111/j.1365-3156.2009.02227.x; Lyke KE, 2004, INFECT IMMUN, V72, P5630, DOI 10.1128/IAI.72.10.5630-5637.2004; Magowan C, 2000, BBA-MOL BASIS DIS, V1502, P461, DOI 10.1016/S0925-4439(00)00069-7; Maitland K, 2005, BRIT J HAEMATOL, V128, P393, DOI 10.1111/j.1365-2141.2004.05312.x; Maitland K, 2006, TRENDS PARASITOL, V22, P457, DOI 10.1016/j.pt.2006.07.006; Maitland Kathryn, 2003, Pediatr Crit Care Med, V4, P426, DOI 10.1097/01.PCC.0000090293.32810.4E; *MAL VACC IN, LIF CYCL MAL PAR MAN; Marchiafava E., 1894, SUMMER AUTUMNAL FEVE; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; McGready R, 2009, LANCET, V374, P1478, DOI 10.1016/S0140-6736(09)61629-9; Medana IM, 2006, INT J PARASITOL, V36, P555, DOI 10.1016/j.ijpara.2006.02.004; Meremikwu M, 2002, COCHRANE DB SYST REV; Meremikwu M, 2000, COCHRANE DB SYST REV, V2; Mishra SK, 2009, NAT REV NEUROL, V5, P189, DOI 10.1038/nrneurol.2009.23; Mithwani S, 2004, BRIT J CLIN PHARMACO, V57, P146, DOI 10.1046/j.1365-2125.2003.01986.x; Molyneux EM, 2005, NEW ENGL J MED, V353, P941, DOI 10.1056/NEJMe058135; Moxon CA, 2009, MOL BIOCHEM PARASIT, V166, P99, DOI 10.1016/j.molbiopara.2009.03.006; Namutangula B, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-138; Newton PN, 2008, PLOS MED, V5, P209, DOI 10.1371/journal.pmed.0050032; Ngoungou EB, 2008, EPILEPSIA, V49, P19, DOI 10.1111/j.1528-1167.2008.01752.x; O'Meara WP, 2008, AM J TROP MED HYG, V79, P185, DOI 10.4269/ajtmh.2008.79.185; OJUKWU JU, 2009, COCHRANE DB SYST REV, V3; Pagnoni F, 2009, TRENDS PARASITOL, V25, P115, DOI 10.1016/j.pt.2008.12.003; PASVOL G, 1991, AM J TROP MED HYG, V45, P702, DOI 10.4269/ajtmh.1991.45.702; Planche T, 2005, TRENDS PARASITOL, V21, P562, DOI 10.1016/j.pt.2005.09.010; Planche T, 2005, CURR OPIN INFECT DIS, V18, P369, DOI 10.1097/01.qco.0000180161.38530.81; Poespoprodjo JR, 2009, CLIN INFECT DIS, V48, P1704, DOI 10.1086/599041; Price RN, 2007, ANTIMICROB AGENTS CH, V51, P4090, DOI 10.1128/AAC.00486-07; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Price RN, 2009, CURR OPIN INFECT DIS, V22, P430, DOI 10.1097/QCO.0b013e32832f14c1; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Rivers EP, 2008, CRIT CARE CLIN, V24, pS1, DOI 10.1016/j.ccc.2008.04.002; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; SABOT O, DISTRIBUTION ARTEMIS; Saul A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000850; Schellenberg D, 1999, AM J TROP MED HYG, V61, P431, DOI 10.4269/ajtmh.1999.61.431; Shillcutt S, 2008, B WORLD HEALTH ORGAN, V86, P101, DOI 10.2471/BLT.07.042259; SINCLAIR D, 2009, COCHRANE DB SYST REV, V3; Snow RW, 2006, AM J TROP MED HYG, V74, P189, DOI 10.4269/ajtmh.2006.74.189; Sokhna C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001471; Stoltzfus R, 2004, COMP QUANTIFICATION; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; TURNER GDH, 1994, AM J PATHOL, V145, P1057; Waltz E, 2007, NAT MED, V13, P6, DOI 10.1038/nm0107-6a; White NJ, 2010, TRENDS PARASITOL, V26, P11, DOI 10.1016/j.pt.2009.10.007; WHITE NJ, 1992, ADV PARASIT, V31, P83, DOI 10.1016/S0065-308X(08)60021-4; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]; WHITE NJ, 1987, LANCET, V1, P708; White VA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004317; *WHO, 2009, REP TECHN CONS INT P; WHO, 2010, GUID TREATM MAL, V2nd; *WHO, 2009, WORLD MAL REP; *WHO FIND DIAGN, 2008, MAL RAP DIAGN TEST P; World Health Organization, 2000, MAN CHILD SER INF SE; World Health Organization, 1998, GUID US IR SUPPL PRE; World Health Organization, 2008, WORLD MAL REP; World Health Organization, 2006, WHO EXP CONS COTR PR; Wu YM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002636	147	65	66	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 24	2010	375	9724					1468	1481		10.1016/S0140-6736(10)60447-3	http://dx.doi.org/10.1016/S0140-6736(10)60447-3			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	590FL	20417858				2022-12-28	WOS:000277210000033
J	Hoffmann, DE; Weber, E				Hoffmann, Diane E.; Weber, Ellen			Medical Marijuana and the Law	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hoffmann, Diane E.; Weber, Ellen] Univ Maryland, Sch Law, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Hoffmann, DE (corresponding author), Univ Maryland, Sch Law, Baltimore, MD 21201 USA.		Weber, Ellen/GRR-9967-2022					*AM MED ASS, 2009, US CANN MED PURP REP; Degenhardt L, 2008, CAN MED ASSOC J, V178, P1685, DOI 10.1503/cmaj.080585; *PROCON ORG, 14 LEG MED MAR STAT; Taylor T., 2008, SUPPORTING RES THERA	4	76	80	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 22	2010	362	16					1453	1457		10.1056/NEJMp1000695	http://dx.doi.org/10.1056/NEJMp1000695			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	586GP	20410512				2022-12-28	WOS:000276894700001
J	Peisajovich, SG; Garbarino, JE; Wei, P; Lim, WA				Peisajovich, Sergio G.; Garbarino, Joan E.; Wei, Ping; Lim, Wendell A.			Rapid Diversification of Cell Signaling Phenotypes by Modular Domain Recombination	SCIENCE			English	Article							PHEROMONE RESPONSE; KINASE CASCADE; PATHWAY; YEAST; PROTEINS; TRANSDUCTION; EVOLUTION; PRINCIPLES	Cell signaling proteins are often modular, containing distinct catalytic and regulatory domains. Recombination of such biological modules has been proposed to be a major source of evolutionary innovation. We systematically analyzed the phenotypic diversity of a signaling response that results from domain recombination by using 11 proteins in the yeast mating pathway to construct a library of 66 chimeric domain recombinants. Domain recombination resulted in greater diversity in pathway response dynamics than did duplication of genes, of single domains, or of two unlinked domains. Domain recombination also led to changes in mating phenotype, including recombinants with increased mating efficiency over the wild type. Thus, novel linkages between preexisting domains may have a major role in the evolution of protein networks and novel phenotypic behaviors.	[Peisajovich, Sergio G.; Garbarino, Joan E.; Wei, Ping; Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Garbarino, Joan E.; Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Wei, Ping] Peking Univ, Ctr Theoret Biol, Beijing 100871, Peoples R China	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Peking University	Lim, WA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, 600 16th St, San Francisco, CA 94158 USA.	lim@cmp.ucsf.edu	Peisajovich, Sergio/C-6641-2011	Wei, Ping/0000-0002-1275-7145	Howard Hughes Medical Institute; Packard Foundation; NIH; NIH Nanomedicine Development Centers; Human Frontier Science Program; Li Foundation; NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055040] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Packard Foundation(The David & Lucile Packard Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Nanomedicine Development Centers; Human Frontier Science Program(Human Frontier Science Program); Li Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Chau for help with Matlab, N. Helman and J. Walter for help with fluorescence microscopy, and members of the Lim laboratory for critical reading of this manuscript and assistance. This work was supported by grants from the Howard Hughes Medical Institute, the Packard Foundation, the NIH, and the NIH Nanomedicine Development Centers (W. A. L.). S. G. P. was supported by a Long-Term Postdoctoral Fellowship from the Human Frontier Science Program. P. W. was supported by the Li Foundation. S. G. P. and W. A. L. conceived the project. S. G. P. and J. G. performed the experiments. P. W. assisted with initial experiments. S. G. P., J. G., and W. A. L. analyzed the results. S. G. P. and W. A. L. wrote the manuscript. The authors declare no competing financial interests.	Bardwell L, 2005, PEPTIDES, V26, P337, DOI 10.1016/j.peptides.2004.10.001; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Bashton M, 2007, STRUCTURE, V15, P85, DOI 10.1016/j.str.2006.11.009; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Chothia C, 2003, SCIENCE, V300, P1701, DOI 10.1126/science.1085371; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; DUEBER JE, 1904, SCIENCE, V301, P2003; Gerhart J, 2007, P NATL ACAD SCI USA, V104, P8582, DOI 10.1073/pnas.0701035104; Harris K, 2001, CURR BIOL, V11, P1815, DOI 10.1016/S0960-9822(01)00567-X; Howard PL, 2003, P NATL ACAD SCI USA, V100, P11267, DOI 10.1073/pnas.1934711100; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Lynch M, 2000, GENETICS, V154, P459; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; MARSH L, 1991, ANNU REV CELL BIOL, V7, P699, DOI 10.1146/annurev.cellbio.7.1.699; Pawson T, 2007, ONCOGENE, V26, P1268, DOI 10.1038/sj.onc.1210255; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; PETER M, 1993, CELL, V73, P747, DOI 10.1016/0092-8674(93)90254-N; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Pryciak PM, 1998, GENE DEV, V12, P2684, DOI 10.1101/gad.12.17.2684; Rogers RL, 2009, GENETICS, V181, P313, DOI 10.1534/genetics.108.091538; SPRAGUE GF, 1991, METHOD ENZYMOL, V194, P77; Takahashi S, 2008, CURR BIOL, V18, P1184, DOI 10.1016/j.cub.2008.07.050; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; Voigt CA, 2002, NAT STRUCT BIOL, V9, P553, DOI 10.1038/nsb805; Yeh BJ, 2007, NATURE, V447, P596, DOI 10.1038/nature05851	25	118	122	4	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2010	328	5976					368	372		10.1126/science.1182376	http://dx.doi.org/10.1126/science.1182376			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583NR	20395511	Green Accepted			2022-12-28	WOS:000276685000041
J	Gupta, RA; Shah, N; Wang, KC; Kim, J; Horlings, HM; Wong, DJ; Tsai, MC; Hung, T; Argani, P; Rinn, JL; Wang, YL; Brzoska, P; Kong, B; Li, R; West, RB; van de Vijver, MJ; Sukumar, S; Chang, HY				Gupta, Rajnish A.; Shah, Nilay; Wang, Kevin C.; Kim, Jeewon; Horlings, Hugo M.; Wong, David J.; Tsai, Miao-Chih; Hung, Tiffany; Argani, Pedram; Rinn, John L.; Wang, Yulei; Brzoska, Pius; Kong, Benjamin; Li, Rui; West, Robert B.; van de Vijver, Marc J.; Sukumar, Saraswati; Chang, Howard Y.			Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis	NATURE			English	Article							AGGRESSIVE BREAST-CANCER; EPITHELIAL-CELLS; GENE-EXPRESSION; CARCINOMA; INVASION; GENOME; SIGNATURE; PATTERNS; SURVIVAL; GROWTH	Large intervening non-coding RNAs (lincRNAs) are pervasively transcribed in the genome(1-3) yet their potential involvement in human disease is not well understood(4,5). Recent studies of dosage compensation, imprinting, and homeotic gene expression suggest that individual lincRNAs can function as the interface between DNA and specific chromatin remodelling activities(6-8). Here we show that lincRNAs in the HOX loci become systematically dys-regulated during breast cancer progression. The lincRNA termed HOTAIR is increased in expression in primary breast tumours and metastases, and HOTAIR expression level in primary tumours is a powerful predictor of eventual metastasis and death. Enforced expression of HOTAIR in epithelial cancer cells induced genome-wide re-targeting of Polycomb repressive complex 2 (PRC2) to an occupancy pattern more resembling embryonic fibroblasts, leading to altered histone H3 lysine 27 methylation, gene expression, and increased cancer invasiveness and metastasis in a manner dependent on PRC2. Conversely, loss of HOTAIR can inhibit cancer invasiveness, particularly in cells that possess excessive PRC2 activity. These findings indicate that lincRNAs have active roles in modulating the cancer epigenome and may be important targets for cancer diagnosis and therapy.	[Gupta, Rajnish A.; Wang, Kevin C.; Wong, David J.; Tsai, Miao-Chih; Hung, Tiffany; Chang, Howard Y.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Gupta, Rajnish A.; Wang, Kevin C.; Wong, David J.; Tsai, Miao-Chih; Hung, Tiffany; Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Kim, Jeewon] Stanford Univ, Sch Med, Stanford Canc Ctr, Stanford, CA 94305 USA; [Kim, Jeewon] Stanford Univ, Sch Med, Transgenic Mouse Res Ctr, Stanford, CA 94305 USA; [Li, Rui; West, Robert B.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Shah, Nilay; Sukumar, Saraswati] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Argani, Pedram] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21231 USA; [Horlings, Hugo M.; van de Vijver, Marc J.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Rinn, John L.] Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; [Rinn, John L.] MIT, Cambridge, MA 02142 USA; [Wang, Yulei; Brzoska, Pius; Kong, Benjamin] Appl Biosyst Inc, Foster City, CA 94404 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford Cancer Institute; Stanford University; Stanford University; Stanford University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Thermo Fisher Scientific; Applied Biosystems	Chang, HY (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	howchang@stanford.edu	乐驰, 叶/H-3399-2011; Shah, Nilay/H-9988-2013; Shah, Nilay/E-4925-2015	West, Robert/0000-0002-8330-8283; van de Vijver, Marc/0000-0002-0385-4787; Rinn, John/0000-0002-7231-7539; Wang, Kevin/0000-0002-5305-6791; Shah, Nilay/0000-0002-8906-6844; Wang, Yulei/0000-0002-9057-9786; Tsai, Miao-Chih/0000-0003-4471-4825; Kim, Jeewon/0000-0002-1063-0239	National Institutes of Health (NIH); Emerald Foundation; American Cancer Society; Dermatology Foundation; Susan Komen Foundation; NSF; Department of Defense BCRP; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA118750] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004361] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emerald Foundation; American Cancer Society(American Cancer Society); Dermatology Foundation; Susan Komen Foundation(Susan G. Komen Breast Cancer Foundation); NSF(National Science Foundation (NSF)); Department of Defense BCRP(United States Department of Defense); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Y. Chen-Tsai, M. Guttman, G. Sen, T. Ridky, P. Khavari, V. Band and Y. Kang for advice and reagents. Supported by National Institutes of Health (NIH), Emerald Foundation, and American Cancer Society (H. Y. C.), Dermatology Foundation (R. A. G., K. C. W. and D. J. W.), Susan Komen Foundation (M.-C. T.), NSF (T. H.), and Department of Defense BCRP (S. S.). H. Y. C. is an Early Career Scientist of the Howard Hughes Medical Institute.	Adler AS, 2006, NAT GENET, V38, P421, DOI 10.1038/ng1752; Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BERGSTRAESSER LM, 1993, CANCER RES, V53, P2644; Calin GA, 2007, CANCER CELL, V12, P215, DOI 10.1016/j.ccr.2007.07.027; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fox BP, 2004, BIOCHEM BIOPH RES CO, V318, P882, DOI 10.1016/j.bbrc.2004.04.102; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Herath NI, 2009, BRIT J CANCER, V100, P1095, DOI 10.1038/sj.bjc.6604970; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Marinkovich MP, 2007, NAT REV CANCER, V7, P370, DOI 10.1038/nrc2089; Naik MU, 2008, CANCER RES, V68, P2194, DOI 10.1158/0008-5472.CAN-07-3057; Novak P, 2008, CANCER RES, V68, P8616, DOI 10.1158/0008-5472.CAN-08-1419; Olmeda D, 2007, CANCER RES, V67, P11721, DOI 10.1158/0008-5472.CAN-07-2318; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wu JM, 2008, CLIN CANCER RES, V14, P1938, DOI 10.1158/1078-0432.CCR-07-4082; Wu XY, 2006, CANCER RES, V66, P9527, DOI 10.1158/0008-5472.CAN-05-4470; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468	30	3956	4245	18	743	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2010	464	7291					1071	U148		10.1038/nature08975	http://dx.doi.org/10.1038/nature08975			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20393566	Green Accepted			2022-12-28	WOS:000276635000045
J	Kirak, O; Frickel, EM; Grotenbreg, GM; Suh, H; Jaenisch, R; Ploegh, HL				Kirak, Oktay; Frickel, Eva-Maria; Grotenbreg, Gijsbert M.; Suh, Heikyung; Jaenisch, Rudolf; Ploegh, Hidde L.			Transnuclear Mice with Predefined T Cell Receptor Specificities Against Toxoplasma gondii Obtained via SCNT	SCIENCE			English	Article							MOUSE CLONING; NEGATIVE SELECTION; NUCLEAR TRANSFER; TCR EXPRESSION; TRICHOSTATIN-A; IMMUNITY; RESPONSES; GENES	Mice that are transgenic for rearranged antigen-specific T cell receptors (TCRs) are essential tools to study T cell development and function. Such TCRs are usually isolated from the relevant T cells after long-term culture, often after repeated antigen stimulation, which unavoidably skews the T cell population used. Random genomic integration of the TCR alpha and beta chain and expression from nonendogenous promoters represent additional drawbacks of transgenics. Using epigenetic reprogramming via somatic cell nuclear transfer, we demonstrated that T cells with predefined specificities against Toxoplasma gondii can be used to generate mouse models that express the TCR from their endogenous loci, without experimentally introduced genetic modification. The relative ease and speed with which such transnuclear models can be obtained holds promise for the construction of other disease models.	[Kirak, Oktay; Frickel, Eva-Maria; Grotenbreg, Gijsbert M.; Suh, Heikyung; Jaenisch, Rudolf; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Jaenisch, Rudolf; Ploegh, Hidde L.] MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Kirak, O (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	kirak@wi.mit.edu; jaenisch@wi.mit.edu; ploegh@wi.mit.edu	Kirak, Oktay/H-6347-2013	Kirak, Oktay/0000-0002-6524-4685	Human Frontiers Science Program; NIH [RO1-HD045022, R37-CA084198]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA084198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062502] Funding Source: NIH RePORTER	Human Frontiers Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are thankful to H. Eisen, M. J. Gubbels, K. van Grinsven, E. Guillen, A. Drake, V. Mahajan, Q. Gao, and G. Yap for fruitful discussions and reagents; J. Dausman, R. Flannery, and J. Jackson for assistance with the management of the mouse colony; P. Wisniewski for FACSorting; and J. Saeij and K. Jensen for the Pru PA7 and assistance with the in vivo imaging. E. M. F. was supported by the Human Frontiers Science Program. R. J. was supported by NIH grants RO1-HD045022 and R37-CA084198. H. L. P. was supported by grants from NIH. We thank L. Clay for financial support. The Whitehead Institute has filed a patent related to the generation of mice with defined antigen receptor specificity using epigenetic reprogramming (international patent application PCT/US2009/049596). The sequences have been submitted to the European Molecular Biology Laboratory Nucleotide Sequence Database, accession number FN601337-FN601346.	Amanna IJ, 2006, IMMUNOL REV, V211, P320, DOI 10.1111/j.0105-2896.2006.00392.x; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Blanchard N, 2008, NAT IMMUNOL, V9, P937, DOI 10.1038/ni.1629; Chen JZ, 2003, MICROBES INFECT, V5, P233, DOI 10.1016/S1286-4579(03)00016-9; Dzierszinski FS, 2008, PARASITE IMMUNOL, V30, P235, DOI 10.1111/j.1365-3024.2007.01016.x; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Frickel EM, 2008, J INFECT DIS, V198, P1625, DOI 10.1086/593019; Gredmark S, 2007, J VIROL, V81, P10300, DOI 10.1128/JVI.01149-07; Harrington LE, 2002, J VIROL, V76, P3329, DOI 10.1128/JVI.76.7.3329-3337.2002; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Inoue K, 2005, CURR BIOL, V15, P1114, DOI 10.1016/j.cub.2005.05.021; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Kishigami S, 2007, J REPROD DEVELOP, V53, P165, DOI 10.1262/jrd.18098; Koralov SB, 2005, J EXP MED, V201, P341, DOI 10.1084/jem.20041577; KRANZ DM, 1984, P NATL ACAD SCI-BIOL, V81, P573, DOI 10.1073/pnas.81.2.573; MAMALAKI C, 1993, DEV IMMUNOL, V3, P159, DOI 10.1155/1993/98015; Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Serwold T, 2007, J IMMUNOL, V179, P928, DOI 10.4049/jimmunol.179.2.928; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SUZUKI Y, 1990, J IMMUNOL, V144, P1954; Wakayama T, 2001, MOL REPROD DEV, V58, P376, DOI 10.1002/1098-2795(20010401)58:4<376::AID-MRD4>3.0.CO;2-L; Wang XCL, 2003, J IMMUNOL METHODS, V280, P25, DOI 10.1016/S0022-1759(03)00079-6; Wilson DC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000815; Wong P, 2003, ANNU REV IMMUNOL, V21, P29, DOI 10.1146/annurev.immunol.21.120601.141114	27	45	46	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2010	328	5975					243	248		10.1126/science.1178590	http://dx.doi.org/10.1126/science.1178590			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580OU	20378817	Green Submitted, Green Accepted			2022-12-28	WOS:000276459600046
J	Roberts, JM; Myatt, L; Spong, CY; Thom, EA; Hauth, JC; Leveno, KJ; Pearson, GD; Wapner, RJ; Varner, MW; Thorp, JM; Mercer, BM; Peaceman, AM; Ramin, SM; Carpenter, MW; Samuels, P; Sciscione, A; Harper, M; Smith, WJ; Saade, G; Sorokin, Y; Anderson, GB				Roberts, James M.; Myatt, Leslie; Spong, Catherine Y.; Thom, Elizabeth A.; Hauth, John C.; Leveno, Kenneth J.; Pearson, Gail D.; Wapner, Ronald J.; Varner, Michael W.; Thorp, John M., Jr.; Mercer, Brian M.; Peaceman, Alan M.; Ramin, Susan M.; Carpenter, Marshall W.; Samuels, Philip; Sciscione, Anthony; Harper, Margaret; Smith, Wendy J.; Saade, George; Sorokin, Yoram; Anderson, Garland B.		Eunice Kennedy Shriver Natl Inst C	Vitamins C and E to Prevent Complications of Pregnancy-Associated Hypertension.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OXIDATIVE STRESS; RANDOMIZED-TRIAL; CLINICAL-TRIALS; PREECLAMPSIA; WOMEN; RISK; PROTEINURIA; RATIO	Background: Oxidative stress has been proposed as a mechanism linking the poor placental perfusion characteristic of preeclampsia with the clinical manifestations of the disorder. We assessed the effects of antioxidant supplementation with vitamins C and E, initiated early in pregnancy, on the risk of serious adverse maternal, fetal, and neonatal outcomes related to pregnancy-associated hypertension. Methods: We conducted a multicenter, randomized, double-blind trial involving nulliparous women who were at low risk for preeclampsia. Women were randomly assigned to begin daily supplementation with 1000 mg of vitamin C and 400 IU of vitamin E or matching placebo between the 9th and 16th weeks of pregnancy. The primary outcome was severe pregnancy-associated hypertension alone or severe or mild hypertension with elevated liver-enzyme levels, thrombocytopenia, elevated serum creatinine levels, eclamptic seizure, medically indicated preterm birth, fetal-growth restriction, or perinatal death. Results: A total of 10,154 women underwent randomization. The two groups were similar with respect to baseline characteristics and adherence to the study drug. Outcome data were available for 9969 women. There was no significant difference between the vitamin and placebo groups in the rates of the primary outcome (6.1% and 5.7%, respectively; relative risk in the vitamin group, 1.07; 95% confidence interval [CI], 0.91 to 1.25) or in the rates of preeclampsia (7.2% and 6.7%, respectively; relative risk, 1.07; 95% CI, 0.93 to 1.24). Rates of adverse perinatal outcomes did not differ significantly between the groups. Conclusions: Vitamin C and E supplementation initiated in the 9th to 16th week of pregnancy in an unselected cohort of low-risk, nulliparous women did not reduce the rate of adverse maternal or perinatal outcomes related to pregnancy-associated hypertension (ClinicalTrials.gov number, NCT00135707). N Engl J Med 2010;362:1282-91.	[Roberts, James M.] Univ Pittsburgh, Dept Obstet, Pittsburgh, PA 15260 USA; [Roberts, James M.] Univ Pittsburgh, Dept Gynecol, Pittsburgh, PA USA; [Myatt, Leslie] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Spong, Catherine Y.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA; [Pearson, Gail D.] NHLBI, Bethesda, MD 20892 USA; [Thom, Elizabeth A.] George Washington Univ, Ctr Biostat, Washington, DC USA; [Hauth, John C.] Univ Alabama, Birmingham, AL USA; [Leveno, Kenneth J.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Wapner, Ronald J.] Columbia Univ, New York, NY USA; [Varner, Michael W.] Univ Utah, Salt Lake City, UT USA; [Thorp, John M., Jr.] Univ N Carolina, Chapel Hill, NC USA; [Harper, Margaret] Wake Forest Univ Hlth Sci, Winston Salem, NC USA; [Mercer, Brian M.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Peaceman, Alan M.] Northwestern Univ, Chicago, IL 60611 USA; [Ramin, Susan M.] Univ Texas Hlth Sci Ctr Houston, Houston, TX USA; [Carpenter, Marshall W.] Brown Univ, Providence, RI 02912 USA; [Samuels, Philip] Ohio State Univ, Columbus, OH 43210 USA; [Sciscione, Anthony] Drexel Univ, Philadelphia, PA 19104 USA; [Smith, Wendy J.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Sorokin, Yoram] Wayne State Univ, Detroit, MI USA; [Saade, George] Univ Texas Med Branch, Galveston, TX USA; [Anderson, Garland B.] Med Ctr, Galveston, TX USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); George Washington University; University of Alabama System; University of Alabama Birmingham; University of Texas System; University of Texas Southwestern Medical Center Dallas; Columbia University; Utah System of Higher Education; University of Utah; University of North Carolina; University of North Carolina Chapel Hill; Wake Forest University; Wake Forest University School of Medicine; Case Western Reserve University; Northwestern University; University of Texas System; University of Texas Health Science Center Houston; Brown University; University System of Ohio; Ohio State University; Drexel University; Oregon Health & Science University; Wayne State University; University of Texas System; University of Texas Medical Branch Galveston	Roberts, JM (corresponding author), Univ Pittsburgh, Dept Obstet, Pittsburgh, PA 15260 USA.		Samuels, Philip/E-4011-2011; Roberts, James/AAI-3283-2020; Varner, Michael/K-9890-2013	Roberts, James/0000-0002-2671-3207; Varner, Michael/0000-0001-9455-3973; Peaceman, Alan/0000-0002-4515-4850	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [UG1HD040560, UG1HD040544, UG1HD040500, UG1HD027869, U10HD040512, U10HD040560, U10HD036801, UG1HD040545, UG1HD034116, U10HD027869, R24HD050924, U10HD040485, U10HD040545, U10HD021410, UG1HD040512, U10HD053097, UG1HD040485, U10HD027915, U10HD040500, U10HD027917, U10HD034208, U10HD034116, U10HD053118, UG1HD053097, UG1HD034208, UG1HD027915, U10HD040544] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD027860, U10HD034136, U01HD021410, U01HD036801] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000080, UL1RR024989, UL1RR024153] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NCRR NIH HHS [UL1 RR024153-05, UL1 RR024989, M01 RR000080, UL1 RR024153, M01 RR000080-45, UL1 RR024989-03, M01 RR00080] Funding Source: Medline; NICHD NIH HHS [U10 HD027915-19, HD34116, U10 HD027917, U10 HD027869, HD21410, U10 HD040560-01, U10 HD036801-11, HD34208, HD27915, HD40485, U10 HD040544-01, U01 HD036801, HD36801, U10 HD040512-11, U10 HD040485-01, U10 HD053118, U10 HD040560, UG1 HD040500, U10 HD034208-12, R24 HD050924, U10 HD034136-10S2, U10 HD040500, U10 HD040512, U10 HD040485, U10 HD040500-11, HD27917, U10 HD021410, U10 HD036801, U10 HD034136, HD53097, U10 HD053097-06, HD40544, U10 HD040545, HD40512, U10 HD021410-22, UG1 HD027915, HD27860, UG1 HD053097, HD53118, UG1 HD040560, U10 HD027915, U10 HD027860-09, U10 HD053097, UG1 HD040545, UG1 HD040485, U10 HD034116-13, HD34136, U10 HD034208, HD27869, UG1 HD034116, U10 HD027860, HD40500, U10 HD040544, U10 HD053118-06, UG1 HD027869, U10 HD027869-10S1, U10 HD027917-18, U10 HD040545-11, HD40560, U10 HD034116, HD40545, UG1 HD040512, UG1 HD034208, UG1 HD040544] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alexander G R, 1999, Matern Child Health J, V3, P225, DOI 10.1023/A:1022381506823; Buchbinder A, 2002, AM J OBSTET GYNECOL, V186, P66, DOI 10.1067/mob.2002.120080; Burton GJ, 2004, J SOC GYNECOL INVEST, V11, P342, DOI 10.1016/j.jsgi.2004.03.003; Carey JC, 2000, NEW ENGL J MED, V342, P534, DOI 10.1056/NEJM200002243420802; Chappell LC, 1999, LANCET, V354, P810, DOI 10.1016/S0140-6736(99)80010-5; Chappell LC, 2002, AM J OBSTET GYNECOL, V187, P127, DOI 10.1067/mob.2002.122969; Food and Nutrition Board Institute of Medicine, 2000, DIET REF INT VIT C V; Gangaram R, 2005, HYPERTENS PREGNANCY, V24, P117, DOI 10.1081/PRG-200059849; Hubel CA, 1999, P SOC EXP BIOL MED, V222, P222, DOI 10.1046/j.1525-1373.1999.d01-139.x; Hubel CA, 1996, AM J OBSTET GYNECOL, V174, P975, DOI 10.1016/S0002-9378(96)70336-8; KUO VS, 1992, AM J OBSTET GYNECOL, V167, P723, DOI 10.1016/S0002-9378(11)91578-6; LACHIN JM, 1988, CONTROL CLIN TRIALS, V9, P365, DOI 10.1016/0197-2456(88)90049-9; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Padayatty SJ, 2006, NEW ENGL J MED, V355, P1065; Papanna R, 2008, OBSTET GYNECOL, V112, P135, DOI 10.1097/AOG.0b013e3181778cfc; Poston L, 2006, LANCET, V367, P1145, DOI 10.1016/S0140-6736(06)68433-X; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Regan CL, 2001, AM J OBSTET GYNECOL, V185, P572, DOI 10.1067/mob.2001.116754; Roggensack AM, 1999, HYPERTENSION, V33, P83, DOI 10.1161/01.HYP.33.1.83; Rumbold AR, 2006, NEW ENGL J MED, V354, P1796, DOI 10.1056/NEJMoa054186; SIBAI BM, 1993, NEW ENGL J MED, V329, P1213, DOI 10.1056/NEJM199310213291701; Spinnato JA, 2007, OBSTET GYNECOL, V110, P1311, DOI 10.1097/01.AOG.0000289576.43441.1f; Villar J, 2009, BJOG-INT J OBSTET GY, V116, P780, DOI 10.1111/j.1471-0528.2009.02158.x; Wiktor H, 2004, VIRCHOWS ARCH, V445, P74, DOI 10.1007/s00428-004-1024-2; Zadehmodarres S, 2006, AUST NZ J OBSTET GYN, V46, P501, DOI 10.1111/j.1479-828X.2006.00649.x; Zhang J, 2008, PLACENTA, V29, P439, DOI 10.1016/j.placenta.2008.02.012; Zusterzeel PLM, 2001, PLACENTA, V22, P213, DOI 10.1053/plac.2000.0606	27	288	305	0	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 8	2010	362	14					1282	1291		10.1056/NEJMoa0908056	http://dx.doi.org/10.1056/NEJMoa0908056			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579SN	20375405	Green Submitted, Green Accepted			2022-12-28	WOS:000276393700007
J	Lee, C; Li, QY; Kalb, W; Liu, XZ; Berger, H; Carpick, RW; Hone, J				Lee, Changgu; Li, Qunyang; Kalb, William; Liu, Xin-Zhou; Berger, Helmuth; Carpick, Robert W.; Hone, James			Frictional Characteristics of Atomically Thin Sheets	SCIENCE			English	Article							FORCE MICROSCOPE; SCALE FRICTION; GRAPHENE; GRAPHITE; CALIBRATION; MODEL	Using friction force microscopy, we compared the nanoscale frictional characteristics of atomically thin sheets of graphene, molybdenum disulfide (MoS2), niobium diselenide, and hexagonal boron nitride exfoliated onto a weakly adherent substrate (silicon oxide) to those of their bulk counterparts. Measurements down to single atomic sheets revealed that friction monotonically increased as the number of layers decreased for all four materials. Suspended graphene membranes showed the same trend, but binding the graphene strongly to a mica surface suppressed the trend. Tip-sample adhesion forces were indistinguishable for all thicknesses and substrate arrangements. Both graphene and MoS2 exhibited atomic lattice stick-slip friction, with the thinnest sheets possessing a sliding-length-dependent increase in static friction. These observations, coupled with finite element modeling, suggest that the trend arises from the thinner sheets' increased susceptibility to out-of-plane elastic deformation. The generality of the results indicates that this may be a universal characteristic of nanoscale friction for atomically thin materials weakly bound to substrates.	[Li, Qunyang; Carpick, Robert W.] Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA; [Lee, Changgu; Kalb, William; Hone, James] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA; [Liu, Xin-Zhou] Leiden Univ, Dept Phys, NL-2300 RA Leiden, Netherlands; [Berger, Helmuth] Ecole Polytech Fed Lausanne, Inst Condensed Matter Phys, CH-1015 Lausanne, Switzerland	University of Pennsylvania; Columbia University; Leiden University; Leiden University - Excl LUMC; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Carpick, RW (corresponding author), Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA.	carpick@seas.upenn.edu	Li, Qunyang/A-2368-2011; Liu, Xin/A-3389-2012; Hone, James C/E-1879-2011	Li, Qunyang/0000-0002-6865-3863; Hone, James C/0000-0002-8084-3301	NSF [DMR-0520020, CMMI-0800154, CHE-0117752, CMMI-0927891]; New York State Office of Science, Technology, and Academic Research (NYSTAR); Defense Advanced Research Projects Agency (DARPA) Center on Nanoscale Science and Technology for Integrated Micro/Nano-Electromechanical Transducers (iMINT) [HR0011-06-1-0048]; Air Force Office of Scientific Research (AFOSR) [MURI FA955009-1-0705]; Swiss NSF; National Centers of Competence in Research (NCCR) MaNEP; Div Of Civil, Mechanical, & Manufact Inn [0800154] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); New York State Office of Science, Technology, and Academic Research (NYSTAR); Defense Advanced Research Projects Agency (DARPA) Center on Nanoscale Science and Technology for Integrated Micro/Nano-Electromechanical Transducers (iMINT)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Swiss NSF(Swiss National Science Foundation (SNSF)); National Centers of Competence in Research (NCCR) MaNEP(Swiss National Science Foundation (SNSF)); Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	We acknowledge support from the NSF under awards NSF/MRSEC (no. DMR-0520020) (R. W. C.), CMMI-0800154 (R. W. C.), CHE-0117752 (J.H.), and CMMI-0927891 (J.H.); the New York State Office of Science, Technology, and Academic Research (NYSTAR) (J.H.); the Defense Advanced Research Projects Agency (DARPA) Center on Nanoscale Science and Technology for Integrated Micro/Nano-Electromechanical Transducers (iMINT, grant HR0011-06-1-0048) (J.H.); Air Force Office of Scientific Research (AFOSR) (MURI FA955009-1-0705) (J.H.); and the Swiss NSF and its National Centers of Competence in Research (NCCR) MaNEP (H. B.). We thank Momentive Performance Materials, Advanced Diamond Technologies, and C. H. Lui for supplying h-BN powder, diamond-coated AFM probes, and graphene samples on mica, respectively. We acknowledge helpful discussions with J. Li, M. Muser, and L. Forro.	CIEPLAK M, 1994, SCIENCE, V265, P1209, DOI 10.1126/science.265.5176.1209; Donnet C, 2004, SURF COAT TECH, V180, P76, DOI 10.1016/j.surfcoat.2003.10.022; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Filleter T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.086102; FUJISAWA S, 1995, PHYS REV B, V51, P7849, DOI 10.1103/PhysRevB.51.7849; Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877; Han MY, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.206805; Johnson KL, 1985, CONTACT MECH, DOI 10.1201/b17110-2; Li Q, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2209953; Lui CH, 2009, NATURE, V462, P339, DOI 10.1038/nature08569; MATE CM, 1987, PHYS REV LETT, V59, P1942, DOI 10.1103/PhysRevLett.59.1942; Medyanik SN, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.136106; Meric I, 2008, NAT NANOTECHNOL, V3, P654, DOI 10.1038/nnano.2008.268; Merkle AP, 2007, TRIBOL LETT, V26, P73, DOI 10.1007/s11249-006-9191-8; Muser MH, 2004, EUROPHYS LETT, V66, P97, DOI 10.1209/epl/i2003-10139-6; Nakada K, 1996, PHYS REV B, V54, P17954, DOI 10.1103/PhysRevB.54.17954; Nemes-Incze P, 2008, CARBON, V46, P1435, DOI 10.1016/j.carbon.2008.06.022; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Park H, 2000, NATURE, V407, P57, DOI 10.1038/35024031; PERSSON BNJ, 1995, J CHEM PHYS, V103, P8679, DOI 10.1063/1.470125; Prandtl L, 1928, Z ANGEW MATH MECH, V8, P85, DOI 10.1002/zamm.19280080202; RUAN JA, 1994, J APPL PHYS, V76, P5022, DOI 10.1063/1.357214; Sader JE, 1999, REV SCI INSTRUM, V70, P3967, DOI 10.1063/1.1150021; Shull KR, 2002, MAT SCI ENG R, V36, P1, DOI 10.1016/S0927-796X(01)00039-0; Singer I. L., 1992, FUNDAMENTALS FRICTIO; Szlufarska I, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/12/123001; Tortonese M, 1997, P SOC PHOTO-OPT INS, V3009, P53, DOI 10.1117/12.271229; Yanson AI, 1998, NATURE, V395, P783, DOI 10.1038/27405; Zhao XY, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.186102	30	1312	1350	50	1393	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	2010	328	5974					76	80		10.1126/science.1184167	http://dx.doi.org/10.1126/science.1184167			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577DR	20360104				2022-12-28	WOS:000276202200037
J	Foti, JJ; Walker, GC				Foti, James J.; Walker, Graham C.			SnapShot: DNA Polymerases I Prokaryotes	CELL			English	Editorial Material									[Foti, James J.; Walker, Graham C.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Foti, JJ (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.			/0000-0001-7243-8261	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Kornberg A., 1992, DNA REPLICATION; Lamers MH, 2006, CELL, V126, P881, DOI 10.1016/j.cell.2006.07.028; Patel PH, 2001, J MOL BIOL, V308, P823, DOI 10.1006/jmbi.2001.4619; Rattray AJ, 2003, ANNU REV GENET, V37, P31, DOI 10.1146/annurev.genet.37.042203.132748; SIMMONS LA, 2008, ECOSAL ESCHERICHIA C; Yang W, 2005, FEBS LETT, V579, P868, DOI 10.1016/j.febslet.2004.11.047	6	3	3	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 1	2010	141	1					192	E1		10.1016/j.cell.2010.03.024	http://dx.doi.org/10.1016/j.cell.2010.03.024			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	577GS	20371354	Green Published, Bronze			2022-12-28	WOS:000276211100024
J	Samara, NL; Datta, AB; Berndsen, CE; Zhang, XB; Yao, TT; Cohen, RE; Wolberger, C				Samara, Nadine L.; Datta, Ajit B.; Berndsen, Christopher E.; Zhang, Xiangbin; Yao, Tingting; Cohen, Robert E.; Wolberger, Cynthia			Structural Insights into the Assembly and Function of the SAGA Deubiquitinating Module	SCIENCE			English	Article							MESSENGER-RNA EXPORT; NUCLEAR-PORE; UBIQUITIN; CHROMATIN; COMPLEX; SUS1; DEUBIQUITYLATION; ASSOCIATION; DOMAIN; UBP8	SAGA is a transcriptional coactivator complex that is conserved across eukaryotes and performs multiple functions during transcriptional activation and elongation. One role is deubiquitination of histone H2B, and this activity resides in a distinct subcomplex called the deubiquitinating module (DUBm), which contains the ubiquitin-specific protease Ubp8, bound to Sgf11, Sus1, and Sgf73. The deubiquitinating activity depends on the presence of all four DUBm proteins. We report here the 1.90 angstrom resolution crystal structure of the DUBm bound to ubiquitin aldehyde, as well as the 2.45 angstrom resolution structure of the uncomplexed DUBm. The structure reveals an arrangement of protein domains that gives rise to a highly interconnected complex, which is stabilized by eight structural zinc atoms that are critical for enzymatic activity. The structure suggests a model for how interactions with the other DUBm proteins activate Ubp8 and allows us to speculate about how the DUBm binds to monoubiquitinated histone H2B in nucleosomes.	[Samara, Nadine L.; Datta, Ajit B.; Berndsen, Christopher E.; Zhang, Xiangbin; Wolberger, Cynthia] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Datta, Ajit B.; Berndsen, Christopher E.; Zhang, Xiangbin; Wolberger, Cynthia] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Yao, Tingting; Cohen, Robert E.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Colorado State University	Wolberger, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.	cwolberg@jhmi.edu	Samara, Nadine/AAT-2720-2020	Wolberger, Cynthia/0000-0001-8578-2969; Berndsen, Christopher/0000-0002-4285-4341	National Institute of General Medical Science, NIH [F32GM089037, Y1-GM-1104]; National Cancer Institute [Y1-CO-1020]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM089037, R01GM095822] Funding Source: NIH RePORTER	National Institute of General Medical Science, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. DiBello for helping with the ubiquitin aldehyde synthesis, E. Hurt for providing the Sus1 clone, S. Corcoran at the General Medicine and Cancer Institutes Collaborative Access Team (GM/CA-CAT) beamline at the Advanced Photon Source for assistance with data collection and processing, and M. Bianchet for advice and discussions. C. E. B. is supported by a Ruth Kirchstein Fellowship from the National Institute of General Medical Science, NIH (F32GM089037), and T.Y. is a Special Fellow of the Leukemia and Lymphoma Society. GM/CA-CAT has been funded in whole or in part with federal funds from the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Science (Y1-GM-1104), NIH. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357. Coordinates and structure factors have been deposited in the Protein Data Bank with accession codes 3MHS (DUBm bound to Ubal) and 3MHH (apo DUBm).	Allen MD, 2007, PROTEIN SCI, V16, P2072, DOI 10.1110/ps.072967807; Atanassov BS, 2009, MOL CELL, V35, P352, DOI 10.1016/j.molcel.2009.06.015; Avvakumov GV, 2006, J BIOL CHEM, V281, P38061, DOI 10.1074/jbc.M606704200; Bonnet J, 2008, TRENDS BIOCHEM SCI, V33, P369, DOI 10.1016/j.tibs.2008.05.005; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Daniel JA, 2007, MUTAT RES-FUND MOL M, V618, P135, DOI 10.1016/j.mrfmmm.2006.09.008; Ellisdon AM, 2010, J BIOL CHEM, V285, P3850, DOI 10.1074/jbc.M109.070839; Helmlinger D, 2006, TRENDS GENET, V22, P562, DOI 10.1016/j.tig.2006.07.010; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Jani DY, 2009, MOL CELL, V33, P727, DOI 10.1016/j.molcel.2009.01.033; Kohler A, 2008, NAT CELL BIOL, V10, P707, DOI 10.1038/ncb1733; Kohler A, 2006, MOL BIOL CELL, V17, P4228, DOI 10.1091/mbc.E06-02-0098; KOUTELOU E, 2010, CURR OPIN CELL BIOL; Latouche M, 2006, MOL CELL NEUROSCI, V31, P438, DOI 10.1016/j.mcn.2005.10.013; Lee HJ, 2006, GENE EXPR PATTERNS, V6, P277, DOI 10.1016/j.modgep.2005.07.007; Lee KK, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-2; Lee KK, 2005, MOL CELL BIOL, V25, P1173, DOI 10.1128/MCB.25.3.1173-1182.2005; Lindblad K, 1996, GENOME RES, V6, P965, DOI 10.1101/gr.6.10.965; Luthra R, 2007, J BIOL CHEM, V282, P3042, DOI 10.1074/jbc.M608741200; Pascual-Garcia P, 2008, GENE DEV, V22, P2811, DOI 10.1101/gad.483308; PICKART CM, 1986, J BIOL CHEM, V261, P210; Renatus M, 2006, STRUCTURE, V14, P1293, DOI 10.1016/j.str.2006.06.012; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Rodriguez-Navarro S, 2009, EMBO REP, V10, P843, DOI 10.1038/embor.2009.168; Weake VM, 2008, EMBO J, V27, P394, DOI 10.1038/sj.emboj.7601966; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Ye Y, 2009, MOL BIOSYST, V5, P1797, DOI 10.1039/b907669g	29	159	163	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 21	2010	328	5981					1025	1029		10.1126/science.1190049	http://dx.doi.org/10.1126/science.1190049			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598YW	20395473	Green Accepted			2022-12-28	WOS:000277877100040
J	Dunoyer, P; Schott, G; Himber, C; Meyer, D; Takeda, A; Carrington, JC; Voinnet, O				Dunoyer, Patrice; Schott, Gregory; Himber, Christophe; Meyer, Denise; Takeda, Atsushi; Carrington, James C.; Voinnet, Olivier			Small RNA Duplexes Function as Mobile Silencing Signals Between Plant Cells	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; SIRNA; INHIBITION; PATHWAYS; MICRORNA	In the plant RNA interference (RNAi) pathway, 21-nucleotide duplexes of small interfering RNA (siRNA) are processed from longer double-stranded RNA precursors by the RNaseIII Dicer-like 4 (DCL4). Single-stranded siRNAs then guide Argonaute 1 (AGO1) to execute posttranscriptional silencing of complementary target RNAs. RNAi is not cell-autonomous in higher plants, but the nature of the mobile nucleic acid(s) signal remains unknown. Using cell-specific rescue of DCL4 function and cell-specific inhibition of RNAi movement, we genetically establish that exogenous and endogenous siRNAs, as opposed to their precursor molecules, act as mobile silencing signals between plant cells. We further demonstrate physical movement of mechanically delivered, labeled siRNA duplexes that functionally recapitulate transgenic RNAi spread. Cell-to-cell movement is unlikely to involve AGO1-bound siRNA single strands, but instead likely involves siRNA duplexes.	[Dunoyer, Patrice; Schott, Gregory; Himber, Christophe; Meyer, Denise; Voinnet, Olivier] Univ Strasbourg, CNRS, Inst Biol Mol Plantes, F-67084 Strasbourg, France; [Takeda, Atsushi; Carrington, James C.] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Oregon State University	Dunoyer, P (corresponding author), Univ Strasbourg, CNRS, Inst Biol Mol Plantes, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.	patrice.dunoyer@ibmp-ulp.u-strasbg.fr; olivier.voinnet@ibmp-ulp.u-strasbg.fr	Perry, George/A-8611-2009; Carrington, James C/A-4656-2012	Perry, George/0000-0002-6547-0172; Carrington, James C/0000-0003-3572-129X	Bettencourt Foundation for Life Science Research; European Research Council [ERC 210890]; Agence National pour la Recherche [ANR-08-JCJC-0063-01]; NIH [AI43288]; NSF [MCB-0618433]; Japanese Society for the Promotion of Science; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI043288, R01AI043288, R37AI043288] Funding Source: NIH RePORTER	Bettencourt Foundation for Life Science Research; European Research Council(European Research Council (ERC)European Commission); Agence National pour la Recherche(French National Research Agency (ANR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research in O.V.'s laboratory is funded by a prize from the Bettencourt Foundation for Life Science Research and a starting grant from the European Research Council "Frontiers of RNAi" ERC 210890. P.D. and G.S. are supported by a research grant from Agence National pour la Recherche (ANR-08-JCJC-0063-01), J.C.C. is supported by grants from the NIH (AI43288) and the NSF (MCB-0618433), and A. T. is supported by a fellowship from the Japanese Society for the Promotion of Science. We thank J. Mutterrer for help with image acquisition, R. Wagner's team for plant care, and members of O.V.'s laboratory for critical reading of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Berezhna SY, 2006, P NATL ACAD SCI USA, V103, P7682, DOI 10.1073/pnas.0600148103; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Chitwood DH, 2009, GENE DEV, V23, P549, DOI 10.1101/gad.1770009; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; DUNOYER P, 2010, EMBO J, DOI DOI 10.1038/EMBOJ.2010.65; Dunoyer P, 2007, NAT GENET, V39, P848, DOI 10.1038/ng2081; Dunoyer P, 2009, TRENDS PLANT SCI, V14, P643, DOI 10.1016/j.tplants.2009.09.003; Havelda Z, 2003, J VIROL, V77, P6082, DOI 10.1128/JVI.77.10.6082-6086.2003; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Merai Z, 2006, J VIROL, V80, P5747, DOI 10.1128/JVI.01963-05; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Schwab R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005980; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Vargason JM, 2003, CELL, V115, P799, DOI 10.1016/S0092-8674(03)00984-X; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Voinnet O, 2005, FEBS LETT, V579, P5858, DOI 10.1016/j.febslet.2005.09.039; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3	22	272	317	3	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 14	2010	328	5980					912	916		10.1126/science.1185880	http://dx.doi.org/10.1126/science.1185880			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20413458				2022-12-28	WOS:000277618800055
J	Cameron, P; Hiroi, M; Ngai, J; Scott, K				Cameron, Peter; Hiroi, Makoto; Ngai, John; Scott, Kristin			The molecular basis for water taste in Drosophila	NATURE			English	Article							GUSTATORY RECEPTOR NEURONS; POX-NEURO; CHANNELS; BEHAVIOR; PROTEIN; SYSTEM; BRAIN	The detection of water and the regulation of water intake are essential for animals to maintain proper osmotic homeostasis(1). Drosophila and other insects have gustatory sensory neurons that mediate the recognition of external water sources(2-4), but little is known about the underlying molecular mechanism for water taste detection. Here we identify a member of the degenerin/epithelial sodium channel family(5), PPK28, as an osmosensitive ion channel that mediates the cellular and behavioural response to water. We use molecular, cellular, calcium imaging and electrophysiological approaches to show that ppk28 is expressed in water-sensing neurons, and that loss of ppk28 abolishes water sensitivity. Moreover, ectopic expression of ppk28 confers water sensitivity to bitter-sensing gustatory neurons in the fly and sensitivity to hypoosmotic solutions when expressed in heterologous cells. These studies link an osmosensitive ion channel to water taste detection and drinking behaviour, providing the framework for examining the molecular basis for water detection in other animals.	[Scott, Kristin] Univ Calif Berkeley, Dept Mol & Cell Biol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Ngai, John] Univ Calif Berkeley, Funct Genom Lab, Berkeley, CA 94720 USA; [Scott, Kristin] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Scott, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Helen Wills Neurosci Inst, 229 Stanley Hall, Berkeley, CA 94720 USA.	kscott@berkeley.edu	Hiroi, Makoto/B-6834-2008	Hiroi, Makoto/0000-0002-0136-5891; Cameron, Peter/0000-0002-1443-557X	NIH (NIDCD); Burroughs-Wellcome CAREER Award; John Merck Award; NIH; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006252] Funding Source: NIH RePORTER	NIH (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Burroughs-Wellcome CAREER Award(Burroughs Wellcome Fund); John Merck Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank K. Vranizan for assistance with microarray analyses. K. Gerhold and D. Bautista provided the TRPV4 construct, protocols and advice for HEK293 experiments; the Roelink laboratory provided tissue culture facilities and advice. G. Agarwaal generated heat map images in Matlab for data presentation. W. Fischler generated the NP1017 G-CaMP data in Supplementary Information. We are grateful to C. Zuker and members of the Scott laboratory for comments on the manuscript. This work was supported by a grant from the NIH (NIDCD), a Burroughs-Wellcome CAREER Award and a John Merck Award to K. S. and a NIH predoctoral fellowship to P. C. K. S. is an HHMI Early Career Scientist.	Awasaki T, 1997, J NEUROBIOL, V32, P707, DOI 10.1002/(SICI)1097-4695(19970620)32:7<707::AID-NEU6>3.0.CO;2-8; Boll W, 2002, DEVELOPMENT, V129, P5667, DOI 10.1242/dev.00157; Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; Chyb S, 2003, P NATL ACAD SCI USA, V100, P14526, DOI 10.1073/pnas.2135339100; Colbert HA, 1997, J NEUROSCI, V17, P8259; EVANS DR, 1962, J GEN PHYSIOL, V45, P487, DOI 10.1085/jgp.45.3.487; Fischler W, 2007, NATURE, V448, P1054, DOI 10.1038/nature06101; Gilbertson TA, 2002, CHEM SENSES, V27, P383, DOI 10.1093/chemse/27.4.383; Hiroi M, 2004, J NEUROBIOL, V61, P333, DOI 10.1002/neu.20063; Hiroi M, 2002, ZOOL SCI, V19, P1009, DOI 10.2108/zsj.19.1009; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Inoshita T, 2006, P NATL ACAD SCI USA, V103, P1094, DOI 10.1073/pnas.0502376103; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; Liu L, 2003, P NATL ACAD SCI USA, V100, P2128, DOI 10.1073/pnas.252785099; Liu L, 2007, NATURE, V450, P294, DOI 10.1038/nature06223; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; Meunier N, 2000, CURR BIOL, V10, P1583, DOI 10.1016/S0960-9822(00)00860-5; Meunier N, 2009, CHEM SENSES, V34, P441, DOI 10.1093/chemse/bjp019; Moon SJ, 2006, CURR BIOL, V16, P1812, DOI 10.1016/j.cub.2006.07.024; Muraki K, 2003, CIRC RES, V93, P829, DOI 10.1161/01.RES.0000097263.10220.0C; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Werner-Reiss U, 1999, J INSECT PHYSIOL, V45, P485, DOI 10.1016/S0022-1910(98)00151-6; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001	27	170	175	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 6	2010	465	7294					91	U101		10.1038/nature09011	http://dx.doi.org/10.1038/nature09011			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591OW	20364123	Green Accepted, Green Submitted			2022-12-28	WOS:000277311900037
J	Jin, Y; Birlea, SA; Fain, PR; Gowan, K; Riccardi, SL; Holland, PJ; Mailloux, CM; Sufit, AJD; Hutton, SM; Amadi-Myers, A; Bennett, DC; Wallace, MR; McCormack, WT; Kemp, EH; Gawkrodger, DJ; Weetman, AP; Picardo, M; Leone, G; Taieb, A; Jouary, T; Ezzedine, K; van Geel, N; Lambert, J; Overbeck, A; Spritz, RA				Jin, Ying; Birlea, Stanca A.; Fain, Pamela R.; Gowan, Katherine; Riccardi, Sheri L.; Holland, Paulene J.; Mailloux, Christina M.; Sufit, Alexandra J. D.; Hutton, Saunie M.; Amadi-Myers, Anita; Bennett, Dorothy C.; Wallace, Margaret R.; McCormack, Wayne T.; Kemp, E. Helen; Gawkrodger, David J.; Weetman, Anthony P.; Picardo, Mauro; Leone, Giovanni; Taieb, Alain; Jouary, Thomas; Ezzedine, Khaled; van Geel, Nanny; Lambert, Jo; Overbeck, Andreas; Spritz, Richard A.			Variant of TYR and Autoimmunity Susceptibility Loci in Generalized Vitiligo.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; RHEUMATOID-ARTHRITIS; HAPLOTYPE MAP; GRANZYME-B; DISEASE; RISK; GENE; PIGMENTATION; TYROSINASE; HLA	Background: Generalized vitiligo is an autoimmune disease characterized by melanocyte loss, which results in patchy depigmentation of skin and hair, and is associated with an elevated risk of other autoimmune diseases. Methods: To identify generalized vitiligo susceptibility loci, we conducted a genomewide association study. We genotyped 579,146 single-nucleotide polymorphisms (SNPs) in 1514 patients with generalized vitiligo who were of European-derived white (CEU) ancestry and compared the genotypes with publicly available control genotypes from 2813 CEU persons. We then tested 50 SNPs in two replication sets, one comprising 677 independent CEU patients and 1106 CEU controls and the other comprising 183 CEU simplex trios with generalized vitiligo and 332 CEU multiplex families. Results: We detected significant associations between generalized vitiligo and SNPs at several loci previously associated with other autoimmune diseases. These included genes encoding major-histocompatibility-complex class I molecules (P=9.05 x 10(sup -23)) and class II molecules (P=4.50 x 10(sup -34)), PTPN22 (P=1.31 x 10(sup -7)), LPP (P=1.01 x 10(sup -11)), IL2RA (P=2.78 x 10(sup -9)), UBASH3A (P=1.26 x 10(sup -9)), and C1QTNF6 (P=2.21 x 10(sup -16)). We also detected associations between generalized vitiligo and SNPs in two additional immune-related loci, RERE (P=7.07 x 10(sup -15)) and GZMB (P=3.44 x 10(sup -8)), and in a locus containing TYR (P=1.60 x 10(sup -18)), encoding tyrosinase. Conclusions: We observed associations between generalized vitiligo and markers implicating multiple genes, some associated with other autoimmune diseases and one (TYR) that may mediate target-cell specificity and indicate a mutually exclusive relationship between susceptibility to vitiligo and susceptibility to melanoma. N Engl J Med 2010;362:1686-97.	[Jin, Ying; Birlea, Stanca A.; Fain, Pamela R.; Gowan, Katherine; Riccardi, Sheri L.; Holland, Paulene J.; Mailloux, Christina M.; Sufit, Alexandra J. D.; Hutton, Saunie M.; Spritz, Richard A.] Univ Colorado, Sch Med, Human Med Genet Program, Aurora, CO 80045 USA; [Fain, Pamela R.] Univ Colorado, Sch Med, Barbara Davis Ctr Childhood Diabet, Aurora, CO 80045 USA; [Birlea, Stanca A.] Univ Colorado, Sch Med, Dept Dermatol, Aurora, CO 80045 USA; [Jin, Ying; Fain, Pamela R.; Spritz, Richard A.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Fain, Pamela R.] Univ Colorado, Sch Med, Dept Med, Aurora, CO 80045 USA; [Amadi-Myers, Anita; Bennett, Dorothy C.] Univ London, Div Basic Med Sci, London, England; [Wallace, Margaret R.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA; [McCormack, Wayne T.] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Kemp, E. Helen; Weetman, Anthony P.] Univ Sheffield, Sch Med, Dept Human Metab, Sheffield, S Yorkshire, England; [Gawkrodger, David J.] Royal Hallamshire Hosp, Dept Dermatol, Sheffield S10 2JF, S Yorkshire, England; [Picardo, Mauro; Leone, Giovanni] Ist Dermatol S Maria & S Gallicano, Lab Fisiopatol Cutanea, Rome, Italy; [Taieb, Alain; Jouary, Thomas; Ezzedine, Khaled] Hop St Andre, Dept Dermatol, Ctr Reference Malad Rares Peau, Bordeaux, France; [van Geel, Nanny; Lambert, Jo] Ghent Univ Hosp, Dept Dermatol, B-9000 Ghent, Belgium; [Overbeck, Andreas] Lumiderm, Madrid, Spain	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of London; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Sheffield; University of Sheffield; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); CHU Bordeaux; Ghent University; Ghent University Hospital	Spritz, RA (corresponding author), Univ Colorado, Sch Med, Human Med Genet Program, POB 6511,Mailstop 8300, Aurora, CO 80045 USA.	richard.spritz@ucdenver.edu	Bennett, Dorothy C/C-2418-2008; Leone, Giovanni/AAW-7785-2021; TAIEB, ALAIN/AAB-1085-2021; Kemp, Elizabeth Helen/D-1665-2011; Ezzedine, Khaled/A-3072-2009; Jo, Lambert LW/AAG-4880-2021; Jo, Lambert LW/ABD-3264-2021; Ezzedine, Khaled/F-2716-2017; Picardo, Mauro/A-6978-2011; GAWKRODGER, DAVID J./AFO-6373-2022	Bennett, Dorothy C/0000-0002-3639-7527; Leone, Giovanni/0000-0001-6120-2712; Kemp, Elizabeth Helen/0000-0002-0313-8916; Ezzedine, Khaled/0000-0002-5468-4589; Picardo, Mauro/0000-0003-4899-6639; GAWKRODGER, DAVID J./0000-0002-6863-7011; Lambert, Jo/0000-0001-5303-9310; McCormack, Wayne/0000-0002-2117-8727	National Institutes of Health [AR45584, AR056292]; Anna and John Sie Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045584, R01AR056292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anna and John Sie Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by grants (AR45584 and AR056292) from the National Institutes of Health and a grant from the Anna and John Sie Foundation.	Alkhateeb A, 2003, PIGM CELL RES, V16, P208, DOI 10.1034/j.1600-0749.2003.00032.x; Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411; Brand OJ, 2007, CLIN ENDOCRINOL, V66, P508, DOI 10.1111/j.1365-2265.2007.02762.x; Carr EJ, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-22; Coenen MJH, 2009, HUM MOL GENET, V18, P4195, DOI 10.1093/hmg/ddp365; Concannon P, 2008, DIABETES, V57, P2858, DOI 10.2337/db08-0753; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Devadas S, 2006, IMMUNITY, V25, P237, DOI 10.1016/j.immuni.2006.06.011; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Fain PR, 2006, PIGM CELL RES, V19, P51, DOI 10.1111/j.1600-0749.2005.00279.x; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gregersen PK, 2006, SEMIN IMMUNOL, V18, P214, DOI 10.1016/j.smim.2006.03.009; Gudbjartsson DF, 2008, NAT GENET, V40, P886, DOI 10.1038/ng.161; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hinks A, 2009, ARTHRITIS RHEUM, V60, P251, DOI 10.1002/art.24187; Hondo Yoshihide, 1997, Journal of Dermatology (Tokyo), V24, P561; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; Ioannidis JPA, 2009, NAT REV GENET, V10, P318, DOI 10.1038/nrg2544; Julia A, 2008, ARTHRITIS RHEUM-US, V58, P2275, DOI 10.1002/art.23623; Liu JB, 2007, J EUR ACAD DERMATOL, V21, P205, DOI 10.1111/j.1468-3083.2006.01899.x; Lotz C, 2004, INT J CANCER, V108, P571, DOI 10.1002/ijc.11602; Luca D, 2008, AM J HUM GENET, V82, P453, DOI 10.1016/j.ajhg.2007.11.003; Majumder PA., 2000, VITILIGO MONOGRAPH B; Ostankovitch M, 2009, J IMMUNOL, V182, P4830, DOI 10.4049/jimmunol.0802902; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rezaei N, 2007, J EUR ACAD DERMATOL, V21, P865, DOI 10.1111/j.1468-3083.2007.02228.x; Spritz RA, 2003, CURR OPIN GENET DEV, V13, P284, DOI 10.1016/S0959-437X(03)00059-5; Spritz Richard A., 2008, V10, P244, DOI 10.1159/000131501; Stromberg S, 2008, PIGM CELL MELANOMA R, V21, P162, DOI 10.1111/j.1755-148X.2007.00429.x; Taieb A, 2007, PIGM CELL RES, V20, P27, DOI 10.1111/j.1600-0749.2006.00355.x; Toyofuku K, 2001, BIOCHEM J, V355, P259, DOI 10.1042/0264-6021:3550259; Trapani JA, 2003, CURR OPIN IMMUNOL, V15, P533, DOI 10.1016/S0952-7915(03)00107-9; TRIPATHI RK, 1991, GENE EXPRESSION, V1, P103; Vella A, 2005, AM J HUM GENET, V76, P773, DOI 10.1086/429843; Waerner T, 2001, CELL GROWTH DIFFER, V12, P201; Wallis RH, 2009, DIABETES, V58, P1007, DOI 10.2337/db08-1215; Wang JG, 2009, SEMIN IMMUNOL, V21, P363, DOI 10.1016/j.smim.2009.04.004; Wang Lei, 2008, Nucl Recept Signal, V6, pe009, DOI 10.1621/nrs.06009	41	261	276	2	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 6	2010	362	18					1686	1697		10.1056/NEJMoa0908547	http://dx.doi.org/10.1056/NEJMoa0908547			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591OQ	20410501	Green Accepted			2022-12-28	WOS:000277311200006
J	Schmidtko, A; Lotsch, J; Freynhagen, R; Geisslinger, G				Schmidtko, Achim; Loetsch, Joern; Freynhagen, Rainer; Geisslinger, Gerd			Ziconotide for treatment of severe chronic pain	LANCET			English	Article							CALCIUM-CHANNEL BLOCKER; COMBINED INTRATHECAL MORPHINE; ORAL ANALGESIC EFFICACY; N-TYPE; OMEGA-CONOTOXIN; OPEN-LABEL; NEUROPATHIC PAIN; CA2+ CHANNELS; DOUBLE-BLIND; T-TYPE	Pharmacological management of severe chronic pain is difficult to achieve with currently available analgesic drugs, and remains a large unmet therapeutic need. The synthetic peptide ziconotide has been approved by the US Food and Drug Administration and the European Medicines Agency for intrathecal treatment of patients with severe chronic pain that is refractory to other treatment modalities. Ziconotide is the first member in the new drug class of selective N-type voltage-sensitive calcium-channel blockers. The ziconotide-induced blockade of N-type calcium channels in the spinal cord inhibits release of pain-relevant neurotransmitters from central terminals of primary afferent neurons. By this mechanism, ziconotide can effectively reduce pain. However, ziconotide has a narrow therapeutic window because of substantial CNS side-effects, and thus treatment with ziconotide is appropriate for only a small subset of patients with severe chronic pain. We provide an overview of the benefits and limitations of intrathecal ziconotide treatment and review potential future developments in this new drug class.	[Schmidtko, Achim; Loetsch, Joern; Geisslinger, Gerd] Goethe Univ Frankfurt, Pharmazentrum Frankfurt ZAFES, Inst Klin Pharmakol, D-60590 Frankfurt, Germany; [Freynhagen, Rainer] Benedictus Krankenhaus, Zentrum Anasthesiol Intens Med Schmerztherapie, Schmerzzentrum Starnberger See, Tutzing, Germany	Goethe University Frankfurt	Geisslinger, G (corresponding author), Goethe Univ Frankfurt, Pharmazentrum Frankfurt ZAFES, Inst Klin Pharmakol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	geisslinger@em.uni-frankfurt.de	Schmidtko, Achim/AAB-2122-2019	Freynhagen, Rainer/0000-0002-3759-1508; Lotsch, Jorn/0000-0002-5818-6958; Schmidtko, Achim/0000-0001-7270-5075	Deutsche Forschungsgemeinschaft [DFG-SFB 815/A14, GE695]; LOEWE Lipid Signaling Forschungszentrum Frankfurt	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); LOEWE Lipid Signaling Forschungszentrum Frankfurt	Research work of AS, Jl, and GG is supported by the Deutsche Forschungsgemeinschaft (DFG-SFB 815/A14, GE695) and the LOEWE Lipid Signaling Forschungszentrum Frankfurt.	Alford DP, 2008, J GEN INTERN MED, V23, P841, DOI 10.1007/s11606-008-0570-8; Altier C, 2004, TRENDS PHARMACOL SCI, V25, P465, DOI 10.1016/j.tips.2004.07.004; [Anonymous], 2006, NATL PBM DRUG MONOGR; Bell TJ, 2004, NEURON, V41, P127, DOI 10.1016/S0896-6273(03)00801-8; Bowersox SS, 1998, TOXICON, V36, P1651, DOI 10.1016/S0041-0101(98)00158-5; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Cizkova D, 2002, EXP BRAIN RES, V147, P456, DOI 10.1007/s00221-002-1217-3; Deer T, 2008, NEUROMODULATION, V11, P92, DOI 10.1111/j.1525-1403.2008.00148.x; Deer T, 2007, NEUROMODULATION, V10, P300, DOI 10.1111/j.1525-1403.2007.00128.x; *EMEA, 2005, SCI DISC ZIC; Feng ZP, 2003, J BIOL CHEM, V278, P20171, DOI 10.1074/jbc.M300581200; Field MJ, 2006, P NATL ACAD SCI USA, V103, P17537, DOI 10.1073/pnas.0409066103; GOHIL K, 1994, BRAIN RES, V653, P258, DOI 10.1016/0006-8993(94)90398-0; Heading Christine E, 2002, Curr Opin Investig Drugs, V3, P915; Hu LY, 1999, J MED CHEM, V42, P4239, DOI 10.1021/jm9902739; Jeon D, 2007, GENES BRAIN BEHAV, V6, P375, DOI 10.1111/j.1601-183X.2006.00267.x; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Kapural L, 2009, PAIN PRACT, V9, P296, DOI 10.1111/j.1533-2500.2009.00289.x; Klotz U, 2006, INT J CLIN PHARM TH, V44, P478; Koganei H, 2009, BIOL PHARM BULL, V32, P1695, DOI 10.1248/bpb.32.1695; Kroenke K, 2009, GEN HOSP PSYCHIAT, V31, P206, DOI 10.1016/j.genhosppsych.2008.12.006; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; Lynch SS, 2006, ANN PHARMACOTHER, V40, P1293, DOI 10.1345/aph.1G584; McGivern JG, 2006, DRUG DISCOV TODAY, V11, P245, DOI 10.1016/S1359-6446(05)03662-7; McGuire D, 1997, J CARDIOVASC PHARM, V30, P400, DOI 10.1097/00005344-199709000-00019; Meng G, 2008, EUR J PHARMACOL, V586, P130, DOI 10.1016/j.ejphar.2008.02.066; Miljanich GP, 2004, CURR MED CHEM, V11, P3029, DOI 10.2174/0929867043363884; MILJANICH GP, 1995, ANNU REV PHARMACOL, V35, P707, DOI 10.1146/annurev.pa.35.040195.003423; Motin L, 2008, NEUROPHARMACOLOGY, V55, P860, DOI 10.1016/j.neuropharm.2008.06.049; Newcomb R, 2000, PEPTIDES, V21, P491, DOI 10.1016/S0196-9781(00)00175-3; O'Connor AB, 2009, AM J MED, V122, pS22, DOI 10.1016/j.amjmed.2009.04.007; Olivera BM, 2007, MOL INTERV, V7, P251, DOI 10.1124/mi.7.5.7; OLIVERA BM, 1987, BIOCHEMISTRY-US, V26, P2086, DOI 10.1021/bi00382a004; OLIVERA BM, 1985, SCIENCE, V230, P1338, DOI 10.1126/science.4071055; Rauck RL, 2009, PAIN PRACT, V9, P327, DOI 10.1111/j.1533-2500.2009.00303.x; Rauck RL, 2006, J PAIN SYMPTOM MANAG, V31, P393, DOI 10.1016/j.jpainsymman.2005.10.003; Schmidtko A, 2009, TRENDS NEUROSCI, V32, P339, DOI 10.1016/j.tins.2009.01.010; Scholz J, 2002, NAT NEUROSCI, V5, P1062, DOI 10.1038/nn942; Seko T, 2002, BIOORG MED CHEM LETT, V12, P2267, DOI 10.1016/S0960-894X(02)00456-0; Seko T, 2001, BIOORG MED CHEM LETT, V11, P2067, DOI 10.1016/S0960-894X(01)00414-0; Smith Howard S, 2009, Ther Clin Risk Manag, V5, P521; Snutch Terrance P, 2005, NeuroRx, V2, P662, DOI 10.1602/neurorx.2.4.662; Staats PS, 2004, JAMA-J AM MED ASSOC, V291, P63, DOI 10.1001/jama.291.1.63; Stanton-Hicks M, 2006, J PAIN SYMPTOM MANAG, V32, P509, DOI 10.1016/j.jpainsymman.2006.08.002; Stix G, 2005, SCI AM, V292, P79; Taylor CP, 2009, PAIN, V142, P13, DOI 10.1016/j.pain.2008.11.019; Thompson James C, 2006, Pain Physician, V9, P147; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Wallace MS, 2008, PAIN MED, V9, P271, DOI 10.1111/j.1526-4637.2007.00355.x; Wallace MS, 2008, ANESTH ANALG, V106, P628, DOI 10.1213/ane.0b013e3181606fad; Wallace Mark S, 2006, Expert Rev Neurother, V6, P1423, DOI 10.1586/14737175.6.10.1423; Wallace MS, 2006, NEUROMODULATION, V9, P75, DOI 10.1111/j.1525-1403.2006.00055.x; Wang YX, 2000, PAIN, V84, P271, DOI 10.1016/S0304-3959(99)00214-6; Webster LR, 2008, PAIN MED, V9, P282, DOI 10.1111/j.1526-4637.2007.00356.x; Webster LR, 2009, J PAIN SYMPTOM MANAG, V37, P363, DOI 10.1016/j.jpainsymman.2008.02.016; Wermeling D, 2003, J CLIN PHARMACOL, V43, P624, DOI 10.1177/0091270003253349; Wermeling DR, 2005, PHARMACOTHERAPY, V25, P1084, DOI 10.1592/phco.2005.25.8.1084; Williams JA, 2008, EXPERT OPIN PHARMACO, V9, P1575, DOI 10.1517/14656566.9.9.1575 ; Yaksh TL, 2006, CNS DRUGS, V20, P339; Yamamoto T, 2006, BIOORG MED CHEM LETT, V16, P798, DOI 10.1016/j.bmcl.2005.11.021; Yamamoto T, 2006, BIOORGAN MED CHEM, V14, P5333, DOI 10.1016/j.bmc.2006.03.040; Yamamoto T, 2009, CURR TOP MED CHEM, V9, P377, DOI 10.2174/156802609788317838; Yokoyama K, 2003, ANESTHESIOLOGY, V99, P1364, DOI 10.1097/00000542-200312000-00019; Zamponi GW, 2009, BIOORG MED CHEM LETT, V19, P6467, DOI 10.1016/j.bmcl.2009.09.008	64	224	230	1	47	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2010	375	9725					1569	1577		10.1016/S0140-6736(10)60354-6	http://dx.doi.org/10.1016/S0140-6736(10)60354-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	596AH	20413151				2022-12-28	WOS:000277655100030
J	Wearden, AJ; Dowrick, C; Chew-Graham, C; Bentall, RP; Morriss, RK; Peters, S; Riste, L; Richardson, G; Lovell, K; Dunn, G				Wearden, Alison J.; Dowrick, Christopher; Chew-Graham, Carolyn; Bentall, Richard P.; Morriss, Richard K.; Peters, Sarah; Riste, Lisa; Richardson, Gerry; Lovell, Karina; Dunn, Graham		FINE Trial Writing Grp; FINE Trial Grp	Nurse led, home based self help treatment for patients in primary care with chronic fatigue syndrome: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COGNITIVE-BEHAVIOR THERAPY; GRADED-EXERCISE; HEALTH-CARE; INTERVENTIONS	Objective To evaluate the effectiveness of home delivered pragmatic rehabilitation-a programme of gradually increasing activity designed collaboratively by the patient and the therapist-and supportive listening-an approach based on non-directive counselling-for patients in primary care with chronic fatigue syndrome/myalgic encephalomyelitis or encephalitis (CFS/ME). Design Single blind, randomised, controlled trial. Setting 186 general practices across the north west of England between February 2005 and May 2007. Participants 296 patients aged 18 or over with CFS/ME (median illness duration seven years) diagnosed using the Oxford criteria. Interventions Participants were randomly allocated to pragmatic rehabilitation, supportive listening, or general practitioner treatment as usual. Both therapies were delivered at home in 10 sessions over 18 weeks by one of three adult specialty general nurses who had received four months' training, including supervised practice, in each of the interventions. GP treatment as usual was unconstrained except that patients were not to be referred for systematic psychological therapies during the treatment period. Main outcome measures The primary clinical outcomes were fatigue and physical functioning at the end of treatment (20 weeks) and 70 weeks from recruitment compared with GP treatment as usual. Lower fatigue scores and higher physical functioning scores denote better outcomes. Results A total of 257 (87%) of the 296 patients who entered the trial were assessed at 70 weeks, the primary outcome point. Analysis was on an intention to treat basis, with robust treatment effects estimated after adjustment for missing data using probability weights. Immediately after treatment (at 20 weeks), patients allocated to pragmatic rehabilitation (n=95) had significantly improved fatigue (effect estimate -1.18, 95% confidence interval -2.18 to -0.18; P=0.021) but not physical functioning (-0.18, 95% CI -5.88 to +5.52; P=0.950) compared with patients allocated to treatment as usual (n=100). At one year after finishing treatment (70 weeks), there were no statistically significant differences in fatigue or physical functioning between patients allocated to pragmatic rehabilitation and those on treatment as usual (-1.00, 95% CI -2.10 to +0.11; P=0.076 and +2.57, 95% CI 3.90 to +9.03; P=0.435). At 20 weeks, patients allocated to supportive listening (n=101) had poorer physical functioning than those allocated to treatment as usual (-7.54, 95% CI -12.76 to -2.33; P=0.005) and no difference in fatigue. At 70 weeks, patients allocated to supportive listening did not differ significantly from those allocated to treatment as usual on either primary outcome. Conclusions For patients with CFS/ME in primary care, pragmatic rehabilitation delivered by trained nurse therapists improves fatigue in the short term compared with unconstrained GP treatment as usual, but the effect is small and not statistically significant at one year follow-up. Supportive listening delivered by trained nurse therapists is not an effective treatment for CFS/ME.	[Wearden, Alison J.; Peters, Sarah; Riste, Lisa] Univ Manchester, Sch Psychol Sci, Manchester M13 9PL, Lancs, England; [Dowrick, Christopher] Univ Liverpool, Sch Populat Community & Behav Sci, Liverpool L69 3BX, Merseyside, England; [Chew-Graham, Carolyn; Dunn, Graham] Univ Manchester, Sch Community Based Med, Manchester M13 9PL, Lancs, England; [Bentall, Richard P.] Univ Bangor, Sch Psychol, Bangor, Gwynedd, Wales; [Morriss, Richard K.] Univ Nottingham, Inst Mental Hlth, Sch Community Hlth Sci, Nottingham NG7 2RD, England; [Richardson, Gerry] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; [Richardson, Gerry] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [Lovell, Karina] Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester M13 9PL, Lancs, England	University of Manchester; University of Liverpool; University of Manchester; Bangor University; University of Nottingham; University of York - UK; University of Hull; University of York - UK; University of Manchester	Wearden, AJ (corresponding author), Univ Manchester, Sch Psychol Sci, Manchester M13 9PL, Lancs, England.	alison.wearden@manchester.ac.uk	Lovell, Karina S E/E-6410-2012	Lovell, Karina S E/0000-0001-8821-895X; Riste, Lisa/0000-0003-2606-0717; Morriss, Richard/0000-0003-2910-4121	UK Medical Research Council [G200212]; UK Department of Health; University of Manchester; MRC [G0200212] Funding Source: UKRI; Medical Research Council [G0200212] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department of Health; University of Manchester; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The UK Medical Research Council (G200212) and the UK Department of Health funded the trial. The study was sponsored by the University of Manchester. The sponsor and the funder of the study had no role in the study design, data collection and analysis, interpretation or reporting of this work, or the decision to submit the work for publication. All authors are independent of the funding source.	Bombardier CH, 1996, MED CARE, V34, P924, DOI 10.1097/00005650-199609000-00005; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Chambers D, 2006, J ROY SOC MED, V99, P506, DOI 10.1258/jrsm.99.10.506; Darbishire L, 2003, BRIT J GEN PRACT, V53, P441; *DEP H6TH, 2002, REP CFS ME WORK GROU; Edmonds M, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD003200.PUB2; Euba R, 1996, BRIT J PSYCHIAT, V168, P121, DOI 10.1192/bjp.168.1.121; Everitt B. S., 2004, STAT ASPECTS DESIGN; FIRST MB, 1995, J PERS DISORD, V9, P83, DOI 10.1521/pedi.1995.9.2.83; First MB, 2002, STRUCTURED CLIN INTE; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Fulcher KY, 1997, BRIT MED J, V314, P1647, DOI 10.1136/bmj.314.7095.1647; HEYTING A, 1992, STAT MED, V11, P2043, DOI 10.1002/sim.4780111603; JENKINS CD, 1988, J CLIN EPIDEMIOL, V41, P313, DOI 10.1016/0895-4356(88)90138-2; Komaroff AL, 1996, AM J MED, V101, P281, DOI 10.1016/S0002-9343(96)00174-X; Little R.J.A., 2002, STAT ANAL MISSING DA; McCrone P, 2003, PSYCHOL MED, V33, P253, DOI 10.1017/S0033291702006980; MELLORCLARK J, 2001, 79 ROYAL COLL GEN PR; *NAT I HLTH CLIN E, 2007, CG53 NIFHACECG NICE; *NAT TASK FORC CHO, 1994, REP NAT TASK FORC CH; Powell P, 2001, BMJ-BRIT MED J, V322, P387, DOI 10.1136/bmj.322.7283.387; Price JR, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001027.pub2; Prins JB, 2001, LANCET, V357, P841, DOI 10.1016/S0140-6736(00)04198-2; Raine R, 2002, BMJ-BRIT MED J, V325, P1082, DOI 10.1136/bmj.325.7372.1082; Ridsdale L, 2001, BRIT J GEN PRACT, V51, P19; RISTE L, 2009, PATIENTS REPORTS MAN; Scheeres K, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-175; SHARPE MC, 1991, J ROY SOC MED, V84, P118, DOI 10.1177/014107689108400224; TOWNSEND P, 1987, J SOC POLICY, V16, P125, DOI 10.1017/S0047279400020341; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wearden AJ, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-9; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	33	68	68	0	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2010	340								c1777	10.1136/bmj.c1777	http://dx.doi.org/10.1136/bmj.c1777			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	589HR	20418251	Green Published, hybrid			2022-12-28	WOS:000277138300001
J	Blendon, RJ; Benson, JM				Blendon, Robert J.; Benson, John M.			Public Opinion at the Time of the Vote on Health Care Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Blendon, Robert J.; Benson, John M.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Blendon, Robert J.] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Blendon, RJ (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.							Blendon RJ, 2009, NEW ENGL J MED, V361, pE13, DOI 10.1056/NEJMp0906392	1	10	10	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 22	2010	362	16								10.1056/NEJMp1003844	http://dx.doi.org/10.1056/NEJMp1003844			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	586GP	20375397				2022-12-28	WOS:000276894700004
J	Riedel, MF; Bohi, P; Li, Y; Hansch, TW; Sinatra, A; Treutlein, P				Riedel, Max F.; Boehi, Pascal; Li, Yun; Haensch, Theodor W.; Sinatra, Alice; Treutlein, Philipp			Atom-chip-based generation of entanglement for quantum metrology	NATURE			English	Article							COHERENCE; STATES; LIMIT	Atom chips provide a versatile quantum laboratory for experiments with ultracold atomic gases(1). They have been used in diverse experiments involving low-dimensional quantum gases(2), cavity quantum electrodynamics(3), atom-surface interactions(4,5), and chip-based atomic clocks(6) and interferometers(7,8). However, a severe limitation of atom chips is that techniques to control atomic interactions and to generate entanglement have not been experimentally available so far. Such techniques enable chip-based studies of entangled many-body systems and are a key prerequisite for atom chip applications in quantum simulations(9), quantum information processing(10) and quantum metrology(11). Here we report the experimental generation of multi-particle entanglement on an atom chip by controlling elastic collisional interactions with a state-dependent potential(12). We use this technique to generate spin-squeezed states of a two-component Bose-Einstein condensate(13); such states are a useful resource for quantum metrology. The observed reduction in spin noise of -3.7 +/- 0.4 dB, combined with the spin coherence, implies four-partite entanglement between the condensate atoms(14); this could be used to improve an interferometric measurement by -2.5 +/- 0.6 dB over the standard quantum limit(15). Our data show good agreement with a dynamical multi-mode simulation(16) and allow us to reconstruct the Wigner function(17) of the spin-squeezed condensate. The techniques reported here could be directly applied to chip-based atomic clocks, currently under development(18).	[Riedel, Max F.; Boehi, Pascal; Haensch, Theodor W.; Treutlein, Philipp] Univ Munich, Fak Phys, D-80799 Munich, Germany; [Riedel, Max F.; Boehi, Pascal; Haensch, Theodor W.; Treutlein, Philipp] Max Planck Inst Quantum Opt, D-85748 Garching, Germany; [Li, Yun; Sinatra, Alice] ENS, Lab Kastler Brossel, F-75005 Paris, France; [Li, Yun] E China Normal Univ, Dept Phys, State Key Lab Precis Spect, Shanghai 200062, Peoples R China; [Treutlein, Philipp] Univ Basel, Dept Phys, CH-4056 Basel, Switzerland	University of Munich; Max Planck Society; UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); East China Normal University; University of Basel	Treutlein, P (corresponding author), Univ Munich, Fak Phys, Schellingstr 4, D-80799 Munich, Germany.	alice.sinatra@lkb.ens.fr; philipp.treutlein@unibas.ch	Treutlein, Philipp/H-6158-2012	Treutlein, Philipp/0000-0001-9025-9574; LI, YUN/0000-0002-8028-9937; Riedel, Max/0000-0002-4257-7655	European Community [247687]; Max Planck Foundation	European Community(European Commission); Max Planck Foundation(Foundation CELLEX)	We thank K. Molmer, J. Reichel, A. Smerzi and A. Sorensen for discussions and J. Halimeh for reading the manuscript. This work was supported by the Nanosystems Initiative Munich and by the European Community's Seventh Framework Programme under grant agreement no. 247687 ( Integrating Project AQUTE). T. W. H. acknowledges support by the Max Planck Foundation.	Aigner S, 2008, SCIENCE, V319, P1226, DOI 10.1126/science.1152458; Appel J, 2009, P NATL ACAD SCI USA, V106, P10960, DOI 10.1073/pnas.0901550106; Bohi P, 2009, NAT PHYS, V5, P592, DOI 10.1038/NPHYS1329; Calarco T, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.022304; Charron E, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.012308; Colombe Y, 2007, NATURE, V450, P272, DOI 10.1038/nature06331; DiVincenzo DP, 2000, FORTSCHR PHYS, V48, P771, DOI 10.1002/1521-3978(200009)48:9/11<771::AID-PROP771>3.0.CO;2-E; Esteve J, 2008, NATURE, V455, P1216, DOI 10.1038/nature07332; Fortagh J, 2007, REV MOD PHYS, V79, P235, DOI 10.1103/RevModPhys.79.235; Giovannetti V, 2004, SCIENCE, V306, P1330, DOI 10.1126/science.1104149; KITAGAWA M, 1993, PHYS REV A, V47, P5138, DOI 10.1103/PhysRevA.47.5138; Li Y, 2009, EUR PHYS J B, V68, P365, DOI 10.1140/epjb/e2008-00472-6; Li Y, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.210401; Lin YJ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.050404; Lloyd S, 1996, SCIENCE, V273, P1073, DOI 10.1126/science.273.5278.1073; Poulsen UV, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.033613; Rosenbusch P, 2009, APPL PHYS B-LASERS O, V95, P227, DOI 10.1007/s00340-009-3451-x; Santarelli C, 1999, PHYS REV LETT, V82, P4619, DOI 10.1103/PhysRevLett.82.4619; Schleier-Smith MH, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.073604; Schumm T, 2005, NAT PHYS, V1, P57, DOI 10.1038/nphys125; SORENSEN A, 2001, NATURE, V63, P409; Sorensen AS, 2001, PHYS REV LETT, V86, P4431, DOI 10.1103/PhysRevLett.86.4431; Treutlein P, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.203005; Treutlein P, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.022312; Vogel A, 2006, APPL PHYS B-LASERS O, V84, P663, DOI 10.1007/s00340-006-2359-y; Wang YJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.090405; Wigner E, 1932, PHYS REV, V40, P0749, DOI 10.1103/PhysRev.40.749; WINELAND DJ, 1994, PHYS REV A, V50, P67, DOI 10.1103/PhysRevA.50.67; Zhao B, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.042312	30	605	608	2	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2010	464	7292					1170	1173		10.1038/nature08988	http://dx.doi.org/10.1038/nature08988			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20357765	Green Submitted			2022-12-28	WOS:000276891100032
J	Ozaltin, E; Hill, K; Subramanian, SV				Ozaltin, Emre; Hill, Kenneth; Subramanian, S. V.			Association of Maternal Stature With Offspring Mortality, Underweight, and Stunting in Low- to Middle-Income Countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REPRODUCTIVE SUCCESS; BODY-SIZE; REGRESSION APPROACH; CHILD-MORTALITY; HEIGHT; DETERMINANTS; FERTILITY	Context Although maternal stature has been associated with offspring mortality and health, the extent to which this association is universal across developing countries is unclear. Objective To examine the association between maternal stature and offspring mortality, underweight, stunting, and wasting in infancy and early childhood in 54 low- to middle-income countries. Design, Setting, and Participants Analysis of 109 Demographic and Health Surveys in 54 countries conducted between 1991 and 2008. Study population consisted of a nationally representative cross-sectional sample of children aged 0 to 59 months born to mothers aged 15 to 49 years. Sample sizes were 2 661 519 (mortality), 587 096 (underweight), 558 347 (stunting), and 568 609 (wasting) children. Main Outcome Measures Likelihood of mortality, underweight, stunting, or wasting in children younger than 5 years. Results The mean response rate across surveys in the mortality data set was 92.8%. In adjusted models, a 1-cm increase in maternal height was associated with a decreased risk of child mortality (absolute risk difference [ARD], 0.0014; relative risk [RR], 0.988; 95% confidence interval [CI], 0.987-0.988), underweight (ARD, 0.0068; RR, 0.968; 95% CI, 0.968-0.969), stunting (ARD, 0.0126; RR, 0.968; 95% CI, 0.967-0.968), and wasting (ARD, 0.0005; RR, 0.994; 95% CI, 0.993-0.995). Absolute risk of dying among children born to the tallest mothers (>= 160 cm) was 0.073 (95% CI, 0.072-0.074) and to those born to the shortest mothers (< 145 cm) was 0.128 (95% CI, 0.126-0.130). Country-specific decrease in the risk for child mortality associated with a 1-cm increase in maternal height varied between 0.978 and 1.011, with the decreased risk being statistically significant in 46 of 54 countries (85%) (alpha =. 05). Conclusion Among 54 low- to middle-income countries, maternal stature was inversely associated with offspring mortality, underweight, and stunting in infancy and childhood. JAMA. 2010; 303(15): 1507-1516 www.jama.com	[Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Ozaltin, Emre; Hill, Kenneth] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Subramanian, SV (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, 677 Huntington Ave, Boston, MA 02115 USA.	svsubram@hsph.harvard.edu			National Institutes of Health [NHLBI K25 HL081275]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	No direct financial support or funding was obtained to conduct this study. Dr Subramanian is supported by a career development grant NHLBI K25 HL081275 from the National Institutes of Health.	Allal N, 2004, P ROY SOC B-BIOL SCI, V271, P465, DOI 10.1098/rspb.2003.2623; [Anonymous], 1995, Bull World Health Organ, V73 Suppl, P1; BAQUI AH, 1994, EUR J CLIN NUTR, V48, P349; Behrman JR, 2004, ECON HUM BIOL, V2, P335, DOI 10.1016/j.ehb.2004.10.002; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Boerma J T, 1993, World Health Stat Q, V46, P222; Cheung YB, 2007, AM J EPIDEMIOL, V166, P1337, DOI 10.1093/aje/kwm223; DEVI MR, 1985, ANN HUM BIOL, V12, P479, DOI 10.1080/03014468500008031; Ethiopia CSA, 2006, DEMOGRAPHIC HLTH SUR; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Finch CE, 2004, SCIENCE, V305, P1736, DOI 10.1126/science.1092556; FRISANCH.AR, 1973, AM J PHYS ANTHROPOL, V39, P255, DOI 10.1002/ajpa.1330390216; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; HART N, 1993, POP STUD-J DEMOG, V47, P27, DOI 10.1080/0032472031000146716; Hernandez-Diaz S, 1999, EUR J CLIN NUTR, V53, P938, DOI 10.1038/sj.ejcn.1600876; Johnson K., 2009, FIELDWORK RELATED FA; Kelly A, 1996, INT J GYNECOL OBSTET, V53, P219, DOI 10.1016/0020-7292(96)02652-5; Kirchengast S, 2000, COLLEGIUM ANTROPOL, V24, P121; Kramer MS, 2003, J NUTR, V133, p1592S, DOI 10.1093/jn/133.5.1592S; LASKER GW, 1976, HUM BIOL, V48, P775; Macro International Inc, 1996, SAMPL MAN DHS 3; MARTORELL R, 1989, HUM ORGAN, V48, P15, DOI 10.17730/humo.48.1.x20u5450x51h5211; MARTORELL R, 1986, HUMAN GROWTH COMPREH, V3; Monden CWS, 2009, AM J HUM BIOL, V21, P305, DOI 10.1002/ajhb.20860; MUELLER WH, 1979, HUM BIOL, V51, P153; Pollet TV, 2008, AM J HUM BIOL, V20, P264, DOI 10.1002/ajhb.20708; Pullum TW, 2008, ASSESSMENT QUALITY D; Rush D, 2000, AM J CLIN NUTR, V72, p212S, DOI 10.1093/ajcn/72.1.212S; Rutstein SO, 2003, GUIDE DHS STAT; Rutstein SO, 2004, DHS WEALTH ASSET IND; Saleemi MA, 2001, ACTA PAEDIATR, V90, P1304, DOI 10.1080/080352501317130371; Sear R, 2004, RES ECON ANTHROPOL, V23, P203, DOI 10.1016/S0190-1281(04)23008-6; Sichieri R, 2000, J ADOLESCENT HEALTH, V26, P414, DOI 10.1016/S1054-139X(99)00004-X; Silventoinen K, 2003, J BIOSOC SCI, V35, P263, DOI 10.1017/S0021932003002633; Stata Corp, 2008, STAT SOFTW REL 10SE; Steckel RH, 2008, J ECON PERSPECT, V22, P129, DOI 10.1257/jep.22.1.129; Strickland Simon S., 2002, Journal of Physiological Anthropology and Applied Human Science, V21, P1, DOI 10.2114/jpa.21.1; STRICKLAND SS, 1997, FORM FUNCTION STUDY; Subramanian SV, 2009, JAMA-J AM MED ASSOC, V301, P1691, DOI 10.1001/jama.2009.548; SULLIVAN JM, 1990, DEMOGRAPHIC HLTH SUR, V1, P113; VAESSEN M, 1996, DEMOGRAPHIC EVALUATI; VANROOSMALEN J, 1992, INT J GYNECOL OBSTET, V37, P169, DOI 10.1016/0020-7292(92)90377-U; World Health Organization, 2006, WHO CHILD GROWTH STA; WRITH ME, 2006, MONITORING HLTH EQUI; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090; DEMOGRAPHIC HLTH SUR	46	263	268	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2010	303	15					1507	1516		10.1001/jama.2010.450	http://dx.doi.org/10.1001/jama.2010.450			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	585SJ	20407060	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000276849000027
J	Braunschweig, H; Radacki, K; Schneider, A				Braunschweig, Holger; Radacki, Krzysztof; Schneider, Achim			Oxoboryl Complexes: Boron-Oxygen Triple Bonds Stabilized in the Coordination Sphere of Platinum	SCIENCE			English	Article							MATRIX-ISOLATION; IMINOBORYL COMPLEXES; INFRARED-SPECTRA; SOLID ARGON; REACTIVITY; INTERMEDIATE; MOLECULE; BORANES; HBO	Monomeric oxoboranes have hitherto been detected only as short-lived species in gas-phase or low-temperature matrix experiments. Here, we report formation of the oxoboryl complex trans-[(Cy(3)P)(2)BrPt(B O)] (Cy being cyclohexyl) by means of reversible liberation of trimethylsilylbromide from the boron-bromine oxidative addition product of dibromo (trimethylsiloxy) borane and [Pt(PCy(3))(2)] in room-temperature toluene solution. The platinum complex is inert toward oligomerization, even under photolytic conditions and at elevated temperatures. The bromide was substituted by thiophenolate, and spectral parameters of both products as well as results of computational and x-ray diffraction studies are in agreement with the formulation of a triple bond between boron and oxygen. The boron-oxygen distance of 120.5(7) picometers shows a bond shortening of 7.2% as compared with a double bond, which is similar to the shortening observed in carbon-carbon analogs.	[Braunschweig, Holger; Radacki, Krzysztof; Schneider, Achim] Univ Wurzburg, Inst Anorgan Chem, D-97074 Wurzburg, Germany	University of Wurzburg	Braunschweig, H (corresponding author), Univ Wurzburg, Inst Anorgan Chem, D-97074 Wurzburg, Germany.	h.braunschweig@mail.uni-wuerzburg.de	Braunschweig, Holger/W-8600-2019	Braunschweig, Holger/0000-0001-9264-1726; Radacki, Krzysztof/0000-0003-3088-6327	Deutsche Forschungsgemeinschaft; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by the Deutsche Forschungsgemeinschaft. A. S. is grateful for a doctoral fellowship of the Fonds der Chemischen Industrie. Crystallographic data for compounds 2 and 3 can be obtained free of charge from the Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif, under reference nos. CCDC 758828 and 758829, respectively.	ANDREWS L, 1991, J PHYS CHEM-US, V95, P8554, DOI 10.1021/j100175a028; BARTON L, 1966, INORG CHEM, V5, P2076, DOI 10.1021/ic50045a062; Berndt, 1993, ANGEW CHEM, V105, P1034; BERNDT A, 1993, ANGEW CHEM INT EDIT, V32, P985, DOI 10.1002/anie.199309851; Bettinger HF, 2007, ORGANOMETALLICS, V26, P6263, DOI 10.1021/om061057i; Bock, 1989, ANGEW CHEM, V101, P77; BOCK H, 1989, ANGEW CHEM INT EDIT, V28, P88, DOI 10.1002/anie.198900881; Braunschweig H, 2006, ANGEW CHEM INT EDIT, V45, P162, DOI 10.1002/anie.200502825; BRAUNSCHWEIG H, 2006, ANGEW CHEM, V118, P169; Braunschweig H, 2008, STRUCT BOND, V130, P1, DOI 10.1007/430_2007_080; Braunschweig H, 2008, J AM CHEM SOC, V130, P7974, DOI 10.1021/ja8016889; Braunschweig H, 2007, CHEM-EUR J, V13, P7171, DOI 10.1002/chem.200700539; BROWN HC, 1980, SCIENCE, V210, P485, DOI 10.1126/science.210.4469.485; Clegg W, 1998, J ORGANOMET CHEM, V550, P183, DOI 10.1016/S0022-328X(97)00233-7; Ehlers AW, 1998, CHEM-EUR J, V4, P210, DOI 10.1002/(SICI)1521-3765(19980210)4:2<210::AID-CHEM210>3.0.CO;2-T; GROTEKLAES M, 1988, CHEM BER-RECL, V121, P809, DOI 10.1002/cber.19881210431; HILDENBRAND DL, 1963, J CHEM PHYS, V39, P1973, DOI 10.1063/1.1734569; Irvine GJ, 1998, CHEM REV, V98, P2685, DOI 10.1021/cr9500085; Ito M, 1997, TETRAHEDRON LETT, V38, P4451, DOI 10.1016/S0040-4039(97)00929-5; KAWASHIMA Y, 1987, CHEM PHYS LETT, V135, P441, DOI 10.1016/0009-2614(87)85186-2; Kays DL, 2008, STRUCT BOND, V130, P29, DOI 10.1007/430_2007_079; Lanzisera DV, 1997, J PHYS CHEM A, V101, P1482, DOI 10.1021/jp963749y; LIPSCOMB WN, 1977, SCIENCE, V196, P1047, DOI 10.1126/science.196.4294.1047; LORY ER, 1971, J AM CHEM SOC, V93, P6301, DOI 10.1021/ja00752a068; PACHALY B, 1985, J AM CHEM SOC, V107, P2987, DOI 10.1021/ja00296a034; PAETZOLD P, 1976, Z NATURFORSCH B, V31, P754; PAETZOLD P, 1995, Z ANORG ALLG CHEM, V621, P732, DOI 10.1002/zaac.19956210506; PAETZOLD P, 1987, ADV INORG CHEM RAD, V31, P123, DOI 10.1016/S0898-8838(08)60223-8; Piers W. E., 2005, ANGEW CHEM, V117, P5142; Piers WE, 2005, ANGEW CHEM INT EDIT, V44, P5016, DOI 10.1002/anie.200500402; Sekiguchi A, 2004, SCIENCE, V305, P1755, DOI 10.1126/science.1102209; SNELSON A, 1972, HIGH TEMP SCI, V4, P141; SNELSON A, 1972, HIGH TEMP SCI, V4, P318; Vidovic D, 2005, J AM CHEM SOC, V127, P4566, DOI 10.1021/ja0507564; WEAST RC, 1979, HDB CHEM PHYS, V60th; WIBERG E, 1953, Z NATURFORSCH B, V8, P610, DOI 10.1515/znb-1953-1014	36	144	145	2	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 16	2010	328	5976					345	347		10.1126/science.1186028	http://dx.doi.org/10.1126/science.1186028			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583NR	20395506				2022-12-28	WOS:000276685000034
J	Godley, LA; van Besien, K				Godley, Lucy A.; van Besien, Koen			The Next Frontier for Stem Cell Transplantation Finding a Donor for All	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CORD BLOOD TRANSPLANTATION; ACUTE-LEUKEMIA; OUTCOMES; MARROW; ADULTS; IMPACT		[Godley, Lucy A.] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; Univ Chicago, Canc Res Ctr, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Godley, LA (corresponding author), Univ Chicago, Dept Med, Hematol Oncol Sect, 5841 S Maryland Ave,MC 2115, Chicago, IL 60637 USA.	lgodley@medicine.bsd.uchicago.edu	van Besien, Koen W./G-4221-2012	van Besien, Koen W./0000-0002-8164-6211	NCI NIH HHS [K24CA116471, K24 CA116471, R01 CA129831] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K24CA116471, R01CA129831] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aversa F, 1998, NEW ENGL J MED, V339, P1186, DOI 10.1056/NEJM199810223391702; Bautista G, 2009, BONE MARROW TRANSPL, V43, P365, DOI 10.1038/bmt.2008.329; Brunstein CG, 2007, BLOOD, V110, P3064, DOI 10.1182/blood-2007-04-067215; Eapen M, 2007, LANCET, V369, P1947, DOI 10.1016/S0140-6736(07)60915-5; Gutman JA, 2010, BLOOD, V115, P757, DOI 10.1182/blood-2009-07-228999; Ichinohe T, 2005, CURR OPIN IMMUNOL, V17, P546, DOI 10.1016/j.coi.2005.07.009; Kelly SS, 2009, BONE MARROW TRANSPL, V44, P673, DOI 10.1038/bmt.2009.284; Lee SJ, 2007, BLOOD, V110, P4576, DOI 10.1182/blood-2007-06-097386; Ooi J, 2009, BONE MARROW TRANSPL, V44, P661, DOI 10.1038/bmt.2009.282; Symons HJ, 2008, BONE MARROW TRANSPL, V42, P365, DOI 10.1038/bmt.2008.215	10	13	14	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2010	303	14					1421	1422		10.1001/jama.2010.413	http://dx.doi.org/10.1001/jama.2010.413			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582KX	20388899				2022-12-28	WOS:000276597300028
J	Cook, RF				Cook, Robert F.			Probing the Nanoscale	SCIENCE			English	Editorial Material							DIELECTRIC CONSTANT FILMS; INDENTATION FRACTURE; NANOINDENTATION; BEHAVIOR		NIST, Nanomech Properties Grp, Gaithersburg, MD 20899 USA	National Institute of Standards & Technology (NIST) - USA	Cook, RF (corresponding author), NIST, Nanomech Properties Grp, Gaithersburg, MD 20899 USA.	robert.cook@nist.gov		Cook, Robert/0000-0003-0422-8881				Feynman R.P., 1992, J MICROELECTROMECH S, V1, P60, DOI 10.1109/84.128057; Galli M, 2009, J MATER RES, V24, P973, DOI 10.1557/JMR.2009.0129; Herbert EG, 2009, J MATER RES, V24, P626, DOI 10.1557/JMR.2009.0089; Ma L, 2009, J MATER RES, V24, P1059, DOI 10.1557/JMR.2009.0134; Morris DJ, 2008, J MATER RES, V23, P2443, DOI 10.1557/JMR.2008.0295; Morris DJ, 2008, J MATER RES, V23, P2429, DOI 10.1557/JMR.2008.0294; Oyen ML, 2006, PHILOS MAG, V86, P5625, DOI 10.1080/14786430600740666; Oyen ML, 2008, J MATER RES, V23, P1307, DOI 10.1557/JMR.2008.0156; Oyen ML, 2003, J MATER RES, V18, P139, DOI 10.1557/JMR.2003.0020; Stan G, 2007, NANO LETT, V7, P3691, DOI 10.1021/nl071986e; Stan G, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2945285; Stan G, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/23/235701	12	16	16	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2010	328	5975					183	184		10.1126/science.1186023	http://dx.doi.org/10.1126/science.1186023			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580OU	20378807				2022-12-28	WOS:000276459600031
J	Hutchins, JRA; Toyoda, Y; Hegemann, B; Poser, I; Heriche, JK; Sykora, MM; Augsburg, M; Hudecz, O; Buschhorn, BA; Bulkescher, J; Conrad, C; Comartin, D; Schleiffer, A; Sarov, M; Pozniakovsky, A; Slabicki, MM; Schloissnig, S; Steinmacher, I; Leuschner, M; Ssykor, A; Lawo, S; Pelletier, L; Stark, H; Nasmyth, K; Ellenberg, J; Durbin, R; Buchholz, F; Mechtler, K; Hyman, AA; Peters, JM				Hutchins, James R. A.; Toyoda, Yusuke; Hegemann, Bjoern; Poser, Ina; Heriche, Jean-Karim; Sykora, Martina M.; Augsburg, Martina; Hudecz, Otto; Buschhorn, Bettina A.; Bulkescher, Jutta; Conrad, Christian; Comartin, David; Schleiffer, Alexander; Sarov, Mihail; Pozniakovsky, Andrei; Slabicki, Mikolaj Michal; Schloissnig, Siegfried; Steinmacher, Ines; Leuschner, Marit; Ssykor, Andrea; Lawo, Steffen; Pelletier, Laurence; Stark, Holger; Nasmyth, Kim; Ellenberg, Jan; Durbin, Richard; Buchholz, Frank; Mechtler, Karl; Hyman, Anthony A.; Peters, Jan-Michael			Systematic Analysis of Human Protein Complexes Identifies Chromosome Segregation Proteins	SCIENCE			English	Article							ANAPHASE-PROMOTING COMPLEX/CYCLOSOME; MAMMALIAN-CELL DIVISION; TISSUE-CULTURE CELLS; CAENORHABDITIS-ELEGANS; MICROTUBULE GENERATION; GLOBAL ANALYSIS; SPINDLE; GENOME; RNAI; CENTROSOME	Chromosome segregation and cell division are essential, highly ordered processes that depend on numerous protein complexes. Results from recent RNA interference screens indicate that the identity and composition of these protein complexes is incompletely understood. Using gene tagging on bacterial artificial chromosomes, protein localization, and tandem-affinity purification-mass spectrometry, the MitoCheck consortium has analyzed about 100 human protein complexes, many of which had not or had only incompletely been characterized. This work has led to the discovery of previously unknown, evolutionarily conserved subunits of the anaphase-promoting complex and the g-tubulin ring complex-large complexes that are essential for spindle assembly and chromosome segregation. The approaches we describe here are generally applicable to high-throughput follow-up analyses of phenotypic screens in mammalian cells.	[Toyoda, Yusuke; Poser, Ina; Augsburg, Martina; Sarov, Mihail; Pozniakovsky, Andrei; Slabicki, Mikolaj Michal; Schloissnig, Siegfried; Leuschner, Marit; Ssykor, Andrea; Buchholz, Frank; Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Hutchins, James R. A.; Hegemann, Bjoern; Sykora, Martina M.; Hudecz, Otto; Buschhorn, Bettina A.; Schleiffer, Alexander; Steinmacher, Ines; Nasmyth, Kim; Mechtler, Karl; Peters, Jan-Michael] Res Inst Mol Pathol IMP, A-1030 Vienna, Austria; [Heriche, Jean-Karim; Durbin, Richard] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Heriche, Jean-Karim; Bulkescher, Jutta; Conrad, Christian; Ellenberg, Jan] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; [Comartin, David; Lawo, Steffen; Pelletier, Laurence] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Comartin, David; Lawo, Steffen; Pelletier, Laurence] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Schloissnig, Siegfried] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Stark, Holger] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	Max Planck Society; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Helmholtz Association; German Cancer Research Center (DKFZ); Max Planck Society	Hyman, AA (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	hyman@mpi-cbg.de; peters@imp.univie.ac.at	Mechtler, Karl/AAF-2717-2019; Hyman, Tony/F-1923-2011; Durbin, Richard/AAE-7178-2019; Ellenberg, Jan/I-4688-2014; Buchholz, Frank/B-4700-2017; Hyman, Anthony A/B-3917-2017; Hegemann, Björn/A-8761-2015; Pelletier, Laurence/F-8858-2013	Mechtler, Karl/0000-0002-3392-9946; Durbin, Richard/0000-0002-9130-1006; Ellenberg, Jan/0000-0001-5909-701X; Buchholz, Frank/0000-0002-4577-3344; Hyman, Anthony A/0000-0003-3664-154X; Hegemann, Björn/0000-0002-1009-2952; Nasmyth, Kim/0000-0001-7030-4403; Holger, Stark/0000-0002-6161-1118; Toyoda, Yusuke/0000-0003-0534-6898; Lawo, Steffen/0000-0002-9659-7416; Schloissnig, Siegfried/0000-0003-4574-8330; Schleiffer, Alexander/0000-0001-6251-2747; Heriche, Jean-Karim/0000-0001-6867-9425	European Commission [LSHG-CT-2004-503464]; Boehringer Ingelheim; Vienna Spots of Excellence Programme; Austrian Science Fund Special Research Programme "Chromosome Dynamics"; Genome Research in Austria Programme; Max Planck Society; Bundesministerium fur Bildung und Forschung [NGFN-2 SMP-RNAi (01GR0402), NGFN-Plus (01GS0859)]; Natural Science and Engineering Research Council of Canada [RGPIN-355644-2008]; National Cancer Institute of Canada [019562]; Human Frontier Science Program [CDA0044/200]; Japan Society for the Promotion of Science	European Commission(European CommissionEuropean Commission Joint Research Centre); Boehringer Ingelheim(Boehringer Ingelheim); Vienna Spots of Excellence Programme; Austrian Science Fund Special Research Programme "Chromosome Dynamics"(Austrian Science Fund (FWF)); Genome Research in Austria Programme; Max Planck Society(Max Planck SocietyFoundation CELLEX); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Human Frontier Science Program(Human Frontier Science Program); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We are grateful to the following colleagues for their excellent assistance: E. Kreidl, M. Mazanek, M. Madalinski, G. Mitulovic, M. Novatchkova, C. Stingl, Y. Sun (IMP and Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna); A. Bird, K. Kozak, D. Krastev, Z. Maliga, D. Richter, M. Theis, M. Toyoda (MPI, Dresden); P. Dube (MPI, Gottingen); and N. Kraut (Boehringer Ingelheim, Vienna). This work was funded in the most part by the European Commission via the Sixth Framework Programme Integrated Project MitoCheck (LSHG-CT-2004-503464). Work in the laboratories of J.-M.P. and K. M. received support from Boehringer Ingelheim, the Vienna Spots of Excellence Programme, the Austrian Science Fund Special Research Programme "Chromosome Dynamics," and the Genome Research in Austria Programme. Work in the laboratories of A. A. H. and F. B. received support from the Max Planck Society and from Bundesministerium fur Bildung und Forschung grants NGFN-2 SMP-RNAi (01GR0402) and NGFN-Plus (01GS0859). Work in the laboratory of L. P. was supported by operating grants from the Natural Science and Engineering Research Council of Canada (RGPIN-355644-2008), the National Cancer Institute of Canada (019562), and the Human Frontier Science Program (CDA0044/200). L. P. holds a Canada Research Chair in Centrosome Biogenesis and Function. Y. T. was supported by a Postdoctoral Fellowship for Research Abroad from the Japan Society for the Promotion of Science.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; CHEESEMAN IM, 2005, SCI STKE, pPL1, DOI DOI 10.1126/STKE.2662005PL1; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kittler R, 2005, P NATL ACAD SCI USA, V102, P2396, DOI 10.1073/pnas.0409861102; Kittler R, 2008, CELL CYCLE, V7, P2123, DOI 10.4161/cc.7.14.6322; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lawo S, 2009, CURR BIOL, V19, P816, DOI 10.1016/j.cub.2009.04.033; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Mankouri HW, 2007, TRENDS BIOCHEM SCI, V32, P538, DOI 10.1016/j.tibs.2007.09.009; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Patel U, 2002, CURR BIOL, V12, pR408, DOI 10.1016/S0960-9822(02)00908-9; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Somma MP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000126; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Theis M, 2009, EMBO J, V28, P1453, DOI 10.1038/emboj.2009.114; Uehara R, 2009, P NATL ACAD SCI USA, V106, P6998, DOI 10.1073/pnas.0901587106; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	29	385	397	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 30	2010	328	5978					593	599		10.1126/science.1181348	http://dx.doi.org/10.1126/science.1181348			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589OJ	20360068	Green Accepted			2022-12-28	WOS:000277159800035
J	Yates, J; James, D				Yates, Janet; James, David			Risk factors at medical school for subsequent professional misconduct: multicentre retrospective case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DISCIPLINARY ACTION; PHYSICIANS DEMOGRAPHICS; BOARD CERTIFICATION; HIDDEN CURRICULUM; STUDENTS; DOCTORS; PERFORMANCE; DIFFICULTIES; ASSOCIATIONS; PERCEPTIONS	Objective To determine whether there are risk factors in a doctor's time at medical school that are associated with subsequent professional misconduct. Design Matched case-control study. Setting Records from medical schools and the General Medical Council (GMC). Participants 59 doctors who had graduated from any one of eight medical schools in the United Kingdom in 195897 and had a proved finding of serious professional misconduct in GMC proceedings in 1999-2004 (cases); 236 controls (four for each case) were selected by systematic sampling from matching graduation cohorts. Case-control status was revealed by the GMC after completion of data entry. Main outcome measure Odds ratios for being a "case," with multivariable conditional logistic regression of potential risk factors including pre-admission characteristics and progress during the course. These data were obtained from anonymised copies of the students' progress files held by their original medical schools. Results Univariate conditional logistic regression analysis found that cases were more likely to be men, to be of lower estimated social class, and to have had academic difficulties during their medical course, especially in the early years. Multivariable analysis showed that male sex (odds ratio 9.80, 95% confidence interval 2.43 to 39.44, P=0.001), lower social class (4.28, 1.52 to 12.09, P=0.006), and failure of early or preclinical examinations (5.47, 2.17 to 13.79, P<0.001) were independently associated with being a case. Conclusions This small study suggests that male sex, a lower socioeconomic background, and early academic difficulties at medical school could be risk factors for subsequent professional misconduct. The findings are preliminary and should be interpreted with caution. Most doctors with risk factors will not come before the GMC's disciplinary panels.	[Yates, Janet; James, David] Univ Nottingham, Sch Med, Queens Med Ctr, Med Educ Unit, Nottingham NG7 2UH, England	University of Nottingham	Yates, J (corresponding author), Univ Nottingham, Sch Med, Queens Med Ctr, Med Educ Unit, Nottingham NG7 2UH, England.	janet.yates@nottingham.ac.uk			GMC; Service Increment for Teaching (SIFT)	GMC; Service Increment for Teaching (SIFT)	The external costs of the study ( photocopying and anonymising student files and transporting them to Nottingham) were funded by the GMC. JY was funded by the Service Increment for Teaching (SIFT). Role of the study sponsors: The GMC agreed to the design of the study and provided the names of cases and controls to participant medical schools in confidence. It had no role in the collection and analysis of data, nor the interpretation of the results. The GMC accepted a full report of the study in July 2009 and agreed to the submission this paper.	Angel C, 2000, BRIT MED J, V321, P1136, DOI 10.1136/bmj.321.7269.1136; Ben-David MF, 2004, MED TEACH, V26, P63, DOI 10.1080/0142159032000156524; Cleland J, 2005, MED TEACH, V27, P504, DOI 10.1080/01421590500156269; D'eon M, 2007, MED TEACH, V29, P295, DOI 10.1080/01421590701291485; Davies H, 2009, MED EDUC, V43, P74, DOI 10.1111/j.1365-2923.2008.03249.x; Department for Education and Skills, 2003, FUT HIGH ED; DONALDSON LJ, 1994, BRIT MED J, V308, P1277, DOI 10.1136/bmj.308.6939.1277; Firth-Cozens J, 2008, BRIT MED J, V336, P731, DOI 10.1136/bmj.39526.359630.BE; Garlick PB, 2008, BMJ-BRIT MED J, V336, P1111, DOI 10.1136/bmj.39508.606157.BE; *GEN MED COUNC, 2003, TOM DOCT; *GEN MED COUNC, 2004, REF DOCT GMC GUID IN; General Medical Council, 2009, MED STUD PROF VAL FI; Greenhalgh T, 2004, BRIT MED J, V328, P1541, DOI 10.1136/bmj.328.7455.1541; Kinnersley P, 2008, BMJ-BRIT MED J, V336, P841, DOI 10.1136/bmj.39525.658565.80; Kohatsu ND, 2004, ARCH INTERN MED, V164, P653, DOI 10.1001/archinte.164.6.653; Lempp H, 2004, BMJ-BRIT MED J, V329, P770, DOI 10.1136/bmj.329.7469.770; Liddell MJ, 2004, MED EDUC, V38, P187, DOI 10.1111/j.1365-2923.2004.01753.x; McManus IC, 2003, BRIT MED J, V327, P139, DOI 10.1136/bmj.327.7407.139; *MED SCH COUNC, 2006, GUID PRINC ADM MED S; Morrison J, 1998, JAMA-J AM MED ASSOC, V279, P1889, DOI 10.1001/jama.279.23.1889; Morrison J, 2001, AM J PSYCHIAT, V158, P474, DOI 10.1176/appi.ajp.158.3.474; National Clinical Assessment Service, 2006, AN 1 4 YEARS REF DAT; *OFF NAT STAT, 2008, SELF COD VERS NS SEC; Paice E, 2004, BRIT MED J, V329, P658, DOI 10.1136/bmj.38133.502569.AE; Paice E, 2009, CLIN TEACH, V6, P13, DOI 10.1111/j.1743-498X.2008.00251.x; Papadakis MA, 2004, ACAD MED, V79, P244, DOI 10.1097/00001888-200403000-00011; Papadakis MA, 2005, NEW ENGL J MED, V353, P2673, DOI 10.1056/NEJMsa052596; Papadakis MA, 2008, ANN INTERN MED, V148, P869, DOI 10.7326/0003-4819-148-11-200806030-00009; Rose, 1995, OFFICIAL SOCIAL CLAS; *SHIPM INQ, 2004, SAF PAT LESS PROP FU; Silber CG, 2005, AM J OBSTET GYNECOL, V192, P318, DOI 10.1016/j.ajog.2004.09.007; Stephenson AE, 2006, MED EDUC, V40, P1072, DOI 10.1111/j.1365-2929.2006.02607.x; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; TARAGIN MI, 1992, AM J MED, V93, P537, DOI 10.1016/0002-9343(92)90582-V; The Bristol Royal Infirmary Inquiry, 2001, LEARN BRIST REP PUBL; Wilkinson JR, 2008, MED EDUC, V42, P364, DOI 10.1111/j.1365-2923.2008.03010.x; Woolf K, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1220; Xu G, 1998, ACAD MED, V73, P1283, DOI 10.1097/00001888-199812000-00019; Yates J, 2006, BMJ-BRIT MED J, V332, P1009, DOI 10.1136/bmj.38730.678310.63; Yates J, 2007, MED EDUC, V41, P65, DOI 10.1111/j.1365-2929.2006.02648.x	40	47	48	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 27	2010	340								c2040	10.1136/bmj.c2040	http://dx.doi.org/10.1136/bmj.c2040			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591PM	20423965	hybrid, Green Published			2022-12-28	WOS:000277314100003
J	Scheen, AJ; Radermecker, RP				Scheen, Andre J.; Radermecker, Regis P.			Addition of incretin therapy to metformin in type 2 diabetes	LANCET			English	Editorial Material							DIPEPTIDYL PEPTIDASE-4 INHIBITOR; NON-INFERIORITY; OPEN-LABEL; EFFICACY; SAFETY; SITAGLIPTIN; EXENATIDE; LIRAGLUTIDE; GLIMEPIRIDE; MELLITUS		[Scheen, Andre J.] Univ Liege, Div Diabet Nutr & Metab Disorders, B-4000 Liege, Belgium; CHU Sart Tilman, Dept Med, Clin Pharmacol Unit, B-4000 Liege, Belgium	University of Liege; University of Liege	Scheen, AJ (corresponding author), Univ Liege, Div Diabet Nutr & Metab Disorders, B-4000 Liege, Belgium.	andre.scheen@chu.ulg.ac.be						BERGENSTAL R, 2009, 69 SCI SESS AM DIAB; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; Charbonnel B, 2006, DIABETES CARE, V29, P2638, DOI 10.2337/dc06-0706; DeFronzo RA, 2005, DIABETES CARE, V28, P1092, DOI 10.2337/diacare.28.5.1092; DeFronzo RA, 2008, CURR MED RES OPIN, V24, P2943, DOI 10.1185/03007990802418851 ; Drucker DJ, 2008, LANCET, V372, P1240, DOI 10.1016/S0140-6736(08)61206-4; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Ferrannini E, 2009, DIABETES OBES METAB, V11, P157, DOI 10.1111/j.1463-1326.2008.00994.x; Nathan D, 2009, DIABETOLOGIA, V52, P17, DOI 10.1007/s00125-008-1157-y; Nauck MA, 2007, DIABETES OBES METAB, V9, P194, DOI 10.1111/j.1463-1326.2006.00704.x; Nauck M, 2009, DIABETES CARE, V32, P84, DOI 10.2337/dc08-1355; Pratley RE, 2010, LANCET, V375, P1447, DOI 10.1016/S0140-6736(10)60307-8; Scott R, 2008, DIABETES OBES METAB, V10, P959, DOI 10.1111/j.1463-1326.2007.00839.x	13	29	29	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 24	2010	375	9724					1410	1412		10.1016/S0140-6736(10)60399-6	http://dx.doi.org/10.1016/S0140-6736(10)60399-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	590FL	20417840	Green Submitted			2022-12-28	WOS:000277210000005
J	Shimamura, T; Weyand, S; Beckstein, O; Rutherford, NG; Hadden, JM; Sharples, D; Sansom, MSP; Iwata, S; Henderson, PJF; Cameron, AD				Shimamura, Tatsuro; Weyand, Simone; Beckstein, Oliver; Rutherford, Nicholas G.; Hadden, Jonathan M.; Sharples, David; Sansom, Mark S. P.; Iwata, So; Henderson, Peter J. F.; Cameron, Alexander D.			Molecular Basis of Alternating Access Membrane Transport by the Sodium-Hydantoin Transporter Mhp1	SCIENCE			English	Article							AMINO-ACID ANTIPORTER; NEUROTRANSMITTER TRANSPORTERS; MICROBACTERIUM-LIQUEFACIENS; CRYSTAL-STRUCTURE; MECHANISM; MODEL	The structure of the sodium-benzylhydantoin transport protein Mhp1 from Microbacterium liquefaciens comprises a five-helix inverted repeat, which is widespread among secondary transporters. Here, we report the crystal structure of an inward-facing conformation of Mhp1 at 3.8 angstroms resolution, complementing its previously described structures in outward-facing and occluded states. From analyses of the three structures and molecular dynamics simulations, we propose a mechanism for the transport cycle in Mhp1. Switching from the outward-to the inward-facing state, to effect the inward release of sodium and benzylhydantoin, is primarily achieved by a rigid body movement of transmembrane helices 3, 4, 8, and 9 relative to the rest of the protein. This forms the basis of an alternating access mechanism applicable to many transporters of this emerging superfamily.	[Shimamura, Tatsuro; Weyand, Simone; Iwata, So; Cameron, Alexander D.] Univ London Imperial Coll Sci Technol & Med, Membrane Prot Crystallog Grp, Div Mol Biosci, London SW7 2AZ, England; [Shimamura, Tatsuro; Weyand, Simone; Iwata, So; Cameron, Alexander D.] Japan Sci & Technol Agcy, Human Receptor Crystallog Project, Sakyo Ku, Kyoto 6068501, Japan; [Shimamura, Tatsuro; Iwata, So] Kyoto Univ, Grad Sch Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Weyand, Simone; Iwata, So; Cameron, Alexander D.] Diamond Light Source, Membrane Prot Lab, Didcot OX11 0DE, Oxon, England; [Beckstein, Oliver; Sansom, Mark S. P.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Rutherford, Nicholas G.; Hadden, Jonathan M.; Sharples, David; Henderson, Peter J. F.] Univ Leeds, Inst Membrane & Syst Biol, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Iwata, So] RIKEN, Syst & Struct Biol Ctr, Tsurumi ku, Kanagawa 2300045, Japan	Imperial College London; Japan Science & Technology Agency (JST); Kyoto University; Diamond Light Source; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Oxford; University of Leeds; RIKEN	Iwata, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Membrane Prot Crystallog Grp, Div Mol Biosci, London SW7 2AZ, England.	s.iwata@imperial.ac.uk; p.j.f.henderson@leeds.ac.uk; a.cameron@imperial.ac.uk	Henderson, Peter JF/Q-1907-2018; Sansom, Mark S.P./C-5157-2009; Beckstein, Oliver/C-9095-2009; Cameron, Alexander/L-7288-2013	Sansom, Mark S.P./0000-0001-6360-7959; Beckstein, Oliver/0000-0003-1340-0831; Henderson, Peter/0000-0002-9187-0938; Cameron, Alexander/0000-0001-8776-3518	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/C51725]; European Union [LSHG-CT-2004-504601, 201924]; Wellcome Trust [062164/Z/00/Z]; Leverhulme Trust; European Molecular Biology Organization; BBSRC MPSi [BBS/B/14418]; S. Suzuki and Ajinomoto Company Incorporated; Japan Science and Technology Agency; MEXT, Japan;  [21370043]; Biotechnology and Biological Sciences Research Council [BB/G020043/1, B19456, BBS/B/14418, BB/C51725X/1, BB/H000267/1, BBS/B/16011, BB/G023425/1, BEP17032] Funding Source: researchfish; BBSRC [BB/G023425/1, BB/H000267/1, BB/G020043/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Leverhulme Trust(Leverhulme Trust); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); BBSRC MPSi(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); S. Suzuki and Ajinomoto Company Incorporated; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) (grant no. BB/C51725) and the European Union (EMeP grant, LSHG-CT-2004-504601, and EDICT grant 201924). The authors are grateful for the use of the Membrane Protein Laboratory funded by the Wellcome Trust (grant 062164/Z/00/Z) at the Diamond Light Source Limited. P.J.F.H. received personal funding from the Leverhulme Trust, S. W. from a European Molecular Biology Organization long-term fellowship, T. S. from a Grant-in-Aid for Scientific Research (B) (grant 21370043) and J.H. from the BBSRC MPSi (grant BBS/B/14418). We appreciate the additional support of S. Suzuki and Ajinomoto Company Incorporated. A part of this work was also supported by a grant from the ERATO IWATA Human Receptor Crystallography Project from the Japan Science and Technology Agency and by the Targeted Proteins Research Program of MEXT, Japan. Data were collected at the European Synchrotron Radiation Facility, and further experiments were carried out at Diamond Light Source. We are grateful to D. Drew for critical reading of the manuscript. The coordinates and the structure factors for Mhp1 have been deposited in the Protein Data Bank (entry 2X79).	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Beckstein O, 2009, J MOL BIOL, V394, P160, DOI 10.1016/j.jmb.2009.09.009; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; CRANE RK, 1961, MEMBRANE TRANSPORT M, P439; Dohan O, 2003, ENDOCR REV, V24, P48, DOI 10.1210/er.2001-0029; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Harada N, 2000, ACTA HAEMATOL-BASEL, V103, P144, DOI 10.1159/000041037; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Leonard GA, 2009, J APPL CRYSTALLOGR, V42, P333, DOI 10.1107/S0021889809001721; Li J, 2009, BIOPHYS J, V97, pL29, DOI 10.1016/j.bpj.2009.09.005; Loo DDF, 2006, J GEN PHYSIOL, V128, P701, DOI 10.1085/jgp.200609643; MITCHELL P, 1967, ADV ENZYMOL RAMB, V29, P33; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shimamura T, 2008, ACTA CRYSTALLOGR F, V64, P1172, DOI 10.1107/S1744309108036920; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Suzuki S, 2006, J BACTERIOL, V188, P3329, DOI 10.1128/JB.188.9.3329-3336.2006; TANFORD C, 1983, P NATL ACAD SCI-BIOL, V80, P3701, DOI 10.1073/pnas.80.12.3701; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Wright EM, 2007, J INTERN MED, V261, P32, DOI 10.1111/j.1365-2796.2006.01746.x; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4	30	220	226	1	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2010	328	5977					470	473		10.1126/science.1186303	http://dx.doi.org/10.1126/science.1186303			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YR	20413494	Green Accepted			2022-12-28	WOS:000276952400034
J	Annas, GJ				Annas, George J.			The Real Pro-Life Stance - Health Care Reform and Abortion Funding	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				Annas GJ, 2009, NEW ENGL J MED, V361, P2589, DOI 10.1056/NEJMp0911513; BELKIN D, 2010, WALL STREET J   0327, pA4; COOPER H, 2010, NY TIMES        0320, pA11; *WHIT HOUS, 2010, EX ORD PAT PROT AFF	4	5	5	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 22	2010	362	16								10.1056/NEJMp1003944	http://dx.doi.org/10.1056/NEJMp1003944			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	586GP	20375398				2022-12-28	WOS:000276894700005
J	Kamerow, D				Kamerow, Douglas			Yankee Doodling Prevention and the new US health reform act	BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Res Triangle Pk, NC USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957					0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 21	2010	340								c2116	10.1136/bmj.c2116	http://dx.doi.org/10.1136/bmj.c2116			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	589HN	20410169				2022-12-28	WOS:000277137900009
J	Levin, LA; Danesh-Meyer, HV				Levin, Leonard A.; Danesh-Meyer, Helen V.			Lost in Translation Bumps in the Road Between Bench and Bedside	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NITRIC-OXIDE SYNTHASE; MODELS; TRIAL		[Levin, Leonard A.] Univ Montreal, Hop Maison Neuve Rosemont, Res Ctr, Montreal, PQ, Canada; [Levin, Leonard A.] Univ Montreal, Dept Ophthalmol, Montreal, PQ, Canada; [Levin, Leonard A.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Danesh-Meyer, Helen V.] Univ Auckland, Sch Med, Dept Ophthalmol, Auckland, New Zealand	Universite de Montreal; Universite de Montreal; University of Wisconsin System; University of Wisconsin Madison; University of Auckland	Levin, LA (corresponding author), 5415 Boul Assompt, Montreal, PQ H1T 2M4, Canada.							Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Kukavica-Ibrulj I, 2008, LAB ANIM-UK, V42, P389, DOI 10.1258/la.2007.06014e; LORENZ EN, 1963, J ATMOS SCI, V20, P130, DOI 10.1175/1520-0469(1963)020<0130:DNF>2.0.CO;2; Neufeld AH, 1999, P NATL ACAD SCI USA, V96, P9944, DOI 10.1073/pnas.96.17.9944; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Pang IH, 2005, INVEST OPHTH VIS SCI, V46, P1313, DOI 10.1167/iovs.04-0829; Perel P, 2007, BMJ-BRIT MED J, V334, P197, DOI 10.1136/bmj.39048.407928.BE; Snow C., 1959, 2 CULTURES SCI REVOL; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Talmadge JE, 2007, AM J PATHOL, V170, P793, DOI 10.2353/ajpath.2007.060929	10	34	36	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2010	303	15					1533	1534		10.1001/jama.2010.463	http://dx.doi.org/10.1001/jama.2010.463			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585SJ	20407063				2022-12-28	WOS:000276849000030
J	Kahn, R; Alperin, P; Eddy, D; Borch-Johnsen, K; Buse, J; Feigelman, J; Gregg, E; Holman, RR; Kirkman, MS; Stern, M; Tuomilehto, J; Wareham, NJ				Kahn, Richard; Alperin, Peter; Eddy, David; Borch-Johnsen, Knut; Buse, John; Feigelman, Justin; Gregg, Edward; Holman, Rury R.; Kirkman, M. Sue; Stern, Michael; Tuomilehto, Jaakko; Wareham, Nick J.			Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis	LANCET			English	Article							PREVENTION; ARCHIMEDES; HEALTH; MODEL; POPULATION; STRATEGIES; MELLITUS; GLUCOSE; ADULTS; IMPACT	Background No clinical trials have assessed the effects or cost-effectiveness of sequential screening strategies to detect new cases of type 2 diabetes. We used a mathematical model to estimate the cost-effectiveness of several screening strategies. Methods We used person-specific data from a representative sample of the US population to create a simulated population of 325 000 people aged 30 years without diabetes. We used the Archimedes model to compare eight simulated screening strategies for type 2 diabetes with a no-screening control strategy. Strategies differed in terms of age at initiation and frequency of screening. Once diagnosed, diabetes treatment was simulated in a standard manner. We calculated the effects of each strategy on the incidence of type 2 diabetes, myocardial infarction, stroke, and microvascular complications in addition to quality of life, costs, and cost per quality-adjusted life-year (QALY). Findings Compared with no screening, all simulated screening strategies reduced the incidence of myocardial infarction (3-9 events prevented per 1000 people screened) and diabetes-related microvascular complications (3-9 events prevented per 1000 people), and increased the number of QALYs (93-194 undiscounted QALYs) added over 50 years. Most strategies prevented a significant number of simulated deaths (2-5 events per 1000 people). There was little or no effect of screening on incidence of stroke (0-1 event prevented per 1000 people). Five screening strategies had costs per QALY of about US$10 500 or less, whereas costs were much higher for screening started at 45 years of age and repeated every year ($15 509), screening started at 60 years of age and repeated every 3 years ($25738), or a maximum screening strategy (screening started at 30 years of age and repeated every 6 months; $40 778). Several strategies differed substantially in the number of QALYs gained. Costs per QALY were sensitive to the disutility assigned to the state of having diabetes diagnosed with or without symptoms. Interpretation In the US population, screening for type 2 diabetes is cost effective when started between the ages of 30 years and 45 years, with screening repeated every 3-5 years.	[Kahn, Richard; Kirkman, M. Sue] Amer Diabet Assoc, Alexandria, VA USA; [Alperin, Peter; Eddy, David; Feigelman, Justin] Archimedes, San Francisco, CA USA; [Borch-Johnsen, Knut] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Buse, John] Univ N Carolina, Sch Med, Dept Med, Div Endocrinol, Chapel Hill, NC USA; [Gregg, Edward] Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA USA; [Holman, Rury R.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Diabet Trials Unit, Oxford, England; [Stern, Michael] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Tuomilehto, Jaakko] Univ Helsinki, Hjelt Inst, Helsinki, Finland; [Wareham, Nick J.] Addenbrookes Hosp, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England	American Diabetes Association; Steno Diabetes Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Centers for Disease Control & Prevention - USA; University of Oxford; University of Texas System; University of Texas Health San Antonio; University of Helsinki; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Kahn, R (corresponding author), 1701 N Beauregard St, Alexandria, VA 22311 USA.	rak6200@gmail.com	Buse, John Bernard/J-9742-2019	Buse, John Bernard/0000-0002-9723-3876; Gregg, Edward/0000-0003-2381-6822	Novo Nordisk; Bayer HealthCare; Pfizer; Medical Research Council [MC_U106179471] Funding Source: researchfish	Novo Nordisk(Novo Nordisk); Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); Pfizer(Pfizer); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Novo Nordisk, Bayer HealthCare, and Pfizer.	*AM DIAB ASS, 2004, DIABETES CARE S1, V27, pS11, DOI DOI 10.2337/DIACARE.27.2007.S11; [Anonymous], MED EXP PAN SURV; *ARCH, ARCH MOD; Calonge N, 2008, ANN INTERN MED, V148, P846, DOI 10.7326/0003-4819-148-11-200806030-00007; Centers for Disease Control and Prevention (CDC), NAT HLTH NUTR EX SUR; Centers for Medicare and Medicaid Services, MEDPAR; Chen THH, 2001, DIABETES RES CLIN PR, V54, pS37; Cherry Donald K, 2008, Natl Health Stat Report, P1; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Coffey JT, 2002, DIABETES CARE, V25, P2238, DOI 10.2337/diacare.25.12.2238; Colagiuri S, 2002, DIABETES CARE, V25, P1378, DOI 10.2337/diacare.25.8.1378; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; *CTR MED MED SERV, HOSP OUTP REG NOT; *CTR MED MED SERV, EXTR SUMM SYST BES B; *CTR MED MED SERV, STAND AN FIL LDS; Eddy DM, 2003, DIABETES CARE, V26, P3102, DOI 10.2337/diacare.26.11.3102; Eddy DM, 2003, DIABETES CARE, V26, P3093, DOI 10.2337/diacare.26.11.3093; Eddy DM, 2005, ANN INTERN MED, V143, P251, DOI 10.7326/0003-4819-143-4-200508160-00006; Edelman D, 2002, DIABETES CARE, V25, P1022, DOI 10.2337/diacare.25.6.1022; Engelgau MM, 1998, JAMA-J AM MED ASSOC, V280, P1757; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gillies CL, 2008, BMJ-BRIT MED J, V336, P1180, DOI 10.1136/bmj.39545.585289.25; Glumer C, 2006, DIABETOLOGIA, V49, P1536, DOI 10.1007/s00125-006-0248-x; Goyder EC, 2000, DIABETIC MED, V17, P469, DOI 10.1046/j.1464-5491.2000.00308.x; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hoerger TJ, 2004, ANN INTERN MED, V140, P689, DOI 10.7326/0003-4819-140-9-200405040-00008; Hofer TP, 2000, INT J TECHNOL ASSESS, V16, P822, DOI 10.1017/S0266462300102090; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Icks A, 2004, DIABETES CARE, V27, P2120, DOI 10.2337/diacare.27.9.2120; Kahn R, 2008, DIABETES CARE, V31, P1686, DOI 10.2337/dc08-9022; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Palmer AJ, 2007, DIABETES CARE, V30, P1638, DOI 10.2337/dc07-9919; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; PATERSON KR, 1993, DIABETIC MED, V10, P777, DOI 10.1111/j.1464-5491.1993.tb00164.x; Retnakaran R, 2006, DIABETES, V55, P1832, DOI 10.2337/db05-1620; Schlessinger L, 2002, J BIOMED INFORM, V35, P37, DOI 10.1016/S1532-0464(02)00006-0; Spijkerman AMW, 2003, DIABETES CARE, V26, P2604, DOI 10.2337/diacare.26.9.2604; Sullivan PW, 2006, MED DECIS MAKING, V26, P401, DOI 10.1177/0272989X06290496; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; UK Prospective Diabetes Study Grp, 1999, DIABETES CARE, V22, P1125; UNCOMMON DRUGSTORE	45	176	180	3	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 17	2010	375	9723					1365	1374		10.1016/S0140-6736(09)62162-0	http://dx.doi.org/10.1016/S0140-6736(09)62162-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588GW	20356621				2022-12-28	WOS:000277057800027
J	Lu, CL; Schneider, MT; Gubbins, P; Leach-Kemon, K; Jamison, D; Murray, CJL				Lu, Chunling; Schneider, Matthew T.; Gubbins, Paul; Leach-Kemon, Katherine; Jamison, Dean; Murray, Christopher J. L.			Public financing of health in developing countries: a cross-national systematic analysis	LANCET			English	Article							FOREIGN-AID; DEBT RELIEF; INITIATIVES; EXPENDITURE; CARE	Background Government spending on health from domestic sources is an important indicator of a government's commitment to the health of its people, and is essential for the sustainability of health programmes. We aimed to systematically analyse all data sources available for government spending on health in developing countries; describe trends in public financing of health; and test the extent to which they were related to changes in gross domestic product (GDP), government size, HIV prevalence, debt relief, and development assistance for health (DAH) to governmental and non-governmental sectors. Methods We did a systematic analysis of all data sources available for government expenditures on health as agent (GHE-A) in developing countries, including government reports and databases from WHO and the International Monetary Fund (IMF). GHE-A consists of domestically and externally financed public health expenditures. We assessed the quality of these sources and used multiple imputation to generate a complete sequence of GHE-A. With these data and those for DAH to governments, we estimated government spending on health from domestic sources. We used panel-regression methods to estimate the association between government domestic spending on health and GDP, government size, HIV prevalence, debt relief, and DAH disbursed to governmental and non-governmental sectors. We tested the robustness of our conclusions using various models and subsets of countries. Findings In all developing countries, public financing of health in constant US$ from domestic sources increased by nearly 100% (IMF 120%; WHO 88%) from 1995 to 2006. Overall, this increase was the product of rising GDP, slight decreases in the share of GDP spent by government, and increases in the share of government spending on health. At the country level, while shares of government expenditures to health increased in many regions, they decreased in many sub-Saharan African countries. The statistical analysis showed that DAH to government had a negative and significant effect on domestic government spending on health such that for every USS1 of DAH to government, government health expenditures from domestic resources were reduced by $0.43 (p=0) to $1.14 (p=0). However, DAH to the non-governmental sector had a positive and significant effect on domestic government health spending. Both results were robust to multiple specifications and subset analyses. Other factors, such as debt relief, had no detectable effect on domestic government health spending. Interpretation To address the negative effect of DAH on domestic government health spending, we recommend strong standardised monitoring of government health expenditures and government spending in other health-related sectors; establishment of collaborative targets to maintain or increase the share of government expenditures going to health; investment in the capacity of developing countries to effectively receive and use DAH; careful assessment of the risks and benefits of expanded DAH to non-governmental sectors; and investigation of the use of global price subsidies or product transfers as mechanisms for DAH.	[Schneider, Matthew T.; Gubbins, Paul; Leach-Kemon, Katherine; Jamison, Dean; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Lu, Chunling] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.	cjlm@u.washington.edu		Schneider, Matthew/0000-0003-4906-9167	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Bill & Melinda Gates Foundation.	ARELLANO M, 1995, J ECONOMETRICS, V68, P29, DOI 10.1016/0304-4076(94)01642-D; Arndt C, 2000, S AFR J ECON, V68, P856; Baldacci E, 2008, WORLD DEV, V36, P1317, DOI 10.1016/j.worlddev.2007.08.003; BECK N, 1995, AM POLIT SCI REV, V89, P634, DOI 10.2307/2082979; Blundell R, 1998, J ECONOMETRICS, V87, P115, DOI 10.1016/S0304-4076(98)00009-8; Clemens M., 2003, CHALLENGING FOREIGN, P125; Davey G, 2006, LANCET, V367, P629, DOI 10.1016/S0140-6736(06)68239-1; De Renzio Paolo, 2007, IMF PROGRAMS HLTH SP; DE S, 2006, NATL RESOURCE FLOWS; Faraci M, 2009, PEDIATR INFECT DIS J, V28, P55, DOI 10.1097/INF.0b013e3181812cb9; Feyzioglu T, 1998, WORLD BANK ECON REV, V12, P29, DOI 10.1093/wber/12.1.29; *GAVI ALL, 2009, PROGR POL COMM PCC M; *GFATM, AFF MED FAC MAL AMFM; *GFATM, REP PORTF MAN PROC C; *GFATM, 2005, GLOB FUND ANN REP 20; Gottret P. E., 2006, HLTH FINANCING REVIS; Gupta S, 2002, B WORLD HEALTH ORGAN, V80, P151; Haacker M, 2004, MACROECONOMICS OF HIV/AIDS, P198; Heller P., 2005, UNDERSTANDING FISCAL; HELLER PS, 1975, AM ECON REV, V65, P429; High Level Forum, 2005, PAR DECL AID EFF OWN; HONAKER J, WHAT DO MISSING VALU; Honaker J, AMELIA 2 PROGRAM MIS; Horton NJ, 2007, AM STAT, V61, P79, DOI 10.1198/000313007X172556; HUDDART J, 2004, ZAMBIA HIV AIDS WORK; *IHP, 2008, LEV TASKF INN INT FO; IMF, 2009, DEBT REL HEAV IND PO; *IMF, 2009, MULT DEBT REL IN MDR; *INT HLTH PARTN RE, 2009, IHP RI IHP; Kaddar M, 2008, B WORLD HEALTH ORGAN, V86, P877, DOI 10.2471/BLT.08.053686; Katz JonathanN., 1996, POLIT ANAL, V6, DOI [10.1093/pan/6.1.1, DOI 10.1093/PAN/6.1.1]; Keele L, 2006, POLIT ANAL, V14, P186, DOI 10.1093/pan/mpj006; King G, 2001, AM POLIT SCI REV, V95, P49, DOI 10.1017/S0003055401000235; KRISTENSEN IP, LAGGING DOG ROBUSTNE; Lienert I, 2003, OECD J BUDGETING OECD J BUDGETING, P35; Lim SS, 2008, LANCET, V372, P2031, DOI 10.1016/S0140-6736(08)61869-3; Little R.J.A., 2002, STAT ANAL MISSING DA; McGreevey W., 2005, ADDITIONALITY DIMENS; Mishra P., 2007, HLTH AID INFANT MORT; Murray CJL, 2007, LANCET, V370, P1040, DOI 10.1016/S0140-6736(07)61478-0; Murray CJL., 2003, HLTH SYSTEMS PERFORM, P533; Musgrove P, 2002, B WORLD HEALTH ORGAN, V80, P134; Ooms G, 2005, LANCET, V365, P1821, DOI 10.1016/S0140-6736(05)66586-5; *ORG EC COOP DEV, SYST HLTH ACC; PACK H, 1993, REV ECON STAT, V75, P258, DOI 10.2307/2109431; *PART REV INT NETW, 2002, STRUCT ADJ PART REV; PESARAN MH, 1995, J ECONOMETRICS, V68, P79, DOI 10.1016/0304-4076(94)01644-F; Pettersson J., 2007, J INT DEV, V19, P1074, DOI DOI 10.1002/(ISSN)1099-1328; Poullier J-P, 2002, NATL HLTH ACCOUNTS C; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Roodman D, 2009, STATA J, V9, P86, DOI 10.1177/1536867X0900900106; Rubin D. B., 2004, MULTIPLE IMPUTATION; STOVER J, 1999, EC IMPACT AIDS WASHI; Swaroop V, 2000, J PUBLIC ECON, V77, P307, DOI 10.1016/S0047-2727(00)00070-0; Swaroop V, 1999, WHAT DOES AID AFRICA; *UN, AFR SUMM HIV AIDS TU; *UN STAT DIV, 2009, NAT ACC; United Nations, 2002, INT C FIN DEV; van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3; Vujicic M, 2009, DIR DEV, P1, DOI 10.1596/978-0-8213-7802-1; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; WHO, 2001, WHO COMM MACR HLTH M; *WHO, NAT HLTH ACC; *WHO, 2009, EXPL NOT; World Health Organization, 2000, WORLD HLTH REP 2000; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; XU K, 2003, HLTH SYSTEM PERFORMA, P543; YONTCHEVA B, 2005, DOES FOREIGN REDUCE	68	236	241	0	66	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 17	2010	375	9723					1375	1387		10.1016/S0140-6736(10)60233-4	http://dx.doi.org/10.1016/S0140-6736(10)60233-4			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	588GW	20381856				2022-12-28	WOS:000277057800028
J	Powell, S; Kubba, H; O'Brien, C; Tremlett, M				Powell, Steven; Kubba, Haytham; O'Brien, Chris; Tremlett, Mike			Clinical review Paediatric obstructive sleep apnoea	BMJ-BRITISH MEDICAL JOURNAL			English	Review							UPPER AIRWAY-OBSTRUCTION; QUALITY-OF-LIFE; APNEA/HYPOPNEA SYNDROME; CHILDREN; TONSILLECTOMY; PATHOPHYSIOLOGY; ADENOIDECTOMY; PREVALENCE; DISORDERS; BEHAVIOR		[Powell, Steven] James Cook Univ Hosp, Dept Otolaryngol, Middlesbrough TS4 3BW, Cleveland, England; [Kubba, Haytham] Royal Hosp Sick Children, Dept Paediat Otolaryngol, Glasgow G3 8SJ, Lanark, Scotland; [O'Brien, Chris] Royal Victoria Infirm, Dept Paediat Resp Med, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Tremlett, Mike] James Cook Univ Hosp, Dept Anaesthesia, Middlesbrough TS4 3BW, Cleveland, England	James Cook University Hospital; University of Glasgow; Newcastle University - UK; James Cook University Hospital	Powell, S (corresponding author), James Cook Univ Hosp, Dept Otolaryngol, Middlesbrough TS4 3BW, Cleveland, England.	steven_m_powell@hotmail.com	Kubba, Haytham/GSO-0455-2022; Kubba, Haytham/AAD-9548-2022; Kubba, Haytham/K-8310-2015	Kubba, Haytham/0000-0003-3245-5117; Kubba, Haytham/0000-0003-3245-5117; Powell, Steven/0000-0001-7181-4608				Alexopoulos EI, 2004, PEDIATR PULM, V38, P161, DOI 10.1002/ppul.20079; Alexopoulos EI, 2006, UROLOGY, V68, P406, DOI 10.1016/j.urology.2006.02.021; ALI NJ, 1993, ARCH DIS CHILD, V68, P360, DOI 10.1136/adc.68.3.360; [Anonymous], 2009, IND TONS POS PAP; Bixler EO, 2009, SLEEP, V32, P731, DOI 10.1093/sleep/32.6.731; Blum RH, 2004, PAEDIATR ANAESTH, V14, P75, DOI 10.1046/j.1460-9592.2003.01193.x; Brietzke SE, 2004, OTOLARYNG HEAD NECK, V131, P827, DOI 10.1016/j.otohns.2004.07.002; Brietzke SE, 2006, OTOLARYNG HEAD NECK, V134, P979, DOI 10.1016/j.otohns.2006.02.033; BRODSKY L, 1989, PEDIATR CLIN N AM, V36, P1551; Brouillette RT, 2000, PEDIATRICS, V105, P405, DOI 10.1542/peds.105.2.405; Brouillette RT, 2001, J PEDIATR-US, V138, P838, DOI 10.1067/mpd.2001.114474; Brunetti L, 2001, CHEST, V120, P1930, DOI 10.1378/chest.120.6.1930; CARROLL JL, 1995, CHEST, V108, P610, DOI 10.1378/chest.108.3.610; Coticchia JM, 2006, ARCH OTOLARYNGOL, V132, P425, DOI 10.1001/archotol.132.4.425; FREEZER NJ, 1995, J PAEDIATR CHILD H, V31, P172, DOI 10.1111/j.1440-1754.1995.tb00779.x; Georgalas C, 2007, CLIN OTOLARYNGOL, V32, P268, DOI 10.1111/j.1365-2273.2007.01459.x; Gozal D, 2008, AM J RESP CRIT CARE, V177, P1142, DOI 10.1164/rccm.200711-1670OC; Gozal David, 2004, Paediatr Respir Rev, V5 Suppl A, pS371, DOI 10.1016/S1526-0542(04)90066-8; GUILLEMINAULT C, 1976, PEDIATRICS, V58, P23; Hill CM, 2007, ARCH DIS CHILD, V92, P637, DOI 10.1136/adc.2006.096156; Hill W, 1889, BMJ-BRIT MED J, V2, P771, DOI 10.1136/bmj.2.4379.771-b; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kotagal S, 2006, BMJ-BRIT MED J, V332, P828, DOI 10.1136/bmj.332.7545.828; Lim J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003136.pub2; Lowe D, 2007, LARYNGOSCOPE, V117, P717, DOI 10.1097/mlg.0b013e318031f0b0; Marcus CL, 2000, RESP PHYSIOL, V119, P143, DOI 10.1016/S0034-5687(99)00109-7; Marcus CL, 2006, PEDIATRICS, V117, pE442, DOI 10.1542/peds.2005-1634; Marcus CL, 2002, PEDIATRICS, V109, P704; Mitchell RB, 2006, INT J PEDIATR OTORHI, V70, P395, DOI 10.1016/j.ijporl.2005.10.020; Mitchell RB, 2004, ARCH OTOLARYNGOL, V130, P409, DOI 10.1001/archotol.130.4.409; Nixon GM, 2004, PEDIATRICS, V113, pE19, DOI 10.1542/peds.113.1.e19; Robb PJ, 2009, CLIN OTOLARYNGOL, V34, P61, DOI 10.1111/j.1749-4486.2009.01862.x; *ROYAL AUSTR COLL, 2008, IND TONS AD CHILDR J; Shine NP, 2005, INT J PEDIATR OTORHI, V69, P1475, DOI 10.1016/j.ijporl.2005.08.008; Sohn H, 2003, OTOLARYNG HEAD NECK, V128, P344, DOI 10.1067/mhn.2003.4; Working Party on Sleep Physiology and Respiratory Control Disorders in Childhood, 2022, STAND SERV CHILDR DI	36	26	26	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2010	340								c1918	10.1136/bmj.c1918	http://dx.doi.org/10.1136/bmj.c1918			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	586KB	20392770				2022-12-28	WOS:000276905400005
J	Volkow, ND; Montaner, J				Volkow, Nora D.; Montaner, Julio			Enhanced HIV Testing, Treatment, and Support for HIV-Infected Substance Users	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACTIVE ANTIRETROVIRAL THERAPY; INJECTION-DRUG USERS; EPIDEMIC; CARE		[Volkow, Nora D.] NIDA, NIH, Bethesda, MD 20892 USA; [Montaner, Julio] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Montaner, Julio] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Montaner, Julio] Int AIDS Soc, Geneva, Switzerland	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); B.C. Centre for Excellence in HIV/AIDS; University of British Columbia	Volkow, ND (corresponding author), 6001 Execut Blvd,Room 5274,MSC 9581, Bethesda, MD 20892 USA.	nvolkow@nida.nih.gov	Montaner, Julio/K-7621-2012		NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA026182] Funding Source: NIH RePORTER; CIHR Funding Source: Medline; NIDA NIH HHS [DP1 DA026182] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); CIHR(Canadian Institutes of Health Research (CIHR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Bruce RD, 2007, INFECT DIS CLIN N AM, V21, P149, DOI 10.1016/j.idc.2007.03.009; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Lert F, 2007, INT J DRUG POLICY, V18, P255, DOI 10.1016/j.drugpo.2007.05.002; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Spaulding AC, 2009, PLOS ONE, V4, pA16, DOI 10.1371/journal.pone.0007558; *SUBST AB MENT HLT, RES 2008 NAT SURV DR; Wood E, 2005, AIDS, V19, P1189, DOI 10.1097/01.aids.0000176219.48484.f1; Wood E, 2008, JAMA-J AM MED ASSOC, V300, P550, DOI 10.1001/jama.300.5.550; Wood E, 2006, DRUG ALCOHOL REV, V25, P451, DOI 10.1080/09595230600883313; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649	10	50	50	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2010	303	14					1423	1424		10.1001/jama.2010.421	http://dx.doi.org/10.1001/jama.2010.421			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582KX	20388900	Green Accepted			2022-12-28	WOS:000276597300029
J	Messersmith, PB				Messersmith, Phillip B.			Holding On by a Hard-Shell Thread	SCIENCE			English	Editorial Material							ADHESIVE PROTEIN; MUSSEL; POLYMERS		[Messersmith, Phillip B.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Messersmith, Phillip B.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Messersmith, Phillip B.] Northwestern Univ, Dept Biol & Chem Engn, Chem Life Proc Inst, Evanston, IL 60208 USA; [Messersmith, Phillip B.] Northwestern Univ, Inst Bionanotechnol Med, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University	Messersmith, PB (corresponding author), Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.	philm@northwestern.edu	Messersmith, Phil/B-6695-2009	Messersmith, Phillip/0000-0002-1197-333X				Broomell CC, 2007, J R SOC INTERFACE, V4, P19, DOI 10.1098/rsif.2006.0153; Cai WB, 2004, J AM CHEM SOC, V126, P15030, DOI 10.1021/ja0442062; Carrington E, 2004, AM MALACOL BULL, V18, P135; Dalsin JL, 2003, J AM CHEM SOC, V125, P4253, DOI 10.1021/ja0284963; Harrington MJ, 2010, SCIENCE, V328, P216, DOI 10.1126/science.1181044; Holten-Andersen N, 2007, NAT MATER, V6, P669, DOI 10.1038/nmat1956; Holten-Andersen N, 2009, LANGMUIR, V25, P3323, DOI 10.1021/la8027012; Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103; Paunesku T, 2003, NAT MATER, V2, P343, DOI 10.1038/nmat875; Statz AR, 2005, J AM CHEM SOC, V127, P7972, DOI 10.1021/ja0522534; Taylor SW, 1996, INORG CHEM, V35, P7572, DOI 10.1021/ic960514s; Xu CJ, 2004, J AM CHEM SOC, V126, P9938, DOI 10.1021/ja0464802; Zurcher S, 2006, J AM CHEM SOC, V128, P1064, DOI 10.1021/ja056256s	13	14	14	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2010	328	5975					180	181		10.1126/science.1187598	http://dx.doi.org/10.1126/science.1187598			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580OU	20378805				2022-12-28	WOS:000276459600029
J	Moschetti, MP; Ritzwoller, MH; Lin, F; Yang, Y				Moschetti, M. P.; Ritzwoller, M. H.; Lin, F.; Yang, Y.			Seismic evidence for widespread western-US deep-crustal deformation caused by extension	NATURE			English	Article							SURFACE-WAVE TOMOGRAPHY; PHASE-VELOCITY; UNITED-STATES; MANTLE FLOW; ANISOTROPY; INVERSION; BENEATH; NOISE; MODEL	Laboratory experiments have established that many of the materials comprising the Earth are strongly anisotropic in terms of seismic-wave speeds(1). Observations of azimuthal(2,3) and radial(4,5) anisotropy in the upper mantle are attributed to the lattice-preferred orientation of olivine caused by the shear strains associated with deformation, and provide some of the most direct evidence for deformation and flow within the Earth's interior. Although observations of crustal radial anisotropy would improve our understanding of crustal deformation and flow patterns resulting from tectonic processes, large-scale observations have been limited to regions of particularly thick crust(6). Here we show that observations from ambient noise tomography in the western United States reveal strong deep (middle to lower)-crustal radial anisotropy that is confined mainly to the geological provinces that have undergone significant extension during the Cenozoic Era (since similar to 65 Myr ago)(7,8). The coincidence of crustal radial anisotropy with the extensional provinces of the western United States suggests that the radial anisotropy results from the lattice-preferred orientation of anisotropic crustal minerals caused by extensional deformation. These observations also provide support for the hypothesis that the deep crust within these regions has undergone widespread and relatively uniform strain in response to crustal thinning and extension(9-11).	[Moschetti, M. P.; Ritzwoller, M. H.; Lin, F.; Yang, Y.] Univ Colorado, Dept Phys, Ctr Imaging Earths Interior, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Moschetti, MP (corresponding author), US Geol Survey, Geol Hazards Sci Ctr, Box 25046, Denver, CO 80225 USA.	mmoschetti@usgs.gov	Yang, Yingjie/L-4951-2015; Yang, Yingjie/C-6988-2009; Lin, Fan-Chi/E-8170-2012	Yang, Yingjie/0000-0002-1105-3824; Lin, Fan-Chi/0000-0003-0394-6830; Moschetti, Morgan/0000-0001-7261-0295	US National Science Foundation, Division of Earth Sciences; US National Defense; American Society for Engineering Education	US National Science Foundation, Division of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); US National Defense; American Society for Engineering Education	This manuscript benefited from discussions with K. Mahan, C. Jones and P. Molnar. Research was supported by the US National Science Foundation, Division of Earth Sciences. M. P. M. received support from an US National Defense Science and Engineering Graduate Fellowship from the American Society for Engineering Education. The facilities of the IRIS Data Management System, and specifically the IRIS Data Management Center, were used to access the waveform and metadata required in this study.	Barmin MP, 2001, PURE APPL GEOPHYS, V158, P1351, DOI 10.1007/PL00001225; Becker TW, 2006, EARTH PLANET SC LETT, V247, P235, DOI 10.1016/j.epsl.2006.05.010; Bensen GD, 2007, GEOPHYS J INT, V169, P1239, DOI 10.1111/j.1365-246X.2007.03374.x; BIRD P, 1991, J GEOPHYS RES-SOLID, V96, P10275, DOI 10.1029/91JB00370; BLOCK L, 1990, TECTONICS, V9, P557, DOI 10.1029/TC009i004p00557; Ekstrom G, 1998, NATURE, V394, P168, DOI 10.1038/28148; Forsyth DW, 2005, GEOPHYS MONOGR SER, V157, P81, DOI 10.1029/156GM06; GILBERT HJ, 2007, EOS, V88; JANECKE SU, 2004, GEOL SOC AM ABSTR, V36, P546; KRUSE S, 1991, J GEOPHYS RES-SOLID, V96, P4435, DOI 10.1029/90JB02621; LEVSHIN AL, 1972, ANN GEOPHYS-FR, V28, P211; Lin FC, 2008, GEOPHYS J INT, V173, P281, DOI 10.1111/j.1365-246X.2008.03720.x; Lin FC, 2009, GEOPHYS J INT, V177, P1091, DOI 10.1111/j.1365-246X.2009.04105.x; LOVE AEH, 1927, TREATISE MATHEMATICA, P298; MAINPRICE D, 1989, J STRUCT GEOL, V11, P175, DOI 10.1016/0191-8141(89)90042-4; Masters G, 2007, MINEOS USER MANUAL; MONTAGNER JP, 1991, J GEOPHYS RES-SOL EA, V96, P20337, DOI 10.1029/91JB01890; Moschetti MP, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001655; MOSCHETTI MP, J GEOPHYS RES UNPUB; Nettles M, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2006JB004819; Rasolofosaon PNJ, 2000, GEOPHYS J INT, V141, P413, DOI 10.1046/j.1365-246x.2000.00093.x; Sabra KG, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023155; Sambridge M, 1999, GEOPHYS J INT, V138, P479, DOI 10.1046/j.1365-246X.1999.00876.x; Shapiro NM, 2005, SCIENCE, V307, P1615, DOI 10.1126/science.1108339; Shapiro NM, 2004, SCIENCE, V305, P233, DOI 10.1126/science.1098276; Shapiro NM, 2002, GEOPHYS J INT, V151, P88, DOI 10.1046/j.1365-246X.2002.01742.x; SIEGESMUND S, 1989, TECTONOPHYSICS, V157, P25, DOI 10.1016/0040-1951(89)90338-7; Silver PG, 1996, ANNU REV EARTH PL SC, V24, P385, DOI 10.1146/annurev.earth.24.1.385; Silver PG, 2002, SCIENCE, V295, P1054, DOI 10.1126/science.1066878; Weiss T, 1999, PURE APPL GEOPHYS, V156, P97, DOI 10.1007/s000240050291; Wernicke B., 1992, CORDILLERAN OROGEN C, P553, DOI DOI 10.1130/DNAG-GNA-G3.553; Yang YJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032278; Yang YJ, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2008JB005833	33	153	155	3	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					885	U94		10.1038/nature08951	http://dx.doi.org/10.1038/nature08951			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20376148				2022-12-28	WOS:000276397300036
J	Tonelli, M; Pannu, N; Manns, B				Tonelli, Marcello; Pannu, Neesh; Manns, Braden			Drug Therapy: Oral Phosphate Binders in Patients with Kidney Failure.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CORONARY-ARTERY CALCIFICATION; CHRONIC-HEMODIALYSIS PATIENTS; CHRONIC-RENAL-FAILURE; LANTHANUM CARBONATE; CALCIUM-CARBONATE; SEVELAMER-HYDROCHLORIDE; DIALYSIS PATIENTS; MAGNESIUM CARBONATE; ALUMINUM-HYDROXIDE; SERUM PHOSPHORUS		[Tonelli, Marcello; Pannu, Neesh] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Tonelli, Marcello] Univ Alberta, Dept Publ Hlth Sci, Edmonton, AB, Canada; [Pannu, Neesh] Univ Alberta, Div Crit Care Med, Edmonton, AB, Canada; [Manns, Braden] Univ Calgary, Dept Med, Calgary, AB, Canada; [Manns, Braden] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Calgary; University of Calgary	Tonelli, M (corresponding author), 7-129 Clin Sci Bldg,8440 112th St, Edmonton, AB T6B 2G3, Canada.	mtonelli-admin@med.ualberta.ca	Manns, Braden J/I-8942-2012; Tonelli, Marcello/B-3028-2009	Tonelli, Marcello/0000-0002-0846-3187	Alberta Heritage Foundation for Medical Research; University of Alberta; University of Calgary; Canadian Institutes of Health Research; Amgen and Merck Frosst Canada; Ab-bott Laboratories	Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); University of Alberta(University of Alberta); University of Calgary; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Amgen and Merck Frosst Canada; Ab-bott Laboratories(Abbott Laboratories)	Supported by an Interdisciplinary Team Grant from the Alberta Heritage Foundation for Medical Research and a joint initiative between Alberta Health and Wellness and the University of Alberta and the University of Calgary. Drs. Tonelli and Manns were also supported by New Investigator Awards from the Canadian Institutes of Health Research, and Dr. Tonelli by a Health Scholar award from the Alberta Heritage Foundation for Medical Research.Drs. Tonelli and Manns report receiving a grant to the Alberta Kidney Disease Network, which is funded in part by Amgen and Merck Frosst Canada; Dr. Tonelli, receiving a grant jointly funded by the Canadian Institutes of Health Research and Ab-bott Laboratories; and Dr. Pannu, receiving a lecture fee from Amgen. No other potential conflict of interest relevant to this article was reported. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.	Albaaj F, 2005, INT J CLIN PRACT, V59, P1091, DOI 10.1111/j.1368-5031.2005.00592.x; Almirall J, 2004, NEPHRON CLIN PRACT, V97, pC17, DOI 10.1159/000077591; Asmus HG, 2005, NEPHROL DIAL TRANSPL, V20, P1653, DOI 10.1093/ndt/gfh894; Barreto DV, 2008, NEPHRON CLIN PRACT, V110, pC273, DOI 10.1159/000170783; Berns JS, 2008, SEMIN DIALYSIS, V21, P203, DOI 10.1111/j.1525-139X.2008.00426.x; Block GA, 2007, KIDNEY INT, V71, P438, DOI 10.1038/sj.ki.5002059; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Block GA, 1998, AM J KIDNEY DIS, V31, P607, DOI 10.1053/ajkd.1998.v31.pm9531176; Block GA, 2005, KIDNEY INT, V68, P1815, DOI 10.1111/j.1523-1755.2005.00600.x; Blumsohn A, 2004, CURR OPIN NEPHROL HY, V13, P397, DOI 10.1097/01.mnh.0000133983.40182.c3; Braun J, 2004, CLIN NEPHROL, V62, P104; BRINGHURST FR, 2004, HARRISONS PRINCIPLES, V2, P2238; Bro S, 1998, AM J KIDNEY DIS, V31, P257, DOI 10.1053/ajkd.1998.v31.pm9469496; Burke SK, 2001, J CLIN PHARMACOL, V41, P199, DOI 10.1177/00912700122009881; Caglar K, 2008, CLIN J AM SOC NEPHRO, V3, P61, DOI 10.2215/CJN.02810707; *CAN AG DRUGS TECH, 2008, CEDAC FIN REC REC RE; Caravaca F, 1998, NEPHROL DIAL TRANSPL, V13, P2605, DOI 10.1093/ndt/13.10.2605; Chertow GM, 2002, KIDNEY INT, V62, P245, DOI 10.1046/j.1523-1755.2002.00434.x; Chiang SS, 2005, CLIN NEPHROL, V63, P461; Culleton BF, 2007, JAMA-J AM MED ASSOC, V298, P1291, DOI 10.1001/jama.298.11.1291; d'Almeida Filho  E J, 2000, Sao Paulo Med J, V118, P179; D'Haese PC, 2003, KIDNEY INT, V63, pS73, DOI 10.1046/j.1523-1755.63.s85.18.x; De Boer IH, 2002, J AM SOC NEPHROL, V13, P2762, DOI 10.1097/01.ASN.0000034202.91413.EB; Delmez J, 2007, CLIN NEPHROL, V68, P386; Delmez JA, 1996, KIDNEY INT, V49, P163, DOI 10.1038/ki.1996.22; Eknoyan G, 2003, AM J KIDNEY DIS, V41, pS1, DOI 10.1016/S0272-6386(03)00111-2; ELLIOTT HL, 1978, BRIT MED J, V1, P1101, DOI 10.1136/bmj.1.6120.1101; Evenepoel P, 2009, NEPHROL DIAL TRANSPL, V24, P278, DOI 10.1093/ndt/gfn488; Ferreira A, 2008, J AM SOC NEPHROL, V19, P405, DOI 10.1681/ASN.2006101089; Finn WF, 2006, CLIN NEPHROL, V65, P191; Finn WF, 2005, CURR MED RES OPIN, V21, P657, DOI 10.1185/030079905X41453; Finn WF, 2004, CLIN NEPHROL, V62, P193; Fischer D, 2006, AM J KIDNEY DIS, V48, P437, DOI 10.1053/j.ajkd.2006.05.026; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Freemont AJ, 2005, CLIN NEPHROL, V64, P428; Giachelli CM, 2009, KIDNEY INT, V75, P890, DOI 10.1038/ki.2008.644; GUILLOT AP, 1982, NEPHRON, V30, P114, DOI 10.1159/000182446; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Hruska KA, 2008, KIDNEY INT, V74, P148, DOI 10.1038/ki.2008.130; Hutchison AJ, 2005, NEPHRON CLIN PRACT, V100, pC8, DOI 10.1159/000084653; Hutchison AJ, 2004, NEPHROL DIAL TRANSPL, V19, P1902, DOI 10.1093/ndt/gfh282; Hutchison AJ, 2008, NEPHROL DIAL TRANSPL, V23, P3677, DOI 10.1093/ndt/gfn310; Hutchison AJ, 2008, NEPHRON CLIN PRACT, V110, pC15, DOI 10.1159/000149239; Isakova T, 2009, KIDNEY INT, V76, P705, DOI 10.1038/ki.2009.246; Isakova T, 2009, J AM SOC NEPHROL, V20, P388, DOI 10.1681/ASN.2008060609; Iwasaki Y, 2005, THER APHER DIAL, V9, P347, DOI 10.1111/j.1744-9987.2005.00295.x; Jamal SA, 2009, NEPHROL DIAL TRANSPL, V24, P3168, DOI 10.1093/ndt/gfp350; Janssen MJA, 1996, CLIN NEPHROL, V45, P111; JESPERSEN B, 1991, NEPHROL DIAL TRANSPL, V6, P98, DOI 10.1093/ndt/6.2.98; Joy MS, 2003, AM J KIDNEY DIS, V42, P96, DOI 10.1016/S0272-6386(03)00554-7; Kalantar-Zadeh K, 2006, KIDNEY INT, V70, P771, DOI 10.1038/sj.ki.5001514; Kates DM, 1997, AM J KIDNEY DIS, V30, P809, DOI 10.1016/S0272-6386(97)90086-X; Katopodis KP, 2006, PERITON DIALYSIS INT, V26, P320; *KDIGO, 2009, KIDNEY INT S113, V76, pS44; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Koiwa F, 2005, THER APHER DIAL, V9, P340, DOI 10.1111/j.1744-9987.2005.00294.x; Levin A, 2007, KIDNEY INT, V71, P31, DOI 10.1038/sj.ki.5002009; Levin A, 2009, KIDNEY INT, V75, P1237, DOI 10.1038/ki.2009.100; Locatelli F, 2010, NEPHROL DIAL TRANSPL, V25, P574, DOI 10.1093/ndt/gfp445; Malluche HH, 2008, CLIN NEPHROL, V70, P284; Manns B, 2004, KIDNEY INT, V66, P1239, DOI 10.1111/j.1523-1755.2004.00877.x; Manns B, 2007, NEPHROL DIAL TRANSPL, V22, P2867, DOI 10.1093/ndt/gfm367; MCBRIDE R, 2007, MASS HIGH TECH  0115; McIntyre CW, 2009, CLIN J AM SOC NEPHRO, V4, P401, DOI 10.2215/CJN.02630608; Mehrotra R, 2008, CLIN J AM SOC NEPHRO, V3, P1437, DOI 10.2215/CJN.04741107; Melamed ML, 2006, KIDNEY INT, V70, P351, DOI 10.1038/sj.ki.5001542; Miyamoto KI, 2004, JPN J PHYSIOL, V54, P93, DOI 10.2170/jjphysiol.54.93; Morey B, 2008, NEPHRON CLIN PRACT, V109, pC173, DOI 10.1159/000145462; MORINIERE P, 1988, NEPHROL DIAL TRANSPL, V3, P651, DOI 10.1093/oxfordjournals.ndt.a091722; Muller D, 2007, CLIN J AM SOC NEPHRO, V2, P1249, DOI 10.2215/CJN.01470307; Navaneethan SD, 2009, AM J KIDNEY DIS, V54, P619, DOI 10.1053/j.ajkd.2009.06.004; Pai AB, 2009, PHARMACOTHERAPY, V29, P554, DOI 10.1592/phco.29.5.554; Pande S, 2006, NEPHRON PHYSIOL, V104, P23, DOI 10.1159/000093277; PARKINSON IS, 1979, LANCET, V1, P406; PARSONS V, 1993, NEPHRON, V63, P379, DOI 10.1159/000187238; Peter WLS, 2008, AM J KIDNEY DIS, V51, P445, DOI 10.1053/j.ajkd.2007.12.002; PFLANZ S, 1994, NEPHROL DIAL TRANSPL, V9, P1121, DOI 10.1093/ndt/9.8.1121; Pieper AK, 2006, AM J KIDNEY DIS, V47, P625, DOI 10.1053/j.ajkd.2005.12.039; Qunibi W, 2008, AM J KIDNEY DIS, V51, P952, DOI 10.1053/j.ajkd.2008.02.298; Raggi P, 2004, J HEART VALVE DIS, V13, P134; Raggi P, 2008, CLIN J AM SOC NEPHRO, V3, P836, DOI 10.2215/CJN.02910707; Ramon I, 2010, EUR J ENDOCRINOL, V162, P1, DOI 10.1530/EJE-09-0597; Ramos R, 2007, PERITON DIALYSIS INT, V27, P697; ROUJOULEH H, 1987, NEPHROLOGIE, V8, P45; Russo D, 2007, KIDNEY INT, V72, P1255, DOI 10.1038/sj.ki.5002518; SALUSKY IB, 1991, NEW ENGL J MED, V324, P527, DOI 10.1056/NEJM199102213240804; Savica V, 2009, J AM SOC NEPHROL, V20, P639, DOI 10.1681/ASN.2008020130; SEXTON J, 2005, PHARM J, V274, P561; SHAH GM, 1987, AM J KIDNEY DIS, V10, P268, DOI 10.1016/S0272-6386(87)80021-5; Sherman RA, 2007, SEMIN DIALYSIS, V20, P16, DOI 10.1111/j.1525-139X.2007.00204.x; Shigematsu T, 2008, THER APHER DIAL, V12, P55, DOI 10.1111/j.1744-9987.2007.00541.x; Shuto E, 2009, J AM SOC NEPHROL, V20, P1504, DOI 10.1681/ASN.2008101106; Slinin Y, 2005, J AM SOC NEPHROL, V16, P1788, DOI 10.1681/ASN.2004040275; Spasovski GB, 2006, NEPHROL DIAL TRANSPL, V21, P2217, DOI 10.1093/ndt/gfl146; Spiegel DM, 2007, J RENAL NUTR, V17, P416, DOI 10.1053/j.jrn.2007.08.005; Sprague SM, 2009, CLIN J AM SOC NEPHRO, V4, P178, DOI 10.2215/CJN.02830608; Sturtevant JM, 2004, NEPHROLOGY, V9, P406, DOI 10.1111/j.1440-1797.2004.00338.x; Suki WN, 2007, KIDNEY INT, V72, P1130, DOI 10.1038/sj.ki.5002466; Sullivan C, 2009, JAMA-J AM MED ASSOC, V301, P629, DOI 10.1001/jama.2009.96; Takei T, 2008, NEPHRON CLIN PRACT, V108, pC278, DOI 10.1159/000127361; Tan SY, 1996, KIDNEY INT, V50, P282, DOI 10.1038/ki.1996.313; Tentori F, 2008, AM J KIDNEY DIS, V52, P519, DOI 10.1053/j.ajkd.2008.03.020; *THOMS, 2009, RED BOOK 2009 PHARM; Tonelli M, 2007, NEPHROL DIAL TRANSPL, V22, P2856, DOI 10.1093/ndt/gfm421; Tonelli M, 2009, AM J KIDNEY DIS, V54, P1108, DOI 10.1053/j.ajkd.2009.05.018; Tzanakis IP, 2008, INT UROL NEPHROL, V40, P193, DOI 10.1007/s11255-007-9300-0; Winkelmayer WC, 2008, AM J KIDNEY DIS, V51, P362, DOI 10.1053/j.ajkd.2008.01.004; Wrong O, 2008, NEPHROL DIAL TRANSPL, V23, P2101, DOI 10.1093/ndt/gfn162; Young EW, 2005, KIDNEY INT, V67, P1179, DOI 10.1111/j.1523-1755.2005.00185.x	109	242	258	0	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 8	2010	362	14					1312	1324		10.1056/NEJMra0912522	http://dx.doi.org/10.1056/NEJMra0912522			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579SN	20375408				2022-12-28	WOS:000276393700010
J	Armitage, JP; Berry, RM				Armitage, Judith P.; Berry, Richard M.			Time for Bacteria to slow down	CELL			English	Editorial Material							FLAGELLAR MOTOR; ESCHERICHIA-COLI; MOTILITY; CLUTCH		[Armitage, Judith P.] Univ Oxford, Dept Biochem, Oxford Ctr Integrat Syst Biol, Oxford OX1 3QU, England; [Berry, Richard M.] Univ Oxford, Dept Phys, Oxford, England	University of Oxford; University of Oxford	Armitage, JP (corresponding author), Univ Oxford, Dept Biochem, Oxford Ctr Integrat Syst Biol, Oxford OX1 3QU, England.	judith.armitage@bioch.ox.ac.uk; r.berry1@physics.ox.ac.uk			BBSRC [BB/E00458X/1, BB/F021224/1, BB/H01991X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F021224/1, BB/E00458X/1, BB/H01991X/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; AMSLER CD, 1993, J BACTERIOL, V175, P6238, DOI 10.1128/JB.175.19.6238-6244.1993; Blair KM, 2008, SCIENCE, V320, P1636, DOI 10.1126/science.1157877; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Paul K, 2010, MOL CELL, V38, P128, DOI 10.1016/j.molcel.2010.03.001; Pilizota T, 2009, P NATL ACAD SCI USA, V106, P11582, DOI 10.1073/pnas.0813164106; Reid SW, 2006, P NATL ACAD SCI USA, V103, P8066, DOI 10.1073/pnas.0509932103; Sowa Y, 2008, Q REV BIOPHYS, V41, P103, DOI 10.1017/S0033583508004691; Wolfe AJ, 2008, J BACTERIOL, V190, P463, DOI 10.1128/JB.01418-07	9	19	19	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 1	2010	141	1					24	26		10.1016/j.cell.2010.03.023	http://dx.doi.org/10.1016/j.cell.2010.03.023			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	577GS	20371342	Bronze			2022-12-28	WOS:000276211100009
J	Silveira, MJ; Kim, SYH; Langa, KM				Silveira, Maria J.; Kim, Scott Y. H.; Langa, Kenneth M.			Advance Directives and Outcomes of Surrogate Decision Making before Death.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OF-LIFE CARE; CRITICALLY-ILL; LIVING WILL; END; HEALTH; PLACE	Background: Recent discussions about health care reform have raised questions regarding the value of advance directives. Methods: We used data from survey proxies in the Health and Retirement Study involving adults 60 years of age or older who had died between 2000 and 2006 to determine the prevalence of the need for decision making and lost decision-making capacity and to test the association between preferences documented in advance directives and outcomes of surrogate decision making. Results: Of 3746 subjects, 42.5% required decision making, of whom 70.3% lacked decision-making capacity and 67.6% of those subjects, in turn, had advance directives. Subjects who had living wills were more likely to want limited care (92.7%) or comfort care (96.2%) than all care possible (1.9%); 83.2% of subjects who requested limited care and 97.1% of subjects who requested comfort care received care consistent with their preferences. Among the 10 subjects who requested all care possible, only 5 received it; however, subjects who requested all care possible were far more likely to receive aggressive care as compared with those who did not request it (adjusted odds ratio, 22.62; 95% confidence interval [CI], 4.45 to 115.00). Subjects with living wills were less likely to receive all care possible (adjusted odds ratio, 0.33; 95% CI, 0.19 to 0.56) than were subjects without living wills. Subjects who had assigned a durable power of attorney for health care were less likely to die in a hospital (adjusted odds ratio, 0.72; 95% CI, 0.55 to 0.93) or receive all care possible (adjusted odds ratio, 0.54; 95% CI, 0.34 to 0.86) than were subjects who had not assigned a durable power of attorney for health care. Conclusions: Between 2000 and 2006, many elderly Americans needed decision making near the end of life at a time when most lacked the capacity to make decisions. Patients who had prepared advance directives received care that was strongly associated with their preferences. These findings support the continued use of advance directives. N Engl J Med 2010;362:1211-8.	[Silveira, Maria J.; Langa, Kenneth M.] Univ Michigan, Vet Affairs Ctr Clin Management Res, Ann Arbor, MI 48109 USA; [Silveira, Maria J.; Langa, Kenneth M.] Univ Michigan, Div Gen Med, Ann Arbor, MI 48109 USA; [Silveira, Maria J.; Kim, Scott Y. H.] Univ Michigan, Bioeth Program, Ann Arbor, MI 48109 USA; [Langa, Kenneth M.] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Kim, Scott Y. H.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Kim, Scott Y. H.] Univ Michigan, Ctr Behav & Decis Sci Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Silveira, MJ (corresponding author), 300 N Ingalls Bldg,Rm 7C27,Box 5429, Ann Arbor, MI 48901 USA.	mariajs@umich.edu		Silveira, Maria/0000-0002-6600-8633; Langa, Kenneth/0000-0002-2798-1836	Ann Arbor Veterans Affairs Center for Clinical Management Research; Division of General Medicine at the University of Michigan; National Institute on Aging [R01 AG027010, U01 AG09740]; Greenwall Faculty Scholarship in Bioethics; NATIONAL INSTITUTE ON AGING [U01AG009740, R01AG027010] Funding Source: NIH RePORTER	Ann Arbor Veterans Affairs Center for Clinical Management Research; Division of General Medicine at the University of Michigan; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Greenwall Faculty Scholarship in Bioethics; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by core funds from the Ann Arbor Veterans Affairs Center for Clinical Management Research and the Division of General Medicine at the University of Michigan (to Dr. Silveira); a grant (R01 AG027010) from the National Institute on Aging and a Paul Beeson Physician Faculty Scholars in Aging Research award (to Dr. Langa); a grant (U01 AG09740) from the National Institute on Aging for the Health and Retirement Study, which was performed at the Survey Research Center, Institute for Social Research, University of Michigan; and a Greenwall Faculty Scholarship in Bioethics (to Dr. Kim).	Brown Barbara A, 2003, J Gerontol Nurs, V29, P4; DANIS M, 1991, NEW ENGL J MED, V324, P882, DOI 10.1056/NEJM199103283241304; Degenholtz HB, 2004, ANN INTERN MED, V141, P113, DOI 10.7326/0003-4819-141-2-200407200-00009; EDINGER W, 1992, J FAM PRACTICE, V35, P650; Fagerlin A, 2004, HASTINGS CENT REP, V34, P30, DOI 10.2307/3527683; Goodman MD, 1998, CRIT CARE MED, V26, P701, DOI 10.1097/00003246-199804000-00018; Juster FT, 1995, J HUM RESOUR, V30, pS7, DOI 10.2307/146277; LO B, 1985, ARCH INTERN MED, V145, P1115, DOI 10.1001/archinte.145.6.1115; O'Brien M, 2009, HILL            0813; SCHNEIDERMAN LJ, 1992, ANN INTERN MED, V117, P599, DOI 10.7326/0003-4819-117-7-599; SEHGAL A, 1992, JAMA-J AM MED ASSOC, V267, P59, DOI 10.1001/jama.267.1.59; SMEDIRA NG, 1990, NEW ENGL J MED, V322, P309, DOI 10.1056/NEJM199002013220506; Smucker W D, 1993, J Am Board Fam Pract, V6, P473; Soldo BJ, 1997, J GERONTOL B-PSYCHOL, V52, P1, DOI 10.1093/geronb/52B.Special_Issue.1; Steinhauser KE, 2001, J PAIN SYMPTOM MANAG, V22, P727, DOI 10.1016/S0885-3924(01)00334-7; TENO JM, 1994, J CLIN ETHIC, V5, P23; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Teno JM, 2007, J AM GERIATR SOC, V55, P189, DOI 10.1111/j.1532-5415.2007.01045.x	18	841	859	3	84	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 1	2010	362	13					1211	1218		10.1056/NEJMsa0907901	http://dx.doi.org/10.1056/NEJMsa0907901			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	577QQ	20357283	Green Accepted			2022-12-28	WOS:000276239500011
J	Garattini, S; Bertele, V				Garattini, Silvio; Bertele, Vittorio			Europe's opportunity to open up drug regulation	BRITISH MEDICAL JOURNAL			English	Editorial Material							METAANALYSIS		[Garattini, Silvio; Bertele, Vittorio] Mario Negri Inst Pharmacol Res, I-20156 Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Garattini, S (corresponding author), Mario Negri Inst Pharmacol Res, Via Giuseppe La Masa 19, I-20156 Milan, Italy.	silvio.garattini@marionegri.it	Garattini, Silvio/AAA-6390-2020; Bertele, Vittorio/AAA-6461-2020	Garattini, Silvio/0000-0003-0647-9297; Bertele, Vittorio/0000-0002-0032-7033				Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; *EUR MED AG, DRAFT BUDG 2010; Garattini S, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1025; Godlee F, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5405; Godlee F, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5351; Juni P, 2004, LANCET, V364, P2021, DOI 10.1016/S0140-6736(04)17514-4; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; OREILLY JT, 1998, INT DRUG APPROVAL SY, V53, P123; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; *US FDA, PERF BUDG OV; VITRY A, 2009, RAJ PHARM        MAR, P1	12	7	7	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 30	2010	340								c1578	10.1136/bmj.c1578	http://dx.doi.org/10.1136/bmj.c1578			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579VJ	20354022				2022-12-28	WOS:000276404100006
J	Carlsbecker, A; Lee, JY; Roberts, CJ; Dettmer, J; Lehesranta, S; Zhou, J; Lindgren, O; Moreno-Risueno, MA; Vaten, A; Thitamadee, S; Campilho, A; Sebastian, J; Bowman, JL; Helariutta, Y; Benfey, PN				Carlsbecker, Annelie; Lee, Ji-Young; Roberts, Christina J.; Dettmer, Jan; Lehesranta, Satu; Zhou, Jing; Lindgren, Ove; Moreno-Risueno, Miguel A.; Vaten, Anne; Thitamadee, Siripong; Campilho, Ana; Sebastian, Jose; Bowman, John L.; Helariutta, Yka; Benfey, Philip N.			Cell signalling by microRNA165/6 directs gene dose-dependent root cell fate	NATURE			English	Article							BINDING-PROTEIN HYL1; CLASS IIIHD-ZIP; ARABIDOPSIS ROOT; TRANSCRIPTION FACTOR; INTERCELLULAR MOVEMENT; VASCULAR DEVELOPMENT; APICAL MERISTEM; KANADI GENES; EXPRESSION; PLANTS	A key question in developmental biology is how cells exchange positional information for proper patterning during organ development. In plant roots the radial tissue organization is highly conserved with a central vascular cylinder in which two water conducting cell types, protoxylem and metaxylem, are patterned centripetally. We show that this patterning occurs through crosstalk between the vascular cylinder and the surrounding endodermis mediated by cell-to-cell movement of a transcription factor in one direction and microRNAs in the other. SHORT ROOT, produced in the vascular cylinder, moves into the endodermis to activate SCARECROW. Together these transcription factors activate MIR165a and MIR166b. Endodermally produced microRNA165/6 then acts to degrade its target mRNAs encoding class III homeodomain-leucine zipper transcription factors in the endodermis and stele periphery. The resulting differential distribution of target mRNA in the vascular cylinder determines xylem cell types in a dosage-dependent manner.	[Carlsbecker, Annelie; Dettmer, Jan; Lehesranta, Satu; Lindgren, Ove; Vaten, Anne; Thitamadee, Siripong; Campilho, Ana; Helariutta, Yka] Univ Helsinki, Inst Biotechnol, Dept Biosci, FIN-00014 Helsinki, Finland; [Carlsbecker, Annelie; Roberts, Christina J.] Uppsala Univ, Evolutionary Biol Ctr, Dept Physiol Bot, SE-75236 Uppsala, Sweden; [Lee, Ji-Young; Zhou, Jing; Sebastian, Jose] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Lee, Ji-Young; Zhou, Jing] Cornell Univ, Grad Field Plant Biol, Ithaca, NY 14853 USA; [Lindgren, Ove] Univ Tartu, Inst Technol, EE-50411 Tartu, Estonia; [Moreno-Risueno, Miguel A.; Benfey, Philip N.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Moreno-Risueno, Miguel A.; Benfey, Philip N.] Duke Univ, IGSP Ctr Syst Biol, Durham, NC 27708 USA; [Bowman, John L.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3800, Australia	University of Helsinki; Uppsala University; Cornell University; Boyce Thompson Institute for Plant Research; Cornell University; University of Tartu; Duke University; Duke University; Monash University	Helariutta, Y (corresponding author), Univ Helsinki, Inst Biotechnol, Dept Biosci, FIN-00014 Helsinki, Finland.	yrjo.helariutta@helsinki.fi; philip.benfey@duke.edu	Campilho, Ana/U-8263-2019; Lee, Ji-Young/E-2196-2012; Helariutta, Yrjo/AAE-8149-2020; Campilho, Ana/H-8790-2013; Lee, Ji-Young/F-7455-2013; MORENO-RISUENO, MIGUEL ANGEL/J-8832-2016; Mueller, Christina Joy/Y-1210-2019	Campilho, Ana/0000-0002-3470-1943; Helariutta, Yrjo/0000-0002-7287-8459; Campilho, Ana/0000-0002-3470-1943; MORENO-RISUENO, MIGUEL ANGEL/0000-0002-9794-1450; Mueller, Christina Joy/0000-0002-8116-0705; Bowman, John/0000-0001-7347-3691; Carlsbecker, Annelie/0000-0002-8450-3718; Lee, Ji-Young/0000-0002-7631-5127; Vaten, Anne/0000-0003-1788-5127	Boyce Thompson Institute; NSF [IOS0818071, NSF DBI-0618969]; Cornell Presidential Life Science Fellowship; NIH [RO1-GM043778]; MICINN, Spanish Government; Academy of Finland; Tekes; ESF; European Molecular Biology Organisation (EMBO) [ALTF 450-2007]; Estonian funding agencies [ETF7361, SF0180071s07]; Nilsson-Ehle Foundation; FORMAS; Carl Trygger's Foundation for Scientific Research; Triad Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043778] Funding Source: NIH RePORTER	Boyce Thompson Institute; NSF(National Science Foundation (NSF)); Cornell Presidential Life Science Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MICINN, Spanish Government(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Academy of Finland(Academy of Finland); Tekes(Finnish Funding Agency for Technology & Innovation (TEKES)); ESF(European Commission); European Molecular Biology Organisation (EMBO)(European Molecular Biology Organization (EMBO)); Estonian funding agencies; Nilsson-Ehle Foundation; FORMAS(Swedish Research Council Formas); Carl Trygger's Foundation for Scientific Research; Triad Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Kainulainen, M. Herpola, G.-B. Berglund and J. Jung for technical assistance; M. Prigge, S. Clark, C. Bellini, N. Sauer, J. Colinas, T. Vernoux, K. Gallagher, A. P. Mahonen, A. Bishopp, M. Bonke, N. Fedoroff, J. C. Fletcher, B. J. Reinhart, I. Pekker, ABRC and NASC for materials, and E. Richards and M. Harrison for comments on the manuscript; M. Tsiantis for sharing results before publication. This work was supported by the Boyce Thompson Institute and NSF IOS0818071 to J.-Y.L., Cornell Presidential Life Science Fellowship to J.Z., grants from the NIH (RO1-GM043778) and from the NSF ARABIDOPSIS 2010 programme to P. N. B., a fellowship from the MICINN, Spanish Government to M.A.M.-R., grants by the Academy of Finland, Tekes and ESF to Y.H., S. L. and A. V., European Molecular Biology Organisation (EMBO, ALTF 450-2007) to J. D., Estonian funding agencies (ETF7361 and SF0180071s07) to O.L., Nilsson-Ehle Foundation to C. J. R, and FORMAS and Carl Trygger's Foundation for Scientific Research to A. C. Imaging at Boyce Thompson Institute was supported by NSF (NSF DBI-0618969) and Triad Foundation.	Baima S, 2001, PLANT PHYSIOL, V126, P643, DOI 10.1104/pp.126.2.643; Boyce C. Kevin, 2005, P479; Chitwood DH, 2009, GENE DEV, V23, P549, DOI 10.1101/gad.1770009; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cui HC, 2007, SCIENCE, V316, P421, DOI 10.1126/science.1139531; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Du TG, 2007, SEMIN CELL DEV BIOL, V18, P171, DOI 10.1016/j.semcdb.2007.01.010; Dunoyer P, 2007, NAT GENET, V39, P848, DOI 10.1038/ng2081; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Esau K., 1977, ANATOMY SEED PLANTS; Floyd SK, 2007, INT J PLANT SCI, V168, P1, DOI 10.1086/509079; Floyd SK, 2004, NATURE, V428, P485, DOI 10.1038/428485a; Gallagher KL, 2009, PLANT J, V57, P785, DOI 10.1111/j.1365-313X.2008.03735.x; Gallagher KL, 2004, CURR BIOL, V14, P1847, DOI 10.1016/j.cub.2004.09.081; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; Hawker NP, 2004, PLANT PHYSIOL, V135, P2261, DOI 10.1104/pp.104.040196; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; Juarez MT, 2004, NATURE, V428, P84, DOI 10.1038/nature02363; Jung JH, 2007, PLANTA, V225, P1327, DOI 10.1007/s00425-006-0439-1; Lee JY, 2006, P NATL ACAD SCI USA, V103, P6055, DOI 10.1073/pnas.0510607103; Levesque MP, 2006, PLOS BIOL, V4, P739, DOI 10.1371/journal.pbio.0040143; Levine E, 2007, PLOS COMPUT BIOL, V3, P2356, DOI 10.1371/journal.pcbi.0030233; Lin SI, 2008, PLANT PHYSIOL, V147, P732, DOI 10.1104/pp.108.116269; Mahonen AP, 2000, GENE DEV, V14, P2938, DOI 10.1101/gad.189200; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Muniz L, 2008, DEVELOPMENT, V135, P2573, DOI 10.1242/dev.019349; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Nogueira FTS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000320; Ohashi-Ito K, 2005, PLANT CELL PHYSIOL, V46, P1646, DOI 10.1093/pcp/pci180; Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804; Prigge MJ, 2005, PLANT CELL, V17, P61, DOI 10.1105/tpc.104.026161; Pryer KM, 2004, ASSEMBLING THE TREE OF LIFE, P138; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Tretter EM, 2008, PLANT PHYSIOL, V147, P58, DOI 10.1104/pp.108.117119; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Zhou GK, 2007, PLANT CELL PHYSIOL, V48, P391, DOI 10.1093/pcp/pcm008	40	589	635	7	168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 20	2010	465	7296					316	321		10.1038/nature08977	http://dx.doi.org/10.1038/nature08977			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598IO	20410882	Green Accepted			2022-12-28	WOS:000277829200033
J	Craven, L; Tuppen, HA; Greggains, GD; Harbottle, SJ; Murphy, JL; Cree, LM; Murdoch, AP; Chinnery, PF; Taylor, RW; Lightowlers, RN; Herbert, M; Turnbull, DM				Craven, Lyndsey; Tuppen, Helen A.; Greggains, Gareth D.; Harbottle, Stephen J.; Murphy, Julie L.; Cree, Lynsey M.; Murdoch, Alison P.; Chinnery, Patrick F.; Taylor, Robert W.; Lightowlers, Robert N.; Herbert, Mary; Turnbull, Douglass M.			Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease	NATURE			English	Article							REAL-TIME PCR; 1555A-GREATER-THAN-G MUTATION; PREVALENCE; MOUSE; MTDNA; QUANTIFICATION; SEGREGATION; DISORDERS; DELETIONS; INSIGHTS	Mutations in mitochondrial DNA ( mtDNA) are a common cause of genetic disease. Pathogenic mutations in mtDNA are detected in approximately 1 in 250 live births(1-3) and at least 1 in 10,000 adults in the UK are affected by mtDNA disease(4). Treatment options for patients with mtDNA disease are extremely limited and are predominantly supportive in nature. Mitochondrial DNA is transmitted maternally and it has been proposed that nuclear transfer techniques may be an approach for the prevention of transmission of human mtDNA disease(5,6). Here we show that transfer of pronuclei between abnormally fertilized human zygotes results in minimal carry-over of donor zygote mtDNA and is compatible with onward development to the blastocyst stage in vitro. By optimizing the procedure we found the average level of carry-over after transfer of two pronuclei is less than 2.0%, with many of the embryos containing no detectable donor mtDNA. We believe that pronuclear transfer between zygotes, as well as the recently described metaphase II spindle transfer, has the potential to prevent the transmission of mtDNA disease in humans.	[Greggains, Gareth D.; Harbottle, Stephen J.; Murdoch, Alison P.; Herbert, Mary] Newcastle Univ, Int Ctr Life, Newcastle Fertil Ctr, Newcastle Upon Tyne NE1 4EP, Tyne & Wear, England; [Craven, Lyndsey; Tuppen, Helen A.; Murphy, Julie L.; Cree, Lynsey M.; Chinnery, Patrick F.; Taylor, Robert W.; Lightowlers, Robert N.; Turnbull, Douglass M.] Newcastle Univ, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Turnbull, Douglass M.] Newcastle Univ, Ctr Brain Ageing & Vital, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Murdoch, Alison P.; Herbert, Mary; Turnbull, Douglass M.] Newcastle Univ, Int Ctr Life, Biosci Ctr, NE England Stem Cell Inst NESCI, Newcastle Upon Tyne NE1 4EP, Tyne & Wear, England; [Greggains, Gareth D.; Herbert, Mary] Newcastle Univ, Int Ctr Life, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 4EP, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Herbert, M (corresponding author), Newcastle Univ, Int Ctr Life, Newcastle Fertil Ctr, Newcastle Upon Tyne NE1 4EP, Tyne & Wear, England.	mary.herbert@ncl.ac.uk; d.m.turnbull@ncl.ac.uk		Cree, Lynsey/0000-0003-2090-1589; Greggains, Gareth/0000-0003-2424-4694; Chinnery, Patrick/0000-0002-7065-6617; Turnbull, Doug/0000-0002-8878-9901; Herbert, Mary/0000-0002-8488-2770; Tuppen, Helen/0000-0001-8762-0824	Muscular Dystrophy Campaign; Wellcome Trust [074454/Z/04/Z]; Medical Research Council [G0601157, G0601943, G0700718]; UK National Institute for Health Research Biomedical Research Centre for Ageing and Age-related Disease; Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; Economic and Social Research Council; Medical Research Council [G0800674, G0601943B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10011] Funding Source: researchfish; MRC [G0800674, G0700718, G0601943, G0601157] Funding Source: UKRI	Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK National Institute for Health Research Biomedical Research Centre for Ageing and Age-related Disease; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Nesbitt, L. Burgess and S. Byerley for help with embryo donation and collection, and V. Wilson and S. Abbs for help with the nuclear genotyping. We thank the patients and staff at Newcastle Fertility Centre, and J. Lawford-Davies, K. Stern, Sir John Burn and Lord Walton of Detchant for helping us to obtain a Human Fertilisation and Embryology Authority research licence and guidance with the legislation. This work was funded by the Muscular Dystrophy Campaign, the Wellcome Trust (074454/Z/04/Z), the Medical Research Council (G0601157, G0601943), One North East, the UK National Institute for Health Research Biomedical Research Centre for Ageing and Age-related Disease and the Newcastle University Centre for Brain Ageing and Vitality supported by the Biotechnology and Biological Sciences Research Council, the Engineering and Physical Sciences Research Council, the Economic and Social Research Council and the Medical Research Council (G0700718). P. F. C. is a Wellcome Trust Senior Fellow in Clinical Science.	Almeida PA, 1995, ZYGOTE, V3, P357, DOI 10.1017/S0967199400002793; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Barritt J A, 2002, Reprod Biomed Online, V4, P243; Battaglia DE, 1996, HUM REPROD, V11, P2217; Bitner-Glindzicz M, 2009, NEW ENGL J MED, V360, P640, DOI 10.1056/NEJMc0806396; Brown DT, 2006, LANCET, V368, P87, DOI 10.1016/S0140-6736(06)68972-1; Chinnery P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub2; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004; Feenan Katie, 2006, Hum Fertil (Camb), V9, P157, DOI 10.1080/14647270600636269; He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067; Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024; Lin DPC, 2004, FERTIL STERIL, V81, P73, DOI 10.1016/j.fertnstert.2003.05.005; Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015; McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004; McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819; Meirelles FV, 1997, GENETICS, V145, P445; PIKO L, 1987, DEV BIOL, V123, P364, DOI 10.1016/0012-1606(87)90395-2; Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930; REIK W, 1993, DEVELOPMENT, V119, P933; Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102; Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217; Steffann J, 2006, J MED GENET, V43, P244, DOI 10.1136/jmg.2005.032326; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; Tajima H, 2007, J ASSIST REPROD GEN, V24, P227, DOI 10.1007/s10815-007-9114-0; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Taylor RW, 2003, J AM COLL CARDIOL, V41, P1786, DOI 10.1016/S0735-1097(03)00300-0; Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74; Vandebona H, 2009, NEW ENGL J MED, V360, P642, DOI 10.1056/NEJMc0806397; Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955	30	312	327	0	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 6	2010	465	7294					82	U89		10.1038/nature08958	http://dx.doi.org/10.1038/nature08958			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591OW	20393463	Green Accepted			2022-12-28	WOS:000277311900035
J	Snow, CE				Snow, Catherine E.			Academic Language and the Challenge of Reading for Learning About Science	SCIENCE			English	Editorial Material								A major challenge to students learning science is the academic language in which science is written. Academic language is designed to be concise, precise, and authoritative. To achieve these goals, it uses sophisticated words and complex grammatical constructions that can disrupt reading comprehension and block learning. Students need help in learning academic vocabulary and how to process academic language if they are to become independent learners of science.	Harvard Univ, Harvard Grad Sch Educ, Cambridge, MA 02138 USA	Harvard University	Snow, CE (corresponding author), Harvard Univ, Harvard Grad Sch Educ, Cambridge, MA 02138 USA.			Snow, Catherine E./0000-0002-6292-1126				[Anonymous], 2001, LINGUIST EDUC, DOI DOI 10.1016/S0898-5898(01)00073-0; [Anonymous], 2007, LANGUAGE DEMANDS SCH; Carnegie Council on Advancing Adolescent Literacy, 2010, TIM ACT AG ADV AD LI; Coxhead A, 2000, TESOL QUART, V34, P213, DOI 10.2307/3587951; Fang ZH, 2006, INT J SCI EDUC, V28, P491, DOI 10.1080/09500690500339092; Halliday M. A. K., 1993, WRITING SCI LITERACY; HALLIDAY MAK, 1993, ANN INT LANG ED C HO; Johnson JC, 2005, SCI SCOPE, V28, P12; Lawrence J. F., 2010, HDB READING RES, V4; Lawrence JF, 2009, READ PSYCHOL, V30, P445, DOI 10.1080/02702710802412008; Moje EB, 2008, HARVARD EDUC REV, V78, P107; MURPHY PK, 2009, J EDUC PSYCHOL, V62, P387; Osborne J, 2010, SCIENCE, V328, P463, DOI 10.1126/science.1183944; Scarcella R., 2003, ACAD ENGLISH CONCEPT; Snow C. E., 2009, J RES EDUC EFF, V2, P325, DOI [10.1080/19345740903167042, DOI 10.1080/19345740903167042]; Snow CE, 2009, CAMBRIDGE HDB LITERA, P112, DOI DOI 10.1017/CBO9780511609664.008	16	271	277	2	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2010	328	5977					450	452		10.1126/science.1182597	http://dx.doi.org/10.1126/science.1182597			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	586YR	20413488				2022-12-28	WOS:000276952400028
J	Kalwij, S; Macintosh, M; Baraitser, P				Kalwij, Sebastian; Macintosh, Mary; Baraitser, Paula			Screening and treatment of Chlamydia trachomatis infections	BRITISH MEDICAL JOURNAL			English	Review							PELVIC-INFLAMMATORY-DISEASE; SEXUALLY-TRANSMITTED INFECTIONS; GENITOURINARY MEDICINE CLINICS; COST-EFFECTIVENESS; PARTNER NOTIFICATION; GENERAL-PRACTICE; WOMEN; PREVALENCE; COHORT; MEN		[Kalwij, Sebastian] Waldron Teaching Practice, London SE8 4BG, England; [Kalwij, Sebastian; Macintosh, Mary; Baraitser, Paula] Hlth Protect Agcy, Ctr Infect Dis, Natl Chlamydia Screening Programme, London NW9 5EQ, England	Health Protection Agency	Kalwij, S (corresponding author), Waldron Teaching Practice, London SE8 4BG, England.	sebastiankalwij@mac.com		Baraitser, Paula/0000-0002-3354-6494				Adams EJ, 2004, SEX TRANSM INFECT, V80, P354, DOI 10.1136/sti.2003.005454; Adams EJ, 2007, SEX TRANSM INFECT, V83, DOI 10.1136/sti.2006.024364; Andersen B, 2005, SEX TRANSM DIS, V32, P377, DOI 10.1097/01.olq.0000154512.86651.07; Apoola A, 2006, SEX TRANSM INFECT, V82, P327, DOI 10.1136/sti.2005.018119; Bakken IJ, 2007, SEX TRANSM DIS, V34, P739, DOI 10.1097/01.olq.0000261326.65503.f6; *CDCP, CHLAM SCREEN FACTSH; European Centre for Disease Prevention and Control, 2009, CHLAM CONTR EUR; Gift TL, 2008, SEX TRANSM DIS, V35, pS66, DOI 10.1097/OLQ.0b013e31818b64ac; Heritage Joanne, 2008, Reprod Health, V5, P11, DOI 10.1186/1742-4755-5-11; LaMontagne DS, 2007, SEX TRANSM INFECT, V83, DOI 10.1136/sti.2006.022053; Land JA, 2010, HUM REPROD UPDATE, V16, P189, DOI 10.1093/humupd/dmp035; Low N, 2006, SEX TRANSM INFECT, V82, P212, DOI 10.1136/sti.2005.017186; Low N, 2004, SEX TRANSM INFECT, V80, P223, DOI 10.1136/sti.2003.005165; LOW N, 2006, RAPID REV EVIDENCE E; LOW N, 2008, EUROSURVEILLANCE, V13, P28; Marrazzo JM, 2007, SEX TRANSM DIS, V34, P147, DOI 10.1097/01.olq.0000230438.12636.eb; Molano M, 2005, J INFECT DIS, V191, P907, DOI 10.1086/428287; National Institute for Health and Clinical Excellence, 2008, CG62 NAT I HLTH CLIN; Oakeshott P., 2010, BRIT MED J, V340, pc1642, DOI [10.1136/bmj.c1642, DOI 10.1136/BMJ.C1642]; Ostergaard L, 2000, CLIN INFECT DIS, V31, P951, DOI 10.1086/318139; Owens SL, 2010, SEX TRANSM INFECT, V86, P112, DOI 10.1136/sti.2009.037226; Pavlin NL, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-62; Risser WL, 2007, INT J STD AIDS, V18, P727, DOI 10.1258/095646207782212351; Satterwhite CL, 2010, SEX TRANSM DIS, V37, P63, DOI 10.1097/OLQ.0b013e3181bc097a; Scholes D, 1996, NEW ENGL J MED, V334, P1362, DOI 10.1056/NEJM199605233342103; Tobin JM, 2004, INT J STD AIDS, V15, P737, DOI 10.1258/0956462042395096; Trelle S, 2007, BMJ-BRIT MED J, V334, P354, DOI 10.1136/bmj.39079.460741.7C; van Bergen JEAM, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-42; van Valkengoed IGM, 2004, INT J EPIDEMIOL, V33, P416, DOI 10.1093/ije/dyh029; Watson EJ, 2002, J MED MICROBIOL, V51, P1021, DOI 10.1099/0022-1317-51-12-1021	30	28	28	1	16	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 21	2010	340								c1915	10.1136/bmj.c1915	http://dx.doi.org/10.1136/bmj.c1915			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589HN	20410164				2022-12-28	WOS:000277137900002
J	Sridhar, D; Woods, N				Sridhar, Devi; Woods, Ngaire			Are there simple conclusions on how to channel health funding?	LANCET			English	Editorial Material									[Sridhar, Devi] Univ Oxford All Souls Coll, Oxford OX1 4AL, England; [Woods, Ngaire] Univ Oxford, Univ Coll, Oxford, England	University of Oxford; University of Oxford	Sridhar, D (corresponding author), Univ Oxford All Souls Coll, Oxford OX1 4AL, England.	devi.sridhar@politics.ox.ac.uk						COLLIER P, 2010, FOREIGN POLICY  0218; DERENZIO P, 2007, AID EFFECTIVENESS AB; Global Economic Governance Programme, 2008, SETT DEV COUNTR AG G; Levine Ruth, 2004, MILLIONS SAVED PROVE; Lu CL, 2010, LANCET, V375, P1375, DOI 10.1016/S0140-6736(10)60233-4; Mccoy D, 2009, HEALTH POLICY PLANN, V24, P407, DOI 10.1093/heapol/czp026; OECD, 2009, MAN AID PRACT DAC ME; OECD, 2009, MAN DEV RES US COUNT; OECD (Organisation for Economic Co-operation and Development), 2005, PAR DECL AID EFF ACC; OOMS G, 2010, LANCET; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; ROBERTSON G, 2010, TIMESONLINE     0302; SRIDHAR D, 2009, COMP ASSESSMENT HLTH	13	16	16	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 17	2010	375	9723					1326	1328		10.1016/S0140-6736(10)60486-2	http://dx.doi.org/10.1016/S0140-6736(10)60486-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	588GW	20381855				2022-12-28	WOS:000277057800007
J	Rosen, R				Rosen, Rebecca			Can the NHS cut costs without substantially damaging the quality of health care? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material									Nuffield Trust, London W1G 7LP, England		Rosen, R (corresponding author), Nuffield Trust, London W1G 7LP, England.	rebecca.rosen@nuffieldtrust.org.uk						CRUMP B, 2009, IMPROVING PRODUCTIVI; Ham C., 2010, WORKING TOGETHER HLT; *NHS, NHS BETT CAR BETT VA; Shih A, 2008, ORGANIZING US HLTH C	4	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 14	2010	340								c1967	10.1136/bmj.c1967	http://dx.doi.org/10.1136/bmj.c1967			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	586KB	20392774				2022-12-28	WOS:000276905400010
J	Zewail, AH				Zewail, Ahmed H.			Four-Dimensional Electron Microscopy	SCIENCE			English	Review							TRANSIENT STRUCTURES; 4D VISUALIZATION; DIFFRACTION; CRYSTALLOGRAPHY; NANOSCALE; FLUORESCENCE; TRANSITIONS	The discovery of the electron over a century ago and the realization of its dual character have given birth to one of the two most powerful imaging instruments: the electron microscope. The electron microscope's ability to resolve three-dimensional (3D) structures on the atomic scale is continuing to affect different fields, including materials science and biology. In this Review, we highlight recent developments and inventions made by introducing the fourth dimension of time in electron microscopy. Today, ultrafast electron microscopy (4D UEM) enables a resolution that is 10 orders of magnitude better than that of conventional microscopes, which are limited by the video-camera rate of recording. After presenting the central concept involved, that of single-electron stroboscopic imaging, we discuss prototypical applications, which include the visualization of complex structures when unfolding on different length and time scales. The developed UEM variant techniques are several, and here we illucidate convergent-beam and near-field imaging, as well as tomography and scanning-pulse microscopy. We conclude with current explorations in imaging of nanomaterials and biostructures and an outlook on possible future directions in space-time, 4D electron microscopy.	CALTECH, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA	California Institute of Technology	Zewail, AH (corresponding author), CALTECH, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA.	zewail@caltech.edu		gaber, sarah/0000-0002-5995-7291	NSF; Gordon and Betty Moore Foundation	NSF(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	In the course of developments at the Center for Ultrafast Science and Technology (UST), I have enjoyed the scholarly discussions with and enthusiasm of J. M. Thomas of Cambridge University, the fruit of which resulted in his overview articles (40, 51-54) and our joint monograph (12) on 4D EM. The dedication and hard work of members of the UST Center made possible the story told here. I particularly wish to acknowledge the effort of D. Shorokhov in helpful discussion and in manuscript preparation. This research was carried out with support from NSF and the Air Force Office of Scientific Research in the Physical Biology Center for UST supported at Caltech by the Gordon and Betty Moore Foundation.	Barwick B, 2008, SCIENCE, V322, P1227, DOI 10.1126/science.1164000; Barwick B, 2009, NATURE, V462, P902, DOI 10.1038/nature08662; Baum P, 2007, SCIENCE, V318, P788, DOI 10.1126/science.1147724; Baum P, 2009, CHEM PHYS, V366, P2, DOI 10.1016/j.chemphys.2009.07.013; Bostanjoglo O, 2002, ADV IMAG ELECT PHYS, V121, P1; Carbone F, 2009, SCIENCE, V325, P181, DOI 10.1126/science.1175005; Chen S, 2006, ANGEW CHEM INT EDIT, V45, P5154, DOI 10.1002/anie.200601778; Davisson C, 1927, PHYS REV, V30, P705, DOI 10.1103/PhysRev.30.705; de Jonge N, 2009, P NATL ACAD SCI USA, V106, P2159, DOI 10.1073/pnas.0809567106; Domer H, 2003, APPL SURF SCI, V208, P442, DOI 10.1016/S0169-4332(02)01430-7; Flannigan DJ, 2009, NANO LETT, V9, P875, DOI 10.1021/nl803770e; Folger T, 2009, SCIENCE, V324, P1512, DOI 10.1126/science.324_1512; Gahlmann A, 2008, PHYS CHEM CHEM PHYS, V10, P2894, DOI 10.1039/b802136h; GAI PL, 2003, ELECT MICROSCOPY HET; Gedik N, 2007, SCIENCE, V316, P425, DOI 10.1126/science.1138834; Harris KDM, 2005, CRYST GROWTH DES, V5, P2124, DOI 10.1021/cg050367l; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Hooke R., 1665, MICROGRAPHIA; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Ihee H, 2001, SCIENCE, V291, P458, DOI 10.1126/science.291.5503.458; Ishioka K, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.121402; de Abajo FJG, 2009, NATURE, V462, P861, DOI 10.1038/462861a; Kanasaki J, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.087402; Kim JS, 2008, SCIENCE, V321, P1472, DOI 10.1126/science.1161517; Kleinschmidt H, 2005, J APPL PHYS, V98, DOI 10.1063/1.2035899; Knoll M, 1932, Z PHYS, V78, P318, DOI 10.1007/BF01342199; Krausz F, 2009, REV MOD PHYS, V81, P163, DOI 10.1103/RevModPhys.81.163; Kwon OH, 2008, NANO LETT, V8, P3557, DOI 10.1021/nl8029866; Kwon OH, 2008, P NATL ACAD SCI USA, V105, P8519, DOI 10.1073/pnas.0803344105; LaGrange T, 2007, ACTA MATER, V55, P5211, DOI 10.1016/j.actamat.2007.05.043; Mark H, 1930, NATURWISSENSCHAFTEN, V18, P205, DOI 10.1007/BF01494849; Min W, 2009, NATURE, V461, P1105, DOI 10.1038/nature08438; Nikiforov MP, 2007, SCI MICROSCOPY, P929; Park H, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.100301; Park HS, 2009, ULTRAMICROSCOPY, V110, P7, DOI 10.1016/j.ultramic.2009.08.005; Park HS, 2009, NANO LETT, V9, P3954, DOI 10.1021/nl9032704; Raman RK, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.077401; Ruan CY, 2004, SCIENCE, V304, P80, DOI 10.1126/science.1094818; Shchelev MY, 2007, QUANTUM ELECTRON+, V37, P927, DOI [10.1070/qe2007v037n10abeh013665, DOI 10.1070/QE2007V037N10ABEH013665]; Shorokhov D, 2009, J AM CHEM SOC, V131, P17998, DOI 10.1021/ja907432p; Siwick BJ, 2003, SCIENCE, V302, P1382, DOI 10.1126/science.1090052; Srinivasan R, 2005, SCIENCE, V307, P558, DOI 10.1126/science.1107291; Srinivasan R, 2003, HELV CHIM ACTA, V86, P1763; Thomas JM, 2005, ANGEW CHEM INT EDIT, V44, P5563, DOI 10.1002/anie.200501466; Thomas JM, 2004, ANGEW CHEM INT EDIT, V43, P2606, DOI 10.1002/anie.200301746; THOMAS JM, 1991, NATURE, V351, P694; Thomas JM, 2009, ANGEW CHEM INT EDIT, V48, P8824, DOI 10.1002/anie.200904052; Thomson GP, 1927, NATURE, V119, P890, DOI 10.1038/119890a0; Yan HG, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.121403; Yang DS, 2008, SCIENCE, V321, P1660, DOI 10.1126/science.1162049; Yang DS, 2009, P NATL ACAD SCI USA, V106, P4122, DOI 10.1073/pnas.0812409106; Yurtsever A, 2009, SCIENCE, V326, P708, DOI 10.1126/science.1179314; Zewail A. H., 2010, 4D ELECT MICROSCOPY; Zewail A. H., 2006, U. S. patent, Patent No. [7,154,091 B2, 7154091]; ZEWAIL AH, 2000, PRIX NOBEL, P110; Zewail AH, 2006, ANNU REV PHYS CHEM, V57, P65, DOI 10.1146/annurev.physchem.57.032905.104748	56	507	522	16	488	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2010	328	5975					187	193		10.1126/science.1166135	http://dx.doi.org/10.1126/science.1166135			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580OU	20378810				2022-12-28	WOS:000276459600034
J	Chou, R; Shekelle, P				Chou, Roger; Shekelle, Paul			Will This Patient Develop Persistent Disabling Low Back Pain?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRIMARY-CARE; INCEPTION COHORT; PROGNOSTIC-FACTORS; CLINICAL-COURSE; SCREENING QUESTIONNAIRE; GENERAL-PRACTICE; WORK DISABILITY; PREDICTORS; RISK; FEAR	Context Low back pain is extremely common. Early identification of patients more likely to develop persistent disabling symptoms could help guide decisions regarding follow-up and management. Objective To systematically review the usefulness of individual risk factors or risk prediction instruments for identifying patients more likely to develop persistent disabling low back pain. Data Sources Electronic searches of MEDLINE (1966-January 2010) and EMBASE (1974-February 2010) and review of the bibliographies of retrieved articles. Study Selection Prospective studies of patients with fewer than 8 weeks of low back pain from which likelihood ratios (LRs) were calculated for prediction of persistent disabling low back pain for findings attainable during the clinical evaluation. Data Extraction Two authors independently assessed studies and extracted data to estimate LRs. Data Synthesis A total of 20 studies evaluating 10 842 patients were identified. Presence of nonorganic signs (median [range] LR, 3.0 [1.7-4.6]), high levels of maladaptive pain coping behaviors (median [range] LR, 2.5 [2.2-2.8]), high baseline functional impairment (median [range] LR, 2.1 [1.2-2.7]), presence of psychiatric comorbidities (median [range] LR, 2.2 [1.9-2.3]), and low general health status (median [range] LR, 1.8 [1.1-2.0]) were the most useful predictors of worse outcomes at 1 year. Low levels of fear avoidance (median [range] LR, 0.39 [0.38-0.40]) and low baseline functional impairment (median [range] LR, 0.40 [0.10-0.52]) were the most useful items for predicting recovery at 1 year. Results were similar for outcomes at 3 to 6 months. Variables related to the work environment, baseline pain, and presence of radiculopathy were less useful for predicting worse outcomes (median LRs approximately 1.5), and a history of prior low back pain episodes and demographic variables were not useful (median LRs approximately 1.0). Several risk prediction instruments were useful for predicting outcomes, but none were extensively validated, and some validation studies showed LRs similar to estimates for individual risk factors. Conclusion The most helpful components for predicting persistent disabling low back pain were maladaptive pain coping behaviors, nonorganic signs, functional impairment, general health status, and presence of psychiatric comorbidities. JAMA. 2010;303(13):1295-1302	[Chou, Roger] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97239 USA; [Chou, Roger] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97239 USA; [Shekelle, Paul] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA	Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Chou, R (corresponding author), Oregon Hlth & Sci Univ, Dept Med, 3181 SW Sam Jackson Pk Rd,MC BICC, Portland, OR 97239 USA.	chour@ohsu.edu		Chou, Roger/0000-0001-9889-8610				*AM AC FAM PHYS, FEAR AV BEL QUEST FA; [Anonymous], OSW DIS IND MAP RES; CATSBARIL WL, 1991, SPINE, V16, P605, DOI 10.1097/00007632-199106000-00001; Cherkin DC, 1996, SPINE, V21, P2900, DOI 10.1097/00007632-199612150-00023; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; COSTE J, 1994, BRIT MED J, V308, P577, DOI 10.1136/bmj.308.6928.577; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; DEYO RA, 1992, JAMA-J AM MED ASSOC, V268, P760, DOI 10.1001/jama.268.6.760; DEYO RA, 1988, J RHEUMATOL, V15, P1557; DEYO RA, 1988, J GEN INTERN MED, V3, P230, DOI 10.1007/BF02596337; Deyo RA, 2006, SPINE, V31, P2724, DOI 10.1097/01.brs.0000244618.06877.cd; Dionne CE, 2005, CAN MED ASSOC J, V172, P1559, DOI 10.1503/cmaj.1041159; Dionne CE, 2007, EUR SPINE J, V16, P641, DOI 10.1007/s00586-006-0180-2; Dixon AN, 1999, J OCCUP REHABIL, V9, P195, DOI 10.1023/A:1021353818130; Francis R S, 1976, J Can Assoc Radiol, V27, P92; FRYMOYER JW, 1991, ORTHOP CLIN N AM, V22, P263; Fulton-Kehoe D, 2008, J OCCUP ENVIRON MED, V50, P1042, DOI 10.1097/JOM.0b013e31817d361e; Grotle M, 2006, CLIN J PAIN, V22, P458, DOI 10.1097/01.ajp.0000208243.33498.cb; Grotle M, 2006, SPINE, V31, P1038, DOI 10.1097/01.brs.0000214878.01709.0e; Grotle M, 2005, SPINE, V30, P976, DOI 10.1097/01.brs.0000158972.34102.6f; HARTVIKSEN G, 1995, MED INFORM, V20, P19, DOI 10.3109/14639239509025341; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Hazard RG, 1997, SPINE, V22, P2951, DOI 10.1097/00007632-199712150-00019; Hazard RG, 1996, SPINE, V21, P945, DOI 10.1097/00007632-199604150-00008; Heneweer H, 2007, SPINE, V32, P586, DOI 10.1097/01.brs.0000256447.72623.56; Henschke N, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a171; Jarvik JG, 2002, ANN INTERN MED, V137, P586, DOI 10.7326/0003-4819-137-7-200210010-00010; KEEFE FJ, 1989, PAIN, V37, P51, DOI 10.1016/0304-3959(89)90152-8; KLENERMAN L, 1995, SPINE, V20, P478, DOI 10.1097/00007632-199502001-00012; Linton SJ, 1998, CLIN J PAIN, V14, P209, DOI 10.1097/00002508-199809000-00007; Linton SJ, 2000, SPINE, V25, P1148, DOI 10.1097/00007632-200005010-00017; Luo XM, 2004, SPINE, V29, P79, DOI 10.1097/01.BRS.0000105527.13866.0F; McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79; McIntosh G, 2000, SPINE, V25, P147, DOI 10.1097/00007632-200001150-00003; *NZ GUID GROUP, AC LOW BACK PAIN SCR; *NZ GUID GROUP, NZ AC LOW BACK PAIN; Pengel LHM, 2003, BMJ-BRIT MED J, V327, P323, DOI 10.1136/bmj.327.7410.323; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Poiraudeau S, 2006, RHEUMATOLOGY, V45, P718, DOI 10.1093/rheumatology/kei231; SACKETT DL, 1992, JAMA-J AM MED ASSOC, V267, P2638, DOI 10.1001/jama.267.19.2638; Schiottz-Christensen B, 1999, FAM PRACT, V16, P223, DOI 10.1093/fampra/16.3.223; SINGER J, 1987, CAN FAM PHYSICIAN, V33, P655; Swinkels-Meewisse IEJ, 2006, SPINE, V31, P658, DOI 10.1097/01.brs.0000203709.65384.9d; Thomas E, 1999, BRIT MED J, V318, P1662, DOI 10.1136/bmj.318.7199.1662; Truchon M, 2005, PAIN, V116, P205, DOI 10.1016/j.pain.2005.04.003; Turner JA, 2006, SPINE, V31, P682, DOI 10.1097/01.brs.0000202762.88787.af; Turner JA, 2008, SPINE, V33, P2809, DOI 10.1097/BRS.0b013e31817df7a7; van der Windt D, 2008, SPINE, V33, P81, DOI 10.1097/BRS.0b013e31815e39f9; vanTulder MW, 1997, SPINE, V22, P427, DOI 10.1097/00007632-199702150-00015; WADDELL G, 1980, SPINE, V5, P117, DOI 10.1097/00007632-198003000-00005; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; R MORRIS DISABILITY	52	410	418	2	47	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2010	303	13					1295	1302		10.1001/jama.2010.344	http://dx.doi.org/10.1001/jama.2010.344			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579FM	20371789				2022-12-28	WOS:000276353700030
J	Yeh, JM; Nekhlyudov, L; Goldie, SJ; Mertens, AC; Diller, L				Yeh, Jennifer M.; Nekhlyudov, Larissa; Goldie, Sue J.; Mertens, Ann C.; Diller, Lisa			A Model-Based Estimate of Cumulative Excess Mortality in Survivors of Childhood Cancer	ANNALS OF INTERNAL MEDICINE			English	Article							LONG-TERM SURVIVORS; 5-YEAR SURVIVORS; ADOLESCENT CANCER; DEATH; OUTCOMES; COHORT	Background: Although childhood cancer survival rates have dramatically increased, survivors face elevated risk for life-threatening late effects, including secondary cancer. Objective: To estimate the cumulative effect of disease-and treatment-related mortality risks on survivor life expectancy. Design: State-transition model to simulate the lifetime clinical course of childhood cancer survivors. Setting: Childhood Cancer Survivor Study. Patients: Five-year survivors of childhood cancer. Measurements: Probabilities of risk for death from the original cancer diagnosis, excess mortality from subsequent cancer and cardiac, pulmonary, external, and other complications, and background mortality (age-specific mortality rates for the general population) were estimated over the lifetime of survivors of childhood cancer. Results: For a cohort of 5-year survivors aged 15 years who received a diagnosis of cancer at age 10 years, the average lifetime probability was 0.10 for late-recurrence mortality; 0.15 for treatment-related subsequent cancer and death from cardiac, pulmonary, and external causes; and 0.05 for death from other excess risks. Life expectancy for the cohort of persons aged 15 years was 50.6 years, a loss of 10.4 years (17.1%) compared with the general population. Reduction in life expectancy varied by diagnosis, ranging from 4.0 years (6.0%) for kidney tumor survivors to more than 17.8 years (>= 28.0%) for brain and bone tumor survivors, and was sensitive to late-recurrence mortality risk and duration of excess mortality risk. Limitation: Estimates are based on data for survivors who received treatment 20 to 40 years ago; patients who received treatment more recently may have more favorable outcomes. Conclusion: Childhood cancer survivors face considerable mortality during adulthood, with excess risks reducing life expectancy by as much as 28%. Monitoring the health of current survivors and carefully evaluating therapies with known late toxicities in patients with newly diagnosed cancer are needed.	[Yeh, Jennifer M.] Harvard Univ, Sch Publ Hlth, Ctr Hlth Decis Sci, Med Sch,Harvard Pilgrim Hlth Care Inst, Boston, MA 02115 USA; Harvard Vanguard Med Associates, Dana Farber Canc Inst, Boston, MA USA; Childrens Hosp, Boston, MA 02115 USA; Emory Univ, Atlanta, GA 30322 USA	Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard Vanguard Medical Associates; Harvard University; Boston Children's Hospital; Emory University	Yeh, JM (corresponding author), Harvard Univ, Sch Publ Hlth, Ctr Hlth Decis Sci, Med Sch,Harvard Pilgrim Hlth Care Inst, 718 Huntington Ave,2nd Floor, Boston, MA 02115 USA.	jyeh@hsph.harvard.edu			National Cancer Institute [R25-CA057711]; NATIONAL CANCER INSTITUTE [R25CA057711, K07CA143044] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant Support: By the National Cancer Institute (R25-CA057711; Dr. Yeh).	Arias Elizabeth, 2007, Natl Vital Stat Rep, V56, P1; Cardous-Ubbink MC, 2004, PEDIATR BLOOD CANCER, V42, P563, DOI 10.1002/pbc.20028; *CDCP, 2009, SER CDCP, V20; *CHILDR ONC GROUP, 2006, LONG TERM FOLL UP GU; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; Green DM, 1999, J CLIN ONCOL, V17, P3207, DOI 10.1200/JCO.1999.17.10.3207; Inskip PD, 2007, INT J CANCER, V121, P2233, DOI 10.1002/ijc.22827; Kadan-Lottick NS, 2003, JAMA-J AM MED ASSOC, V290, P2008, DOI 10.1001/jama.290.15.2008; KIRCHER T, 1987, JAMA-J AM MED ASSOC, V258, P349, DOI 10.1001/jama.258.3.349; KUNTZ KM, 1995, MED DECIS MAKING, V15, P158, DOI 10.1177/0272989X9501500209; Lawless SCW, 2007, PEDIATR BLOOD CANCER, V48, P333, DOI 10.1002/pbc.20723; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; MacArthur AC, 2007, PEDIATR BLOOD CANCER, V48, P460, DOI 10.1002/pbc.20922; Mertens AC, 2001, J CLIN ONCOL, V19, P3163, DOI 10.1200/JCO.2001.19.13.3163; Mertens AC, 2008, JNCI-J NATL CANCER I, V100, P1368, DOI 10.1093/jnci/djn310; Moller TR, 2001, J CLIN ONCOL, V19, P3173; MULROONEY DA, 2009, BMJ-BRIT MED J, V339, DOI DOI 10.1136/BMJ.B4606; *NAT CANC I, 2008, SNAPSH PED CANC; Nathan PC, 2008, J CLIN ONCOL, V26, P4401, DOI 10.1200/JCO.2008.16.9607; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Park ER, 2005, J CLIN ONCOL, V23, P9187, DOI 10.1200/JCO.2005.01.7418; RIES LA, 1999, NIH PUBLICATION; Robison LL, 2002, MED PEDIATR ONCOL, V38, P229, DOI 10.1002/mpo.1316; Simone J.V., 2003, CHILDHOOD CANC SURVI; Simone JV, 2001, J CLIN ONCOL, V19, P3161, DOI 10.1200/JCO.2001.19.13.3161; SIRKEN MG, 1987, AM J PUBLIC HEALTH, V77, P137, DOI 10.2105/AJPH.77.2.137; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Twombly R, 2007, J NATL CANCER I, V99, P1574, DOI 10.1093/jnci/djm218; *US CANC STAT WORK, 2007, US CANC STAT 1999 20, V2008	29	63	63	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 6	2010	152	7					409	W138		10.7326/0003-4819-152-7-201004060-00005	http://dx.doi.org/10.7326/0003-4819-152-7-201004060-00005			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579QI	20368646	Green Accepted			2022-12-28	WOS:000276386900001
J	Cohen, TD				Cohen, Thomas D.			Fishing Antihypernuclei Out of a Quark-Gluon Soup	SCIENCE			English	Editorial Material									[Cohen, Thomas D.] Univ Maryland, Maryland Ctr Fundamental Phys, College Pk, MD 20742 USA; [Cohen, Thomas D.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Cohen, TD (corresponding author), Univ Maryland, Maryland Ctr Fundamental Phys, College Pk, MD 20742 USA.	cohen@umd.edu						Abelev BI, 2010, SCIENCE, V328, P58, DOI 10.1126/science.1183980; Ackermann KH, 2003, NUCL INSTRUM METH A, V499, P624, DOI 10.1016/S0168-9002(02)01960-5; Adams J, 2005, NUCL PHYS A, V757, P102, DOI 10.1016/j.nuclphysa.2005.03.085; Braun-Munzinger P, 2007, NATURE, V448, P302, DOI 10.1038/nature06080	4	3	3	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	2010	328	5974					55	56		10.1126/science.1187769	http://dx.doi.org/10.1126/science.1187769			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577DR	20360100				2022-12-28	WOS:000276202200031
J	Davoli, T; Denchi, EL; de Lange, T				Davoli, Teresa; Denchi, Eros Lazzerini; de Lange, Titia			Persistent Telomere Damage Induces Bypass of Mitosis and Tetraploidy	CELL			English	Article							CELL-CYCLE PROGRESSION; GENOMIC INSTABILITY; S-PHASE; BARRETTS-ESOPHAGUS; COLORECTAL-CANCER; BREAST-CANCER; FISSION YEAST; DNA; ANEUPLOIDY; MICE	Tetraploidization has been proposed as an intermediate step toward aneuploidy in human cancer but a general mechanism for the induction of tetraploidy during tumorigenesis is lacking. We report that tetraploidization occurs in p53-deficient cells experiencing a prolonged DNA damage signal due to persistent telomere dysfunction. Live-cell imaging revealed that these cells have an extended G2 due to ATM/ATR-and Chk1/Chk2-mediated inhibition of Cdk1/CyclinB and eventually bypass mitosis. Despite their lack of mitosis, the cells showed APC/Cdh1-dependent degradation of the replication inhibitor geminin, followed by accumulation of Cdt1, which is required for origin licensing. Cells then entered a second S phase resulting in whole-genome reduplication and tetraploidy. Upon restoration of telomere protection, these tetraploid cells resumed cell division cycles and proliferated. These observations suggest a general mechanism for the induction of tetraploidization in the early stages of tumorigenesis when telomere dysfunction can result from excessive telomere shortening.	[Davoli, Teresa; Denchi, Eros Lazzerini; de Lange, Titia] Rockefeller Univ, Cell Biol & Genet Lab, New York, NY 10065 USA	Rockefeller University	de Lange, T (corresponding author), Rockefeller Univ, Cell Biol & Genet Lab, 1230 York Ave, New York, NY 10065 USA.	delange@mail.rockefeller.edu	lazzerini denchi, eros/F-7913-2010; Denchi, Eros Lazzerini/AAD-8208-2020; de Lange, Titia/B-8263-2011	lazzerini denchi, eros/0000-0001-5378-4644; de Lange, Titia/0000-0002-9267-367X; Davoli, Teresa/0000-0003-4116-9745	Breast Cancer Research Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000379] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Devon White for expert mouse husbandry. Antibodies, DNA constructs, and protocols were generously provided by Drs. A. Ballabeni, J. Pines, A. Miyawaki, and O. Fernandez-Capetillo. We are grateful to Dr. A. Musacchio, Dr. D. Morgan, and members of the de Lange lab for advice and discussion. A. North (RU Bio-imaging RC) and S. Mazel (RU Flow Cytometry RC) are thanked for expert assistance. This work was supported by the Breast Cancer Research Foundation.	Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Ballabeni A, 2004, EMBO J, V23, P3122, DOI 10.1038/sj.emboj.7600314; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Caldwell CM, 2007, J CELL BIOL, V178, P1109, DOI 10.1083/jcb.200703186; CARDER P, 1993, ONCOGENE, V8, P1397; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; DANES BS, 1978, CANCER-AM CANCER SOC, V41, P2330, DOI 10.1002/1097-0142(197806)41:6<2330::AID-CNCR2820410635>3.0.CO;2-X; de Lange T, 1999, CELL, V98, P273, DOI 10.1016/S0092-8674(00)81955-8; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Dikovskaya D, 2007, J CELL BIOL, V176, P183, DOI 10.1083/jcb.200610099; Duelli DM, 2007, CURR BIOL, V17, P431, DOI 10.1016/j.cub.2007.01.049; DUTRILLAUX B, 1991, BREAST CANCER RES TR, V19, P245, DOI 10.1007/BF01961161; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Galipeau PC, 1996, P NATL ACAD SCI USA, V93, P7081, DOI 10.1073/pnas.93.14.7081; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; HAYLES J, 1994, CELL, V78, P813, DOI 10.1016/S0092-8674(94)90542-8; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Itzhaki JE, 1997, NAT GENET, V15, P258, DOI 10.1038/ng0397-258; Kiang L, 2009, MOL CELL BIOL, V29, P4025, DOI 10.1128/MCB.00185-09; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; LEVINE DS, 1991, GASTROENTEROLOGY, V101, P1198, DOI 10.1016/0016-5085(91)90068-V; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Narbonne-Reveau K, 2008, DEVELOPMENT, V135, P1451, DOI 10.1242/dev.016295; Pantic M, 2006, ONCOGENE, V25, P4413, DOI 10.1038/sj.onc.1209486; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; RABINOVITCH PS, 1989, LAB INVEST, V60, P65; Reina-San-Martin B, 2005, P NATL ACAD SCI USA, V102, P1590, DOI 10.1073/pnas.0406289102; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Storchova Z, 2008, J CELL SCI, V121, P3859, DOI 10.1242/jcs.039537; Toledo LI, 2008, GENE DEV, V22, P297, DOI 10.1101/gad.452308; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; Wang X, 2003, GENE DEV, V17, P965, DOI 10.1101/gad.1065103; Weaver BAA, 2006, NATURE, V442, pE9, DOI 10.1038/nature05139; Yoshihara T, 2004, EMBO J, V23, P670, DOI 10.1038/sj.emboj.7600087; Zielke N, 2008, GENE DEV, V22, P1690, DOI 10.1101/gad.469108	52	195	199	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2010	141	1					81	93		10.1016/j.cell.2010.01.031	http://dx.doi.org/10.1016/j.cell.2010.01.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	577GS	20371347	Bronze, Green Accepted			2022-12-28	WOS:000276211100014
J	Speakman, JR				Speakman, John R.			FTO effect on energy demand versus food intake	NATURE			English	Letter							GENE; OBESITY; CHILDREN; EXPENDITURE; VARIANT		Univ Aberdeen, Inst Environm & Biol Sci, Aberdeen AB24 2TZ, Scotland	University of Aberdeen	Speakman, JR (corresponding author), Univ Aberdeen, Inst Environm & Biol Sci, Aberdeen AB24 2TZ, Scotland.	j.speakman@abdn.ac.uk	Speakman, John R./A-9494-2008	Speakman, John R./0000-0002-2457-1823				Arch JRS, 2006, INT J OBESITY, V30, P1322, DOI 10.1038/sj.ijo.0803280; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Do R, 2008, DIABETES, V57, P1147, DOI 10.2337/db07-1267; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Haupt A, 2009, EXP CLIN ENDOCR DIAB, V117, P194, DOI 10.1055/s-0028-1087176; Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; Timpson NJ, 2008, AM J CLIN NUTR, V88, P971, DOI 10.1093/ajcn/88.4.971; Wardle J, 2009, INT J OBESITY, V33, P42, DOI 10.1038/ijo.2008.174; Wardle J, 2008, J CLIN ENDOCR METAB, V93, P3640, DOI 10.1210/jc.2008-0472	11	40	40	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 1	2010	464	7289					E1	E1		10.1038/nature08807	http://dx.doi.org/10.1038/nature08807			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577EO	20360686	Bronze			2022-12-28	WOS:000276205000054
J	Mann, F; Sobel, A				Mann, Farhana; Sobel, Anna			Case Report An agitated young man	BRITISH MEDICAL JOURNAL			English	Editorial Material							NEUROLEPTIC MALIGNANT SYNDROME		[Mann, Farhana] Camden & Islington NHS Fdn Trust, Margarete Ctr, London NW1 2LS, England; [Sobel, Anna] St Anns Hosp, London N15 3TH, England		Mann, F (corresponding author), Camden & Islington NHS Fdn Trust, Margarete Ctr, London NW1 2LS, England.	farhana_haque@hotmail.com		Abdulmagomedov, Suleiman/0000-0001-9162-5062				American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Blair D T, 1993, Clin Nurse Spec, V7, P225, DOI 10.1097/00002800-199307000-00018; CARLOFF SN, 1980, J CLIN PSYCHOL, V41, P79; Davis JM, 2000, PSYCHIAT ANN, V30, P325, DOI 10.3928/0048-5713-20000501-10; *EMEDICINE, NEUR MAL SYNDR; Gurrera RJ, 1999, AM J PSYCHIAT, V156, P169; Kipps CM, 2005, MOVEMENT DISORD, V20, P322, DOI 10.1002/mds.20325; POPE HG, 1991, J CLIN PSYCHIAT, V52, P208; SAKKAS P, 1991, PSYCHOPHARMACOL BULL, V27, P381; Semple D, 2005, OXFORD HDB PSYCHIAT, V1st; STAHL SM, 2008, STAHLS ESSENTIAL PSY, P342; Strawn JR, 2007, AM J PSYCHIAT, V164, P870, DOI 10.1176/appi.ajp.164.6.870; TAYLOR D, 2007, MAUDSLEY PRESCRIBING	13	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 31	2010	340								c732	10.1136/bmj.c732	http://dx.doi.org/10.1136/bmj.c732			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579VL	20356963				2022-12-28	WOS:000276404400022
J	Cook, ER; Anchukaitis, KJ; Buckley, BM; D'Arrigo, RD; Jacoby, GC; Wright, WE				Cook, Edward R.; Anchukaitis, Kevin J.; Buckley, Brendan M.; D'Arrigo, Rosanne D.; Jacoby, Gordon C.; Wright, William E.			Asian Monsoon Failure and Megadrought During the Last Millennium	SCIENCE			English	Article							TROPICAL PACIFIC; CLIMATE-CHANGE; VARIABILITY; DROUGHT; MECHANISM; SEA	The Asian monsoon system affects more than half of humanity worldwide, yet the dynamical processes that govern its complex spatiotemporal variability are not sufficiently understood to model and predict its behavior, due in part to inadequate long-term climate observations. Here we present the Monsoon Asia Drought Atlas (MADA), a seasonally resolved gridded spatial reconstruction of Asian monsoon drought and pluvials over the past millennium, derived from a network of tree-ring chronologies. MADA provides the spatiotemporal details of known historic monsoon failures and reveals the occurrence, severity, and fingerprint of previously unknown monsoon megadroughts and their close linkages to large-scale patterns of tropical Indo-Pacific sea surface temperatures. MADA thus provides a long-term context for recent monsoon variability that is critically needed for climate modeling, prediction, and attribution.	[Cook, Edward R.; Anchukaitis, Kevin J.; Buckley, Brendan M.; D'Arrigo, Rosanne D.; Jacoby, Gordon C.; Wright, William E.] Columbia Univ, Lamont Doherty Earth Observ, Tree Ring Lab, Palisades, NY 10964 USA; [Wright, William E.] Natl Taiwan Univ, Sch Forestry & Nat Resources, Taipei 10617, Taiwan	Columbia University; National Taiwan University	Cook, ER (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Tree Ring Lab, Palisades, NY 10964 USA.	drdendro@ldeo.columbia.edu		Buckley, Brendan/0000-0003-1544-8003; Anchukaitis, Kevin/0000-0002-8509-8080	U.S. National Science Foundation [ATM 04-02474]	U.S. National Science Foundation(National Science Foundation (NSF))	We thank all of our collaborators and contributors (see table S1 for a detailed list) for helping to make the MADA a reality. We also thank two anonymous reviewers for constructive comments and criticisms that improved this paper. This research has been supported by the U.S. National Science Foundation Paleoclimate Program, award ATM 04-02474. Lamont-Doherty Earth Observatory Contribution No. 7344.	Abram NJ, 2008, NAT GEOSCI, V1, P849, DOI 10.1038/ngeo357; [Anonymous], 2003, STRANGE PARALLELS SE; Ashfaq M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036500; Buckley BM, 2007, CLIM DYNAM, V29, P63, DOI 10.1007/s00382-007-0225-1; Buckley BM, 2010, P NATL ACAD SCI USA, V107, P6748, DOI 10.1073/pnas.0910827107; Cook ER, 2007, EARTH-SCI REV, V81, P93, DOI 10.1016/j.earscirev.2006.12.002; Dai A, 2004, J HYDROMETEOROL, V5, P1117, DOI 10.1175/JHM-386.1; Davis Mike., 2001, LATE VICTORIAN HOLOC; Dommenget D, 2007, CLIM DYNAM, V28, P517, DOI 10.1007/s00382-006-0195-8; Duan KQ, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007084; Giese BS, 2010, B AM METEOROL SOC, V91, P177, DOI 10.1175/2009BAMS2903.1; Goes JI, 2005, SCIENCE, V308, P545, DOI 10.1126/science.1106610; Grove RH, 2007, MEDIEV HIST J, V10, P75, DOI 10.1177/097194580701000203; Kripalani RH, 2007, THEOR APPL CLIMATOL, V90, P133, DOI 10.1007/s00704-006-0282-0; Kumar KK, 2006, SCIENCE, V314, P115, DOI 10.1126/science.1131152; Meehl GA, 2006, J CLIMATE, V19, P1605, DOI 10.1175/JCLI3675.1; Overpeck JT, 2007, NATURE, V445, P270, DOI 10.1038/445270a; Parsons James B, 1970, PEASANT REBELLIONS L; Sano M, 2009, CLIM DYNAM, V33, P331, DOI 10.1007/s00382-008-0454-y; Seager R, 2005, J CLIMATE, V18, P4065, DOI 10.1175/JCLI3522.1; Seager R, 2008, J CLIMATE, V21, P6175, DOI 10.1175/2008JCLI2170.1; Shaman J, 2005, J CLIMATE, V18, P2067, DOI 10.1175/JCLI3391.1; Shen C, 2007, CLIMATIC CHANGE, V85, P453, DOI 10.1007/s10584-007-9283-y; Sinha A, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030431; Thompson LG, 2000, SCIENCE, V289, P1916, DOI 10.1126/science.289.5486.1916; Thompson LG, 2006, P NATL ACAD SCI USA, V103, P10536, DOI 10.1073/pnas.0603900103; Vecchi G. A., 2008, EOS T AM GEOPHYS UN, V89, P81, DOI DOI 10.1029/2008EO090002; Walsh RPD, 1999, INT J CLIMATOL, V19, P1025, DOI 10.1002/(SICI)1097-0088(199907)19:9<1025::AID-JOC402>3.0.CO;2-F; Wang PX, 2005, QUATERNARY SCI REV, V24, P595, DOI 10.1016/j.quascirev.2004.10.002	29	829	914	28	366	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2010	328	5977					486	489		10.1126/science.1185188	http://dx.doi.org/10.1126/science.1185188			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586YR	20413498				2022-12-28	WOS:000276952400039
J	van den Broek, P				van den Broek, Paul			Using Texts in Science Education: Cognitive Processes and Knowledge Representation	SCIENCE			English	Review							COMPREHENSION PROCESSES; READERS; INTEGRATION; RECALL	Texts form a powerful tool in teaching concepts and principles in science. How do readers extract information from a text, and what are the limitations in this process? Central to comprehension of and learning from a text is the construction of a coherent mental representation that integrates the textual information and relevant background knowledge. This representation engenders learning if it expands the reader's existing knowledge base or if it corrects misconceptions in this knowledge base. The Landscape Model captures the reading process and the influences of reader characteristics (such as working-memory capacity, reading goal, prior knowledge, and inferential skills) and text characteristics (such as content/structure of presented information, processing demands, and textual cues). The model suggests factors that can optimize-or jeopardize-learning science from text.	[van den Broek, Paul] Leiden Univ, Dept Educ & Child Studies, NL-2333 AK Leiden, Netherlands; [van den Broek, Paul] Univ Minnesota, Ctr Cognit Sci, Minneapolis, MN 55455 USA	Leiden University; Leiden University - Excl LUMC; University of Minnesota System; University of Minnesota Twin Cities	van den Broek, P (corresponding author), Leiden Univ, Dept Educ & Child Studies, Wassenaarseweg 52, NL-2333 AK Leiden, Netherlands.	broekpwvanden@fsw.leidenuniv.nl	江, 鈺麒/G-1379-2014					Cain K., 2007, CHILDRENS COMPREHENS; Dunlosky J, 2002, PSYCHOLOGY OF SCIENCE TEXT COMPREHENSION, P255; Goldman SR, 2002, PSYCHOLOGY OF SCIENCE TEXT COMPREHENSION, P19; GRAESSER AC, 1994, PSYCHOL REV, V101, P371, DOI 10.1037/0033-295X.101.3.371; Hyona J, 2004, LEARN INSTR, V14, P131, DOI 10.1016/j.learninstruc.2004.01.001; Kendeou P, 2007, MEM COGNITION, V35, P1567, DOI 10.3758/BF03193491; KINTSCH W, 1988, PSYCHOL REV, V95, P163, DOI 10.1037/0033-295X.95.2.163; Kintsch W, 1998, COMPREHENSION PARADI; Leon JA, 2002, PSYCHOLOGY OF SCIENCE TEXT COMPREHENSION, P155; Linderholm T, 2000, COGNITION INSTRUCT, V18, P525, DOI 10.1207/S1532690XCI1804_4; LORCH RF, 1995, CONTEMP EDUC PSYCHOL, V20, P51; LORCH RF, 1993, J EXP PSYCHOL LEARN, V19, P1071, DOI 10.1037/0278-7393.19.5.1071; McNamara DS, 1996, COGNITION INSTRUCT, V14, P1, DOI 10.1207/s1532690xci1401_1; O'Brien EJ, 1999, NARRATIVE COMPREHENSION, CAUSALITY, AND COHERENCE, P35; PICHERT JW, 1977, J EDUC PSYCHOL, V69, P309, DOI 10.1037/0022-0663.69.4.309; Rapp DN, 2007, SCI STUD READ, V11, P289, DOI 10.1080/10888430701530417; Schraw G, 1998, J EDUC PSYCHOL, V90, P3, DOI 10.1037/0022-0663.90.1.3; Trabasso T., 1984, LEARNING COMPREHNSIO, P83; van den Broek P, 1999, CONSTRUCTION OF MENTAL REPRESENTATIONS DURING READING, P71; van den Broek P, 2002, PSYCHOLOGY OF SCIENCE TEXT COMPREHENSION, P131; Van den Broek P, 1994, HDB PSYCHOLINGUISTIC, P539; van den Broek P., 2009, DECODING BEHAV BIOL, P107; Van Den Broek P, 2008, APPL COGNITIVE PSYCH, V22, P335, DOI 10.1002/acp.1418; Vosniadou S, 2003, INTENTIONAL CONCEPTUAL CHANGE, P377; Zwaan R. A., 2006, HDB PSYCHOLINGUISTIC, P725, DOI [10.1016/B978-012369374-7/50019-5, DOI 10.1016/B978-012369374-7/50019-5]	25	159	162	3	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 23	2010	328	5977					453	456		10.1126/science.1182594	http://dx.doi.org/10.1126/science.1182594			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	586YR	20413489				2022-12-28	WOS:000276952400029
J	Werner, T; Koshikawa, S; Williams, TM; Carroll, SB				Werner, Thomas; Koshikawa, Shigeyuki; Williams, Thomas M.; Carroll, Sean B.			Generation of a novel wing colour pattern by the Wingless morphogen	NATURE			English	Article							SEGMENT-POLARITY GENE; PIGMENT PATTERNS; NEURAL CREST; YELLOW GENE; DROSOPHILA; ZEBRAFISH; EVOLUTION; ELEMENTS; SPECIFICATION; EXPRESSION	The complex, geometric colour patterns of many animal bodies have important roles in behaviour and ecology. The generation of certain patterns has been the subject of considerable theoretical exploration, however, very little is known about the actual mechanisms underlying colour pattern formation or evolution. Here we have investigated the generation and evolution of the complex, spotted wing pattern of Drosophila guttifera. We show that wing spots are induced by the Wingless morphogen, which is expressed at many discrete sites that are specified by pre-existing positional information that governs the development of wing structures. Furthermore, we demonstrate that the elaborate spot pattern evolved from simpler schemes by co-option of Wingless expression at new sites. This example of a complex design developing and evolving by the layering of new patterns on pre-patterns is likely to be a general theme in other animals.	[Werner, Thomas; Koshikawa, Shigeyuki; Williams, Thomas M.; Carroll, Sean B.] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; [Werner, Thomas; Koshikawa, Shigeyuki; Williams, Thomas M.; Carroll, Sean B.] Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Carroll, SB (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, 1525 Linden Dr, Madison, WI 53706 USA.	sbcarrol@wisc.edu	Koshikawa, Shigeyuki/D-3052-2012	Koshikawa, Shigeyuki/0000-0003-2831-555X	Human Frontiers Science Program Fellowship [LT00640/2005-L]; JSPS; National Institutes of Health [GM076935]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM076935] Funding Source: NIH RePORTER	Human Frontiers Science Program Fellowship(Human Frontier Science Program); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Blair and E. Bier for suggesting Wingless as a candidate inducer; E. Wimmer for the piggyBac, mariner, Hermes and Minos transposon vectors; E. Hare and M. Eisen for the D. guttifera genomic library; M. Rebeiz, K. Vaccaro, V. Kassner, J. Selegue and B. Prud'homme for technical advice; A. Martinez-Arias for discussions; J. Jaenike for D. nigromaculata flies; H. Krause and L. Baev for the UAS-wg construct; B. Prud'homme, H. Dufour, M. Rebeiz, H. Chung and T. Shirangi for comments on the manuscript; and L. Olds for help with the artwork. This work was supported by a Human Frontiers Science Program Fellowship (LT00640/2005-L) to T. W., a JSPS Postdoctoral Fellowship for Research Abroad to S. K., a National Institutes of Health Postdoctoral fellowship (GM076935) to T. M. W., and the Howard Hughes Medical Institute ( S. B. C.).	Ashburner M., 1989, DROSOPHILA LAB HDB; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; BAKER NE, 1988, DEVELOPMENT, V102, P489; BAKER NE, 1988, DEV BIOL, V125, P96, DOI 10.1016/0012-1606(88)90062-0; BARD JBL, 1981, J THEOR BIOL, V93, P363, DOI 10.1016/0022-5193(81)90109-0; BLAIR SS, 1994, DEV BIOL, V162, P229, DOI 10.1006/dbio.1994.1081; CAMPBELL G, 1993, CELL, V74, P1113, DOI 10.1016/0092-8674(93)90732-6; CARROLL SB, 1994, SCIENCE, V265, P109, DOI 10.1126/science.7912449; Chen WS, 2008, CELL, V133, P1093, DOI 10.1016/j.cell.2008.04.048; Cott H.B., 1940, ADAPTIVE COLORATION; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; GOMEZSKARMETA JL, 1995, GENE DEV, V9, P1869, DOI 10.1101/gad.9.15.1869; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; GOTO T, 1989, CELL, V57, P413, DOI 10.1016/0092-8674(89)90916-1; HARDING K, 1989, EMBO J, V8, P1205, DOI 10.1002/j.1460-2075.1989.tb03493.x; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Iwashita M, 2006, PLOS GENET, V2, P1861, DOI 10.1371/journal.pgen.0020197; KONDO S, 1995, NATURE, V376, P765, DOI 10.1038/376765a0; Kondo S, 2009, SEMIN CELL DEV BIOL, V20, P82, DOI 10.1016/j.semcdb.2008.10.008; Lawrence PA, 2001, CURR BIOL, V11, pR638, DOI 10.1016/S0960-9822(01)00380-3; Liu RT, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011914; Markow T. A., 2006, DROSOPHILA GUIDE SPE; MEINHARDT H, 1981, FORTS ZOOL, V26, P163; Meinhardt H., 1982, MODELS BIOL PATTERN; Nakamasu A, 2009, P NATL ACAD SCI USA, V106, P8429, DOI 10.1073/pnas.0808622106; Neumann CJ, 1996, DEVELOPMENT, V122, P3477; Nijhout H.F., 1991, DEV EVOLUTION BUTTER; NOORDERMEER J, 1992, DEVELOPMENT, V116, P711; Parichy DM, 1999, DEVELOPMENT, V126, P3425; Parichy DM, 2003, DEV BIOL, V256, P221, DOI 10.1016/S0012-1606(03)00016-2; Parichy DM, 2000, DEV BIOL, V227, P294, DOI 10.1006/dbio.2000.9899; Perlman SJ, 2003, MOL ECOL, V12, P237, DOI 10.1046/j.1365-294X.2003.01721.x; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Rebeiz M, 2004, DEV BIOL, V271, P431, DOI 10.1016/j.ydbio.2004.04.011; Simmonds AJ, 2001, CELL, V105, P197, DOI 10.1016/S0092-8674(01)00311-7; Simpson P, 1999, DEVELOPMENT, V126, P1349; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; STURTEVANT MA, 1993, GENE DEV, V7, P961, DOI 10.1101/gad.7.6.961; Tanaka R, 2007, DEV BIOL, V304, P53, DOI 10.1016/j.ydbio.2006.12.018; Turing A. M., 1952, PHILOS T R SOC B, V237, P37; VANDENHEUVEL M, 1989, CELL, V59, P739, DOI 10.1016/0092-8674(89)90020-2; WALTER MF, 1991, DEV BIOL, V147, P32, DOI 10.1016/S0012-1606(05)80005-3; Watanabe M, 2006, EMBO REP, V7, P893, DOI 10.1038/sj.embor.7400757; Wheeler M.R., 1965, DROS INFORM SERV, V40, P98; Wittkopp PJ, 2002, CURR BIOL, V12, P1547, DOI 10.1016/S0960-9822(02)01113-2; Wittkopp PJ, 2002, DEVELOPMENT, V129, P1849; Yamaguchi M, 2007, P NATL ACAD SCI USA, V104, P4790, DOI 10.1073/pnas.0607790104; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1	49	152	156	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2010	464	7292					1143	U57		10.1038/nature08896	http://dx.doi.org/10.1038/nature08896			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20376004				2022-12-28	WOS:000276891100027
J	Terragni, PP; Antonelli, M; Fumagalli, R; Faggiano, C; Berardino, M; Pallavicini, FB; Miletto, A; Mangione, S; Sinardi, AU; Pastorelli, M; Vivaldi, N; Pasetto, A; Della Rocca, G; Urbino, R; Filippini, C; Pagano, E; Evangelista, A; Ciccone, G; Mascia, L; Ranieri, VM				Terragni, Pier Paolo; Antonelli, Massimo; Fumagalli, Roberto; Faggiano, Chiara; Berardino, Maurizio; Pallavicini, Franco Bobbio; Miletto, Antonio; Mangione, Salvatore; Sinardi, Angelo U.; Pastorelli, Mauro; Vivaldi, Nicoletta; Pasetto, Alberto; Della Rocca, Giorgio; Urbino, Rosario; Filippini, Claudia; Pagano, Eva; Evangelista, Andrea; Ciccone, Gianni; Mascia, Luciana; Ranieri, V. Marco			Early vs Late Tracheotomy for Prevention of Pneumonia in Mechanically Ventilated Adult ICU Patients A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTENSIVE-CARE-UNIT; CRITICALLY-ILL; PERCUTANEOUS TRACHEOSTOMY; SURGICAL TRACHEOSTOMY; TRANSLARYNGEAL; SCORE; METAANALYSIS; INTUBATION; DIAGNOSIS	Context Tracheotomy is used to replace endotracheal intubation in patients requiring prolonged ventilation; however, there is considerable variability in the time considered optimal for performing tracheotomy. This is of clinical importance because timing is a key criterion for performing a tracheotomy and patients who receive one require a large amount of health care resources. Objective To determine the effectiveness of early tracheotomy (after 6-8 days of laryngeal intubation) compared with late tracheotomy (after 13-15 days of laryngeal intubation) in reducing the incidence of pneumonia and increasing the number of ventilator-free and intensive care unit (ICU)-free days. Design, Setting, and Patients Randomized controlled trial performed in 12 Italian ICUs from June 2004 to June 2008 of 600 adult patients enrolled without lung infection, who had been ventilated for 24 hours, had a Simplified Acute Physiology Score II between 35 and 65, and had a sequential organ failure assessment score of 5 or greater. Intervention Patients who had worsening of respiratory conditions, unchanged or worse sequential organ failure assessment score, and no pneumonia 48 hours after inclusion were randomized to early tracheotomy (n=209; 145 received tracheotomy) or late tracheotomy (n=210; 119 received tracheotomy). Main Outcome Measures The primary endpoint was incidence of ventilator-associated pneumonia; secondary endpoints during the 28 days immediately following randomization were number of ventilator-free days, number of ICU-free days, and number of patients in each group who were still alive. Results Ventilator-associated pneumonia was observed in 30 patients in the early tracheotomy group (14%; 95% confidence interval [CI], 10%-19%) and in 44 patients in the late tracheotomy group (21%; 95% CI, 15%-26%) (P=.07). During the 28 days immediately following randomization, the hazard ratio of developing ventilator-associated pneumonia was 0.66 (95% CI, 0.42-1.04), remaining connected to the ventilator was 0.70 (95% CI, 0.56-0.87), remaining in the ICU was 0.73 (95% CI, 0.55-0.97), and dying was 0.80 (95% CI, 0.56-1.15). Conclusion Among mechanically ventilated adult ICU patients, early tracheotomy compared with late tracheotomy did not result in statistically significant improvement in incidence of ventilator-associated pneumonia.	[Pagano, Eva; Evangelista, Andrea; Ciccone, Gianni] Univ Turin, Osped S Giovanni Battista, Turin, Italy; [Pagano, Eva; Evangelista, Andrea; Ciccone, Gianni] Univ Turin, Canc Epidemiol Unit, CPO Piemonte, CeRMS, Turin, Italy; [Antonelli, Massimo] Univ Cattolica Sacro Cuore, Policlin A Gemelli, Rome, Italy; [Fumagalli, Roberto] Univ Milano Bicocca, Osped San Gerardo Monza, Milan, Italy; [Pallavicini, Franco Bobbio] Azienda Osped Univ San Martino, Genoa, Italy; [Miletto, Antonio] Azienda Osped CTO, Turin, Italy; [Mangione, Salvatore] Univ Palermo, Policlin P Giaccone, Palermo, Italy; [Sinardi, Angelo U.] Univ Messina, Policlin Univ, Messina, Italy; [Pastorelli, Mauro] Osped E Agnelli, Turin, Italy; [Vivaldi, Nicoletta] Osped SS Antonio e Biagio, Alessandria, Italy; [Pasetto, Alberto] Univ Modena, Azienda Osped Univ, I-41100 Modena, Italy; [Della Rocca, Giorgio] Univ Udine, Azienda Osped Univ, I-33100 Udine, Italy	A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin; Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte; University of Turin; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Milano-Bicocca; University of Palermo; AOU Policlinico Gaetano Martino; University of Messina; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; University of Udine; University Hospital of Udine	Ranieri, VM (corresponding author), Univ Turin, Dipartimento Anestesia, Azienda Osped S Giovanni Battista Molinette, Corso Dogliotti 14, I-10126 Turin, Italy.	marco.ranieri@unito.it	Ciccone, Giovannino/K-3136-2016; Fumagalli, Roberto/AAB-9746-2019; Ranieri, Marco/AFX-8152-2022; evangelista, andrea/A-7802-2013; Antonelli, Massimo/F-9848-2010; Antonelli, Massimo/K-9915-2016; mascia, Luciana/L-3039-2018; Pagano, Eva/K-3980-2016	Ciccone, Giovannino/0000-0001-7644-9574; Fumagalli, Roberto/0000-0003-0398-1329; Antonelli, Massimo/0000-0003-3007-1670; Terragni, Pierpaolo/0000-0002-4274-7546; Pagano, Eva/0000-0001-7552-2901; evangelista, andrea/0000-0003-1901-2805; Filippini, Claudia/0000-0003-0194-142X	Regione Piemonte Ricerca Sanitaria Finalizzata [0308/ACR ASx44]	Regione Piemonte Ricerca Sanitaria Finalizzata(Regione Piemonte)	This study was supported by the Regione Piemonte Ricerca Sanitaria Finalizzata grant 0308/ACR ASx44.	*AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801; Antonelli M, 2005, CRIT CARE MED, V33, P1015, DOI 10.1097/01.CCM.0000163401.77581.86; Blot F, 2008, INTENS CARE MED, V34, P1779, DOI 10.1007/s00134-008-1195-4; Boles JM, 2007, EUR RESPIR J, V29, P1033, DOI 10.1183/09031936.00010206; Brochard L, 2002, JAMA-J AM MED ASSOC, V288, P932, DOI 10.1001/jama.288.8.932; Chastre J, 2003, JAMA-J AM MED ASSOC, V290, P2588, DOI 10.1001/jama.290.19.2588; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; CIAGLIA P, 1985, CHEST, V87, P715, DOI 10.1378/chest.87.6.715; Cook D, 1998, JAMA-J AM MED ASSOC, V279, P781, DOI 10.1001/jama.279.10.781; Cook DJ, 1998, JAMA-J AM MED ASSOC, V279, P1605, DOI 10.1001/jama.279.20.1605; Cox CE, 2004, CRIT CARE MED, V32, P2219, DOI 10.1097/01.CCM.0000145232.46143.40; Dewar DM, 1999, CRIT CARE MED, V27, P2640, DOI 10.1097/00003246-199912000-00006; Diehl JL, 1999, AM J RESP CRIT CARE, V159, P383, DOI 10.1164/ajrccm.159.2.9707046; Esteban A, 2000, AM J RESP CRIT CARE, V161, P1450, DOI 10.1164/ajrccm.161.5.9902018; Fartoukh M, 2003, AM J RESP CRIT CARE, V168, P173, DOI 10.1164/rccm.200212-1449OC; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Fischler L, 2000, INTENS CARE MED, V26, P1428, DOI 10.1007/s001340000634; Freeman BD, 2005, CRIT CARE MED, V33, P2513, DOI 10.1097/01.CCM.0000186369.91799.44; Freeman BD, 2000, CHEST, V118, P1412, DOI 10.1378/chest.118.5.1412; Frova G, 2002, INTENS CARE MED, V28, P299, DOI 10.1007/s00134-002-1218-5; Frutos-Vivar F, 2005, CRIT CARE MED, V33, P290, DOI 10.1097/01.CCM.0000150026.85210.13; Gattinoni L, 2006, NEW ENGL J MED, V354, P1775, DOI 10.1056/NEJMoa052052; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Griffiths J, 2005, BMJ-BRIT MED J, V330, P1243, DOI 10.1136/bmj.38467.485671.E0; GRIGGS WM, 1991, INTENS CARE MED, V17, P261, DOI 10.1007/BF01713934; Groves DS, 2007, CURR OPIN CRIT CARE, V13, P90, DOI 10.1097/MCC.0b013e328011721e; Heffner JE, 2001, CHEST, V120, p477S, DOI 10.1378/chest.120.6_suppl.477S; KOLLEF MH, 1993, JAMA-J AM MED ASSOC, V270, P1965, DOI 10.1001/jama.270.16.1965; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; MacIntyre NR, 2001, CHEST, V120, p375S, DOI 10.1378/chest.120.6_suppl.375S; Nathens AB, 2006, CRIT CARE MED, V34, P2919, DOI 10.1097/01.CCM.0000243800.28251.AE; Nieszkowska A, 2005, CRIT CARE MED, V33, P2527, DOI 10.1097/01.CCM.0000186898.58709.AA; PLUMMER AL, 1989, CHEST, V96, P178, DOI 10.1378/chest.96.1.178; PUGIN J, 1991, AM REV RESPIR DIS, V143, P1121, DOI 10.1164/ajrccm/143.5_Pt_1.1121; Rumbak MJ, 2004, CRIT CARE MED, V32, P1689, DOI 10.1097/01.CCM.0000134835.05161.B6; Scales DC, 2008, INTENS CARE MED, V34, P1743, DOI 10.1007/s00134-008-1194-5; Scales DC, 2008, CRIT CARE MED, V36, P2547, DOI 10.1097/CCM.0b013e31818444a5; Scales DC, 2006, CRIT CARE MED, V34, P3039, DOI 10.1097/01.CCM.0000242924.24342.9D; Stocchetti N, 2000, INTENS CARE MED, V26, P1101, DOI 10.1007/s001340051324	41	307	331	0	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2010	303	15					1483	1489		10.1001/jama.2010.447	http://dx.doi.org/10.1001/jama.2010.447			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585SJ	20407057	Green Submitted, Bronze			2022-12-28	WOS:000276849000024
J	Rassi, A; Rassi, A; Marin-Neto, JA				Rassi, Anis, Jr.; Rassi, Anis; Marin-Neto, Jose Antonio			Chagas disease	LANCET			English	Article							TRYPANOSOMA-CRUZI INFECTION; CURRENT EPIDEMIOLOGIC TRENDS; HEART-DISEASE; VENTRICULAR-TACHYCARDIA; NITRIC-OXIDE; FOLLOW-UP; GENETIC-VARIABILITY; CATHETER ABLATION; PREDICTING DEATH; ETIOLOGIC AGENT	Chagas disease is a chronic, systemic, parasitic infection caused by the protozoan Trypanosoma cruzi, and was discovered in 1909. The disease affects about 8 million people in Latin America, of whom 30-40% either have or will develop cardiomyopathy, digestive megasyndromes, or both. In the past three decades, the control and management of Chagas disease has undergone several improvements. Large-scale vector control programmes and screening of blood donors have reduced disease incidence and prevalence. Although more effective trypanocidal drugs are needed, treatment with benznidazole (or nifurtimox) is reasonably safe and effective, and is now recommended for a widened range of patients. Improved models for risk stratification are available, and certain guided treatments could halt or reverse disease progression. By contrast, some challenges remain: Chagas disease is becoming an emerging health problem in non-endemic areas because of growing population movements; early detection and treatment of asymptomatic individuals are underused; and the potential benefits of novel therapies (eg, implantable cardioverter defibrillators) need assessment in prospective randomised trials.	[Rassi, Anis, Jr.] Anis Rassi Hosp, Div Cardiol, Setor Oeste, BR-74110020 Goiania, Go, Brazil; [Marin-Neto, Jose Antonio] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Internal Med, Div Cardiol, BR-14049 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo	Rassi, A (corresponding author), Anis Rassi Hosp, Div Cardiol, Setor Oeste, Ave Jose Alves 453, BR-74110020 Goiania, Go, Brazil.	arassijr@terra.com.br	Rassi, Anis/AAJ-3368-2020; Marin-Neto, Jose Antonio/F-6099-2012; Oliveira, Claudia DL/G-8618-2011	Marin-Neto, Jose Antonio/0000-0002-8651-8833				Abrahamsohn IA, 1996, EXP PARASITOL, V84, P231, DOI 10.1006/expr.1996.0109; Acquatella H, 2007, CIRCULATION, V115, P1124, DOI 10.1161/CIRCULATIONAHA.106.627323; Aguilar HM, 1999, MEM I OSWALDO CRUZ, V94, P387, DOI 10.1590/S0074-02761999000700076; Aliberti JCS, 1996, INFECT IMMUN, V64, P1961, DOI 10.1128/IAI.64.6.1961-1967.1996; Braz LMA, 2008, REV INST MED TROP SP, V50, P65, DOI 10.1590/S0036-46652008000100015; Altclas J, 2005, BONE MARROW TRANSPL, V36, P123, DOI 10.1038/sj.bmt.1705006; Andrade ZA, 1999, MEM I OSWALDO CRUZ, V94, P71, DOI 10.1590/S0074-02761999000700007; ANDRADE ZA, 1983, CIBA F SYMP, V99, P214; Aufderheide AC, 2004, P NATL ACAD SCI USA, V101, P2034, DOI 10.1073/pnas.0307312101; Bern C, 2008, CURR OPIN INFECT DIS, V21, P476, DOI 10.1097/QCO.0b013e32830ef5b6; Bern C, 2007, JAMA-J AM MED ASSOC, V298, P2171, DOI 10.1001/jama.298.18.2171; Bern C, 2009, CLIN INFECT DIS, V49, pE52, DOI 10.1086/605091; BERNSTEIN RE, 1984, J ROY SOC MED, V77, P608, DOI 10.1177/014107688407700715; BITTENCOURT AL, 1976, AM J DIS CHILD, V130, P97, DOI 10.1001/archpedi.1976.02120020099020; Bocchi EA, 2001, ANN THORAC SURG, V71, P1833, DOI 10.1016/S0003-4975(01)02587-5; Bonney KM, 2008, CURR MOL MED, V8, P510, DOI 10.2174/156652408785748004; Brandalise NA, 1985, REV COL BRAS CIR, V12, P196; BRENER Z, 1971, Revista do Instituto de Medicina Tropical de Sao Paulo, V13, P171; Brisse S, 2000, MOL BIOCHEM PARASIT, V111, P95, DOI 10.1016/S0166-6851(00)00302-9; Britto CC, 2009, MEM I OSWALDO CRUZ, V104, P122, DOI 10.1590/S0074-02762009000900018; Campbell DA, 2004, CURR MOL MED, V4, P549, DOI 10.2174/1566524043360249; Campos SV, 2008, J HEART LUNG TRANSPL, V27, P597, DOI 10.1016/j.healun.2008.02.017; Cardinalli-Neto A, 2007, J CARDIOVASC ELECTR, V18, P1236, DOI 10.1111/j.1540-8167.2007.00954.x; Carod-Artal FJ, 2005, STROKE, V36, P965, DOI 10.1161/01.STR.0000163104.92943.50; CARRASCO HA, 1982, AM HEART J, V104, P595, DOI 10.1016/0002-8703(82)90232-0; Chagas Carlos, 1909, Memorias do Instituto Oswaldo Cruz, V1; Chandra M, 2002, INT J PARASITOL, V32, P897, DOI 10.1016/S0020-7519(02)00028-0; Cimo P L, 1993, Tex Med, V89, P48; Coura JR, 2009, MEM I OSWALDO CRUZ, V104, P31, DOI 10.1590/S0074-02762009000900006; Cunha-Neto E, 2006, AUTOIMMUNITY, V39, P41, DOI 10.1080/08916930500485002; d'Avila A, 2002, J INTERV CARD ELECTR, V7, P23, DOI 10.1023/A:1020811915133; Pinto AYD, 2009, REV PANAM SALUD PUBL, V25, P77, DOI 10.1590/S1020-49892009000100012; de Freitas JM, 2006, PLOS PATHOG, V2, P226, DOI 10.1371/journal.ppat.0020024; deAndrade ALSS, 1996, LANCET, V348, P1407, DOI 10.1016/S0140-6736(96)04128-1; Deane L. M., 1964, Revista Brasileira de Malariologia, V16, P27; DEREZENDE JM, 1994, SCI PUBLICATION, V547, P149; Di Noia JM, 2002, J EXP MED, V195, P401, DOI 10.1084/jem.20011433; Dias J. C. P., 1984, Memorias do Instituto Oswaldo Cruz, V79, P85, DOI 10.1590/S0074-02761984000500017; Diez CN, 2008, AM J TROP MED HYG, V78, P624, DOI 10.4269/ajtmh.2008.78.624; DosReis GA, 2005, TRENDS PARASITOL, V21, P237, DOI 10.1016/j.pt.2005.03.008; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Estani SS, 1998, AM J TROP MED HYG, V59, P526, DOI 10.4269/ajtmh.1998.59.526; Fabbro DL, 2007, REV SOC BRAS MED TRO, V40, P1, DOI 10.1590/S0037-86822007000100001; Fiorelli AI, 2005, TRANSPLANT P, V37, P2793, DOI 10.1016/j.transproceed.2005.05.038; FREILIJ H, 1995, CLIN INFECT DIS, V21, P551, DOI 10.1093/clinids/21.3.551; Freitas HFG, 2005, INT J CARDIOL, V102, P239, DOI 10.1016/j.ijcard.2004.05.025; Freitas JM, 2005, INT J PARASITOL, V35, P411, DOI 10.1016/j.ijpara.2004.10.023; FROICHON E, 1974, THESIS U PAULSABATIE; GALVAO C, 2003, ZOOTAXA, V202, P1, DOI DOI 10.11646/ZOOTAXA.202.1.1; Garcia Sérgio Britto, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P91, DOI 10.1590/S0036-46652003000200007; Garillo R., 2004, REBLAMPA, V17, P169; Garzon S A, 1995, Sao Paulo Med J, V113, P802; GASCON J, 2009, ACTA TROP, DOI DOI 10.1016/J.ACTATROPICA.2009.07019; Girones N, 2001, J CLIN INVEST, V107, P985, DOI 10.1172/JCI10734; Gomes YM, 2009, MEM I OSWALDO CRUZ, V104, P115, DOI 10.1590/S0074-02762009000900017; Guerri-Guttenberg RA, 2008, EUR HEART J, V29, P2587, DOI 10.1093/eurheartj/ehn424; Gutierrez FRS, 2009, MEM I OSWALDO CRUZ, V104, P236, DOI 10.1590/S0074-02762009000900030; Herbella FAM, 2008, DIS ESOPHAGUS, V21, P461, DOI 10.1111/j.1442-2050.2008.00811.x; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; IANNI BM, 2001, ARQ BRAS CARDIOL, V771, P59; Kierszenbaum F, 2007, ACTA PARASITOL, V52, P1, DOI 10.2478/s11686-006-0048-y; Koberle F., 1968, Advances in Parasitology, V6, P63, DOI 10.1016/S0065-308X(08)60472-8; KUSCHNIR E, 1985, Arquivos Brasileiros de Cardiologia, V45, P249; LARANJA FS, 1956, CIRCULATION, V14, P1035, DOI 10.1161/01.CIR.14.6.1035; Leiby DA, 1999, NEW ENGL J MED, V341, P1237, DOI 10.1056/NEJM199910143411615; LENT H, 1979, Bulletin of the American Museum of Natural History, V163, P123; Macedo AM, 2004, MEM I OSWALDO CRUZ, V99, P1, DOI 10.1590/S0074-02762004000100001; Manoel-Caetano FD, 2007, CAD SAUDE PUBLICA, V23, P2263, DOI 10.1590/S0102-311X2007001000002; Marin Neto J A, 1999, Arq Bras Cardiol, V72, P247; Marin-Neto JA, 2010, EVIDENCE BASED CARDI, P823; Marin-Neto JA, 2008, AM HEART J, V156, P37, DOI 10.1016/j.ahj.2008.04.001; Marin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296; MARINNETO JA, 1992, AM J CARDIOL, V69, P780, DOI 10.1016/0002-9149(92)90505-S; Martins GA, 1999, INFECT IMMUN, V67, P3864, DOI 10.1128/IAI.67.8.3864-3871.1999; Mathers CD, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000114; Medecins Sans Frontieres, 2008, REV SOC BRAS MED TRO, V41, P315; MENDOZA V, 1986, AM J CARDIOL, V57, P423; Miles MA, 2003, BMJ-BRIT MED J, V326, P1444, DOI 10.1136/bmj.326.7404.1444; Ministerio da Saude. Secretaria de Vigilancia em Saude, 2005, Rev Soc Bras Med Trop, V38 Suppl 3, P7; Minoprio P, 2001, INT J PARASITOL, V31, P588, DOI 10.1016/S0020-7519(01)00171-0; Moncayo A, 2003, MEM I OSWALDO CRUZ, V98, P577, DOI 10.1590/S0074-02762003000500001; Moncayo A, 2009, MEM I OSWALDO CRUZ, V104, P17, DOI 10.1590/S0074-02762009000900005; Mora MC, 2005, J PARASITOL, V91, P1468, DOI 10.1645/GE-549R.1; OLIVEIRA JSM, 1983, AM J CARDIOL, V52, P147, DOI 10.1016/0002-9149(83)90085-1; *ORG PAN SAL, 2006, OPSHDMCD42506; Pereira KS, 2009, J FOOD PROTECT, V72, P441, DOI 10.4315/0362-028X-72.2.441; Pinto Dias J C, 1995, Arq Bras Cardiol, V65, P359; Quiros FR, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-21; Rassi A, 2000, CLIN CARDIOL, V23, P883, DOI 10.1002/clc.4960231205; RASSI A, 2009, TRATADO CLIN MED, P4123; Rassi A, 1992, CHAGAS DIS AM TYP IT, P237; RASSI A, 1999, PACING CLIN ELECTR 2, V22, P862; Rassi A, 2000, TRYPANOSOMA CRUZI DO, P231; Rassi A Jr, 2001, Arq Bras Cardiol, V76, P75; Rassi A, 2009, HEART, V95, P524, DOI 10.1136/hrt.2008.159624; Rassi A, 2007, J CARDIOVASC ELECTR, V18, P1241, DOI 10.1111/j.1540-8167.2007.01011.x; Rassi A, 2007, CIRCULATION, V115, P1101, DOI 10.1161/CIRCULATIONAHA.106.627265; Rassi A, 2006, NEW ENGL J MED, V355, P799, DOI 10.1056/NEJMoa053241; Rassi A, 2009, MEM I OSWALDO CRUZ, V104, P152, DOI 10.1590/S0074-02762009000900021; Rassi Junior A, 1995, Arq Bras Cardiol, V65, P377; REED SG, 1994, J IMMUNOL, V153, P3135; Rocha MOC, 2006, NEW ENGL J MED, V355, P2488; Rochitte CE, 2007, ARTIF ORGANS, V31, P259, DOI 10.1111/j.1525-1594.2007.00373.x; ROSSI MA, 1990, AM HEART J, V120, P233, DOI 10.1016/0002-8703(90)90191-Y; Russomando G, 2005, REV SOC BRAS MED TRO, V38, P49; Russomando G, 1998, AM J TROP MED HYG, V59, P487, DOI 10.4269/ajtmh.1998.59.487; Garcia RLS, 2008, ACTA CIR BRAS, V23, P83, DOI 10.1590/S0102-86502008000700015; Sartori AMC, 2007, ANN TROP MED PARASIT, V101, P31, DOI 10.1179/136485907X154629; Scanavacca M I, 1990, Arq Bras Cardiol, V54, P367; Scanavacca Mauricio Ibrahim, 2002, Arq Bras Cardiol, V79 Suppl 5, P1; SCHMUNIS GA, 1991, TRANSFUSION, V31, P547, DOI 10.1046/j.1537-2995.1991.31691306255.x; Schmunis GA, 1999, MEM I OSWALDO CRUZ, V94, P93, DOI 10.1590/S0074-02761999000700010; Schmunis GA, 2007, MEM I OSWALDO CRUZ, V102, P75, DOI 10.1590/S0074-02762007005000093; Silva JS, 1998, BRAZ J MED BIOL RES, V31, P111, DOI 10.1590/S0100-879X1998000100014; SILVA JS, 1991, J EXP MED, V174, P539, DOI 10.1084/jem.174.3.539; Soares MBP, 2001, AN ACAD BRAS CIENC, V73, P547, DOI 10.1590/S0001-37652001000400008; Sosa E, 1999, PACE, V22, P128, DOI 10.1111/j.1540-8159.1999.tb00311.x; Sosa E, 1998, J CARDIOVASC ELECTR, V9, P229, DOI 10.1111/j.1540-8167.1998.tb00907.x; Tarleton RL, 1999, PARASITOL TODAY, V15, P94, DOI 10.1016/S0169-4758(99)01398-8; Tarleton RL, 2002, WORLD CL PARASITES, V7, P107; Torrico F, 2004, AM J TROP MED HYG, V70, P201, DOI 10.4269/ajtmh.2004.70.201; Tura BR, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-2; TYLER KM, 2003, AM TRYPANOSOMIASIS W, V7, P1; *US CDCP, 2006, MMWR-MORBID MORTAL W, V55, P798; Vaidian Anil K, 2004, Kinetoplastid Biol Dis, V3, P2, DOI 10.1186/1475-9292-3-2; VILLALBA R, 1992, CLIN INFECT DIS, V14, P594, DOI 10.1093/clinids/14.2.594; Viotti R, 2006, ANN INTERN MED, V144, P724, DOI 10.7326/0003-4819-144-10-200605160-00006; Viotti R, 2009, EXPERT REV ANTI-INFE, V7, P157, DOI 10.1586/14787210.7.2.157; ZELEDON R, 1981, ANNU REV ENTOMOL, V26, P101, DOI 10.1146/annurev.en.26.010181.000533; 1999, MEMORIAS I O CRUZ, V94, P429	132	1561	1611	3	245	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 17	2010	375	9723					1388	1402		10.1016/S0140-6736(10)60061-X	http://dx.doi.org/10.1016/S0140-6736(10)60061-X			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588GW	20399979				2022-12-28	WOS:000277057800029
J	Chen, L; Yang, SY; Jakoncic, J; Zhang, JJ; Huang, XY				Chen, Lin; Yang, Shengyu; Jakoncic, Jean; Zhang, J. Jillian; Huang, Xin-Yun			Migrastatin analogues target fascin to block tumour metastasis	NATURE			English	Article							CELL-MIGRATION INHIBITORS; NEGATIVE BREAST-CANCER; ACTIN-BUNDLING PROTEIN; EXPRESSION; CARCINOMA; MOTILITY; GENE; DISCOVERY; FILOPODIA; ROLES	Tumour metastasis is the primary cause of death of cancer patients. Development of new therapeutics preventing tumour metastasis is urgently needed. Migrastatin is a natural product secreted by Streptomyces(1,2), and synthesized migrastatin analogues such as macroketone are potent inhibitors of metastatic tumour cell migration, invasion and metastasis(3-6). Here we show that these migrastatin analogues target the actin-bundling protein fascin to inhibit its activity. X-ray crystal structural studies reveal that migrastatin analogues bind to one of the actin-binding sites on fascin. Our data demonstrate that actin cytoskeletal proteins such as fascin can be explored as new molecular targets for cancer treatment, in a similar manner to the microtubule protein tubulin.	[Chen, Lin; Yang, Shengyu; Zhang, J. Jillian; Huang, Xin-Yun] Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10065 USA; [Jakoncic, Jean] Brookhaven Natl Lab, Natl Synchrotron Light Source, Upton, NY 11973 USA	Cornell University; State University of New York (SUNY) System; United States Department of Energy (DOE); Brookhaven National Laboratory	Huang, XY (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10065 USA.	xyhuang@med.cornell.edu	Yang, Shengyu/I-9531-2012	Yang, Shengyu/0000-0002-7933-6118; Jakoncic, Jean/0000-0002-6315-0933	National Institutes of Health [CA136837]; Department of Defense [W81XWH-06-1-0362]; NATIONAL CANCER INSTITUTE [R01CA136837] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	J. J. Z. and X. Y. H. dedicate this paper to the memory of Yonghong Zhang, who died of cancer on 12 September 2009. We are grateful to W. Gerald (deceased) at Memorial Sloan-Kettering Cancer Center for letting us examine his DNA microarray data on human breast tumour samples for the fascin expression. We thank S. Almo for the fascin plasmid; S. Danishefsky and colleagues for the biotin-conjugated macroketone used in the initial exploration of the conditions for protein purification; members of the J. Massague laboratory for teaching the use of the IVIS Imaging system; the personnel at the beamlines X6A and X4C of the National Synchrotron Light Source for the beamtime and for assistance; and D. Eliezer, T. Maack, L. Palmer, H. Wu and members of our laboratory for critically reading the manuscript. We thank S. Almo and his colleagues, H. Wu and J. Wu, for help with the crystallization experiments. This work was supported by grants from the National Institutes of Health (CA136837) and the Department of Defense (W81XWH-06-1-0362).	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; BRYAN J, 1978, J MOL BIOL, V125, P207, DOI 10.1016/0022-2836(78)90345-5; Cant K, 1996, GENETICS, V143, P249; Doane AS, 2006, ONCOGENE, V25, P3994, DOI 10.1038/sj.onc.1209415; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gaul C, 2004, J AM CHEM SOC, V126, P11326, DOI 10.1021/ja048779q; Grothey A, 2000, BRIT J CANCER, V83, P870, DOI 10.1054/bjoc.2000.1395; Hashimoto Y, 2005, INT J BIOCHEM CELL B, V37, P1787, DOI 10.1016/j.biocel.2005.05.004; Hashimoto Y, 2004, ONCOLOGY-BASEL, V67, P262, DOI 10.1159/000081327; Hashimoto Y, 2007, MOL BIOL CELL, V18, P4591, DOI 10.1091/mbc.E07-02-0157; Ju JH, 2008, BIOORG MED CHEM LETT, V18, P5951, DOI 10.1016/j.bmcl.2008.07.072; Maitra A, 2002, AM J CLIN PATHOL, V118, P52; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; MOSIALOS G, 1994, J VIROL, V68, P7320, DOI 10.1128/JVI.68.11.7320-7328.1994; Nakae K, 2000, J ANTIBIOT, V53, P1228, DOI 10.7164/antibiotics.53.1228; Njardarson JT, 2004, J AM CHEM SOC, V126, P1038, DOI 10.1021/ja039714a; Ono S, 1997, J BIOL CHEM, V272, P2527; OTTO JJ, 1979, CELL, V17, P285, DOI 10.1016/0092-8674(79)90154-5; Pelosi G, 2003, LUNG CANCER-J IASLC, V42, P203, DOI 10.1016/S0169-5002(03)00294-0; Ponomarev V, 2004, EUR J NUCL MED MOL I, V31, P740, DOI 10.1007/s00259-003-1441-5; Rodriguez-Pinilla SM, 2006, CLIN CANCER RES, V12, P1533, DOI 10.1158/1078-0432.CCR-05-2281; Shan DD, 2006, DEV CELL, V10, P707, DOI 10.1016/j.devcel.2006.03.014; Shan DD, 2005, P NATL ACAD SCI USA, V102, P3772, DOI 10.1073/pnas.0500658102; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vignjevic D, 2003, J CELL BIOL, V160, P951, DOI 10.1083/jcb.200208059; Vignjevic D, 2007, CANCER RES, V67, P6844, DOI 10.1158/0008-5472.CAN-07-0929; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Woo EJ, 2002, J ANTIBIOT, V55, P141, DOI 10.7164/antibiotics.55.141; Wu JM, 2008, CLIN CANCER RES, V14, P1938, DOI 10.1158/1078-0432.CCR-07-4082; YAMASHIROMATSUMURA S, 1985, J BIOL CHEM, V260, P5087; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Yang SY, 2005, J BIOL CHEM, V280, P27130, DOI 10.1074/jbc.M501625200; Yoder BJ, 2005, CLIN CANCER RES, V11, P186; Zigeuner R, 2006, UROLOGY, V68, P518, DOI 10.1016/j.urology.2006.03.032	36	202	213	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2010	464	7291					1062	U135		10.1038/nature08978	http://dx.doi.org/10.1038/nature08978			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20393565	Green Accepted			2022-12-28	WOS:000276635000043
J	Smolderen, KG; Spertus, JA; Nallamothu, BK; Krumholz, HM; Tang, FM; Ross, JS; Ting, HH; Alexander, KP; Rathore, SS; Chan, PS				Smolderen, Kim G.; Spertus, John A.; Nallamothu, Brahmajee K.; Krumholz, Harlan M.; Tang, Fengming; Ross, Joseph S.; Ting, Henry H.; Alexander, Karen P.; Rathore, Saif S.; Chan, Paul S.			Health Care Insurance, Financial Concerns in Accessing Care, and Delays to Hospital Presentation in Acute Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREHOSPITAL DELAY; HEART; TIME; THERAPY; TRENDS; RISK; ANGIOPLASTY; ASSOCIATION; DEPRESSION; SERVICES	Context Little is known about how health insurance status affects decisions to seek care during emergency medical conditions such as acute myocardial infarction (AMI). Objective To examine the association between lack of health insurance and financial concerns about accessing care among those with health insurance, and the time from symptom onset to hospital presentation (prehospital delays) during AMI. Design, Setting, and Patients Multicenter, prospective study using a registry of 3721 AMI patients enrolled between April 11, 2005, and December 31, 2008, at 24 US hospitals. Health insurance status was categorized as insured without financial concerns, insured but have financial concerns about accessing care, and uninsured. Insurance information was determined from medical records while financial concerns among those with health insurance were determined from structured interviews. Main Outcome Measure Prehospital delay times (<= 2 hours, >2-6 hours, or >6 hours), adjusted for demographic, clinical, and social and psychological factors using hierarchical ordinal regression models. Results Of 3721 patients, 2294 were insured without financial concerns (61.7%), 689 were insured but had financial concerns about accessing care (18.5%), and 738 were uninsured (19.8%). Uninsured and insured patients with financial concerns were more likely to delay seeking care during AMI and had prehospital delays of greater than 6 hours among 48.6% of uninsured patients and 44.6% of insured patients with financial concerns compared with only 39.3% of insured patients without financial concerns. Prehospital delays of less than 2 hours during AMI occurred among 36.6% of those insured without financial concerns compared with 33.5% of insured patients with financial concerns and 27.5% of uninsured patients (P < .001). After adjusting for potential confounders, prehospital delays were associated with insured patients with financial concerns (adjusted odds ratio, 1.21 [95% confidence interval, 1.05-1.41]; P=.01) and with uninsured patients (adjusted odds ratio, 1.38 [95% confidence interval, 1.17-1.63]; P < .001). Conclusion Lack of health insurance and financial concerns about accessing care among those with health insurance were each associated with delays in seeking emergency care for AMI. JAMA. 2010; 303(14): 1392-1400	[Smolderen, Kim G.] Tilburg Univ, Ctr Res Psychol Somat Dis, Dept Med Psychol & Neuropsychol, NL-5000 LE Tilburg, Netherlands; [Spertus, John A.; Tang, Fengming; Chan, Paul S.] St Lukes Mid Amer Heart Inst, Kansas City, MO USA; [Spertus, John A.; Chan, Paul S.] Univ Missouri, Sch Med, Dept Internal Med, Kansas City, MO USA; [Nallamothu, Brahmajee K.] Univ Michigan, Sch Med, VA Hlth Serv Res & Dev Ctr Excellence, Ann Arbor, MI USA; [Nallamothu, Brahmajee K.] Univ Michigan, Sch Med, Dept Med, Ann Arbor, MI 48104 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT USA; [Krumholz, Harlan M.; Rathore, Saif S.] Yale Univ, Sch Med, MD PhD Program, New Haven, CT USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Sect Hlth Policy & Adm, Dept Epidemiol & Publ Hlth, New Haven, CT 06504 USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Ross, Joseph S.] Mt Sinai Sch Med, Dept Geriatr & Palliat Med, New York, NY USA; [Ross, Joseph S.] James J Peters VA Med Ctr, HSR&D Res Enhancement Award Program, Bronx, NY USA; [Ross, Joseph S.] James J Peters VA Med Ctr, Ctr Geriatr Res Educ & Clin, Bronx, NY USA; [Ting, Henry H.] Mayo Clin, Coll Med, Div Cardiovasc Dis, Rochester, MN USA; [Alexander, Karen P.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA	Tilburg University; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Yale University; Yale University; Yale University; Yale University; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Mayo Clinic; Duke University	Chan, PS (corresponding author), St Lukes Hosp, Mid Amer Heart Inst, 5th Floor,4401 Wornall Rd, Kansas City, MO 64111 USA.	pchan@cc-pc.com	Smolderen, Kim/B-8078-2015; Spertus, John/ABD-3075-2021; , Harlan/AAI-2875-2020	Ross, Joseph/0000-0002-9218-3320; Smolderen, Kim/0000-0001-6104-6254	National Heart, Lung, and Blood Institute Specialized Center of Clinically Oriented Research in Cardiac Dysfunction and Disease [P50 HL077113]; National Institute on Aging [K08 AG032886]; American Federation of Aging Research; National Institutes of Health's Center for Research Resources [UL1 RR024139]; National Institute of General Medical Sciences [5T32GM07205]; Agency for Healthcare Research and Quality [1R36HS018283-01]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R36HS018283] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL077113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute Specialized Center of Clinically Oriented Research in Cardiac Dysfunction and Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation of Aging Research; National Institutes of Health's Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH) study was supported by grant P50 HL077113 from the National Heart, Lung, and Blood Institute Specialized Center of Clinically Oriented Research in Cardiac Dysfunction and Disease. Dr Ross is supported by grant K08 AG032886 from the National Institute on Aging and by the American Federation of Aging Research through the Paul B. Beeson Career Development Award Program. Mr Rathore is supported, in part, by CTSA grant UL1 RR024139 from the National Institutes of Health's Center for Research Resources, grant 5T32GM07205 from the National Institute of General Medical Sciences Medical Scientist Training Program, and dissertation grant 1R36HS018283-01 from the Agency for Healthcare Research and Quality.	Andersen HR, 2003, NEW ENGL J MED, V349, P733, DOI 10.1056/NEJMoa025142; [Anonymous], 4EWARE IMPUTATION VA; Ayanian JZ, 2000, JAMA-J AM MED ASSOC, V284, P2061, DOI 10.1001/jama.284.16.2061; Berkman LF, 2000, AM HEART J, V139, P1; Bitterman RA, 2002, ANN EMERG MED, V40, P470, DOI 10.1067/mem.2002.128799; Blewett LA, 2006, MED CARE RES REV, V63, P663, DOI 10.1177/1077558706293634; BRAVEMAN P, 1994, NEW ENGL J MED, V331, P444, DOI 10.1056/NEJM199408183310706; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Dracup K, 1997, ANN INTERN MED, V126, P645, DOI 10.7326/0003-4819-126-8-199704150-00010; Dracup K, 2009, CIRC-CARDIOVASC QUAL, V2, P524, DOI 10.1161/CIRCOUTCOMES.109.852608; Foraker RE, 2008, ARCH INTERN MED, V168, P1874, DOI 10.1001/archinte.168.17.1874; Gabel JR, 2009, HEALTH AFFAIR, V28, pW595, DOI 10.1377/hlthaff.28.4.w595; Goldberg RJ, 2000, ARCH INTERN MED, V160, P3217, DOI 10.1001/archinte.160.21.3217; Kaiser Commission on Medicaid and the Uninsured, UN PRIM; KEELER EB, 1992, J MED PRACT MANAGE, V8, P317; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Luepker RV, 2000, JAMA-J AM MED ASSOC, V284, P60, DOI 10.1001/jama.284.1.60; Lunceford JK, 2004, STAT MED, V23, P2937, DOI 10.1002/SIM.1903; McGinn AP, 2005, AM HEART J, V150, P392, DOI 10.1016/j.ahj.2005.03.064; Moser DK, 2006, CIRCULATION, V114, P168, DOI 10.1161/CIRCULATIONAHA.106.176040; Otte C, 2007, AM J PSYCHIAT, V164, P1379, DOI 10.1176/appi.ajp.2007.06101617; Rahimi AR, 2007, JAMA-J AM MED ASSOC, V297, P1063, DOI 10.1001/jama.297.10.1063; Ross JS, 2006, JAMA-J AM MED ASSOC, V295, P2027, DOI 10.1001/jama.295.17.2027; Sheifer SE, 2000, CIRCULATION, V102, P1651, DOI 10.1161/01.CIR.102.14.1651; Spertus J, 2005, CIRCULATION, V111, P2572, DOI 10.1161/CIRCULATIONAHA.104.474775; Spertus JA, 2004, CIRCULATION, V110, P3789, DOI 10.1161/01.CIR.0000150392.70749.C7; SPERTUS JA, 1995, J AM COLL CARDIOL, V25, P333, DOI 10.1016/0735-1097(94)00397-9; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Steinbrook R, 2006, NEW ENGL J MED, V354, P2095, DOI 10.1056/NEJMp068097; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; Ting HH, 2008, ARCH INTERN MED, V168, P959, DOI 10.1001/archinte.168.9.959; Ting HH, 2008, AM J MED, V121, P316, DOI 10.1016/j.amjmed.2007.11.017; VOGEL RA, 1994, CLIN CARDIOL, V17, P354, DOI 10.1002/clc.4960170703; Wanerman R, 2002, ANN EMERG MED, V40, P464, DOI 10.1067/mem.2002.126743; Weinick RM, 2005, J GEN INTERN MED, V20, P504, DOI 10.1111/j.1525-1497.2005.0087.x; Wilper AP, 2009, AM J PUBLIC HEALTH, V99, P2289, DOI 10.2105/AJPH.2008.157685	38	103	103	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2010	303	14					1392	1400		10.1001/jama.2010.409	http://dx.doi.org/10.1001/jama.2010.409			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	582KX	20388895	Green Accepted, Bronze			2022-12-28	WOS:000276597300024
J	Frost, PJ; Leadbeatter, S; Wise, MP				Frost, Paul J.; Leadbeatter, Stephen; Wise, Matt P.			The Competent Novice Managing sudden death in hospital	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LIFE CARE; CERTIFICATION; MEDICINE; AUDIT; NEWS; END; BAD		[Frost, Paul J.; Wise, Matt P.] Univ Wales Hosp, Crit Care Directorate, Cardiff CF14 4XW, Wales; [Frost, Paul J.] Cardiff Univ, Schoool Med, Univ Wales Hosp, Cardiff, Wales; [Leadbeatter, Stephen] Univ Wales Hosp, Dept Med Genet Pathol & Haematol, Cardiff CF14 4XW, Wales	Cardiff University; Cardiff University; Cardiff University	Frost, PJ (corresponding author), Univ Wales Hosp, Crit Care Directorate, Cardiff CF14 4XW, Wales.	Paul.Frost@CardiffandVale.Wales.nhs.uk		Wise, Matt/0000-0002-2763-4316				Academy of Medical Royal Colleges, 2008, COD PRACT DIAGN CONF; AWOONORRENNER S, 1991, BRIT MED J, V302, P356, DOI 10.1136/bmj.302.6772.356; Baker JN, 2007, J PALLIAT MED, V10, P420, DOI 10.1089/jpm.2006.0135; Cave J, 2008, BRIT MED J, V336, P326, DOI 10.1136/bmj.39455.639340.AD; Department of Health, 2005, PAT DIES ADV DEV BER; Edmonds P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5048; Ellershaw J, 2007, PALLIATIVE MED, V21, P365, DOI 10.1177/0269216307081117; Fallowfield L, 2004, LANCET, V363, P312, DOI 10.1016/S0140-6736(03)15392-5; *HOSP EP STAT, 2009, HEADL FIG 2008 9; Iversen A, 2009, BMJ-BRIT MED J, V338, P1139; JAMES DS, 1995, J ROY COLL PHYS LOND, V29, P424; Jurkovich GJ, 2000, J TRAUMA, V48, P865, DOI 10.1097/00005373-200005000-00009; LEADBEATTER S, 1986, J ROY COLL PHYS LOND, V20, P273; LEADBEATTER S, 1986, J ROY COLL PHYS LOND, V20, P129; LEASH RM, 1994, DEATH NOTIFICATION; Lserson KV, 2000, ANN EMERG MED, V36, P75, DOI 10.1067/mem.2000.107664; *M CUR PALL CAR I, LIV LIV CAR PATHW 20; Moores TS, 2007, MED EDUC, V41, P942, DOI 10.1111/j.1365-2923.2007.02836.x; National Council for Hospice and Specialist Palliative Care Services, 2003, BREAK BAD NEWS REG G; NEVILLE RG, 1987, J ROY COLL GEN PRACT, V37, P496; Office for National Statistics, MORT STAT DEATHS REG; Redinbaugh EM, 2003, BMJ-BRIT MED J, V327, P185, DOI 10.1136/bmj.327.7408.185; Selinger CP, 2007, POSTGRAD MED J, V83, P285, DOI 10.1136/pgmj.2006.054833; Swift B, 2002, J CLIN PATHOL, V55, P275, DOI 10.1136/jcp.55.4.275; Treloar AJ, 2008, BRIT MED J, V336, P905, DOI 10.1136/bmj.39556.400370.80; *UK TRANSPL, 2003, UK HOSP POL ORG TISS	26	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 13	2010	340								c962	10.1136/bmj.c962	http://dx.doi.org/10.1136/bmj.c962			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	586JZ	20388691				2022-12-28	WOS:000276904800021
J	Huang, J; Zarnitsyna, VI; Liu, BY; Edwards, LJ; Jiang, N; Evavold, BD; Zhu, C				Huang, Jun; Zarnitsyna, Veronika I.; Liu, Baoyu; Edwards, Lindsay J.; Jiang, Ning; Evavold, Brian D.; Zhu, Cheng			The kinetics of two-dimensional TCR and pMHC interactions determine T-cell responsiveness	NATURE			English	Article							LIGAND BINDING-KINETICS; P-SELECTIN; RECEPTOR MICROCLUSTERS; IMPACT; AFFINITY; MICROTOPOLOGY; RECOGNITION; ACTIVATION; THRESHOLD; SURFACES	The T-cell receptor (TCR) interacts with peptide-major histocompatibility complexes (pMHC) to discriminate pathogens from self-antigens and trigger adaptive immune responses. Direct physical contact is required between the T cell and the antigen-presenting cell for cross-junctional binding where the TCR and pMHC are anchored on two-dimensional (2D) membranes of the apposing cells(1). Despite their 2D nature, TCR-pMHC binding kinetics have only been analysed three-dimensionally (3D) with a varying degree of correlation with the T-cell responsiveness(2-4). Here we use two mechanical assays(5,6) to show high 2D affinities between a TCR and its antigenic pMHC driven by rapid on-rates. Compared to their 3D counterparts, 2D affinities and on-rates of the TCR for a panel of pMHC ligands possess far broader dynamic ranges that match that of their corresponding T-cell responses. The best 3D predictor of response is the off-rate, with agonist pMHC dissociating the slowest(2-4). In contrast, 2D off-rates are up to 8,300-fold faster, with the agonist pMHC dissociating the fastest. Our 2D data suggest rapid antigen sampling by T cells and serial engagement of a few agonist pMHCs by TCRs in a large self pMHC background. Thus, the cellular environment amplifies the intrinsic TCR-pMHC binding to generate broad affinities and rapid kinetics that determine T-cell responsiveness.	[Huang, Jun; Zarnitsyna, Veronika I.; Liu, Baoyu; Jiang, Ning; Zhu, Cheng] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Edwards, Lindsay J.; Evavold, Brian D.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	University System of Georgia; Georgia Institute of Technology; Emory University	Zhu, C (corresponding author), Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	bevavol@emory.edu; cheng.zhu@bme.gatech.edu	Zhu, Cheng/A-5724-2011; Huang, Jun/E-8472-2010; Liu, Baoyu/C-4911-2009; Jiang, Ning/M-5448-2017	Liu, Baoyu/0000-0002-0798-6314; Jiang, Ning/0000-0003-1103-5922; Evavold, Brian/0000-0002-3561-3494; Zarnitsyna, Veronika/0000-0003-3096-3695	NIH [AI38282, AI060799]; National Multiple Sclerosis Society [RG4047-A-3];  [NS062358]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI038282, R29AI038282, R01AI060799, R01AI056017, R01AI038282, R56AI060799, R21AI056017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062358, R01NS071518] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the NIH Tetramer Core Facility at Emory University for providing MHC monomers, J. Altman for providing the H-2K<SUP>b</SUP> mutant construct, G. Bao for providing the divalent streptavidin, as well as M. Davis and H.-T. He for commenting on the manuscript. This work was supported by NIH grants AI38282 and AI060799 (to C.Z.) and NS062358, and National Multiple Sclerosis Society Grant RG4047-A-3 (to B. D. E.).	Alam SM, 1999, IMMUNITY, V10, P227, DOI 10.1016/S1074-7613(00)80023-0; Aleksic M, 2010, IMMUNITY, V32, P163, DOI 10.1016/j.immuni.2009.11.013; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Chen W, 2008, BIOPHYS J, V94, P694, DOI 10.1529/biophysj.107.117895; Chen W, 2008, CELL MOL BIOENG, V1, P276, DOI 10.1007/s12195-008-0024-8; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Davis MM, 2007, ANNU REV IMMUNOL, V25, P681, DOI 10.1146/annurev.immunol.24.021605.090600; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; Dustin ML, 2001, ANNU REV CELL DEV BI, V17, P133, DOI 10.1146/annurev.cellbio.17.1.133; Evans E, 2005, BIOPHYS J, V88, P2288, DOI 10.1529/biophysj.104.051698; Evans E, 2004, P NATL ACAD SCI USA, V101, P11281, DOI 10.1073/pnas.0401870101; GASCOIGNE NR, 2001, EXPERT REV MOL MED, P1; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Hochmuth R., 1987, HDB BIOENGINEERING; Howarth M, 2006, NAT METHODS, V3, P267, DOI 10.1038/NMETH861; Huang J, 2004, J BIOL CHEM, V279, P44915, DOI 10.1074/jbc.M407039200; Huang J, 2007, J IMMUNOL, V179, P7653, DOI 10.4049/jimmunol.179.11.7653; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lou JZ, 2006, J CELL BIOL, V174, P1107, DOI 10.1083/jcb.200606056; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Mehta P, 1998, J BIOL CHEM, V273, P32506, DOI 10.1074/jbc.273.49.32506; Nicholson MW, 1998, J BIOL CHEM, V273, P763, DOI 10.1074/jbc.273.2.763; Rosette C, 2001, IMMUNITY, V15, P59, DOI 10.1016/S1074-7613(01)00173-X; Sabatino JJ, 2008, J IMMUNOL, V180, P4451, DOI 10.4049/jimmunol.180.7.4451; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Stone JD, 2009, IMMUNOLOGY, V126, P165, DOI 10.1111/j.1365-2567.2008.03015.x; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Williams TE, 2000, BIOPHYS J, V79, P1858, DOI 10.1016/S0006-3495(00)76435-6; Williams TE, 2001, J BIOL CHEM, V276, P13283, DOI 10.1074/jbc.M010427200; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Wu L, 2007, J BIOL CHEM, V282, P9846, DOI 10.1074/jbc.M609219200; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zarnitsyna VI, 2007, P NATL ACAD SCI USA, V104, P18037, DOI 10.1073/pnas.0704811104; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; Zhang F, 2005, J BIOL CHEM, V280, P42207, DOI 10.1074/jbc.M510407200; Zhu C, 2002, ANN BIOMED ENG, V30, P305, DOI 10.1114/1.1467923; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	39	352	360	2	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					932	U156		10.1038/nature08944	http://dx.doi.org/10.1038/nature08944			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20357766	Green Accepted			2022-12-28	WOS:000276397300046
J	Foell, D; Wulffraat, N; Wedderburn, LR; Wittkowski, H; Frosch, M; Gerss, J; Stanevicha, V; Mihaylova, D; Ferriani, V; Tsakalidou, FK; Foeldvari, I; Cuttica, R; Gonzalez, B; Ravelli, A; Khubchandani, R; Oliveira, S; Armbrust, W; Garay, S; Vojinovic, J; Norambuena, X; Gamir, ML; Garcia-Consuegra, J; Lepore, L; Susic, G; Corona, F; Dolezalova, P; Pistorio, A; Martini, A; Ruperto, N; Roth, J				Foell, Dirk; Wulffraat, Nico; Wedderburn, Lucy R.; Wittkowski, Helmut; Frosch, Michael; Gerss, Joachim; Stanevicha, Valda; Mihaylova, Dimitrina; Ferriani, Virginia; Tsakalidou, Florence Kanakoudi; Foeldvari, Ivan; Cuttica, Ruben; Gonzalez, Benito; Ravelli, Angelo; Khubchandani, Raju; Oliveira, Sheila; Armbrust, Wineke; Garay, Stella; Vojinovic, Jelena; Norambuena, Ximena; Gamir, Maria Luz; Garcia-Consuegra, Julia; Lepore, Loredana; Susic, Gordana; Corona, Fabrizia; Dolezalova, Pavla; Pistorio, Angela; Martini, Alberto; Ruperto, Nicolino; Roth, Johannes		PRINTO	Methotrexate Withdrawal at 6 vs 12 Months in Juvenile Idiopathic Arthritis in Remission A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RHEUMATOID-ARTHRITIS; SELECT CATEGORIES; DISEASE-ACTIVITY; PROTEINS 8; CRITERIA; DISCONTINUATION; INFLAMMATION; VALIDATION; CHILDREN; THERAPY	Context Novel therapies have improved the remission rate in chronic inflammatory disorders including juvenile idiopathic arthritis (JIA). Therefore, strategies of tapering therapy and reliable parameters for detecting subclinical inflammation have now become challenging questions. Objectives To analyze whether longer methotrexate treatment during remission of JIA prevents flares after withdrawal of medication and whether specific biomarkers identify patients at risk for flares. Design, Setting, and Patients Prospective, open, multicenter, medication-withdrawal randomized clinical trial including 364 patients (median age, 11.0 years) with JIA recruited in 61 centers from 29 countries between February 2005 and June 2006. Patients were included at first confirmation of clinical remission while continuing medication. At the time of therapy withdrawal, levels of the phagocyte activation marker myeloid-related proteins 8 and 14 heterocomplex (MRP8/14) were determined. Intervention Patients were randomly assigned to continue with methotrexate therapy for either 6 months (group 1 [n = 183]) or 12 months (group 2 [n = 181]) after induction of disease remission. Main Outcome Measures Primary outcome was relapse rate in the 2 treatment groups; secondary outcome was time to relapse. In a prespecified cohort analysis, the prognostic accuracy of MRP8/14 concentrations for the risk of flares was assessed. Results Intention-to-treat analysis of the primary outcome revealed relapse within 24 months after the inclusion into the study in 98 of 183 patients (relapse rate, 56.7%) in group 1 and 94 of 181 (55.6%) in group 2. The odds ratio for group 1 vs group 2 was 1.02 (95% CI, 0.82-1.27; P=.86). The median relapse-free interval after inclusion was 21.0 months in group 1 and 23.0 months in group 2. The hazard ratio for group 1 vs group 2 was 1.07 (95% CI, 0.82-1.41; P=.61). Median follow-up duration after inclusion was 34.2 and 34.3 months in groups 1 and 2, respectively. Levels of MRP8/14 during remission were significantly higher in patients who subsequently developed flares (median, 715 [IQR, 320-1110] ng/mL) compared with patients maintaining stable remission (400 [IQR, 220-800] ng/mL; P=.003). Low MRP8/14 levels indicated a low risk of flares within the next 3 months following the biomarker test (area under the receiver operating characteristic curve, 0.76; 95% CI, 0.62-0.90). Conclusions In patients with JIA in remission, a 12-month vs 6-month withdrawal of methotrexate did not reduce the relapse rate. Higher MRP8/14 concentrations were associated with risk of relapse after discontinuing methotrexate.	[Foell, Dirk; Wittkowski, Helmut; Frosch, Michael] Univ Munster, Dept Pediat, D-48149 Munster, Germany; [Roth, Johannes] Univ Munster, Inst Immunol, D-48149 Munster, Germany; [Wulffraat, Nico] Wilhelmina Childrens Hosp, Dept Paediat Immunol & Rheumatol, Utrecht, Netherlands; [Wedderburn, Lucy R.] UCL, Inst Child Hlth, Rheumatol Unit, London, England; [Gerss, Joachim] Univ Munster, Dept Med Informat & Biomath, D-4400 Munster, Germany; [Stanevicha, Valda] Riga Stradins Univ, Riga, Latvia; [Mihaylova, Dimitrina] Univ Childrens Hosp, Sofia, Bulgaria; [Ferriani, Virginia] Univ Sao Paulo, Hosp Clin, Fac Med Ribeirao Preto, Sao Paulo, Brazil; [Tsakalidou, Florence Kanakoudi] Aristotle Univ Thessaloniki, Ippokrat Gen Hosp, Thessaloniki, Greece; [Foeldvari, Ivan] Praxis Kinder & Jugendrheumatol, Hamburg, Germany; [Cuttica, Ruben] Hosp Gen Ninos Pedro de Elizalde, Buenos Aires, DF, Argentina; [Gonzalez, Benito] Hosp Ninos Luis Calvo Mackenna, Santiago, Chile; [Ravelli, Angelo; Martini, Alberto] Univ Genoa, IRCCS G Gaslini, Genoa, Italy; [Ravelli, Angelo; Martini, Alberto] Univ Genoa, Dipartimento Pediat, Genoa, Italy; [Khubchandani, Raju] Jaslok Hosp & Res Ctr, Mumbay, India; [Oliveira, Sheila] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil; [Armbrust, Wineke] Univ Groningen, Univ Med Ctr Groningen, Beatrix Kinderkliniek, NL-9713 AV Groningen, Netherlands; [Garay, Stella] Hosp Sor Maria Ludov, La Plata, Buenos Aires, Argentina; [Vojinovic, Jelena] Univ Clin Ctr, Nish, Serbia; [Norambuena, Ximena] Hosp Dr Exequiel Gonzalez Cortes, Santiago, Chile; [Gamir, Maria Luz] Hosp Ramon & Cajal, E-28034 Madrid, Spain; [Garcia-Consuegra, Julia] Hosp Univ La Paz, Madrid, Spain; [Lepore, Loredana] Univ Trieste, Trieste, Italy; [Susic, Gordana] Inst Rheumatol Belgrade, Belgrade, Serbia; [Corona, Fabrizia] IRCCS Policlin Mangiagalli Regina Elena, Milan, Italy; [Dolezalova, Pavla] First Fac Med, Prague, Czech Republic; [Dolezalova, Pavla] Gen Fac Hosp, Prague, Czech Republic; [Pistorio, Angela] IRCCS G Gaslini, Serv Epidemiol & Biostat, Genoa, Italy; [Ruperto, Nicolino] IRCCS G Gaslini, PRINTO, Genoa, Italy	University of Munster; University of Munster; Wilhelmina Kinderziekenhuis; University of London; University College London; University of Munster; Riga Stradins University; Medical University Sofia; Universidade de Sao Paulo; Aristotle University of Thessaloniki; Universidad de Chile; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; Universidade Federal do Rio de Janeiro; University of Groningen; Universidad de Chile; Hospital Universitario Ramon y Cajal; Hospital Universitario La Paz; University of Trieste; IRCCS Ca Granda Ospedale Maggiore Policlinico; Charles University Prague; General University Hospital Prague; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini	Foell, D (corresponding author), Univ Munster, Dept Pediat, Albert Schweitzer Str 33, D-48149 Munster, Germany.	dfoell@uni-muenster.de	Wulffraat, Nico M/AAE-8929-2020; Oliveira, Sheila/F-5213-2016; Frosch, Michael/AAZ-1318-2020; KHUBCHANDANI, RAJU/AAI-9871-2020; Gerß, Joachim WO/B-5702-2013; RAVELLI, ANGELO/J-8161-2016; Dolezalova, Pavla/N-6408-2017; Pistorio, Angela/D-1375-2009; Ruperto, Nicolino/K-3349-2018; Ferriani, Virginia PL/E-2209-2012; Vojinovic, Jelena/V-6726-2019	Wulffraat, Nico M/0000-0001-9548-5562; Oliveira, Sheila/0000-0002-2426-716X; KHUBCHANDANI, RAJU/0000-0003-0294-119X; RAVELLI, ANGELO/0000-0001-9658-0385; Dolezalova, Pavla/0000-0001-8375-661X; Pistorio, Angela/0000-0002-6895-8720; Ruperto, Nicolino/0000-0001-8407-7782; Vojinovic, Jelena/0000-0002-6701-3370; MARTINI, Alberto/0000-0001-7642-1459; Wedderburn, Lucy/0000-0002-7495-1429	PRINTO; Deutsche Rheuma-Liga; Wyeth Pharmaceuticals; Sparks Charity [08ICH09] Funding Source: researchfish	PRINTO; Deutsche Rheuma-Liga; Wyeth Pharmaceuticals(Wyeth); Sparks Charity	The study was supported by grants from the non-for-profit organizations PRINTO and the "Deutsche Rheuma-Liga." Wyeth Pharmaceuticals funded the patients' insurance in Germany.; This study was supported and approved by the PRINTO advisory council, which had no role in the study planning, design, management, or data analysis. The support of PRINTO covered personnel costs at the coordinating center for data collection, sample shipping costs, and an administrative reimbursement to all participating centers ((sic) 100 per patient enrolled).	Bjork P, 2009, PLOS BIOL, V7, P800, DOI 10.1371/journal.pbio.1000097; Bossuyt PM, 2003, LANCET, V361, P71, DOI 10.1016/S0140-6736(03)12122-8; Foell D, 2004, CLIN CHIM ACTA, V344, P37, DOI 10.1016/j.cccn.2004.02.023; Foell D, 2004, ANN RHEUM DIS, V63, P206, DOI 10.1136/ard.2003.005686; Foell D, 2007, NAT CLIN PRACT RHEUM, V3, P382, DOI 10.1038/ncprheum0531; Frosch M, 2000, ARTHRITIS RHEUM-US, V43, P628, DOI 10.1002/1529-0131(200003)43:3<628::AID-ANR20>3.0.CO;2-X; Frosch M, 2009, ARTHRITIS RHEUM-US, V60, P883, DOI 10.1002/art.24349; GIANNINI EH, 1992, NEW ENGL J MED, V326, P1043, DOI 10.1056/NEJM199204163261602; Gottlieb BS, 1997, PEDIATRICS, V100, P994, DOI 10.1542/peds.100.6.994; Greene Maria T, 2009, Curr Gastroenterol Rep, V11, P248; Holtmann MH, 2006, DIGEST DIS SCI, V51, P1516, DOI 10.1007/s10620-005-9037-5; Hopewell S, 2008, LANCET, V371, P281, DOI 10.1016/S0140-6736(07)61835-2; LEBLANC M, 1992, BIOMETRICS, V48, P411, DOI 10.2307/2532300; Lovell DJ, 2008, NEW ENGL J MED, V359, P810, DOI 10.1056/NEJMoa0706290; Petty RE, 2004, J RHEUMATOL, V31, P390; RAVELLI A, 1995, J RHEUMATOL, V22, P1574; Ravelli A, 2007, LANCET, V369, P767, DOI 10.1016/S0140-6736(07)60363-8; Ruperto N, 1997, J RHEUMATOL, V24, P952; Ruperto N, 2005, ARTHRITIS RHEUM, V52, P2854, DOI 10.1002/art.21230; Ruperto N, 2004, ARTHRITIS RHEUM-US, V50, P2191, DOI 10.1002/art.20288; tenWolde S, 1996, LANCET, V347, P347, DOI 10.1016/S0140-6736(96)90535-8; van Lent PLEM, 2008, ANN RHEUM DIS, V67, P1750, DOI 10.1136/ard.2007.077800; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; WALLACE CA, 1993, J RHEUMATOL, V20, P118; Wallace CA, 2006, J RHEUMATOL, V33, P789; Wallace CA, 2005, ARTHRITIS RHEUM-US, V52, P3554, DOI 10.1002/art.21389; Wallace CA, 2004, J RHEUMATOL, V31, P2290; Woo P, 2000, ARTHRITIS RHEUM-US, V43, P1849, DOI 10.1002/1529-0131(200008)43:8<1849::AID-ANR22>3.0.CO;2-F; Wulffraat NM, 2003, ANN RHEUM DIS, V62, P236, DOI 10.1136/ard.62.3.236; ZurWiesch AS, 2004, CLIN EXP RHEUMATOL, V22, P368	30	182	189	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2010	303	13					1266	1273		10.1001/jama.2010.375	http://dx.doi.org/10.1001/jama.2010.375			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579FM	20371785	Bronze			2022-12-28	WOS:000276353700026
J	Henderson, TO; Amsterdam, A; Bhatia, S; Hudson, MM; Meadows, AT; Neglia, JP; Diller, LR; Constine, LS; Smith, RA; Mahoney, MC; Morris, EA; Montgomery, LL; Landier, W; Smith, SM; Robison, LL; Oeffinger, KC				Henderson, Tara O.; Amsterdam, Alison; Bhatia, Smita; Hudson, Melissa M.; Meadows, Anna T.; Neglia, Joseph P.; Diller, Lisa R.; Constine, Louis S.; Smith, Robert A.; Mahoney, Martin C.; Morris, Elizabeth A.; Montgomery, Leslie L.; Landier, Wendy; Smith, Stephanie M.; Robison, Leslie L.; Oeffinger, Kevin C.			Systematic Review: Surveillance for Breast Cancer in Women Treated With Chest Radiation for Childhood, Adolescent, or Young Adult Cancer	ANNALS OF INTERNAL MEDICINE			English	Review							LONG-TERM SURVIVORS; BRCA2 MUTATION CARRIERS; HODGKINS-DISEASE; RISK-FACTORS; SCREENING MAMMOGRAPHY; SUPRADIAPHRAGMATIC RADIATION; COST-EFFECTIVENESS; FEMALE SURVIVORS; 2ND CANCERS; FOLLOW-UP	Background: Women treated with therapeutic chest radiation may develop breast cancer. Purpose: To summarize breast cancer risk and breast cancer surveillance in women after chest radiation for pediatric or young adult cancer. Data Sources: Studies from MEDLINE, EMBASE, the Cochrane Library, and CINAHL (1966 to December 2008). Study Selection: Articles were selected to answer any of 3 questions: What is the incidence and excess risk for breast cancer in women after chest radiation for pediatric or young adult cancer? For these women, are the clinical characteristics of breast cancer and the outcomes after therapy different from those of women with sporadic breast cancer in the general population? What are the potential benefits and harms associated with breast cancer surveillance among women exposed to chest radiation? Data Extraction: Three investigators independently extracted data and assessed study quality. Data Synthesis: Standardized incidence ratios ranged from 13.3 to 55.5; cumulative incidence of breast cancer by age 40 to 45 years ranged from 13% to 20%. Risk for breast cancer increased linearly with chest radiation dose. Available limited evidence suggests that the characteristics of breast cancer in these women and the outcomes after diagnosis are similar to those of women in the general population; mammography can detect breast cancer, although sensitivity is limited. Limitation: The quality of evidence for key questions 2 and 3 is limited by substantial study heterogeneity, variation in study design, and small sample size. Conclusion: Women treated with chest radiation have a substantially elevated risk for breast cancer at a young age, which does not seem to plateau. In this high-risk population, there seems to be a benefit associated with early detection. Further research is required to better define the harms and benefits of lifelong surveillance.	[Oeffinger, Kevin C.] Mem Sloan Kettering Canc Ctr, Dept Pediat, Mt Sinai Med Ctr, New York, NY 10065 USA; Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; City Hope Natl Med Ctr, Duarte, CA 91010 USA; St Jude Childrens Res Hosp, Memphis, TN 38105 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Univ Minnesota, Minneapolis, MN USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Univ Rochester, Med Ctr, Rochester, NY 14642 USA; Montefiore Einstein Ctr Canc Care, Bronx, NY USA; Roswell Pk Canc Inst, Buffalo, NY 14263 USA	Icahn School of Medicine at Mount Sinai; Memorial Sloan Kettering Cancer Center; University of Chicago; City of Hope; St Jude Children's Research Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Dana-Farber Cancer Institute; University of Rochester; Roswell Park Cancer Institute	Oeffinger, KC (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pediat, Mt Sinai Med Ctr, 1275 York Ave,Box 396, New York, NY 10065 USA.	oeffingk@mskcc.org	Robison, Leslie/N-8122-2018; Giger, Maryellen/AAH-1908-2021; Smith, Robert/AAB-6682-2020; Hudson, Melissa M/N-4441-2018	Hudson, Melissa M/0000-0001-6984-2407; Morris, Elizabeth/0000-0001-5069-0992; Smith, Stephanie/0000-0002-3369-7516; Neglia, Joseph/0000-0002-5525-0598	National Cancer Institute [U10 CA098543]; NATIONAL CANCER INSTITUTE [U10CA098543, R01CA134722] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant Support: By the National Cancer Institute (grant U10 CA098543).	Armstrong K, 2007, ANN INTERN MED, V146, P516, DOI 10.7326/0003-4819-146-7-200704030-00008; Begg CB, 2008, JAMA-J AM MED ASSOC, V299, P194, DOI 10.1001/jama.2007.55-a; de Gonzalez A, 2009, JNCI-J NATL CANCER I, V101, P205, DOI 10.1093/jnci/djn440; Bhatia S, 2003, J CLIN ONCOL, V21, P4386, DOI 10.1200/JCO.2003.11.059; Bhatia S, 1996, NEW ENGL J MED, V334, P745, DOI 10.1056/NEJM199603213341201; Bleyer A, 2006, NIH PUB; Bloom JR, 2006, AM J CLIN ONCOL-CANC, V29, P258, DOI 10.1097/01.coc.0000209447.63640.5a; Bradbury A, 2006, J CLIN ONCOL, V24, P3328, DOI 10.1200/JCO.2006.05.8586; Constine LS, 2008, INT J RADIAT ONCOL, V72, P24, DOI 10.1016/j.ijrobp.2008.04.067; Cutuli B, 2001, RADIOTHER ONCOL, V59, P247, DOI 10.1016/S0167-8140(01)00337-1; De Bruin ML, 2009, J CLIN ONCOL, V27, P4239, DOI 10.1200/JCO.2008.19.9174; de Gonzalez AB, 2005, BRIT J CANCER, V93, P590, DOI 10.1038/sj.bjc.6602683; DERSHAW DD, 1992, RADIOLOGY, V184, P421, DOI 10.1148/radiology.184.2.1320281; DEVITA VH, 2005, CANC PRINCIPLES  PRA; Diller L, 2002, J CLIN ONCOL, V20, P2085, DOI 10.1200/JCO.2002.08.031; Easton DF, 1997, AM J HUM GENET, V61, P120, DOI 10.1086/513891; EASTON DF, 1995, AM J HUM GENET, V56, P265; El-Din MAA, 2009, INT J RADIAT ONCOL, V73, P69, DOI 10.1016/j.ijrobp.2008.03.066; Faulkner K, 2005, RADIAT PROT DOSIM, V117, P330, DOI 10.1093/rpd/nci766; Faulkner K, 2005, RADIAT PROT DOSIM, V117, P318, DOI 10.1093/rpd/nci736; Fay Michael P, 2004, Popul Health Metr, V2, P6, DOI 10.1186/1478-7954-2-6; Fay MP, 2003, STAT MED, V22, P1837, DOI 10.1002/sim.1428; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Garwicz S, 2000, INT J CANCER, V88, P672, DOI 10.1002/1097-0215(20001115)88:4<672::AID-IJC24>3.0.CO;2-N; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; Gervais-Fagnou DD, 1999, ONCOLOGY-BASEL, V57, P224, DOI 10.1159/000012035; Goldfrank D, 2006, CANCER EPIDEM BIOMAR, V15, P2311, DOI 10.1158/1055-9965.EPI-06-0176; Griebsch I, 2006, BRIT J CANCER, V95, P801, DOI 10.1038/sj.bjc.6603356; Guibout C, 2005, J CLIN ONCOL, V23, P197, DOI 10.1200/JCO.2005.06.225; HANCOCK SL, 1993, J NATL CANCER I, V85, P25, DOI 10.1093/jnci/85.1.25; Hartman M, 2007, J CLIN ONCOL, V25, P4210, DOI 10.1200/JCO.2006.10.5056; Hill DA, 2005, BLOOD, V106, P3358, DOI 10.1182/blood-2005-04-1535; Hodgson DC, 2007, CANCER-AM CANCER SOC, V110, P2576, DOI 10.1002/cncr.23081; Inskip PD, 2009, J CLIN ONCOL, V27, P3901, DOI 10.1200/JCO.2008.20.7738; Janov A J, 2001, Breast J, V7, P46, DOI 10.1046/j.1524-4741.2001.007001046.x; Kenney LB, 2004, ANN INTERN MED, V141, P590, DOI 10.7326/0003-4819-141-8-200410190-00006; KREMER LC, 2006, LANDELIJKE RICHTLIJN, V6, P214; Kremer LCM, 2002, ANN ONCOL, V13, P819, DOI 10.1093/annonc/mdf167; Kremer LCM, 2002, ANN ONCOL, V13, P503, DOI 10.1093/annonc/mdf118; Kwong A, 2008, BREAST J, V14, P39, DOI 10.1111/j.1524-4741.2007.00524.x; Landier W, 2004, J CLIN ONCOL, V22, P4979, DOI 10.1200/JCO.2004.11.032; Law J, 2007, BRIT J RADIOL, V80, P261, DOI 10.1259/bjr/20496795; Law J, 2006, BRIT J RADIOL, V79, P479, DOI 10.1259/bjr/33577478; Law J, 2002, BRIT J RADIOL, V75, P678, DOI 10.1259/bjr.75.896.750678; Law J, 2001, BRIT J RADIOL, V74, P1121, DOI 10.1259/bjr.74.888.741121; Lee L, 2008, ANN ONCOL, V19, P62, DOI 10.1093/annonc/mdm440; Mertens AC, 2008, JNCI-J NATL CANCER I, V100, P1368, DOI 10.1093/jnci/djn310; Metayer C, 2000, J CLIN ONCOL, V18, P2435, DOI 10.1200/JCO.2000.18.12.2435; Narod SA, 2006, LANCET ONCOL, V7, P402, DOI 10.1016/S1470-2045(06)70624-6; *NAT CANC I, 2008, DEVCAN PROB DEV DYIN; Ng AK, 2002, BLOOD, V100, P1989, DOI 10.1182/blood-2002-02-0634; Norman RPA, 2007, EUR J HEALTH ECON, V8, P137, DOI 10.1007/s10198-007-0042-9; Oeffinger KC, 2007, JAMA-J AM MED ASSOC, V297, P2762, DOI 10.1001/jama.297.24.2762; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Oeffinger KC, 2009, JAMA-J AM MED ASSOC, V301, P404, DOI 10.1001/jama.2008.1039; Plevritis SK, 2006, JAMA-J AM MED ASSOC, V295, P2374, DOI 10.1001/jama.295.20.2374; Preston DL, 2002, RADIAT RES, V158, P220, DOI 10.1667/0033-7587(2002)158[0220:REOBCR]2.0.CO;2; Quan G, 2008, AM J SURG, V195, P645, DOI 10.1016/j.amjsurg.2008.01.007; RIES LA, 1999, NIH PUBLICATION; Ries LA, 2008, SEER CANC STAT REV 1; Sanna G, 2007, ANN ONCOL, V18, P288, DOI 10.1093/annonc/mdl399; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Simone J.V., 2003, CHILDHOOD CANC SURVI; SKINNER R, 2005, THERAPY BASED LONG T; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Taneja Charu, 2009, J Am Coll Radiol, V6, P171, DOI 10.1016/j.jacr.2008.10.003; Taylor AJ, 2007, INT J CANCER, V120, P384, DOI 10.1002/ijc.22261; Travis LB, 2003, JAMA-J AM MED ASSOC, V290, P465, DOI 10.1001/jama.290.4.465; Travis LB, 2005, JNCI-J NATL CANCER I, V97, P1428, DOI 10.1093/jnci/dji290; *UK DEP HLTH CANC, 2003, INCR RISK BREAST CAN; *US FDA, UPD TRENDS MAMM DOS; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1; Verkooijen HM, 2007, BREAST CANCER RES TR, V105, P347, DOI 10.1007/s10549-006-9455-x; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Wahner-Roedler DL, 2003, MAYO CLIN PROC, V78, P708, DOI 10.4065/78.6.708; Warner E, 2004, JAMA-J AM MED ASSOC, V292, P1317, DOI 10.1001/jama.292.11.1317; Warner E, 2008, ANN INTERN MED, V148, P671, DOI 10.7326/0003-4819-148-9-200805060-00007; Wolden SL, 1998, J CLIN ONCOL, V16, P536, DOI 10.1200/JCO.1998.16.2.536; Wolden SL, 2000, J CLIN ONCOL, V18, P765, DOI 10.1200/JCO.2000.18.4.765; YAHALOM J, 1992, J CLIN ONCOL, V10, P1674, DOI 10.1200/JCO.1992.10.11.1674; Yasui Y, 2003, AM J EPIDEMIOL, V158, P1108, DOI 10.1093/aje/kwg278; Young KC, 2005, BRIT J RADIOL, V78, P207, DOI 10.1259/bjr/41095952	82	158	160	1	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 6	2010	152	7					444	W154		10.7326/0003-4819-152-7-201004060-00009	http://dx.doi.org/10.7326/0003-4819-152-7-201004060-00009			23	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579QI	20368650	Green Accepted			2022-12-28	WOS:000276386900005
J	Sugahara, KN; Teesalu, T; Karmali, PP; Kotamraju, VR; Agemy, L; Greenwald, DR; Ruoslahti, E				Sugahara, Kazuki N.; Teesalu, Tambet; Karmali, Priya Prakash; Kotamraju, Venkata Ramana; Agemy, Lilach; Greenwald, Daniel R.; Ruoslahti, Erkki			Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs	SCIENCE			English	Article							ENDOTHELIAL GROWTH-FACTOR; VASCULAR-PERMEABILITY FACTOR; PHAGE DISPLAY; MOUSE MODEL; IN-VIVO; NANOPARTICLES; DOXORUBICIN; CELL; INTEGRINS; DELIVERY	Poor penetration of anticancer drugs into tumors can be an important factor limiting their efficacy. We studied mouse tumor models to show that a previously characterized tumor-penetrating peptide, iRGD, increased vascular and tissue permeability in a tumor-specific and neuropilin-1-dependent manner, allowing coadministered drugs to penetrate into extravascular tumor tissue. Importantly, this effect did not require the drugs to be chemically conjugated to the peptide. Systemic injection with iRGD improved the therapeutic index of drugs of various compositions, including a small molecule (doxorubicin), nanoparticles (nab-paclitaxel and doxorubicin liposomes), and a monoclonal antibody (trastuzumab). Thus, coadministration of iRGD may be a valuable way to enhance the efficacy of anticancer drugs while reducing their side effects, a primary goal of cancer therapy research.	[Sugahara, Kazuki N.; Teesalu, Tambet; Kotamraju, Venkata Ramana; Agemy, Lilach; Ruoslahti, Erkki] Univ Calif Santa Barbara, Vasc Mapping Lab, Ctr Nanomed, Sanford Burnham Med Res Inst, Santa Barbara, CA 93106 USA; [Karmali, Priya Prakash; Ruoslahti, Erkki] Sanford Burnham Med Res Inst, Canc Res Ctr, La Jolla, CA 92037 USA; [Greenwald, Daniel R.] Canc Ctr Santa Barbara, Santa Barbara Hematol Oncol Med Grp, Santa Barbara, CA 93105 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California Santa Barbara; Sanford Burnham Prebys Medical Discovery Institute	Ruoslahti, E (corresponding author), Univ Calif Santa Barbara, Vasc Mapping Lab, Ctr Nanomed, Sanford Burnham Med Res Inst, Biol 2 Bldg, Santa Barbara, CA 93106 USA.	ruoslahti@burnham.org	Teesalu, Tambet/J-1802-2015		National Cancer Institute of the NIH [CA104898, CA119414, CA119335, CA124427, CA115410, CA30199]; U.S. Department of Defense [BC076050, BC08544]; NATIONAL CANCER INSTITUTE [R01CA115410, P01CA104898, R01CA124427, U54CA119335, R01CA119414, P30CA030199] Funding Source: NIH RePORTER	National Cancer Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. Hanahan for transgenic mice, R. M. Hoffman for the GFP-PC-3 cell line, M. J. Sailor and J.-H. Park for advice on the synthesis of iron oxide nanoworms, and E. Engvall for comments on the manuscript. This work was supported by grants CA104898, CA119414, CA119335, CA124427, CA115410, and CA30199 from the National Cancer Institute of the NIH and grants BC076050 and BC08544 from the U.S. Department of Defense. The authors and their institutions have patents on methods and compositions related to peptides and proteins with C-terminal elements and related to internalizing RGD peptides.	Acevedo LM, 2008, BLOOD, V111, P2674, DOI 10.1182/blood-2007-08-110205; Arola OJ, 2000, CANCER RES, V60, P1789; Black Keith L, 2004, Cancer Control, V11, P165; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; FENDLY BM, 1990, CANCER RES, V50, P1550; Hambley TW, 2009, CANCER RES, V69, P1259, DOI 10.1158/0008-5472.CAN-08-3786; Hoffman JA, 2003, CANCER CELL, V4, P383, DOI 10.1016/S1535-6108(03)00273-3; Jia HY, 2006, J BIOL CHEM, V281, P13493, DOI 10.1074/jbc.M512121200; Joyce JA, 2003, CANCER CELL, V4, P393, DOI 10.1016/S1535-6108(03)00271-X; Karmali PP, 2009, NANOMED-NANOTECHNOL, V5, P73, DOI 10.1016/j.nano.2008.07.007; KOIVUNEN E, 1993, J BIOL CHEM, V268, P20205; KOIVUNEN E, 1995, BIO-TECHNOL, V13, P265, DOI 10.1038/nbt0395-265; Laakkonen P, 2002, NAT MED, V8, P751, DOI 10.1038/nm720; Maeda H, 2003, INT IMMUNOPHARMACOL, V3, P319, DOI 10.1016/S1567-5769(02)00271-0; MILES AA, 1952, J PHYSIOL-LONDON, V118, P228, DOI 10.1113/jphysiol.1952.sp004789; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Monsky WL, 1999, CANCER RES, V59, P4129; Murohara T, 1998, CIRCULATION, V97, P99, DOI 10.1161/01.CIR.97.1.99; Murphy EA, 2008, P NATL ACAD SCI USA, V105, P9343, DOI 10.1073/pnas.0803728105; Park JH, 2009, SMALL, V5, P694, DOI 10.1002/smll.200801789; Pastorino F, 2008, CLIN CANCER RES, V14, P7320, DOI 10.1158/1078-0432.CCR-08-0804; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; Petrioli R, 2008, CANCER TREAT REV, V34, P710, DOI 10.1016/j.ctrv.2008.05.004; Porkka K, 2002, P NATL ACAD SCI USA, V99, P7444, DOI 10.1073/pnas.062189599; Primeau T, 2005, IMMUNOL RES, V32, P109, DOI 10.1385/IR:32:1-3:109; Ruoslahti E, 2002, NAT REV CANCER, V2, P83, DOI 10.1038/nrc724; Ruoslahti E, 2010, J CELL BIOL, V188, P759, DOI 10.1083/jcb.200910104; Sugahara KN, 2009, CANCER CELL, V16, P510, DOI 10.1016/j.ccr.2009.10.013; Tagle Danilo A., 1992, Human Molecular Genetics, V1, P121, DOI 10.1093/hmg/1.2.121; Teesalu T, 2009, P NATL ACAD SCI USA, V106, P16157, DOI 10.1073/pnas.0908201106; YUAN F, 1995, CANCER RES, V55, P3752	32	816	861	14	566	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 21	2010	328	5981					1031	1035		10.1126/science.1183057	http://dx.doi.org/10.1126/science.1183057			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598YW	20378772	Green Accepted			2022-12-28	WOS:000277877100042
J	de Calignon, A; Fox, LM; Pitstick, R; Carlson, GA; Bacskai, BJ; Spires-Jones, TL; Hyman, BT				de Calignon, Alix; Fox, Leora M.; Pitstick, Rose; Carlson, George A.; Bacskai, Brian J.; Spires-Jones, Tara L.; Hyman, Bradley T.			Caspase activation precedes and leads to tangles	NATURE			English	Article							MOUSE MODEL; NEUROFIBRILLARY TANGLES; NEURONAL LOSS; TAU-PHOSPHORYLATION; CONGO RED; CLEAVAGE; AGGREGATION; TRUNCATION; DISSOCIATION; EXPRESSION	Studies of post-mortem tissue have shown that the location of fibrillar tau deposits, called neurofibrillary tangles (NFT), matches closely with regions of massive neuronal death(1,2), severe cytological abnormalities(3), and markers of caspase activation and apoptosis(4-6), leading to the idea that tangles cause neurodegeneration in Alzheimer's disease and tau-related frontotemporal dementia. However, using in vivo multiphoton imaging to observe tangles and activation of executioner caspases in living tau transgenic mice (Tg4510 strain), we find the opposite: caspase activation occurs first, and precedes tangle formation by hours to days. New tangles form within a day. After a new tangle forms, the neuron remains alive and caspase activity seems to be suppressed. Similarly, introduction of wild-type 4-repeat tau (tau-4R) into wild-type animals triggered caspase activation, tau truncation and tau aggregation. Adeno-associated virus-mediated expression of a construct mimicking caspase-cleaved tau into wild-type mice led to the appearance of intracellular aggregates, tangle-related conformational-and phospho-epitopes, and the recruitment of full-length endogenous tau to the aggregates. On the basis of these data, we propose a new model in which caspase activation cleaves tau to initiate tangle formation, then truncated tau recruits normal tau to misfold and form tangles. Because tangle-bearing neurons are long-lived, we suggest that tangles are 'off pathway' to acute neuronal death. Soluble tau species, rather than fibrillar tau, may be the critical toxic moiety underlying neurodegeneration.	[de Calignon, Alix; Fox, Leora M.; Bacskai, Brian J.; Spires-Jones, Tara L.; Hyman, Bradley T.] Harvard Univ, Alzheimers Dis Res Lab, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis,Dept Neurol,Med S, Charlestown, MA 02129 USA; [de Calignon, Alix] Univ Paris 06, F-75005 Paris, France; [Pitstick, Rose; Carlson, George A.] McLaughlin Res Inst, Great Falls, MT 59401 USA	Harvard University; Massachusetts General Hospital; UDICE-French Research Universities; Sorbonne Universite; McLaughlin Research Institute for Biomedical Sciences, Inc.	Hyman, BT (corresponding author), Harvard Univ, Alzheimers Dis Res Lab, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis,Dept Neurol,Med S, Charlestown, MA 02129 USA.	bhyman@partners.org	Spires-Jones, Tara/AAR-7697-2020; Bacskai, Brian/AAE-9583-2021	Spires-Jones, Tara/0000-0003-2530-0598; 	Alzheimer's disease Drug Discovery Foundation; Harvard Medical School Shore Award;  [AG08487];  [AG 026249];  [K99 AG033670-01A1]; NATIONAL INSTITUTE ON AGING [P50AG005134, K99AG033670, R01AG008487, R01AG026249, R29AG008487] Funding Source: NIH RePORTER	Alzheimer's disease Drug Discovery Foundation; Harvard Medical School Shore Award; ; ; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by AG08487, AG 026249, K99 AG033670-01A1, Alzheimer's disease Drug Discovery Foundation, Harvard Medical School Shore Award. We thank W. E. Klunk for his generous gift of compound X-34. A. d. C. is a student in the B2M programme (Universite Pierre and Marie Curie, Paris, France) and the results in this manuscript will be presented in her thesis.	Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Basurto-Islas G, 2008, J NEUROPATH EXP NEUR, V67, P470, DOI 10.1097/NEN.0b013e31817275c7; de Calignon A, 2009, J NEUROPATH EXP NEUR, V68, P757, DOI 10.1097/NEN.0b013e3181a9fc66; Delobel P, 2008, AM J PATHOL, V172, P123, DOI 10.2353/ajpath.2008.070627; Ding HP, 2006, J BIOL CHEM, V281, P19107, DOI 10.1074/jbc.M511697200; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Guillozet-Bongaarts AL, 2006, J NEUROCHEM, V97, P1005, DOI 10.1111/j.1471-4159.2006.03784.x; Guillozet-Bongaarts AL, 2005, NEUROBIOL AGING, V26, P1015, DOI 10.1016/j.neurobiolaging.2004.09.019; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Horowitz PM, 2004, J NEUROSCI, V24, P7895, DOI 10.1523/JNEUROSCI.1988-04.2004; Jaworski T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007280; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Mocanu MM, 2008, J NEUROSCI, V28, P737, DOI 10.1523/JNEUROSCI.2824-07.2008; Park SY, 2007, NEUROSCIENCE, V144, P119, DOI 10.1016/j.neuroscience.2006.09.012; Ramalho RM, 2008, MOL MED, V14, P309, DOI 10.2119/2007-00133.Ramalho; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Rohn TT, 2001, AM J PATHOL, V158, P189, DOI 10.1016/S0002-9440(10)63957-0; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Skoch Jesse, 2004, V299, P349; Spires TL, 2006, AM J PATHOL, V168, P1598, DOI 10.2353/ajpath.2006.050840; Spires-Jones TL, 2008, J NEUROSCI, V28, P862, DOI 10.1523/JNEUROSCI.3072-08.2008; Styren SC, 2000, J HISTOCHEM CYTOCHEM, V48, P1223, DOI 10.1177/002215540004800906; Velasco A, 2008, FEBS LETT, V582, P901, DOI 10.1016/j.febslet.2008.02.025; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; Yin HS, 2006, FEBS LETT, V580, P211, DOI 10.1016/j.febslet.2005.11.077; Zhang QP, 2009, ACTA NEUROPATHOL, V117, P687, DOI 10.1007/s00401-009-0491-6	30	374	393	0	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 22	2010	464	7292					1201	U123		10.1038/nature08890	http://dx.doi.org/10.1038/nature08890			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	586FR	20357768	Green Accepted			2022-12-28	WOS:000276891100039
J	Mahesh, SP; Mathura, JR				Mahesh, Sankaranarayana P.; Mathura, Jeevan R., Jr.			Retinal Hemorrhages Associated with High Altitude	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mahesh, Sankaranarayana P.; Mathura, Jeevan R., Jr.] George Washington Univ, Washington, DC 20052 USA	George Washington University	Mahesh, SP (corresponding author), George Washington Univ, Washington, DC 20052 USA.	maheshs@gwu.edu							0	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 22	2010	362	16					1521	1521		10.1056/NEJMicm0909506	http://dx.doi.org/10.1056/NEJMicm0909506			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	586GP	20410517				2022-12-28	WOS:000276894700012
J	van Santvoort, HC; Besselink, MG; Bakker, OJ; Hofker, HS; Boermeester, MA; Dejong, CH; van Goor, H; Schaapherder, AF; van Eijck, CH; Bollen, TL; van Ramshorst, B; Nieuwenhuijs, VB; Timmer, R; Lameris, JS; Kruyt, PM; Manusama, ER; van der Harst, E; van der Schelling, GP; Karsten, T; Hesselink, EJ; van Laarhoven, CJ; Rosman, C; Bosscha, K; de Wit, RJ; Houdijk, AP; van Leeuwen, MS; Buskens, E; Gooszen, HG				van Santvoort, Hjalmar C.; Besselink, Marc G.; Bakker, Olaf J.; Hofker, H. Sijbrand; Boermeester, Marja A.; Dejong, Cornelis H.; van Goor, Harry; Schaapherder, Alexander F.; van Eijck, Casper H.; Bollen, Thomas L.; van Ramshorst, Bert; Nieuwenhuijs, Vincent B.; Timmer, Robin; Lameris, Johan S.; Kruyt, Philip M.; Manusama, Eric R.; van der Harst, Erwin; van der Schelling, George P.; Karsten, Tom; Hesselink, Eric J.; van Laarhoven, Cornelis J.; Rosman, Camiel; Bosscha, Koop; de Wit, Ralph J.; Houdijk, Alexander P.; van Leeuwen, Maarten S.; Buskens, Erik; Gooszen, Hein G.		Dutch Pancreatitis Study Grp	A Step-up Approach or Open Necrosectomy for Necrotizing Pancreatitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOSCOPIC NECROSECTOMY; SURGICAL INTERVENTION; MANAGEMENT; GUIDELINES; DRAINAGE; PATIENT; LAVAGE	BACKGROUND Necrotizing pancreatitis with infected necrotic tissue is associated with a high rate of complications and death. Standard treatment is open necrosectomy. The outcome may be improved by a minimally invasive step-up approach. METHODS In this multicenter study, we randomly assigned 88 patients with necrotizing pancreatitis and suspected or confirmed infected necrotic tissue to undergo primary open necrosectomy or a step-up approach to treatment. The step-up approach consisted of percutaneous drainage followed, if necessary, by minimally invasive retroperitoneal necrosectomy. The primary end point was a composite of major complications (new-onset multiple-organ failure or multiple systemic complications, perforation of a visceral organ or enterocutaneous fistula, or bleeding) or death. RESULTS The primary end point occurred in 31 of 45 patients (69%) assigned to open necrosectomy and in 17 of 43 patients (40%) assigned to the step-up approach (risk ratio with the step-up approach, 0.57; 95% confidence interval, 0.38 to 0.87; P = 0.006). Of the patients assigned to the step-up approach, 35% were treated with percutaneous drainage only. New-onset multiple-organ failure occurred less often in patients assigned to the step-up approach than in those assigned to open necrosectomy (12% vs. 40%, P = 0.002). The rate of death did not differ significantly between groups (19% vs. 16%, P = 0.70). Patients assigned to the step-up approach had a lower rate of incisional hernias (7% vs. 24%, P = 0.03) and new-onset diabetes (16% vs. 38%, P = 0.02). CONCLUSIONS A minimally invasive step-up approach, as compared with open necrosectomy, reduced the rate of the composite end point of major complications or death among patients with necrotizing pancreatitis and infected necrotic tissue. (Current Controlled Trials number, ISRCTN13975868.)	[Gooszen, Hein G.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [van Santvoort, Hjalmar C.; Besselink, Marc G.; Bakker, Olaf J.; van Leeuwen, Maarten S.; Buskens, Erik; Gooszen, Hein G.] Univ Med Ctr, Utrecht, Netherlands; [Hofker, H. Sijbrand; Nieuwenhuijs, Vincent B.; Buskens, Erik] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Boermeester, Marja A.; Lameris, Johan S.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Dejong, Cornelis H.] Maastricht Univ, Med Ctr, Maastricht, Netherlands; [van Goor, Harry; van Laarhoven, Cornelis J.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Rosman, Camiel] Canisius Wilhelmina Hosp, Nijmegen, Netherlands; [Schaapherder, Alexander F.] Leiden Univ, Med Ctr, Leiden, Netherlands; [van Eijck, Casper H.] Erasmus MC, Rotterdam, Netherlands; [Bollen, Thomas L.; van Ramshorst, Bert; Timmer, Robin] St Antonius Hosp, Nieuwegein, Netherlands; [Kruyt, Philip M.] Gelderse Vallei Hosp, Ede, Netherlands; [Manusama, Eric R.] Leeuwarden Med Ctr, Leeuwarden, Netherlands; [van der Harst, Erwin] Maasstad Hosp, Rotterdam, Netherlands; [van der Schelling, George P.] Amphia Hosp, Breda, Netherlands; [Karsten, Tom] Reinier de Graaf Hosp, Delft, Netherlands; [Hesselink, Eric J.] Gelre Hosp, Apeldoorn, Netherlands; [Bosscha, Koop] Jeroen Bosch Hosp, Den Bosch, Netherlands; [de Wit, Ralph J.] Med Spectrum Twente, Enschede, Netherlands; [Houdijk, Alexander P.] Med Ctr Alkmaar, Alkmaar, Netherlands	Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University; Radboud University Nijmegen; Canisius-Wilhelmina Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; St. Antonius Hospital Utrecht; Gelderse Vallei Hospital; Medical Center Leeuwarden; Maasstad Hospital; Amphia Hospital; Reinier de Graaf Hospital; Gelre Hospitals; Jeroen Bosch Ziekenhuis; Medical Spectrum Twente; Medical Center Of Alkmaar	Gooszen, HG (corresponding author), Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	h.gooszen@ok.umcn.nl	Besselink, Marc G/R-4268-2019; rosman, camiel/F-9059-2016; Besselink, Marc/H-3294-2019; Van Eijck, Casper/ABD-1655-2020; bosscha, koop/AAL-2916-2021; van Eijck, casper/K-5983-2019; Bosscha, Koop/AAC-3641-2020; Prokop, W.M./H-8081-2014; van Laarhoven, C.J.H.M./H-8065-2014; van Goor, H./H-8035-2014; Schelling, Gustav/U-2603-2018; Gooszen, H.G./H-8036-2014; Hermans, John J/L-4367-2015	Besselink, Marc G/0000-0003-2650-9350; rosman, camiel/0000-0002-9152-3987; bosscha, koop/0000-0002-7961-3314; van Goor, H./0000-0003-0323-4876; Schelling, Gustav/0000-0002-6538-0652; Hermans, John J/0000-0001-9207-0548; Prokop, Mathias/0000-0001-8157-8055; buskens, erik/0000-0002-6463-1106; Stoot, Jan/0000-0003-3178-0049	Dutch Organization for Health Research and Development [945-06-910]	Dutch Organization for Health Research and Development	Supported by a grant (945-06-910) from the Dutch Organization for Health Research and Development.	Ashley SW, 2001, ANN SURG, V234, P572, DOI 10.1097/00000658-200110000-00016; Banks PA, 2006, AM J GASTROENTEROL, V101, P2379, DOI 10.1111/j.1572-0241.2006.00856.x; Baril NB, 2000, ANN SURG, V231, P361, DOI 10.1097/00000658-200003000-00009; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; BEGER HG, 1988, WORLD J SURG, V12, P255, DOI 10.1007/BF01658069; Besselink MG, 2007, BRIT J SURG, V94, P604, DOI 10.1002/bjs.5546; Besselink MG, 2006, BRIT J SURG, V93, P593, DOI 10.1002/bjs.5287; Besselink MGH, 2007, ARCH SURG-CHICAGO, V142, P1194, DOI 10.1001/archsurg.142.12.1194; Besselink Marc G H, 2006, BMC Surg, V6, P6, DOI 10.1186/1471-2482-6-6; Bolland K, 2000, STAT MED, V19, P2899, DOI 10.1002/1097-0258(20001115)19:21<2899::AID-SIM597>3.0.CO;2-O; BRADLEY EL, 1993, ARCH SURG-CHICAGO, V128, P586; Buchler MW, 2000, ANN SURG, V232, P619; Carter CR, 2000, ANN SURG, V232, P175, DOI 10.1097/00000658-200008000-00004; Castillo CF, 1998, ANN SURG, V228, P676, DOI 10.1097/00000658-199811000-00007; Charnley RM, 2006, ENDOSCOPY, V38, P925, DOI 10.1055/s-2006-944731; Connor S, 2005, SURGERY, V137, P499, DOI 10.1016/j.surg.2005.01.003; DEFRANCES CJ, 2008, NATL HLTH STAT REPOR, V5, P1; Fagenholz PJ, 2007, PANCREAS, V35, P302, DOI 10.1097/MPA.0b013e3180cac24b; Forsmark CE, 2007, GASTROENTEROLOGY, V132, P2022, DOI 10.1053/j.gastro.2007.03.065; Freeny PC, 1998, AM J ROENTGENOL, V170, P969, DOI 10.2214/ajr.170.4.9530046; Gardner TB, 2009, GASTROINTEST ENDOSC, V69, P1085, DOI 10.1016/j.gie.2008.06.061; Horvath KD, 2001, SURG ENDOSC, V15, P677, DOI 10.1007/s004640080010; Howard TJ, 2007, J GASTROINTEST SURG, V11, P43, DOI 10.1007/s11605-007-0112-4; Luijendijk RW, 2000, NEW ENGL J MED, V343, P392, DOI 10.1056/NEJM200008103430603; Nathens AB, 2004, CRIT CARE MED, V32, P2524, DOI 10.1097/01.CCM.0000148222.09869.92; Papachristou GI, 2007, ANN SURG, V245, P943, DOI 10.1097/01.sla.0000254366.19366.69; Rau B, 2005, SURGERY, V138, P28, DOI 10.1016/j.surg.2005.03.010; Rodriguez JR, 2008, ANN SURG, V247, P294, DOI 10.1097/SLA.0b013e31815b6976; Schafer AR, 2007, J AM HIST, V94, P604, DOI 10.2307/25095052; Seifert H, 2009, GUT, V58, P1260, DOI 10.1136/gut.2008.163733; Shaheen NJ, 2006, AM J GASTROENTEROL, V101, P2128, DOI 10.1111/j.1572-0241.2006.00723.x; Steinberg WM, 2006, PANCREAS, V33, P128, DOI 10.1097/01.mpa.0000234074.76501.a6; Traverso LW, 2005, J GASTROINTEST SURG, V9, P436, DOI 10.1016/j.gassur.2004.05.013; Tsiotos GG, 1998, BRIT J SURG, V85, P1650; Uhl W, 2003, PANCREATOLOGY, V3, DOI 10.1159/000067684; van Santvoort H C, 2007, HPB (Oxford), V9, P156, DOI 10.1080/13651820701225688; van Santvoort HC, 2007, WORLD J SURG, V31, P1635, DOI 10.1007/s00268-007-9083-6; Whitcomb DC, 2006, NEW ENGL J MED, V354, P2142, DOI 10.1056/NEJMcp054958; Windsor JA, 2007, BRIT J SURG, V94, P132, DOI 10.1002/bjs.5723	39	840	873	2	55	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 22	2010	362	16					1491	1502		10.1056/NEJMoa0908821	http://dx.doi.org/10.1056/NEJMoa0908821			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	586GP	20410514	Green Published			2022-12-28	WOS:000276894700008
J	Garcia, D; Crowther, MA; Ageno, W				Garcia, David; Crowther, Mark A.; Ageno, Walter			Practice Pointer Practical management of coagulopathy associated with warfarin	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ORAL VITAMIN-K; EXCESSIVE ANTICOAGULATION; OVER-ANTICOAGULATION; CONTROLLED-TRIAL; THERAPY; RISK; THROMBOEMBOLISM; PLACEBO	When choosing a management strategy for a patient who is being treated with a vitamin K antagonist and presents with an INR outside the therapeutic range, consider the risk of both bleeding and thrombosis	[Garcia, David] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA; [Crowther, Mark A.] McMaster Univ, Dept Internal Med, Hamilton, ON, Canada; [Ageno, Walter] Univ Insubria, Varese, Italy	University of New Mexico; McMaster University; University of Insubria	Garcia, D (corresponding author), Univ New Mexico, Dept Internal Med, MSC08 4630, Albuquerque, NM 87131 USA.	davgarcia@salud.unm.edu		ageno, walter/0000-0002-1922-8879	CSL Behring; Aton Pharmaceuticals and Octapharma	CSL Behring; Aton Pharmaceuticals and Octapharma	Competing interests: DG has received consulting honoraria and research funding from CSL Behring; MC has received research support or honoraria from Aton Pharmaceuticals and Octapharma.	Ageno W, 2005, J AM COLL CARDIOL, V46, P732, DOI 10.1016/j.jacc.2005.05.022; Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Baglin TP, 2006, BRIT J HAEMATOL, V132, P277, DOI 10.1111/j.1365-2141.2005.05856.x; Crowther MA, 1998, THROMB HAEMOSTASIS, V79, P1116; Crowther MA, 2000, LANCET, V356, P1551, DOI 10.1016/S0140-6736(00)03125-1; Crowther MA, 2009, ANN INTERN MED, V150, P293, DOI 10.7326/0003-4819-150-5-200903030-00005; Garcia DA, 2006, J AM COLL CARDIOL, V47, P804, DOI 10.1016/j.jacc.2005.09.058; Garcia DA, 2008, ARCH INTERN MED, V168, P63, DOI 10.1001/archinternmed.2007.23; Gunther KE, 2004, THROMB RES, V113, P205, DOI 10.1016/j.thromres.2004.03.004; Hylek EM, 2001, ANN INTERN MED, V135, P393, DOI 10.7326/0003-4819-135-6-200109180-00008; Leissinger CA, 2008, AM J HEMATOL, V83, P137, DOI 10.1002/ajh.21046; Linkins LA, 2003, ANN INTERN MED, V139, P893, DOI 10.7326/0003-4819-139-11-200312020-00007; Panneerselvam S, 1998, BRIT J HAEMATOL, V103, P422, DOI 10.1046/j.1365-2141.1998.00988.x; Patel RJ, 2000, PHARMACOTHERAPY, V20, P1159, DOI 10.1592/phco.20.15.1159.34585; Rosovsky Rachel P, 2008, Hematology Am Soc Hematol Educ Program, P36, DOI 10.1182/asheducation-2008.1.36; Schulman S, 2003, NEW ENGL J MED, V349, P675, DOI 10.1056/NEJMcp025373; Schulman S, 2008, CHEST, V133, p257S, DOI 10.1378/chest.08-0674; Wysokinski WE, 2008, MAYO CLIN PROC, V83, P639, DOI 10.4065/83.6.639	18	11	12	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 19	2010	340								c1813	10.1136/bmj.c1813	http://dx.doi.org/10.1136/bmj.c1813			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589HK	20404060				2022-12-28	WOS:000277137500001
J	van der Ploeg, AT; Clemens, PR; Corzo, D; Escolar, DM; Florence, J; Groeneveld, GJ; Herson, S; Kishnani, PS; Laforet, P; Lake, SL; Lange, DJ; Leshner, RT; Mayhew, JE; Morgan, C; Nozaki, K; Park, DJ; Pestronk, A; Rosenbloom, B; Skrinar, A; van Capelle, CI; van der Beek, NA; Wasserstein, M; Zivkovic, SA				van der Ploeg, Ans T.; Clemens, Paula R.; Corzo, Deyanira; Escolar, Diana M.; Florence, Julaine; Groeneveld, Geert Jan; Herson, Serge; Kishnani, Priya S.; Laforet, Pascal; Lake, Stephen L.; Lange, Dale J.; Leshner, Robert T.; Mayhew, Jill E.; Morgan, Claire; Nozaki, Kenkichi; Park, Dorothy J.; Pestronk, Alan; Rosenbloom, Barry; Skrinar, Alison; van Capelle, Carine I.; van der Beek, Nadine A.; Wasserstein, Melissa; Zivkovic, Sasa A.			A Randomized Study of Alglucosidase Alfa in Late-Onset Pompe's Disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENZYME REPLACEMENT THERAPY; NATURAL COURSE; GLUCOSIDASE; CHILDREN; MULTICENTER; INFANTS; VALUES; ADULT; AGE	Background: Pompe's disease is a metabolic myopathy caused by a deficiency of acid alpha glucosidase (GAA), an enzyme that degrades lysosomal glycogen. Late-onset Pompe's disease is characterized by progressive muscle weakness and loss of respiratory function, leading to early death. We conducted a randomized, placebo-controlled trial of alglucosidase alfa, a recombinant human GAA, for the treatment of late-onset Pompe's disease. Methods: Ninety patients who were 8 years of age or older, ambulatory, and free of invasive ventilation were randomly assigned to receive biweekly intravenous alglucosidase alfa (20 mg per kilogram of body weight) or placebo for 78 weeks at eight centers in the United States and Europe. The two primary end points were distance walked during a 6-minute walk test and percentage of predicted forced vital capacity (FVC). Results: At 78 weeks, the estimated mean changes from baseline in the primary end points favored alglucosidase alfa (an increase of 28.1+/-13.1 m on the 6-minute walk test and an absolute increase of 3.4+/-1.2 percentage points in FVC; P=0.03 and P=0.006, respectively). Similar proportions of patients in the two groups had adverse events, serious adverse events, and infusion-associated reactions; events that occurred only in patients who received the active study drug included anaphylactic reactions and infusion-associated reactions of urticaria, flushing, hyperhidrosis, chest discomfort, vomiting, and increased blood pressure (each of which occurred in 5 to 8% of the patients). Conclusions: In this study population, treatment with alglucosidase alfa was associated with improved walking distance and stabilization of pulmonary function over an 18-month period. (ClinicalTrials.gov number, NCT00158600.) N Engl J Med 2010;362:1396-406.	[van der Ploeg, Ans T.] Erasmus MC Univ, Med Ctr, Div Metab Dis & Genet, Dept Pediat,Ctr Lysosomal & Metab Dis, NL-3015 GJ Rotterdam, Netherlands; [van der Ploeg, Ans T.; van Capelle, Carine I.; van der Beek, Nadine A.] Erasmus MC Univ, Med Ctr, Dept Internal Med, NL-3015 GJ Rotterdam, Netherlands; [van der Ploeg, Ans T.; van Capelle, Carine I.; van der Beek, Nadine A.] Erasmus MC Univ, Med Ctr, Dept Clin Genet, NL-3015 GJ Rotterdam, Netherlands; [van der Ploeg, Ans T.; van Capelle, Carine I.; van der Beek, Nadine A.] Erasmus MC Univ, Med Ctr, Dept Neurol, NL-3015 GJ Rotterdam, Netherlands; [van der Ploeg, Ans T.; van Capelle, Carine I.; van der Beek, Nadine A.] Erasmus MC Univ, Med Ctr, Dept Hosp Pharm, Ctr Lysosomal & Metab Dis, NL-3015 GJ Rotterdam, Netherlands; [Clemens, Paula R.; Zivkovic, Sasa A.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Clemens, Paula R.; Zivkovic, Sasa A.] Dept Vet Affairs Med Ctr, Neurol Serv, Pittsburgh, PA USA; [Corzo, Deyanira; Groeneveld, Geert Jan; Lake, Stephen L.; Morgan, Claire; Pestronk, Alan] Genzyme, Cambridge, MA USA; [Escolar, Diana M.; Leshner, Robert T.; Mayhew, Jill E.] Childrens Natl Med Ctr, Dept Neurol, Ctr Genet Med, Washington, DC 20010 USA; [Florence, Julaine; Nozaki, Kenkichi; Pestronk, Alan] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63130 USA; [Herson, Serge; Laforet, Pascal] Hop La Pitie Salpetriere, AP HP, Ctr Reference Pathol Neuromusculaire, Paris, France; [Kishnani, Priya S.] Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, Durham, NC 27710 USA; [Lange, Dale J.; Wasserstein, Melissa] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Park, Dorothy J.; Rosenbloom, Barry] Tower Hematol Oncol, Beverly Hills, CA USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Sanofi-Aventis; Genzyme Corporation; Children's National Health System; Washington University (WUSTL); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Duke University; Icahn School of Medicine at Mount Sinai	van der Ploeg, AT (corresponding author), Erasmus MC Univ, Med Ctr, Div Metab Dis & Genet, Dept Pediat,Ctr Lysosomal & Metab Dis, Dr Molewaterpl 60, NL-3015 GJ Rotterdam, Netherlands.	a.vanderploeg@erasmusmc.nl		van der Beek, Nadine/0000-0001-9161-3301; Groeneveld, Geert Jan/0000-0002-4655-6667	Genzyme Corporation	Genzyme Corporation(Sanofi-AventisGenzyme Corporation)	Funded by the Genzyme Corporation.	Aldrich TK, 2002, AM J RESP CRIT CARE, V166, P548, DOI 10.1164/rccm.166.4.518; Amalfitano A, 2001, GENET MED, V3, P132, DOI 10.1097/00125817-200103000-00008; Angelini Corrado, 2009, Ther Adv Neurol Disord, V2, P143, DOI 10.1177/1756285609103324; [Anonymous], 1996, Arch Phys Med Rehabil, V77, P1251; BLACK LF, 1969, AM REV RESPIR DIS, V99, P696; Chen YT, 2000, MOL MED TODAY, V6, P245, DOI 10.1016/S1357-4310(00)01694-4; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Hagemans MLC, 2005, NEUROLOGY, V64, P2139, DOI 10.1212/01.WNL.0000165979.46537.56; Hagemans MLC, 2005, BRAIN, V128, P671, DOI 10.1093/brain/awh384; Hagemans MLC, 2004, NEUROLOGY, V63, P1688, DOI 10.1212/01.WNL.0000142597.69707.78; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hirschhorn R, 2001, METABOLIC MOL BASES, P3389; Kishnani PS, 2007, NEUROLOGY, V68, P99, DOI 10.1212/01.wnl.0000251268.41188.04; Kishnani PS, 2006, J PEDIATR-US, V148, P671, DOI 10.1016/j.jpeds.2005.11.033; Kishnani PS, 2009, PEDIATR RES, V66, P329, DOI 10.1203/PDR.0b013e3181b24e94; Kishnani PS, 2006, J PEDIATR-US, V149, P89, DOI 10.1016/j.jpeds.2006.02.035; Laforet P, 2000, NEUROLOGY, V55, P1122, DOI 10.1212/WNL.55.8.1122; Mayhew JE, 2007, MUSCLE NERVE, V35, P36, DOI 10.1002/mus.20654; MEHTA CR, 2000, DIA J, V35, P1095; Mellies U, 2005, NEUROLOGY, V64, P1465, DOI 10.1212/01.WNL.0000158682.85052.C0; Muller-Felber W, 2007, NEUROMUSCULAR DISORD, V17, P698, DOI 10.1016/j.nmd.2007.06.002; Nicolino M, 2009, GENET MED, V11, P210, DOI 10.1097/GIM.0b013e31819d0996; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; STROTHOTTE S, 2009, J NEUROL, P257; Thurberg BL, 2006, LAB INVEST, V86, P1208, DOI 10.1038/labinvest.3700484; van Capelle CI, 2008, NEUROMUSCULAR DISORD, V18, P447, DOI 10.1016/j.nmd.2008.04.009; Van den Hout H, 2000, LANCET, V356, P397, DOI 10.1016/S0140-6736(00)02533-2; van den Hout HMP, 2003, PEDIATRICS, V112, P332, DOI 10.1542/peds.112.2.332; Van der Beek NAME, 2009, NEUROMUSCULAR DISORD, V19, P113, DOI 10.1016/j.nmd.2008.11.007; van der Ploeg AT, 2008, LANCET, V372, P1342, DOI 10.1016/S0140-6736(08)61555-X; Wang JH, 2008, NAT BIOTECHNOL, V26, P901, DOI 10.1038/nbt.1484; Ware JE, 2007, USERS MANUAL SF 36V2; Winkel LPF, 2004, ANN NEUROL, V55, P495, DOI 10.1002/ana.20019; Wokke JHJ, 2008, MUSCLE NERVE, V38, P1236, DOI 10.1002/mus.21025	34	460	467	2	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 15	2010	362	15					1396	1406		10.1056/NEJMoa0909859	http://dx.doi.org/10.1056/NEJMoa0909859			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582XY	20393176				2022-12-28	WOS:000276635300008
J	Cochrane, GM; du Toit, R; Le Mesurier, RT				Cochrane, Gillian M.; du Toit, Renee; Le Mesurier, Richard T.			Management of refractive errors	BRITISH MEDICAL JOURNAL			English	Review							QUALITY-OF-LIFE; VISUAL IMPAIRMENT; GLOBAL BURDEN; CHILDREN; MYOPIA; KERATOCONUS; PROGRESSION; POPULATION; PREVALENCE; ATROPINE		[Le Mesurier, Richard T.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Fred Hollows Fdn, Melbourne, Vic, Australia; [Cochrane, Gillian M.] Vis Cooperat Res Ctr, Sydney, NSW, Australia; [du Toit, Renee] Fred Hollows Fdn New Zealand, Auckland, New Zealand; [Le Mesurier, Richard T.] Fred Hollows Fdn, Sydney, NSW, Australia; [Le Mesurier, Richard T.] Int Agcy Prevent Blindness, Fred Hollows Fdn, Melbourne, Vic, Australia; [Le Mesurier, Richard T.] Int Council Ophthalmol Uncorrected Refract Error, Fred Hollows Fdn, San Francisco, CA USA	Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; Visa Inc	Cochrane, GM (corresponding author), CERA, 32 Gisborne St, Melbourne, Vic 3002, Australia.	cochrane.gm@gmail.com			Australian Federal Government; Centre for Eye Research Australia; University of Melbourne; Royal Victorian Eye and Ear Hospital	Australian Federal Government(Australian Government); Centre for Eye Research Australia; University of Melbourne(University of Melbourne); Royal Victorian Eye and Ear Hospital	This research at the Vision Cooperative Research Centre was partly facilitated by the Australian Federal Government through the Cooperative Research Centres Program and also by the Centre for Eye Research Australia, the University of Melbourne, and the Royal Victorian Eye and Ear Hospital.	Baltussen R, 2009, HEALTH POLICY, V89, P201, DOI 10.1016/j.healthpol.2008.06.003; Braverman R, 2007, CURR OPIN OPHTHALMOL, V18, P379, DOI 10.1097/ICU.0b013e328244dfed; Chia EM, 2006, OPHTHAL EPIDEMIOL, V13, P371, DOI 10.1080/09286580600864794; Chiang PPC, 2006, LANCET, V368, P365, DOI 10.1016/S0140-6736(06)69105-8; Coleman AL, 2006, J AM GERIATR SOC, V54, P883, DOI 10.1111/j.1532-5415.2006.00817.x; ELLWEIN LB, 2002, J COMM EYE HLTH, V15, P37; Evans BJW, 2004, OPHTHAL PHYSL OPT, V24, P161, DOI 10.1111/j.1475-1313.2004.00197.x; Gilbert CE, 2008, BMJ-BRIT MED J, V336, P29, DOI 10.1136/bmj.39395.500046.AE; Holden BA, 2008, ARCH OPHTHALMOL-CHIC, V126, P1731, DOI 10.1001/archopht.126.12.1731; KENNEDY RH, 1986, AM J OPHTHALMOL, V101, P267, DOI 10.1016/0002-9394(86)90817-2; Lee JJ, 2006, J OCUL PHARMACOL TH, V22, P41, DOI 10.1089/jop.2006.22.41; Mutti DO, 2005, INVEST OPHTH VIS SCI, V46, P3074, DOI 10.1167/iovs.04-1040; Pearson AR, 2000, EYE, V14, P625, DOI 10.1038/eye.2000.154; Ramke J, 2008, CLIN EXP OPHTHALMOL, V36, P339, DOI 10.1111/j.1442-9071.2008.01768.x; Resnikoff S, 2008, B WORLD HEALTH ORGAN, V86, P63, DOI 10.2471/BLT.07.041210; Rose KA, 2008, ARCH OPHTHALMOL-CHIC, V126, P527, DOI 10.1001/archopht.126.4.527; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; Salcido AA, 2005, J AAPOS, V9, P114, DOI 10.1016/j.jaapos.2003.10.011; Scanlon PH, 2008, BRIT J OPHTHALMOL, V92, P775, DOI 10.1136/bjo.2007.128561; Shih YF, 2001, ACTA OPHTHALMOL SCAN, V79, P233, DOI 10.1034/j.1600-0420.2001.790304.x; Smith TST, 2009, B WORLD HEALTH ORGAN, V87, P431, DOI 10.2471/BLT.08.055673; Taylor HR, 2005, MED J AUSTRALIA, V182, P565, DOI 10.5694/j.1326-5377.2005.tb06815.x; Taylor HR, 2003, INVEST OPHTH VIS SCI, V44, P1413, DOI 10.1167/iovs.02-0571; Varughese S, 2005, CURR EYE RES, V30, P423, DOI 10.1080/02713680590959295; Vincent JE, 2007, CLIN EXP OPTOM, V90, P429, DOI 10.1111/j.1444-0938.2007.00193.x; Vincent JE, 2006, OPTOMETRY VISION SCI, V83, P803, DOI 10.1097/01.opx.0000239126.46172.80; Vitale S, 2006, JAMA-J AM MED ASSOC, V295, P2158, DOI 10.1001/jama.295.18.2158; Webber AL, 2007, CLIN EXP OPTOM, V90, P250, DOI 10.1111/j.1444-0938.2007.00164.x; Wedner S, 2008, BRIT J OPHTHALMOL, V92, P19, DOI 10.1136/bjo.2007.119198; Williams WR, 2005, ARCH DIS CHILD, V90, P150, DOI 10.1136/adc.2003.046755	30	6	7	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 12	2010	340								c1711	10.1136/bmj.c1711	http://dx.doi.org/10.1136/bmj.c1711			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	586JS	20385718				2022-12-28	WOS:000276904100002
J	Aldrich, TK; Gustave, J; Hall, CB; Cohen, HW; Webber, MP; Zeig-Owens, R; Cosenza, K; Christodoulou, V; Glass, L; Al-Othman, F; Weiden, MD; Kelly, KJ; Prezant, DJ				Aldrich, Thomas K.; Gustave, Jackson; Hall, Charles B.; Cohen, Hillel W.; Webber, Mayris P.; Zeig-Owens, Rachel; Cosenza, Kaitlyn; Christodoulou, Vasilios; Glass, Lara; Al-Othman, Fairouz; Weiden, Michael D.; Kelly, Kerry J.; Prezant, David J.			Lung Function in Rescue Workers at the World Trade Center after 7 Years.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PULMONARY-FUNCTION; CENTER DUST; FOLLOW-UP; RESPIRATORY SYMPTOMS; CENTER DISASTER; FIRE FIGHTERS; FIREFIGHTERS; EXPOSURE; SPIROMETRY; SMOKE	Background: The terrorist attacks on the World Trade Center on September 11, 2001, exposed thousands of Fire Department of New York City (FDNY) rescue workers to dust, leading to substantial declines in lung function in the first year. We sought to determine the longer-term effects of exposure. Methods: Using linear mixed models, we analyzed the forced expiratory volume in 1 second (FEV(sub 1)) of both active and retired FDNY rescue workers on the basis of spirometry routinely performed at intervals of 12 to 18 months from March 12, 2000, to September 11, 2008. Results: Of the 13,954 FDNY workers who were present at the World Trade Center between September 11, 2001, and September 24, 2001, a total of 12,781 (91.6%) participated in this study, contributing 61,746 quality-screened spirometric measurements. The median follow-up was 6.1 years for firefighters and 6.4 years for emergency-medical-services (EMS) workers. In the first year, the mean FEV(sub 1) decreased significantly for all workers, more for firefighters who had never smoked (a reduction of 439 ml; 95% confidence interval [CI], 408 to 471) than for EMS workers who had never smoked (a reduction of 267 ml; 95% CI, 263 to 271) (P<0.001 for both comparisons). There was little or no recovery in FEV(sub 1) during the subsequent 6 years, with a mean annualized reduction in FEV(sub 1) of 25 ml per year for firefighters and 40 ml per year for EMS workers. The proportion of workers who had never smoked and who had an FEV(sub 1) below the lower limit of the normal range increased during the first year, from 3% to 18% for firefighters and from 12% to 22% for EMS workers, stabilizing at about 13% for firefighters and 22% for EMS workers during the subsequent 6 years. Conclusions: Exposure to World Trade Center dust led to large declines in FEV(sub 1) for FDNY rescue workers during the first year. Overall, these declines were persistent, without recovery over the next 6 years, leaving a substantial proportion of workers with abnormal lung function. N Engl J Med 2010;362:1263-72.	[Aldrich, Thomas K.; Zeig-Owens, Rachel; Al-Othman, Fairouz; Prezant, David J.] Montefiore Med Ctr, Dept Med, Div Pulm Med, Bronx, NY 10467 USA; [Hall, Charles B.; Cohen, Hillel W.] Albert Einstein Coll Med, Div Biostat, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Cohen, Hillel W.; Webber, Mayris P.] Albert Einstein Coll Med, Div Epidemiol, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Gustave, Jackson; Webber, Mayris P.; Zeig-Owens, Rachel; Cosenza, Kaitlyn; Christodoulou, Vasilios; Glass, Lara; Weiden, Michael D.; Kelly, Kerry J.; Prezant, David J.] Bur Hlth Serv, Brooklyn, NY USA; [Prezant, David J.] New York City Fire Dept, WTC Med Monitoring Program, Off Med Affairs, Brooklyn, NY 11201 USA; [Weiden, Michael D.] NYU, Dept Med, Div Pulm Med, New York, NY 10016 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; New York University	Prezant, DJ (corresponding author), New York City Fire Dept, WTC Med Monitoring Program, Off Med Affairs, 9 Metrotech Ctr,Rm 4W-1, Brooklyn, NY 11201 USA.	prezand@fdny.nyc.gov	Hall, Charles B./AAX-8216-2020; Zeig-Owens, Rachel/HIA-8364-2022	Cohen, Hillel/0000-0002-4524-0898; Hall, Charles/0000-0001-9982-8120	National Institute of Occupational Safety and Health [U10-OH008243, U10-OH008242, R01-OH07350]; National Institutes of Health [M01 00096, K23HL084191, K24A1080298, R01HL057879]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057879, K23HL084191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [U10OH008242, U10OH008243] Funding Source: NIH RePORTER	National Institute of Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	Supported by grants (U10-OH008243, U10-OH008242, and R01-OH07350) from the National Institute of Occupational Safety and Health and grants (M01 00096, K23HL084191, K24A1080298, and R01HL057879) from the National Institutes of Health.	Banauch GI, 2003, AM J RESP CRIT CARE, V168, P54, DOI 10.1164/rccm.200211-1329OC; Banauch GI, 2006, AM J RESP CRIT CARE, V174, P312, DOI 10.1164/rccm.200511-1736OC; Brackbill RM, 2009, JAMA-J AM MED ASSOC, V302, P502, DOI 10.1001/jama.2009.1121; Buyantseva LV, 2007, J OCCUP ENVIRON MED, V49, P310, DOI 10.1097/JOM.0b013e318032256e; Feldman DM, 2004, CHEST, V125, P1256, DOI 10.1378/chest.125.4.1256; Fireman EM, 2004, ENVIRON HEALTH PERSP, V112, P1564, DOI 10.1289/ehp.7233; Gaughan DM, 2008, J OCCUP ENVIRON MED, V50, P1019, DOI 10.1097/JOM.0b013e3181754161; GIBBS L, 2008, WORLD TRADE CTR MED; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Herbert R, 2006, ENVIRON HEALTH PERSP, V114, P1853, DOI 10.1289/ehp.9592; Kerstjens HAM, 1997, THORAX, V52, P820, DOI 10.1136/thx.52.9.820; LARGE AA, 1990, CHEST, V97, P806, DOI 10.1378/chest.97.4.806; Lebowitz MD, 1996, AM J RESP CRIT CARE, V154, pS273, DOI 10.1164/ajrccm/154.6_Pt_2.S273; LIANG KY, 1993, ANNU REV PUBL HEALTH, V14, P43, DOI 10.1146/annurev.pu.14.050193.000355; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; MUSK AW, 1977, AM J PUBLIC HEALTH, V67, P630, DOI 10.2105/AJPH.67.7.630; MUSK AW, 1979, BRIT J IND MED, V36, P29; MUSK AW, 1977, AM J PUBLIC HEALTH, V67, P626, DOI 10.2105/AJPH.67.7.626; Reibman J, 2009, J OCCUP ENVIRON MED, V51, P534, DOI 10.1097/JOM.0b013e3181a0365b; Schouten JP, 1996, AM J RESP CRIT CARE, V154, pS278, DOI 10.1164/ajrccm/154.6_Pt_2.S278; Skloot G, 2004, CHEST, V125, P1248, DOI 10.1378/chest.125.4.1248; Skloot GS, 2009, CHEST, V135, P492, DOI 10.1378/chest.08-1391; SMITH TJ, 1978, INT ARCH OCC ENV HEA, V41, P139, DOI 10.1007/BF00381798; TASHKIN DP, 1977, CHEST, V71, P445, DOI 10.1378/chest.71.4.445; Webber MP, 2009, ENVIRON HEALTH PERSP, V117, P975, DOI 10.1289/ehp.0800291; Weiden MD, 2010, CHEST, V137, P566, DOI 10.1378/chest.09-1580	27	145	145	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 8	2010	362	14					1263	1272		10.1056/NEJMoa0910087	http://dx.doi.org/10.1056/NEJMoa0910087			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579SN	20375403	Bronze, Green Accepted			2022-12-28	WOS:000276393700005
J	Harris, KM; Henry, JT; Rohman, E; Haas, TS; Maron, BJ				Harris, Kevin M.; Henry, Jason T.; Rohman, Eric; Haas, Tammy S.; Maron, Barry J.			Sudden Death During the Triathlon	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Harris, Kevin M.; Henry, Jason T.; Rohman, Eric; Haas, Tammy S.; Maron, Barry J.] Abbott NW Hosp, Minneapolis Heart Inst Fdn, Minneapolis, MN 55407 USA	Minneapolis Heart Institute Foundation	Harris, KM (corresponding author), Abbott NW Hosp, Minneapolis Heart Inst Fdn, Minneapolis, MN 55407 USA.	kharris@mplsheart.com						Dallam GM, 2005, SPORTS MED, V35, P143, DOI 10.2165/00007256-200535020-00004; Douglas PS, 1997, AM J CARDIOL, V80, P1384, DOI 10.1016/S0002-9149(97)00693-0; Maron BJ, 2009, CIRCULATION, V119, P1085, DOI 10.1161/CIRCULATIONAHA.108.804617; Redelmeier DA, 2007, BRIT MED J, V335, P1275, DOI 10.1136/bmj.39384.551539.25; Rifai N, 1999, AM J CARDIOL, V83, P1085, DOI 10.1016/S0002-9149(99)00020-X	5	60	60	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2010	303	13					1255	1257		10.1001/jama.2010.368	http://dx.doi.org/10.1001/jama.2010.368			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579FM	20371783				2022-12-28	WOS:000276353700019
J	Bhutta, ZA; Lassi, ZS				Bhutta, Zulfiqar A.; Lassi, Zohra S.			Empowering communities for maternal and newborn health	LANCET			English	Editorial Material							CARE; MORTALITY; INTERVENTION; STRATEGIES; SURVIVAL		[Bhutta, Zulfiqar A.; Lassi, Zohra S.] Aga Khan Univ, Women & Child Hlth Div, Karachi 74800, Pakistan	Aga Khan University	Bhutta, ZA (corresponding author), Aga Khan Univ, Women & Child Hlth Div, Karachi 74800, Pakistan.	zulfiqar.bhutta@aku.edu						Azad K, 2010, LANCET, V375, P1193, DOI 10.1016/S0140-6736(10)60142-0; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Bhutta ZA, 2008, B WORLD HEALTH ORGAN, V86, P452, DOI 10.2471/BLT.07.045849; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Carlo WA, 2010, NEW ENGL J MED, V362, P614, DOI 10.1056/NEJMsa0806033; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Pagel C, 2009, LANCET, V374, P1441, DOI 10.1016/S0140-6736(09)61566-X; Rahman A, 2008, LANCET, V372, P902, DOI 10.1016/S0140-6736(08)61400-2; Rosato M, 2006, LANCET, V368, P1180, DOI 10.1016/S0140-6736(06)69475-0; Tripathy P, 2010, LANCET, V375, P1182, DOI 10.1016/S0140-6736(09)62042-0; *US SECR GEN, 2009, MILL DEV GOALS REP 2	14	20	20	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 3	2010	375	9721					1142	1144		10.1016/S0140-6736(10)60324-8	http://dx.doi.org/10.1016/S0140-6736(10)60324-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	585VL	20362800				2022-12-28	WOS:000276858200007
J	Skibbe, DS; Doehlemann, G; Fernandes, J; Walbot, V				Skibbe, David S.; Doehlemann, Gunther; Fernandes, John; Walbot, Virginia			Maize Tumors Caused by Ustilago maydis Require Organ-Specific Genes in Host and Pathogen	SCIENCE			English	Article							TRANSCRIPTOME; EFFECTORS; GENOME	Infection of maize by corn smut (Ustilago maydis) provides an agronomically important model of biotrophic host-pathogen interactions. After penetration of the maize epidermis, fungal colonization of host tissue induces tumor formation on all aerial maize organs. We hypothesized that transformation of different primordia into plant tumors would require organ-specific gene expression by both host and pathogen and documented these differences by transcriptome profiling. Phenotypic screening of U. maydis mutants deleted for genes encoding secreted proteins and maize mutants with organ-specific defects confirmed organ-restricted tumorigenesis. This is the foundation for exploring how individual pathogen effectors, deployed in an organ-specific pattern, interact with host factors to reprogram normal ontogeny into a tumor pathway.	[Skibbe, David S.; Fernandes, John; Walbot, Virginia] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Doehlemann, Gunther] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany	Stanford University; Max Planck Society	Walbot, V (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	walbot@stanford.edu	Doehlemann, Gunther/C-1777-2008	Walbot, Virginia/0000-0002-1596-7279; Doehlemann, Gunther/0000-0002-7353-8456	NSF [IOS-0852788]; Savitzky Fund; European Molecular Biology Organization; Deutsche Forschungsgemeinschaft [FOR 666]	NSF(National Science Foundation (NSF)); Savitzky Fund; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Research was supported by NSF grant IOS-0852788 (V. W.), the Savitzky Fund (D. S. S.), European Molecular Biology Organization STF program (G. D.), and Deutsche Forschungsgemeinschaft priority program FOR 666. We thank R. Kahmann for U. maydis strains. We appreciate critical comments on this manuscript by R. Kahmann, R. Fisher, and M. Barnett. Microarray data have been deposited in Gene Expression Omnibus (GEO) under accession GSE20130.	Banuett F, 2002, MYCOLOGY S, V15, P349; Barazesh S, 2008, TRENDS PLANT SCI, V13, P656, DOI 10.1016/j.tplants.2008.09.007; Bolduc N, 2009, PLANT CELL, V21, P1647, DOI 10.1105/tpc.109.068221; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; CALLOW JA, 1975, NEW PHYTOL, V75, P253, DOI 10.1111/j.1469-8137.1975.tb01394.x; Dodds PN, 2009, NEW PHYTOL, V183, P993, DOI 10.1111/j.1469-8137.2009.02922.x; Doehlemann G, 2008, PLANT J, V56, P181, DOI 10.1111/j.1365-313X.2008.03590.x; Doehlemann G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000290; Fernandes J, 2008, PLANT BIOTECHNOL J, V6, P782, DOI 10.1111/j.1467-7652.2008.00360.x; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Ma J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r22; Martinez-Espinoza AD, 2002, FUNGAL GENET BIOL, V35, P1, DOI 10.1006/fgbi.2001.1301; Mueller O, 2008, FUNGAL GENET BIOL, V45, pS63, DOI 10.1016/j.fgb.2008.03.012; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Skibbe DS, 2009, PLANT J, V59, P622, DOI 10.1111/j.1365-313X.2009.03901.x; SMITH LG, 1992, DEVELOPMENT, V116, P21; Takken FLW, 2009, SCIENCE, V324, P744, DOI 10.1126/science.1171666; Walbot V, 2010, SEX PLANT REPROD, V23, P1, DOI 10.1007/s00497-009-0109-0	19	145	151	0	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	2010	328	5974					89	92		10.1126/science.1185775	http://dx.doi.org/10.1126/science.1185775			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577DR	20360107				2022-12-28	WOS:000276202200041
J	Neely, GG; Kuba, K; Cammarato, A; Isobe, K; Amann, S; Zhang, LY; Murata, M; Elmen, L; Gupta, V; Arora, S; Sarangi, R; Dan, D; Fujisawa, S; Usami, T; Xia, CP; Keene, AC; Alayari, NN; Yamakawa, H; Elling, U; Berger, C; Novatchkova, M; Koglgruber, R; Fukuda, K; Nishina, H; Isobe, M; Pospisilik, JA; Imai, Y; Pfeufer, A; Hicks, AA; Pramstaller, PP; Subramaniam, S; Kimura, A; Ocorr, K; Bodmer, R; Penninger, JM				Neely, G. Gregory; Kuba, Keiji; Cammarato, Anthony; Isobe, Kazuya; Amann, Sabine; Zhang, Liyong; Murata, Mitsushige; Elmen, Lisa; Gupta, Vaijayanti; Arora, Suchir; Sarangi, Rinku; Dan, Debasis; Fujisawa, Susumu; Usami, Takako; Xia, Cui-ping; Keene, Alex C.; Alayari, Nakissa N.; Yamakawa, Hiroyuki; Elling, Ulrich; Berger, Christian; Novatchkova, Maria; Koglgruber, Rubina; Fukuda, Keiichi; Nishina, Hiroshi; Isobe, Mitsuaki; Pospisilik, J. Andrew; Imai, Yumiko; Pfeufer, Arne; Hicks, Andrew A.; Pramstaller, Peter P.; Subramaniam, Sai; Kimura, Akinori; Ocorr, Karen; Bodmer, Rolf; Penninger, Josef M.			A Global In Vivo Drosophila RNAi Screen Identifies NOT3 as a Conserved Regulator of Heart Function	CELL			English	Article							QT INTERVAL DURATION; CARDIAC-ARRHYTHMIAS; COMMON VARIANTS; MUTATIONS; COMPLEX; DYSFUNCTION; CHANNELS; DISEASE; MOUSE	Heart diseases are the most common causes of morbidity and death in humans. Using cardiac-specific RNAi-silencing in Drosophila, we knocked down 7061 evolutionarily conserved genes under conditions of stress. We present a first global road-map of pathways potentially playing conserved roles in the cardiovascular system. One critical pathway identified was the CCR4-Not complex implicated in transcriptional and posttranscriptional regulatory mechanisms. Silencing of CCR4-Not components in adult Drosophila resulted in myofibrillar disarray and dilated cardiomyopathy. Heterozygous not3 knockout mice showed spontaneous impairment of cardiac contractility and increased susceptibility to heart failure. These heart defects were reversed via inhibition of HDACs, suggesting a mechanistic link to epigenetic chromatin remodeling. In humans, we show that a common NOT3 SNP correlates with altered cardiac QT intervals, a known cause of potentially lethal ventricular tachyarrhythmias. Thus, our functional genome-wide screen in Drosophila can identify candidates that directly translate into conserved mammalian genes involved in heart function.	[Kuba, Keiji; Isobe, Kazuya; Fujisawa, Susumu; Imai, Yumiko] Akita Univ, Grad Sch Med, Dept Biol Informat & Expt Therapeut, Akita 0108543, Japan; [Neely, G. Gregory; Amann, Sabine; Xia, Cui-ping; Elling, Ulrich; Berger, Christian; Novatchkova, Maria; Koglgruber, Rubina; Pospisilik, J. Andrew; Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol IMBA, A-1030 Vienna, Austria; [Cammarato, Anthony; Elmen, Lisa; Alayari, Nakissa N.; Ocorr, Karen; Bodmer, Rolf] Sanford Burnham Med Res Inst, Del E Webb Neurosci Aging & Stem Cell Res Ctr, Dev & Aging Program, La Jolla, CA 92037 USA; [Isobe, Kazuya; Isobe, Mitsuaki] Tokyo Med & Dent Univ, Dept Cardiol, Bunkyo Ku, Tokyo 1138510, Japan; [Usami, Takako; Kimura, Akinori] Tokyo Med & Dent Univ, Dept Mol Pathogenesis, Med Res Inst, Bunkyo Ku, Tokyo 1138510, Japan; [Nishina, Hiroshi] Tokyo Med & Dent Univ, Dept Dev & Regenerat Biol, Med Res Inst, Bunkyo Ku, Tokyo 1138510, Japan; [Zhang, Liyong] Univ Toronto, Univ Hlth Network, Toronto Gen Hosp, Div Cardiol, Toronto, ON M5S 1A1, Canada; [Murata, Mitsushige; Yamakawa, Hiroyuki; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Regenerat Med & Adv Cardiac Therapeut, Tokyo 1608582, Japan; [Gupta, Vaijayanti; Arora, Suchir; Sarangi, Rinku; Dan, Debasis; Subramaniam, Sai] Strand Life Sci, Bangalore 560024, Karnataka, India; [Keene, Alex C.] NYU, Dept Biol, New York, NY 10003 USA; [Pfeufer, Arne] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Pfeufer, Arne] Helmholtz Ctr Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Hicks, Andrew A.; Pramstaller, Peter P.] European Acad Bozen Bolzano, Inst Med Genet, I-39100 Bolzano, Italy; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, I-39100 Bolzano, Italy; [Pramstaller, Peter P.] Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany	Akita University; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Sanford Burnham Prebys Medical Discovery Institute; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Keio University; New York University; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; European Academy of Bozen-Bolzano; Krankenhaus Bozen; University of Lubeck	Kuba, K (corresponding author), Akita Univ, Grad Sch Med, Dept Biol Informat & Expt Therapeut, 1-1-1 Hondo, Akita 0108543, Japan.	kuba@med.akita-u.ac.jp; rolf@burnham.org; josef.penninger@imba.oeaw.ac.at	Neely, Greg/AAB-4642-2020; Kimura, Akinori/I-5989-2018; Pramstaller, Peter P/C-2357-2008; Imai, Yumiko/GXW-1144-2022; neely, graham/A-6511-2011; Penninger, Josef M/I-6860-2013; Fukuda, Keiichi/L-3777-2013; Hicks, Andrew Anthony/E-9518-2017; YAMAKAWA, Hiroyuki/L-8582-2013; Pfeufer, Arne/B-6634-2013	Neely, Greg/0000-0002-1957-9732; Kimura, Akinori/0000-0002-4933-2132; Penninger, Josef M/0000-0002-8194-3777; Hicks, Andrew Anthony/0000-0001-6320-0411; YAMAKAWA, Hiroyuki/0000-0003-3100-5077; Pramstaller, Peter P/0000-0002-9831-8302	IMBA; Austrian Ministry of Science; European Research Council; EuGeneHeart; Japanese Ministry of Science [21659198]; Medical Top Track Program; Japan Heart Foundation; Marie Curie International; American Heart Association; German Federal Ministry of Research [01GR0803, 01EZ0874]; UK Foundation [FSID-261/2008]; Cyprus Cardiovascular Disease Educational and Research Trust [YGEIA/1104/17, ERYEX/0406/06]; Global Center of Excellence Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM086207] Funding Source: NIH RePORTER	IMBA; Austrian Ministry of Science; European Research Council(European Research Council (ERC)European Commission); EuGeneHeart; Japanese Ministry of Science; Medical Top Track Program; Japan Heart Foundation; Marie Curie International(European Commission); American Heart Association(American Heart Association); German Federal Ministry of Research; UK Foundation; Cyprus Cardiovascular Disease Educational and Research Trust; Global Center of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all members of our laboratories and the VDRC, the Bioscience Education Research Center (Akita University), and Vincent Chen for helpful discussions and excellent technical support. We thank Eric Olson for the Hand-Gal4 driver and Manfred Frasch for TinCD4-Gal4 driver stocks. We thank the members of the QTSCD consortium for valuable support and discussion. J.M.P. is supported by the IMBA, the Austrian Ministry of Science, a European Research Council Advanced Investigator grant, and EuGeneHeart. K. K. is supported by Kaken (21659198) from the Japanese Ministry of Science, the Medical Top Track Program, and the Japan Heart Foundation. G. G. N. was supported by a Marie Curie International Incoming Fellowship. A. C. was supported by a postdoctoral fellowship and K. O. by a Scientist Development Grant from the American Heart Association. R. B. was supported by grants from the National Heart, Lung, and Blood Institute of the National Institutes of Health. A. P. is supported by grants 01GR0803 and 01EZ0874 from the German Federal Ministry of Research, FSID-261/2008 from the UK Foundation for the Study of Infant Deaths, and YGEIA/1104/17 and ERYEX/0406/06 from the Cyprus Cardiovascular Disease Educational and Research Trust. Y. I. is supported by the Global Center of Excellence Program.	Alayari NN, 2009, JOVE-J VIS EXP, pe1423, DOI DOI 10.3791/1423; Albert TK, 2000, NUCLEIC ACIDS RES, V28, P809, DOI 10.1093/nar/28.3.809; BODMER R, 1995, TRENDS CARDIOVAS MED, V5, P21, DOI 10.1016/1050-1738(94)00032-Q; Cripps RM, 2002, DEV BIOL, V246, P14, DOI 10.1006/dbio.2002.0666; DENIS CL, 1984, GENETICS, V108, P833; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Fink M, 2009, BIOTECHNIQUES, V46, P101, DOI 10.2144/000113078; GORDON T, 1977, JAMA-J AM MED ASSOC, V238, P497, DOI 10.1001/jama.238.6.497; Han Z, 2005, DEVELOPMENT, V132, P3525, DOI 10.1242/dev.01899; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Jayne S, 2006, BIOCHEM J, V398, P461, DOI 10.1042/BJ20060406; Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005; Kuba K, 2007, CIRC RES, V101, pE32, DOI 10.1161/CIRCRESAHA.107.158659; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Laribee RN, 2007, P NATL ACAD SCI USA, V104, P5836, DOI 10.1073/pnas.0607996104; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Lo PCH, 2001, MECH DEVELOP, V104, P49, DOI 10.1016/S0925-4773(01)00361-6; Morita H, 2005, J CLIN INVEST, V115, P518, DOI 10.1172/JCI200524351; Moss AJ, 2005, J CLIN INVEST, V115, P2018, DOI 10.1172/JCI25537; Mudd JO, 2008, NATURE, V451, P919, DOI 10.1038/nature06798; Nabel EG, 2003, NEW ENGL J MED, V349, P60, DOI 10.1056/NEJMra035098; Nerbonne JM, 2004, TRENDS CARDIOVAS MED, V14, P83, DOI 10.1016/j.tcm.2003.12.006; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Ocorr K, 2007, TRENDS CARDIOVAS MED, V17, P177, DOI 10.1016/j.tcm.2007.04.001; Ocorr K, 2007, P NATL ACAD SCI USA, V104, P3943, DOI 10.1073/pnas.0609278104; Paternostro G, 2001, CIRC RES, V88, P1053, DOI 10.1161/hh1001.090857; Peng WM, 2008, GENETICS, V179, P277, DOI 10.1534/genetics.107.085068; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Qian L, 2009, HUM MOL GENET, V18, P3153, DOI 10.1093/hmg/ddp254; Qian L, 2008, P NATL ACAD SCI USA, V105, P19833, DOI 10.1073/pnas.0808705105; Ray VM, 2005, J NEUROGENET, V19, P39, DOI 10.1080/01677060590953066; Rusconi JC, 2007, INT J DEV BIOL, V51, P259, DOI 10.1387/ijdb.062233jr; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Sanyal S, 2006, J COMP PHYSIOL B, V176, P253, DOI 10.1007/s00360-005-0046-7; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	37	162	164	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2010	141	1					142	153		10.1016/j.cell.2010.02.023	http://dx.doi.org/10.1016/j.cell.2010.02.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	577GS	20371351	Green Accepted, Bronze			2022-12-28	WOS:000276211100019
J	Neumann, B; Walter, T; Heriche, JK; Bulkescher, J; Erfle, H; Conrad, C; Rogers, P; Poser, I; Held, M; Liebel, U; Cetin, C; Sieckmann, F; Pau, G; Kabbe, R; Wunsche, A; Satagopam, V; Schmitz, MHA; Chapuis, C; Gerlich, DW; Schneider, R; Eils, R; Huber, W; Peters, JM; Hyman, AA; Durbin, R; Pepperkok, R; Ellenberg, J				Neumann, Beate; Walter, Thomas; Heriche, Jean-Karim; Bulkescher, Jutta; Erfle, Holger; Conrad, Christian; Rogers, Phill; Poser, Ina; Held, Michael; Liebel, Urban; Cetin, Cihan; Sieckmann, Frank; Pau, Gregoire; Kabbe, Rolf; Wuensche, Annelie; Satagopam, Venkata; Schmitz, Michael H. A.; Chapuis, Catherine; Gerlich, Daniel W.; Schneider, Reinhard; Eils, Roland; Huber, Wolfgang; Peters, Jan-Michael; Hyman, Anthony A.; Durbin, Richard; Pepperkok, Rainer; Ellenberg, Jan			Phenotypic profiling of the human genome by time-lapse microscopy reveals cell division genes	NATURE			English	Article							TISSUE-CULTURE CELLS; RNA INTERFERENCE; IDENTIFICATION; ORGANIZATION; ARRAYS	Despite our rapidly growing knowledge about the human genome, we do not know all of the genes required for some of the most basic functions of life. To start to fill this gap we developed a high-throughput phenotypic screening platform combining potent gene silencing by RNA interference, time-lapse microscopy and computational image processing. We carried out a genome-wide phenotypic profiling of each of the similar to 21,000 human protein-coding genes by two-day live imaging of fluorescently labelled chromosomes. Phenotypes were scored quantitatively by computational image processing, which allowed us to identify hundreds of human genes involved in diverse biological functions including cell division, migration and survival. As part of the Mitocheck consortium, this study provides an in-depth analysis of cell division phenotypes and makes the entire high-content data set available as a resource to the community.	[Wuensche, Annelie; Ellenberg, Jan] European Mol Biol Lab, Gene Express Unit, D-69117 Heidelberg, Germany; [Neumann, Beate; Walter, Thomas; Bulkescher, Jutta; Erfle, Holger; Conrad, Christian; Rogers, Phill; Held, Michael; Liebel, Urban] European Mol Biol Lab, MitoCheck Project Grp, D-69117 Heidelberg, Germany; [Erfle, Holger; Conrad, Christian; Cetin, Cihan; Chapuis, Catherine; Pepperkok, Rainer] European Mol Biol Lab, Cell Biol Biophys Unit, D-69117 Heidelberg, Germany; [Satagopam, Venkata; Schneider, Reinhard] European Mol Biol Lab, Computat Biol Unit, D-69117 Heidelberg, Germany; [Heriche, Jean-Karim; Durbin, Richard] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Poser, Ina; Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Schmitz, Michael H. A.; Gerlich, Daniel W.] Swiss Fed Inst Technol Zurich ETHZ, Inst Biochem, CH-8093 Zurich, Switzerland; [Sieckmann, Frank] Leica Microsyst CMS GmbH, D-68165 Mannheim, Germany; [Pau, Gregoire; Huber, Wolfgang] European Mol Biol Lab, European Bioinformat Inst, Cambridge CB10 1SD, England; [Kabbe, Rolf; Eils, Roland] German Canc Res Ctr, Div Theoret Bioinformat, D-69120 Heidelberg, Germany; [Peters, Jan-Michael] Inst Mol Pathol, A-1030 Vienna, Austria	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich; European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Ellenberg, J (corresponding author), European Mol Biol Lab, Gene Express Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	jan.ellenberg@embl.de	Liebel, Urban/D-8519-2011; Ellenberg, Jan/I-4688-2014; chapuis, catherine/AAH-4617-2019; Hyman, Anthony A/B-3917-2017; Hyman, Tony/F-1923-2011; Schneider, Reinhard/C-5441-2009; Durbin, Richard/AAE-7178-2019; Eils, Roland/B-6121-2009; Gerlich, Daniel Wolfram W/A-6991-2016; Walter, Thomas/B-9079-2015	Ellenberg, Jan/0000-0001-5909-701X; chapuis, catherine/0000-0002-3765-0969; Hyman, Anthony A/0000-0003-3664-154X; Schneider, Reinhard/0000-0002-8278-1618; Durbin, Richard/0000-0002-9130-1006; Eils, Roland/0000-0002-0034-4036; Gerlich, Daniel Wolfram W/0000-0003-1637-3365; Heriche, Jean-Karim/0000-0001-6867-9425; Walter, Thomas/0000-0001-7419-7879; Neumann, Beate/0000-0002-6899-502X; Satagopam, Venkata/0000-0002-6532-5880; Pepperkok, Rainer/0000-0002-9762-3583; Huber, Wolfgang/0000-0002-0474-2218	European Commission [LSHG-CT-2004-503464]; Federal Ministry of Education and Research (BMBF) [FKZ01GR0403, FKZ01GR0423]; Wellcome Trust	European Commission(European CommissionEuropean Commission Joint Research Centre); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank J. Gagneur for suggestions on data processing; S. Berthoumieux for assistance in computation; Y. Sun for coordination support in Mitocheck; U. Ringeisen for help in preparing the figures; S. Winkler and L. Burger and EMBL's electronic and mechanical workshops for support in microscope development; Olympus Soft Imaging Solutions (OSIS) and Olympus Europe for collaboration; Leica Microsystems for collaboration; Applied Biosystems for providing unpublished validation data of the siRNA library; and all our colleagues in the Mitocheck consortium for collaboration. This project was funded by grants to J. E. (within the Mitocheck consortium by the European Commission (LSHG-CT-2004-503464) as well as by the Federal Ministry of Education and Research (BMBF) in the framework of the National Genome Research Network (NGFN) (NGFN-2 SMP-RNAi, FKZ01GR0403)), to R. P. (BMBF NGFN2 SMP-Cell, FKZ01GR0423) as well as to J. E. and R. P. by the Landesstiftung Baden Wuerttemberg in the framework of the research programme 'RNS/RNAi'. R. D. is supported by the Wellcome Trust.	Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; Bjorklund M, 2006, NATURE, V439, P1009, DOI 10.1038/nature04469; Boland MV, 1998, CYTOMETRY, V33, P366; Cassimeris L, 2004, MOL BIOL CELL, V15, P1580, DOI 10.1091/mbc.E03-07-0544; Conrad C, 2004, GENOME RES, V14, P1130, DOI 10.1101/gr.2383804; Erfle H, 2007, NAT PROTOC, V2, P392, DOI 10.1038/nprot.2006.483; Glory E, 2007, DEV CELL, V12, P7, DOI 10.1016/j.devcel.2006.12.007; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Grus F H, 2002, BMC Ophthalmol, V2, P4, DOI 10.1186/1471-2415-2-4; Kittler R, 2005, P NATL ACAD SCI USA, V102, P2396, DOI 10.1073/pnas.0409861102; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Liebel U, 2003, FEBS LETT, V554, P394, DOI 10.1016/S0014-5793(03)01197-9; Mora-Bermudez F, 2007, NAT CELL BIOL, V9, P822, DOI 10.1038/ncb1606; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Raemaekers T, 2003, J CELL BIOL, V162, P1017, DOI 10.1083/jcb.200302129; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; WALTER T, J STRUCT BI IN PRESS, P93901; Wang M, 2008, BIOINFORMATICS, V24, P94, DOI 10.1093/bioinformatics/btm530; Zhu CJ, 2005, MOL BIOL CELL, V16, P3187, DOI 10.1091/mbc.E05-02-0167	22	617	626	0	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 1	2010	464	7289					721	727		10.1038/nature08869	http://dx.doi.org/10.1038/nature08869			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577EO	20360735	Green Accepted, Green Published			2022-12-28	WOS:000276205000037
J	Molnar, A; Melnyk, CW; Bassett, A; Hardcastle, TJ; Dunn, R; Baulcombe, DC				Molnar, Attila; Melnyk, Charles W.; Bassett, Andrew; Hardcastle, Thomas J.; Dunn, Ruth; Baulcombe, David C.			Small Silencing RNAs in Plants Are Mobile and Direct Epigenetic Modification in Recipient Cells	SCIENCE			English	Review							POTATO-VIRUS-X; DNA-METHYLATION; POLYMERASE-IV; ARABIDOPSIS-THALIANA; INTERFERING RNA; SIGNAL; EXPRESSION; SEQUENCE; SIRNAS; PHLOEM	A silencing signal in plants with an RNA specificity determinant moves through plasmodesmata and the phloem. To identify the mobile RNA, we grafted Arabidopsis thaliana shoots to roots that would be a recipient for the silencing signal. Using mutants that block small RNA (sRNA) biogenesis in either source or recipient tissue, we found that transgene-derived sRNA as well as a substantial proportion of the endogenous sRNA had moved across the graft union, and we provide evidence that 24-nucleotide mobile sRNAs direct epigenetic modifications in the genome of the recipient cells. Mobile sRNA thus represents a mechanism for transmitting the specification of epigenetic modification and could affect genome defense and responses to external stimuli that have persistent effects in plants.	[Molnar, Attila; Melnyk, Charles W.; Bassett, Andrew; Hardcastle, Thomas J.; Dunn, Ruth; Baulcombe, David C.] Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England	University of Cambridge	Baulcombe, DC (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England.	dcb40@cam.ac.uk	Melnyk, Charles W/R-2846-2017; Molnar, Attila/F-5833-2011	Melnyk, Charles W/0000-0003-3251-800X; Molnar, Attila/0000-0002-1044-6327; Baulcombe, David/0000-0003-0780-6878; Bassett, Andrew/0000-0003-1632-9137; Hardcastle, Thomas/0000-0002-9328-5011	Commonwealth scholarship [CACR 2006-115]; Natural Sciences and Engineering Research Council of Canada [PGS D2 358506-2008]; Royal Society; Gatsby Charitable Foundation; European Union [LSHG-CT-2006-037900]; European Research Council [233325 REVOLUTION]	Commonwealth scholarship; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Royal Society(Royal Society of London); Gatsby Charitable Foundation; European Union(European Commission); European Research Council(European Research Council (ERC)European Commission)	We thank K. Rutherford for data assembly and the Genomics and Bioinformatics core facilities (CRUK Cambridge Research Institute) for Illumina sequencing. Supported by Commonwealth scholarship CACR 2006-115 and Natural Sciences and Engineering Research Council of Canada scholarship PGS D2 358506-2008 (C. W. M.), a Royal Society research professorship (D. C. B.), the Gatsby Charitable Foundation, the European Union Sixth Framework Programme Integrated Project SIROCCO (grant LSHG-CT-2006-037900), and European Research Council advanced investigator grant 233325 REVOLUTION. RNA sequencing raw data are available from Gene Expression Omnibus (GSE20663).	Baurle I, 2007, SCIENCE, V318, P109, DOI 10.1126/science.1146565; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Brosnan CA, 2007, P NATL ACAD SCI USA, V104, P14741, DOI 10.1073/pnas.0706701104; Buhtz A, 2008, PLANT J, V53, P739, DOI 10.1111/j.1365-313X.2007.03368.x; Dalmay T, 2000, PLANT CELL, V12, P369, DOI 10.1105/tpc.12.3.369; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; LEISNER SM, 1993, PLANT CELL, V5, P191, DOI 10.1105/tpc.5.2.191; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lough TJ, 2006, ANNU REV PLANT BIOL, V57, P203, DOI 10.1146/annurev.arplant.56.032604.144145; Melquist S, 1999, GENETICS, V153, P401; Melquist S, 2003, GENE DEV, V17, P2036, DOI 10.1101/gad.1081603; Mosher RA, 2008, P NATL ACAD SCI USA, V105, P3145, DOI 10.1073/pnas.0709632105; Mosher RA, 2009, NATURE, V460, P283, DOI 10.1038/nature08084; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; Pant BD, 2008, PLANT J, V53, P731, DOI 10.1111/j.1365-313X.2007.03363.x; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Voinnet O, 1997, NATURE, V389, P553, DOI 10.1038/39215; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zhang XY, 2007, P NATL ACAD SCI USA, V104, P4536, DOI 10.1073/pnas.0611456104; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003	29	500	565	8	223	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2010	328	5980					872	875		10.1126/science.1187959	http://dx.doi.org/10.1126/science.1187959			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20413459				2022-12-28	WOS:000277618800042
J	Foti, JJ; Walker, GC				Foti, James J.; Walker, Graham C.			SnapShot: DNA Polymerases II Mammals	CELL			English	Editorial Material							THETA		[Foti, James J.; Walker, Graham C.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Foti, JJ (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.			/0000-0001-7243-8261	NATIONAL CANCER INSTITUTE [R01CA021615] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA021615] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arana ME, 2007, DNA REPAIR, V6, P213, DOI 10.1016/j.dnarep.2006.09.012; Guo CX, 2009, CELL MOL LIFE SCI, V66, P2363, DOI 10.1007/s00018-009-0024-4; Kawamura K, 2004, INT J CANCER, V109, P9, DOI 10.1002/ijc.11666; Kunkel TA, 2003, CANCER CELL, V3, P105, DOI 10.1016/S1535-6108(03)00027-8; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Prasad R, 2009, NUCLEIC ACIDS RES, V37, P1868, DOI 10.1093/nar/gkp035; Rattray AJ, 2003, ANNU REV GENET, V37, P31, DOI 10.1146/annurev.genet.37.042203.132748; Seki M, 2005, EMBO REP, V6, P1143, DOI 10.1038/sj.embor.7400582; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08	9	3	3	6	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 16	2010	141	2					370	U185		10.1016/j.cell.2010.04.005	http://dx.doi.org/10.1016/j.cell.2010.04.005			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	584GF	20403330	Green Published, Bronze			2022-12-28	WOS:000276738400027
J	Seaman, MNJ; Peden, AA				Seaman, Matthew N. J.; Peden, Andrew A.			Ricin Toxin Hits a Retrograde Roadblock	CELL			English	Editorial Material							TRANS-GOLGI NETWORK; ENDOSOME		[Seaman, Matthew N. J.; Peden, Andrew A.] Univ Cambridge, Cambridge Inst Med Res, Dept Clin Biochem, Cambridge CB2 0XY, England	University of Cambridge	Seaman, MNJ (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Clin Biochem, Cambridge CB2 0XY, England.	mnjs100@cam.ac.uk; aap20@cam.ac.uk		Peden, Andrew/0000-0003-0144-7712	Medical Research Council [G0700750, G120/952] Funding Source: Medline; MRC [G0700750, G120/952] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Amessou M, 2007, J CELL SCI, V120, P1457, DOI 10.1242/jcs.03436; Bujny MV, 2007, J CELL SCI, V120, P2010, DOI 10.1242/jcs.003111; Hay JC, 1998, J CELL BIOL, V141, P1489, DOI 10.1083/jcb.141.7.1489; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Tai GH, 2004, MOL BIOL CELL, V15, P4011, DOI 10.1091/mbc.e03-12-0876	5	4	6	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 16	2010	141	2					222	224		10.1016/j.cell.2010.03.044	http://dx.doi.org/10.1016/j.cell.2010.03.044			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	584GF	20403318	Bronze			2022-12-28	WOS:000276738400011
J	Berger, LR; de Ruiter, DJ; Churchill, SE; Schmid, P; Carlson, KJ; Dirks, PHGM; Kibii, JM				Berger, Lee R.; de Ruiter, Darryl J.; Churchill, Steven E.; Schmid, Peter; Carlson, Kristian J.; Dirks, Paul H. G. M.; Kibii, Job M.			Australopithecus sediba: A New Species of Homo-Like Australopith from South Africa	SCIENCE			English	Article							OLDUVAI-GORGE; PLIOPLEISTOCENE HOMINID; SYSTEMATIC ASSESSMENT; LAKE TURKANA; EAST; STERKFONTEIN; CRANIA; GENUS; TANZANIA; ETHIOPIA	Despite a rich African Plio-Pleistocene hominin fossil record, the ancestry of Homo and its relation to earlier australopithecines remain unresolved. Here we report on two partial skeletons with an age of 1.95 to 1.78 million years. The fossils were encased in cave deposits at the Malapa site in South Africa. The skeletons were found close together and are directly associated with craniodental remains. Together they represent a new species of Australopithecus that is probably descended from Australopithecus africanus. Combined craniodental and postcranial evidence demonstrates that this new species shares more derived features with early Homo than any other australopith species and thus might help reveal the ancestor of that genus.	[Berger, Lee R.; de Ruiter, Darryl J.; Churchill, Steven E.; Schmid, Peter; Carlson, Kristian J.; Kibii, Job M.] Univ Witwatersrand, Inst Human Evolut, ZA-2050 Wits, South Africa; [Berger, Lee R.; Dirks, Paul H. G. M.] Univ Witwatersrand, Sch Geosci, ZA-2050 Wits, South Africa; [de Ruiter, Darryl J.] Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA; [Churchill, Steven E.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Schmid, Peter] Univ Zurich, Anthropol Inst & Museum, CH-8057 Zurich, Switzerland; [Carlson, Kristian J.] Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA; [Dirks, Paul H. G. M.] James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia	University of Witwatersrand; University of Witwatersrand; Texas A&M University System; Texas A&M University College Station; Duke University; University of Zurich; Indiana University System; Indiana University Bloomington; James Cook University	Berger, LR (corresponding author), Univ Witwatersrand, Inst Human Evolut, Private Bag 3, ZA-2050 Wits, South Africa.	profleeberger@yahoo.com	Berger, Lee Rogers/AAC-3484-2020; Churchill, Steven/AAA-9386-2022	Berger, Lee Rogers/0000-0002-0367-7629; de Ruiter, Darryl/0000-0003-1183-0352	South African Department of Science and Technology; South African National Research Foundation; Institute for Human Evolution; Palaeontological Scientific Trust; Andrew W. Mellon Foundation; AfricaArray Program; U.S. Diplomatic Mission to South Africa	South African Department of Science and Technology; South African National Research Foundation(National Research Foundation - South Africa); Institute for Human Evolution; Palaeontological Scientific Trust; Andrew W. Mellon Foundation; AfricaArray Program; U.S. Diplomatic Mission to South Africa	We thank the South African Heritage Resources Agency for the permits to work at the Malapa site; the Nash family for granting access to the Malapa site and continued support of research on their reserve; the South African Department of Science and Technology, the South African National Research Foundation, the Institute for Human Evolution, the Palaeontological Scientific Trust, the Andrew W. Mellon Foundation, the AfricaArray Program, the U.S. Diplomatic Mission to South Africa, and Sir Richard Branson for funding; the University of the Witwatersrand's Schools of Geosciences and Anatomical Sciences and the Bernard Price Institute for Palaeontology for support and facilities; the Gauteng Government, Gauteng Department of Agriculture, Conservation and Environment and the Cradle of Humankind Management Authority; E. Mbua, P. Kiura, V. Iminjili, and the National Museums of Kenya for access to comparative specimens; Optech and Optron; Duke University; the Ray A. Rothrock Fellowship of Texas A&M University; and the University of Zurich 2009 Field School. Numerous individuals have been involved in the ongoing preparation and excavation of these fossils, including C. Dube, B. Eloff, C. Kemp, M. Kgasi, M. Languza, J. Malaza, G. Mokoma, P. Mukanela, T. Nemvhundi, M. Ngcamphalala, S. Jirah, S. Tshabalala, and C. Yates. Other individuals who have given significant support to this project include B. de Klerk, C. Steininger, B. Kuhn, L. Pollarolo, B. Zipfel, J. Kretzen, D. Conforti, J. McCaffery, C. Dlamini, H. Visser, R. McCrae-Samuel, B. Nkosi, B. Louw, L. Backwell, F. Thackeray, and M. Peltier. T. Stidham helped construct the cladogram in fig. S3. J. Smilg facilitated computed tomography scanning of the specimens. R. Clarke and F. Kirera provided valuable discussions on these and other hominin fossils in Africa.	Aiello L, 1990, INTRO HUMAN EVOLUTIO; Asfaw B, 1999, SCIENCE, V284, P629, DOI 10.1126/science.284.5414.629; Blumenschine RJ, 2003, SCIENCE, V299, P1217, DOI 10.1126/science.1075374; BRAIN C K, 1974, Annals of the Transvaal Museum, V29, P55; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Clarke RJ, 2008, S AFR J SCI, V104, P443, DOI 10.1590/s0038-23532008000600015; Collard M, 2000, P NATL ACAD SCI USA, V97, P5003, DOI 10.1073/pnas.97.9.5003; Curnoe D, 2006, J HUM EVOL, V50, P36, DOI 10.1016/j.jhevol.2005.07.008; Dart RA, 1925, NATURE, V115, P195, DOI 10.1038/115195a0; Dirks PHGM, 2010, SCIENCE, V328, P205, DOI 10.1126/science.1184950; GABUNIA L, 1995, NATURE, V373, P509, DOI 10.1038/373509a0; Grine FE, 1996, J HUM EVOL, V30, P189, DOI 10.1006/jhev.1996.0019; HUGHES AR, 1977, NATURE, V265, P310, DOI 10.1038/265310a0; JOHANSON DC, 1987, NATURE, V327, P205, DOI 10.1038/327205a0; JOHANSON DC, 1979, SCIENCE, V203, P321, DOI 10.1126/science.104384; Kimbel WH, 1997, AM J PHYS ANTHROPOL, V103, P235, DOI 10.1002/(SICI)1096-8644(199706)103:2<235::AID-AJPA8>3.3.CO;2-V; Lague MR, 1996, AM J PHYS ANTHROPOL, V101, P401, DOI 10.1002/(SICI)1096-8644(199611)101:3<401::AID-AJPA8>3.0.CO;2-0; Leakey MG, 2001, NATURE, V410, P433, DOI 10.1038/35068500; Leakey R.E., 1989, P167; Lieberman DE, 2001, NATURE, V410, P419, DOI 10.1038/35068648; Lovejoy CO, 2005, GAIT POSTURE, V21, P113, DOI 10.1016/j.gaitpost.2004.06.010; Rak Y., 1983, AUSTRALOPITHECINE FA, DOI [10.1016/B978-0-12-576280-9.50006-7, DOI 10.1016/B978-0-12-576280-9.50006-7]; RIGHTMIRE GP, 1993, AM J PHYS ANTHROPOL, V90, P1, DOI 10.1002/ajpa.1330900102; ROSE MD, 1984, AM J PHYS ANTHROPOL, V63, P371, DOI 10.1002/ajpa.1330630404; Ruff C, 2009, AM J PHYS ANTHROPOL, V138, P90, DOI 10.1002/ajpa.20907; SKELTON RR, 1992, J HUM EVOL, V23, P309, DOI 10.1016/0047-2484(92)90070-P; Smith HF, 2008, J HUM EVOL, V54, P684, DOI 10.1016/j.jhevol.2007.10.012; Spoor F, 2007, NATURE, V448, P688, DOI 10.1038/nature05986; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; Strait DS, 2004, J HUM EVOL, V47, P399, DOI 10.1016/j.jhevol.2004.08.008; Tobias P.V., 1991, OLDUVAI GORGE, V4; Tobias PV, 1971, BRAIN HOMINID EVOLUT; Walker Alan, 1993, P221; White TD, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P369; Wood B, 1999, SCIENCE, V284, P65, DOI 10.1126/science.284.5411.65; Wood B., 1991, HOMINID CRANIAL REMA, V4	36	350	374	1	187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 9	2010	328	5975					195	204		10.1126/science.1184944	http://dx.doi.org/10.1126/science.1184944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	580OU	20378811	Green Submitted			2022-12-28	WOS:000276459600035
J	Hehemann, JH; Correc, G; Barbeyron, T; Helbert, W; Czjzek, M; Michel, G				Hehemann, Jan-Hendrik; Correc, Gaelle; Barbeyron, Tristan; Helbert, William; Czjzek, Mirjam; Michel, Gurvan			Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota	NATURE			English	Article							GLYCOSIDE HYDROLASES; MAXIMUM-LIKELIHOOD; KAPPA-CARRAGEENASE; SEQUENCE ALIGNMENT; DIFFRACTION DATA; BETA-AGARASES; SP-NOV; POLYSACCHARIDE; EVOLUTION; CLASSIFICATION	Gut microbes supply the human body with energy from dietary polysaccharides through carbohydrate active enzymes, or CAZymes(1), which are absent in the human genome. These enzymes target polysaccharides from terrestrial plants that dominated diet throughout human evolution(2). The array of CAZymes in gut microbes is highly diverse, exemplified by the human gut symbiont Bacteroides thetaiotaomicron(3), which contains 261 glycoside hydrolases and polysaccharide lyases, as well as 208 homologues of susC and susD-genes coding for two outer membrane proteins involved in starch utilization(1,4). A fundamental question that, to our knowledge, has yet to be addressed is how this diversity evolved by acquiring new genes from microbes living outside the gut. Here we characterize the first porphyranases from a member of the marine Bacteroidetes, Zobellia galactanivorans, active on the sulphated polysaccharide porphyran from marine red algae of the genus Porphyra. Furthermore, we show that genes coding for these porphyranases, agarases and associated proteins have been transferred to the gut bacterium Bacteroides plebeius isolated from Japanese individuals(5). Our comparative gut metagenome analyses show that porphyranases and agarases are frequent in the Japanese population(6) and that they are absent in metagenome data(7) from North American individuals. Seaweeds make an important contribution to the daily diet in Japan (14.2 g per person per day)(8), and Porphyra spp. (nori) is the most important nutritional seaweed, traditionally used to prepare sushi(9,10). This indicates that seaweeds with associated marine bacteria may have been the route by which these novel CAZymes were acquired in human gut bacteria, and that contact with non-sterile food may be a general factor in CAZyme diversity in human gut microbes.	[Hehemann, Jan-Hendrik; Correc, Gaelle; Barbeyron, Tristan; Helbert, William; Czjzek, Mirjam; Michel, Gurvan] Univ Paris 06, F-29682 Roscoff, France; [Hehemann, Jan-Hendrik; Correc, Gaelle; Barbeyron, Tristan; Helbert, William; Czjzek, Mirjam; Michel, Gurvan] CNRS, Stn Biol Roscoff, Vegetaux Marins & Biomol UMR 7139, F-29682 Roscoff, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Czjzek, M (corresponding author), Univ Paris 06, F-29682 Roscoff, France.	czjzek@sb-roscoff.fr; gurvan@sb-roscoff.fr	MICHEL, Gurvan/B-3490-2008	MICHEL, Gurvan/0000-0002-3009-6205; Hehemann, Jan-Hendrik/0000-0002-8700-2564	French national research centre (Centre National de la Recherche Scientifique); University Marie Curie; European Marie Curie PhD grant; Region Bretagne; GIS 'Genomique Marine'; French Research Ministry	French national research centre (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); University Marie Curie; European Marie Curie PhD grant; Region Bretagne(Region Bretagne); GIS 'Genomique Marine'; French Research Ministry(Ministry of Research, France)	We thank B. Kloareg and C. de Vargas for critical discussions and reading of the manuscript and M. Jam, A. Jeudy and D. Freudenreich for technical assistance. The 'Marine Plants and Biomolecules' laboratory is funded by the French national research centre (Centre National de la Recherche Scientifique) and the University Marie Curie; J.-H.H. was supported by a European Marie Curie PhD grant; this work was also funded by the 'Region Bretagne' through the program Marine 3D. G. M. was supported by the GIS 'Genomique Marine' and the French Research Ministry (ACI Young Researcher). We thank the beamline scientists and staff at the European Synchrotron Radiation Facilities for technical support during data collections, the NMR Service, University Bretagne Occidentale, for access to the Bruker NMR spectrometer and Genoscope for sequencing the Z. galactanivorans genome.	Allouch J, 2003, J BIOL CHEM, V278, P47171, DOI 10.1074/jbc.M308313200; ANDERSON NS, 1965, J CHEM SOC, P5880, DOI 10.1039/jr9650005880; Barbeyron T, 1998, MOL BIOL EVOL, V15, P528, DOI 10.1093/oxfordjournals.molbev.a025952; Barbeyron T, 2001, INT J SYST EVOL MICR, V51, P985, DOI 10.1099/00207713-51-3-985; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Fukuda S, 2007, EUR J CLIN NUTR, V61, P99, DOI 10.1038/sj.ejcn.1602505; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; Gilbert HJ, 2008, CURR OPIN PLANT BIOL, V11, P338, DOI 10.1016/j.pbi.2008.03.004; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Ishihara K, 2005, BIOSCI BIOTECH BIOCH, V69, P1824, DOI 10.1271/bbb.69.1824; Jam M, 2005, BIOCHEM J, V385, P703, DOI 10.1042/BJ20041044; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KIDBY DK, 1973, ANAL BIOCHEM, V55, P321, DOI 10.1016/0003-2697(73)90323-0; Kitahara M, 2005, INT J SYST EVOL MICR, V55, P2143, DOI 10.1099/ijs.0.63788-0; KLOAREG B., 1988, OCEANOGR MAR BIOL, V26, P259; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kuo CH, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-35; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Maciel JS, 2008, CARBOHYD POLYM, V71, P559, DOI 10.1016/j.carbpol.2007.06.026; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Mc Hugh D.J., 2003, 441 FAO; Michel G, 2001, STRUCTURE, V9, P513, DOI 10.1016/S0969-2126(01)00612-8; Michel G, 2006, APPL MICROBIOL BIOT, V71, P23, DOI 10.1007/s00253-006-0377-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NISIZAWA K, 1987, HYDROBIOLOGIA, V151, P5, DOI 10.1007/BF00046102; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Starr CM, 1996, J CHROMATOGR A, V720, P295, DOI 10.1016/0021-9673(95)00749-0; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; TURVEY JR, 1961, NATURE, V189, P831, DOI 10.1038/189831a0; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Zhong ZP, 2001, APPL ENVIRON MICROB, V67, P5771, DOI 10.1128/AEM.67.12.5771-5779.2001	41	676	717	18	439	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					908	U123		10.1038/nature08937	http://dx.doi.org/10.1038/nature08937			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20376150				2022-12-28	WOS:000276397300041
J	Moynihan, R				Moynihan, Ray			Drug Regulation Rosiglitazone, marketing, and medical science	BRITISH MEDICAL JOURNAL			English	Editorial Material							MYOCARDIAL-INFARCTION; RISK		Univ Newcastle, Newcastle, NSW 2308, Australia	University of Newcastle	Moynihan, R (corresponding author), Univ Newcastle, Newcastle, NSW 2308, Australia.	ray.moynihan@newcastle.edu.au	Moynihan, Ray/ABC-3010-2020					DeAngelis CD, 2010, JAMA-J AM MED ASSOC, V303, P1196, DOI 10.1001/jama.2010.337; *GLAXOSMITHKLINE L, GLAXOSMITHKLINE DIAB; *GSK, 2008, GRANTS CHAR CONTR US; *GSK, 2009, GRANTS CHAR CONTR US; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; MANNUCCI E, 2009, INT J CARDIOL   0326; MARBAUCUS M, 2010, COMMUNICATION   0218; Moynihan R, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1714; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Psaty BM, 2007, NEW ENGL J MED, V357, P67, DOI 10.1056/NEJMe078116; *US DEP HHS, PFIZ FACT SHEET PFIZ; US Senate Committee on Finance, 2010, STAFF REP GLAXOSMITH; Wang AT, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1344; 2010, GUARDIAN        0305	15	10	10	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 7	2010	340								c1848	10.1136/bmj.c1848	http://dx.doi.org/10.1136/bmj.c1848			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	582ZF	20375091				2022-12-28	WOS:000276639400006
J	Moynihan, R				Moynihan, Ray			Lobby Watch American Council on Science and Health	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Newcastle, Newcastle, NSW 2308, Australia	University of Newcastle	Moynihan, R (corresponding author), Univ Newcastle, Newcastle, NSW 2308, Australia.	ray.moynihan@newcastle.edu.au	Repplinger, John/T-4179-2019; Moynihan, Ray/ABC-3010-2020	Repplinger, John/0000-0001-8204-0169; 				Moynihan R, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1848; ROSS G, 2009, WASHINGTON TIME 0304; WHELAN E, 2004, DID ACSH COME	3	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 7	2010	340								c1819	10.1136/bmj.c1819	http://dx.doi.org/10.1136/bmj.c1819			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	582ZF	20375090				2022-12-28	WOS:000276639400003
J	Spatz, ES; Gross, CP				Spatz, Erica S.; Gross, Cary P.			Moving Reform to the Bedside Involvement of Individual Physicians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							QUALITY		[Gross, Cary P.] Yale Univ, Sch Med, Primary Care Ctr, Gen Internal Med Sect, New Haven, CT 06520 USA; [Spatz, Erica S.; Gross, Cary P.] Yale Univ, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06520 USA; [Gross, Cary P.] Yale Univ, Yale Comprehens Canc Ctr, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Gross, CP (corresponding author), Yale Univ, Sch Med, Primary Care Ctr, Gen Internal Med Sect, 333 Cedar St, New Haven, CT 06520 USA.	cary.gross@yale.edu						Baker Gillian K, 2005, N C Med J, V66, P130; Bogardus ST, 2004, ARCH INTERN MED, V164, P1841, DOI 10.1001/archinte.164.17.1841; Casalino LP, 2009, HEALTH AFFAIR, V28, pW533, DOI 10.1377/hlthaff.28.4.w533; Lee SY, 2004, HEALTH POLICY, V67, P257, DOI 10.1016/S0168-8510(03)00124-6; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Mechanic D, 2010, JAMA-J AM MED ASSOC, V303, P555, DOI 10.1001/jama.2010.100; Ross JS, 2007, JAMA-J AM MED ASSOC, V297, P1216, DOI 10.1001/jama.297.11.1216; Shortell SM, 2008, JAMA-J AM MED ASSOC, V300, P95, DOI 10.1001/jama.300.1.95; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012	9	4	4	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2010	303	13					1305	1306		10.1001/jama.2010.383	http://dx.doi.org/10.1001/jama.2010.383			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	579FM	20371791				2022-12-28	WOS:000276353700032
J	Klieb, HBE; Duchnay, M; Skeete, D; Leong, IT; Blackstein, ME				Klieb, Hagen B. E.; Duchnay, Michael; Skeete, Desiree; Leong, Iona T.; Blackstein, Martin E.			Painful palatal swelling	LANCET			English	Editorial Material							EWING SARCOMA		[Klieb, Hagen B. E.] Sunnybrook Hlth Sci Ctr, Dept Dent, Toronto, ON M4N 3M5, Canada; [Klieb, Hagen B. E.] Sunnybrook Hlth Sci Ctr, Dept Anat Pathol, Toronto, ON M4N 3M5, Canada; [Duchnay, Michael] Univ Toronto, Dept Oral Pathol & Oral Med, Toronto, ON, Canada; [Skeete, Desiree; Leong, Iona T.] Mt Sinai Hosp, Dept Anat Pathol, Toronto, ON M5G 1X5, Canada; [Leong, Iona T.] Mt Sinai Hosp, Dept Dent, Toronto, ON M5G 1X5, Canada; [Blackstein, Martin E.] Mt Sinai Hosp, Dept Medicial Oncol, Toronto, ON M5G 1X5, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Klieb, HBE (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Dent, Bayview Campus,Bayview Ave,H Wing,1st Floor,Room, Toronto, ON M4N 3M5, Canada.	hagen.klieb@sunnybrook.ca						Cotterill SJ, 2000, J CLIN ONCOL, V18, P3108, DOI 10.1200/JCO.2000.18.17.3108; Levine RG, 2002, J BONE JOINT SURG AM, V84A, P445, DOI 10.2106/00004623-200203000-00018; Ludwig JA, 2008, CURR OPIN ONCOL, V20, P412, DOI 10.1097/CCO.0b013e328303ba1d; Scurr M, 2006, ONCOLOGIST, V11, P65, DOI 10.1634/theoncologist.11-1-65; Widhe B, 2000, J BONE JOINT SURG AM, V82A, P667, DOI 10.2106/00004623-200005000-00007	5	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 3	2010	375	9721					1224	1224		10.1016/S0140-6736(10)60053-0	http://dx.doi.org/10.1016/S0140-6736(10)60053-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585VL	20362816				2022-12-28	WOS:000276858200034
J	Religa, TL; Sprangers, R; Kay, LE				Religa, Tomasz L.; Sprangers, Remco; Kay, Lewis E.			Dynamic Regulation of Archaeal Proteasome Gate Opening As Studied by TROSY NMR	SCIENCE			English	Article							20S PROTEASOME; PROTEIN-DEGRADATION; STRUCTURAL BASIS; RELAXATION; TERMINI	The proteasome catalyzes the majority of protein degradation in the cell and plays an integral role in cellular homeostasis. Control over proteolysis by the 20S core-particle (CP) proteasome is achieved by gated access of substrate; thus, an understanding of the molecular mechanism by which these gates regulate substrate entry is critical. We used methyl-transverse relaxation optimized nuclear magnetic resonance spectroscopy to show that the amino-terminal residues that compose the gates of the a subunits of the Thermoplasma acidophilum proteasome are highly dynamic over a broad spectrum of time scales and that gating termini are in conformations that extend either well inside (closed gate) or outside (open gate) of the antechamber. Interconversion between these conformers on a time scale of seconds leads to a dynamic regulation of 20S CP proteolysis activity.	[Religa, Tomasz L.; Kay, Lewis E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Religa, Tomasz L.; Kay, Lewis E.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Religa, Tomasz L.; Kay, Lewis E.] Univ Toronto, Dept Chem, Toronto, ON M5S 1A8, Canada; [Sprangers, Remco] Max Planck Inst Dev Biol, Tubingen, Germany	University of Toronto; University of Toronto; University of Toronto; Max Planck Society	Kay, LE (corresponding author), Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	kay@pound.med.utoronto.ca			European Molecular Biology Organization [ALTF 827-2006]; Canadian Institutes of Health Research (CIHR)	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	We thank J. Forman-Kay for providing laboratory space and for valuable discussions, R. Muhandiram for NMR support, X. Li and A. Shimmer for assistance with the plate reader, and F. Hansen and D. Korzhnev for discussions. T. L. R. acknowledges the European Molecular Biology Organization (ALTF 827-2006) and the Canadian Institutes of Health Research (CIHR) for postdoctoral fellowships. L. E. K. holds a Canada Research Chair in Biochemistry. This work was supported by a grant from the CIHR. The structural ensembles of WT alpha<INF>7</INF> and Y8G/D9G a7 have been deposited in the Protein Data Bank (PDB) with accession codes 2ku1 and 2ku2, respectively.	Bajorek M, 2003, CURR BIOL, V13, P1140, DOI 10.1016/S0960-9822(03)00417-2; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Cheng YF, 2009, CURR OPIN STRUC BIOL, V19, P203, DOI 10.1016/j.sbi.2009.02.004; Clore GM, 2008, MOL BIOSYST, V4, P1058, DOI 10.1039/b810232e; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Forster A, 2003, EMBO J, V22, P4356, DOI 10.1093/emboj/cdg436; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; Goldberg AL, 2007, BIOCHEM SOC T, V35, P12, DOI 10.1042/BST0350012; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Kisselev AF, 1998, J BIOL CHEM, V273, P1982, DOI 10.1074/jbc.273.4.1982; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Mittermaier A, 1999, J BIOMOL NMR, V13, P181, DOI 10.1023/A:1008387715167; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Ruepp A, 2001, J STRUCT BIOL, V135, P126, DOI 10.1006/jsbi.2001.4402; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Sprangers R, 2008, BIOCHEMISTRY-US, V47, P6727, DOI 10.1021/bi8005913; Sprangers R, 2007, NATURE, V445, P618, DOI 10.1038/nature05512; Stadtmueller BM, 2010, J BIOL CHEM, V285, P13, DOI 10.1074/jbc.C109.070425; Tsvetkov P, 2009, J BIOL CHEM, V284, P26234, DOI 10.1074/jbc.M109.040493; Tugarinov V, 2003, J AM CHEM SOC, V125, P13868, DOI 10.1021/ja030345s; Tugarinov V, 2007, J AM CHEM SOC, V129, P1743, DOI 10.1021/ja067827z; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Yu YD, 2010, EMBO J, V29, P692, DOI 10.1038/emboj.2009.382	29	177	179	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	2010	328	5974					98	102		10.1126/science.1184991	http://dx.doi.org/10.1126/science.1184991			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577DR	20360109				2022-12-28	WOS:000276202200044
J	Sharma, SV; Lee, DY; Li, BH; Quinlan, MP; Takahashi, F; Maheswaran, S; McDermott, U; Azizian, N; Zou, L; Fischbach, MA; Wong, KK; Brandstetter, K; Wittner, B; Ramaswamy, S; Classon, M; Settleman, J				Sharma, Sreenath V.; Lee, Diana Y.; Li, Bihua; Quinlan, Margaret P.; Takahashi, Fumiyuki; Maheswaran, Shyamala; McDermott, Ultan; Azizian, Nancy; Zou, Lee; Fischbach, Michael A.; Wong, Kwok-Kin; Brandstetter, Kathleyn; Wittner, Ben; Ramaswamy, Sridhar; Classon, Marie; Settleman, Jeff			A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations	CELL			English	Article							STEM-CELLS; THERAPEUTIC RESISTANCE; HISTONE MODIFICATION; GROWTH; INSULIN; MECHANISMS; SENSITIVITY; RETREATMENT; INHIBITORS; DISEASE	Accumulating evidence implicates heterogeneity within cancer cell populations in the response to stressful exposures, including drug treatments. While modeling the acute response to various anticancer agents in drug-sensitive human tumor cell lines, we consistently detected a small subpopulation of reversibly "drug-tolerant" cells. These cells demonstrate >100-fold reduced drug sensitivity and maintain viability via engagement of IGF-1 receptor signaling and an altered chromatin state that requires the histone demethylase RBP2/KDM5A/Jarid1A. This drug-tolerant phenotype is transiently acquired and relinquished at low frequency by individual cells within the population, implicating the dynamic regulation of phenotypic heterogeneity in drug tolerance. The drug-tolerant subpopulation can be selectively ablated by treatment with IGF-1 receptor inhibitors or chromatin-modifying agents, potentially yielding a therapeutic opportunity. Together, these findings suggest that cancer cell populations employ a dynamic survival strategy in which individual cells transiently assume a reversibly drug-tolerant state to protect the population from eradication by potentially lethal exposures.	[Sharma, Sreenath V.; Lee, Diana Y.; Li, Bihua; Quinlan, Margaret P.; Takahashi, Fumiyuki; Maheswaran, Shyamala; McDermott, Ultan; Azizian, Nancy; Zou, Lee; Fischbach, Michael A.; Wittner, Ben; Ramaswamy, Sridhar; Classon, Marie; Settleman, Jeff] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Wong, Kwok-Kin; Brandstetter, Kathleyn] Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute	Classon, M (corresponding author), Massachusetts Gen Hosp, Ctr Canc, 149 13th St, Charlestown, MA 02129 USA.	classon@helix.mgh.harvard.edu; settleman@helix.mgh.harvard.edu	Hu, Ruogu/B-2203-2008	Fischbach, Michael/0000-0003-3079-8247; wong, kwok kin/0000-0001-6323-235X; azizian, nancy/0000-0002-1158-0608; McDermott, Ultan/0000-0001-9032-4700	LUNGevity Foundation; Goldman Philanthropic; NIH [RO1CA115830, P20 CA090578]; NATIONAL CANCER INSTITUTE [P20CA090578, P50CA090578, R01CA115830] Funding Source: NIH RePORTER	LUNGevity Foundation; Goldman Philanthropic; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the members of the Settleman laboratory, Luisa Di Stefano, Daniel Haber, and Kurt Isselbacher for helpful discussions through the course of these studies. We also thank Lisa Drew and Jeff Hanke (AstraZeneca) for providing AZ628; James Christensen (Pfizer) for providing PF-2341066; Robert Schlegel (Novartis) for providing AEW541; Jeff Engelman for providing the drug-resistant HCC827 cells; and Toshi Shioda for providing shRNA plasmids and performing gene expression array analysis. This work was supported by an award from the LUNGevity Foundation and Goldman Philanthropic Partnerships to S. V. S. and NIH RO1CA115830 and NIH P20 CA090578 to J. S.	Ahmed S, 2004, MOL CELL BIOL, V24, P3660, DOI 10.1128/MCB.24.9.3660-3669.2004; Baege AC, 2004, J VIROL, V78, P5720, DOI 10.1128/JVI.78.11.5720-5727.2004; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Buck E, 2008, CANCER RES, V68, P8322, DOI 10.1158/0008-5472.CAN-07-6720; Cara S, 2001, ANN ONCOL, V12, P23, DOI 10.1023/A:1008389706725; Casa AJ, 2008, FRONT BIOSCI-LANDMRK, V13, P3273, DOI 10.2741/2925; Chakravarti A, 2002, CANCER RES, V62, P200; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Dallas NA, 2009, CANCER RES, V69, P1951, DOI 10.1158/0008-5472.CAN-08-2023; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; Eckstein N, 2009, CANCER RES, V69, P2996, DOI 10.1158/0008-5472.CAN-08-3153; Eot-Houllier G, 2009, CANCER LETT, V274, P169, DOI 10.1016/j.canlet.2008.06.005; ERNST M, 1990, ENDOCRINOLOGY, V127, P807, DOI 10.1210/endo-127-2-807; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; FATTAEY AR, 1993, ONCOGENE, V8, P3149; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Garcia-Echeverria C, 2004, CANCER CELL, V5, P231, DOI 10.1016/S1535-6108(04)00051-0; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Glasspool RM, 2006, BRIT J CANCER, V94, P1087, DOI 10.1038/sj.bjc.6603024; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Ji HB, 2006, CANCER CELL, V9, P485, DOI 10.1016/j.ccr.2006.04.022; Kang MK, 2007, STEM CELLS DEV, V16, P837, DOI 10.1089/scd.2007.0006; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Kurata T, 2004, ANN ONCOL, V15, P173, DOI 10.1093/annonc/mdh006; Lan F, 2008, CURR OPIN CELL BIOL, V20, P316, DOI 10.1016/j.ceb.2008.03.004; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Quinlan MP, 2008, MOL CELL BIOL, V28, P2659, DOI 10.1128/MCB.01661-07; Redmond KM, 2008, FRONT BIOSCI-LANDMRK, V13, P5138, DOI 10.2741/3070; Rothenberg SM, 2008, P NATL ACAD SCI USA, V105, P12480, DOI 10.1073/pnas.0803217105; Secombe J, 2007, GENE DEV, V21, P537, DOI 10.1101/gad.1523007; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Stewart MH, 2006, NAT METHODS, V3, P807, DOI 10.1038/nmeth939; Trumpp A, 2008, NAT CLIN PRACT ONCOL, V5, P337, DOI 10.1038/ncponc1110; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Yano S, 2005, ONCOL RES, V15, P107, DOI 10.3727/096504005775082020	42	1584	1642	3	130	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2010	141	1					69	80		10.1016/j.cell.2010.02.027	http://dx.doi.org/10.1016/j.cell.2010.02.027			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	577GS	20371346	Green Accepted, Bronze			2022-12-28	WOS:000276211100013
J	Venter, JC				Venter, J. Craig			Multiple personal genomes await	NATURE			English	Editorial Material							SEQUENCE		J Craig Venter Inst, La Jolla, CA 92121 USA	J. Craig Venter Institute	Venter, JC (corresponding author), J Craig Venter Inst, La Jolla, CA 92121 USA.	jcventer@jcvi.org						Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	7	89	97	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 1	2010	464	7289					676	677		10.1038/464676a	http://dx.doi.org/10.1038/464676a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	577EO	20360717	Bronze			2022-12-28	WOS:000276205000019
